<SEC-DOCUMENT>0001356090-22-000006.txt : 20220509
<SEC-HEADER>0001356090-22-000006.hdr.sgml : 20220509
<ACCEPTANCE-DATETIME>20220509161945
ACCESSION NUMBER:		0001356090-22-000006
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		105
CONFORMED PERIOD OF REPORT:	20220331
FILED AS OF DATE:		20220509
DATE AS OF CHANGE:		20220509

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PRECIGEN, INC.
		CENTRAL INDEX KEY:			0001356090
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			VA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36042
		FILM NUMBER:		22905295

	BUSINESS ADDRESS:	
		STREET 1:		20374 SENECA MEADOWS PARKWAY
		CITY:			GERMANTOWN
		STATE:			MD
		ZIP:			20876
		BUSINESS PHONE:		301-556-9900

	MAIL ADDRESS:	
		STREET 1:		20374 SENECA MEADOWS PARKWAY
		CITY:			GERMANTOWN
		STATE:			MD
		ZIP:			20876

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	INTREXON CORP
		DATE OF NAME CHANGE:	20060313
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>pgen-20220331.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:ee4b2abd-b2ae-467e-99f1-1b489525c45b,g:388a974a-f6e3-4fd9-acf5-6762aafe5cec,d:7169a803a6aa44ea981603d220cab84f--><html xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns="http://www.w3.org/1999/xhtml" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:pgen="http://www.dna.com/20220331" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>pgen-20220331</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80L2ZyYWc6Y2QyM2MxODljN2Y5NGFmNGEyZmJlMjE5ZTBmMWE4MzIvdGFibGU6ZjE0NzNhMjMyNzgyNGE5NTg2NjQ2MGQwMjE0OTg3YTEvdGFibGVyYW5nZTpmMTQ3M2EyMzI3ODI0YTk1ODY2NDYwZDAyMTQ5ODdhMV8zLTEtMS0xLTE1NjA0_00eb5578-c45f-42f5-ba78-e4c0e9a5e5ed">false</ix:nonNumeric><ix:nonNumeric contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80L2ZyYWc6Y2QyM2MxODljN2Y5NGFmNGEyZmJlMjE5ZTBmMWE4MzIvdGFibGU6ZjE0NzNhMjMyNzgyNGE5NTg2NjQ2MGQwMjE0OTg3YTEvdGFibGVyYW5nZTpmMTQ3M2EyMzI3ODI0YTk1ODY2NDYwZDAyMTQ5ODdhMV80LTEtMS0xLTE1NjA0_f0540bf5-3a61-4469-857c-a5b9cb37f076">2022</ix:nonNumeric><ix:nonNumeric contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80L2ZyYWc6Y2QyM2MxODljN2Y5NGFmNGEyZmJlMjE5ZTBmMWE4MzIvdGFibGU6ZjE0NzNhMjMyNzgyNGE5NTg2NjQ2MGQwMjE0OTg3YTEvdGFibGVyYW5nZTpmMTQ3M2EyMzI3ODI0YTk1ODY2NDYwZDAyMTQ5ODdhMV81LTEtMS0xLTE1NjA0_1f929a46-6a32-4bfc-a547-0cbb0b187e86">Q1</ix:nonNumeric><ix:nonNumeric contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80L2ZyYWc6Y2QyM2MxODljN2Y5NGFmNGEyZmJlMjE5ZTBmMWE4MzIvdGFibGU6ZjE0NzNhMjMyNzgyNGE5NTg2NjQ2MGQwMjE0OTg3YTEvdGFibGVyYW5nZTpmMTQ3M2EyMzI3ODI0YTk1ODY2NDYwZDAyMTQ5ODdhMV82LTEtMS0xLTE1NjA0_5cf859e9-8239-4a96-b7d7-22d70ded8aca">0001356090</ix:nonNumeric><ix:nonNumeric contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" name="dei:CurrentFiscalYearEndDate" format="ixt:date-month-day" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80L2ZyYWc6Y2QyM2MxODljN2Y5NGFmNGEyZmJlMjE5ZTBmMWE4MzIvdGFibGU6ZjE0NzNhMjMyNzgyNGE5NTg2NjQ2MGQwMjE0OTg3YTEvdGFibGVyYW5nZTpmMTQ3M2EyMzI3ODI0YTk1ODY2NDYwZDAyMTQ5ODdhMV83LTEtMS0xLTE1NjA0_aead33e0-42b6-4edd-83c8-c9c79f4c2779">12/31</ix:nonNumeric><ix:nonNumeric contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" name="us-gaap:AccountingStandardsUpdateExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOjBhOTMzMGI4ZDdjNjRlNjJhZGYxZjYyOTEyOTcxNzk2L3RhYmxlcmFuZ2U6MGE5MzMwYjhkN2M2NGU2MmFkZjFmNjI5MTI5NzE3OTZfMy0wLTEtMS0yNzgyOA_dceab1cb-aeda-411c-b999-aa5bab34bbb4">http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate202006Member</ix:nonNumeric><ix:nonNumeric contextRef="i8598f9bdba3a401d83a4f654f841906a_D20180701-20180731" name="pgen:ShareLendingAgreementLengthOfTimeForSharesToBeReturnedUponTermination" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83My9mcmFnOmM1ZGIyMTNkZWJkZjRlMzA5OGU3ODI0MjJjNjU2ZTg5L3RleHRyZWdpb246YzVkYjIxM2RlYmRmNGUzMDk4ZTc4MjQyMmM2NTZlODlfMTA3OA_34a88b8d-8f7c-4b2a-8636-4d319d40194f">P5D</ix:nonNumeric><ix:nonNumeric contextRef="ia09e6a5c583541aba441ce841c40debc_I20220331" name="us-gaap:LesseeOperatingLeaseRemainingLeaseTerm" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83OS9mcmFnOjgxNjNjNDA5NjZlOTQxMTdhMzUxODA5ZTdhYWE0ZDRkL3RleHRyZWdpb246ODE2M2M0MDk2NmU5NDExN2EzNTE4MDllN2FhYTRkNGRfMzQw_862490a9-7afa-4299-a0ee-2b7d4d6c6c09">P1Y</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="pgen-20220331.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idd1a990cf89548329a16f155a243b641_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i1449114c17b04272b57978d40430259c_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="if864bcd9dba1429abb391816fd5eca4a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2d74b8a9aabd40c7b32c2739892226f3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">pgen:RelatedPartiesAggregatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0af1a8b31e524c11a45ac7677dc93883_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">pgen:RelatedPartiesAggregatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i4c74e34c64854220ad796ce8372be421_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie204f1c632a1470eb0dd741618a1aadb_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic80f3fa4ad914e09aed3f5c24de3aa03_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i553b0d1d547844e597e5fce605969c48_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i999d1a77cd4548c9868b086286dd0c31_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7bb2ea92baa54c14ac275f16ff730de2_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i436ff3c3e4284ab2abb2d891f39c72e5_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pgen:OtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic08aaf9f98534b94a2b999b85acdb0cd_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pgen:OtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b33b3bdd85544d6853b80b9b9363fdc_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica51236575994a4ab8e30322fc2f55a4_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic68a1c0debad4505be9f262586727573_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8630822867d746dcb299e334c2f62bb2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic1386437e5414589a78d1e1f9863e05e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9419bc7141e84a9d88053ffc38b7a8dd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3be10a01a9624d3ab98ae41d043b6197_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7abd6540a1a64f77872b8ddc7e797fff_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d0633214e1c47539bd414801031b325_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5814e59f587a427ca84c1523af21ce68_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibf63cfed8810400aacf2e390e0bc4982_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifac0484be833462696c138be338f4ac6_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8fddc81d9d8244a98bf2f57ae43c0bae_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1795fa79607445cbc20904ee4dda36d_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idc509430d95b4d7eb55ea6c26d1c41c3_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia10c8c844d4940a3b0ebde37f5f75f25_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6855b33dd4b34c1793117831d12003ea_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64c8fed916fd4230bfb10137e40b9037_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia32c9ea65a164766b40eee00dd09cb45_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7048090cfae14c5c8420c6cad3ffd931_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6fad92c0b19f40d8b718694baf49e9b0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i54a90f374db746b78de00be9871944ac_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i71fe82fdf1f84583b3319fa0acac22be_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic2060c890f6b479aab80d7691e262567_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0dd2258d887948a091305e7302f4f7ed_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia65599dbd22c42928733e6325a88a14e_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibbe9dcfa0a15492fae0547b188e7d154_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i943c56b57428465184de8ac8b4b0a16a_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd2510608a8747ddbc103832b4650fb2_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae096e93867e42a99d564859635c4326_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if7b79aae0fa241fb908efc36ca29e3d3_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i13ea040140e440418a940e8363605b6b_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ied4a3135345f415ca6385fc1d425993e_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf47d6aef2e44be1a923ae69756f5dae_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5aabaff5f1154c5891d0a750ae3d1e8f_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ae4da9032b64f15ae1225c9f68e0a94_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i37cfff500eac4815a708c1afd75ce14a_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63eddf4feb1441d8920e87a7e333621c_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d80cdb2ed0f480faecf8cdc7f92f497_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i026820ce93f04afc9c498f6af35f806b_I20220101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006RetrospectiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf421d5fc50e4e85892b55cbde212eab_I20220101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006RetrospectiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f92c06e9bad430cac755e9610e9f9b5_I20220101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006RetrospectiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia9d87a352497452f99e9459f9be7d3fa_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006RetrospectiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icdf8637396524cf1ace92d8e586b1a80_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfByMeansOtherThanSaleAbandonmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">pgen:MBPTitanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if6cb7e8397b34ee6a457ba010484ed09_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfByMeansOtherThanSaleAbandonmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">pgen:MBPTitanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c206d84156440a49a72497604ec8972_D20140301-20140331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pgen:IntrexonEnergyPartnersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2014-03-01</xbrli:startDate><xbrli:endDate>2014-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e48cd233bc847118ac00256b671c120_I20140331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">pgen:IntrexonEnergyPartnersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2014-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i06c7dcadcbde427c93346762e97a9ff8_D20140301-20140331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">pgen:IntrexonEnergyPartnersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2014-03-01</xbrli:startDate><xbrli:endDate>2014-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i116e7745d66e431e9372cd8064a125ac_I20140331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">pgen:IntrexonEnergyPartnersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2014-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia8700e0f55454cbba3fb9fd96a94fbbb_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">pgen:IntrexonEnergyPartnersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="board_seat"><xbrli:measure>pgen:board_seat</xbrli:measure></xbrli:unit><xbrli:context id="i3f3182d245524e2f81bd8b3e49a24b72_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">pgen:OtherAccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">pgen:IntrexonEnergyPartnersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic5473cecc9e948a696238d2b93f19451_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">pgen:OtherAccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">pgen:IntrexonEnergyPartnersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icbe6e461c61143b794043bae863a8df6_D20151201-20151231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pgen:IntrexonEnergyPartnersIILLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2015-12-01</xbrli:startDate><xbrli:endDate>2015-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib9f1d3ecd2254255a55eaec2585ccedb_I20151231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">pgen:IntrexonEnergyPartnersIILLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2015-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ae9c5a2b8e94b08b425df57ed7b8b69_D20151201-20151231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">pgen:IntrexonEnergyPartnersIILLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2015-12-01</xbrli:startDate><xbrli:endDate>2015-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iab1aff7710f9412391af1e5fd6967099_I20151231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">pgen:IntrexonEnergyPartnersIILLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2015-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iebe277ea9243444d8b84ba5c80f13e43_D20151201-20151231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">pgen:IntrexonEnergyPartnersIILLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">pgen:AllInvestorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2015-12-01</xbrli:startDate><xbrli:endDate>2015-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i68a8c3e611e7457496584dcd01bb9d77_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">pgen:IntrexonEnergyPartnersIILLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i66b17135fbc04c12a62fb56fd2cabc18_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">pgen:OtherAccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">pgen:IntrexonEnergyPartnersIILLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1cd2167114c44a24bb2c013a330df7c4_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">pgen:OtherAccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">pgen:IntrexonEnergyPartnersIILLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie03a332075e24203bc226247706f4c0b_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pgen:CastleCreekBiosciencesIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d962f9fc84242dfaab1b8772723f495_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pgen:CastleCreekBiosciencesIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b919455fac14c5b89317ce54cc48c01_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pgen:OtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie1435bc431da4d2fbeee0800a5bb6070_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pgen:OtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ee3165dd570445e98d48bc112a7c856_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57c5cf448af9439d8ce80e1a7c173246_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic5c07296b0ad4a3795796cdd98b70bfe_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">pgen:UpfrontAndMilestonePaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63f44e56a2d54df9a4c54a505c5e504c_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">pgen:UpfrontAndMilestonePaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie8e1602cebb942fe9f1248b8494a1a7d_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pgen:IntrexonEnergyPartnersLLAndIntrexonEnergyPartnersIILLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i59e18c9f66844d49a7936ec00a3794ef_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5d4f45253f074c3c817131697acd88c6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b9d5326a05846d7a58b2f6cf8712aa2_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pgen:PrepaidProductAndServiceRevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87bf374ed035409bafb6050993401656_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pgen:PrepaidProductAndServiceRevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0fb51aa6c5ef4219b2b7da5ce705fc81_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pgen:DeferredRevenueOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie776f343946740da9a363c1b9559d961_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pgen:DeferredRevenueOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a7efd03f87243c8b506adee6b95d76e_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib61d2084282545aeadc53945fd070cea_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i138b7762559a4bd0bef0907b1fc149a0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e69243d3b7549888b5f4fb6f0bb9475_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8efdfb34bb074c228a7b56cd68c54e92_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i21f7dad991b3443cabf8b801717a7102_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i872f3add0d1843ac827dc54132c0479a_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i19f61ce6754f4459a9aef0d9e6199717_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7c555a88343545dd9e8dbf1fba6af596_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i852b481436844bb180bbb9ccb677b04e_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i93715ce18b404d1e829abbd13ffd87fa_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c91bed02b6948bc8b34c10b4ed941d8_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd71ea23afbd46ddbe3c2deffaf893b0_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if8a7409f0d5e4c7aac820b7c228efe86_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i271b0c1c542f467982ba61825dd48dd5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied4c7ca414574920a941d3fac029e286_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i531349a928d146fa9cfde02f1ec3e68f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb99f08c2199410b935f7e65fbd62cb9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie74b31c2e1fd45cdacc1a2277e851ddc_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i09a9ddaf3caa4498b7f5d33b60e82854_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0c064cf87f8c47afbfc9a5d1fbd79533_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia1c952fbceb14ed981c1efbc9b58c1f5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if6f497049bf74c16a1396dfc4d1e650a_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pgen:A3.5ConvertibleNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e4b384138dc464ea318892a265c9e5f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pgen:A3.5ConvertibleNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie8e3dddd71c4443985fe28d70f1e2c9a_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PublicUtilitiesInventoryAxis">pgen:SuppliesEmbryosAndOtherProductionMaterialsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3940f9d38d364dccb21e61d867617045_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PublicUtilitiesInventoryAxis">pgen:SuppliesEmbryosAndOtherProductionMaterialsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf3c07cd4a91470ba7f63dbc88e4bc6a_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PublicUtilitiesInventoryAxis">pgen:WorkInProcessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i92fec9005efa4d79987abea15d951226_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PublicUtilitiesInventoryAxis">pgen:WorkInProcessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i42bf8b0d2e814be082d3b0bf6da63af4_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PublicUtilitiesInventoryAxis">pgen:LivestockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iecc97711a44b47019e38b94af754e168_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PublicUtilitiesInventoryAxis">pgen:LivestockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i22be83bf68b14b30a42ca5908e204306_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PublicUtilitiesInventoryAxis">pgen:FeedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5527892baeab40f6a59e15f38b3b3dc4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PublicUtilitiesInventoryAxis">pgen:FeedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="reporting_unit"><xbrli:measure>pgen:reporting_unit</xbrli:measure></xbrli:unit><xbrli:context id="i677ca2bcecca4536be4af0d96b5861f8_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i35dfe924439843b5af0a65df16408eaa_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i93a0684a8757410bb11d784429689ade_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2492744906d942a6a9d8a0cdfa3ac7c6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i23dbbf6a562e498c8fa7683328ca8a94_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64684d6563664cf59533e60bfe5b9921_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d132006c1d145eaac64d45ccb86b656_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">pgen:FirstNationalBankofOmahaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">pgen:TransOvaGeneticsLcMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i19a165412c0146749eb84baeba26cbf7_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">pgen:FirstNationalBankofOmahaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">pgen:TransOvaGeneticsLcMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3207747902c548a1a820a9bbe7e15b04_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">pgen:FirstNationalBankofOmahaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">pgen:TransOvaGeneticsLcMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a365a7536554cd6b37d69868458c0ae_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">pgen:ExemplarGeneticsLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">pgen:AmericanStateBankMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i822f03f707534638b1196ee45d5740e2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">pgen:ExemplarGeneticsLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">pgen:AmericanStateBankMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2d8dc6d1111e4706a024929613e40a55_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5d949c0fb90e44e48aa23d89122c630b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i30632d5609ff45ee847fb10488a6417a_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableToBanksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4adfe5f20a0a4ef987ffe40825f234ad_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableToBanksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib33f36cb52e14c6e8a14e68692d39463_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">pgen:OtherLongTermDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia99a2463349745cc99f7555e4c6a7a5d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">pgen:OtherLongTermDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9756753ac1d54cf49cebd859fa402242_I20180731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pgen:A3.5ConvertibleNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36c9e83acbc5433596f7bc29c25d3981_D20180701-20180731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pgen:A3.5ConvertibleNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2018-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i78bbba80cecb4e08a63655e020bbcd37_D20180701-20180731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pgen:A3.5ConvertibleNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2018-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="day"><xbrli:measure>pgen:day</xbrli:measure></xbrli:unit><xbrli:context id="i3c051e9f9a3d440f9f4a49368f5c7480_D20180701-20180731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pgen:A3.5ConvertibleNotesDue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2018-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i735cf6b5a38a4c71b70373ae0908abde_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pgen:A3.5ConvertibleNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c9c4caf2a40476d8e1647cd3cd7dab5_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pgen:A3.5ConvertibleNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib8940548e4f34495a851495a8177a0e5_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableToBanksMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">pgen:AmericanStateBankMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">pgen:TransOvaGeneticsLcMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4eac7d5551844a73b17f500e6471b7d6_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableToBanksMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">pgen:AmericanStateBankMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">pgen:TransOvaGeneticsLcMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic4808534316144d29d8b9683055df43b_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i30c081f8014842aabc417374b020f10a_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i72d8140387894893965c60c951b48995_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i942228f442bc4c7185a791f7d76e9464_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1fd4ac078b6b4bd3b73092a493efc484_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a7f574cfb2544578c335065e1d56a9c_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">pgen:GeneratedAfter2017Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied3594fa3f424f1284f8857f0f9d9e48_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie2a968b6094d45cda5605e526b7e92bf_D20210101-20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8598f9bdba3a401d83a4f654f841906a_D20180701-20180731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2018-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i93aa43f8711240658d7f03498645c20e_I20180731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3cffe5138aae46519a9c02056913cbba_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if3b3a8896f5b4e35ac21bb5d15996bf1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i356ed50b56d84ebc908b0db1a4e37562_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib4e65996659d4890b8c61dca95aca459_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2fae103728264503ab2e0c1e85de1fa1_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">pgen:CostOfProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifbf81220cc4d45d9aa7386783cc59848_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">pgen:CostOfProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id10f7e933b844c0c974c05850b687893_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">pgen:CostOfServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5b6126b9ae8a467c975a767e23eefb22_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">pgen:CostOfServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifc7b7a85c17a4f719952d2594387e412_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45c4b76fe6d6445d8c45f82b8265fa07_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd0d01ceff2445fda5c004b555eca6e7_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice47f63e56544bee9874b31fbdaf9439_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i76c7b4e5ff1a48fcadf331282aabc8db_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pgen:PrecigenStockOptionPlan2008PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b18ccdba7b24f00b51da1d09ef35311_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pgen:PrecigenStockOptionPlan2013PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2cb8b077e2f643509dd676e06445a3b0_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pgen:PrecigenStockOptionPlan2013PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i41a9bb8a5068442cb2b3e00d415ced02_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pgen:PrecigenStockOptionPlan2019PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie9b2e87da42e47ccab3223507b32451a_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pgen:PrecigenStockOptionPlan2019PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5431bc10b5384e398f2da6195a9b96c3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pgen:PrecigenStockOptionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifbfcb80618ad460ab47bac77d7292bc6_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pgen:PrecigenStockOptionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib0b5090cc97842718a2c0490412cb4ca_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pgen:PrecigenStockOptionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia76d4feded9342679caddb3d64f9f4ff_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pgen:PrecigenStockOptionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48d145e276444d3888545e838877b8de_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">pgen:ExecutiveChairmanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if5b1b22e280a4090aecc9398d2cdea50_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">pgen:ExecutiveChairmanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id74f0b524f01452d8d2d8d74d2292022_D20200901-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">pgen:ExecutiveChairmanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0af19287e90a415ea59ea804de00d129_D20200901-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">pgen:ExecutiveChairmanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ideb4dd8ae78341f79f57af0fb7ddc27a_D20200901-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">pgen:ExecutiveChairmanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i59bc005983d548a9b090b14a8066e997_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">pgen:ExecutiveChairmanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5189760c78094b18a54d1b9ae10c326e_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">pgen:ExecutiveChairmanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia09e6a5c583541aba441ce841c40debc_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id3592de1ea59450cab6771569bdb2819_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e1e4f70ee384bbdbc72a4af43c0088e_D20201201-20201201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pgen:XYLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">pgen:LicensingAndPatentInfringementSuitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-01</xbrli:startDate><xbrli:endDate>2020-12-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="claim"><xbrli:measure>pgen:claim</xbrli:measure></xbrli:unit><xbrli:context id="i4e403613e684438d80d697b08493e995_I20201130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pgen:XYLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">pgen:LicensingAndPatentInfringementSuitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i531c6a806994442783b99222cf391d82_I20161231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pgen:XYLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">pgen:LicensingAndPatentInfringementSuitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i92eb050585b540e3800cec27efae3099_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pgen:XYLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">pgen:LicensingAndPatentInfringementSuitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="patent"><xbrli:measure>pgen:patent</xbrli:measure></xbrli:unit><xbrli:context id="i6c06e66e33bb485785e90d05f2a08b59_D20200901-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">pgen:MethaneBioconversionPlatformDisclosuresMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pgen:SecuritiesAndExchangeCommissionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i95a19f694d074542bcb9b8a97cf37bd8_D20220301-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pgen:IntrexonEnergyPartnersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ae0faf7e643440fae62e6c31bc0d0b0_D20220301-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pgen:IntrexonEnergyPartnersIILLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i23eaa581e78f4aea9ecce173012954db_D20220301-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pgen:IntrexonEnergyPartnersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">pgen:IntrexonEnergyPartnersLLAndIntrexonEnergyPartnersIILLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic7d0ad563c924cf39cfee9ad185abd2d_D20220301-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">pgen:IntrexonEnergyPartnersLLAndIntrexonEnergyPartnersIILLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pgen:IntrexonEnergyPartnersIILLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i87cc2f18c9f0471f8bc8ab42417029c1_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pgen:IntrexonEnergyPartnersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i823414b73a894b4b82ccc11ca83d746e_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pgen:IntrexonEnergyPartnersIILLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib9c7f0031bb24fe38f91d5540eda5855_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">pgen:ThirdSecurityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">pgen:ExecutiveChairmanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i65e674d88ff54f86a6d42d5a8329e35c_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">pgen:ThirdSecurityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i033c578bc61340d6be52ccd5a2c876ac_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">pgen:ThirdSecurityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac54c563a6c7429ebca9d25950c5a88a_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pgen:BiopharmaceuticalsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i130e7434090749d3927853a57ecb1485_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pgen:BiopharmaceuticalsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic90cdb87070e4510bfb77391109bd015_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pgen:ExemplarSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1379bdeed3124397a5045d15e0c107f8_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pgen:ExemplarSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie637642bb2524234aedb229fe66afbf3_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pgen:TransOvaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ida88d53a25ce48349d9f4162d6b088a5_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pgen:TransOvaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia48b472a445a4200a8254bcce2227a72_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pgen:ReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5e8ae689a8804c098cef0e54bd63c3ef_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pgen:ReportableSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f12f7718c574755bd4056b0eb47020b_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d2c97b816ee436cb18d90482a754e10_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c2fe0628bc145c2966d9bc2ce259b60_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">pgen:UpfrontAndMilestonePaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6841cb0561af477da53d5c395af9e6cc_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">pgen:UpfrontAndMilestonePaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i576c4b11dd9b44298653de992854ba4e_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">pgen:CorporateAndReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i72f2477327d94768809a6aa578dd8221_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">pgen:CorporateAndReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifa062aac5f0147e2a1dfff1ad00a491c_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i64f363e45b3f4b5f871a0d7d9ea6ca4f_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6408cfb01bd44cebadc3b26397941b33_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc375dc8cd7b45b48cfab364c5a82fa5_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b3c7721f0ef415c9513b33bb836c7ee_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pgen:BiopharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ac6979a51bb4a92b3b04995d0432dbc_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pgen:ExemplarSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8edc30ca4e6f4b8993b2065b289bfbd5_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pgen:TransOvaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i04211b6ebbd848dda476f17cf818169c_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pgen:BiopharmaceuticalsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie2bd06ad475c4200a82ace0d4ad7872d_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pgen:ExemplarSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie8790f324a3d408fb7149e93f1d33708_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pgen:TransOvaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9051a486c0e7466bac7d683d545e64a6_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pgen:BiopharmaceuticalsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i31eca9c164994ce3ad55697fdabbc18f_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pgen:ExemplarSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7aee8cbc73ec4aad80c7b5ec0d52e55c_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pgen:TransOvaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i13cba4a8d5c742ce8d33b04cbd96f97a_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pgen:BiopharmaceuticalsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i87b549534d7048538c9a43c0eba0ccc2_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pgen:ExemplarSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0cfc596ca5a04165b80a4b0e08e40e65_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pgen:TransOvaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if3a5fe3120f24eb38dace9b8bfea5b2f_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">pgen:EliminationsAndReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ied5b0b30354b46978a4d414674afd3d4_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">pgen:EliminationsAndReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idbeb7dcf502e424db307e185fd1e576a_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i46d345a1060047b6af3e5f2700f3127b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idec0f08a8c3d49fc821a1cf2c9544f25_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id6db753435f04670b618c70cb75e3463_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001356090</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i7169a803a6aa44ea981603d220cab84f_1"></div><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_7">Table of Contents</a></span></div></div><div style="margin-top:4pt;text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="15" style="border-bottom:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:15pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM&#160;<ix:nonNumeric contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xL2ZyYWc6OTE2N2U0MzAyNTBlNGY2ZDk5MjAwMDUyMmIyZmMzZGUvdGV4dHJlZ2lvbjo5MTY3ZTQzMDI1MGU0ZjZkOTkyMDAwNTIyYjJmYzNkZV8yMDY3_fb891eea-c5a8-45d8-b09c-01636fc415d7">10-Q</ix:nonNumeric></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.044%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" name="dei:DocumentQuarterlyReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xL2ZyYWc6OTE2N2U0MzAyNTBlNGY2ZDk5MjAwMDUyMmIyZmMzZGUvdGFibGU6Nzg1ZTE5MTBkZmFmNDlkOGE1OWFmMWVjMTk3ZDdhMTgvdGFibGVyYW5nZTo3ODVlMTkxMGRmYWY0OWQ4YTU5YWYxZWMxOTdkN2ExOF8wLTAtMS0xLTE1NjA0_a92e52d0-5933-4d9e-ac4d-86e37fae7ab2">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xL2ZyYWc6OTE2N2U0MzAyNTBlNGY2ZDk5MjAwMDUyMmIyZmMzZGUvdGV4dHJlZ2lvbjo5MTY3ZTQzMDI1MGU0ZjZkOTkyMDAwNTIyYjJmYzNkZV8xMjM_c1cb6a61-06ea-4340-86f5-63a46eb15b3f">March&#160;31, 2022</ix:nonNumeric> </span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OR</span></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.044%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xL2ZyYWc6OTE2N2U0MzAyNTBlNGY2ZDk5MjAwMDUyMmIyZmMzZGUvdGFibGU6MGNjMTRhNmFiNzdmNDNiOTkyYjEyOWE4NzQ0YjUwNGUvdGFibGVyYW5nZTowY2MxNGE2YWI3N2Y0M2I5OTJiMTI5YTg3NDRiNTA0ZV8wLTAtMS0xLTE1NjA0_30d6d371-c573-4f86-ae7c-8d439237ae3c">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.</span></div><div style="margin-bottom:9pt;margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission File Number: <ix:nonNumeric contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xL2ZyYWc6OTE2N2U0MzAyNTBlNGY2ZDk5MjAwMDUyMmIyZmMzZGUvdGV4dHJlZ2lvbjo5MTY3ZTQzMDI1MGU0ZjZkOTkyMDAwNTIyYjJmYzNkZV8yMDY4_54993760-416a-4268-8fdf-c002494f5061">001-36042</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xL2ZyYWc6OTE2N2U0MzAyNTBlNGY2ZDk5MjAwMDUyMmIyZmMzZGUvdGV4dHJlZ2lvbjo5MTY3ZTQzMDI1MGU0ZjZkOTkyMDAwNTIyYjJmYzNkZV8yMDY5_e6496588-ac7c-4568-a7d2-4138eeea2c80">PRECIGEN, INC.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.748%"><tr><td style="width:1.0%"></td><td style="width:18.511%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.571%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.684%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.743%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.891%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xL2ZyYWc6OTE2N2U0MzAyNTBlNGY2ZDk5MjAwMDUyMmIyZmMzZGUvdGFibGU6MzAyZGI2MzM5OGZhNGJjOGI0MWYwZDJmZWYxYTIyZjIvdGFibGVyYW5nZTozMDJkYjYzMzk4ZmE0YmM4YjQxZjBkMmZlZjFhMjJmMl8wLTEtMS0xLTE1NjA0_801d34bc-e44f-4ea5-af4f-fd300e60773f">Virginia</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xL2ZyYWc6OTE2N2U0MzAyNTBlNGY2ZDk5MjAwMDUyMmIyZmMzZGUvdGFibGU6MzAyZGI2MzM5OGZhNGJjOGI0MWYwZDJmZWYxYTIyZjIvdGFibGVyYW5nZTozMDJkYjYzMzk4ZmE0YmM4YjQxZjBkMmZlZjFhMjJmMl8wLTQtMS0xLTE1NjA0_15be6bf0-fc5b-4710-bc91-7cd64e44d3a2">26-0084895</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(State or other jurisdiction of<br/>incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(I.R.S. Employer<br/>Identification Number)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xL2ZyYWc6OTE2N2U0MzAyNTBlNGY2ZDk5MjAwMDUyMmIyZmMzZGUvdGFibGU6MzAyZGI2MzM5OGZhNGJjOGI0MWYwZDJmZWYxYTIyZjIvdGFibGVyYW5nZTozMDJkYjYzMzk4ZmE0YmM4YjQxZjBkMmZlZjFhMjJmMl8zLTEtMS0xLTE1NjA0_82b29ef8-087e-458f-882b-860e03c02647">20374 Seneca Meadows Parkway</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xL2ZyYWc6OTE2N2U0MzAyNTBlNGY2ZDk5MjAwMDUyMmIyZmMzZGUvdGFibGU6MzAyZGI2MzM5OGZhNGJjOGI0MWYwZDJmZWYxYTIyZjIvdGFibGVyYW5nZTozMDJkYjYzMzk4ZmE0YmM4YjQxZjBkMmZlZjFhMjJmMl80LTEtMS0xLTE1NjA0_86588631-850c-4afa-966c-ef8248866aa2">Germantown,</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xL2ZyYWc6OTE2N2U0MzAyNTBlNGY2ZDk5MjAwMDUyMmIyZmMzZGUvdGFibGU6MzAyZGI2MzM5OGZhNGJjOGI0MWYwZDJmZWYxYTIyZjIvdGFibGVyYW5nZTozMDJkYjYzMzk4ZmE0YmM4YjQxZjBkMmZlZjFhMjJmMl80LTItMS0xLTE1NjA0_47df00ae-262d-46de-a706-bb7860e6c284">Maryland</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xL2ZyYWc6OTE2N2U0MzAyNTBlNGY2ZDk5MjAwMDUyMmIyZmMzZGUvdGFibGU6MzAyZGI2MzM5OGZhNGJjOGI0MWYwZDJmZWYxYTIyZjIvdGFibGVyYW5nZTozMDJkYjYzMzk4ZmE0YmM4YjQxZjBkMmZlZjFhMjJmMl80LTQtMS0xLTE1NjA0_f59f0192-b2df-4c8b-b54d-79bcc1fa95c6">20876</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Zip Code)</span></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xL2ZyYWc6OTE2N2U0MzAyNTBlNGY2ZDk5MjAwMDUyMmIyZmMzZGUvdGV4dHJlZ2lvbjo5MTY3ZTQzMDI1MGU0ZjZkOTkyMDAwNTIyYjJmYzNkZV8yMDcw_cc94fbe3-71d7-4750-994a-dd3765021dce">301</ix:nonNumeric>) <ix:nonNumeric contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xL2ZyYWc6OTE2N2U0MzAyNTBlNGY2ZDk5MjAwMDUyMmIyZmMzZGUvdGV4dHJlZ2lvbjo5MTY3ZTQzMDI1MGU0ZjZkOTkyMDAwNTIyYjJmYzNkZV8yMDcx_fe950010-d5c9-44c2-8d81-a8157d8906e8">556-9900</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Registrant's telephone number, including area code)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">N/A</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Former name, former address and former fiscal year, if changed since last report)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Exchange Act:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.721%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.556%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.668%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.410%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.945%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xL2ZyYWc6OTE2N2U0MzAyNTBlNGY2ZDk5MjAwMDUyMmIyZmMzZGUvdGFibGU6YTc1YzI0Y2ViZjk3NGI4MjlhYjI3MGQ3ZDI0ZWFlY2UvdGFibGVyYW5nZTphNzVjMjRjZWJmOTc0YjgyOWFiMjcwZDdkMjRlYWVjZV8xLTAtMS0xLTE1NjA0_f2463e05-5130-48ab-83ff-c804f6c6c631">Common Stock, no par value</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xL2ZyYWc6OTE2N2U0MzAyNTBlNGY2ZDk5MjAwMDUyMmIyZmMzZGUvdGFibGU6YTc1YzI0Y2ViZjk3NGI4MjlhYjI3MGQ3ZDI0ZWFlY2UvdGFibGVyYW5nZTphNzVjMjRjZWJmOTc0YjgyOWFiMjcwZDdkMjRlYWVjZV8xLTItMS0xLTE1NjA0_fa1dbe16-02c2-4557-8ff5-68f6571ff22e">PGEN</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xL2ZyYWc6OTE2N2U0MzAyNTBlNGY2ZDk5MjAwMDUyMmIyZmMzZGUvdGFibGU6YTc1YzI0Y2ViZjk3NGI4MjlhYjI3MGQ3ZDI0ZWFlY2UvdGFibGVyYW5nZTphNzVjMjRjZWJmOTc0YjgyOWFiMjcwZDdkMjRlYWVjZV8xLTQtMS0xLTE1NjA0_10a4c48e-0410-45f1-b705-c1e969a192d7">Nasdaq Global Select Market</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:10pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d)&#160;of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xL2ZyYWc6OTE2N2U0MzAyNTBlNGY2ZDk5MjAwMDUyMmIyZmMzZGUvdGV4dHJlZ2lvbjo5MTY3ZTQzMDI1MGU0ZjZkOTkyMDAwNTIyYjJmYzNkZV8yMDY0_c2288ba1-b5e5-40b9-9aff-d4e69d2b518e">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:20pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xL2ZyYWc6OTE2N2U0MzAyNTBlNGY2ZDk5MjAwMDUyMmIyZmMzZGUvdGV4dHJlZ2lvbjo5MTY3ZTQzMDI1MGU0ZjZkOTkyMDAwNTIyYjJmYzNkZV8yMDY2_9293dcd7-d699-4e0a-8470-e947ea274d1f">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule&#160;12b-2 of the Exchange Act.</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.730%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.590%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.560%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.581%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xL2ZyYWc6OTE2N2U0MzAyNTBlNGY2ZDk5MjAwMDUyMmIyZmMzZGUvdGFibGU6ZjJiMWVhNzU1YWU1NDUxODkwODQwYTU4MzhhOTc2ZDQvdGFibGVyYW5nZTpmMmIxZWE3NTVhZTU0NTE4OTA4NDBhNTgzOGE5NzZkNF8wLTAtMS0xLTI3ODQ0_76d83332-2e86-4388-a236-de2fba2eb596">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smaller&#160;reporting&#160;company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xL2ZyYWc6OTE2N2U0MzAyNTBlNGY2ZDk5MjAwMDUyMmIyZmMzZGUvdGFibGU6ZjJiMWVhNzU1YWU1NDUxODkwODQwYTU4MzhhOTc2ZDQvdGFibGVyYW5nZTpmMmIxZWE3NTVhZTU0NTE4OTA4NDBhNTgzOGE5NzZkNF8yLTYtMS0xLTE1NjA0_00bc9370-bbe3-4179-9dc8-96f83e2c33c0">&#9744;</ix:nonNumeric></span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xL2ZyYWc6OTE2N2U0MzAyNTBlNGY2ZDk5MjAwMDUyMmIyZmMzZGUvdGFibGU6ZjJiMWVhNzU1YWU1NDUxODkwODQwYTU4MzhhOTc2ZDQvdGFibGVyYW5nZTpmMmIxZWE3NTVhZTU0NTE4OTA4NDBhNTgzOGE5NzZkNF80LTYtMS0xLTE1NjA0_63943451-1922-477a-897d-ca16ef8d0e1f">&#9744;</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:9pt;margin-top:10pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule&#160;12b-2 of the Exchange Act).&#160;&#160;&#160;&#160;Yes&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" name="dei:EntityShellCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xL2ZyYWc6OTE2N2U0MzAyNTBlNGY2ZDk5MjAwMDUyMmIyZmMzZGUvdGV4dHJlZ2lvbjo5MTY3ZTQzMDI1MGU0ZjZkOTkyMDAwNTIyYjJmYzNkZV8yMDY1_9e87f6c0-779e-43ed-b9bb-659b903dcbc9">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span></div><div style="margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of April&#160;30, 2022, <ix:nonFraction unitRef="shares" contextRef="idd1a990cf89548329a16f155a243b641_I20220430" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xL2ZyYWc6OTE2N2U0MzAyNTBlNGY2ZDk5MjAwMDUyMmIyZmMzZGUvdGV4dHJlZ2lvbjo5MTY3ZTQzMDI1MGU0ZjZkOTkyMDAwNTIyYjJmYzNkZV8xOTg2_0b741f79-aebc-482c-b99c-5b468f6d7c46">207,693,277</ix:nonFraction> shares of common stock, no par value per share, were issued and outstanding.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i7169a803a6aa44ea981603d220cab84f_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PRECIGEN, INC.</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FORM 10-Q</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:4.178%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.782%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.740%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Item&#160;No.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Page</span></td></tr><tr><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_13">PART I - FINANCIAL INFORMATION</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_16">Condensed Consolidated Financial Statements (unaudited):</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_16">4</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_19">Condensed Consolidated Balance Sheets as of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_19">March</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_19"> 3</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_19">1</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_19">, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_19">2 </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_19">and December&#160;31, 202</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">1</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_19">4</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_22">Condensed Consolidated Statements of Operations for the Three </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_22">Months Ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_22">March</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_22"> 3</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_22">1</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_22">, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_22">2</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_22"> and 202</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">1</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_22">6</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_25">Condensed Consolidated Statements of Comprehensive Loss for the Three</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_25"> Months Ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_25">March</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_25"> 3</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_25">1</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_25">, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_25">2</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_25"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_25">and 202</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">1</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_25">7</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_28">Condensed Consolidated Statements of Shareholders' Equity for the Three </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_28">Months Ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_28">March</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_28"> 3</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_28">1</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_28">, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_28">2</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_28"> and 202</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">1</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_28">8</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_31">Condensed Consolidated Statements of Cash Flows for the </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_31">Three</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_31"> Months Ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_31">March</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_31"> 3</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_31">1</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_31">, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_31">2</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_31"> and 202</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">1</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_31">9</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_34">Notes to the Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_34">11</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_94">Management's Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_94">31</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_97">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_97">44</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_100">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_100">45</a></span></div></td></tr><tr style="height:15pt"><td colspan="9" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_103">PART II - OTHER INFORMATION</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_106">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_106">46</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_109">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_109">46</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_112">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_112">46</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_115">Defaults on Senior Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_115">46</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_118">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_118">46</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_121">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_121">46</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_124">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_124">47</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_127">Signatures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_127">48</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;margin-top:13pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intrexon</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Trans Ova Genetics</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Progentus</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, UltraCAR-T</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, RheoSwitch</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, UltraVector</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, RTS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and RheoSwitch Therapeutic System</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> are our and/or our affiliates' registered trademarks in the United States and ActoBiotics&#8482;, GenVec&#8482;, Precigen&#8482;, AdenoVerse&#8482;, ActoBio Therapeutics&#8482;, UltraPorator&#8482;, AttSite&#8482;, and Precigen Therapeutics&#8482; are our and/or our affiliates' common law trademarks in the United States. This Quarterly Report on Form 10-Q, or Quarterly Report, and the information incorporated herein by reference contain references to trademarks, service marks, and trade names owned by us or other companies. Solely for convenience, trademarks, service marks, and trade names referred to in this Quarterly Report and the information incorporated herein, including logos, artwork, and other visual displays, may appear without the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> or &#8482; symbols, but such references are not intended to indicate, in any way, that we will not assert, to the fullest extent under applicable law, our rights or the rights of the applicable licensor to these trademarks, service marks, and trade names. We do not intend our use or display of other companies' trade names, service marks, or trademarks to imply a relationship with, or endorsement or sponsorship of us by, any other companies. Other trademarks, trade names, and service marks appearing in this Quarterly Report are the property of their respective owners. Unless the context requires otherwise, references in this Quarterly Report to "Precigen", "we", "us", and "our" refer to Precigen, Inc.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i7169a803a6aa44ea981603d220cab84f_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Special Note Regarding Forward-Looking Statements</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Quarterly Report contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which statements involve substantial risks and uncertainties. All statements, other than statements of historical facts, included in this Quarterly Report, including statements regarding our strategy; future events, including their outcome or timing; future operations; future financial position; future revenue; projected costs; prospects; plans; objectives of management; and expected market growth, are forward-looking statements. The words "aim", "anticipate", "assume", "believe", "continue", "could", "due", "estimate", "expect", "intend", "may", "plan", "positioned", "potential", "predict", "project", "seek", "should", "target", "will", "would", and the negatives of these terms or similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. These statements may relate to, among other things: (i) the impact of the COVID-19 pandemic on our clinical trials, businesses, operating results, cash flows, and/or financial condition; (ii) the timeliness of regulatory approvals; (iii) our strategy and overall approach to our business model, our efforts to realign our business, and our ability to exercise more control and ownership over the development process and commercialization path; (iv) our ability to successfully enter new markets or develop additional product candidates, including the expected timing and results of investigational studies and preclinical and clinical trials, including any delays or potential delays as a result of the COVID-19 pandemic, whether with our collaborators or independently; (v) our ability to consistently manufacture our product candidates on a timely basis or to establish agreements with third-party manufacturers; (vi) our ability to successfully enter into optimal strategic relationships with our subsidiaries and operating companies that we may form in the future; (vii) our ability to hold or generate significant operating capital, including through partnering, asset sales, and operating cost reductions; (viii) actual or anticipated variations in our operating results; (ix) actual or anticipated fluctuations in competitors' or collaborators' operating results or changes in their respective growth rates; (x) our cash position; (xi) market conditions in our industry; (xii) the volatility of our stock price; (xiii) the ability, and the ability of our collaborators, to protect our intellectual property and other proprietary rights and technologies; (xiv) our ability, and the ability of our collaborators, to adapt to changes in laws or regulations or policies, including federal, state, and local government responses to the COVID-19 pandemic; (xv) outcomes of pending and future litigation; (xvi) the rate and degree of market acceptance of any products developed by us, our subsidiaries, collaborations, or joint ventures, or JVs, and competition from existing technologies and products or new technologies and products that may emerge; (xvii) our ability to retain and recruit key personnel; (xviii) expectations related to the use of proceeds from public offerings and other financing efforts; (xix) estimates regarding expenses, future revenue, capital requirements, and needs for additional financing; and (xx) the effects, duration, and severity of the ongoing COVID-19 pandemic and the actions we and others have taken or may take in response.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forward-looking statements are based on our beliefs, assumptions, and expectations of our future performance, and may also concern our expectations relating to our subsidiaries and other affiliates. We caution you that the foregoing list may not contain all of the forward-looking statements made in this Quarterly Report.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may not actually achieve the plans, intentions, or expectations disclosed in our forward-looking statements, and you should not place undue reliance on our forward-looking statements. Actual results or events could differ materially from the plans, intentions, and expectations disclosed in the forward-looking statements we make. We have included important factors in the cautionary statements included in this Quarterly Report, particularly in Part II, Item&#160;1A, "Risk Factors," that could cause actual results or events to differ materially from the forward-looking statements that we make. Our forward-looking statements do not reflect the potential impact of any future acquisitions, mergers, dispositions, JVs, or investments that we may make.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You should read this Quarterly Report, the documents that we reference in this Quarterly Report, our Annual Report on Form 10-K for the year ended December&#160;31, 2021, the other reports we have filed with the Securities and Exchange Commission, or SEC, and the documents that we have filed as exhibits to our filings with the SEC completely and with the understanding that our actual future results may be materially different from what we expect. We do not assume any obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i7169a803a6aa44ea981603d220cab84f_13"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I. FINANCIAL INFORMATION</span></div><div id="i7169a803a6aa44ea981603d220cab84f_16"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1. Condensed Consolidated Financial Statements</span></div><div id="i7169a803a6aa44ea981603d220cab84f_19"></div><div style="margin-top:18pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Precigen, Inc. and Subsidiaries</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Balance Sheets</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Amounts in thousands, except share data)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjRlMzYxNzEwNjFjNjRhYzI5ZTM3YTcxYWNkYjYxZDI5L3RhYmxlcmFuZ2U6NGUzNjE3MTA2MWM2NGFjMjllMzdhNzFhY2RiNjFkMjlfMy0xLTEtMS0xNTYwNA_00b8da1b-fab5-45d7-9bdb-8cfc94464932">40,321</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjRlMzYxNzEwNjFjNjRhYzI5ZTM3YTcxYWNkYjYxZDI5L3RhYmxlcmFuZ2U6NGUzNjE3MTA2MWM2NGFjMjllMzdhNzFhY2RiNjFkMjlfMy0zLTEtMS0xNTYwNA_e638ae8c-3978-4ed1-ac22-306932f0b970">42,920</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:ShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjRlMzYxNzEwNjFjNjRhYzI5ZTM3YTcxYWNkYjYxZDI5L3RhYmxlcmFuZ2U6NGUzNjE3MTA2MWM2NGFjMjllMzdhNzFhY2RiNjFkMjlfNS0xLTEtMS0xNTYwNA_032227d7-87f8-46fc-98f3-9de53232f5e1">71,821</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231" decimals="-3" name="us-gaap:ShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjRlMzYxNzEwNjFjNjRhYzI5ZTM3YTcxYWNkYjYxZDI5L3RhYmxlcmFuZ2U6NGUzNjE3MTA2MWM2NGFjMjllMzdhNzFhY2RiNjFkMjlfNS0zLTEtMS0xNTYwNA_a7700db0-65b8-4c93-9c02-ebd2d4f74958">72,240</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade, less allowance for credit losses of $<ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjRlMzYxNzEwNjFjNjRhYzI5ZTM3YTcxYWNkYjYxZDI5L3RhYmxlcmFuZ2U6NGUzNjE3MTA2MWM2NGFjMjllMzdhNzFhY2RiNjFkMjlfOC0wLTEtMS0xNTYwNC90ZXh0cmVnaW9uOjJmNmNiNjBiYzMzOTRhNmE4ZWUxNDNiODRlNzM3OWFhXzQ3_f993ad38-d182-42e3-aa23-a498e3132518">4,631</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjRlMzYxNzEwNjFjNjRhYzI5ZTM3YTcxYWNkYjYxZDI5L3RhYmxlcmFuZ2U6NGUzNjE3MTA2MWM2NGFjMjllMzdhNzFhY2RiNjFkMjlfOC0wLTEtMS0xNTYwNC90ZXh0cmVnaW9uOjJmNmNiNjBiYzMzOTRhNmE4ZWUxNDNiODRlNzM3OWFhXzU0_25d1309a-fa5d-4542-bace-447cbf4b51fe">4,288</ix:nonFraction> as of March&#160;31, 2022 and December&#160;31, 2021, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjRlMzYxNzEwNjFjNjRhYzI5ZTM3YTcxYWNkYjYxZDI5L3RhYmxlcmFuZ2U6NGUzNjE3MTA2MWM2NGFjMjllMzdhNzFhY2RiNjFkMjlfOC0xLTEtMS0xNTYwNA_905b1534-4644-4973-94be-5ed18db78f92">24,308</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjRlMzYxNzEwNjFjNjRhYzI5ZTM3YTcxYWNkYjYxZDI5L3RhYmxlcmFuZ2U6NGUzNjE3MTA2MWM2NGFjMjllMzdhNzFhY2RiNjFkMjlfOC0zLTEtMS0xNTYwNA_030b6476-89bb-42f3-87b5-91536340f815">20,832</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Related parties, less allowance for credit losses of $<ix:nonFraction unitRef="usd" contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231" decimals="-3" name="pgen:RelatedPartyReceivableAllowanceforCreditLossCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjRlMzYxNzEwNjFjNjRhYzI5ZTM3YTcxYWNkYjYxZDI5L3RhYmxlcmFuZ2U6NGUzNjE3MTA2MWM2NGFjMjllMzdhNzFhY2RiNjFkMjlfOS0wLTEtMS0xNTYwNC90ZXh0cmVnaW9uOmIyMzI1NTg5MzNlMDQyNTViZTZkYjkwYzRhZTEyZmIzXzU3_4f0de8dd-3a13-40a8-b8e8-dc22729d5394"><ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="pgen:RelatedPartyReceivableAllowanceforCreditLossCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjRlMzYxNzEwNjFjNjRhYzI5ZTM3YTcxYWNkYjYxZDI5L3RhYmxlcmFuZ2U6NGUzNjE3MTA2MWM2NGFjMjllMzdhNzFhY2RiNjFkMjlfOS0wLTEtMS0xNTYwNC90ZXh0cmVnaW9uOmIyMzI1NTg5MzNlMDQyNTViZTZkYjkwYzRhZTEyZmIzXzU3_c197b940-2cf2-4adf-8c3a-8a4e4105edec">1,509</ix:nonFraction></ix:nonFraction> as of March&#160;31, 2022 and December&#160;31, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:DueFromRelatedPartiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjRlMzYxNzEwNjFjNjRhYzI5ZTM3YTcxYWNkYjYxZDI5L3RhYmxlcmFuZ2U6NGUzNjE3MTA2MWM2NGFjMjllMzdhNzFhY2RiNjFkMjlfOS0xLTEtMS0xNTYwNA_6f5e1c53-b97f-4bb8-bd56-d43860eccfdb">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231" decimals="-3" name="us-gaap:DueFromRelatedPartiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjRlMzYxNzEwNjFjNjRhYzI5ZTM3YTcxYWNkYjYxZDI5L3RhYmxlcmFuZ2U6NGUzNjE3MTA2MWM2NGFjMjllMzdhNzFhY2RiNjFkMjlfOS0zLTEtMS0xNTYwNA_b46f515d-9bbd-4e23-a476-2cc4a6347f0e">73</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:OtherReceivablesNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjRlMzYxNzEwNjFjNjRhYzI5ZTM3YTcxYWNkYjYxZDI5L3RhYmxlcmFuZ2U6NGUzNjE3MTA2MWM2NGFjMjllMzdhNzFhY2RiNjFkMjlfMTEtMS0xLTEtMTU2MDQ_61cf4ee8-0bf7-446e-8bd6-df6ee0a2a564">543</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231" decimals="-3" name="us-gaap:OtherReceivablesNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjRlMzYxNzEwNjFjNjRhYzI5ZTM3YTcxYWNkYjYxZDI5L3RhYmxlcmFuZ2U6NGUzNjE3MTA2MWM2NGFjMjllMzdhNzFhY2RiNjFkMjlfMTEtMy0xLTEtMTU2MDQ_d321c342-b933-407d-b449-d8ced2ad83f8">566</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:InventoryGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjRlMzYxNzEwNjFjNjRhYzI5ZTM3YTcxYWNkYjYxZDI5L3RhYmxlcmFuZ2U6NGUzNjE3MTA2MWM2NGFjMjllMzdhNzFhY2RiNjFkMjlfMTItMS0xLTEtMTU2MDQ_e174490f-c2ef-438b-8a27-196088ec02a8">12,730</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231" decimals="-3" name="us-gaap:InventoryGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjRlMzYxNzEwNjFjNjRhYzI5ZTM3YTcxYWNkYjYxZDI5L3RhYmxlcmFuZ2U6NGUzNjE3MTA2MWM2NGFjMjllMzdhNzFhY2RiNjFkMjlfMTItMy0xLTEtMTU2MDQ_92cd0bdb-cdda-4e2f-aedc-0f6b949efd21">13,261</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjRlMzYxNzEwNjFjNjRhYzI5ZTM3YTcxYWNkYjYxZDI5L3RhYmxlcmFuZ2U6NGUzNjE3MTA2MWM2NGFjMjllMzdhNzFhY2RiNjFkMjlfMTMtMS0xLTEtMTU2MDQ_afd08244-2dfd-47d6-a135-736df0c261c1">5,199</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjRlMzYxNzEwNjFjNjRhYzI5ZTM3YTcxYWNkYjYxZDI5L3RhYmxlcmFuZ2U6NGUzNjE3MTA2MWM2NGFjMjllMzdhNzFhY2RiNjFkMjlfMTMtMy0xLTEtMTU2MDQ_7ddc551d-8dee-4d3f-832e-20a4e3621e6c">6,736</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjRlMzYxNzEwNjFjNjRhYzI5ZTM3YTcxYWNkYjYxZDI5L3RhYmxlcmFuZ2U6NGUzNjE3MTA2MWM2NGFjMjllMzdhNzFhY2RiNjFkMjlfMTUtMS0xLTEtMTU2MDQ_206ade53-a5a9-4a7a-b906-a61954a731b5">154,937</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjRlMzYxNzEwNjFjNjRhYzI5ZTM3YTcxYWNkYjYxZDI5L3RhYmxlcmFuZ2U6NGUzNjE3MTA2MWM2NGFjMjllMzdhNzFhY2RiNjFkMjlfMTUtMy0xLTEtMTU2MDQ_c11127f0-a5f9-4e33-9ab3-3d40a3696a71">156,628</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjRlMzYxNzEwNjFjNjRhYzI5ZTM3YTcxYWNkYjYxZDI5L3RhYmxlcmFuZ2U6NGUzNjE3MTA2MWM2NGFjMjllMzdhNzFhY2RiNjFkMjlfMTYtMS0xLTEtMTU2MDQ_d1b01cbd-f2b0-4e76-a042-7056776dd5a1">29,914</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjRlMzYxNzEwNjFjNjRhYzI5ZTM3YTcxYWNkYjYxZDI5L3RhYmxlcmFuZ2U6NGUzNjE3MTA2MWM2NGFjMjllMzdhNzFhY2RiNjFkMjlfMTYtMy0xLTEtMTU2MDQ_43064f21-e818-4b94-9386-f3de9a46f37b">48,562</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjRlMzYxNzEwNjFjNjRhYzI5ZTM3YTcxYWNkYjYxZDI5L3RhYmxlcmFuZ2U6NGUzNjE3MTA2MWM2NGFjMjllMzdhNzFhY2RiNjFkMjlfMTgtMS0xLTEtMTU2MDQ_ab83efa5-e63a-4824-a963-7e5a8e88ba63">33,583</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjRlMzYxNzEwNjFjNjRhYzI5ZTM3YTcxYWNkYjYxZDI5L3RhYmxlcmFuZ2U6NGUzNjE3MTA2MWM2NGFjMjllMzdhNzFhY2RiNjFkMjlfMTgtMy0xLTEtMTU2MDQ_a26d1361-f9bd-4d84-9653-2adbd9a1427e">34,315</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjRlMzYxNzEwNjFjNjRhYzI5ZTM3YTcxYWNkYjYxZDI5L3RhYmxlcmFuZ2U6NGUzNjE3MTA2MWM2NGFjMjllMzdhNzFhY2RiNjFkMjlfMTktMS0xLTEtMTU2MDQ_f0af5d61-cdd6-4938-8064-c4ccc031f967">51,427</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjRlMzYxNzEwNjFjNjRhYzI5ZTM3YTcxYWNkYjYxZDI5L3RhYmxlcmFuZ2U6NGUzNjE3MTA2MWM2NGFjMjllMzdhNzFhY2RiNjFkMjlfMTktMy0xLTEtMTU2MDQ_e17b6eaa-70b0-4ec5-a40f-8be2dfb671d5">54,115</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjRlMzYxNzEwNjFjNjRhYzI5ZTM3YTcxYWNkYjYxZDI5L3RhYmxlcmFuZ2U6NGUzNjE3MTA2MWM2NGFjMjllMzdhNzFhY2RiNjFkMjlfMjAtMS0xLTEtMTU2MDQ_036ec93c-caa9-4cfa-bd43-9ba8eddf6d3e">53,613</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjRlMzYxNzEwNjFjNjRhYzI5ZTM3YTcxYWNkYjYxZDI5L3RhYmxlcmFuZ2U6NGUzNjE3MTA2MWM2NGFjMjllMzdhNzFhY2RiNjFkMjlfMjAtMy0xLTEtMTU2MDQ_e516ee0a-54d0-4163-ba01-803438dd6559">54,148</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjRlMzYxNzEwNjFjNjRhYzI5ZTM3YTcxYWNkYjYxZDI5L3RhYmxlcmFuZ2U6NGUzNjE3MTA2MWM2NGFjMjllMzdhNzFhY2RiNjFkMjlfMjItMS0xLTEtMTU2MDQ_d819bc1e-4caa-425f-a2f1-d08d129c77ef">10,963</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjRlMzYxNzEwNjFjNjRhYzI5ZTM3YTcxYWNkYjYxZDI5L3RhYmxlcmFuZ2U6NGUzNjE3MTA2MWM2NGFjMjllMzdhNzFhY2RiNjFkMjlfMjItMy0xLTEtMTU2MDQ_d19df57c-31ce-4f6e-bc35-90bd324d3ad7">10,900</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjRlMzYxNzEwNjFjNjRhYzI5ZTM3YTcxYWNkYjYxZDI5L3RhYmxlcmFuZ2U6NGUzNjE3MTA2MWM2NGFjMjllMzdhNzFhY2RiNjFkMjlfMjMtMS0xLTEtMTU2MDQ_69060085-9232-4881-b084-a119f0ea7d22">1,131</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjRlMzYxNzEwNjFjNjRhYzI5ZTM3YTcxYWNkYjYxZDI5L3RhYmxlcmFuZ2U6NGUzNjE3MTA2MWM2NGFjMjllMzdhNzFhY2RiNjFkMjlfMjMtMy0xLTEtMTU2MDQ_5c04024b-0c79-4443-9673-04a75d79057c">1,188</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjRlMzYxNzEwNjFjNjRhYzI5ZTM3YTcxYWNkYjYxZDI5L3RhYmxlcmFuZ2U6NGUzNjE3MTA2MWM2NGFjMjllMzdhNzFhY2RiNjFkMjlfMjQtMS0xLTEtMTU2MDQ_769ebefd-54d2-4008-9589-72b7ecb54b1d">335,568</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjRlMzYxNzEwNjFjNjRhYzI5ZTM3YTcxYWNkYjYxZDI5L3RhYmxlcmFuZ2U6NGUzNjE3MTA2MWM2NGFjMjllMzdhNzFhY2RiNjFkMjlfMjQtMy0xLTEtMTU2MDQ_efb19348-cc7d-421f-8337-a8e3451126bf">359,856</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:7pt;margin-top:13pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Precigen, Inc. and Subsidiaries</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Balance Sheets</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:18pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Amounts in thousands, except share data)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities and Shareholders' Equity</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfMy0xLTEtMS0xNTYwNA_e4d08b23-2f96-47e2-b9ff-79f5fc4cfae9">4,415</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfMy0zLTEtMS0xNTYwNA_15a8e7db-bf37-4907-8389-03d4f14d2a0e">5,405</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation and benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfNC0xLTEtMS0xNTYwNA_a17058b5-fdcc-45c0-8411-9811bef3d29b">6,052</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfNC0zLTEtMS0xNTYwNA_efee86bf-ca2a-4b92-8c01-b6f51e1b0c44">11,223</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfNS0xLTEtMS0xNTYwNA_f376cc6a-0682-41c3-83c4-f0ae24d418e3">10,494</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfNS0zLTEtMS0xNTYwNA_19b21a76-b1e0-48b3-9073-6778320b9309">11,595</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfNi0xLTEtMS0xNTYwNA_fb8ca5b7-9fe3-4112-afc5-edb00be60d7b">2,669</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfNi0zLTEtMS0xNTYwNA_acb0fbeb-abb9-4049-8bef-8508d80866d8">4,442</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:LongTermDebtCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfOC0xLTEtMS0xNTYwNA_b25a94c2-f92c-42d0-884a-6353ac4797dd">355</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231" decimals="-3" name="us-gaap:LongTermDebtCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfOC0zLTEtMS0xNTYwNA_6cb8546e-a5e6-49d4-a3bf-9c2d37bc54e2">402</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfMTAtMS0xLTEtMTU2MDQ_9799016e-b9b5-4df4-b016-769a0df79d2a">1,590</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfMTAtMy0xLTEtMTU2MDQ_2219a016-e32d-421e-85dd-1bf0fcddefcd">1,551</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Related party payables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:DueToRelatedPartiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfMTEtMS0xLTEtMTU2MDQ_998e7a47-007b-4efc-b934-567ddcd1fb92">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231" decimals="-3" name="us-gaap:DueToRelatedPartiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfMTEtMy0xLTEtMTU2MDQ_8e363afc-6548-4b44-aa5f-cdbd1008e25f">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfMTMtMS0xLTEtMTU2MDQ_ca6862de-1507-44d5-85b4-ed45026913ff">25,601</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfMTMtMy0xLTEtMTU2MDQ_0e3b2160-c53b-498e-9f24-3bc96e1360cc">34,645</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, net of current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfMTQtMS0xLTEtMTU2MDQ_a3c810c6-d3a9-43c4-99b9-ff554dad2ef2">201,112</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfMTQtMy0xLTEtMTU2MDQ_59ebb6db-f246-481a-a547-270daa480a2f">182,749</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue, net of current portion, including $<ix:nonFraction unitRef="usd" contextRef="i2d74b8a9aabd40c7b32c2739892226f3_I20211231" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfMTYtMC0xLTEtMTU2MDQvdGV4dHJlZ2lvbjpmNDVlZGI2MjdjNTg0OWEzOGU1OTY3YjQyMTlhNDcyZV81Ng_99ce89f6-56a4-4a88-ae7f-b8503f29c1d3"><ix:nonFraction unitRef="usd" contextRef="i0af1a8b31e524c11a45ac7677dc93883_I20220331" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfMTYtMC0xLTEtMTU2MDQvdGV4dHJlZ2lvbjpmNDVlZGI2MjdjNTg0OWEzOGU1OTY3YjQyMTlhNDcyZV81Ng_a2480ee5-24ea-4408-ad07-1616a9764587">21,205</ix:nonFraction></ix:nonFraction> from related parties as of March&#160;31, 2022 and December&#160;31, 2021</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfMTYtMS0xLTEtMTU2MDQ_4c5c8a31-9bc2-4127-8fd1-e61762e9f5c0">23,023</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfMTYtMy0xLTEtMTU2MDQ_54cc7153-080b-441e-b5b8-101a028393ae">23,023</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities, net of current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfMTctMS0xLTEtMTU2MDQ_daedd81c-98bd-4c35-9031-f5daf1ec182a">9,508</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfMTctMy0xLTEtMTU2MDQ_001af610-1811-40b8-9cc4-7f025365dadc">9,502</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfMTgtMS0xLTEtMTU2MDQ_1616f2fc-9abb-4c7a-aece-f7e141adbe89">2,438</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfMTgtMy0xLTEtMTU2MDQ_4177c241-f3dd-479d-819a-87cffc209c5d">2,539</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfMTktMS0xLTEtMTU2MDQ_71084ee2-0057-4ad4-995f-975921682b11">50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfMTktMy0xLTEtMTU2MDQ_6603048c-d0f1-4c66-8c96-7a3a2a6d1c2c">50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfMjAtMS0xLTEtMTU2MDQ_575c3122-584d-4fd3-8b1a-5c5cce02a012">261,732</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfMjAtMy0xLTEtMTU2MDQ_decf67bc-2353-40f5-a058-08c85a857c4d">252,508</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies (Note 16)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfMjEtMS0xLTEtMTU2MDQ_61dc2308-1243-4756-bf53-57502467f75d"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfMjEtMy0xLTEtMTU2MDQ_c1d4b005-184b-425c-9d69-dff716e9050c"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shareholders' equity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, <ix:nonFraction unitRef="usdPerShare" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="INF" name="us-gaap:CommonStockNoParValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfMjMtMC0xLTEtMTU2MDQvdGV4dHJlZ2lvbjpkNjI5OWZkMDc5YTQ0N2U2ODA3YWFmYWI4Y2U0Yzc1Yl8xOA_0ae9f19c-6c81-402f-bff1-6c5468fd3670"><ix:nonFraction unitRef="usdPerShare" contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231" decimals="INF" name="us-gaap:CommonStockNoParValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfMjMtMC0xLTEtMTU2MDQvdGV4dHJlZ2lvbjpkNjI5OWZkMDc5YTQ0N2U2ODA3YWFmYWI4Y2U0Yzc1Yl8xOA_d34da9e3-007c-42c8-9298-5251e2edfe79">no</ix:nonFraction></ix:nonFraction> par value, <ix:nonFraction unitRef="shares" contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfMjMtMC0xLTEtMTU2MDQvdGV4dHJlZ2lvbjpkNjI5OWZkMDc5YTQ0N2U2ODA3YWFmYWI4Y2U0Yzc1Yl8zMg_1324be32-f778-4d4a-96ad-5afa265924f9"><ix:nonFraction unitRef="shares" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfMjMtMC0xLTEtMTU2MDQvdGV4dHJlZ2lvbjpkNjI5OWZkMDc5YTQ0N2U2ODA3YWFmYWI4Y2U0Yzc1Yl8zMg_47375297-657e-4a5c-91ec-17a54b13241e">400,000,000</ix:nonFraction></ix:nonFraction> shares authorized as of March&#160;31, 2022 and December&#160;31, 2021; <ix:nonFraction unitRef="shares" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfMjMtMC0xLTEtMTU2MDQvdGV4dHJlZ2lvbjpkNjI5OWZkMDc5YTQ0N2U2ODA3YWFmYWI4Y2U0Yzc1Yl83MA_0e560657-ce7d-4986-bf20-646aac56da6f"><ix:nonFraction unitRef="shares" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfMjMtMC0xLTEtMTU2MDQvdGV4dHJlZ2lvbjpkNjI5OWZkMDc5YTQ0N2U2ODA3YWFmYWI4Y2U0Yzc1Yl83MA_b6b5b8c3-90ab-4b1f-a970-2d61081d1f51">207,693,277</ix:nonFraction></ix:nonFraction> shares and <ix:nonFraction unitRef="shares" contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfMjMtMC0xLTEtMTU2MDQvdGV4dHJlZ2lvbjpkNjI5OWZkMDc5YTQ0N2U2ODA3YWFmYWI4Y2U0Yzc1Yl84NA_5ba0b332-8936-46e1-b0f5-d3bca8107d74"><ix:nonFraction unitRef="shares" contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfMjMtMC0xLTEtMTU2MDQvdGV4dHJlZ2lvbjpkNjI5OWZkMDc5YTQ0N2U2ODA3YWFmYWI4Y2U0Yzc1Yl84NA_d05b8a66-47a5-4d2b-a2d8-dd18c97f0a5d">206,739,874</ix:nonFraction></ix:nonFraction> shares issued and outstanding as of March&#160;31, 2022 and December&#160;31, 2021, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:CommonStockValueOutstanding" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfMjMtMS0xLTEtMTU2MDQ_fbbaf2b7-f232-4128-9a88-e8fcc8289949">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231" decimals="-3" name="us-gaap:CommonStockValueOutstanding" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfMjMtMy0xLTEtMTU2MDQ_5194c52d-2145-45dc-83fa-c4c79e6c4d85">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfMjQtMS0xLTEtMTU2MDQ_34e595ee-f323-4eb8-ac2a-da773b7d870e">1,991,670</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfMjQtMy0xLTEtMTU2MDQ_66ae9f2d-d434-46aa-a847-76a4e570ef18">2,022,701</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfMjUtMS0xLTEtMTU2MDQ_1efbf4df-252f-4513-9d21-9b53f43b7ece">1,916,135</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfMjUtMy0xLTEtMTU2MDQ_54712c24-519f-45f1-91e9-360b9acf6b9a">1,915,556</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfMjYtMS0xLTEtMTU2MDQ_7994e893-c1c6-43a0-a472-1fe743ecd52a">1,699</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfMjYtMy0xLTEtMTU2MDQ_7dac784a-d6af-41b1-93c4-325c08947596">203</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shareholders' equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfMjctMS0xLTEtMTU2MDQ_d762aea5-7c09-4344-b41b-b43d4c784320">73,836</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfMjctMy0xLTEtMTU2MDQ_9912220c-4327-4341-a400-6944567d960a">107,348</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and shareholders' equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfMzAtMS0xLTEtMTU2MDQ_ea511310-c875-40b0-8560-bad6d611f8e9">335,568</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfMzAtMy0xLTEtMTU2MDQ_c478e2d9-386b-48af-941f-f4b80d73c561">359,856</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="i7169a803a6aa44ea981603d220cab84f_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Precigen, Inc. and Subsidiaries</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Operations</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.567%"><tr><td style="width:1.0%"></td><td style="width:69.056%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.431%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.432%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:24pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Amounts in thousands, except share and per share data)</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended&#160;<br/>&#160;March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenues</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Collaboration and licensing revenues</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c74e34c64854220ad796ce8372be421_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMy0xLTEtMS0xNTYwNA_23be207b-4676-42af-835f-d099a2861a35">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie204f1c632a1470eb0dd741618a1aadb_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMy0zLTEtMS0xNTYwNA_95dbf3ef-3fef-418e-a1a4-a79a985fcaff">66</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic80f3fa4ad914e09aed3f5c24de3aa03_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfNC0xLTEtMS0xNTYwNA_72dc61a9-1a1f-450e-9474-2108f6ca1f92">8,724</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i553b0d1d547844e597e5fce605969c48_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfNC0zLTEtMS0xNTYwNA_1ceb22be-6b45-47d4-8ae0-9c11a70df2d2">6,381</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i999d1a77cd4548c9868b086286dd0c31_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfNS0xLTEtMS0xNTYwNA_11fc59cc-2451-4dc1-bffc-b52b3c491042">23,209</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bb2ea92baa54c14ac275f16ff730de2_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfNS0zLTEtMS0xNTYwNA_1563c55d-3fb7-490c-b017-67ccd05ddd1c">17,931</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i436ff3c3e4284ab2abb2d891f39c72e5_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfNi0xLTEtMS0xNTYwNA_124b6440-3762-481b-9515-bbe2264a045c">88</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic08aaf9f98534b94a2b999b85acdb0cd_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfNi0zLTEtMS0xNTYwNA_a85b1cb3-ff8a-4a6e-bcae-411a70d267b8">133</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b33b3bdd85544d6853b80b9b9363fdc_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfNy0xLTEtMS0xNTYwNA_d51c2cf3-3a03-4de2-9a02-5e27beead174">32,021</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica51236575994a4ab8e30322fc2f55a4_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfNy0zLTEtMS0xNTYwNA_b7cf3f2c-8c7e-41cc-a17c-f1162968982f">24,511</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Expenses</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic80f3fa4ad914e09aed3f5c24de3aa03_D20220101-20220331" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfOS0xLTEtMS0xNTYwNA_4710ff9e-5905-43a9-9228-f1b641e949cc">7,510</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i553b0d1d547844e597e5fce605969c48_D20210101-20210331" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfOS0zLTEtMS0xNTYwNA_863b7baa-b0ed-444f-a155-b7539e8a24d1">5,574</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i999d1a77cd4548c9868b086286dd0c31_D20220101-20220331" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMTAtMS0xLTEtMTU2MDQ_03d05b52-111a-47ef-b57b-e086e0b66bfc">9,589</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bb2ea92baa54c14ac275f16ff730de2_D20210101-20210331" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMTAtMy0xLTEtMTU2MDQ_89842ee2-d8c1-4ca9-af73-4be8ff863917">7,402</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b33b3bdd85544d6853b80b9b9363fdc_D20220101-20220331" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMTEtMS0xLTEtMTU2MDQ_5f82e422-49f4-425a-b1d3-9971e9cc5ff1">12,760</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica51236575994a4ab8e30322fc2f55a4_D20210101-20210331" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMTEtMy0xLTEtMTU2MDQ_c66eb572-80eb-42a1-806b-670fc1d5791b">10,521</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b33b3bdd85544d6853b80b9b9363fdc_D20220101-20220331" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMTItMS0xLTEtMTU2MDQ_d3f42171-8a8a-42e4-912c-dfc426af7d80">19,576</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica51236575994a4ab8e30322fc2f55a4_D20210101-20210331" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMTItMy0xLTEtMTU2MDQ_add0d2fe-d816-45fc-a2ec-d84b734c6902">18,702</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment of goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b33b3bdd85544d6853b80b9b9363fdc_D20220101-20220331" decimals="-3" name="us-gaap:GoodwillImpairmentLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMTMtMS0xLTEtMTU2MDQ_22e8fb86-7e4c-4b47-99d3-962b779546fd">482</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica51236575994a4ab8e30322fc2f55a4_D20210101-20210331" decimals="-3" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMTMtMy0xLTEtMTU2MDQ_b694488c-9f7d-4fc5-bf2f-a38d342be19c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b33b3bdd85544d6853b80b9b9363fdc_D20220101-20220331" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMTUtMS0xLTEtMTU2MDQ_745f3a85-9297-4d90-bf48-3fa02d2b951d">49,917</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica51236575994a4ab8e30322fc2f55a4_D20210101-20210331" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMTUtMy0xLTEtMTU2MDQ_ff3f14cf-3328-4bd4-a68f-dbefbb89313a">42,199</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating loss</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7b33b3bdd85544d6853b80b9b9363fdc_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMTYtMS0xLTEtMTU2MDQ_18e2395d-1e76-4283-9b10-86d0271a8b09">17,896</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica51236575994a4ab8e30322fc2f55a4_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMTYtMy0xLTEtMTU2MDQ_98c83525-ac03-4474-9ffc-0571393adc28">17,688</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Expense, Net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7b33b3bdd85544d6853b80b9b9363fdc_D20220101-20220331" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMjAtMS0xLTEtMTU2MDQ_649325fb-f5fe-48fb-9afc-ed15f9468db4">2,069</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica51236575994a4ab8e30322fc2f55a4_D20210101-20210331" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMjAtMy0xLTEtMTU2MDQ_b1f01bd1-11d6-4ee8-949b-1970ca2cbc9c">4,539</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b33b3bdd85544d6853b80b9b9363fdc_D20220101-20220331" decimals="-3" name="us-gaap:InvestmentIncomeNonoperating" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMjEtMS0xLTEtMTU2MDQ_fe98d6f3-39a5-45f7-9203-3ae2a18e9efa">434</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica51236575994a4ab8e30322fc2f55a4_D20210101-20210331" decimals="-3" name="us-gaap:InvestmentIncomeNonoperating" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMjEtMy0xLTEtMTU2MDQ_79b2da58-b476-41f5-aaf1-be09bb8b7870">392</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b33b3bdd85544d6853b80b9b9363fdc_D20220101-20220331" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMjItMS0xLTEtMTU2MDQ_6933a01e-8909-4044-b9a5-0f523ed3d68c">223</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica51236575994a4ab8e30322fc2f55a4_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMjItMy0xLTEtMTU2MDQ_fe3fcd17-f5c5-412c-a4fc-4de87811537f">58</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other expense, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7b33b3bdd85544d6853b80b9b9363fdc_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMjMtMS0xLTEtMTU2MDQ_fc8be1a3-7414-4356-898e-a2ebd1ef2833">1,412</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica51236575994a4ab8e30322fc2f55a4_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMjMtMy0xLTEtMTU2MDQ_d20d0131-eff2-4cdb-9df2-87304367b526">4,205</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in net loss of affiliates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7b33b3bdd85544d6853b80b9b9363fdc_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMjQtMS0xLTEtMTU2MDQ_0b94980b-4161-4fb3-a368-9fe91d5183a5">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica51236575994a4ab8e30322fc2f55a4_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMjQtMy0xLTEtMTU2MDQ_61fc7589-c856-4e80-9776-ba90bce2605e">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from continuing operations before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7b33b3bdd85544d6853b80b9b9363fdc_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMjUtMS0xLTEtMTU2MDQ_bde86072-3d82-4ee3-bb4c-94000301e23c">19,309</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica51236575994a4ab8e30322fc2f55a4_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMjUtMy0xLTEtMTU2MDQ_7be0dec1-ff66-4190-a563-9825f1a2f143">21,896</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b33b3bdd85544d6853b80b9b9363fdc_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMjYtMS0xLTEtMTU2MDQ_eac24baf-1668-4ae1-aa13-159b16f45b76">58</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica51236575994a4ab8e30322fc2f55a4_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMjYtMy0xLTEtMTU2MDQ_6b736b79-51d1-4c9c-a981-0b53c7c6a7b9">52</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from continuing operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7b33b3bdd85544d6853b80b9b9363fdc_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMjctMS0xLTEtMTU2MDQ_a149bac9-a622-43d1-b1af-84675926cb35">19,251</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica51236575994a4ab8e30322fc2f55a4_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMjctMy0xLTEtMTU2MDQ_299bbbb3-c4f2-47a6-a4a3-bf13da7499e5">21,844</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from discontinued operations, net of income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" decimals="-3" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMjgtMS0xLTEtMTU2MDQ_1e585bbf-88f9-44c8-a90b-31f795e45e2a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331" decimals="-3" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMjgtMy0xLTEtMTU2MDQ_e4892879-ae1f-4d88-8e7e-97b8f4973626">4,526</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMjktMS0xLTEtMTU2MDQ_6c0ecc9e-d617-4a44-9e5e-ed1707406428">19,251</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMjktMy0xLTEtMTU2MDQ_880235a0-834a-43e2-8c0e-49de7f77c856">17,318</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Loss per Share</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss from continuing operations per share, basic and diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMzctMS0xLTEtMTU2MDQ_861d8925-3c67-480f-a4d1-193b52891769"><ix:nonFraction unitRef="usdPerShare" contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMzctMS0xLTEtMTU2MDQ_e30ac5bf-4067-40e5-b564-de3e9a621f69">0.10</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMzctMy0xLTEtMTU2MDQ_8ef84829-0d3f-4818-9c2e-76d735e32a72"><ix:nonFraction unitRef="usdPerShare" contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMzctMy0xLTEtMTU2MDQ_deb126de-0546-4750-988f-fb1ca90cfbb7">0.11</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income from discontinued operations per share, basic and diluted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMzgtMS0xLTEtMTU2MDQ_37438b7e-947c-4669-990f-c8d76600afc4"><ix:nonFraction unitRef="usdPerShare" contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMzgtMS0xLTEtMTU2MDQ_b677d259-a71b-4daf-845a-a7f56e160e20">&#8212;</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMzgtMy0xLTEtMTU2MDQ_3e689e20-f804-40f3-8404-9f668e02e5bd"><ix:nonFraction unitRef="usdPerShare" contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMzgtMy0xLTEtMTU2MDQ_ce710377-b434-42ad-82d8-a9f9d353d9a3">0.02</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per share, basic and diluted</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMzktMS0xLTEtMTU2MDQ_06692149-c64d-4eec-9239-a59920fa3cdc"><ix:nonFraction unitRef="usdPerShare" contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMzktMS0xLTEtMTU2MDQ_1ecc99f1-ef55-4a99-8a7b-bedd98bf0865">0.10</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMzktMy0xLTEtMTU2MDQ_27880b9e-1fef-4d9d-9fb0-0aaef9525920"><ix:nonFraction unitRef="usdPerShare" contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMzktMy0xLTEtMTU2MDQ_336d8ea2-0f1b-4a06-b7db-8f432081ccac">0.09</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding, basic and diluted</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfNDAtMS0xLTEtMTU2MDQ_922f64f2-cce4-44e6-a45a-f795fd4d34b4"><ix:nonFraction unitRef="shares" contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfNDAtMS0xLTEtMTU2MDQ_9ec8d592-6068-4a90-af4b-4f6be5686c30">199,629,218</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfNDAtMy0xLTEtMTU2MDQ_1e4471f2-0912-4ede-b8c8-c57a28b053da"><ix:nonFraction unitRef="shares" contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfNDAtMy0xLTEtMTU2MDQ_e580fb76-9c84-48ab-887b-d945eacc3ac7">193,499,546</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="i7169a803a6aa44ea981603d220cab84f_25"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Precigen, Inc. and Subsidiaries</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Comprehensive Loss</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.444%"><tr><td style="width:1.0%"></td><td style="width:69.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.296%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.573%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.298%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended&#160;<br/>&#160;March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Amounts in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yNS9mcmFnOmI5MDhmNzFkYjRjYzRlNjNhMDdkODJmMDY0MDcyZmVjL3RhYmxlOjE0MTNlMGE2ZDBjNDRmNThhYjVkNjMzY2ZhZTAyMjY1L3RhYmxlcmFuZ2U6MTQxM2UwYTZkMGM0NGY1OGFiNWQ2MzNjZmFlMDIyNjVfMi0xLTEtMS0xNTYwNA_914d5f4d-ba94-4c31-85b8-67927b24ddb7">19,251</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yNS9mcmFnOmI5MDhmNzFkYjRjYzRlNjNhMDdkODJmMDY0MDcyZmVjL3RhYmxlOjE0MTNlMGE2ZDBjNDRmNThhYjVkNjMzY2ZhZTAyMjY1L3RhYmxlcmFuZ2U6MTQxM2UwYTZkMGM0NGY1OGFiNWQ2MzNjZmFlMDIyNjVfMi0zLTEtMS0xNTYwNA_b4af0aa4-500d-4b69-8251-0df7ef3be659">17,318</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized loss on investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yNS9mcmFnOmI5MDhmNzFkYjRjYzRlNjNhMDdkODJmMDY0MDcyZmVjL3RhYmxlOjE0MTNlMGE2ZDBjNDRmNThhYjVkNjMzY2ZhZTAyMjY1L3RhYmxlcmFuZ2U6MTQxM2UwYTZkMGM0NGY1OGFiNWQ2MzNjZmFlMDIyNjVfNC0xLTEtMS0xNTYwNA_81da0813-1252-4666-a27b-b76009c6e9a6">802</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yNS9mcmFnOmI5MDhmNzFkYjRjYzRlNjNhMDdkODJmMDY0MDcyZmVjL3RhYmxlOjE0MTNlMGE2ZDBjNDRmNThhYjVkNjMzY2ZhZTAyMjY1L3RhYmxlcmFuZ2U6MTQxM2UwYTZkMGM0NGY1OGFiNWQ2MzNjZmFlMDIyNjVfNC0zLTEtMS0xNTYwNA_825b6ea0-8fe5-4342-9686-3f663f1ea972">48</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yNS9mcmFnOmI5MDhmNzFkYjRjYzRlNjNhMDdkODJmMDY0MDcyZmVjL3RhYmxlOjE0MTNlMGE2ZDBjNDRmNThhYjVkNjMzY2ZhZTAyMjY1L3RhYmxlcmFuZ2U6MTQxM2UwYTZkMGM0NGY1OGFiNWQ2MzNjZmFlMDIyNjVfNS0xLTEtMS0xNTYwNA_30998d8b-d5b8-4c06-8d38-7121f90489f9">1,100</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yNS9mcmFnOmI5MDhmNzFkYjRjYzRlNjNhMDdkODJmMDY0MDcyZmVjL3RhYmxlOjE0MTNlMGE2ZDBjNDRmNThhYjVkNjMzY2ZhZTAyMjY1L3RhYmxlcmFuZ2U6MTQxM2UwYTZkMGM0NGY1OGFiNWQ2MzNjZmFlMDIyNjVfNS0zLTEtMS0xNTYwNA_34fe9edd-7443-459f-97dd-3b211b8bb737">2,203</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive loss</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yNS9mcmFnOmI5MDhmNzFkYjRjYzRlNjNhMDdkODJmMDY0MDcyZmVjL3RhYmxlOjE0MTNlMGE2ZDBjNDRmNThhYjVkNjMzY2ZhZTAyMjY1L3RhYmxlcmFuZ2U6MTQxM2UwYTZkMGM0NGY1OGFiNWQ2MzNjZmFlMDIyNjVfNy0xLTEtMS0xNTYwNA_c991b769-e75f-4959-8ccf-c4ba4bc3ae7d">21,153</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yNS9mcmFnOmI5MDhmNzFkYjRjYzRlNjNhMDdkODJmMDY0MDcyZmVjL3RhYmxlOjE0MTNlMGE2ZDBjNDRmNThhYjVkNjMzY2ZhZTAyMjY1L3RhYmxlcmFuZ2U6MTQxM2UwYTZkMGM0NGY1OGFiNWQ2MzNjZmFlMDIyNjVfNy0zLTEtMS0xNTYwNA_957ad770-a88b-4825-ab47-f1c5ddc2bac5">19,569</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><div id="i7169a803a6aa44ea981603d220cab84f_28"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Precigen, Inc. and Subsidiaries</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Shareholders' Equity</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:2pt;margin-top:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.168%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.315%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.419%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.800%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.558%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.800%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.535%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:23pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Amounts in thousands, except share data)</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-in<br/>Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Income (Loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Deficit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Shareholders'<br/>Equity</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic68a1c0debad4505be9f262586727573_I20211231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOjBhOTMzMGI4ZDdjNjRlNjJhZGYxZjYyOTEyOTcxNzk2L3RhYmxlcmFuZ2U6MGE5MzMwYjhkN2M2NGU2MmFkZjFmNjI5MTI5NzE3OTZfMi0xLTEtMS0xNTYwNA_7d644f3f-a7e8-454d-94f9-878570173489">206,739,874</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic68a1c0debad4505be9f262586727573_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOjBhOTMzMGI4ZDdjNjRlNjJhZGYxZjYyOTEyOTcxNzk2L3RhYmxlcmFuZ2U6MGE5MzMwYjhkN2M2NGU2MmFkZjFmNjI5MTI5NzE3OTZfMi0zLTEtMS0xNTYwNA_8dd2b669-3c19-4673-ae42-2167800bad4f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8630822867d746dcb299e334c2f62bb2_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOjBhOTMzMGI4ZDdjNjRlNjJhZGYxZjYyOTEyOTcxNzk2L3RhYmxlcmFuZ2U6MGE5MzMwYjhkN2M2NGU2MmFkZjFmNjI5MTI5NzE3OTZfMi01LTEtMS0xNTYwNA_dd959d4d-2230-451c-bcd8-bfa256c0c8d4">2,022,701</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1386437e5414589a78d1e1f9863e05e_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOjBhOTMzMGI4ZDdjNjRlNjJhZGYxZjYyOTEyOTcxNzk2L3RhYmxlcmFuZ2U6MGE5MzMwYjhkN2M2NGU2MmFkZjFmNjI5MTI5NzE3OTZfMi03LTEtMS0xNTYwNA_431eb5a9-94c5-4903-be78-60aeaf1b7058">203</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9419bc7141e84a9d88053ffc38b7a8dd_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOjBhOTMzMGI4ZDdjNjRlNjJhZGYxZjYyOTEyOTcxNzk2L3RhYmxlcmFuZ2U6MGE5MzMwYjhkN2M2NGU2MmFkZjFmNjI5MTI5NzE3OTZfMi05LTEtMS0xNTYwNA_beb301ff-715e-4c29-93eb-e882788fd470">1,915,556</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOjBhOTMzMGI4ZDdjNjRlNjJhZGYxZjYyOTEyOTcxNzk2L3RhYmxlcmFuZ2U6MGE5MzMwYjhkN2M2NGU2MmFkZjFmNjI5MTI5NzE3OTZfMi0xMS0xLTEtMTU2MDQ_8717564d-a43e-49bd-bd69-737ce07d202a">107,348</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOjBhOTMzMGI4ZDdjNjRlNjJhZGYxZjYyOTEyOTcxNzk2L3RhYmxlcmFuZ2U6MGE5MzMwYjhkN2M2NGU2MmFkZjFmNjI5MTI5NzE3OTZfMy0wLTEtMS0yNzgyOA_dceab1cb-aeda-411c-b999-aa5bab34bbb4">Cumulative effect of adoption of ASU 2020-06</span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3be10a01a9624d3ab98ae41d043b6197_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOjBhOTMzMGI4ZDdjNjRlNjJhZGYxZjYyOTEyOTcxNzk2L3RhYmxlcmFuZ2U6MGE5MzMwYjhkN2M2NGU2MmFkZjFmNjI5MTI5NzE3OTZfMy01LTEtMS0yNzM4OQ_28735025-dc16-4cfb-9e24-b8badca77c4e">36,868</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7abd6540a1a64f77872b8ddc7e797fff_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOjBhOTMzMGI4ZDdjNjRlNjJhZGYxZjYyOTEyOTcxNzk2L3RhYmxlcmFuZ2U6MGE5MzMwYjhkN2M2NGU2MmFkZjFmNjI5MTI5NzE3OTZfMy05LTEtMS0yNzM4OQ_8895cebd-4f29-4bfb-82b3-f81064009bdd">18,672</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3d0633214e1c47539bd414801031b325_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOjBhOTMzMGI4ZDdjNjRlNjJhZGYxZjYyOTEyOTcxNzk2L3RhYmxlcmFuZ2U6MGE5MzMwYjhkN2M2NGU2MmFkZjFmNjI5MTI5NzE3OTZfMy0xMS0xLTEtMjczODk_ad2627b7-0aaa-4ca6-949d-3a9c88885949">18,196</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5814e59f587a427ca84c1523af21ce68_D20220101-20220331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOjBhOTMzMGI4ZDdjNjRlNjJhZGYxZjYyOTEyOTcxNzk2L3RhYmxlcmFuZ2U6MGE5MzMwYjhkN2M2NGU2MmFkZjFmNjI5MTI5NzE3OTZfMy01LTEtMS0xNTYwNA_aa4dbdb4-9ac1-437a-98d8-5734b572d182">3,562</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOjBhOTMzMGI4ZDdjNjRlNjJhZGYxZjYyOTEyOTcxNzk2L3RhYmxlcmFuZ2U6MGE5MzMwYjhkN2M2NGU2MmFkZjFmNjI5MTI5NzE3OTZfMy0xMS0xLTEtMTU2MDQ_6f2a527c-fff0-431e-8a0a-bf9f663f3ca4">3,562</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issued upon vesting of restricted stock units and for exercises of stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibf63cfed8810400aacf2e390e0bc4982_D20220101-20220331" decimals="INF" name="pgen:StockIssuedDuringPeriodSharesStockOptionsExercisedAndRestrictedStockAwards" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOjBhOTMzMGI4ZDdjNjRlNjJhZGYxZjYyOTEyOTcxNzk2L3RhYmxlcmFuZ2U6MGE5MzMwYjhkN2M2NGU2MmFkZjFmNjI5MTI5NzE3OTZfNC0xLTEtMS0xNTYwNA_663b06dd-1229-42a2-89c8-5ada42e23550">354,089</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5814e59f587a427ca84c1523af21ce68_D20220101-20220331" decimals="-3" name="pgen:StockIssuedDuringPeriodValueRestrictedStockAwardsVestedAndStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOjBhOTMzMGI4ZDdjNjRlNjJhZGYxZjYyOTEyOTcxNzk2L3RhYmxlcmFuZ2U6MGE5MzMwYjhkN2M2NGU2MmFkZjFmNjI5MTI5NzE3OTZfNC01LTEtMS0xNTYwNA_34882586-930e-490c-8d47-65e2585269d4">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" decimals="-3" name="pgen:StockIssuedDuringPeriodValueRestrictedStockAwardsVestedAndStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOjBhOTMzMGI4ZDdjNjRlNjJhZGYxZjYyOTEyOTcxNzk2L3RhYmxlcmFuZ2U6MGE5MzMwYjhkN2M2NGU2MmFkZjFmNjI5MTI5NzE3OTZfNC0xMS0xLTEtMTU2MDQ_212585c0-7ce9-44be-b36c-fb18b1e751d5">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issued for accrued compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibf63cfed8810400aacf2e390e0bc4982_D20220101-20220331" decimals="INF" name="pgen:StockIssuedDuringThePeriodSharesAccruedCompensation" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOjBhOTMzMGI4ZDdjNjRlNjJhZGYxZjYyOTEyOTcxNzk2L3RhYmxlcmFuZ2U6MGE5MzMwYjhkN2M2NGU2MmFkZjFmNjI5MTI5NzE3OTZfNS0xLTEtMS0xNTYwNA_e7700d70-31aa-45f9-99a3-fa41060ae88e">315,327</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5814e59f587a427ca84c1523af21ce68_D20220101-20220331" decimals="-3" name="pgen:StockIssuedDuringThePeriodValueAccruedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOjBhOTMzMGI4ZDdjNjRlNjJhZGYxZjYyOTEyOTcxNzk2L3RhYmxlcmFuZ2U6MGE5MzMwYjhkN2M2NGU2MmFkZjFmNjI5MTI5NzE3OTZfNS01LTEtMS0xNTYwNA_2ecb4ca6-32e7-498c-a319-bad94f21ab59">1,698</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" decimals="-3" name="pgen:StockIssuedDuringThePeriodValueAccruedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOjBhOTMzMGI4ZDdjNjRlNjJhZGYxZjYyOTEyOTcxNzk2L3RhYmxlcmFuZ2U6MGE5MzMwYjhkN2M2NGU2MmFkZjFmNjI5MTI5NzE3OTZfNS0xMS0xLTEtMTU2MDQ_358ca2e7-cf43-4108-9b7b-020564f11afb">1,698</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issued as payment for services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibf63cfed8810400aacf2e390e0bc4982_D20220101-20220331" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOjBhOTMzMGI4ZDdjNjRlNjJhZGYxZjYyOTEyOTcxNzk2L3RhYmxlcmFuZ2U6MGE5MzMwYjhkN2M2NGU2MmFkZjFmNjI5MTI5NzE3OTZfNi0xLTEtMS0xNTYwNA_6d5a4761-433c-4ff5-aeca-0cf4d1e51c8d">283,987</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5814e59f587a427ca84c1523af21ce68_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOjBhOTMzMGI4ZDdjNjRlNjJhZGYxZjYyOTEyOTcxNzk2L3RhYmxlcmFuZ2U6MGE5MzMwYjhkN2M2NGU2MmFkZjFmNjI5MTI5NzE3OTZfNi01LTEtMS0xNTYwNA_bde2ae73-eefd-4a29-ab26-9c592c0171af">576</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOjBhOTMzMGI4ZDdjNjRlNjJhZGYxZjYyOTEyOTcxNzk2L3RhYmxlcmFuZ2U6MGE5MzMwYjhkN2M2NGU2MmFkZjFmNjI5MTI5NzE3OTZfNi0xMS0xLTEtMTU2MDQ_0a4cd6e5-5589-412c-9159-44c3c2c65990">576</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifac0484be833462696c138be338f4ac6_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOjBhOTMzMGI4ZDdjNjRlNjJhZGYxZjYyOTEyOTcxNzk2L3RhYmxlcmFuZ2U6MGE5MzMwYjhkN2M2NGU2MmFkZjFmNjI5MTI5NzE3OTZfMjAtOS0xLTEtMTU2MDQ_ea6dc8b0-5a4e-47f9-a0de-c905f08ad5d2">19,251</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOjBhOTMzMGI4ZDdjNjRlNjJhZGYxZjYyOTEyOTcxNzk2L3RhYmxlcmFuZ2U6MGE5MzMwYjhkN2M2NGU2MmFkZjFmNjI5MTI5NzE3OTZfMjAtMTEtMS0xLTE1NjA0_cf32c078-d96a-4965-91ac-3cd7266cb035">19,251</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8fddc81d9d8244a98bf2f57ae43c0bae_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOjBhOTMzMGI4ZDdjNjRlNjJhZGYxZjYyOTEyOTcxNzk2L3RhYmxlcmFuZ2U6MGE5MzMwYjhkN2M2NGU2MmFkZjFmNjI5MTI5NzE3OTZfMjItNy0xLTEtMTU2MDQ_7077e4fc-b7b5-4606-9730-a571e1db1853">1,902</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOjBhOTMzMGI4ZDdjNjRlNjJhZGYxZjYyOTEyOTcxNzk2L3RhYmxlcmFuZ2U6MGE5MzMwYjhkN2M2NGU2MmFkZjFmNjI5MTI5NzE3OTZfMjItMTEtMS0xLTE1NjA0_ff4fb6c4-1ac4-44b4-b53b-abb2c49818b1">1,902</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances at March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id1795fa79607445cbc20904ee4dda36d_I20220331" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOjBhOTMzMGI4ZDdjNjRlNjJhZGYxZjYyOTEyOTcxNzk2L3RhYmxlcmFuZ2U6MGE5MzMwYjhkN2M2NGU2MmFkZjFmNjI5MTI5NzE3OTZfMjMtMS0xLTEtMTU2MDQ_5d6311d9-7659-4cc7-a255-012641a8f9b6">207,693,277</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1795fa79607445cbc20904ee4dda36d_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOjBhOTMzMGI4ZDdjNjRlNjJhZGYxZjYyOTEyOTcxNzk2L3RhYmxlcmFuZ2U6MGE5MzMwYjhkN2M2NGU2MmFkZjFmNjI5MTI5NzE3OTZfMjMtMy0xLTEtMTU2MDQ_34a2af5f-43f3-4e02-a894-10281d33257d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc509430d95b4d7eb55ea6c26d1c41c3_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOjBhOTMzMGI4ZDdjNjRlNjJhZGYxZjYyOTEyOTcxNzk2L3RhYmxlcmFuZ2U6MGE5MzMwYjhkN2M2NGU2MmFkZjFmNjI5MTI5NzE3OTZfMjMtNS0xLTEtMTU2MDQ_8253dc0a-091b-41f0-bfd4-d3e6d397b937">1,991,670</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia10c8c844d4940a3b0ebde37f5f75f25_I20220331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOjBhOTMzMGI4ZDdjNjRlNjJhZGYxZjYyOTEyOTcxNzk2L3RhYmxlcmFuZ2U6MGE5MzMwYjhkN2M2NGU2MmFkZjFmNjI5MTI5NzE3OTZfMjMtNy0xLTEtMTU2MDQ_863fada6-90ad-49c5-93ab-c6224a753c51">1,699</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6855b33dd4b34c1793117831d12003ea_I20220331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOjBhOTMzMGI4ZDdjNjRlNjJhZGYxZjYyOTEyOTcxNzk2L3RhYmxlcmFuZ2U6MGE5MzMwYjhkN2M2NGU2MmFkZjFmNjI5MTI5NzE3OTZfMjMtOS0xLTEtMTU2MDQ_a6e7a7d0-00c8-4480-9558-2d5f1e407f08">1,916,135</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOjBhOTMzMGI4ZDdjNjRlNjJhZGYxZjYyOTEyOTcxNzk2L3RhYmxlcmFuZ2U6MGE5MzMwYjhkN2M2NGU2MmFkZjFmNjI5MTI5NzE3OTZfMjMtMTEtMS0xLTE1NjA0_c5b5f53a-9d8b-4bbf-a0aa-4c0cdc1d43d8">73,836</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.168%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.315%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.419%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.800%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.558%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.800%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.535%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:23pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Amounts in thousands, except share data)</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-in<br/>Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Income (Loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Deficit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Shareholders'<br/>Equity</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i64c8fed916fd4230bfb10137e40b9037_I20201231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOmNlNzc3ZmE3ZWYwNDQ4MGRhYWY5MjhhZTA0MDk3NmJhL3RhYmxlcmFuZ2U6Y2U3NzdmYTdlZjA0NDgwZGFhZjkyOGFlMDQwOTc2YmFfMi0xLTEtMS0xNTYwNA_ad9e0e81-0174-42fd-ae85-b58f503ccfec">187,663,207</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64c8fed916fd4230bfb10137e40b9037_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOmNlNzc3ZmE3ZWYwNDQ4MGRhYWY5MjhhZTA0MDk3NmJhL3RhYmxlcmFuZ2U6Y2U3NzdmYTdlZjA0NDgwZGFhZjkyOGFlMDQwOTc2YmFfMi0zLTEtMS0xNTYwNA_2c320731-299a-4344-8649-8e5c71fa6c0e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia32c9ea65a164766b40eee00dd09cb45_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOmNlNzc3ZmE3ZWYwNDQ4MGRhYWY5MjhhZTA0MDk3NmJhL3RhYmxlcmFuZ2U6Y2U3NzdmYTdlZjA0NDgwZGFhZjkyOGFlMDQwOTc2YmFfMi01LTEtMS0xNTYwNA_070e667b-5357-425c-8560-b5f9f539164e">1,886,567</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7048090cfae14c5c8420c6cad3ffd931_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOmNlNzc3ZmE3ZWYwNDQ4MGRhYWY5MjhhZTA0MDk3NmJhL3RhYmxlcmFuZ2U6Y2U3NzdmYTdlZjA0NDgwZGFhZjkyOGFlMDQwOTc2YmFfMi03LTEtMS0xNTYwNA_327cf159-387f-47ac-a24e-4d5b1fe05981">3,997</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6fad92c0b19f40d8b718694baf49e9b0_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOmNlNzc3ZmE3ZWYwNDQ4MGRhYWY5MjhhZTA0MDk3NmJhL3RhYmxlcmFuZ2U6Y2U3NzdmYTdlZjA0NDgwZGFhZjkyOGFlMDQwOTc2YmFfMi05LTEtMS0xNTYwNA_c6fdc035-002c-4a46-961e-27b31a8fa749">1,823,390</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54a90f374db746b78de00be9871944ac_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOmNlNzc3ZmE3ZWYwNDQ4MGRhYWY5MjhhZTA0MDk3NmJhL3RhYmxlcmFuZ2U6Y2U3NzdmYTdlZjA0NDgwZGFhZjkyOGFlMDQwOTc2YmFfMi0xMS0xLTEtMTU2MDQ_162a53e2-54a2-4b68-aaa9-2217a790c837">67,174</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71fe82fdf1f84583b3319fa0acac22be_D20210101-20210331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOmNlNzc3ZmE3ZWYwNDQ4MGRhYWY5MjhhZTA0MDk3NmJhL3RhYmxlcmFuZ2U6Y2U3NzdmYTdlZjA0NDgwZGFhZjkyOGFlMDQwOTc2YmFfMy01LTEtMS0xNTYwNA_5435daf3-8420-4532-a701-d315b602de15">5,415</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOmNlNzc3ZmE3ZWYwNDQ4MGRhYWY5MjhhZTA0MDk3NmJhL3RhYmxlcmFuZ2U6Y2U3NzdmYTdlZjA0NDgwZGFhZjkyOGFlMDQwOTc2YmFfMy0xMS0xLTEtMTU2MDQ_836b83c3-89bb-4ec7-88ea-bd95e6b00265">5,415</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issued upon vesting of restricted stock units and for exercises of stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic2060c890f6b479aab80d7691e262567_D20210101-20210331" decimals="INF" name="pgen:StockIssuedDuringPeriodSharesStockOptionsExercisedAndRestrictedStockAwards" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOmNlNzc3ZmE3ZWYwNDQ4MGRhYWY5MjhhZTA0MDk3NmJhL3RhYmxlcmFuZ2U6Y2U3NzdmYTdlZjA0NDgwZGFhZjkyOGFlMDQwOTc2YmFfNC0xLTEtMS0xNTYwNA_ab889a0a-6d46-46de-a061-834e8b5451d0">1,426,157</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71fe82fdf1f84583b3319fa0acac22be_D20210101-20210331" decimals="-3" name="pgen:StockIssuedDuringPeriodValueRestrictedStockAwardsVestedAndStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOmNlNzc3ZmE3ZWYwNDQ4MGRhYWY5MjhhZTA0MDk3NmJhL3RhYmxlcmFuZ2U6Y2U3NzdmYTdlZjA0NDgwZGFhZjkyOGFlMDQwOTc2YmFfNC01LTEtMS0xNTYwNA_3ff239f0-081f-436c-bed3-484736b1d897">153</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331" decimals="-3" name="pgen:StockIssuedDuringPeriodValueRestrictedStockAwardsVestedAndStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOmNlNzc3ZmE3ZWYwNDQ4MGRhYWY5MjhhZTA0MDk3NmJhL3RhYmxlcmFuZ2U6Y2U3NzdmYTdlZjA0NDgwZGFhZjkyOGFlMDQwOTc2YmFfNC0xMS0xLTEtMTU2MDQ_531ae180-7feb-4ec9-b63b-2b58983f8b3a">153</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issued as payment for services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic2060c890f6b479aab80d7691e262567_D20210101-20210331" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOmNlNzc3ZmE3ZWYwNDQ4MGRhYWY5MjhhZTA0MDk3NmJhL3RhYmxlcmFuZ2U6Y2U3NzdmYTdlZjA0NDgwZGFhZjkyOGFlMDQwOTc2YmFfNi0xLTEtMS0xNTYwNA_cbdcdc2e-19b8-4dff-a6a8-f454b5852324">74,771</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71fe82fdf1f84583b3319fa0acac22be_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOmNlNzc3ZmE3ZWYwNDQ4MGRhYWY5MjhhZTA0MDk3NmJhL3RhYmxlcmFuZ2U6Y2U3NzdmYTdlZjA0NDgwZGFhZjkyOGFlMDQwOTc2YmFfNi01LTEtMS0xNTYwNA_f5d36855-42b6-44d6-8418-4bdaa1d24e85">577</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOmNlNzc3ZmE3ZWYwNDQ4MGRhYWY5MjhhZTA0MDk3NmJhL3RhYmxlcmFuZ2U6Y2U3NzdmYTdlZjA0NDgwZGFhZjkyOGFlMDQwOTc2YmFfNi0xMS0xLTEtMTU2MDQ_8649d179-7041-4153-9275-f2713c2458f2">577</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issued in public offerings, net of issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOmNlNzc3ZmE3ZWYwNDQ4MGRhYWY5MjhhZTA0MDk3NmJhL3RhYmxlcmFuZ2U6Y2U3NzdmYTdlZjA0NDgwZGFhZjkyOGFlMDQwOTc2YmFfNy0xLTEtMS0xNTYwNA_ab14abc0-19c3-4a68-9c8a-184b49294130">17,250,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71fe82fdf1f84583b3319fa0acac22be_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOmNlNzc3ZmE3ZWYwNDQ4MGRhYWY5MjhhZTA0MDk3NmJhL3RhYmxlcmFuZ2U6Y2U3NzdmYTdlZjA0NDgwZGFhZjkyOGFlMDQwOTc2YmFfNy01LTEtMS0xNTYwNA_6e7f4ecb-cd43-45cb-ba8b-3c594e777a38">121,045</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOmNlNzc3ZmE3ZWYwNDQ4MGRhYWY5MjhhZTA0MDk3NmJhL3RhYmxlcmFuZ2U6Y2U3NzdmYTdlZjA0NDgwZGFhZjkyOGFlMDQwOTc2YmFfNy0xMS0xLTEtMTU2MDQ_46e63df1-44e3-4e57-ab31-95739c509b94">121,045</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0dd2258d887948a091305e7302f4f7ed_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOmNlNzc3ZmE3ZWYwNDQ4MGRhYWY5MjhhZTA0MDk3NmJhL3RhYmxlcmFuZ2U6Y2U3NzdmYTdlZjA0NDgwZGFhZjkyOGFlMDQwOTc2YmFfMjAtOS0xLTEtMTU2MDQ_c33729af-0f5f-45bf-a26c-0dd6b114844c">17,318</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOmNlNzc3ZmE3ZWYwNDQ4MGRhYWY5MjhhZTA0MDk3NmJhL3RhYmxlcmFuZ2U6Y2U3NzdmYTdlZjA0NDgwZGFhZjkyOGFlMDQwOTc2YmFfMjAtMTEtMS0xLTE1NjA0_ef7dc2d0-21f1-4201-a975-35e807087d27">17,318</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia65599dbd22c42928733e6325a88a14e_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOmNlNzc3ZmE3ZWYwNDQ4MGRhYWY5MjhhZTA0MDk3NmJhL3RhYmxlcmFuZ2U6Y2U3NzdmYTdlZjA0NDgwZGFhZjkyOGFlMDQwOTc2YmFfMjItNy0xLTEtMTU2MDQ_2410d162-f3de-42d7-8049-39a926224884">2,251</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOmNlNzc3ZmE3ZWYwNDQ4MGRhYWY5MjhhZTA0MDk3NmJhL3RhYmxlcmFuZ2U6Y2U3NzdmYTdlZjA0NDgwZGFhZjkyOGFlMDQwOTc2YmFfMjItMTEtMS0xLTE1NjA0_1ff621a7-7acc-4287-a19c-7d590229c9c7">2,251</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances at March 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibbe9dcfa0a15492fae0547b188e7d154_I20210331" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOmNlNzc3ZmE3ZWYwNDQ4MGRhYWY5MjhhZTA0MDk3NmJhL3RhYmxlcmFuZ2U6Y2U3NzdmYTdlZjA0NDgwZGFhZjkyOGFlMDQwOTc2YmFfMjMtMS0xLTEtMTU2MDQ_a55f90a6-e0fb-41b3-9134-38fe31e5f0c1">206,414,135</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe9dcfa0a15492fae0547b188e7d154_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOmNlNzc3ZmE3ZWYwNDQ4MGRhYWY5MjhhZTA0MDk3NmJhL3RhYmxlcmFuZ2U6Y2U3NzdmYTdlZjA0NDgwZGFhZjkyOGFlMDQwOTc2YmFfMjMtMy0xLTEtMTU2MDQ_e0561e6e-31d7-40b8-88f1-86094d7267e5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i943c56b57428465184de8ac8b4b0a16a_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOmNlNzc3ZmE3ZWYwNDQ4MGRhYWY5MjhhZTA0MDk3NmJhL3RhYmxlcmFuZ2U6Y2U3NzdmYTdlZjA0NDgwZGFhZjkyOGFlMDQwOTc2YmFfMjMtNS0xLTEtMTU2MDQ_0e7d1c9d-9152-4b1f-b7f7-9a19306c749a">2,013,757</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd2510608a8747ddbc103832b4650fb2_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOmNlNzc3ZmE3ZWYwNDQ4MGRhYWY5MjhhZTA0MDk3NmJhL3RhYmxlcmFuZ2U6Y2U3NzdmYTdlZjA0NDgwZGFhZjkyOGFlMDQwOTc2YmFfMjMtNy0xLTEtMTU2MDQ_908c8d58-d0ed-4a2c-aa7a-33b476856771">1,746</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae096e93867e42a99d564859635c4326_I20210331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOmNlNzc3ZmE3ZWYwNDQ4MGRhYWY5MjhhZTA0MDk3NmJhL3RhYmxlcmFuZ2U6Y2U3NzdmYTdlZjA0NDgwZGFhZjkyOGFlMDQwOTc2YmFfMjMtOS0xLTEtMTU2MDQ_0870a53f-417b-4d83-8d9b-bc29fedc62b1">1,840,708</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7b79aae0fa241fb908efc36ca29e3d3_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOmNlNzc3ZmE3ZWYwNDQ4MGRhYWY5MjhhZTA0MDk3NmJhL3RhYmxlcmFuZ2U6Y2U3NzdmYTdlZjA0NDgwZGFhZjkyOGFlMDQwOTc2YmFfMjMtMTEtMS0xLTE1NjA0_fc3f9eca-05eb-4258-895e-051eed34b59e">174,795</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><div id="i7169a803a6aa44ea981603d220cab84f_31"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Precigen, Inc. and Subsidiaries</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Cash Flows</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended&#160;<br/>&#160;March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Amounts in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from operating activities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMy0xLTEtMS0xNTYwNA_7f8826b8-5c26-4cb9-8cf2-65748e10886a">19,251</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMy0zLTEtMS0xNTYwNA_2d6fc7a0-7181-4452-9b74-90ea95f07c87">17,318</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net loss to net cash used in operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfNS0xLTEtMS0xNTYwNA_e62e036e-b94d-4aab-851a-904ebdd356a4">3,292</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfNS0zLTEtMS0xNTYwNA_987f272d-7387-4e2f-a89c-2ab1247d7aa0">3,523</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss (gain) on disposals of assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:GainLossOnDispositionOfAssets1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfNi0xLTEtMS0xNTYwNA_de2c74c3-735d-43dc-8be4-e232616509a9">125</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331" decimals="-3" name="us-gaap:GainLossOnDispositionOfAssets1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfNi0zLTEtMS0xNTYwNA_b0baa570-19e1-410d-852f-965c33a247f1">343</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment of goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" decimals="-3" name="us-gaap:GoodwillImpairmentLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfNy0xLTEtMS0xNTYwNA_bb1ec256-3940-4323-9f0c-b2f790678dad">482</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331" decimals="-3" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfNy0zLTEtMS0xNTYwNA_ef784fc9-f966-4c08-83bf-a3db57eaf4e0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of premiums on investments, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMTMtMS0xLTEtMTU2MDQ_c4bc9773-edc3-44e9-8fc1-a9ab6ea21032">265</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMTMtMy0xLTEtMTU2MDQ_e9907966-5859-43c4-9bc2-a097b297be21">57</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in net loss of affiliates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMTQtMS0xLTEtMTU2MDQ_b8394fb6-47ed-4f25-b0dc-ad4e5b6133f4">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMTQtMy0xLTEtMTU2MDQ_fc047362-7365-4c16-aab8-2771cfce52f7">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMTUtMS0xLTEtMTU2MDQ_452fe974-a55a-4f88-8852-18538452d9a4">3,562</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMTUtMy0xLTEtMTU2MDQ_f2d0b9e2-8c38-417d-b642-f400cd5816f4">5,415</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issued as payment for services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" decimals="-3" name="pgen:SharesIssuedDuringPeriodValueIssuedForServices" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMTYtMS0xLTEtMTU2MDQ_f7dd4775-940f-435d-b631-1a739017e13b">576</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331" decimals="-3" name="pgen:SharesIssuedDuringPeriodValueIssuedForServices" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMTYtMy0xLTEtMTU2MDQ_916565fd-8e62-4667-89d8-4e4bc147934e">577</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for credit losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMTctMS0xLTEtMTU2MDQ_e234077c-d9e2-4c0e-9604-141bad415aec">334</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMTctMy0xLTEtMTU2MDQ_ac02c8a1-3e82-453c-9773-dbb5e0235346">162</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accretion of debt discount and amortization of deferred financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" decimals="-3" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMTgtMS0xLTEtMTU2MDQ_14bffbbb-cd2c-421a-bed9-2da702e8d404">284</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331" decimals="-3" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMTgtMy0xLTEtMTU2MDQ_0ad35c33-d96e-4b4a-bfa9-253bcb16b4aa">2,751</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMTktMS0xLTEtMTU2MDQ_907f5c1e-8626-4c62-9963-8532348c91dd">58</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMTktMy0xLTEtMTU2MDQ_63d2ba9d-5b88-4435-94b4-7f02b6f2b575">56</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncash gain on termination of operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" decimals="-3" name="pgen:NoncashGainLossOnTerminationOfLease" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMjAtMS0xLTEtMjczOTY_14397878-57c6-4db1-ae09-71a77e4b6b36">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331" decimals="-3" name="pgen:NoncashGainLossOnTerminationOfLease" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMjAtMy0xLTEtMjczOTY_7420725b-b8f7-4a3e-9870-fff6eeb860ff">4,602</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other noncash items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" decimals="-3" name="us-gaap:OtherNoncashIncomeExpense" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMjAtMS0xLTEtMTU2MDQ_7291666c-3f52-4c44-82d2-ed144935c848">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMjAtMy0xLTEtMTU2MDQ_9dae3f44-963b-4930-a1d2-aea1324a3b4c">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMjMtMS0xLTEtMTU2MDQ_1c0c3353-ef23-43a8-8ac1-7e11818c11b9">3,696</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMjMtMy0xLTEtMTU2MDQ_8c046fea-0b17-4126-b435-1b2a7649a7f1">4,949</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Related parties</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInDueFromRelatedPartiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMjQtMS0xLTEtMTU2MDQ_8f8b4c60-38f2-4968-ab1a-1f88cce9c541">58</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInDueFromRelatedPartiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMjQtMy0xLTEtMTU2MDQ_dc65adc4-321b-4b57-b761-034ccb71f5b3">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherReceivables" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMjYtMS0xLTEtMTU2MDQ_7fa941e4-960e-40c3-8c2c-038fda16e590">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherReceivables" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMjYtMy0xLTEtMTU2MDQ_dc9c1be8-694c-45a3-90dc-bb518f60f442">279</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMjctMS0xLTEtMTU2MDQ_e26f506c-4343-4835-8af0-f0d7f73d4138">531</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMjctMy0xLTEtMTU2MDQ_b3516d21-819c-48da-a097-1ddca8a424e2">721</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMjgtMS0xLTEtMTU2MDQ_81ab0ad0-c5f2-4b42-bb6e-56ddde3edc4d">1,571</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMjgtMy0xLTEtMTU2MDQ_8663c6c4-aa28-4a8d-9002-d119267eba02">844</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMjktMS0xLTEtMTU2MDQ_60255235-edc6-4177-87ac-06598ff99e54">42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMjktMy0xLTEtMTU2MDQ_837189f3-bc05-42a9-906e-8630b67e8ffb">95</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableTrade" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMzAtMS0xLTEtMTU2MDQ_b4499e29-a102-4736-8df3-8f0e5440bb05">588</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableTrade" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMzAtMy0xLTEtMTU2MDQ_c73c38ab-130c-4722-abec-c4119e876260">189</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation and benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMzEtMS0xLTEtMTU2MDQ_14761a1f-2d20-477b-8845-231831c5fce3">3,462</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMzEtMy0xLTEtMTU2MDQ_b8523d43-4ba5-400b-989a-86042a5c2dc7">1,893</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMzItMS0xLTEtMTU2MDQ_27b9a9da-465b-4ee5-b982-8a7aedfbc400">1,086</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMzItMy0xLTEtMTU2MDQ_ba757d08-a616-42fb-815d-9674859db805">2,216</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMzMtMS0xLTEtMTU2MDQ_4d70b85b-e77a-431c-96f0-9a8e9fdac7d7">1,767</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331" decimals="-3" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMzMtMy0xLTEtMTU2MDQ_41628ca9-ac04-4d76-aa07-ca4c1c69e7e6">1,054</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMzQtMS0xLTEtMTU2MDQ_6d3b4c05-17a9-4127-a0d8-d9e37635e2d1">18</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331" decimals="-3" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMzQtMy0xLTEtMTU2MDQ_63e6a9c8-7a16-40d7-b542-5c6b31d524cd">218</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Related party payables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMzUtMS0xLTEtMTU2MDQ_afe3f8fb-4e38-4629-bb2c-f437052b38e4">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331" decimals="-3" name="us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMzUtMy0xLTEtMTU2MDQ_2e3e591b-310d-4e92-9bb5-2c0b451764d9">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 79.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMzctMS0xLTEtMTU2MDQ_807e52b2-dc41-432b-ae25-2736423cace4">18,783</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMzctMy0xLTEtMTU2MDQ_e0c3f4f1-7729-4019-a6c3-6b22344f68c8">16,384</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Precigen, Inc. and Subsidiaries</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Cash Flows</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended&#160;<br/>&#160;March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">(Amounts in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from investing activities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of investments</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsToAcquireInvestments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjhlYjgwOTUzMjk0ODQ4NzU4YjU3NWQyZjk5NjM2NTBmL3RhYmxlcmFuZ2U6OGViODA5NTMyOTQ4NDg3NThiNTc1ZDJmOTk2MzY1MGZfMy0xLTEtMS0xNTYwNA_28366ac6-dc25-4b86-bee6-8f11c4922267">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331" decimals="-3" name="us-gaap:PaymentsToAcquireInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjhlYjgwOTUzMjk0ODQ4NzU4YjU3NWQyZjk5NjM2NTBmL3RhYmxlcmFuZ2U6OGViODA5NTMyOTQ4NDg3NThiNTc1ZDJmOTk2MzY1MGZfMy0zLTEtMS0xNTYwNA_26cacc86-f8c4-4177-bdb6-5466cca65ed0">174,221</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and maturities of investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" decimals="-3" name="us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjhlYjgwOTUzMjk0ODQ4NzU4YjU3NWQyZjk5NjM2NTBmL3RhYmxlcmFuZ2U6OGViODA5NTMyOTQ4NDg3NThiNTc1ZDJmOTk2MzY1MGZfNC0xLTEtMS0xNTYwNA_c2014849-7d64-4aa5-a6f1-09e812723847">18,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331" decimals="-3" name="us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjhlYjgwOTUzMjk0ODQ4NzU4YjU3NWQyZjk5NjM2NTBmL3RhYmxlcmFuZ2U6OGViODA5NTMyOTQ4NDg3NThiNTc1ZDJmOTk2MzY1MGZfNC0zLTEtMS0xNTYwNA_9d1acaf6-6973-4686-a8dd-e4f2bb69b7cf">40,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjhlYjgwOTUzMjk0ODQ4NzU4YjU3NWQyZjk5NjM2NTBmL3RhYmxlcmFuZ2U6OGViODA5NTMyOTQ4NDg3NThiNTc1ZDJmOTk2MzY1MGZfMTAtMS0xLTEtMTU2MDQ_a6e55c37-b7a8-42d3-af68-168998fd0512">1,579</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjhlYjgwOTUzMjk0ODQ4NzU4YjU3NWQyZjk5NjM2NTBmL3RhYmxlcmFuZ2U6OGViODA5NTMyOTQ4NDg3NThiNTc1ZDJmOTk2MzY1MGZfMTAtMy0xLTEtMTU2MDQ_ce00562b-2fbd-4ee2-9c6d-f0c5db4e085a">1,014</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sale of assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" decimals="-3" name="us-gaap:ProceedsFromSaleOfOtherAssetsInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjhlYjgwOTUzMjk0ODQ4NzU4YjU3NWQyZjk5NjM2NTBmL3RhYmxlcmFuZ2U6OGViODA5NTMyOTQ4NDg3NThiNTc1ZDJmOTk2MzY1MGZfMTEtMS0xLTEtMTU2MDQ_41c8cb03-2b67-47f1-90da-1c5b4acb323a">147</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331" decimals="-3" name="us-gaap:ProceedsFromSaleOfOtherAssetsInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjhlYjgwOTUzMjk0ODQ4NzU4YjU3NWQyZjk5NjM2NTBmL3RhYmxlcmFuZ2U6OGViODA5NTMyOTQ4NDg3NThiNTc1ZDJmOTk2MzY1MGZfMTEtMy0xLTEtMTU2MDQ_c051bf8a-cddb-4ba3-bee9-8b8140695e51">1,944</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from repayment of notes receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" decimals="-3" name="us-gaap:ProceedsFromCollectionOfNotesReceivable" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjhlYjgwOTUzMjk0ODQ4NzU4YjU3NWQyZjk5NjM2NTBmL3RhYmxlcmFuZ2U6OGViODA5NTMyOTQ4NDg3NThiNTc1ZDJmOTk2MzY1MGZfMTQtMS0xLTEtMTU2MDQ_c18fc676-0852-4d46-8691-1434558b02e0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331" decimals="-3" name="us-gaap:ProceedsFromCollectionOfNotesReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjhlYjgwOTUzMjk0ODQ4NzU4YjU3NWQyZjk5NjM2NTBmL3RhYmxlcmFuZ2U6OGViODA5NTMyOTQ4NDg3NThiNTc1ZDJmOTk2MzY1MGZfMTQtMy0xLTEtMTU2MDQ_48609359-84d5-4efb-a663-c45257e1f0ae">3,689</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 79.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in) investing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" decimals="-3" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjhlYjgwOTUzMjk0ODQ4NzU4YjU3NWQyZjk5NjM2NTBmL3RhYmxlcmFuZ2U6OGViODA5NTMyOTQ4NDg3NThiNTc1ZDJmOTk2MzY1MGZfMTUtMS0xLTEtMTU2MDQ_ada59aa6-909b-4cf2-9299-8181df39587f">16,568</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjhlYjgwOTUzMjk0ODQ4NzU4YjU3NWQyZjk5NjM2NTBmL3RhYmxlcmFuZ2U6OGViODA5NTMyOTQ4NDg3NThiNTc1ZDJmOTk2MzY1MGZfMTUtMy0xLTEtMTU2MDQ_befcdaa1-dc62-40a1-81bd-f1c7c69279b8">129,102</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from financing activities</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from issuance of shares, net of issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjhlYjgwOTUzMjk0ODQ4NzU4YjU3NWQyZjk5NjM2NTBmL3RhYmxlcmFuZ2U6OGViODA5NTMyOTQ4NDg3NThiNTc1ZDJmOTk2MzY1MGZfMTctMS0xLTEtMTU2MDQ_969bb0ca-b2b9-4d5c-9f53-0b7e220a2eb7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjhlYjgwOTUzMjk0ODQ4NzU4YjU3NWQyZjk5NjM2NTBmL3RhYmxlcmFuZ2U6OGViODA5NTMyOTQ4NDg3NThiNTc1ZDJmOTk2MzY1MGZfMTctMy0xLTEtMTU2MDQ_d0af8d59-aa26-497d-b96f-7b54b5cc328e">121,045</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" decimals="-3" name="us-gaap:RepaymentsOfLongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjhlYjgwOTUzMjk0ODQ4NzU4YjU3NWQyZjk5NjM2NTBmL3RhYmxlcmFuZ2U6OGViODA5NTMyOTQ4NDg3NThiNTc1ZDJmOTk2MzY1MGZfMjItMS0xLTEtMTU2MDQ_44b20660-33f4-47e0-ab67-06c5c3b023c0">164</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331" decimals="-3" name="us-gaap:RepaymentsOfLongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjhlYjgwOTUzMjk0ODQ4NzU4YjU3NWQyZjk5NjM2NTBmL3RhYmxlcmFuZ2U6OGViODA5NTMyOTQ4NDg3NThiNTc1ZDJmOTk2MzY1MGZfMjItMy0xLTEtMTU2MDQ_45c7d0c3-00d7-4e31-8312-306fd72aa9ed">116</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from stock option exercises</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjhlYjgwOTUzMjk0ODQ4NzU4YjU3NWQyZjk5NjM2NTBmL3RhYmxlcmFuZ2U6OGViODA5NTMyOTQ4NDg3NThiNTc1ZDJmOTk2MzY1MGZfMjMtMS0xLTEtMTU2MDQ_edb7a559-72f5-41ef-8c0d-2d4397dccaae">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjhlYjgwOTUzMjk0ODQ4NzU4YjU3NWQyZjk5NjM2NTBmL3RhYmxlcmFuZ2U6OGViODA5NTMyOTQ4NDg3NThiNTc1ZDJmOTk2MzY1MGZfMjMtMy0xLTEtMTU2MDQ_a954d784-46cf-442a-8c04-a6846f18df3e">111</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 79.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash (used in) provided by financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjhlYjgwOTUzMjk0ODQ4NzU4YjU3NWQyZjk5NjM2NTBmL3RhYmxlcmFuZ2U6OGViODA5NTMyOTQ4NDg3NThiNTc1ZDJmOTk2MzY1MGZfMjUtMS0xLTEtMTU2MDQ_ad411274-832a-4cc7-952c-ac42d597e026">163</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjhlYjgwOTUzMjk0ODQ4NzU4YjU3NWQyZjk5NjM2NTBmL3RhYmxlcmFuZ2U6OGViODA5NTMyOTQ4NDg3NThiNTc1ZDJmOTk2MzY1MGZfMjUtMy0xLTEtMTU2MDQ_6cba4e8b-90d4-4b9c-b9ee-80bf5f69dbe0">121,040</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash, cash equivalents, and restricted cash</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjhlYjgwOTUzMjk0ODQ4NzU4YjU3NWQyZjk5NjM2NTBmL3RhYmxlcmFuZ2U6OGViODA5NTMyOTQ4NDg3NThiNTc1ZDJmOTk2MzY1MGZfMjYtMS0xLTEtMTU2MDQ_e0008fa6-f364-4c01-996c-52efb263d1b8">230</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjhlYjgwOTUzMjk0ODQ4NzU4YjU3NWQyZjk5NjM2NTBmL3RhYmxlcmFuZ2U6OGViODA5NTMyOTQ4NDg3NThiNTc1ZDJmOTk2MzY1MGZfMjYtMy0xLTEtMTU2MDQ_ff3d3839-45f9-4b01-972b-18c4242b21ed">11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 79.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net decrease in cash, cash equivalents, and restricted cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjhlYjgwOTUzMjk0ODQ4NzU4YjU3NWQyZjk5NjM2NTBmL3RhYmxlcmFuZ2U6OGViODA5NTMyOTQ4NDg3NThiNTc1ZDJmOTk2MzY1MGZfMjctMS0xLTEtMTU2MDQ_0d2b1196-bc4a-4355-8743-56a5422d0501">2,608</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjhlYjgwOTUzMjk0ODQ4NzU4YjU3NWQyZjk5NjM2NTBmL3RhYmxlcmFuZ2U6OGViODA5NTMyOTQ4NDg3NThiNTc1ZDJmOTk2MzY1MGZfMjctMy0xLTEtMTU2MDQ_196b66d9-78dc-4a6a-aa0a-66b2791799c2">24,457</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash, cash equivalents, and restricted cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjhlYjgwOTUzMjk0ODQ4NzU4YjU3NWQyZjk5NjM2NTBmL3RhYmxlcmFuZ2U6OGViODA5NTMyOTQ4NDg3NThiNTc1ZDJmOTk2MzY1MGZfMjktMS0xLTEtMTU2MDQ_e6727e3e-a347-4fcb-87c7-3c1e7fa79962">43,343</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54a90f374db746b78de00be9871944ac_I20201231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjhlYjgwOTUzMjk0ODQ4NzU4YjU3NWQyZjk5NjM2NTBmL3RhYmxlcmFuZ2U6OGViODA5NTMyOTQ4NDg3NThiNTc1ZDJmOTk2MzY1MGZfMjktMy0xLTEtMTU2MDQ_f24ec33d-8166-41a6-b42e-7f37786f2fc9">52,250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjhlYjgwOTUzMjk0ODQ4NzU4YjU3NWQyZjk5NjM2NTBmL3RhYmxlcmFuZ2U6OGViODA5NTMyOTQ4NDg3NThiNTc1ZDJmOTk2MzY1MGZfMzAtMS0xLTEtMTU2MDQ_a40c1449-f1bb-4566-bd38-5e16b2dbef59">40,735</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7b79aae0fa241fb908efc36ca29e3d3_I20210331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjhlYjgwOTUzMjk0ODQ4NzU4YjU3NWQyZjk5NjM2NTBmL3RhYmxlcmFuZ2U6OGViODA5NTMyOTQ4NDg3NThiNTc1ZDJmOTk2MzY1MGZfMzAtMy0xLTEtMTU2MDQ_06ebc34b-c48b-46d3-9598-fa2d780a18d1">27,793</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Supplemental disclosure of cash flow information</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid during the period for interest</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjhlYjgwOTUzMjk0ODQ4NzU4YjU3NWQyZjk5NjM2NTBmL3RhYmxlcmFuZ2U6OGViODA5NTMyOTQ4NDg3NThiNTc1ZDJmOTk2MzY1MGZfMzItMS0xLTEtMTU2MDQ_686568a9-2f86-46c5-9c71-38c29981c0cd">3,535</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjhlYjgwOTUzMjk0ODQ4NzU4YjU3NWQyZjk5NjM2NTBmL3RhYmxlcmFuZ2U6OGViODA5NTMyOTQ4NDg3NThiNTc1ZDJmOTk2MzY1MGZfMzItMy0xLTEtMTU2MDQ_dfa39306-04f9-44c0-9dc0-13df81c592db">3,539</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid during the period for income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" decimals="-3" name="us-gaap:IncomeTaxesPaid" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjhlYjgwOTUzMjk0ODQ4NzU4YjU3NWQyZjk5NjM2NTBmL3RhYmxlcmFuZ2U6OGViODA5NTMyOTQ4NDg3NThiNTc1ZDJmOTk2MzY1MGZfMzMtMS0xLTEtMTU2MDQ_5e50cc4c-6600-47bd-87a0-d1ef7101fb2b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331" decimals="-3" name="us-gaap:IncomeTaxesPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjhlYjgwOTUzMjk0ODQ4NzU4YjU3NWQyZjk5NjM2NTBmL3RhYmxlcmFuZ2U6OGViODA5NTMyOTQ4NDg3NThiNTc1ZDJmOTk2MzY1MGZfMzMtMy0xLTEtMTU2MDQ_3b682430-1d65-41ee-88db-17c0c648166e">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Significant noncash activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation paid in equity awards</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" decimals="-3" name="pgen:AccruedCompensationPaidinEquityAwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjhlYjgwOTUzMjk0ODQ4NzU4YjU3NWQyZjk5NjM2NTBmL3RhYmxlcmFuZ2U6OGViODA5NTMyOTQ4NDg3NThiNTc1ZDJmOTk2MzY1MGZfMzctMS0xLTEtMTU2MDQ_644fff22-0980-4851-9045-05893080fd3c">1,698</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331" decimals="-3" name="pgen:AccruedCompensationPaidinEquityAwards" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjhlYjgwOTUzMjk0ODQ4NzU4YjU3NWQyZjk5NjM2NTBmL3RhYmxlcmFuZ2U6OGViODA5NTMyOTQ4NDg3NThiNTc1ZDJmOTk2MzY1MGZfMzctMy0xLTEtMTU2MDQ_c760ab8e-1257-4ea8-81aa-d5baed32e048">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of property and equipment included in accounts payable and other accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjhlYjgwOTUzMjk0ODQ4NzU4YjU3NWQyZjk5NjM2NTBmL3RhYmxlcmFuZ2U6OGViODA5NTMyOTQ4NDg3NThiNTc1ZDJmOTk2MzY1MGZfMzgtMS0xLTEtMTU2MDQ_64a236e4-0194-47ac-9794-178e705218e2">251</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjhlYjgwOTUzMjk0ODQ4NzU4YjU3NWQyZjk5NjM2NTBmL3RhYmxlcmFuZ2U6OGViODA5NTMyOTQ4NDg3NThiNTc1ZDJmOTk2MzY1MGZfMzgtMy0xLTEtMTU2MDQ_c8d27fc5-9244-4b05-9f0d-c63c45c6b913">255</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sale of assets included in accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" decimals="-3" name="pgen:SaleOfAssetsIncludedInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjhlYjgwOTUzMjk0ODQ4NzU4YjU3NWQyZjk5NjM2NTBmL3RhYmxlcmFuZ2U6OGViODA5NTMyOTQ4NDg3NThiNTc1ZDJmOTk2MzY1MGZfNDAtMS0xLTEtMTU2MDQ_6401b1e1-200b-4f35-bc11-519c77172e01">132</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331" decimals="-3" name="pgen:SaleOfAssetsIncludedInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjhlYjgwOTUzMjk0ODQ4NzU4YjU3NWQyZjk5NjM2NTBmL3RhYmxlcmFuZ2U6OGViODA5NTMyOTQ4NDg3NThiNTc1ZDJmOTk2MzY1MGZfNDAtMy0xLTEtMTU2MDQ_28437ade-4ba3-40f9-a4e8-447609deacb3">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of the cash, cash equivalents, and restricted cash balances as of March&#160;31, 2022 and December&#160;31, 2021 as shown above:</span></div><div style="margin-top:15pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjU5OWNjNTQ4Y2UyNzQzYjg4NjMxNjJjOWRkNDhlNjE4L3RhYmxlcmFuZ2U6NTk5Y2M1NDhjZTI3NDNiODg2MzE2MmM5ZGQ0OGU2MThfMS0xLTEtMS0xNTYwNA_4320d194-5626-44ba-8578-0da368f77124">40,321</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjU5OWNjNTQ4Y2UyNzQzYjg4NjMxNjJjOWRkNDhlNjE4L3RhYmxlcmFuZ2U6NTk5Y2M1NDhjZTI3NDNiODg2MzE2MmM5ZGQ0OGU2MThfMS0zLTEtMS0xNTYwNA_89a058d9-f69e-4d12-833a-1b18da41e804">42,920</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash included in other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalentsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjU5OWNjNTQ4Y2UyNzQzYjg4NjMxNjJjOWRkNDhlNjE4L3RhYmxlcmFuZ2U6NTk5Y2M1NDhjZTI3NDNiODg2MzE2MmM5ZGQ0OGU2MThfNC0xLTEtMS0xNTYwNA_7d01add1-0fce-45b9-a112-cd9b6597cd41">414</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalentsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjU5OWNjNTQ4Y2UyNzQzYjg4NjMxNjJjOWRkNDhlNjE4L3RhYmxlcmFuZ2U6NTk5Y2M1NDhjZTI3NDNiODg2MzE2MmM5ZGQ0OGU2MThfNC0zLTEtMS0xNTYwNA_f2c33531-bab4-4bb7-9264-4d1698292d69">423</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents, and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjU5OWNjNTQ4Y2UyNzQzYjg4NjMxNjJjOWRkNDhlNjE4L3RhYmxlcmFuZ2U6NTk5Y2M1NDhjZTI3NDNiODg2MzE2MmM5ZGQ0OGU2MThfNS0xLTEtMS0xNTYwNA_9f3cb61e-2374-42a3-b765-c9d4f82a1df9">40,735</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjU5OWNjNTQ4Y2UyNzQzYjg4NjMxNjJjOWRkNDhlNjE4L3RhYmxlcmFuZ2U6NTk5Y2M1NDhjZTI3NDNiODg2MzE2MmM5ZGQ0OGU2MThfNS0zLTEtMS0xNTYwNA_205d5fa6-fe0c-46f8-afc1-e30670141212">43,343</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><div id="i7169a803a6aa44ea981603d220cab84f_34"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Precigen, Inc. and Subsidiaries</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to the Condensed Consolidated Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(Amounts in thousands, except share and per share data)</span></div><div id="i7169a803a6aa44ea981603d220cab84f_37"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1. <ix:nonNumeric contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zNy9mcmFnOjVhYjUzYjVlY2JjNzRmYjBiM2VhNGYyNWU1NjgzNTk5L3RleHRyZWdpb246NWFiNTNiNWVjYmM3NGZiMGIzZWE0ZjI1ZTU2ODM1OTlfMzMzNA_62f6432e-1740-421b-9125-f3ddaea8185b" continuedAt="i617e0f8713aa429eaee1d6506f69c670" escape="true">Organization</ix:nonNumeric></span></div><ix:continuation id="i617e0f8713aa429eaee1d6506f69c670"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Precigen, Inc. ("Precigen"), a Virginia corporation, is a synthetic biology company with an increasing focus on its discovery and clinical stage activities to advance the next generation of gene and cellular therapies to target the most urgent and intractable challenges in immuno-oncology, autoimmune disorders, and infectious diseases. Precigen operates through the following subsidiaries: </span></div><div style="margin-top:12pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PGEN Therapeutics, Inc. ("PGEN Therapeutics") is a dedicated discovery and clinical stage biopharmaceutical company advancing the next generation of gene and cell therapies using precision technology to target urgent and intractable diseases in immuno-oncology, autoimmune disorders, and infectious diseases. PGEN Therapeutics is a wholly owned subsidiary of Precigen with primary operations in Maryland.</span></div><div style="margin-top:12pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Precigen ActoBio, Inc. ("ActoBio") is pioneering a proprietary class of microbe-based biopharmaceuticals that enable expression and local delivery of disease-modifying therapeutics and is a wholly owned subsidiary of Precigen with primary operations in Belgium.</span></div><div style="margin-top:12pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exemplar Genetics, LLC, doing business as Precigen Exemplar ("Exemplar"), is committed to enabling the study of life-threatening human diseases through the development of MiniSwine Yucatan miniature pig research models and services, as well as enabling the production of cells and organs in its genetically engineered swine for regenerative medicine applications and is a wholly owned subsidiary of Precigen with primary operations in Iowa.</span></div><div style="margin-top:12pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trans Ova Genetics, L.C., including its wholly owned subsidiary Progentus, L.C., are providers of reproductive technologies, including services and products sold to cattle breeders and other producers and are hereinafter collectively referred to as "Trans Ova." Trans Ova is a wholly owned subsidiary with primary operations in California, Iowa, Maryland, Missouri, Texas, Washington, and Wisconsin.</span></div><div style="margin-top:12pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective October 1, 2019, Precigen transferred substantially all of its proprietary methane bioconversion platform ("MBP") assets to a wholly owned subsidiary, MBP Titan LLC ("MBP Titan"). MBP Titan's proprietary technology is designed to convert natural gas into more valuable and usable energy and chemical products through novel, highly engineered bacteria that utilize specific energy feedstocks. Prior to October 1, 2019, the operation transferred to MBP Titan was an operating division within Precigen. Beginning in the second quarter of 2020, the Company suspended MBP Titan's operations and began the process to wind down MBP Titan's activities and had substantially completed the wind down by December 31, 2020, with the final disposition of certain property and equipment and the facility operating lease occurring in January 2021. With the exception of certain assets and obligations with which the Company has a continuing involvement after the wind down, MBP Titan has been presented as discontinued operations for all periods presented. See Note 3 for further discussion.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Precigen and its consolidated subsidiaries are hereinafter referred to as the "Company."</span></div></ix:continuation><div id="i7169a803a6aa44ea981603d220cab84f_40"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2. <ix:nonNumeric contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80MC9mcmFnOmJlNWZjYmY0ODg0YTQ3MjNhNzllZDYyYzFlM2U1MTYyL3RleHRyZWdpb246YmU1ZmNiZjQ4ODRhNDcyM2E3OWVkNjJjMWUzZTUxNjJfMTA1NTU_9d29198d-73ef-43d7-a405-27d7535dd05e" continuedAt="ice739f99706547749af39926dca4a9e8" escape="true">Summary of Significant Accounting Policies</ix:nonNumeric></span></div><ix:continuation id="ice739f99706547749af39926dca4a9e8" continuedAt="if83f2e30121b4d7587a120fc020c1671"><ix:nonNumeric contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80MC9mcmFnOmJlNWZjYmY0ODg0YTQ3MjNhNzllZDYyYzFlM2U1MTYyL3RleHRyZWdpb246YmU1ZmNiZjQ4ODRhNDcyM2E3OWVkNjJjMWUzZTUxNjJfMTA2MTM_f2b393c8-4c61-42f6-8e8e-f52308d87961" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying interim condensed consolidated financial statements are unaudited and have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP"). Certain information and footnote disclosures normally included in the Company's annual financial statements have been condensed or omitted. These interim condensed consolidated financial statements, in the opinion of management, reflect all normal recurring adjustments necessary for fair statement of the Company's financial position as of March&#160;31, 2022 and results of operations and cash flows for the interim periods ended March&#160;31, 2022 and 2021. The year-end condensed consolidated balance sheet data was derived from the Company's audited financial statements but does not include all disclosures required by U.S. GAAP. These interim financial results are not necessarily indicative of the results to be expected for the year ending December&#160;31, 2022, or for any other future annual or interim period. The accompanying interim unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related notes thereto included in the Company's Annual Report on Form 10-K for the year ended December&#160;31, 2021.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_7">Table of Contents</a></span></div></div><ix:continuation id="if83f2e30121b4d7587a120fc020c1671" continuedAt="id1f8a3e29bb54fdbb965c3d9ab605832"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" name="us-gaap:ConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80MC9mcmFnOmJlNWZjYmY0ODg0YTQ3MjNhNzllZDYyYzFlM2U1MTYyL3RleHRyZWdpb246YmU1ZmNiZjQ4ODRhNDcyM2E3OWVkNjJjMWUzZTUxNjJfMTA2MjU_7d6e4d7a-ab40-4007-9f49-096bdb07a713" escape="true">The accompanying condensed consolidated financial statements reflect the operations of Precigen and its subsidiaries. All intercompany accounts and transactions have been eliminated.</ix:nonNumeric></span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Liquidity </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management believes that existing liquid assets as of March&#160;31, 2022 will allow the Company to continue its operations for at least a year from the issuance date of these condensed consolidated financial statements. These condensed consolidated financial statements are presented in United States dollars. The Company is subject to a number of risks similar to those of other companies conducting high-risk, early-stage research and development of therapeutic product candidates. Principal among these risks are dependence on key individuals and intellectual property, competition from other products and companies, and the technical risks associated with the successful research, development, and clinical manufacturing of its and its collaborators' therapeutic product candidates. Additionally, the accompanying condensed consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. During the three months ended March 31, 2022, the Company incurred a net loss of $<ix:nonFraction unitRef="usd" contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80MC9mcmFnOmJlNWZjYmY0ODg0YTQ3MjNhNzllZDYyYzFlM2U1MTYyL3RleHRyZWdpb246YmU1ZmNiZjQ4ODRhNDcyM2E3OWVkNjJjMWUzZTUxNjJfMjU2Mw_c9a29005-d88d-4217-9c1d-bf7053d5ddd5">19,251</ix:nonFraction> and, as of March&#160;31, 2022, had an accumulated deficit of $<ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80MC9mcmFnOmJlNWZjYmY0ODg0YTQ3MjNhNzllZDYyYzFlM2U1MTYyL3RleHRyZWdpb246YmU1ZmNiZjQ4ODRhNDcyM2E3OWVkNjJjMWUzZTUxNjJfMjYxMQ_1efbf4df-252f-4513-9d21-9b53f43b7ece">1,916,135</ix:nonFraction>. Management expects operating losses and negative cash flows to continue for the foreseeable future and, as a result, the Company will require additional capital to fund its operations and execute its business plan. In the absence of a significant source of recurring revenue, the Company's long-term success is dependent upon its ability to continue to raise additional capital in order to fund ongoing research and development (which could occur through debt or equity issuances, sales or partnerships of non-core assets, corroborations or licensing of core or non-core assets, or other transactions), adequately satisfy or renegotiate long-term debt obligations, obtain regulatory approval of its therapeutic product candidates, successfully commercialize its therapeutic product candidates, generate revenue, meet its obligations and, ultimately, attain profitable operations.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Risks and Uncertainties</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">COVID-19 has had and continues to have an extensive impact on the global health and economic environments. Furthermore, there is uncertainty regarding the duration and severity of the ongoing pandemic, and the Company could experience delays or other pandemic-related events that may adversely impact the Company's clinical as well as preclinical pipeline candidates in the future.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is closely monitoring the impact of COVID-19 on all aspects of its businesses. Given the dynamic nature of these circumstances, the full impact of the COVID-19 pandemic on the Company's ongoing business, results of operations, and overall financial performance in future periods cannot be reasonably estimated at this time, and it could have a material adverse effect on the Company's results of operations, cash flows, and financial position, including resulting impairments to goodwill and long-lived assets and additional credit losses.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 3 for further discussion of the impact of COVID-19 on MBP Titan.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" name="us-gaap:EquityMethodInvestmentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80MC9mcmFnOmJlNWZjYmY0ODg0YTQ3MjNhNzllZDYyYzFlM2U1MTYyL3RleHRyZWdpb246YmU1ZmNiZjQ4ODRhNDcyM2E3OWVkNjJjMWUzZTUxNjJfMTA2MDE_fc7dbb4c-8ea1-42e3-a1c4-7715e3bd1714" continuedAt="id7466aa3319043f886005fae9afb5ea4" escape="true">Equity Method Investments</ix:nonNumeric></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="id7466aa3319043f886005fae9afb5ea4">The Company accounts for its investments in each of its joint ventures ("JVs")  using the equity method of accounting based upon relative ownership interest.</ix:continuation> See additional discussion related to certain of the Company's JVs in Note 4. </span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" name="us-gaap:ConsolidationVariableInterestEntityPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80MC9mcmFnOmJlNWZjYmY0ODg0YTQ3MjNhNzllZDYyYzFlM2U1MTYyL3RleHRyZWdpb246YmU1ZmNiZjQ4ODRhNDcyM2E3OWVkNjJjMWUzZTUxNjJfMTA2MTY_999a47cc-0792-44b5-83c4-8996a4a58180" continuedAt="ibd406ad789ac454cafb9489d0772ae3e" escape="true">Variable Interest Entities</ix:nonNumeric></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ibd406ad789ac454cafb9489d0772ae3e">As of March&#160;31, 2022 and December&#160;31, 2021, the Company determined that its JVs were variable interest entities ("VIEs"). The Company was not the primary beneficiary for these entities since it did not have the power to direct the activities that most significantly impact the economic performance of the VIEs.</ix:continuation> As of March&#160;31, 2022 and December&#160;31, 2021, the Company had <ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="INF" name="us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80MC9mcmFnOmJlNWZjYmY0ODg0YTQ3MjNhNzllZDYyYzFlM2U1MTYyL3RleHRyZWdpb246YmU1ZmNiZjQ4ODRhNDcyM2E3OWVkNjJjMWUzZTUxNjJfNjM5NQ_738f05e0-ed93-4ecb-b75c-794ae7879f76"><ix:nonFraction unitRef="usd" contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231" decimals="INF" name="us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80MC9mcmFnOmJlNWZjYmY0ODg0YTQ3MjNhNzllZDYyYzFlM2U1MTYyL3RleHRyZWdpb246YmU1ZmNiZjQ4ODRhNDcyM2E3OWVkNjJjMWUzZTUxNjJfNjM5NQ_9be33a57-5996-49fb-b410-a1a1f7ea735e">no</ix:nonFraction></ix:nonFraction> risk of loss related to the identified VIEs. See Note 4 for discussion of the Company's future funding commitments for its significant JVs.</span></div><ix:nonNumeric contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" name="us-gaap:EarningsPerSharePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80MC9mcmFnOmJlNWZjYmY0ODg0YTQ3MjNhNzllZDYyYzFlM2U1MTYyL3RleHRyZWdpb246YmU1ZmNiZjQ4ODRhNDcyM2E3OWVkNjJjMWUzZTUxNjJfMzI5ODUzNDkwMzI1OA_19ff09b2-0be7-4c04-8f7f-6b08b7800e41" continuedAt="i016c88c4603445d58848b5870a08c719" escape="true"><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Loss per Share</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net loss per share is calculated by dividing net loss attributable to common shareholders by the weighted average shares outstanding during the period, without consideration of common stock equivalents. Diluted net loss per share is calculated by adjusting weighted average shares outstanding for the dilutive effect of common stock equivalents outstanding for the period, using the treasury-stock method. For purposes of the diluted net loss per share calculation, shares to be issued pursuant to convertible debt, stock options, RSUs, and warrants are considered to be common stock equivalents but are excluded from the </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_7">Table of Contents</a></span></div></div><ix:continuation id="id1f8a3e29bb54fdbb965c3d9ab605832" continuedAt="ie30530df8fc249edbd4ea3e3722f3572"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i016c88c4603445d58848b5870a08c719">calculation of diluted net loss per share because their effect would be anti-dilutive and, therefore, basic and diluted net loss per share were the same for all periods presented.</ix:continuation></span></div><ix:nonNumeric contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80MC9mcmFnOmJlNWZjYmY0ODg0YTQ3MjNhNzllZDYyYzFlM2U1MTYyL3RleHRyZWdpb246YmU1ZmNiZjQ4ODRhNDcyM2E3OWVkNjJjMWUzZTUxNjJfMzI5ODUzNDkwMzMwMw_ee0a05b0-0ebc-44ac-8d24-7bdf936a3c33" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following potentially dilutive securities as of March&#160;31, 2022 and 2021, have been excluded from the above computations of diluted weighted average shares outstanding for the three months then ended as they would have been anti-dilutive:</span></div><div style="margin-top:17pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:70.894%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.537%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible debt</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i13ea040140e440418a940e8363605b6b_D20220101-20220331" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80MC9mcmFnOmJlNWZjYmY0ODg0YTQ3MjNhNzllZDYyYzFlM2U1MTYyL3RhYmxlOjMyYWRkZWUwZTQ0MjQ0NjJiYzFjMzA0NWE0YTQ5NzEyL3RhYmxlcmFuZ2U6MzJhZGRlZTBlNDQyNDQ2MmJjMWMzMDQ1YTRhNDk3MTJfMi0xLTEtMS0yNTU1OQ_8689bf46-8068-4e93-ac5d-9b6adf12a1c8"><ix:nonFraction unitRef="shares" contextRef="i13ea040140e440418a940e8363605b6b_D20220101-20220331" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80MC9mcmFnOmJlNWZjYmY0ODg0YTQ3MjNhNzllZDYyYzFlM2U1MTYyL3RhYmxlOjMyYWRkZWUwZTQ0MjQ0NjJiYzFjMzA0NWE0YTQ5NzEyL3RhYmxlcmFuZ2U6MzJhZGRlZTBlNDQyNDQ2MmJjMWMzMDQ1YTRhNDk3MTJfMi0xLTEtMS0yNTU1OQ_d5c45955-6f85-4f23-9780-e1acabbef105">11,732,440</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ied4a3135345f415ca6385fc1d425993e_D20210101-20210331" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80MC9mcmFnOmJlNWZjYmY0ODg0YTQ3MjNhNzllZDYyYzFlM2U1MTYyL3RhYmxlOjMyYWRkZWUwZTQ0MjQ0NjJiYzFjMzA0NWE0YTQ5NzEyL3RhYmxlcmFuZ2U6MzJhZGRlZTBlNDQyNDQ2MmJjMWMzMDQ1YTRhNDk3MTJfMi0zLTEtMS0yNTU1OQ_024a0f3c-d132-4907-80dc-9b7399de7649"><ix:nonFraction unitRef="shares" contextRef="ied4a3135345f415ca6385fc1d425993e_D20210101-20210331" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80MC9mcmFnOmJlNWZjYmY0ODg0YTQ3MjNhNzllZDYyYzFlM2U1MTYyL3RhYmxlOjMyYWRkZWUwZTQ0MjQ0NjJiYzFjMzA0NWE0YTQ5NzEyL3RhYmxlcmFuZ2U6MzJhZGRlZTBlNDQyNDQ2MmJjMWMzMDQ1YTRhNDk3MTJfMi0zLTEtMS0yNTU1OQ_baa896fd-ebb4-4f2f-a348-ee7b7c8b30d5">11,732,440</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idf47d6aef2e44be1a923ae69756f5dae_D20220101-20220331" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80MC9mcmFnOmJlNWZjYmY0ODg0YTQ3MjNhNzllZDYyYzFlM2U1MTYyL3RhYmxlOjMyYWRkZWUwZTQ0MjQ0NjJiYzFjMzA0NWE0YTQ5NzEyL3RhYmxlcmFuZ2U6MzJhZGRlZTBlNDQyNDQ2MmJjMWMzMDQ1YTRhNDk3MTJfMy0xLTEtMS0yNTU1OQ_34782806-8a1f-47aa-914e-e0d5901f6787"><ix:nonFraction unitRef="shares" contextRef="idf47d6aef2e44be1a923ae69756f5dae_D20220101-20220331" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80MC9mcmFnOmJlNWZjYmY0ODg0YTQ3MjNhNzllZDYyYzFlM2U1MTYyL3RhYmxlOjMyYWRkZWUwZTQ0MjQ0NjJiYzFjMzA0NWE0YTQ5NzEyL3RhYmxlcmFuZ2U6MzJhZGRlZTBlNDQyNDQ2MmJjMWMzMDQ1YTRhNDk3MTJfMy0xLTEtMS0yNTU1OQ_94766b78-2d8e-45e1-8347-1b0d32041a96">16,034,553</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5aabaff5f1154c5891d0a750ae3d1e8f_D20210101-20210331" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80MC9mcmFnOmJlNWZjYmY0ODg0YTQ3MjNhNzllZDYyYzFlM2U1MTYyL3RhYmxlOjMyYWRkZWUwZTQ0MjQ0NjJiYzFjMzA0NWE0YTQ5NzEyL3RhYmxlcmFuZ2U6MzJhZGRlZTBlNDQyNDQ2MmJjMWMzMDQ1YTRhNDk3MTJfMy0zLTEtMS0yNTU1OQ_192af577-464c-4ae0-be7d-d6a1932287e6"><ix:nonFraction unitRef="shares" contextRef="i5aabaff5f1154c5891d0a750ae3d1e8f_D20210101-20210331" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80MC9mcmFnOmJlNWZjYmY0ODg0YTQ3MjNhNzllZDYyYzFlM2U1MTYyL3RhYmxlOjMyYWRkZWUwZTQ0MjQ0NjJiYzFjMzA0NWE0YTQ5NzEyL3RhYmxlcmFuZ2U6MzJhZGRlZTBlNDQyNDQ2MmJjMWMzMDQ1YTRhNDk3MTJfMy0zLTEtMS0yNTU1OQ_c36e6235-706e-45ba-8558-21275c23145d">11,451,614</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2ae4da9032b64f15ae1225c9f68e0a94_D20220101-20220331" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80MC9mcmFnOmJlNWZjYmY0ODg0YTQ3MjNhNzllZDYyYzFlM2U1MTYyL3RhYmxlOjMyYWRkZWUwZTQ0MjQ0NjJiYzFjMzA0NWE0YTQ5NzEyL3RhYmxlcmFuZ2U6MzJhZGRlZTBlNDQyNDQ2MmJjMWMzMDQ1YTRhNDk3MTJfNC0xLTEtMS0yNTU1OQ_1a4e1756-e558-49f6-b480-37ce5a53b43f"><ix:nonFraction unitRef="shares" contextRef="i2ae4da9032b64f15ae1225c9f68e0a94_D20220101-20220331" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80MC9mcmFnOmJlNWZjYmY0ODg0YTQ3MjNhNzllZDYyYzFlM2U1MTYyL3RhYmxlOjMyYWRkZWUwZTQ0MjQ0NjJiYzFjMzA0NWE0YTQ5NzEyL3RhYmxlcmFuZ2U6MzJhZGRlZTBlNDQyNDQ2MmJjMWMzMDQ1YTRhNDk3MTJfNC0xLTEtMS0yNTU1OQ_1d5c605f-0194-4511-b0a2-99fb42400339">1,185,205</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i37cfff500eac4815a708c1afd75ce14a_D20210101-20210331" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80MC9mcmFnOmJlNWZjYmY0ODg0YTQ3MjNhNzllZDYyYzFlM2U1MTYyL3RhYmxlOjMyYWRkZWUwZTQ0MjQ0NjJiYzFjMzA0NWE0YTQ5NzEyL3RhYmxlcmFuZ2U6MzJhZGRlZTBlNDQyNDQ2MmJjMWMzMDQ1YTRhNDk3MTJfNC0zLTEtMS0yNTU1OQ_97ccfbcb-d9cd-4b38-9a12-c6091cbcb00e"><ix:nonFraction unitRef="shares" contextRef="i37cfff500eac4815a708c1afd75ce14a_D20210101-20210331" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80MC9mcmFnOmJlNWZjYmY0ODg0YTQ3MjNhNzllZDYyYzFlM2U1MTYyL3RhYmxlOjMyYWRkZWUwZTQ0MjQ0NjJiYzFjMzA0NWE0YTQ5NzEyL3RhYmxlcmFuZ2U6MzJhZGRlZTBlNDQyNDQ2MmJjMWMzMDQ1YTRhNDk3MTJfNC0zLTEtMS0yNTU1OQ_f13fa212-9abf-4e77-8946-139c2c37cf7b">790,364</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i63eddf4feb1441d8920e87a7e333621c_D20220101-20220331" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80MC9mcmFnOmJlNWZjYmY0ODg0YTQ3MjNhNzllZDYyYzFlM2U1MTYyL3RhYmxlOjMyYWRkZWUwZTQ0MjQ0NjJiYzFjMzA0NWE0YTQ5NzEyL3RhYmxlcmFuZ2U6MzJhZGRlZTBlNDQyNDQ2MmJjMWMzMDQ1YTRhNDk3MTJfNS0xLTEtMS0yNTU1OQ_373394fe-710d-4c25-958c-56fe2655b5d2"><ix:nonFraction unitRef="shares" contextRef="i63eddf4feb1441d8920e87a7e333621c_D20220101-20220331" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80MC9mcmFnOmJlNWZjYmY0ODg0YTQ3MjNhNzllZDYyYzFlM2U1MTYyL3RhYmxlOjMyYWRkZWUwZTQ0MjQ0NjJiYzFjMzA0NWE0YTQ5NzEyL3RhYmxlcmFuZ2U6MzJhZGRlZTBlNDQyNDQ2MmJjMWMzMDQ1YTRhNDk3MTJfNS0xLTEtMS0yNTU1OQ_bb612d5f-9e68-4bae-9dbd-70351adfcdbe">121,888</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0d80cdb2ed0f480faecf8cdc7f92f497_D20210101-20210331" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80MC9mcmFnOmJlNWZjYmY0ODg0YTQ3MjNhNzllZDYyYzFlM2U1MTYyL3RhYmxlOjMyYWRkZWUwZTQ0MjQ0NjJiYzFjMzA0NWE0YTQ5NzEyL3RhYmxlcmFuZ2U6MzJhZGRlZTBlNDQyNDQ2MmJjMWMzMDQ1YTRhNDk3MTJfNS0zLTEtMS0yNTU1OQ_166a1aea-ced7-44db-9c5a-d58f17d41341"><ix:nonFraction unitRef="shares" contextRef="i0d80cdb2ed0f480faecf8cdc7f92f497_D20210101-20210331" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80MC9mcmFnOmJlNWZjYmY0ODg0YTQ3MjNhNzllZDYyYzFlM2U1MTYyL3RhYmxlOjMyYWRkZWUwZTQ0MjQ0NjJiYzFjMzA0NWE0YTQ5NzEyL3RhYmxlcmFuZ2U6MzJhZGRlZTBlNDQyNDQ2MmJjMWMzMDQ1YTRhNDk3MTJfNS0zLTEtMS0yNTU1OQ_28482338-f59f-44b8-829d-cff6b72d2de5">133,264</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80MC9mcmFnOmJlNWZjYmY0ODg0YTQ3MjNhNzllZDYyYzFlM2U1MTYyL3RhYmxlOjMyYWRkZWUwZTQ0MjQ0NjJiYzFjMzA0NWE0YTQ5NzEyL3RhYmxlcmFuZ2U6MzJhZGRlZTBlNDQyNDQ2MmJjMWMzMDQ1YTRhNDk3MTJfNi0xLTEtMS0yNTU1OQ_4b1c0f22-b57a-4e1e-b0c5-bd13a50b406b"><ix:nonFraction unitRef="shares" contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80MC9mcmFnOmJlNWZjYmY0ODg0YTQ3MjNhNzllZDYyYzFlM2U1MTYyL3RhYmxlOjMyYWRkZWUwZTQ0MjQ0NjJiYzFjMzA0NWE0YTQ5NzEyL3RhYmxlcmFuZ2U6MzJhZGRlZTBlNDQyNDQ2MmJjMWMzMDQ1YTRhNDk3MTJfNi0xLTEtMS0yNTU1OQ_b4bead26-2735-4dcd-97d8-c03c262f669c">29,074,086</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80MC9mcmFnOmJlNWZjYmY0ODg0YTQ3MjNhNzllZDYyYzFlM2U1MTYyL3RhYmxlOjMyYWRkZWUwZTQ0MjQ0NjJiYzFjMzA0NWE0YTQ5NzEyL3RhYmxlcmFuZ2U6MzJhZGRlZTBlNDQyNDQ2MmJjMWMzMDQ1YTRhNDk3MTJfNi0zLTEtMS0yNTU1OQ_17e449bb-fefb-4cab-9e02-80e5ffb3b453"><ix:nonFraction unitRef="shares" contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80MC9mcmFnOmJlNWZjYmY0ODg0YTQ3MjNhNzllZDYyYzFlM2U1MTYyL3RhYmxlOjMyYWRkZWUwZTQ0MjQ0NjJiYzFjMzA0NWE0YTQ5NzEyL3RhYmxlcmFuZ2U6MzJhZGRlZTBlNDQyNDQ2MmJjMWMzMDQ1YTRhNDk3MTJfNi0zLTEtMS0yNTU1OQ_4464e212-4cc4-4d3b-a3a5-1c96bcfde708">24,107,682</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80MC9mcmFnOmJlNWZjYmY0ODg0YTQ3MjNhNzllZDYyYzFlM2U1MTYyL3RleHRyZWdpb246YmU1ZmNiZjQ4ODRhNDcyM2E3OWVkNjJjMWUzZTUxNjJfMTA2MDU_adf3ade6-61af-4ed2-9cdd-31e8221c78dd" continuedAt="ib5837fc071384c6d9a07e6bbe627e44a" escape="true">Segment Information</ix:nonNumeric></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ib5837fc071384c6d9a07e6bbe627e44a">The Company's chief operating decision maker ("CODM") regularly reviews disaggregated financial information for various operating segments. Starting in 2021, the financial information regularly reviewed by the CODM was revised and the operating segments, which were determined to be operating and reportable segments, were (i) Biopharmaceuticals, (ii) Exemplar, and (iii) Trans Ova. The Biopharmaceuticals reportable segment is primarily comprised of the Company's legal entities of PGEN Therapeutics and ActoBio. All of Precigen's consolidated subsidiaries and operating divisions that did not meet the quantitative thresholds to report separately are combined and reported in a single category, All Other. See Note 1 for a description of PGEN Therapeutics, ActoBio, Exemplar, and Trans Ova. Corporate expenses, which are not allocated to the segments and are managed at a consolidated level, include costs associated with general and administrative functions, including the Company's finance, accounting, legal, human resources, information technology, corporate communication, and investor relations functions. Corporate expenses exclude interest expense, depreciation and amortization, gain or loss on disposals of assets, stock-based compensation expense, loss on settlement agreement, and equity in net loss of affiliates and include unrealized and realized gains and losses on the Company's securities portfolio as well as dividend income.</ix:continuation> See Note 18 for further discussion of the Company's segments.</span></div><ix:nonNumeric contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80MC9mcmFnOmJlNWZjYmY0ODg0YTQ3MjNhNzllZDYyYzFlM2U1MTYyL3RleHRyZWdpb246YmU1ZmNiZjQ4ODRhNDcyM2E3OWVkNjJjMWUzZTUxNjJfMTA2MjM_989b3f77-ee0e-42e1-a27a-1061bcca5fc3" escape="true"><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80MC9mcmFnOmJlNWZjYmY0ODg0YTQ3MjNhNzllZDYyYzFlM2U1MTYyL3RleHRyZWdpb246YmU1ZmNiZjQ4ODRhNDcyM2E3OWVkNjJjMWUzZTUxNjJfMTA1MjA_006485b5-7678-4021-b82c-12fae14f5170" continuedAt="i305f242550894a49951ba24b87caf62c" escape="true"><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In August 2020, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Debt&#8212;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#8212;Contracts in Entity's Own Equity (Subtopic 815-40)&#8212;Accounting for Convertible Instruments and Contracts in an Entity's Own Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> ("ASU 2020-06"</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Under ASU 2020-06, the embedded conversion features are no longer separated from the host contract for convertible instruments with conversion features that are not required to be accounted for as derivatives under Topic 815, or that do not result in substantial premiums accounted for as paid-in capital. Consequently, a convertible debt instrument will be accounted for as a single liability measured at its amortized cost, as long as no other features require bifurcation and recognition as derivatives. The new guidance also requires the if-converted method to be applied for all convertible instruments. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We adopted ASU 2020-06 on January 1, 2022 using the modified retrospective transition method, which resulted in an increase to our reported long-term debt outstanding, net of current portion, of $<ix:nonFraction unitRef="usd" contextRef="i026820ce93f04afc9c498f6af35f806b_I20220101" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80MC9mcmFnOmJlNWZjYmY0ODg0YTQ3MjNhNzllZDYyYzFlM2U1MTYyL3RleHRyZWdpb246YmU1ZmNiZjQ4ODRhNDcyM2E3OWVkNjJjMWUzZTUxNjJfMjE5OTAyMzI3NTUzMQ_79ac055d-2150-4103-9e59-b38075c17a7c">18,196</ix:nonFraction>, a decrease to our additional paid-in capital of $<ix:nonFraction unitRef="usd" contextRef="icf421d5fc50e4e85892b55cbde212eab_I20220101" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80MC9mcmFnOmJlNWZjYmY0ODg0YTQ3MjNhNzllZDYyYzFlM2U1MTYyL3RleHRyZWdpb246YmU1ZmNiZjQ4ODRhNDcyM2E3OWVkNjJjMWUzZTUxNjJfMjE5OTAyMzI3NTU0Ng_9871878d-ccfd-45ab-8aa2-aa90748fb15d">36,868</ix:nonFraction>, and a corresponding cumulative-effect reduction to our opening accumulated deficit of $<ix:nonFraction unitRef="usd" contextRef="i4f92c06e9bad430cac755e9610e9f9b5_I20220101" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80MC9mcmFnOmJlNWZjYmY0ODg0YTQ3MjNhNzllZDYyYzFlM2U1MTYyL3RleHRyZWdpb246YmU1ZmNiZjQ4ODRhNDcyM2E3OWVkNjJjMWUzZTUxNjJfMjE5OTAyMzI3NTUzOQ_78307361-5530-42d5-8a79-757ffe524ef3">18,672</ix:nonFraction>. The adoption of ASU 2020-06 is expected to reduce non-cash interest expense related to existing convertible debt outstanding by approximately $<ix:nonFraction unitRef="usd" contextRef="ia9d87a352497452f99e9459f9be7d3fa_D20220101-20221231" decimals="-3" sign="-" name="pgen:InterestExpenseDebtAmortizationofDebtDiscountPremiumandDebtIssuanceCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80MC9mcmFnOmJlNWZjYmY0ODg0YTQ3MjNhNzllZDYyYzFlM2U1MTYyL3RleHRyZWdpb246YmU1ZmNiZjQ4ODRhNDcyM2E3OWVkNjJjMWUzZTUxNjJfMjE5OTAyMzI3NTU1Mw_ca1bf7f1-2270-47f7-8c83-8e64a296c167">11,800</ix:nonFraction> for the year ending December 31, 2022, and did not have an impact on our consolidated cash flows. The use of the if-converted method did not have an impact on our overall earnings per share calculation.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_7">Table of Contents</a></span></div></div><ix:continuation id="i305f242550894a49951ba24b87caf62c"><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:continuation id="ie30530df8fc249edbd4ea3e3722f3572">Recently Issued Accounting Pronouncements Not Yet Adopted</ix:continuation></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are no accounting standards which have not yet been adopted that are expected to have a significant impact on our financial statements and related disclosures.</span></div></ix:continuation><div id="i7169a803a6aa44ea981603d220cab84f_43"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3. <ix:nonNumeric contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" name="us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80My9mcmFnOmZiOTRjN2FlZjIyYzQ5OWNiZmJkM2ExNzE2NzMyMDY4L3RleHRyZWdpb246ZmI5NGM3YWVmMjJjNDk5Y2JmYmQzYTE3MTY3MzIwNjhfODM4Ng_dd7052c6-5328-4bbe-83b8-99b44726529e" continuedAt="i8b1cedba6f24478e8f30fd9783269a87" escape="true">Discontinued Operations</ix:nonNumeric></span></div><ix:continuation id="i8b1cedba6f24478e8f30fd9783269a87" continuedAt="id190e737b0104ff3885cd1e86a4d82f4"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Where applicable, the notes to the accompanying condensed consolidated financial statements have been updated to reflect information pertaining to the Company's continuing operations based on the discontinued operations summarized below.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">MBP Titan</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of market uncertainty driven by the COVID-19 pandemic and the state of the energy sector raising significant challenges for the strategic alternatives pursued by MBP Titan, beginning in the second quarter of 2020 and throughout the remainder of 2020, the Company suspended MBP Titan's operations, preserved certain of MBP Titan's intellectual property, terminated all of its personnel, and undertook steps to dispose of its other assets and obligations. The wind down of MBP Titan's activities was substantially completed by December 31, 2020, with the final disposition of certain property and equipment and the facility operating lease occurring in January 2021. This discontinuation of operations represented the continuation of a strategic shift to becoming a primarily healthcare company advancing technologies and products that address complex healthcare challenges that the Company commenced in 2020. The assets, liabilities, and expenses related to the discontinued operations of MBP Titan are reclassified and presented as discontinued operations in the accompanying condensed consolidated financial statements for all periods.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The January 2021 sale of property and equipment resulted in a gain on disposal of assets of $<ix:nonFraction unitRef="usd" contextRef="icdf8637396524cf1ace92d8e586b1a80_D20220101-20220331" decimals="-3" name="us-gaap:GainLossOnDispositionOfAssets1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80My9mcmFnOmZiOTRjN2FlZjIyYzQ5OWNiZmJkM2ExNzE2NzMyMDY4L3RleHRyZWdpb246ZmI5NGM3YWVmMjJjNDk5Y2JmYmQzYTE3MTY3MzIwNjhfMTU3MA_7347517d-f394-45bd-a956-0fafc6005193">464</ix:nonFraction>, which is included in income from discontinued operations in the accompanying condensed consolidated statement of operations for the three months ended March 31, 2021. In January 2021, the Company executed termination and recapture agreements with the landlord of the leased facility used in MBP Titan's operations, thereby relieving the Company of all of its obligations related to the facility that were originally due to expire in July 2025. This lease termination resulted in a gain of $<ix:nonFraction unitRef="usd" contextRef="icdf8637396524cf1ace92d8e586b1a80_D20220101-20220331" decimals="-3" name="us-gaap:GainLossOnTerminationOfLease" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80My9mcmFnOmZiOTRjN2FlZjIyYzQ5OWNiZmJkM2ExNzE2NzMyMDY4L3RleHRyZWdpb246ZmI5NGM3YWVmMjJjNDk5Y2JmYmQzYTE3MTY3MzIwNjhfMjAzMg_db59c864-8aa4-40b1-ae41-2197a893ae9d">4,602</ix:nonFraction>, which is also included in income from discontinued operations in the accompanying condensed consolidated statement of operations for the three months ended March 31, 2021.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After the wind down of MBP Titan, certain assets and contractual obligations which were previously managed by MBP Titan continue to be managed at the Precigen corporate level. These remaining assets and contractual obligations include the Company's equity interest in and collaboration agreements with Intrexon Energy Partners, LLC ("Intrexon Energy Partners"), and Intrexon Energy Partners II, LLC ("Intrexon Energy Partners II"), including the associated deferred revenue remaining under each collaboration agreement (Notes 4 and 5), as well as the associated intellectual property developed by MBP Titan to date. These assets, liabilities, and related historical revenue and equity losses are included in the Company's operating results from continuing operations in the accompanying condensed consolidated financial statements for all periods presented as a result of the Company's continuing involvement.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were <ix:nonFraction unitRef="usd" contextRef="icdf8637396524cf1ace92d8e586b1a80_D20220101-20220331" decimals="INF" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80My9mcmFnOmZiOTRjN2FlZjIyYzQ5OWNiZmJkM2ExNzE2NzMyMDY4L3RleHRyZWdpb246ZmI5NGM3YWVmMjJjNDk5Y2JmYmQzYTE3MTY3MzIwNjhfMzI5ODUzNDg5NzM3Mg_788d4ff6-08f2-4ac4-a2af-1b8b5f35b58a">no</ix:nonFraction> discontinued operations related to MBP Titan for the three months ended March 31, 2022. <ix:nonNumeric contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" name="us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80My9mcmFnOmZiOTRjN2FlZjIyYzQ5OWNiZmJkM2ExNzE2NzMyMDY4L3RleHRyZWdpb246ZmI5NGM3YWVmMjJjNDk5Y2JmYmQzYTE3MTY3MzIwNjhfODM4Nw_6c607219-ec87-41dd-bc88-5b8671779c43" continuedAt="i338e1d500a084be9a38c25201a089005" escape="true">The following table presents the financial results of discontinued operations related to MBP Titan for the three months ended March 31, 2021:</ix:nonNumeric></span></div><div style="margin-top:12pt"><ix:continuation id="i338e1d500a084be9a38c25201a089005" continuedAt="i252edf8e191c481faf8341168412e3af"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.274%"><tr><td style="width:1.0%"></td><td style="width:83.696%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.426%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.478%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended&#160;<br/>&#160;March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating gains</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80My9mcmFnOmZiOTRjN2FlZjIyYzQ5OWNiZmJkM2ExNzE2NzMyMDY4L3RhYmxlOmM4MmM5MmIxYzA3NTQwYmRiNjgwOWIwYmY4ZDhmYzEwL3RhYmxlcmFuZ2U6YzgyYzkyYjFjMDc1NDBiZGI2ODA5YjBiZjhkOGZjMTBfMy0zLTEtMS0xNTYwNA_fde0dbd5-2cc6-470b-a7ef-bf32d86f66a3">4,526</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6cb7e8397b34ee6a457ba010484ed09_D20210101-20210331" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80My9mcmFnOmZiOTRjN2FlZjIyYzQ5OWNiZmJkM2ExNzE2NzMyMDY4L3RhYmxlOmM4MmM5MmIxYzA3NTQwYmRiNjgwOWIwYmY4ZDhmYzEwL3RhYmxlcmFuZ2U6YzgyYzkyYjFjMDc1NDBiZGI2ODA5YjBiZjhkOGZjMTBfNC0zLTEtMS0xNTYwNA_8e2ce411-2afd-4f16-af2f-c108c30a6590">4,526</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6cb7e8397b34ee6a457ba010484ed09_D20210101-20210331" decimals="-3" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80My9mcmFnOmZiOTRjN2FlZjIyYzQ5OWNiZmJkM2ExNzE2NzMyMDY4L3RhYmxlOmM4MmM5MmIxYzA3NTQwYmRiNjgwOWIwYmY4ZDhmYzEwL3RhYmxlcmFuZ2U6YzgyYzkyYjFjMDc1NDBiZGI2ODA5YjBiZjhkOGZjMTBfOS0zLTEtMS0xNTYwNA_3005d26d-a927-4862-8f72-297d547cf22c">4,526</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from discontinued operations</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6cb7e8397b34ee6a457ba010484ed09_D20210101-20210331" decimals="-3" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80My9mcmFnOmZiOTRjN2FlZjIyYzQ5OWNiZmJkM2ExNzE2NzMyMDY4L3RhYmxlOmM4MmM5MmIxYzA3NTQwYmRiNjgwOWIwYmY4ZDhmYzEwL3RhYmxlcmFuZ2U6YzgyYzkyYjFjMDc1NDBiZGI2ODA5YjBiZjhkOGZjMTBfMTEtMy0xLTEtMTU2MDQ_5a380377-44c4-46b2-b52d-c8bd8e3b56a7">4,526</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div></ix:continuation><div style="margin-top:12pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_7">Table of Contents</a></span></div></div><ix:continuation id="id190e737b0104ff3885cd1e86a4d82f4"><ix:continuation id="i252edf8e191c481faf8341168412e3af"><div style="margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the significant noncash items, purchases of property, plant and equipment, and proceeds from sales of assets for the discontinued operations related to MBP Titan for the three months ended March 31, 2021 that are included in the accompanying condensed consolidated statements of cash flows.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"><tr><td style="width:1.0%"></td><td style="width:84.203%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.991%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended&#160;<br/>&#160;March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjustments to reconcile net loss to net cash used in operating activities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on disposals of assets, net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if6cb7e8397b34ee6a457ba010484ed09_D20210101-20210331" decimals="-3" name="us-gaap:GainLossOnDispositionOfAssets1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80My9mcmFnOmZiOTRjN2FlZjIyYzQ5OWNiZmJkM2ExNzE2NzMyMDY4L3RhYmxlOmE4MTVhNWM4NzEwMTQ4MDBiMTgyMzgxNjVkZTAxY2JkL3RhYmxlcmFuZ2U6YTgxNWE1Yzg3MTAxNDgwMGIxODIzODE2NWRlMDFjYmRfNi0zLTEtMS0xNTYwNA_85f5984a-65b7-4313-8112-7e3a8375fac8">464</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncash gain on termination of leases</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if6cb7e8397b34ee6a457ba010484ed09_D20210101-20210331" decimals="-3" name="us-gaap:GainLossOnTerminationOfLease" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80My9mcmFnOmZiOTRjN2FlZjIyYzQ5OWNiZmJkM2ExNzE2NzMyMDY4L3RhYmxlOmE4MTVhNWM4NzEwMTQ4MDBiMTgyMzgxNjVkZTAxY2JkL3RhYmxlcmFuZ2U6YTgxNWE1Yzg3MTAxNDgwMGIxODIzODE2NWRlMDFjYmRfMTItMy0xLTEtMTU2MDQ_d0f24592-4402-43a2-9c29-57bba01a31e9">4,602</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from investing activities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sales of assets</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6cb7e8397b34ee6a457ba010484ed09_D20210101-20210331" decimals="-3" name="us-gaap:ProceedsFromSaleOfOtherAssetsInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80My9mcmFnOmZiOTRjN2FlZjIyYzQ5OWNiZmJkM2ExNzE2NzMyMDY4L3RhYmxlOmE4MTVhNWM4NzEwMTQ4MDBiMTgyMzgxNjVkZTAxY2JkL3RhYmxlcmFuZ2U6YTgxNWE1Yzg3MTAxNDgwMGIxODIzODE2NWRlMDFjYmRfMTctMy0xLTEtMTU2MDQ_2bd2b7aa-5dc3-4cf1-aa44-7f2a3ff71770">1,083</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div style="margin-top:7pt"><span><br/></span></div><div id="i7169a803a6aa44ea981603d220cab84f_46"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4. <ix:nonNumeric contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" name="us-gaap:EquityMethodInvestmentsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80Ni9mcmFnOmQ1MDJiMjAyNTU4MzQ4NGNhZGIyZjJhZDJiMzEwMjliL3RleHRyZWdpb246ZDUwMmIyMDI1NTgzNDg0Y2FkYjJmMmFkMmIzMTAyOWJfNDY5OQ_8470753c-d45b-4310-ad9d-b8ef732c761b" continuedAt="i697d3cd2392841af8cd272dc47ce51d3" escape="true">Investments in Joint Ventures</ix:nonNumeric></span></div><ix:continuation id="i697d3cd2392841af8cd272dc47ce51d3" continuedAt="i83cf16545b0946ea98d0795107bc7e45"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intrexon Energy Partners</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2014, the Company and certain investors (the "IEP Investors"), including an affiliate of Third Security, LLC ("Third Security"), entered into a Limited Liability Company Agreement that governs the affairs and conduct of business of Intrexon Energy Partners, a JV formed to optimize and scale-up the Company's MBP technology for the production of certain fuels and lubricants. The Company also entered into an exclusive channel collaboration ("ECC") with Intrexon Energy Partners providing exclusive rights to the Company's technology for the use in bioconversion for the production of certain fuels and lubricants, as a result of which the Company received a technology access fee of $<ix:nonFraction unitRef="usd" contextRef="i9c206d84156440a49a72497604ec8972_D20140301-20140331" decimals="INF" name="pgen:CollaborativeArrangementConsiderationReceivedValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80Ni9mcmFnOmQ1MDJiMjAyNTU4MzQ4NGNhZGIyZjJhZDJiMzEwMjliL3RleHRyZWdpb246ZDUwMmIyMDI1NTgzNDg0Y2FkYjJmMmFkMmIzMTAyOWJfNzMz_6d493a6e-c139-4c0d-a1b3-17e5616bcaf0">25,000</ix:nonFraction> while retaining a <ix:nonFraction unitRef="number" contextRef="i2e48cd233bc847118ac00256b671c120_I20140331" decimals="INF" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80Ni9mcmFnOmQ1MDJiMjAyNTU4MzQ4NGNhZGIyZjJhZDJiMzEwMjliL3RleHRyZWdpb246ZDUwMmIyMDI1NTgzNDg0Y2FkYjJmMmFkMmIzMTAyOWJfNzU0_e763b7a8-4152-4871-8624-ea4af09bd995">50</ix:nonFraction>% membership interest in Intrexon Energy Partners. The IEP Investors made initial capital contributions, totaling $<ix:nonFraction unitRef="usd" contextRef="i06c7dcadcbde427c93346762e97a9ff8_D20140301-20140331" decimals="INF" name="us-gaap:PaymentsToAcquireInterestInJointVenture" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80Ni9mcmFnOmQ1MDJiMjAyNTU4MzQ4NGNhZGIyZjJhZDJiMzEwMjliL3RleHRyZWdpb246ZDUwMmIyMDI1NTgzNDg0Y2FkYjJmMmFkMmIzMTAyOWJfODY5_1aaf79bc-90a3-4280-b872-0925830ed930">25,000</ix:nonFraction> in the aggregate, in exchange for pro rata membership interests in Intrexon Energy Partners totaling <ix:nonFraction unitRef="number" contextRef="i116e7745d66e431e9372cd8064a125ac_I20140331" decimals="INF" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80Ni9mcmFnOmQ1MDJiMjAyNTU4MzQ4NGNhZGIyZjJhZDJiMzEwMjliL3RleHRyZWdpb246ZDUwMmIyMDI1NTgzNDg0Y2FkYjJmMmFkMmIzMTAyOWJfOTcz_aa13521c-551e-4e88-8578-343360bdcaca">50</ix:nonFraction>%. In addition, Precigen committed to make capital contributions of up to $<ix:nonFraction unitRef="usd" contextRef="i2e48cd233bc847118ac00256b671c120_I20140331" decimals="INF" name="pgen:JointVentureAdditionalCapitalContributionsCommitted" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80Ni9mcmFnOmQ1MDJiMjAyNTU4MzQ4NGNhZGIyZjJhZDJiMzEwMjliL3RleHRyZWdpb246ZDUwMmIyMDI1NTgzNDg0Y2FkYjJmMmFkMmIzMTAyOWJfMTA0OA_ea1444a4-6cdb-4574-9068-1ec2b3c8837a">25,000</ix:nonFraction>, and the IEP Investors, as a group and pro rata in accordance with their respective membership interests in Intrexon Energy Partners, committed to make additional capital contributions of up to $<ix:nonFraction unitRef="usd" contextRef="i116e7745d66e431e9372cd8064a125ac_I20140331" decimals="INF" name="pgen:JointVentureAdditionalCapitalContributionsCommitted" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80Ni9mcmFnOmQ1MDJiMjAyNTU4MzQ4NGNhZGIyZjJhZDJiMzEwMjliL3RleHRyZWdpb246ZDUwMmIyMDI1NTgzNDg0Y2FkYjJmMmFkMmIzMTAyOWJfMTI0NQ_338fe5d8-47b1-43dc-9c2c-830514bfe7c1">25,000</ix:nonFraction>, at the request of Intrexon Energy Partners' board of managers (the "Intrexon Energy Partners Board") and subject to certain limitations. As of March&#160;31, 2022, the Company's remaining commitment was $<ix:nonFraction unitRef="usd" contextRef="ia8700e0f55454cbba3fb9fd96a94fbbb_I20220331" decimals="-3" name="pgen:JointVentureAdditionalCapitalContributionsCommittedRemainingCommitment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80Ni9mcmFnOmQ1MDJiMjAyNTU4MzQ4NGNhZGIyZjJhZDJiMzEwMjliL3RleHRyZWdpb246ZDUwMmIyMDI1NTgzNDg0Y2FkYjJmMmFkMmIzMTAyOWJfMTQzNQ_f9144e9b-4ba6-416b-9141-810058f6e52c">4,225</ix:nonFraction>. Intrexon Energy Partners is governed by the Intrexon Energy Partners Board, which has <ix:nonFraction unitRef="board_seat" contextRef="ia8700e0f55454cbba3fb9fd96a94fbbb_I20220331" decimals="INF" name="pgen:NumberofSeatsonGoverningBoard" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80Ni9mcmFnOmQ1MDJiMjAyNTU4MzQ4NGNhZGIyZjJhZDJiMzEwMjliL3RleHRyZWdpb246ZDUwMmIyMDI1NTgzNDg0Y2FkYjJmMmFkMmIzMTAyOWJfMTUyNQ_caebb5d8-4913-437e-8e8d-840032f881d9">five</ix:nonFraction> members. <ix:nonFraction unitRef="board_seat" contextRef="ia8700e0f55454cbba3fb9fd96a94fbbb_I20220331" decimals="INF" name="pgen:NumberofSeatsonGoverningBoardInternallySelected" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80Ni9mcmFnOmQ1MDJiMjAyNTU4MzQ4NGNhZGIyZjJhZDJiMzEwMjliL3RleHRyZWdpb246ZDUwMmIyMDI1NTgzNDg0Y2FkYjJmMmFkMmIzMTAyOWJfMTUzNw_db48f5ae-f4e7-4aa4-8655-16f8b77302c9">Two</ix:nonFraction> members of the Intrexon Energy Partners Board are designated by the Company and <ix:nonFraction unitRef="board_seat" contextRef="ia8700e0f55454cbba3fb9fd96a94fbbb_I20220331" decimals="INF" name="pgen:NumberofSeatsonGoverningBoardExternallySelected" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80Ni9mcmFnOmQ1MDJiMjAyNTU4MzQ4NGNhZGIyZjJhZDJiMzEwMjliL3RleHRyZWdpb246ZDUwMmIyMDI1NTgzNDg0Y2FkYjJmMmFkMmIzMTAyOWJfMTYyMA_a41bd40b-2622-4648-a3d8-830bb3b504d4">three</ix:nonFraction> members are designated by a majority of the IEP Investors. The Company and the IEP Investors have the right, but not the obligation, to make additional capital contributions above the initial limits when and if solicited by the Intrexon Energy Partners Board.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's investment in Intrexon Energy Partners was $(<ix:nonFraction unitRef="usd" contextRef="i3f3182d245524e2f81bd8b3e49a24b72_I20220331" decimals="-3" sign="-" name="us-gaap:EquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80Ni9mcmFnOmQ1MDJiMjAyNTU4MzQ4NGNhZGIyZjJhZDJiMzEwMjliL3RleHRyZWdpb246ZDUwMmIyMDI1NTgzNDg0Y2FkYjJmMmFkMmIzMTAyOWJfMTk0MA_f5187665-b6f1-4c74-8f1c-277c74f6af5e">429</ix:nonFraction>) and $(<ix:nonFraction unitRef="usd" contextRef="ic5473cecc9e948a696238d2b93f19451_I20211231" decimals="-3" sign="-" name="us-gaap:EquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80Ni9mcmFnOmQ1MDJiMjAyNTU4MzQ4NGNhZGIyZjJhZDJiMzEwMjliL3RleHRyZWdpb246ZDUwMmIyMDI1NTgzNDg0Y2FkYjJmMmFkMmIzMTAyOWJfMTk0Nw_ca1e12ad-c9cb-450f-9385-008f9fdc0e88">428</ix:nonFraction>) as of March&#160;31, 2022 and December&#160;31, 2021, respectively, and is included in other accrued liabilities in the accompanying condensed consolidated balance sheets, which represents the Company's equity in losses for contractually committed contributions to Intrexon Energy Partners.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 3 and 16 for additional discussion regarding the Company's investment in Intrexon Energy Partners.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intrexon Energy Partners II</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2015, the Company and certain investors (the "IEPII Investors"), entered into a Limited Liability Company Agreement that governs the affairs and conduct of business of Intrexon Energy Partners II, a JV formed to utilize the Company's MBP technology for the production of 1,4-butanediol, an industrial chemical used to manufacture spandex, polyurethane, plastics, and polyester. The Company also entered into an ECC with Intrexon Energy Partners II that provides exclusive rights to the Company's technology for use in the field, as a result of which the Company received a technology access fee of $<ix:nonFraction unitRef="usd" contextRef="icbe6e461c61143b794043bae863a8df6_D20151201-20151231" decimals="INF" name="pgen:CollaborativeArrangementConsiderationReceivedValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80Ni9mcmFnOmQ1MDJiMjAyNTU4MzQ4NGNhZGIyZjJhZDJiMzEwMjliL3RleHRyZWdpb246ZDUwMmIyMDI1NTgzNDg0Y2FkYjJmMmFkMmIzMTAyOWJfMjk2Mw_62f612c4-3b54-4359-9d4f-a293952f448d">18,000</ix:nonFraction> while retaining a <ix:nonFraction unitRef="number" contextRef="ib9f1d3ecd2254255a55eaec2585ccedb_I20151231" decimals="INF" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80Ni9mcmFnOmQ1MDJiMjAyNTU4MzQ4NGNhZGIyZjJhZDJiMzEwMjliL3RleHRyZWdpb246ZDUwMmIyMDI1NTgzNDg0Y2FkYjJmMmFkMmIzMTAyOWJfMjk4NA_caa7863b-be1d-4841-b459-1542e0d91421">50</ix:nonFraction>% membership interest in Intrexon Energy Partners II. The IEPII Investors made initial capital contributions, totaling $<ix:nonFraction unitRef="usd" contextRef="i5ae9c5a2b8e94b08b425df57ed7b8b69_D20151201-20151231" decimals="INF" name="us-gaap:PaymentsToAcquireInterestInJointVenture" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80Ni9mcmFnOmQ1MDJiMjAyNTU4MzQ4NGNhZGIyZjJhZDJiMzEwMjliL3RleHRyZWdpb246ZDUwMmIyMDI1NTgzNDg0Y2FkYjJmMmFkMmIzMTAyOWJfMzEwNA_eff67aa5-adc5-4d99-9141-bade50f25d90">18,000</ix:nonFraction> in the aggregate, in exchange for pro rata membership interests in Intrexon Energy Partners II totaling <ix:nonFraction unitRef="number" contextRef="iab1aff7710f9412391af1e5fd6967099_I20151231" decimals="INF" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80Ni9mcmFnOmQ1MDJiMjAyNTU4MzQ4NGNhZGIyZjJhZDJiMzEwMjliL3RleHRyZWdpb246ZDUwMmIyMDI1NTgzNDg0Y2FkYjJmMmFkMmIzMTAyOWJfMzIxMQ_bed30ff5-5ee6-4f82-bfaf-003d6f8bf62f">50</ix:nonFraction>%. In December 2015, the owners of Intrexon Energy Partners II made a capital contribution of $<ix:nonFraction unitRef="usd" contextRef="iebe277ea9243444d8b84ba5c80f13e43_D20151201-20151231" decimals="-3" name="us-gaap:PaymentsToAcquireInterestInJointVenture" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80Ni9mcmFnOmQ1MDJiMjAyNTU4MzQ4NGNhZGIyZjJhZDJiMzEwMjliL3RleHRyZWdpb246ZDUwMmIyMDI1NTgzNDg0Y2FkYjJmMmFkMmIzMTAyOWJfMzMwNg_f9ffe823-8742-47e9-8a52-3607b2fcf2ac">4,000</ix:nonFraction>, half of which was paid by the Company. Precigen committed to make additional capital contributions of up to $<ix:nonFraction unitRef="usd" contextRef="ib9f1d3ecd2254255a55eaec2585ccedb_I20151231" decimals="INF" name="pgen:JointVentureAdditionalCapitalContributionsCommitted" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80Ni9mcmFnOmQ1MDJiMjAyNTU4MzQ4NGNhZGIyZjJhZDJiMzEwMjliL3RleHRyZWdpb246ZDUwMmIyMDI1NTgzNDg0Y2FkYjJmMmFkMmIzMTAyOWJfMzQxOA_e11bf182-e5ad-4b50-b11c-9377b2847baf">10,000</ix:nonFraction>, and the IEPII Investors, as a group and pro rata in accordance with their respective membership interests in Intrexon Energy Partners II, committed to make additional capital contributions of up to $<ix:nonFraction unitRef="usd" contextRef="iab1aff7710f9412391af1e5fd6967099_I20151231" decimals="INF" name="pgen:JointVentureAdditionalCapitalContributionsCommitted" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80Ni9mcmFnOmQ1MDJiMjAyNTU4MzQ4NGNhZGIyZjJhZDJiMzEwMjliL3RleHRyZWdpb246ZDUwMmIyMDI1NTgzNDg0Y2FkYjJmMmFkMmIzMTAyOWJfMzYyMA_7f7f67e2-cc05-4c12-997b-8accf480501a">10,000</ix:nonFraction>, at the request of Intrexon Energy Partners II's board of managers (the "Intrexon Energy Partners II Board") and subject to certain limitations. As of March&#160;31, 2022, the Company's remaining commitment was $<ix:nonFraction unitRef="usd" contextRef="i68a8c3e611e7457496584dcd01bb9d77_I20220331" decimals="-3" name="pgen:JointVentureAdditionalCapitalContributionsCommittedRemainingCommitment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80Ni9mcmFnOmQ1MDJiMjAyNTU4MzQ4NGNhZGIyZjJhZDJiMzEwMjliL3RleHRyZWdpb246ZDUwMmIyMDI1NTgzNDg0Y2FkYjJmMmFkMmIzMTAyOWJfMzgxNw_a1933e6b-3831-4f83-abcf-87aff9e20e66">10,000</ix:nonFraction>. Intrexon Energy Partners II is governed by the Intrexon Energy Partners II Board, which has <ix:nonFraction unitRef="board_seat" contextRef="ib9f1d3ecd2254255a55eaec2585ccedb_I20151231" decimals="INF" name="pgen:NumberofSeatsonGoverningBoard" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80Ni9mcmFnOmQ1MDJiMjAyNTU4MzQ4NGNhZGIyZjJhZDJiMzEwMjliL3RleHRyZWdpb246ZDUwMmIyMDI1NTgzNDg0Y2FkYjJmMmFkMmIzMTAyOWJfMzkxMw_ff34e383-0c62-4de2-a8cc-4a47eb4b960a">five</ix:nonFraction> </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_7">Table of Contents</a></span></div></div><ix:continuation id="i83cf16545b0946ea98d0795107bc7e45"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">members. <ix:nonFraction unitRef="board_seat" contextRef="ib9f1d3ecd2254255a55eaec2585ccedb_I20151231" decimals="INF" name="pgen:NumberofSeatsonGoverningBoardInternallySelected" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80Ni9mcmFnOmQ1MDJiMjAyNTU4MzQ4NGNhZGIyZjJhZDJiMzEwMjliL3RleHRyZWdpb246ZDUwMmIyMDI1NTgzNDg0Y2FkYjJmMmFkMmIzMTAyOWJfMzkyNQ_1edbd0b1-ca03-4600-a1f7-b1c8f7afebfe">One</ix:nonFraction> member of the Intrexon Energy Partners II Board is designated by the Company and <ix:nonFraction unitRef="board_seat" contextRef="ib9f1d3ecd2254255a55eaec2585ccedb_I20151231" decimals="INF" name="pgen:NumberofSeatsonGoverningBoardExternallySelected" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80Ni9mcmFnOmQ1MDJiMjAyNTU4MzQ4NGNhZGIyZjJhZDJiMzEwMjliL3RleHRyZWdpb246ZDUwMmIyMDI1NTgzNDg0Y2FkYjJmMmFkMmIzMTAyOWJfNDAwOQ_6aeb8916-f412-4649-9246-36c1a9ff9951">four</ix:nonFraction> members are designated by a majority of the IEPII Investors. The Company and the IEPII Investors have the right, but not the obligation, to make additional capital contributions above the initial limits when and if solicited by the Intrexon Energy Partners II Board.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's investment in Intrexon Energy Partners II was $(<ix:nonFraction unitRef="usd" contextRef="i66b17135fbc04c12a62fb56fd2cabc18_I20211231" decimals="-3" sign="-" name="us-gaap:EquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80Ni9mcmFnOmQ1MDJiMjAyNTU4MzQ4NGNhZGIyZjJhZDJiMzEwMjliL3RleHRyZWdpb246ZDUwMmIyMDI1NTgzNDg0Y2FkYjJmMmFkMmIzMTAyOWJfNDMzOQ_5ca440be-0e7d-47b5-94a0-6135d494bd29"><ix:nonFraction unitRef="usd" contextRef="i1cd2167114c44a24bb2c013a330df7c4_I20220331" decimals="-3" sign="-" name="us-gaap:EquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80Ni9mcmFnOmQ1MDJiMjAyNTU4MzQ4NGNhZGIyZjJhZDJiMzEwMjliL3RleHRyZWdpb246ZDUwMmIyMDI1NTgzNDg0Y2FkYjJmMmFkMmIzMTAyOWJfNDMzOQ_a3ddfeee-61fd-4ad0-9b5b-7a7ee68c434f">435</ix:nonFraction></ix:nonFraction>) as of March&#160;31, 2022 and December&#160;31, 2021, and is included in other accrued liabilities in the accompanying condensed consolidated balance sheets, which represents the Company's equity in losses for contractually committed contributions to Intrexon Energy Partners II.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Notes 3 and 16 for additional discussion regarding the Company's investment in Intrexon Energy Partners II.</span></div></ix:continuation><div id="i7169a803a6aa44ea981603d220cab84f_49"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5. <ix:nonNumeric contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" name="us-gaap:CollaborativeArrangementDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80OS9mcmFnOjg2NGZhYzcxZGQ0YzQ0YWM4YjA3ZmI5NDM1ZGY5YThiL3RleHRyZWdpb246ODY0ZmFjNzFkZDRjNDRhYzhiMDdmYjk0MzVkZjlhOGJfNDIzMA_3f545884-bd9c-412b-b436-4cf8292a0f81" continuedAt="i1235bdbb6da14e9c8c8da60c4f6831aa" escape="true">Collaboration and Licensing Revenue</ix:nonNumeric></span></div><ix:continuation id="i1235bdbb6da14e9c8c8da60c4f6831aa" continuedAt="i43f16f54c27241a989433eaaf663e6dc"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Historically, the Company has derived collaboration and licensing revenue through agreements with counterparties for the development and commercialization of products enabled by the Company's technology platforms. These collaborations and licensing agreements may provide for multiple promises to be satisfied by the Company and typically include a license to the Company's technology platforms, participation in collaboration committees, and performance of certain research and development services. Based on the nature of the promises in the Company's collaboration and licensing agreements, the Company typically combines most of its promises into a single performance obligation because the promises are highly interrelated and not individually distinct. Options to acquire additional services are considered to determine if they constitute material rights. At contract inception, the transaction price is typically the upfront payment received and is allocated to the performance obligations. The Company has determined the transaction price should be recognized as revenue based on its measure of progress under the agreement primarily based on inputs necessary to fulfill the performance obligation.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes the reimbursement payments received for research and development efforts in the period when the services are performed, in connection with the single performance obligation discussed above. The reimbursements relate specifically to the Company's efforts to provide services, and the reimbursements are consistent with what the Company would typically charge other collaborators for similar services. The Company assesses the uncertainty of when and if any milestones will be achieved to determine whether the milestone is included in the transaction price. The Company then assesses whether the revenue is constrained based on whether it is probable that a significant reversal of revenue would not occur when the uncertainty is resolved. Royalties, including sales-based milestones, received under the agreements will be recognized as revenue when sales have occurred because the Company applies the sales- or usage-based royalties recognition exception provided for under ASC Topic 606. The Company determined the application of this exception is appropriate because at the time the royalties are generated, the technology license granted in the agreement is the predominant item to which the royalties relate. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines whether collaborations and licensing agreements are individually significant for disclosure based on a number of factors, including total revenue recorded by the Company pursuant to collaboration and licensing agreements, collaborators or licensees with equity method investments, or other qualitative factors. Collaboration and licensing revenues generated from consolidated subsidiaries are eliminated in consolidation.</span></div><ix:nonNumeric contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" name="pgen:CollaborationandLicensingRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80OS9mcmFnOjg2NGZhYzcxZGQ0YzQ0YWM4YjA3ZmI5NDM1ZGY5YThiL3RleHRyZWdpb246ODY0ZmFjNzFkZDRjNDRhYzhiMDdmYjk0MzVkZjlhOGJfNDIxNg_27384353-7b4a-437a-b365-c4f86a5779bf" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the amounts recorded as revenue in the condensed consolidated statements of operations for each significant counterparty to a collaboration or licensing agreement for the three months ended March&#160;31, 2022 and 2021.</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:70.728%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.616%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.619%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended&#160;<br/>&#160;March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Castle Creek Biosciences, Inc.</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie03a332075e24203bc226247706f4c0b_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80OS9mcmFnOjg2NGZhYzcxZGQ0YzQ0YWM4YjA3ZmI5NDM1ZGY5YThiL3RhYmxlOjFhMzY3ODZmMzlmNzRiMjg5YmU0ZWNmNzAwZDM4YjU0L3RhYmxlcmFuZ2U6MWEzNjc4NmYzOWY3NGIyODliZTRlY2Y3MDBkMzhiNTRfNi0xLTEtMS0xNTYwNA_01c9419f-692d-48ad-ab71-db7b8523da98">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d962f9fc84242dfaab1b8772723f495_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80OS9mcmFnOjg2NGZhYzcxZGQ0YzQ0YWM4YjA3ZmI5NDM1ZGY5YThiL3RhYmxlOjFhMzY3ODZmMzlmNzRiMjg5YmU0ZWNmNzAwZDM4YjU0L3RhYmxlcmFuZ2U6MWEzNjc4NmYzOWY3NGIyODliZTRlY2Y3MDBkMzhiNTRfNi0zLTEtMS0xNTYwNA_93f476e4-e31a-427e-aa26-3a0141b37db8">59</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b919455fac14c5b89317ce54cc48c01_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80OS9mcmFnOjg2NGZhYzcxZGQ0YzQ0YWM4YjA3ZmI5NDM1ZGY5YThiL3RhYmxlOjFhMzY3ODZmMzlmNzRiMjg5YmU0ZWNmNzAwZDM4YjU0L3RhYmxlcmFuZ2U6MWEzNjc4NmYzOWY3NGIyODliZTRlY2Y3MDBkMzhiNTRfNy0xLTEtMS0xNTYwNA_81e93b21-409f-4155-a0e7-10e04183f84f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1435bc431da4d2fbeee0800a5bb6070_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80OS9mcmFnOjg2NGZhYzcxZGQ0YzQ0YWM4YjA3ZmI5NDM1ZGY5YThiL3RhYmxlOjFhMzY3ODZmMzlmNzRiMjg5YmU0ZWNmNzAwZDM4YjU0L3RhYmxlcmFuZ2U6MWEzNjc4NmYzOWY3NGIyODliZTRlY2Y3MDBkMzhiNTRfNy0zLTEtMS0xNTYwNA_7a181153-7337-4e22-abcc-6d8f7615252d">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total (1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ee3165dd570445e98d48bc112a7c856_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80OS9mcmFnOjg2NGZhYzcxZGQ0YzQ0YWM4YjA3ZmI5NDM1ZGY5YThiL3RhYmxlOjFhMzY3ODZmMzlmNzRiMjg5YmU0ZWNmNzAwZDM4YjU0L3RhYmxlcmFuZ2U6MWEzNjc4NmYzOWY3NGIyODliZTRlY2Y3MDBkMzhiNTRfOC0xLTEtMS0xNTYwNA_3f8f5374-42a4-4140-8ac3-cc7c07670456">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57c5cf448af9439d8ce80e1a7c173246_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80OS9mcmFnOjg2NGZhYzcxZGQ0YzQ0YWM4YjA3ZmI5NDM1ZGY5YThiL3RhYmxlOjFhMzY3ODZmMzlmNzRiMjg5YmU0ZWNmNzAwZDM4YjU0L3RhYmxlcmFuZ2U6MWEzNjc4NmYzOWY3NGIyODliZTRlY2Y3MDBkMzhiNTRfOC0zLTEtMS0xNTYwNA_8b23f13d-30cf-4d63-913d-76fee8ec8cea">66</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:7pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Collaboration and licensing revenues include the recognition of $<ix:nonFraction unitRef="usd" contextRef="ic5c07296b0ad4a3795796cdd98b70bfe_D20220101-20220331" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80OS9mcmFnOjg2NGZhYzcxZGQ0YzQ0YWM4YjA3ZmI5NDM1ZGY5YThiL3RleHRyZWdpb246ODY0ZmFjNzFkZDRjNDRhYzhiMDdmYjk0MzVkZjlhOGJfMzIzMA_2351b5b8-d34e-4d90-9616-5dd1d3ee9b8d">0</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i63f44e56a2d54df9a4c54a505c5e504c_D20210101-20210331" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80OS9mcmFnOjg2NGZhYzcxZGQ0YzQ0YWM4YjA3ZmI5NDM1ZGY5YThiL3RleHRyZWdpb246ODY0ZmFjNzFkZDRjNDRhYzhiMDdmYjk0MzVkZjlhOGJfMzIzNw_0c88f7b7-71f0-4df3-a1b1-87873e5b4c55">66</ix:nonFraction> for the three months ended March 31, 2022 and 2021, respectively, associated with upfront and milestone payments which were previously deferred.</span></div></ix:nonNumeric><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no significant changes to the agreements with our collaborators and licensees in the three months ended March 31, 2022.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_7">Table of Contents</a></span></div></div><ix:continuation id="i43f16f54c27241a989433eaaf663e6dc"><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deferred Revenue</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred revenue primarily consists of upfront and milestone consideration received for the Company's collaboration and licensing agreements. Revenue is recognized as services are performed. The arrangements classified as long-term (of which $<ix:nonFraction unitRef="usd" contextRef="ie8e1602cebb942fe9f1248b8494a1a7d_I20220331" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80OS9mcmFnOjg2NGZhYzcxZGQ0YzQ0YWM4YjA3ZmI5NDM1ZGY5YThiL3RleHRyZWdpb246ODY0ZmFjNzFkZDRjNDRhYzhiMDdmYjk0MzVkZjlhOGJfMzg0ODI5MDcwMjU2MA_150eb5cc-55cd-4a8b-8a9c-05ebe7d3da89">21,205</ix:nonFraction> is related to agreements with Intrexon Energy Partners L.L.C. and Intrexon Energy Partners II, L.L.C.) are not active while the respective counterparties evaluate the status of the project and its desired future development activities since the Company cannot reasonably estimate the amount of service to be performed over the next year.</span></div><ix:nonNumeric contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" name="us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80OS9mcmFnOjg2NGZhYzcxZGQ0YzQ0YWM4YjA3ZmI5NDM1ZGY5YThiL3RleHRyZWdpb246ODY0ZmFjNzFkZDRjNDRhYzhiMDdmYjk0MzVkZjlhOGJfNDIzMw_288c07bd-5c32-43c8-a92b-5b035c43e17b" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred revenue consisted of the following:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:70.894%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.537%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Collaboration and licensing agreements</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59e18c9f66844d49a7936ec00a3794ef_I20220331" decimals="-3" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80OS9mcmFnOjg2NGZhYzcxZGQ0YzQ0YWM4YjA3ZmI5NDM1ZGY5YThiL3RhYmxlOjU5M2E3ZjMxNGNiZjQ1OTliNjZkZDZkY2ExNzYxYmIzL3RhYmxlcmFuZ2U6NTkzYTdmMzE0Y2JmNDU5OWI2NmRkNmRjYTE3NjFiYjNfMS0xLTEtMS0xNTYwNA_86e7fbb9-4907-4c45-b13b-382b8246d8fa">23,023</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d4f45253f074c3c817131697acd88c6_I20211231" decimals="-3" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80OS9mcmFnOjg2NGZhYzcxZGQ0YzQ0YWM4YjA3ZmI5NDM1ZGY5YThiL3RhYmxlOjU5M2E3ZjMxNGNiZjQ1OTliNjZkZDZkY2ExNzYxYmIzL3RhYmxlcmFuZ2U6NTkzYTdmMzE0Y2JmNDU5OWI2NmRkNmRjYTE3NjFiYjNfMS0zLTEtMS0xNTYwNA_e3f86bd8-5fb5-47df-9d61-85e9b4fd454f">23,023</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid product and service revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b9d5326a05846d7a58b2f6cf8712aa2_I20220331" decimals="-3" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80OS9mcmFnOjg2NGZhYzcxZGQ0YzQ0YWM4YjA3ZmI5NDM1ZGY5YThiL3RhYmxlOjU5M2E3ZjMxNGNiZjQ1OTliNjZkZDZkY2ExNzYxYmIzL3RhYmxlcmFuZ2U6NTkzYTdmMzE0Y2JmNDU5OWI2NmRkNmRjYTE3NjFiYjNfMi0xLTEtMS0xNTYwNA_5c895f0f-38cf-4b0d-bae3-5905f72827bf">2,511</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87bf374ed035409bafb6050993401656_I20211231" decimals="-3" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80OS9mcmFnOjg2NGZhYzcxZGQ0YzQ0YWM4YjA3ZmI5NDM1ZGY5YThiL3RhYmxlOjU5M2E3ZjMxNGNiZjQ1OTliNjZkZDZkY2ExNzYxYmIzL3RhYmxlcmFuZ2U6NTkzYTdmMzE0Y2JmNDU5OWI2NmRkNmRjYTE3NjFiYjNfMi0zLTEtMS0xNTYwNA_f5efa5d5-5d9b-4452-b81b-a8cdd791ccaf">4,229</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0fb51aa6c5ef4219b2b7da5ce705fc81_I20220331" decimals="-3" name="us-gaap:ContractWithCustomerLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80OS9mcmFnOjg2NGZhYzcxZGQ0YzQ0YWM4YjA3ZmI5NDM1ZGY5YThiL3RhYmxlOjU5M2E3ZjMxNGNiZjQ1OTliNjZkZDZkY2ExNzYxYmIzL3RhYmxlcmFuZ2U6NTkzYTdmMzE0Y2JmNDU5OWI2NmRkNmRjYTE3NjFiYjNfMy0xLTEtMS0xNTYwNA_f3ccdcfe-ae31-4933-b7d4-894f018077fd">158</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie776f343946740da9a363c1b9559d961_I20211231" decimals="-3" name="us-gaap:ContractWithCustomerLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80OS9mcmFnOjg2NGZhYzcxZGQ0YzQ0YWM4YjA3ZmI5NDM1ZGY5YThiL3RhYmxlOjU5M2E3ZjMxNGNiZjQ1OTliNjZkZDZkY2ExNzYxYmIzL3RhYmxlcmFuZ2U6NTkzYTdmMzE0Y2JmNDU5OWI2NmRkNmRjYTE3NjFiYjNfMy0zLTEtMS0xNTYwNA_0440a7b1-d8ca-4ed3-a714-57d193b48b24">213</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80OS9mcmFnOjg2NGZhYzcxZGQ0YzQ0YWM4YjA3ZmI5NDM1ZGY5YThiL3RhYmxlOjU5M2E3ZjMxNGNiZjQ1OTliNjZkZDZkY2ExNzYxYmIzL3RhYmxlcmFuZ2U6NTkzYTdmMzE0Y2JmNDU5OWI2NmRkNmRjYTE3NjFiYjNfNC0xLTEtMS0xNTYwNA_38a45ad6-f415-4bd3-856f-9ed94e9fe96b">25,692</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231" decimals="-3" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80OS9mcmFnOjg2NGZhYzcxZGQ0YzQ0YWM4YjA3ZmI5NDM1ZGY5YThiL3RhYmxlOjU5M2E3ZjMxNGNiZjQ1OTliNjZkZDZkY2ExNzYxYmIzL3RhYmxlcmFuZ2U6NTkzYTdmMzE0Y2JmNDU5OWI2NmRkNmRjYTE3NjFiYjNfNC0zLTEtMS0xNTYwNA_054e3293-9363-4187-8a0c-deb3098b7c75">27,465</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of deferred revenue</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80OS9mcmFnOjg2NGZhYzcxZGQ0YzQ0YWM4YjA3ZmI5NDM1ZGY5YThiL3RhYmxlOjU5M2E3ZjMxNGNiZjQ1OTliNjZkZDZkY2ExNzYxYmIzL3RhYmxlcmFuZ2U6NTkzYTdmMzE0Y2JmNDU5OWI2NmRkNmRjYTE3NjFiYjNfNS0xLTEtMS0xNTYwNA_579e0677-26a8-4755-9cf5-61ee13c2920b">2,669</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80OS9mcmFnOjg2NGZhYzcxZGQ0YzQ0YWM4YjA3ZmI5NDM1ZGY5YThiL3RhYmxlOjU5M2E3ZjMxNGNiZjQ1OTliNjZkZDZkY2ExNzYxYmIzL3RhYmxlcmFuZ2U6NTkzYTdmMzE0Y2JmNDU5OWI2NmRkNmRjYTE3NjFiYjNfNS0zLTEtMS0xNTYwNA_47980d84-8073-4322-9a9f-820d20a0ba5b">4,442</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term portion of deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80OS9mcmFnOjg2NGZhYzcxZGQ0YzQ0YWM4YjA3ZmI5NDM1ZGY5YThiL3RhYmxlOjU5M2E3ZjMxNGNiZjQ1OTliNjZkZDZkY2ExNzYxYmIzL3RhYmxlcmFuZ2U6NTkzYTdmMzE0Y2JmNDU5OWI2NmRkNmRjYTE3NjFiYjNfNi0xLTEtMS0xNTYwNA_91bff512-6c76-4885-ba05-3eac6b2e1fe3">23,023</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80OS9mcmFnOjg2NGZhYzcxZGQ0YzQ0YWM4YjA3ZmI5NDM1ZGY5YThiL3RhYmxlOjU5M2E3ZjMxNGNiZjQ1OTliNjZkZDZkY2ExNzYxYmIzL3RhYmxlcmFuZ2U6NTkzYTdmMzE0Y2JmNDU5OWI2NmRkNmRjYTE3NjFiYjNfNi0zLTEtMS0xNTYwNA_79f9f20c-7d74-4d8b-8dc6-bfa3963d237b">23,023</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80OS9mcmFnOjg2NGZhYzcxZGQ0YzQ0YWM4YjA3ZmI5NDM1ZGY5YThiL3RhYmxlOjU5M2E3ZjMxNGNiZjQ1OTliNjZkZDZkY2ExNzYxYmIzL3RhYmxlcmFuZ2U6NTkzYTdmMzE0Y2JmNDU5OWI2NmRkNmRjYTE3NjFiYjNfNy0xLTEtMS0xNTYwNA_446bc4a8-1876-4ece-a70b-2d31ed5825ee">25,692</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231" decimals="-3" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80OS9mcmFnOjg2NGZhYzcxZGQ0YzQ0YWM4YjA3ZmI5NDM1ZGY5YThiL3RhYmxlOjU5M2E3ZjMxNGNiZjQ1OTliNjZkZDZkY2ExNzYxYmIzL3RhYmxlcmFuZ2U6NTkzYTdmMzE0Y2JmNDU5OWI2NmRkNmRjYTE3NjFiYjNfNy0zLTEtMS0xNTYwNA_5780696c-2e47-451a-994d-d2608847f3b8">27,465</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:17pt;text-align:center"><span><br/></span></div><ix:nonNumeric contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" xsi:nil="true" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80OS9mcmFnOjg2NGZhYzcxZGQ0YzQ0YWM4YjA3ZmI5NDM1ZGY5YThiL3RleHRyZWdpb246ODY0ZmFjNzFkZDRjNDRhYzhiMDdmYjk0MzVkZjlhOGJfNDIzOA_e5abbfae-b0fe-4f9a-86d7-d53e790571ec" escape="true"></ix:nonNumeric><div id="i7169a803a6aa44ea981603d220cab84f_52"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6. <ix:nonNumeric contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" name="us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81Mi9mcmFnOjU4Zjc1NjhmZmQ5YTRiZmI4NDYxZmZjZDhjMWEzOTk5L3RleHRyZWdpb246NThmNzU2OGZmZDlhNGJmYjg0NjFmZmNkOGMxYTM5OTlfNzg1_599f4f12-ccf5-4550-9dd0-f5b1bff25bb9" continuedAt="ib510b1e9d0804d44b082c17a9c5ef72f" escape="true">Short-term and Long-term Investments</ix:nonNumeric></span></div><ix:continuation id="ib510b1e9d0804d44b082c17a9c5ef72f" continuedAt="i70e8e28fe7ce4e8c98369380190e5902"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's investments are classified as available-for-sale. <ix:nonNumeric contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" name="us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81Mi9mcmFnOjU4Zjc1NjhmZmQ5YTRiZmI4NDYxZmZjZDhjMWEzOTk5L3RleHRyZWdpb246NThmNzU2OGZmZDlhNGJmYjg0NjFmZmNkOGMxYTM5OTlfNzgz_92d5d06f-5e4c-46c4-9952-40186848b0ac" continuedAt="ie1c9a99f176a415aab93507aabb4fdd5" escape="true">The following table summarizes the amortized cost, gross unrealized gains and losses, and fair value of available-for-sale investments as of March&#160;31, 2022:</ix:nonNumeric></span></div><ix:continuation id="ie1c9a99f176a415aab93507aabb4fdd5"><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.321%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.501%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate<br/>Fair&#160;Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government debt securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a7efd03f87243c8b506adee6b95d76e_I20220331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81Mi9mcmFnOjU4Zjc1NjhmZmQ5YTRiZmI4NDYxZmZjZDhjMWEzOTk5L3RhYmxlOmNmNWU2YzdjNmJiMTRmZGY5MDlkYTNjY2Y0MzYxZWVkL3RhYmxlcmFuZ2U6Y2Y1ZTZjN2M2YmIxNGZkZjkwOWRhM2NjZjQzNjFlZWRfMS0xLTEtMS0xNTYwNA_b6633f4e-2c44-4c26-800a-0f1f2c50b770">102,771</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a7efd03f87243c8b506adee6b95d76e_I20220331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81Mi9mcmFnOjU4Zjc1NjhmZmQ5YTRiZmI4NDYxZmZjZDhjMWEzOTk5L3RhYmxlOmNmNWU2YzdjNmJiMTRmZGY5MDlkYTNjY2Y0MzYxZWVkL3RhYmxlcmFuZ2U6Y2Y1ZTZjN2M2YmIxNGZkZjkwOWRhM2NjZjQzNjFlZWRfMS0zLTEtMS0xNTYwNA_101e8366-939d-4c6e-a0ed-ac56244c6270">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7a7efd03f87243c8b506adee6b95d76e_I20220331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81Mi9mcmFnOjU4Zjc1NjhmZmQ5YTRiZmI4NDYxZmZjZDhjMWEzOTk5L3RhYmxlOmNmNWU2YzdjNmJiMTRmZGY5MDlkYTNjY2Y0MzYxZWVkL3RhYmxlcmFuZ2U6Y2Y1ZTZjN2M2YmIxNGZkZjkwOWRhM2NjZjQzNjFlZWRfMS01LTEtMS0xNTYwNA_cd9ae467-9710-47ad-968e-a0de01fc197f">1,133</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a7efd03f87243c8b506adee6b95d76e_I20220331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81Mi9mcmFnOjU4Zjc1NjhmZmQ5YTRiZmI4NDYxZmZjZDhjMWEzOTk5L3RhYmxlOmNmNWU2YzdjNmJiMTRmZGY5MDlkYTNjY2Y0MzYxZWVkL3RhYmxlcmFuZ2U6Y2Y1ZTZjN2M2YmIxNGZkZjkwOWRhM2NjZjQzNjFlZWRfMS03LTEtMS0xNTYwNA_8e47e966-04a6-47b7-8b58-39f071735895">101,638</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib61d2084282545aeadc53945fd070cea_I20220331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81Mi9mcmFnOjU4Zjc1NjhmZmQ5YTRiZmI4NDYxZmZjZDhjMWEzOTk5L3RhYmxlOmNmNWU2YzdjNmJiMTRmZGY5MDlkYTNjY2Y0MzYxZWVkL3RhYmxlcmFuZ2U6Y2Y1ZTZjN2M2YmIxNGZkZjkwOWRhM2NjZjQzNjFlZWRfMi0xLTEtMS0xNTYwNA_10df7c01-c88f-4d33-af3a-77a51f0b1ad3">97</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib61d2084282545aeadc53945fd070cea_I20220331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81Mi9mcmFnOjU4Zjc1NjhmZmQ5YTRiZmI4NDYxZmZjZDhjMWEzOTk5L3RhYmxlOmNmNWU2YzdjNmJiMTRmZGY5MDlkYTNjY2Y0MzYxZWVkL3RhYmxlcmFuZ2U6Y2Y1ZTZjN2M2YmIxNGZkZjkwOWRhM2NjZjQzNjFlZWRfMi0zLTEtMS0xNTYwNA_f9927fdc-de46-4c04-a90d-aeaa8346f9b7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib61d2084282545aeadc53945fd070cea_I20220331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81Mi9mcmFnOjU4Zjc1NjhmZmQ5YTRiZmI4NDYxZmZjZDhjMWEzOTk5L3RhYmxlOmNmNWU2YzdjNmJiMTRmZGY5MDlkYTNjY2Y0MzYxZWVkL3RhYmxlcmFuZ2U6Y2Y1ZTZjN2M2YmIxNGZkZjkwOWRhM2NjZjQzNjFlZWRfMi01LTEtMS0xNTYwNA_0b2af56f-3029-4835-a3c3-36057f332928">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib61d2084282545aeadc53945fd070cea_I20220331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81Mi9mcmFnOjU4Zjc1NjhmZmQ5YTRiZmI4NDYxZmZjZDhjMWEzOTk5L3RhYmxlOmNmNWU2YzdjNmJiMTRmZGY5MDlkYTNjY2Y0MzYxZWVkL3RhYmxlcmFuZ2U6Y2Y1ZTZjN2M2YmIxNGZkZjkwOWRhM2NjZjQzNjFlZWRfMi03LTEtMS0xNTYwNA_8589311c-65cb-454e-9ece-83dc984109cb">97</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81Mi9mcmFnOjU4Zjc1NjhmZmQ5YTRiZmI4NDYxZmZjZDhjMWEzOTk5L3RhYmxlOmNmNWU2YzdjNmJiMTRmZGY5MDlkYTNjY2Y0MzYxZWVkL3RhYmxlcmFuZ2U6Y2Y1ZTZjN2M2YmIxNGZkZjkwOWRhM2NjZjQzNjFlZWRfMy0xLTEtMS0xNTYwNA_cda2d359-6df7-4586-aed0-d6c11b1f23f5">102,868</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81Mi9mcmFnOjU4Zjc1NjhmZmQ5YTRiZmI4NDYxZmZjZDhjMWEzOTk5L3RhYmxlOmNmNWU2YzdjNmJiMTRmZGY5MDlkYTNjY2Y0MzYxZWVkL3RhYmxlcmFuZ2U6Y2Y1ZTZjN2M2YmIxNGZkZjkwOWRhM2NjZjQzNjFlZWRfMy0zLTEtMS0xNTYwNA_c0434aca-178e-40fe-b8fb-65c2b573d878">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81Mi9mcmFnOjU4Zjc1NjhmZmQ5YTRiZmI4NDYxZmZjZDhjMWEzOTk5L3RhYmxlOmNmNWU2YzdjNmJiMTRmZGY5MDlkYTNjY2Y0MzYxZWVkL3RhYmxlcmFuZ2U6Y2Y1ZTZjN2M2YmIxNGZkZjkwOWRhM2NjZjQzNjFlZWRfMy01LTEtMS0xNTYwNA_e0c10806-c580-49bf-91e1-c3655ea190ae">1,133</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81Mi9mcmFnOjU4Zjc1NjhmZmQ5YTRiZmI4NDYxZmZjZDhjMWEzOTk5L3RhYmxlOmNmNWU2YzdjNmJiMTRmZGY5MDlkYTNjY2Y0MzYxZWVkL3RhYmxlcmFuZ2U6Y2Y1ZTZjN2M2YmIxNGZkZjkwOWRhM2NjZjQzNjFlZWRfMy03LTEtMS0xNTYwNA_f3e6875b-ab7b-4de7-becd-ee709b81be52">101,735</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the amortized cost, gross unrealized gains and losses, and fair value of available-for-sale investments as of December&#160;31, 2021:</span></div><div style="margin-bottom:4pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.321%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.501%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate<br/>Fair&#160;Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government debt securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i138b7762559a4bd0bef0907b1fc149a0_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81Mi9mcmFnOjU4Zjc1NjhmZmQ5YTRiZmI4NDYxZmZjZDhjMWEzOTk5L3RhYmxlOmU0YjZkNTNjY2Q3NzQ3YzE4NzRjMDQ5N2QwM2M2OThmL3RhYmxlcmFuZ2U6ZTRiNmQ1M2NjZDc3NDdjMTg3NGMwNDk3ZDAzYzY5OGZfMS0xLTEtMS0xNTYwNA_819b508f-a374-497c-9bfd-8334d924f473">121,036</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i138b7762559a4bd0bef0907b1fc149a0_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81Mi9mcmFnOjU4Zjc1NjhmZmQ5YTRiZmI4NDYxZmZjZDhjMWEzOTk5L3RhYmxlOmU0YjZkNTNjY2Q3NzQ3YzE4NzRjMDQ5N2QwM2M2OThmL3RhYmxlcmFuZ2U6ZTRiNmQ1M2NjZDc3NDdjMTg3NGMwNDk3ZDAzYzY5OGZfMS0zLTEtMS0xNTYwNA_e03fd3ec-c18a-4029-8a9c-51b04a50d759">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i138b7762559a4bd0bef0907b1fc149a0_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81Mi9mcmFnOjU4Zjc1NjhmZmQ5YTRiZmI4NDYxZmZjZDhjMWEzOTk5L3RhYmxlOmU0YjZkNTNjY2Q3NzQ3YzE4NzRjMDQ5N2QwM2M2OThmL3RhYmxlcmFuZ2U6ZTRiNmQ1M2NjZDc3NDdjMTg3NGMwNDk3ZDAzYzY5OGZfMS01LTEtMS0xNTYwNA_023eb7ea-3f0d-4c67-88d9-8fd39917be41">331</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i138b7762559a4bd0bef0907b1fc149a0_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81Mi9mcmFnOjU4Zjc1NjhmZmQ5YTRiZmI4NDYxZmZjZDhjMWEzOTk5L3RhYmxlOmU0YjZkNTNjY2Q3NzQ3YzE4NzRjMDQ5N2QwM2M2OThmL3RhYmxlcmFuZ2U6ZTRiNmQ1M2NjZDc3NDdjMTg3NGMwNDk3ZDAzYzY5OGZfMS03LTEtMS0xNTYwNA_c1f16d53-21be-46a1-9176-536795244513">120,705</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e69243d3b7549888b5f4fb6f0bb9475_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81Mi9mcmFnOjU4Zjc1NjhmZmQ5YTRiZmI4NDYxZmZjZDhjMWEzOTk5L3RhYmxlOmU0YjZkNTNjY2Q3NzQ3YzE4NzRjMDQ5N2QwM2M2OThmL3RhYmxlcmFuZ2U6ZTRiNmQ1M2NjZDc3NDdjMTg3NGMwNDk3ZDAzYzY5OGZfMi0xLTEtMS0xNTYwNA_a50bd8bf-8b3d-464b-bf46-e90be6de6ef7">97</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e69243d3b7549888b5f4fb6f0bb9475_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81Mi9mcmFnOjU4Zjc1NjhmZmQ5YTRiZmI4NDYxZmZjZDhjMWEzOTk5L3RhYmxlOmU0YjZkNTNjY2Q3NzQ3YzE4NzRjMDQ5N2QwM2M2OThmL3RhYmxlcmFuZ2U6ZTRiNmQ1M2NjZDc3NDdjMTg3NGMwNDk3ZDAzYzY5OGZfMi0zLTEtMS0xNTYwNA_f0f76066-1ef2-4797-9bcc-af0b744fdc0e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e69243d3b7549888b5f4fb6f0bb9475_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81Mi9mcmFnOjU4Zjc1NjhmZmQ5YTRiZmI4NDYxZmZjZDhjMWEzOTk5L3RhYmxlOmU0YjZkNTNjY2Q3NzQ3YzE4NzRjMDQ5N2QwM2M2OThmL3RhYmxlcmFuZ2U6ZTRiNmQ1M2NjZDc3NDdjMTg3NGMwNDk3ZDAzYzY5OGZfMi01LTEtMS0xNTYwNA_9991692e-e2f5-4253-b073-cc84dbda3318">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e69243d3b7549888b5f4fb6f0bb9475_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81Mi9mcmFnOjU4Zjc1NjhmZmQ5YTRiZmI4NDYxZmZjZDhjMWEzOTk5L3RhYmxlOmU0YjZkNTNjY2Q3NzQ3YzE4NzRjMDQ5N2QwM2M2OThmL3RhYmxlcmFuZ2U6ZTRiNmQ1M2NjZDc3NDdjMTg3NGMwNDk3ZDAzYzY5OGZfMi03LTEtMS0xNTYwNA_c3f99999-9469-460d-acf3-92e1fbd209b2">97</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81Mi9mcmFnOjU4Zjc1NjhmZmQ5YTRiZmI4NDYxZmZjZDhjMWEzOTk5L3RhYmxlOmU0YjZkNTNjY2Q3NzQ3YzE4NzRjMDQ5N2QwM2M2OThmL3RhYmxlcmFuZ2U6ZTRiNmQ1M2NjZDc3NDdjMTg3NGMwNDk3ZDAzYzY5OGZfMy0xLTEtMS0xNTYwNA_e18006af-9c9d-487b-b620-c8e59606bb5e">121,133</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81Mi9mcmFnOjU4Zjc1NjhmZmQ5YTRiZmI4NDYxZmZjZDhjMWEzOTk5L3RhYmxlOmU0YjZkNTNjY2Q3NzQ3YzE4NzRjMDQ5N2QwM2M2OThmL3RhYmxlcmFuZ2U6ZTRiNmQ1M2NjZDc3NDdjMTg3NGMwNDk3ZDAzYzY5OGZfMy0zLTEtMS0xNTYwNA_a360cc52-0184-4291-bb2e-b12a13ccf81e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81Mi9mcmFnOjU4Zjc1NjhmZmQ5YTRiZmI4NDYxZmZjZDhjMWEzOTk5L3RhYmxlOmU0YjZkNTNjY2Q3NzQ3YzE4NzRjMDQ5N2QwM2M2OThmL3RhYmxlcmFuZ2U6ZTRiNmQ1M2NjZDc3NDdjMTg3NGMwNDk3ZDAzYzY5OGZfMy01LTEtMS0xNTYwNA_84ae6b44-0d66-43ce-a709-14e060b84a1b">331</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81Mi9mcmFnOjU4Zjc1NjhmZmQ5YTRiZmI4NDYxZmZjZDhjMWEzOTk5L3RhYmxlOmU0YjZkNTNjY2Q3NzQ3YzE4NzRjMDQ5N2QwM2M2OThmL3RhYmxlcmFuZ2U6ZTRiNmQ1M2NjZDc3NDdjMTg3NGMwNDk3ZDAzYzY5OGZfMy03LTEtMS0xNTYwNA_e8591ec0-83c5-41d8-a203-6ac18008b368">120,802</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><ix:nonNumeric contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" name="srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81Mi9mcmFnOjU4Zjc1NjhmZmQ5YTRiZmI4NDYxZmZjZDhjMWEzOTk5L3RleHRyZWdpb246NThmNzU2OGZmZDlhNGJmYjg0NjFmZmNkOGMxYTM5OTlfNzgw_1bd0d8aa-e069-49e4-bb53-92e035a58faf" escape="true"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of available-for-sale investments classified by their contractual maturities as of March&#160;31, 2022 was:</span></div><div style="margin-top:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.497%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due within one year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81Mi9mcmFnOjU4Zjc1NjhmZmQ5YTRiZmI4NDYxZmZjZDhjMWEzOTk5L3RhYmxlOjJmZGQ4MGJjZjlhNDQ4MGM4NGQ0YTEyZTNkNmVlNTVjL3RhYmxlcmFuZ2U6MmZkZDgwYmNmOWE0NDgwYzg0ZDRhMTJlM2Q2ZWU1NWNfMC0xLTEtMS0xNTYwNA_880ef763-2819-44ae-9f50-186a2c8276ff">71,821</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After one year through two years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81Mi9mcmFnOjU4Zjc1NjhmZmQ5YTRiZmI4NDYxZmZjZDhjMWEzOTk5L3RhYmxlOjJmZGQ4MGJjZjlhNDQ4MGM4NGQ0YTEyZTNkNmVlNTVjL3RhYmxlcmFuZ2U6MmZkZDgwYmNmOWE0NDgwYzg0ZDRhMTJlM2Q2ZWU1NWNfMS0xLTEtMS0xNTYwNA_b67983ae-c7b1-4958-b64f-5ce3d7d2572a">29,914</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81Mi9mcmFnOjU4Zjc1NjhmZmQ5YTRiZmI4NDYxZmZjZDhjMWEzOTk5L3RhYmxlOjJmZGQ4MGJjZjlhNDQ4MGM4NGQ0YTEyZTNkNmVlNTVjL3RhYmxlcmFuZ2U6MmZkZDgwYmNmOWE0NDgwYzg0ZDRhMTJlM2Q2ZWU1NWNfMi0xLTEtMS0xNTYwNA_6a18f1bf-9c80-4d39-a78f-eaf0875352b3">101,735</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i70e8e28fe7ce4e8c98369380190e5902">Changes in market interest rates and bond yields cause certain investments to fall below their cost basis, resulting in unrealized losses on investments.</ix:continuation> We do not intend to sell these investments and nor is it more likely than not that the Company will be required to sell these investments, prior to maturity or recovery of amortized cost.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><div id="i7169a803a6aa44ea981603d220cab84f_55"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_7">Table of Contents</a></span></div></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7. <ix:nonNumeric contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81NS9mcmFnOjMzMjkyOWUzOGUyNTQzMzg4ZmY3NjY5OGZjOWJhMjc1L3RleHRyZWdpb246MzMyOTI5ZTM4ZTI1NDMzODhmZjc2Njk4ZmM5YmEyNzVfMTc3OQ_d2221b21-fc03-4ec5-a5ed-32980aec7750" continuedAt="ife3fcd94656d4ba9b7f956d61737b1f2" escape="true">Fair Value Measurements</ix:nonNumeric></span></div><ix:continuation id="ife3fcd94656d4ba9b7f956d61737b1f2"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amount of cash and cash equivalents, receivables, accounts payable, accrued compensation and benefits, other accrued liabilities, and related party payables approximate fair value due to the short maturity of these instruments.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets</span></div><ix:nonNumeric contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81NS9mcmFnOjMzMjkyOWUzOGUyNTQzMzg4ZmY3NjY5OGZjOWJhMjc1L3RleHRyZWdpb246MzMyOTI5ZTM4ZTI1NDMzODhmZjc2Njk4ZmM5YmEyNzVfMTc3NA_47935a56-a095-4fb4-bc7f-502c6f14fa8d" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the placement in the fair value hierarchy of financial assets that are measured at fair value on a recurring basis as of March&#160;31, 2022:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:41.988%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.579%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Quoted Prices in Active Markets<br/>(Level&#160;1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Significant Other Observable Inputs<br/>(Level&#160;2)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Significant Unobservable Inputs<br/>(Level&#160;3)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government debt securities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8efdfb34bb074c228a7b56cd68c54e92_I20220331" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81NS9mcmFnOjMzMjkyOWUzOGUyNTQzMzg4ZmY3NjY5OGZjOWJhMjc1L3RhYmxlOmM1MTg5ZDY3ZTE5MzQ4NTQ4ZjkwODc5MjkzOTI0YmYwL3RhYmxlcmFuZ2U6YzUxODlkNjdlMTkzNDg1NDhmOTA4NzkyOTM5MjRiZjBfMi0xLTEtMS0xNTYwNA_0341f6ec-599e-467a-86ec-bfdd7cae2959">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21f7dad991b3443cabf8b801717a7102_I20220331" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81NS9mcmFnOjMzMjkyOWUzOGUyNTQzMzg4ZmY3NjY5OGZjOWJhMjc1L3RhYmxlOmM1MTg5ZDY3ZTE5MzQ4NTQ4ZjkwODc5MjkzOTI0YmYwL3RhYmxlcmFuZ2U6YzUxODlkNjdlMTkzNDg1NDhmOTA4NzkyOTM5MjRiZjBfMi0zLTEtMS0xNTYwNA_bb0a769a-727b-417d-af09-5e4f09dfc0d9">101,638</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i872f3add0d1843ac827dc54132c0479a_I20220331" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81NS9mcmFnOjMzMjkyOWUzOGUyNTQzMzg4ZmY3NjY5OGZjOWJhMjc1L3RhYmxlOmM1MTg5ZDY3ZTE5MzQ4NTQ4ZjkwODc5MjkzOTI0YmYwL3RhYmxlcmFuZ2U6YzUxODlkNjdlMTkzNDg1NDhmOTA4NzkyOTM5MjRiZjBfMi01LTEtMS0xNTYwNA_2c4464da-9728-40c9-8381-261ed82e7df3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a7efd03f87243c8b506adee6b95d76e_I20220331" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81NS9mcmFnOjMzMjkyOWUzOGUyNTQzMzg4ZmY3NjY5OGZjOWJhMjc1L3RhYmxlOmM1MTg5ZDY3ZTE5MzQ4NTQ4ZjkwODc5MjkzOTI0YmYwL3RhYmxlcmFuZ2U6YzUxODlkNjdlMTkzNDg1NDhmOTA4NzkyOTM5MjRiZjBfMi03LTEtMS0xNTYwNA_5e20133f-1fc6-40a6-a01e-8fa677d42e74">101,638</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19f61ce6754f4459a9aef0d9e6199717_I20220331" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81NS9mcmFnOjMzMjkyOWUzOGUyNTQzMzg4ZmY3NjY5OGZjOWJhMjc1L3RhYmxlOmM1MTg5ZDY3ZTE5MzQ4NTQ4ZjkwODc5MjkzOTI0YmYwL3RhYmxlcmFuZ2U6YzUxODlkNjdlMTkzNDg1NDhmOTA4NzkyOTM5MjRiZjBfMy0xLTEtMS0xNTYwNA_bf1c351f-1efb-4784-9111-5a66619d73d8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c555a88343545dd9e8dbf1fba6af596_I20220331" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81NS9mcmFnOjMzMjkyOWUzOGUyNTQzMzg4ZmY3NjY5OGZjOWJhMjc1L3RhYmxlOmM1MTg5ZDY3ZTE5MzQ4NTQ4ZjkwODc5MjkzOTI0YmYwL3RhYmxlcmFuZ2U6YzUxODlkNjdlMTkzNDg1NDhmOTA4NzkyOTM5MjRiZjBfMy0zLTEtMS0xNTYwNA_9f7940d8-74f3-4cae-bacb-ba928ca31880">97</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i852b481436844bb180bbb9ccb677b04e_I20220331" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81NS9mcmFnOjMzMjkyOWUzOGUyNTQzMzg4ZmY3NjY5OGZjOWJhMjc1L3RhYmxlOmM1MTg5ZDY3ZTE5MzQ4NTQ4ZjkwODc5MjkzOTI0YmYwL3RhYmxlcmFuZ2U6YzUxODlkNjdlMTkzNDg1NDhmOTA4NzkyOTM5MjRiZjBfMy01LTEtMS0xNTYwNA_6f132093-b240-4926-aa30-6c930edaac2c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib61d2084282545aeadc53945fd070cea_I20220331" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81NS9mcmFnOjMzMjkyOWUzOGUyNTQzMzg4ZmY3NjY5OGZjOWJhMjc1L3RhYmxlOmM1MTg5ZDY3ZTE5MzQ4NTQ4ZjkwODc5MjkzOTI0YmYwL3RhYmxlcmFuZ2U6YzUxODlkNjdlMTkzNDg1NDhmOTA4NzkyOTM5MjRiZjBfMy03LTEtMS0xNTYwNA_da97bcfe-2a73-4868-9e2e-28096500b6b7">97</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93715ce18b404d1e829abbd13ffd87fa_I20220331" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81NS9mcmFnOjMzMjkyOWUzOGUyNTQzMzg4ZmY3NjY5OGZjOWJhMjc1L3RhYmxlOmM1MTg5ZDY3ZTE5MzQ4NTQ4ZjkwODc5MjkzOTI0YmYwL3RhYmxlcmFuZ2U6YzUxODlkNjdlMTkzNDg1NDhmOTA4NzkyOTM5MjRiZjBfNC0xLTEtMS0xNTYwNA_a1b38a5e-30d6-4f82-b180-5ccd1d644130">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c91bed02b6948bc8b34c10b4ed941d8_I20220331" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81NS9mcmFnOjMzMjkyOWUzOGUyNTQzMzg4ZmY3NjY5OGZjOWJhMjc1L3RhYmxlOmM1MTg5ZDY3ZTE5MzQ4NTQ4ZjkwODc5MjkzOTI0YmYwL3RhYmxlcmFuZ2U6YzUxODlkNjdlMTkzNDg1NDhmOTA4NzkyOTM5MjRiZjBfNC0zLTEtMS0xNTYwNA_b4bba836-5d0a-4121-8ef8-f5f35842a75a">101,735</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd71ea23afbd46ddbe3c2deffaf893b0_I20220331" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81NS9mcmFnOjMzMjkyOWUzOGUyNTQzMzg4ZmY3NjY5OGZjOWJhMjc1L3RhYmxlOmM1MTg5ZDY3ZTE5MzQ4NTQ4ZjkwODc5MjkzOTI0YmYwL3RhYmxlcmFuZ2U6YzUxODlkNjdlMTkzNDg1NDhmOTA4NzkyOTM5MjRiZjBfNC01LTEtMS0xNTYwNA_40e1a374-1864-44d2-9204-4179ebcd0f1e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81NS9mcmFnOjMzMjkyOWUzOGUyNTQzMzg4ZmY3NjY5OGZjOWJhMjc1L3RhYmxlOmM1MTg5ZDY3ZTE5MzQ4NTQ4ZjkwODc5MjkzOTI0YmYwL3RhYmxlcmFuZ2U6YzUxODlkNjdlMTkzNDg1NDhmOTA4NzkyOTM5MjRiZjBfNC03LTEtMS0xNTYwNA_5517146b-df47-4da6-b140-176f825ec787">101,735</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the placement in the fair value hierarchy of financial assets that are measured at fair value on a recurring basis as of December&#160;31, 2021:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:41.988%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.579%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Quoted Prices in Active Markets<br/>(Level&#160;1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Significant Other Observable Inputs<br/>(Level&#160;2)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Significant Unobservable Inputs<br/>(Level&#160;3)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government debt securities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8a7409f0d5e4c7aac820b7c228efe86_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81NS9mcmFnOjMzMjkyOWUzOGUyNTQzMzg4ZmY3NjY5OGZjOWJhMjc1L3RhYmxlOmMxNTNmMTQ5YjVhZjQwMzA5N2EyNzFhODE1ZjU0NDkxL3RhYmxlcmFuZ2U6YzE1M2YxNDliNWFmNDAzMDk3YTI3MWE4MTVmNTQ0OTFfMi0xLTEtMS0xNTYwNA_faa49e44-45d8-4ba5-acc6-7593697ca4ce">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i271b0c1c542f467982ba61825dd48dd5_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81NS9mcmFnOjMzMjkyOWUzOGUyNTQzMzg4ZmY3NjY5OGZjOWJhMjc1L3RhYmxlOmMxNTNmMTQ5YjVhZjQwMzA5N2EyNzFhODE1ZjU0NDkxL3RhYmxlcmFuZ2U6YzE1M2YxNDliNWFmNDAzMDk3YTI3MWE4MTVmNTQ0OTFfMi0zLTEtMS0xNTYwNA_5713f1b6-06a7-45a1-80e5-f15d1eb6c732">120,705</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied4c7ca414574920a941d3fac029e286_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81NS9mcmFnOjMzMjkyOWUzOGUyNTQzMzg4ZmY3NjY5OGZjOWJhMjc1L3RhYmxlOmMxNTNmMTQ5YjVhZjQwMzA5N2EyNzFhODE1ZjU0NDkxL3RhYmxlcmFuZ2U6YzE1M2YxNDliNWFmNDAzMDk3YTI3MWE4MTVmNTQ0OTFfMi01LTEtMS0xNTYwNA_1e3d3afa-94f3-4e67-8fa9-d37e07b15855">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i138b7762559a4bd0bef0907b1fc149a0_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81NS9mcmFnOjMzMjkyOWUzOGUyNTQzMzg4ZmY3NjY5OGZjOWJhMjc1L3RhYmxlOmMxNTNmMTQ5YjVhZjQwMzA5N2EyNzFhODE1ZjU0NDkxL3RhYmxlcmFuZ2U6YzE1M2YxNDliNWFmNDAzMDk3YTI3MWE4MTVmNTQ0OTFfMi03LTEtMS0xNTYwNA_8415407c-874f-4303-b6f8-1c703ec35099">120,705</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i531349a928d146fa9cfde02f1ec3e68f_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81NS9mcmFnOjMzMjkyOWUzOGUyNTQzMzg4ZmY3NjY5OGZjOWJhMjc1L3RhYmxlOmMxNTNmMTQ5YjVhZjQwMzA5N2EyNzFhODE1ZjU0NDkxL3RhYmxlcmFuZ2U6YzE1M2YxNDliNWFmNDAzMDk3YTI3MWE4MTVmNTQ0OTFfMy0xLTEtMS0xNTYwNA_0869e9fa-ae9b-4f2c-905d-d71482d97291">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb99f08c2199410b935f7e65fbd62cb9_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81NS9mcmFnOjMzMjkyOWUzOGUyNTQzMzg4ZmY3NjY5OGZjOWJhMjc1L3RhYmxlOmMxNTNmMTQ5YjVhZjQwMzA5N2EyNzFhODE1ZjU0NDkxL3RhYmxlcmFuZ2U6YzE1M2YxNDliNWFmNDAzMDk3YTI3MWE4MTVmNTQ0OTFfMy0zLTEtMS0xNTYwNA_fba2602d-6a21-4d9f-a2a4-54f359ace45b">97</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie74b31c2e1fd45cdacc1a2277e851ddc_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81NS9mcmFnOjMzMjkyOWUzOGUyNTQzMzg4ZmY3NjY5OGZjOWJhMjc1L3RhYmxlOmMxNTNmMTQ5YjVhZjQwMzA5N2EyNzFhODE1ZjU0NDkxL3RhYmxlcmFuZ2U6YzE1M2YxNDliNWFmNDAzMDk3YTI3MWE4MTVmNTQ0OTFfMy01LTEtMS0xNTYwNA_71b1997d-0d2f-4461-9293-99ba4131a417">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e69243d3b7549888b5f4fb6f0bb9475_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81NS9mcmFnOjMzMjkyOWUzOGUyNTQzMzg4ZmY3NjY5OGZjOWJhMjc1L3RhYmxlOmMxNTNmMTQ5YjVhZjQwMzA5N2EyNzFhODE1ZjU0NDkxL3RhYmxlcmFuZ2U6YzE1M2YxNDliNWFmNDAzMDk3YTI3MWE4MTVmNTQ0OTFfMy03LTEtMS0xNTYwNA_fc588386-31e3-4003-82d3-d648f20bc4f7">97</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09a9ddaf3caa4498b7f5d33b60e82854_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81NS9mcmFnOjMzMjkyOWUzOGUyNTQzMzg4ZmY3NjY5OGZjOWJhMjc1L3RhYmxlOmMxNTNmMTQ5YjVhZjQwMzA5N2EyNzFhODE1ZjU0NDkxL3RhYmxlcmFuZ2U6YzE1M2YxNDliNWFmNDAzMDk3YTI3MWE4MTVmNTQ0OTFfNC0xLTEtMS0xNTYwNA_99a8260b-2145-4140-9812-6869f9f06248">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c064cf87f8c47afbfc9a5d1fbd79533_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81NS9mcmFnOjMzMjkyOWUzOGUyNTQzMzg4ZmY3NjY5OGZjOWJhMjc1L3RhYmxlOmMxNTNmMTQ5YjVhZjQwMzA5N2EyNzFhODE1ZjU0NDkxL3RhYmxlcmFuZ2U6YzE1M2YxNDliNWFmNDAzMDk3YTI3MWE4MTVmNTQ0OTFfNC0zLTEtMS0xNTYwNA_898a7968-483b-4dc3-90c0-d0fb6b2170ba">120,802</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1c952fbceb14ed981c1efbc9b58c1f5_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81NS9mcmFnOjMzMjkyOWUzOGUyNTQzMzg4ZmY3NjY5OGZjOWJhMjc1L3RhYmxlOmMxNTNmMTQ5YjVhZjQwMzA5N2EyNzFhODE1ZjU0NDkxL3RhYmxlcmFuZ2U6YzE1M2YxNDliNWFmNDAzMDk3YTI3MWE4MTVmNTQ0OTFfNC01LTEtMS0xNTYwNA_9443e5ab-8119-499a-b2b5-9929067dfc96">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81NS9mcmFnOjMzMjkyOWUzOGUyNTQzMzg4ZmY3NjY5OGZjOWJhMjc1L3RhYmxlOmMxNTNmMTQ5YjVhZjQwMzA5N2EyNzFhODE1ZjU0NDkxL3RhYmxlcmFuZ2U6YzE1M2YxNDliNWFmNDAzMDk3YTI3MWE4MTVmNTQ0OTFfNC03LTEtMS0xNTYwNA_76cddfb1-cf42-4991-a93b-31fa1765d74d">120,802</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The method used to estimate the fair value of the Level 2 short-term and long-term debt investments in the tables above is based on professional pricing sources for identical or comparable instruments, rather than direct observations of quoted prices in active markets.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Liabilities</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying values of the Company's long-term debt, excluding the <ix:nonFraction unitRef="number" contextRef="if6f497049bf74c16a1396dfc4d1e650a_I20220331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81NS9mcmFnOjMzMjkyOWUzOGUyNTQzMzg4ZmY3NjY5OGZjOWJhMjc1L3RleHRyZWdpb246MzMyOTI5ZTM4ZTI1NDMzODhmZjc2Njk4ZmM5YmEyNzVfOTQy_79db7b9a-0594-44a0-aa4c-c2a453bb92a7">3.50</ix:nonFraction>% convertible senior notes due 2023 (the "Convertible Notes"), approximates fair value due to the length of time to maturity and/or the existence of interest rates that approximate prevailing market rates. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The calculated fair value of the Convertible Notes (Note 11) was approximately $<ix:nonFraction unitRef="usd" contextRef="if6f497049bf74c16a1396dfc4d1e650a_I20220331" decimals="-3" name="us-gaap:ConvertibleDebtFairValueDisclosures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81NS9mcmFnOjMzMjkyOWUzOGUyNTQzMzg4ZmY3NjY5OGZjOWJhMjc1L3RleHRyZWdpb246MzMyOTI5ZTM4ZTI1NDMzODhmZjc2Njk4ZmM5YmEyNzVfMTIyOQ_9583d9fa-df14-4a12-823a-e203c81eebc9">164,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i3e4b384138dc464ea318892a265c9e5f_I20211231" decimals="-3" name="us-gaap:ConvertibleDebtFairValueDisclosures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81NS9mcmFnOjMzMjkyOWUzOGUyNTQzMzg4ZmY3NjY5OGZjOWJhMjc1L3RleHRyZWdpb246MzMyOTI5ZTM4ZTI1NDMzODhmZjc2Njk4ZmM5YmEyNzVfMTIzNg_ccf9b4c1-cf0e-4612-885b-64b46b81339a">160,000</ix:nonFraction> as of March&#160;31, 2022 and December&#160;31, 2021, respectively, and is based on the recent third-party trades of the instrument as of the balance sheet date. The fair value of the Convertible Notes is classified as Level 2 within the fair value hierarchy as there is not an active market for the Convertible Notes, however, third-party trades of the instrument are considered observable inputs. The Convertible Notes are reflected on the accompanying condensed consolidated balance sheets at amortized cost, which was $<ix:nonFraction unitRef="usd" contextRef="if6f497049bf74c16a1396dfc4d1e650a_I20220331" decimals="-3" name="us-gaap:ConvertibleDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81NS9mcmFnOjMzMjkyOWUzOGUyNTQzMzg4ZmY3NjY5OGZjOWJhMjc1L3RleHRyZWdpb246MzMyOTI5ZTM4ZTI1NDMzODhmZjc2Njk4ZmM5YmEyNzVfMTcyNA_bd29c03a-6d99-4546-9bc8-a7f6c24026b3">198,362</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i3e4b384138dc464ea318892a265c9e5f_I20211231" decimals="-3" name="us-gaap:ConvertibleDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81NS9mcmFnOjMzMjkyOWUzOGUyNTQzMzg4ZmY3NjY5OGZjOWJhMjc1L3RleHRyZWdpb246MzMyOTI5ZTM4ZTI1NDMzODhmZjc2Njk4ZmM5YmEyNzVfMTczMQ_cfe7a677-2fa3-41e3-87e2-34ebce70bdba">179,882</ix:nonFraction> as of March&#160;31, 2022 and December&#160;31, 2021, respectively (see Note 2 regarding adoption of ASU 2020-06 on January 1, 2022).</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><div id="i7169a803a6aa44ea981603d220cab84f_58"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8. <ix:nonNumeric contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" name="us-gaap:InventoryDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81OC9mcmFnOjYwNGVkYzRkYjExYjRmOGJhZjZjMTAyYmI1YTc1YTc5L3RleHRyZWdpb246NjA0ZWRjNGRiMTFiNGY4YmFmNmMxMDJiYjVhNzVhNzlfNTY_9ce43cfe-6105-486e-8563-c7cf6d66529d" continuedAt="i980e3afe68e5444cad0c4a1ff2fe3c7d" escape="true">Inventory</ix:nonNumeric></span></div><ix:continuation id="i980e3afe68e5444cad0c4a1ff2fe3c7d"><ix:nonNumeric contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81OC9mcmFnOjYwNGVkYzRkYjExYjRmOGJhZjZjMTAyYmI1YTc1YTc5L3RleHRyZWdpb246NjA0ZWRjNGRiMTFiNGY4YmFmNmMxMDJiYjVhNzVhNzlfNjA_d1e5b736-4eab-46f8-8269-f0c19cdf0b46" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory consists of the following:</span></div><div style="margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplies, embryos and other production materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8e3dddd71c4443985fe28d70f1e2c9a_I20220331" decimals="-3" name="us-gaap:InventoryGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81OC9mcmFnOjYwNGVkYzRkYjExYjRmOGJhZjZjMTAyYmI1YTc1YTc5L3RhYmxlOmIwYjQ1NDA1ZWY1ODRiZWY4ZDQzZGI3ZGZhODdkOTA5L3RhYmxlcmFuZ2U6YjBiNDU0MDVlZjU4NGJlZjhkNDNkYjdkZmE4N2Q5MDlfMS0xLTEtMS0xNTYwNA_e46e5b7e-1e5c-4e37-9fec-05fccfd00431">2,931</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3940f9d38d364dccb21e61d867617045_I20211231" decimals="-3" name="us-gaap:InventoryGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81OC9mcmFnOjYwNGVkYzRkYjExYjRmOGJhZjZjMTAyYmI1YTc1YTc5L3RhYmxlOmIwYjQ1NDA1ZWY1ODRiZWY4ZDQzZGI3ZGZhODdkOTA5L3RhYmxlcmFuZ2U6YjBiNDU0MDVlZjU4NGJlZjhkNDNkYjdkZmE4N2Q5MDlfMS0zLTEtMS0xNTYwNA_6fe61b35-76da-4853-aa03-71b6f87e4127">2,588</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf3c07cd4a91470ba7f63dbc88e4bc6a_I20220331" decimals="-3" name="us-gaap:InventoryGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81OC9mcmFnOjYwNGVkYzRkYjExYjRmOGJhZjZjMTAyYmI1YTc1YTc5L3RhYmxlOmIwYjQ1NDA1ZWY1ODRiZWY4ZDQzZGI3ZGZhODdkOTA5L3RhYmxlcmFuZ2U6YjBiNDU0MDVlZjU4NGJlZjhkNDNkYjdkZmE4N2Q5MDlfMi0xLTEtMS0xNTYwNA_68d8ed12-f007-4118-89a5-fa5b7b44efb3">2,539</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92fec9005efa4d79987abea15d951226_I20211231" decimals="-3" name="us-gaap:InventoryGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81OC9mcmFnOjYwNGVkYzRkYjExYjRmOGJhZjZjMTAyYmI1YTc1YTc5L3RhYmxlOmIwYjQ1NDA1ZWY1ODRiZWY4ZDQzZGI3ZGZhODdkOTA5L3RhYmxlcmFuZ2U6YjBiNDU0MDVlZjU4NGJlZjhkNDNkYjdkZmE4N2Q5MDlfMi0zLTEtMS0xNTYwNA_5b117eda-74a2-4717-b3f3-65c30f7193ec">2,564</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Livestock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42bf8b0d2e814be082d3b0bf6da63af4_I20220331" decimals="-3" name="us-gaap:InventoryGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81OC9mcmFnOjYwNGVkYzRkYjExYjRmOGJhZjZjMTAyYmI1YTc1YTc5L3RhYmxlOmIwYjQ1NDA1ZWY1ODRiZWY4ZDQzZGI3ZGZhODdkOTA5L3RhYmxlcmFuZ2U6YjBiNDU0MDVlZjU4NGJlZjhkNDNkYjdkZmE4N2Q5MDlfMy0xLTEtMS0xNTYwNA_5c20c8f2-4c5b-4c72-948a-70025e994523">5,918</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecc97711a44b47019e38b94af754e168_I20211231" decimals="-3" name="us-gaap:InventoryGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81OC9mcmFnOjYwNGVkYzRkYjExYjRmOGJhZjZjMTAyYmI1YTc1YTc5L3RhYmxlOmIwYjQ1NDA1ZWY1ODRiZWY4ZDQzZGI3ZGZhODdkOTA5L3RhYmxlcmFuZ2U6YjBiNDU0MDVlZjU4NGJlZjhkNDNkYjdkZmE4N2Q5MDlfMy0zLTEtMS0xNTYwNA_eddae0f8-c542-44c4-b216-7f5d6895ba65">6,310</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Feed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22be83bf68b14b30a42ca5908e204306_I20220331" decimals="-3" name="us-gaap:InventoryGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81OC9mcmFnOjYwNGVkYzRkYjExYjRmOGJhZjZjMTAyYmI1YTc1YTc5L3RhYmxlOmIwYjQ1NDA1ZWY1ODRiZWY4ZDQzZGI3ZGZhODdkOTA5L3RhYmxlcmFuZ2U6YjBiNDU0MDVlZjU4NGJlZjhkNDNkYjdkZmE4N2Q5MDlfNC0xLTEtMS0xNTYwNA_0bdb714d-2bae-43ec-bde1-50251dff9d2a">1,342</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5527892baeab40f6a59e15f38b3b3dc4_I20211231" decimals="-3" name="us-gaap:InventoryGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81OC9mcmFnOjYwNGVkYzRkYjExYjRmOGJhZjZjMTAyYmI1YTc1YTc5L3RhYmxlOmIwYjQ1NDA1ZWY1ODRiZWY4ZDQzZGI3ZGZhODdkOTA5L3RhYmxlcmFuZ2U6YjBiNDU0MDVlZjU4NGJlZjhkNDNkYjdkZmE4N2Q5MDlfNC0zLTEtMS0xNTYwNA_40a9cd17-7951-467c-99d1-de34aff8f413">1,799</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventory</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:InventoryGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81OC9mcmFnOjYwNGVkYzRkYjExYjRmOGJhZjZjMTAyYmI1YTc1YTc5L3RhYmxlOmIwYjQ1NDA1ZWY1ODRiZWY4ZDQzZGI3ZGZhODdkOTA5L3RhYmxlcmFuZ2U6YjBiNDU0MDVlZjU4NGJlZjhkNDNkYjdkZmE4N2Q5MDlfNS0xLTEtMS0xNTYwNA_d45d35fe-6ade-48a7-ab96-5c15bba2501b">12,730</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231" decimals="-3" name="us-gaap:InventoryGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81OC9mcmFnOjYwNGVkYzRkYjExYjRmOGJhZjZjMTAyYmI1YTc1YTc5L3RhYmxlOmIwYjQ1NDA1ZWY1ODRiZWY4ZDQzZGI3ZGZhODdkOTA5L3RhYmxlcmFuZ2U6YjBiNDU0MDVlZjU4NGJlZjhkNDNkYjdkZmE4N2Q5MDlfNS0zLTEtMS0xNTYwNA_a368aa82-6e88-47d2-a4d9-64469292e580">13,261</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i7169a803a6aa44ea981603d220cab84f_61"></div><div style="margin-top:21pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9. <ix:nonNumeric contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82MS9mcmFnOjIxNDY0N2Q2NmZmMTQzZDQ4MjYyYTJlZDM1ZmQ0NTgyL3RleHRyZWdpb246MjE0NjQ3ZDY2ZmYxNDNkNDgyNjJhMmVkMzVmZDQ1ODJfMjI3_2540b99e-fb3d-4ca9-b391-4d9603de6cea" continuedAt="i1d50d889e9dc440e89b79428c324ba97" escape="true">Property, Plant and Equipment, Net</ix:nonNumeric></span></div><ix:continuation id="i1d50d889e9dc440e89b79428c324ba97"><ix:nonNumeric contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82MS9mcmFnOjIxNDY0N2Q2NmZmMTQzZDQ4MjYyYTJlZDM1ZmQ0NTgyL3RleHRyZWdpb246MjE0NjQ3ZDY2ZmYxNDNkNDgyNjJhMmVkMzVmZDQ1ODJfMjI4_a666dd0a-6198-4016-9788-1c3fb12a13ca" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment consist of the following:</span></div><div style="margin-top:17pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:70.894%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.537%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land and land improvements</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:LandAndLandImprovements" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82MS9mcmFnOjIxNDY0N2Q2NmZmMTQzZDQ4MjYyYTJlZDM1ZmQ0NTgyL3RhYmxlOjZmZmIxNmI1NGU2YTQyM2FiMTIyODI0MjI3ZGNlNWI4L3RhYmxlcmFuZ2U6NmZmYjE2YjU0ZTZhNDIzYWIxMjI4MjQyMjdkY2U1YjhfMS0xLTEtMS0xNTYwNA_28d17571-9312-4187-a8ea-db2772a975f3">11,118</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231" decimals="-3" name="us-gaap:LandAndLandImprovements" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82MS9mcmFnOjIxNDY0N2Q2NmZmMTQzZDQ4MjYyYTJlZDM1ZmQ0NTgyL3RhYmxlOjZmZmIxNmI1NGU2YTQyM2FiMTIyODI0MjI3ZGNlNWI4L3RhYmxlcmFuZ2U6NmZmYjE2YjU0ZTZhNDIzYWIxMjI4MjQyMjdkY2U1YjhfMS0zLTEtMS0xNTYwNA_c6c686f7-585c-4f4e-ae0c-209130837bac">11,118</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and building improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:BuildingsAndImprovementsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82MS9mcmFnOjIxNDY0N2Q2NmZmMTQzZDQ4MjYyYTJlZDM1ZmQ0NTgyL3RhYmxlOjZmZmIxNmI1NGU2YTQyM2FiMTIyODI0MjI3ZGNlNWI4L3RhYmxlcmFuZ2U6NmZmYjE2YjU0ZTZhNDIzYWIxMjI4MjQyMjdkY2U1YjhfMi0xLTEtMS0xNTYwNA_67ac664d-fc0a-41fe-b4c4-f2c4840b7591">12,903</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231" decimals="-3" name="us-gaap:BuildingsAndImprovementsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82MS9mcmFnOjIxNDY0N2Q2NmZmMTQzZDQ4MjYyYTJlZDM1ZmQ0NTgyL3RhYmxlOjZmZmIxNmI1NGU2YTQyM2FiMTIyODI0MjI3ZGNlNWI4L3RhYmxlcmFuZ2U6NmZmYjE2YjU0ZTZhNDIzYWIxMjI4MjQyMjdkY2U1YjhfMi0zLTEtMS0xNTYwNA_9de0cd96-0b9a-4b17-a0ac-7ba959d9b99f">12,896</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:FurnitureAndFixturesGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82MS9mcmFnOjIxNDY0N2Q2NmZmMTQzZDQ4MjYyYTJlZDM1ZmQ0NTgyL3RhYmxlOjZmZmIxNmI1NGU2YTQyM2FiMTIyODI0MjI3ZGNlNWI4L3RhYmxlcmFuZ2U6NmZmYjE2YjU0ZTZhNDIzYWIxMjI4MjQyMjdkY2U1YjhfMy0xLTEtMS0xNTYwNA_83457b3a-af98-431c-8f5d-f538dffc2664">1,193</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231" decimals="-3" name="us-gaap:FurnitureAndFixturesGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82MS9mcmFnOjIxNDY0N2Q2NmZmMTQzZDQ4MjYyYTJlZDM1ZmQ0NTgyL3RhYmxlOjZmZmIxNmI1NGU2YTQyM2FiMTIyODI0MjI3ZGNlNWI4L3RhYmxlcmFuZ2U6NmZmYjE2YjU0ZTZhNDIzYWIxMjI4MjQyMjdkY2U1YjhfMy0zLTEtMS0xNTYwNA_d5706319-db67-428c-96fc-1e3c33f22122">1,162</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:MachineryAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82MS9mcmFnOjIxNDY0N2Q2NmZmMTQzZDQ4MjYyYTJlZDM1ZmQ0NTgyL3RhYmxlOjZmZmIxNmI1NGU2YTQyM2FiMTIyODI0MjI3ZGNlNWI4L3RhYmxlcmFuZ2U6NmZmYjE2YjU0ZTZhNDIzYWIxMjI4MjQyMjdkY2U1YjhfNC0xLTEtMS0xNTYwNA_053ca392-8c3a-477f-8c76-b1040e7deeac">34,304</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231" decimals="-3" name="us-gaap:MachineryAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82MS9mcmFnOjIxNDY0N2Q2NmZmMTQzZDQ4MjYyYTJlZDM1ZmQ0NTgyL3RhYmxlOjZmZmIxNmI1NGU2YTQyM2FiMTIyODI0MjI3ZGNlNWI4L3RhYmxlcmFuZ2U6NmZmYjE2YjU0ZTZhNDIzYWIxMjI4MjQyMjdkY2U1YjhfNC0zLTEtMS0xNTYwNA_3f6de83b-94ff-4dc2-a147-16c7e47fab74">33,584</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:LeaseholdImprovementsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82MS9mcmFnOjIxNDY0N2Q2NmZmMTQzZDQ4MjYyYTJlZDM1ZmQ0NTgyL3RhYmxlOjZmZmIxNmI1NGU2YTQyM2FiMTIyODI0MjI3ZGNlNWI4L3RhYmxlcmFuZ2U6NmZmYjE2YjU0ZTZhNDIzYWIxMjI4MjQyMjdkY2U1YjhfNS0xLTEtMS0xNTYwNA_d3ebf0d3-c16e-4971-9bf9-194e0364bcff">4,822</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231" decimals="-3" name="us-gaap:LeaseholdImprovementsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82MS9mcmFnOjIxNDY0N2Q2NmZmMTQzZDQ4MjYyYTJlZDM1ZmQ0NTgyL3RhYmxlOjZmZmIxNmI1NGU2YTQyM2FiMTIyODI0MjI3ZGNlNWI4L3RhYmxlcmFuZ2U6NmZmYjE2YjU0ZTZhNDIzYWIxMjI4MjQyMjdkY2U1YjhfNS0zLTEtMS0xNTYwNA_d0521df1-b409-4227-9912-680be8e9d74a">4,822</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breeding stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="pgen:BreedingandProductionAnimalsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82MS9mcmFnOjIxNDY0N2Q2NmZmMTQzZDQ4MjYyYTJlZDM1ZmQ0NTgyL3RhYmxlOjZmZmIxNmI1NGU2YTQyM2FiMTIyODI0MjI3ZGNlNWI4L3RhYmxlcmFuZ2U6NmZmYjE2YjU0ZTZhNDIzYWIxMjI4MjQyMjdkY2U1YjhfNi0xLTEtMS0xNTYwNA_49870a84-e110-4d79-ba4d-47d4bf15f65b">953</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231" decimals="-3" name="pgen:BreedingandProductionAnimalsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82MS9mcmFnOjIxNDY0N2Q2NmZmMTQzZDQ4MjYyYTJlZDM1ZmQ0NTgyL3RhYmxlOjZmZmIxNmI1NGU2YTQyM2FiMTIyODI0MjI3ZGNlNWI4L3RhYmxlcmFuZ2U6NmZmYjE2YjU0ZTZhNDIzYWIxMjI4MjQyMjdkY2U1YjhfNi0zLTEtMS0xNTYwNA_3ed28ac8-bf31-4a7b-bcc3-4cb584380044">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer hardware and software</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="pgen:ComputerHardwareandSoftware" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82MS9mcmFnOjIxNDY0N2Q2NmZmMTQzZDQ4MjYyYTJlZDM1ZmQ0NTgyL3RhYmxlOjZmZmIxNmI1NGU2YTQyM2FiMTIyODI0MjI3ZGNlNWI4L3RhYmxlcmFuZ2U6NmZmYjE2YjU0ZTZhNDIzYWIxMjI4MjQyMjdkY2U1YjhfNy0xLTEtMS0xNTYwNA_0a5b28f2-3f28-462b-aced-eeecdb50f084">5,169</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231" decimals="-3" name="pgen:ComputerHardwareandSoftware" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82MS9mcmFnOjIxNDY0N2Q2NmZmMTQzZDQ4MjYyYTJlZDM1ZmQ0NTgyL3RhYmxlOjZmZmIxNmI1NGU2YTQyM2FiMTIyODI0MjI3ZGNlNWI4L3RhYmxlcmFuZ2U6NmZmYjE2YjU0ZTZhNDIzYWIxMjI4MjQyMjdkY2U1YjhfNy0zLTEtMS0xNTYwNA_a2c71bc3-1032-490a-9715-c5127dde120e">5,131</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction and other assets in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:ConstructionInProgressGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82MS9mcmFnOjIxNDY0N2Q2NmZmMTQzZDQ4MjYyYTJlZDM1ZmQ0NTgyL3RhYmxlOjZmZmIxNmI1NGU2YTQyM2FiMTIyODI0MjI3ZGNlNWI4L3RhYmxlcmFuZ2U6NmZmYjE2YjU0ZTZhNDIzYWIxMjI4MjQyMjdkY2U1YjhfOC0xLTEtMS0xNTYwNA_263a054e-d133-4cfa-b14e-f87c7da24382">3,596</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231" decimals="-3" name="us-gaap:ConstructionInProgressGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82MS9mcmFnOjIxNDY0N2Q2NmZmMTQzZDQ4MjYyYTJlZDM1ZmQ0NTgyL3RhYmxlOjZmZmIxNmI1NGU2YTQyM2FiMTIyODI0MjI3ZGNlNWI4L3RhYmxlcmFuZ2U6NmZmYjE2YjU0ZTZhNDIzYWIxMjI4MjQyMjdkY2U1YjhfOC0zLTEtMS0xNTYwNA_248aba36-5dc7-4a84-861a-b60801059658">3,824</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82MS9mcmFnOjIxNDY0N2Q2NmZmMTQzZDQ4MjYyYTJlZDM1ZmQ0NTgyL3RhYmxlOjZmZmIxNmI1NGU2YTQyM2FiMTIyODI0MjI3ZGNlNWI4L3RhYmxlcmFuZ2U6NmZmYjE2YjU0ZTZhNDIzYWIxMjI4MjQyMjdkY2U1YjhfOS0xLTEtMS0xNTYwNA_a90c4964-5b69-4c1e-be4a-056c525f6305">74,058</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82MS9mcmFnOjIxNDY0N2Q2NmZmMTQzZDQ4MjYyYTJlZDM1ZmQ0NTgyL3RhYmxlOjZmZmIxNmI1NGU2YTQyM2FiMTIyODI0MjI3ZGNlNWI4L3RhYmxlcmFuZ2U6NmZmYjE2YjU0ZTZhNDIzYWIxMjI4MjQyMjdkY2U1YjhfOS0zLTEtMS0xNTYwNA_3c0a0156-7921-4f7a-a867-ea9e1ec5e9ed">73,537</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82MS9mcmFnOjIxNDY0N2Q2NmZmMTQzZDQ4MjYyYTJlZDM1ZmQ0NTgyL3RhYmxlOjZmZmIxNmI1NGU2YTQyM2FiMTIyODI0MjI3ZGNlNWI4L3RhYmxlcmFuZ2U6NmZmYjE2YjU0ZTZhNDIzYWIxMjI4MjQyMjdkY2U1YjhfMTAtMS0xLTEtMTU2MDQ_7c05c5ad-76f8-453b-808c-ef3bb37a7b10">40,475</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82MS9mcmFnOjIxNDY0N2Q2NmZmMTQzZDQ4MjYyYTJlZDM1ZmQ0NTgyL3RhYmxlOjZmZmIxNmI1NGU2YTQyM2FiMTIyODI0MjI3ZGNlNWI4L3RhYmxlcmFuZ2U6NmZmYjE2YjU0ZTZhNDIzYWIxMjI4MjQyMjdkY2U1YjhfMTAtMy0xLTEtMTU2MDQ_9b1b2572-10a7-4c38-b4ba-c8824c98c4ce">39,222</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82MS9mcmFnOjIxNDY0N2Q2NmZmMTQzZDQ4MjYyYTJlZDM1ZmQ0NTgyL3RhYmxlOjZmZmIxNmI1NGU2YTQyM2FiMTIyODI0MjI3ZGNlNWI4L3RhYmxlcmFuZ2U6NmZmYjE2YjU0ZTZhNDIzYWIxMjI4MjQyMjdkY2U1YjhfMTEtMS0xLTEtMTU2MDQ_3adedaff-6900-4283-a5a3-6b32ff07df92">33,583</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82MS9mcmFnOjIxNDY0N2Q2NmZmMTQzZDQ4MjYyYTJlZDM1ZmQ0NTgyL3RhYmxlOjZmZmIxNmI1NGU2YTQyM2FiMTIyODI0MjI3ZGNlNWI4L3RhYmxlcmFuZ2U6NmZmYjE2YjU0ZTZhNDIzYWIxMjI4MjQyMjdkY2U1YjhfMTEtMy0xLTEtMTU2MDQ_b7387e4f-819a-4d26-8f51-664eceb75416">34,315</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense was $<ix:nonFraction unitRef="usd" contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" decimals="-3" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82MS9mcmFnOjIxNDY0N2Q2NmZmMTQzZDQ4MjYyYTJlZDM1ZmQ0NTgyL3RleHRyZWdpb246MjE0NjQ3ZDY2ZmYxNDNkNDgyNjJhMmVkMzVmZDQ1ODJfMTI3_1298478f-5bca-4653-8754-3da49fb33e75">1,483</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331" decimals="-3" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82MS9mcmFnOjIxNDY0N2Q2NmZmMTQzZDQ4MjYyYTJlZDM1ZmQ0NTgyL3RleHRyZWdpb246MjE0NjQ3ZDY2ZmYxNDNkNDgyNjJhMmVkMzVmZDQ1ODJfMTM0_5cc3a40a-572e-4056-9b2e-467cbb52051d">1,593</ix:nonFraction> for the three months ended March 31, 2022 and 2021, respectively.</span></div></ix:continuation><div id="i7169a803a6aa44ea981603d220cab84f_64"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10. <ix:nonNumeric contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82NC9mcmFnOjI3N2RmOTkyZjJlMjRlMDhhZjQwMzNhZTFhYzE4YThlL3RleHRyZWdpb246Mjc3ZGY5OTJmMmUyNGUwOGFmNDAzM2FlMWFjMThhOGVfNDE3_724a7db9-b157-4c5e-9a43-e917a61ca55b" continuedAt="i614734b1e25d43d788a9a7a230b853af" escape="true">Goodwill and Intangible Assets, Net</ix:nonNumeric></span></div><ix:continuation id="i614734b1e25d43d788a9a7a230b853af" continuedAt="ie67ddfa66a264304b13ee3865afb3388"><ix:nonNumeric contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82NC9mcmFnOjI3N2RmOTkyZjJlMjRlMDhhZjQwMzNhZTFhYzE4YThlL3RleHRyZWdpb246Mjc3ZGY5OTJmMmUyNGUwOGFmNDAzM2FlMWFjMThhOGVfNDI0_7f7da55c-1bf5-43ca-85b9-4e19b657ff66" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the carrying amount of goodwill for the three months ended March 31, 2022 were as follows:</span></div><div style="margin-top:17pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:85.263%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.537%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82NC9mcmFnOjI3N2RmOTkyZjJlMjRlMDhhZjQwMzNhZTFhYzE4YThlL3RhYmxlOjZiY2NjNDlkMDIwZDQ1ZTI4MDZhYTU3ZjQ0ODg5OTBmL3RhYmxlcmFuZ2U6NmJjY2M0OWQwMjBkNDVlMjgwNmFhNTdmNDQ4ODk5MGZfMC0xLTEtMS0xNTYwNA_5ef67d83-a5f6-4865-8e5f-b7bdae1a5b49">54,148</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" decimals="-3" name="us-gaap:GoodwillImpairmentLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82NC9mcmFnOjI3N2RmOTkyZjJlMjRlMDhhZjQwMzNhZTFhYzE4YThlL3RhYmxlOjZiY2NjNDlkMDIwZDQ1ZTI4MDZhYTU3ZjQ0ODg5OTBmL3RhYmxlcmFuZ2U6NmJjY2M0OWQwMjBkNDVlMjgwNmFhNTdmNDQ4ODk5MGZfMS0xLTEtMS0xNTYwNA_5281b6ba-0e40-406f-9b22-22ed24517e21">482</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82NC9mcmFnOjI3N2RmOTkyZjJlMjRlMDhhZjQwMzNhZTFhYzE4YThlL3RhYmxlOjZiY2NjNDlkMDIwZDQ1ZTI4MDZhYTU3ZjQ0ODg5OTBmL3RhYmxlcmFuZ2U6NmJjY2M0OWQwMjBkNDVlMjgwNmFhNTdmNDQ4ODk5MGZfMi0xLTEtMS0xNTYwNA_b733300d-c9f8-48ca-bb86-59bd12ccf14b">53</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at March 31, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82NC9mcmFnOjI3N2RmOTkyZjJlMjRlMDhhZjQwMzNhZTFhYzE4YThlL3RhYmxlOjZiY2NjNDlkMDIwZDQ1ZTI4MDZhYTU3ZjQ0ODg5OTBmL3RhYmxlcmFuZ2U6NmJjY2M0OWQwMjBkNDVlMjgwNmFhNTdmNDQ4ODk5MGZfMy0xLTEtMS0xNTYwNA_6e370045-2f52-43c1-aa2f-d818a3446c5a">53,613</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded $<ix:nonFraction unitRef="usd" contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" decimals="-3" name="us-gaap:GoodwillImpairmentLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82NC9mcmFnOjI3N2RmOTkyZjJlMjRlMDhhZjQwMzNhZTFhYzE4YThlL3RleHRyZWdpb246Mjc3ZGY5OTJmMmUyNGUwOGFmNDAzM2FlMWFjMThhOGVfMzg0ODI5MDY5OTA1NQ_b62786c2-c95c-4d1c-9d5c-1132990747c1">482</ix:nonFraction> of goodwill impairment related to the total goodwill assigned to <ix:nonFraction unitRef="reporting_unit" contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" decimals="INF" name="pgen:NumberOfReportingUnitsImpaired" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82NC9mcmFnOjI3N2RmOTkyZjJlMjRlMDhhZjQwMzNhZTFhYzE4YThlL3RleHRyZWdpb246Mjc3ZGY5OTJmMmUyNGUwOGFmNDAzM2FlMWFjMThhOGVfMjE5OTAyMzI1Nzg2MA_d4cae2d7-0289-46de-87ee-6d11a062fe5b">one</ix:nonFraction> reporting unit within the biopharmaceutical segment during the first quarter of 2022.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had $<ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82NC9mcmFnOjI3N2RmOTkyZjJlMjRlMDhhZjQwMzNhZTFhYzE4YThlL3RleHRyZWdpb246Mjc3ZGY5OTJmMmUyNGUwOGFmNDAzM2FlMWFjMThhOGVfMTM4_ad90c179-abaf-45f8-ac1e-5bff50f3ab3a">44,125</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231" decimals="-3" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82NC9mcmFnOjI3N2RmOTkyZjJlMjRlMDhhZjQwMzNhZTFhYzE4YThlL3RleHRyZWdpb246Mjc3ZGY5OTJmMmUyNGUwOGFmNDAzM2FlMWFjMThhOGVfMjE5OTAyMzI1NjAyMQ_5da73370-22bb-4c23-8c64-c2ad9df1edf6">43,643</ix:nonFraction> of cumulative impairment losses as of March&#160;31, 2022 and December&#160;31, 2021, respectively.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_7">Table of Contents</a></span></div></div><ix:continuation id="ie67ddfa66a264304b13ee3865afb3388"><ix:nonNumeric contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82NC9mcmFnOjI3N2RmOTkyZjJlMjRlMDhhZjQwMzNhZTFhYzE4YThlL3RleHRyZWdpb246Mjc3ZGY5OTJmMmUyNGUwOGFmNDAzM2FlMWFjMThhOGVfNDM4_10b1eef2-91f5-4071-9a94-586b52a2ce71" escape="true"><div style="margin-top:15pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets consist of the following as of March&#160;31, 2022:</span></div><div style="margin-top:17pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:56.462%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.558%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents, developed technologies and know-how</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i677ca2bcecca4536be4af0d96b5861f8_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82NC9mcmFnOjI3N2RmOTkyZjJlMjRlMDhhZjQwMzNhZTFhYzE4YThlL3RhYmxlOjM1Y2M0ZTFlNmYyMjQ1YmI4YjhkNTJiZGJmNTgyN2E3L3RhYmxlcmFuZ2U6MzVjYzRlMWU2ZjIyNDViYjhiOGQ1MmJkYmY1ODI3YTdfMS0xLTEtMS0xNTYwNA_05d35e2b-a251-48ff-9e38-644736e7a2d8">90,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i677ca2bcecca4536be4af0d96b5861f8_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82NC9mcmFnOjI3N2RmOTkyZjJlMjRlMDhhZjQwMzNhZTFhYzE4YThlL3RhYmxlOjM1Y2M0ZTFlNmYyMjQ1YmI4YjhkNTJiZGJmNTgyN2E3L3RhYmxlcmFuZ2U6MzVjYzRlMWU2ZjIyNDViYjhiOGQ1MmJkYmY1ODI3YTdfMS0zLTEtMS0xNTYwNA_aebc915e-2df3-47e1-8556-4dd2ff66b3d0">39,595</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i677ca2bcecca4536be4af0d96b5861f8_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82NC9mcmFnOjI3N2RmOTkyZjJlMjRlMDhhZjQwMzNhZTFhYzE4YThlL3RhYmxlOjM1Y2M0ZTFlNmYyMjQ1YmI4YjhkNTJiZGJmNTgyN2E3L3RhYmxlcmFuZ2U6MzVjYzRlMWU2ZjIyNDViYjhiOGQ1MmJkYmY1ODI3YTdfMS01LTEtMS0xNTYwNA_a60ca44d-381c-4f23-b795-94e4a51b3e62">50,405</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35dfe924439843b5af0a65df16408eaa_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82NC9mcmFnOjI3N2RmOTkyZjJlMjRlMDhhZjQwMzNhZTFhYzE4YThlL3RhYmxlOjM1Y2M0ZTFlNmYyMjQ1YmI4YjhkNTJiZGJmNTgyN2E3L3RhYmxlcmFuZ2U6MzVjYzRlMWU2ZjIyNDViYjhiOGQ1MmJkYmY1ODI3YTdfMi0xLTEtMS0xNTYwNA_425feed6-056c-410c-9ff4-2cb4f1a5b3da">10,850</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i35dfe924439843b5af0a65df16408eaa_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82NC9mcmFnOjI3N2RmOTkyZjJlMjRlMDhhZjQwMzNhZTFhYzE4YThlL3RhYmxlOjM1Y2M0ZTFlNmYyMjQ1YmI4YjhkNTJiZGJmNTgyN2E3L3RhYmxlcmFuZ2U6MzVjYzRlMWU2ZjIyNDViYjhiOGQ1MmJkYmY1ODI3YTdfMi0zLTEtMS0xNTYwNA_359b6d16-0ca3-409d-a176-e3ea38579db9">10,480</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35dfe924439843b5af0a65df16408eaa_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82NC9mcmFnOjI3N2RmOTkyZjJlMjRlMDhhZjQwMzNhZTFhYzE4YThlL3RhYmxlOjM1Y2M0ZTFlNmYyMjQ1YmI4YjhkNTJiZGJmNTgyN2E3L3RhYmxlcmFuZ2U6MzVjYzRlMWU2ZjIyNDViYjhiOGQ1MmJkYmY1ODI3YTdfMi01LTEtMS0xNTYwNA_3684970b-98c8-48ca-a860-ac09ea464761">370</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93a0684a8757410bb11d784429689ade_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82NC9mcmFnOjI3N2RmOTkyZjJlMjRlMDhhZjQwMzNhZTFhYzE4YThlL3RhYmxlOjM1Y2M0ZTFlNmYyMjQ1YmI4YjhkNTJiZGJmNTgyN2E3L3RhYmxlcmFuZ2U6MzVjYzRlMWU2ZjIyNDViYjhiOGQ1MmJkYmY1ODI3YTdfMy0xLTEtMS0xNTYwNA_c7bc9681-15ac-4a6d-b3d8-e7917ec11090">5,900</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i93a0684a8757410bb11d784429689ade_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82NC9mcmFnOjI3N2RmOTkyZjJlMjRlMDhhZjQwMzNhZTFhYzE4YThlL3RhYmxlOjM1Y2M0ZTFlNmYyMjQ1YmI4YjhkNTJiZGJmNTgyN2E3L3RhYmxlcmFuZ2U6MzVjYzRlMWU2ZjIyNDViYjhiOGQ1MmJkYmY1ODI3YTdfMy0zLTEtMS0xNTYwNA_2123f432-9ab3-44ec-8a22-c5dafa847965">5,248</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93a0684a8757410bb11d784429689ade_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82NC9mcmFnOjI3N2RmOTkyZjJlMjRlMDhhZjQwMzNhZTFhYzE4YThlL3RhYmxlOjM1Y2M0ZTFlNmYyMjQ1YmI4YjhkNTJiZGJmNTgyN2E3L3RhYmxlcmFuZ2U6MzVjYzRlMWU2ZjIyNDViYjhiOGQ1MmJkYmY1ODI3YTdfMy01LTEtMS0xNTYwNA_797b9e02-96ef-44fd-9c9a-43541e59a36f">652</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82NC9mcmFnOjI3N2RmOTkyZjJlMjRlMDhhZjQwMzNhZTFhYzE4YThlL3RhYmxlOjM1Y2M0ZTFlNmYyMjQ1YmI4YjhkNTJiZGJmNTgyN2E3L3RhYmxlcmFuZ2U6MzVjYzRlMWU2ZjIyNDViYjhiOGQ1MmJkYmY1ODI3YTdfNC0xLTEtMS0xNTYwNA_1ae15016-31c7-4b0f-8e87-bf5179ad317b">106,750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82NC9mcmFnOjI3N2RmOTkyZjJlMjRlMDhhZjQwMzNhZTFhYzE4YThlL3RhYmxlOjM1Y2M0ZTFlNmYyMjQ1YmI4YjhkNTJiZGJmNTgyN2E3L3RhYmxlcmFuZ2U6MzVjYzRlMWU2ZjIyNDViYjhiOGQ1MmJkYmY1ODI3YTdfNC0zLTEtMS0xNTYwNA_73b5e685-c358-4832-a19a-be47d77df32a">55,323</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82NC9mcmFnOjI3N2RmOTkyZjJlMjRlMDhhZjQwMzNhZTFhYzE4YThlL3RhYmxlOjM1Y2M0ZTFlNmYyMjQ1YmI4YjhkNTJiZGJmNTgyN2E3L3RhYmxlcmFuZ2U6MzVjYzRlMWU2ZjIyNDViYjhiOGQ1MmJkYmY1ODI3YTdfNC01LTEtMS0xNTYwNA_cfee2d81-9431-49a9-bf52-1747ef2e0334">51,427</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:5pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets consist of the following as of December&#160;31, 2021:</span></div><div style="margin-top:15pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:56.462%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.558%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents, developed technologies and know-how</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2492744906d942a6a9d8a0cdfa3ac7c6_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82NC9mcmFnOjI3N2RmOTkyZjJlMjRlMDhhZjQwMzNhZTFhYzE4YThlL3RhYmxlOjMyNGE5N2ExNzNlYjQzMDQ4YzM2YjJlMzE5NjQ2NzA5L3RhYmxlcmFuZ2U6MzI0YTk3YTE3M2ViNDMwNDhjMzZiMmUzMTk2NDY3MDlfMS0xLTEtMS0xNTYwNA_23144934-46b2-4b31-a948-b08dabac2a9a">91,373</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2492744906d942a6a9d8a0cdfa3ac7c6_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82NC9mcmFnOjI3N2RmOTkyZjJlMjRlMDhhZjQwMzNhZTFhYzE4YThlL3RhYmxlOjMyNGE5N2ExNzNlYjQzMDQ4YzM2YjJlMzE5NjQ2NzA5L3RhYmxlcmFuZ2U6MzI0YTk3YTE3M2ViNDMwNDhjMzZiMmUzMTk2NDY3MDlfMS0zLTEtMS0xNTYwNA_6a073f56-5870-400d-b5dc-4a63d0a8bc44">38,630</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2492744906d942a6a9d8a0cdfa3ac7c6_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82NC9mcmFnOjI3N2RmOTkyZjJlMjRlMDhhZjQwMzNhZTFhYzE4YThlL3RhYmxlOjMyNGE5N2ExNzNlYjQzMDQ4YzM2YjJlMzE5NjQ2NzA5L3RhYmxlcmFuZ2U6MzI0YTk3YTE3M2ViNDMwNDhjMzZiMmUzMTk2NDY3MDlfMS01LTEtMS0xNTYwNA_1a196394-2592-410b-9a6b-ab3ce2b61c36">52,743</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23dbbf6a562e498c8fa7683328ca8a94_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82NC9mcmFnOjI3N2RmOTkyZjJlMjRlMDhhZjQwMzNhZTFhYzE4YThlL3RhYmxlOjMyNGE5N2ExNzNlYjQzMDQ4YzM2YjJlMzE5NjQ2NzA5L3RhYmxlcmFuZ2U6MzI0YTk3YTE3M2ViNDMwNDhjMzZiMmUzMTk2NDY3MDlfMi0xLTEtMS0xNTYwNA_62cbe9e2-76b8-45c2-9c98-c386b22b9502">10,850</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i23dbbf6a562e498c8fa7683328ca8a94_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82NC9mcmFnOjI3N2RmOTkyZjJlMjRlMDhhZjQwMzNhZTFhYzE4YThlL3RhYmxlOjMyNGE5N2ExNzNlYjQzMDQ4YzM2YjJlMzE5NjQ2NzA5L3RhYmxlcmFuZ2U6MzI0YTk3YTE3M2ViNDMwNDhjMzZiMmUzMTk2NDY3MDlfMi0zLTEtMS0xNTYwNA_d8cfca6f-3e88-4fda-8abd-f7b42b5858ae">10,252</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23dbbf6a562e498c8fa7683328ca8a94_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82NC9mcmFnOjI3N2RmOTkyZjJlMjRlMDhhZjQwMzNhZTFhYzE4YThlL3RhYmxlOjMyNGE5N2ExNzNlYjQzMDQ4YzM2YjJlMzE5NjQ2NzA5L3RhYmxlcmFuZ2U6MzI0YTk3YTE3M2ViNDMwNDhjMzZiMmUzMTk2NDY3MDlfMi01LTEtMS0xNTYwNA_cf27c9d9-5ba3-4bc1-9025-03487e8b9156">598</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64684d6563664cf59533e60bfe5b9921_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82NC9mcmFnOjI3N2RmOTkyZjJlMjRlMDhhZjQwMzNhZTFhYzE4YThlL3RhYmxlOjMyNGE5N2ExNzNlYjQzMDQ4YzM2YjJlMzE5NjQ2NzA5L3RhYmxlcmFuZ2U6MzI0YTk3YTE3M2ViNDMwNDhjMzZiMmUzMTk2NDY3MDlfMy0xLTEtMS0xNTYwNA_c53683e6-3d36-4d34-aad5-d609e36046e9">5,900</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64684d6563664cf59533e60bfe5b9921_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82NC9mcmFnOjI3N2RmOTkyZjJlMjRlMDhhZjQwMzNhZTFhYzE4YThlL3RhYmxlOjMyNGE5N2ExNzNlYjQzMDQ4YzM2YjJlMzE5NjQ2NzA5L3RhYmxlcmFuZ2U6MzI0YTk3YTE3M2ViNDMwNDhjMzZiMmUzMTk2NDY3MDlfMy0zLTEtMS0xNTYwNA_7a25d2ab-c51b-4266-ba09-2e7fe1c12d40">5,126</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64684d6563664cf59533e60bfe5b9921_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82NC9mcmFnOjI3N2RmOTkyZjJlMjRlMDhhZjQwMzNhZTFhYzE4YThlL3RhYmxlOjMyNGE5N2ExNzNlYjQzMDQ4YzM2YjJlMzE5NjQ2NzA5L3RhYmxlcmFuZ2U6MzI0YTk3YTE3M2ViNDMwNDhjMzZiMmUzMTk2NDY3MDlfMy01LTEtMS0xNTYwNA_2bc3e9c0-60f9-452f-b1bc-d8d4f98b4b5c">774</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82NC9mcmFnOjI3N2RmOTkyZjJlMjRlMDhhZjQwMzNhZTFhYzE4YThlL3RhYmxlOjMyNGE5N2ExNzNlYjQzMDQ4YzM2YjJlMzE5NjQ2NzA5L3RhYmxlcmFuZ2U6MzI0YTk3YTE3M2ViNDMwNDhjMzZiMmUzMTk2NDY3MDlfNC0xLTEtMS0xNTYwNA_4e44ca9a-7b00-42f4-9ea2-7bcbc06adeff">108,123</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82NC9mcmFnOjI3N2RmOTkyZjJlMjRlMDhhZjQwMzNhZTFhYzE4YThlL3RhYmxlOjMyNGE5N2ExNzNlYjQzMDQ4YzM2YjJlMzE5NjQ2NzA5L3RhYmxlcmFuZ2U6MzI0YTk3YTE3M2ViNDMwNDhjMzZiMmUzMTk2NDY3MDlfNC0zLTEtMS0xNTYwNA_bac567af-9e2c-41a5-84f0-5ca13e3c8e81">54,008</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82NC9mcmFnOjI3N2RmOTkyZjJlMjRlMDhhZjQwMzNhZTFhYzE4YThlL3RhYmxlOjMyNGE5N2ExNzNlYjQzMDQ4YzM2YjJlMzE5NjQ2NzA5L3RhYmxlcmFuZ2U6MzI0YTk3YTE3M2ViNDMwNDhjMzZiMmUzMTk2NDY3MDlfNC01LTEtMS0xNTYwNA_5d0735b4-25d3-46c2-95e4-51d0047117c6">54,115</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense was $<ix:nonFraction unitRef="usd" contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82NC9mcmFnOjI3N2RmOTkyZjJlMjRlMDhhZjQwMzNhZTFhYzE4YThlL3RleHRyZWdpb246Mjc3ZGY5OTJmMmUyNGUwOGFmNDAzM2FlMWFjMThhOGVfMzI1_69535904-a9ff-44ae-9cb3-bf73acc12554">1,809</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82NC9mcmFnOjI3N2RmOTkyZjJlMjRlMDhhZjQwMzNhZTFhYzE4YThlL3RleHRyZWdpb246Mjc3ZGY5OTJmMmUyNGUwOGFmNDAzM2FlMWFjMThhOGVfMzMy_14120bee-07ee-4112-aad3-781e391ef1ac">1,930</ix:nonFraction> for the three months ended March 31, 2022 and 2021, respectively.</span></div></ix:continuation><div id="i7169a803a6aa44ea981603d220cab84f_67"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11. <ix:nonNumeric contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RleHRyZWdpb246MjdiMjcyODZiZDVlNDYzMTliY2UxMjZmYTUyZjliNWRfNzcwNw_b145808e-40b8-432b-82fa-a64ca67e1a77" continuedAt="i3ee1aef5d0d5430c985edcea9beac425" escape="true">Lines of Credit and Long-Term Debt</ix:nonNumeric></span></div><ix:continuation id="i3ee1aef5d0d5430c985edcea9beac425" continuedAt="id33cc788829d4a128c74d74857e3e3bb"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Lines of Credit</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trans Ova had a $<ix:nonFraction unitRef="usd" contextRef="i9d132006c1d145eaac64d45ccb86b656_I20220331" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RleHRyZWdpb246MjdiMjcyODZiZDVlNDYzMTliY2UxMjZmYTUyZjliNWRfNzY_278f3764-bf14-445b-98db-742b0a8c2258">5,000</ix:nonFraction> revolving line of credit with First National Bank of Omaha that matured on April 1, 2022. The line of credit bore interest at the greater of the U.S. Prime Rate or <ix:nonFraction unitRef="number" contextRef="i19a165412c0146749eb84baeba26cbf7_I20220331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RleHRyZWdpb246MjdiMjcyODZiZDVlNDYzMTliY2UxMjZmYTUyZjliNWRfMjQ0_b2942942-f8c4-42d4-96d7-32de3be6e477">3.00</ix:nonFraction>%, and the actual rate was <ix:nonFraction unitRef="number" contextRef="i9d132006c1d145eaac64d45ccb86b656_I20220331" decimals="4" name="us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RleHRyZWdpb246MjdiMjcyODZiZDVlNDYzMTliY2UxMjZmYTUyZjliNWRfMjcy_361079c4-0ae0-4ef7-a06e-cf643d58da16">3.50</ix:nonFraction>% as of March&#160;31, 2022. As of March&#160;31, 2022 and December&#160;31, 2021, there was <ix:nonFraction unitRef="usd" contextRef="i9d132006c1d145eaac64d45ccb86b656_I20220331" decimals="INF" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RleHRyZWdpb246MjdiMjcyODZiZDVlNDYzMTliY2UxMjZmYTUyZjliNWRfMzEy_e1ca45a8-7b41-42db-ad6d-e6fffa3fe627"><ix:nonFraction unitRef="usd" contextRef="i3207747902c548a1a820a9bbe7e15b04_I20211231" decimals="INF" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RleHRyZWdpb246MjdiMjcyODZiZDVlNDYzMTliY2UxMjZmYTUyZjliNWRfMzEy_fe291902-9e0e-43d0-8755-52fe377c1dbd">no</ix:nonFraction></ix:nonFraction> outstanding balance. The amount available under the line of credit was based on eligible accounts receivable and inventory up to the maximum principal amount and was $<ix:nonFraction unitRef="usd" contextRef="i9d132006c1d145eaac64d45ccb86b656_I20220331" decimals="-3" name="us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RleHRyZWdpb246MjdiMjcyODZiZDVlNDYzMTliY2UxMjZmYTUyZjliNWRfNDgw_4df77f52-8343-4c21-a9c7-111bcb9edd20">5,000</ix:nonFraction> as of March&#160;31, 2022.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exemplar has a $<ix:nonFraction unitRef="usd" contextRef="i6a365a7536554cd6b37d69868458c0ae_I20220331" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RleHRyZWdpb246MjdiMjcyODZiZDVlNDYzMTliY2UxMjZmYTUyZjliNWRfNzQz_abdfa51c-52d1-450d-8402-dbf81c954dec">700</ix:nonFraction> revolving line of credit with American State Bank that matures on October 31, 2022. As of March&#160;31, 2022, the line of credit bore interest at a stated rate of <ix:nonFraction unitRef="number" contextRef="i6a365a7536554cd6b37d69868458c0ae_I20220331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RleHRyZWdpb246MjdiMjcyODZiZDVlNDYzMTliY2UxMjZmYTUyZjliNWRfODc2_57a4dbc8-c290-4fed-9b8d-9c9c997cf87f">4.00</ix:nonFraction>% per annum. As of March&#160;31, 2022 and December&#160;31, 2021, there was <ix:nonFraction unitRef="usd" contextRef="i6a365a7536554cd6b37d69868458c0ae_I20220331" decimals="INF" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RleHRyZWdpb246MjdiMjcyODZiZDVlNDYzMTliY2UxMjZmYTUyZjliNWRfOTE3_91e299cb-ae32-4263-8c7a-e03c80bad037"><ix:nonFraction unitRef="usd" contextRef="i822f03f707534638b1196ee45d5740e2_I20211231" decimals="INF" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RleHRyZWdpb246MjdiMjcyODZiZDVlNDYzMTliY2UxMjZmYTUyZjliNWRfOTE3_9b8d0067-393a-460e-819f-3f44141c392d">no</ix:nonFraction></ix:nonFraction> outstanding balance.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-Term Debt</span></div><ix:nonNumeric contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RleHRyZWdpb246MjdiMjcyODZiZDVlNDYzMTliY2UxMjZmYTUyZjliNWRfNzY5OQ_653cfece-00fb-42d4-9f1d-b441e9e27e64" continuedAt="ia919cb165cd84093808001dd3ffd053b" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt consists of the following:</span></div><div style="margin-top:17pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:70.894%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.537%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible debt (1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d8dc6d1111e4706a024929613e40a55_I20220331" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RhYmxlOjk5MWExY2MzYzgxNzQzNzU5OTZiYmRhMjgyZDQ1YTljL3RhYmxlcmFuZ2U6OTkxYTFjYzNjODE3NDM3NTk5NmJiZGEyODJkNDVhOWNfMS0xLTEtMS0xNTYwNA_ad107e7e-9e6a-4035-81ec-dd7d6f687c04">198,362</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d949c0fb90e44e48aa23d89122c630b_I20211231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RhYmxlOjk5MWExY2MzYzgxNzQzNzU5OTZiYmRhMjgyZDQ1YTljL3RhYmxlcmFuZ2U6OTkxYTFjYzNjODE3NDM3NTk5NmJiZGEyODJkNDVhOWNfMS0zLTEtMS0xNTYwNA_e5fa00bb-91b7-441b-a811-293f7d15bffc">179,882</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30632d5609ff45ee847fb10488a6417a_I20220331" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RhYmxlOjk5MWExY2MzYzgxNzQzNzU5OTZiYmRhMjgyZDQ1YTljL3RhYmxlcmFuZ2U6OTkxYTFjYzNjODE3NDM3NTk5NmJiZGEyODJkNDVhOWNfMi0xLTEtMS0xNTYwNA_1547cff3-d12d-47c3-9b58-22ab0d163b47">3,105</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4adfe5f20a0a4ef987ffe40825f234ad_I20211231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RhYmxlOjk5MWExY2MzYzgxNzQzNzU5OTZiYmRhMjgyZDQ1YTljL3RhYmxlcmFuZ2U6OTkxYTFjYzNjODE3NDM3NTk5NmJiZGEyODJkNDVhOWNfMi0zLTEtMS0xNTYwNA_44bb374f-b818-41cd-8ecc-d980df8448a7">3,217</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib33f36cb52e14c6e8a14e68692d39463_I20220331" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RhYmxlOjk5MWExY2MzYzgxNzQzNzU5OTZiYmRhMjgyZDQ1YTljL3RhYmxlcmFuZ2U6OTkxYTFjYzNjODE3NDM3NTk5NmJiZGEyODJkNDVhOWNfMy0xLTEtMS0xNTYwNA_7b2f143b-ad48-4e3b-8af2-102d4627b3e6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia99a2463349745cc99f7555e4c6a7a5d_I20211231" decimals="-3" name="us-gaap:LongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RhYmxlOjk5MWExY2MzYzgxNzQzNzU5OTZiYmRhMjgyZDQ1YTljL3RhYmxlcmFuZ2U6OTkxYTFjYzNjODE3NDM3NTk5NmJiZGEyODJkNDVhOWNfMy0zLTEtMS0xNTYwNA_35f003e3-4738-4e5d-851b-3c90356db42f">52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RhYmxlOjk5MWExY2MzYzgxNzQzNzU5OTZiYmRhMjgyZDQ1YTljL3RhYmxlcmFuZ2U6OTkxYTFjYzNjODE3NDM3NTk5NmJiZGEyODJkNDVhOWNfNC0xLTEtMS0xNTYwNA_442f3cb6-4078-4bb1-ab01-298408785b6d">201,467</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RhYmxlOjk5MWExY2MzYzgxNzQzNzU5OTZiYmRhMjgyZDQ1YTljL3RhYmxlcmFuZ2U6OTkxYTFjYzNjODE3NDM3NTk5NmJiZGEyODJkNDVhOWNfNC0zLTEtMS0xNTYwNA_efa35f39-c48a-4b89-b8fd-0b6334c6b965">183,151</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:LongTermDebtCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RhYmxlOjk5MWExY2MzYzgxNzQzNzU5OTZiYmRhMjgyZDQ1YTljL3RhYmxlcmFuZ2U6OTkxYTFjYzNjODE3NDM3NTk5NmJiZGEyODJkNDVhOWNfNS0xLTEtMS0xNTYwNA_f93884ec-00b2-417e-bd6e-8b2ee386c24b">355</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231" decimals="-3" name="us-gaap:LongTermDebtCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RhYmxlOjk5MWExY2MzYzgxNzQzNzU5OTZiYmRhMjgyZDQ1YTljL3RhYmxlcmFuZ2U6OTkxYTFjYzNjODE3NDM3NTk5NmJiZGEyODJkNDVhOWNfNS0zLTEtMS0xNTYwNA_37bae98e-e553-438e-b29f-da41048029c9">402</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, less current portion</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RhYmxlOjk5MWExY2MzYzgxNzQzNzU5OTZiYmRhMjgyZDQ1YTljL3RhYmxlcmFuZ2U6OTkxYTFjYzNjODE3NDM3NTk5NmJiZGEyODJkNDVhOWNfNi0xLTEtMS0xNTYwNA_e19ccc92-540e-495f-9561-8295bb74398d">201,112</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RhYmxlOjk5MWExY2MzYzgxNzQzNzU5OTZiYmRhMjgyZDQ1YTljL3RhYmxlcmFuZ2U6OTkxYTFjYzNjODE3NDM3NTk5NmJiZGEyODJkNDVhOWNfNi0zLTEtMS0xNTYwNA_2c8aca98-356d-44c1-80cf-a789f5810aa9">182,749</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="id33cc788829d4a128c74d74857e3e3bb" continuedAt="i859363fe3aae49909cda8ebf7b3f247a"><div style="margin-top:13pt;padding-left:36pt;text-indent:-18pt"><ix:continuation id="ia919cb165cd84093808001dd3ffd053b"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">See Note 2 regarding adoption of ASU 2020-06 as of January 1, 2022.</span></ix:continuation></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Convertible Debt</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Precigen Convertible Notes</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2018, Precigen completed a registered underwritten public offering of $<ix:nonFraction unitRef="usd" contextRef="i9756753ac1d54cf49cebd859fa402242_I20180731" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RleHRyZWdpb246MjdiMjcyODZiZDVlNDYzMTliY2UxMjZmYTUyZjliNWRfMTEyMg_87bd9d74-ce1c-4904-b5b4-8420753b5ca7">200,000</ix:nonFraction> aggregate principal amount of Convertible Notes and issued the Convertible Notes under an indenture (the "Base Indenture") between Precigen and The Bank of New York Mellon Trust Company, N.A., as trustee, as supplemented by the First Supplemental Indenture (together with the Base Indenture, the "Indenture"). Precigen received net proceeds of $<ix:nonFraction unitRef="usd" contextRef="i36c9e83acbc5433596f7bc29c25d3981_D20180701-20180731" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RleHRyZWdpb246MjdiMjcyODZiZDVlNDYzMTliY2UxMjZmYTUyZjliNWRfMTQ2OQ_4e428bb4-49e3-4569-aed7-de668e9b4369">193,958</ix:nonFraction> after deducting underwriting discounts and offering expenses of $<ix:nonFraction unitRef="usd" contextRef="i9756753ac1d54cf49cebd859fa402242_I20180731" decimals="-3" name="us-gaap:DeferredFinanceCostsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RleHRyZWdpb246MjdiMjcyODZiZDVlNDYzMTliY2UxMjZmYTUyZjliNWRfMTUzNg_c55e508c-18f3-45c4-87f1-f25cff69f542">6,042</ix:nonFraction>.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Convertible Notes are senior unsecured obligations of Precigen and bear interest at a rate of <ix:nonFraction unitRef="number" contextRef="i9756753ac1d54cf49cebd859fa402242_I20180731" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RleHRyZWdpb246MjdiMjcyODZiZDVlNDYzMTliY2UxMjZmYTUyZjliNWRfMTYzOA_d5489a47-dbdf-47b6-9c88-ca2e890075cc">3.50</ix:nonFraction>% per year, payable semiannually in arrears on January 1 and July 1 of each year beginning on January 1, 2019. The Convertible Notes mature on July 1, 2023 and are repayable in cash, unless earlier repurchased or converted. Upon conversion by the holders, the Convertible Notes are convertible into cash, shares of Precigen's common stock or a combination of cash and shares, at Precigen's election. The initial conversion rate of the Convertible Notes is <ix:nonFraction unitRef="number" contextRef="i36c9e83acbc5433596f7bc29c25d3981_D20180701-20180731" decimals="INF" name="us-gaap:DebtInstrumentConvertibleConversionRatio1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RleHRyZWdpb246MjdiMjcyODZiZDVlNDYzMTliY2UxMjZmYTUyZjliNWRfMjA5NQ_0938b100-0d9e-4113-aacf-15234b49848f">58.6622</ix:nonFraction> shares of Precigen common stock per $<ix:nonFraction unitRef="usd" contextRef="i36c9e83acbc5433596f7bc29c25d3981_D20180701-20180731" decimals="INF" name="pgen:ConvertibleDebtPrincipalAmountInitialConversionRate" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RleHRyZWdpb246MjdiMjcyODZiZDVlNDYzMTliY2UxMjZmYTUyZjliNWRfMjEzNA_b30511a6-8192-45ac-82ee-e0870a3b165f">1,000</ix:nonFraction> principal amount of Convertible Notes (equivalent to an initial conversion price of approximately $<ix:nonFraction unitRef="usdPerShare" contextRef="i9756753ac1d54cf49cebd859fa402242_I20180731" decimals="2" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RleHRyZWdpb246MjdiMjcyODZiZDVlNDYzMTliY2UxMjZmYTUyZjliNWRfMjIzNQ_3a3df1a0-4b55-425c-a404-894d78dc9d1f">17.05</ix:nonFraction> per share of common stock). The conversion rate is subject to adjustment upon the occurrence of certain events, but will not be adjusted for any accrued and unpaid interest. In addition, following certain corporate events that occur prior to the maturity date as defined in the Indenture, Precigen will increase the conversion rate for a holder who elects to convert its Convertible Notes in connection with such a corporate event in certain circumstances. Prior to April 1, 2023, the holders may convert the Convertible Notes at their option only upon the satisfaction of the following circumstances:</span></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">During any calendar quarter commencing after the calendar quarter ended on September 30, 2018, if the last reported sales price of Precigen's common stock for at least <ix:nonFraction unitRef="day" contextRef="i78bbba80cecb4e08a63655e020bbcd37_D20180701-20180731" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RleHRyZWdpb246MjdiMjcyODZiZDVlNDYzMTliY2UxMjZmYTUyZjliNWRfMzAwOQ_5fdb0a73-fa5e-4137-8d24-8b32347de0eb">20</ix:nonFraction> trading days (whether or not consecutive) during the last <ix:nonFraction unitRef="day" contextRef="i78bbba80cecb4e08a63655e020bbcd37_D20180701-20180731" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RleHRyZWdpb246MjdiMjcyODZiZDVlNDYzMTliY2UxMjZmYTUyZjliNWRfMzA3MA_74ee9c76-9b05-4e4e-8b6f-5124851237cd">30</ix:nonFraction> consecutive trading days of the immediately preceding calendar quarter is greater than or equal to <ix:nonFraction unitRef="number" contextRef="i78bbba80cecb4e08a63655e020bbcd37_D20180701-20180731" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RleHRyZWdpb246MjdiMjcyODZiZDVlNDYzMTliY2UxMjZmYTUyZjliNWRfMzE3Mg_66ebf62d-e34e-488d-b538-13adbbe08321">130</ix:nonFraction>% of the conversion price on each applicable trading day;</span></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">During the <ix:nonFraction unitRef="day" contextRef="i3c051e9f9a3d440f9f4a49368f5c7480_D20180701-20180731" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdTradingDays" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RleHRyZWdpb246MjdiMjcyODZiZDVlNDYzMTliY2UxMjZmYTUyZjliNWRfMzI0Mg_2df6eb62-8e99-47b6-a3d7-1b4ac8b759d4">five</ix:nonFraction> business day period after any <ix:nonFraction unitRef="day" contextRef="i3c051e9f9a3d440f9f4a49368f5c7480_D20180701-20180731" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RleHRyZWdpb246MjdiMjcyODZiZDVlNDYzMTliY2UxMjZmYTUyZjliNWRfMzI3NQ_93384b64-527e-45b6-a23e-793886ca32ef">five</ix:nonFraction> consecutive trading day period in which the trading price, as defined in the Indenture, for the Convertible Notes is less than <ix:nonFraction unitRef="number" contextRef="i3c051e9f9a3d440f9f4a49368f5c7480_D20180701-20180731" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RleHRyZWdpb246MjdiMjcyODZiZDVlNDYzMTliY2UxMjZmYTUyZjliNWRfMzQwNQ_7b2af2fc-54eb-48de-aa36-346f7f2f7566">98</ix:nonFraction>% of the product of the last reported sales price of Precigen's common stock and the conversion rate for the Convertible Notes on each such trading day; or</span></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Upon the occurrence of specified corporate events as defined in the Indenture.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None of the above events allowing for conversion prior to April 1, 2023 occurred during the three months ended March&#160;31, 2022. On or after April 1, 2023 until June 30, 2023, holders may convert their Convertible Notes at any time. Precigen may not redeem the Convertible Notes prior to the maturity date.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If Precigen undergoes a fundamental change, as defined in the Indenture, holders of the Convertible Notes may require Precigen to repurchase for cash all or any portion of their Convertible Notes at a fundamental change repurchase price equal to <ix:nonFraction unitRef="number" contextRef="i36c9e83acbc5433596f7bc29c25d3981_D20180701-20180731" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RleHRyZWdpb246MjdiMjcyODZiZDVlNDYzMTliY2UxMjZmYTUyZjliNWRfNDE4MA_e1bd2998-f545-4211-9c91-d24f2bbb9065">100</ix:nonFraction>% of the principal amount of the Convertible Notes to be repurchased, plus accrued and unpaid interest to, but excluding, the fundamental change repurchase date. The Indenture contains customary events of default, as defined in the agreement, and, if any of the events occur, could require repayment of a portion or all of the Convertible Notes, including accrued and unpaid interest. Additionally, the Indenture provides that Precigen shall not consolidate with or merge with or into, or sell, convey, transfer or lease all or substantially all of its properties and assets to, another entity, unless (i) the surviving entity is organized under the laws of the United States and such entity expressly assumes all of Precigen's obligations under the Convertible Notes and the Indenture; and (ii) immediately after such transaction, no default or event of default has occurred and is continuing under the Indenture.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net proceeds received from the issuance of the Convertible Notes were initially allocated between long-term debt, the liability component, in the amount of $<ix:nonFraction unitRef="usd" contextRef="i9756753ac1d54cf49cebd859fa402242_I20180731" decimals="-3" name="us-gaap:ConvertibleDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RleHRyZWdpb246MjdiMjcyODZiZDVlNDYzMTliY2UxMjZmYTUyZjliNWRfNTI1Ng_5b3a96fc-24fa-4e30-83ac-0cd55b712b14">143,723</ix:nonFraction>, and additional paid-in capital, the equity component, in the amount of $<ix:nonFraction unitRef="usd" contextRef="i36c9e83acbc5433596f7bc29c25d3981_D20180701-20180731" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RleHRyZWdpb246MjdiMjcyODZiZDVlNDYzMTliY2UxMjZmYTUyZjliNWRfNTMzMQ_87ddf4d5-c44f-43cd-8745-c8435b5bce66">50,235</ix:nonFraction>. Additional paid-in capital was further reduced by $<ix:nonFraction unitRef="usd" contextRef="i36c9e83acbc5433596f7bc29c25d3981_D20180701-20180731" decimals="-3" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RleHRyZWdpb246MjdiMjcyODZiZDVlNDYzMTliY2UxMjZmYTUyZjliNWRfNTM4NQ_23116c86-b146-44bb-9be0-c728bdfe378b">13,367</ix:nonFraction> of deferred taxes resulting from the difference between the carrying amount and the tax basis of the Convertible Notes that is created by the equity component, which also resulted in deferred tax benefit recognized from the reversal of valuation allowances on the then current year domestic operating losses in the same amount. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As described in Note 2, the Company adopted ASU 2020-06 on January 1, 2022. Pursuant to ASU 2020-06, the equity components of the Convertible Notes separated from the debt components as required under the cash conversion model is required to be recombined into the Convertible Notes as a single instrument upon the adoption of ASU 2020-06. The </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i859363fe3aae49909cda8ebf7b3f247a"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Convertible Notes shall be accounted for as if the conversion option had not been separated. As the Company elected the modified retrospective approach, the difference between the accounting under the cash conversion model and new model after the adoption of ASU 2020-06 (i.e., the single debt instrument with no separation) was recorded as an adjustment on the adoption date (i.e., January 1, 2022) through accumulated deficit. Tax accounting consequences of the adoption also required the reversal of the previously reported deferred tax benefit on the date of adoption.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Adoption of ASU 2020-06 resulted in an increase to long-term debt outstanding, net of current portion, of $<ix:nonFraction unitRef="usd" contextRef="i026820ce93f04afc9c498f6af35f806b_I20220101" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RleHRyZWdpb246MjdiMjcyODZiZDVlNDYzMTliY2UxMjZmYTUyZjliNWRfMjE5OTAyMzI2OTQ1Ng_79ac055d-2150-4103-9e59-b38075c17a7c">18,196</ix:nonFraction>, a decrease to additional paid-in capital of $<ix:nonFraction unitRef="usd" contextRef="icf421d5fc50e4e85892b55cbde212eab_I20220101" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RleHRyZWdpb246MjdiMjcyODZiZDVlNDYzMTliY2UxMjZmYTUyZjliNWRfMjE5OTAyMzI2OTQ2OA_9871878d-ccfd-45ab-8aa2-aa90748fb15d">36,868</ix:nonFraction>, and a decrease to accumulated deficit of $<ix:nonFraction unitRef="usd" contextRef="i4f92c06e9bad430cac755e9610e9f9b5_I20220101" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RleHRyZWdpb246MjdiMjcyODZiZDVlNDYzMTliY2UxMjZmYTUyZjliNWRfMjE5OTAyMzI2OTQ2Mg_78307361-5530-42d5-8a79-757ffe524ef3">18,672</ix:nonFraction>. Interest expense recognized on the convertible notes in future periods will be reduced as a result of accounting for the convertible debt instrument as a single liability measured at its amortized cost.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As of March&#160;31, 2022, the outstanding principal balance on the Convertible Notes was $<ix:nonFraction unitRef="usd" contextRef="if6f497049bf74c16a1396dfc4d1e650a_I20220331" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RleHRyZWdpb246MjdiMjcyODZiZDVlNDYzMTliY2UxMjZmYTUyZjliNWRfNTc4OQ_ee3a9b72-561a-4fd6-b852-2636223ee295">200,000</ix:nonFraction> and the carrying value of long-term debt was $<ix:nonFraction unitRef="usd" contextRef="if6f497049bf74c16a1396dfc4d1e650a_I20220331" decimals="-3" name="us-gaap:ConvertibleDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RleHRyZWdpb246MjdiMjcyODZiZDVlNDYzMTliY2UxMjZmYTUyZjliNWRfNTgzNw_bd29c03a-6d99-4546-9bc8-a7f6c24026b3">198,362</ix:nonFraction>. The effective interest rate on the Convertible Notes, including amortization of the long-term debt discount and debt issuance costs, is <ix:nonFraction unitRef="number" contextRef="if6f497049bf74c16a1396dfc4d1e650a_I20220331" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RleHRyZWdpb246MjdiMjcyODZiZDVlNDYzMTliY2UxMjZmYTUyZjliNWRfNTk3Nw_afb2d3ec-6789-48fa-b477-1caa7a077da0">4.25</ix:nonFraction>%. As of March&#160;31, 2022, the unamortized long-term debt discount and debt issuance costs totaled $<ix:nonFraction unitRef="usd" contextRef="if6f497049bf74c16a1396dfc4d1e650a_I20220331" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RleHRyZWdpb246MjdiMjcyODZiZDVlNDYzMTliY2UxMjZmYTUyZjliNWRfNjA2Mw_db5e02ab-c628-428e-a264-fd574218584e">1,638</ix:nonFraction>.</span></div><ix:nonNumeric contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" name="us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RleHRyZWdpb246MjdiMjcyODZiZDVlNDYzMTliY2UxMjZmYTUyZjliNWRfNzcxNQ_b524e638-ee3d-4b37-b2cf-f85de467d3a8" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of interest expense related to the Convertible Notes were as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.514%"><tr><td style="width:1.0%"></td><td style="width:70.264%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended&#160;<br/>&#160;March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash interest expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i735cf6b5a38a4c71b70373ae0908abde_D20220101-20220331" decimals="-3" name="us-gaap:InterestExpenseDebtExcludingAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RhYmxlOjJhZjcwZGUzZGI1ODQ0ZGQ5MDMxNGU1ZmRhYjM1YzIxL3RhYmxlcmFuZ2U6MmFmNzBkZTNkYjU4NDRkZDkwMzE0ZTVmZGFiMzVjMjFfMi0xLTEtMS0xNTYwNA_4eae4757-86ef-4b7f-b5f3-28a23f65b609">1,750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c9c4caf2a40476d8e1647cd3cd7dab5_D20210101-20210331" decimals="-3" name="us-gaap:InterestExpenseDebtExcludingAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RhYmxlOjJhZjcwZGUzZGI1ODQ0ZGQ5MDMxNGU1ZmRhYjM1YzIxL3RhYmxlcmFuZ2U6MmFmNzBkZTNkYjU4NDRkZDkwMzE0ZTVmZGFiMzVjMjFfMi0zLTEtMS0xNTYwNA_5a49da87-53de-4486-a6ef-3219c0a2101a">1,750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i735cf6b5a38a4c71b70373ae0908abde_D20220101-20220331" decimals="-3" name="pgen:InterestExpenseDebtAmortizationofDebtDiscountPremiumandDebtIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RhYmxlOjJhZjcwZGUzZGI1ODQ0ZGQ5MDMxNGU1ZmRhYjM1YzIxL3RhYmxlcmFuZ2U6MmFmNzBkZTNkYjU4NDRkZDkwMzE0ZTVmZGFiMzVjMjFfMy0xLTEtMS0xNTYwNA_e04a24b5-e2af-468f-b1fd-11dfbeea61d3">284</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c9c4caf2a40476d8e1647cd3cd7dab5_D20210101-20210331" decimals="-3" name="pgen:InterestExpenseDebtAmortizationofDebtDiscountPremiumandDebtIssuanceCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RhYmxlOjJhZjcwZGUzZGI1ODQ0ZGQ5MDMxNGU1ZmRhYjM1YzIxL3RhYmxlcmFuZ2U6MmFmNzBkZTNkYjU4NDRkZDkwMzE0ZTVmZGFiMzVjMjFfMy0zLTEtMS0xNTYwNA_c5bc5274-486d-42c5-8d49-ab9eb883e9e8">2,751</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total interest expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i735cf6b5a38a4c71b70373ae0908abde_D20220101-20220331" decimals="-3" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RhYmxlOjJhZjcwZGUzZGI1ODQ0ZGQ5MDMxNGU1ZmRhYjM1YzIxL3RhYmxlcmFuZ2U6MmFmNzBkZTNkYjU4NDRkZDkwMzE0ZTVmZGFiMzVjMjFfNC0xLTEtMS0xNTYwNA_4d22ac76-0824-4051-bb69-e782678b16cc">2,034</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c9c4caf2a40476d8e1647cd3cd7dab5_D20210101-20210331" decimals="-3" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RhYmxlOjJhZjcwZGUzZGI1ODQ0ZGQ5MDMxNGU1ZmRhYjM1YzIxL3RhYmxlcmFuZ2U6MmFmNzBkZTNkYjU4NDRkZDkwMzE0ZTVmZGFiMzVjMjFfNC0zLTEtMS0xNTYwNA_fb3f79f1-ecd8-4f8d-8f62-381f30e1a4be">4,501</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-top:13pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued interest of $<ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:InterestPayableCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RleHRyZWdpb246MjdiMjcyODZiZDVlNDYzMTliY2UxMjZmYTUyZjliNWRfNjE3NA_d9935721-63e1-4aca-80e9-e21918b28734">1,750</ix:nonFraction> is included in other accrued liabilities on the accompanying condensed consolidated balance sheet as of March&#160;31, 2022.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Notes Payable</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trans Ova has a note payable that matures in April 2033 and had an outstanding principal balance of $<ix:nonFraction unitRef="usd" contextRef="ib8940548e4f34495a851495a8177a0e5_I20220331" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RleHRyZWdpb246MjdiMjcyODZiZDVlNDYzMTliY2UxMjZmYTUyZjliNWRfNzQzMg_619651e9-5e08-47bb-9971-b62c2cf6a2b2">3,105</ix:nonFraction> as of March&#160;31, 2022. Trans Ova pays monthly installments of $<ix:nonFraction unitRef="usd" contextRef="i4eac7d5551844a73b17f500e6471b7d6_D20220101-20220331" decimals="-3" name="us-gaap:DebtInstrumentPeriodicPayment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RleHRyZWdpb246MjdiMjcyODZiZDVlNDYzMTliY2UxMjZmYTUyZjliNWRfNzQ4NA_70248988-ef46-4d09-ade7-a89cd226f7b0">39</ix:nonFraction>, which includes interest at <ix:nonFraction unitRef="number" contextRef="ib8940548e4f34495a851495a8177a0e5_I20220331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RleHRyZWdpb246MjdiMjcyODZiZDVlNDYzMTliY2UxMjZmYTUyZjliNWRfNzUxNQ_80925dea-8150-463f-b9ad-ebd1f3cbe523">3.95</ix:nonFraction>%. The note payable is collateralized by certain of Trans Ova's real estate and non-real estate assets.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Future Maturities</span></div><ix:nonNumeric contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RleHRyZWdpb246MjdiMjcyODZiZDVlNDYzMTliY2UxMjZmYTUyZjliNWRfNzcwNA_a2782f18-8a47-4c03-9d22-cb717255deef" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future maturities of long-term debt as of March&#160;31, 2022 are as follows:</span></div><div style="margin-top:17pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:85.263%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.537%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RhYmxlOmYwOTlkNzkyNGJkODQwMzY4NzhiMWYyMjBmYzhhYzdkL3RhYmxlcmFuZ2U6ZjA5OWQ3OTI0YmQ4NDAzNjg3OGIxZjIyMGZjOGFjN2RfMC0xLTEtMS0xNTYwNA_faf68894-ecb6-4c48-bf52-8e881f81246e">265</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RhYmxlOmYwOTlkNzkyNGJkODQwMzY4NzhiMWYyMjBmYzhhYzdkL3RhYmxlcmFuZ2U6ZjA5OWQ3OTI0YmQ4NDAzNjg3OGIxZjIyMGZjOGFjN2RfMS0xLTEtMS0xNTYwNA_f611599b-f539-4319-b206-7eb8be878133">200,365</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RhYmxlOmYwOTlkNzkyNGJkODQwMzY4NzhiMWYyMjBmYzhhYzdkL3RhYmxlcmFuZ2U6ZjA5OWQ3OTI0YmQ4NDAzNjg3OGIxZjIyMGZjOGFjN2RfMi0xLTEtMS0xNTYwNA_7921b8d6-4bbb-4d6a-b609-4aff17dff529">380</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RhYmxlOmYwOTlkNzkyNGJkODQwMzY4NzhiMWYyMjBmYzhhYzdkL3RhYmxlcmFuZ2U6ZjA5OWQ3OTI0YmQ4NDAzNjg3OGIxZjIyMGZjOGFjN2RfMy0xLTEtMS0xNTYwNA_dceb4132-571f-4864-8c4b-33401df2a14a">395</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RhYmxlOmYwOTlkNzkyNGJkODQwMzY4NzhiMWYyMjBmYzhhYzdkL3RhYmxlcmFuZ2U6ZjA5OWQ3OTI0YmQ4NDAzNjg3OGIxZjIyMGZjOGFjN2RfNC0xLTEtMS0xNTYwNA_6bec2dc6-f60b-4871-b2d6-85a9e564775a">411</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RhYmxlOmYwOTlkNzkyNGJkODQwMzY4NzhiMWYyMjBmYzhhYzdkL3RhYmxlcmFuZ2U6ZjA5OWQ3OTI0YmQ4NDAzNjg3OGIxZjIyMGZjOGFjN2RfNS0xLTEtMS0xNTYwNA_a87e53a6-3259-40b3-a882-3af0b6c444f8">428</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RhYmxlOmYwOTlkNzkyNGJkODQwMzY4NzhiMWYyMjBmYzhhYzdkL3RhYmxlcmFuZ2U6ZjA5OWQ3OTI0YmQ4NDAzNjg3OGIxZjIyMGZjOGFjN2RfNi0xLTEtMS0xNTYwNA_def1b21b-1d9d-4540-8811-a236bc242a21">861</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RhYmxlOmYwOTlkNzkyNGJkODQwMzY4NzhiMWYyMjBmYzhhYzdkL3RhYmxlcmFuZ2U6ZjA5OWQ3OTI0YmQ4NDAzNjg3OGIxZjIyMGZjOGFjN2RfNy0xLTEtMS0xNTYwNA_f56acbf4-62a0-4c1e-85f7-f8a3b5f9d62a">203,105</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i7169a803a6aa44ea981603d220cab84f_70"></div><div style="margin-top:21pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12. <ix:nonNumeric contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83MC9mcmFnOjIwOWNjNDk5ZjQ3NDQyMGI5N2Q5ZTFkODQ4MjYwMDUwL3RleHRyZWdpb246MjA5Y2M0OTlmNDc0NDIwYjk3ZDllMWQ4NDgyNjAwNTBfMjE0MQ_65b1bc9a-6ec7-45e7-a3e0-c05d03c349e3" continuedAt="idcaf23e8ee4447c2979b9dd832571bdc" escape="true">Income Taxes</ix:nonNumeric></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="idcaf23e8ee4447c2979b9dd832571bdc" continuedAt="ib0d4f6a675f840ad92c368fe95cc52d1">Tax provisions for interim periods are calculated using an estimate of actual taxable income or loss for the respective period, rather than estimating the Company's annual effective income tax rate, as the Company is currently unable to reliably estimate its income for the full year. The Company has U.S. taxable loss of approximately $<ix:nonFraction unitRef="usd" contextRef="ic4808534316144d29d8b9683055df43b_D20220101-20220331" decimals="-3" sign="-" name="pgen:TaxableIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83MC9mcmFnOjIwOWNjNDk5ZjQ3NDQyMGI5N2Q5ZTFkODQ4MjYwMDUwL3RleHRyZWdpb246MjA5Y2M0OTlmNDc0NDIwYjk3ZDllMWQ4NDgyNjAwNTBfMzU4_cde9c116-cea8-44ef-b1d2-1fafbff573c5">5,300</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i30c081f8014842aabc417374b020f10a_D20210101-20210331" decimals="-3" sign="-" name="pgen:TaxableIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83MC9mcmFnOjIwOWNjNDk5ZjQ3NDQyMGI5N2Q5ZTFkODQ4MjYwMDUwL3RleHRyZWdpb246MjA5Y2M0OTlmNDc0NDIwYjk3ZDllMWQ4NDgyNjAwNTBfMzY1_6bfb1a3a-4778-437a-9368-d72f177ee30f">40,400</ix:nonFraction> for the three months ended March 31, 2022 and 2021, respectively. <ix:nonNumeric contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83MC9mcmFnOjIwOWNjNDk5ZjQ3NDQyMGI5N2Q5ZTFkODQ4MjYwMDUwL3RleHRyZWdpb246MjA5Y2M0OTlmNDc0NDIwYjk3ZDllMWQ4NDgyNjAwNTBfMjEzOA_ab262226-572e-45d1-a552-be98c662357b" continuedAt="i5cf8b2dacc394c3aac559eb6889c24c3" escape="true">The following table presents the components of income tax benefit from continuing operations.</ix:nonNumeric></ix:continuation></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ib0d4f6a675f840ad92c368fe95cc52d1"><div style="margin-top:17pt"><ix:continuation id="i5cf8b2dacc394c3aac559eb6889c24c3"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:70.728%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.616%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.619%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended&#160;<br/>&#160;March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current foreign income tax expense from continuing operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72d8140387894893965c60c951b48995_D20220101-20220331" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83MC9mcmFnOjIwOWNjNDk5ZjQ3NDQyMGI5N2Q5ZTFkODQ4MjYwMDUwL3RhYmxlOjZhMzMxY2ZlY2M2ZjRkODViMTUxYzdiNmU0MWI0YmU0L3RhYmxlcmFuZ2U6NmEzMzFjZmVjYzZmNGQ4NWIxNTFjN2I2ZTQxYjRiZTRfNC0xLTEtMS0xNTYwNA_f7572628-b56a-4eb2-887c-5712cb124ff5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942228f442bc4c7185a791f7d76e9464_D20210101-20210331" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83MC9mcmFnOjIwOWNjNDk5ZjQ3NDQyMGI5N2Q5ZTFkODQ4MjYwMDUwL3RhYmxlOjZhMzMxY2ZlY2M2ZjRkODViMTUxYzdiNmU0MWI0YmU0L3RhYmxlcmFuZ2U6NmEzMzFjZmVjYzZmNGQ4NWIxNTFjN2I2ZTQxYjRiZTRfNC0zLTEtMS0xNTYwNA_858bb173-0bd0-4b75-a7b5-7be3d3d7af0e">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax benefit from continuing operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7b33b3bdd85544d6853b80b9b9363fdc_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83MC9mcmFnOjIwOWNjNDk5ZjQ3NDQyMGI5N2Q5ZTFkODQ4MjYwMDUwL3RhYmxlOjZhMzMxY2ZlY2M2ZjRkODViMTUxYzdiNmU0MWI0YmU0L3RhYmxlcmFuZ2U6NmEzMzFjZmVjYzZmNGQ4NWIxNTFjN2I2ZTQxYjRiZTRfNS0xLTEtMS0xNTYwNA_30659237-ebf3-454a-ad67-6adae7e89533">58</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica51236575994a4ab8e30322fc2f55a4_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83MC9mcmFnOjIwOWNjNDk5ZjQ3NDQyMGI5N2Q5ZTFkODQ4MjYwMDUwL3RhYmxlOjZhMzMxY2ZlY2M2ZjRkODViMTUxYzdiNmU0MWI0YmU0L3RhYmxlcmFuZ2U6NmEzMzFjZmVjYzZmNGQ4NWIxNTFjN2I2ZTQxYjRiZTRfNS0zLTEtMS0xNTYwNA_7d91a626-49a5-4c5d-927b-72e93356422d">56</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total income tax benefit from continuing operations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7b33b3bdd85544d6853b80b9b9363fdc_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83MC9mcmFnOjIwOWNjNDk5ZjQ3NDQyMGI5N2Q5ZTFkODQ4MjYwMDUwL3RhYmxlOjZhMzMxY2ZlY2M2ZjRkODViMTUxYzdiNmU0MWI0YmU0L3RhYmxlcmFuZ2U6NmEzMzFjZmVjYzZmNGQ4NWIxNTFjN2I2ZTQxYjRiZTRfNi0xLTEtMS0xNTYwNA_54ca1fb9-1e54-4d5d-a7b2-eba26dbd8c04">58</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica51236575994a4ab8e30322fc2f55a4_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83MC9mcmFnOjIwOWNjNDk5ZjQ3NDQyMGI5N2Q5ZTFkODQ4MjYwMDUwL3RhYmxlOjZhMzMxY2ZlY2M2ZjRkODViMTUxYzdiNmU0MWI0YmU0L3RhYmxlcmFuZ2U6NmEzMzFjZmVjYzZmNGQ4NWIxNTFjN2I2ZTQxYjRiZTRfNi0zLTEtMS0xNTYwNA_e9d897b5-7bbe-40c3-bb0f-f0eb9f404ce6">52</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's net deferred tax assets, excluding certain deferred tax liabilities totaling $<ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:DeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83MC9mcmFnOjIwOWNjNDk5ZjQ3NDQyMGI5N2Q5ZTFkODQ4MjYwMDUwL3RleHRyZWdpb246MjA5Y2M0OTlmNDc0NDIwYjk3ZDllMWQ4NDgyNjAwNTBfNjM1_389c9175-052c-444e-8915-c3bdc39263d1">2,438</ix:nonFraction>, are offset by a valuation allowance due to the Company's history of net losses combined with an inability to confirm recovery of the tax benefits of the Company's losses and other net deferred tax assets. In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, the Company had net operating loss carryforwards for U.S. federal income tax purposes of approximately $<ix:nonFraction unitRef="usd" contextRef="i1fd4ac078b6b4bd3b73092a493efc484_I20220331" decimals="-3" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83MC9mcmFnOjIwOWNjNDk5ZjQ3NDQyMGI5N2Q5ZTFkODQ4MjYwMDUwL3RleHRyZWdpb246MjA5Y2M0OTlmNDc0NDIwYjk3ZDllMWQ4NDgyNjAwNTBfMTQ4NA_aa78a1ce-1cda-4b4e-980b-f31654e25869">861,000</ix:nonFraction> available to offset future taxable income, including approximately $<ix:nonFraction unitRef="usd" contextRef="i6a7f574cfb2544578c335065e1d56a9c_I20220331" decimals="-3" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83MC9mcmFnOjIwOWNjNDk5ZjQ3NDQyMGI5N2Q5ZTFkODQ4MjYwMDUwL3RleHRyZWdpb246MjA5Y2M0OTlmNDc0NDIwYjk3ZDllMWQ4NDgyNjAwNTBfMTU1NA_662def9b-6187-477d-947c-53c514534d20">609,000</ix:nonFraction> generated after 2017, U.S. capital loss carryforwards of approximately $<ix:nonFraction unitRef="usd" contextRef="i1fd4ac078b6b4bd3b73092a493efc484_I20220331" decimals="-3" name="us-gaap:DeferredTaxAssetsCapitalLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83MC9mcmFnOjIwOWNjNDk5ZjQ3NDQyMGI5N2Q5ZTFkODQ4MjYwMDUwL3RleHRyZWdpb246MjA5Y2M0OTlmNDc0NDIwYjk3ZDllMWQ4NDgyNjAwNTBfMTYyOA_df5e9935-3ef4-48a3-b3ae-e42d1f0c1339">212,500</ix:nonFraction>, and federal and state research and development tax credits of approximately $<ix:nonFraction unitRef="usd" contextRef="i1fd4ac078b6b4bd3b73092a493efc484_I20220331" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83MC9mcmFnOjIwOWNjNDk5ZjQ3NDQyMGI5N2Q5ZTFkODQ4MjYwMDUwL3RleHRyZWdpb246MjA5Y2M0OTlmNDc0NDIwYjk3ZDllMWQ4NDgyNjAwNTBfMTcwOA_f4770e8c-bbd9-4178-930b-f98cb4b78b8c">11,300</ix:nonFraction>, prior to consideration of annual limitations that may be imposed under Section&#160;382 of the Internal Revenue Code of 1986, as amended. Net operating loss carryforwards generated prior to 2018 have begun to expire in 2022, and capital loss carryforwards will expire if unutilized beginning in 2024. As of March&#160;31, 2022, the Company's foreign subsidiaries have foreign loss carryforwards of approximately $<ix:nonFraction unitRef="usd" contextRef="ied3594fa3f424f1284f8857f0f9d9e48_I20220331" decimals="-3" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83MC9mcmFnOjIwOWNjNDk5ZjQ3NDQyMGI5N2Q5ZTFkODQ4MjYwMDUwL3RleHRyZWdpb246MjA5Y2M0OTlmNDc0NDIwYjk3ZDllMWQ4NDgyNjAwNTBfMjEwMg_d6734cf3-2d41-4d7a-958a-cf6a782713a8">74,200</ix:nonFraction>, most of which do not expire.</span></div></ix:continuation><div id="i7169a803a6aa44ea981603d220cab84f_73"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13. <ix:nonNumeric contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83My9mcmFnOmM1ZGIyMTNkZWJkZjRlMzA5OGU3ODI0MjJjNjU2ZTg5L3RleHRyZWdpb246YzVkYjIxM2RlYmRmNGUzMDk4ZTc4MjQyMmM2NTZlODlfMjcyMQ_cf08cc5e-bbc0-4c6c-ae51-4004c5c19102" continuedAt="i1d23c06966a44626a93beb3cfe5ebcf8" escape="true">Shareholders' Equity</ix:nonNumeric></span></div><ix:continuation id="i1d23c06966a44626a93beb3cfe5ebcf8" continuedAt="ie2259e7448d44799a0a5d299ef270128"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Issuances of Precigen Common Stock</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, the Company closed a public offering of <ix:nonFraction unitRef="shares" contextRef="ie2a968b6094d45cda5605e526b7e92bf_D20210101-20210131" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83My9mcmFnOmM1ZGIyMTNkZWJkZjRlMzA5OGU3ODI0MjJjNjU2ZTg5L3RleHRyZWdpb246YzVkYjIxM2RlYmRmNGUzMDk4ZTc4MjQyMmM2NTZlODlfMTIy_b6bd501e-2d50-4ef9-a83d-787e570d700e">17,250,000</ix:nonFraction> shares of its common stock, resulting in net proceeds of $<ix:nonFraction unitRef="usd" contextRef="ie2a968b6094d45cda5605e526b7e92bf_D20210101-20210131" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83My9mcmFnOmM1ZGIyMTNkZWJkZjRlMzA5OGU3ODI0MjJjNjU2ZTg5L3RleHRyZWdpb246YzVkYjIxM2RlYmRmNGUzMDk4ZTc4MjQyMmM2NTZlODlfMTgy_1ae4921d-c253-4f84-af9b-f6ca6f8c39c3">121,045</ix:nonFraction>, after deducting underwriting discounts and of capitalized offering expenses.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 11  for discussion regarding conversion features of the convertible notes.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Lending Agreement</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Concurrently with the offering of the Convertible Notes (Note 11), Precigen entered into a share lending agreement (the "Share Lending Agreement") with J.P. Morgan Securities LLC (the "Share Borrower") pursuant to which Precigen loaned and delivered <ix:nonFraction unitRef="shares" contextRef="i8598f9bdba3a401d83a4f654f841906a_D20180701-20180731" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesOther" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83My9mcmFnOmM1ZGIyMTNkZWJkZjRlMzA5OGU3ODI0MjJjNjU2ZTg5L3RleHRyZWdpb246YzVkYjIxM2RlYmRmNGUzMDk4ZTc4MjQyMmM2NTZlODlfODk3_bec30f7d-4fd7-4698-af26-9e1d6708c754">7,479,431</ix:nonFraction> shares of its common stock (the "Borrowed Shares") to the Share Borrower. The Share Lending Agreement will terminate, and the Borrowed Shares will be returned to Precigen within <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83My9mcmFnOmM1ZGIyMTNkZWJkZjRlMzA5OGU3ODI0MjJjNjU2ZTg5L3RleHRyZWdpb246YzVkYjIxM2RlYmRmNGUzMDk4ZTc4MjQyMmM2NTZlODlfMTA3OA_34a88b8d-8f7c-4b2a-8636-4d319d40194f">five</span> business days of such termination, upon (i) termination by the Share Borrower or (ii) the earliest to occur of (a) October 1, 2023 and (b) the date, if any, on which the Share Lending Agreement is either mutually terminated or terminated by one party upon a default by the other party. The Share Borrower maintains collateral in the form of cash or certain permitted non-cash collateral with a market value at least equal to the market value of the Borrowed Shares as security for the obligation of the Share Borrower to return the Borrowed Shares when required by the terms above. The Borrowed Shares were offered and sold to the public at a price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i93aa43f8711240658d7f03498645c20e_I20180731" decimals="INF" name="us-gaap:SharesIssuedPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83My9mcmFnOmM1ZGIyMTNkZWJkZjRlMzA5OGU3ODI0MjJjNjU2ZTg5L3RleHRyZWdpb246YzVkYjIxM2RlYmRmNGUzMDk4ZTc4MjQyMmM2NTZlODlfMTczMw_4cc04bef-07f8-4891-88b5-69b901233e84">13.37</ix:nonFraction> per share under a registered offering (the "Borrowed Shares Offering"). Precigen did not receive any proceeds from the sale of the Borrowed Shares to the public or any lending fees from the Share Lending Agreement. The Share Borrower or its affiliates received all the proceeds from the sale of the Borrowed Shares to the public. Affiliates of Third Security purchased all of the shares of common stock in the Borrowed Shares Offering.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Share Lending Agreement was entered into at fair value and met the requirements for equity classification. Therefore, the value is netted against the issuance of the Borrowed Shares in additional paid-in capital. Additionally, the Borrowed Shares are not included in the denominator for loss per share attributable to Precigen shareholders unless the Share Borrower defaults on the Share Lending Agreement.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ie2259e7448d44799a0a5d299ef270128"><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Components of Accumulated Other Comprehensive (Loss) Income </span></div><ix:nonNumeric contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83My9mcmFnOmM1ZGIyMTNkZWJkZjRlMzA5OGU3ODI0MjJjNjU2ZTg5L3RleHRyZWdpb246YzVkYjIxM2RlYmRmNGUzMDk4ZTc4MjQyMmM2NTZlODlfMjcxNg_2a8eb43d-f69e-4d69-8db8-ac5e76f6002b" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of accumulated other comprehensive (loss) income are as follows:</span></div><div style="margin-top:17pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:70.894%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.537%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized loss on investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3cffe5138aae46519a9c02056913cbba_I20220331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83My9mcmFnOmM1ZGIyMTNkZWJkZjRlMzA5OGU3ODI0MjJjNjU2ZTg5L3RhYmxlOmJhMmNlMTY2NmE4ZTRhNTNiNTU0NWQ0ZTcwNjk1N2NkL3RhYmxlcmFuZ2U6YmEyY2UxNjY2YThlNGE1M2I1NTQ1ZDRlNzA2OTU3Y2RfMS0xLTEtMS0xNTYwNA_ffa6d51b-98f6-4527-97cb-94272de1951c">1,133</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if3b3a8896f5b4e35ac21bb5d15996bf1_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83My9mcmFnOmM1ZGIyMTNkZWJkZjRlMzA5OGU3ODI0MjJjNjU2ZTg5L3RhYmxlOmJhMmNlMTY2NmE4ZTRhNTNiNTU0NWQ0ZTcwNjk1N2NkL3RhYmxlcmFuZ2U6YmEyY2UxNjY2YThlNGE1M2I1NTQ1ZDRlNzA2OTU3Y2RfMS0zLTEtMS0xNTYwNA_a44769dc-f85b-4a37-93e2-9f45d9e85079">331</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) on foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i356ed50b56d84ebc908b0db1a4e37562_I20220331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83My9mcmFnOmM1ZGIyMTNkZWJkZjRlMzA5OGU3ODI0MjJjNjU2ZTg5L3RhYmxlOmJhMmNlMTY2NmE4ZTRhNTNiNTU0NWQ0ZTcwNjk1N2NkL3RhYmxlcmFuZ2U6YmEyY2UxNjY2YThlNGE1M2I1NTQ1ZDRlNzA2OTU3Y2RfMi0xLTEtMS0xNTYwNA_ad91b12b-c10e-476d-a580-e7e89b2ea41f">566</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4e65996659d4890b8c61dca95aca459_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83My9mcmFnOmM1ZGIyMTNkZWJkZjRlMzA5OGU3ODI0MjJjNjU2ZTg5L3RhYmxlOmJhMmNlMTY2NmE4ZTRhNTNiNTU0NWQ0ZTcwNjk1N2NkL3RhYmxlcmFuZ2U6YmEyY2UxNjY2YThlNGE1M2I1NTQ1ZDRlNzA2OTU3Y2RfMi0zLTEtMS0xNTYwNA_a58e401c-d12f-4897-90e5-713faccf953b">534</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accumulated other comprehensive (loss) income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia10c8c844d4940a3b0ebde37f5f75f25_I20220331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83My9mcmFnOmM1ZGIyMTNkZWJkZjRlMzA5OGU3ODI0MjJjNjU2ZTg5L3RhYmxlOmJhMmNlMTY2NmE4ZTRhNTNiNTU0NWQ0ZTcwNjk1N2NkL3RhYmxlcmFuZ2U6YmEyY2UxNjY2YThlNGE1M2I1NTQ1ZDRlNzA2OTU3Y2RfMy0xLTEtMS0xNTYwNA_4d77c894-2fdb-4299-a1a3-c9d3093b3478">1,699</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1386437e5414589a78d1e1f9863e05e_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83My9mcmFnOmM1ZGIyMTNkZWJkZjRlMzA5OGU3ODI0MjJjNjU2ZTg5L3RhYmxlOmJhMmNlMTY2NmE4ZTRhNTNiNTU0NWQ0ZTcwNjk1N2NkL3RhYmxlcmFuZ2U6YmEyY2UxNjY2YThlNGE1M2I1NTQ1ZDRlNzA2OTU3Y2RfMy0zLTEtMS0xNTYwNA_100f5c4f-e59e-45e7-9f6b-b0a16fa3bf96">203</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i7169a803a6aa44ea981603d220cab84f_76"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14. <ix:nonNumeric contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RleHRyZWdpb246NDM1NTMzZTBlZmRhNGM3ZThlNDgxMGVkNDMwZGFiNmVfMzQ1Ng_3d36eced-b801-472b-b812-660835627cb3" continuedAt="i5bc81429105d4e259bcb3e02665973d9" escape="true">Share-Based Payments</ix:nonNumeric></span></div><ix:continuation id="i5bc81429105d4e259bcb3e02665973d9" continuedAt="ibfd077ea2bca4c428f3275b258f0e5e9"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures the fair value of stock options and restricted stock units ("RSUs") issued to employees and nonemployees as of the grant date for recognition of stock-based compensation expense. Stock-based compensation expense for employees and nonemployees is recognized over the requisite service period, which is typically the vesting period. <ix:nonNumeric contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RleHRyZWdpb246NDM1NTMzZTBlZmRhNGM3ZThlNDgxMGVkNDMwZGFiNmVfMzQ1OQ_1007994f-7f18-423a-86c2-12d3549c3eef" continuedAt="ic255a617aef94799b17a46a458de8cea" escape="true">Stock-based compensation costs included in the condensed consolidated statements of operations are presented below:</ix:nonNumeric></span></div><div style="margin-top:17pt;text-align:center"><ix:continuation id="ic255a617aef94799b17a46a458de8cea"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"><tr><td style="width:1.0%"></td><td style="width:70.091%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.927%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.928%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended&#160;<br/>&#160;March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fae103728264503ab2e0c1e85de1fa1_D20220101-20220331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RhYmxlOjU5MzhjNzkzZjgyYTQ1YTNiMjZmYmY3N2MwNDdlMzQyL3RhYmxlcmFuZ2U6NTkzOGM3OTNmODJhNDVhM2IyNmZiZjc3YzA0N2UzNDJfMi0xLTEtMS0xNTYwNA_2bb35ec5-f1b3-4528-8b0a-927abb87d4ec">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbf81220cc4d45d9aa7386783cc59848_D20210101-20210331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RhYmxlOjU5MzhjNzkzZjgyYTQ1YTNiMjZmYmY3N2MwNDdlMzQyL3RhYmxlcmFuZ2U6NTkzOGM3OTNmODJhNDVhM2IyNmZiZjc3YzA0N2UzNDJfMi0zLTEtMS0xNTYwNA_75bbc3dc-f764-47cc-8a90-d43f53b33fe4">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id10f7e933b844c0c974c05850b687893_D20220101-20220331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RhYmxlOjU5MzhjNzkzZjgyYTQ1YTNiMjZmYmY3N2MwNDdlMzQyL3RhYmxlcmFuZ2U6NTkzOGM3OTNmODJhNDVhM2IyNmZiZjc3YzA0N2UzNDJfMy0xLTEtMS0xNTYwNA_f02f4455-93dd-40f8-aeb8-856a554d8ee6">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b6126b9ae8a467c975a767e23eefb22_D20210101-20210331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RhYmxlOjU5MzhjNzkzZjgyYTQ1YTNiMjZmYmY3N2MwNDdlMzQyL3RhYmxlcmFuZ2U6NTkzOGM3OTNmODJhNDVhM2IyNmZiZjc3YzA0N2UzNDJfMy0zLTEtMS0xNTYwNA_845f2bc3-c7c9-490c-9513-196678abe78e">65</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc7b7a85c17a4f719952d2594387e412_D20220101-20220331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RhYmxlOjU5MzhjNzkzZjgyYTQ1YTNiMjZmYmY3N2MwNDdlMzQyL3RhYmxlcmFuZ2U6NTkzOGM3OTNmODJhNDVhM2IyNmZiZjc3YzA0N2UzNDJfNC0xLTEtMS0xNTYwNA_cd727173-6e7e-40ec-926f-e5c11d0ea9b9">548</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45c4b76fe6d6445d8c45f82b8265fa07_D20210101-20210331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RhYmxlOjU5MzhjNzkzZjgyYTQ1YTNiMjZmYmY3N2MwNDdlMzQyL3RhYmxlcmFuZ2U6NTkzOGM3OTNmODJhNDVhM2IyNmZiZjc3YzA0N2UzNDJfNC0zLTEtMS0xNTYwNA_76de6ddd-7502-49b0-b051-f2905c920d75">1,038</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd0d01ceff2445fda5c004b555eca6e7_D20220101-20220331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RhYmxlOjU5MzhjNzkzZjgyYTQ1YTNiMjZmYmY3N2MwNDdlMzQyL3RhYmxlcmFuZ2U6NTkzOGM3OTNmODJhNDVhM2IyNmZiZjc3YzA0N2UzNDJfNS0xLTEtMS0xNTYwNA_ee745c51-8096-4f6b-8087-3ad75ad9b859">2,975</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice47f63e56544bee9874b31fbdaf9439_D20210101-20210331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RhYmxlOjU5MzhjNzkzZjgyYTQ1YTNiMjZmYmY3N2MwNDdlMzQyL3RhYmxlcmFuZ2U6NTkzOGM3OTNmODJhNDVhM2IyNmZiZjc3YzA0N2UzNDJfNS0zLTEtMS0xNTYwNA_ab88dee6-2beb-40ec-97e1-082d6741d03b">4,303</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RhYmxlOjU5MzhjNzkzZjgyYTQ1YTNiMjZmYmY3N2MwNDdlMzQyL3RhYmxlcmFuZ2U6NTkzOGM3OTNmODJhNDVhM2IyNmZiZjc3YzA0N2UzNDJfNy0xLTEtMS0xNTYwNA_02dae7e5-8c6e-446d-aeb6-71d6d392209a">3,562</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RhYmxlOjU5MzhjNzkzZjgyYTQ1YTNiMjZmYmY3N2MwNDdlMzQyL3RhYmxlcmFuZ2U6NTkzOGM3OTNmODJhNDVhM2IyNmZiZjc3YzA0N2UzNDJfNy0zLTEtMS0xNTYwNA_73a7e4bb-186f-43cb-beea-69bd90c629ad">5,415</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Precigen Stock Option Plans</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April&#160;2008, Precigen adopted the 2008 Equity Incentive Plan (the "2008 Plan") for employees and nonemployees pursuant to which Precigen's board of directors granted share-based awards, including stock options, to officers, key employees and nonemployees. Upon the effectiveness of the 2013 Omnibus Incentive Plan (the "2013 Plan"), <ix:nonFraction unitRef="shares" contextRef="i76c7b4e5ff1a48fcadf331282aabc8db_I20220331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RleHRyZWdpb246NDM1NTMzZTBlZmRhNGM3ZThlNDgxMGVkNDMwZGFiNmVfODYz_f94f57b4-b628-4cce-acf7-7b06369da161">no</ix:nonFraction> new awards may be granted under the 2008 Plan. As of March&#160;31, 2022, there were <ix:nonFraction unitRef="shares" contextRef="i76c7b4e5ff1a48fcadf331282aabc8db_I20220331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RleHRyZWdpb246NDM1NTMzZTBlZmRhNGM3ZThlNDgxMGVkNDMwZGFiNmVfOTM0_a670f8f0-23aa-403b-9930-422424a81dde">14,843</ix:nonFraction> stock options outstanding under the 2008 Plan.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Precigen adopted the 2013 Plan for employees and nonemployees pursuant to which Precigen's board of directors may grant share-based awards, including stock options and shares of common stock, to employees, officers, consultants, advisors, and nonemployee directors. The 2013 Plan became effective in August 2013, and as of March&#160;31, 2022, there were <ix:nonFraction unitRef="shares" contextRef="i7b18ccdba7b24f00b51da1d09ef35311_I20220331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RleHRyZWdpb246NDM1NTMzZTBlZmRhNGM3ZThlNDgxMGVkNDMwZGFiNmVfMTMyMg_f05b13c5-0c99-48b6-897c-86dfa0c0a143">27,000,000</ix:nonFraction> shares authorized for issuance under the 2013 Plan, of which <ix:nonFraction unitRef="shares" contextRef="i7b18ccdba7b24f00b51da1d09ef35311_I20220331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RleHRyZWdpb246NDM1NTMzZTBlZmRhNGM3ZThlNDgxMGVkNDMwZGFiNmVfMTM4Ng_3ad9c0f5-f465-48db-aeda-4d006a9ec1ce">14,121,502</ix:nonFraction> stock options and <ix:nonFraction unitRef="shares" contextRef="i7b18ccdba7b24f00b51da1d09ef35311_I20220331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RleHRyZWdpb246NDM1NTMzZTBlZmRhNGM3ZThlNDgxMGVkNDMwZGFiNmVfMTQwNw_f3e5bd1f-5ee3-4696-921c-7c18727372bf">569,445</ix:nonFraction> RSUs were outstanding and <ix:nonFraction unitRef="shares" contextRef="i7b18ccdba7b24f00b51da1d09ef35311_I20220331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RleHRyZWdpb246NDM1NTMzZTBlZmRhNGM3ZThlNDgxMGVkNDMwZGFiNmVfMTQzNg_2ed4ba2a-c193-4cc5-9c07-ed86acfad7d0">2,085,537</ix:nonFraction> shares were available for grant. In April 2022, Precigen's board of directors approved, subject to shareholder approval at Precigen's annual meeting in June 2022, an increase of <ix:nonFraction unitRef="shares" contextRef="i2cb8b077e2f643509dd676e06445a3b0_I20220430" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RleHRyZWdpb246NDM1NTMzZTBlZmRhNGM3ZThlNDgxMGVkNDMwZGFiNmVfMzI5ODUzNDg4NzM0Mg_c2f1adbc-ab01-40ee-b468-603757fb47c0">10,000,000</ix:nonFraction> shares of common stock to be reserved for issuance under the 2013 Plan.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2019, Precigen adopted the 2019 Incentive Plan for Non-Employee Service Providers (the "2019 Plan"), which became effective upon shareholder approval in June 2019. The 2019 Plan permits the grant of share-based awards, including stock options, restricted stock awards, and RSUs, to non-employee service providers, including board members. As of March&#160;31, 2022, there were <ix:nonFraction unitRef="shares" contextRef="i41a9bb8a5068442cb2b3e00d415ced02_I20220331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RleHRyZWdpb246NDM1NTMzZTBlZmRhNGM3ZThlNDgxMGVkNDMwZGFiNmVfMTg0MQ_c91572a5-3f65-4e67-b5e0-6c9d196cda0a">5,000,000</ix:nonFraction> shares authorized for issuance under the 2019 Plan, of which <ix:nonFraction unitRef="shares" contextRef="i41a9bb8a5068442cb2b3e00d415ced02_I20220331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RleHRyZWdpb246NDM1NTMzZTBlZmRhNGM3ZThlNDgxMGVkNDMwZGFiNmVfMTkwNQ_9b38bcca-ebb5-457b-8f17-f9d5be961c6f">1,898,208</ix:nonFraction> stock options and <ix:nonFraction unitRef="shares" contextRef="i41a9bb8a5068442cb2b3e00d415ced02_I20220331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RleHRyZWdpb246NDM1NTMzZTBlZmRhNGM3ZThlNDgxMGVkNDMwZGFiNmVfMTkyNg_b3f899bb-9d8a-4930-a381-807e32196747">615,760</ix:nonFraction> RSUs were outstanding and <ix:nonFraction unitRef="shares" contextRef="i41a9bb8a5068442cb2b3e00d415ced02_I20220331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RleHRyZWdpb246NDM1NTMzZTBlZmRhNGM3ZThlNDgxMGVkNDMwZGFiNmVfMTk1NQ_4533c1d9-b20a-4eec-be31-775c40a6f000">243,025</ix:nonFraction> shares were available for grant. In April 2022, Precigen's board of directors approved, subject to shareholder approval at Precigen's annual meeting in June 2022, an increase of <ix:nonFraction unitRef="shares" contextRef="ie9b2e87da42e47ccab3223507b32451a_I20220430" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RleHRyZWdpb246NDM1NTMzZTBlZmRhNGM3ZThlNDgxMGVkNDMwZGFiNmVfMzI5ODUzNDg4NzM1NA_536200fa-61ff-46c3-a00b-280e53b3b569">7,000,000</ix:nonFraction> shares of common stock to be reserved for issuance under the 2019 Plan.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ibfd077ea2bca4c428f3275b258f0e5e9"><ix:nonNumeric contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RleHRyZWdpb246NDM1NTMzZTBlZmRhNGM3ZThlNDgxMGVkNDMwZGFiNmVfMzQ2MA_c949757c-c222-411d-ae64-c9ea62b42606" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock option activity was as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.648%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.500%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Remaining Contractual Term (Years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5431bc10b5384e398f2da6195a9b96c3_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RhYmxlOjAxMGM3YmY0ZjFiZTRkNmJhZmFjOTIxMWY3ZGVhOWU1L3RhYmxlcmFuZ2U6MDEwYzdiZjRmMWJlNGQ2YmFmYWM5MjExZjdkZWE5ZTVfMS0xLTEtMS0xNTYwNA_c6491f8e-c246-41b8-97da-e8e416c5e0e3">12,260,187</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5431bc10b5384e398f2da6195a9b96c3_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RhYmxlOjAxMGM3YmY0ZjFiZTRkNmJhZmFjOTIxMWY3ZGVhOWU1L3RhYmxlcmFuZ2U6MDEwYzdiZjRmMWJlNGQ2YmFmYWM5MjExZjdkZWE5ZTVfMS0zLTEtMS0xNTYwNA_61762991-590d-426f-8c53-46647dde4e48">14.06</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ifbfcb80618ad460ab47bac77d7292bc6_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RhYmxlOjAxMGM3YmY0ZjFiZTRkNmJhZmFjOTIxMWY3ZGVhOWU1L3RhYmxlcmFuZ2U6MDEwYzdiZjRmMWJlNGQ2YmFmYWM5MjExZjdkZWE5ZTVfMS01LTEtMS0xNTYwNA_128262f6-02c3-4fd3-88a6-ce6f7799c6f1">6.79</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib0b5090cc97842718a2c0490412cb4ca_D20220101-20220331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RhYmxlOjAxMGM3YmY0ZjFiZTRkNmJhZmFjOTIxMWY3ZGVhOWU1L3RhYmxlcmFuZ2U6MDEwYzdiZjRmMWJlNGQ2YmFmYWM5MjExZjdkZWE5ZTVfMi0xLTEtMS0xNTYwNA_e6427fba-6d31-458b-abbc-d3dfde65feb3">4,009,390</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib0b5090cc97842718a2c0490412cb4ca_D20220101-20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RhYmxlOjAxMGM3YmY0ZjFiZTRkNmJhZmFjOTIxMWY3ZGVhOWU1L3RhYmxlcmFuZ2U6MDEwYzdiZjRmMWJlNGQ2YmFmYWM5MjExZjdkZWE5ZTVfMi0zLTEtMS0xNTYwNA_4cab46ab-6515-4b26-9f49-ed07beabdd02">2.27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ib0b5090cc97842718a2c0490412cb4ca_D20220101-20220331" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RhYmxlOjAxMGM3YmY0ZjFiZTRkNmJhZmFjOTIxMWY3ZGVhOWU1L3RhYmxlcmFuZ2U6MDEwYzdiZjRmMWJlNGQ2YmFmYWM5MjExZjdkZWE5ZTVfNC0xLTEtMS0xNTYwNA_58f9aafc-c499-4c3b-a328-652b036fdc4d">375</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib0b5090cc97842718a2c0490412cb4ca_D20220101-20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RhYmxlOjAxMGM3YmY0ZjFiZTRkNmJhZmFjOTIxMWY3ZGVhOWU1L3RhYmxlcmFuZ2U6MDEwYzdiZjRmMWJlNGQ2YmFmYWM5MjExZjdkZWE5ZTVfNC0zLTEtMS0xNTYwNA_4e517ccc-bec7-4b34-a05b-55f0c16a4e9a">2.28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ib0b5090cc97842718a2c0490412cb4ca_D20220101-20220331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RhYmxlOjAxMGM3YmY0ZjFiZTRkNmJhZmFjOTIxMWY3ZGVhOWU1L3RhYmxlcmFuZ2U6MDEwYzdiZjRmMWJlNGQ2YmFmYWM5MjExZjdkZWE5ZTVfNS0xLTEtMS0xNTYwNA_843a50eb-7a1b-4ed8-9b3d-3d92ddb6f7aa">210,613</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib0b5090cc97842718a2c0490412cb4ca_D20220101-20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RhYmxlOjAxMGM3YmY0ZjFiZTRkNmJhZmFjOTIxMWY3ZGVhOWU1L3RhYmxlcmFuZ2U6MDEwYzdiZjRmMWJlNGQ2YmFmYWM5MjExZjdkZWE5ZTVfNS0zLTEtMS0xNTYwNA_fa136e82-ad51-4036-b284-a997d7b372b7">5.63</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ib0b5090cc97842718a2c0490412cb4ca_D20220101-20220331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RhYmxlOjAxMGM3YmY0ZjFiZTRkNmJhZmFjOTIxMWY3ZGVhOWU1L3RhYmxlcmFuZ2U6MDEwYzdiZjRmMWJlNGQ2YmFmYWM5MjExZjdkZWE5ZTVfNi0xLTEtMS0xNTYwNA_3a10a05e-cf91-46f3-a79b-459f0c0102a0">24,036</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib0b5090cc97842718a2c0490412cb4ca_D20220101-20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RhYmxlOjAxMGM3YmY0ZjFiZTRkNmJhZmFjOTIxMWY3ZGVhOWU1L3RhYmxlcmFuZ2U6MDEwYzdiZjRmMWJlNGQ2YmFmYWM5MjExZjdkZWE5ZTVfNi0zLTEtMS0xNTYwNA_b0e5fdba-3e44-433e-8ece-6b8d96405afd">11.85</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances at March 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia76d4feded9342679caddb3d64f9f4ff_I20220331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RhYmxlOjAxMGM3YmY0ZjFiZTRkNmJhZmFjOTIxMWY3ZGVhOWU1L3RhYmxlcmFuZ2U6MDEwYzdiZjRmMWJlNGQ2YmFmYWM5MjExZjdkZWE5ZTVfNy0xLTEtMS0xNTYwNA_67f98fe3-8fe6-4205-8c27-29f354dd0677">16,034,553</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia76d4feded9342679caddb3d64f9f4ff_I20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RhYmxlOjAxMGM3YmY0ZjFiZTRkNmJhZmFjOTIxMWY3ZGVhOWU1L3RhYmxlcmFuZ2U6MDEwYzdiZjRmMWJlNGQ2YmFmYWM5MjExZjdkZWE5ZTVfNy0zLTEtMS0xNTYwNA_d260b47f-20aa-42c9-8b97-abb7fabf9a30">11.22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib0b5090cc97842718a2c0490412cb4ca_D20220101-20220331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RhYmxlOjAxMGM3YmY0ZjFiZTRkNmJhZmFjOTIxMWY3ZGVhOWU1L3RhYmxlcmFuZ2U6MDEwYzdiZjRmMWJlNGQ2YmFmYWM5MjExZjdkZWE5ZTVfNy01LTEtMS0xNTYwNA_bdaa955e-afd7-41f9-9eda-eec745d31a28">7.31</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exercisable at March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia76d4feded9342679caddb3d64f9f4ff_I20220331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RhYmxlOjAxMGM3YmY0ZjFiZTRkNmJhZmFjOTIxMWY3ZGVhOWU1L3RhYmxlcmFuZ2U6MDEwYzdiZjRmMWJlNGQ2YmFmYWM5MjExZjdkZWE5ZTVfOC0xLTEtMS0xNTYwNA_22835b2b-ba3c-47c0-a6be-9484cd99337e">8,937,195</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia76d4feded9342679caddb3d64f9f4ff_I20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RhYmxlOjAxMGM3YmY0ZjFiZTRkNmJhZmFjOTIxMWY3ZGVhOWU1L3RhYmxlcmFuZ2U6MDEwYzdiZjRmMWJlNGQ2YmFmYWM5MjExZjdkZWE5ZTVfOC0zLTEtMS0xNTYwNA_41d94437-8df1-4c15-a975-c73891a24fda">14.85</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib0b5090cc97842718a2c0490412cb4ca_D20220101-20220331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RhYmxlOjAxMGM3YmY0ZjFiZTRkNmJhZmFjOTIxMWY3ZGVhOWU1L3RhYmxlcmFuZ2U6MDEwYzdiZjRmMWJlNGQ2YmFmYWM5MjExZjdkZWE5ZTVfOC01LTEtMS0xNTYwNA_e9989327-e159-444e-a2e0-cffc25e7526e">5.99</ix:nonNumeric></span></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" name="us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RleHRyZWdpb246NDM1NTMzZTBlZmRhNGM3ZThlNDgxMGVkNDMwZGFiNmVfMzQ0Nw_42ca791f-767f-42d3-9b75-450df9ac2b96" escape="true"><div style="margin-bottom:17pt;margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSU activity was as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.648%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.500%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of Restricted Stock Units</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Grant Date Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Remaining Contractual Term (Years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5431bc10b5384e398f2da6195a9b96c3_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RhYmxlOjhlZWM5MmZmY2JlYzRkYjBiYjBmOGYzMWUyOTU5YWY0L3RhYmxlcmFuZ2U6OGVlYzkyZmZjYmVjNGRiMGJiMGY4ZjMxZTI5NTlhZjRfMS0xLTEtMS0xNTYwNA_62414282-3e43-4395-b4df-d92a3a35d3e6">468,481</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5431bc10b5384e398f2da6195a9b96c3_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RhYmxlOjhlZWM5MmZmY2JlYzRkYjBiYjBmOGYzMWUyOTU5YWY0L3RhYmxlcmFuZ2U6OGVlYzkyZmZjYmVjNGRiMGJiMGY4ZjMxZTI5NTlhZjRfMS0zLTEtMS0xNTYwNA_0175802c-2a49-4295-a340-9709d0230029">8.47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ifbfcb80618ad460ab47bac77d7292bc6_D20210101-20211231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RhYmxlOjhlZWM5MmZmY2JlYzRkYjBiYjBmOGYzMWUyOTU5YWY0L3RhYmxlcmFuZ2U6OGVlYzkyZmZjYmVjNGRiMGJiMGY4ZjMxZTI5NTlhZjRfMS01LTEtMS0xNTYwNA_e13dc75b-4287-409b-b4d7-ce9af4687784">0.33</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib0b5090cc97842718a2c0490412cb4ca_D20220101-20220331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RhYmxlOjhlZWM5MmZmY2JlYzRkYjBiYjBmOGYzMWUyOTU5YWY0L3RhYmxlcmFuZ2U6OGVlYzkyZmZjYmVjNGRiMGJiMGY4ZjMxZTI5NTlhZjRfMi0xLTEtMS0xNTYwNA_50bd51d0-83aa-4a57-996c-ab13aa279fce">1,387,831</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib0b5090cc97842718a2c0490412cb4ca_D20220101-20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RhYmxlOjhlZWM5MmZmY2JlYzRkYjBiYjBmOGYzMWUyOTU5YWY0L3RhYmxlcmFuZ2U6OGVlYzkyZmZjYmVjNGRiMGJiMGY4ZjMxZTI5NTlhZjRfMi0zLTEtMS0xNTYwNA_6a1c2297-ea1a-4aaa-ba52-0de7f724330e">2.12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ib0b5090cc97842718a2c0490412cb4ca_D20220101-20220331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RhYmxlOjhlZWM5MmZmY2JlYzRkYjBiYjBmOGYzMWUyOTU5YWY0L3RhYmxlcmFuZ2U6OGVlYzkyZmZjYmVjNGRiMGJiMGY4ZjMxZTI5NTlhZjRfMy0xLTEtMS0xNTYwNA_4e6fb0d6-77c6-44a7-8b66-2d33f2041383">669,041</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib0b5090cc97842718a2c0490412cb4ca_D20220101-20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RhYmxlOjhlZWM5MmZmY2JlYzRkYjBiYjBmOGYzMWUyOTU5YWY0L3RhYmxlcmFuZ2U6OGVlYzkyZmZjYmVjNGRiMGJiMGY4ZjMxZTI5NTlhZjRfMy0zLTEtMS0xNTYwNA_6af9e7f7-1f0b-47d8-9e3a-abc7c7916259">5.71</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ib0b5090cc97842718a2c0490412cb4ca_D20220101-20220331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RhYmxlOjhlZWM5MmZmY2JlYzRkYjBiYjBmOGYzMWUyOTU5YWY0L3RhYmxlcmFuZ2U6OGVlYzkyZmZjYmVjNGRiMGJiMGY4ZjMxZTI5NTlhZjRfNC0xLTEtMS0xNTYwNA_120bed37-6d5a-40ea-93e7-8d292f7eafed">2,066</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib0b5090cc97842718a2c0490412cb4ca_D20220101-20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RhYmxlOjhlZWM5MmZmY2JlYzRkYjBiYjBmOGYzMWUyOTU5YWY0L3RhYmxlcmFuZ2U6OGVlYzkyZmZjYmVjNGRiMGJiMGY4ZjMxZTI5NTlhZjRfNC0zLTEtMS0xNTYwNA_a70f919a-3f0a-4fd4-b92a-f92522e73c7a">7.26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances at March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia76d4feded9342679caddb3d64f9f4ff_I20220331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RhYmxlOjhlZWM5MmZmY2JlYzRkYjBiYjBmOGYzMWUyOTU5YWY0L3RhYmxlcmFuZ2U6OGVlYzkyZmZjYmVjNGRiMGJiMGY4ZjMxZTI5NTlhZjRfNS0xLTEtMS0xNTYwNA_bb9c4056-8220-4041-8d5c-bf1bd64aae13">1,185,205</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia76d4feded9342679caddb3d64f9f4ff_I20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RhYmxlOjhlZWM5MmZmY2JlYzRkYjBiYjBmOGYzMWUyOTU5YWY0L3RhYmxlcmFuZ2U6OGVlYzkyZmZjYmVjNGRiMGJiMGY4ZjMxZTI5NTlhZjRfNS0zLTEtMS0xNTYwNA_4fe13bc3-eee1-4b57-9907-0bd8d31777a7">2.60</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib0b5090cc97842718a2c0490412cb4ca_D20220101-20220331" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RhYmxlOjhlZWM5MmZmY2JlYzRkYjBiYjBmOGYzMWUyOTU5YWY0L3RhYmxlcmFuZ2U6OGVlYzkyZmZjYmVjNGRiMGJiMGY4ZjMxZTI5NTlhZjRfNS01LTEtMS0xNTYwNA_9a5d74ee-036c-422e-842e-3048ff12e9f5">0.59</ix:nonNumeric></span></td></tr></table></div></ix:nonNumeric><div style="margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Precigen currently uses authorized and unissued shares to satisfy share award exercises.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's Executive Chairman ("Executive Chairman"), who previously served as an employee and executive officer until September 24, 2020, received a base salary of $<ix:nonFraction unitRef="usd" contextRef="i48d145e276444d3888545e838877b8de_D20200701-20200930" decimals="-3" name="pgen:CompensationArrangementWithIndividualAllocatedShareBasedCompensationExpenseMonthlyExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RleHRyZWdpb246NDM1NTMzZTBlZmRhNGM3ZThlNDgxMGVkNDMwZGFiNmVfMjMxOQ_6d04a09e-167b-4d63-a723-692944488e8a">200</ix:nonFraction> per month through March 31, 2020, payable in fully-vested shares of Precigen common stock with such shares subject to a <ix:nonNumeric contextRef="if5b1b22e280a4090aecc9398d2cdea50_D20200701-20200930" name="pgen:LockupPeriodOnRestrictedStockUnitShares" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RleHRyZWdpb246NDM1NTMzZTBlZmRhNGM3ZThlNDgxMGVkNDMwZGFiNmVfMzQ1NQ_7e702971-6035-48a3-950d-d266b95f4629">three-year</ix:nonNumeric> lock-up on resale. In September 2020, the Company's board of directors, upon the recommendation of the compensation committee of the board, approved a new compensation arrangement for the Executive Chairman consisting of (i) an annual retainer of $<ix:nonFraction unitRef="usd" contextRef="id74f0b524f01452d8d2d8d74d2292022_D20200901-20200930" decimals="-3" name="pgen:CompensationArrangementWithIndividualAnnualCashRetainer" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RleHRyZWdpb246NDM1NTMzZTBlZmRhNGM3ZThlNDgxMGVkNDMwZGFiNmVfMjY5Nw_5b20042f-a8da-43c8-a765-66f60b497d62">100</ix:nonFraction> payable in cash or, at the Executive Chairman's election, shares of Precigen common stock; (ii) an annual grant of fully vested stock options having a grant date fair value of $<ix:nonFraction unitRef="usd" contextRef="i0af19287e90a415ea59ea804de00d129_D20200901-20200930" decimals="-3" name="pgen:CompensationArrangementWithIndividualAnnualStockOptionGrantGrantDateFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RleHRyZWdpb246NDM1NTMzZTBlZmRhNGM3ZThlNDgxMGVkNDMwZGFiNmVfMjg3Ng_e1a47d6b-b252-4284-8fe7-3adba4a7a3db">250</ix:nonFraction>; and (iii) an annual grant of RSUs having a grant date fair value of $<ix:nonFraction unitRef="usd" contextRef="ideb4dd8ae78341f79f57af0fb7ddc27a_D20200901-20200930" decimals="-3" name="pgen:CompensationArrangementWithIndividualAnnualRSUGrantGrantDateFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RleHRyZWdpb246NDM1NTMzZTBlZmRhNGM3ZThlNDgxMGVkNDMwZGFiNmVfMjk0OA_7a86eebc-d301-44a8-ad33-d46a47935f71">250</ix:nonFraction> vesting over <ix:nonNumeric contextRef="ideb4dd8ae78341f79f57af0fb7ddc27a_D20200901-20200930" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RleHRyZWdpb246NDM1NTMzZTBlZmRhNGM3ZThlNDgxMGVkNDMwZGFiNmVfMjk2NA_2f3a8645-24da-4763-9e80-f5d62af1c65b">one year</ix:nonNumeric>. The new compensation arrangement began in calendar year 2021 and was prorated for the nine months of 2020 not covered by the Executive Chairman's previous compensation arrangement discussed above. Expense associated with the arrangements above is included in selling, general, and administrative expenses in the Company's condensed consolidated statements of operations and totaled $<ix:nonFraction unitRef="usd" contextRef="i59bc005983d548a9b090b14a8066e997_D20220101-20220331" decimals="-3" name="pgen:CompensationArrangementWithIndividualExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RleHRyZWdpb246NDM1NTMzZTBlZmRhNGM3ZThlNDgxMGVkNDMwZGFiNmVfMzM1MA_a234cc23-ec3e-479b-8340-436a56c5924e">433</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i5189760c78094b18a54d1b9ae10c326e_D20210101-20210331" decimals="-3" name="pgen:CompensationArrangementWithIndividualExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RleHRyZWdpb246NDM1NTMzZTBlZmRhNGM3ZThlNDgxMGVkNDMwZGFiNmVfMzM1Nw_9666b628-7310-428f-bb72-2657079e1882">400</ix:nonFraction> for the three months ended March 31, 2022 and 2021.</span></div></ix:continuation><div id="i7169a803a6aa44ea981603d220cab84f_79"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">15. <ix:nonNumeric contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83OS9mcmFnOjgxNjNjNDA5NjZlOTQxMTdhMzUxODA5ZTdhYWE0ZDRkL3RleHRyZWdpb246ODE2M2M0MDk2NmU5NDExN2EzNTE4MDllN2FhYTRkNGRfMTEwMw_5d525017-3777-4dce-ae18-cd7a3342941a" continuedAt="i9ebae4c10c3a473b8d311fda66873b30" escape="true">Operating Leases</ix:nonNumeric></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i9ebae4c10c3a473b8d311fda66873b30" continuedAt="i91693d71c64e428980584b0472b2a62a">The Company leases certain facilities and equipment under operating leases. Leases with a lease term of twelve months or less are considered short-term leases and are not recorded on the balance sheet, and expense for these leases is recognized over the term of the lease. All other leases have remaining terms of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83OS9mcmFnOjgxNjNjNDA5NjZlOTQxMTdhMzUxODA5ZTdhYWE0ZDRkL3RleHRyZWdpb246ODE2M2M0MDk2NmU5NDExN2EzNTE4MDllN2FhYTRkNGRfMzQw_862490a9-7afa-4299-a0ee-2b7d4d6c6c09">one</span> to <ix:nonNumeric contextRef="id3592de1ea59450cab6771569bdb2819_I20220331" name="us-gaap:LesseeOperatingLeaseRemainingLeaseTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83OS9mcmFnOjgxNjNjNDA5NjZlOTQxMTdhMzUxODA5ZTdhYWE0ZDRkL3RleHRyZWdpb246ODE2M2M0MDk2NmU5NDExN2EzNTE4MDllN2FhYTRkNGRfMzQ2_e75dbeb2-9999-4f4b-91ac-8e862433dbf0">nine years</ix:nonNumeric>, some of which may include options to extend the lease and some of which may include options to terminate the lease within <ix:nonNumeric contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" name="pgen:LesseeOperatingLeaseTerminationPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83OS9mcmFnOjgxNjNjNDA5NjZlOTQxMTdhMzUxODA5ZTdhYWE0ZDRkL3RleHRyZWdpb246ODE2M2M0MDk2NmU5NDExN2EzNTE4MDllN2FhYTRkNGRfNDcy_c2c8aa5f-71c3-4834-9d7a-ceb3d91012fc">one year</ix:nonNumeric>. The Company uses judgment to determine whether it is reasonably possible to extend the lease beyond the initial term or terminate before the initial term ends and the length of the possible extension or early termination. The leases are renewable at the option of the Company and do not contain residual value guarantees, covenants, or other restrictions. </ix:continuation></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i91693d71c64e428980584b0472b2a62a"><ix:nonNumeric contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83OS9mcmFnOjgxNjNjNDA5NjZlOTQxMTdhMzUxODA5ZTdhYWE0ZDRkL3RleHRyZWdpb246ODE2M2M0MDk2NmU5NDExN2EzNTE4MDllN2FhYTRkNGRfMTExMQ_5c8f1339-56b7-4159-8992-6bdaab9b93e7" continuedAt="i5c898fd8c46d4f70988ed8b1d6ad3598" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease costs were as follows:</span></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"><tr><td style="width:1.0%"></td><td style="width:69.960%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.993%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended&#160;<br/>&#160;March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease costs</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" decimals="-3" name="us-gaap:OperatingLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83OS9mcmFnOjgxNjNjNDA5NjZlOTQxMTdhMzUxODA5ZTdhYWE0ZDRkL3RhYmxlOjljNGMwYzc5YWY1YTQwODk4MWViYWQ1YWEyYzkzMjE4L3RhYmxlcmFuZ2U6OWM0YzBjNzlhZjVhNDA4OTgxZWJhZDVhYTJjOTMyMThfMi0xLTEtMS0xNTYwNA_b33990c1-1f02-4d98-b26b-e8750f78a702">729</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331" decimals="-3" name="us-gaap:OperatingLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83OS9mcmFnOjgxNjNjNDA5NjZlOTQxMTdhMzUxODA5ZTdhYWE0ZDRkL3RhYmxlOjljNGMwYzc5YWY1YTQwODk4MWViYWQ1YWEyYzkzMjE4L3RhYmxlcmFuZ2U6OWM0YzBjNzlhZjVhNDA4OTgxZWJhZDVhYTJjOTMyMThfMi0zLTEtMS0xNTYwNA_dc6329dd-0f1f-499f-8a8f-8e708d4bec54">839</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" decimals="-3" name="us-gaap:ShortTermLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83OS9mcmFnOjgxNjNjNDA5NjZlOTQxMTdhMzUxODA5ZTdhYWE0ZDRkL3RhYmxlOjljNGMwYzc5YWY1YTQwODk4MWViYWQ1YWEyYzkzMjE4L3RhYmxlcmFuZ2U6OWM0YzBjNzlhZjVhNDA4OTgxZWJhZDVhYTJjOTMyMThfMy0xLTEtMS0xNTYwNA_79700c44-52b5-4bde-8382-597316bea9af">463</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331" decimals="-3" name="us-gaap:ShortTermLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83OS9mcmFnOjgxNjNjNDA5NjZlOTQxMTdhMzUxODA5ZTdhYWE0ZDRkL3RhYmxlOjljNGMwYzc5YWY1YTQwODk4MWViYWQ1YWEyYzkzMjE4L3RhYmxlcmFuZ2U6OWM0YzBjNzlhZjVhNDA4OTgxZWJhZDVhYTJjOTMyMThfMy0zLTEtMS0xNTYwNA_76778c38-cc81-41e0-b9d9-31e13d430023">506</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" decimals="-3" name="us-gaap:VariableLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83OS9mcmFnOjgxNjNjNDA5NjZlOTQxMTdhMzUxODA5ZTdhYWE0ZDRkL3RhYmxlOjljNGMwYzc5YWY1YTQwODk4MWViYWQ1YWEyYzkzMjE4L3RhYmxlcmFuZ2U6OWM0YzBjNzlhZjVhNDA4OTgxZWJhZDVhYTJjOTMyMThfNC0xLTEtMS0xNTYwNA_8a7c6263-096c-4e06-ab1b-ba5a93f72657">117</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331" decimals="-3" name="us-gaap:VariableLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83OS9mcmFnOjgxNjNjNDA5NjZlOTQxMTdhMzUxODA5ZTdhYWE0ZDRkL3RhYmxlOjljNGMwYzc5YWY1YTQwODk4MWViYWQ1YWEyYzkzMjE4L3RhYmxlcmFuZ2U6OWM0YzBjNzlhZjVhNDA4OTgxZWJhZDVhYTJjOTMyMThfNC0zLTEtMS0xNTYwNA_35f8fd12-9682-4db4-8f1e-0784591f369e">230</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease costs</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83OS9mcmFnOjgxNjNjNDA5NjZlOTQxMTdhMzUxODA5ZTdhYWE0ZDRkL3RhYmxlOjljNGMwYzc5YWY1YTQwODk4MWViYWQ1YWEyYzkzMjE4L3RhYmxlcmFuZ2U6OWM0YzBjNzlhZjVhNDA4OTgxZWJhZDVhYTJjOTMyMThfNS0xLTEtMS0xNTYwNA_b36c8a7d-b7a4-4b11-a682-539537e50779">1,309</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83OS9mcmFnOjgxNjNjNDA5NjZlOTQxMTdhMzUxODA5ZTdhYWE0ZDRkL3RhYmxlOjljNGMwYzc5YWY1YTQwODk4MWViYWQ1YWEyYzkzMjE4L3RhYmxlcmFuZ2U6OWM0YzBjNzlhZjVhNDA4OTgxZWJhZDVhYTJjOTMyMThfNS0zLTEtMS0xNTYwNA_6a92b72b-7aba-4189-a466-ba2a75cb2e27">1,575</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83OS9mcmFnOjgxNjNjNDA5NjZlOTQxMTdhMzUxODA5ZTdhYWE0ZDRkL3RleHRyZWdpb246ODE2M2M0MDk2NmU5NDExN2EzNTE4MDllN2FhYTRkNGRfMTEwNQ_80e35b6e-9764-4425-be9d-5d703c40fa3b" escape="true"><div style="margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, maturities of lease liabilities, excluding short-term and variable leases, for continuing operations were as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.497%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83OS9mcmFnOjgxNjNjNDA5NjZlOTQxMTdhMzUxODA5ZTdhYWE0ZDRkL3RhYmxlOmMxMTA5ZjcxN2RmNzQ3ZGQ4MzdlZDQ4YzQwYTU2NmY5L3RhYmxlcmFuZ2U6YzExMDlmNzE3ZGY3NDdkZDgzN2VkNDhjNDBhNTY2ZjlfMC0xLTEtMS0xNTYwNA_a314eb25-e489-4ec3-b980-c6c8b4c6267d">2,117</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83OS9mcmFnOjgxNjNjNDA5NjZlOTQxMTdhMzUxODA5ZTdhYWE0ZDRkL3RhYmxlOmMxMTA5ZjcxN2RmNzQ3ZGQ4MzdlZDQ4YzQwYTU2NmY5L3RhYmxlcmFuZ2U6YzExMDlmNzE3ZGY3NDdkZDgzN2VkNDhjNDBhNTY2ZjlfMS0xLTEtMS0xNTYwNA_96f14645-ef0e-4502-a6eb-fe22940175d3">2,519</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83OS9mcmFnOjgxNjNjNDA5NjZlOTQxMTdhMzUxODA5ZTdhYWE0ZDRkL3RhYmxlOmMxMTA5ZjcxN2RmNzQ3ZGQ4MzdlZDQ4YzQwYTU2NmY5L3RhYmxlcmFuZ2U6YzExMDlmNzE3ZGY3NDdkZDgzN2VkNDhjNDBhNTY2ZjlfMi0xLTEtMS0xNTYwNA_9ae4c2cb-8d84-46f0-aae0-766d371303b0">2,528</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83OS9mcmFnOjgxNjNjNDA5NjZlOTQxMTdhMzUxODA5ZTdhYWE0ZDRkL3RhYmxlOmMxMTA5ZjcxN2RmNzQ3ZGQ4MzdlZDQ4YzQwYTU2NmY5L3RhYmxlcmFuZ2U6YzExMDlmNzE3ZGY3NDdkZDgzN2VkNDhjNDBhNTY2ZjlfMy0xLTEtMS0xNTYwNA_9bd37341-47df-406c-b4b4-f82197ac6d3a">2,259</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83OS9mcmFnOjgxNjNjNDA5NjZlOTQxMTdhMzUxODA5ZTdhYWE0ZDRkL3RhYmxlOmMxMTA5ZjcxN2RmNzQ3ZGQ4MzdlZDQ4YzQwYTU2NmY5L3RhYmxlcmFuZ2U6YzExMDlmNzE3ZGY3NDdkZDgzN2VkNDhjNDBhNTY2ZjlfNC0xLTEtMS0xNTYwNA_975068ab-da9d-4c41-9fdd-9633ae1cfbe0">1,778</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83OS9mcmFnOjgxNjNjNDA5NjZlOTQxMTdhMzUxODA5ZTdhYWE0ZDRkL3RhYmxlOmMxMTA5ZjcxN2RmNzQ3ZGQ4MzdlZDQ4YzQwYTU2NmY5L3RhYmxlcmFuZ2U6YzExMDlmNzE3ZGY3NDdkZDgzN2VkNDhjNDBhNTY2ZjlfNS0xLTEtMS0xNTYwNA_20639b66-6bb8-43f8-a754-d779847f54b7">1,345</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83OS9mcmFnOjgxNjNjNDA5NjZlOTQxMTdhMzUxODA5ZTdhYWE0ZDRkL3RhYmxlOmMxMTA5ZjcxN2RmNzQ3ZGQ4MzdlZDQ4YzQwYTU2NmY5L3RhYmxlcmFuZ2U6YzExMDlmNzE3ZGY3NDdkZDgzN2VkNDhjNDBhNTY2ZjlfNi0xLTEtMS0xNTYwNA_bf61e3c6-7505-45c6-8f5b-49d39f476561">3,292</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83OS9mcmFnOjgxNjNjNDA5NjZlOTQxMTdhMzUxODA5ZTdhYWE0ZDRkL3RhYmxlOmMxMTA5ZjcxN2RmNzQ3ZGQ4MzdlZDQ4YzQwYTU2NmY5L3RhYmxlcmFuZ2U6YzExMDlmNzE3ZGY3NDdkZDgzN2VkNDhjNDBhNTY2ZjlfNy0xLTEtMS0xNTYwNA_e821892c-6164-454f-b732-4f2098b310cb">15,838</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83OS9mcmFnOjgxNjNjNDA5NjZlOTQxMTdhMzUxODA5ZTdhYWE0ZDRkL3RhYmxlOmMxMTA5ZjcxN2RmNzQ3ZGQ4MzdlZDQ4YzQwYTU2NmY5L3RhYmxlcmFuZ2U6YzExMDlmNzE3ZGY3NDdkZDgzN2VkNDhjNDBhNTY2ZjlfOC0xLTEtMS0xNTYwNA_487d32f1-ea1d-4244-9225-0b267cd84733">4,740</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83OS9mcmFnOjgxNjNjNDA5NjZlOTQxMTdhMzUxODA5ZTdhYWE0ZDRkL3RhYmxlOmMxMTA5ZjcxN2RmNzQ3ZGQ4MzdlZDQ4YzQwYTU2NmY5L3RhYmxlcmFuZ2U6YzExMDlmNzE3ZGY3NDdkZDgzN2VkNDhjNDBhNTY2ZjlfOS0xLTEtMS0xNTYwNA_e310bbc2-1bbd-41a5-a4e5-6fed0391c4f3">11,098</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83OS9mcmFnOjgxNjNjNDA5NjZlOTQxMTdhMzUxODA5ZTdhYWE0ZDRkL3RhYmxlOmMxMTA5ZjcxN2RmNzQ3ZGQ4MzdlZDQ4YzQwYTU2NmY5L3RhYmxlcmFuZ2U6YzExMDlmNzE3ZGY3NDdkZDgzN2VkNDhjNDBhNTY2ZjlfMTAtMS0xLTEtMTU2MDQ_245dc8ec-9b6d-47ac-beb7-87d0cc4a6081">1,590</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83OS9mcmFnOjgxNjNjNDA5NjZlOTQxMTdhMzUxODA5ZTdhYWE0ZDRkL3RhYmxlOmMxMTA5ZjcxN2RmNzQ3ZGQ4MzdlZDQ4YzQwYTU2NmY5L3RhYmxlcmFuZ2U6YzExMDlmNzE3ZGY3NDdkZDgzN2VkNDhjNDBhNTY2ZjlfMTEtMS0xLTEtMTU2MDQ_c7178307-480a-4926-9460-169c7a0d7b17">9,508</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83OS9mcmFnOjgxNjNjNDA5NjZlOTQxMTdhMzUxODA5ZTdhYWE0ZDRkL3RhYmxlOmMxMTA5ZjcxN2RmNzQ3ZGQ4MzdlZDQ4YzQwYTU2NmY5L3RhYmxlcmFuZ2U6YzExMDlmNzE3ZGY3NDdkZDgzN2VkNDhjNDBhNTY2ZjlfMTItMS0xLTEtMTU2MDQ_5e8005c9-ae16-454a-8c2a-230be9243c99">11,098</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:continuation id="i5c898fd8c46d4f70988ed8b1d6ad3598"><div style="margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other information related to operating leases in continuing operations was as follows:</span></div><div style="margin-bottom:4pt;margin-top:17pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term (years)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1449114c17b04272b57978d40430259c_I20220331" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83OS9mcmFnOjgxNjNjNDA5NjZlOTQxMTdhMzUxODA5ZTdhYWE0ZDRkL3RhYmxlOmI1OWU0ODgwNTI4MjQ3OWZhYTVhOWFmNDUyMzUwNzc4L3RhYmxlcmFuZ2U6YjU5ZTQ4ODA1MjgyNDc5ZmFhNWE5YWY0NTIzNTA3NzhfMS0xLTEtMS0xNTYwNA_c24400cd-6b1c-4c38-b6a5-0bb93535e5cc">6.30</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83OS9mcmFnOjgxNjNjNDA5NjZlOTQxMTdhMzUxODA5ZTdhYWE0ZDRkL3RhYmxlOmI1OWU0ODgwNTI4MjQ3OWZhYTVhOWFmNDUyMzUwNzc4L3RhYmxlcmFuZ2U6YjU5ZTQ4ODA1MjgyNDc5ZmFhNWE5YWY0NTIzNTA3NzhfMS0zLTEtMS0xNTYwNA_16dd08b5-d031-4861-ae8b-58a4832b5ace">6.65</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1449114c17b04272b57978d40430259c_I20220331" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83OS9mcmFnOjgxNjNjNDA5NjZlOTQxMTdhMzUxODA5ZTdhYWE0ZDRkL3RhYmxlOmI1OWU0ODgwNTI4MjQ3OWZhYTVhOWFmNDUyMzUwNzc4L3RhYmxlcmFuZ2U6YjU5ZTQ4ODA1MjgyNDc5ZmFhNWE5YWY0NTIzNTA3NzhfMi0xLTEtMS0xNTYwNA_cb4dfda4-ecdf-4112-8194-c49c4b23ad62">10.99</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83OS9mcmFnOjgxNjNjNDA5NjZlOTQxMTdhMzUxODA5ZTdhYWE0ZDRkL3RhYmxlOmI1OWU0ODgwNTI4MjQ3OWZhYTVhOWFmNDUyMzUwNzc4L3RhYmxlcmFuZ2U6YjU5ZTQ4ODA1MjgyNDc5ZmFhNWE5YWY0NTIzNTA3NzhfMi0zLTEtMS0xNTYwNA_4ad26024-56d0-4053-8302-5ca2147b0589">10.99</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended&#160;<br/>&#160;March 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Supplemental disclosure of cash flow information</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for operating lease liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" decimals="-3" name="us-gaap:OperatingLeasePayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83OS9mcmFnOjgxNjNjNDA5NjZlOTQxMTdhMzUxODA5ZTdhYWE0ZDRkL3RhYmxlOjk4MjZlNDM4ODExNDRkYjc5NzE4NmM3OGM5M2VjNmJhL3RhYmxlcmFuZ2U6OTgyNmU0Mzg4MTE0NGRiNzk3MTg2Yzc4YzkzZWM2YmFfMy0xLTEtMS0xNTYwNA_797572cd-f9ad-45bb-b101-a7fa53f5c134">744</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83OS9mcmFnOjgxNjNjNDA5NjZlOTQxMTdhMzUxODA5ZTdhYWE0ZDRkL3RhYmxlOjk4MjZlNDM4ODExNDRkYjc5NzE4NmM3OGM5M2VjNmJhL3RhYmxlcmFuZ2U6OTgyNmU0Mzg4MTE0NGRiNzk3MTg2Yzc4YzkzZWM2YmFfMy0zLTEtMS0xNTYwNA_858829b3-cda2-4ad9-8c7c-6fabdd3db1c0">1,005</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets obtained in exchange for new lease liabilities (includes new leases or modifications of existing leases)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83OS9mcmFnOjgxNjNjNDA5NjZlOTQxMTdhMzUxODA5ZTdhYWE0ZDRkL3RhYmxlOjk4MjZlNDM4ODExNDRkYjc5NzE4NmM3OGM5M2VjNmJhL3RhYmxlcmFuZ2U6OTgyNmU0Mzg4MTE0NGRiNzk3MTg2Yzc4YzkzZWM2YmFfNC0xLTEtMS0xNTYwNA_2c977505-661d-42ab-80c9-b5b28678ea73">556</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83OS9mcmFnOjgxNjNjNDA5NjZlOTQxMTdhMzUxODA5ZTdhYWE0ZDRkL3RhYmxlOjk4MjZlNDM4ODExNDRkYjc5NzE4NmM3OGM5M2VjNmJhL3RhYmxlcmFuZ2U6OTgyNmU0Mzg4MTE0NGRiNzk3MTg2Yzc4YzkzZWM2YmFfNC0zLTEtMS0xNTYwNA_2ea2c078-c64b-4846-8dce-de7f501ab69a">55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div id="i7169a803a6aa44ea981603d220cab84f_82"></div><div style="margin-top:21pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">16. <ix:nonNumeric contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl84Mi9mcmFnOmJlNjkyYzJjZDI5NDQ4MGE4NmFmZjc2ZGM4ZTVkNWEyL3RleHRyZWdpb246YmU2OTJjMmNkMjk0NDgwYTg2YWZmNzZkYzhlNWQ1YTJfNzkyNw_eb6cef51-34e9-4e0b-b17a-14088951e70f" continuedAt="ia9c624aa59f1491ea7957d75b1ece38b" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><ix:continuation id="ia9c624aa59f1491ea7957d75b1ece38b" continuedAt="ib72694cf234c4353a7387200a1dc4a23"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingencies</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 1, 2020, Trans Ova settled <ix:nonFraction unitRef="claim" contextRef="i1e1e4f70ee384bbdbc72a4af43c0088e_D20201201-20201201" decimals="INF" name="us-gaap:LossContingencyClaimsSettledNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl84Mi9mcmFnOmJlNjkyYzJjZDI5NDQ4MGE4NmFmZjc2ZGM4ZTVkNWEyL3RleHRyZWdpb246YmU2OTJjMmNkMjk0NDgwYTg2YWZmNzZkYzhlNWQ1YTJfOTI_e6614b97-6a8f-4cf5-b25b-1fc36b39f31d">one</ix:nonFraction> of <ix:nonFraction unitRef="claim" contextRef="i4e403613e684438d80d697b08493e995_I20201130" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl84Mi9mcmFnOmJlNjkyYzJjZDI5NDQ4MGE4NmFmZjc2ZGM4ZTVkNWEyL3RleHRyZWdpb246YmU2OTJjMmNkMjk0NDgwYTg2YWZmNzZkYzhlNWQ1YTJfOTg_9b07f671-f900-43f2-9c22-96d27a145768">two</ix:nonFraction> patent infringement lawsuits brought by XY, LLC ("XY"). The lawsuit, originally filed in 2012, was tried and appealed between 2016 and 2020. On December 1, 2020, the parties reached a settlement resolving all remaining disputes. As part of that settlement, Trans Ova remitted to XY a settlement payment, which, in addition to all the other monies Trans Ova had previously paid XY, constituted full payment and satisfaction of the judgment, including pre-judgment interest, post-judgment interest, costs, and all past, current and future royalty obligations under the judgment. In exchange, XY released and forever discharged Trans Ova from all obligations arising out of the judgment.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_7">Table of </a></span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_7">Contents</a></span></div></div><ix:continuation id="ib72694cf234c4353a7387200a1dc4a23" continuedAt="ibd16360fe8f74618818a3f44067edc15"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">XY filed a second lawsuit in December 2016, alleging infringement of <ix:nonFraction unitRef="claim" contextRef="i531c6a806994442783b99222cf391d82_I20161231" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl84Mi9mcmFnOmJlNjkyYzJjZDI5NDQ4MGE4NmFmZjc2ZGM4ZTVkNWEyL3RleHRyZWdpb246YmU2OTJjMmNkMjk0NDgwYTg2YWZmNzZkYzhlNWQ1YTJfMzI5ODUzNDkxMTIyMw_a1923fac-f6b4-403d-acc7-50735693a5d1">seven</ix:nonFraction> additional patents. Two of those patents were later invalidated in different proceedings and dismissed from the lawsuit. A third patent was settled out of the case in April 2022. There are thus currently <ix:nonFraction unitRef="patent" contextRef="i92eb050585b540e3800cec27efae3099_I20220331" decimals="INF" name="pgen:LossContingencyNumberOfPatentsAtIssue" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl84Mi9mcmFnOmJlNjkyYzJjZDI5NDQ4MGE4NmFmZjc2ZGM4ZTVkNWEyL3RleHRyZWdpb246YmU2OTJjMmNkMjk0NDgwYTg2YWZmNzZkYzhlNWQ1YTJfMzg0ODI5MDcxNjg0NA_1ef64dad-a491-40e9-b256-943b48e088e3">four</ix:nonFraction> patents remaining in the case. Of these, one patent expired on May 9, 2021, and another expires on May 21, 2022. As for the last two patents, Trans Ova has stopped practicing the technologies claimed therein. The Company expects a trial to occur sometime in 2023. While Trans Ova is confident in its claims and defenses, litigation is uncertain and there is a possibility that the Trans Ova is found liable and ordered to pay damages for past infringement. In the interim, Trans Ova shall continue to operate its business otherwise unaffected by the litigation.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2020, the Company reached a final settlement with the Securities and Exchange Commission ("SEC") with respect to an investigation concerning the Company's disclosures regarding its MBP program in the first three quarters of 2017. Under the terms of the settlement, the Company, without admitting or denying the allegations of the SEC, consented to the entry of an administrative order requiring that the Company: (i) cease and desist from committing or causing any violations and future violations under Section 13(a) of the Securities Exchange Act of 1934, as amended, and Rules 13a-11 and 12b-20 promulgated thereunder; and (ii) pay a $<ix:nonFraction unitRef="usd" contextRef="i6c06e66e33bb485785e90d05f2a08b59_D20200901-20200930" decimals="-3" name="us-gaap:PaymentsForLegalSettlements" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl84Mi9mcmFnOmJlNjkyYzJjZDI5NDQ4MGE4NmFmZjc2ZGM4ZTVkNWEyL3RleHRyZWdpb246YmU2OTJjMmNkMjk0NDgwYTg2YWZmNzZkYzhlNWQ1YTJfMjIxNA_a4df1675-3bb0-414a-b781-f66e18fc49b3">2,500</ix:nonFraction> civil money penalty to the SEC (which was paid in September 2020).</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, several shareholder class action lawsuits were filed in the United States District Court for the Northern District of California on behalf of certain purchasers of the Company's common stock. The complaints name as defendants the Company and certain of its current and former officers. The plaintiffs' claims track the allegations in the SEC's administrative order described above but challenge disclosures about the MBP program through September 2020, i.e., the date of the SEC administrative order. The plaintiffs seek compensatory damages, interest, and an award of reasonable attorneys' fees and costs. In April 2021, the court granted an order consolidating the claims and appointed a lead plaintiff and lead counsel in the case, captioned </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Abailla v. Precigen, Inc., F/K/A Intrexon Corp., et al</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In May 2021, the lead plaintiff filed an amended complaint. The defendants moved to dismiss that complaint. In September 2021, the court issued an order mooting the defendants' motion to dismiss in light of the lead plaintiff's stated intent to file a second amended complaint in response to the motion to dismiss. On September 27, 2021, the lead plaintiff filed a second amended complaint. On April 7, 2022, at a hearing on the Company&#8217;s motion, the Court indicated that the second amended complaint would be dismissed with leave to amend. Plaintiffs&#8217; counsel indicated a new complaint would be filed. The defendants intend to move to dismiss that complaint.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2020, a derivative shareholder action, captioned </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Edward D. Wright, derivatively on behalf of Precigen, Inc. F/K/A Intrexon Corp. v. Alvarez et al</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, was filed in the Circuit Court for Fairfax County in Virginia on behalf of Precigen, Inc. asserting similar claims under state law against Precigen's current directors and certain officers. The plaintiff seeks damages, forfeiture of benefits received by defendants, and an award of reasonable attorneys' fees and costs. The case was stayed by an order entered on June 14, 2021. On September 24, 2021, an individual shareholder filed a lawsuit in the Circuit Court for Henrico County styled </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Kent v. Precigen, Inc.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Case CL21-6349. The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Kent</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> action demands inspection of certain books and records of the Company pursuant to Virginia statutory and common law. On April 1, 2022, the court denied the demurrer and referred the matter to a hearing on the merits. The Company is evaluating how best to proceed.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company intends to defend the lawsuits vigorously; however, there can be no assurances regarding the ultimate outcome of these lawsuits.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has previously entered into strategic collaborations, including ECCs and JVs, to fund and develop products enabled by its technologies. These relationships involve complex interests, and the Company's interests may diverge with those of its collaborators, which can occur as a result of operations under those collaborations, business or technological developments, or as the Company transitions away from, or terminates, certain strategic collaborations. The Company has had, and has, disagreements and disputes with certain collaborators and JV partners, including the IEP Investors and the IEPII Investors. While the Company believes it is entitled to payment for work performed per its collaborations and JVs, consistent with its policy for accounting for accounts receivable, in 2019, the Company has fully reserved the amount of any disputed accounts receivable that remained outstanding. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 29, 2021, the Company received a letter from a group of investors in each of Intrexon Energy Partners and Intrexon Energy Partners II, purporting to refer certain issues to arbitration pursuant to the arbitration provisions of the Amended and Restated Limited Liability Company Agreements of Intrexon Energy Partners and Intrexon Energy Partners II (the &#8220;Arbitration Matters&#8221;). On January 25, 2022, the Company filed a petition in the Court of Chancery for the State of Delaware seeking to enjoin the arbitration proceeding. In March 2022, the Court of Chancery for the State of Delaware determined that arbitration should proceed. The structure of the arbitration requires each party to propose terms for resolution of each matter and the arbitration panel will be required to award one of the two proposals for each matter without compromise. The Company has proposed terms that the Company would acquire the membership interests of the IEP Investors in exchange of $<ix:nonFraction unitRef="usd" contextRef="i95a19f694d074542bcb9b8a97cf37bd8_D20220301-20220331" decimals="-3" name="pgen:ProposedPaymentsForMembershipInterests" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl84Mi9mcmFnOmJlNjkyYzJjZDI5NDQ4MGE4NmFmZjc2ZGM4ZTVkNWEyL3RleHRyZWdpb246YmU2OTJjMmNkMjk0NDgwYTg2YWZmNzZkYzhlNWQ1YTJfMzg0ODI5MDczMDU0MA_0d4f2980-4836-4835-80f3-18045d02db7b">5,000</ix:nonFraction>, and the membership interests of the IEPII Investors in exchange of $<ix:nonFraction unitRef="usd" contextRef="i6ae0faf7e643440fae62e6c31bc0d0b0_D20220301-20220331" decimals="-3" name="pgen:ProposedPaymentsForMembershipInterests" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl84Mi9mcmFnOmJlNjkyYzJjZDI5NDQ4MGE4NmFmZjc2ZGM4ZTVkNWEyL3RleHRyZWdpb246YmU2OTJjMmNkMjk0NDgwYTg2YWZmNzZkYzhlNWQ1YTJfMzg0ODI5MDczMDU2Nw_44b514ce-c45a-46bb-8733-319f00122220">2,000</ix:nonFraction>.  The investor group has proposed terms that the Company would acquire the membership interests of each individual investor in exchange of $<ix:nonFraction unitRef="usd" contextRef="i23eaa581e78f4aea9ecce173012954db_D20220301-20220331" decimals="-3" name="pgen:ProposedPaymentsForMembershipInterests" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl84Mi9mcmFnOmJlNjkyYzJjZDI5NDQ4MGE4NmFmZjc2ZGM4ZTVkNWEyL3RleHRyZWdpb246YmU2OTJjMmNkMjk0NDgwYTg2YWZmNzZkYzhlNWQ1YTJfMzg0ODI5MDczMDU3MA_bcea20fd-bbf7-444d-9fe7-ec1e92f980a1">34,000</ix:nonFraction> for the membership interests of the IEP Investors and $<ix:nonFraction unitRef="usd" contextRef="ic7d0ad563c924cf39cfee9ad185abd2d_D20220301-20220331" decimals="-3" name="pgen:ProposedPaymentsForMembershipInterests" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl84Mi9mcmFnOmJlNjkyYzJjZDI5NDQ4MGE4NmFmZjc2ZGM4ZTVkNWEyL3RleHRyZWdpb246YmU2OTJjMmNkMjk0NDgwYTg2YWZmNzZkYzhlNWQ1YTJfMzg0ODI5MDczMDU4OQ_c927ba00-0259-4839-82cf-f905c55ffa71">12,000</ix:nonFraction> for the membership interests of the IEPII Investors, representing the purchase price of their original investments, as well as, in addition, accrued interest from the date of their original investments, which approximates $<ix:nonFraction unitRef="usd" contextRef="i87cc2f18c9f0471f8bc8ab42417029c1_I20220331" decimals="-3" name="us-gaap:InterestReceivable" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl84Mi9mcmFnOmJlNjkyYzJjZDI5NDQ4MGE4NmFmZjc2ZGM4ZTVkNWEyL3RleHRyZWdpb246YmU2OTJjMmNkMjk0NDgwYTg2YWZmNzZkYzhlNWQ1YTJfMzg0ODI5MDczMDYwMw_16d9a65a-b92b-4f0d-bce9-f121c0edc56d">18,000</ix:nonFraction> for the IEP Investors and $<ix:nonFraction unitRef="usd" contextRef="i823414b73a894b4b82ccc11ca83d746e_I20220331" decimals="-3" name="us-gaap:InterestReceivable" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl84Mi9mcmFnOmJlNjkyYzJjZDI5NDQ4MGE4NmFmZjc2ZGM4ZTVkNWEyL3RleHRyZWdpb246YmU2OTJjMmNkMjk0NDgwYTg2YWZmNzZkYzhlNWQ1YTJfMzg0ODI5MDczMDYwNg_0fdf9c00-278d-4ced-abf0-7e92dc95a70a">6,000</ix:nonFraction> for the IEPII Investors. The Company expects the arbitration will </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_7">Table of </a></span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_7">Contents</a></span></div></div><ix:continuation id="ibd16360fe8f74618818a3f44067edc15"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">be concluded in the second quarter of 2022</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the Company believes the investor groups&#8217; claims are without merit, there can be no assurance that the panel will award the Company&#8217;s proposal and will not award the investors&#8217; proposal with respect to either of the Arbitration Matters.  In addition, as disclosed in Note 5, as of March 31, 2022, the Company has a deferred revenue liability of $<ix:nonFraction unitRef="usd" contextRef="ie8e1602cebb942fe9f1248b8494a1a7d_I20220331" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl84Mi9mcmFnOmJlNjkyYzJjZDI5NDQ4MGE4NmFmZjc2ZGM4ZTVkNWEyL3RleHRyZWdpb246YmU2OTJjMmNkMjk0NDgwYTg2YWZmNzZkYzhlNWQ1YTJfMzg0ODI5MDczMDU1NA_150eb5cc-55cd-4a8b-8a9c-05ebe7d3da89">21,205</ix:nonFraction> related to consideration previously received from Intrexon Energy Partners and Intrexon Energy Partners II that will be re-evaluated upon conclusion of the Arbitration Matters.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Such disagreements and disputes result in management distraction and may result in further litigation, arbitration, unfavorable settlements, or concessions by the Company, or adverse regulatory action, any of which could harm the Company's business or operations.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the course of its business, the Company is involved in litigation or legal matters, including governmental investigations. Such matters are subject to many uncertainties and outcomes are not predictable with assurance. The Company accrues liabilities for such matters when it is probable that future expenditures will be made and such expenditures can be reasonably estimated. As of March&#160;31, 2022, the Company does not believe that any such matters, individually or in the aggregate, will have a material adverse effect on the Company's business, financial condition, results of operations, or cash flows.</span></div></ix:continuation><div id="i7169a803a6aa44ea981603d220cab84f_85"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">17. <ix:nonNumeric contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl84NS9mcmFnOjJkNTJjMjkyZDQxNDQwYWNhNTA2YmVhZjRlOTU2OTk1L3RleHRyZWdpb246MmQ1MmMyOTJkNDE0NDBhY2E1MDZiZWFmNGU5NTY5OTVfMjE2Nw_4bdd879d-9c74-4dd5-8bce-7836600e4892" continuedAt="ic21247272fab4ff396061943348a38f7" escape="true">Related Party Transactions</ix:nonNumeric></span></div><ix:continuation id="ic21247272fab4ff396061943348a38f7"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Third Security and Affiliates</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's Executive Chairman is also the Senior Managing Director and Chairman of Third Security and owns <ix:nonFraction unitRef="number" contextRef="ib9c7f0031bb24fe38f91d5540eda5855_I20220331" decimals="INF" name="pgen:RelatedPartyOwnershipInterest" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl84NS9mcmFnOjJkNTJjMjkyZDQxNDQwYWNhNTA2YmVhZjRlOTU2OTk1L3RleHRyZWdpb246MmQ1MmMyOTJkNDE0NDBhY2E1MDZiZWFmNGU5NTY5OTVfMTc2_738b8197-1f51-4c3d-8927-ad752996717f">100</ix:nonFraction>% of the equity interests of Third Security. The Company had an agreement with Third Security under which the Company reimbursed Third Security for certain tax-related services performed by Third Security as requested by the Company. The Company also reimburses Third Security for certain out-of-pocket expenses incurred on the Company's behalf. The agreement with Third Security expired on December 31, 2021. As the Company evaluates its alternatives, it continues to utilize these services on a limited basis under the terms of the original agreement. The total expenses incurred by the Company under these arrangements were $<ix:nonFraction unitRef="usd" contextRef="i65e674d88ff54f86a6d42d5a8329e35c_D20220101-20220331" decimals="-3" name="us-gaap:ProfessionalAndContractServicesExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl84NS9mcmFnOjJkNTJjMjkyZDQxNDQwYWNhNTA2YmVhZjRlOTU2OTk1L3RleHRyZWdpb246MmQ1MmMyOTJkNDE0NDBhY2E1MDZiZWFmNGU5NTY5OTVfNTk2_1bf6d4e3-c2b5-454b-a78c-d60938bc0b10">26</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i033c578bc61340d6be52ccd5a2c876ac_D20210101-20210331" decimals="-3" name="us-gaap:ProfessionalAndContractServicesExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl84NS9mcmFnOjJkNTJjMjkyZDQxNDQwYWNhNTA2YmVhZjRlOTU2OTk1L3RleHRyZWdpb246MmQ1MmMyOTJkNDE0NDBhY2E1MDZiZWFmNGU5NTY5OTVfNjAz_a4e7ddd0-61ff-4dba-b462-1d7e5611809d">41</ix:nonFraction> for the three months ended March 31, 2022 and 2021, respectively.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See also Note 14 regarding compensation arrangements between the Company and its Executive Chairman.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through November 2021, the Company also subleased certain administrative offices to Third Security. The significant terms of the lease mirrored the terms of the Company's lease with the landlord, and the Company recorded sublease income of $<ix:nonFraction unitRef="usd" contextRef="i033c578bc61340d6be52ccd5a2c876ac_D20210101-20210331" decimals="-3" name="us-gaap:SubleaseIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl84NS9mcmFnOjJkNTJjMjkyZDQxNDQwYWNhNTA2YmVhZjRlOTU2OTk1L3RleHRyZWdpb246MmQ1MmMyOTJkNDE0NDBhY2E1MDZiZWFmNGU5NTY5OTVfMTAwOQ_032e4763-0290-4039-90ad-a3b5e5bcdd22">20</ix:nonFraction> for the three months ended March 31, 2021.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Notes 1, 3, and 13 regarding additional transactions with affiliates of Third Security.</span></div></ix:continuation><div id="i7169a803a6aa44ea981603d220cab84f_91"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18. <ix:nonNumeric contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RleHRyZWdpb246MDg2Y2EwY2I3NTUxNGNkN2JhZmRhN2VhMjUwMDVmZDhfMzA5OA_69a64268-cb64-48c3-b734-3acac639d628" continuedAt="id671109c31674cfa92c25e0cf7ba56d3" escape="true">Segments</ix:nonNumeric></span></div><ix:continuation id="id671109c31674cfa92c25e0cf7ba56d3" continuedAt="ie328c9e1a69f422a8f2b1543a9e35ceb"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's CODM assesses the operating performance of and allocates resources for several operating segments using Segment Adjusted EBITDA as a basis. Management believes this financial metric is a key indicator of operating results since it excludes noncash revenues and expenses that are not reflective of the underlying business performance of an individual enterprise.&#160;The Company defines Segment Adjusted EBITDA as net income (loss) before (i) interest expense, (ii) income tax expense or benefit, (iii) depreciation and amortization, (iv) stock-based compensation expense, (v) loss on settlement agreements where noncash consideration is paid, (vi) adjustments for accrued bonuses paid in equity awards, (vii) gain or loss on disposals of assets, (viii) loss on impairment of goodwill and other noncurrent assets, (ix) equity in net loss of affiliates, and (x) recognition of previously deferred revenue associated with upfront and milestone payments as well as cash outflows from capital expenditures and investments in affiliates, but includes proceeds from the sale of assets in the period sold. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because the Company uses Segment Adjusted EBITDA as its primary measure of segment performance, it has included this measure in its discussion of segment operating results.&#160;The Company has also disclosed revenues from external customers and intersegment revenues for each reportable segment.&#160;Corporate expenses are not allocated to the segments and are managed at a consolidated level.&#160;The CODM does not use total assets by segment to evaluate segment performance or allocate resources, and accordingly, these amounts are not required to be disclosed.&#160;The Company's segment presentation excludes amounts related to the operations of MBP Titan which are reported as discontinued operations (Note 3).</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March 31, 2022, the Company's reportable segments were (i) Biopharmaceuticals, (ii) Exemplar, and (iii) Trans Ova. These identified reportable segments met the quantitative thresholds to be reported separately for the three months ended March 31, 2022. See Note 2 for a description of Biopharmaceuticals. See Note 1 for a description of Exemplar and Trans Ova.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_7">Table of </a></span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_7">Contents</a></span></div></div><ix:continuation id="ie328c9e1a69f422a8f2b1543a9e35ceb" continuedAt="i2ad20fd40e46452aa394b310be061b4b"><ix:nonNumeric contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RleHRyZWdpb246MDg2Y2EwY2I3NTUxNGNkN2JhZmRhN2VhMjUwMDVmZDhfMzA5NQ_a53c0a31-c0c5-4d5b-a337-dc0f9686c11b" continuedAt="i37650560e28846e1a69d935e26292517" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment Adjusted EBITDA by reportable segment was as follows:</span></div><div style="margin-top:15pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.736%"><tr><td style="width:1.0%"></td><td style="width:69.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.251%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.571%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.254%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended&#160;<br/>&#160;March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biopharmaceuticals</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac54c563a6c7429ebca9d25950c5a88a_D20220101-20220331" decimals="-3" sign="-" name="pgen:NetIncomeLossAttributabletoParentAdjustedEBITDAIncludingCashPaidforCapitalExpendituresandInvestmentsinAffiliates" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmYxYTIxZTM1ZGRhNjQzMTJhYzM2OWYzZDJhNjM4ZTY2L3RhYmxlcmFuZ2U6ZjFhMjFlMzVkZGE2NDMxMmFjMzY5ZjNkMmE2MzhlNjZfMi0xLTEtMS0xNTYwNA_4aeda177-ac38-434a-b0fe-315cd327ed83">11,620</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i130e7434090749d3927853a57ecb1485_D20210101-20210331" decimals="-3" sign="-" name="pgen:NetIncomeLossAttributabletoParentAdjustedEBITDAIncludingCashPaidforCapitalExpendituresandInvestmentsinAffiliates" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmYxYTIxZTM1ZGRhNjQzMTJhYzM2OWYzZDJhNjM4ZTY2L3RhYmxlcmFuZ2U6ZjFhMjFlMzVkZGE2NDMxMmFjMzY5ZjNkMmE2MzhlNjZfMi0zLTEtMS0xNTYwNA_6c50c4e7-cc96-42d1-abbe-c603542c970d">8,854</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exemplar</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic90cdb87070e4510bfb77391109bd015_D20220101-20220331" decimals="-3" name="pgen:NetIncomeLossAttributabletoParentAdjustedEBITDAIncludingCashPaidforCapitalExpendituresandInvestmentsinAffiliates" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmYxYTIxZTM1ZGRhNjQzMTJhYzM2OWYzZDJhNjM4ZTY2L3RhYmxlcmFuZ2U6ZjFhMjFlMzVkZGE2NDMxMmFjMzY5ZjNkMmE2MzhlNjZfMy0xLTEtMS0xNTYwNA_a9e36ae4-2ba3-4df6-8b62-e7a340f1beff">3,558</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1379bdeed3124397a5045d15e0c107f8_D20210101-20210331" decimals="-3" name="pgen:NetIncomeLossAttributabletoParentAdjustedEBITDAIncludingCashPaidforCapitalExpendituresandInvestmentsinAffiliates" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmYxYTIxZTM1ZGRhNjQzMTJhYzM2OWYzZDJhNjM4ZTY2L3RhYmxlcmFuZ2U6ZjFhMjFlMzVkZGE2NDMxMmFjMzY5ZjNkMmE2MzhlNjZfMy0zLTEtMS0xNTYwNA_936331d7-5f48-4c9f-aea5-1e9a53b91fc6">1,806</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trans Ova</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie637642bb2524234aedb229fe66afbf3_D20220101-20220331" decimals="-3" name="pgen:NetIncomeLossAttributabletoParentAdjustedEBITDAIncludingCashPaidforCapitalExpendituresandInvestmentsinAffiliates" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmYxYTIxZTM1ZGRhNjQzMTJhYzM2OWYzZDJhNjM4ZTY2L3RhYmxlcmFuZ2U6ZjFhMjFlMzVkZGE2NDMxMmFjMzY5ZjNkMmE2MzhlNjZfNC0xLTEtMS0xNTYwNA_7a84f290-b234-4090-8dd8-c48ff465e10b">5,397</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida88d53a25ce48349d9f4162d6b088a5_D20210101-20210331" decimals="-3" name="pgen:NetIncomeLossAttributabletoParentAdjustedEBITDAIncludingCashPaidforCapitalExpendituresandInvestmentsinAffiliates" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmYxYTIxZTM1ZGRhNjQzMTJhYzM2OWYzZDJhNjM4ZTY2L3RhYmxlcmFuZ2U6ZjFhMjFlMzVkZGE2NDMxMmFjMzY5ZjNkMmE2MzhlNjZfNC0zLTEtMS0xNTYwNA_c49dcd51-9e4e-45c6-853b-78f9798e3fb2">6,421</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment Adjusted EBITDA for reportable segments</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" decimals="-3" sign="-" name="pgen:NetIncomeLossAttributabletoParentAdjustedEBITDAIncludingCashPaidforCapitalExpendituresandInvestmentsinAffiliates" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmYxYTIxZTM1ZGRhNjQzMTJhYzM2OWYzZDJhNjM4ZTY2L3RhYmxlcmFuZ2U6ZjFhMjFlMzVkZGE2NDMxMmFjMzY5ZjNkMmE2MzhlNjZfNS0xLTEtMS0xNTYwNA_52fdae20-54f5-4846-b650-c5565925f162">2,665</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331" decimals="-3" sign="-" name="pgen:NetIncomeLossAttributabletoParentAdjustedEBITDAIncludingCashPaidforCapitalExpendituresandInvestmentsinAffiliates" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmYxYTIxZTM1ZGRhNjQzMTJhYzM2OWYzZDJhNjM4ZTY2L3RhYmxlcmFuZ2U6ZjFhMjFlMzVkZGE2NDMxMmFjMzY5ZjNkMmE2MzhlNjZfNS0zLTEtMS0xNTYwNA_fcd5ec91-a7f6-4f85-851a-c018a4962129">627</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" name="us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RleHRyZWdpb246MDg2Y2EwY2I3NTUxNGNkN2JhZmRhN2VhMjUwMDVmZDhfMzA5Ng_85248f02-5928-4d93-848f-48a66b38e8d9" escape="true"><div style="margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below reconciles Segment Adjusted EBITDA for reportable segments to consolidated net loss from continuing operations before income taxes:</span></div><div style="margin-top:17pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.538%"><tr><td style="width:1.0%"></td><td style="width:70.561%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.698%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.541%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.700%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended&#160;<br/>&#160;March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment Adjusted EBITDA for reportable segments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia48b472a445a4200a8254bcce2227a72_D20220101-20220331" decimals="-3" sign="-" name="pgen:NetIncomeLossAttributabletoParentAdjustedEBITDAIncludingCashPaidforCapitalExpendituresandInvestmentsinAffiliates" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmY5OGNiOTNlMjQyNzQzOWM4NGYxMzlkYWYyYTg3NDUzL3RhYmxlcmFuZ2U6Zjk4Y2I5M2UyNDI3NDM5Yzg0ZjEzOWRhZjJhODc0NTNfMi0xLTEtMS0xNTYwNA_a2a91cd3-58b4-4999-9d63-652c0864fcc2">2,665</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e8ae689a8804c098cef0e54bd63c3ef_D20210101-20210331" decimals="-3" sign="-" name="pgen:NetIncomeLossAttributabletoParentAdjustedEBITDAIncludingCashPaidforCapitalExpendituresandInvestmentsinAffiliates" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmY5OGNiOTNlMjQyNzQzOWM4NGYxMzlkYWYyYTg3NDUzL3RhYmxlcmFuZ2U6Zjk4Y2I5M2UyNDI3NDM5Yzg0ZjEzOWRhZjJhODc0NTNfMi0zLTEtMS0xNTYwNA_11ee35b8-faf2-4d6d-ac92-655dfb0b6fb7">627</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remove cash paid for capital expenditures, net of proceeds from sale of assets, and cash paid for investments in affiliates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f12f7718c574755bd4056b0eb47020b_D20220101-20220331" decimals="-3" name="pgen:CapitalExpendituresNetOfProceedsFromSaleOfAssetsAndInvestmentsInAffiliates" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmY5OGNiOTNlMjQyNzQzOWM4NGYxMzlkYWYyYTg3NDUzL3RhYmxlcmFuZ2U6Zjk4Y2I5M2UyNDI3NDM5Yzg0ZjEzOWRhZjJhODc0NTNfNC0xLTEtMS0xNTYwNA_e3933cd1-7dca-45d6-bf40-790417d537c7">1,314</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d2c97b816ee436cb18d90482a754e10_D20210101-20210331" decimals="-3" name="pgen:CapitalExpendituresNetOfProceedsFromSaleOfAssetsAndInvestmentsInAffiliates" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmY5OGNiOTNlMjQyNzQzOWM4NGYxMzlkYWYyYTg3NDUzL3RhYmxlcmFuZ2U6Zjk4Y2I5M2UyNDI3NDM5Yzg0ZjEzOWRhZjJhODc0NTNfNC0zLTEtMS0xNTYwNA_62d8754a-fcce-4f97-b266-3de7c1a377d0">597</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add recognition of previously deferred revenue associated with upfront and milestone payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c2fe0628bc145c2966d9bc2ce259b60_D20220101-20220331" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmY5OGNiOTNlMjQyNzQzOWM4NGYxMzlkYWYyYTg3NDUzL3RhYmxlcmFuZ2U6Zjk4Y2I5M2UyNDI3NDM5Yzg0ZjEzOWRhZjJhODc0NTNfNS0xLTEtMS0xNTYwNA_0088fd34-2c49-421e-a0ae-ef45ffedc79e">1,446</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6841cb0561af477da53d5c395af9e6cc_D20210101-20210331" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmY5OGNiOTNlMjQyNzQzOWM4NGYxMzlkYWYyYTg3NDUzL3RhYmxlcmFuZ2U6Zjk4Y2I5M2UyNDI3NDM5Yzg0ZjEzOWRhZjJhODc0NTNfNS0zLTEtMS0xNTYwNA_521c407c-9c3d-4337-aec9-3b06639fa258">307</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i576c4b11dd9b44298653de992854ba4e_D20220101-20220331" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmY5OGNiOTNlMjQyNzQzOWM4NGYxMzlkYWYyYTg3NDUzL3RhYmxlcmFuZ2U6Zjk4Y2I5M2UyNDI3NDM5Yzg0ZjEzOWRhZjJhODc0NTNfNy0xLTEtMS0xNTYwNA_7d9df5f8-d8bd-42d0-b11f-9dc430a48a72">2,069</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i72f2477327d94768809a6aa578dd8221_D20210101-20210331" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmY5OGNiOTNlMjQyNzQzOWM4NGYxMzlkYWYyYTg3NDUzL3RhYmxlcmFuZ2U6Zjk4Y2I5M2UyNDI3NDM5Yzg0ZjEzOWRhZjJhODc0NTNfNy0zLTEtMS0xNTYwNA_4136c553-b4a8-493b-a6e0-55326976683c">4,539</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i576c4b11dd9b44298653de992854ba4e_D20220101-20220331" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmY5OGNiOTNlMjQyNzQzOWM4NGYxMzlkYWYyYTg3NDUzL3RhYmxlcmFuZ2U6Zjk4Y2I5M2UyNDI3NDM5Yzg0ZjEzOWRhZjJhODc0NTNfOC0xLTEtMS0xNTYwNA_3ac3b93c-8627-4f57-8c97-c04b34e25cf3">3,292</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i72f2477327d94768809a6aa578dd8221_D20210101-20210331" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmY5OGNiOTNlMjQyNzQzOWM4NGYxMzlkYWYyYTg3NDUzL3RhYmxlcmFuZ2U6Zjk4Y2I5M2UyNDI3NDM5Yzg0ZjEzOWRhZjJhODc0NTNfOC0zLTEtMS0xNTYwNA_a78e4498-af14-4c88-8825-c7dc8812dc0f">3,523</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on disposals of assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i576c4b11dd9b44298653de992854ba4e_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:GainLossOnDispositionOfAssets1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmY5OGNiOTNlMjQyNzQzOWM4NGYxMzlkYWYyYTg3NDUzL3RhYmxlcmFuZ2U6Zjk4Y2I5M2UyNDI3NDM5Yzg0ZjEzOWRhZjJhODc0NTNfOS0xLTEtMS0xNTYwNA_3b03952c-fd57-4701-8ad6-2c6c60897aa9">125</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i72f2477327d94768809a6aa578dd8221_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:GainLossOnDispositionOfAssets1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmY5OGNiOTNlMjQyNzQzOWM4NGYxMzlkYWYyYTg3NDUzL3RhYmxlcmFuZ2U6Zjk4Y2I5M2UyNDI3NDM5Yzg0ZjEzOWRhZjJhODc0NTNfOS0zLTEtMS0xNTYwNA_e0a9cfb8-a4a6-4bee-ab66-1bacc6c62ddb">121</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i576c4b11dd9b44298653de992854ba4e_D20220101-20220331" decimals="-3" name="us-gaap:AssetImpairmentCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmY5OGNiOTNlMjQyNzQzOWM4NGYxMzlkYWYyYTg3NDUzL3RhYmxlcmFuZ2U6Zjk4Y2I5M2UyNDI3NDM5Yzg0ZjEzOWRhZjJhODc0NTNfMTAtMS0xLTEtMTU2MDQ_4bb4f3ca-6bc4-4936-bac2-ca1f5c5ed59c">482</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72f2477327d94768809a6aa578dd8221_D20210101-20210331" decimals="-3" name="us-gaap:AssetImpairmentCharges" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmY5OGNiOTNlMjQyNzQzOWM4NGYxMzlkYWYyYTg3NDUzL3RhYmxlcmFuZ2U6Zjk4Y2I5M2UyNDI3NDM5Yzg0ZjEzOWRhZjJhODc0NTNfMTAtMy0xLTEtMTU2MDQ_16376ea5-2e31-4245-9647-060a1cde682a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i576c4b11dd9b44298653de992854ba4e_D20220101-20220331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmY5OGNiOTNlMjQyNzQzOWM4NGYxMzlkYWYyYTg3NDUzL3RhYmxlcmFuZ2U6Zjk4Y2I5M2UyNDI3NDM5Yzg0ZjEzOWRhZjJhODc0NTNfMTItMS0xLTEtMTU2MDQ_9f6bc394-1ffc-4383-a49c-377950039971">3,562</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i72f2477327d94768809a6aa578dd8221_D20210101-20210331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmY5OGNiOTNlMjQyNzQzOWM4NGYxMzlkYWYyYTg3NDUzL3RhYmxlcmFuZ2U6Zjk4Y2I5M2UyNDI3NDM5Yzg0ZjEzOWRhZjJhODc0NTNfMTItMy0xLTEtMTU2MDQ_3dfab2d6-0bbc-4127-8a53-9ab8cce18dda">5,415</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustment related to accrued bonuses paid in equity awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i576c4b11dd9b44298653de992854ba4e_D20220101-20220331" decimals="-3" name="pgen:AdjustmentForBonusesPaidInEquityAwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmY5OGNiOTNlMjQyNzQzOWM4NGYxMzlkYWYyYTg3NDUzL3RhYmxlcmFuZ2U6Zjk4Y2I5M2UyNDI3NDM5Yzg0ZjEzOWRhZjJhODc0NTNfMTMtMS0xLTEtMTU2MDQ_a61041d2-6dd1-43a9-9e48-c9cc4912be67">1,698</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72f2477327d94768809a6aa578dd8221_D20210101-20210331" decimals="-3" name="pgen:AdjustmentForBonusesPaidInEquityAwards" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmY5OGNiOTNlMjQyNzQzOWM4NGYxMzlkYWYyYTg3NDUzL3RhYmxlcmFuZ2U6Zjk4Y2I5M2UyNDI3NDM5Yzg0ZjEzOWRhZjJhODc0NTNfMTMtMy0xLTEtMTU2MDQ_a1dddffe-f524-4291-b71d-e13e4044f1fe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in net loss of affiliates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i576c4b11dd9b44298653de992854ba4e_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmY5OGNiOTNlMjQyNzQzOWM4NGYxMzlkYWYyYTg3NDUzL3RhYmxlcmFuZ2U6Zjk4Y2I5M2UyNDI3NDM5Yzg0ZjEzOWRhZjJhODc0NTNfMTQtMS0xLTEtMTU2MDQ_73b5bada-ab28-47a6-b325-f0f27928b09c">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i72f2477327d94768809a6aa578dd8221_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmY5OGNiOTNlMjQyNzQzOWM4NGYxMzlkYWYyYTg3NDUzL3RhYmxlcmFuZ2U6Zjk4Y2I5M2UyNDI3NDM5Yzg0ZjEzOWRhZjJhODc0NTNfMTQtMy0xLTEtMTU2MDQ_925efd00-8097-4936-8ba9-18136f0bdb90">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i576c4b11dd9b44298653de992854ba4e_D20220101-20220331" decimals="-3" name="us-gaap:OtherNoncashIncomeExpense" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmY5OGNiOTNlMjQyNzQzOWM4NGYxMzlkYWYyYTg3NDUzL3RhYmxlcmFuZ2U6Zjk4Y2I5M2UyNDI3NDM5Yzg0ZjEzOWRhZjJhODc0NTNfMTUtMS0xLTEtMTU2MDQ_a4470195-d4f2-44a4-a6f3-4a1c00830996">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i72f2477327d94768809a6aa578dd8221_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmY5OGNiOTNlMjQyNzQzOWM4NGYxMzlkYWYyYTg3NDUzL3RhYmxlcmFuZ2U6Zjk4Y2I5M2UyNDI3NDM5Yzg0ZjEzOWRhZjJhODc0NTNfMTUtMy0xLTEtMTU2MDQ_7e707853-5e2c-4e5c-9b10-1b6c1c3c485c">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unallocated corporate costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifa062aac5f0147e2a1dfff1ad00a491c_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmY5OGNiOTNlMjQyNzQzOWM4NGYxMzlkYWYyYTg3NDUzL3RhYmxlcmFuZ2U6Zjk4Y2I5M2UyNDI3NDM5Yzg0ZjEzOWRhZjJhODc0NTNfMTYtMS0xLTEtMTU2MDQ_44edbaa2-4e74-4a51-ba90-6b3d43c836cf">10,060</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64f363e45b3f4b5f871a0d7d9ea6ca4f_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmY5OGNiOTNlMjQyNzQzOWM4NGYxMzlkYWYyYTg3NDUzL3RhYmxlcmFuZ2U6Zjk4Y2I5M2UyNDI3NDM5Yzg0ZjEzOWRhZjJhODc0NTNfMTYtMy0xLTEtMTU2MDQ_5c995e66-ab80-4d7d-897b-dd4c91a562a4">8,194</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eliminations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6408cfb01bd44cebadc3b26397941b33_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmY5OGNiOTNlMjQyNzQzOWM4NGYxMzlkYWYyYTg3NDUzL3RhYmxlcmFuZ2U6Zjk4Y2I5M2UyNDI3NDM5Yzg0ZjEzOWRhZjJhODc0NTNfMTctMS0xLTEtMTU2MDQ_b0c200e7-1d0e-4a97-b5ef-d47f32878974">1,511</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icc375dc8cd7b45b48cfab364c5a82fa5_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmY5OGNiOTNlMjQyNzQzOWM4NGYxMzlkYWYyYTg3NDUzL3RhYmxlcmFuZ2U6Zjk4Y2I5M2UyNDI3NDM5Yzg0ZjEzOWRhZjJhODc0NTNfMTctMy0xLTEtMTU2MDQ_82c1a506-1c70-459f-a26b-10fb2cc96bc2">371</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated net loss from continuing operations before income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmY5OGNiOTNlMjQyNzQzOWM4NGYxMzlkYWYyYTg3NDUzL3RhYmxlcmFuZ2U6Zjk4Y2I5M2UyNDI3NDM5Yzg0ZjEzOWRhZjJhODc0NTNfMTgtMS0xLTEtMTU2MDQ_1d1f6a97-a0bc-4f6b-958f-2a2aa6116c45">19,309</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmY5OGNiOTNlMjQyNzQzOWM4NGYxMzlkYWYyYTg3NDUzL3RhYmxlcmFuZ2U6Zjk4Y2I5M2UyNDI3NDM5Yzg0ZjEzOWRhZjJhODc0NTNfMTgtMy0xLTEtMTU2MDQ_e8901185-d88b-4e19-aff1-00e9a502b9d6">21,896</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><ix:continuation id="i37650560e28846e1a69d935e26292517"><div style="margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues by reportable segment were as follows:</span></div><div style="margin-top:17pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.841%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Biopharmaceuticals</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exemplar</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Trans Ova</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b3c7721f0ef415c9513b33bb836c7ee_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmU5MmViYmMzYjQ0MzRiZjZiMTk5OGUwYjU3NDA1ZDc2L3RhYmxlcmFuZ2U6ZTkyZWJiYzNiNDQzNGJmNmIxOTk4ZTBiNTc0MDVkNzZfMi0xLTEtMS0xNTYwNA_f074554d-391c-480e-a4b6-53cab0841cfb">84</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ac6979a51bb4a92b3b04995d0432dbc_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmU5MmViYmMzYjQ0MzRiZjZiMTk5OGUwYjU3NDA1ZDc2L3RhYmxlcmFuZ2U6ZTkyZWJiYzNiNDQzNGJmNmIxOTk4ZTBiNTc0MDVkNzZfMi0zLTEtMS0xNTYwNA_be9b1c96-b885-4f70-ba7f-fe0d3d14d3ed">5,429</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8edc30ca4e6f4b8993b2065b289bfbd5_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmU5MmViYmMzYjQ0MzRiZjZiMTk5OGUwYjU3NDA1ZDc2L3RhYmxlcmFuZ2U6ZTkyZWJiYzNiNDQzNGJmNmIxOTk4ZTBiNTc0MDVkNzZfMi01LTEtMS0xNTYwNA_20631f6d-4cd2-45da-8fe0-5769aa8db430">26,508</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f12f7718c574755bd4056b0eb47020b_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmU5MmViYmMzYjQ0MzRiZjZiMTk5OGUwYjU3NDA1ZDc2L3RhYmxlcmFuZ2U6ZTkyZWJiYzNiNDQzNGJmNmIxOTk4ZTBiNTc0MDVkNzZfMi03LTEtMS0xNTYwNA_286b00e3-c9bc-433c-8941-687917cba5ff">32,021</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04211b6ebbd848dda476f17cf818169c_D20220101-20220331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmU5MmViYmMzYjQ0MzRiZjZiMTk5OGUwYjU3NDA1ZDc2L3RhYmxlcmFuZ2U6ZTkyZWJiYzNiNDQzNGJmNmIxOTk4ZTBiNTc0MDVkNzZfMy0xLTEtMS0xNTYwNA_ac9b07c0-f31a-43e2-b585-7131a2aee3c4">1,446</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2bd06ad475c4200a82ace0d4ad7872d_D20220101-20220331" decimals="-3" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmU5MmViYmMzYjQ0MzRiZjZiMTk5OGUwYjU3NDA1ZDc2L3RhYmxlcmFuZ2U6ZTkyZWJiYzNiNDQzNGJmNmIxOTk4ZTBiNTc0MDVkNzZfMy0zLTEtMS0xNTYwNA_d9dfd126-3fde-48cc-8305-eb00eace6766">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8790f324a3d408fb7149e93f1d33708_D20220101-20220331" decimals="-3" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmU5MmViYmMzYjQ0MzRiZjZiMTk5OGUwYjU3NDA1ZDc2L3RhYmxlcmFuZ2U6ZTkyZWJiYzNiNDQzNGJmNmIxOTk4ZTBiNTc0MDVkNzZfMy01LTEtMS0xNTYwNA_a295f395-c468-420a-bcfc-97e125251c2f">147</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6408cfb01bd44cebadc3b26397941b33_D20220101-20220331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmU5MmViYmMzYjQ0MzRiZjZiMTk5OGUwYjU3NDA1ZDc2L3RhYmxlcmFuZ2U6ZTkyZWJiYzNiNDQzNGJmNmIxOTk4ZTBiNTc0MDVkNzZfMy03LTEtMS0xNTYwNA_6edeeec8-111e-4aa8-81b3-d9b082473b8b">1,593</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b3c7721f0ef415c9513b33bb836c7ee_D20220101-20220331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmU5MmViYmMzYjQ0MzRiZjZiMTk5OGUwYjU3NDA1ZDc2L3RhYmxlcmFuZ2U6ZTkyZWJiYzNiNDQzNGJmNmIxOTk4ZTBiNTc0MDVkNzZfNC0xLTEtMS0xNTYwNA_0554e127-b1f6-478c-abc1-8e92c9eba828">1,530</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ac6979a51bb4a92b3b04995d0432dbc_D20220101-20220331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmU5MmViYmMzYjQ0MzRiZjZiMTk5OGUwYjU3NDA1ZDc2L3RhYmxlcmFuZ2U6ZTkyZWJiYzNiNDQzNGJmNmIxOTk4ZTBiNTc0MDVkNzZfNC0zLTEtMS0xNTYwNA_a99818b1-47e4-43b5-95e0-32d115102b16">5,429</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8edc30ca4e6f4b8993b2065b289bfbd5_D20220101-20220331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmU5MmViYmMzYjQ0MzRiZjZiMTk5OGUwYjU3NDA1ZDc2L3RhYmxlcmFuZ2U6ZTkyZWJiYzNiNDQzNGJmNmIxOTk4ZTBiNTc0MDVkNzZfNC01LTEtMS0xNTYwNA_26ecd6ab-6eaa-4baf-9170-d498ca16b707">26,655</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f12f7718c574755bd4056b0eb47020b_D20220101-20220331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmU5MmViYmMzYjQ0MzRiZjZiMTk5OGUwYjU3NDA1ZDc2L3RhYmxlcmFuZ2U6ZTkyZWJiYzNiNDQzNGJmNmIxOTk4ZTBiNTc0MDVkNzZfNC03LTEtMS0xNTYwNA_e4592262-7bf9-435c-a2ca-34ca1ca33efa">33,614</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.841%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Biopharmaceuticals</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exemplar</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Trans Ova</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9051a486c0e7466bac7d683d545e64a6_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOjYwZmQ2YjAzNzg5MDRlMjhhMDQ0OWM1ZmNmZmFiODIwL3RhYmxlcmFuZ2U6NjBmZDZiMDM3ODkwNGUyOGEwNDQ5YzVmY2ZmYWI4MjBfMi0xLTEtMS0xNTYwNA_f1aefe05-3337-4c08-9003-329452746cb5">178</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31eca9c164994ce3ad55697fdabbc18f_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOjYwZmQ2YjAzNzg5MDRlMjhhMDQ0OWM1ZmNmZmFiODIwL3RhYmxlcmFuZ2U6NjBmZDZiMDM3ODkwNGUyOGEwNDQ5YzVmY2ZmYWI4MjBfMi0zLTEtMS0xNTYwNA_20f3a6b0-33fe-4c84-9fac-9e093bae734e">3,257</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7aee8cbc73ec4aad80c7b5ec0d52e55c_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOjYwZmQ2YjAzNzg5MDRlMjhhMDQ0OWM1ZmNmZmFiODIwL3RhYmxlcmFuZ2U6NjBmZDZiMDM3ODkwNGUyOGEwNDQ5YzVmY2ZmYWI4MjBfMi01LTEtMS0xNTYwNA_7435484a-475b-4014-a790-e99f600ef996">21,076</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d2c97b816ee436cb18d90482a754e10_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOjYwZmQ2YjAzNzg5MDRlMjhhMDQ0OWM1ZmNmZmFiODIwL3RhYmxlcmFuZ2U6NjBmZDZiMDM3ODkwNGUyOGEwNDQ5YzVmY2ZmYWI4MjBfMi03LTEtMS0xNTYwNA_59494875-3af1-45f7-aeed-36c3c715067d">24,511</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13cba4a8d5c742ce8d33b04cbd96f97a_D20210101-20210331" decimals="-3" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOjYwZmQ2YjAzNzg5MDRlMjhhMDQ0OWM1ZmNmZmFiODIwL3RhYmxlcmFuZ2U6NjBmZDZiMDM3ODkwNGUyOGEwNDQ5YzVmY2ZmYWI4MjBfMy0xLTEtMS0xNTYwNA_588dc1cb-2c74-43b1-a5e7-1d1e13274c3a">241</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87b549534d7048538c9a43c0eba0ccc2_D20210101-20210331" decimals="-3" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOjYwZmQ2YjAzNzg5MDRlMjhhMDQ0OWM1ZmNmZmFiODIwL3RhYmxlcmFuZ2U6NjBmZDZiMDM3ODkwNGUyOGEwNDQ5YzVmY2ZmYWI4MjBfMy0zLTEtMS0xNTYwNA_a8013696-acd1-4bcb-8ea5-cc36e95c546e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cfc596ca5a04165b80a4b0e08e40e65_D20210101-20210331" decimals="-3" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOjYwZmQ2YjAzNzg5MDRlMjhhMDQ0OWM1ZmNmZmFiODIwL3RhYmxlcmFuZ2U6NjBmZDZiMDM3ODkwNGUyOGEwNDQ5YzVmY2ZmYWI4MjBfMy01LTEtMS0xNTYwNA_a3b266b0-7c28-4dea-b3a0-1b0e1b6869da">107</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc375dc8cd7b45b48cfab364c5a82fa5_D20210101-20210331" decimals="-3" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOjYwZmQ2YjAzNzg5MDRlMjhhMDQ0OWM1ZmNmZmFiODIwL3RhYmxlcmFuZ2U6NjBmZDZiMDM3ODkwNGUyOGEwNDQ5YzVmY2ZmYWI4MjBfMy03LTEtMS0xNTYwNA_6d6696ca-7a34-40bb-b504-12d32dea12e5">348</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9051a486c0e7466bac7d683d545e64a6_D20210101-20210331" decimals="-3" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOjYwZmQ2YjAzNzg5MDRlMjhhMDQ0OWM1ZmNmZmFiODIwL3RhYmxlcmFuZ2U6NjBmZDZiMDM3ODkwNGUyOGEwNDQ5YzVmY2ZmYWI4MjBfNC0xLTEtMS0xNTYwNA_75aa59cc-6e46-4cb1-afb9-d30ac2ec9059">419</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31eca9c164994ce3ad55697fdabbc18f_D20210101-20210331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOjYwZmQ2YjAzNzg5MDRlMjhhMDQ0OWM1ZmNmZmFiODIwL3RhYmxlcmFuZ2U6NjBmZDZiMDM3ODkwNGUyOGEwNDQ5YzVmY2ZmYWI4MjBfNC0zLTEtMS0xNTYwNA_7e040938-0af0-463f-be1d-3f3d4b815f0e">3,257</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7aee8cbc73ec4aad80c7b5ec0d52e55c_D20210101-20210331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOjYwZmQ2YjAzNzg5MDRlMjhhMDQ0OWM1ZmNmZmFiODIwL3RhYmxlcmFuZ2U6NjBmZDZiMDM3ODkwNGUyOGEwNDQ5YzVmY2ZmYWI4MjBfNC01LTEtMS0xNTYwNA_cd758d9c-7aaf-4f55-b804-72c932363bfc">21,183</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d2c97b816ee436cb18d90482a754e10_D20210101-20210331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOjYwZmQ2YjAzNzg5MDRlMjhhMDQ0OWM1ZmNmZmFiODIwL3RhYmxlcmFuZ2U6NjBmZDZiMDM3ODkwNGUyOGEwNDQ5YzVmY2ZmYWI4MjBfNC03LTEtMS0xNTYwNA_25263648-f69e-419d-b07b-7467661fc091">24,859</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_7">Table of </a></span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_7">Contents</a></span></div></div><div style="margin-top:17pt;text-align:center"><span><br/></span></div><ix:continuation id="i2ad20fd40e46452aa394b310be061b4b" continuedAt="i957ceafd959144d39d62713f7c4988f2"><ix:nonNumeric contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" name="us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RleHRyZWdpb246MDg2Y2EwY2I3NTUxNGNkN2JhZmRhN2VhMjUwMDVmZDhfMzA5Nw_36fc5704-483a-41f0-b449-336f40e3f731" escape="true"><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below reconciles total segment revenues from reportable segments to total consolidated revenues:</span></div><div style="margin-top:15pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.953%"><tr><td style="width:1.0%"></td><td style="width:70.392%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.780%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.546%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.782%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended&#160;<br/>&#160;March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues from reportable segments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia48b472a445a4200a8254bcce2227a72_D20220101-20220331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmJhZTBmMTA1YzgyZjQ0NjBhZWY4YTExYTc0MTM4MTNiL3RhYmxlcmFuZ2U6YmFlMGYxMDVjODJmNDQ2MGFlZjhhMTFhNzQxMzgxM2JfMi0xLTEtMS0xNTYwNA_83bd4301-050e-4de8-afcb-c2bce98306a7">33,614</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e8ae689a8804c098cef0e54bd63c3ef_D20210101-20210331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmJhZTBmMTA1YzgyZjQ0NjBhZWY4YTExYTc0MTM4MTNiL3RhYmxlcmFuZ2U6YmFlMGYxMDVjODJmNDQ2MGFlZjhhMTFhNzQxMzgxM2JfMi0zLTEtMS0xNTYwNA_c279c68c-26c5-4b31-aa8b-7c330e2e54e5">24,859</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Elimination of intersegment revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if3a5fe3120f24eb38dace9b8bfea5b2f_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmJhZTBmMTA1YzgyZjQ0NjBhZWY4YTExYTc0MTM4MTNiL3RhYmxlcmFuZ2U6YmFlMGYxMDVjODJmNDQ2MGFlZjhhMTFhNzQxMzgxM2JfNC0xLTEtMS0xNTYwNA_681ea202-edc8-4084-8d20-784a8e142a1c">1,593</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied5b0b30354b46978a4d414674afd3d4_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmJhZTBmMTA1YzgyZjQ0NjBhZWY4YTExYTc0MTM4MTNiL3RhYmxlcmFuZ2U6YmFlMGYxMDVjODJmNDQ2MGFlZjhhMTFhNzQxMzgxM2JfNC0zLTEtMS0xNTYwNA_a66ba46e-52ee-4cfb-85cc-19942c2d996a">348</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total consolidated revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmJhZTBmMTA1YzgyZjQ0NjBhZWY4YTExYTc0MTM4MTNiL3RhYmxlcmFuZ2U6YmFlMGYxMDVjODJmNDQ2MGFlZjhhMTFhNzQxMzgxM2JfNS0xLTEtMS0xNTYwNA_74917924-cf7e-47af-ac1b-bb60ef821a3a">32,021</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmJhZTBmMTA1YzgyZjQ0NjBhZWY4YTExYTc0MTM4MTNiL3RhYmxlcmFuZ2U6YmFlMGYxMDVjODJmNDQ2MGFlZjhhMTFhNzQxMzgxM2JfNS0zLTEtMS0xNTYwNA_f2ca2fb8-5d91-4cb6-86df-35486581c628">24,511</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">For the three months ended March 31, 2022 and 2021,<ix:nonFraction unitRef="number" contextRef="ic90cdb87070e4510bfb77391109bd015_D20220101-20220331" decimals="3" name="pgen:PercentageOfRevenueAttributableToCustomer" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RleHRyZWdpb246MDg2Y2EwY2I3NTUxNGNkN2JhZmRhN2VhMjUwMDVmZDhfMjE5OTAyMzI1OTc3Mg_c0438876-4387-4e94-b3c6-6f6b25025369">13.0</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i1379bdeed3124397a5045d15e0c107f8_D20210101-20210331" decimals="3" name="pgen:PercentageOfRevenueAttributableToCustomer" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RleHRyZWdpb246MDg2Y2EwY2I3NTUxNGNkN2JhZmRhN2VhMjUwMDVmZDhfMjE5OTAyMzI1OTc4MA_30cb3373-b6c1-45f3-ac44-36f8699e6152">8.4</ix:nonFraction>%, respectively, of total consolidated revenue was attributable to one customer in the Exemplar segment.</span></div></ix:continuation><div style="margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i957ceafd959144d39d62713f7c4988f2">As of March&#160;31, 2022 and December&#160;31, 2021, the Company had $<ix:nonFraction unitRef="usd" contextRef="idbeb7dcf502e424db307e185fd1e576a_I20220331" decimals="-3" name="pgen:LongLivedAssetsIncludingPropertyPlantandEquipmentandRightOfUseAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RleHRyZWdpb246MDg2Y2EwY2I3NTUxNGNkN2JhZmRhN2VhMjUwMDVmZDhfMjg2OQ_42434fa4-6b7d-4e19-baf7-2ee3b99368c1">4,148</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i46d345a1060047b6af3e5f2700f3127b_I20211231" decimals="-3" name="pgen:LongLivedAssetsIncludingPropertyPlantandEquipmentandRightOfUseAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RleHRyZWdpb246MDg2Y2EwY2I3NTUxNGNkN2JhZmRhN2VhMjUwMDVmZDhfMjg3Ng_cb2d6a78-cca9-47cd-a634-a21fce2f6e39">4,463</ix:nonFraction>, respectively, of long-lived assets in foreign countries. The Company recognized revenues derived in foreign countries totaling $<ix:nonFraction unitRef="usd" contextRef="idec0f08a8c3d49fc821a1cf2c9544f25_D20220101-20220331" decimals="-3" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RleHRyZWdpb246MDg2Y2EwY2I3NTUxNGNkN2JhZmRhN2VhMjUwMDVmZDhfMzAwNw_467a4e6e-072a-4cab-b306-953adde618ab">205</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="id6db753435f04670b618c70cb75e3463_D20210101-20210331" decimals="-3" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RleHRyZWdpb246MDg2Y2EwY2I3NTUxNGNkN2JhZmRhN2VhMjUwMDVmZDhfMzAxNA_71b8744d-48bb-41b1-9a55-fcab64e93dcd">99</ix:nonFraction> for the three months ended March 31, 2022 and 2021, respectively</ix:continuation>.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><div id="i7169a803a6aa44ea981603d220cab84f_94"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_7">Table of </a></span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_7">Contents</a></span></div></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;2. Management's Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The following "Management's Discussion and Analysis of Financial Condition and Results of Operations" should be read in conjunction with the unaudited financial information and the notes thereto included in this Quarterly Report on Form 10-Q, or Quarterly Report, and our Annual Report on Form 10-K for the year ended December&#160;31, 2021, or Annual Report.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The following discussion contains forward-looking statements that reflect our plans, estimates, expectations, and beliefs. Our actual results could differ materially from those discussed in the forward-looking statements and you are cautioned not to place undue reliance on forward-looking statements. Factors that could cause or contribute to these differences include those discussed below and elsewhere in this Quarterly Report, particularly in "Special Note Regarding Forward-Looking Statements" and "Risk Factors." The forward-looking statements included in this Quarterly Report are made only as of the date hereof.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We are a dedicated discovery and clinical-stage biopharmaceutical company advancing the next generation of gene and cell therapies with the overall goal of improving outcomes for patients with significant unmet medical needs. We are leveraging our proprietary technology platforms to develop product candidates designed to target urgent and intractable diseases in our core therapeutic areas of immuno-oncology, autoimmune disorders, and infectious diseases. We have developed an extensive pipeline of therapies across multiple indications within these core focus areas.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We believe that our array of technology platforms uniquely positions us among other biotechnology companies to advance precision medicine. Precision medicine is the practice of therapeutic product development that takes into account specific genetic variations within populations impacted by a disease to design targeted therapies to improve outcomes for a disease or patient population. Our proprietary and complementary technology platforms provide a strong foundation to realize the core promise of precision medicine by supporting our efforts to construct powerful gene programs to drive efficacy, deliver these programs through viral, non-viral, and microbe-based approaches to drive lower costs, and control gene expression to drive safety. Our therapeutic platforms, including UltraCAR-T, AdenoVerse immunotherapy, and ActoBiotics, are designed to allow us to precisely control the level and physiological location of gene expression and modify biological molecules to control the function and output of living cells to treat underlying disease conditions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We are actively advancing our lead clinical programs, including: PRGN-3005 and PRGN-3006, which are built on our UltraCAR-T platform; and PRGN-2009 and PRGN-2012, which are based on our AdenoVerse immunotherapy platform. In addition, we have completed a Phase 1b/2a study of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">AG019, which is built on our ActoBiotics platform. We also have a robust pipeline of preclinical programs that we are pursuing in order to drive long-term value creation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We have developed a proprietary electroporation device, UltraPorator, designed to further streamline and ensure the rapid and cost-effective manufacturing of UltraCAR-T therapies. UltraPorator has received </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">U.S. Food and Drug Administration, or </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">FDA, clearance for manufacturing UltraCAR-T cells in clinical trials, and since November 2020, we have been dosing patients with UltraCAR-T cells manufactured with UltraPorator in our PRGN-3005 and PRGN-3006 clinical trials.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We exercise discipline in our portfolio management by systematically evaluating data from our preclinical programs in order to make rapid "go" and "no go" decisions. Through this process, we believe we can more effectively allocate resources to programs that we believe show the most promise and advance such programs to clinical trials.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Healthcare Business</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our healthcare business focuses on human therapeutics and developing research models and services for healthcare research applications. Our Biopharmaceuticals segment includes our wholly owned subsidiaries PGEN Therapeutics, Inc., or PGEN Therapeutics, and Precigen ActoBio, Inc., or ActoBio, and our majority ownership interest in Triple-Gene LLC, doing business as Precigen Triple-Gene, or Triple-Gene, as well as royalty interests in therapeutics and therapeutic platforms from companies not controlled by us. Exemplar Genetics LLC, doing business as Precigen Exemplar, or Exemplar, is a wholly owned subsidiary which is focused on developing research models and services for healthcare research applications.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Biopharmaceuticals</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">PGEN Therapeutics</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PGEN Therapeutics is a dedicated discovery and clinical stage biopharmaceutical company advancing the next generation of gene and cell therapies using precision technology to target urgent and intractable diseases in immuno-oncology, autoimmune </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_7">Table of </a></span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_7">Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">disorders and infectious diseases. PGEN Therapeutics operates as an innovation engine, progressing a preclinical and clinical pipeline of well-differentiated therapies toward clinical proof-of-concept and commercialization.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">PGEN Therapeutics is developing therapies primarily built on our UltraCAR-T therapeutics platform and our "off-the-shelf" AdenoVerse immunotherapy platform. Through our UltraCAR-T therapeutics platform, we are able to precision-engineer UltraCAR-T cells to produce a homogeneous cell product that simultaneously expresses antigen-specific chimeric antigen receptor, or CAR, kill switch, and our proprietary membrane-bound interleukin-15, or mbIL15, genes in any genetically modified UltraCAR-T cell. Our decentralized and rapid proprietary manufacturing process allows us to manufacture UltraCAR-T cells overnight at a medical center's current good manufacturing practices facility, or cGMP, and reinfuse the patient the following day after gene transfer. This process improves upon current approaches to CAR-T manufacturing, which require extensive </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">ex vivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> expansion following viral vector transduction to achieve clinically relevant cell numbers that we believe can result in the exhaustion of CAR-T cells prior to their administration, limiting their potential for persistence in patients. We have developed a proprietary electroporation device, UltraPorator, designed to further streamline and ensure the rapid and cost-effective manufacturing of UltraCAR-T therapies. The UltraPorator system includes proprietary hardware and software solutions and potentially represents major advancements over current electroporation devices by significantly reducing the processing time and contamination risk. UltraPorator is intended to be a viable scale-up and commercialization solution for decentralized UltraCAR-T manufacturing. Our AdenoVerse immunotherapy platform utilizes a library of proprietary adenovectors for the efficient gene delivery of therapeutic effectors, immunomodulators, and vaccine antigens. We have established proprietary manufacturing cell lines and production methodologies from our AdenoVerse immunotherapy platform, which we believe are easily scalable for commercial supply. We believe that our proprietary gorilla adenovectors, part of the AdenoVerse technology, have superior performance characteristics as compared to current competition, including standard human adenovirus serotype 5, rare human adenovirus types and other non-human primate adenovirus types.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The most advanced programs within PGEN Therapeutics are as follows:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">PRGN-3005 is a first-in-class, investigational autologous CAR-T therapy that utilizes our UltraCAR-T platform to simultaneously express a CAR targeting the unshed portion of the Mucin 16 antigen, mbIL15, and kill switch genes. PRGN-3005 is currently being evaluated in a Phase 1/1b clinical trial for the treatment of advanced, recurrent platinum-resistant ovarian , fallopian tube, or primary peritoneal cancer. </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In January 2022, we announced the completion of enrollment in the dose escalation phase of both IP and IV arms without lymphodepletion in the ongoing Phase 1 clinical trial. We have received FDA clearance to incorporate lymphodepletion at Dose Level 3 of the IV arm.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">PRGN-3006 is a first-in-class, investigational autologous CAR-T therapy that utilizes our UltraCAR-T platform to express a CAR to target CD33 (Siglec-3), mbIL15 and a</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">kill switch gene. PRGN-3006 is currently being evaluated in a Phase 1/1b clinical trial for the treatment of relapsed or refractory, or r/r, acute myeloid leukemia, or AML, high-risk myelodysplastic syndromes, or MDS, and chronic myelomonocytic leukemia, or CMML. In January 2022, we announced the completion of enrollment in the dose escalation phase in both the non-lymphodepletion and the lymphodepletion cohorts of this Phase 1 trial. An expansion phase is planned at the MTD. On April 4, 2022, we announced that PRGN-3006 was granted Fast Track designation in patients with r/r AML by the FDA.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> Previously </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">PRGN-3006 was granted Orphan Drug Designation in patients with AML by the FDA. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">PRGN-3007 is a first-in-class, investigational autologous CAR-T therapy that utilizes the next generation UltraCAR-T platform to express a CAR to target ROR1, mbIL15, kill switch, and a novel mechanism for the intrinsic blockade of the programmed death 1, or PD-1, gene expression. PRGN-3007 has received FDA clearance to initiate a Phase 1/1b clinical trial for patients with advanced receptor tyrosine kinase-like orphan receptor 1-positive, or ROR1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">+</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, hematological (Arm 1) and solid tumors (Arm 2). The target patient population for Arm 1 includes relapsed or refractory CLL, relapsed or refractory MCL, relapsed or refractory B-ALL, and relapsed or refractory DLBCL. The target patient population for Arm 2 includes locally advanced unresectable or metastatic histologically confirmed TNBC. The study will enroll in two parts: an initial 3+3 dose escalation in each arm followed by a dose expansion at the maximum tolerated dose. Arm 1 and Arm 2 will enroll in parallel.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">PRGN-2009 is a first-in-class, "off-the-shelf" investigational immunotherapy designed to activate the immune system to recognize and target human papillomavirus-positive, or HPV+, solid tumors. PRGN-2009 leverages our UltraVector and AdenoVerse platforms to optimize HPV type 16 and HPV type 18, antigen design for delivery via a proprietary gorilla adenovector with a large genetic payload capacity and the ability for repeat administrations. PRGN-2009 is in a Phase 1/2 clinical trial as a monotherapy or in combination with bintrafusp alfa, or M7824, an investigational bifunctional fusion protein, for patients with HPV-associated cancers in collaboration with the National Cancer Institute, or NCI, pursuant to a cooperative research and development arrangement, or CRADA.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">PRGN-2012 is a first-in-class, investigational "off-the-shelf" AdenoVerse immunotherapy for the treatment of recurrent respiratory papillomatosis, or RRP. PRGN-2012 is an innovative therapeutic vaccine with optimized antigen design that uses our gorilla adenovector technology, part of our proprietary AdenoVerse platform, to elicit immune responses directed against </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_7">Table of </a></span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_7">Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">cells infected with HPV type 6 and HPV type 11. PRGN-2012 is in a Phase 1/2 clinical trial for adult patients with RRP. PRGN-2012 is being developed in collaboration with the Center for Cancer Research at the NCI pursuant to a CRADA. PRGN-2012</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">has been granted Orphan Drug designation for treatment of RRP by the FDA.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In addition to our clinical programs, PGEN Therapeutics has a robust pipeline of preclinical programs in our core therapeutic areas of immune-oncology, infectious diseases, and autoimmune disorders that we are pursuing in order to drive long-term value creation. Our pipeline includes a number of product candidates, including UltraCAR-T therapeutics for various cancers, and "off-the-shelf" AdenoVerse therapeutic platforms. We expect to continue development of various preclinical programs to identify product candidates for evaluation in clinical trials.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Precigen ActoBio, Inc.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">ActoBio is pioneering a proprietary class of microbe-based biopharmaceuticals that enable expression and local delivery of disease-modifying therapeutics. We refer to these microbe-based biopharmaceuticals as ActoBiotics. Our ActoBiotics platform is a unique delivery platform precisely tailored for specific disease modification with the potential for superior efficacy and safety. ActoBiotics combine the advantages of highly selective protein-based therapeutic agents with local delivery by the well-characterized and food-grade bacterium </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Lactococcus lactis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, or </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">L. lactis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. ActoBiotics can be delivered orally in a capsule, through an oral rinse, or in a topical solution. We believe ActoBiotics have the potential to provide superior safety and efficacy via the sustained release of appropriate quantities of select therapeutic agents as compared to injectable biologics, while reducing the side effects commonly attributed to systemic delivery and corresponding peaks in concentration.</span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">ActoBiotics work via genetically modified bacteria that deliver proteins and peptides at mucosal sites, rather than the insertion of one or more genes into a human cell by means of a virus or other delivery mechanism. By foregoing this insertion, ActoBiotics allow "gene therapy" without the need for cell transformation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">ActoBio's most advanced internal pipeline candidate, AG019, is a first-in-class disease modifying antigen-specific, investigational immunotherapy for the prevention, delay, or reversal of type 1 diabetes mellitus, or T1D. AG019 is an easy-to-take capsule formulation of ActoBiotics engineered to deliver the autoantigen human proinsulin, or hPINS, and the tolerance-enhancing cytokine human interleukin-10 to the mucosal lining of gastro-intestinal tissues in patients with T1D. We have completed a Phase 1b/2a clinical trial of AG019 for the treatment of early-onset T1D. The Phase 1b portion of the study evaluated the safety and tolerability of AG019 monotherapy administered as a single dose and repeated daily doses in adult and adolescent patients. The Phase 2a double-blind portion of the study investigated the safety and tolerability of AG019 in combination with teplizumab, or PRV-031. The primary endpoint of assessing safety and tolerability in both the Phase 1b AG019 monotherapy and the Phase 2a AG019 combination therapy has been met. AG019 was well-tolerated when administered to adults and adolescents either as monotherapy or in combination with teplizumab. A single 8-week treatment cycle of oral AG019 as a monotherapy and in combination with teplizumab showed stabilization or increase of C-peptide levels during the first 6 months post treatment initiation in recent-onset T1D. </span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Precigen Triple-Gene</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Triple-Gene is a clinical stage gene therapy company focused on developing advanced treatments for complex cardiovascular diseases. Triple-Gene's most advanced candidate, INXN-4001, a non-viral triple-effector plasmid based on our UltraVector platform designed for constitutive expression of human S100A1, SDF-1a, and VEGF-165. INXN-4001 is engineered to address multiple pathways of heart failure. Utilizing a single plasmid comprising all three genes, instead of each individual gene on separately delivered plasmids, INXN-4001 can control for delivery and ensure expression of the three genes in all transfected cells. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We have completed a first-in-human, open label Phase 1 study designed to evaluate the safety of retrograde coronary sinus infusion, or RCSI, of INXN-4001 in outpatient left ventricular assist device, or LVAD, recipients.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Phase 1 trial met the primary endpoints to evaluate safety and feasibility for INXN-4001. </span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Partnered Program</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We have partnered with Castle Creek Biosciences, Inc., or Castle Creek, to advance product candidates D-Fi (debcoemagene autoficel), formerly designated FCX-007, for the treatment of recessive dystrophic epidermolysis bullosa, or RDEB, and FCX-013 for the treatment of localized scleroderma. In October 2020, Castle Creek announced the dosing of the first patient in the ongoing Phase 3 trial of D-Fi and the dosing of the first patient in the ongoing Phase 1/2 trial of FCX-013. The FDA has granted Orphan Drug designation to D-Fi for the treatment of Dystrophic Epidermolysis Bullosa, which includes RDEB. In addition, D-Fi has been granted Rare Pediatric Disease designation, Fast Track designation, and Regenerative Medicine Advanced Therapy designation by the FDA for treatment of RDEB. The FDA has granted Orphan Drug designation to </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_7">Table of </a></span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_7">Contents</a></span></div></div><div><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">FCX-013 for the treatment of localized scleroderma. In addition, FCX-013 has been granted Rare Pediatric Disease designation and Fast Track designation for the treatment of moderate to severe localized scleroderma. Pursuant to the collaboration, we licensed our technology platforms to Castle Creek for use in certain specified fields, and in exchange, we received and were entitled to certain access fees, milestone payments, royalties, and sublicensing fees related to the development and commercialization of product candidates. In March 2020, we and Castle Creek terminated the original collaboration agreement by mutual agreement, with the parties agreeing that FCX-007 and FCX-013 would be treated as "Retained Products" under the terms of the original agreement. Castle Creek retains a license to continue to develop and commercialize the Retained Products within the field of use for so long as Castle Creek continues to pursue such development and commercialization, and we are also entitled to certain royalties with respect to the Retained Products. </span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Precigen Exemplar</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Exemplar is committed to enabling the study of life-threatening human diseases through the development of MiniSwine Yucatan miniature pig research models and services, as well as enabling the production of cells and organs in its genetically engineered swine for regenerative medicine applications. Historically, researchers have lacked animal models that faithfully represent human diseases. As a result, a sizeable barrier has blocked progress in the discovery of human disease mechanisms; novel diagnostics, procedures, devices, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">prevention</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> strategies and therapeutics; and the ability to predict in humans the efficacy of those next-generation procedures, devices, and therapeutics. Exemplar's MiniSwine models are genetically engineered to exhibit a wide variety of human disease states, which provides a more accurate platform to test the efficacy of new medications and devices.</span></div><div style="margin-top:18pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Non-Healthcare Business</span></div><div style="margin-top:12pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2022, our only non-healthcare business is our established bovine genetics company, Trans Ova Genetics, L.C., or Trans Ova.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trans Ova</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Trans Ova is internationally recognized as a provider of industry-leading bovine reproductive technologies. Trans Ova offers bovine embryo transfer technologies, in addition to other advanced reproductive technologies, including </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">in vitro</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> fertilization, or IVF, sexed-semen, genetic preservation, and cloning. Through extensive research programs and applied science, Trans Ova has developed and implemented new technologies that, we believe, have helped to move the science of bovine genetic improvement forward. We are evaluating strategic alternatives to determine the optimal means to utilize these technology assets and Trans Ova's broad customer base and deep industry knowledge to maximize the value of the business for our shareholders, including a potential sale of the business, the development of collaborations with third parties, and other strategic opportunities.</span></div><div style="margin-top:18pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">COVID-19 Impact</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">COVID-19 has had and continues to have an extensive impact on the global health and economic environments. </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, there is</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> uncertainty regarding the duration and severity of the ongoing pandemic, and we could experience delays of other pandemic-related events that may adversely impact our clinical as well as preclinical pipeline candidates in the future. </span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We are also closely monitoring the impact of COVID-19 on all aspects of our businesses. Given the dynamic nature of these circumstances, the full impact of the COVID-19 pandemic on our ongoing business, results of operations, and overall financial performance cannot be reasonably estimated at this time. </span></div><div><span><br/></span></div><div><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The health and safety of our employees is of the utmost importance. We have implemented safety measures in our facilities for the well-being of our employees and visitors. These measures have permitted us to continue to advance our programs, with the ultimate goal of benefiting patients.</span></div><div><span><br/></span></div><div><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">For more information regarding the risks associated with COVID-19 and its impact on our business, see "Risk Factors" in Part II - Item 1A.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_7">Table of </a></span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_7">Contents</a></span></div></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Discontinued Operations</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Historically, we developed technology platforms for application across a variety of diverse end markets, including health, food, energy, and the environment. In January 2020, we announced that we were increasing our focus on our healthcare opportunities, which reflected our most advanced platforms, and in connection therewith, we divested a number of our non-healthcare assets (referred to collectively as the Transactions) and changed our name to Precigen, Inc.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, as a result of market uncertainty driven by the COVID-19 pandemic and the state of the energy sector raising significant challenges for the strategic alternatives pursued by MBP Titan, LLC, or MBP Titan, our methane bioconversion business, we suspended MBP Titan's operations, preserved certain of MBP Titan's intellectual property, terminated all of its personnel, and undertook steps to dispose of its other assets and obligations. The wind down of MBP Titan's activities was substantially complete by December 31, 2020, with the final disposition of certain property and equipment and the facility operating lease occurring in January 2021. This discontinuation of operations represented the continuation of a strategic shift that we commenced in early 2020 to becoming a primarily healthcare company advancing technologies and products that address complex healthcare challenges. After the wind down of MBP Titan, certain assets and contractual obligations which were originally related to MBP Titan continue to be managed at the Precigen corporate level. These remaining assets and contractual obligations include our equity interests in and collaboration agreements with Intrexon Energy Partners, LLC, or Intrexon Energy Partners, and Intrexon Energy Partners II, LLC, or Intrexon Energy Partners II, including the associated deferred revenue remaining under each collaboration agreement, as well as the associated intellectual property.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See also "Notes to the Condensed Consolidated Financial Statements (Unaudited) - Note 3" appearing elsewhere in this Quarterly Report for additional discussion of our discontinued operations.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See "Notes to the Condensed Consolidated Financial Statements (Unaudited) - Note 4" appearing elsewhere in this Quarterly Report for a discussion of Intrexon Energy Partners and Intrexon Energy Partners II.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Segments</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, our reportable segments were (i) Biopharmaceuticals, (ii) Exemplar, and (iii) Trans Ova. These identified reportable segments met the quantitative thresholds to be reported separately for the three months ended March 31, 2022.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate expenses, which are not allocated to the segments and are managed at a consolidated level, include costs associated with general and administrative functions, including our finance, accounting, legal, human resources, information technology, corporate communication, and investor relations functions. Corporate expenses exclude interest expense, depreciation and amortization, gain or loss on disposals of assets, stock-based compensation expense, loss on settlement agreement, and equity in net loss of affiliates. See "Notes to the Condensed Consolidated Financial Statements (Unaudited) - Note 18" appearing elsewhere in this Quarterly Report for a discussion of our reportable segments and Segment Adjusted EBITDA. </span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial overview</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have incurred significant losses since our inception. We anticipate that we may continue to incur significant losses for the foreseeable future, and we may never achieve or maintain profitability. Our historical collaboration and licensing revenues were generated under a business model from which we have gradually transitioned, and we do not expect to expend significant resources servicing our historical collaborations in the future. We may enter into strategic transactions for individual platforms or programs in the future from which we may generate new collaboration and licensing revenues. We continue to generate product and service revenues through our Trans Ova and Exemplar subsidiaries, and in the three months ended March 31, 2022, both of these subsidiaries generated positive Segment Adjusted EBITDA. Products currently in our clinical pipeline will require regulatory approval and/or commercial scale-up before they may commence significant product sales and operating profits.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As we continue our efforts to focus our business and generate additional capital, we may be willing to enter into transactions involving one or more of our operating segments and reporting units for which we have goodwill and intangible assets. These efforts could result in us identifying impairment indicators or recording impairment charges in future periods. In addition, market changes and changes in judgements, assumptions, and estimates that we have made in assessing the fair value of goodwill could cause us to consider some portion or all of certain assets to become impaired.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_7">Table of </a></span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_7">Contents</a></span></div></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sources of revenue</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Historically, we have derived our collaboration and licensing revenues through agreements with counterparties for the development and commercialization of products enabled by our technologies. Generally, the terms of these collaborations provide that we receive some or all of the following: (i) technology access fees upon signing; (ii) reimbursements of costs incurred by us for our research and development and/or manufacturing efforts related to specific applications provided for in the collaboration; (iii) milestone payments upon the achievement of specified development, regulatory and commercial activities; and (iv) royalties on sales of products arising from the collaboration.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our technology access fees and milestone payments may be in the form of cash or securities of the collaborator. Our collaborations contain multiple arrangements, and we typically defer revenues from the technology access fees and milestone payments received and recognize such revenues in the future over the anticipated performance period. We are also entitled to sublicensing revenues in those situations where our collaborators choose to license our technologies to other parties.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As we continue to shift our focus on our healthcare business, we have and may continue to mutually terminate collaboration agreements or repurchase rights to the exclusive fields from collaborators, relieving us of any further performance obligations under the agreement. Upon such circumstances or when we determine no further performance obligations are required of us under an agreement, we may recognize any remaining deferred revenue as either collaboration revenue or as a reduction of operating expense, depending on the circumstances. See "Notes to the Condensed Consolidated Financial Statements (Unaudited) - Note 5" appearing elsewhere in the Quarterly Report for a discussion of changes to our significant collaborations.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generate product and service revenues primarily through sales of products or services that are created from technologies developed or owned by us. Our primary current revenues arise from Trans Ova and include sales of advanced reproductive technologies, including our bovine embryo transfer and IVF processes and from genetic preservation and sexed semen processes, and applications of such processes to other livestock, as well as sales of livestock and embryos produced using these processes and used in production. Exemplar also generates product and service revenues through the development and sale of genetically engineered miniature swine models. We recognize revenue when control of the promised product is transferred to the customer or when the promised service is completed.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In future periods, in connection with our focus on healthcare, our revenues will primarily depend on our ability to advance and create our own programs and the extent to which we bring products enabled by our technologies to market. Other than for collaboration revenues recognized upon cancellation or modification of an existing collaboration or for revenues generated pursuant to future strategic transactions for any of our existing platforms or programs, we expect our collaboration revenues will continue to decrease in the near term. Our revenues will also depend upon our ability to maintain or improve the volume and pricing of Trans Ova's and Exemplar's current product and service offerings and to develop and scale up production of new offerings from the various technologies of our subsidiaries. As we focus on our healthcare business, we anticipate that our expenses will increase substantially if, and as, we continue to advance the preclinical and clinical development of our existing product candidates and our research programs. We expect a significant period of time could pass before commercialization of our various product candidates or before the achievement of contractual milestones and the realization of royalties on product candidates commercialized under our collaborations and revenues sufficient to achieve profitability. Accordingly, there can be no assurance as to the timing, magnitude, and predictability of revenues to which we might be entitled.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of products and services</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of products and services includes primarily labor and related costs, drugs and supplies used primarily in Trans Ova's embryo transfer and IVF processes, livestock and feed used in production, and facility charges, including rent and depreciation. Fluctuations in the price of livestock and feed have not had a significant impact on our operating margins and no derivative financial instruments are used to mitigate the price risk.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and development expenses</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize research and development expenses as they are incurred. Our research and development expenses consist primarily of:</span></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">salaries and benefits, including stock-based compensation expense, for personnel in research and development functions;</span></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">fees paid to consultants and contract research organizations who perform research on our behalf and under our direction;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_7">Table of </a></span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_7">Contents</a></span></div></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">costs related to laboratory supplies used in our research and development efforts and acquiring, developing, and manufacturing preclinical study and clinical trial materials;</span></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">costs related to certain in-licensed technology rights or reacquired in-process research and development;</span></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">amortization of patents and related technologies acquired in mergers and acquisitions; and</span></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">facility-related expenses, which include direct depreciation costs and unallocated expenses for rent and maintenance of facilities and other operating costs.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our research and development expenses are generally incurred by our reportable segments and primarily relate to either costs incurred to expand or otherwise improve our technologies or the costs incurred to develop our own products and services. Our Biopharmaceuticals segment is progressing preclinical and clinical programs that target urgent and intractable diseases in our core therapeutic areas of immuno-oncology, autoimmune disorders, and infectious diseases, including PRGN-3005, PRGN-3006, PRGN-2009, PRGN-2012, and AG019. Exemplar's research and development activities relate to new and improved pig research models. Trans Ova's research and development activities support new and improved product and service offerings for its customers. The following table summarizes our research and development expenses incurred by reportable segment and reconciles those expenses to research and development expenses on the condensed consolidated statements of operations for the three months ended March 31, 2022 and 2021.</span></div><div style="margin-top:17pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.514%"><tr><td style="width:1.0%"></td><td style="width:70.264%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended&#160;<br/>&#160;March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biopharmaceuticals</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,718&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,063&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exemplar</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trans Ova</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">961&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">385&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total research and development expenses from reportable segments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,762&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,522&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eliminations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total consolidated research and development expenses</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,760&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,521&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount of research and development expenses may be impacted by, among other things, the number and nature of our own proprietary programs, and the number and size of programs we may support on behalf of collaboration agreements. We expect that our research and development expenses will increase as we continue to develop our own proprietary programs, including progression of these programs into preclinical and clinical stages. We believe these increases will likely include increased costs paid to consultants and contract research organizations and increased costs related to laboratory supplies.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses may also increase as a result of in-licensing of technologies or ongoing research and development operations that we might assume through mergers and acquisitions.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Selling, general and administrative expenses</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative, or SG&amp;A, expenses consist primarily of salaries and related costs, including stock-based compensation expense, for employees in executive, operational, finance, information technology, legal, and corporate communications functions. Other significant SG&amp;A expenses include rent and utilities, insurance, accounting, and legal services (including the cost of settling any claims and lawsuits), and expenses associated with obtaining and maintaining our intellectual property.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SG&amp;A expenses may fluctuate in the future depending on the scaling of our corporate functions required to support our corporate initiatives and the outcomes of legal claims and assessments against us.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other income (expense), net</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income consists of interest earned on our cash and cash equivalents and short-term and long-term investments and may fluctuate based on amounts invested and current interest rates.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_7">Table of </a></span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_7">Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense decreased in the current period, and is expected to decrease in future periods upon the adoption of a new accounting standard effective January 1, 2022, which simplified the accounting for the Convertible Notes. See "Notes to the Condensed Consolidated Financial Statements (Unaudited) - Note 2" appearing elsewhere in this Quarterly Report for further discussion.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity in net income (loss) of affiliates</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity in net income or loss of affiliates is our pro-rata share of our equity method investments' operating results, adjusted for accretion of basis difference. We account for investments in our JVs using the equity method of accounting since we have the ability to exercise significant influence, but not control, over the operating activities of these entities. </span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Segment performance</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use Segment Adjusted EBITDA as our primary measure of segment performance. We define Segment Adjusted EBITDA as net income (loss) before (i) interest expense, (ii) income tax expense or benefit, (iii) depreciation and amortization, (iv) stock-based compensation expense, (v) loss on settlement agreements where noncash consideration is paid, (vi) adjustments for accrued bonuses paid in equity awards, (vii) gain or loss on disposals of assets, (viii) loss on impairment of goodwill and other noncurrent assets, (ix) equity in net loss of affiliates, and (x) recognition of previously deferred revenue associated with upfront and milestone payments as well as cash outflows from capital expenditures and investments in affiliates, but includes proceeds from the sale of assets in the period sold. Corporate expenses are not allocated to the segments and are managed at a consolidated level. See "Notes to the Condensed Consolidated Financial Statements (Unaudited) - Note 18" appearing elsewhere in this Quarterly Report for further discussion of Segment Adjusted EBITDA.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_7">Table of </a></span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_7">Contents</a></span></div></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of operations</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Comparison of the three months ended March 31, 2022 and the three months ended March 31, 2021 </span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our results of operations for the three months ended March 31, 2022 and 2021, together with the changes in those items in dollars and as a percentage:</span></div><div style="margin-bottom:6pt;margin-top:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.321%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.501%"></td><td style="width:0.1%"></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended&#160;<br/>&#160;March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Dollar<br/>Change</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Percent<br/>Change</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Collaboration and licensing revenues</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,724&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,381&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,343&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,209&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,931&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,278&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,021&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,511&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,510&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,510&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,574&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,936&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,589&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,402&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,187&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,760&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,521&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,239&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,576&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,702&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">874&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment of goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">482&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">482&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,917&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,199&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,718&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating loss</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,896)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,688)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(208)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,412)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,205)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,793&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in net loss of affiliates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from continuing operations before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,309)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21,896)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,587&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from continuing operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,251)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21,844)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,593&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from discontinued operations, net of income taxes (1)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,526&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,526)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,251)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,318)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,933)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:13pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">See "Notes to the Condensed Consolidated Financial Statements (Unaudited) - Note 3" appearing elsewhere in this Quarterly Report.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Product revenues and gross margin</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product revenues increased $2.3 million, or 37%, over the three months ended March 31, 2021. The increase in product revenue was primarily due to higher customer demand for animals as a result of stronger beef and dairy industries in the current year. Gross margin on products improved in the current period as a result of the increased revenues and increased focus on selling higher margin products.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Service revenues and gross margin</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Service revenues increased $5.3 million, or 29%, over the three months ended March 31, 2021. Trans Ova's revenues improved primarily due to an increase in services performed as a result of higher customer demand as the beef and dairy industries have been stronger in the current year and a change in pricing structure with certain customers. Additionally, Exemplar's service revenues improved in the current period due to an increase in services performed resulting from a higher demand from existing and new customers as well as a combination of price increases and a change in the pricing structure with certain customers. Gross margin on services remained comparable to the prior year as increased revenues were offset by increased costs for supplies, drugs, and personnel costs.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_7">Table of </a></span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_7">Contents</a></span></div></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and development expenses</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses increased $2.2 million, or 21%, over the three months ended March 31, 2021. Contract research organization costs and lab supplies increased $1.6 million with the advancement of our clinical and preclinical programs.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Selling, general and administrative expenses</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SG&amp;A expenses increased $0.9 million, or 5%, over the three months ended March 31, 2021. Professional fees increased $1.6 million, primarily due to increased legal fees associated with certain litigation matters. This increase was partially offset with a decrease in salaries, benefits, and other personnel costs of $1.3 million primarily due to reduced stock compensation in 2022 and reduced head count.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Total other expense, net</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total other expense, net, is comprised primarily of interest expense associated with our Convertible Notes issued July 2018. The current period decrease is primarily due to the adoption of a new accounting standard effective January 1, 2022 noted above, which simplified the accounting for the Convertible Notes and reduced non-cash interest expense.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Segment performance</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes Segment Adjusted EBITDA, which is our primary measure of segment performance, for the three months ended March 31, 2022 and 2021, for each of our reportable segments as well as unallocated corporate costs.</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.321%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.501%"></td><td style="width:0.1%"></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended&#160;<br/>&#160;March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Dollar<br/>Change</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Percent<br/>Change</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment Adjusted EBITDA:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt;padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biopharmaceuticals</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,620)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,854)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,766)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exemplar</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,558&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,806&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,752&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trans Ova</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,397&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,421&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,024)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unallocated corporate costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,060)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,194)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,866)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a reconciliation of Segment Adjusted EBITDA to net loss from continuing operations before income taxes, see "Notes to the Condensed Consolidated Financial Statements (Unaudited) - Note 18" appearing elsewhere in this Quarterly Report.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes revenues from external customers for the three months ended March 31, 2022 and 2021, for each of our reportable segments.</span></div><div style="margin-bottom:6pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.321%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.501%"></td><td style="width:0.1%"></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended&#160;<br/>&#160;March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Dollar<br/>Change</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Percent<br/>Change</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biopharmaceuticals</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(94)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exemplar</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,429&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,257&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,172&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trans Ova</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,508&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,076&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,432&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:16pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Biopharmaceuticals</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment Adjusted EBITDA declined as we had increased costs associated with the advancement of our clinical and preclinical programs.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Exemplar</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues for Exemplar increased due to an increase in services performed resulting from a higher demand from existing and new customers. The improvement in Segment Adjusted EBITDA was primarily due to the increased revenues.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_7">Table of </a></span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_7">Contents</a></span></div></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trans Ova</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues for Trans Ova increased primarily due to (i) higher customer demand for pregnant cows, (ii) more procedures performed as a result of stronger beef and dairy industries in the current year, and (iii) a change in the pricing structure with certain customers. Segment Adjusted EBITDA declined due to (i) increased costs for supplies and drugs, (ii) increased costs for certain legal matters, and (iii) increased salaries, benefits, and other personnel costs.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Unallocated Corporate Costs</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unallocated corporate costs increased primarily due to increased professional fees including legal fees associated with certain litigation matters.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and capital resources</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sources of liquidity</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have incurred losses from operations since our inception, and as of March&#160;31, 2022, we had an accumulated deficit of $1.9 billion. From our inception through March&#160;31, 2022, we have funded our operations principally with proceeds received from private and public equity and debt offerings, cash received from our collaborators, and through product and service sales made directly to customers. As of March&#160;31, 2022, we had cash and cash equivalents of $40.3 million and short-term and long-term investments of $101.7 million. Cash in excess of immediate requirements is typically invested primarily in money market funds and U.S. government debt securities in order to maintain liquidity and preserve capital.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently generate cash receipts primarily from sales of products and services and from strategic transactions.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trans Ova is subject to certain restrictive covenants under its line of credit, which matured on April 1, 2022, which is discussed in "Notes to the Condensed Consolidated Financial Statements (Unaudited) - Note 11" appearing elsewhere in this Quarterly Report. As of March&#160;31, 2022, Trans Ova was in compliance with these debt covenants.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash flows</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the significant sources and uses of cash for the periods set forth below:</span></div><div style="margin-top:17pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended&#160;<br/>&#160;March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating activities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,783)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,384)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,568&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(129,102)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing activities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(163)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121,040&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash, cash equivalents, and restricted cash</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(230)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net decrease in cash, cash equivalents, and restricted cash</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,608)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,457)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:16pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash flows from operating activities:</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March 31, 2022, our net loss was $19.3 million, which includes the following significant noncash expenses totaling $7.5 million from continuing operations: (i) $3.6 million of stock-based compensation expense, (ii) $3.3 million of depreciation and amortization expense, and (iii) $0.6 million of shares issued as payment for services. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March 31, 2021, our net loss was $17.3 million, which includes the following significant noncash expenses totaling $12.3 million from both continuing and discontinued operations: (i)  $5.4 million of stock-based compensation expense, (ii) $3.5 million of depreciation and amortization expense, (iii) $2.8 million accretion of debt discount and amortization of deferred financing costs, and (iv) $0.6 million of shares issued as payment for services. These expenses were partially offset by a $4.6 million noncash gain recognized upon the termination of our MBP Titan facility lease in January 2021.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_7">Table of </a></span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_7">Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cash outflows from operations during the three months ended March 31, 2022 increased $2.4 million from the three months ended March 31, 2021 primarily due to increased costs associated with the advancement of our clinical and preclinical programs.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash flows from investing activities:</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March 31, 2022, we received $18.0 million of proceeds from maturities of investments.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March 31, 2021, we purchased $133.7 million of investments, net of maturities, primarily using the proceeds received from the underwritten public offering discussed below.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash flows from financing activities:</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March 31, 2022, we made payments of long-term debt of $0.2 million.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March 31, 2021, we received $121.0 million proceeds from the sale of our common stock in an underwritten public offering.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Future capital requirements</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe our existing liquid assets will enable us to fund our operating expenses and capital requirements for at least the next 12 months. Our future capital requirements will depend on many factors, including:</span></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">progress in our research and development programs, as well as the magnitude of these programs;</span></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any delays or potential delays to our clinical trials as a result of the COVID-19 pandemic;</span></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the timing of regulatory approval of our product candidates and those of our collaborations;</span></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the timing, receipt, and amount of any payments received in connection with strategic transactions;</span></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the timing, receipt, and amount of upfront, milestone, and other payments, if any, from present and future collaborators, if any;</span></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the timing, receipt, and amount of sales and royalties, if any, from our product candidates;</span></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the timing and capital requirements to scale up our various product candidates and service offerings and customer acceptance thereof;</span></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to maintain and establish additional collaborative arrangements and/or new strategic initiatives;</span></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the resources, time, and cost required for the preparation, filing, prosecution, maintenance, and enforcement of our intellectual property portfolio;</span></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">strategic mergers and acquisitions, if any, including both the upfront acquisition cost as well as the cost to integrate, maintain, and expand the strategic target;</span></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the costs associated with legal activities, including litigation, arising in the course of our business activities and our ability to prevail in any such legal disputes; and</span></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the effects, duration, and severity of the ongoing COVID-19 pandemic and the actions we have taken or may take in response, any of which could significantly impact our business, operations, and financial results.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Until such time, if ever, as we can regularly generate positive operating cash flows, we plan to finance our cash needs through a combination of equity offerings, debt financings, government, or other third-party funding, strategic alliances, sales of assets, and licensing arrangements. As the COVID-19 pandemic continues to negatively impact the economy, our future access to capital on favorable terms may be materially impacted. We may not be able to raise sufficient additional funds on terms that are favorable to us, if at all. To the extent that we raise additional capital through the sale of equity or convertible debt securities, </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_7">Table of </a></span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_7">Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the ownership interests of our common shareholders will be diluted, and the terms of these securities may include liquidation or other preferences that adversely affect the rights of our common shareholders. Our current stock price may make it more difficult to pursue equity financings and lead to substantial dilution if the price of our common stock does not increase. Debt financing, if available, may involve agreements that include covenants limiting or restricting our ability to take specific actions, such as incurring additional debt, making capital expenditures, or declaring dividends. If we raise additional funds through strategic transactions, collaborations, or licensing arrangements with third parties, we may have to relinquish valuable rights to our technologies, future revenue streams, research programs, or product candidates, or to grant licenses on terms that may not be favorable to us.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to a number of risks similar to those of other companies conducting high-risk, early-stage research and development of product candidates. Principal among these risks are dependence on key individuals and intellectual property, competition from other products and companies, and the technical risks associated with the successful research, development, and clinical manufacturing of its product candidates. Our success is dependent upon our ability to continue to raise additional capital in order to fund ongoing research and development, adequately satisfy or renegotiate long-term debt obligations, obtain regulatory approval of our products, successfully commercialize our products, generate revenue, meet our obligations, and, ultimately, attain profitable operations. Our ability to achieve what is necessary for our success may be negatively impacted by the uncertainty caused by the COVID-19 pandemic.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See the section entitled "Risk Factors" in our Annual Report for additional risks associated with our substantial capital requirements.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contractual obligations and commitments</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our significant contractual obligations and commitments from continuing operations as of March&#160;31, 2022 and the effects such obligations are expected to have on our liquidity and cash flows in future periods:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.993%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.503%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Less Than 1&#160;Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1 - 3 Years</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3 - 5 Years</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">More Than 5&#160;Years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,838&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,718&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,035&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,788&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,297&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible debt (1)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash interest payable on convertible debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, excluding convertible debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">355&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">752&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">814&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,184&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229,443&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,073&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209,287&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,602&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,481&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">See "Notes to the Condensed Consolidated Financial Statements (Unaudited) - Notes 11" appearing elsewhere in this Quarterly Report for further discussion of our convertible debt.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the obligations in the table above, as of March&#160;31, 2022 we also have the following significant contractual obligations described below.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In conjunction with the formation of our JVs, we committed to making future capital contributions subject to certain conditions and limitations. As of March&#160;31, 2022, our remaining capital contribution commitments to our JVs were $14.2 million. These future capital contributions are not included in the table above due to the uncertainty of the timing and amounts of such contributions.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are party to in-licensed research and development agreements with various academic and commercial institutions where we could be required to make future payments for annual maintenance fees as well as for milestones and royalties we might receive upon commercial sales of products that incorporate their technologies. These agreements are generally subject to termination by us and therefore no amounts are included in the tables above. As of March&#160;31, 2022, we also had research and development commitments with third parties totaling $22.7 million that had not yet been incurred.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_7">Table of </a></span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_7">Contents</a></span></div></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net operating losses</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, we had net operating loss carryforwards of approximately $861.0 million for U.S. federal income tax purposes available to offset future taxable income, including $609.0 million generated after 2017, U.S. capital loss carryforwards of $212.5 million, and U.S. federal and state research and development tax credits of approximately $11.3 million, prior to consideration of annual limitations that may be imposed under Section 382 of the Internal Revenue Code of 1986, as amended, or Section 382. Net operating loss carryforwards generated prior to 2018 have begun to expire in 2022, and capital loss carryforwards will expire if unutilized beginning in 2024. Our foreign subsidiaries included in continuing operations have foreign loss carryforwards of approximately $74.2 million, most of which do not expire. Excluding certain deferred tax liabilities totaling $2.4 million, our remaining net deferred tax assets, which primarily relate to these loss carryforwards, are offset by a valuation allowance due to our history of net losses.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of our past issuances of stock, as well as due to prior mergers and acquisitions, certain of our net operating losses have been subject to limitations pursuant to Section 382. As of March&#160;31, 2022, Precigen has utilized all net operating losses subject to Section 382 limitations, other than those losses inherited via acquisitions. As of March&#160;31, 2022, approximately $42.1 million of available domestic net operating losses were inherited via acquisitions and are limited based on the value of the target at the time of the transaction. Future changes in stock ownership may also trigger an ownership change and, consequently, a Section 382 limitation.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Off-balance sheet arrangements</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We did not have during the periods presented, and we do not currently have, any off-balance sheet arrangements as defined under SEC rules.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical accounting policies and estimates</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management's discussion and analysis of our financial condition and results of operations is based on our condensed consolidated financial statements, which we have prepared in accordance with generally accepted accounting principles in the United States. The preparation of these condensed consolidated financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported revenues and expenses during the reporting periods. We evaluate these estimates and judgments on an ongoing basis. We base our estimates on historical experience and on various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Our actual results may differ from these estimates under different assumptions or conditions.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no material changes to our critical accounting policies from those described in "Management's Discussion and Analysis of Financial Condition and Results of Operations" included in our Annual Report.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent accounting pronouncements</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For information with respect to recent accounting pronouncements and the impact of these pronouncements on our condensed consolidated financial statements, see "Notes to the Condensed Consolidated Financial Statements (Unaudited) - Note 2" appearing elsewhere in this Quarterly Report.</span></div><div id="i7169a803a6aa44ea981603d220cab84f_97"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;3. Quantitative and Qualitative Disclosures About Market Risk</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following sections provide quantitative information on our exposure to interest rate risk. We make use of sensitivity analyses that are inherently limited in estimating actual losses in fair value that can occur from changes in market conditions.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest rate risk</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had cash, cash equivalents and short-term and long-term investments of $142.1 million and $163.7 million as of March&#160;31, 2022 and December&#160;31, 2021, respectively. Our cash and cash equivalents and short-term and long-term investments consist of cash, money market funds, U.S. government debt securities, and certificates of deposit. The primary objectives of our investment activities are to preserve principal, maintain liquidity, and maximize income without significantly increasing risk. Our investments consist of U.S. government debt securities and certificates of deposit, which may be subject to market risk due to changes in prevailing interest rates that may cause the fair values of our investments to fluctuate. We believe that a </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">hypothetical 100 basis point increase in interest rates would not materially affect the fair value of our interest-sensitive financial instruments and any such losses would only be realized if we sold the investments prior to maturity.</span></div><div id="i7169a803a6aa44ea981603d220cab84f_100"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;4. Controls and Procedures</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to Rule 13a-15(b) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), we carried out an evaluation, under supervision and with the participation of our management, including our Chief Executive Officer ("CEO"), who is our principal executive officer, and our Chief Financial Officer ("CFO"), who is our principal financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as defined under Rule 13a-15(e) and 15d-15(e) under the Exchange Act) as of the end of the period covered by this report. Based upon that evaluation, as of the end of the period covered by this report, our CEO and CFO concluded that our disclosure controls and procedures are effective at the reasonable assurance level to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act, is recorded, processed, summarized and reported, within the time periods specified in the SEC's rules and forms, and that such information is accumulated and communicated to our management, including our CEO and CFO, as appropriate, to allow timely decisions regarding required disclosure.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There has been no change in our internal control over financial reporting during the three months ended March&#160;31, 2022, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><div id="i7169a803a6aa44ea981603d220cab84f_103"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7169a803a6aa44ea981603d220cab84f_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II. OTHER INFORMATION</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i7169a803a6aa44ea981603d220cab84f_106"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1. Legal Proceedings</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the course of our business, we are involved in litigation or legal matters, including governmental investigations. Such matters are subject to many uncertainties and outcomes are not predictable with assurance. We accrue liabilities for such matters when it is probable that future expenditures will be made and such expenditures can be reasonably estimated. As of March&#160;31, 2022, we do not believe that any such matters, individually or in the aggregate, will have a material adverse effect on our business, financial condition, results of operations, or cash flows.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See "Notes to the Condensed Consolidated Financial Statements (Unaudited) - Note 16" appearing elsewhere in this Quarterly Report for further discussion of ongoing legal matters.</span></div><div id="i7169a803a6aa44ea981603d220cab84f_109"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1A. Risk Factors</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As disclosed in "Summary of Risk Factors" and "Item 1A. Risk Factors" in our Annual Report, there are a number of risks and uncertainties that may have a material effect on the operating results of our business and our financial condition. There are no additional material updates or changes to our risk factors since the filing of our Annual Report.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In evaluating our risks, readers also should carefully consider the risk factors discussed in our Annual Report, which could materially affect our business, financial condition, or operating results, in addition to the other information set forth in this report and in our other filings with the SEC.</span></div><div id="i7169a803a6aa44ea981603d220cab84f_112"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;2. Unregistered Sales of Equity Securities and Use of Proceeds</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i7169a803a6aa44ea981603d220cab84f_115"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;3. Defaults on Senior Securities</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i7169a803a6aa44ea981603d220cab84f_118"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;4. Mine Safety Disclosures</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="i7169a803a6aa44ea981603d220cab84f_121"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;5. Other Information</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><div id="i7169a803a6aa44ea981603d220cab84f_124"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;6. Exhibits</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.959%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit<br/>No.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="pgen-20220331xexx311.htm">Certification of Helen Sabzevari, Chief Executive Officer (Principal Executive Officer) of the Company, pursuant to Rules 13a-14(a) and 15d-14(a) promulgated under the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="pgen-20220331xexx312.htm">Certification of Harry Thomasian Jr., Chief Financial Officer (Principal Financial Officer) of the Company, pursuant to Rules 13a-14(a) and 15d-14(a) promulgated under the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1**</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="pgen-20220331xexx321.htm">Certification of Helen Sabzevari, Chief Executive Officer (Principal Executive Officer) of the Company, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2**</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="pgen-20220331xexx322.htm">Certification of Harry Thomasian Jr., Chief Financial Officer (Principal Financial Officer) of the Company, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101**</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interactive Data File (Quarterly Report on Form 10-Q, for the quarterly period ended March&#160;31, 2022, formatted in Inline XBRL (eXtensible Business Reporting Language)).</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Attached as Exhibit 101.0 to this Quarterly Report on Form 10-Q are the following documents formatted in XBRL: (i) the Condensed Consolidated Balance Sheets as of March&#160;31, 2022 and December&#160;31, 2021, (ii) the Condensed Consolidated Statements of Operations for the three months ended March 31, 2022 and 2021, (iii) the Condensed Consolidated Statements of Comprehensive Loss for the three months ended March 31, 2022 and 2021, (iv) the Condensed Consolidated Statements of Shareholders' Equity for the three months ended March 31, 2022 and 2021, (v) the Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2022 and 2021, and (vi) the Notes to the Condensed Consolidated Financial Statements.</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104**</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (embedded within the Inline XBRL document).</span></td></tr></table></div><div style="margin-top:7pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">**&#160;&#160;&#160;&#160;Furnished herewith.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><div id="i7169a803a6aa44ea981603d220cab84f_127"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"><tr><td style="width:1.0%"></td><td style="width:37.223%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.127%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.091%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.997%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.962%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Precigen, Inc.</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Registrant)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: May 9, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;&#160;HARRY THOMASIAN JR.</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Harry Thomasian Jr.</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Financial Officer</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial and Accounting Officer)</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>pgen-20220331xexx311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="idb3717a260244a71b4212d97c6938ff8_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;31.1</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION&#160;302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Helen Sabzevari, certify that&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this Quarterly Report on Form&#160;10-Q of Precigen, Inc.&#59;</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a-15(e)&#160;and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.24pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.24pt">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and</font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.24pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; May&#160;9, 2022 </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:31.432%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; HELEN SABZEVARI</font></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Helen Sabzevari</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>pgen-20220331xexx312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i1477242fba7f464a80c7a47f468c8b6f_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;31.2</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION&#160;302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Harry Thomasian Jr., certify that&#58;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this Quarterly Report on Form&#160;10-Q of Precigen, Inc.&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a-15(e)&#160;and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.24pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.24pt">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.24pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; May&#160;9, 2022 </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:31.432%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; HARRY THOMASIAN JR.</font></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Harry Thomasian Jr.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer)</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>pgen-20220331xexx321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i9a11c761d32342cfbecd93cc2667890a_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;32.1</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION&#160;1350</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO SECTION&#160;906</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Helen Sabzevari, Chief Executive Officer of Precigen, Inc. (the &#34;Company&#34;), do hereby certify, pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge&#58;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the Quarterly Report on Form&#160;10-Q of the Company for the quarter ended March&#160;31, 2022 (the &#34;Report&#34;) fully complies with the requirements of Section&#160;13(a)&#160;or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; May&#160;9, 2022 </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:31.432%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; HELEN SABZEVARI</font></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Helen Sabzevari</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</font></td></tr></table></div><div style="margin-top:7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A signed original of this written statement required by Section&#160;906, or other document authenticating, acknowledging or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section&#160;906, has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This certification accompanies the Form 10-Q to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of the Registrant under the Securities Act of 1933 or the Securities Exchange Act of 1934 (whether made before or after the date of the Form 10-Q), irrespective of any general incorporation language contained in such filing.</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>5
<FILENAME>pgen-20220331xexx322.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="idc54b7eeeaf64ba191a69c3eaffba7b2_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;32.2</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION&#160;1350</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO SECTION&#160;906</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Harry Thomasian Jr., Chief Financial Officer of Precigen, Inc. (the &#34;Company&#34;), do hereby certify, pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge&#58;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the Quarterly Report on Form&#160;10-Q of the Company for the quarter ended March&#160;31, 2022 (the &#34;Report&#34;) fully complies with the requirements of Section&#160;13(a)&#160;or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; May&#160;9, 2022 </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:7pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:31.432%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; HARRY THOMASIAN JR.</font></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Harry Thomasian Jr.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer)</font></td></tr></table></div><div style="margin-top:7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A signed original of this written statement required by Section&#160;906, or other document authenticating, acknowledging or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section&#160;906, has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This certification accompanies the Form 10-Q to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of the Registrant under the Securities Act of 1933 or the Securities Exchange Act of 1934 (whether made before or after the date of the Form 10-Q), irrespective of any general incorporation language contained in such filing.</font></div><div style="margin-top:12pt"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>pgen-20220331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:ee4b2abd-b2ae-467e-99f1-1b489525c45b,g:388a974a-f6e3-4fd9-acf5-6762aafe5cec-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:pgen="http://www.dna.com/20220331" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.dna.com/20220331">
  <xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="pgen-20220331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="pgen-20220331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="pgen-20220331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="pgen-20220331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.dna.com/role/CoverPage">
        <link:definition>0001001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheets" roleURI="http://www.dna.com/role/CondensedConsolidatedBalanceSheets">
        <link:definition>1001002 - Statement - Condensed Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsParenthetical" roleURI="http://www.dna.com/role/CondensedConsolidatedBalanceSheetsParenthetical">
        <link:definition>1002003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofOperations" roleURI="http://www.dna.com/role/CondensedConsolidatedStatementsofOperations">
        <link:definition>1003004 - Statement - Condensed Consolidated Statements of Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofOperationsParenthetical" roleURI="http://www.dna.com/role/CondensedConsolidatedStatementsofOperationsParenthetical">
        <link:definition>1004005 - Statement - Condensed Consolidated Statements of Operations (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofComprehensiveLoss" roleURI="http://www.dna.com/role/CondensedConsolidatedStatementsofComprehensiveLoss">
        <link:definition>1005006 - Statement - Condensed Consolidated Statements of Comprehensive Loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofShareholdersEquity" roleURI="http://www.dna.com/role/CondensedConsolidatedStatementsofShareholdersEquity">
        <link:definition>1006007 - Statement - Condensed Consolidated Statements of Shareholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofCashFlows" roleURI="http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows">
        <link:definition>1007008 - Statement - Condensed Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Organization" roleURI="http://www.dna.com/role/Organization">
        <link:definition>2101101 - Disclosure - Organization</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPolicies" roleURI="http://www.dna.com/role/SummaryofSignificantAccountingPolicies">
        <link:definition>2102102 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesPolicies" roleURI="http://www.dna.com/role/SummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>2203201 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesTables" roleURI="http://www.dna.com/role/SummaryofSignificantAccountingPoliciesTables">
        <link:definition>2304301 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesLiquidityAdditionalInformationDetails" roleURI="http://www.dna.com/role/SummaryofSignificantAccountingPoliciesLiquidityAdditionalInformationDetails">
        <link:definition>2405401 - Disclosure - Summary of Significant Accounting Policies - Liquidity - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesVariableInterestEntitiesAdditionalInformationDetails" roleURI="http://www.dna.com/role/SummaryofSignificantAccountingPoliciesVariableInterestEntitiesAdditionalInformationDetails">
        <link:definition>2406402 - Disclosure - Summary of Significant Accounting Policies - Variable Interest Entities - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesNetLossPerShareAdditionalInformationDetails" roleURI="http://www.dna.com/role/SummaryofSignificantAccountingPoliciesNetLossPerShareAdditionalInformationDetails">
        <link:definition>2407403 - Disclosure - Summary of Significant Accounting Policies - Net Loss Per Share - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesRecentlyAdoptedAccountingPronouncementsAdditionalInformationDetails" roleURI="http://www.dna.com/role/SummaryofSignificantAccountingPoliciesRecentlyAdoptedAccountingPronouncementsAdditionalInformationDetails">
        <link:definition>2408404 - Disclosure - Summary of Significant Accounting Policies - Recently Adopted Accounting Pronouncements - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DiscontinuedOperations" roleURI="http://www.dna.com/role/DiscontinuedOperations">
        <link:definition>2109103 - Disclosure - Discontinued Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DiscontinuedOperationsTables" roleURI="http://www.dna.com/role/DiscontinuedOperationsTables">
        <link:definition>2310302 - Disclosure - Discontinued Operations (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DiscontinuedOperationsNarrativeDetails" roleURI="http://www.dna.com/role/DiscontinuedOperationsNarrativeDetails">
        <link:definition>2411405 - Disclosure - Discontinued Operations - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DiscontinuedOperationsSummaryofFinancialResultsforMBPTitanDetails" roleURI="http://www.dna.com/role/DiscontinuedOperationsSummaryofFinancialResultsforMBPTitanDetails">
        <link:definition>2412406 - Disclosure - Discontinued Operations - Summary of Financial Results for MBP Titan (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DiscontinuedOperationsNoncashItemsandPurchasesofPropertyPlantandEquipmentforMBPTitanDetails" roleURI="http://www.dna.com/role/DiscontinuedOperationsNoncashItemsandPurchasesofPropertyPlantandEquipmentforMBPTitanDetails">
        <link:definition>2413407 - Disclosure - Discontinued Operations - Non-cash Items and Purchases of Property, Plant and Equipment for MBP Titan (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsinJointVentures" roleURI="http://www.dna.com/role/InvestmentsinJointVentures">
        <link:definition>2114104 - Disclosure - Investments in Joint Ventures</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsinJointVenturesIntrexonEnergyPartnersAdditionalInformationDetails" roleURI="http://www.dna.com/role/InvestmentsinJointVenturesIntrexonEnergyPartnersAdditionalInformationDetails">
        <link:definition>2415408 - Disclosure - Investments in Joint Ventures - Intrexon Energy Partners - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsinJointVenturesIntrexonEnergyPartnersIIAdditionalInformationDetails" roleURI="http://www.dna.com/role/InvestmentsinJointVenturesIntrexonEnergyPartnersIIAdditionalInformationDetails">
        <link:definition>2416409 - Disclosure - Investments in Joint Ventures - Intrexon Energy Partners II - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborationandLicensingRevenue" roleURI="http://www.dna.com/role/CollaborationandLicensingRevenue">
        <link:definition>2117105 - Disclosure - Collaboration and Licensing Revenue</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborationandLicensingRevenueTables" roleURI="http://www.dna.com/role/CollaborationandLicensingRevenueTables">
        <link:definition>2318303 - Disclosure - Collaboration and Licensing Revenue (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborationandLicensingRevenueSummarizedCollaborationandLicensingRevenueDetails" roleURI="http://www.dna.com/role/CollaborationandLicensingRevenueSummarizedCollaborationandLicensingRevenueDetails">
        <link:definition>2419410 - Disclosure - Collaboration and Licensing Revenue - Summarized Collaboration and Licensing Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborationandLicensingRevenueSummaryofDeferredRevenueDetails" roleURI="http://www.dna.com/role/CollaborationandLicensingRevenueSummaryofDeferredRevenueDetails">
        <link:definition>2420411 - Disclosure - Collaboration and Licensing Revenue - Summary of Deferred Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShorttermandLongtermInvestments" roleURI="http://www.dna.com/role/ShorttermandLongtermInvestments">
        <link:definition>2121106 - Disclosure - Short-term and Long-term Investments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShorttermandLongtermInvestmentsTables" roleURI="http://www.dna.com/role/ShorttermandLongtermInvestmentsTables">
        <link:definition>2322304 - Disclosure - Short-term and Long-term Investments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShorttermandLongtermInvestmentsSummaryofAmortizedCostGrossUnrealizedGainsandLossesandFairValueofShorttermandLongtermInvestmentsDetails" roleURI="http://www.dna.com/role/ShorttermandLongtermInvestmentsSummaryofAmortizedCostGrossUnrealizedGainsandLossesandFairValueofShorttermandLongtermInvestmentsDetails">
        <link:definition>2423412 - Disclosure - Short-term and Long-term Investments - Summary of Amortized Cost, Gross Unrealized Gains and Losses, and Fair Value of Short-term and Long-term Investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShorttermandLongtermInvestmentsContractualObligationFiscalYearMaturityDetails" roleURI="http://www.dna.com/role/ShorttermandLongtermInvestmentsContractualObligationFiscalYearMaturityDetails">
        <link:definition>2424413 - Disclosure - Short-term and Long-term Investments - Contractual Obligation, Fiscal Year Maturity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://www.dna.com/role/FairValueMeasurements">
        <link:definition>2125107 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://www.dna.com/role/FairValueMeasurementsTables">
        <link:definition>2326305 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsSummaryofPlacementintheFairValueHierarchyofFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails" roleURI="http://www.dna.com/role/FairValueMeasurementsSummaryofPlacementintheFairValueHierarchyofFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails">
        <link:definition>2427414 - Disclosure - Fair Value Measurements - Summary of Placement in the Fair Value Hierarchy of Financial Assets that are Measured at Fair Value on a Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsAdditionalInformationDetails" roleURI="http://www.dna.com/role/FairValueMeasurementsAdditionalInformationDetails">
        <link:definition>2428415 - Disclosure - Fair Value Measurements - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Inventory" roleURI="http://www.dna.com/role/Inventory">
        <link:definition>2129108 - Disclosure - Inventory</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoryTables" roleURI="http://www.dna.com/role/InventoryTables">
        <link:definition>2330306 - Disclosure - Inventory (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoryDetails" roleURI="http://www.dna.com/role/InventoryDetails">
        <link:definition>2431416 - Disclosure - Inventory (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyPlantandEquipmentNet" roleURI="http://www.dna.com/role/PropertyPlantandEquipmentNet">
        <link:definition>2132109 - Disclosure - Property, Plant and Equipment, Net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyPlantandEquipmentNetTables" roleURI="http://www.dna.com/role/PropertyPlantandEquipmentNetTables">
        <link:definition>2333307 - Disclosure - Property, Plant and Equipment, Net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetails" roleURI="http://www.dna.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetails">
        <link:definition>2434417 - Disclosure - Property, Plant and Equipment, Net - Schedule of Property, Plant and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyPlantandEquipmentNetAdditionalInformationDetails" roleURI="http://www.dna.com/role/PropertyPlantandEquipmentNetAdditionalInformationDetails">
        <link:definition>2435418 - Disclosure - Property, Plant and Equipment, Net - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsNet" roleURI="http://www.dna.com/role/GoodwillandIntangibleAssetsNet">
        <link:definition>2136110 - Disclosure - Goodwill and Intangible Assets, Net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsNetTables" roleURI="http://www.dna.com/role/GoodwillandIntangibleAssetsNetTables">
        <link:definition>2337308 - Disclosure - Goodwill and Intangible Assets, Net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsNetScheduleofChangesinCarryingAmountofGoodwillDetails" roleURI="http://www.dna.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesinCarryingAmountofGoodwillDetails">
        <link:definition>2438419 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Changes in Carrying Amount of Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsNetAdditionalInformationDetails" roleURI="http://www.dna.com/role/GoodwillandIntangibleAssetsNetAdditionalInformationDetails">
        <link:definition>2439420 - Disclosure - Goodwill and Intangible Assets, Net - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsNetScheduleofIntangibleAssetsDetails" roleURI="http://www.dna.com/role/GoodwillandIntangibleAssetsNetScheduleofIntangibleAssetsDetails">
        <link:definition>2440421 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LinesofCreditandLongTermDebt" roleURI="http://www.dna.com/role/LinesofCreditandLongTermDebt">
        <link:definition>2141111 - Disclosure - Lines of Credit and Long-Term Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LinesofCreditandLongTermDebtTables" roleURI="http://www.dna.com/role/LinesofCreditandLongTermDebtTables">
        <link:definition>2342309 - Disclosure - Lines of Credit and Long-Term Debt (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LinesofCreditandLongTermDebtLinesofCreditAdditionalInformationDetails" roleURI="http://www.dna.com/role/LinesofCreditandLongTermDebtLinesofCreditAdditionalInformationDetails">
        <link:definition>2443422 - Disclosure - Lines of Credit and Long-Term Debt - Lines of Credit - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LinesofCreditandLongTermDebtScheduleofLongTermDebtInstrumentsDetails" roleURI="http://www.dna.com/role/LinesofCreditandLongTermDebtScheduleofLongTermDebtInstrumentsDetails">
        <link:definition>2444423 - Disclosure - Lines of Credit and Long-Term Debt - Schedule of Long-Term Debt Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LinesofCreditandLongTermDebtLongTermDebtAdditionalInformationDetails" roleURI="http://www.dna.com/role/LinesofCreditandLongTermDebtLongTermDebtAdditionalInformationDetails">
        <link:definition>2445424 - Disclosure - Lines of Credit and Long-Term Debt - Long-Term Debt - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LinesofCreditandLongTermDebtScheduleofComponentsofInterestExpenseDetails" roleURI="http://www.dna.com/role/LinesofCreditandLongTermDebtScheduleofComponentsofInterestExpenseDetails">
        <link:definition>2446425 - Disclosure - Lines of Credit and Long-Term Debt - Schedule of Components of Interest Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LinesofCreditandLongTermDebtScheduleofFutureMaturitiesofLongTermDebtDetails" roleURI="http://www.dna.com/role/LinesofCreditandLongTermDebtScheduleofFutureMaturitiesofLongTermDebtDetails">
        <link:definition>2447426 - Disclosure - Lines of Credit and Long-Term Debt - Schedule of Future Maturities of Long-Term Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.dna.com/role/IncomeTaxes">
        <link:definition>2148112 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTables" roleURI="http://www.dna.com/role/IncomeTaxesTables">
        <link:definition>2349310 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesNarrativeDetails" roleURI="http://www.dna.com/role/IncomeTaxesNarrativeDetails">
        <link:definition>2450427 - Disclosure - Income Taxes - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesComponentsofIncomeTaxBenefitsDetails" roleURI="http://www.dna.com/role/IncomeTaxesComponentsofIncomeTaxBenefitsDetails">
        <link:definition>2451428 - Disclosure - Income Taxes - Components of Income Tax Benefits (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquity" roleURI="http://www.dna.com/role/ShareholdersEquity">
        <link:definition>2152113 - Disclosure - Shareholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityTables" roleURI="http://www.dna.com/role/ShareholdersEquityTables">
        <link:definition>2353311 - Disclosure - Shareholders' Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityIssuancesofPrecigenCommonStockDetails" roleURI="http://www.dna.com/role/ShareholdersEquityIssuancesofPrecigenCommonStockDetails">
        <link:definition>2454429 - Disclosure - Shareholders' Equity - Issuances of Precigen Common Stock (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityShareLendingAgreementDetails" roleURI="http://www.dna.com/role/ShareholdersEquityShareLendingAgreementDetails">
        <link:definition>2455430 - Disclosure - Shareholders' Equity - Share Lending Agreement (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityComponentsofAccumulatedOtherComprehensiveIncomeLossDetails" roleURI="http://www.dna.com/role/ShareholdersEquityComponentsofAccumulatedOtherComprehensiveIncomeLossDetails">
        <link:definition>2456431 - Disclosure - Shareholders' Equity - Components of Accumulated Other Comprehensive Income (Loss) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedPayments" roleURI="http://www.dna.com/role/ShareBasedPayments">
        <link:definition>2157114 - Disclosure - Share-Based Payments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedPaymentsTables" roleURI="http://www.dna.com/role/ShareBasedPaymentsTables">
        <link:definition>2358312 - Disclosure - Share-Based Payments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedPaymentsScheduleofStockBasedCompensationCostsDetails" roleURI="http://www.dna.com/role/ShareBasedPaymentsScheduleofStockBasedCompensationCostsDetails">
        <link:definition>2459432 - Disclosure - Share-Based Payments - Schedule of Stock-Based Compensation Costs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedPaymentsAdditionalInformationDetails" roleURI="http://www.dna.com/role/ShareBasedPaymentsAdditionalInformationDetails">
        <link:definition>2460433 - Disclosure - Share-Based Payments - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedPaymentsScheduleofStockOptionActivityDetails" roleURI="http://www.dna.com/role/ShareBasedPaymentsScheduleofStockOptionActivityDetails">
        <link:definition>2461434 - Disclosure - Share-Based Payments - Schedule of Stock Option Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedPaymentsScheduleofRestrictedStockUnitActivityDetails" roleURI="http://www.dna.com/role/ShareBasedPaymentsScheduleofRestrictedStockUnitActivityDetails">
        <link:definition>2462435 - Disclosure - Share-Based Payments - Schedule of Restricted Stock Unit Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OperatingLeases" roleURI="http://www.dna.com/role/OperatingLeases">
        <link:definition>2163115 - Disclosure - Operating Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OperatingLeasesTables" roleURI="http://www.dna.com/role/OperatingLeasesTables">
        <link:definition>2364313 - Disclosure - Operating Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OperatingLeasesAdditionalInformationDetails" roleURI="http://www.dna.com/role/OperatingLeasesAdditionalInformationDetails">
        <link:definition>2465436 - Disclosure - Operating Leases - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OperatingLeasesComponentsofLeaseCostsDetails" roleURI="http://www.dna.com/role/OperatingLeasesComponentsofLeaseCostsDetails">
        <link:definition>2466437 - Disclosure - Operating Leases - Components of Lease Costs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OperatingLeasesMaturitiesofLeaseLiabilitiesDetails" roleURI="http://www.dna.com/role/OperatingLeasesMaturitiesofLeaseLiabilitiesDetails">
        <link:definition>2467438 - Disclosure - Operating Leases - Maturities of Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OperatingLeasesMaturitiesofLeaseLiabilitiesDetails_1" roleURI="http://www.dna.com/role/OperatingLeasesMaturitiesofLeaseLiabilitiesDetails_1">
        <link:definition>2467438 - Disclosure - Operating Leases - Maturities of Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OperatingLeasesLeaseTermsandDiscountRatesDetails" roleURI="http://www.dna.com/role/OperatingLeasesLeaseTermsandDiscountRatesDetails">
        <link:definition>2468439 - Disclosure - Operating Leases - Lease Terms and Discount Rates (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OperatingLeasesOtherInformationDetails" roleURI="http://www.dna.com/role/OperatingLeasesOtherInformationDetails">
        <link:definition>2469440 - Disclosure - Operating Leases - Other Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.dna.com/role/CommitmentsandContingencies">
        <link:definition>2170116 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesContingenciesAdditionalInformationDetails" roleURI="http://www.dna.com/role/CommitmentsandContingenciesContingenciesAdditionalInformationDetails">
        <link:definition>2471441 - Disclosure - Commitments and Contingencies - Contingencies - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyTransactions" roleURI="http://www.dna.com/role/RelatedPartyTransactions">
        <link:definition>2172117 - Disclosure - Related Party Transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyTransactionsAdditionalInformationDetails" roleURI="http://www.dna.com/role/RelatedPartyTransactionsAdditionalInformationDetails">
        <link:definition>2473442 - Disclosure - Related Party Transactions - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Segments" roleURI="http://www.dna.com/role/Segments">
        <link:definition>2174118 - Disclosure - Segments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentsTables" roleURI="http://www.dna.com/role/SegmentsTables">
        <link:definition>2375314 - Disclosure - Segments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentsAdjustedEBITDAbyReportableSegmentDetails" roleURI="http://www.dna.com/role/SegmentsAdjustedEBITDAbyReportableSegmentDetails">
        <link:definition>2476443 - Disclosure - Segments - Adjusted EBITDA by Reportable Segment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentsReconciliationofNetLossBeforeIncomeTaxesDetails" roleURI="http://www.dna.com/role/SegmentsReconciliationofNetLossBeforeIncomeTaxesDetails">
        <link:definition>2477444 - Disclosure - Segments - Reconciliation of Net Loss Before Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentsRevenuesbyReportableSegmentDetails" roleURI="http://www.dna.com/role/SegmentsRevenuesbyReportableSegmentDetails">
        <link:definition>2478445 - Disclosure - Segments - Revenues by Reportable Segment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentsAdditionalInformationDetails" roleURI="http://www.dna.com/role/SegmentsAdditionalInformationDetails">
        <link:definition>2479446 - Disclosure - Segments - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="pgen_PrecigenStockOptionPlan2019PlanMember" abstract="true" name="PrecigenStockOptionPlan2019PlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pgen_NumberOfReportingUnitsImpaired" abstract="false" name="NumberOfReportingUnitsImpaired" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="pgen_TaxableIncomeLoss" abstract="false" name="TaxableIncomeLoss" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pgen_LivestockMember" abstract="true" name="LivestockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pgen_PercentageOfRevenueAttributableToCustomer" abstract="false" name="PercentageOfRevenueAttributableToCustomer" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="pgen_FeedMember" abstract="true" name="FeedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pgen_OtherLongTermDebtMember" abstract="true" name="OtherLongTermDebtMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pgen_NetIncomeLossAttributabletoParentAdjustedEBITDAIncludingCashPaidforCapitalExpendituresandInvestmentsinAffiliates" abstract="false" name="NetIncomeLossAttributabletoParentAdjustedEBITDAIncludingCashPaidforCapitalExpendituresandInvestmentsinAffiliates" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pgen_MethaneBioconversionPlatformDisclosuresMember" abstract="true" name="MethaneBioconversionPlatformDisclosuresMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pgen_NumberofSeatsonGoverningBoardInternallySelected" abstract="false" name="NumberofSeatsonGoverningBoardInternallySelected" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="pgen_CollaborationandLicensingRevenueTableTextBlock" abstract="false" name="CollaborationandLicensingRevenueTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="pgen_CostOfProductsMember" abstract="true" name="CostOfProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pgen_CorporateAndReconcilingItemsMember" abstract="true" name="CorporateAndReconcilingItemsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pgen_NoncashGainLossOnTerminationOfLease" abstract="false" name="NoncashGainLossOnTerminationOfLease" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pgen_StockIssuedDuringThePeriodSharesAccruedCompensation" abstract="false" name="StockIssuedDuringThePeriodSharesAccruedCompensation" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="pgen_NumberofSeatsonGoverningBoard" abstract="false" name="NumberofSeatsonGoverningBoard" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="pgen_OtherAccruedLiabilitiesMember" abstract="true" name="OtherAccruedLiabilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pgen_PrecigenStockOptionPlan2008PlanMember" abstract="true" name="PrecigenStockOptionPlan2008PlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pgen_InterestExpenseDebtAmortizationofDebtDiscountPremiumandDebtIssuanceCosts" abstract="false" name="InterestExpenseDebtAmortizationofDebtDiscountPremiumandDebtIssuanceCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pgen_OtherMember" abstract="true" name="OtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pgen_StockIssuedDuringPeriodSharesStockOptionsExercisedAndRestrictedStockAwards" abstract="false" name="StockIssuedDuringPeriodSharesStockOptionsExercisedAndRestrictedStockAwards" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="pgen_SharesIssuedDuringPeriodValueIssuedForServices" abstract="false" name="SharesIssuedDuringPeriodValueIssuedForServices" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pgen_LesseeOperatingLeaseTerminationPeriod" abstract="false" name="LesseeOperatingLeaseTerminationPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="pgen_CompensationArrangementWithIndividualAnnualRSUGrantGrantDateFairValue" abstract="false" name="CompensationArrangementWithIndividualAnnualRSUGrantGrantDateFairValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pgen_RelatedPartiesAggregatedMember" abstract="true" name="RelatedPartiesAggregatedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pgen_ExemplarSegmentMember" abstract="true" name="ExemplarSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pgen_StockIssuedDuringPeriodValueRestrictedStockAwardsVestedAndStockOptionsExercised" abstract="false" name="StockIssuedDuringPeriodValueRestrictedStockAwardsVestedAndStockOptionsExercised" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pgen_GeneratedAfter2017Member" abstract="true" name="GeneratedAfter2017Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pgen_ConvertibleDebtPrincipalAmountInitialConversionRate" abstract="false" name="ConvertibleDebtPrincipalAmountInitialConversionRate" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pgen_DeferredRevenueOtherMember" abstract="true" name="DeferredRevenueOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pgen_BiopharmaceuticalsSegmentMember" abstract="true" name="BiopharmaceuticalsSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pgen_ShareLendingAgreementLengthOfTimeForSharesToBeReturnedUponTermination" abstract="false" name="ShareLendingAgreementLengthOfTimeForSharesToBeReturnedUponTermination" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="pgen_A3.5ConvertibleNotesDue2023Member" abstract="true" name="A3.5ConvertibleNotesDue2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pgen_SecuritiesAndExchangeCommissionMember" abstract="true" name="SecuritiesAndExchangeCommissionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pgen_LicensingAndPatentInfringementSuitMember" abstract="true" name="LicensingAndPatentInfringementSuitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pgen_CompensationArrangementWithIndividualAnnualStockOptionGrantGrantDateFairValue" abstract="false" name="CompensationArrangementWithIndividualAnnualStockOptionGrantGrantDateFairValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pgen_RelatedPartyReceivableAllowanceforCreditLossCurrent" abstract="false" name="RelatedPartyReceivableAllowanceforCreditLossCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pgen_CompensationArrangementWithIndividualAllocatedShareBasedCompensationExpenseMonthlyExpense" abstract="false" name="CompensationArrangementWithIndividualAllocatedShareBasedCompensationExpenseMonthlyExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pgen_ProposedPaymentsForMembershipInterests" abstract="false" name="ProposedPaymentsForMembershipInterests" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pgen_AllInvestorsMember" abstract="true" name="AllInvestorsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pgen_SaleOfAssetsIncludedInAccountsReceivable" abstract="false" name="SaleOfAssetsIncludedInAccountsReceivable" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pgen_IntrexonEnergyPartnersMember" abstract="true" name="IntrexonEnergyPartnersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pgen_SuppliesEmbryosAndOtherProductionMaterialsMember" abstract="true" name="SuppliesEmbryosAndOtherProductionMaterialsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pgen_ExemplarGeneticsLLCMember" abstract="true" name="ExemplarGeneticsLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pgen_LongLivedAssetsIncludingPropertyPlantandEquipmentandRightOfUseAssets" abstract="false" name="LongLivedAssetsIncludingPropertyPlantandEquipmentandRightOfUseAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pgen_BreedingandProductionAnimalsGross" abstract="false" name="BreedingandProductionAnimalsGross" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pgen_CostOfServicesMember" abstract="true" name="CostOfServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pgen_MBPTitanMember" abstract="true" name="MBPTitanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pgen_ContractWithCustomerAssetAndLiabilityLineItems" abstract="true" name="ContractWithCustomerAssetAndLiabilityLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="pgen_UpfrontAndMilestonePaymentsMember" abstract="true" name="UpfrontAndMilestonePaymentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pgen_FirstNationalBankofOmahaMember" abstract="true" name="FirstNationalBankofOmahaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pgen_CompensationArrangementWithIndividualAnnualCashRetainer" abstract="false" name="CompensationArrangementWithIndividualAnnualCashRetainer" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pgen_RelatedPartyOwnershipInterest" abstract="false" name="RelatedPartyOwnershipInterest" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="pgen_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsReconciliationAbstract" abstract="true" name="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsReconciliationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="pgen_ThirdSecurityMember" abstract="true" name="ThirdSecurityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pgen_CollaborativeArrangementConsiderationReceivedValue" abstract="false" name="CollaborativeArrangementConsiderationReceivedValue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pgen_CompensationArrangementWithIndividualExpense" abstract="false" name="CompensationArrangementWithIndividualExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pgen_IntrexonEnergyPartnersIILLCMember" abstract="true" name="IntrexonEnergyPartnersIILLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pgen_CastleCreekBiosciencesIncMember" abstract="true" name="CastleCreekBiosciencesIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pgen_AmericanStateBankMember" abstract="true" name="AmericanStateBankMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pgen_JointVentureAdditionalCapitalContributionsCommitted" abstract="false" name="JointVentureAdditionalCapitalContributionsCommitted" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pgen_WorkInProcessMember" abstract="true" name="WorkInProcessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pgen_XYLLCMember" abstract="true" name="XYLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pgen_EliminationsAndReconcilingItemsMember" abstract="true" name="EliminationsAndReconcilingItemsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pgen_ContractWithCustomerAssetAndLiabilityTable" abstract="true" name="ContractWithCustomerAssetAndLiabilityTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="pgen_PrepaidProductAndServiceRevenuesMember" abstract="true" name="PrepaidProductAndServiceRevenuesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pgen_ReportableSegmentsMember" abstract="true" name="ReportableSegmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pgen_AdjustmentForBonusesPaidInEquityAwards" abstract="false" name="AdjustmentForBonusesPaidInEquityAwards" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pgen_LockupPeriodOnRestrictedStockUnitShares" abstract="false" name="LockupPeriodOnRestrictedStockUnitShares" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="pgen_CapitalExpendituresNetOfProceedsFromSaleOfAssetsAndInvestmentsInAffiliates" abstract="false" name="CapitalExpendituresNetOfProceedsFromSaleOfAssetsAndInvestmentsInAffiliates" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pgen_JointVentureAdditionalCapitalContributionsCommittedRemainingCommitment" abstract="false" name="JointVentureAdditionalCapitalContributionsCommittedRemainingCommitment" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pgen_PrecigenStockOptionPlanMember" abstract="true" name="PrecigenStockOptionPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pgen_LossContingencyNumberOfPatentsAtIssue" abstract="false" name="LossContingencyNumberOfPatentsAtIssue" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="pgen_NumberofSeatsonGoverningBoardExternallySelected" abstract="false" name="NumberofSeatsonGoverningBoardExternallySelected" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="pgen_ComputerHardwareandSoftware" abstract="false" name="ComputerHardwareandSoftware" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pgen_TransOvaGeneticsLcMember" abstract="true" name="TransOvaGeneticsLcMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pgen_ExecutiveChairmanMember" abstract="true" name="ExecutiveChairmanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pgen_AccruedCompensationPaidinEquityAwards" abstract="false" name="AccruedCompensationPaidinEquityAwards" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pgen_TransOvaSegmentMember" abstract="true" name="TransOvaSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pgen_PrecigenStockOptionPlan2013PlanMember" abstract="true" name="PrecigenStockOptionPlan2013PlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pgen_IntrexonEnergyPartnersLLAndIntrexonEnergyPartnersIILLCMember" abstract="true" name="IntrexonEnergyPartnersLLAndIntrexonEnergyPartnersIILLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pgen_StockIssuedDuringThePeriodValueAccruedCompensation" abstract="false" name="StockIssuedDuringThePeriodValueAccruedCompensation" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>pgen-20220331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:ee4b2abd-b2ae-467e-99f1-1b489525c45b,g:388a974a-f6e3-4fd9-acf5-6762aafe5cec-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.dna.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="pgen-20220331.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.dna.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_5322170f-0b66-4855-a70d-a37867489bf6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_521b06c1-c44d-4fc3-92c9-d64ceaa7054d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_5322170f-0b66-4855-a70d-a37867489bf6" xlink:to="loc_us-gaap_Liabilities_521b06c1-c44d-4fc3-92c9-d64ceaa7054d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_95723bd8-143b-4918-ab6d-27651194d02b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_5322170f-0b66-4855-a70d-a37867489bf6" xlink:to="loc_us-gaap_CommitmentsAndContingencies_95723bd8-143b-4918-ab6d-27651194d02b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_a28557d6-a93c-4a68-a428-0a45147fb61a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_5322170f-0b66-4855-a70d-a37867489bf6" xlink:to="loc_us-gaap_StockholdersEquity_a28557d6-a93c-4a68-a428-0a45147fb61a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_eb6997ab-4239-4154-906f-6048e4fe898e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_0f4c2d46-af85-4649-ab9e-4ea0e92b34d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_eb6997ab-4239-4154-906f-6048e4fe898e" xlink:to="loc_us-gaap_AccountsPayableCurrent_0f4c2d46-af85-4649-ab9e-4ea0e92b34d1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_1d650ffd-1e93-4256-a2f9-573ddf8402cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_eb6997ab-4239-4154-906f-6048e4fe898e" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_1d650ffd-1e93-4256-a2f9-573ddf8402cc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_c110883c-33c6-4bf3-a810-da4176fb055d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_eb6997ab-4239-4154-906f-6048e4fe898e" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_c110883c-33c6-4bf3-a810-da4176fb055d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_0782f700-65f6-42f3-81e8-a31edf6814c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_eb6997ab-4239-4154-906f-6048e4fe898e" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_0782f700-65f6-42f3-81e8-a31edf6814c2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_63f55bcf-8e50-4564-a2ee-2d092e8b9530" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_eb6997ab-4239-4154-906f-6048e4fe898e" xlink:to="loc_us-gaap_LongTermDebtCurrent_63f55bcf-8e50-4564-a2ee-2d092e8b9530" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToRelatedPartiesCurrent_8da57e9c-fa10-425d-9013-ed479c896d5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_eb6997ab-4239-4154-906f-6048e4fe898e" xlink:to="loc_us-gaap_DueToRelatedPartiesCurrent_8da57e9c-fa10-425d-9013-ed479c896d5d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_f421ad84-6cd7-4f84-9758-63f87c8a4604" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_eb6997ab-4239-4154-906f-6048e4fe898e" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_f421ad84-6cd7-4f84-9758-63f87c8a4604" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_844e229e-c3d5-458f-b715-74e7285db5dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValueOutstanding_99ada025-6ef0-4b5f-8395-d9aa9195e378" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValueOutstanding"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_844e229e-c3d5-458f-b715-74e7285db5dd" xlink:to="loc_us-gaap_CommonStockValueOutstanding_99ada025-6ef0-4b5f-8395-d9aa9195e378" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_b40b0a9d-20ee-473a-969f-57e08f314d07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_844e229e-c3d5-458f-b715-74e7285db5dd" xlink:to="loc_us-gaap_AdditionalPaidInCapital_b40b0a9d-20ee-473a-969f-57e08f314d07" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_b731e8f0-08ba-42e4-ad8b-e014edc3d180" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_844e229e-c3d5-458f-b715-74e7285db5dd" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_b731e8f0-08ba-42e4-ad8b-e014edc3d180" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_e84e12a7-dee6-498c-acd4-e96bcedb908a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_844e229e-c3d5-458f-b715-74e7285db5dd" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_e84e12a7-dee6-498c-acd4-e96bcedb908a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_65bd695f-ecdd-41b9-b0fe-541d82321167" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_a5b81693-3e5b-4801-9106-8fdabd103cc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_65bd695f-ecdd-41b9-b0fe-541d82321167" xlink:to="loc_us-gaap_AssetsCurrent_a5b81693-3e5b-4801-9106-8fdabd103cc1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_d84f8bd0-21c0-4398-b79b-028eee0ec0d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_65bd695f-ecdd-41b9-b0fe-541d82321167" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_d84f8bd0-21c0-4398-b79b-028eee0ec0d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_2a29c656-c727-48ca-8124-204ec8e5d5e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_65bd695f-ecdd-41b9-b0fe-541d82321167" xlink:to="loc_us-gaap_Goodwill_2a29c656-c727-48ca-8124-204ec8e5d5e8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_be4d670a-a7fe-419b-b797-06349a02d33e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_65bd695f-ecdd-41b9-b0fe-541d82321167" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_be4d670a-a7fe-419b-b797-06349a02d33e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_cee03485-5984-4f0a-8e4a-024ebab183dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_65bd695f-ecdd-41b9-b0fe-541d82321167" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_cee03485-5984-4f0a-8e4a-024ebab183dc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_da14fa64-9a59-416e-bc36-839c5815bc28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_65bd695f-ecdd-41b9-b0fe-541d82321167" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_da14fa64-9a59-416e-bc36-839c5815bc28" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_38001c9c-498e-4266-bad7-76859cd23969" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_65bd695f-ecdd-41b9-b0fe-541d82321167" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_38001c9c-498e-4266-bad7-76859cd23969" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_a288a97d-727c-44c2-8631-1ed8ffac6e19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_56e21da5-8eb2-4e67-924a-bb63d419a680" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_a288a97d-727c-44c2-8631-1ed8ffac6e19" xlink:to="loc_us-gaap_LiabilitiesCurrent_56e21da5-8eb2-4e67-924a-bb63d419a680" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_106869da-6eab-481f-a05a-6a12ea912f37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_a288a97d-727c-44c2-8631-1ed8ffac6e19" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_106869da-6eab-481f-a05a-6a12ea912f37" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_f0739832-a069-4a7b-a83b-d73392f8ea06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_a288a97d-727c-44c2-8631-1ed8ffac6e19" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_f0739832-a069-4a7b-a83b-d73392f8ea06" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_7e63c278-c0cd-44e3-899f-8855ad9f92f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_a288a97d-727c-44c2-8631-1ed8ffac6e19" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_7e63c278-c0cd-44e3-899f-8855ad9f92f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_a295d201-4953-47f2-8be3-9e3504e44e80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_a288a97d-727c-44c2-8631-1ed8ffac6e19" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_a295d201-4953-47f2-8be3-9e3504e44e80" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_880ca453-396d-4287-9f1f-d8825acda4dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_a288a97d-727c-44c2-8631-1ed8ffac6e19" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_880ca453-396d-4287-9f1f-d8825acda4dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_b8bb8c6e-1bfa-42ef-9da2-a2464b002b5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryGross_40159661-c3a6-4f90-8aee-20b53a152511" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_b8bb8c6e-1bfa-42ef-9da2-a2464b002b5e" xlink:to="loc_us-gaap_InventoryGross_40159661-c3a6-4f90-8aee-20b53a152511" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueFromRelatedPartiesCurrent_a824d5a6-4a7e-4276-88e4-7a5e1e082f14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueFromRelatedPartiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_b8bb8c6e-1bfa-42ef-9da2-a2464b002b5e" xlink:to="loc_us-gaap_DueFromRelatedPartiesCurrent_a824d5a6-4a7e-4276-88e4-7a5e1e082f14" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_1197be87-4f39-49fa-b4d7-89ad7addd467" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_b8bb8c6e-1bfa-42ef-9da2-a2464b002b5e" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_1197be87-4f39-49fa-b4d7-89ad7addd467" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_77cbc094-a40b-4cab-81d9-a87e45385477" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_b8bb8c6e-1bfa-42ef-9da2-a2464b002b5e" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_77cbc094-a40b-4cab-81d9-a87e45385477" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_9f99c251-8fc0-4458-9500-a0fc6a09bbfd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_b8bb8c6e-1bfa-42ef-9da2-a2464b002b5e" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_9f99c251-8fc0-4458-9500-a0fc6a09bbfd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_b65a7c70-4a69-49f9-9bcf-cd9ec1ff309c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_b8bb8c6e-1bfa-42ef-9da2-a2464b002b5e" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_b65a7c70-4a69-49f9-9bcf-cd9ec1ff309c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_f65698f9-cbf3-4281-a638-260945076b84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_b8bb8c6e-1bfa-42ef-9da2-a2464b002b5e" xlink:to="loc_us-gaap_ShortTermInvestments_f65698f9-cbf3-4281-a638-260945076b84" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dna.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="pgen-20220331.xsd#CondensedConsolidatedStatementsofOperations"/>
  <link:calculationLink xlink:role="http://www.dna.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_f01cfb10-59b9-460a-8ad4-987f79bdd123" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_e7a537da-bc6e-48a8-bc9b-7705621b8e2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareBasic_f01cfb10-59b9-460a-8ad4-987f79bdd123" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_e7a537da-bc6e-48a8-bc9b-7705621b8e2a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_88124f56-0a37-4c33-a906-c57f3e022cdb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareBasic_f01cfb10-59b9-460a-8ad4-987f79bdd123" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_88124f56-0a37-4c33-a906-c57f3e022cdb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_a17166f1-08c7-4baf-9cc1-c8ddd40ae78a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_289a30e6-61f4-4177-a49b-c08f1ecd79e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_a17166f1-08c7-4baf-9cc1-c8ddd40ae78a" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_289a30e6-61f4-4177-a49b-c08f1ecd79e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_3462edd1-15cf-4217-89d3-c09df7ea5e97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_a17166f1-08c7-4baf-9cc1-c8ddd40ae78a" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_3462edd1-15cf-4217-89d3-c09df7ea5e97" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1dd38a5b-bb2d-4787-bdf7-00c44d0509ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_861420a8-25d0-4a70-87a5-4600970c4e54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1dd38a5b-bb2d-4787-bdf7-00c44d0509ad" xlink:to="loc_us-gaap_OperatingIncomeLoss_861420a8-25d0-4a70-87a5-4600970c4e54" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_2e6fc073-734a-4e19-8d1b-2139226780e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1dd38a5b-bb2d-4787-bdf7-00c44d0509ad" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_2e6fc073-734a-4e19-8d1b-2139226780e9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_6f340a10-ead6-4398-bd1d-44bb39774aa3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1dd38a5b-bb2d-4787-bdf7-00c44d0509ad" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_6f340a10-ead6-4398-bd1d-44bb39774aa3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_cea2d815-cf3d-4d80-b861-cd3f701dd352" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_6d9adb10-e316-4241-b318-1c165ea8aa05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_cea2d815-cf3d-4d80-b861-cd3f701dd352" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_6d9adb10-e316-4241-b318-1c165ea8aa05" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_7915f6a3-0858-4238-81ba-e6f8a70bc3a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_cea2d815-cf3d-4d80-b861-cd3f701dd352" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_7915f6a3-0858-4238-81ba-e6f8a70bc3a5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_2b84762a-e886-409f-ab92-72959dcfdb5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_27e90f4c-291a-43d0-962e-40174a6b5503" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_2b84762a-e886-409f-ab92-72959dcfdb5b" xlink:to="loc_us-gaap_OperatingExpenses_27e90f4c-291a-43d0-962e-40174a6b5503" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_65363a75-2f84-4ec3-a41d-5c8b3bd93ff7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_2b84762a-e886-409f-ab92-72959dcfdb5b" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_65363a75-2f84-4ec3-a41d-5c8b3bd93ff7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_ebbafb6f-4a47-4402-859e-1279342eb783" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_b7ba04a2-d63b-4528-bd6c-6f5c5d72777f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_ebbafb6f-4a47-4402-859e-1279342eb783" xlink:to="loc_us-gaap_InterestExpense_b7ba04a2-d63b-4528-bd6c-6f5c5d72777f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNonoperating_210771de-0317-4c85-810c-77966d8e465d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeNonoperating"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_ebbafb6f-4a47-4402-859e-1279342eb783" xlink:to="loc_us-gaap_InvestmentIncomeNonoperating_210771de-0317-4c85-810c-77966d8e465d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_d7f6be4a-f480-43fd-8499-8ed046d52a02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_ebbafb6f-4a47-4402-859e-1279342eb783" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_d7f6be4a-f480-43fd-8499-8ed046d52a02" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_87395f9d-a936-4482-b0e7-560ac016565e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_70c680db-c3a2-4fd4-8dba-40bcf4b91190" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_87395f9d-a936-4482-b0e7-560ac016565e" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_70c680db-c3a2-4fd4-8dba-40bcf4b91190" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_bdfdd120-b09c-4118-8df1-b7cc4b5dfefe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_87395f9d-a936-4482-b0e7-560ac016565e" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_bdfdd120-b09c-4118-8df1-b7cc4b5dfefe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_c46a652a-971d-4ac8-b53c-78554ce7c27f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_87395f9d-a936-4482-b0e7-560ac016565e" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_c46a652a-971d-4ac8-b53c-78554ce7c27f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_b9484815-de51-4d5f-86e5-7d825de46ddb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_87395f9d-a936-4482-b0e7-560ac016565e" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_b9484815-de51-4d5f-86e5-7d825de46ddb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_e357a49f-148b-4d79-9ca0-cdf730a8a3dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_4fa615d7-a956-439c-a58f-6a786bf70872" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareDiluted_e357a49f-148b-4d79-9ca0-cdf730a8a3dd" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_4fa615d7-a956-439c-a58f-6a786bf70872" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_a960950a-6e68-42ef-bd21-b10fa935e3ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareDiluted_e357a49f-148b-4d79-9ca0-cdf730a8a3dd" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_a960950a-6e68-42ef-bd21-b10fa935e3ae" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dna.com/role/CondensedConsolidatedStatementsofComprehensiveLoss" xlink:type="simple" xlink:href="pgen-20220331.xsd#CondensedConsolidatedStatementsofComprehensiveLoss"/>
  <link:calculationLink xlink:role="http://www.dna.com/role/CondensedConsolidatedStatementsofComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_e943b795-a8cb-4b6a-b067-397f58eb0ece" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_6b88a9d1-5c8a-4d81-94cb-bade22691b48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_e943b795-a8cb-4b6a-b067-397f58eb0ece" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_6b88a9d1-5c8a-4d81-94cb-bade22691b48" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_d8e53390-efac-43f0-951b-5ece0d15e541" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_e943b795-a8cb-4b6a-b067-397f58eb0ece" xlink:to="loc_us-gaap_NetIncomeLoss_d8e53390-efac-43f0-951b-5ece0d15e541" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_3e324e79-00c3-4447-8a15-15df944ef8e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_e943b795-a8cb-4b6a-b067-397f58eb0ece" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_3e324e79-00c3-4447-8a15-15df944ef8e9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="pgen-20220331.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_7e6476a7-8fb4-4a4b-8d59-eaf2f501c14c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_c2555253-0dbd-4b37-b92f-1893ea6641b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_7e6476a7-8fb4-4a4b-8d59-eaf2f501c14c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_c2555253-0dbd-4b37-b92f-1893ea6641b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_021e5be6-1d2b-4860-b4f7-9d15d0500acd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_7e6476a7-8fb4-4a4b-8d59-eaf2f501c14c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_021e5be6-1d2b-4860-b4f7-9d15d0500acd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1790b762-1c15-4108-bd1f-e9afc6e7d787" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_7e6476a7-8fb4-4a4b-8d59-eaf2f501c14c" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1790b762-1c15-4108-bd1f-e9afc6e7d787" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_098a6f85-213c-4d1c-83f7-01ba044a8056" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_7e6476a7-8fb4-4a4b-8d59-eaf2f501c14c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_098a6f85-213c-4d1c-83f7-01ba044a8056" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_71a4c0c2-cbbe-49c9-b654-20b1db9c0e23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_a8d425f0-6dc0-4644-8d51-3208224c2d92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_71a4c0c2-cbbe-49c9-b654-20b1db9c0e23" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_a8d425f0-6dc0-4644-8d51-3208224c2d92" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_cbf9b058-5597-460f-92e2-27e1d3932cc0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_71a4c0c2-cbbe-49c9-b654-20b1db9c0e23" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_cbf9b058-5597-460f-92e2-27e1d3932cc0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_2cce7b55-67be-4fc0-80a4-d31c21a9e1e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_71a4c0c2-cbbe-49c9-b654-20b1db9c0e23" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_2cce7b55-67be-4fc0-80a4-d31c21a9e1e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_401339b9-a26a-4b2d-8937-05170ae2391b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_96e698e5-91f3-4196-a17e-8a47b931937e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_401339b9-a26a-4b2d-8937-05170ae2391b" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_96e698e5-91f3-4196-a17e-8a47b931937e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollectionOfNotesReceivable_6c4a1bc2-a962-4e83-b055-54c7bbb4aa6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromCollectionOfNotesReceivable"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_401339b9-a26a-4b2d-8937-05170ae2391b" xlink:to="loc_us-gaap_ProceedsFromCollectionOfNotesReceivable_6c4a1bc2-a962-4e83-b055-54c7bbb4aa6d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_f15a8c69-33a8-47f1-b5f9-28ba97237d0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_401339b9-a26a-4b2d-8937-05170ae2391b" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_f15a8c69-33a8-47f1-b5f9-28ba97237d0b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_845eca65-a443-4da0-987b-e6386f9dfb56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_401339b9-a26a-4b2d-8937-05170ae2391b" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_845eca65-a443-4da0-987b-e6386f9dfb56" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities_1be921bf-29cb-4c33-94a6-c2e18b64bda5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_401339b9-a26a-4b2d-8937-05170ae2391b" xlink:to="loc_us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities_1be921bf-29cb-4c33-94a6-c2e18b64bda5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_381dff56-716b-4735-acdb-90e9fcb35a2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_481f8957-9665-4b90-a9e8-e8732614c402" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_381dff56-716b-4735-acdb-90e9fcb35a2d" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_481f8957-9665-4b90-a9e8-e8732614c402" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_SharesIssuedDuringPeriodValueIssuedForServices_79663767-c21c-49c5-805c-cd90d0d845ee" xlink:href="pgen-20220331.xsd#pgen_SharesIssuedDuringPeriodValueIssuedForServices"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_381dff56-716b-4735-acdb-90e9fcb35a2d" xlink:to="loc_pgen_SharesIssuedDuringPeriodValueIssuedForServices_79663767-c21c-49c5-805c-cd90d0d845ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_20811884-03a5-4fbd-8ea9-af58fc8358ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_381dff56-716b-4735-acdb-90e9fcb35a2d" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_20811884-03a5-4fbd-8ea9-af58fc8358ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_64b12963-3c54-42b9-9d5f-9083394e4413" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_381dff56-716b-4735-acdb-90e9fcb35a2d" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_64b12963-3c54-42b9-9d5f-9083394e4413" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDueFromRelatedPartiesCurrent_f633091a-f282-453d-9c37-ccbfb82c9a59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDueFromRelatedPartiesCurrent"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_381dff56-716b-4735-acdb-90e9fcb35a2d" xlink:to="loc_us-gaap_IncreaseDecreaseInDueFromRelatedPartiesCurrent_f633091a-f282-453d-9c37-ccbfb82c9a59" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherReceivables_73ecb5c8-1ab0-499c-81ee-cdcd72fc85f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherReceivables"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_381dff56-716b-4735-acdb-90e9fcb35a2d" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherReceivables_73ecb5c8-1ab0-499c-81ee-cdcd72fc85f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_5056b647-c5bd-4fad-acde-5aae8cb2f80d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_381dff56-716b-4735-acdb-90e9fcb35a2d" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_5056b647-c5bd-4fad-acde-5aae8cb2f80d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_5deffab5-7eda-4ef0-a092-87bbb6a2408a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_381dff56-716b-4735-acdb-90e9fcb35a2d" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_5deffab5-7eda-4ef0-a092-87bbb6a2408a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_20123834-c089-4e04-acf4-cb1913c60add" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_381dff56-716b-4735-acdb-90e9fcb35a2d" xlink:to="loc_us-gaap_NetIncomeLoss_20123834-c089-4e04-acf4-cb1913c60add" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_NoncashGainLossOnTerminationOfLease_cb69aeaa-12a3-4282-8911-aee0f2e70255" xlink:href="pgen-20220331.xsd#pgen_NoncashGainLossOnTerminationOfLease"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_381dff56-716b-4735-acdb-90e9fcb35a2d" xlink:to="loc_pgen_NoncashGainLossOnTerminationOfLease_cb69aeaa-12a3-4282-8911-aee0f2e70255" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_5f09497e-b5df-43da-bd8f-b3dc76d370a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_381dff56-716b-4735-acdb-90e9fcb35a2d" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_5f09497e-b5df-43da-bd8f-b3dc76d370a5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_d00a761f-29cb-4d35-a7a9-18414024e69a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_381dff56-716b-4735-acdb-90e9fcb35a2d" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_d00a761f-29cb-4d35-a7a9-18414024e69a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities_d48a9bc0-71cc-4494-b3d6-919f4cc0dc30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherAccruedLiabilities"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_381dff56-716b-4735-acdb-90e9fcb35a2d" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities_d48a9bc0-71cc-4494-b3d6-919f4cc0dc30" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_06e4eb88-1df7-4acd-97b9-8f0876dfb2a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_381dff56-716b-4735-acdb-90e9fcb35a2d" xlink:to="loc_us-gaap_ShareBasedCompensation_06e4eb88-1df7-4acd-97b9-8f0876dfb2a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_cbc15be7-e21d-40cc-933e-463fac27ac09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="15" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_381dff56-716b-4735-acdb-90e9fcb35a2d" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_cbc15be7-e21d-40cc-933e-463fac27ac09" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_cf19b44a-b141-44da-80cf-7d1abd970f18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:calculationArc order="16" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_381dff56-716b-4735-acdb-90e9fcb35a2d" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_cf19b44a-b141-44da-80cf-7d1abd970f18" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets1_440c081b-47a6-4ce1-a065-f66a42053dc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets1"/>
    <link:calculationArc order="17" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_381dff56-716b-4735-acdb-90e9fcb35a2d" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets1_440c081b-47a6-4ce1-a065-f66a42053dc1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_59461c3f-1990-41e6-b433-b49736b7400a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:calculationArc order="18" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_381dff56-716b-4735-acdb-90e9fcb35a2d" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_59461c3f-1990-41e6-b433-b49736b7400a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_bea2e34b-e75b-4301-9991-b67b7d5d543c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="19" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_381dff56-716b-4735-acdb-90e9fcb35a2d" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_bea2e34b-e75b-4301-9991-b67b7d5d543c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent_f207db17-1450-4a9b-bff6-63d629517187" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent"/>
    <link:calculationArc order="20" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_381dff56-716b-4735-acdb-90e9fcb35a2d" xlink:to="loc_us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent_f207db17-1450-4a9b-bff6-63d629517187" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_51e86f4e-ae62-43b6-a26b-d65f567b654d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:calculationArc order="21" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_381dff56-716b-4735-acdb-90e9fcb35a2d" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_51e86f4e-ae62-43b6-a26b-d65f567b654d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_7b5f473f-4665-4596-b41b-38353088a83a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="22" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_381dff56-716b-4735-acdb-90e9fcb35a2d" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_7b5f473f-4665-4596-b41b-38353088a83a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_ad4a593f-709b-4344-80f2-e7f10d8399af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="23" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_381dff56-716b-4735-acdb-90e9fcb35a2d" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_ad4a593f-709b-4344-80f2-e7f10d8399af" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_8e903f99-43d1-47b4-85c8-11a3bb875732" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:calculationArc order="24" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_381dff56-716b-4735-acdb-90e9fcb35a2d" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_8e903f99-43d1-47b4-85c8-11a3bb875732" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_cf6e91b0-b194-45ed-965d-6ecbb1edc3bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:calculationArc order="25" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_381dff56-716b-4735-acdb-90e9fcb35a2d" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_cf6e91b0-b194-45ed-965d-6ecbb1edc3bc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_af384fb4-3ceb-41ac-a79e-b73de78f7d1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_8861e789-ba46-42af-ac6d-9634a8ee0bd1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_af384fb4-3ceb-41ac-a79e-b73de78f7d1c" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_8861e789-ba46-42af-ac6d-9634a8ee0bd1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_122ae2c9-732b-4008-81ba-019eed3affe6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_af384fb4-3ceb-41ac-a79e-b73de78f7d1c" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_122ae2c9-732b-4008-81ba-019eed3affe6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dna.com/role/CollaborationandLicensingRevenueSummaryofDeferredRevenueDetails" xlink:type="simple" xlink:href="pgen-20220331.xsd#CollaborationandLicensingRevenueSummaryofDeferredRevenueDetails"/>
  <link:calculationLink xlink:role="http://www.dna.com/role/CollaborationandLicensingRevenueSummaryofDeferredRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_0a3d6a27-99c1-469c-8f42-bd8290902535" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_c8dbb588-d1cb-4ac8-bc6c-5d9cb64f6186" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ContractWithCustomerLiability_0a3d6a27-99c1-469c-8f42-bd8290902535" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_c8dbb588-d1cb-4ac8-bc6c-5d9cb64f6186" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_b6a1910a-19f7-41a2-958e-5c0faf1991f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ContractWithCustomerLiability_0a3d6a27-99c1-469c-8f42-bd8290902535" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_b6a1910a-19f7-41a2-958e-5c0faf1991f2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dna.com/role/ShorttermandLongtermInvestmentsSummaryofAmortizedCostGrossUnrealizedGainsandLossesandFairValueofShorttermandLongtermInvestmentsDetails" xlink:type="simple" xlink:href="pgen-20220331.xsd#ShorttermandLongtermInvestmentsSummaryofAmortizedCostGrossUnrealizedGainsandLossesandFairValueofShorttermandLongtermInvestmentsDetails"/>
  <link:calculationLink xlink:role="http://www.dna.com/role/ShorttermandLongtermInvestmentsSummaryofAmortizedCostGrossUnrealizedGainsandLossesandFairValueofShorttermandLongtermInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_f7c41f02-abdd-4af7-8152-678cf8b2c979" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_1a47550c-348b-47ca-a29d-2842164c4eba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_f7c41f02-abdd-4af7-8152-678cf8b2c979" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_1a47550c-348b-47ca-a29d-2842164c4eba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_01a5261d-ac53-4737-93a2-b427b425963a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_f7c41f02-abdd-4af7-8152-678cf8b2c979" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_01a5261d-ac53-4737-93a2-b427b425963a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_10f7bb16-a7ca-43a7-adcf-b33a12cd292a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_f7c41f02-abdd-4af7-8152-678cf8b2c979" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_10f7bb16-a7ca-43a7-adcf-b33a12cd292a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dna.com/role/ShorttermandLongtermInvestmentsContractualObligationFiscalYearMaturityDetails" xlink:type="simple" xlink:href="pgen-20220331.xsd#ShorttermandLongtermInvestmentsContractualObligationFiscalYearMaturityDetails"/>
  <link:calculationLink xlink:role="http://www.dna.com/role/ShorttermandLongtermInvestmentsContractualObligationFiscalYearMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_b841b3a9-3ee5-4d62-9cbb-f528439b491d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_1e195ac5-960b-429f-bd88-87dc3c907c99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_b841b3a9-3ee5-4d62-9cbb-f528439b491d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_1e195ac5-960b-429f-bd88-87dc3c907c99" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_3fa81baa-72f9-4bb9-ac4e-00a6ba4279b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_b841b3a9-3ee5-4d62-9cbb-f528439b491d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_3fa81baa-72f9-4bb9-ac4e-00a6ba4279b7" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dna.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetails" xlink:type="simple" xlink:href="pgen-20220331.xsd#PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetails"/>
  <link:calculationLink xlink:role="http://www.dna.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_e1d00c43-fd7c-4d59-8d20-e26109aa0f41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandAndLandImprovements_c1df17e8-3c73-4346-88b6-f56dc8988b05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LandAndLandImprovements"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_e1d00c43-fd7c-4d59-8d20-e26109aa0f41" xlink:to="loc_us-gaap_LandAndLandImprovements_c1df17e8-3c73-4346-88b6-f56dc8988b05" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross_6e2fa474-e0c8-4cef-80ae-032ab0ad487f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingsAndImprovementsGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_e1d00c43-fd7c-4d59-8d20-e26109aa0f41" xlink:to="loc_us-gaap_BuildingsAndImprovementsGross_6e2fa474-e0c8-4cef-80ae-032ab0ad487f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesGross_f36564cd-7b0f-4bc3-8052-4b93b1cf5539" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesGross"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_e1d00c43-fd7c-4d59-8d20-e26109aa0f41" xlink:to="loc_us-gaap_FurnitureAndFixturesGross_f36564cd-7b0f-4bc3-8052-4b93b1cf5539" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentGross_317083a6-4816-4b4a-9574-081fa43107c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MachineryAndEquipmentGross"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_e1d00c43-fd7c-4d59-8d20-e26109aa0f41" xlink:to="loc_us-gaap_MachineryAndEquipmentGross_317083a6-4816-4b4a-9574-081fa43107c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsGross_3bf9e234-9865-4dd7-9e40-c791a47743cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsGross"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_e1d00c43-fd7c-4d59-8d20-e26109aa0f41" xlink:to="loc_us-gaap_LeaseholdImprovementsGross_3bf9e234-9865-4dd7-9e40-c791a47743cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_BreedingandProductionAnimalsGross_a4a8de6b-5d13-4af7-946e-7300993a9a17" xlink:href="pgen-20220331.xsd#pgen_BreedingandProductionAnimalsGross"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_e1d00c43-fd7c-4d59-8d20-e26109aa0f41" xlink:to="loc_pgen_BreedingandProductionAnimalsGross_a4a8de6b-5d13-4af7-946e-7300993a9a17" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_ComputerHardwareandSoftware_5ed59379-680a-4263-b871-25c7638ea28c" xlink:href="pgen-20220331.xsd#pgen_ComputerHardwareandSoftware"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_e1d00c43-fd7c-4d59-8d20-e26109aa0f41" xlink:to="loc_pgen_ComputerHardwareandSoftware_5ed59379-680a-4263-b871-25c7638ea28c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressGross_033b2a4e-c7e0-481c-af2e-83693a61d138" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressGross"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_e1d00c43-fd7c-4d59-8d20-e26109aa0f41" xlink:to="loc_us-gaap_ConstructionInProgressGross_033b2a4e-c7e0-481c-af2e-83693a61d138" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_bd55be31-698b-4b21-a2cd-15443ff566f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_39ff20d7-dae9-4ced-9c5d-106632144dfd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_bd55be31-698b-4b21-a2cd-15443ff566f7" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_39ff20d7-dae9-4ced-9c5d-106632144dfd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_4dc43bb7-7316-4db5-bb96-76aee3389a7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_bd55be31-698b-4b21-a2cd-15443ff566f7" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_4dc43bb7-7316-4db5-bb96-76aee3389a7c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dna.com/role/GoodwillandIntangibleAssetsNetScheduleofIntangibleAssetsDetails" xlink:type="simple" xlink:href="pgen-20220331.xsd#GoodwillandIntangibleAssetsNetScheduleofIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.dna.com/role/GoodwillandIntangibleAssetsNetScheduleofIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_e29e96f0-f5ee-4745-b51e-2b403d141f82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_07d9bf00-3bc0-4328-8b7a-3323b24a50fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_e29e96f0-f5ee-4745-b51e-2b403d141f82" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_07d9bf00-3bc0-4328-8b7a-3323b24a50fa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_b88537b8-14bf-4ce0-be62-a1548994783a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_e29e96f0-f5ee-4745-b51e-2b403d141f82" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_b88537b8-14bf-4ce0-be62-a1548994783a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dna.com/role/LinesofCreditandLongTermDebtScheduleofLongTermDebtInstrumentsDetails" xlink:type="simple" xlink:href="pgen-20220331.xsd#LinesofCreditandLongTermDebtScheduleofLongTermDebtInstrumentsDetails"/>
  <link:calculationLink xlink:role="http://www.dna.com/role/LinesofCreditandLongTermDebtScheduleofLongTermDebtInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_761a7136-283a-42df-993f-62ad6144a134" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_d23fa52c-6e6b-458a-bb94-4450ae947e54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_761a7136-283a-42df-993f-62ad6144a134" xlink:to="loc_us-gaap_LongTermDebtCurrent_d23fa52c-6e6b-458a-bb94-4450ae947e54" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_c5938170-e437-4027-90a4-cca960770065" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_761a7136-283a-42df-993f-62ad6144a134" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_c5938170-e437-4027-90a4-cca960770065" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dna.com/role/LinesofCreditandLongTermDebtScheduleofComponentsofInterestExpenseDetails" xlink:type="simple" xlink:href="pgen-20220331.xsd#LinesofCreditandLongTermDebtScheduleofComponentsofInterestExpenseDetails"/>
  <link:calculationLink xlink:role="http://www.dna.com/role/LinesofCreditandLongTermDebtScheduleofComponentsofInterestExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_56b8fccd-c7b7-4288-a3cc-f61cbd4f0c73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebtExcludingAmortization_678da97b-c7b3-4491-b56d-b32337f4849a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebtExcludingAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InterestExpenseDebt_56b8fccd-c7b7-4288-a3cc-f61cbd4f0c73" xlink:to="loc_us-gaap_InterestExpenseDebtExcludingAmortization_678da97b-c7b3-4491-b56d-b32337f4849a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_InterestExpenseDebtAmortizationofDebtDiscountPremiumandDebtIssuanceCosts_06f2618b-ab43-49a5-8d86-f1343269822b" xlink:href="pgen-20220331.xsd#pgen_InterestExpenseDebtAmortizationofDebtDiscountPremiumandDebtIssuanceCosts"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InterestExpenseDebt_56b8fccd-c7b7-4288-a3cc-f61cbd4f0c73" xlink:to="loc_pgen_InterestExpenseDebtAmortizationofDebtDiscountPremiumandDebtIssuanceCosts_06f2618b-ab43-49a5-8d86-f1343269822b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dna.com/role/LinesofCreditandLongTermDebtScheduleofFutureMaturitiesofLongTermDebtDetails" xlink:type="simple" xlink:href="pgen-20220331.xsd#LinesofCreditandLongTermDebtScheduleofFutureMaturitiesofLongTermDebtDetails"/>
  <link:calculationLink xlink:role="http://www.dna.com/role/LinesofCreditandLongTermDebtScheduleofFutureMaturitiesofLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_e5d7eb66-cf35-4480-bd72-1468d4d349f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_ba8f1c89-1bc5-4cce-ab55-1f1334fea076" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_e5d7eb66-cf35-4480-bd72-1468d4d349f1" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_ba8f1c89-1bc5-4cce-ab55-1f1334fea076" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_816867a4-23d3-4c35-aaf4-f86b6af1ad2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_e5d7eb66-cf35-4480-bd72-1468d4d349f1" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_816867a4-23d3-4c35-aaf4-f86b6af1ad2b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_81f71845-a28a-4c72-b524-a2ff25832156" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_e5d7eb66-cf35-4480-bd72-1468d4d349f1" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_81f71845-a28a-4c72-b524-a2ff25832156" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_da318add-8b78-4a7f-869a-4f7c159203ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_e5d7eb66-cf35-4480-bd72-1468d4d349f1" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_da318add-8b78-4a7f-869a-4f7c159203ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_9613f209-8c43-41f1-a27e-82a0b97d56b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_e5d7eb66-cf35-4480-bd72-1468d4d349f1" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_9613f209-8c43-41f1-a27e-82a0b97d56b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_47dc9f9a-41d4-46d8-a22a-a44bb0eed66b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_e5d7eb66-cf35-4480-bd72-1468d4d349f1" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_47dc9f9a-41d4-46d8-a22a-a44bb0eed66b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_f44bdad3-17ac-4d8a-bca2-41165d8f93d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_e5d7eb66-cf35-4480-bd72-1468d4d349f1" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_f44bdad3-17ac-4d8a-bca2-41165d8f93d4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dna.com/role/IncomeTaxesComponentsofIncomeTaxBenefitsDetails" xlink:type="simple" xlink:href="pgen-20220331.xsd#IncomeTaxesComponentsofIncomeTaxBenefitsDetails"/>
  <link:calculationLink xlink:role="http://www.dna.com/role/IncomeTaxesComponentsofIncomeTaxBenefitsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_fc8757cc-fecd-43d2-bb7a-b579bbe7e689" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_3f8bd24e-724d-4fb2-a3c9-1aaa166878d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_fc8757cc-fecd-43d2-bb7a-b579bbe7e689" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_3f8bd24e-724d-4fb2-a3c9-1aaa166878d1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_2cabd63c-80a3-4d4b-b9df-53872e478585" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_fc8757cc-fecd-43d2-bb7a-b579bbe7e689" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_2cabd63c-80a3-4d4b-b9df-53872e478585" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dna.com/role/OperatingLeasesComponentsofLeaseCostsDetails" xlink:type="simple" xlink:href="pgen-20220331.xsd#OperatingLeasesComponentsofLeaseCostsDetails"/>
  <link:calculationLink xlink:role="http://www.dna.com/role/OperatingLeasesComponentsofLeaseCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_8b2290aa-2e1a-4670-9ee4-1c1003d61843" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_5905e94d-5425-42df-b538-1c549aceb61f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_8b2290aa-2e1a-4670-9ee4-1c1003d61843" xlink:to="loc_us-gaap_OperatingLeaseCost_5905e94d-5425-42df-b538-1c549aceb61f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost_d9f4c5f1-3be2-41a5-8aca-aa459f0b9e73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_8b2290aa-2e1a-4670-9ee4-1c1003d61843" xlink:to="loc_us-gaap_ShortTermLeaseCost_d9f4c5f1-3be2-41a5-8aca-aa459f0b9e73" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_6afcbc18-2838-42f1-a9bf-caa59670cebb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableLeaseCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_8b2290aa-2e1a-4670-9ee4-1c1003d61843" xlink:to="loc_us-gaap_VariableLeaseCost_6afcbc18-2838-42f1-a9bf-caa59670cebb" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dna.com/role/OperatingLeasesMaturitiesofLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="pgen-20220331.xsd#OperatingLeasesMaturitiesofLeaseLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.dna.com/role/OperatingLeasesMaturitiesofLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_faff4b70-2517-47fc-9b10-5266e765c7e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_85454c85-74a4-4521-ba1e-c1cefa9af24d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_faff4b70-2517-47fc-9b10-5266e765c7e3" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_85454c85-74a4-4521-ba1e-c1cefa9af24d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_90ac5167-7bcb-445b-9069-529088bbc0f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_faff4b70-2517-47fc-9b10-5266e765c7e3" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_90ac5167-7bcb-445b-9069-529088bbc0f7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_bd55fd68-8dd0-42c4-86aa-b11fc81ebf1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_faff4b70-2517-47fc-9b10-5266e765c7e3" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_bd55fd68-8dd0-42c4-86aa-b11fc81ebf1f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_58c397e3-0e29-4d79-884f-47acc5727c47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_faff4b70-2517-47fc-9b10-5266e765c7e3" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_58c397e3-0e29-4d79-884f-47acc5727c47" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0d5addac-6282-4841-99a3-00fa5fec75fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_faff4b70-2517-47fc-9b10-5266e765c7e3" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0d5addac-6282-4841-99a3-00fa5fec75fe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_d7c75f0b-c323-4ab8-a19f-ef3896494525" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_faff4b70-2517-47fc-9b10-5266e765c7e3" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_d7c75f0b-c323-4ab8-a19f-ef3896494525" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_fc2fe6c2-0cf7-44d0-9cc9-f02c745f6a5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_faff4b70-2517-47fc-9b10-5266e765c7e3" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_fc2fe6c2-0cf7-44d0-9cc9-f02c745f6a5b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_2995ddf8-6bb7-4848-a02a-c1bfbf8e4c7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_926a1d23-ede6-40fa-b783-58f004a27523" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_2995ddf8-6bb7-4848-a02a-c1bfbf8e4c7b" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_926a1d23-ede6-40fa-b783-58f004a27523" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_ca8cc66e-549a-4db6-9a4f-3ab68453dfbd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_2995ddf8-6bb7-4848-a02a-c1bfbf8e4c7b" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_ca8cc66e-549a-4db6-9a4f-3ab68453dfbd" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dna.com/role/OperatingLeasesMaturitiesofLeaseLiabilitiesDetails_1" xlink:type="simple" xlink:href="pgen-20220331.xsd#OperatingLeasesMaturitiesofLeaseLiabilitiesDetails_1"/>
  <link:calculationLink xlink:role="http://www.dna.com/role/OperatingLeasesMaturitiesofLeaseLiabilitiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2a4e19d7-e0f2-4deb-a271-2990803d9008" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0aef14a6-1f85-4c44-9a4c-c6534855969a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2a4e19d7-e0f2-4deb-a271-2990803d9008" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0aef14a6-1f85-4c44-9a4c-c6534855969a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_c145c49d-8f71-4d26-80b4-109db7b3f4ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2a4e19d7-e0f2-4deb-a271-2990803d9008" xlink:to="loc_us-gaap_OperatingLeaseLiability_c145c49d-8f71-4d26-80b4-109db7b3f4ea" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>pgen-20220331_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:ee4b2abd-b2ae-467e-99f1-1b489525c45b,g:388a974a-f6e3-4fd9-acf5-6762aafe5cec-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.dna.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="pgen-20220331.xsd#CondensedConsolidatedBalanceSheetsParenthetical"/>
  <link:definitionLink xlink:role="http://www.dna.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended" id="i8f755e6e78354c97b04f0b213c2f077b_CondensedConsolidatedBalanceSheetsParenthetical">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_d27ed768-4588-40eb-b002-33a90908e0c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_ac25d33a-719c-4163-8ee1-463423df3d40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d27ed768-4588-40eb-b002-33a90908e0c3" xlink:to="loc_us-gaap_AssetsAbstract_ac25d33a-719c-4163-8ee1-463423df3d40" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_0ba49d46-9b32-4ffc-abab-77adb78bf867" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_ac25d33a-719c-4163-8ee1-463423df3d40" xlink:to="loc_us-gaap_AssetsCurrentAbstract_0ba49d46-9b32-4ffc-abab-77adb78bf867" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_b30451ba-70cd-47de-af5c-c142cddb747b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_0ba49d46-9b32-4ffc-abab-77adb78bf867" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_b30451ba-70cd-47de-af5c-c142cddb747b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_RelatedPartyReceivableAllowanceforCreditLossCurrent_9b563db0-148b-4a96-b6e5-834f47c7e2d8" xlink:href="pgen-20220331.xsd#pgen_RelatedPartyReceivableAllowanceforCreditLossCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_0ba49d46-9b32-4ffc-abab-77adb78bf867" xlink:to="loc_pgen_RelatedPartyReceivableAllowanceforCreditLossCurrent_9b563db0-148b-4a96-b6e5-834f47c7e2d8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_f1b3e57e-db5b-412a-93dc-855f09771d6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d27ed768-4588-40eb-b002-33a90908e0c3" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_f1b3e57e-db5b-412a-93dc-855f09771d6d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_0bfb1374-edfe-4cdb-a3b8-266fb04716a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_f1b3e57e-db5b-412a-93dc-855f09771d6d" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_0bfb1374-edfe-4cdb-a3b8-266fb04716a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_a6030d9b-c00d-4cfe-b06b-8919760652d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_f1b3e57e-db5b-412a-93dc-855f09771d6d" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_a6030d9b-c00d-4cfe-b06b-8919760652d9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_e749bff8-7752-43a3-a1bf-1f3aaad78c58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d27ed768-4588-40eb-b002-33a90908e0c3" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_e749bff8-7752-43a3-a1bf-1f3aaad78c58" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockNoParValue_896a23ca-7148-4351-8f71-b78fa3560f3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockNoParValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_e749bff8-7752-43a3-a1bf-1f3aaad78c58" xlink:to="loc_us-gaap_CommonStockNoParValue_896a23ca-7148-4351-8f71-b78fa3560f3d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_3b241619-0d3d-49d0-935a-0c5275c83840" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_e749bff8-7752-43a3-a1bf-1f3aaad78c58" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_3b241619-0d3d-49d0-935a-0c5275c83840" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_428f397a-d774-4560-abaf-8ff0415b822a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_e749bff8-7752-43a3-a1bf-1f3aaad78c58" xlink:to="loc_us-gaap_CommonStockSharesIssued_428f397a-d774-4560-abaf-8ff0415b822a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_ecaa8349-bc6b-4aad-80c3-85751f635aa0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_e749bff8-7752-43a3-a1bf-1f3aaad78c58" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_ecaa8349-bc6b-4aad-80c3-85751f635aa0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_cb381c54-1980-48a8-b75f-7fead85ef594" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_d27ed768-4588-40eb-b002-33a90908e0c3" xlink:to="loc_us-gaap_StatementTable_cb381c54-1980-48a8-b75f-7fead85ef594" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_adbc7f63-d4bf-43bf-b187-655199fc8cb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_cb381c54-1980-48a8-b75f-7fead85ef594" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_adbc7f63-d4bf-43bf-b187-655199fc8cb9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_adbc7f63-d4bf-43bf-b187-655199fc8cb9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_adbc7f63-d4bf-43bf-b187-655199fc8cb9" xlink:to="loc_us-gaap_RelatedPartyDomain_adbc7f63-d4bf-43bf-b187-655199fc8cb9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_c5090211-be1b-4c50-89be-1dfa0ca96ba2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_adbc7f63-d4bf-43bf-b187-655199fc8cb9" xlink:to="loc_us-gaap_RelatedPartyDomain_c5090211-be1b-4c50-89be-1dfa0ca96ba2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_RelatedPartiesAggregatedMember_1e23950a-1970-4b8b-8dbf-fefd15b6809c" xlink:href="pgen-20220331.xsd#pgen_RelatedPartiesAggregatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_c5090211-be1b-4c50-89be-1dfa0ca96ba2" xlink:to="loc_pgen_RelatedPartiesAggregatedMember_1e23950a-1970-4b8b-8dbf-fefd15b6809c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dna.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="pgen-20220331.xsd#CondensedConsolidatedStatementsofOperations"/>
  <link:definitionLink xlink:role="http://www.dna.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="extended" id="ia6116b45c6cb404ebd4fbd9239ff237f_CondensedConsolidatedStatementsofOperations">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_f148f0db-97b4-46ee-afcf-6d2fce13cfce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_5ab9b757-cf72-4676-a267-b68be1238d1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f148f0db-97b4-46ee-afcf-6d2fce13cfce" xlink:to="loc_us-gaap_RevenuesAbstract_5ab9b757-cf72-4676-a267-b68be1238d1b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1f5a42b7-459e-4b63-99a3-02ac5e1f8c0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_5ab9b757-cf72-4676-a267-b68be1238d1b" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1f5a42b7-459e-4b63-99a3-02ac5e1f8c0b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_f393ae63-2d87-466f-962b-98a801451171" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f148f0db-97b4-46ee-afcf-6d2fce13cfce" xlink:to="loc_us-gaap_OperatingExpensesAbstract_f393ae63-2d87-466f-962b-98a801451171" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_314b0422-180b-4c66-b6da-02f88185216c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_f393ae63-2d87-466f-962b-98a801451171" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_314b0422-180b-4c66-b6da-02f88185216c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_d86c440c-8e31-4708-8bb8-1595181ab175" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_f393ae63-2d87-466f-962b-98a801451171" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_d86c440c-8e31-4708-8bb8-1595181ab175" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_6e937d51-6cc8-44d1-9b13-98cc92e524a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_f393ae63-2d87-466f-962b-98a801451171" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_6e937d51-6cc8-44d1-9b13-98cc92e524a5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_b9bdddb3-dbe9-42c7-874b-3539e25464c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_f393ae63-2d87-466f-962b-98a801451171" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_b9bdddb3-dbe9-42c7-874b-3539e25464c2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_846307ea-dc59-46d4-87c3-6f6035bd3deb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_f393ae63-2d87-466f-962b-98a801451171" xlink:to="loc_us-gaap_OperatingExpenses_846307ea-dc59-46d4-87c3-6f6035bd3deb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_e1676b47-7bed-43ae-aa67-4bbaa508b862" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f148f0db-97b4-46ee-afcf-6d2fce13cfce" xlink:to="loc_us-gaap_OperatingIncomeLoss_e1676b47-7bed-43ae-aa67-4bbaa508b862" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_ce829225-6ade-48ce-9721-52d9b49dbd34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f148f0db-97b4-46ee-afcf-6d2fce13cfce" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_ce829225-6ade-48ce-9721-52d9b49dbd34" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_7504a292-61a4-4204-a9ec-851d66c57de8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_ce829225-6ade-48ce-9721-52d9b49dbd34" xlink:to="loc_us-gaap_InterestExpense_7504a292-61a4-4204-a9ec-851d66c57de8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNonoperating_d3fe6f59-a469-48b6-8792-2fac1c673e78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeNonoperating"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_ce829225-6ade-48ce-9721-52d9b49dbd34" xlink:to="loc_us-gaap_InvestmentIncomeNonoperating_d3fe6f59-a469-48b6-8792-2fac1c673e78" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_41f3c130-15ac-4af9-a998-bb50348d3aa1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_ce829225-6ade-48ce-9721-52d9b49dbd34" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_41f3c130-15ac-4af9-a998-bb50348d3aa1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_c543d996-62fc-4e22-9916-d779c16bb844" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_ce829225-6ade-48ce-9721-52d9b49dbd34" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_c543d996-62fc-4e22-9916-d779c16bb844" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_bf7ec0f3-27df-4dd3-9a8f-f72569f2fac4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f148f0db-97b4-46ee-afcf-6d2fce13cfce" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_bf7ec0f3-27df-4dd3-9a8f-f72569f2fac4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f5682f24-08da-4e46-951a-52518b2897d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f148f0db-97b4-46ee-afcf-6d2fce13cfce" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f5682f24-08da-4e46-951a-52518b2897d1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_44036d66-2052-4435-9908-3125bd3d44ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f148f0db-97b4-46ee-afcf-6d2fce13cfce" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_44036d66-2052-4435-9908-3125bd3d44ea" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_b072f0cf-bcd0-4b64-a3ca-fd7d82509a2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f148f0db-97b4-46ee-afcf-6d2fce13cfce" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_b072f0cf-bcd0-4b64-a3ca-fd7d82509a2a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_11c3b5b7-84cd-46f5-aed3-b5da5b856a31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f148f0db-97b4-46ee-afcf-6d2fce13cfce" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_11c3b5b7-84cd-46f5-aed3-b5da5b856a31" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_15757cff-538d-48fd-be79-341977d41168" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f148f0db-97b4-46ee-afcf-6d2fce13cfce" xlink:to="loc_us-gaap_NetIncomeLoss_15757cff-538d-48fd-be79-341977d41168" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_5dc5eb06-dd80-4a0b-b010-1f58f54aff63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f148f0db-97b4-46ee-afcf-6d2fce13cfce" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_5dc5eb06-dd80-4a0b-b010-1f58f54aff63" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_93e37e37-e47f-4e75-9177-55205defd1cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_5dc5eb06-dd80-4a0b-b010-1f58f54aff63" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_93e37e37-e47f-4e75-9177-55205defd1cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_00b8ab5b-bd50-4c62-bf23-b5e91425c3f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_5dc5eb06-dd80-4a0b-b010-1f58f54aff63" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_00b8ab5b-bd50-4c62-bf23-b5e91425c3f9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_dab82b5e-867b-4dd5-a794-18886e79663f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_5dc5eb06-dd80-4a0b-b010-1f58f54aff63" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_dab82b5e-867b-4dd5-a794-18886e79663f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_d43f355c-38bb-4b08-8b2f-d4dd3a3b5c24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_5dc5eb06-dd80-4a0b-b010-1f58f54aff63" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_d43f355c-38bb-4b08-8b2f-d4dd3a3b5c24" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_6d8a837b-f9f3-44f9-90eb-0db180143b74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_5dc5eb06-dd80-4a0b-b010-1f58f54aff63" xlink:to="loc_us-gaap_EarningsPerShareBasic_6d8a837b-f9f3-44f9-90eb-0db180143b74" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_c79d69f6-f33e-4a2a-8e35-9088741de38f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_5dc5eb06-dd80-4a0b-b010-1f58f54aff63" xlink:to="loc_us-gaap_EarningsPerShareDiluted_c79d69f6-f33e-4a2a-8e35-9088741de38f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a6fe9e05-0b48-45ff-a018-3b340acc17f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f148f0db-97b4-46ee-afcf-6d2fce13cfce" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a6fe9e05-0b48-45ff-a018-3b340acc17f5" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_219751c6-9ee6-41fc-81ca-1da6311589fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f148f0db-97b4-46ee-afcf-6d2fce13cfce" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_219751c6-9ee6-41fc-81ca-1da6311589fb" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_b107718b-435a-4286-ad0b-c749f91bc746" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_f148f0db-97b4-46ee-afcf-6d2fce13cfce" xlink:to="loc_us-gaap_StatementTable_b107718b-435a-4286-ad0b-c749f91bc746" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_9eba1cc2-13db-4c4c-afaa-c746dae4836e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOperatingActivitiesSegmentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_b107718b-435a-4286-ad0b-c749f91bc746" xlink:to="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_9eba1cc2-13db-4c4c-afaa-c746dae4836e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentOperatingActivitiesDomain_9eba1cc2-13db-4c4c-afaa-c746dae4836e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentOperatingActivitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_9eba1cc2-13db-4c4c-afaa-c746dae4836e" xlink:to="loc_us-gaap_SegmentOperatingActivitiesDomain_9eba1cc2-13db-4c4c-afaa-c746dae4836e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentOperatingActivitiesDomain_e15a619c-0079-429b-9c2a-711bc70cc9a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentOperatingActivitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_9eba1cc2-13db-4c4c-afaa-c746dae4836e" xlink:to="loc_us-gaap_SegmentOperatingActivitiesDomain_e15a619c-0079-429b-9c2a-711bc70cc9a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentContinuingOperationsMember_35d25438-ce48-4127-8fd8-9ca187ceaf2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentContinuingOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentOperatingActivitiesDomain_e15a619c-0079-429b-9c2a-711bc70cc9a8" xlink:to="loc_us-gaap_SegmentContinuingOperationsMember_35d25438-ce48-4127-8fd8-9ca187ceaf2d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_7c2ab6dc-c4a3-4e00-a1f8-4024d8172f8d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_b107718b-435a-4286-ad0b-c749f91bc746" xlink:to="loc_srt_ProductOrServiceAxis_7c2ab6dc-c4a3-4e00-a1f8-4024d8172f8d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_7c2ab6dc-c4a3-4e00-a1f8-4024d8172f8d_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_7c2ab6dc-c4a3-4e00-a1f8-4024d8172f8d" xlink:to="loc_srt_ProductsAndServicesDomain_7c2ab6dc-c4a3-4e00-a1f8-4024d8172f8d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_97951bc9-f5b8-44be-a7d0-d2c10165853c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_7c2ab6dc-c4a3-4e00-a1f8-4024d8172f8d" xlink:to="loc_srt_ProductsAndServicesDomain_97951bc9-f5b8-44be-a7d0-d2c10165853c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_ec3a00d1-ab9d-4b50-99ab-99f3a9f8b76a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_97951bc9-f5b8-44be-a7d0-d2c10165853c" xlink:to="loc_us-gaap_ProductMember_ec3a00d1-ab9d-4b50-99ab-99f3a9f8b76a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_10b98b47-30bc-452a-af43-9517b38010f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_97951bc9-f5b8-44be-a7d0-d2c10165853c" xlink:to="loc_us-gaap_ServiceMember_10b98b47-30bc-452a-af43-9517b38010f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_OtherMember_6efee24f-76cd-44b0-b33e-b6082faff066" xlink:href="pgen-20220331.xsd#pgen_OtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_97951bc9-f5b8-44be-a7d0-d2c10165853c" xlink:to="loc_pgen_OtherMember_6efee24f-76cd-44b0-b33e-b6082faff066" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_e12406a4-95b5-42c5-bbe6-18f160b58352" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_b107718b-435a-4286-ad0b-c749f91bc746" xlink:to="loc_us-gaap_TypeOfArrangementAxis_e12406a4-95b5-42c5-bbe6-18f160b58352" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_e12406a4-95b5-42c5-bbe6-18f160b58352_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_e12406a4-95b5-42c5-bbe6-18f160b58352" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_e12406a4-95b5-42c5-bbe6-18f160b58352_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_6413305c-4e45-4673-9e08-af0a826fd545" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_e12406a4-95b5-42c5-bbe6-18f160b58352" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_6413305c-4e45-4673-9e08-af0a826fd545" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementMember_ea47b67f-3ca5-40d2-ae20-ef6ea63f964e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_6413305c-4e45-4673-9e08-af0a826fd545" xlink:to="loc_us-gaap_CollaborativeArrangementMember_ea47b67f-3ca5-40d2-ae20-ef6ea63f964e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dna.com/role/CondensedConsolidatedStatementsofOperationsParenthetical" xlink:type="simple" xlink:href="pgen-20220331.xsd#CondensedConsolidatedStatementsofOperationsParenthetical"/>
  <link:definitionLink xlink:role="http://www.dna.com/role/CondensedConsolidatedStatementsofOperationsParenthetical" xlink:type="extended" id="ie78dd1f40a5343c1afa21ac9a6096917_CondensedConsolidatedStatementsofOperationsParenthetical">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_2e01eda4-3550-453f-984c-caed1b915376" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9b8f15f3-e6be-4768-b057-5218635f5830" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_2e01eda4-3550-453f-984c-caed1b915376" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9b8f15f3-e6be-4768-b057-5218635f5830" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_fd1b3ceb-44a7-4576-9774-e019458141e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_2e01eda4-3550-453f-984c-caed1b915376" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_fd1b3ceb-44a7-4576-9774-e019458141e4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_10d531a8-d20f-4c7e-9507-3244d349b51b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_fd1b3ceb-44a7-4576-9774-e019458141e4" xlink:to="loc_us-gaap_TypeOfArrangementAxis_10d531a8-d20f-4c7e-9507-3244d349b51b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_10d531a8-d20f-4c7e-9507-3244d349b51b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_10d531a8-d20f-4c7e-9507-3244d349b51b" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_10d531a8-d20f-4c7e-9507-3244d349b51b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_795a440e-cd0b-424f-8d3b-7cada4fc95f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_10d531a8-d20f-4c7e-9507-3244d349b51b" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_795a440e-cd0b-424f-8d3b-7cada4fc95f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementMember_53de797f-5251-4486-a71b-29c35aea68d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_795a440e-cd0b-424f-8d3b-7cada4fc95f6" xlink:to="loc_us-gaap_CollaborativeArrangementMember_53de797f-5251-4486-a71b-29c35aea68d6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_07dd336f-5632-4d0c-bb13-8c26d6678834" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOperatingActivitiesSegmentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_fd1b3ceb-44a7-4576-9774-e019458141e4" xlink:to="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_07dd336f-5632-4d0c-bb13-8c26d6678834" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentOperatingActivitiesDomain_07dd336f-5632-4d0c-bb13-8c26d6678834_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentOperatingActivitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_07dd336f-5632-4d0c-bb13-8c26d6678834" xlink:to="loc_us-gaap_SegmentOperatingActivitiesDomain_07dd336f-5632-4d0c-bb13-8c26d6678834_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentOperatingActivitiesDomain_3ec56ffa-4ad9-469d-b094-720e22c3355e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentOperatingActivitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_07dd336f-5632-4d0c-bb13-8c26d6678834" xlink:to="loc_us-gaap_SegmentOperatingActivitiesDomain_3ec56ffa-4ad9-469d-b094-720e22c3355e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentContinuingOperationsMember_c83c0cbf-fef7-41c1-8935-fda5f2a2e473" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentContinuingOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentOperatingActivitiesDomain_3ec56ffa-4ad9-469d-b094-720e22c3355e" xlink:to="loc_us-gaap_SegmentContinuingOperationsMember_c83c0cbf-fef7-41c1-8935-fda5f2a2e473" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_2cee016d-dde1-433a-936f-8293e7737fd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_fd1b3ceb-44a7-4576-9774-e019458141e4" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_2cee016d-dde1-433a-936f-8293e7737fd9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_2cee016d-dde1-433a-936f-8293e7737fd9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_2cee016d-dde1-433a-936f-8293e7737fd9" xlink:to="loc_us-gaap_RelatedPartyDomain_2cee016d-dde1-433a-936f-8293e7737fd9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_192ca6af-7b7e-4bce-940c-eccffeb09c96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_2cee016d-dde1-433a-936f-8293e7737fd9" xlink:to="loc_us-gaap_RelatedPartyDomain_192ca6af-7b7e-4bce-940c-eccffeb09c96" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_RelatedPartiesAggregatedMember_d2f54b8e-8d9a-450e-9aba-19d9cce7abb5" xlink:href="pgen-20220331.xsd#pgen_RelatedPartiesAggregatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_192ca6af-7b7e-4bce-940c-eccffeb09c96" xlink:to="loc_pgen_RelatedPartiesAggregatedMember_d2f54b8e-8d9a-450e-9aba-19d9cce7abb5" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dna.com/role/CondensedConsolidatedStatementsofShareholdersEquity" xlink:type="simple" xlink:href="pgen-20220331.xsd#CondensedConsolidatedStatementsofShareholdersEquity"/>
  <link:definitionLink xlink:role="http://www.dna.com/role/CondensedConsolidatedStatementsofShareholdersEquity" xlink:type="extended" id="ic79d1e81405a41259d62e2d18df2f156_CondensedConsolidatedStatementsofShareholdersEquity">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_344bb495-44b1-46a5-afeb-1232eb40f496" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5bb9b6a1-879a-43c0-94e9-de875bca8f94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_344bb495-44b1-46a5-afeb-1232eb40f496" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5bb9b6a1-879a-43c0-94e9-de875bca8f94" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_bc93e59c-e254-4f19-9df1-f6f0307bb6ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5bb9b6a1-879a-43c0-94e9-de875bca8f94" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_bc93e59c-e254-4f19-9df1-f6f0307bb6ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_d7beec31-708f-48c9-8fbe-abd8da5890d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5bb9b6a1-879a-43c0-94e9-de875bca8f94" xlink:to="loc_us-gaap_StockholdersEquity_d7beec31-708f-48c9-8fbe-abd8da5890d6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_bad6e0eb-22c4-4856-ae26-40620f08a382" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5bb9b6a1-879a-43c0-94e9-de875bca8f94" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_bad6e0eb-22c4-4856-ae26-40620f08a382" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_StockIssuedDuringPeriodSharesStockOptionsExercisedAndRestrictedStockAwards_43b63f01-ac4f-43ce-b79f-dd1d97194463" xlink:href="pgen-20220331.xsd#pgen_StockIssuedDuringPeriodSharesStockOptionsExercisedAndRestrictedStockAwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5bb9b6a1-879a-43c0-94e9-de875bca8f94" xlink:to="loc_pgen_StockIssuedDuringPeriodSharesStockOptionsExercisedAndRestrictedStockAwards_43b63f01-ac4f-43ce-b79f-dd1d97194463" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_StockIssuedDuringPeriodValueRestrictedStockAwardsVestedAndStockOptionsExercised_f9fbace0-6e66-46fb-a829-c68fd3b4bf37" xlink:href="pgen-20220331.xsd#pgen_StockIssuedDuringPeriodValueRestrictedStockAwardsVestedAndStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5bb9b6a1-879a-43c0-94e9-de875bca8f94" xlink:to="loc_pgen_StockIssuedDuringPeriodValueRestrictedStockAwardsVestedAndStockOptionsExercised_f9fbace0-6e66-46fb-a829-c68fd3b4bf37" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_StockIssuedDuringThePeriodSharesAccruedCompensation_280f0fdb-2252-4a37-80e6-5262b4702961" xlink:href="pgen-20220331.xsd#pgen_StockIssuedDuringThePeriodSharesAccruedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5bb9b6a1-879a-43c0-94e9-de875bca8f94" xlink:to="loc_pgen_StockIssuedDuringThePeriodSharesAccruedCompensation_280f0fdb-2252-4a37-80e6-5262b4702961" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_StockIssuedDuringThePeriodValueAccruedCompensation_92413bb2-7746-4ebe-ae0a-23189190cef4" xlink:href="pgen-20220331.xsd#pgen_StockIssuedDuringThePeriodValueAccruedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5bb9b6a1-879a-43c0-94e9-de875bca8f94" xlink:to="loc_pgen_StockIssuedDuringThePeriodValueAccruedCompensation_92413bb2-7746-4ebe-ae0a-23189190cef4" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_a5b5eeb9-8bc9-4411-86b7-38c99c98ff7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5bb9b6a1-879a-43c0-94e9-de875bca8f94" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_a5b5eeb9-8bc9-4411-86b7-38c99c98ff7f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueIssuedForServices_c63e8263-37c6-4bf9-bf71-2af198e1d76e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5bb9b6a1-879a-43c0-94e9-de875bca8f94" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueIssuedForServices_c63e8263-37c6-4bf9-bf71-2af198e1d76e" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_61a5e2b6-be2e-4378-84f6-e2f4a19a3f52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5bb9b6a1-879a-43c0-94e9-de875bca8f94" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_61a5e2b6-be2e-4378-84f6-e2f4a19a3f52" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_c09f6255-4e20-47fc-b172-35dc3a01196a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5bb9b6a1-879a-43c0-94e9-de875bca8f94" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_c09f6255-4e20-47fc-b172-35dc3a01196a" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_a3640d2b-4561-40f0-83b9-94b01c18f036" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5bb9b6a1-879a-43c0-94e9-de875bca8f94" xlink:to="loc_us-gaap_NetIncomeLoss_a3640d2b-4561-40f0-83b9-94b01c18f036" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_29de6b44-9937-42e5-91b6-a084ffabfc24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5bb9b6a1-879a-43c0-94e9-de875bca8f94" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_29de6b44-9937-42e5-91b6-a084ffabfc24" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_34fcd480-190d-47b2-b769-343df9208fe0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_8376ae45-1e39-4c6f-a581-42b0ad9251d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_95cd4584-4a42-4c04-a968-ab27f149f536" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5bb9b6a1-879a-43c0-94e9-de875bca8f94" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_95cd4584-4a42-4c04-a968-ab27f149f536" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_f33a6b94-9f8a-4f32-9d32-8894bd712254" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_344bb495-44b1-46a5-afeb-1232eb40f496" xlink:to="loc_us-gaap_StatementTable_f33a6b94-9f8a-4f32-9d32-8894bd712254" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_67370747-1a27-4674-b050-1539fd6d2477" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_f33a6b94-9f8a-4f32-9d32-8894bd712254" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_67370747-1a27-4674-b050-1539fd6d2477" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_67370747-1a27-4674-b050-1539fd6d2477_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_67370747-1a27-4674-b050-1539fd6d2477" xlink:to="loc_us-gaap_EquityComponentDomain_67370747-1a27-4674-b050-1539fd6d2477_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_6a875881-038e-4af2-8767-7e4b104f7c5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_67370747-1a27-4674-b050-1539fd6d2477" xlink:to="loc_us-gaap_EquityComponentDomain_6a875881-038e-4af2-8767-7e4b104f7c5b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_25e3d080-a173-4d48-a935-02002574a602" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_6a875881-038e-4af2-8767-7e4b104f7c5b" xlink:to="loc_us-gaap_CommonStockMember_25e3d080-a173-4d48-a935-02002574a602" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_17110c2e-9e8c-4c1d-bda1-73cb3590ddee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_6a875881-038e-4af2-8767-7e4b104f7c5b" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_17110c2e-9e8c-4c1d-bda1-73cb3590ddee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_4f6d92ba-3e0d-40c4-b750-0cedffe3777b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_6a875881-038e-4af2-8767-7e4b104f7c5b" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_4f6d92ba-3e0d-40c4-b750-0cedffe3777b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_60cb0a16-9cf6-4864-b05d-fa152a040e89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_6a875881-038e-4af2-8767-7e4b104f7c5b" xlink:to="loc_us-gaap_RetainedEarningsMember_60cb0a16-9cf6-4864-b05d-fa152a040e89" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_01b84df0-b9b6-455d-a2a4-9c05ded96169" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_f33a6b94-9f8a-4f32-9d32-8894bd712254" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_01b84df0-b9b6-455d-a2a4-9c05ded96169" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_01b84df0-b9b6-455d-a2a4-9c05ded96169_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_01b84df0-b9b6-455d-a2a4-9c05ded96169" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_01b84df0-b9b6-455d-a2a4-9c05ded96169_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_d5182879-6cfb-44aa-abc8-0e89028bb7fd" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_01b84df0-b9b6-455d-a2a4-9c05ded96169" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_d5182879-6cfb-44aa-abc8-0e89028bb7fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_b1332381-7e86-437e-9467-0c52ccb7d664" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_d5182879-6cfb-44aa-abc8-0e89028bb7fd" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_b1332381-7e86-437e-9467-0c52ccb7d664" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dna.com/role/SummaryofSignificantAccountingPoliciesNetLossPerShareAdditionalInformationDetails" xlink:type="simple" xlink:href="pgen-20220331.xsd#SummaryofSignificantAccountingPoliciesNetLossPerShareAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.dna.com/role/SummaryofSignificantAccountingPoliciesNetLossPerShareAdditionalInformationDetails" xlink:type="extended" id="idff72dfc0d4f4e3ea4f32fdcf7472e40_SummaryofSignificantAccountingPoliciesNetLossPerShareAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_1ce28620-5497-4d85-9d8f-33cda4e263c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_6429ebfb-c5c2-4da2-ad73-be677526f7b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_1ce28620-5497-4d85-9d8f-33cda4e263c0" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_6429ebfb-c5c2-4da2-ad73-be677526f7b2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_e0520502-8e18-449d-9a4f-908023646a62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_1ce28620-5497-4d85-9d8f-33cda4e263c0" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_e0520502-8e18-449d-9a4f-908023646a62" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_6781eba0-da97-4a7c-94b2-5ed17e54512f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_e0520502-8e18-449d-9a4f-908023646a62" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_6781eba0-da97-4a7c-94b2-5ed17e54512f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_6781eba0-da97-4a7c-94b2-5ed17e54512f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_6781eba0-da97-4a7c-94b2-5ed17e54512f" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_6781eba0-da97-4a7c-94b2-5ed17e54512f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_b84650c5-d78b-4880-af75-5dc51a306d0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_6781eba0-da97-4a7c-94b2-5ed17e54512f" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_b84650c5-d78b-4880-af75-5dc51a306d0d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_22979b36-119a-4eb3-b629-68b61ce3ac37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_b84650c5-d78b-4880-af75-5dc51a306d0d" xlink:to="loc_us-gaap_ConvertibleDebtMember_22979b36-119a-4eb3-b629-68b61ce3ac37" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember_bcd0a4de-3d18-4cb8-9ee1-231fde5f3480" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_b84650c5-d78b-4880-af75-5dc51a306d0d" xlink:to="loc_us-gaap_StockOptionMember_bcd0a4de-3d18-4cb8-9ee1-231fde5f3480" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_4e6cdc25-afae-48f6-a853-44e2b48e6cbc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_b84650c5-d78b-4880-af75-5dc51a306d0d" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_4e6cdc25-afae-48f6-a853-44e2b48e6cbc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_d9da6da7-6d84-41ee-890c-9f06b8ff3959" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_b84650c5-d78b-4880-af75-5dc51a306d0d" xlink:to="loc_us-gaap_WarrantMember_d9da6da7-6d84-41ee-890c-9f06b8ff3959" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dna.com/role/SummaryofSignificantAccountingPoliciesRecentlyAdoptedAccountingPronouncementsAdditionalInformationDetails" xlink:type="simple" xlink:href="pgen-20220331.xsd#SummaryofSignificantAccountingPoliciesRecentlyAdoptedAccountingPronouncementsAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.dna.com/role/SummaryofSignificantAccountingPoliciesRecentlyAdoptedAccountingPronouncementsAdditionalInformationDetails" xlink:type="extended" id="i721dc501e6ec4e78a8c26a4d297db3d5_SummaryofSignificantAccountingPoliciesRecentlyAdoptedAccountingPronouncementsAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b4952277-ce6d-4def-90e3-260940b495de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_67aade89-8c3a-470c-8716-b8f357973cc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b4952277-ce6d-4def-90e3-260940b495de" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_67aade89-8c3a-470c-8716-b8f357973cc1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_97764d96-82e0-4622-84a8-b30cb0c5a545" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b4952277-ce6d-4def-90e3-260940b495de" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_97764d96-82e0-4622-84a8-b30cb0c5a545" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_InterestExpenseDebtAmortizationofDebtDiscountPremiumandDebtIssuanceCosts_ab892bc4-694d-434b-a54a-0115303b96e1" xlink:href="pgen-20220331.xsd#pgen_InterestExpenseDebtAmortizationofDebtDiscountPremiumandDebtIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b4952277-ce6d-4def-90e3-260940b495de" xlink:to="loc_pgen_InterestExpenseDebtAmortizationofDebtDiscountPremiumandDebtIssuanceCosts_ab892bc4-694d-434b-a54a-0115303b96e1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_b7729eab-a5a7-43e5-ac03-367c4cd1b810" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b4952277-ce6d-4def-90e3-260940b495de" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_b7729eab-a5a7-43e5-ac03-367c4cd1b810" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_e3404b56-0f0c-4b61-b217-4b18c5583653" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_b7729eab-a5a7-43e5-ac03-367c4cd1b810" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_e3404b56-0f0c-4b61-b217-4b18c5583653" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_e3404b56-0f0c-4b61-b217-4b18c5583653_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_e3404b56-0f0c-4b61-b217-4b18c5583653" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_e3404b56-0f0c-4b61-b217-4b18c5583653_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_9d53e925-a0dc-4277-b8f3-f8be72d80887" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_e3404b56-0f0c-4b61-b217-4b18c5583653" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_9d53e925-a0dc-4277-b8f3-f8be72d80887" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_82c01baa-af34-4120-9ae6-b88504a07cc1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_9d53e925-a0dc-4277-b8f3-f8be72d80887" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_82c01baa-af34-4120-9ae6-b88504a07cc1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_210119fb-6ab9-4fec-99b9-c1251bfbbd0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_b7729eab-a5a7-43e5-ac03-367c4cd1b810" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_210119fb-6ab9-4fec-99b9-c1251bfbbd0b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_210119fb-6ab9-4fec-99b9-c1251bfbbd0b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_210119fb-6ab9-4fec-99b9-c1251bfbbd0b" xlink:to="loc_us-gaap_TypeOfAdoptionMember_210119fb-6ab9-4fec-99b9-c1251bfbbd0b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_39e31a3a-1e65-431c-9c54-8c7ca5aeaa9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_210119fb-6ab9-4fec-99b9-c1251bfbbd0b" xlink:to="loc_us-gaap_TypeOfAdoptionMember_39e31a3a-1e65-431c-9c54-8c7ca5aeaa9e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate202006RetrospectiveMember_86eadd65-004b-4a4a-b77d-ae2e2c2a18c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate202006RetrospectiveMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_39e31a3a-1e65-431c-9c54-8c7ca5aeaa9e" xlink:to="loc_us-gaap_AccountingStandardsUpdate202006RetrospectiveMember_86eadd65-004b-4a4a-b77d-ae2e2c2a18c0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_7b9a2f23-91d7-4dfe-bb90-94966f4ac9d9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_b7729eab-a5a7-43e5-ac03-367c4cd1b810" xlink:to="loc_srt_StatementScenarioAxis_7b9a2f23-91d7-4dfe-bb90-94966f4ac9d9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_7b9a2f23-91d7-4dfe-bb90-94966f4ac9d9_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_7b9a2f23-91d7-4dfe-bb90-94966f4ac9d9" xlink:to="loc_srt_ScenarioUnspecifiedDomain_7b9a2f23-91d7-4dfe-bb90-94966f4ac9d9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_9f9457b2-0a75-4df2-b042-30fa0f302367" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_7b9a2f23-91d7-4dfe-bb90-94966f4ac9d9" xlink:to="loc_srt_ScenarioUnspecifiedDomain_9f9457b2-0a75-4df2-b042-30fa0f302367" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_cad54c3b-7c6e-490a-8580-9d037ad30abf" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_9f9457b2-0a75-4df2-b042-30fa0f302367" xlink:to="loc_srt_ScenarioForecastMember_cad54c3b-7c6e-490a-8580-9d037ad30abf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_78fca014-7580-46e0-a38a-d507a6d0e2cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_b7729eab-a5a7-43e5-ac03-367c4cd1b810" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_78fca014-7580-46e0-a38a-d507a6d0e2cd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_78fca014-7580-46e0-a38a-d507a6d0e2cd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_78fca014-7580-46e0-a38a-d507a6d0e2cd" xlink:to="loc_us-gaap_EquityComponentDomain_78fca014-7580-46e0-a38a-d507a6d0e2cd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_62fd6af3-c693-42cc-aff2-470bd2422a62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_78fca014-7580-46e0-a38a-d507a6d0e2cd" xlink:to="loc_us-gaap_EquityComponentDomain_62fd6af3-c693-42cc-aff2-470bd2422a62" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_17d824a5-1cec-4f53-97f8-0dacda233684" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_62fd6af3-c693-42cc-aff2-470bd2422a62" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_17d824a5-1cec-4f53-97f8-0dacda233684" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_54a3dcde-fe96-404b-9b8f-518796fa6a38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_62fd6af3-c693-42cc-aff2-470bd2422a62" xlink:to="loc_us-gaap_RetainedEarningsMember_54a3dcde-fe96-404b-9b8f-518796fa6a38" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dna.com/role/DiscontinuedOperationsNarrativeDetails" xlink:type="simple" xlink:href="pgen-20220331.xsd#DiscontinuedOperationsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.dna.com/role/DiscontinuedOperationsNarrativeDetails" xlink:type="extended" id="i66f58bdaaef440ea99646d33431e6818_DiscontinuedOperationsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_34733308-cd06-4df3-bcbf-7272c0a0633a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets1_36587a8d-62f7-4959-81f8-25d4a805c1c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_34733308-cd06-4df3-bcbf-7272c0a0633a" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets1_36587a8d-62f7-4959-81f8-25d4a805c1c9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnTerminationOfLease_00fe3af9-284a-4ee7-9a27-b3da0139f297" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnTerminationOfLease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_34733308-cd06-4df3-bcbf-7272c0a0633a" xlink:to="loc_us-gaap_GainLossOnTerminationOfLease_00fe3af9-284a-4ee7-9a27-b3da0139f297" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_ca38e9bf-5948-42be-ae8f-8ed66321df1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_34733308-cd06-4df3-bcbf-7272c0a0633a" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_ca38e9bf-5948-42be-ae8f-8ed66321df1c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_65b160dc-2b64-4326-8b3b-c8ca92ca251a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_34733308-cd06-4df3-bcbf-7272c0a0633a" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_65b160dc-2b64-4326-8b3b-c8ca92ca251a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_127705c6-08ff-4728-80c5-604bf281de77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_65b160dc-2b64-4326-8b3b-c8ca92ca251a" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_127705c6-08ff-4728-80c5-604bf281de77" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_127705c6-08ff-4728-80c5-604bf281de77_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_127705c6-08ff-4728-80c5-604bf281de77" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_127705c6-08ff-4728-80c5-604bf281de77_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_42ed8537-ddcc-442f-9ec5-bfe6d300c499" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_127705c6-08ff-4728-80c5-604bf281de77" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_42ed8537-ddcc-442f-9ec5-bfe6d300c499" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_MBPTitanMember_51039542-a3e4-4827-8bd9-d08bc08b5484" xlink:href="pgen-20220331.xsd#pgen_MBPTitanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_42ed8537-ddcc-442f-9ec5-bfe6d300c499" xlink:to="loc_pgen_MBPTitanMember_51039542-a3e4-4827-8bd9-d08bc08b5484" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_cf450ed7-b5ed-4687-9334-b63908823370" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_65b160dc-2b64-4326-8b3b-c8ca92ca251a" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_cf450ed7-b5ed-4687-9334-b63908823370" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_cf450ed7-b5ed-4687-9334-b63908823370_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_cf450ed7-b5ed-4687-9334-b63908823370" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_cf450ed7-b5ed-4687-9334-b63908823370_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_d3b223c8-e5a5-4045-aa31-de99956c69ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_cf450ed7-b5ed-4687-9334-b63908823370" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_d3b223c8-e5a5-4045-aa31-de99956c69ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleAbandonmentMember_2807af1f-b927-4ed5-9a71-4c800d903c45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleAbandonmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_d3b223c8-e5a5-4045-aa31-de99956c69ea" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleAbandonmentMember_2807af1f-b927-4ed5-9a71-4c800d903c45" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dna.com/role/DiscontinuedOperationsSummaryofFinancialResultsforMBPTitanDetails" xlink:type="simple" xlink:href="pgen-20220331.xsd#DiscontinuedOperationsSummaryofFinancialResultsforMBPTitanDetails"/>
  <link:definitionLink xlink:role="http://www.dna.com/role/DiscontinuedOperationsSummaryofFinancialResultsforMBPTitanDetails" xlink:type="extended" id="i79cafb87d4aa4388ad81004f496f56c6_DiscontinuedOperationsSummaryofFinancialResultsforMBPTitanDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_2e6ea882-5f97-47c9-92e0-bb97fe844bea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_6f2687c6-885e-4357-9bf5-8c2dbb073bf0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_2e6ea882-5f97-47c9-92e0-bb97fe844bea" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_6f2687c6-885e-4357-9bf5-8c2dbb073bf0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_0cca511b-9973-4fcd-b42c-1ccd85e404ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_2e6ea882-5f97-47c9-92e0-bb97fe844bea" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_0cca511b-9973-4fcd-b42c-1ccd85e404ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_2c66246e-f99c-422a-9a78-8320dcfefa4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_2e6ea882-5f97-47c9-92e0-bb97fe844bea" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_2c66246e-f99c-422a-9a78-8320dcfefa4e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_e08e067d-b4ab-402d-b85e-1ca64b13ecc0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_2e6ea882-5f97-47c9-92e0-bb97fe844bea" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_e08e067d-b4ab-402d-b85e-1ca64b13ecc0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_cf664f47-0649-4d58-bd61-2f589c4e7a01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_2e6ea882-5f97-47c9-92e0-bb97fe844bea" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_cf664f47-0649-4d58-bd61-2f589c4e7a01" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_991df2e8-639e-4be0-a786-d8262fb9c182" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_cf664f47-0649-4d58-bd61-2f589c4e7a01" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_991df2e8-639e-4be0-a786-d8262fb9c182" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_991df2e8-639e-4be0-a786-d8262fb9c182_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_991df2e8-639e-4be0-a786-d8262fb9c182" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_991df2e8-639e-4be0-a786-d8262fb9c182_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_da8b1135-88b8-4685-8c89-b37d4af1eb97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_991df2e8-639e-4be0-a786-d8262fb9c182" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_da8b1135-88b8-4685-8c89-b37d4af1eb97" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_MBPTitanMember_571bae8d-c29b-406d-9e40-a5fef1e5b338" xlink:href="pgen-20220331.xsd#pgen_MBPTitanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_da8b1135-88b8-4685-8c89-b37d4af1eb97" xlink:to="loc_pgen_MBPTitanMember_571bae8d-c29b-406d-9e40-a5fef1e5b338" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_fdb0febf-cff9-4bf5-9cce-079f150c3e86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_cf664f47-0649-4d58-bd61-2f589c4e7a01" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_fdb0febf-cff9-4bf5-9cce-079f150c3e86" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_fdb0febf-cff9-4bf5-9cce-079f150c3e86_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_fdb0febf-cff9-4bf5-9cce-079f150c3e86" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_fdb0febf-cff9-4bf5-9cce-079f150c3e86_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_593ff935-13bf-49eb-95db-ecc868f181b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_fdb0febf-cff9-4bf5-9cce-079f150c3e86" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_593ff935-13bf-49eb-95db-ecc868f181b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleAbandonmentMember_328c93da-084e-4e01-85f0-2d7b04fd2358" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleAbandonmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_593ff935-13bf-49eb-95db-ecc868f181b4" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleAbandonmentMember_328c93da-084e-4e01-85f0-2d7b04fd2358" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dna.com/role/DiscontinuedOperationsNoncashItemsandPurchasesofPropertyPlantandEquipmentforMBPTitanDetails" xlink:type="simple" xlink:href="pgen-20220331.xsd#DiscontinuedOperationsNoncashItemsandPurchasesofPropertyPlantandEquipmentforMBPTitanDetails"/>
  <link:definitionLink xlink:role="http://www.dna.com/role/DiscontinuedOperationsNoncashItemsandPurchasesofPropertyPlantandEquipmentforMBPTitanDetails" xlink:type="extended" id="ib5b262e5127f4d6e802da1c9a788e330_DiscontinuedOperationsNoncashItemsandPurchasesofPropertyPlantandEquipmentforMBPTitanDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_0923c041-fab6-40db-869f-456c0903b183" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2786af5a-4c9f-4f8b-ac96-9199a0f3b820" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_0923c041-fab6-40db-869f-456c0903b183" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2786af5a-4c9f-4f8b-ac96-9199a0f3b820" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets1_0910b9ad-22fb-4c7f-a06c-8b03af720ba7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2786af5a-4c9f-4f8b-ac96-9199a0f3b820" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets1_0910b9ad-22fb-4c7f-a06c-8b03af720ba7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnTerminationOfLease_806b4a8c-fb82-4070-a369-40ec4afaa8f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnTerminationOfLease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2786af5a-4c9f-4f8b-ac96-9199a0f3b820" xlink:to="loc_us-gaap_GainLossOnTerminationOfLease_806b4a8c-fb82-4070-a369-40ec4afaa8f2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalCashFlowElementsInvestingActivitiesAbstract_0b7c4229-3397-4a37-aea2-3af378e4d261" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalCashFlowElementsInvestingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_0923c041-fab6-40db-869f-456c0903b183" xlink:to="loc_us-gaap_AdditionalCashFlowElementsInvestingActivitiesAbstract_0b7c4229-3397-4a37-aea2-3af378e4d261" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities_f91c31fa-bfa6-4bde-8f98-2ad4f7b5c450" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdditionalCashFlowElementsInvestingActivitiesAbstract_0b7c4229-3397-4a37-aea2-3af378e4d261" xlink:to="loc_us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities_f91c31fa-bfa6-4bde-8f98-2ad4f7b5c450" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_63b105fe-8c79-43be-ac84-f4214438beaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_0923c041-fab6-40db-869f-456c0903b183" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_63b105fe-8c79-43be-ac84-f4214438beaf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_79909bc3-a02f-4b38-bedf-34b86fa3b535" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_63b105fe-8c79-43be-ac84-f4214438beaf" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_79909bc3-a02f-4b38-bedf-34b86fa3b535" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_79909bc3-a02f-4b38-bedf-34b86fa3b535_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_79909bc3-a02f-4b38-bedf-34b86fa3b535" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_79909bc3-a02f-4b38-bedf-34b86fa3b535_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_68fe1673-a8d3-4563-ab3e-dde7372c556b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_79909bc3-a02f-4b38-bedf-34b86fa3b535" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_68fe1673-a8d3-4563-ab3e-dde7372c556b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleAbandonmentMember_6e93d217-fba9-4d33-9148-e497688ca636" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleAbandonmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_68fe1673-a8d3-4563-ab3e-dde7372c556b" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleAbandonmentMember_6e93d217-fba9-4d33-9148-e497688ca636" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cc7e8e39-8482-4bfb-81c9-7edcea013d14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_63b105fe-8c79-43be-ac84-f4214438beaf" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cc7e8e39-8482-4bfb-81c9-7edcea013d14" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_cc7e8e39-8482-4bfb-81c9-7edcea013d14_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cc7e8e39-8482-4bfb-81c9-7edcea013d14" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_cc7e8e39-8482-4bfb-81c9-7edcea013d14_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c93e30d3-c025-4f3e-99c1-e4ff48cff7a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cc7e8e39-8482-4bfb-81c9-7edcea013d14" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c93e30d3-c025-4f3e-99c1-e4ff48cff7a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_MBPTitanMember_adf6519d-c75b-46b7-96c2-b35abd82c802" xlink:href="pgen-20220331.xsd#pgen_MBPTitanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c93e30d3-c025-4f3e-99c1-e4ff48cff7a4" xlink:to="loc_pgen_MBPTitanMember_adf6519d-c75b-46b7-96c2-b35abd82c802" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dna.com/role/InvestmentsinJointVenturesIntrexonEnergyPartnersAdditionalInformationDetails" xlink:type="simple" xlink:href="pgen-20220331.xsd#InvestmentsinJointVenturesIntrexonEnergyPartnersAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.dna.com/role/InvestmentsinJointVenturesIntrexonEnergyPartnersAdditionalInformationDetails" xlink:type="extended" id="i8daf1ebe45f4406fb7af3e058cf06b76_InvestmentsinJointVenturesIntrexonEnergyPartnersAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_4471fe7d-93df-4529-9465-e06056307fdc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_CollaborativeArrangementConsiderationReceivedValue_6e4997a7-9a79-453c-9b88-aae5a77776c5" xlink:href="pgen-20220331.xsd#pgen_CollaborativeArrangementConsiderationReceivedValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_4471fe7d-93df-4529-9465-e06056307fdc" xlink:to="loc_pgen_CollaborativeArrangementConsiderationReceivedValue_6e4997a7-9a79-453c-9b88-aae5a77776c5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_58d60e24-4990-4c12-b851-7233ede39074" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_4471fe7d-93df-4529-9465-e06056307fdc" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_58d60e24-4990-4c12-b851-7233ede39074" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInterestInJointVenture_ab307d5e-6a49-4b30-b7b9-5b01d6fdf573" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireInterestInJointVenture"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_4471fe7d-93df-4529-9465-e06056307fdc" xlink:to="loc_us-gaap_PaymentsToAcquireInterestInJointVenture_ab307d5e-6a49-4b30-b7b9-5b01d6fdf573" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_JointVentureAdditionalCapitalContributionsCommitted_691a5f82-f27d-4ae7-b56c-04c2ad640f03" xlink:href="pgen-20220331.xsd#pgen_JointVentureAdditionalCapitalContributionsCommitted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_4471fe7d-93df-4529-9465-e06056307fdc" xlink:to="loc_pgen_JointVentureAdditionalCapitalContributionsCommitted_691a5f82-f27d-4ae7-b56c-04c2ad640f03" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_JointVentureAdditionalCapitalContributionsCommittedRemainingCommitment_2d442fae-d476-4b19-97b7-8355ff9332e3" xlink:href="pgen-20220331.xsd#pgen_JointVentureAdditionalCapitalContributionsCommittedRemainingCommitment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_4471fe7d-93df-4529-9465-e06056307fdc" xlink:to="loc_pgen_JointVentureAdditionalCapitalContributionsCommittedRemainingCommitment_2d442fae-d476-4b19-97b7-8355ff9332e3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_NumberofSeatsonGoverningBoard_af5279b8-8b06-4a2b-87bc-f77f2ba80175" xlink:href="pgen-20220331.xsd#pgen_NumberofSeatsonGoverningBoard"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_4471fe7d-93df-4529-9465-e06056307fdc" xlink:to="loc_pgen_NumberofSeatsonGoverningBoard_af5279b8-8b06-4a2b-87bc-f77f2ba80175" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_NumberofSeatsonGoverningBoardInternallySelected_4be884bd-bbba-4bc7-b233-c1fd9d177358" xlink:href="pgen-20220331.xsd#pgen_NumberofSeatsonGoverningBoardInternallySelected"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_4471fe7d-93df-4529-9465-e06056307fdc" xlink:to="loc_pgen_NumberofSeatsonGoverningBoardInternallySelected_4be884bd-bbba-4bc7-b233-c1fd9d177358" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_NumberofSeatsonGoverningBoardExternallySelected_783dfc70-ffb2-4f16-85a0-4ed133c70c35" xlink:href="pgen-20220331.xsd#pgen_NumberofSeatsonGoverningBoardExternallySelected"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_4471fe7d-93df-4529-9465-e06056307fdc" xlink:to="loc_pgen_NumberofSeatsonGoverningBoardExternallySelected_783dfc70-ffb2-4f16-85a0-4ed133c70c35" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_53a6d4cb-440c-43e7-91ad-b44d64eb6447" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_4471fe7d-93df-4529-9465-e06056307fdc" xlink:to="loc_us-gaap_EquityMethodInvestments_53a6d4cb-440c-43e7-91ad-b44d64eb6447" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_90477953-b897-4a0e-8ca0-6c6ca7ca0270" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_4471fe7d-93df-4529-9465-e06056307fdc" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_90477953-b897-4a0e-8ca0-6c6ca7ca0270" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_9e43d569-d438-476b-b3d6-b9bb47ed0d28" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_90477953-b897-4a0e-8ca0-6c6ca7ca0270" xlink:to="loc_srt_CounterpartyNameAxis_9e43d569-d438-476b-b3d6-b9bb47ed0d28" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9e43d569-d438-476b-b3d6-b9bb47ed0d28_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_9e43d569-d438-476b-b3d6-b9bb47ed0d28" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9e43d569-d438-476b-b3d6-b9bb47ed0d28_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_3ae377d9-abc9-4951-a077-7d8f06372b0e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_9e43d569-d438-476b-b3d6-b9bb47ed0d28" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_3ae377d9-abc9-4951-a077-7d8f06372b0e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_IntrexonEnergyPartnersMember_094480e0-feaf-4992-9a71-fb11e15daa3d" xlink:href="pgen-20220331.xsd#pgen_IntrexonEnergyPartnersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_3ae377d9-abc9-4951-a077-7d8f06372b0e" xlink:to="loc_pgen_IntrexonEnergyPartnersMember_094480e0-feaf-4992-9a71-fb11e15daa3d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_d3ab58ed-6aba-4323-a8ed-9526af7e5ad8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_90477953-b897-4a0e-8ca0-6c6ca7ca0270" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_d3ab58ed-6aba-4323-a8ed-9526af7e5ad8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_d3ab58ed-6aba-4323-a8ed-9526af7e5ad8_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_d3ab58ed-6aba-4323-a8ed-9526af7e5ad8" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_d3ab58ed-6aba-4323-a8ed-9526af7e5ad8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_16a32014-b3b8-4f7d-a67f-86b7496280d3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_d3ab58ed-6aba-4323-a8ed-9526af7e5ad8" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_16a32014-b3b8-4f7d-a67f-86b7496280d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_IntrexonEnergyPartnersMember_a4f5b0bc-9999-4fbe-b943-e3132647ddc1" xlink:href="pgen-20220331.xsd#pgen_IntrexonEnergyPartnersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_16a32014-b3b8-4f7d-a67f-86b7496280d3" xlink:to="loc_pgen_IntrexonEnergyPartnersMember_a4f5b0bc-9999-4fbe-b943-e3132647ddc1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_2c706b48-34f2-471b-9cef-a75da5a7cdca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_90477953-b897-4a0e-8ca0-6c6ca7ca0270" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_2c706b48-34f2-471b-9cef-a75da5a7cdca" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_2c706b48-34f2-471b-9cef-a75da5a7cdca_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_2c706b48-34f2-471b-9cef-a75da5a7cdca" xlink:to="loc_us-gaap_RelatedPartyDomain_2c706b48-34f2-471b-9cef-a75da5a7cdca_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_ac31cace-f875-4e0f-8418-dc832c5f1049" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_2c706b48-34f2-471b-9cef-a75da5a7cdca" xlink:to="loc_us-gaap_RelatedPartyDomain_ac31cace-f875-4e0f-8418-dc832c5f1049" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestorMember_a1ed42a7-23d5-402e-836f-2ea1729a19a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_ac31cace-f875-4e0f-8418-dc832c5f1049" xlink:to="loc_us-gaap_InvestorMember_a1ed42a7-23d5-402e-836f-2ea1729a19a9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_dd1e0dc2-01b8-4733-a496-ed5b2fa6091b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_90477953-b897-4a0e-8ca0-6c6ca7ca0270" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_dd1e0dc2-01b8-4733-a496-ed5b2fa6091b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_dd1e0dc2-01b8-4733-a496-ed5b2fa6091b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_dd1e0dc2-01b8-4733-a496-ed5b2fa6091b" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_dd1e0dc2-01b8-4733-a496-ed5b2fa6091b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_ec7c51a5-1942-4db3-ab26-886233335ff1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_dd1e0dc2-01b8-4733-a496-ed5b2fa6091b" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_ec7c51a5-1942-4db3-ab26-886233335ff1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_OtherAccruedLiabilitiesMember_eaeb2f81-7a0f-4ae5-a91a-722998133f85" xlink:href="pgen-20220331.xsd#pgen_OtherAccruedLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_ec7c51a5-1942-4db3-ab26-886233335ff1" xlink:to="loc_pgen_OtherAccruedLiabilitiesMember_eaeb2f81-7a0f-4ae5-a91a-722998133f85" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_ba4b3d9d-71ca-49ce-b48e-dfeee4151adf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_90477953-b897-4a0e-8ca0-6c6ca7ca0270" xlink:to="loc_us-gaap_TypeOfArrangementAxis_ba4b3d9d-71ca-49ce-b48e-dfeee4151adf" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_ba4b3d9d-71ca-49ce-b48e-dfeee4151adf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_ba4b3d9d-71ca-49ce-b48e-dfeee4151adf" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_ba4b3d9d-71ca-49ce-b48e-dfeee4151adf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_956bb57e-14f1-4d12-96be-52192792f9e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_ba4b3d9d-71ca-49ce-b48e-dfeee4151adf" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_956bb57e-14f1-4d12-96be-52192792f9e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementMember_30a62572-3f1c-480d-abf6-8c27d666703a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_956bb57e-14f1-4d12-96be-52192792f9e5" xlink:to="loc_us-gaap_CollaborativeArrangementMember_30a62572-3f1c-480d-abf6-8c27d666703a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dna.com/role/InvestmentsinJointVenturesIntrexonEnergyPartnersIIAdditionalInformationDetails" xlink:type="simple" xlink:href="pgen-20220331.xsd#InvestmentsinJointVenturesIntrexonEnergyPartnersIIAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.dna.com/role/InvestmentsinJointVenturesIntrexonEnergyPartnersIIAdditionalInformationDetails" xlink:type="extended" id="icb3e0609111c47b8bc5eb8b8a9a1bb1f_InvestmentsinJointVenturesIntrexonEnergyPartnersIIAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a0a86a95-985d-43ac-b04a-b75c0bdf5ad1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_CollaborativeArrangementConsiderationReceivedValue_bea8e7e8-ae4e-43c5-9dae-751b079b9a7e" xlink:href="pgen-20220331.xsd#pgen_CollaborativeArrangementConsiderationReceivedValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a0a86a95-985d-43ac-b04a-b75c0bdf5ad1" xlink:to="loc_pgen_CollaborativeArrangementConsiderationReceivedValue_bea8e7e8-ae4e-43c5-9dae-751b079b9a7e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_0d129bbf-b461-42d0-b3b5-68f02e0674b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a0a86a95-985d-43ac-b04a-b75c0bdf5ad1" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_0d129bbf-b461-42d0-b3b5-68f02e0674b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInterestInJointVenture_4b068bef-452b-45ef-9a31-f3cccca7e9c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireInterestInJointVenture"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a0a86a95-985d-43ac-b04a-b75c0bdf5ad1" xlink:to="loc_us-gaap_PaymentsToAcquireInterestInJointVenture_4b068bef-452b-45ef-9a31-f3cccca7e9c6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_JointVentureAdditionalCapitalContributionsCommitted_fcb07fc2-d287-4f20-972e-8f718bd24448" xlink:href="pgen-20220331.xsd#pgen_JointVentureAdditionalCapitalContributionsCommitted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a0a86a95-985d-43ac-b04a-b75c0bdf5ad1" xlink:to="loc_pgen_JointVentureAdditionalCapitalContributionsCommitted_fcb07fc2-d287-4f20-972e-8f718bd24448" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_JointVentureAdditionalCapitalContributionsCommittedRemainingCommitment_9409a6fd-a396-48af-9fdf-46b676002fa9" xlink:href="pgen-20220331.xsd#pgen_JointVentureAdditionalCapitalContributionsCommittedRemainingCommitment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a0a86a95-985d-43ac-b04a-b75c0bdf5ad1" xlink:to="loc_pgen_JointVentureAdditionalCapitalContributionsCommittedRemainingCommitment_9409a6fd-a396-48af-9fdf-46b676002fa9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_NumberofSeatsonGoverningBoard_dcae36ed-0dc6-4a31-a065-fdf8cffcba80" xlink:href="pgen-20220331.xsd#pgen_NumberofSeatsonGoverningBoard"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a0a86a95-985d-43ac-b04a-b75c0bdf5ad1" xlink:to="loc_pgen_NumberofSeatsonGoverningBoard_dcae36ed-0dc6-4a31-a065-fdf8cffcba80" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_NumberofSeatsonGoverningBoardInternallySelected_1a7c4acb-f970-4822-9af3-cb68586df7df" xlink:href="pgen-20220331.xsd#pgen_NumberofSeatsonGoverningBoardInternallySelected"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a0a86a95-985d-43ac-b04a-b75c0bdf5ad1" xlink:to="loc_pgen_NumberofSeatsonGoverningBoardInternallySelected_1a7c4acb-f970-4822-9af3-cb68586df7df" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_NumberofSeatsonGoverningBoardExternallySelected_67639da5-a71d-43cb-8f25-6e500a933f6a" xlink:href="pgen-20220331.xsd#pgen_NumberofSeatsonGoverningBoardExternallySelected"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a0a86a95-985d-43ac-b04a-b75c0bdf5ad1" xlink:to="loc_pgen_NumberofSeatsonGoverningBoardExternallySelected_67639da5-a71d-43cb-8f25-6e500a933f6a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_b7e5119d-7a37-4194-8d3e-87e36190c458" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a0a86a95-985d-43ac-b04a-b75c0bdf5ad1" xlink:to="loc_us-gaap_EquityMethodInvestments_b7e5119d-7a37-4194-8d3e-87e36190c458" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_1bb00797-f182-4f11-8f61-68c7dcab7fa4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a0a86a95-985d-43ac-b04a-b75c0bdf5ad1" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_1bb00797-f182-4f11-8f61-68c7dcab7fa4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_5015ec12-e944-4a8f-a5e4-6c1864fadf91" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_1bb00797-f182-4f11-8f61-68c7dcab7fa4" xlink:to="loc_srt_CounterpartyNameAxis_5015ec12-e944-4a8f-a5e4-6c1864fadf91" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_5015ec12-e944-4a8f-a5e4-6c1864fadf91_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_5015ec12-e944-4a8f-a5e4-6c1864fadf91" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_5015ec12-e944-4a8f-a5e4-6c1864fadf91_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_f70d2564-cfc7-4b36-9a1f-9497d2529a58" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_5015ec12-e944-4a8f-a5e4-6c1864fadf91" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_f70d2564-cfc7-4b36-9a1f-9497d2529a58" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_IntrexonEnergyPartnersIILLCMember_6d054a4e-ee2d-47c1-ba1b-6a78fc78c29d" xlink:href="pgen-20220331.xsd#pgen_IntrexonEnergyPartnersIILLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_f70d2564-cfc7-4b36-9a1f-9497d2529a58" xlink:to="loc_pgen_IntrexonEnergyPartnersIILLCMember_6d054a4e-ee2d-47c1-ba1b-6a78fc78c29d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_3b236b2e-106b-41ab-872c-d223df485161" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_1bb00797-f182-4f11-8f61-68c7dcab7fa4" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_3b236b2e-106b-41ab-872c-d223df485161" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_3b236b2e-106b-41ab-872c-d223df485161_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_3b236b2e-106b-41ab-872c-d223df485161" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_3b236b2e-106b-41ab-872c-d223df485161_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_32970344-34c8-4c8d-83a0-a7acb32777f0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_3b236b2e-106b-41ab-872c-d223df485161" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_32970344-34c8-4c8d-83a0-a7acb32777f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_IntrexonEnergyPartnersIILLCMember_859f6509-b3dd-48dc-8c51-57fb97d2ac11" xlink:href="pgen-20220331.xsd#pgen_IntrexonEnergyPartnersIILLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_32970344-34c8-4c8d-83a0-a7acb32777f0" xlink:to="loc_pgen_IntrexonEnergyPartnersIILLCMember_859f6509-b3dd-48dc-8c51-57fb97d2ac11" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_5c7d6d94-5ed9-453e-99af-c85d18eea57a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_1bb00797-f182-4f11-8f61-68c7dcab7fa4" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_5c7d6d94-5ed9-453e-99af-c85d18eea57a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_5c7d6d94-5ed9-453e-99af-c85d18eea57a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_5c7d6d94-5ed9-453e-99af-c85d18eea57a" xlink:to="loc_us-gaap_RelatedPartyDomain_5c7d6d94-5ed9-453e-99af-c85d18eea57a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_baf9c024-f942-44fc-bc80-033eaf8414a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_5c7d6d94-5ed9-453e-99af-c85d18eea57a" xlink:to="loc_us-gaap_RelatedPartyDomain_baf9c024-f942-44fc-bc80-033eaf8414a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestorMember_3f903717-9a63-4e34-91db-f42ac3fb4ab9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_baf9c024-f942-44fc-bc80-033eaf8414a3" xlink:to="loc_us-gaap_InvestorMember_3f903717-9a63-4e34-91db-f42ac3fb4ab9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_AllInvestorsMember_c5d9d965-028a-4202-9458-2727129c0077" xlink:href="pgen-20220331.xsd#pgen_AllInvestorsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_baf9c024-f942-44fc-bc80-033eaf8414a3" xlink:to="loc_pgen_AllInvestorsMember_c5d9d965-028a-4202-9458-2727129c0077" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_2b9f845f-a7be-4305-82cd-1adc38d1baf4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_1bb00797-f182-4f11-8f61-68c7dcab7fa4" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_2b9f845f-a7be-4305-82cd-1adc38d1baf4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_2b9f845f-a7be-4305-82cd-1adc38d1baf4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_2b9f845f-a7be-4305-82cd-1adc38d1baf4" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_2b9f845f-a7be-4305-82cd-1adc38d1baf4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_5abd7384-3c7b-433a-812d-d9b0fb9e30b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_2b9f845f-a7be-4305-82cd-1adc38d1baf4" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_5abd7384-3c7b-433a-812d-d9b0fb9e30b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_OtherAccruedLiabilitiesMember_1f34d56a-ac6a-4f01-b21e-4d6d0c158aef" xlink:href="pgen-20220331.xsd#pgen_OtherAccruedLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_5abd7384-3c7b-433a-812d-d9b0fb9e30b2" xlink:to="loc_pgen_OtherAccruedLiabilitiesMember_1f34d56a-ac6a-4f01-b21e-4d6d0c158aef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_ead1f195-e2cb-403e-9b43-a7e627e594a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_1bb00797-f182-4f11-8f61-68c7dcab7fa4" xlink:to="loc_us-gaap_TypeOfArrangementAxis_ead1f195-e2cb-403e-9b43-a7e627e594a0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_ead1f195-e2cb-403e-9b43-a7e627e594a0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_ead1f195-e2cb-403e-9b43-a7e627e594a0" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_ead1f195-e2cb-403e-9b43-a7e627e594a0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_cbf57732-0c30-43ff-89d4-7bdcee9514b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_ead1f195-e2cb-403e-9b43-a7e627e594a0" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_cbf57732-0c30-43ff-89d4-7bdcee9514b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementMember_78ec7cdc-4b14-4dd4-8c6b-27a7351dea84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_cbf57732-0c30-43ff-89d4-7bdcee9514b8" xlink:to="loc_us-gaap_CollaborativeArrangementMember_78ec7cdc-4b14-4dd4-8c6b-27a7351dea84" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dna.com/role/CollaborationandLicensingRevenueSummarizedCollaborationandLicensingRevenueDetails" xlink:type="simple" xlink:href="pgen-20220331.xsd#CollaborationandLicensingRevenueSummarizedCollaborationandLicensingRevenueDetails"/>
  <link:definitionLink xlink:role="http://www.dna.com/role/CollaborationandLicensingRevenueSummarizedCollaborationandLicensingRevenueDetails" xlink:type="extended" id="i4b000b6c0cc9443ca3ad43f82e689c75_CollaborationandLicensingRevenueSummarizedCollaborationandLicensingRevenueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_7fa0db2c-e069-4f78-a2de-aa95289f4cd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_bd1f0628-25f8-424e-9fa9-0211f2811574" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_7fa0db2c-e069-4f78-a2de-aa95289f4cd3" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_bd1f0628-25f8-424e-9fa9-0211f2811574" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_1af2340d-2f6a-4b56-8f97-dd40f8eb28e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_7fa0db2c-e069-4f78-a2de-aa95289f4cd3" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_1af2340d-2f6a-4b56-8f97-dd40f8eb28e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_fd514fd3-0327-49fe-8a28-e41425f3d25f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_7fa0db2c-e069-4f78-a2de-aa95289f4cd3" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_fd514fd3-0327-49fe-8a28-e41425f3d25f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_06043ad4-8666-488b-a0ae-39f6181c0e41" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_fd514fd3-0327-49fe-8a28-e41425f3d25f" xlink:to="loc_srt_CounterpartyNameAxis_06043ad4-8666-488b-a0ae-39f6181c0e41" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_06043ad4-8666-488b-a0ae-39f6181c0e41_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_06043ad4-8666-488b-a0ae-39f6181c0e41" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_06043ad4-8666-488b-a0ae-39f6181c0e41_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_552c4600-0c88-45e2-8cd5-1e2d36b327cf" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_06043ad4-8666-488b-a0ae-39f6181c0e41" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_552c4600-0c88-45e2-8cd5-1e2d36b327cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_CastleCreekBiosciencesIncMember_62396bbc-74c5-46ab-90a5-08a41739b275" xlink:href="pgen-20220331.xsd#pgen_CastleCreekBiosciencesIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_552c4600-0c88-45e2-8cd5-1e2d36b327cf" xlink:to="loc_pgen_CastleCreekBiosciencesIncMember_62396bbc-74c5-46ab-90a5-08a41739b275" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_OtherMember_9a801098-acfe-48e0-8563-03a07e05ce9d" xlink:href="pgen-20220331.xsd#pgen_OtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_552c4600-0c88-45e2-8cd5-1e2d36b327cf" xlink:to="loc_pgen_OtherMember_9a801098-acfe-48e0-8563-03a07e05ce9d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_443cfdb7-3aa3-4f08-8b3b-1a570d08521d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_fd514fd3-0327-49fe-8a28-e41425f3d25f" xlink:to="loc_us-gaap_TypeOfArrangementAxis_443cfdb7-3aa3-4f08-8b3b-1a570d08521d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_443cfdb7-3aa3-4f08-8b3b-1a570d08521d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_443cfdb7-3aa3-4f08-8b3b-1a570d08521d" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_443cfdb7-3aa3-4f08-8b3b-1a570d08521d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_ddb2f488-5e33-44cc-962f-51b5f8d38373" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_443cfdb7-3aa3-4f08-8b3b-1a570d08521d" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_ddb2f488-5e33-44cc-962f-51b5f8d38373" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementMember_fbd54be1-f15e-4790-90d5-c637b944f26f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_ddb2f488-5e33-44cc-962f-51b5f8d38373" xlink:to="loc_us-gaap_CollaborativeArrangementMember_fbd54be1-f15e-4790-90d5-c637b944f26f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_UpfrontAndMilestonePaymentsMember_1d4999e4-784e-43db-9efd-60fcb2260e03" xlink:href="pgen-20220331.xsd#pgen_UpfrontAndMilestonePaymentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_ddb2f488-5e33-44cc-962f-51b5f8d38373" xlink:to="loc_pgen_UpfrontAndMilestonePaymentsMember_1d4999e4-784e-43db-9efd-60fcb2260e03" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dna.com/role/CollaborationandLicensingRevenueSummaryofDeferredRevenueDetails" xlink:type="simple" xlink:href="pgen-20220331.xsd#CollaborationandLicensingRevenueSummaryofDeferredRevenueDetails"/>
  <link:definitionLink xlink:role="http://www.dna.com/role/CollaborationandLicensingRevenueSummaryofDeferredRevenueDetails" xlink:type="extended" id="ic68983834eda448bb59433c8cd7137fc_CollaborationandLicensingRevenueSummaryofDeferredRevenueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_pgen_ContractWithCustomerAssetAndLiabilityLineItems_17ec046b-ec52-415e-bfc5-f04dac7f3fd4" xlink:href="pgen-20220331.xsd#pgen_ContractWithCustomerAssetAndLiabilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_f2557005-04d5-46ac-9451-e70839aea88a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pgen_ContractWithCustomerAssetAndLiabilityLineItems_17ec046b-ec52-415e-bfc5-f04dac7f3fd4" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_f2557005-04d5-46ac-9451-e70839aea88a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_febdf61b-44c6-493d-95a5-26bf5b9d92c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pgen_ContractWithCustomerAssetAndLiabilityLineItems_17ec046b-ec52-415e-bfc5-f04dac7f3fd4" xlink:to="loc_us-gaap_ContractWithCustomerLiability_febdf61b-44c6-493d-95a5-26bf5b9d92c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_de82a880-b7c4-45ee-90b8-4be1ad762e0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_pgen_ContractWithCustomerAssetAndLiabilityLineItems_17ec046b-ec52-415e-bfc5-f04dac7f3fd4" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_de82a880-b7c4-45ee-90b8-4be1ad762e0a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_ContractWithCustomerAssetAndLiabilityTable_7b0c94a6-afd9-42a1-b610-b3ea61a03943" xlink:href="pgen-20220331.xsd#pgen_ContractWithCustomerAssetAndLiabilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_pgen_ContractWithCustomerAssetAndLiabilityLineItems_17ec046b-ec52-415e-bfc5-f04dac7f3fd4" xlink:to="loc_pgen_ContractWithCustomerAssetAndLiabilityTable_7b0c94a6-afd9-42a1-b610-b3ea61a03943" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_0bddc2e1-35f5-4fc1-9322-a6f0b60de54b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_pgen_ContractWithCustomerAssetAndLiabilityTable_7b0c94a6-afd9-42a1-b610-b3ea61a03943" xlink:to="loc_srt_ProductOrServiceAxis_0bddc2e1-35f5-4fc1-9322-a6f0b60de54b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_0bddc2e1-35f5-4fc1-9322-a6f0b60de54b_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_0bddc2e1-35f5-4fc1-9322-a6f0b60de54b" xlink:to="loc_srt_ProductsAndServicesDomain_0bddc2e1-35f5-4fc1-9322-a6f0b60de54b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_b9f775a3-89b5-44c4-a595-e718da4e9d25" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_0bddc2e1-35f5-4fc1-9322-a6f0b60de54b" xlink:to="loc_srt_ProductsAndServicesDomain_b9f775a3-89b5-44c4-a595-e718da4e9d25" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_PrepaidProductAndServiceRevenuesMember_62dd691a-8601-4a6e-bd0f-074a85b6b2b1" xlink:href="pgen-20220331.xsd#pgen_PrepaidProductAndServiceRevenuesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_b9f775a3-89b5-44c4-a595-e718da4e9d25" xlink:to="loc_pgen_PrepaidProductAndServiceRevenuesMember_62dd691a-8601-4a6e-bd0f-074a85b6b2b1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_DeferredRevenueOtherMember_6d5e8c7d-b4f5-4dec-b709-c7ed3a17af81" xlink:href="pgen-20220331.xsd#pgen_DeferredRevenueOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_b9f775a3-89b5-44c4-a595-e718da4e9d25" xlink:to="loc_pgen_DeferredRevenueOtherMember_6d5e8c7d-b4f5-4dec-b709-c7ed3a17af81" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_4b03b0e4-c945-4787-aa7d-1de708dbaedd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_pgen_ContractWithCustomerAssetAndLiabilityTable_7b0c94a6-afd9-42a1-b610-b3ea61a03943" xlink:to="loc_us-gaap_TypeOfArrangementAxis_4b03b0e4-c945-4787-aa7d-1de708dbaedd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_4b03b0e4-c945-4787-aa7d-1de708dbaedd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_4b03b0e4-c945-4787-aa7d-1de708dbaedd" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_4b03b0e4-c945-4787-aa7d-1de708dbaedd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_4b8466ce-ea9d-4ca3-864e-b763986e6de7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_4b03b0e4-c945-4787-aa7d-1de708dbaedd" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_4b8466ce-ea9d-4ca3-864e-b763986e6de7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementMember_c030ee00-7712-4361-883d-8940afa523b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_4b8466ce-ea9d-4ca3-864e-b763986e6de7" xlink:to="loc_us-gaap_CollaborativeArrangementMember_c030ee00-7712-4361-883d-8940afa523b3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_5c444250-bf27-4d3f-beda-c360da8bb800" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_pgen_ContractWithCustomerAssetAndLiabilityTable_7b0c94a6-afd9-42a1-b610-b3ea61a03943" xlink:to="loc_srt_CounterpartyNameAxis_5c444250-bf27-4d3f-beda-c360da8bb800" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_5c444250-bf27-4d3f-beda-c360da8bb800_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_5c444250-bf27-4d3f-beda-c360da8bb800" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_5c444250-bf27-4d3f-beda-c360da8bb800_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_06701b27-8c10-49c4-843f-a0dff6eeafe6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_5c444250-bf27-4d3f-beda-c360da8bb800" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_06701b27-8c10-49c4-843f-a0dff6eeafe6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_IntrexonEnergyPartnersLLAndIntrexonEnergyPartnersIILLCMember_e174250e-61e9-44bb-a8c7-e3b6ccb43c84" xlink:href="pgen-20220331.xsd#pgen_IntrexonEnergyPartnersLLAndIntrexonEnergyPartnersIILLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_06701b27-8c10-49c4-843f-a0dff6eeafe6" xlink:to="loc_pgen_IntrexonEnergyPartnersLLAndIntrexonEnergyPartnersIILLCMember_e174250e-61e9-44bb-a8c7-e3b6ccb43c84" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dna.com/role/ShorttermandLongtermInvestmentsSummaryofAmortizedCostGrossUnrealizedGainsandLossesandFairValueofShorttermandLongtermInvestmentsDetails" xlink:type="simple" xlink:href="pgen-20220331.xsd#ShorttermandLongtermInvestmentsSummaryofAmortizedCostGrossUnrealizedGainsandLossesandFairValueofShorttermandLongtermInvestmentsDetails"/>
  <link:definitionLink xlink:role="http://www.dna.com/role/ShorttermandLongtermInvestmentsSummaryofAmortizedCostGrossUnrealizedGainsandLossesandFairValueofShorttermandLongtermInvestmentsDetails" xlink:type="extended" id="i1df3083599054cb2b30c4cec8e6085c2_ShorttermandLongtermInvestmentsSummaryofAmortizedCostGrossUnrealizedGainsandLossesandFairValueofShorttermandLongtermInvestmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_3fabff28-dbd0-4c2e-80c4-d43a560de437" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_e13652f4-3633-4c21-8804-c2c5184f2552" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_3fabff28-dbd0-4c2e-80c4-d43a560de437" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_e13652f4-3633-4c21-8804-c2c5184f2552" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_60eeb29f-13e6-4911-ae53-c77f67685a0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_3fabff28-dbd0-4c2e-80c4-d43a560de437" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_60eeb29f-13e6-4911-ae53-c77f67685a0c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_9ef7eede-d71d-4e95-ad19-671b6d896510" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_3fabff28-dbd0-4c2e-80c4-d43a560de437" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_9ef7eede-d71d-4e95-ad19-671b6d896510" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_419ef5f0-225e-4300-b64c-fb580e8d0c6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_3fabff28-dbd0-4c2e-80c4-d43a560de437" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_419ef5f0-225e-4300-b64c-fb580e8d0c6e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_c3bd2c27-38c7-462d-9d8c-f54d192564e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_3fabff28-dbd0-4c2e-80c4-d43a560de437" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_c3bd2c27-38c7-462d-9d8c-f54d192564e5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_9ede94fa-b18d-4b8d-bda1-1f1cfe9f7bf6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_c3bd2c27-38c7-462d-9d8c-f54d192564e5" xlink:to="loc_us-gaap_FinancialInstrumentAxis_9ede94fa-b18d-4b8d-bda1-1f1cfe9f7bf6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9ede94fa-b18d-4b8d-bda1-1f1cfe9f7bf6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_9ede94fa-b18d-4b8d-bda1-1f1cfe9f7bf6" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9ede94fa-b18d-4b8d-bda1-1f1cfe9f7bf6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_aaa9daa1-d44a-45c3-84ab-81d06107592e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_9ede94fa-b18d-4b8d-bda1-1f1cfe9f7bf6" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_aaa9daa1-d44a-45c3-84ab-81d06107592e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentDebtSecuritiesMember_0853874b-3da5-47a2-8e8f-72a09920f96a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_aaa9daa1-d44a-45c3-84ab-81d06107592e" xlink:to="loc_us-gaap_USGovernmentDebtSecuritiesMember_0853874b-3da5-47a2-8e8f-72a09920f96a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_ed67b59f-c648-4641-8d01-8c6936ae0f67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_aaa9daa1-d44a-45c3-84ab-81d06107592e" xlink:to="loc_us-gaap_CertificatesOfDepositMember_ed67b59f-c648-4641-8d01-8c6936ae0f67" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dna.com/role/FairValueMeasurementsSummaryofPlacementintheFairValueHierarchyofFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails" xlink:type="simple" xlink:href="pgen-20220331.xsd#FairValueMeasurementsSummaryofPlacementintheFairValueHierarchyofFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails"/>
  <link:definitionLink xlink:role="http://www.dna.com/role/FairValueMeasurementsSummaryofPlacementintheFairValueHierarchyofFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails" xlink:type="extended" id="ib20ce89af2644c51a532fc637e4483ea_FairValueMeasurementsSummaryofPlacementintheFairValueHierarchyofFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9ae8e765-46b4-46e7-9a3a-ebb7a79abcc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_0db0ea8e-11f7-4ecc-9f19-4fb68ed63c20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9ae8e765-46b4-46e7-9a3a-ebb7a79abcc5" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_0db0ea8e-11f7-4ecc-9f19-4fb68ed63c20" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_c3ce6d7c-a061-4a94-8aff-c069758f872e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_0db0ea8e-11f7-4ecc-9f19-4fb68ed63c20" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_c3ce6d7c-a061-4a94-8aff-c069758f872e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4a93dbbe-9b2e-4d36-a67d-0067096edeb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9ae8e765-46b4-46e7-9a3a-ebb7a79abcc5" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4a93dbbe-9b2e-4d36-a67d-0067096edeb7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_88b466c7-fd4f-4ce3-a361-ad242982af94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4a93dbbe-9b2e-4d36-a67d-0067096edeb7" xlink:to="loc_us-gaap_FinancialInstrumentAxis_88b466c7-fd4f-4ce3-a361-ad242982af94" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_88b466c7-fd4f-4ce3-a361-ad242982af94_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_88b466c7-fd4f-4ce3-a361-ad242982af94" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_88b466c7-fd4f-4ce3-a361-ad242982af94_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c823122e-5153-4975-8ef9-0e048d0ad12c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_88b466c7-fd4f-4ce3-a361-ad242982af94" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c823122e-5153-4975-8ef9-0e048d0ad12c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentDebtSecuritiesMember_810968fd-60c5-4ff3-aeb5-470d42b4b7ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c823122e-5153-4975-8ef9-0e048d0ad12c" xlink:to="loc_us-gaap_USGovernmentDebtSecuritiesMember_810968fd-60c5-4ff3-aeb5-470d42b4b7ea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_981e7d99-9f6a-4da8-b275-1844d575a711" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c823122e-5153-4975-8ef9-0e048d0ad12c" xlink:to="loc_us-gaap_CertificatesOfDepositMember_981e7d99-9f6a-4da8-b275-1844d575a711" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a6453ccb-6c24-4524-9045-3a433099769e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4a93dbbe-9b2e-4d36-a67d-0067096edeb7" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a6453ccb-6c24-4524-9045-3a433099769e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a6453ccb-6c24-4524-9045-3a433099769e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a6453ccb-6c24-4524-9045-3a433099769e" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a6453ccb-6c24-4524-9045-3a433099769e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9ee0a00f-a9fe-4c1f-b886-006fad8d4037" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a6453ccb-6c24-4524-9045-3a433099769e" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9ee0a00f-a9fe-4c1f-b886-006fad8d4037" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_f53f0b4d-6f69-412f-87cb-0d066df19669" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9ee0a00f-a9fe-4c1f-b886-006fad8d4037" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_f53f0b4d-6f69-412f-87cb-0d066df19669" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_ceda6fc3-f355-457b-8f20-66a23ced43cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9ee0a00f-a9fe-4c1f-b886-006fad8d4037" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_ceda6fc3-f355-457b-8f20-66a23ced43cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_873cc182-f7e2-4de9-9d27-79230ddc85ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9ee0a00f-a9fe-4c1f-b886-006fad8d4037" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_873cc182-f7e2-4de9-9d27-79230ddc85ba" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dna.com/role/FairValueMeasurementsAdditionalInformationDetails" xlink:type="simple" xlink:href="pgen-20220331.xsd#FairValueMeasurementsAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.dna.com/role/FairValueMeasurementsAdditionalInformationDetails" xlink:type="extended" id="ia8b40ca26aa74a86a9b63c160a77b8f2_FairValueMeasurementsAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3780b69c-b1ce-402e-8ab1-204df93b0cc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_fa72c122-7ccb-4d09-ada6-659df12455da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3780b69c-b1ce-402e-8ab1-204df93b0cc1" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_fa72c122-7ccb-4d09-ada6-659df12455da" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtFairValueDisclosures_186cf21b-7178-4fe6-8ab9-eb8990e87f27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtFairValueDisclosures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3780b69c-b1ce-402e-8ab1-204df93b0cc1" xlink:to="loc_us-gaap_ConvertibleDebtFairValueDisclosures_186cf21b-7178-4fe6-8ab9-eb8990e87f27" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebt_c539e910-988b-4112-9ab3-6774f5727881" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3780b69c-b1ce-402e-8ab1-204df93b0cc1" xlink:to="loc_us-gaap_ConvertibleDebt_c539e910-988b-4112-9ab3-6774f5727881" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e91c98a2-bd16-43ff-94ed-66a41be2337a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3780b69c-b1ce-402e-8ab1-204df93b0cc1" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e91c98a2-bd16-43ff-94ed-66a41be2337a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_feb0a8fc-647a-4f58-b328-01e82eb35ccd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e91c98a2-bd16-43ff-94ed-66a41be2337a" xlink:to="loc_us-gaap_DebtInstrumentAxis_feb0a8fc-647a-4f58-b328-01e82eb35ccd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_feb0a8fc-647a-4f58-b328-01e82eb35ccd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_feb0a8fc-647a-4f58-b328-01e82eb35ccd" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_feb0a8fc-647a-4f58-b328-01e82eb35ccd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_7d4708e9-cbb4-46f4-b233-8be40f9c2920" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_feb0a8fc-647a-4f58-b328-01e82eb35ccd" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_7d4708e9-cbb4-46f4-b233-8be40f9c2920" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_A3.5ConvertibleNotesDue2023Member_3177ba4f-8893-497e-bc73-0d87509a2a21" xlink:href="pgen-20220331.xsd#pgen_A3.5ConvertibleNotesDue2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d4708e9-cbb4-46f4-b233-8be40f9c2920" xlink:to="loc_pgen_A3.5ConvertibleNotesDue2023Member_3177ba4f-8893-497e-bc73-0d87509a2a21" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dna.com/role/InventoryDetails" xlink:type="simple" xlink:href="pgen-20220331.xsd#InventoryDetails"/>
  <link:definitionLink xlink:role="http://www.dna.com/role/InventoryDetails" xlink:type="extended" id="i729a3d112908471390cf0fa13e970bc0_InventoryDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLineItems_dceb054a-bb2b-4536-852c-9929bc089569" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryGross_6e30b228-bd74-4231-9cb7-f100097e8693" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InventoryLineItems_dceb054a-bb2b-4536-852c-9929bc089569" xlink:to="loc_us-gaap_InventoryGross_6e30b228-bd74-4231-9cb7-f100097e8693" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryCurrentTable_5c910bed-e4fb-4594-8d77-3fb99cb7d8a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryCurrentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_InventoryLineItems_dceb054a-bb2b-4536-852c-9929bc089569" xlink:to="loc_us-gaap_InventoryCurrentTable_5c910bed-e4fb-4594-8d77-3fb99cb7d8a1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PublicUtilitiesInventoryAxis_2aed9aff-2de5-4504-ad7c-98216b0609de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PublicUtilitiesInventoryAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_InventoryCurrentTable_5c910bed-e4fb-4594-8d77-3fb99cb7d8a1" xlink:to="loc_us-gaap_PublicUtilitiesInventoryAxis_2aed9aff-2de5-4504-ad7c-98216b0609de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PublicUtilitiesInventoryTypeDomain_2aed9aff-2de5-4504-ad7c-98216b0609de_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PublicUtilitiesInventoryTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PublicUtilitiesInventoryAxis_2aed9aff-2de5-4504-ad7c-98216b0609de" xlink:to="loc_us-gaap_PublicUtilitiesInventoryTypeDomain_2aed9aff-2de5-4504-ad7c-98216b0609de_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PublicUtilitiesInventoryTypeDomain_7fb2309a-ebc5-40e8-9a90-2bc62e40eaa9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PublicUtilitiesInventoryTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PublicUtilitiesInventoryAxis_2aed9aff-2de5-4504-ad7c-98216b0609de" xlink:to="loc_us-gaap_PublicUtilitiesInventoryTypeDomain_7fb2309a-ebc5-40e8-9a90-2bc62e40eaa9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_SuppliesEmbryosAndOtherProductionMaterialsMember_fc3b1b15-bc51-4d4b-a558-daddafed6e42" xlink:href="pgen-20220331.xsd#pgen_SuppliesEmbryosAndOtherProductionMaterialsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PublicUtilitiesInventoryTypeDomain_7fb2309a-ebc5-40e8-9a90-2bc62e40eaa9" xlink:to="loc_pgen_SuppliesEmbryosAndOtherProductionMaterialsMember_fc3b1b15-bc51-4d4b-a558-daddafed6e42" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_WorkInProcessMember_08cbabd2-28e4-473c-acd0-61a0df8e3e49" xlink:href="pgen-20220331.xsd#pgen_WorkInProcessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PublicUtilitiesInventoryTypeDomain_7fb2309a-ebc5-40e8-9a90-2bc62e40eaa9" xlink:to="loc_pgen_WorkInProcessMember_08cbabd2-28e4-473c-acd0-61a0df8e3e49" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_LivestockMember_65a5cee1-a865-42ac-a074-06ded714b02c" xlink:href="pgen-20220331.xsd#pgen_LivestockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PublicUtilitiesInventoryTypeDomain_7fb2309a-ebc5-40e8-9a90-2bc62e40eaa9" xlink:to="loc_pgen_LivestockMember_65a5cee1-a865-42ac-a074-06ded714b02c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_FeedMember_29b308d3-a2d9-4abb-aad5-c23afbb18e0d" xlink:href="pgen-20220331.xsd#pgen_FeedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PublicUtilitiesInventoryTypeDomain_7fb2309a-ebc5-40e8-9a90-2bc62e40eaa9" xlink:to="loc_pgen_FeedMember_29b308d3-a2d9-4abb-aad5-c23afbb18e0d" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dna.com/role/GoodwillandIntangibleAssetsNetAdditionalInformationDetails" xlink:type="simple" xlink:href="pgen-20220331.xsd#GoodwillandIntangibleAssetsNetAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.dna.com/role/GoodwillandIntangibleAssetsNetAdditionalInformationDetails" xlink:type="extended" id="ia11b8d242e9843a893c70afe181a6e5d_GoodwillandIntangibleAssetsNetAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_be30a94c-0a0c-44db-9cf1-f8fd8f53814f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_e35ad153-510d-4da1-b9f8-11e878eb21ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_be30a94c-0a0c-44db-9cf1-f8fd8f53814f" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_e35ad153-510d-4da1-b9f8-11e878eb21ff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_NumberOfReportingUnitsImpaired_5f9a7c57-8e1e-414c-a2a2-239ff9881e2c" xlink:href="pgen-20220331.xsd#pgen_NumberOfReportingUnitsImpaired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_be30a94c-0a0c-44db-9cf1-f8fd8f53814f" xlink:to="loc_pgen_NumberOfReportingUnitsImpaired_5f9a7c57-8e1e-414c-a2a2-239ff9881e2c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_d47e1b30-d299-4cc1-b5ef-a937497aed9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_be30a94c-0a0c-44db-9cf1-f8fd8f53814f" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_d47e1b30-d299-4cc1-b5ef-a937497aed9a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_620a9a65-f58a-4826-b8db-babd2a54cdc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_be30a94c-0a0c-44db-9cf1-f8fd8f53814f" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_620a9a65-f58a-4826-b8db-babd2a54cdc6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_580d0276-58e0-4bfe-a70d-7bc63f6f31a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_be30a94c-0a0c-44db-9cf1-f8fd8f53814f" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_580d0276-58e0-4bfe-a70d-7bc63f6f31a5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_f7fc87ee-d404-4c5b-af82-2e6997ec6574" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_580d0276-58e0-4bfe-a70d-7bc63f6f31a5" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_f7fc87ee-d404-4c5b-af82-2e6997ec6574" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_f7fc87ee-d404-4c5b-af82-2e6997ec6574_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_f7fc87ee-d404-4c5b-af82-2e6997ec6574" xlink:to="loc_us-gaap_SegmentDomain_f7fc87ee-d404-4c5b-af82-2e6997ec6574_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_a3ec1586-d9e2-4d31-988f-d3568039df8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_f7fc87ee-d404-4c5b-af82-2e6997ec6574" xlink:to="loc_us-gaap_SegmentDomain_a3ec1586-d9e2-4d31-988f-d3568039df8d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_BiopharmaceuticalsSegmentMember_177e70e6-954e-484b-9994-3116bf3c9cf6" xlink:href="pgen-20220331.xsd#pgen_BiopharmaceuticalsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_a3ec1586-d9e2-4d31-988f-d3568039df8d" xlink:to="loc_pgen_BiopharmaceuticalsSegmentMember_177e70e6-954e-484b-9994-3116bf3c9cf6" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dna.com/role/GoodwillandIntangibleAssetsNetScheduleofIntangibleAssetsDetails" xlink:type="simple" xlink:href="pgen-20220331.xsd#GoodwillandIntangibleAssetsNetScheduleofIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.dna.com/role/GoodwillandIntangibleAssetsNetScheduleofIntangibleAssetsDetails" xlink:type="extended" id="i48af6edbe9be4b5caf4f45b892265074_GoodwillandIntangibleAssetsNetScheduleofIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ef67e409-5edf-4b15-af6a-d6d619cf31f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_abb722a4-1cfc-44c1-a8e7-d65ebb990364" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNetAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ef67e409-5edf-4b15-af6a-d6d619cf31f1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_abb722a4-1cfc-44c1-a8e7-d65ebb990364" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_3c6357b9-fbc0-40b8-9192-c2f2a0f358f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_abb722a4-1cfc-44c1-a8e7-d65ebb990364" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_3c6357b9-fbc0-40b8-9192-c2f2a0f358f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_467416ce-9e8a-4f2b-86d2-ff333ba03bab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_abb722a4-1cfc-44c1-a8e7-d65ebb990364" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_467416ce-9e8a-4f2b-86d2-ff333ba03bab" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_0cd64b22-e7df-470b-b49e-06e358b3cdb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_abb722a4-1cfc-44c1-a8e7-d65ebb990364" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_0cd64b22-e7df-470b-b49e-06e358b3cdb6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_0936849b-9cce-4078-8395-09f5a119a2a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ef67e409-5edf-4b15-af6a-d6d619cf31f1" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_0936849b-9cce-4078-8395-09f5a119a2a1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_430da71e-0304-4e06-825a-d8dc52a0876c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_0936849b-9cce-4078-8395-09f5a119a2a1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_430da71e-0304-4e06-825a-d8dc52a0876c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_430da71e-0304-4e06-825a-d8dc52a0876c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_430da71e-0304-4e06-825a-d8dc52a0876c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_430da71e-0304-4e06-825a-d8dc52a0876c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ec5af0e3-510e-4ecd-80a8-70ebad475170" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_430da71e-0304-4e06-825a-d8dc52a0876c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ec5af0e3-510e-4ecd-80a8-70ebad475170" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntellectualPropertyMember_a816a078-7deb-401e-8e96-7d120bc9ad54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntellectualPropertyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ec5af0e3-510e-4ecd-80a8-70ebad475170" xlink:to="loc_us-gaap_IntellectualPropertyMember_a816a078-7deb-401e-8e96-7d120bc9ad54" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_e1620bbe-43cc-42ce-aabd-ec8594d0e4f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ec5af0e3-510e-4ecd-80a8-70ebad475170" xlink:to="loc_us-gaap_CustomerRelationshipsMember_e1620bbe-43cc-42ce-aabd-ec8594d0e4f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_99a24708-df54-45ea-9995-25c120147e37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ec5af0e3-510e-4ecd-80a8-70ebad475170" xlink:to="loc_us-gaap_TrademarksMember_99a24708-df54-45ea-9995-25c120147e37" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dna.com/role/LinesofCreditandLongTermDebtLinesofCreditAdditionalInformationDetails" xlink:type="simple" xlink:href="pgen-20220331.xsd#LinesofCreditandLongTermDebtLinesofCreditAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.dna.com/role/LinesofCreditandLongTermDebtLinesofCreditAdditionalInformationDetails" xlink:type="extended" id="i98e3c29641d440fcaf781d80741dcb71_LinesofCreditandLongTermDebtLinesofCreditAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_db3d4ddf-4111-4c54-a540-94dd977ac124" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_3bf9d55b-9dcf-4a64-9b71-f757efbeaaa5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_db3d4ddf-4111-4c54-a540-94dd977ac124" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_3bf9d55b-9dcf-4a64-9b71-f757efbeaaa5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_97a5ae8d-2deb-46e9-b905-63650d3a0ba5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_db3d4ddf-4111-4c54-a540-94dd977ac124" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_97a5ae8d-2deb-46e9-b905-63650d3a0ba5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_d3b2bd00-98be-49de-b501-b7e6ad86a960" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_db3d4ddf-4111-4c54-a540-94dd977ac124" xlink:to="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_d3b2bd00-98be-49de-b501-b7e6ad86a960" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_b4b6f568-3783-4814-868a-f7d95ef42a32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_db3d4ddf-4111-4c54-a540-94dd977ac124" xlink:to="loc_us-gaap_LineOfCredit_b4b6f568-3783-4814-868a-f7d95ef42a32" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_6b1f7960-5a76-406c-9b57-621de93e7089" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_db3d4ddf-4111-4c54-a540-94dd977ac124" xlink:to="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_6b1f7960-5a76-406c-9b57-621de93e7089" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_833adf25-4ad0-4e0f-a6fd-63c527879f27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_db3d4ddf-4111-4c54-a540-94dd977ac124" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_833adf25-4ad0-4e0f-a6fd-63c527879f27" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_4199535d-001e-40de-a7ac-f6dfaf60dcca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_833adf25-4ad0-4e0f-a6fd-63c527879f27" xlink:to="loc_us-gaap_CreditFacilityAxis_4199535d-001e-40de-a7ac-f6dfaf60dcca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_4199535d-001e-40de-a7ac-f6dfaf60dcca_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_4199535d-001e-40de-a7ac-f6dfaf60dcca" xlink:to="loc_us-gaap_CreditFacilityDomain_4199535d-001e-40de-a7ac-f6dfaf60dcca_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_b8454601-0d23-402a-96d7-573246576c3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_4199535d-001e-40de-a7ac-f6dfaf60dcca" xlink:to="loc_us-gaap_CreditFacilityDomain_b8454601-0d23-402a-96d7-573246576c3d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_8e63858b-d5ac-45c8-a375-24ddd78da4c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_b8454601-0d23-402a-96d7-573246576c3d" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_8e63858b-d5ac-45c8-a375-24ddd78da4c5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_bcaf808e-4d2d-4779-ab13-d5a152f66dca" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_833adf25-4ad0-4e0f-a6fd-63c527879f27" xlink:to="loc_dei_LegalEntityAxis_bcaf808e-4d2d-4779-ab13-d5a152f66dca" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_bcaf808e-4d2d-4779-ab13-d5a152f66dca_default" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_bcaf808e-4d2d-4779-ab13-d5a152f66dca" xlink:to="loc_dei_EntityDomain_bcaf808e-4d2d-4779-ab13-d5a152f66dca_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_2bcc320c-be59-4b2b-938e-66d953ed8044" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_bcaf808e-4d2d-4779-ab13-d5a152f66dca" xlink:to="loc_dei_EntityDomain_2bcc320c-be59-4b2b-938e-66d953ed8044" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_TransOvaGeneticsLcMember_f225cfd4-aa7c-40b0-8d8d-d6d62962b8c7" xlink:href="pgen-20220331.xsd#pgen_TransOvaGeneticsLcMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_2bcc320c-be59-4b2b-938e-66d953ed8044" xlink:to="loc_pgen_TransOvaGeneticsLcMember_f225cfd4-aa7c-40b0-8d8d-d6d62962b8c7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_ExemplarGeneticsLLCMember_2c1fdbfd-47e0-41f1-ba1b-a277609e9517" xlink:href="pgen-20220331.xsd#pgen_ExemplarGeneticsLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_2bcc320c-be59-4b2b-938e-66d953ed8044" xlink:to="loc_pgen_ExemplarGeneticsLLCMember_2c1fdbfd-47e0-41f1-ba1b-a277609e9517" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_e90f9f3e-b92b-4298-92ef-44ad09762967" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_833adf25-4ad0-4e0f-a6fd-63c527879f27" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_e90f9f3e-b92b-4298-92ef-44ad09762967" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_e90f9f3e-b92b-4298-92ef-44ad09762967_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_e90f9f3e-b92b-4298-92ef-44ad09762967" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_e90f9f3e-b92b-4298-92ef-44ad09762967_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_400688a5-2a3b-49f7-950c-ea72c2a72365" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_e90f9f3e-b92b-4298-92ef-44ad09762967" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_400688a5-2a3b-49f7-950c-ea72c2a72365" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_FirstNationalBankofOmahaMember_f218b3dd-2063-461b-bba5-877186ebd215" xlink:href="pgen-20220331.xsd#pgen_FirstNationalBankofOmahaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_400688a5-2a3b-49f7-950c-ea72c2a72365" xlink:to="loc_pgen_FirstNationalBankofOmahaMember_f218b3dd-2063-461b-bba5-877186ebd215" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_AmericanStateBankMember_39b89448-cce0-4981-bfdb-86849138cc89" xlink:href="pgen-20220331.xsd#pgen_AmericanStateBankMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_400688a5-2a3b-49f7-950c-ea72c2a72365" xlink:to="loc_pgen_AmericanStateBankMember_39b89448-cce0-4981-bfdb-86849138cc89" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_6e0367fe-6b94-4f6c-8b5f-f0be1e18c708" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_833adf25-4ad0-4e0f-a6fd-63c527879f27" xlink:to="loc_srt_RangeAxis_6e0367fe-6b94-4f6c-8b5f-f0be1e18c708" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6e0367fe-6b94-4f6c-8b5f-f0be1e18c708_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_6e0367fe-6b94-4f6c-8b5f-f0be1e18c708" xlink:to="loc_srt_RangeMember_6e0367fe-6b94-4f6c-8b5f-f0be1e18c708_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_8c76c53e-2364-4aa7-878f-f885a2f76b16" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_6e0367fe-6b94-4f6c-8b5f-f0be1e18c708" xlink:to="loc_srt_RangeMember_8c76c53e-2364-4aa7-878f-f885a2f76b16" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_d763aed7-b0c6-4125-aa02-753740575334" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_8c76c53e-2364-4aa7-878f-f885a2f76b16" xlink:to="loc_srt_MinimumMember_d763aed7-b0c6-4125-aa02-753740575334" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dna.com/role/LinesofCreditandLongTermDebtScheduleofLongTermDebtInstrumentsDetails" xlink:type="simple" xlink:href="pgen-20220331.xsd#LinesofCreditandLongTermDebtScheduleofLongTermDebtInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://www.dna.com/role/LinesofCreditandLongTermDebtScheduleofLongTermDebtInstrumentsDetails" xlink:type="extended" id="i5b5644c943974cd99ea3ce89658e289c_LinesofCreditandLongTermDebtScheduleofLongTermDebtInstrumentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_27b6c389-5d39-47d2-a3bc-c442ac28985d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_7bfb4005-2c60-44ec-bb5f-aa2cb2dd2933" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_27b6c389-5d39-47d2-a3bc-c442ac28985d" xlink:to="loc_us-gaap_LongTermDebt_7bfb4005-2c60-44ec-bb5f-aa2cb2dd2933" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_06101dd5-ed65-4219-99ba-271335d0d009" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_27b6c389-5d39-47d2-a3bc-c442ac28985d" xlink:to="loc_us-gaap_LongTermDebtCurrent_06101dd5-ed65-4219-99ba-271335d0d009" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_ffd9368d-b95a-4195-ba34-484b692ba74b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_27b6c389-5d39-47d2-a3bc-c442ac28985d" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_ffd9368d-b95a-4195-ba34-484b692ba74b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_d5cce891-4822-4b30-9e94-67c05eff56ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_27b6c389-5d39-47d2-a3bc-c442ac28985d" xlink:to="loc_us-gaap_DebtInstrumentTable_d5cce891-4822-4b30-9e94-67c05eff56ff" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_03078367-45f8-483e-983b-fea0023aec01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_d5cce891-4822-4b30-9e94-67c05eff56ff" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_03078367-45f8-483e-983b-fea0023aec01" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_03078367-45f8-483e-983b-fea0023aec01_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_03078367-45f8-483e-983b-fea0023aec01" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_03078367-45f8-483e-983b-fea0023aec01_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_67ba794e-a463-40e9-ba19-f22d851bf737" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_03078367-45f8-483e-983b-fea0023aec01" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_67ba794e-a463-40e9-ba19-f22d851bf737" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_f7e31666-eb6d-491a-846d-5cb864ce3d24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_67ba794e-a463-40e9-ba19-f22d851bf737" xlink:to="loc_us-gaap_ConvertibleDebtMember_f7e31666-eb6d-491a-846d-5cb864ce3d24" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableToBanksMember_61f25bf8-3f51-4569-a6f1-b3ae2af32209" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableToBanksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_67ba794e-a463-40e9-ba19-f22d851bf737" xlink:to="loc_us-gaap_NotesPayableToBanksMember_61f25bf8-3f51-4569-a6f1-b3ae2af32209" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_OtherLongTermDebtMember_458c8f57-951f-4739-91be-17f46a70eeda" xlink:href="pgen-20220331.xsd#pgen_OtherLongTermDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_67ba794e-a463-40e9-ba19-f22d851bf737" xlink:to="loc_pgen_OtherLongTermDebtMember_458c8f57-951f-4739-91be-17f46a70eeda" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dna.com/role/LinesofCreditandLongTermDebtLongTermDebtAdditionalInformationDetails" xlink:type="simple" xlink:href="pgen-20220331.xsd#LinesofCreditandLongTermDebtLongTermDebtAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.dna.com/role/LinesofCreditandLongTermDebtLongTermDebtAdditionalInformationDetails" xlink:type="extended" id="ib3f552b8cdae41ddb1eb34eb1bd38b27_LinesofCreditandLongTermDebtLongTermDebtAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_c9585b3a-9b03-46e5-b428-ec68188933b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_c1b4b8a7-1e4b-46db-9a06-7cd0a7bfe287" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c9585b3a-9b03-46e5-b428-ec68188933b9" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_c1b4b8a7-1e4b-46db-9a06-7cd0a7bfe287" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_df0e99bf-5612-4091-9ed9-1780b85cfbcc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c9585b3a-9b03-46e5-b428-ec68188933b9" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_df0e99bf-5612-4091-9ed9-1780b85cfbcc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross_aae844fa-00f3-4314-ace5-1f1f914d9da2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c9585b3a-9b03-46e5-b428-ec68188933b9" xlink:to="loc_us-gaap_DeferredFinanceCostsGross_aae844fa-00f3-4314-ace5-1f1f914d9da2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_33ed955c-6fdb-4b8a-b1f2-8f7548f7aa72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c9585b3a-9b03-46e5-b428-ec68188933b9" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_33ed955c-6fdb-4b8a-b1f2-8f7548f7aa72" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_43f2c42f-6a48-4233-bee3-7f1a27fe3ebd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c9585b3a-9b03-46e5-b428-ec68188933b9" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_43f2c42f-6a48-4233-bee3-7f1a27fe3ebd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_ConvertibleDebtPrincipalAmountInitialConversionRate_23887f32-c0be-4994-b167-ff9ddc707a24" xlink:href="pgen-20220331.xsd#pgen_ConvertibleDebtPrincipalAmountInitialConversionRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c9585b3a-9b03-46e5-b428-ec68188933b9" xlink:to="loc_pgen_ConvertibleDebtPrincipalAmountInitialConversionRate_23887f32-c0be-4994-b167-ff9ddc707a24" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_70ef2647-2614-4074-ae0f-0d5199a77a35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c9585b3a-9b03-46e5-b428-ec68188933b9" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_70ef2647-2614-4074-ae0f-0d5199a77a35" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_f6a4df8f-8670-4de2-8490-6051ac6b9f81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c9585b3a-9b03-46e5-b428-ec68188933b9" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_f6a4df8f-8670-4de2-8490-6051ac6b9f81" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_97cb41a5-a4b7-4342-a1a4-b1ec69d02a24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c9585b3a-9b03-46e5-b428-ec68188933b9" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_97cb41a5-a4b7-4342-a1a4-b1ec69d02a24" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_44edae6a-c9ee-4728-a12c-92c1f1a08e3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c9585b3a-9b03-46e5-b428-ec68188933b9" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_44edae6a-c9ee-4728-a12c-92c1f1a08e3b" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_1f7acc1d-235a-48cb-9f59-294039cf19bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c9585b3a-9b03-46e5-b428-ec68188933b9" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_1f7acc1d-235a-48cb-9f59-294039cf19bd" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebt_2b25f661-bb18-43ce-a803-c9dbfe2cc1d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c9585b3a-9b03-46e5-b428-ec68188933b9" xlink:to="loc_us-gaap_ConvertibleDebt_2b25f661-bb18-43ce-a803-c9dbfe2cc1d7" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_b186f83b-b179-4de4-a303-619f1eac39aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c9585b3a-9b03-46e5-b428-ec68188933b9" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_b186f83b-b179-4de4-a303-619f1eac39aa" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_071f02de-6cc8-4b3d-b966-5397fb343054" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c9585b3a-9b03-46e5-b428-ec68188933b9" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_071f02de-6cc8-4b3d-b966-5397fb343054" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_d2008e4f-503c-4a28-a973-39870a3359cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c9585b3a-9b03-46e5-b428-ec68188933b9" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_d2008e4f-503c-4a28-a973-39870a3359cd" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_bd115c78-267f-48d0-9680-196ee5d69063" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c9585b3a-9b03-46e5-b428-ec68188933b9" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_bd115c78-267f-48d0-9680-196ee5d69063" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_443cbf03-36fa-417e-9a74-932f6407b17c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c9585b3a-9b03-46e5-b428-ec68188933b9" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_443cbf03-36fa-417e-9a74-932f6407b17c" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_6781124b-fb4e-4e43-95f0-f2e116f45d6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c9585b3a-9b03-46e5-b428-ec68188933b9" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_6781124b-fb4e-4e43-95f0-f2e116f45d6a" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrentAndNoncurrent_089f6770-29c4-4e29-99e1-4627df78db55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPayableCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c9585b3a-9b03-46e5-b428-ec68188933b9" xlink:to="loc_us-gaap_InterestPayableCurrentAndNoncurrent_089f6770-29c4-4e29-99e1-4627df78db55" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_31588912-a8fe-481d-92c0-fc789bf555ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c9585b3a-9b03-46e5-b428-ec68188933b9" xlink:to="loc_us-gaap_LongTermDebt_31588912-a8fe-481d-92c0-fc789bf555ac" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPayment_617fe774-034d-470e-b4e9-90581f142e9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentPeriodicPayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c9585b3a-9b03-46e5-b428-ec68188933b9" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPayment_617fe774-034d-470e-b4e9-90581f142e9c" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_c64da79d-ab04-4d47-93ef-59103f55e3ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c9585b3a-9b03-46e5-b428-ec68188933b9" xlink:to="loc_us-gaap_DebtInstrumentTable_c64da79d-ab04-4d47-93ef-59103f55e3ea" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_c5c07ec1-3f91-4438-86c4-9618de0dcdcf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_c64da79d-ab04-4d47-93ef-59103f55e3ea" xlink:to="loc_us-gaap_DebtInstrumentAxis_c5c07ec1-3f91-4438-86c4-9618de0dcdcf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c5c07ec1-3f91-4438-86c4-9618de0dcdcf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_c5c07ec1-3f91-4438-86c4-9618de0dcdcf" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c5c07ec1-3f91-4438-86c4-9618de0dcdcf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_00006ea9-503f-4988-a7b5-be5c013df288" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_c5c07ec1-3f91-4438-86c4-9618de0dcdcf" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_00006ea9-503f-4988-a7b5-be5c013df288" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_A3.5ConvertibleNotesDue2023Member_340d78e2-ffd8-4ad2-830f-29476c20332b" xlink:href="pgen-20220331.xsd#pgen_A3.5ConvertibleNotesDue2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_00006ea9-503f-4988-a7b5-be5c013df288" xlink:to="loc_pgen_A3.5ConvertibleNotesDue2023Member_340d78e2-ffd8-4ad2-830f-29476c20332b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_e702e8b3-e566-49f0-bfc8-122ffca9c3c3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_c64da79d-ab04-4d47-93ef-59103f55e3ea" xlink:to="loc_srt_RangeAxis_e702e8b3-e566-49f0-bfc8-122ffca9c3c3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e702e8b3-e566-49f0-bfc8-122ffca9c3c3_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_e702e8b3-e566-49f0-bfc8-122ffca9c3c3" xlink:to="loc_srt_RangeMember_e702e8b3-e566-49f0-bfc8-122ffca9c3c3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_786ef8fa-c0bf-4a30-a9e9-e5a1fc6f903d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_e702e8b3-e566-49f0-bfc8-122ffca9c3c3" xlink:to="loc_srt_RangeMember_786ef8fa-c0bf-4a30-a9e9-e5a1fc6f903d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_9dd5a43e-9b71-4026-a688-8e2839c08196" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_786ef8fa-c0bf-4a30-a9e9-e5a1fc6f903d" xlink:to="loc_srt_MinimumMember_9dd5a43e-9b71-4026-a688-8e2839c08196" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_6bb8ab17-c957-4df4-8fbc-94e7ef3e360b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_786ef8fa-c0bf-4a30-a9e9-e5a1fc6f903d" xlink:to="loc_srt_MaximumMember_6bb8ab17-c957-4df4-8fbc-94e7ef3e360b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_6031f87b-14b3-4fce-a7b1-fb0177b19a57" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_c64da79d-ab04-4d47-93ef-59103f55e3ea" xlink:to="loc_dei_LegalEntityAxis_6031f87b-14b3-4fce-a7b1-fb0177b19a57" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_6031f87b-14b3-4fce-a7b1-fb0177b19a57_default" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_6031f87b-14b3-4fce-a7b1-fb0177b19a57" xlink:to="loc_dei_EntityDomain_6031f87b-14b3-4fce-a7b1-fb0177b19a57_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_e097d0c6-5a06-4230-9c00-291f59b7b1cb" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_6031f87b-14b3-4fce-a7b1-fb0177b19a57" xlink:to="loc_dei_EntityDomain_e097d0c6-5a06-4230-9c00-291f59b7b1cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_TransOvaGeneticsLcMember_19f1a53f-fc95-48f0-9567-d83895834a9d" xlink:href="pgen-20220331.xsd#pgen_TransOvaGeneticsLcMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_e097d0c6-5a06-4230-9c00-291f59b7b1cb" xlink:to="loc_pgen_TransOvaGeneticsLcMember_19f1a53f-fc95-48f0-9567-d83895834a9d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_5cd61a4c-b169-4477-8e54-f18b46698370" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_c64da79d-ab04-4d47-93ef-59103f55e3ea" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_5cd61a4c-b169-4477-8e54-f18b46698370" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_5cd61a4c-b169-4477-8e54-f18b46698370_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_5cd61a4c-b169-4477-8e54-f18b46698370" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_5cd61a4c-b169-4477-8e54-f18b46698370_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_83a81714-128a-4736-9ad1-daa0ca0ccb6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_5cd61a4c-b169-4477-8e54-f18b46698370" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_83a81714-128a-4736-9ad1-daa0ca0ccb6f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_acc5b32d-67d0-4bd7-96ae-79a6ea54486a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_83a81714-128a-4736-9ad1-daa0ca0ccb6f" xlink:to="loc_us-gaap_ConvertibleDebtMember_acc5b32d-67d0-4bd7-96ae-79a6ea54486a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableToBanksMember_6aa06286-6092-43d9-8863-97760af3de60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableToBanksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_83a81714-128a-4736-9ad1-daa0ca0ccb6f" xlink:to="loc_us-gaap_NotesPayableToBanksMember_6aa06286-6092-43d9-8863-97760af3de60" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_95b195bd-b703-42e5-bae1-17b3a692bb1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_c64da79d-ab04-4d47-93ef-59103f55e3ea" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_95b195bd-b703-42e5-bae1-17b3a692bb1d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_95b195bd-b703-42e5-bae1-17b3a692bb1d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_95b195bd-b703-42e5-bae1-17b3a692bb1d" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_95b195bd-b703-42e5-bae1-17b3a692bb1d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_992047a1-447f-43b2-b67a-0b84e2972413" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_95b195bd-b703-42e5-bae1-17b3a692bb1d" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_992047a1-447f-43b2-b67a-0b84e2972413" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_AmericanStateBankMember_0c9c666f-8edc-46cf-8026-c4284d23632c" xlink:href="pgen-20220331.xsd#pgen_AmericanStateBankMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_992047a1-447f-43b2-b67a-0b84e2972413" xlink:to="loc_pgen_AmericanStateBankMember_0c9c666f-8edc-46cf-8026-c4284d23632c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_175cfe2c-02e6-4646-928c-2ff2c80c8ee3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_c64da79d-ab04-4d47-93ef-59103f55e3ea" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_175cfe2c-02e6-4646-928c-2ff2c80c8ee3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_175cfe2c-02e6-4646-928c-2ff2c80c8ee3_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_175cfe2c-02e6-4646-928c-2ff2c80c8ee3" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_175cfe2c-02e6-4646-928c-2ff2c80c8ee3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_a5f514b4-7070-4b5c-a3e4-9536ab867fed" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_175cfe2c-02e6-4646-928c-2ff2c80c8ee3" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_a5f514b4-7070-4b5c-a3e4-9536ab867fed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_d7ad577f-da31-48ac-a8b5-7dacd217d350" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_a5f514b4-7070-4b5c-a3e4-9536ab867fed" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_d7ad577f-da31-48ac-a8b5-7dacd217d350" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_603b4c64-2e4a-4920-b4ed-140aeaa3de41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_c64da79d-ab04-4d47-93ef-59103f55e3ea" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_603b4c64-2e4a-4920-b4ed-140aeaa3de41" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_603b4c64-2e4a-4920-b4ed-140aeaa3de41_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_603b4c64-2e4a-4920-b4ed-140aeaa3de41" xlink:to="loc_us-gaap_TypeOfAdoptionMember_603b4c64-2e4a-4920-b4ed-140aeaa3de41_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_3d3151b9-c231-4b38-ab39-a00873251455" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_603b4c64-2e4a-4920-b4ed-140aeaa3de41" xlink:to="loc_us-gaap_TypeOfAdoptionMember_3d3151b9-c231-4b38-ab39-a00873251455" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate202006RetrospectiveMember_63f6ca0f-c470-4c36-8cd0-b6e74dd663e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate202006RetrospectiveMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_3d3151b9-c231-4b38-ab39-a00873251455" xlink:to="loc_us-gaap_AccountingStandardsUpdate202006RetrospectiveMember_63f6ca0f-c470-4c36-8cd0-b6e74dd663e7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_4820073e-e409-4f7f-a489-55c50b17be49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_c64da79d-ab04-4d47-93ef-59103f55e3ea" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_4820073e-e409-4f7f-a489-55c50b17be49" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_4820073e-e409-4f7f-a489-55c50b17be49_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_4820073e-e409-4f7f-a489-55c50b17be49" xlink:to="loc_us-gaap_EquityComponentDomain_4820073e-e409-4f7f-a489-55c50b17be49_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_3c934d9e-7476-4b49-938d-ab0faef8185a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_4820073e-e409-4f7f-a489-55c50b17be49" xlink:to="loc_us-gaap_EquityComponentDomain_3c934d9e-7476-4b49-938d-ab0faef8185a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_c5c9128c-1eaf-4282-937d-dbf08b82cb70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3c934d9e-7476-4b49-938d-ab0faef8185a" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_c5c9128c-1eaf-4282-937d-dbf08b82cb70" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_124a0985-ad1b-473f-981b-d88aeed57de6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3c934d9e-7476-4b49-938d-ab0faef8185a" xlink:to="loc_us-gaap_RetainedEarningsMember_124a0985-ad1b-473f-981b-d88aeed57de6" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dna.com/role/LinesofCreditandLongTermDebtScheduleofComponentsofInterestExpenseDetails" xlink:type="simple" xlink:href="pgen-20220331.xsd#LinesofCreditandLongTermDebtScheduleofComponentsofInterestExpenseDetails"/>
  <link:definitionLink xlink:role="http://www.dna.com/role/LinesofCreditandLongTermDebtScheduleofComponentsofInterestExpenseDetails" xlink:type="extended" id="ief78434de08744f096a4956452a81b9d_LinesofCreditandLongTermDebtScheduleofComponentsofInterestExpenseDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_269c3793-c74e-4ff2-9a94-cc1e1ed93feb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebtExcludingAmortization_6846a212-955f-4aaf-8b57-8fcfc1fa5a6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebtExcludingAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_269c3793-c74e-4ff2-9a94-cc1e1ed93feb" xlink:to="loc_us-gaap_InterestExpenseDebtExcludingAmortization_6846a212-955f-4aaf-8b57-8fcfc1fa5a6b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_InterestExpenseDebtAmortizationofDebtDiscountPremiumandDebtIssuanceCosts_dd2a48c1-7885-4b1d-97c2-3039dde3eb34" xlink:href="pgen-20220331.xsd#pgen_InterestExpenseDebtAmortizationofDebtDiscountPremiumandDebtIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_269c3793-c74e-4ff2-9a94-cc1e1ed93feb" xlink:to="loc_pgen_InterestExpenseDebtAmortizationofDebtDiscountPremiumandDebtIssuanceCosts_dd2a48c1-7885-4b1d-97c2-3039dde3eb34" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_ecd2d0af-bff0-4ece-9c59-82d31b3622b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_269c3793-c74e-4ff2-9a94-cc1e1ed93feb" xlink:to="loc_us-gaap_InterestExpenseDebt_ecd2d0af-bff0-4ece-9c59-82d31b3622b9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_bbca3219-9fd6-46d6-9ada-b5029c296a19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_269c3793-c74e-4ff2-9a94-cc1e1ed93feb" xlink:to="loc_us-gaap_DebtInstrumentTable_bbca3219-9fd6-46d6-9ada-b5029c296a19" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_b7696ca5-b422-4a43-9331-c65ae2943ba2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_bbca3219-9fd6-46d6-9ada-b5029c296a19" xlink:to="loc_us-gaap_DebtInstrumentAxis_b7696ca5-b422-4a43-9331-c65ae2943ba2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_b7696ca5-b422-4a43-9331-c65ae2943ba2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_b7696ca5-b422-4a43-9331-c65ae2943ba2" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_b7696ca5-b422-4a43-9331-c65ae2943ba2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_fe7a1b49-89ec-44b1-a5d8-b8aea6bc7321" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_b7696ca5-b422-4a43-9331-c65ae2943ba2" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_fe7a1b49-89ec-44b1-a5d8-b8aea6bc7321" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_A3.5ConvertibleNotesDue2023Member_00ad6777-888f-477c-a170-4a9094a2cbc1" xlink:href="pgen-20220331.xsd#pgen_A3.5ConvertibleNotesDue2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fe7a1b49-89ec-44b1-a5d8-b8aea6bc7321" xlink:to="loc_pgen_A3.5ConvertibleNotesDue2023Member_00ad6777-888f-477c-a170-4a9094a2cbc1" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dna.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="pgen-20220331.xsd#IncomeTaxesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.dna.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended" id="iacafec7961f84362a1eb569a0445868f_IncomeTaxesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_dae90117-0003-4d0c-b1eb-682bd3348f4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_TaxableIncomeLoss_3a4c9d1c-9868-4309-8fd4-d6f9dfebc171" xlink:href="pgen-20220331.xsd#pgen_TaxableIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_dae90117-0003-4d0c-b1eb-682bd3348f4b" xlink:to="loc_pgen_TaxableIncomeLoss_3a4c9d1c-9868-4309-8fd4-d6f9dfebc171" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_401fc767-2f14-45d4-8486-2405eb4d4a70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_dae90117-0003-4d0c-b1eb-682bd3348f4b" xlink:to="loc_us-gaap_DeferredTaxLiabilities_401fc767-2f14-45d4-8486-2405eb4d4a70" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_457b015a-b6ee-4c7c-acad-ac59cd9888b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_dae90117-0003-4d0c-b1eb-682bd3348f4b" xlink:to="loc_us-gaap_OperatingLossCarryforwards_457b015a-b6ee-4c7c-acad-ac59cd9888b2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards_bef18845-1769-47cb-878c-957e58032a48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsCapitalLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_dae90117-0003-4d0c-b1eb-682bd3348f4b" xlink:to="loc_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards_bef18845-1769-47cb-878c-957e58032a48" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_13c23548-2598-401f-8b08-5d8d070d2a4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_dae90117-0003-4d0c-b1eb-682bd3348f4b" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_13c23548-2598-401f-8b08-5d8d070d2a4d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_fd0956ad-e1eb-40e9-af8c-6500d6996ec6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_dae90117-0003-4d0c-b1eb-682bd3348f4b" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_fd0956ad-e1eb-40e9-af8c-6500d6996ec6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis_a339885a-b7d8-4619-b917-63d6468fb9d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_fd0956ad-e1eb-40e9-af8c-6500d6996ec6" xlink:to="loc_us-gaap_TaxCreditCarryforwardAxis_a339885a-b7d8-4619-b917-63d6468fb9d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_a339885a-b7d8-4619-b917-63d6468fb9d8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_a339885a-b7d8-4619-b917-63d6468fb9d8" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_a339885a-b7d8-4619-b917-63d6468fb9d8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_675cc8d0-e215-4980-a3aa-94ac199f1145" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_a339885a-b7d8-4619-b917-63d6468fb9d8" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_675cc8d0-e215-4980-a3aa-94ac199f1145" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_GeneratedAfter2017Member_d78d485d-7013-4648-a9bc-465a6a259340" xlink:href="pgen-20220331.xsd#pgen_GeneratedAfter2017Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_675cc8d0-e215-4980-a3aa-94ac199f1145" xlink:to="loc_pgen_GeneratedAfter2017Member_d78d485d-7013-4648-a9bc-465a6a259340" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_def73d20-a550-4df0-a451-0bdd047dc521" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_fd0956ad-e1eb-40e9-af8c-6500d6996ec6" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_def73d20-a550-4df0-a451-0bdd047dc521" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_def73d20-a550-4df0-a451-0bdd047dc521_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_def73d20-a550-4df0-a451-0bdd047dc521" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_def73d20-a550-4df0-a451-0bdd047dc521_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_b680c854-4a99-40e4-8ca3-54e2654b832a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_def73d20-a550-4df0-a451-0bdd047dc521" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_b680c854-4a99-40e4-8ca3-54e2654b832a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_ce08cba9-288a-412b-b710-6aa7ba52df53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_b680c854-4a99-40e4-8ca3-54e2654b832a" xlink:to="loc_us-gaap_DomesticCountryMember_ce08cba9-288a-412b-b710-6aa7ba52df53" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_84e07c3e-5156-403d-b2c4-2db7e01943e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_b680c854-4a99-40e4-8ca3-54e2654b832a" xlink:to="loc_us-gaap_ForeignCountryMember_84e07c3e-5156-403d-b2c4-2db7e01943e1" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dna.com/role/IncomeTaxesComponentsofIncomeTaxBenefitsDetails" xlink:type="simple" xlink:href="pgen-20220331.xsd#IncomeTaxesComponentsofIncomeTaxBenefitsDetails"/>
  <link:definitionLink xlink:role="http://www.dna.com/role/IncomeTaxesComponentsofIncomeTaxBenefitsDetails" xlink:type="extended" id="i61fe550328854911b1e6bd5b0c4babd2_IncomeTaxesComponentsofIncomeTaxBenefitsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_7d6ab78e-11b8-4c8e-a8f0-bcfa83854acf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_3584dd2a-8f31-4134-aa19-428160ee2ae8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_7d6ab78e-11b8-4c8e-a8f0-bcfa83854acf" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_3584dd2a-8f31-4134-aa19-428160ee2ae8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_197166ef-eead-4f9f-b604-3b664c1dec67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_7d6ab78e-11b8-4c8e-a8f0-bcfa83854acf" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_197166ef-eead-4f9f-b604-3b664c1dec67" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_a6ce13e7-7c53-45fb-aa17-a5557b0cb763" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_7d6ab78e-11b8-4c8e-a8f0-bcfa83854acf" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_a6ce13e7-7c53-45fb-aa17-a5557b0cb763" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_26005f58-d097-43a6-9ad5-2ea307db45f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_7d6ab78e-11b8-4c8e-a8f0-bcfa83854acf" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_26005f58-d097-43a6-9ad5-2ea307db45f7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_559d3d95-67fe-4bb7-8796-25861c0c849e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOperatingActivitiesSegmentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_26005f58-d097-43a6-9ad5-2ea307db45f7" xlink:to="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_559d3d95-67fe-4bb7-8796-25861c0c849e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentOperatingActivitiesDomain_559d3d95-67fe-4bb7-8796-25861c0c849e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentOperatingActivitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_559d3d95-67fe-4bb7-8796-25861c0c849e" xlink:to="loc_us-gaap_SegmentOperatingActivitiesDomain_559d3d95-67fe-4bb7-8796-25861c0c849e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentOperatingActivitiesDomain_cd485dd8-5942-4250-898d-8f59e3071425" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentOperatingActivitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_559d3d95-67fe-4bb7-8796-25861c0c849e" xlink:to="loc_us-gaap_SegmentOperatingActivitiesDomain_cd485dd8-5942-4250-898d-8f59e3071425" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentContinuingOperationsMember_2fa94230-696a-43ba-80d0-c18d0f254d47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentContinuingOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentOperatingActivitiesDomain_cd485dd8-5942-4250-898d-8f59e3071425" xlink:to="loc_us-gaap_SegmentContinuingOperationsMember_2fa94230-696a-43ba-80d0-c18d0f254d47" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_859a99ef-c089-4db3-9f7e-0d3fe42a2371" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_26005f58-d097-43a6-9ad5-2ea307db45f7" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_859a99ef-c089-4db3-9f7e-0d3fe42a2371" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_859a99ef-c089-4db3-9f7e-0d3fe42a2371_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_859a99ef-c089-4db3-9f7e-0d3fe42a2371" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_859a99ef-c089-4db3-9f7e-0d3fe42a2371_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_e5847e3e-97cd-4268-8e52-be0261be538d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_859a99ef-c089-4db3-9f7e-0d3fe42a2371" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_e5847e3e-97cd-4268-8e52-be0261be538d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_6ef16bbc-4624-4733-95fa-6cf946e6bc7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_e5847e3e-97cd-4268-8e52-be0261be538d" xlink:to="loc_us-gaap_ForeignCountryMember_6ef16bbc-4624-4733-95fa-6cf946e6bc7c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dna.com/role/ShareholdersEquityComponentsofAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="pgen-20220331.xsd#ShareholdersEquityComponentsofAccumulatedOtherComprehensiveIncomeLossDetails"/>
  <link:definitionLink xlink:role="http://www.dna.com/role/ShareholdersEquityComponentsofAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="extended" id="i71dc7bc457384f1f94ea16b1d349ffef_ShareholdersEquityComponentsofAccumulatedOtherComprehensiveIncomeLossDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_80c551a0-8448-4cf9-997a-9afc403e0728" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_33a4614e-45a8-4e8d-968a-28e707033e66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_80c551a0-8448-4cf9-997a-9afc403e0728" xlink:to="loc_us-gaap_StockholdersEquity_33a4614e-45a8-4e8d-968a-28e707033e66" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_119299f2-6b44-4eb5-9441-5e7604f45fb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_80c551a0-8448-4cf9-997a-9afc403e0728" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_119299f2-6b44-4eb5-9441-5e7604f45fb5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_86effc20-766d-4743-88e5-712dd803d95e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_119299f2-6b44-4eb5-9441-5e7604f45fb5" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_86effc20-766d-4743-88e5-712dd803d95e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_86effc20-766d-4743-88e5-712dd803d95e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_86effc20-766d-4743-88e5-712dd803d95e" xlink:to="loc_us-gaap_EquityComponentDomain_86effc20-766d-4743-88e5-712dd803d95e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_c7defe6f-a56f-4e07-ad6d-6edd0d5b52f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_86effc20-766d-4743-88e5-712dd803d95e" xlink:to="loc_us-gaap_EquityComponentDomain_c7defe6f-a56f-4e07-ad6d-6edd0d5b52f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_798a23c2-8afe-4ce7-8e8d-90b667d85132" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_c7defe6f-a56f-4e07-ad6d-6edd0d5b52f8" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_798a23c2-8afe-4ce7-8e8d-90b667d85132" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_3b67dd3c-5eee-4847-b41d-b8f6903b038a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_798a23c2-8afe-4ce7-8e8d-90b667d85132" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_3b67dd3c-5eee-4847-b41d-b8f6903b038a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_d8169c95-d1be-4213-a208-ca5cf88fe9c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_798a23c2-8afe-4ce7-8e8d-90b667d85132" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_d8169c95-d1be-4213-a208-ca5cf88fe9c2" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dna.com/role/ShareBasedPaymentsScheduleofStockBasedCompensationCostsDetails" xlink:type="simple" xlink:href="pgen-20220331.xsd#ShareBasedPaymentsScheduleofStockBasedCompensationCostsDetails"/>
  <link:definitionLink xlink:role="http://www.dna.com/role/ShareBasedPaymentsScheduleofStockBasedCompensationCostsDetails" xlink:type="extended" id="ifd8c583197d7466b8cd8db4b788ef698_ShareBasedPaymentsScheduleofStockBasedCompensationCostsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_71e64f83-a727-424b-8434-0a410d7a6812" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_bd899892-3219-4350-aa72-b77eb394c65d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_71e64f83-a727-424b-8434-0a410d7a6812" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_bd899892-3219-4350-aa72-b77eb394c65d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_2cf9f353-774a-4b2d-8dde-b0e51e47d580" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_71e64f83-a727-424b-8434-0a410d7a6812" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_2cf9f353-774a-4b2d-8dde-b0e51e47d580" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_43eb45ae-4a5c-4086-809e-59372f0d1608" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_2cf9f353-774a-4b2d-8dde-b0e51e47d580" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_43eb45ae-4a5c-4086-809e-59372f0d1608" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_43eb45ae-4a5c-4086-809e-59372f0d1608_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_43eb45ae-4a5c-4086-809e-59372f0d1608" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_43eb45ae-4a5c-4086-809e-59372f0d1608_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_159a6b2e-82ca-4645-bcf1-1eeca1fb1a62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_43eb45ae-4a5c-4086-809e-59372f0d1608" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_159a6b2e-82ca-4645-bcf1-1eeca1fb1a62" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_CostOfProductsMember_8aaa7cda-e6c1-43f7-bd8f-5aadcab0c2ef" xlink:href="pgen-20220331.xsd#pgen_CostOfProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_159a6b2e-82ca-4645-bcf1-1eeca1fb1a62" xlink:to="loc_pgen_CostOfProductsMember_8aaa7cda-e6c1-43f7-bd8f-5aadcab0c2ef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_CostOfServicesMember_ffd56764-1c6f-4b28-afc7-0a23e3b32f74" xlink:href="pgen-20220331.xsd#pgen_CostOfServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_159a6b2e-82ca-4645-bcf1-1eeca1fb1a62" xlink:to="loc_pgen_CostOfServicesMember_ffd56764-1c6f-4b28-afc7-0a23e3b32f74" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_abbb0b96-c104-4483-9a69-ad5b3bc538f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_159a6b2e-82ca-4645-bcf1-1eeca1fb1a62" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_abbb0b96-c104-4483-9a69-ad5b3bc538f4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_39aba409-b3b5-474e-8302-99a29cd8f122" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_159a6b2e-82ca-4645-bcf1-1eeca1fb1a62" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_39aba409-b3b5-474e-8302-99a29cd8f122" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dna.com/role/ShareBasedPaymentsAdditionalInformationDetails" xlink:type="simple" xlink:href="pgen-20220331.xsd#ShareBasedPaymentsAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.dna.com/role/ShareBasedPaymentsAdditionalInformationDetails" xlink:type="extended" id="icc423ea9996541b7be788299bbaff5d3_ShareBasedPaymentsAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_91a942c7-77cc-4ae5-82c7-6db9701275b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_76762b45-58d7-4f03-97d5-30a083529fbc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_91a942c7-77cc-4ae5-82c7-6db9701275b1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_76762b45-58d7-4f03-97d5-30a083529fbc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_ca18d168-5f1b-4e13-9a8b-98ab0749214d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_91a942c7-77cc-4ae5-82c7-6db9701275b1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_ca18d168-5f1b-4e13-9a8b-98ab0749214d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_0374eed9-8825-49ed-b7c7-1cb6a95684d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_91a942c7-77cc-4ae5-82c7-6db9701275b1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_0374eed9-8825-49ed-b7c7-1cb6a95684d7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_a8099c74-ae71-4d70-80b5-41803d21459b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_91a942c7-77cc-4ae5-82c7-6db9701275b1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_a8099c74-ae71-4d70-80b5-41803d21459b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_CompensationArrangementWithIndividualAllocatedShareBasedCompensationExpenseMonthlyExpense_57b7da8a-69da-4639-82ab-a36b1cf845f6" xlink:href="pgen-20220331.xsd#pgen_CompensationArrangementWithIndividualAllocatedShareBasedCompensationExpenseMonthlyExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_91a942c7-77cc-4ae5-82c7-6db9701275b1" xlink:to="loc_pgen_CompensationArrangementWithIndividualAllocatedShareBasedCompensationExpenseMonthlyExpense_57b7da8a-69da-4639-82ab-a36b1cf845f6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_LockupPeriodOnRestrictedStockUnitShares_518c6588-c94e-4c14-8d32-8581eb8438bb" xlink:href="pgen-20220331.xsd#pgen_LockupPeriodOnRestrictedStockUnitShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_91a942c7-77cc-4ae5-82c7-6db9701275b1" xlink:to="loc_pgen_LockupPeriodOnRestrictedStockUnitShares_518c6588-c94e-4c14-8d32-8581eb8438bb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_CompensationArrangementWithIndividualAnnualCashRetainer_571c887a-1688-402e-bd0e-502df65ccbf2" xlink:href="pgen-20220331.xsd#pgen_CompensationArrangementWithIndividualAnnualCashRetainer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_91a942c7-77cc-4ae5-82c7-6db9701275b1" xlink:to="loc_pgen_CompensationArrangementWithIndividualAnnualCashRetainer_571c887a-1688-402e-bd0e-502df65ccbf2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_CompensationArrangementWithIndividualAnnualStockOptionGrantGrantDateFairValue_eb672fb2-4e14-4351-8b94-3e77937b5f7f" xlink:href="pgen-20220331.xsd#pgen_CompensationArrangementWithIndividualAnnualStockOptionGrantGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_91a942c7-77cc-4ae5-82c7-6db9701275b1" xlink:to="loc_pgen_CompensationArrangementWithIndividualAnnualStockOptionGrantGrantDateFairValue_eb672fb2-4e14-4351-8b94-3e77937b5f7f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_CompensationArrangementWithIndividualAnnualRSUGrantGrantDateFairValue_2fdbb31e-f395-4066-9149-0841bd1924c5" xlink:href="pgen-20220331.xsd#pgen_CompensationArrangementWithIndividualAnnualRSUGrantGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_91a942c7-77cc-4ae5-82c7-6db9701275b1" xlink:to="loc_pgen_CompensationArrangementWithIndividualAnnualRSUGrantGrantDateFairValue_2fdbb31e-f395-4066-9149-0841bd1924c5" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_b9ee717e-49ee-43b7-b447-c639d99b1ed5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_91a942c7-77cc-4ae5-82c7-6db9701275b1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_b9ee717e-49ee-43b7-b447-c639d99b1ed5" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_CompensationArrangementWithIndividualExpense_570ccc63-fe16-4f16-acb7-8252f47f0ad1" xlink:href="pgen-20220331.xsd#pgen_CompensationArrangementWithIndividualExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_91a942c7-77cc-4ae5-82c7-6db9701275b1" xlink:to="loc_pgen_CompensationArrangementWithIndividualExpense_570ccc63-fe16-4f16-acb7-8252f47f0ad1" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e82ba94f-6131-48b7-b542-16fab851089b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_91a942c7-77cc-4ae5-82c7-6db9701275b1" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e82ba94f-6131-48b7-b542-16fab851089b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_3e7076a9-1c46-422d-9255-9b5ebffcb01d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e82ba94f-6131-48b7-b542-16fab851089b" xlink:to="loc_us-gaap_PlanNameAxis_3e7076a9-1c46-422d-9255-9b5ebffcb01d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_3e7076a9-1c46-422d-9255-9b5ebffcb01d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_3e7076a9-1c46-422d-9255-9b5ebffcb01d" xlink:to="loc_us-gaap_PlanNameDomain_3e7076a9-1c46-422d-9255-9b5ebffcb01d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_71808811-6260-45e0-b027-aada346d1b2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_3e7076a9-1c46-422d-9255-9b5ebffcb01d" xlink:to="loc_us-gaap_PlanNameDomain_71808811-6260-45e0-b027-aada346d1b2f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_PrecigenStockOptionPlan2008PlanMember_e885741f-86f8-4e0d-b36b-bc7bdd97408c" xlink:href="pgen-20220331.xsd#pgen_PrecigenStockOptionPlan2008PlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_71808811-6260-45e0-b027-aada346d1b2f" xlink:to="loc_pgen_PrecigenStockOptionPlan2008PlanMember_e885741f-86f8-4e0d-b36b-bc7bdd97408c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_PrecigenStockOptionPlan2013PlanMember_d5dc53cc-d14f-4b5b-a966-209213c31a95" xlink:href="pgen-20220331.xsd#pgen_PrecigenStockOptionPlan2013PlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_71808811-6260-45e0-b027-aada346d1b2f" xlink:to="loc_pgen_PrecigenStockOptionPlan2013PlanMember_d5dc53cc-d14f-4b5b-a966-209213c31a95" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_PrecigenStockOptionPlan2019PlanMember_ac0ff4bd-bf84-4f28-a2ac-de0637fc99d9" xlink:href="pgen-20220331.xsd#pgen_PrecigenStockOptionPlan2019PlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_71808811-6260-45e0-b027-aada346d1b2f" xlink:to="loc_pgen_PrecigenStockOptionPlan2019PlanMember_ac0ff4bd-bf84-4f28-a2ac-de0637fc99d9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_44aad4e4-f8b6-4f3e-aad3-ca2e8cd567d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e82ba94f-6131-48b7-b542-16fab851089b" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_44aad4e4-f8b6-4f3e-aad3-ca2e8cd567d1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_44aad4e4-f8b6-4f3e-aad3-ca2e8cd567d1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_44aad4e4-f8b6-4f3e-aad3-ca2e8cd567d1" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_44aad4e4-f8b6-4f3e-aad3-ca2e8cd567d1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_daab5cc7-76fd-464e-a7bc-fa7a45ffbf6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_44aad4e4-f8b6-4f3e-aad3-ca2e8cd567d1" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_daab5cc7-76fd-464e-a7bc-fa7a45ffbf6a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_ba696664-705e-4cd4-81a4-ed0bab88ae51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_daab5cc7-76fd-464e-a7bc-fa7a45ffbf6a" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_ba696664-705e-4cd4-81a4-ed0bab88ae51" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_76f0cd10-f5dc-4a0d-9e19-ff29fd0ab757" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e82ba94f-6131-48b7-b542-16fab851089b" xlink:to="loc_us-gaap_AwardTypeAxis_76f0cd10-f5dc-4a0d-9e19-ff29fd0ab757" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_76f0cd10-f5dc-4a0d-9e19-ff29fd0ab757_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_76f0cd10-f5dc-4a0d-9e19-ff29fd0ab757" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_76f0cd10-f5dc-4a0d-9e19-ff29fd0ab757_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4b81cdac-68bc-49e5-8e8b-f8792deda180" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_76f0cd10-f5dc-4a0d-9e19-ff29fd0ab757" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4b81cdac-68bc-49e5-8e8b-f8792deda180" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_72c1649f-1813-4094-812b-188fbcba742a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4b81cdac-68bc-49e5-8e8b-f8792deda180" xlink:to="loc_us-gaap_EmployeeStockOptionMember_72c1649f-1813-4094-812b-188fbcba742a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_3ddba8d7-4589-4c76-9520-2f601a3c5e20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4b81cdac-68bc-49e5-8e8b-f8792deda180" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_3ddba8d7-4589-4c76-9520-2f601a3c5e20" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_0f745f5e-d1fb-4314-af8b-54d01cb1ecc7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e82ba94f-6131-48b7-b542-16fab851089b" xlink:to="loc_srt_TitleOfIndividualAxis_0f745f5e-d1fb-4314-af8b-54d01cb1ecc7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_0f745f5e-d1fb-4314-af8b-54d01cb1ecc7_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_0f745f5e-d1fb-4314-af8b-54d01cb1ecc7" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_0f745f5e-d1fb-4314-af8b-54d01cb1ecc7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_e6c8dbc6-f485-4d73-bb00-48f44112e496" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_0f745f5e-d1fb-4314-af8b-54d01cb1ecc7" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_e6c8dbc6-f485-4d73-bb00-48f44112e496" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_ExecutiveChairmanMember_06cbf82f-a8e1-4ecd-a8dc-69a91efbd111" xlink:href="pgen-20220331.xsd#pgen_ExecutiveChairmanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_e6c8dbc6-f485-4d73-bb00-48f44112e496" xlink:to="loc_pgen_ExecutiveChairmanMember_06cbf82f-a8e1-4ecd-a8dc-69a91efbd111" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_71d5d87f-b5dc-4b2d-8d5b-30eb618ff356" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e82ba94f-6131-48b7-b542-16fab851089b" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_71d5d87f-b5dc-4b2d-8d5b-30eb618ff356" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_71d5d87f-b5dc-4b2d-8d5b-30eb618ff356_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_71d5d87f-b5dc-4b2d-8d5b-30eb618ff356" xlink:to="loc_us-gaap_RelatedPartyDomain_71d5d87f-b5dc-4b2d-8d5b-30eb618ff356_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_bd230a3b-3e82-4f06-8dc5-689fbbcc8ede" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_71d5d87f-b5dc-4b2d-8d5b-30eb618ff356" xlink:to="loc_us-gaap_RelatedPartyDomain_bd230a3b-3e82-4f06-8dc5-689fbbcc8ede" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_ExecutiveChairmanMember_21052a5c-9197-467b-b228-7905627ae83e" xlink:href="pgen-20220331.xsd#pgen_ExecutiveChairmanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_bd230a3b-3e82-4f06-8dc5-689fbbcc8ede" xlink:to="loc_pgen_ExecutiveChairmanMember_21052a5c-9197-467b-b228-7905627ae83e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_1242e1ff-32ee-4313-8fbc-de6a0fcd0742" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e82ba94f-6131-48b7-b542-16fab851089b" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_1242e1ff-32ee-4313-8fbc-de6a0fcd0742" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_1242e1ff-32ee-4313-8fbc-de6a0fcd0742_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_1242e1ff-32ee-4313-8fbc-de6a0fcd0742" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_1242e1ff-32ee-4313-8fbc-de6a0fcd0742_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_d6b78f9c-d4ae-423b-bca9-4a91f8f6f333" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_1242e1ff-32ee-4313-8fbc-de6a0fcd0742" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_d6b78f9c-d4ae-423b-bca9-4a91f8f6f333" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_29aaf17e-96b1-4dfa-80c5-831dfbd3daa0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_d6b78f9c-d4ae-423b-bca9-4a91f8f6f333" xlink:to="loc_us-gaap_SubsequentEventMember_29aaf17e-96b1-4dfa-80c5-831dfbd3daa0" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dna.com/role/ShareBasedPaymentsScheduleofStockOptionActivityDetails" xlink:type="simple" xlink:href="pgen-20220331.xsd#ShareBasedPaymentsScheduleofStockOptionActivityDetails"/>
  <link:definitionLink xlink:role="http://www.dna.com/role/ShareBasedPaymentsScheduleofStockOptionActivityDetails" xlink:type="extended" id="id7b0a46c12124019bc5a9d3853a3a05a_ShareBasedPaymentsScheduleofStockOptionActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ba358937-8f07-466d-8629-36ba1a824abc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_b1414294-1624-478f-9177-2a81cf6aaaa1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ba358937-8f07-466d-8629-36ba1a824abc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_b1414294-1624-478f-9177-2a81cf6aaaa1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_819afb50-4d69-474b-9611-851084c749fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_b1414294-1624-478f-9177-2a81cf6aaaa1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_819afb50-4d69-474b-9611-851084c749fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3f08887d-3043-466c-bb58-12cb66d8245e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_b1414294-1624-478f-9177-2a81cf6aaaa1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3f08887d-3043-466c-bb58-12cb66d8245e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_28194c76-b405-4b82-8971-e9ea4848a2b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_b1414294-1624-478f-9177-2a81cf6aaaa1" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_28194c76-b405-4b82-8971-e9ea4848a2b1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_116c1ae0-0e33-435c-ab0c-ce505a7713c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_b1414294-1624-478f-9177-2a81cf6aaaa1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_116c1ae0-0e33-435c-ab0c-ce505a7713c4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_23c06d40-9062-4d26-b50c-f3bc05b740b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_b1414294-1624-478f-9177-2a81cf6aaaa1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_23c06d40-9062-4d26-b50c-f3bc05b740b2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_418d7a54-9de6-498e-b212-6a2ec2c47138" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0b5f72cc-1c33-4785-9290-dcc388ef8faf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ba358937-8f07-466d-8629-36ba1a824abc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0b5f72cc-1c33-4785-9290-dcc388ef8faf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_99475233-d520-4c54-9088-f8ff4d85ee40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ba358937-8f07-466d-8629-36ba1a824abc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_99475233-d520-4c54-9088-f8ff4d85ee40" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_06bafe19-e674-4dff-b759-d1b11f11fa36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_99475233-d520-4c54-9088-f8ff4d85ee40" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_06bafe19-e674-4dff-b759-d1b11f11fa36" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_f912ed95-1a7e-4ba4-8701-dba0a43dcf4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_99475233-d520-4c54-9088-f8ff4d85ee40" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_f912ed95-1a7e-4ba4-8701-dba0a43dcf4d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_3a30291b-af2a-4417-bfe7-730dee723842" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_99475233-d520-4c54-9088-f8ff4d85ee40" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_3a30291b-af2a-4417-bfe7-730dee723842" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_bb77767a-d0a0-4500-810f-a81bbbf34ff4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_99475233-d520-4c54-9088-f8ff4d85ee40" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_bb77767a-d0a0-4500-810f-a81bbbf34ff4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_184b73a1-5039-42ee-8f6c-fc31c5fb0d74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_99475233-d520-4c54-9088-f8ff4d85ee40" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_184b73a1-5039-42ee-8f6c-fc31c5fb0d74" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_5c9adc9c-7652-4d73-b25a-7c1b67bd9b57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0c66355c-a9b1-4903-85a9-1957fff3a4c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ba358937-8f07-466d-8629-36ba1a824abc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0c66355c-a9b1-4903-85a9-1957fff3a4c0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_4997d927-7437-478b-8979-2a033c700955" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ba358937-8f07-466d-8629-36ba1a824abc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_4997d927-7437-478b-8979-2a033c700955" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_1de6ea81-3756-489b-a347-5c312a496a4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_4997d927-7437-478b-8979-2a033c700955" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_1de6ea81-3756-489b-a347-5c312a496a4c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_c22fb4ea-ee6d-4b06-aaf6-780dd409aa86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_4997d927-7437-478b-8979-2a033c700955" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_c22fb4ea-ee6d-4b06-aaf6-780dd409aa86" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_881aca6b-f57f-4e67-864f-991ddad302b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ba358937-8f07-466d-8629-36ba1a824abc" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_881aca6b-f57f-4e67-864f-991ddad302b5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_0f6fa9cb-6719-485c-aaf9-e2531dd52cb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_881aca6b-f57f-4e67-864f-991ddad302b5" xlink:to="loc_us-gaap_PlanNameAxis_0f6fa9cb-6719-485c-aaf9-e2531dd52cb1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_0f6fa9cb-6719-485c-aaf9-e2531dd52cb1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_0f6fa9cb-6719-485c-aaf9-e2531dd52cb1" xlink:to="loc_us-gaap_PlanNameDomain_0f6fa9cb-6719-485c-aaf9-e2531dd52cb1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_b585dcc0-fd6d-428e-ab41-fe30e6a29a90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_0f6fa9cb-6719-485c-aaf9-e2531dd52cb1" xlink:to="loc_us-gaap_PlanNameDomain_b585dcc0-fd6d-428e-ab41-fe30e6a29a90" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_PrecigenStockOptionPlanMember_e1befb35-9654-46fa-ba67-52c2b3b6e6b6" xlink:href="pgen-20220331.xsd#pgen_PrecigenStockOptionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_b585dcc0-fd6d-428e-ab41-fe30e6a29a90" xlink:to="loc_pgen_PrecigenStockOptionPlanMember_e1befb35-9654-46fa-ba67-52c2b3b6e6b6" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dna.com/role/ShareBasedPaymentsScheduleofRestrictedStockUnitActivityDetails" xlink:type="simple" xlink:href="pgen-20220331.xsd#ShareBasedPaymentsScheduleofRestrictedStockUnitActivityDetails"/>
  <link:definitionLink xlink:role="http://www.dna.com/role/ShareBasedPaymentsScheduleofRestrictedStockUnitActivityDetails" xlink:type="extended" id="iffab0d3416b64f7dac8b2df028a70b95_ShareBasedPaymentsScheduleofRestrictedStockUnitActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9244ddcd-6afc-4423-9b9c-c19de1e1052c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_b536abd6-618b-4772-beef-66c31e967d3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9244ddcd-6afc-4423-9b9c-c19de1e1052c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_b536abd6-618b-4772-beef-66c31e967d3d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_f184c65b-dacd-4abb-a730-8bb3f4cd3143" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_b536abd6-618b-4772-beef-66c31e967d3d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_f184c65b-dacd-4abb-a730-8bb3f4cd3143" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_3f94bde3-8d7c-4c7b-97be-118e711ce338" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_b536abd6-618b-4772-beef-66c31e967d3d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_3f94bde3-8d7c-4c7b-97be-118e711ce338" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_9996ca49-684c-4514-b149-3e088a07b9a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_b536abd6-618b-4772-beef-66c31e967d3d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_9996ca49-684c-4514-b149-3e088a07b9a2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_6816157f-7025-44f9-a7b0-386eef372815" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_b536abd6-618b-4772-beef-66c31e967d3d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_6816157f-7025-44f9-a7b0-386eef372815" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_44849925-88fc-4a58-9457-926681d7cc12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_34402aa9-5149-49cc-9372-51df029319ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9244ddcd-6afc-4423-9b9c-c19de1e1052c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_34402aa9-5149-49cc-9372-51df029319ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_c49427e5-d24c-41c3-a48a-08c3207d63c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_34402aa9-5149-49cc-9372-51df029319ef" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_c49427e5-d24c-41c3-a48a-08c3207d63c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_5a4b0060-f27a-4aee-a3b9-0220eadc7257" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_34402aa9-5149-49cc-9372-51df029319ef" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_5a4b0060-f27a-4aee-a3b9-0220eadc7257" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_d3f86650-f5c2-4282-befe-e8667251ebb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_34402aa9-5149-49cc-9372-51df029319ef" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_d3f86650-f5c2-4282-befe-e8667251ebb1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_253672a3-f40f-4eaf-aa8f-c5a33437d8b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_34402aa9-5149-49cc-9372-51df029319ef" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_253672a3-f40f-4eaf-aa8f-c5a33437d8b4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_8d3dd512-b74e-44f6-b0f7-4f700e46160a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_bf6ab47f-d0c6-4d0b-ba5a-7754f792de89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9244ddcd-6afc-4423-9b9c-c19de1e1052c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_bf6ab47f-d0c6-4d0b-ba5a-7754f792de89" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dc0e6680-7d1f-4dde-9992-9d02c3f90890" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_bf6ab47f-d0c6-4d0b-ba5a-7754f792de89" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dc0e6680-7d1f-4dde-9992-9d02c3f90890" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bed40850-6586-4531-84fb-ee9f2aab1e37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9244ddcd-6afc-4423-9b9c-c19de1e1052c" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bed40850-6586-4531-84fb-ee9f2aab1e37" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_741962a4-6a53-4928-a6e6-a7a1c14e2f8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bed40850-6586-4531-84fb-ee9f2aab1e37" xlink:to="loc_us-gaap_PlanNameAxis_741962a4-6a53-4928-a6e6-a7a1c14e2f8d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_741962a4-6a53-4928-a6e6-a7a1c14e2f8d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_741962a4-6a53-4928-a6e6-a7a1c14e2f8d" xlink:to="loc_us-gaap_PlanNameDomain_741962a4-6a53-4928-a6e6-a7a1c14e2f8d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_f897d37a-d19a-46d0-a669-033f38d18f5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_741962a4-6a53-4928-a6e6-a7a1c14e2f8d" xlink:to="loc_us-gaap_PlanNameDomain_f897d37a-d19a-46d0-a669-033f38d18f5a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_PrecigenStockOptionPlanMember_cb2d0019-6533-4438-a991-6286d60def70" xlink:href="pgen-20220331.xsd#pgen_PrecigenStockOptionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_f897d37a-d19a-46d0-a669-033f38d18f5a" xlink:to="loc_pgen_PrecigenStockOptionPlanMember_cb2d0019-6533-4438-a991-6286d60def70" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dna.com/role/OperatingLeasesAdditionalInformationDetails" xlink:type="simple" xlink:href="pgen-20220331.xsd#OperatingLeasesAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.dna.com/role/OperatingLeasesAdditionalInformationDetails" xlink:type="extended" id="i264f8c17aa8448399e94aa09a5c3d096_OperatingLeasesAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_369164c9-4de2-4030-9b8e-52acaab9002f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_2734ff08-e211-49f7-afea-11e7542e1c83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_369164c9-4de2-4030-9b8e-52acaab9002f" xlink:to="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_2734ff08-e211-49f7-afea-11e7542e1c83" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_LesseeOperatingLeaseTerminationPeriod_54d3a974-1cc8-4e59-9c6d-867cd4443b27" xlink:href="pgen-20220331.xsd#pgen_LesseeOperatingLeaseTerminationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_369164c9-4de2-4030-9b8e-52acaab9002f" xlink:to="loc_pgen_LesseeOperatingLeaseTerminationPeriod_54d3a974-1cc8-4e59-9c6d-867cd4443b27" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_731f9db1-db8a-4901-9fb0-dc9e9d9dc08b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_369164c9-4de2-4030-9b8e-52acaab9002f" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_731f9db1-db8a-4901-9fb0-dc9e9d9dc08b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_23e3378c-55be-4661-956d-948dd9170fdd" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_731f9db1-db8a-4901-9fb0-dc9e9d9dc08b" xlink:to="loc_srt_RangeAxis_23e3378c-55be-4661-956d-948dd9170fdd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_23e3378c-55be-4661-956d-948dd9170fdd_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_23e3378c-55be-4661-956d-948dd9170fdd" xlink:to="loc_srt_RangeMember_23e3378c-55be-4661-956d-948dd9170fdd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_04e5f71d-c363-49bf-b0f2-bbcf87dd15d0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_23e3378c-55be-4661-956d-948dd9170fdd" xlink:to="loc_srt_RangeMember_04e5f71d-c363-49bf-b0f2-bbcf87dd15d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_6481e45c-f939-42ab-b6b5-5f8b19ea9e34" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_04e5f71d-c363-49bf-b0f2-bbcf87dd15d0" xlink:to="loc_srt_MinimumMember_6481e45c-f939-42ab-b6b5-5f8b19ea9e34" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a247bee9-95d6-4603-8156-05aa192ed058" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_04e5f71d-c363-49bf-b0f2-bbcf87dd15d0" xlink:to="loc_srt_MaximumMember_a247bee9-95d6-4603-8156-05aa192ed058" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dna.com/role/CommitmentsandContingenciesContingenciesAdditionalInformationDetails" xlink:type="simple" xlink:href="pgen-20220331.xsd#CommitmentsandContingenciesContingenciesAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.dna.com/role/CommitmentsandContingenciesContingenciesAdditionalInformationDetails" xlink:type="extended" id="i2adbe8682a354150a04fe820123f1490_CommitmentsandContingenciesContingenciesAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_2725b463-609b-45db-87e7-e075244070df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyClaimsSettledNumber_4d40746e-7bbd-49ee-aa59-089d8ee1e68f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyClaimsSettledNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_2725b463-609b-45db-87e7-e075244070df" xlink:to="loc_us-gaap_LossContingencyClaimsSettledNumber_4d40746e-7bbd-49ee-aa59-089d8ee1e68f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_5aaed886-d928-4a79-92f4-7e1e2be16a6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_2725b463-609b-45db-87e7-e075244070df" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_5aaed886-d928-4a79-92f4-7e1e2be16a6c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_LossContingencyNumberOfPatentsAtIssue_fc44b83e-9a78-46a8-8ef5-5fa294ddffa3" xlink:href="pgen-20220331.xsd#pgen_LossContingencyNumberOfPatentsAtIssue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_2725b463-609b-45db-87e7-e075244070df" xlink:to="loc_pgen_LossContingencyNumberOfPatentsAtIssue_fc44b83e-9a78-46a8-8ef5-5fa294ddffa3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLegalSettlements_eea2bca7-ef9a-4055-a0a9-d963fb14e578" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForLegalSettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_2725b463-609b-45db-87e7-e075244070df" xlink:to="loc_us-gaap_PaymentsForLegalSettlements_eea2bca7-ef9a-4055-a0a9-d963fb14e578" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_ProposedPaymentsForMembershipInterests_9e1df7c1-1525-4a0f-87e8-720a447823a0" xlink:href="pgen-20220331.xsd#pgen_ProposedPaymentsForMembershipInterests"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_2725b463-609b-45db-87e7-e075244070df" xlink:to="loc_pgen_ProposedPaymentsForMembershipInterests_9e1df7c1-1525-4a0f-87e8-720a447823a0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestReceivable_6551e896-14b4-4176-944c-9670bf0453a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_2725b463-609b-45db-87e7-e075244070df" xlink:to="loc_us-gaap_InterestReceivable_6551e896-14b4-4176-944c-9670bf0453a0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_7fb9958f-500d-419a-a66f-b259236dcc54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_2725b463-609b-45db-87e7-e075244070df" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_7fb9958f-500d-419a-a66f-b259236dcc54" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_ffa95efd-4feb-4d00-84c5-1369c39eca69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_2725b463-609b-45db-87e7-e075244070df" xlink:to="loc_us-gaap_LossContingenciesTable_ffa95efd-4feb-4d00-84c5-1369c39eca69" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_e9e7fc8a-63d9-407f-ae95-b06ace27ed41" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_ffa95efd-4feb-4d00-84c5-1369c39eca69" xlink:to="loc_srt_CounterpartyNameAxis_e9e7fc8a-63d9-407f-ae95-b06ace27ed41" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_e9e7fc8a-63d9-407f-ae95-b06ace27ed41_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_e9e7fc8a-63d9-407f-ae95-b06ace27ed41" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_e9e7fc8a-63d9-407f-ae95-b06ace27ed41_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_fff7975b-8e0d-4639-816e-f2e8304443de" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_e9e7fc8a-63d9-407f-ae95-b06ace27ed41" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_fff7975b-8e0d-4639-816e-f2e8304443de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_XYLLCMember_282ec82a-0a44-47ba-b24a-14b9005cce89" xlink:href="pgen-20220331.xsd#pgen_XYLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_fff7975b-8e0d-4639-816e-f2e8304443de" xlink:to="loc_pgen_XYLLCMember_282ec82a-0a44-47ba-b24a-14b9005cce89" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_SecuritiesAndExchangeCommissionMember_9e20976e-0521-4381-b0f4-daceeeb75206" xlink:href="pgen-20220331.xsd#pgen_SecuritiesAndExchangeCommissionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_fff7975b-8e0d-4639-816e-f2e8304443de" xlink:to="loc_pgen_SecuritiesAndExchangeCommissionMember_9e20976e-0521-4381-b0f4-daceeeb75206" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_IntrexonEnergyPartnersMember_6561d6ea-954f-4909-aa07-7c85f9457abc" xlink:href="pgen-20220331.xsd#pgen_IntrexonEnergyPartnersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_fff7975b-8e0d-4639-816e-f2e8304443de" xlink:to="loc_pgen_IntrexonEnergyPartnersMember_6561d6ea-954f-4909-aa07-7c85f9457abc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_IntrexonEnergyPartnersIILLCMember_de4ebcdf-b19d-4634-badb-7c79596b1322" xlink:href="pgen-20220331.xsd#pgen_IntrexonEnergyPartnersIILLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_fff7975b-8e0d-4639-816e-f2e8304443de" xlink:to="loc_pgen_IntrexonEnergyPartnersIILLCMember_de4ebcdf-b19d-4634-badb-7c79596b1322" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_74dde634-601b-425c-b0b6-30195dd2a2df" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_ffa95efd-4feb-4d00-84c5-1369c39eca69" xlink:to="loc_srt_LitigationCaseAxis_74dde634-601b-425c-b0b6-30195dd2a2df" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_74dde634-601b-425c-b0b6-30195dd2a2df_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_74dde634-601b-425c-b0b6-30195dd2a2df" xlink:to="loc_srt_LitigationCaseTypeDomain_74dde634-601b-425c-b0b6-30195dd2a2df_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_011ccf2c-de0a-4df8-b4b9-bad047c99f91" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_74dde634-601b-425c-b0b6-30195dd2a2df" xlink:to="loc_srt_LitigationCaseTypeDomain_011ccf2c-de0a-4df8-b4b9-bad047c99f91" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_LicensingAndPatentInfringementSuitMember_289f274a-387e-4bfb-aed4-212e3d8ea0bb" xlink:href="pgen-20220331.xsd#pgen_LicensingAndPatentInfringementSuitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_011ccf2c-de0a-4df8-b4b9-bad047c99f91" xlink:to="loc_pgen_LicensingAndPatentInfringementSuitMember_289f274a-387e-4bfb-aed4-212e3d8ea0bb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_MethaneBioconversionPlatformDisclosuresMember_df104179-7840-40eb-a5ca-e4abcec95092" xlink:href="pgen-20220331.xsd#pgen_MethaneBioconversionPlatformDisclosuresMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_011ccf2c-de0a-4df8-b4b9-bad047c99f91" xlink:to="loc_pgen_MethaneBioconversionPlatformDisclosuresMember_df104179-7840-40eb-a5ca-e4abcec95092" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_b6ac54ae-9f9d-46ae-88f7-2c2609f3721d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_ffa95efd-4feb-4d00-84c5-1369c39eca69" xlink:to="loc_dei_LegalEntityAxis_b6ac54ae-9f9d-46ae-88f7-2c2609f3721d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_b6ac54ae-9f9d-46ae-88f7-2c2609f3721d_default" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_b6ac54ae-9f9d-46ae-88f7-2c2609f3721d" xlink:to="loc_dei_EntityDomain_b6ac54ae-9f9d-46ae-88f7-2c2609f3721d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_fd5b6395-dbb4-4acb-abd4-2bd21d6bb486" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_b6ac54ae-9f9d-46ae-88f7-2c2609f3721d" xlink:to="loc_dei_EntityDomain_fd5b6395-dbb4-4acb-abd4-2bd21d6bb486" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_IntrexonEnergyPartnersLLAndIntrexonEnergyPartnersIILLCMember_0dc5e43b-9f0e-46cf-af10-b5b185dd9d35" xlink:href="pgen-20220331.xsd#pgen_IntrexonEnergyPartnersLLAndIntrexonEnergyPartnersIILLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_fd5b6395-dbb4-4acb-abd4-2bd21d6bb486" xlink:to="loc_pgen_IntrexonEnergyPartnersLLAndIntrexonEnergyPartnersIILLCMember_0dc5e43b-9f0e-46cf-af10-b5b185dd9d35" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dna.com/role/RelatedPartyTransactionsAdditionalInformationDetails" xlink:type="simple" xlink:href="pgen-20220331.xsd#RelatedPartyTransactionsAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.dna.com/role/RelatedPartyTransactionsAdditionalInformationDetails" xlink:type="extended" id="i152fa2241efe4c5e930edb17c1bfd4e6_RelatedPartyTransactionsAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_1ef7434c-d54d-4e40-8b47-89d1a2522515" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_RelatedPartyOwnershipInterest_b9668dcf-fba9-4a45-92fb-b82e0fe491a0" xlink:href="pgen-20220331.xsd#pgen_RelatedPartyOwnershipInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1ef7434c-d54d-4e40-8b47-89d1a2522515" xlink:to="loc_pgen_RelatedPartyOwnershipInterest_b9668dcf-fba9-4a45-92fb-b82e0fe491a0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfessionalAndContractServicesExpense_e33faa92-a12e-450f-b1ba-67600e65fb42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfessionalAndContractServicesExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1ef7434c-d54d-4e40-8b47-89d1a2522515" xlink:to="loc_us-gaap_ProfessionalAndContractServicesExpense_e33faa92-a12e-450f-b1ba-67600e65fb42" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome_d4ef2de1-2d4c-43d0-b10b-72db20dc1204" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubleaseIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1ef7434c-d54d-4e40-8b47-89d1a2522515" xlink:to="loc_us-gaap_SubleaseIncome_d4ef2de1-2d4c-43d0-b10b-72db20dc1204" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_8bf674aa-ef57-4eaf-8a0f-7c5df3d0718c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1ef7434c-d54d-4e40-8b47-89d1a2522515" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_8bf674aa-ef57-4eaf-8a0f-7c5df3d0718c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_60605f36-edb0-4770-82b1-a693ec99155e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_8bf674aa-ef57-4eaf-8a0f-7c5df3d0718c" xlink:to="loc_dei_LegalEntityAxis_60605f36-edb0-4770-82b1-a693ec99155e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_60605f36-edb0-4770-82b1-a693ec99155e_default" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_60605f36-edb0-4770-82b1-a693ec99155e" xlink:to="loc_dei_EntityDomain_60605f36-edb0-4770-82b1-a693ec99155e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_1e59e880-2bf5-4532-9046-646c0408199f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_60605f36-edb0-4770-82b1-a693ec99155e" xlink:to="loc_dei_EntityDomain_1e59e880-2bf5-4532-9046-646c0408199f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_ThirdSecurityMember_50aeeef3-3bf9-4142-ba2e-63eb0bd0d5e1" xlink:href="pgen-20220331.xsd#pgen_ThirdSecurityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_1e59e880-2bf5-4532-9046-646c0408199f" xlink:to="loc_pgen_ThirdSecurityMember_50aeeef3-3bf9-4142-ba2e-63eb0bd0d5e1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_4a97154e-7f14-4ca4-8ccf-6ddf8968d9ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_8bf674aa-ef57-4eaf-8a0f-7c5df3d0718c" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_4a97154e-7f14-4ca4-8ccf-6ddf8968d9ea" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_4a97154e-7f14-4ca4-8ccf-6ddf8968d9ea_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_4a97154e-7f14-4ca4-8ccf-6ddf8968d9ea" xlink:to="loc_us-gaap_RelatedPartyDomain_4a97154e-7f14-4ca4-8ccf-6ddf8968d9ea_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_44c68aca-09e7-41fb-a8d8-a1549f84e41b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_4a97154e-7f14-4ca4-8ccf-6ddf8968d9ea" xlink:to="loc_us-gaap_RelatedPartyDomain_44c68aca-09e7-41fb-a8d8-a1549f84e41b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_ExecutiveChairmanMember_8d7bd5f0-2a3c-4361-8f6c-09da2d4ff354" xlink:href="pgen-20220331.xsd#pgen_ExecutiveChairmanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_44c68aca-09e7-41fb-a8d8-a1549f84e41b" xlink:to="loc_pgen_ExecutiveChairmanMember_8d7bd5f0-2a3c-4361-8f6c-09da2d4ff354" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_ThirdSecurityMember_d233b099-2e9b-42fa-8f48-478d64657f58" xlink:href="pgen-20220331.xsd#pgen_ThirdSecurityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_44c68aca-09e7-41fb-a8d8-a1549f84e41b" xlink:to="loc_pgen_ThirdSecurityMember_d233b099-2e9b-42fa-8f48-478d64657f58" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dna.com/role/SegmentsAdjustedEBITDAbyReportableSegmentDetails" xlink:type="simple" xlink:href="pgen-20220331.xsd#SegmentsAdjustedEBITDAbyReportableSegmentDetails"/>
  <link:definitionLink xlink:role="http://www.dna.com/role/SegmentsAdjustedEBITDAbyReportableSegmentDetails" xlink:type="extended" id="iab37323cbb3e47c2b4e3e74a5e5f567b_SegmentsAdjustedEBITDAbyReportableSegmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_f6ed4c5b-d199-4576-9095-487ab7a92f17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_NetIncomeLossAttributabletoParentAdjustedEBITDAIncludingCashPaidforCapitalExpendituresandInvestmentsinAffiliates_a6af0ec5-3cc1-42f7-8909-df13a6f50878" xlink:href="pgen-20220331.xsd#pgen_NetIncomeLossAttributabletoParentAdjustedEBITDAIncludingCashPaidforCapitalExpendituresandInvestmentsinAffiliates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f6ed4c5b-d199-4576-9095-487ab7a92f17" xlink:to="loc_pgen_NetIncomeLossAttributabletoParentAdjustedEBITDAIncludingCashPaidforCapitalExpendituresandInvestmentsinAffiliates_a6af0ec5-3cc1-42f7-8909-df13a6f50878" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_9577337e-c763-44c7-a9d4-88252b408eb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f6ed4c5b-d199-4576-9095-487ab7a92f17" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_9577337e-c763-44c7-a9d4-88252b408eb2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_a2a3a12a-2377-40d6-b73c-d055bcb18206" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_9577337e-c763-44c7-a9d4-88252b408eb2" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_a2a3a12a-2377-40d6-b73c-d055bcb18206" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_a2a3a12a-2377-40d6-b73c-d055bcb18206_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a2a3a12a-2377-40d6-b73c-d055bcb18206" xlink:to="loc_us-gaap_SegmentDomain_a2a3a12a-2377-40d6-b73c-d055bcb18206_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c49375e6-e7d2-4f15-b829-639990c81ed3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a2a3a12a-2377-40d6-b73c-d055bcb18206" xlink:to="loc_us-gaap_SegmentDomain_c49375e6-e7d2-4f15-b829-639990c81ed3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_BiopharmaceuticalsSegmentMember_1c010e41-59b7-4aad-85ab-bfcabb8ba711" xlink:href="pgen-20220331.xsd#pgen_BiopharmaceuticalsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c49375e6-e7d2-4f15-b829-639990c81ed3" xlink:to="loc_pgen_BiopharmaceuticalsSegmentMember_1c010e41-59b7-4aad-85ab-bfcabb8ba711" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_ExemplarSegmentMember_15238358-c35f-48bb-b95c-a9d599d196a4" xlink:href="pgen-20220331.xsd#pgen_ExemplarSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c49375e6-e7d2-4f15-b829-639990c81ed3" xlink:to="loc_pgen_ExemplarSegmentMember_15238358-c35f-48bb-b95c-a9d599d196a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_TransOvaSegmentMember_2336c33d-06f1-4c0b-a2ff-128ec4f6947d" xlink:href="pgen-20220331.xsd#pgen_TransOvaSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c49375e6-e7d2-4f15-b829-639990c81ed3" xlink:to="loc_pgen_TransOvaSegmentMember_2336c33d-06f1-4c0b-a2ff-128ec4f6947d" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dna.com/role/SegmentsReconciliationofNetLossBeforeIncomeTaxesDetails" xlink:type="simple" xlink:href="pgen-20220331.xsd#SegmentsReconciliationofNetLossBeforeIncomeTaxesDetails"/>
  <link:definitionLink xlink:role="http://www.dna.com/role/SegmentsReconciliationofNetLossBeforeIncomeTaxesDetails" xlink:type="extended" id="i6b3b4402f6ab484397abe05f584b86eb_SegmentsReconciliationofNetLossBeforeIncomeTaxesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_dea874f7-073e-4266-a626-68802ec41643" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_NetIncomeLossAttributabletoParentAdjustedEBITDAIncludingCashPaidforCapitalExpendituresandInvestmentsinAffiliates_90423b14-bd9b-4768-8022-c1618c0a9031" xlink:href="pgen-20220331.xsd#pgen_NetIncomeLossAttributabletoParentAdjustedEBITDAIncludingCashPaidforCapitalExpendituresandInvestmentsinAffiliates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_dea874f7-073e-4266-a626-68802ec41643" xlink:to="loc_pgen_NetIncomeLossAttributabletoParentAdjustedEBITDAIncludingCashPaidforCapitalExpendituresandInvestmentsinAffiliates_90423b14-bd9b-4768-8022-c1618c0a9031" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_CapitalExpendituresNetOfProceedsFromSaleOfAssetsAndInvestmentsInAffiliates_d39c8095-7e8d-437d-82a7-39d13237ab24" xlink:href="pgen-20220331.xsd#pgen_CapitalExpendituresNetOfProceedsFromSaleOfAssetsAndInvestmentsInAffiliates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_dea874f7-073e-4266-a626-68802ec41643" xlink:to="loc_pgen_CapitalExpendituresNetOfProceedsFromSaleOfAssetsAndInvestmentsInAffiliates_d39c8095-7e8d-437d-82a7-39d13237ab24" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_0f027369-c868-4526-994e-0d66b4930c51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_dea874f7-073e-4266-a626-68802ec41643" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_0f027369-c868-4526-994e-0d66b4930c51" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_ccdbb5cb-d738-4920-96fc-06c9af0dba64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_dea874f7-073e-4266-a626-68802ec41643" xlink:to="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_ccdbb5cb-d738-4920-96fc-06c9af0dba64" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_b606b83c-efc8-4244-a436-a105702e7275" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_ccdbb5cb-d738-4920-96fc-06c9af0dba64" xlink:to="loc_us-gaap_InterestExpense_b606b83c-efc8-4244-a436-a105702e7275" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_286aa1f0-2f63-4863-a9e6-e7304720d893" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_ccdbb5cb-d738-4920-96fc-06c9af0dba64" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_286aa1f0-2f63-4863-a9e6-e7304720d893" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets1_a895842d-725e-4abf-92b7-43c178b4997c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_ccdbb5cb-d738-4920-96fc-06c9af0dba64" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets1_a895842d-725e-4abf-92b7-43c178b4997c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_6333adb4-bd76-45cb-a11e-8b68c66fd306" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_ccdbb5cb-d738-4920-96fc-06c9af0dba64" xlink:to="loc_us-gaap_AssetImpairmentCharges_6333adb4-bd76-45cb-a11e-8b68c66fd306" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_725ca09b-de6f-459c-a0a3-086c57912b03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_ccdbb5cb-d738-4920-96fc-06c9af0dba64" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_725ca09b-de6f-459c-a0a3-086c57912b03" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_AdjustmentForBonusesPaidInEquityAwards_04425a07-717d-42cf-ba33-6bbc2af7c83c" xlink:href="pgen-20220331.xsd#pgen_AdjustmentForBonusesPaidInEquityAwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_ccdbb5cb-d738-4920-96fc-06c9af0dba64" xlink:to="loc_pgen_AdjustmentForBonusesPaidInEquityAwards_04425a07-717d-42cf-ba33-6bbc2af7c83c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_84efdf28-487a-4edd-8427-ce4890d42956" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_ccdbb5cb-d738-4920-96fc-06c9af0dba64" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_84efdf28-487a-4edd-8427-ce4890d42956" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_079c1f22-bbfa-45da-a174-cf73dfa8e5e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_ccdbb5cb-d738-4920-96fc-06c9af0dba64" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_079c1f22-bbfa-45da-a174-cf73dfa8e5e3" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_15ab752e-be9e-4061-88a2-30e7661a014d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_dea874f7-073e-4266-a626-68802ec41643" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_15ab752e-be9e-4061-88a2-30e7661a014d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6650fc5c-d7a8-44ba-81e0-60a2b867ddd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_dea874f7-073e-4266-a626-68802ec41643" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6650fc5c-d7a8-44ba-81e0-60a2b867ddd4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_e3ed2e69-bf03-46ee-8e30-86664113bfce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6650fc5c-d7a8-44ba-81e0-60a2b867ddd4" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_e3ed2e69-bf03-46ee-8e30-86664113bfce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e3ed2e69-bf03-46ee-8e30-86664113bfce_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e3ed2e69-bf03-46ee-8e30-86664113bfce" xlink:to="loc_us-gaap_SegmentDomain_e3ed2e69-bf03-46ee-8e30-86664113bfce_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_9d7081d8-66f5-45c9-bc8c-1b81e0284916" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e3ed2e69-bf03-46ee-8e30-86664113bfce" xlink:to="loc_us-gaap_SegmentDomain_9d7081d8-66f5-45c9-bc8c-1b81e0284916" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_ReportableSegmentsMember_b114a344-acef-4a52-b485-2f02dcc83407" xlink:href="pgen-20220331.xsd#pgen_ReportableSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_9d7081d8-66f5-45c9-bc8c-1b81e0284916" xlink:to="loc_pgen_ReportableSegmentsMember_b114a344-acef-4a52-b485-2f02dcc83407" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_b2d16806-db43-4122-a796-34dc44b1f576" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6650fc5c-d7a8-44ba-81e0-60a2b867ddd4" xlink:to="loc_srt_ConsolidationItemsAxis_b2d16806-db43-4122-a796-34dc44b1f576" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_b2d16806-db43-4122-a796-34dc44b1f576_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_b2d16806-db43-4122-a796-34dc44b1f576" xlink:to="loc_srt_ConsolidationItemsDomain_b2d16806-db43-4122-a796-34dc44b1f576_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_bf8874c5-5b02-4051-abdd-d9f540472098" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_b2d16806-db43-4122-a796-34dc44b1f576" xlink:to="loc_srt_ConsolidationItemsDomain_bf8874c5-5b02-4051-abdd-d9f540472098" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_7b9e36f4-86f8-4a02-ab54-60876f22974d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_bf8874c5-5b02-4051-abdd-d9f540472098" xlink:to="loc_us-gaap_OperatingSegmentsMember_7b9e36f4-86f8-4a02-ab54-60876f22974d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_CorporateAndReconcilingItemsMember_5669b30e-ce86-43e5-b516-922ef496e7f5" xlink:href="pgen-20220331.xsd#pgen_CorporateAndReconcilingItemsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_bf8874c5-5b02-4051-abdd-d9f540472098" xlink:to="loc_pgen_CorporateAndReconcilingItemsMember_5669b30e-ce86-43e5-b516-922ef496e7f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_11c14c62-2bcd-4464-8ffc-87bfeb4666eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_bf8874c5-5b02-4051-abdd-d9f540472098" xlink:to="loc_us-gaap_CorporateNonSegmentMember_11c14c62-2bcd-4464-8ffc-87bfeb4666eb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_b3d702b4-e8e6-4bac-a767-b756af665633" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_bf8874c5-5b02-4051-abdd-d9f540472098" xlink:to="loc_us-gaap_IntersegmentEliminationMember_b3d702b4-e8e6-4bac-a767-b756af665633" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_2793f0c9-401b-419d-8477-861255c49d3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6650fc5c-d7a8-44ba-81e0-60a2b867ddd4" xlink:to="loc_us-gaap_TypeOfArrangementAxis_2793f0c9-401b-419d-8477-861255c49d3c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_2793f0c9-401b-419d-8477-861255c49d3c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_2793f0c9-401b-419d-8477-861255c49d3c" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_2793f0c9-401b-419d-8477-861255c49d3c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_09a6f8ee-5b7a-4781-8c32-5372bb9dce02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_2793f0c9-401b-419d-8477-861255c49d3c" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_09a6f8ee-5b7a-4781-8c32-5372bb9dce02" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_UpfrontAndMilestonePaymentsMember_c2882ae0-a942-443c-8a7e-595efe80101d" xlink:href="pgen-20220331.xsd#pgen_UpfrontAndMilestonePaymentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_09a6f8ee-5b7a-4781-8c32-5372bb9dce02" xlink:to="loc_pgen_UpfrontAndMilestonePaymentsMember_c2882ae0-a942-443c-8a7e-595efe80101d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dna.com/role/SegmentsRevenuesbyReportableSegmentDetails" xlink:type="simple" xlink:href="pgen-20220331.xsd#SegmentsRevenuesbyReportableSegmentDetails"/>
  <link:definitionLink xlink:role="http://www.dna.com/role/SegmentsRevenuesbyReportableSegmentDetails" xlink:type="extended" id="ibee92715117c4a2d8b750eae8600d60d_SegmentsRevenuesbyReportableSegmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_1f7a0660-af24-43ff-8823-a9993c57bd19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_80e86f43-bb75-440c-956d-948733f01426" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1f7a0660-af24-43ff-8823-a9993c57bd19" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_80e86f43-bb75-440c-956d-948733f01426" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_a7458c40-0208-4468-85c5-98201d2ddf2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1f7a0660-af24-43ff-8823-a9993c57bd19" xlink:to="loc_us-gaap_Revenues_a7458c40-0208-4468-85c5-98201d2ddf2a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e1c4c551-9a10-4abc-8735-c0b00161b8fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1f7a0660-af24-43ff-8823-a9993c57bd19" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e1c4c551-9a10-4abc-8735-c0b00161b8fe" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_cc38b4e8-5133-4432-adb5-2c45847ea439" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e1c4c551-9a10-4abc-8735-c0b00161b8fe" xlink:to="loc_srt_ConsolidationItemsAxis_cc38b4e8-5133-4432-adb5-2c45847ea439" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_cc38b4e8-5133-4432-adb5-2c45847ea439_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_cc38b4e8-5133-4432-adb5-2c45847ea439" xlink:to="loc_srt_ConsolidationItemsDomain_cc38b4e8-5133-4432-adb5-2c45847ea439_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_2ab2b2d3-e0cc-442e-ab40-6fbe57ad8575" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_cc38b4e8-5133-4432-adb5-2c45847ea439" xlink:to="loc_srt_ConsolidationItemsDomain_2ab2b2d3-e0cc-442e-ab40-6fbe57ad8575" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_57ceaac6-502d-4103-81b0-fbc646a9712c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_2ab2b2d3-e0cc-442e-ab40-6fbe57ad8575" xlink:to="loc_us-gaap_OperatingSegmentsMember_57ceaac6-502d-4103-81b0-fbc646a9712c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_989122a5-2aa1-4f2f-aeb8-8075a1386ac5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_2ab2b2d3-e0cc-442e-ab40-6fbe57ad8575" xlink:to="loc_us-gaap_IntersegmentEliminationMember_989122a5-2aa1-4f2f-aeb8-8075a1386ac5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_EliminationsAndReconcilingItemsMember_42818d40-2b44-4108-8ba8-302f9d723f07" xlink:href="pgen-20220331.xsd#pgen_EliminationsAndReconcilingItemsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_2ab2b2d3-e0cc-442e-ab40-6fbe57ad8575" xlink:to="loc_pgen_EliminationsAndReconcilingItemsMember_42818d40-2b44-4108-8ba8-302f9d723f07" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_e2306388-c6fb-4fb4-a5b6-f2597a3c7858" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e1c4c551-9a10-4abc-8735-c0b00161b8fe" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_e2306388-c6fb-4fb4-a5b6-f2597a3c7858" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e2306388-c6fb-4fb4-a5b6-f2597a3c7858_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e2306388-c6fb-4fb4-a5b6-f2597a3c7858" xlink:to="loc_us-gaap_SegmentDomain_e2306388-c6fb-4fb4-a5b6-f2597a3c7858_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_285787ed-cd1a-495e-8b11-9bcb5ba6107b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e2306388-c6fb-4fb4-a5b6-f2597a3c7858" xlink:to="loc_us-gaap_SegmentDomain_285787ed-cd1a-495e-8b11-9bcb5ba6107b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_BiopharmaceuticalsSegmentMember_6576bc55-a316-44dd-b4db-8f6e473975f0" xlink:href="pgen-20220331.xsd#pgen_BiopharmaceuticalsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_285787ed-cd1a-495e-8b11-9bcb5ba6107b" xlink:to="loc_pgen_BiopharmaceuticalsSegmentMember_6576bc55-a316-44dd-b4db-8f6e473975f0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_ExemplarSegmentMember_9afb165e-9375-4a69-b444-e6b2743fcfb3" xlink:href="pgen-20220331.xsd#pgen_ExemplarSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_285787ed-cd1a-495e-8b11-9bcb5ba6107b" xlink:to="loc_pgen_ExemplarSegmentMember_9afb165e-9375-4a69-b444-e6b2743fcfb3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_TransOvaSegmentMember_72c83b96-9ffc-4bda-9edb-3766e94d6f99" xlink:href="pgen-20220331.xsd#pgen_TransOvaSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_285787ed-cd1a-495e-8b11-9bcb5ba6107b" xlink:to="loc_pgen_TransOvaSegmentMember_72c83b96-9ffc-4bda-9edb-3766e94d6f99" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_ReportableSegmentsMember_3aa5a87d-3bda-4af9-86c8-44f264ecbf91" xlink:href="pgen-20220331.xsd#pgen_ReportableSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_285787ed-cd1a-495e-8b11-9bcb5ba6107b" xlink:to="loc_pgen_ReportableSegmentsMember_3aa5a87d-3bda-4af9-86c8-44f264ecbf91" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dna.com/role/SegmentsAdditionalInformationDetails" xlink:type="simple" xlink:href="pgen-20220331.xsd#SegmentsAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.dna.com/role/SegmentsAdditionalInformationDetails" xlink:type="extended" id="icd3daee29f2747d9ad8dfd087ebf0750_SegmentsAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_d5fa4773-2ebb-4469-9fbc-e549a371c8cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_PercentageOfRevenueAttributableToCustomer_444fb514-a8ea-4408-8047-bb46bf5bb02f" xlink:href="pgen-20220331.xsd#pgen_PercentageOfRevenueAttributableToCustomer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d5fa4773-2ebb-4469-9fbc-e549a371c8cf" xlink:to="loc_pgen_PercentageOfRevenueAttributableToCustomer_444fb514-a8ea-4408-8047-bb46bf5bb02f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_LongLivedAssetsIncludingPropertyPlantandEquipmentandRightOfUseAssets_a75bfafc-9ec0-47cb-899b-f00b89157acf" xlink:href="pgen-20220331.xsd#pgen_LongLivedAssetsIncludingPropertyPlantandEquipmentandRightOfUseAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d5fa4773-2ebb-4469-9fbc-e549a371c8cf" xlink:to="loc_pgen_LongLivedAssetsIncludingPropertyPlantandEquipmentandRightOfUseAssets_a75bfafc-9ec0-47cb-899b-f00b89157acf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_f2632b73-5b84-43d3-8220-7783d63c7170" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d5fa4773-2ebb-4469-9fbc-e549a371c8cf" xlink:to="loc_us-gaap_Revenues_f2632b73-5b84-43d3-8220-7783d63c7170" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_93146917-860b-4f5e-8b07-5c7467030f1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d5fa4773-2ebb-4469-9fbc-e549a371c8cf" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_93146917-860b-4f5e-8b07-5c7467030f1b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_a0bfc32c-1092-4af8-af94-6fc7f9d6a579" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_93146917-860b-4f5e-8b07-5c7467030f1b" xlink:to="loc_srt_StatementGeographicalAxis_a0bfc32c-1092-4af8-af94-6fc7f9d6a579" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_a0bfc32c-1092-4af8-af94-6fc7f9d6a579_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_a0bfc32c-1092-4af8-af94-6fc7f9d6a579" xlink:to="loc_srt_SegmentGeographicalDomain_a0bfc32c-1092-4af8-af94-6fc7f9d6a579_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_a8563744-e145-4a69-aaec-b3c0d8719dc8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_a0bfc32c-1092-4af8-af94-6fc7f9d6a579" xlink:to="loc_srt_SegmentGeographicalDomain_a8563744-e145-4a69-aaec-b3c0d8719dc8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_26b02b7a-c6b6-4b65-81b2-575fd6294de6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_a8563744-e145-4a69-aaec-b3c0d8719dc8" xlink:to="loc_us-gaap_NonUsMember_26b02b7a-c6b6-4b65-81b2-575fd6294de6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_390af84d-56eb-4332-8d82-b315780b9079" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_93146917-860b-4f5e-8b07-5c7467030f1b" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_390af84d-56eb-4332-8d82-b315780b9079" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_390af84d-56eb-4332-8d82-b315780b9079_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_390af84d-56eb-4332-8d82-b315780b9079" xlink:to="loc_us-gaap_SegmentDomain_390af84d-56eb-4332-8d82-b315780b9079_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_6c70d811-8a83-4cf7-bfcd-57f5fb217c28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_390af84d-56eb-4332-8d82-b315780b9079" xlink:to="loc_us-gaap_SegmentDomain_6c70d811-8a83-4cf7-bfcd-57f5fb217c28" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_ExemplarSegmentMember_f1c96e37-c085-4c47-a2b8-e7ceb31fdb6f" xlink:href="pgen-20220331.xsd#pgen_ExemplarSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_6c70d811-8a83-4cf7-bfcd-57f5fb217c28" xlink:to="loc_pgen_ExemplarSegmentMember_f1c96e37-c085-4c47-a2b8-e7ceb31fdb6f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd#eedm"/>
  <link:definitionLink xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate202006Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate202006Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember" xlink:to="loc_us-gaap_AccountingStandardsUpdate202006Member" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>pgen-20220331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:ee4b2abd-b2ae-467e-99f1-1b489525c45b,g:388a974a-f6e3-4fd9-acf5-6762aafe5cec-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_pgen_ProposedPaymentsForMembershipInterests_308da0cb-7c89-4ce8-9074-b413925e5c07_terseLabel_en-US" xlink:label="lab_pgen_ProposedPaymentsForMembershipInterests" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for membership interests</link:label>
    <link:label id="lab_pgen_ProposedPaymentsForMembershipInterests_label_en-US" xlink:label="lab_pgen_ProposedPaymentsForMembershipInterests" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proposed Payments For Membership Interests</link:label>
    <link:label id="lab_pgen_ProposedPaymentsForMembershipInterests_documentation_en-US" xlink:label="lab_pgen_ProposedPaymentsForMembershipInterests" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proposed Payments For Membership Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_ProposedPaymentsForMembershipInterests" xlink:href="pgen-20220331.xsd#pgen_ProposedPaymentsForMembershipInterests"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pgen_ProposedPaymentsForMembershipInterests" xlink:to="lab_pgen_ProposedPaymentsForMembershipInterests" xlink:type="arc" order="1"/>
    <link:label id="lab_pgen_SaleOfAssetsIncludedInAccountsReceivable_4739119f-2415-4eda-8083-6e04d61bb058_terseLabel_en-US" xlink:label="lab_pgen_SaleOfAssetsIncludedInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of assets included in accounts receivable</link:label>
    <link:label id="lab_pgen_SaleOfAssetsIncludedInAccountsReceivable_label_en-US" xlink:label="lab_pgen_SaleOfAssetsIncludedInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Assets Included in Accounts Receivable</link:label>
    <link:label id="lab_pgen_SaleOfAssetsIncludedInAccountsReceivable_documentation_en-US" xlink:label="lab_pgen_SaleOfAssetsIncludedInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Assets Included in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_SaleOfAssetsIncludedInAccountsReceivable" xlink:href="pgen-20220331.xsd#pgen_SaleOfAssetsIncludedInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pgen_SaleOfAssetsIncludedInAccountsReceivable" xlink:to="lab_pgen_SaleOfAssetsIncludedInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_280c76df-8909-4051-882d-1be5a35dd6b4_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental disclosure of cash flow information</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_66d3dd80-7af6-474b-8300-747f232ecb71_verboseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental disclosure of cash flow information</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_2e0d0fa9-af72-4dba-812c-610704a97031_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized loss on investments</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:to="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_f2cfce13-c238-40b5-b559-d620caf2066e_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Loss Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtMember_4030341a-5f9f-446a-bf06-960c4ee4194e_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible debt</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtMember_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtMember" xlink:to="lab_us-gaap_ConvertibleDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_97b7157f-f2cf-4d5c-a4dd-376d75b61e4d_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_711833d8-4b0d-467b-be0d-7b7a225afe1a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_a17e32a7-59ce-4dda-b6fd-40a379772170_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_9d932817-f1bc-44bb-b6ad-b1b08c49c2dc_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_64ddfa0a-767d-4ea2-a359-270f65cdad92_netLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) attributable to parent</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_948539f0-e551-4f94-a5cc-5da7a5795109_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_d90602cf-7a1f-4710-aab2-2f13d9bde533_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation and benefits</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_bba1a358-037d-4fe5-952f-bb055b8e94e9_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesNetCurrentAbstract_bb4d8244-32a4-48f5-91f3-71dcaf2ba0e3_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables</link:label>
    <link:label id="lab_us-gaap_ReceivablesNetCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, Net, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesNetCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesNetCurrentAbstract" xlink:to="lab_us-gaap_ReceivablesNetCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_e48ada8b-51bc-4296-9406-2636a7a68a92_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_8d8b305f-2b24-46f5-b0af-400190cedd6e_negatedLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_9fec98f4-854c-4682-ad0e-9f69e5638203_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Future Maturities of Long-Term Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Long-term Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_f36edfd8-1039-41f1-912f-8ce01d4fc687_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other expenses:</link:label>
    <link:label id="lab_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Other Significant Reconciling Item, Consolidated [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract" xlink:to="lab_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsGross_36c3529b-7bd6-4c40-a106-2953f6d41e30_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsGross_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsGross" xlink:to="lab_us-gaap_LeaseholdImprovementsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_5ce0b46d-efb5-4343-9b14-2a787ecf344c_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_be8db5c9-5147-4944-bbbd-72d08bea74e0_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_92fc1984-636b-4088-9a48-35036e6756ab_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_c32f1733-064d-4b9e-a93f-975dbfa6e854_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion price (in usd per share)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Conversion Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_c92b8b58-ec28-4e1a-94be-09049c33d41f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_pgen_InterestExpenseDebtAmortizationofDebtDiscountPremiumandDebtIssuanceCosts_4fd0444d-dc08-4cad-8308-da7ea9336639_terseLabel_en-US" xlink:label="lab_pgen_InterestExpenseDebtAmortizationofDebtDiscountPremiumandDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash interest expense</link:label>
    <link:label id="lab_pgen_InterestExpenseDebtAmortizationofDebtDiscountPremiumandDebtIssuanceCosts_label_en-US" xlink:label="lab_pgen_InterestExpenseDebtAmortizationofDebtDiscountPremiumandDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt, Amortization of Debt Discount (Premium) and Debt Issuance Costs</link:label>
    <link:label id="lab_pgen_InterestExpenseDebtAmortizationofDebtDiscountPremiumandDebtIssuanceCosts_documentation_en-US" xlink:label="lab_pgen_InterestExpenseDebtAmortizationofDebtDiscountPremiumandDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments and amortization expense attributable to debt issuance costs.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_InterestExpenseDebtAmortizationofDebtDiscountPremiumandDebtIssuanceCosts" xlink:href="pgen-20220331.xsd#pgen_InterestExpenseDebtAmortizationofDebtDiscountPremiumandDebtIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pgen_InterestExpenseDebtAmortizationofDebtDiscountPremiumandDebtIssuanceCosts" xlink:to="lab_pgen_InterestExpenseDebtAmortizationofDebtDiscountPremiumandDebtIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_5d6aaff5-54e2-4503-8c6f-dd0fd6c28458_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Deferred Revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:to="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_8023348f-7e3f-4379-b248-26e9406ade0f_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_33b09823-5bc5-4a9e-9e7b-255d2e54caa3_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining lease term (years)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_pgen_ExemplarSegmentMember_54b5ee0a-ffa8-4ee5-8cb6-b2931a125bad_terseLabel_en-US" xlink:label="lab_pgen_ExemplarSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exemplar</link:label>
    <link:label id="lab_pgen_ExemplarSegmentMember_label_en-US" xlink:label="lab_pgen_ExemplarSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exemplar Segment [Member]</link:label>
    <link:label id="lab_pgen_ExemplarSegmentMember_documentation_en-US" xlink:label="lab_pgen_ExemplarSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exemplar Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_ExemplarSegmentMember" xlink:href="pgen-20220331.xsd#pgen_ExemplarSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pgen_ExemplarSegmentMember" xlink:to="lab_pgen_ExemplarSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_ecc04333-ceb1-4032-9b6b-3bffb635eae0_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_pgen_PrecigenStockOptionPlan2008PlanMember_894a316e-5816-4282-b4a3-9c9d5928a4ed_terseLabel_en-US" xlink:label="lab_pgen_PrecigenStockOptionPlan2008PlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Precigen Stock Option Plan 2008 Plan</link:label>
    <link:label id="lab_pgen_PrecigenStockOptionPlan2008PlanMember_label_en-US" xlink:label="lab_pgen_PrecigenStockOptionPlan2008PlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Precigen Stock Option Plan 2008 Plan [Member]</link:label>
    <link:label id="lab_pgen_PrecigenStockOptionPlan2008PlanMember_documentation_en-US" xlink:label="lab_pgen_PrecigenStockOptionPlan2008PlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Precigen Stock Option Plan 2008 Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_PrecigenStockOptionPlan2008PlanMember" xlink:href="pgen-20220331.xsd#pgen_PrecigenStockOptionPlan2008PlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pgen_PrecigenStockOptionPlan2008PlanMember" xlink:to="lab_pgen_PrecigenStockOptionPlan2008PlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7b773419-41a8-4f56-89e3-bade5037a34c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_1208fcbf-c61e-4571-abc9-dd4f4402194f_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_label_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_753896dc-0fcc-4410-a51e-83c4e281a85d_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_7bf510ca-43eb-42a4-8a11-cda3c3c35728_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining shares available to grant (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_53c38200-324a-4d9b-af2a-0eaf2c3a7032_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net decrease in cash, cash equivalents, and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_60cb4c08-5683-42cd-8014-5eacb4a1ff0a_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_84c7bebb-a963-4f1d-9143-af84fbaa4f89_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument redemption price, percentage</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption Price, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_ba3b34f3-0bd2-4d27-bd6e-1079e5aaa1c7_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_93ff9d70-bd51-471a-b15b-109f45c3fe45_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CertificatesOfDepositMember_ca9efb04-702a-4c14-8990-bd9cdce7bb7c_terseLabel_en-US" xlink:label="lab_us-gaap_CertificatesOfDepositMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certificates of deposit</link:label>
    <link:label id="lab_us-gaap_CertificatesOfDepositMember_label_en-US" xlink:label="lab_us-gaap_CertificatesOfDepositMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certificates of Deposit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CertificatesOfDepositMember" xlink:to="lab_us-gaap_CertificatesOfDepositMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_b109f1b0-9b9d-444c-a803-b42227abd18f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Amortized Cost, Gross Unrealized Gains and Losses, and Fair Value of Short-term and Long-term Investments</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnDispositionOfAssets1_6448d543-198d-4241-aba3-8177f36ad0c2_negatedLabel_en-US" xlink:label="lab_us-gaap_GainLossOnDispositionOfAssets1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss (gain) on disposals of assets, net</link:label>
    <link:label id="lab_us-gaap_GainLossOnDispositionOfAssets1_de47eee1-6f02-4375-ba28-2ea2cd7e8394_netLabel_en-US" xlink:label="lab_us-gaap_GainLossOnDispositionOfAssets1" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) on disposition of assets</link:label>
    <link:label id="lab_us-gaap_GainLossOnDispositionOfAssets1_f9aa6608-4b43-4bf2-aa13-9a89f5646ded_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnDispositionOfAssets1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on disposals of assets, net</link:label>
    <link:label id="lab_us-gaap_GainLossOnDispositionOfAssets1_ccd0d1a3-f7e5-44d5-ab4b-bdc714de15ad_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnDispositionOfAssets1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on disposals of assets</link:label>
    <link:label id="lab_us-gaap_GainLossOnDispositionOfAssets1_label_en-US" xlink:label="lab_us-gaap_GainLossOnDispositionOfAssets1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnDispositionOfAssets1" xlink:to="lab_us-gaap_GainLossOnDispositionOfAssets1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_a67902e6-3619-41fb-b3d4-d2ee5ab886cb_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_cfe0fcfe-655d-4aad-a9c7-5663f391f241_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_6f5b91c8-ccfb-434f-bad3-0d1ace374995_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_80a2dd06-330d-44db-9e49-f6a450cf4377_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f3b4967f-1e1d-4e6b-b8d9-e59915927080_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_3a898995-5d69-45bb-8028-9ee319128431_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization expense</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableLeaseCost_cc3a2dda-dac6-4e47-8fa9-e13eb0b4a26b_terseLabel_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable lease costs</link:label>
    <link:label id="lab_us-gaap_VariableLeaseCost_label_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableLeaseCost" xlink:to="lab_us-gaap_VariableLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_d6b142be-fdd4-49d6-9642-1f41af3dd228_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average discount rate</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_fca77eff-4772-4096-9be9-d45922b53806_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_4c26cf2f-7fc9-4bb0-a76c-b6349e9bf9b6_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_aaa83d48-d638-4443-904b-fb8822bf28b0_verboseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_02d2dba3-0b4d-410b-82c2-a2e2b59d26ff_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Add recognition of previously deferred revenue associated with upfront and milestone payments</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_b84ef3e2-38ae-426c-89b4-eac7ba781543_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pgen_LicensingAndPatentInfringementSuitMember_6887040b-5c95-4114-bb00-94bba2c62a28_terseLabel_en-US" xlink:label="lab_pgen_LicensingAndPatentInfringementSuitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing and patent infringement suit</link:label>
    <link:label id="lab_pgen_LicensingAndPatentInfringementSuitMember_label_en-US" xlink:label="lab_pgen_LicensingAndPatentInfringementSuitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing And Patent Infringement Suit [Member]</link:label>
    <link:label id="lab_pgen_LicensingAndPatentInfringementSuitMember_documentation_en-US" xlink:label="lab_pgen_LicensingAndPatentInfringementSuitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing And Patent Infringement Suit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_LicensingAndPatentInfringementSuitMember" xlink:href="pgen-20220331.xsd#pgen_LicensingAndPatentInfringementSuitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pgen_LicensingAndPatentInfringementSuitMember" xlink:to="lab_pgen_LicensingAndPatentInfringementSuitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_9f224795-35e8-43b2-aebe-84f79cdf6dc7_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_3a89c06c-a3b2-4269-af1c-ab67e95d268e_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_label_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_855032f5-a5be-4453-b209-10ee686440ef_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_pgen_MBPTitanMember_0a91544e-d816-48b9-9943-19b0cd216bb4_terseLabel_en-US" xlink:label="lab_pgen_MBPTitanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MBP Titan</link:label>
    <link:label id="lab_pgen_MBPTitanMember_label_en-US" xlink:label="lab_pgen_MBPTitanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MBP Titan [Member]</link:label>
    <link:label id="lab_pgen_MBPTitanMember_documentation_en-US" xlink:label="lab_pgen_MBPTitanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MBP Titan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_MBPTitanMember" xlink:href="pgen-20220331.xsd#pgen_MBPTitanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pgen_MBPTitanMember" xlink:to="lab_pgen_MBPTitanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6816f25d-d502-46b4-baa7-d0d9e0135bbc_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockOptionMember_b9a09c47-0262-4c66-bfa5-c93026629a05_terseLabel_en-US" xlink:label="lab_us-gaap_StockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options</link:label>
    <link:label id="lab_us-gaap_StockOptionMember_label_en-US" xlink:label="lab_us-gaap_StockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockOptionMember" xlink:to="lab_us-gaap_StockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_591a05b4-8082-4426-8525-52a2be1445d6_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_847d6a31-b210-4115-9df6-a58909b6c929_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_ca0f1812-a390-41cf-a9b3-d0c3edbff1da_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_cee3e12f-820a-40b7-a56b-67a02450d80f_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_210f3b7a-ad21-4bd5-8317-930d005ae121_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:to="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_ebe51653-1b73-4130-9908-dacebefd27f4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Remaining Contractual Term (Years)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_c58dcdd8-2348-4f11-8a12-4c43fb6fb613_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_4c8e1851-3c60-42ec-8577-12396a7ee66e_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLineItems_2e26a025-c3c6-455a-a4f3-1193e8ef1c40_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLineItems_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_a432f79d-9d37-435d-8447-e917cb39a12b_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill accumulated impairment losses</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impaired, Accumulated Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_37009576-c936-47a5-93b0-801c2299d2d7_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_pgen_LockupPeriodOnRestrictedStockUnitShares_3eade732-fccc-4f26-952b-d8b673a704bc_terseLabel_en-US" xlink:label="lab_pgen_LockupPeriodOnRestrictedStockUnitShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lock-up period</link:label>
    <link:label id="lab_pgen_LockupPeriodOnRestrictedStockUnitShares_label_en-US" xlink:label="lab_pgen_LockupPeriodOnRestrictedStockUnitShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lockup Period On Restricted Stock Unit Shares</link:label>
    <link:label id="lab_pgen_LockupPeriodOnRestrictedStockUnitShares_documentation_en-US" xlink:label="lab_pgen_LockupPeriodOnRestrictedStockUnitShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period of time during which issued shares are subject to a lock-up on resale.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_LockupPeriodOnRestrictedStockUnitShares" xlink:href="pgen-20220331.xsd#pgen_LockupPeriodOnRestrictedStockUnitShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pgen_LockupPeriodOnRestrictedStockUnitShares" xlink:to="lab_pgen_LockupPeriodOnRestrictedStockUnitShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_bd1ad91b-4bd6-4f5f-abed-740661d5dff3_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_94b2c8cb-1dfa-49c0-986a-9b58bd896f86_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Net</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_e0a0516d-e741-4cb9-a6e6-4c5f40802dc6_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_8e7303d0-f373-46ab-a7f1-3f279617a4a4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_e9656c48-1bb8-4115-b093-b85dc224328f_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balances at beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_fdad442f-528e-4fcc-b5d5-8822289998a3_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balances at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesIssuedPricePerShare_bca501c6-3ad7-4e9e-9204-f9ce555cf331_terseLabel_en-US" xlink:label="lab_us-gaap_SharesIssuedPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowed shares, public offering price per share (in usd per share)</link:label>
    <link:label id="lab_us-gaap_SharesIssuedPricePerShare_label_en-US" xlink:label="lab_us-gaap_SharesIssuedPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssuedPricePerShare" xlink:to="lab_us-gaap_SharesIssuedPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_46c13085-67b1-41f6-a5b2-e4f0b4aef0be_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock price consecutive trading days</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Consecutive Trading Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_e5ece9ea-73e2-4577-b234-b0f807532c85_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_9d61664b-0b7d-4139-95a7-eb129a510587_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_a28da3e5-64e8-432f-b2a0-6fb7ce2c6e78_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_pgen_LossContingencyNumberOfPatentsAtIssue_248a66e3-0d71-431e-82ba-67183055af80_terseLabel_en-US" xlink:label="lab_pgen_LossContingencyNumberOfPatentsAtIssue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, number of patents</link:label>
    <link:label id="lab_pgen_LossContingencyNumberOfPatentsAtIssue_label_en-US" xlink:label="lab_pgen_LossContingencyNumberOfPatentsAtIssue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of Patents At Issue</link:label>
    <link:label id="lab_pgen_LossContingencyNumberOfPatentsAtIssue_documentation_en-US" xlink:label="lab_pgen_LossContingencyNumberOfPatentsAtIssue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of Patents At Issue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_LossContingencyNumberOfPatentsAtIssue" xlink:href="pgen-20220331.xsd#pgen_LossContingencyNumberOfPatentsAtIssue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pgen_LossContingencyNumberOfPatentsAtIssue" xlink:to="lab_pgen_LossContingencyNumberOfPatentsAtIssue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_9e2a9ce0-010d-451a-8edc-b8ce74e64939_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_pgen_ContractWithCustomerAssetAndLiabilityLineItems_6dfde876-5c6f-4081-93cc-9cb014d15ab8_terseLabel_en-US" xlink:label="lab_pgen_ContractWithCustomerAssetAndLiabilityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Asset And Liability [Line Items]</link:label>
    <link:label id="lab_pgen_ContractWithCustomerAssetAndLiabilityLineItems_label_en-US" xlink:label="lab_pgen_ContractWithCustomerAssetAndLiabilityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Asset And Liability [Line Items]</link:label>
    <link:label id="lab_pgen_ContractWithCustomerAssetAndLiabilityLineItems_documentation_en-US" xlink:label="lab_pgen_ContractWithCustomerAssetAndLiabilityLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Line Items] for Contract With Customer, Asset And Liability [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_ContractWithCustomerAssetAndLiabilityLineItems" xlink:href="pgen-20220331.xsd#pgen_ContractWithCustomerAssetAndLiabilityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pgen_ContractWithCustomerAssetAndLiabilityLineItems" xlink:to="lab_pgen_ContractWithCustomerAssetAndLiabilityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_0b0b34b5-9a85-4c7c-a7c1-9463cb4bd7c8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_pgen_LivestockMember_91ce72a8-e599-4134-9a70-b6dde147cb6f_terseLabel_en-US" xlink:label="lab_pgen_LivestockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Livestock</link:label>
    <link:label id="lab_pgen_LivestockMember_label_en-US" xlink:label="lab_pgen_LivestockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Livestock [Member]</link:label>
    <link:label id="lab_pgen_LivestockMember_documentation_en-US" xlink:label="lab_pgen_LivestockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Livestock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_LivestockMember" xlink:href="pgen-20220331.xsd#pgen_LivestockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pgen_LivestockMember" xlink:to="lab_pgen_LivestockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pgen_FeedMember_0c1b11e5-9366-477a-b20d-713a8c105b67_terseLabel_en-US" xlink:label="lab_pgen_FeedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Feed</link:label>
    <link:label id="lab_pgen_FeedMember_label_en-US" xlink:label="lab_pgen_FeedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Feed [Member]</link:label>
    <link:label id="lab_pgen_FeedMember_documentation_en-US" xlink:label="lab_pgen_FeedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Feed [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_FeedMember" xlink:href="pgen-20220331.xsd#pgen_FeedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pgen_FeedMember" xlink:to="lab_pgen_FeedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_50708153-dd58-49c2-9455-d2598bea794f_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryCurrentTable_b32dde20-fd39-4b5f-94c6-39a0bccf6e26_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryCurrentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Current [Table]</link:label>
    <link:label id="lab_us-gaap_InventoryCurrentTable_label_en-US" xlink:label="lab_us-gaap_InventoryCurrentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Current [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryCurrentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryCurrentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryCurrentTable" xlink:to="lab_us-gaap_InventoryCurrentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_eed7d90a-c32d-4bb0-a9f7-ad318acc00c5_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_b461dbb8-773f-4c4b-805c-2712c891b12f_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property and equipment included in accounts payable and other accrued liabilities</link:label>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_label_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_5f3e6f23-ce1d-41be-8cbd-940f588108de_verboseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets obtained in exchange for new lease liabilities (includes new leases or modifications of existing leases)</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeNonoperating_bfc32faf-acf3-443c-91e9-edba1e9b250b_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeNonoperating" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeNonoperating_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeNonoperating" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Nonoperating</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNonoperating" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeNonoperating"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeNonoperating" xlink:to="lab_us-gaap_InvestmentIncomeNonoperating" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1ab4ce80-1059-4c86-8bc9-a18d9fd55799_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate202006RetrospectiveMember_c6365fa5-365c-4805-a07e-8adf7878b604_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate202006RetrospectiveMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2020-06 Retrospective</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate202006RetrospectiveMember_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate202006RetrospectiveMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2020-06 Retrospective [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate202006RetrospectiveMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate202006RetrospectiveMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate202006RetrospectiveMember" xlink:to="lab_us-gaap_AccountingStandardsUpdate202006RetrospectiveMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ee553096-f1da-4c64-b268-ac8633f39600_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_521d1d73-ad29-41c1-9366-e73144509b03_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_302021e6-9d44-4485-98db-dff4cdaf7cf1_totalLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss per share, basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_5112d5a1-f331-4451-8f5d-acd187279e8b_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Claims pending resolution</link:label>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Pending Claims, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:to="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_pgen_ComputerHardwareandSoftware_4bfe3b12-e151-4861-94b8-8827d271d188_terseLabel_en-US" xlink:label="lab_pgen_ComputerHardwareandSoftware" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer hardware and software</link:label>
    <link:label id="lab_pgen_ComputerHardwareandSoftware_label_en-US" xlink:label="lab_pgen_ComputerHardwareandSoftware" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer Hardware and Software</link:label>
    <link:label id="lab_pgen_ComputerHardwareandSoftware_documentation_en-US" xlink:label="lab_pgen_ComputerHardwareandSoftware" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount before accumulated depreciation and amortization of computer hardware and purchased software.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_ComputerHardwareandSoftware" xlink:href="pgen-20220331.xsd#pgen_ComputerHardwareandSoftware"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pgen_ComputerHardwareandSoftware" xlink:to="lab_pgen_ComputerHardwareandSoftware" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_c28ccf1f-f471-477e-81e2-4679263db01c_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubleaseIncome_0d79e078-4733-40fb-a1fd-49fd2592d09d_terseLabel_en-US" xlink:label="lab_us-gaap_SubleaseIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sublease rental income</link:label>
    <link:label id="lab_us-gaap_SubleaseIncome_label_en-US" xlink:label="lab_us-gaap_SubleaseIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sublease Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubleaseIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubleaseIncome" xlink:to="lab_us-gaap_SubleaseIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_pgen_ThirdSecurityMember_29b54a2d-e4f9-42bd-be25-6070feb198d0_terseLabel_en-US" xlink:label="lab_pgen_ThirdSecurityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third Security, LLC</link:label>
    <link:label id="lab_pgen_ThirdSecurityMember_label_en-US" xlink:label="lab_pgen_ThirdSecurityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third Security [Member]</link:label>
    <link:label id="lab_pgen_ThirdSecurityMember_documentation_en-US" xlink:label="lab_pgen_ThirdSecurityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third Security, LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_ThirdSecurityMember" xlink:href="pgen-20220331.xsd#pgen_ThirdSecurityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pgen_ThirdSecurityMember" xlink:to="lab_pgen_ThirdSecurityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pgen_PrecigenStockOptionPlanMember_ea3573c0-9fe8-4fe6-af0f-de8c0c4c281e_terseLabel_en-US" xlink:label="lab_pgen_PrecigenStockOptionPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Precigen Stock Option Plans</link:label>
    <link:label id="lab_pgen_PrecigenStockOptionPlanMember_label_en-US" xlink:label="lab_pgen_PrecigenStockOptionPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Precigen Stock Option Plan [Member]</link:label>
    <link:label id="lab_pgen_PrecigenStockOptionPlanMember_documentation_en-US" xlink:label="lab_pgen_PrecigenStockOptionPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Precigen Stock Option Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_PrecigenStockOptionPlanMember" xlink:href="pgen-20220331.xsd#pgen_PrecigenStockOptionPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pgen_PrecigenStockOptionPlanMember" xlink:to="lab_pgen_PrecigenStockOptionPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2e258fc3-ebc4-4a01-a522-3af2ce940ee8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSUs outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_83eb0eeb-3207-4db6-be2b-3434b133be2f_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balances at beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_765aa30b-0584-4454-b02c-2c98beeb78b4_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balances at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_078d2dbb-9472-40e3-bfa5-edf63af8c029_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebt_ef0d8788-6b44-4f58-96d2-7f343ae1df16_totalLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebt_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebt" xlink:to="lab_us-gaap_InterestExpenseDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnTerminationOfLease_1bc49f9c-54e0-4ce4-99b7-7aa1cd831264_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnTerminationOfLease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on lease termination</link:label>
    <link:label id="lab_us-gaap_GainLossOnTerminationOfLease_5663d98f-f2c7-4445-b15a-9f452379e864_negatedLabel_en-US" xlink:label="lab_us-gaap_GainLossOnTerminationOfLease" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash gain on termination of leases</link:label>
    <link:label id="lab_us-gaap_GainLossOnTerminationOfLease_label_en-US" xlink:label="lab_us-gaap_GainLossOnTerminationOfLease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Termination of Lease</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnTerminationOfLease" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnTerminationOfLease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnTerminationOfLease" xlink:to="lab_us-gaap_GainLossOnTerminationOfLease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_c04b7b35-7770-42d8-854c-c7d0651294e4_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_pgen_RelatedPartiesAggregatedMember_1c0b9fb0-35fa-4da0-a56b-73d297b541eb_terseLabel_en-US" xlink:label="lab_pgen_RelatedPartiesAggregatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Parties, Aggregated</link:label>
    <link:label id="lab_pgen_RelatedPartiesAggregatedMember_label_en-US" xlink:label="lab_pgen_RelatedPartiesAggregatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Parties, Aggregated [Member]</link:label>
    <link:label id="lab_pgen_RelatedPartiesAggregatedMember_documentation_en-US" xlink:label="lab_pgen_RelatedPartiesAggregatedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Parties, Aggregated [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_RelatedPartiesAggregatedMember" xlink:href="pgen-20220331.xsd#pgen_RelatedPartiesAggregatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pgen_RelatedPartiesAggregatedMember" xlink:to="lab_pgen_RelatedPartiesAggregatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_1ad6cba4-7cd6-4b9d-921a-75e85d271038_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Restricted Stock Units</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestorMember_de78a2fb-a265-4aa9-8476-2eb4d83054bf_terseLabel_en-US" xlink:label="lab_us-gaap_InvestorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investors</link:label>
    <link:label id="lab_us-gaap_InvestorMember_label_en-US" xlink:label="lab_us-gaap_InvestorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investor [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestorMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestorMember" xlink:to="lab_us-gaap_InvestorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MachineryAndEquipmentGross_969b22e2-7735-4d8d-8e83-68db3d0845d2_terseLabel_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment</link:label>
    <link:label id="lab_us-gaap_MachineryAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MachineryAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MachineryAndEquipmentGross" xlink:to="lab_us-gaap_MachineryAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_cb50a380-c398-4e99-8f8f-defc8acec4e9_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pgen_AmericanStateBankMember_9bf710ad-eb40-481e-90cf-064573557281_terseLabel_en-US" xlink:label="lab_pgen_AmericanStateBankMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">American State Bank</link:label>
    <link:label id="lab_pgen_AmericanStateBankMember_label_en-US" xlink:label="lab_pgen_AmericanStateBankMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">American State Bank [Member]</link:label>
    <link:label id="lab_pgen_AmericanStateBankMember_documentation_en-US" xlink:label="lab_pgen_AmericanStateBankMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">American State Bank [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_AmericanStateBankMember" xlink:href="pgen-20220331.xsd#pgen_AmericanStateBankMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pgen_AmericanStateBankMember" xlink:to="lab_pgen_AmericanStateBankMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_1eee8685-9319-4fd6-bec9-02f537d8f454_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_8aad54e8-cb2e-4fda-965b-e25be1761621_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares authorized for issuance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_edc850dc-2616-4708-b0c5-b2e2b423b992_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilities" xlink:to="lab_us-gaap_DeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_73b114d0-85f0-4cd7-bed1-e3bcad785850_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other noncash items</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_948d5d4a-1c88-452d-b0de-40b9f712ad8a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_f6142ad5-4f8d-4559-9c0c-6b1fb667c110_terseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for credit losses</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:to="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_30565c97-1146-4880-998b-2e7eaf14e5d5_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_4c7389d5-031a-4d0f-87d0-5a2ecc0dddcc_totalLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_6b093311-9f34-4c78-9248-3eac9650bff2_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_c7449534-f0a7-48fc-9691-195a7bf6b6b1_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss from continuing operating per share, diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Per Diluted Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:type="arc" order="1"/>
    <link:label id="lab_pgen_PrecigenStockOptionPlan2013PlanMember_18939150-c500-42ca-9c67-99a512d299ce_terseLabel_en-US" xlink:label="lab_pgen_PrecigenStockOptionPlan2013PlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Precigen Stock Option Plan 2013 Plan</link:label>
    <link:label id="lab_pgen_PrecigenStockOptionPlan2013PlanMember_label_en-US" xlink:label="lab_pgen_PrecigenStockOptionPlan2013PlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Precigen Stock Option Plan 2013 Plan [Member]</link:label>
    <link:label id="lab_pgen_PrecigenStockOptionPlan2013PlanMember_documentation_en-US" xlink:label="lab_pgen_PrecigenStockOptionPlan2013PlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Precigen Stock Option Plan 2013 Plan [Member] [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_PrecigenStockOptionPlan2013PlanMember" xlink:href="pgen-20220331.xsd#pgen_PrecigenStockOptionPlan2013PlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pgen_PrecigenStockOptionPlan2013PlanMember" xlink:to="lab_pgen_PrecigenStockOptionPlan2013PlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_74c295a5-6c34-48cb-b07c-4434e4716715_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_e7fc2fe3-61a5-4ade-9a16-44aa6f3b8aad_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_304a60b0-d1d0-4820-9bb7-33005c5f1d06_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_cd25dd44-e25d-49b3-a5fa-63420c2c1b70_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_4ea4e252-2499-4f49-b20b-2ec651a641bd_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of financial assets measured at fair value on a recurring basis</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_4c15d146-dff9-401a-b10f-87bd2e98e249_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quoted Prices in Active Markets (Level&#160;1)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_9e060798-13d0-4f75-a2ba-1bea4fdc422c_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_58df5d6a-2b77-4d81-b2b9-db32a09fe507_negatedLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_21dd4586-7f14-4fff-8bd0-40038a53d053_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_pgen_PrecigenStockOptionPlan2019PlanMember_bb00bc99-374e-4643-9d45-9a12dc3e6818_terseLabel_en-US" xlink:label="lab_pgen_PrecigenStockOptionPlan2019PlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Precigen Stock Option Plan 2019 Plan</link:label>
    <link:label id="lab_pgen_PrecigenStockOptionPlan2019PlanMember_label_en-US" xlink:label="lab_pgen_PrecigenStockOptionPlan2019PlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Precigen Stock Option Plan 2019 Plan [Member]</link:label>
    <link:label id="lab_pgen_PrecigenStockOptionPlan2019PlanMember_documentation_en-US" xlink:label="lab_pgen_PrecigenStockOptionPlan2019PlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Precigen Stock Option Plan 2019 Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_PrecigenStockOptionPlan2019PlanMember" xlink:href="pgen-20220331.xsd#pgen_PrecigenStockOptionPlan2019PlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pgen_PrecigenStockOptionPlan2019PlanMember" xlink:to="lab_pgen_PrecigenStockOptionPlan2019PlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_ad151c32-8d72-4303-b773-d49e48782ac6_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_9768f69b-95d4-4c77-b177-82091cda69e7_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payment, Due [Abstract]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payment, Due [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_5666df93-42d7-414e-b951-68bc0be239a2_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_335bf753-0bb6-4235-b5f5-6680a8cd0317_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and shareholders' equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_a19af083-ce83-4fe7-8247-dfd058a84851_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_4e2a4886-f87a-41ac-8224-3348254d4377_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_pgen_OtherAccruedLiabilitiesMember_af3f9de1-f6c5-4354-92b4-01cb188b58b1_terseLabel_en-US" xlink:label="lab_pgen_OtherAccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities</link:label>
    <link:label id="lab_pgen_OtherAccruedLiabilitiesMember_label_en-US" xlink:label="lab_pgen_OtherAccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities [Member]</link:label>
    <link:label id="lab_pgen_OtherAccruedLiabilitiesMember_documentation_en-US" xlink:label="lab_pgen_OtherAccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_OtherAccruedLiabilitiesMember" xlink:href="pgen-20220331.xsd#pgen_OtherAccruedLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pgen_OtherAccruedLiabilitiesMember" xlink:to="lab_pgen_OtherAccruedLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_8a3b54fe-58ac-4e93-acfe-a9e646f960a8_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) from discontinued operations per share, diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_712b063c-be25-4d64-804c-01de64f455f8_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_2cfc18ef-ebf9-4baa-bdc7-15ad35acf34c_verboseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of deferred revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_f6024897-aa1f-4560-84d3-51e36d2a7ebd_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_pgen_IntrexonEnergyPartnersMember_64cbb44b-4d04-4480-9a70-da017b976e4e_verboseLabel_en-US" xlink:label="lab_pgen_IntrexonEnergyPartnersMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intrexon Energy Partners, LLC</link:label>
    <link:label id="lab_pgen_IntrexonEnergyPartnersMember_29629715-bfe7-4325-a0e6-baf9a804909d_terseLabel_en-US" xlink:label="lab_pgen_IntrexonEnergyPartnersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intrexon Energy Partners [Member]</link:label>
    <link:label id="lab_pgen_IntrexonEnergyPartnersMember_label_en-US" xlink:label="lab_pgen_IntrexonEnergyPartnersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intrexon Energy Partners [Member]</link:label>
    <link:label id="lab_pgen_IntrexonEnergyPartnersMember_documentation_en-US" xlink:label="lab_pgen_IntrexonEnergyPartnersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intrexon Energy Partners, LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_IntrexonEnergyPartnersMember" xlink:href="pgen-20220331.xsd#pgen_IntrexonEnergyPartnersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pgen_IntrexonEnergyPartnersMember" xlink:to="lab_pgen_IntrexonEnergyPartnersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementScenarioAxis_f15cdace-00e6-49b5-95b0-24d62fa4f880_terseLabel_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:label id="lab_srt_StatementScenarioAxis_label_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis" xlink:to="lab_srt_StatementScenarioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_031a5ae7-bb69-4622-aa79-4eed201f730c_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales and maturities of investments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale and Maturity of Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:to="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_7b01e1e5-979d-41f1-9fd6-a05b26c3e710_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ServiceMember_21e5a23d-eea3-4b0d-ae0e-625add5408cf_terseLabel_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Services</link:label>
    <link:label id="lab_us-gaap_ServiceMember_label_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ServiceMember" xlink:to="lab_us-gaap_ServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_c7918f01-586e-4e0c-b79e-74958e78d8a7_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_73b0b11a-2f46-46a0-9b44-15f4fd535966_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Information</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_5b9fa898-6909-4350-8ce8-0e2ce22abbce_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_pgen_CompensationArrangementWithIndividualAnnualRSUGrantGrantDateFairValue_8c9a9c2a-4c58-4333-ac65-9720f6c0e9e5_terseLabel_en-US" xlink:label="lab_pgen_CompensationArrangementWithIndividualAnnualRSUGrantGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation arrangement with individual, annual RSU grant, grant date fair value</link:label>
    <link:label id="lab_pgen_CompensationArrangementWithIndividualAnnualRSUGrantGrantDateFairValue_label_en-US" xlink:label="lab_pgen_CompensationArrangementWithIndividualAnnualRSUGrantGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Arrangement With Individual, Annual RSU Grant, Grant Date Fair Value</link:label>
    <link:label id="lab_pgen_CompensationArrangementWithIndividualAnnualRSUGrantGrantDateFairValue_documentation_en-US" xlink:label="lab_pgen_CompensationArrangementWithIndividualAnnualRSUGrantGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Arrangement With Individual, Annual RSU Grant, Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_CompensationArrangementWithIndividualAnnualRSUGrantGrantDateFairValue" xlink:href="pgen-20220331.xsd#pgen_CompensationArrangementWithIndividualAnnualRSUGrantGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pgen_CompensationArrangementWithIndividualAnnualRSUGrantGrantDateFairValue" xlink:to="lab_pgen_CompensationArrangementWithIndividualAnnualRSUGrantGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_469c1cfa-6593-4e3c-9d44-1b5332923169_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Shareholders' Equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_dd54cdd5-6608-4579-a57a-46360833db6c_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_4ff8bc7c-c7ff-4c12-a46b-5e6e43dfb8f0_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_pgen_IntrexonEnergyPartnersIILLCMember_b8e5f6b4-96d9-403c-a37d-339e7e858ee3_verboseLabel_en-US" xlink:label="lab_pgen_IntrexonEnergyPartnersIILLCMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intrexon Energy Partners II, LLC</link:label>
    <link:label id="lab_pgen_IntrexonEnergyPartnersIILLCMember_label_en-US" xlink:label="lab_pgen_IntrexonEnergyPartnersIILLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intrexon Energy Partners II, LLC [Member]</link:label>
    <link:label id="lab_pgen_IntrexonEnergyPartnersIILLCMember_documentation_en-US" xlink:label="lab_pgen_IntrexonEnergyPartnersIILLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intrexon Energy Partners II, LLC [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_IntrexonEnergyPartnersIILLCMember" xlink:href="pgen-20220331.xsd#pgen_IntrexonEnergyPartnersIILLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pgen_IntrexonEnergyPartnersIILLCMember" xlink:to="lab_pgen_IntrexonEnergyPartnersIILLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_d90e62c6-3e8c-4738-8aed-1affea208f95_verboseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership interest</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_e7579f07-2ff1-4ae4-a808-d2685214f881_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_98380a27-a727-4677-af6f-c96fcc44e0e2_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_882b325f-f9ec-4c7d-9b3c-dc18c74fb2aa_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_1942b1db-598f-4991-84f2-3aa997372455_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_a5a7dd00-ade2-420b-a5d4-449866f83b1d_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCredit_f6442f4e-ed4c-41a7-822a-d86510714b2a_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit facility, outstanding balance</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_label_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Line of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCredit" xlink:to="lab_us-gaap_LineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_62d43767-5bb8-404e-8047-132f8617bc4d_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate changes on cash, cash equivalents, and restricted cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1_0263f62c-9df9-4aa4-a702-aee5fddcfd42_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Conversion Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_47939cc9-d598-40d4-9bae-8656c432f3f0_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_1017a7c4-25ef-4a7e-9ccb-60ef995371c1_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_66d97d9b-65a4-46e1-8e66-86d7c2c24242_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_6beb9f51-cbe4-4f56-a0e5-bcb27c7a5f3f_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_bededce1-bfb0-4552-9a25-d7d3cf0872b0_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Gains</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_pgen_CorporateAndReconcilingItemsMember_810b7693-63fb-43a9-8bf7-b4e9401c4dd4_terseLabel_en-US" xlink:label="lab_pgen_CorporateAndReconcilingItemsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate And Reconciling Items</link:label>
    <link:label id="lab_pgen_CorporateAndReconcilingItemsMember_label_en-US" xlink:label="lab_pgen_CorporateAndReconcilingItemsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate And Reconciling Items [Member]</link:label>
    <link:label id="lab_pgen_CorporateAndReconcilingItemsMember_documentation_en-US" xlink:label="lab_pgen_CorporateAndReconcilingItemsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate And Reconciling Items [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_CorporateAndReconcilingItemsMember" xlink:href="pgen-20220331.xsd#pgen_CorporateAndReconcilingItemsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pgen_CorporateAndReconcilingItemsMember" xlink:to="lab_pgen_CorporateAndReconcilingItemsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_d546138f-30b9-4e56-992f-66b9e02caf89_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_be6b7636-4186-4683-8349-d749da79432d_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_85caccab-7200-49fe-a9a0-5d152808fb55_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_pgen_DeferredRevenueOtherMember_3db4e412-9d13-4e5b-9fbc-ab3b95ad30b1_terseLabel_en-US" xlink:label="lab_pgen_DeferredRevenueOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_pgen_DeferredRevenueOtherMember_label_en-US" xlink:label="lab_pgen_DeferredRevenueOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue Other [Member]</link:label>
    <link:label id="lab_pgen_DeferredRevenueOtherMember_documentation_en-US" xlink:label="lab_pgen_DeferredRevenueOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other deferred revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_DeferredRevenueOtherMember" xlink:href="pgen-20220331.xsd#pgen_DeferredRevenueOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pgen_DeferredRevenueOtherMember" xlink:to="lab_pgen_DeferredRevenueOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_9aa0d301-29a1-4319-93f4-d3147bbf1b03_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_3d8a71a7-8e63-4cfe-a8cd-12cef6682619_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_2418f65d-d7c6-4342-be2e-69f59f3ae807_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued in private placement or in public offering, net of issuance costs</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_76123b87-d69f-4da4-91bf-9fb0379139eb_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued during the period, value</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_3c38893c-b21f-45d6-a7b4-c5ae89cd1684_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash included in other assets</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash and Cash Equivalents, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_9a6677a8-7474-4dde-9394-da9d96d2c06a_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_248867f7-9754-4bcd-ace5-32acfd623f7e_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) on foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_1f44a05e-5bcd-49ce-83e0-89b27054054b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lines of Credit and Long-Term Debt</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_fba3f059-67ff-4448-b9f5-8b49a31d683b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable, weighted average exercise price, at end of period (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_aac65a85-0e4b-4d91-8fe3-dbf03450002e_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due within one year</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_88de922a-9d79-4a5d-8f2d-bceebafbd964_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payments</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_238040c2-07a6-40e3-bc70-1da94895ea6f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Unobservable Inputs (Level&#160;3)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_pgen_CollaborationandLicensingRevenueTableTextBlock_9618b015-f728-4502-8b29-2f94ae14a63b_terseLabel_en-US" xlink:label="lab_pgen_CollaborationandLicensingRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summarized Collaboration and Licensing Revenues</link:label>
    <link:label id="lab_pgen_CollaborationandLicensingRevenueTableTextBlock_label_en-US" xlink:label="lab_pgen_CollaborationandLicensingRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration and Licensing Revenue [Table Text Block]</link:label>
    <link:label id="lab_pgen_CollaborationandLicensingRevenueTableTextBlock_documentation_en-US" xlink:label="lab_pgen_CollaborationandLicensingRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tabular disclosure of summarized revenues recognized for each significant collaboration and licensing agreement and aggregated nonsignificant collaborations and licensing agreements.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_CollaborationandLicensingRevenueTableTextBlock" xlink:href="pgen-20220331.xsd#pgen_CollaborationandLicensingRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pgen_CollaborationandLicensingRevenueTableTextBlock" xlink:to="lab_pgen_CollaborationandLicensingRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_02bddb36-6d0f-4e3a-9122-cf882481132f_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureTextBlock" xlink:to="lab_us-gaap_InventoryDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_f65d7e02-3e11-4b9b-91c1-3987491be92d_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_98ca5d41-15de-4882-a375-51198475e6f5_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balances, weighted average remaining contractual period</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_36ad24a3-bc9f-4dad-9916-e5ca678d38ac_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued in private placement or in public offering, net of issuance costs (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_35fc0fbd-5e12-48e4-8708-904eb09aec23_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_0e51c26c-cb18-449f-bcf4-117ebb0e1be2_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_ccb91753-6323-40a2-bf56-cf01fa1200a9_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_pgen_ShareLendingAgreementLengthOfTimeForSharesToBeReturnedUponTermination_f1210150-120f-4805-9e95-2fd858c28e4f_terseLabel_en-US" xlink:label="lab_pgen_ShareLendingAgreementLengthOfTimeForSharesToBeReturnedUponTermination" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share lending agreement, length of time for shares to be returned upon termination</link:label>
    <link:label id="lab_pgen_ShareLendingAgreementLengthOfTimeForSharesToBeReturnedUponTermination_label_en-US" xlink:label="lab_pgen_ShareLendingAgreementLengthOfTimeForSharesToBeReturnedUponTermination" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Lending Agreement, Length Of Time For Shares To Be Returned Upon Termination</link:label>
    <link:label id="lab_pgen_ShareLendingAgreementLengthOfTimeForSharesToBeReturnedUponTermination_documentation_en-US" xlink:label="lab_pgen_ShareLendingAgreementLengthOfTimeForSharesToBeReturnedUponTermination" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Lending Agreement, Length Of Time For Shares To Be Returned Upon Termination</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_ShareLendingAgreementLengthOfTimeForSharesToBeReturnedUponTermination" xlink:href="pgen-20220331.xsd#pgen_ShareLendingAgreementLengthOfTimeForSharesToBeReturnedUponTermination"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pgen_ShareLendingAgreementLengthOfTimeForSharesToBeReturnedUponTermination" xlink:to="lab_pgen_ShareLendingAgreementLengthOfTimeForSharesToBeReturnedUponTermination" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock_34de7670-5b30-42db-baf0-1f4a911493a7_terseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Interest Expense</link:label>
    <link:label id="lab_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock_label_en-US" xlink:label="lab_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income and Interest Expense Disclosure [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock" xlink:to="lab_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_68142f92-9b73-412d-b38d-12b0ee374f0c_totalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other expense, net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_b9cf086e-c303-4766-a922-99397998e01a_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balances at beginning of period (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_687b6e43-290b-4583-9c13-4602bb105eb8_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balances at end of period (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_7a5a43e1-2abe-472e-9e63-227d180973a4_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_pgen_StockIssuedDuringThePeriodValueAccruedCompensation_fc78e00e-ddeb-4ba1-a06f-7bbf4b6b9e04_terseLabel_en-US" xlink:label="lab_pgen_StockIssuedDuringThePeriodValueAccruedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued for accrued compensation</link:label>
    <link:label id="lab_pgen_StockIssuedDuringThePeriodValueAccruedCompensation_label_en-US" xlink:label="lab_pgen_StockIssuedDuringThePeriodValueAccruedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During The Period, Value, Accrued Compensation</link:label>
    <link:label id="lab_pgen_StockIssuedDuringThePeriodValueAccruedCompensation_documentation_en-US" xlink:label="lab_pgen_StockIssuedDuringThePeriodValueAccruedCompensation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value of stock issued in lieu of cash for accrued compensation.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_StockIssuedDuringThePeriodValueAccruedCompensation" xlink:href="pgen-20220331.xsd#pgen_StockIssuedDuringThePeriodValueAccruedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pgen_StockIssuedDuringThePeriodValueAccruedCompensation" xlink:to="lab_pgen_StockIssuedDuringThePeriodValueAccruedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_25b0c102-b3a7-46b7-8bea-08154ec8a3fe_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies (Note 16)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_9097dcc4-a893-4e23-bdbd-858d6a6e4f34_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_9f9ea90f-f7a7-4346-a6c0-ae8fc43ee515_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive (loss) income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_3ce67406-4a1e-4458-950f-9126fb8fc084_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_e87d804d-4a43-4e5a-8c90-7a12d35eb1a7_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable allowance for credit losses</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_2d2f6daa-5be2-4591-bc1a-be0dddaf1123_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_126ed076-9c33-47d9-a578-20101e4d6cd9_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis" xlink:to="lab_us-gaap_DisposalGroupClassificationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_605351f5-726e-453b-802a-e28e7b7d4e50_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_pgen_TransOvaGeneticsLcMember_d510986c-265c-4491-abd4-bd271c11ee5a_terseLabel_en-US" xlink:label="lab_pgen_TransOvaGeneticsLcMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trans Ova Genetics, LC</link:label>
    <link:label id="lab_pgen_TransOvaGeneticsLcMember_label_en-US" xlink:label="lab_pgen_TransOvaGeneticsLcMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trans Ova Genetics Lc [Member]</link:label>
    <link:label id="lab_pgen_TransOvaGeneticsLcMember_documentation_en-US" xlink:label="lab_pgen_TransOvaGeneticsLcMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trans Ova Genetics LC [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_TransOvaGeneticsLcMember" xlink:href="pgen-20220331.xsd#pgen_TransOvaGeneticsLcMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pgen_TransOvaGeneticsLcMember" xlink:to="lab_pgen_TransOvaGeneticsLcMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_f7bf7170-2b55-4ea4-a6e0-4e5a05648db3_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term and Long-term Investments</link:label>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_c5e6abc3-49cc-4b56-9561-d8bebc6566ef_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_3d63c497-055c-4e63-900a-826201c9f589_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyClaimsSettledNumber_225006c8-6e10-4a7d-ba95-4555028f0e9b_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyClaimsSettledNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, claims settled, number</link:label>
    <link:label id="lab_us-gaap_LossContingencyClaimsSettledNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyClaimsSettledNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Claims Settled, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyClaimsSettledNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyClaimsSettledNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyClaimsSettledNumber" xlink:to="lab_us-gaap_LossContingencyClaimsSettledNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DueFromRelatedPartiesCurrent_4749edc9-7d0a-421c-ac0a-711734205332_terseLabel_en-US" xlink:label="lab_us-gaap_DueFromRelatedPartiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related parties, less allowance for credit losses of $1,509 as of March&#160;31, 2022 and December&#160;31, 2021</link:label>
    <link:label id="lab_us-gaap_DueFromRelatedPartiesCurrent_label_en-US" xlink:label="lab_us-gaap_DueFromRelatedPartiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due from Related Parties, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueFromRelatedPartiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueFromRelatedPartiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DueFromRelatedPartiesCurrent" xlink:to="lab_us-gaap_DueFromRelatedPartiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_899250b6-0cbf-4ffd-aabb-c821aa1d649d_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_label_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfArrangementAxis" xlink:to="lab_us-gaap_TypeOfArrangementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_b2698195-6b71-417f-a1ed-7ddd693dc0a7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value adjustment</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_1614bce0-380d-40b1-bd24-5561b65330cd_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentOperatingActivitiesDomain_b2bc5311-b73b-4915-99e3-7e3291b007dc_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentOperatingActivitiesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Activities [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentOperatingActivitiesDomain_label_en-US" xlink:label="lab_us-gaap_SegmentOperatingActivitiesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Activities [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentOperatingActivitiesDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentOperatingActivitiesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentOperatingActivitiesDomain" xlink:to="lab_us-gaap_SegmentOperatingActivitiesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfessionalAndContractServicesExpense_49ebc796-fcb2-492c-beba-45d1552ee553_terseLabel_en-US" xlink:label="lab_us-gaap_ProfessionalAndContractServicesExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expense for services</link:label>
    <link:label id="lab_us-gaap_ProfessionalAndContractServicesExpense_label_en-US" xlink:label="lab_us-gaap_ProfessionalAndContractServicesExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Professional and Contract Services Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfessionalAndContractServicesExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfessionalAndContractServicesExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfessionalAndContractServicesExpense" xlink:to="lab_us-gaap_ProfessionalAndContractServicesExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_44e59b10-50f0-4d4f-aaab-4b835320a6e7_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_c3a3d91b-927f-49e1-8700-0577c08e6c3b_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_68f74d90-d935-4be3-ba9a-6943d34fee7d_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expenses [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_dbab8d54-aa96-44b0-b802-a5ce4782353c_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_pgen_UpfrontAndMilestonePaymentsMember_efa9e37d-31aa-4886-9eb3-e7c610cef56e_verboseLabel_en-US" xlink:label="lab_pgen_UpfrontAndMilestonePaymentsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upfront and milestone payments</link:label>
    <link:label id="lab_pgen_UpfrontAndMilestonePaymentsMember_57fbe186-a5c7-4ff2-aa8f-227bb5f6e699_terseLabel_en-US" xlink:label="lab_pgen_UpfrontAndMilestonePaymentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Add recognition of previously deferred revenue associated with upfront and milestone payments</link:label>
    <link:label id="lab_pgen_UpfrontAndMilestonePaymentsMember_label_en-US" xlink:label="lab_pgen_UpfrontAndMilestonePaymentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upfront And Milestone Payments [Member]</link:label>
    <link:label id="lab_pgen_UpfrontAndMilestonePaymentsMember_documentation_en-US" xlink:label="lab_pgen_UpfrontAndMilestonePaymentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upfront and milestone payments received as collaboration for the entity's collaborations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_UpfrontAndMilestonePaymentsMember" xlink:href="pgen-20220331.xsd#pgen_UpfrontAndMilestonePaymentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pgen_UpfrontAndMilestonePaymentsMember" xlink:to="lab_pgen_UpfrontAndMilestonePaymentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ffe1ffa0-e711-420f-8323-43e1f164508f_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3067e1f0-bbb6-44b2-a0b3-b1d8de22efb8_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues from external customers</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_9b458272-6593-41a7-acde-4bef549f8c3b_verboseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating gains</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Operating Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_pgen_FirstNationalBankofOmahaMember_47905589-e1fe-4cad-bb89-ea71d1bda35e_terseLabel_en-US" xlink:label="lab_pgen_FirstNationalBankofOmahaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First National Bank of Omaha</link:label>
    <link:label id="lab_pgen_FirstNationalBankofOmahaMember_label_en-US" xlink:label="lab_pgen_FirstNationalBankofOmahaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First National Bank of Omaha [Member]</link:label>
    <link:label id="lab_pgen_FirstNationalBankofOmahaMember_documentation_en-US" xlink:label="lab_pgen_FirstNationalBankofOmahaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First National Bank of Omaha [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_FirstNationalBankofOmahaMember" xlink:href="pgen-20220331.xsd#pgen_FirstNationalBankofOmahaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pgen_FirstNationalBankofOmahaMember" xlink:to="lab_pgen_FirstNationalBankofOmahaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_9b5793b4-502f-496c-b479-e6f8d93aaae3_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireInterestInJointVenture_8bf1798e-49aa-433b-95f1-3546b04ffb14_verboseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInterestInJointVenture" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital contributions</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireInterestInJointVenture_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInterestInJointVenture" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Interest in Joint Venture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInterestInJointVenture" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireInterestInJointVenture"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireInterestInJointVenture" xlink:to="lab_us-gaap_PaymentsToAcquireInterestInJointVenture" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_5f064720-58d7-4c6e-a1ba-e5e31663fae0_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_dc734186-2b4d-420e-8a73-80afdfa2485f_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_40d15354-1a40-410e-be19-4d86bbfeb276_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueIssuedForServices_53c555be-85f1-4e3c-aba6-fdb4bac90efa_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued as payment for services</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueIssuedForServices_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Issued for Services</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_52ea2d7b-95e7-4e41-b88f-f2f07e964334_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsTable_7d3c28b4-4924-407e-90db-93de24bec3f2_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsTable_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable" xlink:to="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_3523a5ab-2409-4e58-b8cd-e4a010a40db6_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_99868503-92c6-475f-8bed-4d9e3d649dc2_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_deee8c70-1904-4c41-9a7f-87b5e2539185_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating loss</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities_190c9181-5d23-495c-8bd2-b4d0bda8f277_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of assets</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Other Assets, Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities" xlink:to="lab_us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_12c9d0b4-a520-43ba-b46a-667cd6cac325_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_ac1b3ca1-db5b-4124-b220-0d41be6b861f_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_16b0e894-db6a-4572-b989-3d9c23385dd1_negatedLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock_50a7c6a9-6a57-496b-9862-f18e133e6b80_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration and Licensing Revenue</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:to="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_baed99d9-3156-460a-88e7-f9a01ed3356b_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_4eb0e4f3-0468-4aa0-8ea2-443e4f425b1a_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_4de9382d-6a05-4fc7-ba24-dd36c0776091_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInReceivablesAbstract_1812a747-4af6-4298-9080-36c9a5e23b70_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInReceivablesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInReceivablesAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInReceivablesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Receivables [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivablesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInReceivablesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInReceivablesAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInReceivablesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_602c6846-a3fa-4345-82e8-2c43607a325a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PublicUtilitiesInventoryAxis_ceef3c1e-50b9-4a3a-be49-4a869998fd7d_terseLabel_en-US" xlink:label="lab_us-gaap_PublicUtilitiesInventoryAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory [Axis]</link:label>
    <link:label id="lab_us-gaap_PublicUtilitiesInventoryAxis_label_en-US" xlink:label="lab_us-gaap_PublicUtilitiesInventoryAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PublicUtilitiesInventoryAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PublicUtilitiesInventoryAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PublicUtilitiesInventoryAxis" xlink:to="lab_us-gaap_PublicUtilitiesInventoryAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_e560df03-3829-4da9-bafc-de542f34a5f1_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_64311356-e868-4a72-82d5-c9572f759069_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_351db3b3-f066-4eec-8408-7a2b87f53e0e_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation expense</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_f81fdbce-2c08-4540-8e00-dcc741947296_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPayableCurrentAndNoncurrent_8eb8c2e7-1971-41fb-bec4-8f865b807b4d_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued interest</link:label>
    <link:label id="lab_us-gaap_InterestPayableCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_InterestPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPayableCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPayableCurrentAndNoncurrent" xlink:to="lab_us-gaap_InterestPayableCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_pgen_WorkInProcessMember_4be35d73-1736-4b67-9582-862ccc9f26f8_terseLabel_en-US" xlink:label="lab_pgen_WorkInProcessMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work in process</link:label>
    <link:label id="lab_pgen_WorkInProcessMember_label_en-US" xlink:label="lab_pgen_WorkInProcessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work In Process [Member]</link:label>
    <link:label id="lab_pgen_WorkInProcessMember_documentation_en-US" xlink:label="lab_pgen_WorkInProcessMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work In Process [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_WorkInProcessMember" xlink:href="pgen-20220331.xsd#pgen_WorkInProcessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pgen_WorkInProcessMember" xlink:to="lab_pgen_WorkInProcessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsPolicy_922aa32a-cc28-4e71-b019-704a2ac74351_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsPolicy_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsPolicy" xlink:to="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_17a96ce6-8d7c-4a9a-b72e-0dcd42e37d77_terseLabel_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_label_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_56ef0495-489f-4a79-adb7-09e6447186b4_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid during the period for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaid" xlink:to="lab_us-gaap_IncomeTaxesPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_ee1d7069-effa-4412-a333-6728e0823f3c_negatedLabel_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment losses</link:label>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetImpairmentCharges" xlink:to="lab_us-gaap_AssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_5c0a9a7d-0d77-4216-b81b-d85c95ade1a0_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense), net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_pgen_SuppliesEmbryosAndOtherProductionMaterialsMember_5205f136-e1a1-4be7-840f-78180d0b55f7_terseLabel_en-US" xlink:label="lab_pgen_SuppliesEmbryosAndOtherProductionMaterialsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplies, embryos and other production materials</link:label>
    <link:label id="lab_pgen_SuppliesEmbryosAndOtherProductionMaterialsMember_label_en-US" xlink:label="lab_pgen_SuppliesEmbryosAndOtherProductionMaterialsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplies, Embryos And Other Production Materials [Member]</link:label>
    <link:label id="lab_pgen_SuppliesEmbryosAndOtherProductionMaterialsMember_documentation_en-US" xlink:label="lab_pgen_SuppliesEmbryosAndOtherProductionMaterialsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplies, Embryos And Other Production Materials [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_SuppliesEmbryosAndOtherProductionMaterialsMember" xlink:href="pgen-20220331.xsd#pgen_SuppliesEmbryosAndOtherProductionMaterialsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pgen_SuppliesEmbryosAndOtherProductionMaterialsMember" xlink:to="lab_pgen_SuppliesEmbryosAndOtherProductionMaterialsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_42dc79e7-6d57-406f-a466-7e14dd690059_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_pgen_StockIssuedDuringPeriodValueRestrictedStockAwardsVestedAndStockOptionsExercised_522de4a0-0dce-4ebf-a1c4-5f88220b81a4_terseLabel_en-US" xlink:label="lab_pgen_StockIssuedDuringPeriodValueRestrictedStockAwardsVestedAndStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued upon vesting of restricted stock units and for exercises of stock options</link:label>
    <link:label id="lab_pgen_StockIssuedDuringPeriodValueRestrictedStockAwardsVestedAndStockOptionsExercised_label_en-US" xlink:label="lab_pgen_StockIssuedDuringPeriodValueRestrictedStockAwardsVestedAndStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Restricted Stock Awards Vested and Stock Options Exercised</link:label>
    <link:label id="lab_pgen_StockIssuedDuringPeriodValueRestrictedStockAwardsVestedAndStockOptionsExercised_documentation_en-US" xlink:label="lab_pgen_StockIssuedDuringPeriodValueRestrictedStockAwardsVestedAndStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value of stock issued related to Restricted Stock Awards vested during the period and as a result of the exercise of stock options.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_StockIssuedDuringPeriodValueRestrictedStockAwardsVestedAndStockOptionsExercised" xlink:href="pgen-20220331.xsd#pgen_StockIssuedDuringPeriodValueRestrictedStockAwardsVestedAndStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pgen_StockIssuedDuringPeriodValueRestrictedStockAwardsVestedAndStockOptionsExercised" xlink:to="lab_pgen_StockIssuedDuringPeriodValueRestrictedStockAwardsVestedAndStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_29af93c7-97da-492a-97c4-773f6eb2b401_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_7d1ac9ae-1811-4b14-a88e-3031db2a3585_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit facility, interest rate at period end</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Interest Rate at Period End</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:to="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:type="arc" order="1"/>
    <link:label id="lab_pgen_RelatedPartyReceivableAllowanceforCreditLossCurrent_291f9a42-80b2-4e6c-a11a-50b77b030e71_terseLabel_en-US" xlink:label="lab_pgen_RelatedPartyReceivableAllowanceforCreditLossCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related party receivable, allowance for credit losses</link:label>
    <link:label id="lab_pgen_RelatedPartyReceivableAllowanceforCreditLossCurrent_label_en-US" xlink:label="lab_pgen_RelatedPartyReceivableAllowanceforCreditLossCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Receivable, Allowance for Credit Loss, Current</link:label>
    <link:label id="lab_pgen_RelatedPartyReceivableAllowanceforCreditLossCurrent_documentation_en-US" xlink:label="lab_pgen_RelatedPartyReceivableAllowanceforCreditLossCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_RelatedPartyReceivableAllowanceforCreditLossCurrent" xlink:href="pgen-20220331.xsd#pgen_RelatedPartyReceivableAllowanceforCreditLossCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pgen_RelatedPartyReceivableAllowanceforCreditLossCurrent" xlink:to="lab_pgen_RelatedPartyReceivableAllowanceforCreditLossCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_fab1252e-2b59-47ee-a9a1-0dda47c00e34_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USGovernmentDebtSecuritiesMember_5fe7267c-121b-4099-b1d9-ea5672fe0090_terseLabel_en-US" xlink:label="lab_us-gaap_USGovernmentDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. government debt securities</link:label>
    <link:label id="lab_us-gaap_USGovernmentDebtSecuritiesMember_c2345cf9-fb74-41d7-9b78-34191fd31e26_verboseLabel_en-US" xlink:label="lab_us-gaap_USGovernmentDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. government debt securities</link:label>
    <link:label id="lab_us-gaap_USGovernmentDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USGovernmentDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Government Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USGovernmentDebtSecuritiesMember" xlink:to="lab_us-gaap_USGovernmentDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pgen_IntrexonEnergyPartnersLLAndIntrexonEnergyPartnersIILLCMember_8b75638d-78a8-4ea4-b6d5-0e0ef639bdce_terseLabel_en-US" xlink:label="lab_pgen_IntrexonEnergyPartnersLLAndIntrexonEnergyPartnersIILLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intrexon Energy Partners L.L. and Intrexon Energy Partners II, L.L.C</link:label>
    <link:label id="lab_pgen_IntrexonEnergyPartnersLLAndIntrexonEnergyPartnersIILLCMember_label_en-US" xlink:label="lab_pgen_IntrexonEnergyPartnersLLAndIntrexonEnergyPartnersIILLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intrexon Energy Partners L.L. and Intrexon Energy Partners II, L.L.C [Member]</link:label>
    <link:label id="lab_pgen_IntrexonEnergyPartnersLLAndIntrexonEnergyPartnersIILLCMember_documentation_en-US" xlink:label="lab_pgen_IntrexonEnergyPartnersLLAndIntrexonEnergyPartnersIILLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intrexon Energy Partners L.L. and Intrexon Energy Partners II, L.L.C</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_IntrexonEnergyPartnersLLAndIntrexonEnergyPartnersIILLCMember" xlink:href="pgen-20220331.xsd#pgen_IntrexonEnergyPartnersLLAndIntrexonEnergyPartnersIILLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pgen_IntrexonEnergyPartnersLLAndIntrexonEnergyPartnersIILLCMember" xlink:to="lab_pgen_IntrexonEnergyPartnersLLAndIntrexonEnergyPartnersIILLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pgen_CollaborativeArrangementConsiderationReceivedValue_d01adce7-b445-4647-a477-ac05f2801325_terseLabel_en-US" xlink:label="lab_pgen_CollaborativeArrangementConsiderationReceivedValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative arrangement consideration received, value</link:label>
    <link:label id="lab_pgen_CollaborativeArrangementConsiderationReceivedValue_label_en-US" xlink:label="lab_pgen_CollaborativeArrangementConsiderationReceivedValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement Consideration Received Value</link:label>
    <link:label id="lab_pgen_CollaborativeArrangementConsiderationReceivedValue_documentation_en-US" xlink:label="lab_pgen_CollaborativeArrangementConsiderationReceivedValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value of consideration received by the entity for collaboration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_CollaborativeArrangementConsiderationReceivedValue" xlink:href="pgen-20220331.xsd#pgen_CollaborativeArrangementConsiderationReceivedValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pgen_CollaborativeArrangementConsiderationReceivedValue" xlink:to="lab_pgen_CollaborativeArrangementConsiderationReceivedValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_6d92b499-4698-4bf3-9789-5d834dc44ddb_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_pgen_CostOfServicesMember_19220c21-7a04-4648-929b-18870ce36913_terseLabel_en-US" xlink:label="lab_pgen_CostOfServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of services</link:label>
    <link:label id="lab_pgen_CostOfServicesMember_label_en-US" xlink:label="lab_pgen_CostOfServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost Of Services [Member]</link:label>
    <link:label id="lab_pgen_CostOfServicesMember_documentation_en-US" xlink:label="lab_pgen_CostOfServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost Of Services [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_CostOfServicesMember" xlink:href="pgen-20220331.xsd#pgen_CostOfServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pgen_CostOfServicesMember" xlink:to="lab_pgen_CostOfServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_3ea40170-4982-49af-b371-182768d25c26_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_f96b90ac-3ed2-43fd-9ae6-c989d87f755f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_651fe546-3e7d-4863-98f3-283d8af54fb7_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expired (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_aa011da5-f99f-48ee-b687-2f92dadfca70_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturities of Lease Liabilities</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_bdcb2b1b-f17c-4100-bc2c-05e00eef3146_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_116f0439-5ed7-4b64-8bf5-fcd2c011cbe9_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total shareholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_8eca2f82-6de8-4527-8d73-d0e68d9bed50_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balances</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_aea503af-0df4-4baa-ad7e-4abe509972bb_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balances</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_ed49f63d-d41c-4f2b-b8b0-341183ce5826_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Precigen shareholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_pgen_RelatedPartyOwnershipInterest_3d63038c-17b2-4f1d-b1c5-ef155d3d32a5_terseLabel_en-US" xlink:label="lab_pgen_RelatedPartyOwnershipInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership interest</link:label>
    <link:label id="lab_pgen_RelatedPartyOwnershipInterest_label_en-US" xlink:label="lab_pgen_RelatedPartyOwnershipInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Ownership Interest</link:label>
    <link:label id="lab_pgen_RelatedPartyOwnershipInterest_documentation_en-US" xlink:label="lab_pgen_RelatedPartyOwnershipInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The percentage of ownership of common stock or equity participation in a related party.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_RelatedPartyOwnershipInterest" xlink:href="pgen-20220331.xsd#pgen_RelatedPartyOwnershipInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pgen_RelatedPartyOwnershipInterest" xlink:to="lab_pgen_RelatedPartyOwnershipInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_c22819b7-bfcc-41d4-aba8-0008afee7bec_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued as payment for services (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Issued for Services</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_90579e99-082d-47c0-b7da-a00734d62c41_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwards" xlink:to="lab_us-gaap_OperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_f2b74bb3-fdcd-455d-b4ab-d92cc57d9754_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_pgen_A3.5ConvertibleNotesDue2023Member_a7b5347f-a525-4554-8a41-99b01e781057_terseLabel_en-US" xlink:label="lab_pgen_A3.5ConvertibleNotesDue2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.5% Convertible Notes Due 2023</link:label>
    <link:label id="lab_pgen_A3.5ConvertibleNotesDue2023Member_label_en-US" xlink:label="lab_pgen_A3.5ConvertibleNotesDue2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.5% Convertible Notes Due 2023 [Member]</link:label>
    <link:label id="lab_pgen_A3.5ConvertibleNotesDue2023Member_documentation_en-US" xlink:label="lab_pgen_A3.5ConvertibleNotesDue2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.5% Convertible Notes Due 2023 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_A3.5ConvertibleNotesDue2023Member" xlink:href="pgen-20220331.xsd#pgen_A3.5ConvertibleNotesDue2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pgen_A3.5ConvertibleNotesDue2023Member" xlink:to="lab_pgen_A3.5ConvertibleNotesDue2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_faa45b75-ae4a-4de7-8360-07d126b3d633_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_3d977f22-154d-4423-b762-e6dcf50d7d9a_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in Joint Ventures</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments and Joint Ventures Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:to="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_pgen_GeneratedAfter2017Member_033c32d1-2d7d-431e-86fb-e5137eefa994_terseLabel_en-US" xlink:label="lab_pgen_GeneratedAfter2017Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Generated After 2017</link:label>
    <link:label id="lab_pgen_GeneratedAfter2017Member_label_en-US" xlink:label="lab_pgen_GeneratedAfter2017Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Generated After 2017 [Member]</link:label>
    <link:label id="lab_pgen_GeneratedAfter2017Member_documentation_en-US" xlink:label="lab_pgen_GeneratedAfter2017Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Generated After 2017 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_GeneratedAfter2017Member" xlink:href="pgen-20220331.xsd#pgen_GeneratedAfter2017Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pgen_GeneratedAfter2017Member" xlink:to="lab_pgen_GeneratedAfter2017Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f96f0598-7e1a-4efd-b85e-d2595508a644_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_pgen_ExemplarGeneticsLLCMember_b081cf70-55b9-42d6-be80-c50a0beff908_terseLabel_en-US" xlink:label="lab_pgen_ExemplarGeneticsLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exemplar Genetics, LLC</link:label>
    <link:label id="lab_pgen_ExemplarGeneticsLLCMember_label_en-US" xlink:label="lab_pgen_ExemplarGeneticsLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exemplar Genetics, LLC [Member]</link:label>
    <link:label id="lab_pgen_ExemplarGeneticsLLCMember_documentation_en-US" xlink:label="lab_pgen_ExemplarGeneticsLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exemplar Genetics, LLC [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_ExemplarGeneticsLLCMember" xlink:href="pgen-20220331.xsd#pgen_ExemplarGeneticsLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pgen_ExemplarGeneticsLLCMember" xlink:to="lab_pgen_ExemplarGeneticsLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_5bc4ecec-09e5-4f52-a795-680bdfb6c41c_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities_94739f59-6d7f-46cc-9b82-c2a64d92d64a_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationVariableInterestEntityPolicy_90ad709a-256e-41dc-b3b5-97237adf557f_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entities</link:label>
    <link:label id="lab_us-gaap_ConsolidationVariableInterestEntityPolicy_label_en-US" xlink:label="lab_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Variable Interest Entity, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationVariableInterestEntityPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:to="lab_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_pgen_MethaneBioconversionPlatformDisclosuresMember_22426879-32f5-4ca0-a17a-e182c0f0456c_terseLabel_en-US" xlink:label="lab_pgen_MethaneBioconversionPlatformDisclosuresMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Methane Bioconversion Platform Disclosures</link:label>
    <link:label id="lab_pgen_MethaneBioconversionPlatformDisclosuresMember_label_en-US" xlink:label="lab_pgen_MethaneBioconversionPlatformDisclosuresMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Methane Bioconversion Platform Disclosures [Member]</link:label>
    <link:label id="lab_pgen_MethaneBioconversionPlatformDisclosuresMember_documentation_en-US" xlink:label="lab_pgen_MethaneBioconversionPlatformDisclosuresMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Methane Bioconversion Platform Disclosures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_MethaneBioconversionPlatformDisclosuresMember" xlink:href="pgen-20220331.xsd#pgen_MethaneBioconversionPlatformDisclosuresMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pgen_MethaneBioconversionPlatformDisclosuresMember" xlink:to="lab_pgen_MethaneBioconversionPlatformDisclosuresMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pgen_CastleCreekBiosciencesIncMember_906ea762-9016-4efb-8eb5-55ef444a987f_terseLabel_en-US" xlink:label="lab_pgen_CastleCreekBiosciencesIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Castle Creek Biosciences, Inc.</link:label>
    <link:label id="lab_pgen_CastleCreekBiosciencesIncMember_label_en-US" xlink:label="lab_pgen_CastleCreekBiosciencesIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Castle Creek Biosciences, Inc. [Member]</link:label>
    <link:label id="lab_pgen_CastleCreekBiosciencesIncMember_documentation_en-US" xlink:label="lab_pgen_CastleCreekBiosciencesIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Castle Creek Biosciences, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_CastleCreekBiosciencesIncMember" xlink:href="pgen-20220331.xsd#pgen_CastleCreekBiosciencesIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pgen_CastleCreekBiosciencesIncMember" xlink:to="lab_pgen_CastleCreekBiosciencesIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_34a3ce4c-796e-4dc3-95aa-e3a5d2eca983_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Accumulated Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_dc17a1ba-9ceb-4aff-9111-84d9e67948cd_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After one year through two years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_bb915433-dab4-436a-80b3-8ee68ce69412_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_0a939df4-b084-415a-8c81-301df3784051_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease liabilities, net of current portion</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_8483105e-a0df-4717-8e88-d7a536080415_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term portion of operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_139ced6c-29ef-4bcb-9591-c304354fdaf4_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Axis]</link:label>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_label_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_7482a919-8817-4b96-885c-9298196ea18f_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current income tax expense from continuing operations</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_fca365a8-8752-4995-9790-6c748bd0ca0b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate principal amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_ba1914fc-d011-4961-b64c-edf187044eec_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_ef1b837a-4b41-4409-9ecd-970fe62a8a3c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_pgen_TransOvaSegmentMember_75a237c8-bddc-4afd-8e47-9d6f60b24272_terseLabel_en-US" xlink:label="lab_pgen_TransOvaSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trans Ova</link:label>
    <link:label id="lab_pgen_TransOvaSegmentMember_label_en-US" xlink:label="lab_pgen_TransOvaSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trans Ova Segment [Member]</link:label>
    <link:label id="lab_pgen_TransOvaSegmentMember_documentation_en-US" xlink:label="lab_pgen_TransOvaSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trans Ova Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_TransOvaSegmentMember" xlink:href="pgen-20220331.xsd#pgen_TransOvaSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pgen_TransOvaSegmentMember" xlink:to="lab_pgen_TransOvaSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_a674bbb2-d1d4-4bb6-8211-0743f2b46022_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation and benefits</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Employee Related Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_114fad6b-fb7c-41f0-9af6-07808a279e7c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective interest rate on convertible notes</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Effective Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_pgen_NumberofSeatsonGoverningBoardInternallySelected_c038d6d4-d2e9-495b-9382-3f88d6977530_terseLabel_en-US" xlink:label="lab_pgen_NumberofSeatsonGoverningBoardInternallySelected" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total number of seats on the joint venture's governing board, internally selected</link:label>
    <link:label id="lab_pgen_NumberofSeatsonGoverningBoardInternallySelected_label_en-US" xlink:label="lab_pgen_NumberofSeatsonGoverningBoardInternallySelected" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Seats on Governing Board, Internally Selected</link:label>
    <link:label id="lab_pgen_NumberofSeatsonGoverningBoardInternallySelected_documentation_en-US" xlink:label="lab_pgen_NumberofSeatsonGoverningBoardInternallySelected" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The number of seats on the governing board selected internally.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_NumberofSeatsonGoverningBoardInternallySelected" xlink:href="pgen-20220331.xsd#pgen_NumberofSeatsonGoverningBoardInternallySelected"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pgen_NumberofSeatsonGoverningBoardInternallySelected" xlink:to="lab_pgen_NumberofSeatsonGoverningBoardInternallySelected" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_51ac03b8-d834-4541-85d7-5dd0ad3a4927_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_23ce0959-4fa6-4304-aca3-b7a83493f776_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_077791a8-cd61-4ee6-ac57-f4af0170f10c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_39756af0-b9ac-410c-acaf-033379ff79c0_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseTypeDomain_0487624c-c52f-4899-b0ab-e8f1859dec91_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain" xlink:to="lab_srt_LitigationCaseTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_95d4b3e5-8b89-4da6-b26f-76307f6d8f12_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock units</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_b8c2e50e-b2ef-4bb2-a6ad-9d1ca2ddfb95_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_2be3b2f7-1aa6-45ea-83db-65455d4db259_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock_d062c43a-bba9-4a2e-a64a-4c2b63606cc3_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Revenue from Segments to Consolidated</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Revenue from Segments to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" xlink:to="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_8b6b12f7-a6eb-48a5-91dd-acd86655cb70_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term of contract</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:to="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestments_e3ef539b-df09-4538-a5a5-b247976efb8d_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestments" xlink:to="lab_us-gaap_EquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_a50a3bb0-182e-44fb-a924-a752d12433dc_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents, and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_0b2222a0-e3d0-43b6-84bc-e795395da6f5_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_9a65bd58-0bbb-41cd-ab34-c55c0407eab3_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_f60a6f70-a539-411f-b2e3-6e5c6208393e_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureAbstract" xlink:to="lab_us-gaap_InventoryDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_pgen_NumberofSeatsonGoverningBoard_ccaf05d7-d480-46d0-a78a-fabae129c249_terseLabel_en-US" xlink:label="lab_pgen_NumberofSeatsonGoverningBoard" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total number of seats on the joint venture's governing board</link:label>
    <link:label id="lab_pgen_NumberofSeatsonGoverningBoard_label_en-US" xlink:label="lab_pgen_NumberofSeatsonGoverningBoard" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Seats on Governing Board</link:label>
    <link:label id="lab_pgen_NumberofSeatsonGoverningBoard_documentation_en-US" xlink:label="lab_pgen_NumberofSeatsonGoverningBoard" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of seats on the governing board.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_NumberofSeatsonGoverningBoard" xlink:href="pgen-20220331.xsd#pgen_NumberofSeatsonGoverningBoard"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pgen_NumberofSeatsonGoverningBoard" xlink:to="lab_pgen_NumberofSeatsonGoverningBoard" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebt_d1dd3285-7111-4fdb-bf1f-aa2bb0863000_verboseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying value of convertible debt</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebt_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebt" xlink:to="lab_us-gaap_ConvertibleDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_e9cda47a-795c-4846-85d6-a6ba3ac3c34d_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from stock option exercises</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermInvestments_063246b4-260e-4298-a59d-c779786e38f1_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term investments</link:label>
    <link:label id="lab_us-gaap_ShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermInvestments" xlink:to="lab_us-gaap_ShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_pgen_ReportableSegmentsMember_2509fe59-8579-46b1-a01b-3cf2de358476_verboseLabel_en-US" xlink:label="lab_pgen_ReportableSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Adjusted EBITDA for reportable segments</link:label>
    <link:label id="lab_pgen_ReportableSegmentsMember_8dd28166-3a9c-420e-8819-d9297c074c67_terseLabel_en-US" xlink:label="lab_pgen_ReportableSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total segment revenues from reportable segments</link:label>
    <link:label id="lab_pgen_ReportableSegmentsMember_label_en-US" xlink:label="lab_pgen_ReportableSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reportable Segments [Member]</link:label>
    <link:label id="lab_pgen_ReportableSegmentsMember_documentation_en-US" xlink:label="lab_pgen_ReportableSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reportable Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_ReportableSegmentsMember" xlink:href="pgen-20220331.xsd#pgen_ReportableSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pgen_ReportableSegmentsMember" xlink:to="lab_pgen_ReportableSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleAbandonmentMember_2d11cc39-680b-4806-8925-3699681c334e_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleAbandonmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations, Disposed of by Means Other than Sale, Abandonment</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleAbandonmentMember_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleAbandonmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations, Disposed of by Means Other than Sale, Abandonment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleAbandonmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleAbandonmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleAbandonmentMember" xlink:to="lab_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleAbandonmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c2739cfd-1380-41b6-85e8-5202a3e50cbf_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_14a14803-405b-4df1-b5b5-dd745512cdc0_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3097a189-3eb8-4590-a0f7-8f910ec51894_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' equity, including portion attributable to noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_b658bd39-e21b-4bfb-b48d-8156371c17b8_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax benefit</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_7cd7ca03-ce8c-4928-a6a7-02e293d3d82c_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total income tax benefit from continuing operations</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_3377f2f5-a508-49d0-8f98-fae348c320d7_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade, less allowance for credit losses of $4,631 and $4,288 as of March&#160;31, 2022 and December&#160;31, 2021, respectively</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_0e873c10-72ad-4fd4-8c45-7c60c33aca03_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_d26c5bde-e27b-43a7-b9fa-43e4947a4b1f_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from long-term debt, net of issuance costs</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_pgen_AccruedCompensationPaidinEquityAwards_b81bf9fc-8c81-4cac-a0f8-c9517a1a485e_terseLabel_en-US" xlink:label="lab_pgen_AccruedCompensationPaidinEquityAwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation paid in equity awards</link:label>
    <link:label id="lab_pgen_AccruedCompensationPaidinEquityAwards_label_en-US" xlink:label="lab_pgen_AccruedCompensationPaidinEquityAwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Compensation Paid in Equity Awards</link:label>
    <link:label id="lab_pgen_AccruedCompensationPaidinEquityAwards_documentation_en-US" xlink:label="lab_pgen_AccruedCompensationPaidinEquityAwards" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Compensation Paid in Equity Awards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_AccruedCompensationPaidinEquityAwards" xlink:href="pgen-20220331.xsd#pgen_AccruedCompensationPaidinEquityAwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pgen_AccruedCompensationPaidinEquityAwards" xlink:to="lab_pgen_AccruedCompensationPaidinEquityAwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_f7d603e1-21f5-491d-a2a0-58db871962b1_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_29a4efd2-6bcd-4f86-9a72-b46fe17b8200_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_e4900c9e-05cd-44e0-acd9-07878b777161_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_aafbd4ee-7573-4406-b59b-f27979b72c50_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_389b87fb-a558-41ca-afcf-cc400b513829_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_ab3579af-f58b-4073-a14b-7d159f381640_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_f10a2938-f37f-4aaf-b724-76ced375ba3e_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntellectualPropertyMember_d1d3c80e-ba2b-4f73-a753-00e8780d2e2f_terseLabel_en-US" xlink:label="lab_us-gaap_IntellectualPropertyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents, developed technologies and know-how</link:label>
    <link:label id="lab_us-gaap_IntellectualPropertyMember_label_en-US" xlink:label="lab_us-gaap_IntellectualPropertyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intellectual Property [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntellectualPropertyMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntellectualPropertyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntellectualPropertyMember" xlink:to="lab_us-gaap_IntellectualPropertyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_a721633e-61aa-43e1-8f51-250b0305337b_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_d7405b32-8dba-41ab-9766-9b9aed729811_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_ae7c3b64-d1fb-4e04-990b-ff16767d25dc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Information by Reportable Segment</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1b24992c-66ce-4b08-b734-9b5464fcd9bc_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_cfc34775-1455-4de8-8342-44ad162beaa3_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments and Joint Ventures [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments and Joint Ventures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:to="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_065fa5b9-99a4-40bb-a4aa-513e33e33b32_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_487a75e2-d0d5-4414-8cb2-822e137665e6_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expired (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_d72885b2-1cec-49e1-8c46-b0e5d361817a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_1fee3384-fd74-47d4-8a08-54755a76c76c_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_pgen_TaxableIncomeLoss_56df84c6-1113-4047-9786-fc84d78a2357_terseLabel_en-US" xlink:label="lab_pgen_TaxableIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxable loss</link:label>
    <link:label id="lab_pgen_TaxableIncomeLoss_label_en-US" xlink:label="lab_pgen_TaxableIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxable Income Loss</link:label>
    <link:label id="lab_pgen_TaxableIncomeLoss_documentation_en-US" xlink:label="lab_pgen_TaxableIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxable income (loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_TaxableIncomeLoss" xlink:href="pgen-20220331.xsd#pgen_TaxableIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pgen_TaxableIncomeLoss" xlink:to="lab_pgen_TaxableIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_cf7c817e-bda0-4fde-a7d2-77c1af4b1a94_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_54a3f4cf-fbd7-4229-9064-bef8cc4946db_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less current portion</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent" xlink:to="lab_us-gaap_LongTermDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_73d503cb-110f-4f37-8ce1-48ebc4147f89_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_71f18446-7ba4-4226-a75d-6db53fc4089b_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_87f827ea-294d-41fe-8ccc-9f262caa13c9_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermLeaseCost_4c3752bb-f857-4885-ae12-ed5a39739217_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term lease costs</link:label>
    <link:label id="lab_us-gaap_ShortTermLeaseCost_label_en-US" xlink:label="lab_us-gaap_ShortTermLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermLeaseCost" xlink:to="lab_us-gaap_ShortTermLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0098b33d-1a04-4cac-81e5-6d53bdd9c069_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesPayableToBanksMember_967c68a8-50a0-4ea8-90e7-f99f3f94694a_terseLabel_en-US" xlink:label="lab_us-gaap_NotesPayableToBanksMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes payable</link:label>
    <link:label id="lab_us-gaap_NotesPayableToBanksMember_label_en-US" xlink:label="lab_us-gaap_NotesPayableToBanksMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable to Banks [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableToBanksMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableToBanksMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesPayableToBanksMember" xlink:to="lab_us-gaap_NotesPayableToBanksMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_6e4237ea-8dee-41ad-8025-cd667adf5c4b_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_5bf2aba6-8ef8-4659-a6d1-141e90a76dbe_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:to="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_pgen_LesseeOperatingLeaseTerminationPeriod_8eeb4402-93e4-420d-952c-5c566a11752a_terseLabel_en-US" xlink:label="lab_pgen_LesseeOperatingLeaseTerminationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Termination period</link:label>
    <link:label id="lab_pgen_LesseeOperatingLeaseTerminationPeriod_label_en-US" xlink:label="lab_pgen_LesseeOperatingLeaseTerminationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Termination Period</link:label>
    <link:label id="lab_pgen_LesseeOperatingLeaseTerminationPeriod_documentation_en-US" xlink:label="lab_pgen_LesseeOperatingLeaseTerminationPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Termination Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_LesseeOperatingLeaseTerminationPeriod" xlink:href="pgen-20220331.xsd#pgen_LesseeOperatingLeaseTerminationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pgen_LesseeOperatingLeaseTerminationPeriod" xlink:to="lab_pgen_LesseeOperatingLeaseTerminationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_pgen_AdjustmentForBonusesPaidInEquityAwards_66c6f774-5f2e-43b8-b1c7-2d851bbb3c1f_terseLabel_en-US" xlink:label="lab_pgen_AdjustmentForBonusesPaidInEquityAwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment related to accrued bonuses paid in equity awards</link:label>
    <link:label id="lab_pgen_AdjustmentForBonusesPaidInEquityAwards_label_en-US" xlink:label="lab_pgen_AdjustmentForBonusesPaidInEquityAwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment For Bonuses Paid In Equity Awards</link:label>
    <link:label id="lab_pgen_AdjustmentForBonusesPaidInEquityAwards_documentation_en-US" xlink:label="lab_pgen_AdjustmentForBonusesPaidInEquityAwards" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment For Bonuses Paid In Equity Awards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_AdjustmentForBonusesPaidInEquityAwards" xlink:href="pgen-20220331.xsd#pgen_AdjustmentForBonusesPaidInEquityAwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pgen_AdjustmentForBonusesPaidInEquityAwards" xlink:to="lab_pgen_AdjustmentForBonusesPaidInEquityAwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsGross_868754ac-b976-4a9c-82e2-c862854ead64_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt issuance costs</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsGross_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsGross" xlink:to="lab_us-gaap_DeferredFinanceCostsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_509a950d-2f35-4239-98f9-5eaaf42728b3_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseAxis_7d69d08e-c519-4882-8601-95552d55721e_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_label_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis" xlink:to="lab_srt_LitigationCaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_0b03163e-5970-448f-b7c4-d102ad02409c_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_pgen_JointVentureAdditionalCapitalContributionsCommitted_a7e05e38-2e2a-4ff3-a69e-25312cba9552_terseLabel_en-US" xlink:label="lab_pgen_JointVentureAdditionalCapitalContributionsCommitted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum additional capital contribution committed</link:label>
    <link:label id="lab_pgen_JointVentureAdditionalCapitalContributionsCommitted_label_en-US" xlink:label="lab_pgen_JointVentureAdditionalCapitalContributionsCommitted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Joint Venture Additional Capital Contributions Committed</link:label>
    <link:label id="lab_pgen_JointVentureAdditionalCapitalContributionsCommitted_documentation_en-US" xlink:label="lab_pgen_JointVentureAdditionalCapitalContributionsCommitted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of additional capital contributions to the joint venture for which the entity is committed, maximum.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_JointVentureAdditionalCapitalContributionsCommitted" xlink:href="pgen-20220331.xsd#pgen_JointVentureAdditionalCapitalContributionsCommitted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pgen_JointVentureAdditionalCapitalContributionsCommitted" xlink:to="lab_pgen_JointVentureAdditionalCapitalContributionsCommitted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_477c90ee-5595-4a01-8783-27845d68d383_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_c8f1310c-29ba-4bec-bf74-3314c7d023fc_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term investments</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireInvestments_6c265f2f-2957-4d04-8635-703c9c851423_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticCountryMember_d5cf4293-bdf6-4a9c-8a43-7f142a3623a0_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic</link:label>
    <link:label id="lab_us-gaap_DomesticCountryMember_label_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticCountryMember" xlink:to="lab_us-gaap_DomesticCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_cda38a71-9f89-410a-aa6a-65417c9c3462_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Fair&#160;Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_d3fe62ec-2d90-49c0-9e0b-a3b821fffb18_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtFairValueDisclosures_0576e109-f21c-4e38-9a76-c7cecf839708_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of convertible debt</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtFairValueDisclosures_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt, Fair Value Disclosures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtFairValueDisclosures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:to="lab_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_84951024-3ad6-4522-89c5-f1f1f77ca97e_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_17ac4be6-e412-4688-91fe-9fd87d460118_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_77182af3-a909-4c6b-88cb-f44601480257_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from continuing operations before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_effcafcb-3b28-4c51-b784-29711f1b7bba_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated net loss from continuing operations before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_d91e4037-093d-416d-a082-98edd71ced6f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Other Observable Inputs (Level&#160;2)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_767ff9c8-b350-4784-adbb-0a4ac569c932_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_label_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfAdoptionMember" xlink:to="lab_us-gaap_TypeOfAdoptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebtExcludingAmortization_09182021-2df3-429d-94ef-45791e5a3d8a_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebtExcludingAmortization_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt, Excluding Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebtExcludingAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:to="lab_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_c66a5fc8-ae74-4a26-8c3b-caed1b6ca3e4_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Noncurrent</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_55819b64-400b-4d18-b2c3-3adea27c80ad_netLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue, net of current portion, related party</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_3e2585d2-5443-4466-bf66-46fbf0f927e8_verboseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term portion of deferred revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_pgen_JointVentureAdditionalCapitalContributionsCommittedRemainingCommitment_ac913cc6-cb64-4c7e-a845-1d730a9e3813_terseLabel_en-US" xlink:label="lab_pgen_JointVentureAdditionalCapitalContributionsCommittedRemainingCommitment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional capital contributions committed, remaining commitment</link:label>
    <link:label id="lab_pgen_JointVentureAdditionalCapitalContributionsCommittedRemainingCommitment_label_en-US" xlink:label="lab_pgen_JointVentureAdditionalCapitalContributionsCommittedRemainingCommitment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Joint Venture Additional Capital Contributions Committed, Remaining Commitment</link:label>
    <link:label id="lab_pgen_JointVentureAdditionalCapitalContributionsCommittedRemainingCommitment_documentation_en-US" xlink:label="lab_pgen_JointVentureAdditionalCapitalContributionsCommittedRemainingCommitment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining amount of additional capital contributions to the joint venture for which the entity is committed.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_JointVentureAdditionalCapitalContributionsCommittedRemainingCommitment" xlink:href="pgen-20220331.xsd#pgen_JointVentureAdditionalCapitalContributionsCommittedRemainingCommitment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pgen_JointVentureAdditionalCapitalContributionsCommittedRemainingCommitment" xlink:to="lab_pgen_JointVentureAdditionalCapitalContributionsCommittedRemainingCommitment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_9e56c8df-8ba5-4e67-8a93-730301430a19_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unallocated corporate costs</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_label_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate, Non-Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateNonSegmentMember" xlink:to="lab_us-gaap_CorporateNonSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_7742f199-7dac-4a05-8163-05c16a61cc24_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_5aff23f7-d06a-4fc4-bf14-f05d598db619_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_9b4bca2f-61bb-4466-a1b3-27f473e4e392_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade_f423f3bd-a671-4dee-8329-761a07f8318b_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable, Trade</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_a3fee533-a1c7-458d-ad6c-50f3f0183d39_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_26a9f0e3-174f-4d6c-be1d-62b0557f8542_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock price trading days</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Trading Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_864c2d6f-0856-4ce2-8027-70b7183232d6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock-Based Compensation Costs</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioForecastMember_eea4a3e5-deb1-492d-880e-2c3070d48b41_terseLabel_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast</link:label>
    <link:label id="lab_srt_ScenarioForecastMember_label_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioForecastMember" xlink:to="lab_srt_ScenarioForecastMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_b94695de-a6fc-4429-8d12-1c28e60d1b81_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_pgen_BreedingandProductionAnimalsGross_80dd082a-d176-432f-a37b-9d95ac75b0f4_terseLabel_en-US" xlink:label="lab_pgen_BreedingandProductionAnimalsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Breeding stock</link:label>
    <link:label id="lab_pgen_BreedingandProductionAnimalsGross_label_en-US" xlink:label="lab_pgen_BreedingandProductionAnimalsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Breeding and Production Animals, Gross</link:label>
    <link:label id="lab_pgen_BreedingandProductionAnimalsGross_documentation_en-US" xlink:label="lab_pgen_BreedingandProductionAnimalsGross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount before accumulated depreciation of animals maintained to create offspring or to produce goods to be sold for profit.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_BreedingandProductionAnimalsGross" xlink:href="pgen-20220331.xsd#pgen_BreedingandProductionAnimalsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pgen_BreedingandProductionAnimalsGross" xlink:to="lab_pgen_BreedingandProductionAnimalsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_a3a2f2dd-4d0c-4189-a64a-0904ee89feb6_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of shares, net of issuance costs</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_7730bba4-e1f2-4498-aecc-8b51cd0e2915_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_616cf4d9-3ba2-4e01-b200-c716679b3a2d_terseLabel_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_label_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EquityMethodInvesteeNameDomain" xlink:to="lab_srt_EquityMethodInvesteeNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_fc2910c1-6ce9-41fe-b804-4f5cc2ca7146_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_1a8824b9-b292-4af5-a647-8d84d9f2812e_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_66912328-94ae-45a8-8f1d-fba04c82e881_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid during the period for interest</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_c19c2cb3-423f-4436-968d-deb4fb6a8fdb_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualAxis_1be0a579-3b5f-47d5-bd7b-c4a5e8629924_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:label id="lab_srt_TitleOfIndividualAxis_label_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualAxis" xlink:to="lab_srt_TitleOfIndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_aaf38208-d567-4d3b-9cb0-a3d48670b742_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_a6f1dc07-1229-43b3-ac08-0ff73e3a2b62_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_d2e01cf8-a41e-4dfe-87fa-7b2ba2c365ca_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_822e5a22-9c43-42d9-b1ed-48e71860132c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, interest rate, stated percentage</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_pgen_AllInvestorsMember_0f47f35d-2e69-4b8c-89da-e97666b631c9_terseLabel_en-US" xlink:label="lab_pgen_AllInvestorsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Investors</link:label>
    <link:label id="lab_pgen_AllInvestorsMember_label_en-US" xlink:label="lab_pgen_AllInvestorsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Investors [Member]</link:label>
    <link:label id="lab_pgen_AllInvestorsMember_documentation_en-US" xlink:label="lab_pgen_AllInvestorsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Investors of Entity [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_AllInvestorsMember" xlink:href="pgen-20220331.xsd#pgen_AllInvestorsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pgen_AllInvestorsMember" xlink:to="lab_pgen_AllInvestorsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4bd6da9d-d498-4ed1-bd2e-8e9e4f01c431_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_pgen_XYLLCMember_50b4b2b0-0dc3-400b-b35d-a0b23ab1c37c_terseLabel_en-US" xlink:label="lab_pgen_XYLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">XY, LLC</link:label>
    <link:label id="lab_pgen_XYLLCMember_label_en-US" xlink:label="lab_pgen_XYLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">XY, LLC [Member]</link:label>
    <link:label id="lab_pgen_XYLLCMember_documentation_en-US" xlink:label="lab_pgen_XYLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">XY, LLC [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_XYLLCMember" xlink:href="pgen-20220331.xsd#pgen_XYLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pgen_XYLLCMember" xlink:to="lab_pgen_XYLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_1ed95ed6-0b55-4eb9-943d-b75a1c217b0a_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Line of Credit</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_96244831-f7eb-4640-a6c3-70acfbb0c5e9_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_f757865e-eee2-40db-9b8b-e804fcca90ee_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_pgen_CompensationArrangementWithIndividualExpense_2f277ee6-21cb-426e-a8c5-9b813a678c63_terseLabel_en-US" xlink:label="lab_pgen_CompensationArrangementWithIndividualExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expense for certain compensation arrangements</link:label>
    <link:label id="lab_pgen_CompensationArrangementWithIndividualExpense_label_en-US" xlink:label="lab_pgen_CompensationArrangementWithIndividualExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Arrangement With Individual, Expense</link:label>
    <link:label id="lab_pgen_CompensationArrangementWithIndividualExpense_documentation_en-US" xlink:label="lab_pgen_CompensationArrangementWithIndividualExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Arrangement With Individual, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_CompensationArrangementWithIndividualExpense" xlink:href="pgen-20220331.xsd#pgen_CompensationArrangementWithIndividualExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pgen_CompensationArrangementWithIndividualExpense" xlink:to="lab_pgen_CompensationArrangementWithIndividualExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_294c20a5-e1fc-4fdc-90d9-df890787264e_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_26a2377e-23f2-43b9-97f3-54a191051e1c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_dd8fb347-5032-41d9-9363-f4bbf9f0d61e_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Lease Costs</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_01540e34-f29f-4a4a-83ef-51f3d739489e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_pgen_NetIncomeLossAttributabletoParentAdjustedEBITDAIncludingCashPaidforCapitalExpendituresandInvestmentsinAffiliates_2e19d023-d5f9-4a06-821d-44ffc36e0b85_verboseLabel_en-US" xlink:label="lab_pgen_NetIncomeLossAttributabletoParentAdjustedEBITDAIncludingCashPaidforCapitalExpendituresandInvestmentsinAffiliates" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Adjusted EBITDA for reportable segments</link:label>
    <link:label id="lab_pgen_NetIncomeLossAttributabletoParentAdjustedEBITDAIncludingCashPaidforCapitalExpendituresandInvestmentsinAffiliates_label_en-US" xlink:label="lab_pgen_NetIncomeLossAttributabletoParentAdjustedEBITDAIncludingCashPaidforCapitalExpendituresandInvestmentsinAffiliates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent, Adjusted EBITDA, Including Cash Paid for Capital Expenditures and Investments in Affiliates</link:label>
    <link:label id="lab_pgen_NetIncomeLossAttributabletoParentAdjustedEBITDAIncludingCashPaidforCapitalExpendituresandInvestmentsinAffiliates_documentation_en-US" xlink:label="lab_pgen_NetIncomeLossAttributabletoParentAdjustedEBITDAIncludingCashPaidforCapitalExpendituresandInvestmentsinAffiliates" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Adjusted EBITDA defined as net income (loss) before (i) interest expense, (ii) income tax expense/benefit, (iii) depreciation and amortization, (iv) stock-based compensation expense, (v) loss on settlement agreements where noncash consideration is paid; (vi) adjustments for accrued bonuses paid in equity awards; (vii) gain or loss on disposal of assets; (viii) loss on impairment of goodwill and other noncurrent assets, (ix) write-off of reacquired in-process research and development, (x) equity in net income (loss) of affiliates, and (xi) recognition of previously deferred revenue associated with upfront and milestone payments as well as cash outflows from capital expenditures and investments in affiliates, but includes proceeds from the sale of assets in the period sold.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_NetIncomeLossAttributabletoParentAdjustedEBITDAIncludingCashPaidforCapitalExpendituresandInvestmentsinAffiliates" xlink:href="pgen-20220331.xsd#pgen_NetIncomeLossAttributabletoParentAdjustedEBITDAIncludingCashPaidforCapitalExpendituresandInvestmentsinAffiliates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pgen_NetIncomeLossAttributabletoParentAdjustedEBITDAIncludingCashPaidforCapitalExpendituresandInvestmentsinAffiliates" xlink:to="lab_pgen_NetIncomeLossAttributabletoParentAdjustedEBITDAIncludingCashPaidforCapitalExpendituresandInvestmentsinAffiliates" xlink:type="arc" order="1"/>
    <link:label id="lab_pgen_CompensationArrangementWithIndividualAllocatedShareBasedCompensationExpenseMonthlyExpense_089bcc7c-57d8-4213-b934-5899086b3114_verboseLabel_en-US" xlink:label="lab_pgen_CompensationArrangementWithIndividualAllocatedShareBasedCompensationExpenseMonthlyExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Monthly compensation, in the form of equity</link:label>
    <link:label id="lab_pgen_CompensationArrangementWithIndividualAllocatedShareBasedCompensationExpenseMonthlyExpense_label_en-US" xlink:label="lab_pgen_CompensationArrangementWithIndividualAllocatedShareBasedCompensationExpenseMonthlyExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Arrangement With Individual, Allocated Share-Based Compensation Expense, Monthly Expense</link:label>
    <link:label id="lab_pgen_CompensationArrangementWithIndividualAllocatedShareBasedCompensationExpenseMonthlyExpense_documentation_en-US" xlink:label="lab_pgen_CompensationArrangementWithIndividualAllocatedShareBasedCompensationExpenseMonthlyExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of monthly expense recognized from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments), awarded to key employees or individuals.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_CompensationArrangementWithIndividualAllocatedShareBasedCompensationExpenseMonthlyExpense" xlink:href="pgen-20220331.xsd#pgen_CompensationArrangementWithIndividualAllocatedShareBasedCompensationExpenseMonthlyExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pgen_CompensationArrangementWithIndividualAllocatedShareBasedCompensationExpenseMonthlyExpense" xlink:to="lab_pgen_CompensationArrangementWithIndividualAllocatedShareBasedCompensationExpenseMonthlyExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherReceivablesNetCurrent_2c98ddd5-f834-4f63-a2dd-503afd092e67_terseLabel_en-US" xlink:label="lab_us-gaap_OtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherReceivablesNetCurrent_label_en-US" xlink:label="lab_us-gaap_OtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Receivables, Net, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherReceivablesNetCurrent" xlink:to="lab_us-gaap_OtherReceivablesNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_aafe5449-2763-46af-abee-0bf547ad96ef_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAxis_4dc37984-03a9-4a9e-af59-2434f37d2552_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward [Axis]</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAxis_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis" xlink:to="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_40a5f0fd-5095-411c-b472-7cb5558bfcce_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares outstanding, basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_d8486065-5799-4303-ba03-98c06d210eb5_totalLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss per share, diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_pgen_CapitalExpendituresNetOfProceedsFromSaleOfAssetsAndInvestmentsInAffiliates_105cca93-f795-4a8d-9f99-48e061b08706_terseLabel_en-US" xlink:label="lab_pgen_CapitalExpendituresNetOfProceedsFromSaleOfAssetsAndInvestmentsInAffiliates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remove cash paid for capital expenditures, net of proceeds from sale of assets, and cash paid for investments in affiliates</link:label>
    <link:label id="lab_pgen_CapitalExpendituresNetOfProceedsFromSaleOfAssetsAndInvestmentsInAffiliates_label_en-US" xlink:label="lab_pgen_CapitalExpendituresNetOfProceedsFromSaleOfAssetsAndInvestmentsInAffiliates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditures, Net Of Proceeds From Sale Of Assets, And Investments in Affiliates</link:label>
    <link:label id="lab_pgen_CapitalExpendituresNetOfProceedsFromSaleOfAssetsAndInvestmentsInAffiliates_documentation_en-US" xlink:label="lab_pgen_CapitalExpendituresNetOfProceedsFromSaleOfAssetsAndInvestmentsInAffiliates" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditures and Investments in Affiliates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_CapitalExpendituresNetOfProceedsFromSaleOfAssetsAndInvestmentsInAffiliates" xlink:href="pgen-20220331.xsd#pgen_CapitalExpendituresNetOfProceedsFromSaleOfAssetsAndInvestmentsInAffiliates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pgen_CapitalExpendituresNetOfProceedsFromSaleOfAssetsAndInvestmentsInAffiliates" xlink:to="lab_pgen_CapitalExpendituresNetOfProceedsFromSaleOfAssetsAndInvestmentsInAffiliates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_ca257f75-4c0e-4599-85f3-c8d063b95c53_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_e9b20c33-bc45-4606-b806-13547a5e1e25_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accretion of debt discount and amortization of deferred financing costs</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs and Discounts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:to="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DueToRelatedPartiesCurrent_0dc53566-fdcd-4717-9341-f704a49e2b93_terseLabel_en-US" xlink:label="lab_us-gaap_DueToRelatedPartiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related party payables</link:label>
    <link:label id="lab_us-gaap_DueToRelatedPartiesCurrent_label_en-US" xlink:label="lab_us-gaap_DueToRelatedPartiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due to Related Parties, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToRelatedPartiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DueToRelatedPartiesCurrent" xlink:to="lab_us-gaap_DueToRelatedPartiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_pgen_CompensationArrangementWithIndividualAnnualCashRetainer_8f512475-6988-431d-9e3a-c2cc0e6e238d_terseLabel_en-US" xlink:label="lab_pgen_CompensationArrangementWithIndividualAnnualCashRetainer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Yearly compensation, payable in cash or equity</link:label>
    <link:label id="lab_pgen_CompensationArrangementWithIndividualAnnualCashRetainer_label_en-US" xlink:label="lab_pgen_CompensationArrangementWithIndividualAnnualCashRetainer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Arrangement With Individual, Annual Cash Retainer</link:label>
    <link:label id="lab_pgen_CompensationArrangementWithIndividualAnnualCashRetainer_documentation_en-US" xlink:label="lab_pgen_CompensationArrangementWithIndividualAnnualCashRetainer" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Arrangement With Individual, Annual Cash Retainer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_CompensationArrangementWithIndividualAnnualCashRetainer" xlink:href="pgen-20220331.xsd#pgen_CompensationArrangementWithIndividualAnnualCashRetainer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pgen_CompensationArrangementWithIndividualAnnualCashRetainer" xlink:to="lab_pgen_CompensationArrangementWithIndividualAnnualCashRetainer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_97ad7de4-81b8-48a2-841e-f13a1ea1240c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of common share price over conversion price for conversion</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductMember_dfad4a5c-ba4c-4587-be70-a34c04c39541_terseLabel_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Products</link:label>
    <link:label id="lab_us-gaap_ProductMember_label_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductMember" xlink:to="lab_us-gaap_ProductMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock_0b3e9365-389d-48e6-ae76-d8d59de1b40a_terseLabel_en-US" xlink:label="lab_srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Obligation, Fiscal Year Maturity</link:label>
    <link:label id="lab_srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock_label_en-US" xlink:label="lab_srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Obligation, Fiscal Year Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock" xlink:to="lab_srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_079a1daa-ac1a-4521-8c02-d3476f155e7b_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:to="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonUsMember_31173b62-b637-43a2-b9ba-75379313969e_terseLabel_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-US</link:label>
    <link:label id="lab_us-gaap_NonUsMember_label_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonUsMember" xlink:to="lab_us-gaap_NonUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_baa7e914-8384-4050-840c-b53b694a13e9_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive loss</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_8f54ce85-2597-422e-86ca-04badb9f3fc1_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_pgen_ExecutiveChairmanMember_01498b4a-68ec-4d16-868c-275e0a5f6ecc_verboseLabel_en-US" xlink:label="lab_pgen_ExecutiveChairmanMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Executive Chairman</link:label>
    <link:label id="lab_pgen_ExecutiveChairmanMember_label_en-US" xlink:label="lab_pgen_ExecutiveChairmanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Executive Chairman [Member]</link:label>
    <link:label id="lab_pgen_ExecutiveChairmanMember_documentation_en-US" xlink:label="lab_pgen_ExecutiveChairmanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Executive Chairman [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_ExecutiveChairmanMember" xlink:href="pgen-20220331.xsd#pgen_ExecutiveChairmanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pgen_ExecutiveChairmanMember" xlink:to="lab_pgen_ExecutiveChairmanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_e95496b1-fc23-4778-a0fe-1f36f47be1d0_totalLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiability" xlink:to="lab_us-gaap_ContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_dd2a3fa1-a3cf-465a-a284-2532733f8840_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash (used in) provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_07eb4366-137f-4720-bb99-bbf81ed003f9_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive loss:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_6ca86aec-e6d0-449e-9f09-cd7fef8636c0_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_5dfac728-d750-4409-b630-70f72c0996e9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Remaining Contractual Term (Years)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_394b5870-c720-417d-921b-f575d5cd389c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation arrangement by share-based payment award, award vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_ac6d7055-35bc-4056-af82-28f365a63bea_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:to="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_57ee5ffa-0ee5-4bc8-9eb7-57c9e0c3e800_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity in net loss of affiliates</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_de14f045-d6d4-4061-8f01-95e5446296a6_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity in net loss of affiliates</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_pgen_ContractWithCustomerAssetAndLiabilityTable_01af0ebd-c2d2-400f-be51-678ada50a0dc_terseLabel_en-US" xlink:label="lab_pgen_ContractWithCustomerAssetAndLiabilityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Asset And Liability [Table]</link:label>
    <link:label id="lab_pgen_ContractWithCustomerAssetAndLiabilityTable_label_en-US" xlink:label="lab_pgen_ContractWithCustomerAssetAndLiabilityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Asset And Liability [Table]</link:label>
    <link:label id="lab_pgen_ContractWithCustomerAssetAndLiabilityTable_documentation_en-US" xlink:label="lab_pgen_ContractWithCustomerAssetAndLiabilityTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Asset And Liability [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_ContractWithCustomerAssetAndLiabilityTable" xlink:href="pgen-20220331.xsd#pgen_ContractWithCustomerAssetAndLiabilityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pgen_ContractWithCustomerAssetAndLiabilityTable" xlink:to="lab_pgen_ContractWithCustomerAssetAndLiabilityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_0644f530-182b-4c7c-9387-f6159a678d7d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss from continuing operations per share, basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Per Basic Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_9d7bcba5-3c2d-4a60-a8bc-dae95a88bfb8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restricted Stock Unit Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_62e285b7-6763-45f7-a875-cb99c2a99169_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from discontinued operations, net of income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_36b89d5d-04fe-4b81-8e80-5e2132f0ff93_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_606e4f23-8dde-4354-bc89-764e66f0fcde_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_29764bec-50bd-4fd3-9a37-3183d42bd15d_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_0dfb4515-288b-4273-befa-6cded89c79a4_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_06b4e64e-9a23-47d0-a82a-ee83a46757bf_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockNoParValue_8e9f1e1d-929c-4e91-8d47-f54e654d33b7_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockNoParValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, no par value (in usd per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockNoParValue_label_en-US" xlink:label="lab_us-gaap_CommonStockNoParValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, No Par Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockNoParValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockNoParValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockNoParValue" xlink:to="lab_us-gaap_CommonStockNoParValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_c4ef70cb-f7b0-409d-b87d-e78f89ddbffc_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Placement in the Fair Value Hierarchy of Financial Assets that are Measured at Fair Value on a Recurring Basis</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCountryMember_a8f8ba3c-3da8-4299-9bf6-8d29b5108c47_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_ForeignCountryMember_label_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCountryMember" xlink:to="lab_us-gaap_ForeignCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pgen_BiopharmaceuticalsSegmentMember_28e706bb-f2d5-4640-bfcf-265da7eb2050_terseLabel_en-US" xlink:label="lab_pgen_BiopharmaceuticalsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Biopharmaceuticals</link:label>
    <link:label id="lab_pgen_BiopharmaceuticalsSegmentMember_label_en-US" xlink:label="lab_pgen_BiopharmaceuticalsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Biopharmaceuticals Segment [Member]</link:label>
    <link:label id="lab_pgen_BiopharmaceuticalsSegmentMember_documentation_en-US" xlink:label="lab_pgen_BiopharmaceuticalsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PGEN Therapeutics Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_BiopharmaceuticalsSegmentMember" xlink:href="pgen-20220331.xsd#pgen_BiopharmaceuticalsSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pgen_BiopharmaceuticalsSegmentMember" xlink:to="lab_pgen_BiopharmaceuticalsSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_6d11b4ee-8474-4f2a-a105-0ded6e7763a7_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_4871c142-25ee-4c8c-b4ee-f396b7403a19_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total accumulated other comprehensive (loss) income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_9807b7f1-f4a4-492f-8c0a-9ef2dfe83074_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_80c3213c-c34a-435b-9677-c4d889e542f6_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_e0fd7e2a-c31c-47c6-90e2-350e9598265c_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balances (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_38eef101-391f-4ac8-a9c3-26cb259c07b7_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balances (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1dbbaf33-17c7-4eed-8b09-556f6bf079ba_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_32cf6f63-0e87-4f70-8653-3540ff75eb12_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of products and services</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_fc326380-ed96-42f7-8c86-2e004f4ce9c9_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentContinuingOperationsMember_8b53bb8b-302b-462e-bfab-cd01f8b057ba_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentContinuingOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Continuing Operations</link:label>
    <link:label id="lab_us-gaap_SegmentContinuingOperationsMember_label_en-US" xlink:label="lab_us-gaap_SegmentContinuingOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Continuing Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentContinuingOperationsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentContinuingOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentContinuingOperationsMember" xlink:to="lab_us-gaap_SegmentContinuingOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pgen_OtherLongTermDebtMember_87e0df96-6edd-4152-8191-df53c8757dd1_terseLabel_en-US" xlink:label="lab_pgen_OtherLongTermDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_pgen_OtherLongTermDebtMember_label_en-US" xlink:label="lab_pgen_OtherLongTermDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Long-Term Debt [Member]</link:label>
    <link:label id="lab_pgen_OtherLongTermDebtMember_documentation_en-US" xlink:label="lab_pgen_OtherLongTermDebtMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Long-Term Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_OtherLongTermDebtMember" xlink:href="pgen-20220331.xsd#pgen_OtherLongTermDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pgen_OtherLongTermDebtMember" xlink:to="lab_pgen_OtherLongTermDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_53ca9abf-b897-4393-b5ea-a428277c8636_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_6fb853b3-06a5-46e3-b49b-db7543ef9d6e_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLenderDomain_2f8aa292-9b1c-489c-9105-c7992ba6687f_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Lender [Domain]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLenderDomain_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Lender [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain" xlink:to="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_29295d2a-1a00-46e7-9074-6d13786fb7c0_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Deferred Revenue by Collaborator</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_163eb47f-674c-4b2a-9b77-96bde1565295_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PublicUtilitiesInventoryTypeDomain_07544e05-0feb-4a74-a75a-cf386e3ee27e_terseLabel_en-US" xlink:label="lab_us-gaap_PublicUtilitiesInventoryTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory [Domain]</link:label>
    <link:label id="lab_us-gaap_PublicUtilitiesInventoryTypeDomain_label_en-US" xlink:label="lab_us-gaap_PublicUtilitiesInventoryTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PublicUtilitiesInventoryTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PublicUtilitiesInventoryTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PublicUtilitiesInventoryTypeDomain" xlink:to="lab_us-gaap_PublicUtilitiesInventoryTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_pgen_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsReconciliationAbstract_fe21f5bf-f213-4648-a05e-ce8f080f78f5_terseLabel_en-US" xlink:label="lab_pgen_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents, and restricted cash</link:label>
    <link:label id="lab_pgen_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsReconciliationAbstract_label_en-US" xlink:label="lab_pgen_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Reconciliation [Abstract]</link:label>
    <link:label id="lab_pgen_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsReconciliationAbstract_documentation_en-US" xlink:label="lab_pgen_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Reconciliation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsReconciliationAbstract" xlink:href="pgen-20220331.xsd#pgen_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsReconciliationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pgen_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsReconciliationAbstract" xlink:to="lab_pgen_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsReconciliationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_c7a4abe8-0719-4e69-8c48-3d36f23614fd_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized loss on investments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_0238904f-dec3-4903-ac62-7418ac16aa20_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_pgen_NoncashGainLossOnTerminationOfLease_11f975f9-ae1c-4b2d-a5b5-95b0ee9525d7_negatedTerseLabel_en-US" xlink:label="lab_pgen_NoncashGainLossOnTerminationOfLease" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash gain on termination of operating leases</link:label>
    <link:label id="lab_pgen_NoncashGainLossOnTerminationOfLease_label_en-US" xlink:label="lab_pgen_NoncashGainLossOnTerminationOfLease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Gain (Loss) on Termination of Lease</link:label>
    <link:label id="lab_pgen_NoncashGainLossOnTerminationOfLease_documentation_en-US" xlink:label="lab_pgen_NoncashGainLossOnTerminationOfLease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Gain (Loss) on Termination of Lease</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_NoncashGainLossOnTerminationOfLease" xlink:href="pgen-20220331.xsd#pgen_NoncashGainLossOnTerminationOfLease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pgen_NoncashGainLossOnTerminationOfLease" xlink:to="lab_pgen_NoncashGainLossOnTerminationOfLease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_193e7452-b653-4526-abcf-9a8c5429a7b3_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCost_d3aaaa21-4e9e-4e63-8882-3b1a4d15b5e1_totalLabel_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease costs</link:label>
    <link:label id="lab_us-gaap_LeaseCost_label_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCost" xlink:to="lab_us-gaap_LeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_e9476168-b62a-41e4-a3d3-57a8739cd08a_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7ede14d3-97a4-4ea6-8546-861c93091300_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_dcab9403-86b9-4910-bb70-6bd92777f531_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development tax credits</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards, Research</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_f8a1f423-1530-4d76-bcaa-41f27bfe9da0_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_1aca2c51-0fe6-41f3-b350-52ed3a0b10a4_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_a2a982cf-22b0-4612-8d1b-577324947a30_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table]</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_44e64424-4bbe-4f01-80f0-be70f29bdb68_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant noncash activities</link:label>
    <link:label id="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_b7547323-2026-4e01-8f6a-ad12b45733f2_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesGross_5e931a30-08ab-4b69-ab21-060d2755a74e_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and fixtures</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesGross_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesGross" xlink:to="lab_us-gaap_FurnitureAndFixturesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_pgen_SecuritiesAndExchangeCommissionMember_9f10bdd9-0f72-4962-9588-e52fffb76afa_terseLabel_en-US" xlink:label="lab_pgen_SecuritiesAndExchangeCommissionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Division Of Enforcement Of The Securities And Exchange Commission</link:label>
    <link:label id="lab_pgen_SecuritiesAndExchangeCommissionMember_label_en-US" xlink:label="lab_pgen_SecuritiesAndExchangeCommissionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securities And Exchange Commission [Member]</link:label>
    <link:label id="lab_pgen_SecuritiesAndExchangeCommissionMember_documentation_en-US" xlink:label="lab_pgen_SecuritiesAndExchangeCommissionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securities And Exchange Commission</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_SecuritiesAndExchangeCommissionMember" xlink:href="pgen-20220331.xsd#pgen_SecuritiesAndExchangeCommissionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pgen_SecuritiesAndExchangeCommissionMember" xlink:to="lab_pgen_SecuritiesAndExchangeCommissionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestReceivable_2a77500c-b2eb-4bf5-907f-6bde7b0a5823_terseLabel_en-US" xlink:label="lab_us-gaap_InterestReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest receivable</link:label>
    <link:label id="lab_us-gaap_InterestReceivable_label_en-US" xlink:label="lab_us-gaap_InterestReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestReceivable" xlink:to="lab_us-gaap_InterestReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_2a0bc12f-2159-4a66-b0bb-e2f0f2b86659_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_1e8d0a0b-fdaf-4af9-bb2a-c4de8616662e_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_2018d357-c011-41cf-8995-64e2f39052d9_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_8dda3fa8-c6f6-46d7-bc89-600dc6ac078c_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_91d59ae7-0090-4015-88b5-a49a66f7ca10_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_pgen_PrepaidProductAndServiceRevenuesMember_2ce59b89-7e97-41a7-bd5d-a965ca367439_terseLabel_en-US" xlink:label="lab_pgen_PrepaidProductAndServiceRevenuesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid product and service revenues</link:label>
    <link:label id="lab_pgen_PrepaidProductAndServiceRevenuesMember_label_en-US" xlink:label="lab_pgen_PrepaidProductAndServiceRevenuesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Product And Service Revenues [Member]</link:label>
    <link:label id="lab_pgen_PrepaidProductAndServiceRevenuesMember_documentation_en-US" xlink:label="lab_pgen_PrepaidProductAndServiceRevenuesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Product And Service Revenues [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_PrepaidProductAndServiceRevenuesMember" xlink:href="pgen-20220331.xsd#pgen_PrepaidProductAndServiceRevenuesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pgen_PrepaidProductAndServiceRevenuesMember" xlink:to="lab_pgen_PrepaidProductAndServiceRevenuesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_671af3ad-22fd-4093-ad11-db8b30293930_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOperatingActivitiesSegmentAxis_b1eb5408-f7bd-48ef-aa80-fe15cbd24d97_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Activities [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementOperatingActivitiesSegmentAxis_label_en-US" xlink:label="lab_us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Activities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOperatingActivitiesSegmentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:to="lab_us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityAxis_04ebb53a-afef-463b-a20d-b7edfb2b743a_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lender Name [Axis]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lender Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis" xlink:to="lab_us-gaap_LineOfCreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_3279a129-093c-45aa-a664-0ef92faee343_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_32b6fed5-20c5-4eaf-befb-878bd6389a21_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_8207a1cf-6768-4c75-a1af-67491beab05d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_c93bf132-c4c2-4a18-9492-4cd71c8ad23b_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of long-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_01ce2d87-a6ed-4d0d-ab2b-ee74efd97d1e_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementMember_90f04d68-2e1c-4292-96c7-22d468141fb9_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration and licensing agreements</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementMember_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementMember" xlink:to="lab_us-gaap_CollaborativeArrangementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_77d375e2-065f-453b-9d59-fd2dc1d98d91_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, gross</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_pgen_StockIssuedDuringThePeriodSharesAccruedCompensation_a519f1a5-1f04-4692-8833-12797262f5ec_terseLabel_en-US" xlink:label="lab_pgen_StockIssuedDuringThePeriodSharesAccruedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued for accrued compensation (in shares)</link:label>
    <link:label id="lab_pgen_StockIssuedDuringThePeriodSharesAccruedCompensation_label_en-US" xlink:label="lab_pgen_StockIssuedDuringThePeriodSharesAccruedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During The Period, Shares, Accrued Compensation</link:label>
    <link:label id="lab_pgen_StockIssuedDuringThePeriodSharesAccruedCompensation_documentation_en-US" xlink:label="lab_pgen_StockIssuedDuringThePeriodSharesAccruedCompensation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares issued in lieu of cash for accrued compensation.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_StockIssuedDuringThePeriodSharesAccruedCompensation" xlink:href="pgen-20220331.xsd#pgen_StockIssuedDuringThePeriodSharesAccruedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pgen_StockIssuedDuringThePeriodSharesAccruedCompensation" xlink:to="lab_pgen_StockIssuedDuringThePeriodSharesAccruedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryGross_efac9bea-ae3d-4c3b-9a5e-23f4828a8643_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_InventoryGross_label_en-US" xlink:label="lab_us-gaap_InventoryGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryGross" xlink:to="lab_us-gaap_InventoryGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_9bcdfcd5-8ac0-4706-a83f-515e62dae242_terseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_fee37c5c-f115-42e1-99a4-a525d7f53b1d_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_28404466-aa96-4383-ab6a-fa147f837acd_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit facility, current borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Current Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TrademarksMember_aecb9a1d-8e1c-4663-8dc9-8577d8963618_terseLabel_en-US" xlink:label="lab_us-gaap_TrademarksMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks</link:label>
    <link:label id="lab_us-gaap_TrademarksMember_label_en-US" xlink:label="lab_us-gaap_TrademarksMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TrademarksMember" xlink:to="lab_us-gaap_TrademarksMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pgen_NumberofSeatsonGoverningBoardExternallySelected_3d7c209e-1dd0-40d5-bdc6-92dbf6914174_terseLabel_en-US" xlink:label="lab_pgen_NumberofSeatsonGoverningBoardExternallySelected" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total number of seats on the joint venture's governing board, externally selected</link:label>
    <link:label id="lab_pgen_NumberofSeatsonGoverningBoardExternallySelected_label_en-US" xlink:label="lab_pgen_NumberofSeatsonGoverningBoardExternallySelected" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Seats on Governing Board, Externally Selected</link:label>
    <link:label id="lab_pgen_NumberofSeatsonGoverningBoardExternallySelected_documentation_en-US" xlink:label="lab_pgen_NumberofSeatsonGoverningBoardExternallySelected" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The number of seats on the governing board, externally selected.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_NumberofSeatsonGoverningBoardExternallySelected" xlink:href="pgen-20220331.xsd#pgen_NumberofSeatsonGoverningBoardExternallySelected"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pgen_NumberofSeatsonGoverningBoardExternallySelected" xlink:to="lab_pgen_NumberofSeatsonGoverningBoardExternallySelected" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_95fa43b0-59ca-4a6b-8f95-b4f9f209fc6f_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityTable" xlink:to="lab_us-gaap_LineOfCreditFacilityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_f382d85b-8066-4c72-8ef9-9ab3e97a90ef_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) from discontinued operations per share, basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_27e20c94-910d-4ec1-ab44-791c184b0345_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balances at beginning of period (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_37b4a3f6-4561-4db5-98a6-c387276928f9_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balances at period end (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantMember_c3f8a69b-5632-44ad-938d-de1ecbfb4bf8_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants</link:label>
    <link:label id="lab_us-gaap_WarrantMember_label_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantMember" xlink:to="lab_us-gaap_WarrantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pgen_CompensationArrangementWithIndividualAnnualStockOptionGrantGrantDateFairValue_8412eb5d-0e17-406a-a3bd-1a430f0599a4_terseLabel_en-US" xlink:label="lab_pgen_CompensationArrangementWithIndividualAnnualStockOptionGrantGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation arrangement with individual, annual stock option grant, grant date fair value</link:label>
    <link:label id="lab_pgen_CompensationArrangementWithIndividualAnnualStockOptionGrantGrantDateFairValue_label_en-US" xlink:label="lab_pgen_CompensationArrangementWithIndividualAnnualStockOptionGrantGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Arrangement With Individual, Annual Stock Option Grant, Grant Date Fair Value</link:label>
    <link:label id="lab_pgen_CompensationArrangementWithIndividualAnnualStockOptionGrantGrantDateFairValue_documentation_en-US" xlink:label="lab_pgen_CompensationArrangementWithIndividualAnnualStockOptionGrantGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Arrangement With Individual, Annual Stock Option Grant, Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_CompensationArrangementWithIndividualAnnualStockOptionGrantGrantDateFairValue" xlink:href="pgen-20220331.xsd#pgen_CompensationArrangementWithIndividualAnnualStockOptionGrantGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pgen_CompensationArrangementWithIndividualAnnualStockOptionGrantGrantDateFairValue" xlink:to="lab_pgen_CompensationArrangementWithIndividualAnnualStockOptionGrantGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_84de8abb-a145-4f4c-859f-f9da69df0dec_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, net of current portion</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_4d75c95f-aeb5-4e54-95bf-759cb310a237_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, less current portion</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_7ba7b107-9615-45a2-9573-f5aa4030d64b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_4a5b6301-a2b7-4ed7-98bc-49b4c00dd5c0_verboseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation costs</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_ec069926-69ae-4189-8aa7-182f4369a235_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_1deec919-a6de-4a1f-8cf9-e2aba90dd6a6_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable at period end, weighted average remaining contractual period</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_4cdd7620-4c31-4a2d-8e38-ab7f7578ed1b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_41502d12-8a4b-45d7-a76e-c379aa1aeb76_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_45f4b3de-203a-4152-ab44-d88af049a64c_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Loss per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_fabe2bbf-c186-4a19-997e-ede0c06ba47e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Grant Date Fair Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_f1f9e317-fb50-4741-8aea-69b0106c7a27_negatedLabel_en-US" xlink:label="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of premiums on investments, net</link:label>
    <link:label id="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_label_en-US" xlink:label="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accretion (Amortization) of Discounts and Premiums, Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:to="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_dcf68d5a-b144-433a-8fc6-e489158fa28a_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesOther_0b896a8d-c040-4b5d-a234-db1336493dad_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesOther" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowed shares, number issued (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesOther_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesOther" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b569f4ea-6a5e-4871-8435-a23923bd3287_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_02c61e61-9804-4f62-93a7-bfcf6c58cc51_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">End of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5a0b62e8-cb5e-4e68-87e0-a9b09c448653_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents, and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_pgen_EliminationsAndReconcilingItemsMember_76e4fca4-c787-46d2-bc32-8065498b9bb7_terseLabel_en-US" xlink:label="lab_pgen_EliminationsAndReconcilingItemsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Elimination of intersegment revenues</link:label>
    <link:label id="lab_pgen_EliminationsAndReconcilingItemsMember_label_en-US" xlink:label="lab_pgen_EliminationsAndReconcilingItemsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eliminations And Reconciling Items [Member]</link:label>
    <link:label id="lab_pgen_EliminationsAndReconcilingItemsMember_documentation_en-US" xlink:label="lab_pgen_EliminationsAndReconcilingItemsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eliminations And Reconciling Items [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_EliminationsAndReconcilingItemsMember" xlink:href="pgen-20220331.xsd#pgen_EliminationsAndReconcilingItemsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pgen_EliminationsAndReconcilingItemsMember" xlink:to="lab_pgen_EliminationsAndReconcilingItemsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardNameDomain_157e3375-9308-4e34-b95e-e419ea4546f9_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardNameDomain_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_4dda1e35-ed63-45f3-8e7d-ab717b22831f_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_ea386b22-1b05-4ed3-b2bf-cc17e5f52f64_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_5dccdc0e-0967-42f2-b2be-7a76db328367_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Carrying Amount</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_8fd68b3f-985a-4b22-ad94-d1ce659875ea_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_6567aff7-aa7d-4395-a2db-cf384acfdc04_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net [Abstract]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_267dc0d4-ca77-4936-8b2e-9242e78d8f72_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_pgen_StockIssuedDuringPeriodSharesStockOptionsExercisedAndRestrictedStockAwards_bb956159-6522-4a80-ab96-b49de6a3a021_terseLabel_en-US" xlink:label="lab_pgen_StockIssuedDuringPeriodSharesStockOptionsExercisedAndRestrictedStockAwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued upon vesting of restricted stock units and for exercises of stock options (in shares)</link:label>
    <link:label id="lab_pgen_StockIssuedDuringPeriodSharesStockOptionsExercisedAndRestrictedStockAwards_label_en-US" xlink:label="lab_pgen_StockIssuedDuringPeriodSharesStockOptionsExercisedAndRestrictedStockAwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Stock Options Exercised and Restricted Stock Awards</link:label>
    <link:label id="lab_pgen_StockIssuedDuringPeriodSharesStockOptionsExercisedAndRestrictedStockAwards_documentation_en-US" xlink:label="lab_pgen_StockIssuedDuringPeriodSharesStockOptionsExercisedAndRestrictedStockAwards" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares issued during the period related to Restricted Stock Awards and exercises of stock options.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_StockIssuedDuringPeriodSharesStockOptionsExercisedAndRestrictedStockAwards" xlink:href="pgen-20220331.xsd#pgen_StockIssuedDuringPeriodSharesStockOptionsExercisedAndRestrictedStockAwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pgen_StockIssuedDuringPeriodSharesStockOptionsExercisedAndRestrictedStockAwards" xlink:to="lab_pgen_StockIssuedDuringPeriodSharesStockOptionsExercisedAndRestrictedStockAwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_bf0b6dfb-47a0-4eb4-a029-a0b030c456f0_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_85f44ee2-dcaa-4701-be3a-44aed5732ad4_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from discontinued operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_e25fe84d-c889-419e-94cf-c2ff3c064a13_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain" xlink:to="lab_us-gaap_DisposalGroupClassificationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_cc610dd4-aa52-4862-901c-afd55c6ab8a2_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_94ba32db-f504-4176-945f-223aacbf16ba_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_e914bb1b-1f72-4a2a-b39d-3cb6799ec6af_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares outstanding, diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_5e1e0ed2-043e-49ff-a36e-82c0c270ba88_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromCollectionOfNotesReceivable_5cde453c-c390-408f-83cc-4f8ed1b46535_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromCollectionOfNotesReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from repayment of notes receivable</link:label>
    <link:label id="lab_us-gaap_ProceedsFromCollectionOfNotesReceivable_label_en-US" xlink:label="lab_us-gaap_ProceedsFromCollectionOfNotesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Collection of Notes Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollectionOfNotesReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromCollectionOfNotesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromCollectionOfNotesReceivable" xlink:to="lab_us-gaap_ProceedsFromCollectionOfNotesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_ea28f8af-61bc-4386-b18c-4cccc84b7332_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_pgen_ConvertibleDebtPrincipalAmountInitialConversionRate_b3eadbad-4104-4e6d-aec7-9e5ee27d2f1d_terseLabel_en-US" xlink:label="lab_pgen_ConvertibleDebtPrincipalAmountInitialConversionRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal amount used in conversion</link:label>
    <link:label id="lab_pgen_ConvertibleDebtPrincipalAmountInitialConversionRate_label_en-US" xlink:label="lab_pgen_ConvertibleDebtPrincipalAmountInitialConversionRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt Principal Amount Initial Conversion Rate</link:label>
    <link:label id="lab_pgen_ConvertibleDebtPrincipalAmountInitialConversionRate_documentation_en-US" xlink:label="lab_pgen_ConvertibleDebtPrincipalAmountInitialConversionRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount in principal used in the initial conversion rate of the Convertible Notes.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_ConvertibleDebtPrincipalAmountInitialConversionRate" xlink:href="pgen-20220331.xsd#pgen_ConvertibleDebtPrincipalAmountInitialConversionRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pgen_ConvertibleDebtPrincipalAmountInitialConversionRate" xlink:to="lab_pgen_ConvertibleDebtPrincipalAmountInitialConversionRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_9b491906-63e9-4960-a4b5-3d65fba07197_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDomain_0f643c09-7a83-4103-8308-7d5237b07c60_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_70913e2b-b761-4165-b2d7-3d8635752069_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock Option Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_08937c48-9dcd-492e-877d-be2d2bebaedc_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders' Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_bdb13e78-0dd5-44f9-86af-1d840cda6073_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:to="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalCashFlowElementsInvestingActivitiesAbstract_4a6c1bb5-592e-481d-b5d8-7135f07f0738_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalCashFlowElementsInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Cash Flow Elements, Investing Activities [Abstract]</link:label>
    <link:label id="lab_us-gaap_AdditionalCashFlowElementsInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdditionalCashFlowElementsInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Cash Flow Elements, Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalCashFlowElementsInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalCashFlowElementsInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalCashFlowElementsInvestingActivitiesAbstract" xlink:to="lab_us-gaap_AdditionalCashFlowElementsInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_895fd773-54e1-4f81-a517-5c127a18a399_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity component of convertible debt, net of issuance costs and deferred taxes</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LandAndLandImprovements_ed29b175-50bf-4b98-b749-b98cf9230aee_terseLabel_en-US" xlink:label="lab_us-gaap_LandAndLandImprovements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land and land improvements</link:label>
    <link:label id="lab_us-gaap_LandAndLandImprovements_label_en-US" xlink:label="lab_us-gaap_LandAndLandImprovements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land and Land Improvements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandAndLandImprovements" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LandAndLandImprovements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LandAndLandImprovements" xlink:to="lab_us-gaap_LandAndLandImprovements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_a1208618-ccd9-4b0f-85c6-394f69ce87dd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Net Loss per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_ceaebc5e-d171-43a3-9c6c-938b8030fba9_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_91dbbe68-9f48-4169-a551-13a258bd2d48_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Expense, Net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount_5e50fead-9cb9-4d95-a942-5976db3dd9a8_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum risk of loss related to the identified VIEs</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount" xlink:to="lab_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_8c690a56-a539-4a57-9db6-f9388f4fc01f_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d8c59832-7716-4414-b661-0327432f618e_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_ed9d7127-ad51-4609-9b1b-93fc47f9b1b1_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_54df2bb0-d884-4dd2-81be-e1a8f08f7533_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_631fe07f-b69a-4604-a9cb-84e3be03fcd4_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:to="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e703afc6-54cc-4a55-ac2f-92d53d1c0fbb_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_e2d1c92d-4684-4a1b-b8ff-c8c20fe9006e_negatedLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Accumulated depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_pgen_NumberOfReportingUnitsImpaired_80e6cd0d-b540-492d-bdde-0773fdf2042a_terseLabel_en-US" xlink:label="lab_pgen_NumberOfReportingUnitsImpaired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reporting units impaired</link:label>
    <link:label id="lab_pgen_NumberOfReportingUnitsImpaired_label_en-US" xlink:label="lab_pgen_NumberOfReportingUnitsImpaired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Reporting Units Impaired</link:label>
    <link:label id="lab_pgen_NumberOfReportingUnitsImpaired_documentation_en-US" xlink:label="lab_pgen_NumberOfReportingUnitsImpaired" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Reporting Units Impaired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_NumberOfReportingUnitsImpaired" xlink:href="pgen-20220331.xsd#pgen_NumberOfReportingUnitsImpaired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pgen_NumberOfReportingUnitsImpaired" xlink:to="lab_pgen_NumberOfReportingUnitsImpaired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_8a4cc85e-f1f2-4247-b638-ea4d61f0dd76_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_5ceae38a-f7d4-4d4f-aaab-80b65412c092_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_a9b334d5-3b2b-4d71-bc0d-6ea4075d27a3_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_3c4687f4-d38e-4f5f-a93a-fdc8e078fc67_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDueFromRelatedPartiesCurrent_9cbf0e7e-0a7f-44ac-b463-2173cd17c3e3_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDueFromRelatedPartiesCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related parties</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDueFromRelatedPartiesCurrent_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDueFromRelatedPartiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Due from Related Parties, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDueFromRelatedPartiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDueFromRelatedPartiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDueFromRelatedPartiesCurrent" xlink:to="lab_us-gaap_IncreaseDecreaseInDueFromRelatedPartiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_574f4539-1f62-4fd6-b503-d1c9bcfb53e4_verboseLabel_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eliminations</link:label>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_7bbfc8a1-299a-42d5-a1c2-330ebdd258fc_terseLabel_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment revenues</link:label>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_label_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment Eliminations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntersegmentEliminationMember" xlink:to="lab_us-gaap_IntersegmentEliminationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pgen_PercentageOfRevenueAttributableToCustomer_2eeab532-16d3-4d9d-9440-e3187c425283_terseLabel_en-US" xlink:label="lab_pgen_PercentageOfRevenueAttributableToCustomer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of revenue attributable to customer</link:label>
    <link:label id="lab_pgen_PercentageOfRevenueAttributableToCustomer_label_en-US" xlink:label="lab_pgen_PercentageOfRevenueAttributableToCustomer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Revenue Attributable To Customer</link:label>
    <link:label id="lab_pgen_PercentageOfRevenueAttributableToCustomer_documentation_en-US" xlink:label="lab_pgen_PercentageOfRevenueAttributableToCustomer" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Revenue Attributable To Customer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_PercentageOfRevenueAttributableToCustomer" xlink:href="pgen-20220331.xsd#pgen_PercentageOfRevenueAttributableToCustomer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pgen_PercentageOfRevenueAttributableToCustomer" xlink:to="lab_pgen_PercentageOfRevenueAttributableToCustomer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_9c30ae88-60d9-4807-82cb-ac154680b4d3_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit facility, maximum borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_1e0835a0-613a-4851-b522-8b1d49b125ca_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_b43fb7c0-825c-42f2-8947-bc97eb158c3f_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_de1df04d-38f6-4ad5-9518-9ad2ac05aa04_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_1588bca9-67fa-489c-804d-b79670cb43bb_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_b4fa86b8-ef16-4a2a-8cf9-bfb3e90e7ddd_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible notes, unamortized discount and issuance costs</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForLegalSettlements_50e1c445-389f-4972-887e-344e66f8032e_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForLegalSettlements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for civil money penalty</link:label>
    <link:label id="lab_us-gaap_PaymentsForLegalSettlements_label_en-US" xlink:label="lab_us-gaap_PaymentsForLegalSettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Legal Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLegalSettlements" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForLegalSettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForLegalSettlements" xlink:to="lab_us-gaap_PaymentsForLegalSettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_32bc084d-e62b-44d1-ad1e-94bee6ae8250_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:to="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingsAndImprovementsGross_2b7152e1-7e5c-4a12-820d-d90992c82625_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingsAndImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings and building improvements</link:label>
    <link:label id="lab_us-gaap_BuildingsAndImprovementsGross_label_en-US" xlink:label="lab_us-gaap_BuildingsAndImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings and Improvements, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingsAndImprovementsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingsAndImprovementsGross" xlink:to="lab_us-gaap_BuildingsAndImprovementsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_6b9e460e-6f7c-4ce5-9c6a-08256dff792b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_8e041f66-35d1-4eff-a449-7ee41b586382_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_30cdc4d6-cc42-43c7-b77a-23c0843eab80_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_pgen_LongLivedAssetsIncludingPropertyPlantandEquipmentandRightOfUseAssets_9e89fbc9-6a71-4bf2-869f-8b1a64e920e8_verboseLabel_en-US" xlink:label="lab_pgen_LongLivedAssetsIncludingPropertyPlantandEquipmentandRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-lived assets</link:label>
    <link:label id="lab_pgen_LongLivedAssetsIncludingPropertyPlantandEquipmentandRightOfUseAssets_label_en-US" xlink:label="lab_pgen_LongLivedAssetsIncludingPropertyPlantandEquipmentandRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Assets, Including Property, Plant, and Equipment and Right Of Use Assets</link:label>
    <link:label id="lab_pgen_LongLivedAssetsIncludingPropertyPlantandEquipmentandRightOfUseAssets_documentation_en-US" xlink:label="lab_pgen_LongLivedAssetsIncludingPropertyPlantandEquipmentandRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Assets, Including Property, Plant, and Equipment and Right Of Use Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_LongLivedAssetsIncludingPropertyPlantandEquipmentandRightOfUseAssets" xlink:href="pgen-20220331.xsd#pgen_LongLivedAssetsIncludingPropertyPlantandEquipmentandRightOfUseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pgen_LongLivedAssetsIncludingPropertyPlantandEquipmentandRightOfUseAssets" xlink:to="lab_pgen_LongLivedAssetsIncludingPropertyPlantandEquipmentandRightOfUseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_4a1f2674-e79e-470f-8515-5a525866fc6b_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recently Issued and Adopted Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent_49afc5fa-c9d4-4d48-a264-4b9a10d6ebbb_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related party payables</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Due to Related Parties, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent" xlink:to="lab_us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_3c1b6dbc-aad3-492a-a1af-8ab0c8febda6_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherReceivables_bc7ef69a-2961-432f-9032-9087f7ea4ae5_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherReceivables" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherReceivables_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherReceivables" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_43e3b06f-920c-47f0-8856-1d5ff357391a_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_b696afe3-0466-4013-8126-140ee0c53bc8_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before income taxes</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:to="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_5388a46c-d07e-4a53-af6e-dc76d32d18e6_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_55ab92a2-f05d-4c40-80a1-2be525f1a149_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_89744516-8050-4da5-bba2-221c9d384aa5_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_7f0bc7a3-837b-4868-9bc4-3e5a9d0cc88b_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressGross_f3ed8695-3a64-4879-9732-f1cda9f18639_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction and other assets in progress</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressGross_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressGross" xlink:to="lab_us-gaap_ConstructionInProgressGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_74f16ef7-cbd2-4fea-bff4-f473cf526e35_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from continuing operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_pgen_CostOfProductsMember_f87d4aa8-e9f3-4b83-813d-faf96b87a0fa_terseLabel_en-US" xlink:label="lab_pgen_CostOfProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of products</link:label>
    <link:label id="lab_pgen_CostOfProductsMember_label_en-US" xlink:label="lab_pgen_CostOfProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost Of Products [Member]</link:label>
    <link:label id="lab_pgen_CostOfProductsMember_documentation_en-US" xlink:label="lab_pgen_CostOfProductsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost Of Products [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_CostOfProductsMember" xlink:href="pgen-20220331.xsd#pgen_CostOfProductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pgen_CostOfProductsMember" xlink:to="lab_pgen_CostOfProductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards_03291627-7c0d-4a57-86de-b8e275f86426_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets, capital loss carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Capital Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsCapitalLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_e8db354e-afd1-47f7-91e7-358be01ed671_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Changes in Carrying Amount of Goodwill</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_38143981-7b03-47b3-86d3-83c1c26569be_terseLabel_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_label_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain" xlink:to="lab_srt_ScenarioUnspecifiedDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_50b59797-4f58-4a4d-9535-cd0061abc8ee_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_9505d8be-ab50-49f3-aa01-c2783ebdc575_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_pgen_SharesIssuedDuringPeriodValueIssuedForServices_4dc77369-b7ff-423a-9717-bc3be97e083e_terseLabel_en-US" xlink:label="lab_pgen_SharesIssuedDuringPeriodValueIssuedForServices" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued as payment for services</link:label>
    <link:label id="lab_pgen_SharesIssuedDuringPeriodValueIssuedForServices_label_en-US" xlink:label="lab_pgen_SharesIssuedDuringPeriodValueIssuedForServices" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued During Period, Value, Issued For Services</link:label>
    <link:label id="lab_pgen_SharesIssuedDuringPeriodValueIssuedForServices_documentation_en-US" xlink:label="lab_pgen_SharesIssuedDuringPeriodValueIssuedForServices" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued During Period, Value, Issued For Services . Stock Compensation Expense Is Related To Both Options And RSU's.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_SharesIssuedDuringPeriodValueIssuedForServices" xlink:href="pgen-20220331.xsd#pgen_SharesIssuedDuringPeriodValueIssuedForServices"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pgen_SharesIssuedDuringPeriodValueIssuedForServices" xlink:to="lab_pgen_SharesIssuedDuringPeriodValueIssuedForServices" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValueOutstanding_411f94c7-6a02-4c29-95f5-1dad42aa6379_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValueOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, no par value, 400,000,000 shares authorized as of March&#160;31, 2022 and December&#160;31, 2021; 207,693,277 shares and 206,739,874 shares issued and outstanding as of March&#160;31, 2022 and December&#160;31, 2021, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValueOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockValueOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValueOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValueOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValueOutstanding" xlink:to="lab_us-gaap_CommonStockValueOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_6197302e-d11e-4706-b06b-c22084784f47_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease costs</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_a2b8238e-b212-46e0-8871-009155dbb3fb_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryLineItems_f16195f0-547f-498c-a0a6-f76d14a99df7_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory [Line Items]</link:label>
    <link:label id="lab_us-gaap_InventoryLineItems_label_en-US" xlink:label="lab_us-gaap_InventoryLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryLineItems" xlink:to="lab_us-gaap_InventoryLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_pgen_OtherMember_4815675f-ef38-4d15-816f-8d61ee153e90_terseLabel_en-US" xlink:label="lab_pgen_OtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_pgen_OtherMember_label_en-US" xlink:label="lab_pgen_OtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other [Member]</link:label>
    <link:label id="lab_pgen_OtherMember_documentation_en-US" xlink:label="lab_pgen_OtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_OtherMember" xlink:href="pgen-20220331.xsd#pgen_OtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pgen_OtherMember" xlink:to="lab_pgen_OtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_85f00254-50bc-4d7b-a372-a32d5513a351_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_7f110188-17d5-4c14-ad1a-5d4c149fe7a5_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_56569525-b308-4c69-97c2-661d78a0c116_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_da3abb61-475d-46cb-9a69-a8ff3425456d_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax benefit from continuing operations</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPayment_d705e1b8-b9d1-4237-ad8b-ecd980eb390a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, periodic payment</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPayment_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPayment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentPeriodicPayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentPeriodicPayment" xlink:to="lab_us-gaap_DebtInstrumentPeriodicPayment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate202006Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate202006Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2020-06 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate202006Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate202006Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate202006Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate202006Member" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>pgen-20220331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:ee4b2abd-b2ae-467e-99f1-1b489525c45b,g:388a974a-f6e3-4fd9-acf5-6762aafe5cec-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.dna.com/role/CoverPage" xlink:type="simple" xlink:href="pgen-20220331.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.dna.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_568ceb66-25ec-4fae-9363-dd7260c71289" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_7447a2a8-02bc-443f-b44f-819eb4d681c2" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_568ceb66-25ec-4fae-9363-dd7260c71289" xlink:to="loc_dei_DocumentType_7447a2a8-02bc-443f-b44f-819eb4d681c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_db42f01a-5e6e-4be3-b99c-5345ce6372e9" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_568ceb66-25ec-4fae-9363-dd7260c71289" xlink:to="loc_dei_DocumentQuarterlyReport_db42f01a-5e6e-4be3-b99c-5345ce6372e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_262b9da0-3d4b-46ad-a210-2a26118c712f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_568ceb66-25ec-4fae-9363-dd7260c71289" xlink:to="loc_dei_DocumentPeriodEndDate_262b9da0-3d4b-46ad-a210-2a26118c712f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_5451d234-0ba5-4e97-9a14-ab3235802c05" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_568ceb66-25ec-4fae-9363-dd7260c71289" xlink:to="loc_dei_DocumentTransitionReport_5451d234-0ba5-4e97-9a14-ab3235802c05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_5952a2e6-db62-43e9-a204-88a715e14013" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_568ceb66-25ec-4fae-9363-dd7260c71289" xlink:to="loc_dei_EntityFileNumber_5952a2e6-db62-43e9-a204-88a715e14013" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_f4e98b4a-74b3-403f-9314-2714b9d4fd18" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_568ceb66-25ec-4fae-9363-dd7260c71289" xlink:to="loc_dei_EntityRegistrantName_f4e98b4a-74b3-403f-9314-2714b9d4fd18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_427dbae4-5dd5-420b-a5b6-a287175c3596" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_568ceb66-25ec-4fae-9363-dd7260c71289" xlink:to="loc_dei_EntityIncorporationStateCountryCode_427dbae4-5dd5-420b-a5b6-a287175c3596" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_763def75-baaa-4215-950d-1a911ada4fc2" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_568ceb66-25ec-4fae-9363-dd7260c71289" xlink:to="loc_dei_EntityTaxIdentificationNumber_763def75-baaa-4215-950d-1a911ada4fc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_669be18d-0cde-4737-8a03-f99f4ac9d241" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_568ceb66-25ec-4fae-9363-dd7260c71289" xlink:to="loc_dei_EntityAddressAddressLine1_669be18d-0cde-4737-8a03-f99f4ac9d241" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_fba41126-9bf8-4d49-b3e5-c741b479767f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_568ceb66-25ec-4fae-9363-dd7260c71289" xlink:to="loc_dei_EntityAddressCityOrTown_fba41126-9bf8-4d49-b3e5-c741b479767f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_4ecdf7bc-45c9-4679-87a8-b54f4dfebfc1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_568ceb66-25ec-4fae-9363-dd7260c71289" xlink:to="loc_dei_EntityAddressStateOrProvince_4ecdf7bc-45c9-4679-87a8-b54f4dfebfc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_4f0db7b8-ec24-49b9-835c-4638f82faecc" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_568ceb66-25ec-4fae-9363-dd7260c71289" xlink:to="loc_dei_EntityAddressPostalZipCode_4f0db7b8-ec24-49b9-835c-4638f82faecc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_d90da8a8-37be-433e-9ef7-f18518286519" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_568ceb66-25ec-4fae-9363-dd7260c71289" xlink:to="loc_dei_CityAreaCode_d90da8a8-37be-433e-9ef7-f18518286519" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_b978cd73-2997-4afd-a50e-c99ec81284c6" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_568ceb66-25ec-4fae-9363-dd7260c71289" xlink:to="loc_dei_LocalPhoneNumber_b978cd73-2997-4afd-a50e-c99ec81284c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_4237f389-32d0-4b18-b430-3d5cd9f2e678" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_568ceb66-25ec-4fae-9363-dd7260c71289" xlink:to="loc_dei_Security12bTitle_4237f389-32d0-4b18-b430-3d5cd9f2e678" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_a4ab75ec-bee7-494b-a83a-4ed28fa0af19" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_568ceb66-25ec-4fae-9363-dd7260c71289" xlink:to="loc_dei_TradingSymbol_a4ab75ec-bee7-494b-a83a-4ed28fa0af19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_c2479a26-63a8-43a8-b9cc-9022d57314f1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_568ceb66-25ec-4fae-9363-dd7260c71289" xlink:to="loc_dei_SecurityExchangeName_c2479a26-63a8-43a8-b9cc-9022d57314f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_716b496e-a0ed-4698-8a39-f2d873886a14" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_568ceb66-25ec-4fae-9363-dd7260c71289" xlink:to="loc_dei_EntityCurrentReportingStatus_716b496e-a0ed-4698-8a39-f2d873886a14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_60e454cf-ea76-4aa5-8a1d-68be5ca51855" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_568ceb66-25ec-4fae-9363-dd7260c71289" xlink:to="loc_dei_EntityInteractiveDataCurrent_60e454cf-ea76-4aa5-8a1d-68be5ca51855" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_2b228cec-191a-4786-971e-fd1e90e54616" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_568ceb66-25ec-4fae-9363-dd7260c71289" xlink:to="loc_dei_EntityFilerCategory_2b228cec-191a-4786-971e-fd1e90e54616" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_1c9035d3-2412-4580-ab07-0dd1002824de" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_568ceb66-25ec-4fae-9363-dd7260c71289" xlink:to="loc_dei_EntitySmallBusiness_1c9035d3-2412-4580-ab07-0dd1002824de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_35ec72d4-4f88-4807-8812-9b62079f946b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_568ceb66-25ec-4fae-9363-dd7260c71289" xlink:to="loc_dei_EntityEmergingGrowthCompany_35ec72d4-4f88-4807-8812-9b62079f946b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_418f0f9c-b161-4886-8acf-5498543fd1c9" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_568ceb66-25ec-4fae-9363-dd7260c71289" xlink:to="loc_dei_EntityShellCompany_418f0f9c-b161-4886-8acf-5498543fd1c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_35c38af9-db37-46de-bf3c-bd00bf760e74" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_568ceb66-25ec-4fae-9363-dd7260c71289" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_35c38af9-db37-46de-bf3c-bd00bf760e74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_bc5c61f9-fc2b-409b-b7d7-bd1f9b5de6c2" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_568ceb66-25ec-4fae-9363-dd7260c71289" xlink:to="loc_dei_AmendmentFlag_bc5c61f9-fc2b-409b-b7d7-bd1f9b5de6c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_58609fb5-8335-4479-ad7e-6f684b631785" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_568ceb66-25ec-4fae-9363-dd7260c71289" xlink:to="loc_dei_DocumentFiscalYearFocus_58609fb5-8335-4479-ad7e-6f684b631785" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_0e5e7096-7f31-48c5-8475-5e1a059bd8bb" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_568ceb66-25ec-4fae-9363-dd7260c71289" xlink:to="loc_dei_DocumentFiscalPeriodFocus_0e5e7096-7f31-48c5-8475-5e1a059bd8bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_b8a8c827-0252-4466-8a78-ec41f461a011" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_568ceb66-25ec-4fae-9363-dd7260c71289" xlink:to="loc_dei_EntityCentralIndexKey_b8a8c827-0252-4466-8a78-ec41f461a011" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_66e81653-266a-41f9-94f9-e88e6b01dce7" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_568ceb66-25ec-4fae-9363-dd7260c71289" xlink:to="loc_dei_CurrentFiscalYearEndDate_66e81653-266a-41f9-94f9-e88e6b01dce7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dna.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="pgen-20220331.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.dna.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_11986b40-70f2-404a-a269-1f57cd141eab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_04d49c11-3375-4aa5-a354-10598599a365" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_11986b40-70f2-404a-a269-1f57cd141eab" xlink:to="loc_us-gaap_AssetsAbstract_04d49c11-3375-4aa5-a354-10598599a365" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_93dc135d-8bd6-493b-b8bb-d142edb3651a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_04d49c11-3375-4aa5-a354-10598599a365" xlink:to="loc_us-gaap_AssetsCurrentAbstract_93dc135d-8bd6-493b-b8bb-d142edb3651a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_3a5c3290-dc3c-4e2a-94ca-1ffdbcdccfe9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_93dc135d-8bd6-493b-b8bb-d142edb3651a" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_3a5c3290-dc3c-4e2a-94ca-1ffdbcdccfe9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_4e939629-e9ca-42be-bf3e-6011c384b733" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_93dc135d-8bd6-493b-b8bb-d142edb3651a" xlink:to="loc_us-gaap_ShortTermInvestments_4e939629-e9ca-42be-bf3e-6011c384b733" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrentAbstract_966854ec-1306-471c-bf5f-9cc276e35460" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesNetCurrentAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_93dc135d-8bd6-493b-b8bb-d142edb3651a" xlink:to="loc_us-gaap_ReceivablesNetCurrentAbstract_966854ec-1306-471c-bf5f-9cc276e35460" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_f89315e2-2adf-4a47-81d8-cdeb634a20de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesNetCurrentAbstract_966854ec-1306-471c-bf5f-9cc276e35460" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_f89315e2-2adf-4a47-81d8-cdeb634a20de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueFromRelatedPartiesCurrent_657c39b5-3a91-4df1-bde1-b5b186ab45a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueFromRelatedPartiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesNetCurrentAbstract_966854ec-1306-471c-bf5f-9cc276e35460" xlink:to="loc_us-gaap_DueFromRelatedPartiesCurrent_657c39b5-3a91-4df1-bde1-b5b186ab45a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_d73e381a-66f9-42b7-a555-a79038eec17e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesNetCurrentAbstract_966854ec-1306-471c-bf5f-9cc276e35460" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_d73e381a-66f9-42b7-a555-a79038eec17e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryGross_4eb5f0c7-8071-4570-a51b-b08544e96954" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryGross"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_93dc135d-8bd6-493b-b8bb-d142edb3651a" xlink:to="loc_us-gaap_InventoryGross_4eb5f0c7-8071-4570-a51b-b08544e96954" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_ab88c55a-2e9f-4216-a64f-78e11d241114" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_93dc135d-8bd6-493b-b8bb-d142edb3651a" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_ab88c55a-2e9f-4216-a64f-78e11d241114" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_4b5fda16-fa46-4f9d-b01c-5a7f2a56a7f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_93dc135d-8bd6-493b-b8bb-d142edb3651a" xlink:to="loc_us-gaap_AssetsCurrent_4b5fda16-fa46-4f9d-b01c-5a7f2a56a7f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_8a7ce228-4b6d-4197-9c17-db1b3d94e28f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_04d49c11-3375-4aa5-a354-10598599a365" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_8a7ce228-4b6d-4197-9c17-db1b3d94e28f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_817e8157-ffa5-4af5-a998-8ea917c51658" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_04d49c11-3375-4aa5-a354-10598599a365" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_817e8157-ffa5-4af5-a998-8ea917c51658" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_85d68f18-e6f0-4e9d-9fd1-1e4d6439f2ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_04d49c11-3375-4aa5-a354-10598599a365" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_85d68f18-e6f0-4e9d-9fd1-1e4d6439f2ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_ee736ec4-9e99-4d72-8130-5ca056554e49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_04d49c11-3375-4aa5-a354-10598599a365" xlink:to="loc_us-gaap_Goodwill_ee736ec4-9e99-4d72-8130-5ca056554e49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_ca203c51-5aa7-469a-b8a6-06e0f61e7d7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_04d49c11-3375-4aa5-a354-10598599a365" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_ca203c51-5aa7-469a-b8a6-06e0f61e7d7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_e18acb07-39ba-4d3e-8af4-b2359b4c1c16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_04d49c11-3375-4aa5-a354-10598599a365" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_e18acb07-39ba-4d3e-8af4-b2359b4c1c16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_dbc37906-9fba-4441-8045-0cbf622a185e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_04d49c11-3375-4aa5-a354-10598599a365" xlink:to="loc_us-gaap_Assets_dbc37906-9fba-4441-8045-0cbf622a185e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_fbef8495-d651-4915-80bf-f4ce54aeacb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_11986b40-70f2-404a-a269-1f57cd141eab" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_fbef8495-d651-4915-80bf-f4ce54aeacb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_c6e66383-0292-47cf-abaf-996f6cf40500" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_fbef8495-d651-4915-80bf-f4ce54aeacb2" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_c6e66383-0292-47cf-abaf-996f6cf40500" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_a8e55f9c-228d-4d9a-9d12-781121e6d4fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_c6e66383-0292-47cf-abaf-996f6cf40500" xlink:to="loc_us-gaap_AccountsPayableCurrent_a8e55f9c-228d-4d9a-9d12-781121e6d4fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_a37af0b9-72b7-4932-8e72-da8d97d6e9d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_c6e66383-0292-47cf-abaf-996f6cf40500" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_a37af0b9-72b7-4932-8e72-da8d97d6e9d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_95d2b2bd-edd8-4f7e-a4b6-a5ccbd20491e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_c6e66383-0292-47cf-abaf-996f6cf40500" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_95d2b2bd-edd8-4f7e-a4b6-a5ccbd20491e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_cb621824-e692-4650-a752-c7be666e5673" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_c6e66383-0292-47cf-abaf-996f6cf40500" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_cb621824-e692-4650-a752-c7be666e5673" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_7b63eddb-f5c6-4a3c-8ae6-0dec17acfb16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_c6e66383-0292-47cf-abaf-996f6cf40500" xlink:to="loc_us-gaap_LongTermDebtCurrent_7b63eddb-f5c6-4a3c-8ae6-0dec17acfb16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_38316508-2bc1-4cba-80e7-1d6026f9d957" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_c6e66383-0292-47cf-abaf-996f6cf40500" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_38316508-2bc1-4cba-80e7-1d6026f9d957" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToRelatedPartiesCurrent_428f973b-ad46-4663-86ec-59d80c4422ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_c6e66383-0292-47cf-abaf-996f6cf40500" xlink:to="loc_us-gaap_DueToRelatedPartiesCurrent_428f973b-ad46-4663-86ec-59d80c4422ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_358aede9-c3c2-4de9-8477-ac6c9deb0c71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_c6e66383-0292-47cf-abaf-996f6cf40500" xlink:to="loc_us-gaap_LiabilitiesCurrent_358aede9-c3c2-4de9-8477-ac6c9deb0c71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_6a051c33-15ad-4009-aead-ac0fe7af64bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_fbef8495-d651-4915-80bf-f4ce54aeacb2" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_6a051c33-15ad-4009-aead-ac0fe7af64bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_3c2fa75c-a1e5-4f3e-b8a1-4ed3fc94e5a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_fbef8495-d651-4915-80bf-f4ce54aeacb2" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_3c2fa75c-a1e5-4f3e-b8a1-4ed3fc94e5a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_4c99e4a7-360f-43c8-8e13-6bd143776e37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_fbef8495-d651-4915-80bf-f4ce54aeacb2" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_4c99e4a7-360f-43c8-8e13-6bd143776e37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_717aa073-76e7-4d08-b462-f5ec355e5b77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_fbef8495-d651-4915-80bf-f4ce54aeacb2" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_717aa073-76e7-4d08-b462-f5ec355e5b77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_4bd7c301-b92a-469c-b850-efe88651fcc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_fbef8495-d651-4915-80bf-f4ce54aeacb2" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_4bd7c301-b92a-469c-b850-efe88651fcc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_198c5247-6966-473d-8108-9684c4f0795f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_fbef8495-d651-4915-80bf-f4ce54aeacb2" xlink:to="loc_us-gaap_Liabilities_198c5247-6966-473d-8108-9684c4f0795f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_1ee323d4-a040-423c-8443-91703f987297" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_fbef8495-d651-4915-80bf-f4ce54aeacb2" xlink:to="loc_us-gaap_CommitmentsAndContingencies_1ee323d4-a040-423c-8443-91703f987297" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_cf5dfe84-d2ac-466d-855c-438d01d92a19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_fbef8495-d651-4915-80bf-f4ce54aeacb2" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_cf5dfe84-d2ac-466d-855c-438d01d92a19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValueOutstanding_b179e4c6-72a6-4514-ae63-524fdeb6025b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValueOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_cf5dfe84-d2ac-466d-855c-438d01d92a19" xlink:to="loc_us-gaap_CommonStockValueOutstanding_b179e4c6-72a6-4514-ae63-524fdeb6025b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_6071af41-f27e-4138-b8bc-ac76e13fbdd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_cf5dfe84-d2ac-466d-855c-438d01d92a19" xlink:to="loc_us-gaap_AdditionalPaidInCapital_6071af41-f27e-4138-b8bc-ac76e13fbdd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_8764d794-76d3-46c5-abe8-890e8fdf0f3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_cf5dfe84-d2ac-466d-855c-438d01d92a19" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_8764d794-76d3-46c5-abe8-890e8fdf0f3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_6a301db7-7f2f-492a-93cf-0af4b133cc70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_cf5dfe84-d2ac-466d-855c-438d01d92a19" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_6a301db7-7f2f-492a-93cf-0af4b133cc70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_a847e578-ea58-4152-a275-03be4f00c39b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_cf5dfe84-d2ac-466d-855c-438d01d92a19" xlink:to="loc_us-gaap_StockholdersEquity_a847e578-ea58-4152-a275-03be4f00c39b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_3d10331b-d303-4b07-b141-45e950832a6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_fbef8495-d651-4915-80bf-f4ce54aeacb2" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_3d10331b-d303-4b07-b141-45e950832a6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dna.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="pgen-20220331.xsd#CondensedConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://www.dna.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_9b02d127-37a3-4dcb-895a-e876cc2bebb3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_cb381c54-1980-48a8-b75f-7fead85ef594" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_9b02d127-37a3-4dcb-895a-e876cc2bebb3" xlink:to="loc_us-gaap_StatementTable_cb381c54-1980-48a8-b75f-7fead85ef594" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_adbc7f63-d4bf-43bf-b187-655199fc8cb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_cb381c54-1980-48a8-b75f-7fead85ef594" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_adbc7f63-d4bf-43bf-b187-655199fc8cb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_c5090211-be1b-4c50-89be-1dfa0ca96ba2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_adbc7f63-d4bf-43bf-b187-655199fc8cb9" xlink:to="loc_us-gaap_RelatedPartyDomain_c5090211-be1b-4c50-89be-1dfa0ca96ba2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_RelatedPartiesAggregatedMember_1e23950a-1970-4b8b-8dbf-fefd15b6809c" xlink:href="pgen-20220331.xsd#pgen_RelatedPartiesAggregatedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_c5090211-be1b-4c50-89be-1dfa0ca96ba2" xlink:to="loc_pgen_RelatedPartiesAggregatedMember_1e23950a-1970-4b8b-8dbf-fefd15b6809c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_d27ed768-4588-40eb-b002-33a90908e0c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_cb381c54-1980-48a8-b75f-7fead85ef594" xlink:to="loc_us-gaap_StatementLineItems_d27ed768-4588-40eb-b002-33a90908e0c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_ac25d33a-719c-4163-8ee1-463423df3d40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d27ed768-4588-40eb-b002-33a90908e0c3" xlink:to="loc_us-gaap_AssetsAbstract_ac25d33a-719c-4163-8ee1-463423df3d40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_0ba49d46-9b32-4ffc-abab-77adb78bf867" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ac25d33a-719c-4163-8ee1-463423df3d40" xlink:to="loc_us-gaap_AssetsCurrentAbstract_0ba49d46-9b32-4ffc-abab-77adb78bf867" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_b30451ba-70cd-47de-af5c-c142cddb747b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_0ba49d46-9b32-4ffc-abab-77adb78bf867" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_b30451ba-70cd-47de-af5c-c142cddb747b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_RelatedPartyReceivableAllowanceforCreditLossCurrent_9b563db0-148b-4a96-b6e5-834f47c7e2d8" xlink:href="pgen-20220331.xsd#pgen_RelatedPartyReceivableAllowanceforCreditLossCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_0ba49d46-9b32-4ffc-abab-77adb78bf867" xlink:to="loc_pgen_RelatedPartyReceivableAllowanceforCreditLossCurrent_9b563db0-148b-4a96-b6e5-834f47c7e2d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_f1b3e57e-db5b-412a-93dc-855f09771d6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d27ed768-4588-40eb-b002-33a90908e0c3" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_f1b3e57e-db5b-412a-93dc-855f09771d6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_0bfb1374-edfe-4cdb-a3b8-266fb04716a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_f1b3e57e-db5b-412a-93dc-855f09771d6d" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_0bfb1374-edfe-4cdb-a3b8-266fb04716a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_a6030d9b-c00d-4cfe-b06b-8919760652d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_f1b3e57e-db5b-412a-93dc-855f09771d6d" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_a6030d9b-c00d-4cfe-b06b-8919760652d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_e749bff8-7752-43a3-a1bf-1f3aaad78c58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d27ed768-4588-40eb-b002-33a90908e0c3" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_e749bff8-7752-43a3-a1bf-1f3aaad78c58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockNoParValue_896a23ca-7148-4351-8f71-b78fa3560f3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockNoParValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_e749bff8-7752-43a3-a1bf-1f3aaad78c58" xlink:to="loc_us-gaap_CommonStockNoParValue_896a23ca-7148-4351-8f71-b78fa3560f3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_3b241619-0d3d-49d0-935a-0c5275c83840" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_e749bff8-7752-43a3-a1bf-1f3aaad78c58" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_3b241619-0d3d-49d0-935a-0c5275c83840" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_428f397a-d774-4560-abaf-8ff0415b822a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_e749bff8-7752-43a3-a1bf-1f3aaad78c58" xlink:to="loc_us-gaap_CommonStockSharesIssued_428f397a-d774-4560-abaf-8ff0415b822a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_ecaa8349-bc6b-4aad-80c3-85751f635aa0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_e749bff8-7752-43a3-a1bf-1f3aaad78c58" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_ecaa8349-bc6b-4aad-80c3-85751f635aa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dna.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="pgen-20220331.xsd#CondensedConsolidatedStatementsofOperations"/>
  <link:presentationLink xlink:role="http://www.dna.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_958f2ccf-6485-43b6-8fcb-f59fd9920293" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_b107718b-435a-4286-ad0b-c749f91bc746" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_958f2ccf-6485-43b6-8fcb-f59fd9920293" xlink:to="loc_us-gaap_StatementTable_b107718b-435a-4286-ad0b-c749f91bc746" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_9eba1cc2-13db-4c4c-afaa-c746dae4836e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOperatingActivitiesSegmentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_b107718b-435a-4286-ad0b-c749f91bc746" xlink:to="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_9eba1cc2-13db-4c4c-afaa-c746dae4836e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentOperatingActivitiesDomain_e15a619c-0079-429b-9c2a-711bc70cc9a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentOperatingActivitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_9eba1cc2-13db-4c4c-afaa-c746dae4836e" xlink:to="loc_us-gaap_SegmentOperatingActivitiesDomain_e15a619c-0079-429b-9c2a-711bc70cc9a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentContinuingOperationsMember_35d25438-ce48-4127-8fd8-9ca187ceaf2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentContinuingOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentOperatingActivitiesDomain_e15a619c-0079-429b-9c2a-711bc70cc9a8" xlink:to="loc_us-gaap_SegmentContinuingOperationsMember_35d25438-ce48-4127-8fd8-9ca187ceaf2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_7c2ab6dc-c4a3-4e00-a1f8-4024d8172f8d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_b107718b-435a-4286-ad0b-c749f91bc746" xlink:to="loc_srt_ProductOrServiceAxis_7c2ab6dc-c4a3-4e00-a1f8-4024d8172f8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_97951bc9-f5b8-44be-a7d0-d2c10165853c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_7c2ab6dc-c4a3-4e00-a1f8-4024d8172f8d" xlink:to="loc_srt_ProductsAndServicesDomain_97951bc9-f5b8-44be-a7d0-d2c10165853c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_ec3a00d1-ab9d-4b50-99ab-99f3a9f8b76a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_97951bc9-f5b8-44be-a7d0-d2c10165853c" xlink:to="loc_us-gaap_ProductMember_ec3a00d1-ab9d-4b50-99ab-99f3a9f8b76a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_10b98b47-30bc-452a-af43-9517b38010f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ServiceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_97951bc9-f5b8-44be-a7d0-d2c10165853c" xlink:to="loc_us-gaap_ServiceMember_10b98b47-30bc-452a-af43-9517b38010f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_OtherMember_6efee24f-76cd-44b0-b33e-b6082faff066" xlink:href="pgen-20220331.xsd#pgen_OtherMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_97951bc9-f5b8-44be-a7d0-d2c10165853c" xlink:to="loc_pgen_OtherMember_6efee24f-76cd-44b0-b33e-b6082faff066" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_e12406a4-95b5-42c5-bbe6-18f160b58352" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_b107718b-435a-4286-ad0b-c749f91bc746" xlink:to="loc_us-gaap_TypeOfArrangementAxis_e12406a4-95b5-42c5-bbe6-18f160b58352" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_6413305c-4e45-4673-9e08-af0a826fd545" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_e12406a4-95b5-42c5-bbe6-18f160b58352" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_6413305c-4e45-4673-9e08-af0a826fd545" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementMember_ea47b67f-3ca5-40d2-ae20-ef6ea63f964e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_6413305c-4e45-4673-9e08-af0a826fd545" xlink:to="loc_us-gaap_CollaborativeArrangementMember_ea47b67f-3ca5-40d2-ae20-ef6ea63f964e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_f148f0db-97b4-46ee-afcf-6d2fce13cfce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_b107718b-435a-4286-ad0b-c749f91bc746" xlink:to="loc_us-gaap_StatementLineItems_f148f0db-97b4-46ee-afcf-6d2fce13cfce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_5ab9b757-cf72-4676-a267-b68be1238d1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f148f0db-97b4-46ee-afcf-6d2fce13cfce" xlink:to="loc_us-gaap_RevenuesAbstract_5ab9b757-cf72-4676-a267-b68be1238d1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1f5a42b7-459e-4b63-99a3-02ac5e1f8c0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_5ab9b757-cf72-4676-a267-b68be1238d1b" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1f5a42b7-459e-4b63-99a3-02ac5e1f8c0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_f393ae63-2d87-466f-962b-98a801451171" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f148f0db-97b4-46ee-afcf-6d2fce13cfce" xlink:to="loc_us-gaap_OperatingExpensesAbstract_f393ae63-2d87-466f-962b-98a801451171" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_314b0422-180b-4c66-b6da-02f88185216c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_f393ae63-2d87-466f-962b-98a801451171" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_314b0422-180b-4c66-b6da-02f88185216c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_d86c440c-8e31-4708-8bb8-1595181ab175" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_f393ae63-2d87-466f-962b-98a801451171" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_d86c440c-8e31-4708-8bb8-1595181ab175" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_6e937d51-6cc8-44d1-9b13-98cc92e524a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_f393ae63-2d87-466f-962b-98a801451171" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_6e937d51-6cc8-44d1-9b13-98cc92e524a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_b9bdddb3-dbe9-42c7-874b-3539e25464c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_f393ae63-2d87-466f-962b-98a801451171" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_b9bdddb3-dbe9-42c7-874b-3539e25464c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_846307ea-dc59-46d4-87c3-6f6035bd3deb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_f393ae63-2d87-466f-962b-98a801451171" xlink:to="loc_us-gaap_OperatingExpenses_846307ea-dc59-46d4-87c3-6f6035bd3deb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_e1676b47-7bed-43ae-aa67-4bbaa508b862" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f148f0db-97b4-46ee-afcf-6d2fce13cfce" xlink:to="loc_us-gaap_OperatingIncomeLoss_e1676b47-7bed-43ae-aa67-4bbaa508b862" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_ce829225-6ade-48ce-9721-52d9b49dbd34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f148f0db-97b4-46ee-afcf-6d2fce13cfce" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_ce829225-6ade-48ce-9721-52d9b49dbd34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_7504a292-61a4-4204-a9ec-851d66c57de8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_ce829225-6ade-48ce-9721-52d9b49dbd34" xlink:to="loc_us-gaap_InterestExpense_7504a292-61a4-4204-a9ec-851d66c57de8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNonoperating_d3fe6f59-a469-48b6-8792-2fac1c673e78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeNonoperating"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_ce829225-6ade-48ce-9721-52d9b49dbd34" xlink:to="loc_us-gaap_InvestmentIncomeNonoperating_d3fe6f59-a469-48b6-8792-2fac1c673e78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_41f3c130-15ac-4af9-a998-bb50348d3aa1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_ce829225-6ade-48ce-9721-52d9b49dbd34" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_41f3c130-15ac-4af9-a998-bb50348d3aa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_c543d996-62fc-4e22-9916-d779c16bb844" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_ce829225-6ade-48ce-9721-52d9b49dbd34" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_c543d996-62fc-4e22-9916-d779c16bb844" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_bf7ec0f3-27df-4dd3-9a8f-f72569f2fac4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f148f0db-97b4-46ee-afcf-6d2fce13cfce" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_bf7ec0f3-27df-4dd3-9a8f-f72569f2fac4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f5682f24-08da-4e46-951a-52518b2897d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f148f0db-97b4-46ee-afcf-6d2fce13cfce" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f5682f24-08da-4e46-951a-52518b2897d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_44036d66-2052-4435-9908-3125bd3d44ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f148f0db-97b4-46ee-afcf-6d2fce13cfce" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_44036d66-2052-4435-9908-3125bd3d44ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_b072f0cf-bcd0-4b64-a3ca-fd7d82509a2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f148f0db-97b4-46ee-afcf-6d2fce13cfce" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_b072f0cf-bcd0-4b64-a3ca-fd7d82509a2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_11c3b5b7-84cd-46f5-aed3-b5da5b856a31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f148f0db-97b4-46ee-afcf-6d2fce13cfce" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_11c3b5b7-84cd-46f5-aed3-b5da5b856a31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_15757cff-538d-48fd-be79-341977d41168" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f148f0db-97b4-46ee-afcf-6d2fce13cfce" xlink:to="loc_us-gaap_NetIncomeLoss_15757cff-538d-48fd-be79-341977d41168" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_5dc5eb06-dd80-4a0b-b010-1f58f54aff63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f148f0db-97b4-46ee-afcf-6d2fce13cfce" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_5dc5eb06-dd80-4a0b-b010-1f58f54aff63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_93e37e37-e47f-4e75-9177-55205defd1cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_5dc5eb06-dd80-4a0b-b010-1f58f54aff63" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_93e37e37-e47f-4e75-9177-55205defd1cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_00b8ab5b-bd50-4c62-bf23-b5e91425c3f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_5dc5eb06-dd80-4a0b-b010-1f58f54aff63" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_00b8ab5b-bd50-4c62-bf23-b5e91425c3f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_dab82b5e-867b-4dd5-a794-18886e79663f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_5dc5eb06-dd80-4a0b-b010-1f58f54aff63" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_dab82b5e-867b-4dd5-a794-18886e79663f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_d43f355c-38bb-4b08-8b2f-d4dd3a3b5c24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_5dc5eb06-dd80-4a0b-b010-1f58f54aff63" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_d43f355c-38bb-4b08-8b2f-d4dd3a3b5c24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_6d8a837b-f9f3-44f9-90eb-0db180143b74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_5dc5eb06-dd80-4a0b-b010-1f58f54aff63" xlink:to="loc_us-gaap_EarningsPerShareBasic_6d8a837b-f9f3-44f9-90eb-0db180143b74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_c79d69f6-f33e-4a2a-8e35-9088741de38f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_5dc5eb06-dd80-4a0b-b010-1f58f54aff63" xlink:to="loc_us-gaap_EarningsPerShareDiluted_c79d69f6-f33e-4a2a-8e35-9088741de38f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a6fe9e05-0b48-45ff-a018-3b340acc17f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f148f0db-97b4-46ee-afcf-6d2fce13cfce" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a6fe9e05-0b48-45ff-a018-3b340acc17f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_219751c6-9ee6-41fc-81ca-1da6311589fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f148f0db-97b4-46ee-afcf-6d2fce13cfce" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_219751c6-9ee6-41fc-81ca-1da6311589fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dna.com/role/CondensedConsolidatedStatementsofOperationsParenthetical" xlink:type="simple" xlink:href="pgen-20220331.xsd#CondensedConsolidatedStatementsofOperationsParenthetical"/>
  <link:presentationLink xlink:role="http://www.dna.com/role/CondensedConsolidatedStatementsofOperationsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_4f9fd5e4-9f79-4151-8ac6-a240c3dc3279" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_fd1b3ceb-44a7-4576-9774-e019458141e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4f9fd5e4-9f79-4151-8ac6-a240c3dc3279" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_fd1b3ceb-44a7-4576-9774-e019458141e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_10d531a8-d20f-4c7e-9507-3244d349b51b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_fd1b3ceb-44a7-4576-9774-e019458141e4" xlink:to="loc_us-gaap_TypeOfArrangementAxis_10d531a8-d20f-4c7e-9507-3244d349b51b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_795a440e-cd0b-424f-8d3b-7cada4fc95f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_10d531a8-d20f-4c7e-9507-3244d349b51b" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_795a440e-cd0b-424f-8d3b-7cada4fc95f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementMember_53de797f-5251-4486-a71b-29c35aea68d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_795a440e-cd0b-424f-8d3b-7cada4fc95f6" xlink:to="loc_us-gaap_CollaborativeArrangementMember_53de797f-5251-4486-a71b-29c35aea68d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_07dd336f-5632-4d0c-bb13-8c26d6678834" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOperatingActivitiesSegmentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_fd1b3ceb-44a7-4576-9774-e019458141e4" xlink:to="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_07dd336f-5632-4d0c-bb13-8c26d6678834" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentOperatingActivitiesDomain_3ec56ffa-4ad9-469d-b094-720e22c3355e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentOperatingActivitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_07dd336f-5632-4d0c-bb13-8c26d6678834" xlink:to="loc_us-gaap_SegmentOperatingActivitiesDomain_3ec56ffa-4ad9-469d-b094-720e22c3355e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentContinuingOperationsMember_c83c0cbf-fef7-41c1-8935-fda5f2a2e473" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentContinuingOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentOperatingActivitiesDomain_3ec56ffa-4ad9-469d-b094-720e22c3355e" xlink:to="loc_us-gaap_SegmentContinuingOperationsMember_c83c0cbf-fef7-41c1-8935-fda5f2a2e473" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_2cee016d-dde1-433a-936f-8293e7737fd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_fd1b3ceb-44a7-4576-9774-e019458141e4" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_2cee016d-dde1-433a-936f-8293e7737fd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_192ca6af-7b7e-4bce-940c-eccffeb09c96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_2cee016d-dde1-433a-936f-8293e7737fd9" xlink:to="loc_us-gaap_RelatedPartyDomain_192ca6af-7b7e-4bce-940c-eccffeb09c96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_RelatedPartiesAggregatedMember_d2f54b8e-8d9a-450e-9aba-19d9cce7abb5" xlink:href="pgen-20220331.xsd#pgen_RelatedPartiesAggregatedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_192ca6af-7b7e-4bce-940c-eccffeb09c96" xlink:to="loc_pgen_RelatedPartiesAggregatedMember_d2f54b8e-8d9a-450e-9aba-19d9cce7abb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_2e01eda4-3550-453f-984c-caed1b915376" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_fd1b3ceb-44a7-4576-9774-e019458141e4" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_2e01eda4-3550-453f-984c-caed1b915376" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9b8f15f3-e6be-4768-b057-5218635f5830" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_2e01eda4-3550-453f-984c-caed1b915376" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9b8f15f3-e6be-4768-b057-5218635f5830" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dna.com/role/CondensedConsolidatedStatementsofComprehensiveLoss" xlink:type="simple" xlink:href="pgen-20220331.xsd#CondensedConsolidatedStatementsofComprehensiveLoss"/>
  <link:presentationLink xlink:role="http://www.dna.com/role/CondensedConsolidatedStatementsofComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_17abc44b-a7c5-4e85-91b7-4c539f9adcc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_94f2ba96-dacd-42bb-aa51-90fbffb4e128" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_17abc44b-a7c5-4e85-91b7-4c539f9adcc9" xlink:to="loc_us-gaap_NetIncomeLoss_94f2ba96-dacd-42bb-aa51-90fbffb4e128" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_bcf933cf-8f5e-4aaa-8f79-6d510aeac3cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_17abc44b-a7c5-4e85-91b7-4c539f9adcc9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_bcf933cf-8f5e-4aaa-8f79-6d510aeac3cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_2d3d63d8-f412-441a-a881-b764243b1cb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_bcf933cf-8f5e-4aaa-8f79-6d510aeac3cd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_2d3d63d8-f412-441a-a881-b764243b1cb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_393726ce-5fe2-41be-b678-62612875671e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_bcf933cf-8f5e-4aaa-8f79-6d510aeac3cd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_393726ce-5fe2-41be-b678-62612875671e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_35ac1c67-37e8-4ea3-82c4-92b91e5e8665" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_bcf933cf-8f5e-4aaa-8f79-6d510aeac3cd" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_35ac1c67-37e8-4ea3-82c4-92b91e5e8665" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dna.com/role/CondensedConsolidatedStatementsofShareholdersEquity" xlink:type="simple" xlink:href="pgen-20220331.xsd#CondensedConsolidatedStatementsofShareholdersEquity"/>
  <link:presentationLink xlink:role="http://www.dna.com/role/CondensedConsolidatedStatementsofShareholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_33af455e-289b-4823-a2aa-09cb8196909c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_f33a6b94-9f8a-4f32-9d32-8894bd712254" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_33af455e-289b-4823-a2aa-09cb8196909c" xlink:to="loc_us-gaap_StatementTable_f33a6b94-9f8a-4f32-9d32-8894bd712254" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_67370747-1a27-4674-b050-1539fd6d2477" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_f33a6b94-9f8a-4f32-9d32-8894bd712254" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_67370747-1a27-4674-b050-1539fd6d2477" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_6a875881-038e-4af2-8767-7e4b104f7c5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_67370747-1a27-4674-b050-1539fd6d2477" xlink:to="loc_us-gaap_EquityComponentDomain_6a875881-038e-4af2-8767-7e4b104f7c5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_25e3d080-a173-4d48-a935-02002574a602" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_6a875881-038e-4af2-8767-7e4b104f7c5b" xlink:to="loc_us-gaap_CommonStockMember_25e3d080-a173-4d48-a935-02002574a602" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_17110c2e-9e8c-4c1d-bda1-73cb3590ddee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_6a875881-038e-4af2-8767-7e4b104f7c5b" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_17110c2e-9e8c-4c1d-bda1-73cb3590ddee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_4f6d92ba-3e0d-40c4-b750-0cedffe3777b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_6a875881-038e-4af2-8767-7e4b104f7c5b" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_4f6d92ba-3e0d-40c4-b750-0cedffe3777b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_60cb0a16-9cf6-4864-b05d-fa152a040e89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_6a875881-038e-4af2-8767-7e4b104f7c5b" xlink:to="loc_us-gaap_RetainedEarningsMember_60cb0a16-9cf6-4864-b05d-fa152a040e89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_01b84df0-b9b6-455d-a2a4-9c05ded96169" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_f33a6b94-9f8a-4f32-9d32-8894bd712254" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_01b84df0-b9b6-455d-a2a4-9c05ded96169" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_d5182879-6cfb-44aa-abc8-0e89028bb7fd" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_01b84df0-b9b6-455d-a2a4-9c05ded96169" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_d5182879-6cfb-44aa-abc8-0e89028bb7fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_b1332381-7e86-437e-9467-0c52ccb7d664" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_d5182879-6cfb-44aa-abc8-0e89028bb7fd" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_b1332381-7e86-437e-9467-0c52ccb7d664" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_344bb495-44b1-46a5-afeb-1232eb40f496" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_f33a6b94-9f8a-4f32-9d32-8894bd712254" xlink:to="loc_us-gaap_StatementLineItems_344bb495-44b1-46a5-afeb-1232eb40f496" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5bb9b6a1-879a-43c0-94e9-de875bca8f94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_344bb495-44b1-46a5-afeb-1232eb40f496" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5bb9b6a1-879a-43c0-94e9-de875bca8f94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_bc93e59c-e254-4f19-9df1-f6f0307bb6ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5bb9b6a1-879a-43c0-94e9-de875bca8f94" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_bc93e59c-e254-4f19-9df1-f6f0307bb6ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_d7beec31-708f-48c9-8fbe-abd8da5890d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5bb9b6a1-879a-43c0-94e9-de875bca8f94" xlink:to="loc_us-gaap_StockholdersEquity_d7beec31-708f-48c9-8fbe-abd8da5890d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_bad6e0eb-22c4-4856-ae26-40620f08a382" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5bb9b6a1-879a-43c0-94e9-de875bca8f94" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_bad6e0eb-22c4-4856-ae26-40620f08a382" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_StockIssuedDuringPeriodSharesStockOptionsExercisedAndRestrictedStockAwards_43b63f01-ac4f-43ce-b79f-dd1d97194463" xlink:href="pgen-20220331.xsd#pgen_StockIssuedDuringPeriodSharesStockOptionsExercisedAndRestrictedStockAwards"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5bb9b6a1-879a-43c0-94e9-de875bca8f94" xlink:to="loc_pgen_StockIssuedDuringPeriodSharesStockOptionsExercisedAndRestrictedStockAwards_43b63f01-ac4f-43ce-b79f-dd1d97194463" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_StockIssuedDuringPeriodValueRestrictedStockAwardsVestedAndStockOptionsExercised_f9fbace0-6e66-46fb-a829-c68fd3b4bf37" xlink:href="pgen-20220331.xsd#pgen_StockIssuedDuringPeriodValueRestrictedStockAwardsVestedAndStockOptionsExercised"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5bb9b6a1-879a-43c0-94e9-de875bca8f94" xlink:to="loc_pgen_StockIssuedDuringPeriodValueRestrictedStockAwardsVestedAndStockOptionsExercised_f9fbace0-6e66-46fb-a829-c68fd3b4bf37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_StockIssuedDuringThePeriodSharesAccruedCompensation_280f0fdb-2252-4a37-80e6-5262b4702961" xlink:href="pgen-20220331.xsd#pgen_StockIssuedDuringThePeriodSharesAccruedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5bb9b6a1-879a-43c0-94e9-de875bca8f94" xlink:to="loc_pgen_StockIssuedDuringThePeriodSharesAccruedCompensation_280f0fdb-2252-4a37-80e6-5262b4702961" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_StockIssuedDuringThePeriodValueAccruedCompensation_92413bb2-7746-4ebe-ae0a-23189190cef4" xlink:href="pgen-20220331.xsd#pgen_StockIssuedDuringThePeriodValueAccruedCompensation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5bb9b6a1-879a-43c0-94e9-de875bca8f94" xlink:to="loc_pgen_StockIssuedDuringThePeriodValueAccruedCompensation_92413bb2-7746-4ebe-ae0a-23189190cef4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_a5b5eeb9-8bc9-4411-86b7-38c99c98ff7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5bb9b6a1-879a-43c0-94e9-de875bca8f94" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_a5b5eeb9-8bc9-4411-86b7-38c99c98ff7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueIssuedForServices_c63e8263-37c6-4bf9-bf71-2af198e1d76e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5bb9b6a1-879a-43c0-94e9-de875bca8f94" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueIssuedForServices_c63e8263-37c6-4bf9-bf71-2af198e1d76e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_61a5e2b6-be2e-4378-84f6-e2f4a19a3f52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5bb9b6a1-879a-43c0-94e9-de875bca8f94" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_61a5e2b6-be2e-4378-84f6-e2f4a19a3f52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_c09f6255-4e20-47fc-b172-35dc3a01196a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5bb9b6a1-879a-43c0-94e9-de875bca8f94" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_c09f6255-4e20-47fc-b172-35dc3a01196a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_a3640d2b-4561-40f0-83b9-94b01c18f036" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5bb9b6a1-879a-43c0-94e9-de875bca8f94" xlink:to="loc_us-gaap_NetIncomeLoss_a3640d2b-4561-40f0-83b9-94b01c18f036" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_29de6b44-9937-42e5-91b6-a084ffabfc24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5bb9b6a1-879a-43c0-94e9-de875bca8f94" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_29de6b44-9937-42e5-91b6-a084ffabfc24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_34fcd480-190d-47b2-b769-343df9208fe0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5bb9b6a1-879a-43c0-94e9-de875bca8f94" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_34fcd480-190d-47b2-b769-343df9208fe0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_8376ae45-1e39-4c6f-a581-42b0ad9251d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5bb9b6a1-879a-43c0-94e9-de875bca8f94" xlink:to="loc_us-gaap_StockholdersEquity_8376ae45-1e39-4c6f-a581-42b0ad9251d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_95cd4584-4a42-4c04-a968-ab27f149f536" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5bb9b6a1-879a-43c0-94e9-de875bca8f94" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_95cd4584-4a42-4c04-a968-ab27f149f536" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="pgen-20220331.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_9bce1429-77fc-4092-9c91-bd6cc06d9979" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_c1c46b1c-15f7-47e2-a787-12fad5352639" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_9bce1429-77fc-4092-9c91-bd6cc06d9979" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_c1c46b1c-15f7-47e2-a787-12fad5352639" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_49eb8dd9-e9a9-4242-8f2b-34c7a9529103" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_c1c46b1c-15f7-47e2-a787-12fad5352639" xlink:to="loc_us-gaap_NetIncomeLoss_49eb8dd9-e9a9-4242-8f2b-34c7a9529103" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_32e82438-1cfd-42f8-a0e9-ee018ac09bed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_c1c46b1c-15f7-47e2-a787-12fad5352639" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_32e82438-1cfd-42f8-a0e9-ee018ac09bed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_6aa462bf-5e47-4ab2-af1a-bb839c8c2ce9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_32e82438-1cfd-42f8-a0e9-ee018ac09bed" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_6aa462bf-5e47-4ab2-af1a-bb839c8c2ce9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets1_1c2f9c31-d2c2-4e98-863b-6ce9758efa16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_32e82438-1cfd-42f8-a0e9-ee018ac09bed" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets1_1c2f9c31-d2c2-4e98-863b-6ce9758efa16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_0e649a1e-5412-4d6d-86b8-e90bed3b812b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_32e82438-1cfd-42f8-a0e9-ee018ac09bed" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_0e649a1e-5412-4d6d-86b8-e90bed3b812b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_50a1b9a5-ed03-4684-923a-857296a23579" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_32e82438-1cfd-42f8-a0e9-ee018ac09bed" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_50a1b9a5-ed03-4684-923a-857296a23579" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_077c2579-fd9c-4435-a488-77fe59ba31ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_32e82438-1cfd-42f8-a0e9-ee018ac09bed" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_077c2579-fd9c-4435-a488-77fe59ba31ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_2fa1b5e2-a108-42b6-a121-ff19b84de00b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_32e82438-1cfd-42f8-a0e9-ee018ac09bed" xlink:to="loc_us-gaap_ShareBasedCompensation_2fa1b5e2-a108-42b6-a121-ff19b84de00b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_SharesIssuedDuringPeriodValueIssuedForServices_763b6d49-9498-425f-87e2-ae3fe4f5fb7c" xlink:href="pgen-20220331.xsd#pgen_SharesIssuedDuringPeriodValueIssuedForServices"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_32e82438-1cfd-42f8-a0e9-ee018ac09bed" xlink:to="loc_pgen_SharesIssuedDuringPeriodValueIssuedForServices_763b6d49-9498-425f-87e2-ae3fe4f5fb7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_4df2c5bb-9671-4504-80ce-c78fa5985fbf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_32e82438-1cfd-42f8-a0e9-ee018ac09bed" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_4df2c5bb-9671-4504-80ce-c78fa5985fbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_09d111b3-80c0-4252-b008-85044138ba37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_32e82438-1cfd-42f8-a0e9-ee018ac09bed" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_09d111b3-80c0-4252-b008-85044138ba37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_cda311bb-8818-4093-8934-626d483497cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_32e82438-1cfd-42f8-a0e9-ee018ac09bed" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_cda311bb-8818-4093-8934-626d483497cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_NoncashGainLossOnTerminationOfLease_6af978fc-e702-4ace-9835-9bc604cae6e1" xlink:href="pgen-20220331.xsd#pgen_NoncashGainLossOnTerminationOfLease"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_32e82438-1cfd-42f8-a0e9-ee018ac09bed" xlink:to="loc_pgen_NoncashGainLossOnTerminationOfLease_6af978fc-e702-4ace-9835-9bc604cae6e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_1b5987df-059e-4b5c-92d9-074e814c01dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_32e82438-1cfd-42f8-a0e9-ee018ac09bed" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_1b5987df-059e-4b5c-92d9-074e814c01dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c93d8968-0458-43e0-af55-6951752f3355" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_32e82438-1cfd-42f8-a0e9-ee018ac09bed" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c93d8968-0458-43e0-af55-6951752f3355" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivablesAbstract_b7380c54-70e0-4642-a0ba-a9643f82e555" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInReceivablesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c93d8968-0458-43e0-af55-6951752f3355" xlink:to="loc_us-gaap_IncreaseDecreaseInReceivablesAbstract_b7380c54-70e0-4642-a0ba-a9643f82e555" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_99b4e900-5132-4aad-952e-c89fc20e2dc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInReceivablesAbstract_b7380c54-70e0-4642-a0ba-a9643f82e555" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_99b4e900-5132-4aad-952e-c89fc20e2dc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDueFromRelatedPartiesCurrent_c2488dc7-a101-4bcd-b274-99e7eafb08eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDueFromRelatedPartiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInReceivablesAbstract_b7380c54-70e0-4642-a0ba-a9643f82e555" xlink:to="loc_us-gaap_IncreaseDecreaseInDueFromRelatedPartiesCurrent_c2488dc7-a101-4bcd-b274-99e7eafb08eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherReceivables_e9c2a952-d6b8-4476-a21b-560167474205" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherReceivables"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInReceivablesAbstract_b7380c54-70e0-4642-a0ba-a9643f82e555" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherReceivables_e9c2a952-d6b8-4476-a21b-560167474205" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_aa00564a-4447-4fe6-863c-f2b644ab0ed2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c93d8968-0458-43e0-af55-6951752f3355" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_aa00564a-4447-4fe6-863c-f2b644ab0ed2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_0f789c2a-421c-4cc9-a9a3-f6514de96899" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c93d8968-0458-43e0-af55-6951752f3355" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_0f789c2a-421c-4cc9-a9a3-f6514de96899" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_afe4456b-2d40-4d30-bea9-0e3fc2815c19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c93d8968-0458-43e0-af55-6951752f3355" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_afe4456b-2d40-4d30-bea9-0e3fc2815c19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_55e6689e-db3e-406c-b1b8-2193f0b373d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c93d8968-0458-43e0-af55-6951752f3355" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_55e6689e-db3e-406c-b1b8-2193f0b373d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_e069c026-42ee-43a4-b250-8a0fc1765b13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c93d8968-0458-43e0-af55-6951752f3355" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_e069c026-42ee-43a4-b250-8a0fc1765b13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities_53793d4a-142f-4215-89dc-2ba0ac681a76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherAccruedLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c93d8968-0458-43e0-af55-6951752f3355" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities_53793d4a-142f-4215-89dc-2ba0ac681a76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_2c574bbc-df99-45db-a27e-208b6af2d592" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c93d8968-0458-43e0-af55-6951752f3355" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_2c574bbc-df99-45db-a27e-208b6af2d592" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_f702ac6f-86f5-4ed5-b28f-503cc66a3299" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c93d8968-0458-43e0-af55-6951752f3355" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_f702ac6f-86f5-4ed5-b28f-503cc66a3299" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent_3bed0948-c77d-4ed1-a7c9-a77b76561505" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c93d8968-0458-43e0-af55-6951752f3355" xlink:to="loc_us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent_3bed0948-c77d-4ed1-a7c9-a77b76561505" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b5d31a12-0f63-4b09-b3ce-c918bcd9b203" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c93d8968-0458-43e0-af55-6951752f3355" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b5d31a12-0f63-4b09-b3ce-c918bcd9b203" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_5b4ef8fd-f9ae-41c5-96ec-e22ef136ba12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_9bce1429-77fc-4092-9c91-bd6cc06d9979" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_5b4ef8fd-f9ae-41c5-96ec-e22ef136ba12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_80bb480a-8162-4c53-8e9c-4950fb6d18fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_5b4ef8fd-f9ae-41c5-96ec-e22ef136ba12" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_80bb480a-8162-4c53-8e9c-4950fb6d18fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_e887eb9f-3571-4583-a706-97ea95c4b138" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_5b4ef8fd-f9ae-41c5-96ec-e22ef136ba12" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_e887eb9f-3571-4583-a706-97ea95c4b138" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_636d97be-b2bd-4198-ab8b-e68a3a1893d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_5b4ef8fd-f9ae-41c5-96ec-e22ef136ba12" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_636d97be-b2bd-4198-ab8b-e68a3a1893d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities_22be5d7b-d943-4c15-9bbc-e129c22c0e92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_5b4ef8fd-f9ae-41c5-96ec-e22ef136ba12" xlink:to="loc_us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities_22be5d7b-d943-4c15-9bbc-e129c22c0e92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollectionOfNotesReceivable_cd54487c-3d7e-42b1-9ea5-f5fa9ab9da29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromCollectionOfNotesReceivable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_5b4ef8fd-f9ae-41c5-96ec-e22ef136ba12" xlink:to="loc_us-gaap_ProceedsFromCollectionOfNotesReceivable_cd54487c-3d7e-42b1-9ea5-f5fa9ab9da29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_5978e568-fa4b-4b84-97d2-0e330a23e2f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_5b4ef8fd-f9ae-41c5-96ec-e22ef136ba12" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_5978e568-fa4b-4b84-97d2-0e330a23e2f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_0a924705-4909-4aa0-af48-ae3a35f10624" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_9bce1429-77fc-4092-9c91-bd6cc06d9979" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_0a924705-4909-4aa0-af48-ae3a35f10624" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_e9fe68e6-703e-4269-9453-449b7d1c4726" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_0a924705-4909-4aa0-af48-ae3a35f10624" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_e9fe68e6-703e-4269-9453-449b7d1c4726" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_59c4c262-ff57-46c5-937e-f85145b1bd0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_0a924705-4909-4aa0-af48-ae3a35f10624" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_59c4c262-ff57-46c5-937e-f85145b1bd0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_e2b910c9-7b42-4e06-8036-fe7670c206af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_0a924705-4909-4aa0-af48-ae3a35f10624" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_e2b910c9-7b42-4e06-8036-fe7670c206af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_39d8fd70-1cdd-47e7-8084-79b25f487e7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_0a924705-4909-4aa0-af48-ae3a35f10624" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_39d8fd70-1cdd-47e7-8084-79b25f487e7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e576610e-3166-4c9d-976d-b8e547269ff6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_9bce1429-77fc-4092-9c91-bd6cc06d9979" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e576610e-3166-4c9d-976d-b8e547269ff6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_4dad8d7a-5550-4789-8981-9e139dba2fe8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_9bce1429-77fc-4092-9c91-bd6cc06d9979" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_4dad8d7a-5550-4789-8981-9e139dba2fe8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_f43fd500-2a1c-4ace-8f36-262ad25b3edf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_9bce1429-77fc-4092-9c91-bd6cc06d9979" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_f43fd500-2a1c-4ace-8f36-262ad25b3edf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7198aa6b-4ddb-4a22-b90f-72a3ad23db04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_f43fd500-2a1c-4ace-8f36-262ad25b3edf" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7198aa6b-4ddb-4a22-b90f-72a3ad23db04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d886bbc0-340c-44a3-90cc-569e80a3d81b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_f43fd500-2a1c-4ace-8f36-262ad25b3edf" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d886bbc0-340c-44a3-90cc-569e80a3d81b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_3b09611f-d56a-47d0-9fe3-0d64f48433a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_9bce1429-77fc-4092-9c91-bd6cc06d9979" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_3b09611f-d56a-47d0-9fe3-0d64f48433a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_723c2588-12ae-4bb5-866c-99426cb2726f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_3b09611f-d56a-47d0-9fe3-0d64f48433a8" xlink:to="loc_us-gaap_InterestPaidNet_723c2588-12ae-4bb5-866c-99426cb2726f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid_e4467680-81d7-4d27-8d55-f68ab25a2649" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_3b09611f-d56a-47d0-9fe3-0d64f48433a8" xlink:to="loc_us-gaap_IncomeTaxesPaid_e4467680-81d7-4d27-8d55-f68ab25a2649" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_4a22c432-79d0-4f72-9dad-45ebea378388" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_9bce1429-77fc-4092-9c91-bd6cc06d9979" xlink:to="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_4a22c432-79d0-4f72-9dad-45ebea378388" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_AccruedCompensationPaidinEquityAwards_e1bc7595-8d07-400f-8f43-6dedbd7cb92a" xlink:href="pgen-20220331.xsd#pgen_AccruedCompensationPaidinEquityAwards"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_4a22c432-79d0-4f72-9dad-45ebea378388" xlink:to="loc_pgen_AccruedCompensationPaidinEquityAwards_e1bc7595-8d07-400f-8f43-6dedbd7cb92a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_8add17e0-470e-4d9a-9d81-62924cdb9792" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_4a22c432-79d0-4f72-9dad-45ebea378388" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_8add17e0-470e-4d9a-9d81-62924cdb9792" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_SaleOfAssetsIncludedInAccountsReceivable_ec8588f7-914e-4f19-8833-dec625d6e596" xlink:href="pgen-20220331.xsd#pgen_SaleOfAssetsIncludedInAccountsReceivable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_4a22c432-79d0-4f72-9dad-45ebea378388" xlink:to="loc_pgen_SaleOfAssetsIncludedInAccountsReceivable_ec8588f7-914e-4f19-8833-dec625d6e596" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsReconciliationAbstract_e9c537ce-9f6f-4040-ba0f-242f455d47bf" xlink:href="pgen-20220331.xsd#pgen_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsReconciliationAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_9bce1429-77fc-4092-9c91-bd6cc06d9979" xlink:to="loc_pgen_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsReconciliationAbstract_e9c537ce-9f6f-4040-ba0f-242f455d47bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_8a37a438-faf9-4984-bef6-04ddf556540d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pgen_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsReconciliationAbstract_e9c537ce-9f6f-4040-ba0f-242f455d47bf" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_8a37a438-faf9-4984-bef6-04ddf556540d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_b15199f1-c131-45d2-898d-f5242042c23d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pgen_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsReconciliationAbstract_e9c537ce-9f6f-4040-ba0f-242f455d47bf" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_b15199f1-c131-45d2-898d-f5242042c23d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_23f60580-8093-44b9-8025-b896e4efbee7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pgen_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsReconciliationAbstract_e9c537ce-9f6f-4040-ba0f-242f455d47bf" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_23f60580-8093-44b9-8025-b896e4efbee7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dna.com/role/Organization" xlink:type="simple" xlink:href="pgen-20220331.xsd#Organization"/>
  <link:presentationLink xlink:role="http://www.dna.com/role/Organization" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_3bdf61a1-b520-4394-9218-76a0cbf5f367" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_ee778f4d-a053-4bdf-a7a6-75b35f158b41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_3bdf61a1-b520-4394-9218-76a0cbf5f367" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_ee778f4d-a053-4bdf-a7a6-75b35f158b41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dna.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="pgen-20220331.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.dna.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_521d10d0-481b-4e26-9cdb-24fff87a1b50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_d5f0a50e-4256-4402-be52-c218f8e89763" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_521d10d0-481b-4e26-9cdb-24fff87a1b50" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_d5f0a50e-4256-4402-be52-c218f8e89763" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dna.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="pgen-20220331.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.dna.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_0775a700-cb57-4be6-b684-52eccbc5eaa0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_6805ba36-addb-46ac-a41e-835ce9ad3c98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0775a700-cb57-4be6-b684-52eccbc5eaa0" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_6805ba36-addb-46ac-a41e-835ce9ad3c98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_4cd5d42d-2e0b-4049-a31f-4ceaf33a5576" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0775a700-cb57-4be6-b684-52eccbc5eaa0" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_4cd5d42d-2e0b-4049-a31f-4ceaf33a5576" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsPolicy_c3cf4c39-99f4-4a2b-ad6a-b72d2105ae1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsPolicy"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0775a700-cb57-4be6-b684-52eccbc5eaa0" xlink:to="loc_us-gaap_EquityMethodInvestmentsPolicy_c3cf4c39-99f4-4a2b-ad6a-b72d2105ae1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationVariableInterestEntityPolicy_0a9b02af-316f-4e6a-91d6-5bf852252000" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationVariableInterestEntityPolicy"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0775a700-cb57-4be6-b684-52eccbc5eaa0" xlink:to="loc_us-gaap_ConsolidationVariableInterestEntityPolicy_0a9b02af-316f-4e6a-91d6-5bf852252000" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_411a75d5-5702-4a47-ba29-a67532b387b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0775a700-cb57-4be6-b684-52eccbc5eaa0" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_411a75d5-5702-4a47-ba29-a67532b387b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_f97ebfdc-da3d-40e5-8e60-a8dcd01a6e80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0775a700-cb57-4be6-b684-52eccbc5eaa0" xlink:to="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_f97ebfdc-da3d-40e5-8e60-a8dcd01a6e80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_267404e9-e6a7-41d4-8070-ec918dcf6fdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0775a700-cb57-4be6-b684-52eccbc5eaa0" xlink:to="loc_us-gaap_UseOfEstimates_267404e9-e6a7-41d4-8070-ec918dcf6fdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_fafec362-34aa-4e87-99f7-d535e31ea15f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0775a700-cb57-4be6-b684-52eccbc5eaa0" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_fafec362-34aa-4e87-99f7-d535e31ea15f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dna.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="pgen-20220331.xsd#SummaryofSignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://www.dna.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_9f8256f2-0252-4389-a8e4-90ecbc747a0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_65d73159-13d0-473e-ad9b-eebb8cef15f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9f8256f2-0252-4389-a8e4-90ecbc747a0d" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_65d73159-13d0-473e-ad9b-eebb8cef15f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dna.com/role/SummaryofSignificantAccountingPoliciesLiquidityAdditionalInformationDetails" xlink:type="simple" xlink:href="pgen-20220331.xsd#SummaryofSignificantAccountingPoliciesLiquidityAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.dna.com/role/SummaryofSignificantAccountingPoliciesLiquidityAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_4f2d1d41-5d6d-4738-984d-c2caf0322a68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_4355d575-c6c0-4d47-96c3-a46b95068028" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4f2d1d41-5d6d-4738-984d-c2caf0322a68" xlink:to="loc_us-gaap_NetIncomeLoss_4355d575-c6c0-4d47-96c3-a46b95068028" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_1122821f-6224-4ee1-b782-e44b9a733da3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4f2d1d41-5d6d-4738-984d-c2caf0322a68" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_1122821f-6224-4ee1-b782-e44b9a733da3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dna.com/role/SummaryofSignificantAccountingPoliciesVariableInterestEntitiesAdditionalInformationDetails" xlink:type="simple" xlink:href="pgen-20220331.xsd#SummaryofSignificantAccountingPoliciesVariableInterestEntitiesAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.dna.com/role/SummaryofSignificantAccountingPoliciesVariableInterestEntitiesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_f637aaae-e0a4-45dd-b926-95b72b64f79e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount_f07919b5-d173-4b66-81e3-381f4bd595ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_f637aaae-e0a4-45dd-b926-95b72b64f79e" xlink:to="loc_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount_f07919b5-d173-4b66-81e3-381f4bd595ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dna.com/role/SummaryofSignificantAccountingPoliciesNetLossPerShareAdditionalInformationDetails" xlink:type="simple" xlink:href="pgen-20220331.xsd#SummaryofSignificantAccountingPoliciesNetLossPerShareAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.dna.com/role/SummaryofSignificantAccountingPoliciesNetLossPerShareAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_c8092041-f232-41a6-add3-edcc3623779f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_e0520502-8e18-449d-9a4f-908023646a62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c8092041-f232-41a6-add3-edcc3623779f" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_e0520502-8e18-449d-9a4f-908023646a62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_6781eba0-da97-4a7c-94b2-5ed17e54512f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_e0520502-8e18-449d-9a4f-908023646a62" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_6781eba0-da97-4a7c-94b2-5ed17e54512f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_b84650c5-d78b-4880-af75-5dc51a306d0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_6781eba0-da97-4a7c-94b2-5ed17e54512f" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_b84650c5-d78b-4880-af75-5dc51a306d0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_22979b36-119a-4eb3-b629-68b61ce3ac37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_b84650c5-d78b-4880-af75-5dc51a306d0d" xlink:to="loc_us-gaap_ConvertibleDebtMember_22979b36-119a-4eb3-b629-68b61ce3ac37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember_bcd0a4de-3d18-4cb8-9ee1-231fde5f3480" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_b84650c5-d78b-4880-af75-5dc51a306d0d" xlink:to="loc_us-gaap_StockOptionMember_bcd0a4de-3d18-4cb8-9ee1-231fde5f3480" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_4e6cdc25-afae-48f6-a853-44e2b48e6cbc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_b84650c5-d78b-4880-af75-5dc51a306d0d" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_4e6cdc25-afae-48f6-a853-44e2b48e6cbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_d9da6da7-6d84-41ee-890c-9f06b8ff3959" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_b84650c5-d78b-4880-af75-5dc51a306d0d" xlink:to="loc_us-gaap_WarrantMember_d9da6da7-6d84-41ee-890c-9f06b8ff3959" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_1ce28620-5497-4d85-9d8f-33cda4e263c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_e0520502-8e18-449d-9a4f-908023646a62" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_1ce28620-5497-4d85-9d8f-33cda4e263c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_6429ebfb-c5c2-4da2-ad73-be677526f7b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_1ce28620-5497-4d85-9d8f-33cda4e263c0" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_6429ebfb-c5c2-4da2-ad73-be677526f7b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dna.com/role/SummaryofSignificantAccountingPoliciesRecentlyAdoptedAccountingPronouncementsAdditionalInformationDetails" xlink:type="simple" xlink:href="pgen-20220331.xsd#SummaryofSignificantAccountingPoliciesRecentlyAdoptedAccountingPronouncementsAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.dna.com/role/SummaryofSignificantAccountingPoliciesRecentlyAdoptedAccountingPronouncementsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_a468e735-610b-4229-9414-2fbc511c4fd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_b7729eab-a5a7-43e5-ac03-367c4cd1b810" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a468e735-610b-4229-9414-2fbc511c4fd4" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_b7729eab-a5a7-43e5-ac03-367c4cd1b810" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_e3404b56-0f0c-4b61-b217-4b18c5583653" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_b7729eab-a5a7-43e5-ac03-367c4cd1b810" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_e3404b56-0f0c-4b61-b217-4b18c5583653" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_9d53e925-a0dc-4277-b8f3-f8be72d80887" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_e3404b56-0f0c-4b61-b217-4b18c5583653" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_9d53e925-a0dc-4277-b8f3-f8be72d80887" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_82c01baa-af34-4120-9ae6-b88504a07cc1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_9d53e925-a0dc-4277-b8f3-f8be72d80887" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_82c01baa-af34-4120-9ae6-b88504a07cc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_210119fb-6ab9-4fec-99b9-c1251bfbbd0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_b7729eab-a5a7-43e5-ac03-367c4cd1b810" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_210119fb-6ab9-4fec-99b9-c1251bfbbd0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_39e31a3a-1e65-431c-9c54-8c7ca5aeaa9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_210119fb-6ab9-4fec-99b9-c1251bfbbd0b" xlink:to="loc_us-gaap_TypeOfAdoptionMember_39e31a3a-1e65-431c-9c54-8c7ca5aeaa9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate202006RetrospectiveMember_86eadd65-004b-4a4a-b77d-ae2e2c2a18c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate202006RetrospectiveMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_39e31a3a-1e65-431c-9c54-8c7ca5aeaa9e" xlink:to="loc_us-gaap_AccountingStandardsUpdate202006RetrospectiveMember_86eadd65-004b-4a4a-b77d-ae2e2c2a18c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_7b9a2f23-91d7-4dfe-bb90-94966f4ac9d9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_b7729eab-a5a7-43e5-ac03-367c4cd1b810" xlink:to="loc_srt_StatementScenarioAxis_7b9a2f23-91d7-4dfe-bb90-94966f4ac9d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_9f9457b2-0a75-4df2-b042-30fa0f302367" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_7b9a2f23-91d7-4dfe-bb90-94966f4ac9d9" xlink:to="loc_srt_ScenarioUnspecifiedDomain_9f9457b2-0a75-4df2-b042-30fa0f302367" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_cad54c3b-7c6e-490a-8580-9d037ad30abf" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_9f9457b2-0a75-4df2-b042-30fa0f302367" xlink:to="loc_srt_ScenarioForecastMember_cad54c3b-7c6e-490a-8580-9d037ad30abf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_78fca014-7580-46e0-a38a-d507a6d0e2cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_b7729eab-a5a7-43e5-ac03-367c4cd1b810" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_78fca014-7580-46e0-a38a-d507a6d0e2cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_62fd6af3-c693-42cc-aff2-470bd2422a62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_78fca014-7580-46e0-a38a-d507a6d0e2cd" xlink:to="loc_us-gaap_EquityComponentDomain_62fd6af3-c693-42cc-aff2-470bd2422a62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_17d824a5-1cec-4f53-97f8-0dacda233684" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_62fd6af3-c693-42cc-aff2-470bd2422a62" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_17d824a5-1cec-4f53-97f8-0dacda233684" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_54a3dcde-fe96-404b-9b8f-518796fa6a38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_62fd6af3-c693-42cc-aff2-470bd2422a62" xlink:to="loc_us-gaap_RetainedEarningsMember_54a3dcde-fe96-404b-9b8f-518796fa6a38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b4952277-ce6d-4def-90e3-260940b495de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_b7729eab-a5a7-43e5-ac03-367c4cd1b810" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b4952277-ce6d-4def-90e3-260940b495de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_67aade89-8c3a-470c-8716-b8f357973cc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b4952277-ce6d-4def-90e3-260940b495de" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_67aade89-8c3a-470c-8716-b8f357973cc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_97764d96-82e0-4622-84a8-b30cb0c5a545" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b4952277-ce6d-4def-90e3-260940b495de" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_97764d96-82e0-4622-84a8-b30cb0c5a545" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_InterestExpenseDebtAmortizationofDebtDiscountPremiumandDebtIssuanceCosts_ab892bc4-694d-434b-a54a-0115303b96e1" xlink:href="pgen-20220331.xsd#pgen_InterestExpenseDebtAmortizationofDebtDiscountPremiumandDebtIssuanceCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b4952277-ce6d-4def-90e3-260940b495de" xlink:to="loc_pgen_InterestExpenseDebtAmortizationofDebtDiscountPremiumandDebtIssuanceCosts_ab892bc4-694d-434b-a54a-0115303b96e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dna.com/role/DiscontinuedOperations" xlink:type="simple" xlink:href="pgen-20220331.xsd#DiscontinuedOperations"/>
  <link:presentationLink xlink:role="http://www.dna.com/role/DiscontinuedOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_617bdf4f-4f64-42aa-a8fb-a676f5f13efa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_3ce1bf38-1648-4f56-9c27-6e1c3188e3f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_617bdf4f-4f64-42aa-a8fb-a676f5f13efa" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_3ce1bf38-1648-4f56-9c27-6e1c3188e3f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dna.com/role/DiscontinuedOperationsTables" xlink:type="simple" xlink:href="pgen-20220331.xsd#DiscontinuedOperationsTables"/>
  <link:presentationLink xlink:role="http://www.dna.com/role/DiscontinuedOperationsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_ae4f39d7-ec13-47b8-b934-a4dc1c16da9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_68cf62c3-d9c6-4599-8f10-75cd799ece28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_ae4f39d7-ec13-47b8-b934-a4dc1c16da9d" xlink:to="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_68cf62c3-d9c6-4599-8f10-75cd799ece28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dna.com/role/DiscontinuedOperationsNarrativeDetails" xlink:type="simple" xlink:href="pgen-20220331.xsd#DiscontinuedOperationsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.dna.com/role/DiscontinuedOperationsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_19dee0be-036d-432f-9795-07c1ab9be69b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_65b160dc-2b64-4326-8b3b-c8ca92ca251a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_19dee0be-036d-432f-9795-07c1ab9be69b" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_65b160dc-2b64-4326-8b3b-c8ca92ca251a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_127705c6-08ff-4728-80c5-604bf281de77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_65b160dc-2b64-4326-8b3b-c8ca92ca251a" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_127705c6-08ff-4728-80c5-604bf281de77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_42ed8537-ddcc-442f-9ec5-bfe6d300c499" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_127705c6-08ff-4728-80c5-604bf281de77" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_42ed8537-ddcc-442f-9ec5-bfe6d300c499" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_MBPTitanMember_51039542-a3e4-4827-8bd9-d08bc08b5484" xlink:href="pgen-20220331.xsd#pgen_MBPTitanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_42ed8537-ddcc-442f-9ec5-bfe6d300c499" xlink:to="loc_pgen_MBPTitanMember_51039542-a3e4-4827-8bd9-d08bc08b5484" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_cf450ed7-b5ed-4687-9334-b63908823370" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_65b160dc-2b64-4326-8b3b-c8ca92ca251a" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_cf450ed7-b5ed-4687-9334-b63908823370" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_d3b223c8-e5a5-4045-aa31-de99956c69ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_cf450ed7-b5ed-4687-9334-b63908823370" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_d3b223c8-e5a5-4045-aa31-de99956c69ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleAbandonmentMember_2807af1f-b927-4ed5-9a71-4c800d903c45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleAbandonmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_d3b223c8-e5a5-4045-aa31-de99956c69ea" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleAbandonmentMember_2807af1f-b927-4ed5-9a71-4c800d903c45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_34733308-cd06-4df3-bcbf-7272c0a0633a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_65b160dc-2b64-4326-8b3b-c8ca92ca251a" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_34733308-cd06-4df3-bcbf-7272c0a0633a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets1_36587a8d-62f7-4959-81f8-25d4a805c1c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_34733308-cd06-4df3-bcbf-7272c0a0633a" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets1_36587a8d-62f7-4959-81f8-25d4a805c1c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnTerminationOfLease_00fe3af9-284a-4ee7-9a27-b3da0139f297" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnTerminationOfLease"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_34733308-cd06-4df3-bcbf-7272c0a0633a" xlink:to="loc_us-gaap_GainLossOnTerminationOfLease_00fe3af9-284a-4ee7-9a27-b3da0139f297" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_ca38e9bf-5948-42be-ae8f-8ed66321df1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_34733308-cd06-4df3-bcbf-7272c0a0633a" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_ca38e9bf-5948-42be-ae8f-8ed66321df1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dna.com/role/DiscontinuedOperationsSummaryofFinancialResultsforMBPTitanDetails" xlink:type="simple" xlink:href="pgen-20220331.xsd#DiscontinuedOperationsSummaryofFinancialResultsforMBPTitanDetails"/>
  <link:presentationLink xlink:role="http://www.dna.com/role/DiscontinuedOperationsSummaryofFinancialResultsforMBPTitanDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_d6516759-6444-4f07-a8a4-9d04e938dc57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_cf664f47-0649-4d58-bd61-2f589c4e7a01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_d6516759-6444-4f07-a8a4-9d04e938dc57" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_cf664f47-0649-4d58-bd61-2f589c4e7a01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_991df2e8-639e-4be0-a786-d8262fb9c182" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_cf664f47-0649-4d58-bd61-2f589c4e7a01" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_991df2e8-639e-4be0-a786-d8262fb9c182" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_da8b1135-88b8-4685-8c89-b37d4af1eb97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_991df2e8-639e-4be0-a786-d8262fb9c182" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_da8b1135-88b8-4685-8c89-b37d4af1eb97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_MBPTitanMember_571bae8d-c29b-406d-9e40-a5fef1e5b338" xlink:href="pgen-20220331.xsd#pgen_MBPTitanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_da8b1135-88b8-4685-8c89-b37d4af1eb97" xlink:to="loc_pgen_MBPTitanMember_571bae8d-c29b-406d-9e40-a5fef1e5b338" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_fdb0febf-cff9-4bf5-9cce-079f150c3e86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_cf664f47-0649-4d58-bd61-2f589c4e7a01" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_fdb0febf-cff9-4bf5-9cce-079f150c3e86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_593ff935-13bf-49eb-95db-ecc868f181b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_fdb0febf-cff9-4bf5-9cce-079f150c3e86" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_593ff935-13bf-49eb-95db-ecc868f181b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleAbandonmentMember_328c93da-084e-4e01-85f0-2d7b04fd2358" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleAbandonmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_593ff935-13bf-49eb-95db-ecc868f181b4" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleAbandonmentMember_328c93da-084e-4e01-85f0-2d7b04fd2358" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_2e6ea882-5f97-47c9-92e0-bb97fe844bea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_cf664f47-0649-4d58-bd61-2f589c4e7a01" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_2e6ea882-5f97-47c9-92e0-bb97fe844bea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_6f2687c6-885e-4357-9bf5-8c2dbb073bf0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_2e6ea882-5f97-47c9-92e0-bb97fe844bea" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_6f2687c6-885e-4357-9bf5-8c2dbb073bf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_0cca511b-9973-4fcd-b42c-1ccd85e404ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_2e6ea882-5f97-47c9-92e0-bb97fe844bea" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_0cca511b-9973-4fcd-b42c-1ccd85e404ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_2c66246e-f99c-422a-9a78-8320dcfefa4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_2e6ea882-5f97-47c9-92e0-bb97fe844bea" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_2c66246e-f99c-422a-9a78-8320dcfefa4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_e08e067d-b4ab-402d-b85e-1ca64b13ecc0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_2e6ea882-5f97-47c9-92e0-bb97fe844bea" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_e08e067d-b4ab-402d-b85e-1ca64b13ecc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dna.com/role/DiscontinuedOperationsNoncashItemsandPurchasesofPropertyPlantandEquipmentforMBPTitanDetails" xlink:type="simple" xlink:href="pgen-20220331.xsd#DiscontinuedOperationsNoncashItemsandPurchasesofPropertyPlantandEquipmentforMBPTitanDetails"/>
  <link:presentationLink xlink:role="http://www.dna.com/role/DiscontinuedOperationsNoncashItemsandPurchasesofPropertyPlantandEquipmentforMBPTitanDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_0a7e5809-c12a-4b9d-8dd8-27058faf88f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_63b105fe-8c79-43be-ac84-f4214438beaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_0a7e5809-c12a-4b9d-8dd8-27058faf88f5" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_63b105fe-8c79-43be-ac84-f4214438beaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_79909bc3-a02f-4b38-bedf-34b86fa3b535" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_63b105fe-8c79-43be-ac84-f4214438beaf" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_79909bc3-a02f-4b38-bedf-34b86fa3b535" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_68fe1673-a8d3-4563-ab3e-dde7372c556b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_79909bc3-a02f-4b38-bedf-34b86fa3b535" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_68fe1673-a8d3-4563-ab3e-dde7372c556b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleAbandonmentMember_6e93d217-fba9-4d33-9148-e497688ca636" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleAbandonmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_68fe1673-a8d3-4563-ab3e-dde7372c556b" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleAbandonmentMember_6e93d217-fba9-4d33-9148-e497688ca636" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cc7e8e39-8482-4bfb-81c9-7edcea013d14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_63b105fe-8c79-43be-ac84-f4214438beaf" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cc7e8e39-8482-4bfb-81c9-7edcea013d14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c93e30d3-c025-4f3e-99c1-e4ff48cff7a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_cc7e8e39-8482-4bfb-81c9-7edcea013d14" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c93e30d3-c025-4f3e-99c1-e4ff48cff7a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_MBPTitanMember_adf6519d-c75b-46b7-96c2-b35abd82c802" xlink:href="pgen-20220331.xsd#pgen_MBPTitanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c93e30d3-c025-4f3e-99c1-e4ff48cff7a4" xlink:to="loc_pgen_MBPTitanMember_adf6519d-c75b-46b7-96c2-b35abd82c802" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_0923c041-fab6-40db-869f-456c0903b183" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_63b105fe-8c79-43be-ac84-f4214438beaf" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_0923c041-fab6-40db-869f-456c0903b183" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2786af5a-4c9f-4f8b-ac96-9199a0f3b820" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_0923c041-fab6-40db-869f-456c0903b183" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2786af5a-4c9f-4f8b-ac96-9199a0f3b820" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets1_0910b9ad-22fb-4c7f-a06c-8b03af720ba7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2786af5a-4c9f-4f8b-ac96-9199a0f3b820" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets1_0910b9ad-22fb-4c7f-a06c-8b03af720ba7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnTerminationOfLease_806b4a8c-fb82-4070-a369-40ec4afaa8f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnTerminationOfLease"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2786af5a-4c9f-4f8b-ac96-9199a0f3b820" xlink:to="loc_us-gaap_GainLossOnTerminationOfLease_806b4a8c-fb82-4070-a369-40ec4afaa8f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalCashFlowElementsInvestingActivitiesAbstract_0b7c4229-3397-4a37-aea2-3af378e4d261" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalCashFlowElementsInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_0923c041-fab6-40db-869f-456c0903b183" xlink:to="loc_us-gaap_AdditionalCashFlowElementsInvestingActivitiesAbstract_0b7c4229-3397-4a37-aea2-3af378e4d261" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities_f91c31fa-bfa6-4bde-8f98-2ad4f7b5c450" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdditionalCashFlowElementsInvestingActivitiesAbstract_0b7c4229-3397-4a37-aea2-3af378e4d261" xlink:to="loc_us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities_f91c31fa-bfa6-4bde-8f98-2ad4f7b5c450" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dna.com/role/InvestmentsinJointVentures" xlink:type="simple" xlink:href="pgen-20220331.xsd#InvestmentsinJointVentures"/>
  <link:presentationLink xlink:role="http://www.dna.com/role/InvestmentsinJointVentures" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_afb021ef-cc59-4d5e-96b7-7d15255215f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_5fec56ce-9411-489d-bc14-e1d38c3a212e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_afb021ef-cc59-4d5e-96b7-7d15255215f3" xlink:to="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_5fec56ce-9411-489d-bc14-e1d38c3a212e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dna.com/role/InvestmentsinJointVenturesIntrexonEnergyPartnersAdditionalInformationDetails" xlink:type="simple" xlink:href="pgen-20220331.xsd#InvestmentsinJointVenturesIntrexonEnergyPartnersAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.dna.com/role/InvestmentsinJointVenturesIntrexonEnergyPartnersAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_50db820a-9968-4761-8cbc-5cf82f79754e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_90477953-b897-4a0e-8ca0-6c6ca7ca0270" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_50db820a-9968-4761-8cbc-5cf82f79754e" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_90477953-b897-4a0e-8ca0-6c6ca7ca0270" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_9e43d569-d438-476b-b3d6-b9bb47ed0d28" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_90477953-b897-4a0e-8ca0-6c6ca7ca0270" xlink:to="loc_srt_CounterpartyNameAxis_9e43d569-d438-476b-b3d6-b9bb47ed0d28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_3ae377d9-abc9-4951-a077-7d8f06372b0e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_9e43d569-d438-476b-b3d6-b9bb47ed0d28" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_3ae377d9-abc9-4951-a077-7d8f06372b0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_IntrexonEnergyPartnersMember_094480e0-feaf-4992-9a71-fb11e15daa3d" xlink:href="pgen-20220331.xsd#pgen_IntrexonEnergyPartnersMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_3ae377d9-abc9-4951-a077-7d8f06372b0e" xlink:to="loc_pgen_IntrexonEnergyPartnersMember_094480e0-feaf-4992-9a71-fb11e15daa3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_d3ab58ed-6aba-4323-a8ed-9526af7e5ad8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_90477953-b897-4a0e-8ca0-6c6ca7ca0270" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_d3ab58ed-6aba-4323-a8ed-9526af7e5ad8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_16a32014-b3b8-4f7d-a67f-86b7496280d3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_d3ab58ed-6aba-4323-a8ed-9526af7e5ad8" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_16a32014-b3b8-4f7d-a67f-86b7496280d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_IntrexonEnergyPartnersMember_a4f5b0bc-9999-4fbe-b943-e3132647ddc1" xlink:href="pgen-20220331.xsd#pgen_IntrexonEnergyPartnersMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_16a32014-b3b8-4f7d-a67f-86b7496280d3" xlink:to="loc_pgen_IntrexonEnergyPartnersMember_a4f5b0bc-9999-4fbe-b943-e3132647ddc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_2c706b48-34f2-471b-9cef-a75da5a7cdca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_90477953-b897-4a0e-8ca0-6c6ca7ca0270" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_2c706b48-34f2-471b-9cef-a75da5a7cdca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_ac31cace-f875-4e0f-8418-dc832c5f1049" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_2c706b48-34f2-471b-9cef-a75da5a7cdca" xlink:to="loc_us-gaap_RelatedPartyDomain_ac31cace-f875-4e0f-8418-dc832c5f1049" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestorMember_a1ed42a7-23d5-402e-836f-2ea1729a19a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestorMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_ac31cace-f875-4e0f-8418-dc832c5f1049" xlink:to="loc_us-gaap_InvestorMember_a1ed42a7-23d5-402e-836f-2ea1729a19a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_dd1e0dc2-01b8-4733-a496-ed5b2fa6091b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_90477953-b897-4a0e-8ca0-6c6ca7ca0270" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_dd1e0dc2-01b8-4733-a496-ed5b2fa6091b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_ec7c51a5-1942-4db3-ab26-886233335ff1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_dd1e0dc2-01b8-4733-a496-ed5b2fa6091b" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_ec7c51a5-1942-4db3-ab26-886233335ff1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_OtherAccruedLiabilitiesMember_eaeb2f81-7a0f-4ae5-a91a-722998133f85" xlink:href="pgen-20220331.xsd#pgen_OtherAccruedLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_ec7c51a5-1942-4db3-ab26-886233335ff1" xlink:to="loc_pgen_OtherAccruedLiabilitiesMember_eaeb2f81-7a0f-4ae5-a91a-722998133f85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_ba4b3d9d-71ca-49ce-b48e-dfeee4151adf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_90477953-b897-4a0e-8ca0-6c6ca7ca0270" xlink:to="loc_us-gaap_TypeOfArrangementAxis_ba4b3d9d-71ca-49ce-b48e-dfeee4151adf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_956bb57e-14f1-4d12-96be-52192792f9e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_ba4b3d9d-71ca-49ce-b48e-dfeee4151adf" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_956bb57e-14f1-4d12-96be-52192792f9e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementMember_30a62572-3f1c-480d-abf6-8c27d666703a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_956bb57e-14f1-4d12-96be-52192792f9e5" xlink:to="loc_us-gaap_CollaborativeArrangementMember_30a62572-3f1c-480d-abf6-8c27d666703a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_4471fe7d-93df-4529-9465-e06056307fdc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_90477953-b897-4a0e-8ca0-6c6ca7ca0270" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_4471fe7d-93df-4529-9465-e06056307fdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_CollaborativeArrangementConsiderationReceivedValue_6e4997a7-9a79-453c-9b88-aae5a77776c5" xlink:href="pgen-20220331.xsd#pgen_CollaborativeArrangementConsiderationReceivedValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_4471fe7d-93df-4529-9465-e06056307fdc" xlink:to="loc_pgen_CollaborativeArrangementConsiderationReceivedValue_6e4997a7-9a79-453c-9b88-aae5a77776c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_58d60e24-4990-4c12-b851-7233ede39074" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_4471fe7d-93df-4529-9465-e06056307fdc" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_58d60e24-4990-4c12-b851-7233ede39074" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInterestInJointVenture_ab307d5e-6a49-4b30-b7b9-5b01d6fdf573" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireInterestInJointVenture"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_4471fe7d-93df-4529-9465-e06056307fdc" xlink:to="loc_us-gaap_PaymentsToAcquireInterestInJointVenture_ab307d5e-6a49-4b30-b7b9-5b01d6fdf573" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_JointVentureAdditionalCapitalContributionsCommitted_691a5f82-f27d-4ae7-b56c-04c2ad640f03" xlink:href="pgen-20220331.xsd#pgen_JointVentureAdditionalCapitalContributionsCommitted"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_4471fe7d-93df-4529-9465-e06056307fdc" xlink:to="loc_pgen_JointVentureAdditionalCapitalContributionsCommitted_691a5f82-f27d-4ae7-b56c-04c2ad640f03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_JointVentureAdditionalCapitalContributionsCommittedRemainingCommitment_2d442fae-d476-4b19-97b7-8355ff9332e3" xlink:href="pgen-20220331.xsd#pgen_JointVentureAdditionalCapitalContributionsCommittedRemainingCommitment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_4471fe7d-93df-4529-9465-e06056307fdc" xlink:to="loc_pgen_JointVentureAdditionalCapitalContributionsCommittedRemainingCommitment_2d442fae-d476-4b19-97b7-8355ff9332e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_NumberofSeatsonGoverningBoard_af5279b8-8b06-4a2b-87bc-f77f2ba80175" xlink:href="pgen-20220331.xsd#pgen_NumberofSeatsonGoverningBoard"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_4471fe7d-93df-4529-9465-e06056307fdc" xlink:to="loc_pgen_NumberofSeatsonGoverningBoard_af5279b8-8b06-4a2b-87bc-f77f2ba80175" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_NumberofSeatsonGoverningBoardInternallySelected_4be884bd-bbba-4bc7-b233-c1fd9d177358" xlink:href="pgen-20220331.xsd#pgen_NumberofSeatsonGoverningBoardInternallySelected"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_4471fe7d-93df-4529-9465-e06056307fdc" xlink:to="loc_pgen_NumberofSeatsonGoverningBoardInternallySelected_4be884bd-bbba-4bc7-b233-c1fd9d177358" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_NumberofSeatsonGoverningBoardExternallySelected_783dfc70-ffb2-4f16-85a0-4ed133c70c35" xlink:href="pgen-20220331.xsd#pgen_NumberofSeatsonGoverningBoardExternallySelected"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_4471fe7d-93df-4529-9465-e06056307fdc" xlink:to="loc_pgen_NumberofSeatsonGoverningBoardExternallySelected_783dfc70-ffb2-4f16-85a0-4ed133c70c35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_53a6d4cb-440c-43e7-91ad-b44d64eb6447" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_4471fe7d-93df-4529-9465-e06056307fdc" xlink:to="loc_us-gaap_EquityMethodInvestments_53a6d4cb-440c-43e7-91ad-b44d64eb6447" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dna.com/role/InvestmentsinJointVenturesIntrexonEnergyPartnersIIAdditionalInformationDetails" xlink:type="simple" xlink:href="pgen-20220331.xsd#InvestmentsinJointVenturesIntrexonEnergyPartnersIIAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.dna.com/role/InvestmentsinJointVenturesIntrexonEnergyPartnersIIAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_15bc1b4f-5f24-4ec1-8757-9f489fda3657" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_1bb00797-f182-4f11-8f61-68c7dcab7fa4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_15bc1b4f-5f24-4ec1-8757-9f489fda3657" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_1bb00797-f182-4f11-8f61-68c7dcab7fa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_5015ec12-e944-4a8f-a5e4-6c1864fadf91" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_1bb00797-f182-4f11-8f61-68c7dcab7fa4" xlink:to="loc_srt_CounterpartyNameAxis_5015ec12-e944-4a8f-a5e4-6c1864fadf91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_f70d2564-cfc7-4b36-9a1f-9497d2529a58" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_5015ec12-e944-4a8f-a5e4-6c1864fadf91" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_f70d2564-cfc7-4b36-9a1f-9497d2529a58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_IntrexonEnergyPartnersIILLCMember_6d054a4e-ee2d-47c1-ba1b-6a78fc78c29d" xlink:href="pgen-20220331.xsd#pgen_IntrexonEnergyPartnersIILLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_f70d2564-cfc7-4b36-9a1f-9497d2529a58" xlink:to="loc_pgen_IntrexonEnergyPartnersIILLCMember_6d054a4e-ee2d-47c1-ba1b-6a78fc78c29d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_3b236b2e-106b-41ab-872c-d223df485161" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_1bb00797-f182-4f11-8f61-68c7dcab7fa4" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_3b236b2e-106b-41ab-872c-d223df485161" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_32970344-34c8-4c8d-83a0-a7acb32777f0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_3b236b2e-106b-41ab-872c-d223df485161" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_32970344-34c8-4c8d-83a0-a7acb32777f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_IntrexonEnergyPartnersIILLCMember_859f6509-b3dd-48dc-8c51-57fb97d2ac11" xlink:href="pgen-20220331.xsd#pgen_IntrexonEnergyPartnersIILLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_32970344-34c8-4c8d-83a0-a7acb32777f0" xlink:to="loc_pgen_IntrexonEnergyPartnersIILLCMember_859f6509-b3dd-48dc-8c51-57fb97d2ac11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_5c7d6d94-5ed9-453e-99af-c85d18eea57a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_1bb00797-f182-4f11-8f61-68c7dcab7fa4" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_5c7d6d94-5ed9-453e-99af-c85d18eea57a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_baf9c024-f942-44fc-bc80-033eaf8414a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_5c7d6d94-5ed9-453e-99af-c85d18eea57a" xlink:to="loc_us-gaap_RelatedPartyDomain_baf9c024-f942-44fc-bc80-033eaf8414a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestorMember_3f903717-9a63-4e34-91db-f42ac3fb4ab9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestorMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_baf9c024-f942-44fc-bc80-033eaf8414a3" xlink:to="loc_us-gaap_InvestorMember_3f903717-9a63-4e34-91db-f42ac3fb4ab9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_AllInvestorsMember_c5d9d965-028a-4202-9458-2727129c0077" xlink:href="pgen-20220331.xsd#pgen_AllInvestorsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_baf9c024-f942-44fc-bc80-033eaf8414a3" xlink:to="loc_pgen_AllInvestorsMember_c5d9d965-028a-4202-9458-2727129c0077" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_2b9f845f-a7be-4305-82cd-1adc38d1baf4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_1bb00797-f182-4f11-8f61-68c7dcab7fa4" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_2b9f845f-a7be-4305-82cd-1adc38d1baf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_5abd7384-3c7b-433a-812d-d9b0fb9e30b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_2b9f845f-a7be-4305-82cd-1adc38d1baf4" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_5abd7384-3c7b-433a-812d-d9b0fb9e30b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_OtherAccruedLiabilitiesMember_1f34d56a-ac6a-4f01-b21e-4d6d0c158aef" xlink:href="pgen-20220331.xsd#pgen_OtherAccruedLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_5abd7384-3c7b-433a-812d-d9b0fb9e30b2" xlink:to="loc_pgen_OtherAccruedLiabilitiesMember_1f34d56a-ac6a-4f01-b21e-4d6d0c158aef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_ead1f195-e2cb-403e-9b43-a7e627e594a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_1bb00797-f182-4f11-8f61-68c7dcab7fa4" xlink:to="loc_us-gaap_TypeOfArrangementAxis_ead1f195-e2cb-403e-9b43-a7e627e594a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_cbf57732-0c30-43ff-89d4-7bdcee9514b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_ead1f195-e2cb-403e-9b43-a7e627e594a0" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_cbf57732-0c30-43ff-89d4-7bdcee9514b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementMember_78ec7cdc-4b14-4dd4-8c6b-27a7351dea84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_cbf57732-0c30-43ff-89d4-7bdcee9514b8" xlink:to="loc_us-gaap_CollaborativeArrangementMember_78ec7cdc-4b14-4dd4-8c6b-27a7351dea84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a0a86a95-985d-43ac-b04a-b75c0bdf5ad1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_1bb00797-f182-4f11-8f61-68c7dcab7fa4" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a0a86a95-985d-43ac-b04a-b75c0bdf5ad1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_CollaborativeArrangementConsiderationReceivedValue_bea8e7e8-ae4e-43c5-9dae-751b079b9a7e" xlink:href="pgen-20220331.xsd#pgen_CollaborativeArrangementConsiderationReceivedValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a0a86a95-985d-43ac-b04a-b75c0bdf5ad1" xlink:to="loc_pgen_CollaborativeArrangementConsiderationReceivedValue_bea8e7e8-ae4e-43c5-9dae-751b079b9a7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_0d129bbf-b461-42d0-b3b5-68f02e0674b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a0a86a95-985d-43ac-b04a-b75c0bdf5ad1" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_0d129bbf-b461-42d0-b3b5-68f02e0674b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInterestInJointVenture_4b068bef-452b-45ef-9a31-f3cccca7e9c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireInterestInJointVenture"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a0a86a95-985d-43ac-b04a-b75c0bdf5ad1" xlink:to="loc_us-gaap_PaymentsToAcquireInterestInJointVenture_4b068bef-452b-45ef-9a31-f3cccca7e9c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_JointVentureAdditionalCapitalContributionsCommitted_fcb07fc2-d287-4f20-972e-8f718bd24448" xlink:href="pgen-20220331.xsd#pgen_JointVentureAdditionalCapitalContributionsCommitted"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a0a86a95-985d-43ac-b04a-b75c0bdf5ad1" xlink:to="loc_pgen_JointVentureAdditionalCapitalContributionsCommitted_fcb07fc2-d287-4f20-972e-8f718bd24448" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_JointVentureAdditionalCapitalContributionsCommittedRemainingCommitment_9409a6fd-a396-48af-9fdf-46b676002fa9" xlink:href="pgen-20220331.xsd#pgen_JointVentureAdditionalCapitalContributionsCommittedRemainingCommitment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a0a86a95-985d-43ac-b04a-b75c0bdf5ad1" xlink:to="loc_pgen_JointVentureAdditionalCapitalContributionsCommittedRemainingCommitment_9409a6fd-a396-48af-9fdf-46b676002fa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_NumberofSeatsonGoverningBoard_dcae36ed-0dc6-4a31-a065-fdf8cffcba80" xlink:href="pgen-20220331.xsd#pgen_NumberofSeatsonGoverningBoard"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a0a86a95-985d-43ac-b04a-b75c0bdf5ad1" xlink:to="loc_pgen_NumberofSeatsonGoverningBoard_dcae36ed-0dc6-4a31-a065-fdf8cffcba80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_NumberofSeatsonGoverningBoardInternallySelected_1a7c4acb-f970-4822-9af3-cb68586df7df" xlink:href="pgen-20220331.xsd#pgen_NumberofSeatsonGoverningBoardInternallySelected"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a0a86a95-985d-43ac-b04a-b75c0bdf5ad1" xlink:to="loc_pgen_NumberofSeatsonGoverningBoardInternallySelected_1a7c4acb-f970-4822-9af3-cb68586df7df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_NumberofSeatsonGoverningBoardExternallySelected_67639da5-a71d-43cb-8f25-6e500a933f6a" xlink:href="pgen-20220331.xsd#pgen_NumberofSeatsonGoverningBoardExternallySelected"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a0a86a95-985d-43ac-b04a-b75c0bdf5ad1" xlink:to="loc_pgen_NumberofSeatsonGoverningBoardExternallySelected_67639da5-a71d-43cb-8f25-6e500a933f6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_b7e5119d-7a37-4194-8d3e-87e36190c458" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a0a86a95-985d-43ac-b04a-b75c0bdf5ad1" xlink:to="loc_us-gaap_EquityMethodInvestments_b7e5119d-7a37-4194-8d3e-87e36190c458" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dna.com/role/CollaborationandLicensingRevenue" xlink:type="simple" xlink:href="pgen-20220331.xsd#CollaborationandLicensingRevenue"/>
  <link:presentationLink xlink:role="http://www.dna.com/role/CollaborationandLicensingRevenue" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_88024210-de71-4e9c-aa78-44714d77d614" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_cb56a9cb-04e4-4776-aff1-3a0159a851ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_88024210-de71-4e9c-aa78-44714d77d614" xlink:to="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_cb56a9cb-04e4-4776-aff1-3a0159a851ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dna.com/role/CollaborationandLicensingRevenueTables" xlink:type="simple" xlink:href="pgen-20220331.xsd#CollaborationandLicensingRevenueTables"/>
  <link:presentationLink xlink:role="http://www.dna.com/role/CollaborationandLicensingRevenueTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f1db0ca9-1e32-4cf8-941b-31ef1186fb68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_CollaborationandLicensingRevenueTableTextBlock_4891aa86-40ac-4f5c-8639-c64e3f68e2e4" xlink:href="pgen-20220331.xsd#pgen_CollaborationandLicensingRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f1db0ca9-1e32-4cf8-941b-31ef1186fb68" xlink:to="loc_pgen_CollaborationandLicensingRevenueTableTextBlock_4891aa86-40ac-4f5c-8639-c64e3f68e2e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_c9bf5e71-e817-4f3a-8c64-a9d0f647c968" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f1db0ca9-1e32-4cf8-941b-31ef1186fb68" xlink:to="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_c9bf5e71-e817-4f3a-8c64-a9d0f647c968" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_a0629240-9900-4f44-bddf-d2a62707ac46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f1db0ca9-1e32-4cf8-941b-31ef1186fb68" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_a0629240-9900-4f44-bddf-d2a62707ac46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dna.com/role/CollaborationandLicensingRevenueSummarizedCollaborationandLicensingRevenueDetails" xlink:type="simple" xlink:href="pgen-20220331.xsd#CollaborationandLicensingRevenueSummarizedCollaborationandLicensingRevenueDetails"/>
  <link:presentationLink xlink:role="http://www.dna.com/role/CollaborationandLicensingRevenueSummarizedCollaborationandLicensingRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c5f772a3-f89f-4059-a975-2a1128d2550a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_fd514fd3-0327-49fe-8a28-e41425f3d25f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c5f772a3-f89f-4059-a975-2a1128d2550a" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_fd514fd3-0327-49fe-8a28-e41425f3d25f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_06043ad4-8666-488b-a0ae-39f6181c0e41" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_fd514fd3-0327-49fe-8a28-e41425f3d25f" xlink:to="loc_srt_CounterpartyNameAxis_06043ad4-8666-488b-a0ae-39f6181c0e41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_552c4600-0c88-45e2-8cd5-1e2d36b327cf" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_06043ad4-8666-488b-a0ae-39f6181c0e41" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_552c4600-0c88-45e2-8cd5-1e2d36b327cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_CastleCreekBiosciencesIncMember_62396bbc-74c5-46ab-90a5-08a41739b275" xlink:href="pgen-20220331.xsd#pgen_CastleCreekBiosciencesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_552c4600-0c88-45e2-8cd5-1e2d36b327cf" xlink:to="loc_pgen_CastleCreekBiosciencesIncMember_62396bbc-74c5-46ab-90a5-08a41739b275" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_OtherMember_9a801098-acfe-48e0-8563-03a07e05ce9d" xlink:href="pgen-20220331.xsd#pgen_OtherMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_552c4600-0c88-45e2-8cd5-1e2d36b327cf" xlink:to="loc_pgen_OtherMember_9a801098-acfe-48e0-8563-03a07e05ce9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_443cfdb7-3aa3-4f08-8b3b-1a570d08521d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_fd514fd3-0327-49fe-8a28-e41425f3d25f" xlink:to="loc_us-gaap_TypeOfArrangementAxis_443cfdb7-3aa3-4f08-8b3b-1a570d08521d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_ddb2f488-5e33-44cc-962f-51b5f8d38373" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_443cfdb7-3aa3-4f08-8b3b-1a570d08521d" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_ddb2f488-5e33-44cc-962f-51b5f8d38373" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementMember_fbd54be1-f15e-4790-90d5-c637b944f26f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_ddb2f488-5e33-44cc-962f-51b5f8d38373" xlink:to="loc_us-gaap_CollaborativeArrangementMember_fbd54be1-f15e-4790-90d5-c637b944f26f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_UpfrontAndMilestonePaymentsMember_1d4999e4-784e-43db-9efd-60fcb2260e03" xlink:href="pgen-20220331.xsd#pgen_UpfrontAndMilestonePaymentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_ddb2f488-5e33-44cc-962f-51b5f8d38373" xlink:to="loc_pgen_UpfrontAndMilestonePaymentsMember_1d4999e4-784e-43db-9efd-60fcb2260e03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_7fa0db2c-e069-4f78-a2de-aa95289f4cd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_fd514fd3-0327-49fe-8a28-e41425f3d25f" xlink:to="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_7fa0db2c-e069-4f78-a2de-aa95289f4cd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_bd1f0628-25f8-424e-9fa9-0211f2811574" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_7fa0db2c-e069-4f78-a2de-aa95289f4cd3" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_bd1f0628-25f8-424e-9fa9-0211f2811574" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_1af2340d-2f6a-4b56-8f97-dd40f8eb28e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_7fa0db2c-e069-4f78-a2de-aa95289f4cd3" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_1af2340d-2f6a-4b56-8f97-dd40f8eb28e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dna.com/role/CollaborationandLicensingRevenueSummaryofDeferredRevenueDetails" xlink:type="simple" xlink:href="pgen-20220331.xsd#CollaborationandLicensingRevenueSummaryofDeferredRevenueDetails"/>
  <link:presentationLink xlink:role="http://www.dna.com/role/CollaborationandLicensingRevenueSummaryofDeferredRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_af565873-d7d7-470a-9dd4-4ac074d07d50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_ContractWithCustomerAssetAndLiabilityTable_7b0c94a6-afd9-42a1-b610-b3ea61a03943" xlink:href="pgen-20220331.xsd#pgen_ContractWithCustomerAssetAndLiabilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_af565873-d7d7-470a-9dd4-4ac074d07d50" xlink:to="loc_pgen_ContractWithCustomerAssetAndLiabilityTable_7b0c94a6-afd9-42a1-b610-b3ea61a03943" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_0bddc2e1-35f5-4fc1-9322-a6f0b60de54b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pgen_ContractWithCustomerAssetAndLiabilityTable_7b0c94a6-afd9-42a1-b610-b3ea61a03943" xlink:to="loc_srt_ProductOrServiceAxis_0bddc2e1-35f5-4fc1-9322-a6f0b60de54b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_b9f775a3-89b5-44c4-a595-e718da4e9d25" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_0bddc2e1-35f5-4fc1-9322-a6f0b60de54b" xlink:to="loc_srt_ProductsAndServicesDomain_b9f775a3-89b5-44c4-a595-e718da4e9d25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_PrepaidProductAndServiceRevenuesMember_62dd691a-8601-4a6e-bd0f-074a85b6b2b1" xlink:href="pgen-20220331.xsd#pgen_PrepaidProductAndServiceRevenuesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_b9f775a3-89b5-44c4-a595-e718da4e9d25" xlink:to="loc_pgen_PrepaidProductAndServiceRevenuesMember_62dd691a-8601-4a6e-bd0f-074a85b6b2b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_DeferredRevenueOtherMember_6d5e8c7d-b4f5-4dec-b709-c7ed3a17af81" xlink:href="pgen-20220331.xsd#pgen_DeferredRevenueOtherMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_b9f775a3-89b5-44c4-a595-e718da4e9d25" xlink:to="loc_pgen_DeferredRevenueOtherMember_6d5e8c7d-b4f5-4dec-b709-c7ed3a17af81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_4b03b0e4-c945-4787-aa7d-1de708dbaedd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pgen_ContractWithCustomerAssetAndLiabilityTable_7b0c94a6-afd9-42a1-b610-b3ea61a03943" xlink:to="loc_us-gaap_TypeOfArrangementAxis_4b03b0e4-c945-4787-aa7d-1de708dbaedd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_4b8466ce-ea9d-4ca3-864e-b763986e6de7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_4b03b0e4-c945-4787-aa7d-1de708dbaedd" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_4b8466ce-ea9d-4ca3-864e-b763986e6de7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementMember_c030ee00-7712-4361-883d-8940afa523b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_4b8466ce-ea9d-4ca3-864e-b763986e6de7" xlink:to="loc_us-gaap_CollaborativeArrangementMember_c030ee00-7712-4361-883d-8940afa523b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_5c444250-bf27-4d3f-beda-c360da8bb800" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pgen_ContractWithCustomerAssetAndLiabilityTable_7b0c94a6-afd9-42a1-b610-b3ea61a03943" xlink:to="loc_srt_CounterpartyNameAxis_5c444250-bf27-4d3f-beda-c360da8bb800" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_06701b27-8c10-49c4-843f-a0dff6eeafe6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_5c444250-bf27-4d3f-beda-c360da8bb800" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_06701b27-8c10-49c4-843f-a0dff6eeafe6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_IntrexonEnergyPartnersLLAndIntrexonEnergyPartnersIILLCMember_e174250e-61e9-44bb-a8c7-e3b6ccb43c84" xlink:href="pgen-20220331.xsd#pgen_IntrexonEnergyPartnersLLAndIntrexonEnergyPartnersIILLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_06701b27-8c10-49c4-843f-a0dff6eeafe6" xlink:to="loc_pgen_IntrexonEnergyPartnersLLAndIntrexonEnergyPartnersIILLCMember_e174250e-61e9-44bb-a8c7-e3b6ccb43c84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_ContractWithCustomerAssetAndLiabilityLineItems_17ec046b-ec52-415e-bfc5-f04dac7f3fd4" xlink:href="pgen-20220331.xsd#pgen_ContractWithCustomerAssetAndLiabilityLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pgen_ContractWithCustomerAssetAndLiabilityTable_7b0c94a6-afd9-42a1-b610-b3ea61a03943" xlink:to="loc_pgen_ContractWithCustomerAssetAndLiabilityLineItems_17ec046b-ec52-415e-bfc5-f04dac7f3fd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_f2557005-04d5-46ac-9451-e70839aea88a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pgen_ContractWithCustomerAssetAndLiabilityLineItems_17ec046b-ec52-415e-bfc5-f04dac7f3fd4" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_f2557005-04d5-46ac-9451-e70839aea88a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_febdf61b-44c6-493d-95a5-26bf5b9d92c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pgen_ContractWithCustomerAssetAndLiabilityLineItems_17ec046b-ec52-415e-bfc5-f04dac7f3fd4" xlink:to="loc_us-gaap_ContractWithCustomerLiability_febdf61b-44c6-493d-95a5-26bf5b9d92c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_de82a880-b7c4-45ee-90b8-4be1ad762e0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pgen_ContractWithCustomerAssetAndLiabilityLineItems_17ec046b-ec52-415e-bfc5-f04dac7f3fd4" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_de82a880-b7c4-45ee-90b8-4be1ad762e0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dna.com/role/ShorttermandLongtermInvestments" xlink:type="simple" xlink:href="pgen-20220331.xsd#ShorttermandLongtermInvestments"/>
  <link:presentationLink xlink:role="http://www.dna.com/role/ShorttermandLongtermInvestments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_fb0fd080-a7b8-4ae8-b659-0e93fd193a12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_2ffdd48f-e638-4f4e-99be-9b82605b9f9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_fb0fd080-a7b8-4ae8-b659-0e93fd193a12" xlink:to="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_2ffdd48f-e638-4f4e-99be-9b82605b9f9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dna.com/role/ShorttermandLongtermInvestmentsTables" xlink:type="simple" xlink:href="pgen-20220331.xsd#ShorttermandLongtermInvestmentsTables"/>
  <link:presentationLink xlink:role="http://www.dna.com/role/ShorttermandLongtermInvestmentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_92e40018-00ea-4b9a-9f39-5a040133d87f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_ad5f162d-b086-47bb-80e1-54efab6c44ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_92e40018-00ea-4b9a-9f39-5a040133d87f" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_ad5f162d-b086-47bb-80e1-54efab6c44ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock_b577ef48-763e-4582-a59a-f35030557db2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_92e40018-00ea-4b9a-9f39-5a040133d87f" xlink:to="loc_srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock_b577ef48-763e-4582-a59a-f35030557db2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dna.com/role/ShorttermandLongtermInvestmentsSummaryofAmortizedCostGrossUnrealizedGainsandLossesandFairValueofShorttermandLongtermInvestmentsDetails" xlink:type="simple" xlink:href="pgen-20220331.xsd#ShorttermandLongtermInvestmentsSummaryofAmortizedCostGrossUnrealizedGainsandLossesandFairValueofShorttermandLongtermInvestmentsDetails"/>
  <link:presentationLink xlink:role="http://www.dna.com/role/ShorttermandLongtermInvestmentsSummaryofAmortizedCostGrossUnrealizedGainsandLossesandFairValueofShorttermandLongtermInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_f02fcb5a-888a-4b17-aeca-235904b0b625" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_c3bd2c27-38c7-462d-9d8c-f54d192564e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_f02fcb5a-888a-4b17-aeca-235904b0b625" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_c3bd2c27-38c7-462d-9d8c-f54d192564e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_9ede94fa-b18d-4b8d-bda1-1f1cfe9f7bf6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_c3bd2c27-38c7-462d-9d8c-f54d192564e5" xlink:to="loc_us-gaap_FinancialInstrumentAxis_9ede94fa-b18d-4b8d-bda1-1f1cfe9f7bf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_aaa9daa1-d44a-45c3-84ab-81d06107592e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_9ede94fa-b18d-4b8d-bda1-1f1cfe9f7bf6" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_aaa9daa1-d44a-45c3-84ab-81d06107592e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentDebtSecuritiesMember_0853874b-3da5-47a2-8e8f-72a09920f96a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_aaa9daa1-d44a-45c3-84ab-81d06107592e" xlink:to="loc_us-gaap_USGovernmentDebtSecuritiesMember_0853874b-3da5-47a2-8e8f-72a09920f96a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_ed67b59f-c648-4641-8d01-8c6936ae0f67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_aaa9daa1-d44a-45c3-84ab-81d06107592e" xlink:to="loc_us-gaap_CertificatesOfDepositMember_ed67b59f-c648-4641-8d01-8c6936ae0f67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_3fabff28-dbd0-4c2e-80c4-d43a560de437" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_c3bd2c27-38c7-462d-9d8c-f54d192564e5" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_3fabff28-dbd0-4c2e-80c4-d43a560de437" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_e13652f4-3633-4c21-8804-c2c5184f2552" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_3fabff28-dbd0-4c2e-80c4-d43a560de437" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_e13652f4-3633-4c21-8804-c2c5184f2552" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_60eeb29f-13e6-4911-ae53-c77f67685a0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_3fabff28-dbd0-4c2e-80c4-d43a560de437" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_60eeb29f-13e6-4911-ae53-c77f67685a0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_9ef7eede-d71d-4e95-ad19-671b6d896510" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_3fabff28-dbd0-4c2e-80c4-d43a560de437" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_9ef7eede-d71d-4e95-ad19-671b6d896510" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_419ef5f0-225e-4300-b64c-fb580e8d0c6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_3fabff28-dbd0-4c2e-80c4-d43a560de437" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_419ef5f0-225e-4300-b64c-fb580e8d0c6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dna.com/role/ShorttermandLongtermInvestmentsContractualObligationFiscalYearMaturityDetails" xlink:type="simple" xlink:href="pgen-20220331.xsd#ShorttermandLongtermInvestmentsContractualObligationFiscalYearMaturityDetails"/>
  <link:presentationLink xlink:role="http://www.dna.com/role/ShorttermandLongtermInvestmentsContractualObligationFiscalYearMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_0795c667-ef20-4565-afcf-ffbb090be5af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_433cefb9-212d-4e55-90ee-5021784c06c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_0795c667-ef20-4565-afcf-ffbb090be5af" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_433cefb9-212d-4e55-90ee-5021784c06c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_0f97ccfc-40ec-49f0-a3ad-e05388105778" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_0795c667-ef20-4565-afcf-ffbb090be5af" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_0f97ccfc-40ec-49f0-a3ad-e05388105778" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_15ec5657-18ae-4765-9e57-32f0a3ddcbef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_0795c667-ef20-4565-afcf-ffbb090be5af" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_15ec5657-18ae-4765-9e57-32f0a3ddcbef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dna.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="pgen-20220331.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://www.dna.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_07a465b8-9a99-492a-b19e-6c2009a0c263" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_5817f73d-87d2-4690-8036-b94be9ba29a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_07a465b8-9a99-492a-b19e-6c2009a0c263" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_5817f73d-87d2-4690-8036-b94be9ba29a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dna.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="pgen-20220331.xsd#FairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://www.dna.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_51805a74-a48e-41e8-93c5-4c297b9fef3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_55c40957-cf73-4f6d-b15d-bbca600c7e11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_51805a74-a48e-41e8-93c5-4c297b9fef3b" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_55c40957-cf73-4f6d-b15d-bbca600c7e11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dna.com/role/FairValueMeasurementsSummaryofPlacementintheFairValueHierarchyofFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails" xlink:type="simple" xlink:href="pgen-20220331.xsd#FairValueMeasurementsSummaryofPlacementintheFairValueHierarchyofFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://www.dna.com/role/FairValueMeasurementsSummaryofPlacementintheFairValueHierarchyofFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_c51e7ee8-5c81-4cae-a01f-93ad5dc4932a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4a93dbbe-9b2e-4d36-a67d-0067096edeb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_c51e7ee8-5c81-4cae-a01f-93ad5dc4932a" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4a93dbbe-9b2e-4d36-a67d-0067096edeb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_88b466c7-fd4f-4ce3-a361-ad242982af94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4a93dbbe-9b2e-4d36-a67d-0067096edeb7" xlink:to="loc_us-gaap_FinancialInstrumentAxis_88b466c7-fd4f-4ce3-a361-ad242982af94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c823122e-5153-4975-8ef9-0e048d0ad12c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_88b466c7-fd4f-4ce3-a361-ad242982af94" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c823122e-5153-4975-8ef9-0e048d0ad12c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentDebtSecuritiesMember_810968fd-60c5-4ff3-aeb5-470d42b4b7ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c823122e-5153-4975-8ef9-0e048d0ad12c" xlink:to="loc_us-gaap_USGovernmentDebtSecuritiesMember_810968fd-60c5-4ff3-aeb5-470d42b4b7ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_981e7d99-9f6a-4da8-b275-1844d575a711" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c823122e-5153-4975-8ef9-0e048d0ad12c" xlink:to="loc_us-gaap_CertificatesOfDepositMember_981e7d99-9f6a-4da8-b275-1844d575a711" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a6453ccb-6c24-4524-9045-3a433099769e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4a93dbbe-9b2e-4d36-a67d-0067096edeb7" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a6453ccb-6c24-4524-9045-3a433099769e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9ee0a00f-a9fe-4c1f-b886-006fad8d4037" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a6453ccb-6c24-4524-9045-3a433099769e" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9ee0a00f-a9fe-4c1f-b886-006fad8d4037" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_f53f0b4d-6f69-412f-87cb-0d066df19669" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9ee0a00f-a9fe-4c1f-b886-006fad8d4037" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_f53f0b4d-6f69-412f-87cb-0d066df19669" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_ceda6fc3-f355-457b-8f20-66a23ced43cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9ee0a00f-a9fe-4c1f-b886-006fad8d4037" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_ceda6fc3-f355-457b-8f20-66a23ced43cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_873cc182-f7e2-4de9-9d27-79230ddc85ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9ee0a00f-a9fe-4c1f-b886-006fad8d4037" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_873cc182-f7e2-4de9-9d27-79230ddc85ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9ae8e765-46b4-46e7-9a3a-ebb7a79abcc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4a93dbbe-9b2e-4d36-a67d-0067096edeb7" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9ae8e765-46b4-46e7-9a3a-ebb7a79abcc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_0db0ea8e-11f7-4ecc-9f19-4fb68ed63c20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9ae8e765-46b4-46e7-9a3a-ebb7a79abcc5" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_0db0ea8e-11f7-4ecc-9f19-4fb68ed63c20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_c3ce6d7c-a061-4a94-8aff-c069758f872e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_0db0ea8e-11f7-4ecc-9f19-4fb68ed63c20" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_c3ce6d7c-a061-4a94-8aff-c069758f872e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dna.com/role/FairValueMeasurementsAdditionalInformationDetails" xlink:type="simple" xlink:href="pgen-20220331.xsd#FairValueMeasurementsAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.dna.com/role/FairValueMeasurementsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_572a4597-b363-44cc-ba25-7e3266181fff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e91c98a2-bd16-43ff-94ed-66a41be2337a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_572a4597-b363-44cc-ba25-7e3266181fff" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e91c98a2-bd16-43ff-94ed-66a41be2337a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_feb0a8fc-647a-4f58-b328-01e82eb35ccd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e91c98a2-bd16-43ff-94ed-66a41be2337a" xlink:to="loc_us-gaap_DebtInstrumentAxis_feb0a8fc-647a-4f58-b328-01e82eb35ccd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_7d4708e9-cbb4-46f4-b233-8be40f9c2920" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_feb0a8fc-647a-4f58-b328-01e82eb35ccd" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_7d4708e9-cbb4-46f4-b233-8be40f9c2920" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_A3.5ConvertibleNotesDue2023Member_3177ba4f-8893-497e-bc73-0d87509a2a21" xlink:href="pgen-20220331.xsd#pgen_A3.5ConvertibleNotesDue2023Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d4708e9-cbb4-46f4-b233-8be40f9c2920" xlink:to="loc_pgen_A3.5ConvertibleNotesDue2023Member_3177ba4f-8893-497e-bc73-0d87509a2a21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3780b69c-b1ce-402e-8ab1-204df93b0cc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e91c98a2-bd16-43ff-94ed-66a41be2337a" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3780b69c-b1ce-402e-8ab1-204df93b0cc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_fa72c122-7ccb-4d09-ada6-659df12455da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3780b69c-b1ce-402e-8ab1-204df93b0cc1" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_fa72c122-7ccb-4d09-ada6-659df12455da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtFairValueDisclosures_186cf21b-7178-4fe6-8ab9-eb8990e87f27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtFairValueDisclosures"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3780b69c-b1ce-402e-8ab1-204df93b0cc1" xlink:to="loc_us-gaap_ConvertibleDebtFairValueDisclosures_186cf21b-7178-4fe6-8ab9-eb8990e87f27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebt_c539e910-988b-4112-9ab3-6774f5727881" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3780b69c-b1ce-402e-8ab1-204df93b0cc1" xlink:to="loc_us-gaap_ConvertibleDebt_c539e910-988b-4112-9ab3-6774f5727881" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dna.com/role/Inventory" xlink:type="simple" xlink:href="pgen-20220331.xsd#Inventory"/>
  <link:presentationLink xlink:role="http://www.dna.com/role/Inventory" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_4081d787-c1fe-46eb-9ab9-52e502c90e3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock_3dc84392-a16e-4de2-9631-b9ddf09e3645" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_4081d787-c1fe-46eb-9ab9-52e502c90e3a" xlink:to="loc_us-gaap_InventoryDisclosureTextBlock_3dc84392-a16e-4de2-9631-b9ddf09e3645" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dna.com/role/InventoryTables" xlink:type="simple" xlink:href="pgen-20220331.xsd#InventoryTables"/>
  <link:presentationLink xlink:role="http://www.dna.com/role/InventoryTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_68c5c0d2-3a52-448b-8883-4dc3eb50c6cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_2361c8ff-717d-4165-8e6e-bf87f56f1549" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_68c5c0d2-3a52-448b-8883-4dc3eb50c6cb" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_2361c8ff-717d-4165-8e6e-bf87f56f1549" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dna.com/role/InventoryDetails" xlink:type="simple" xlink:href="pgen-20220331.xsd#InventoryDetails"/>
  <link:presentationLink xlink:role="http://www.dna.com/role/InventoryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_a4c2b80e-9f4f-41ce-9d32-463514b4f8d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryCurrentTable_5c910bed-e4fb-4594-8d77-3fb99cb7d8a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryCurrentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_a4c2b80e-9f4f-41ce-9d32-463514b4f8d7" xlink:to="loc_us-gaap_InventoryCurrentTable_5c910bed-e4fb-4594-8d77-3fb99cb7d8a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PublicUtilitiesInventoryAxis_2aed9aff-2de5-4504-ad7c-98216b0609de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PublicUtilitiesInventoryAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryCurrentTable_5c910bed-e4fb-4594-8d77-3fb99cb7d8a1" xlink:to="loc_us-gaap_PublicUtilitiesInventoryAxis_2aed9aff-2de5-4504-ad7c-98216b0609de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PublicUtilitiesInventoryTypeDomain_7fb2309a-ebc5-40e8-9a90-2bc62e40eaa9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PublicUtilitiesInventoryTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PublicUtilitiesInventoryAxis_2aed9aff-2de5-4504-ad7c-98216b0609de" xlink:to="loc_us-gaap_PublicUtilitiesInventoryTypeDomain_7fb2309a-ebc5-40e8-9a90-2bc62e40eaa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_SuppliesEmbryosAndOtherProductionMaterialsMember_fc3b1b15-bc51-4d4b-a558-daddafed6e42" xlink:href="pgen-20220331.xsd#pgen_SuppliesEmbryosAndOtherProductionMaterialsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PublicUtilitiesInventoryTypeDomain_7fb2309a-ebc5-40e8-9a90-2bc62e40eaa9" xlink:to="loc_pgen_SuppliesEmbryosAndOtherProductionMaterialsMember_fc3b1b15-bc51-4d4b-a558-daddafed6e42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_WorkInProcessMember_08cbabd2-28e4-473c-acd0-61a0df8e3e49" xlink:href="pgen-20220331.xsd#pgen_WorkInProcessMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PublicUtilitiesInventoryTypeDomain_7fb2309a-ebc5-40e8-9a90-2bc62e40eaa9" xlink:to="loc_pgen_WorkInProcessMember_08cbabd2-28e4-473c-acd0-61a0df8e3e49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_LivestockMember_65a5cee1-a865-42ac-a074-06ded714b02c" xlink:href="pgen-20220331.xsd#pgen_LivestockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PublicUtilitiesInventoryTypeDomain_7fb2309a-ebc5-40e8-9a90-2bc62e40eaa9" xlink:to="loc_pgen_LivestockMember_65a5cee1-a865-42ac-a074-06ded714b02c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_FeedMember_29b308d3-a2d9-4abb-aad5-c23afbb18e0d" xlink:href="pgen-20220331.xsd#pgen_FeedMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PublicUtilitiesInventoryTypeDomain_7fb2309a-ebc5-40e8-9a90-2bc62e40eaa9" xlink:to="loc_pgen_FeedMember_29b308d3-a2d9-4abb-aad5-c23afbb18e0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLineItems_dceb054a-bb2b-4536-852c-9929bc089569" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryCurrentTable_5c910bed-e4fb-4594-8d77-3fb99cb7d8a1" xlink:to="loc_us-gaap_InventoryLineItems_dceb054a-bb2b-4536-852c-9929bc089569" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryGross_6e30b228-bd74-4231-9cb7-f100097e8693" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryLineItems_dceb054a-bb2b-4536-852c-9929bc089569" xlink:to="loc_us-gaap_InventoryGross_6e30b228-bd74-4231-9cb7-f100097e8693" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dna.com/role/PropertyPlantandEquipmentNet" xlink:type="simple" xlink:href="pgen-20220331.xsd#PropertyPlantandEquipmentNet"/>
  <link:presentationLink xlink:role="http://www.dna.com/role/PropertyPlantandEquipmentNet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_17fa8cd0-207f-4593-b487-d3e71c634e2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_41dcf43a-d4d8-49a2-bb54-12abc6fa331b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_17fa8cd0-207f-4593-b487-d3e71c634e2f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_41dcf43a-d4d8-49a2-bb54-12abc6fa331b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dna.com/role/PropertyPlantandEquipmentNetTables" xlink:type="simple" xlink:href="pgen-20220331.xsd#PropertyPlantandEquipmentNetTables"/>
  <link:presentationLink xlink:role="http://www.dna.com/role/PropertyPlantandEquipmentNetTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_f1b4aad1-fb86-4710-8590-9f25ce3335fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_6919d3be-7e2f-496b-9420-69d45e4be7c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_f1b4aad1-fb86-4710-8590-9f25ce3335fb" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_6919d3be-7e2f-496b-9420-69d45e4be7c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dna.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetails" xlink:type="simple" xlink:href="pgen-20220331.xsd#PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetails"/>
  <link:presentationLink xlink:role="http://www.dna.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_8fcf6213-d7ef-4613-a7d6-b7e0dceebaca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandAndLandImprovements_ed4cb830-e14c-44e8-bff7-674fe6d7fb4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LandAndLandImprovements"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_8fcf6213-d7ef-4613-a7d6-b7e0dceebaca" xlink:to="loc_us-gaap_LandAndLandImprovements_ed4cb830-e14c-44e8-bff7-674fe6d7fb4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross_31d7cce0-0815-49c3-9c8b-220ae3816b34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingsAndImprovementsGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_8fcf6213-d7ef-4613-a7d6-b7e0dceebaca" xlink:to="loc_us-gaap_BuildingsAndImprovementsGross_31d7cce0-0815-49c3-9c8b-220ae3816b34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesGross_c497f588-98c1-4d80-b676-5a7828270f33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_8fcf6213-d7ef-4613-a7d6-b7e0dceebaca" xlink:to="loc_us-gaap_FurnitureAndFixturesGross_c497f588-98c1-4d80-b676-5a7828270f33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentGross_0806468a-6c54-449c-b592-15f82daa2246" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MachineryAndEquipmentGross"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_8fcf6213-d7ef-4613-a7d6-b7e0dceebaca" xlink:to="loc_us-gaap_MachineryAndEquipmentGross_0806468a-6c54-449c-b592-15f82daa2246" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsGross_ed38d190-e9d1-437b-8e04-c586c2da94a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsGross"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_8fcf6213-d7ef-4613-a7d6-b7e0dceebaca" xlink:to="loc_us-gaap_LeaseholdImprovementsGross_ed38d190-e9d1-437b-8e04-c586c2da94a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_BreedingandProductionAnimalsGross_6a6e34ef-baed-4740-97d1-9d00779fe5b2" xlink:href="pgen-20220331.xsd#pgen_BreedingandProductionAnimalsGross"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_8fcf6213-d7ef-4613-a7d6-b7e0dceebaca" xlink:to="loc_pgen_BreedingandProductionAnimalsGross_6a6e34ef-baed-4740-97d1-9d00779fe5b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_ComputerHardwareandSoftware_4c86dd87-36bd-4469-abdc-429097c21579" xlink:href="pgen-20220331.xsd#pgen_ComputerHardwareandSoftware"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_8fcf6213-d7ef-4613-a7d6-b7e0dceebaca" xlink:to="loc_pgen_ComputerHardwareandSoftware_4c86dd87-36bd-4469-abdc-429097c21579" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressGross_8000c531-f096-46b2-a678-d4f4dced7996" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressGross"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_8fcf6213-d7ef-4613-a7d6-b7e0dceebaca" xlink:to="loc_us-gaap_ConstructionInProgressGross_8000c531-f096-46b2-a678-d4f4dced7996" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_1857b334-64b0-4840-8e6d-56db6fe7be49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_8fcf6213-d7ef-4613-a7d6-b7e0dceebaca" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_1857b334-64b0-4840-8e6d-56db6fe7be49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_7adc55d4-7fc6-4711-87fa-af1c2f1b2e68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_8fcf6213-d7ef-4613-a7d6-b7e0dceebaca" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_7adc55d4-7fc6-4711-87fa-af1c2f1b2e68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_7b61d790-8302-429b-ae1b-306e61ffee28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_8fcf6213-d7ef-4613-a7d6-b7e0dceebaca" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_7b61d790-8302-429b-ae1b-306e61ffee28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dna.com/role/PropertyPlantandEquipmentNetAdditionalInformationDetails" xlink:type="simple" xlink:href="pgen-20220331.xsd#PropertyPlantandEquipmentNetAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.dna.com/role/PropertyPlantandEquipmentNetAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_28b800c2-6852-42ac-b8bb-2bbf3d93d99e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_763be2e1-aa7b-4273-b9f4-0529a9a30375" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_28b800c2-6852-42ac-b8bb-2bbf3d93d99e" xlink:to="loc_us-gaap_Depreciation_763be2e1-aa7b-4273-b9f4-0529a9a30375" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dna.com/role/GoodwillandIntangibleAssetsNet" xlink:type="simple" xlink:href="pgen-20220331.xsd#GoodwillandIntangibleAssetsNet"/>
  <link:presentationLink xlink:role="http://www.dna.com/role/GoodwillandIntangibleAssetsNet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_7d02d615-f8ef-4706-8c0e-dced7e4a77b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_a7dede68-ac1a-4a54-8c76-29c9a3bcff30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_7d02d615-f8ef-4706-8c0e-dced7e4a77b0" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_a7dede68-ac1a-4a54-8c76-29c9a3bcff30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dna.com/role/GoodwillandIntangibleAssetsNetTables" xlink:type="simple" xlink:href="pgen-20220331.xsd#GoodwillandIntangibleAssetsNetTables"/>
  <link:presentationLink xlink:role="http://www.dna.com/role/GoodwillandIntangibleAssetsNetTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_09ea7b88-d304-4703-8ec0-db1d4f4c98e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_10248d78-a62e-4f70-8318-50cd502c163e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_09ea7b88-d304-4703-8ec0-db1d4f4c98e1" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_10248d78-a62e-4f70-8318-50cd502c163e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_ddf6d672-63d5-4cd5-9ab2-bf2164140691" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_09ea7b88-d304-4703-8ec0-db1d4f4c98e1" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_ddf6d672-63d5-4cd5-9ab2-bf2164140691" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dna.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesinCarryingAmountofGoodwillDetails" xlink:type="simple" xlink:href="pgen-20220331.xsd#GoodwillandIntangibleAssetsNetScheduleofChangesinCarryingAmountofGoodwillDetails"/>
  <link:presentationLink xlink:role="http://www.dna.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesinCarryingAmountofGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_dc338345-c0f5-441c-bae6-9b077af4f250" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_581c0076-c358-43a5-9ef7-7d4b9f2f81e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_dc338345-c0f5-441c-bae6-9b077af4f250" xlink:to="loc_us-gaap_GoodwillRollForward_581c0076-c358-43a5-9ef7-7d4b9f2f81e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_a1867eac-bde7-4cf2-b8e2-2289124a573b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_581c0076-c358-43a5-9ef7-7d4b9f2f81e7" xlink:to="loc_us-gaap_Goodwill_a1867eac-bde7-4cf2-b8e2-2289124a573b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_f130b143-9ef2-4cdb-adb2-dc785619ceb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_581c0076-c358-43a5-9ef7-7d4b9f2f81e7" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_f130b143-9ef2-4cdb-adb2-dc785619ceb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_20d7d8d6-a903-4932-927f-8d342db323ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_581c0076-c358-43a5-9ef7-7d4b9f2f81e7" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_20d7d8d6-a903-4932-927f-8d342db323ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_4856d933-df16-4218-8f69-1f4613d4c7d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_581c0076-c358-43a5-9ef7-7d4b9f2f81e7" xlink:to="loc_us-gaap_Goodwill_4856d933-df16-4218-8f69-1f4613d4c7d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dna.com/role/GoodwillandIntangibleAssetsNetAdditionalInformationDetails" xlink:type="simple" xlink:href="pgen-20220331.xsd#GoodwillandIntangibleAssetsNetAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.dna.com/role/GoodwillandIntangibleAssetsNetAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6c4e6e8a-dff8-4e77-b5e3-4e33143be0d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_580d0276-58e0-4bfe-a70d-7bc63f6f31a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6c4e6e8a-dff8-4e77-b5e3-4e33143be0d6" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_580d0276-58e0-4bfe-a70d-7bc63f6f31a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_f7fc87ee-d404-4c5b-af82-2e6997ec6574" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_580d0276-58e0-4bfe-a70d-7bc63f6f31a5" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_f7fc87ee-d404-4c5b-af82-2e6997ec6574" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_a3ec1586-d9e2-4d31-988f-d3568039df8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_f7fc87ee-d404-4c5b-af82-2e6997ec6574" xlink:to="loc_us-gaap_SegmentDomain_a3ec1586-d9e2-4d31-988f-d3568039df8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_BiopharmaceuticalsSegmentMember_177e70e6-954e-484b-9994-3116bf3c9cf6" xlink:href="pgen-20220331.xsd#pgen_BiopharmaceuticalsSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_a3ec1586-d9e2-4d31-988f-d3568039df8d" xlink:to="loc_pgen_BiopharmaceuticalsSegmentMember_177e70e6-954e-484b-9994-3116bf3c9cf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_be30a94c-0a0c-44db-9cf1-f8fd8f53814f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_580d0276-58e0-4bfe-a70d-7bc63f6f31a5" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_be30a94c-0a0c-44db-9cf1-f8fd8f53814f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_e35ad153-510d-4da1-b9f8-11e878eb21ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_be30a94c-0a0c-44db-9cf1-f8fd8f53814f" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_e35ad153-510d-4da1-b9f8-11e878eb21ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_NumberOfReportingUnitsImpaired_5f9a7c57-8e1e-414c-a2a2-239ff9881e2c" xlink:href="pgen-20220331.xsd#pgen_NumberOfReportingUnitsImpaired"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_be30a94c-0a0c-44db-9cf1-f8fd8f53814f" xlink:to="loc_pgen_NumberOfReportingUnitsImpaired_5f9a7c57-8e1e-414c-a2a2-239ff9881e2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_d47e1b30-d299-4cc1-b5ef-a937497aed9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_be30a94c-0a0c-44db-9cf1-f8fd8f53814f" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_d47e1b30-d299-4cc1-b5ef-a937497aed9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_620a9a65-f58a-4826-b8db-babd2a54cdc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_be30a94c-0a0c-44db-9cf1-f8fd8f53814f" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_620a9a65-f58a-4826-b8db-babd2a54cdc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dna.com/role/GoodwillandIntangibleAssetsNetScheduleofIntangibleAssetsDetails" xlink:type="simple" xlink:href="pgen-20220331.xsd#GoodwillandIntangibleAssetsNetScheduleofIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.dna.com/role/GoodwillandIntangibleAssetsNetScheduleofIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b5f14d5b-90b1-48a3-9a3d-87fcb63f8db9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_0936849b-9cce-4078-8395-09f5a119a2a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b5f14d5b-90b1-48a3-9a3d-87fcb63f8db9" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_0936849b-9cce-4078-8395-09f5a119a2a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_430da71e-0304-4e06-825a-d8dc52a0876c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_0936849b-9cce-4078-8395-09f5a119a2a1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_430da71e-0304-4e06-825a-d8dc52a0876c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ec5af0e3-510e-4ecd-80a8-70ebad475170" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_430da71e-0304-4e06-825a-d8dc52a0876c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ec5af0e3-510e-4ecd-80a8-70ebad475170" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntellectualPropertyMember_a816a078-7deb-401e-8e96-7d120bc9ad54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntellectualPropertyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ec5af0e3-510e-4ecd-80a8-70ebad475170" xlink:to="loc_us-gaap_IntellectualPropertyMember_a816a078-7deb-401e-8e96-7d120bc9ad54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_e1620bbe-43cc-42ce-aabd-ec8594d0e4f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ec5af0e3-510e-4ecd-80a8-70ebad475170" xlink:to="loc_us-gaap_CustomerRelationshipsMember_e1620bbe-43cc-42ce-aabd-ec8594d0e4f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_99a24708-df54-45ea-9995-25c120147e37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ec5af0e3-510e-4ecd-80a8-70ebad475170" xlink:to="loc_us-gaap_TrademarksMember_99a24708-df54-45ea-9995-25c120147e37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ef67e409-5edf-4b15-af6a-d6d619cf31f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_0936849b-9cce-4078-8395-09f5a119a2a1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ef67e409-5edf-4b15-af6a-d6d619cf31f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_abb722a4-1cfc-44c1-a8e7-d65ebb990364" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNetAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ef67e409-5edf-4b15-af6a-d6d619cf31f1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_abb722a4-1cfc-44c1-a8e7-d65ebb990364" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_3c6357b9-fbc0-40b8-9192-c2f2a0f358f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_abb722a4-1cfc-44c1-a8e7-d65ebb990364" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_3c6357b9-fbc0-40b8-9192-c2f2a0f358f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_467416ce-9e8a-4f2b-86d2-ff333ba03bab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_abb722a4-1cfc-44c1-a8e7-d65ebb990364" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_467416ce-9e8a-4f2b-86d2-ff333ba03bab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_0cd64b22-e7df-470b-b49e-06e358b3cdb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_abb722a4-1cfc-44c1-a8e7-d65ebb990364" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_0cd64b22-e7df-470b-b49e-06e358b3cdb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dna.com/role/LinesofCreditandLongTermDebt" xlink:type="simple" xlink:href="pgen-20220331.xsd#LinesofCreditandLongTermDebt"/>
  <link:presentationLink xlink:role="http://www.dna.com/role/LinesofCreditandLongTermDebt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_0734bfc0-e41d-4199-8779-8e69495f8fc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_324391d0-f2af-4033-9678-2842c5f61e41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_0734bfc0-e41d-4199-8779-8e69495f8fc6" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_324391d0-f2af-4033-9678-2842c5f61e41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dna.com/role/LinesofCreditandLongTermDebtTables" xlink:type="simple" xlink:href="pgen-20220331.xsd#LinesofCreditandLongTermDebtTables"/>
  <link:presentationLink xlink:role="http://www.dna.com/role/LinesofCreditandLongTermDebtTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_cd78aaae-0f2f-42ae-b980-f838aec49415" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_e8ce6543-4386-4f62-9daf-4923a3d5adf6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_cd78aaae-0f2f-42ae-b980-f838aec49415" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_e8ce6543-4386-4f62-9daf-4923a3d5adf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock_5cb52a58-1ccd-44d6-a324-b56fa1f1f2fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_cd78aaae-0f2f-42ae-b980-f838aec49415" xlink:to="loc_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock_5cb52a58-1ccd-44d6-a324-b56fa1f1f2fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_5ad9d6a4-45ee-4226-ad64-46aa054a9228" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_cd78aaae-0f2f-42ae-b980-f838aec49415" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_5ad9d6a4-45ee-4226-ad64-46aa054a9228" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dna.com/role/LinesofCreditandLongTermDebtLinesofCreditAdditionalInformationDetails" xlink:type="simple" xlink:href="pgen-20220331.xsd#LinesofCreditandLongTermDebtLinesofCreditAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.dna.com/role/LinesofCreditandLongTermDebtLinesofCreditAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_abde313b-6256-4a1a-8e14-9106ee965103" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_833adf25-4ad0-4e0f-a6fd-63c527879f27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_abde313b-6256-4a1a-8e14-9106ee965103" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_833adf25-4ad0-4e0f-a6fd-63c527879f27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_4199535d-001e-40de-a7ac-f6dfaf60dcca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_833adf25-4ad0-4e0f-a6fd-63c527879f27" xlink:to="loc_us-gaap_CreditFacilityAxis_4199535d-001e-40de-a7ac-f6dfaf60dcca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_b8454601-0d23-402a-96d7-573246576c3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_4199535d-001e-40de-a7ac-f6dfaf60dcca" xlink:to="loc_us-gaap_CreditFacilityDomain_b8454601-0d23-402a-96d7-573246576c3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_8e63858b-d5ac-45c8-a375-24ddd78da4c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_b8454601-0d23-402a-96d7-573246576c3d" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_8e63858b-d5ac-45c8-a375-24ddd78da4c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_bcaf808e-4d2d-4779-ab13-d5a152f66dca" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_833adf25-4ad0-4e0f-a6fd-63c527879f27" xlink:to="loc_dei_LegalEntityAxis_bcaf808e-4d2d-4779-ab13-d5a152f66dca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_2bcc320c-be59-4b2b-938e-66d953ed8044" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_bcaf808e-4d2d-4779-ab13-d5a152f66dca" xlink:to="loc_dei_EntityDomain_2bcc320c-be59-4b2b-938e-66d953ed8044" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_TransOvaGeneticsLcMember_f225cfd4-aa7c-40b0-8d8d-d6d62962b8c7" xlink:href="pgen-20220331.xsd#pgen_TransOvaGeneticsLcMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_2bcc320c-be59-4b2b-938e-66d953ed8044" xlink:to="loc_pgen_TransOvaGeneticsLcMember_f225cfd4-aa7c-40b0-8d8d-d6d62962b8c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_ExemplarGeneticsLLCMember_2c1fdbfd-47e0-41f1-ba1b-a277609e9517" xlink:href="pgen-20220331.xsd#pgen_ExemplarGeneticsLLCMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_2bcc320c-be59-4b2b-938e-66d953ed8044" xlink:to="loc_pgen_ExemplarGeneticsLLCMember_2c1fdbfd-47e0-41f1-ba1b-a277609e9517" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_e90f9f3e-b92b-4298-92ef-44ad09762967" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_833adf25-4ad0-4e0f-a6fd-63c527879f27" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_e90f9f3e-b92b-4298-92ef-44ad09762967" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_400688a5-2a3b-49f7-950c-ea72c2a72365" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_e90f9f3e-b92b-4298-92ef-44ad09762967" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_400688a5-2a3b-49f7-950c-ea72c2a72365" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_FirstNationalBankofOmahaMember_f218b3dd-2063-461b-bba5-877186ebd215" xlink:href="pgen-20220331.xsd#pgen_FirstNationalBankofOmahaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_400688a5-2a3b-49f7-950c-ea72c2a72365" xlink:to="loc_pgen_FirstNationalBankofOmahaMember_f218b3dd-2063-461b-bba5-877186ebd215" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_AmericanStateBankMember_39b89448-cce0-4981-bfdb-86849138cc89" xlink:href="pgen-20220331.xsd#pgen_AmericanStateBankMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_400688a5-2a3b-49f7-950c-ea72c2a72365" xlink:to="loc_pgen_AmericanStateBankMember_39b89448-cce0-4981-bfdb-86849138cc89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_6e0367fe-6b94-4f6c-8b5f-f0be1e18c708" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_833adf25-4ad0-4e0f-a6fd-63c527879f27" xlink:to="loc_srt_RangeAxis_6e0367fe-6b94-4f6c-8b5f-f0be1e18c708" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_8c76c53e-2364-4aa7-878f-f885a2f76b16" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_6e0367fe-6b94-4f6c-8b5f-f0be1e18c708" xlink:to="loc_srt_RangeMember_8c76c53e-2364-4aa7-878f-f885a2f76b16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_d763aed7-b0c6-4125-aa02-753740575334" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_8c76c53e-2364-4aa7-878f-f885a2f76b16" xlink:to="loc_srt_MinimumMember_d763aed7-b0c6-4125-aa02-753740575334" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_db3d4ddf-4111-4c54-a540-94dd977ac124" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_833adf25-4ad0-4e0f-a6fd-63c527879f27" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_db3d4ddf-4111-4c54-a540-94dd977ac124" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_3bf9d55b-9dcf-4a64-9b71-f757efbeaaa5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_db3d4ddf-4111-4c54-a540-94dd977ac124" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_3bf9d55b-9dcf-4a64-9b71-f757efbeaaa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_97a5ae8d-2deb-46e9-b905-63650d3a0ba5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_db3d4ddf-4111-4c54-a540-94dd977ac124" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_97a5ae8d-2deb-46e9-b905-63650d3a0ba5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_d3b2bd00-98be-49de-b501-b7e6ad86a960" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_db3d4ddf-4111-4c54-a540-94dd977ac124" xlink:to="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_d3b2bd00-98be-49de-b501-b7e6ad86a960" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_b4b6f568-3783-4814-868a-f7d95ef42a32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_db3d4ddf-4111-4c54-a540-94dd977ac124" xlink:to="loc_us-gaap_LineOfCredit_b4b6f568-3783-4814-868a-f7d95ef42a32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_6b1f7960-5a76-406c-9b57-621de93e7089" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_db3d4ddf-4111-4c54-a540-94dd977ac124" xlink:to="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_6b1f7960-5a76-406c-9b57-621de93e7089" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dna.com/role/LinesofCreditandLongTermDebtScheduleofLongTermDebtInstrumentsDetails" xlink:type="simple" xlink:href="pgen-20220331.xsd#LinesofCreditandLongTermDebtScheduleofLongTermDebtInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.dna.com/role/LinesofCreditandLongTermDebtScheduleofLongTermDebtInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_c550f513-2127-4551-a105-b317afa53dca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_d5cce891-4822-4b30-9e94-67c05eff56ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_c550f513-2127-4551-a105-b317afa53dca" xlink:to="loc_us-gaap_DebtInstrumentTable_d5cce891-4822-4b30-9e94-67c05eff56ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_03078367-45f8-483e-983b-fea0023aec01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_d5cce891-4822-4b30-9e94-67c05eff56ff" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_03078367-45f8-483e-983b-fea0023aec01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_67ba794e-a463-40e9-ba19-f22d851bf737" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_03078367-45f8-483e-983b-fea0023aec01" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_67ba794e-a463-40e9-ba19-f22d851bf737" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_f7e31666-eb6d-491a-846d-5cb864ce3d24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_67ba794e-a463-40e9-ba19-f22d851bf737" xlink:to="loc_us-gaap_ConvertibleDebtMember_f7e31666-eb6d-491a-846d-5cb864ce3d24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableToBanksMember_61f25bf8-3f51-4569-a6f1-b3ae2af32209" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableToBanksMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_67ba794e-a463-40e9-ba19-f22d851bf737" xlink:to="loc_us-gaap_NotesPayableToBanksMember_61f25bf8-3f51-4569-a6f1-b3ae2af32209" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_OtherLongTermDebtMember_458c8f57-951f-4739-91be-17f46a70eeda" xlink:href="pgen-20220331.xsd#pgen_OtherLongTermDebtMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_67ba794e-a463-40e9-ba19-f22d851bf737" xlink:to="loc_pgen_OtherLongTermDebtMember_458c8f57-951f-4739-91be-17f46a70eeda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_27b6c389-5d39-47d2-a3bc-c442ac28985d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_d5cce891-4822-4b30-9e94-67c05eff56ff" xlink:to="loc_us-gaap_DebtInstrumentLineItems_27b6c389-5d39-47d2-a3bc-c442ac28985d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_7bfb4005-2c60-44ec-bb5f-aa2cb2dd2933" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_27b6c389-5d39-47d2-a3bc-c442ac28985d" xlink:to="loc_us-gaap_LongTermDebt_7bfb4005-2c60-44ec-bb5f-aa2cb2dd2933" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_06101dd5-ed65-4219-99ba-271335d0d009" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_27b6c389-5d39-47d2-a3bc-c442ac28985d" xlink:to="loc_us-gaap_LongTermDebtCurrent_06101dd5-ed65-4219-99ba-271335d0d009" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_ffd9368d-b95a-4195-ba34-484b692ba74b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_27b6c389-5d39-47d2-a3bc-c442ac28985d" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_ffd9368d-b95a-4195-ba34-484b692ba74b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dna.com/role/LinesofCreditandLongTermDebtLongTermDebtAdditionalInformationDetails" xlink:type="simple" xlink:href="pgen-20220331.xsd#LinesofCreditandLongTermDebtLongTermDebtAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.dna.com/role/LinesofCreditandLongTermDebtLongTermDebtAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_1b6f9498-9f1a-45c0-9773-02b348e11e91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_c64da79d-ab04-4d47-93ef-59103f55e3ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_1b6f9498-9f1a-45c0-9773-02b348e11e91" xlink:to="loc_us-gaap_DebtInstrumentTable_c64da79d-ab04-4d47-93ef-59103f55e3ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_c5c07ec1-3f91-4438-86c4-9618de0dcdcf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c64da79d-ab04-4d47-93ef-59103f55e3ea" xlink:to="loc_us-gaap_DebtInstrumentAxis_c5c07ec1-3f91-4438-86c4-9618de0dcdcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_00006ea9-503f-4988-a7b5-be5c013df288" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_c5c07ec1-3f91-4438-86c4-9618de0dcdcf" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_00006ea9-503f-4988-a7b5-be5c013df288" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_A3.5ConvertibleNotesDue2023Member_340d78e2-ffd8-4ad2-830f-29476c20332b" xlink:href="pgen-20220331.xsd#pgen_A3.5ConvertibleNotesDue2023Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_00006ea9-503f-4988-a7b5-be5c013df288" xlink:to="loc_pgen_A3.5ConvertibleNotesDue2023Member_340d78e2-ffd8-4ad2-830f-29476c20332b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_e702e8b3-e566-49f0-bfc8-122ffca9c3c3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c64da79d-ab04-4d47-93ef-59103f55e3ea" xlink:to="loc_srt_RangeAxis_e702e8b3-e566-49f0-bfc8-122ffca9c3c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_786ef8fa-c0bf-4a30-a9e9-e5a1fc6f903d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_e702e8b3-e566-49f0-bfc8-122ffca9c3c3" xlink:to="loc_srt_RangeMember_786ef8fa-c0bf-4a30-a9e9-e5a1fc6f903d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_9dd5a43e-9b71-4026-a688-8e2839c08196" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_786ef8fa-c0bf-4a30-a9e9-e5a1fc6f903d" xlink:to="loc_srt_MinimumMember_9dd5a43e-9b71-4026-a688-8e2839c08196" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_6bb8ab17-c957-4df4-8fbc-94e7ef3e360b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_786ef8fa-c0bf-4a30-a9e9-e5a1fc6f903d" xlink:to="loc_srt_MaximumMember_6bb8ab17-c957-4df4-8fbc-94e7ef3e360b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_6031f87b-14b3-4fce-a7b1-fb0177b19a57" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c64da79d-ab04-4d47-93ef-59103f55e3ea" xlink:to="loc_dei_LegalEntityAxis_6031f87b-14b3-4fce-a7b1-fb0177b19a57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_e097d0c6-5a06-4230-9c00-291f59b7b1cb" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_6031f87b-14b3-4fce-a7b1-fb0177b19a57" xlink:to="loc_dei_EntityDomain_e097d0c6-5a06-4230-9c00-291f59b7b1cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_TransOvaGeneticsLcMember_19f1a53f-fc95-48f0-9567-d83895834a9d" xlink:href="pgen-20220331.xsd#pgen_TransOvaGeneticsLcMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_e097d0c6-5a06-4230-9c00-291f59b7b1cb" xlink:to="loc_pgen_TransOvaGeneticsLcMember_19f1a53f-fc95-48f0-9567-d83895834a9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_5cd61a4c-b169-4477-8e54-f18b46698370" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c64da79d-ab04-4d47-93ef-59103f55e3ea" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_5cd61a4c-b169-4477-8e54-f18b46698370" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_83a81714-128a-4736-9ad1-daa0ca0ccb6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_5cd61a4c-b169-4477-8e54-f18b46698370" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_83a81714-128a-4736-9ad1-daa0ca0ccb6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_acc5b32d-67d0-4bd7-96ae-79a6ea54486a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_83a81714-128a-4736-9ad1-daa0ca0ccb6f" xlink:to="loc_us-gaap_ConvertibleDebtMember_acc5b32d-67d0-4bd7-96ae-79a6ea54486a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableToBanksMember_6aa06286-6092-43d9-8863-97760af3de60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableToBanksMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_83a81714-128a-4736-9ad1-daa0ca0ccb6f" xlink:to="loc_us-gaap_NotesPayableToBanksMember_6aa06286-6092-43d9-8863-97760af3de60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_95b195bd-b703-42e5-bae1-17b3a692bb1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c64da79d-ab04-4d47-93ef-59103f55e3ea" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_95b195bd-b703-42e5-bae1-17b3a692bb1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_992047a1-447f-43b2-b67a-0b84e2972413" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_95b195bd-b703-42e5-bae1-17b3a692bb1d" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_992047a1-447f-43b2-b67a-0b84e2972413" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_AmericanStateBankMember_0c9c666f-8edc-46cf-8026-c4284d23632c" xlink:href="pgen-20220331.xsd#pgen_AmericanStateBankMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_992047a1-447f-43b2-b67a-0b84e2972413" xlink:to="loc_pgen_AmericanStateBankMember_0c9c666f-8edc-46cf-8026-c4284d23632c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_175cfe2c-02e6-4646-928c-2ff2c80c8ee3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c64da79d-ab04-4d47-93ef-59103f55e3ea" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_175cfe2c-02e6-4646-928c-2ff2c80c8ee3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_a5f514b4-7070-4b5c-a3e4-9536ab867fed" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_175cfe2c-02e6-4646-928c-2ff2c80c8ee3" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_a5f514b4-7070-4b5c-a3e4-9536ab867fed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_d7ad577f-da31-48ac-a8b5-7dacd217d350" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_a5f514b4-7070-4b5c-a3e4-9536ab867fed" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_d7ad577f-da31-48ac-a8b5-7dacd217d350" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_603b4c64-2e4a-4920-b4ed-140aeaa3de41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c64da79d-ab04-4d47-93ef-59103f55e3ea" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_603b4c64-2e4a-4920-b4ed-140aeaa3de41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_3d3151b9-c231-4b38-ab39-a00873251455" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_603b4c64-2e4a-4920-b4ed-140aeaa3de41" xlink:to="loc_us-gaap_TypeOfAdoptionMember_3d3151b9-c231-4b38-ab39-a00873251455" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate202006RetrospectiveMember_63f6ca0f-c470-4c36-8cd0-b6e74dd663e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate202006RetrospectiveMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_3d3151b9-c231-4b38-ab39-a00873251455" xlink:to="loc_us-gaap_AccountingStandardsUpdate202006RetrospectiveMember_63f6ca0f-c470-4c36-8cd0-b6e74dd663e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_4820073e-e409-4f7f-a489-55c50b17be49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c64da79d-ab04-4d47-93ef-59103f55e3ea" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_4820073e-e409-4f7f-a489-55c50b17be49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_3c934d9e-7476-4b49-938d-ab0faef8185a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_4820073e-e409-4f7f-a489-55c50b17be49" xlink:to="loc_us-gaap_EquityComponentDomain_3c934d9e-7476-4b49-938d-ab0faef8185a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_c5c9128c-1eaf-4282-937d-dbf08b82cb70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3c934d9e-7476-4b49-938d-ab0faef8185a" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_c5c9128c-1eaf-4282-937d-dbf08b82cb70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_124a0985-ad1b-473f-981b-d88aeed57de6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3c934d9e-7476-4b49-938d-ab0faef8185a" xlink:to="loc_us-gaap_RetainedEarningsMember_124a0985-ad1b-473f-981b-d88aeed57de6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_c9585b3a-9b03-46e5-b428-ec68188933b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c64da79d-ab04-4d47-93ef-59103f55e3ea" xlink:to="loc_us-gaap_DebtInstrumentLineItems_c9585b3a-9b03-46e5-b428-ec68188933b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_c1b4b8a7-1e4b-46db-9a06-7cd0a7bfe287" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c9585b3a-9b03-46e5-b428-ec68188933b9" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_c1b4b8a7-1e4b-46db-9a06-7cd0a7bfe287" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_df0e99bf-5612-4091-9ed9-1780b85cfbcc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c9585b3a-9b03-46e5-b428-ec68188933b9" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_df0e99bf-5612-4091-9ed9-1780b85cfbcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross_aae844fa-00f3-4314-ace5-1f1f914d9da2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c9585b3a-9b03-46e5-b428-ec68188933b9" xlink:to="loc_us-gaap_DeferredFinanceCostsGross_aae844fa-00f3-4314-ace5-1f1f914d9da2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_33ed955c-6fdb-4b8a-b1f2-8f7548f7aa72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c9585b3a-9b03-46e5-b428-ec68188933b9" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_33ed955c-6fdb-4b8a-b1f2-8f7548f7aa72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_43f2c42f-6a48-4233-bee3-7f1a27fe3ebd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c9585b3a-9b03-46e5-b428-ec68188933b9" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_43f2c42f-6a48-4233-bee3-7f1a27fe3ebd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_ConvertibleDebtPrincipalAmountInitialConversionRate_23887f32-c0be-4994-b167-ff9ddc707a24" xlink:href="pgen-20220331.xsd#pgen_ConvertibleDebtPrincipalAmountInitialConversionRate"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c9585b3a-9b03-46e5-b428-ec68188933b9" xlink:to="loc_pgen_ConvertibleDebtPrincipalAmountInitialConversionRate_23887f32-c0be-4994-b167-ff9ddc707a24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_70ef2647-2614-4074-ae0f-0d5199a77a35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c9585b3a-9b03-46e5-b428-ec68188933b9" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_70ef2647-2614-4074-ae0f-0d5199a77a35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_f6a4df8f-8670-4de2-8490-6051ac6b9f81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c9585b3a-9b03-46e5-b428-ec68188933b9" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_f6a4df8f-8670-4de2-8490-6051ac6b9f81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_97cb41a5-a4b7-4342-a1a4-b1ec69d02a24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c9585b3a-9b03-46e5-b428-ec68188933b9" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_97cb41a5-a4b7-4342-a1a4-b1ec69d02a24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_44edae6a-c9ee-4728-a12c-92c1f1a08e3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c9585b3a-9b03-46e5-b428-ec68188933b9" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_44edae6a-c9ee-4728-a12c-92c1f1a08e3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_1f7acc1d-235a-48cb-9f59-294039cf19bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c9585b3a-9b03-46e5-b428-ec68188933b9" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_1f7acc1d-235a-48cb-9f59-294039cf19bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebt_2b25f661-bb18-43ce-a803-c9dbfe2cc1d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebt"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c9585b3a-9b03-46e5-b428-ec68188933b9" xlink:to="loc_us-gaap_ConvertibleDebt_2b25f661-bb18-43ce-a803-c9dbfe2cc1d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_b186f83b-b179-4de4-a303-619f1eac39aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c9585b3a-9b03-46e5-b428-ec68188933b9" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_b186f83b-b179-4de4-a303-619f1eac39aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_071f02de-6cc8-4b3d-b966-5397fb343054" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c9585b3a-9b03-46e5-b428-ec68188933b9" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_071f02de-6cc8-4b3d-b966-5397fb343054" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_d2008e4f-503c-4a28-a973-39870a3359cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c9585b3a-9b03-46e5-b428-ec68188933b9" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_d2008e4f-503c-4a28-a973-39870a3359cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_bd115c78-267f-48d0-9680-196ee5d69063" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c9585b3a-9b03-46e5-b428-ec68188933b9" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_bd115c78-267f-48d0-9680-196ee5d69063" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_443cbf03-36fa-417e-9a74-932f6407b17c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c9585b3a-9b03-46e5-b428-ec68188933b9" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_443cbf03-36fa-417e-9a74-932f6407b17c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_6781124b-fb4e-4e43-95f0-f2e116f45d6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c9585b3a-9b03-46e5-b428-ec68188933b9" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_6781124b-fb4e-4e43-95f0-f2e116f45d6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrentAndNoncurrent_089f6770-29c4-4e29-99e1-4627df78db55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPayableCurrentAndNoncurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c9585b3a-9b03-46e5-b428-ec68188933b9" xlink:to="loc_us-gaap_InterestPayableCurrentAndNoncurrent_089f6770-29c4-4e29-99e1-4627df78db55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_31588912-a8fe-481d-92c0-fc789bf555ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c9585b3a-9b03-46e5-b428-ec68188933b9" xlink:to="loc_us-gaap_LongTermDebt_31588912-a8fe-481d-92c0-fc789bf555ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPayment_617fe774-034d-470e-b4e9-90581f142e9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentPeriodicPayment"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c9585b3a-9b03-46e5-b428-ec68188933b9" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPayment_617fe774-034d-470e-b4e9-90581f142e9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dna.com/role/LinesofCreditandLongTermDebtScheduleofComponentsofInterestExpenseDetails" xlink:type="simple" xlink:href="pgen-20220331.xsd#LinesofCreditandLongTermDebtScheduleofComponentsofInterestExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.dna.com/role/LinesofCreditandLongTermDebtScheduleofComponentsofInterestExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_c3735d8d-a6fa-4ced-953c-16ba456c3bf8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_bbca3219-9fd6-46d6-9ada-b5029c296a19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_c3735d8d-a6fa-4ced-953c-16ba456c3bf8" xlink:to="loc_us-gaap_DebtInstrumentTable_bbca3219-9fd6-46d6-9ada-b5029c296a19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_b7696ca5-b422-4a43-9331-c65ae2943ba2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_bbca3219-9fd6-46d6-9ada-b5029c296a19" xlink:to="loc_us-gaap_DebtInstrumentAxis_b7696ca5-b422-4a43-9331-c65ae2943ba2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_fe7a1b49-89ec-44b1-a5d8-b8aea6bc7321" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_b7696ca5-b422-4a43-9331-c65ae2943ba2" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_fe7a1b49-89ec-44b1-a5d8-b8aea6bc7321" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_A3.5ConvertibleNotesDue2023Member_00ad6777-888f-477c-a170-4a9094a2cbc1" xlink:href="pgen-20220331.xsd#pgen_A3.5ConvertibleNotesDue2023Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fe7a1b49-89ec-44b1-a5d8-b8aea6bc7321" xlink:to="loc_pgen_A3.5ConvertibleNotesDue2023Member_00ad6777-888f-477c-a170-4a9094a2cbc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_269c3793-c74e-4ff2-9a94-cc1e1ed93feb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_bbca3219-9fd6-46d6-9ada-b5029c296a19" xlink:to="loc_us-gaap_DebtInstrumentLineItems_269c3793-c74e-4ff2-9a94-cc1e1ed93feb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebtExcludingAmortization_6846a212-955f-4aaf-8b57-8fcfc1fa5a6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebtExcludingAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_269c3793-c74e-4ff2-9a94-cc1e1ed93feb" xlink:to="loc_us-gaap_InterestExpenseDebtExcludingAmortization_6846a212-955f-4aaf-8b57-8fcfc1fa5a6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_InterestExpenseDebtAmortizationofDebtDiscountPremiumandDebtIssuanceCosts_dd2a48c1-7885-4b1d-97c2-3039dde3eb34" xlink:href="pgen-20220331.xsd#pgen_InterestExpenseDebtAmortizationofDebtDiscountPremiumandDebtIssuanceCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_269c3793-c74e-4ff2-9a94-cc1e1ed93feb" xlink:to="loc_pgen_InterestExpenseDebtAmortizationofDebtDiscountPremiumandDebtIssuanceCosts_dd2a48c1-7885-4b1d-97c2-3039dde3eb34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_ecd2d0af-bff0-4ece-9c59-82d31b3622b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_269c3793-c74e-4ff2-9a94-cc1e1ed93feb" xlink:to="loc_us-gaap_InterestExpenseDebt_ecd2d0af-bff0-4ece-9c59-82d31b3622b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dna.com/role/LinesofCreditandLongTermDebtScheduleofFutureMaturitiesofLongTermDebtDetails" xlink:type="simple" xlink:href="pgen-20220331.xsd#LinesofCreditandLongTermDebtScheduleofFutureMaturitiesofLongTermDebtDetails"/>
  <link:presentationLink xlink:role="http://www.dna.com/role/LinesofCreditandLongTermDebtScheduleofFutureMaturitiesofLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_f9ed2cf9-f21c-4264-94de-967a73c045ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_68522dc8-47bf-4fcb-bb00-a44036008182" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_f9ed2cf9-f21c-4264-94de-967a73c045ef" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_68522dc8-47bf-4fcb-bb00-a44036008182" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_207d3403-49dd-413f-a850-f88f05e516e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_f9ed2cf9-f21c-4264-94de-967a73c045ef" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_207d3403-49dd-413f-a850-f88f05e516e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_912777e9-1abb-421e-8625-0d25be87b310" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_f9ed2cf9-f21c-4264-94de-967a73c045ef" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_912777e9-1abb-421e-8625-0d25be87b310" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_fec91eca-d664-4ba1-9456-0e918e9c262f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_f9ed2cf9-f21c-4264-94de-967a73c045ef" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_fec91eca-d664-4ba1-9456-0e918e9c262f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_539a6cb1-d04d-45b2-8b50-0067056b5e9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_f9ed2cf9-f21c-4264-94de-967a73c045ef" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_539a6cb1-d04d-45b2-8b50-0067056b5e9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_b0467642-738d-4d84-9d59-6d4e5016b340" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_f9ed2cf9-f21c-4264-94de-967a73c045ef" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_b0467642-738d-4d84-9d59-6d4e5016b340" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_e1233f3e-0958-49d7-87b1-f419f5fb7a66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_f9ed2cf9-f21c-4264-94de-967a73c045ef" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_e1233f3e-0958-49d7-87b1-f419f5fb7a66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_2b77f4a3-ecb3-4f7f-8d56-28ef2f260255" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_f9ed2cf9-f21c-4264-94de-967a73c045ef" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_2b77f4a3-ecb3-4f7f-8d56-28ef2f260255" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dna.com/role/IncomeTaxes" xlink:type="simple" xlink:href="pgen-20220331.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.dna.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_ae042558-fc20-400d-b31b-2df911fe19c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_9f60f7b6-a782-48f2-b554-66b362bb0cdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ae042558-fc20-400d-b31b-2df911fe19c8" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_9f60f7b6-a782-48f2-b554-66b362bb0cdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dna.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="pgen-20220331.xsd#IncomeTaxesTables"/>
  <link:presentationLink xlink:role="http://www.dna.com/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_ba8d04d8-a0b0-4376-94bb-11c01aafd63f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_aa5bf078-cbb6-4943-a582-c6c71adfb4ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ba8d04d8-a0b0-4376-94bb-11c01aafd63f" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_aa5bf078-cbb6-4943-a582-c6c71adfb4ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dna.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="pgen-20220331.xsd#IncomeTaxesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.dna.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_ed1c91f9-09c9-4b23-8fbc-8558b81f0cc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_fd0956ad-e1eb-40e9-af8c-6500d6996ec6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ed1c91f9-09c9-4b23-8fbc-8558b81f0cc9" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_fd0956ad-e1eb-40e9-af8c-6500d6996ec6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis_a339885a-b7d8-4619-b917-63d6468fb9d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_fd0956ad-e1eb-40e9-af8c-6500d6996ec6" xlink:to="loc_us-gaap_TaxCreditCarryforwardAxis_a339885a-b7d8-4619-b917-63d6468fb9d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_675cc8d0-e215-4980-a3aa-94ac199f1145" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_a339885a-b7d8-4619-b917-63d6468fb9d8" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_675cc8d0-e215-4980-a3aa-94ac199f1145" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_GeneratedAfter2017Member_d78d485d-7013-4648-a9bc-465a6a259340" xlink:href="pgen-20220331.xsd#pgen_GeneratedAfter2017Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_675cc8d0-e215-4980-a3aa-94ac199f1145" xlink:to="loc_pgen_GeneratedAfter2017Member_d78d485d-7013-4648-a9bc-465a6a259340" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_def73d20-a550-4df0-a451-0bdd047dc521" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_fd0956ad-e1eb-40e9-af8c-6500d6996ec6" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_def73d20-a550-4df0-a451-0bdd047dc521" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_b680c854-4a99-40e4-8ca3-54e2654b832a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_def73d20-a550-4df0-a451-0bdd047dc521" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_b680c854-4a99-40e4-8ca3-54e2654b832a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_ce08cba9-288a-412b-b710-6aa7ba52df53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_b680c854-4a99-40e4-8ca3-54e2654b832a" xlink:to="loc_us-gaap_DomesticCountryMember_ce08cba9-288a-412b-b710-6aa7ba52df53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_84e07c3e-5156-403d-b2c4-2db7e01943e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_b680c854-4a99-40e4-8ca3-54e2654b832a" xlink:to="loc_us-gaap_ForeignCountryMember_84e07c3e-5156-403d-b2c4-2db7e01943e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_dae90117-0003-4d0c-b1eb-682bd3348f4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_fd0956ad-e1eb-40e9-af8c-6500d6996ec6" xlink:to="loc_us-gaap_OperatingLossCarryforwardsLineItems_dae90117-0003-4d0c-b1eb-682bd3348f4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_TaxableIncomeLoss_3a4c9d1c-9868-4309-8fd4-d6f9dfebc171" xlink:href="pgen-20220331.xsd#pgen_TaxableIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_dae90117-0003-4d0c-b1eb-682bd3348f4b" xlink:to="loc_pgen_TaxableIncomeLoss_3a4c9d1c-9868-4309-8fd4-d6f9dfebc171" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_401fc767-2f14-45d4-8486-2405eb4d4a70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_dae90117-0003-4d0c-b1eb-682bd3348f4b" xlink:to="loc_us-gaap_DeferredTaxLiabilities_401fc767-2f14-45d4-8486-2405eb4d4a70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_457b015a-b6ee-4c7c-acad-ac59cd9888b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_dae90117-0003-4d0c-b1eb-682bd3348f4b" xlink:to="loc_us-gaap_OperatingLossCarryforwards_457b015a-b6ee-4c7c-acad-ac59cd9888b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards_bef18845-1769-47cb-878c-957e58032a48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsCapitalLossCarryforwards"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_dae90117-0003-4d0c-b1eb-682bd3348f4b" xlink:to="loc_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards_bef18845-1769-47cb-878c-957e58032a48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_13c23548-2598-401f-8b08-5d8d070d2a4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_dae90117-0003-4d0c-b1eb-682bd3348f4b" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_13c23548-2598-401f-8b08-5d8d070d2a4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dna.com/role/IncomeTaxesComponentsofIncomeTaxBenefitsDetails" xlink:type="simple" xlink:href="pgen-20220331.xsd#IncomeTaxesComponentsofIncomeTaxBenefitsDetails"/>
  <link:presentationLink xlink:role="http://www.dna.com/role/IncomeTaxesComponentsofIncomeTaxBenefitsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_84c5ab7f-ce40-4aac-81e3-f90652ed1994" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_26005f58-d097-43a6-9ad5-2ea307db45f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_84c5ab7f-ce40-4aac-81e3-f90652ed1994" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_26005f58-d097-43a6-9ad5-2ea307db45f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_559d3d95-67fe-4bb7-8796-25861c0c849e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOperatingActivitiesSegmentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_26005f58-d097-43a6-9ad5-2ea307db45f7" xlink:to="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_559d3d95-67fe-4bb7-8796-25861c0c849e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentOperatingActivitiesDomain_cd485dd8-5942-4250-898d-8f59e3071425" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentOperatingActivitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_559d3d95-67fe-4bb7-8796-25861c0c849e" xlink:to="loc_us-gaap_SegmentOperatingActivitiesDomain_cd485dd8-5942-4250-898d-8f59e3071425" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentContinuingOperationsMember_2fa94230-696a-43ba-80d0-c18d0f254d47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentContinuingOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentOperatingActivitiesDomain_cd485dd8-5942-4250-898d-8f59e3071425" xlink:to="loc_us-gaap_SegmentContinuingOperationsMember_2fa94230-696a-43ba-80d0-c18d0f254d47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_859a99ef-c089-4db3-9f7e-0d3fe42a2371" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_26005f58-d097-43a6-9ad5-2ea307db45f7" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_859a99ef-c089-4db3-9f7e-0d3fe42a2371" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_e5847e3e-97cd-4268-8e52-be0261be538d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_859a99ef-c089-4db3-9f7e-0d3fe42a2371" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_e5847e3e-97cd-4268-8e52-be0261be538d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_6ef16bbc-4624-4733-95fa-6cf946e6bc7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_e5847e3e-97cd-4268-8e52-be0261be538d" xlink:to="loc_us-gaap_ForeignCountryMember_6ef16bbc-4624-4733-95fa-6cf946e6bc7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_7d6ab78e-11b8-4c8e-a8f0-bcfa83854acf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_26005f58-d097-43a6-9ad5-2ea307db45f7" xlink:to="loc_us-gaap_OperatingLossCarryforwardsLineItems_7d6ab78e-11b8-4c8e-a8f0-bcfa83854acf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_3584dd2a-8f31-4134-aa19-428160ee2ae8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_7d6ab78e-11b8-4c8e-a8f0-bcfa83854acf" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_3584dd2a-8f31-4134-aa19-428160ee2ae8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_197166ef-eead-4f9f-b604-3b664c1dec67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_7d6ab78e-11b8-4c8e-a8f0-bcfa83854acf" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_197166ef-eead-4f9f-b604-3b664c1dec67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_a6ce13e7-7c53-45fb-aa17-a5557b0cb763" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_7d6ab78e-11b8-4c8e-a8f0-bcfa83854acf" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_a6ce13e7-7c53-45fb-aa17-a5557b0cb763" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dna.com/role/ShareholdersEquity" xlink:type="simple" xlink:href="pgen-20220331.xsd#ShareholdersEquity"/>
  <link:presentationLink xlink:role="http://www.dna.com/role/ShareholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_069fb94f-0eec-450d-adc5-c4caec589240" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_b9796387-446e-480b-9064-1cf7e444c9c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_069fb94f-0eec-450d-adc5-c4caec589240" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_b9796387-446e-480b-9064-1cf7e444c9c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dna.com/role/ShareholdersEquityTables" xlink:type="simple" xlink:href="pgen-20220331.xsd#ShareholdersEquityTables"/>
  <link:presentationLink xlink:role="http://www.dna.com/role/ShareholdersEquityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_4dc79e7e-48c8-411e-9693-af535c8babe6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_3ba6e5a3-234c-4494-81fa-2a6d533acac6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_4dc79e7e-48c8-411e-9693-af535c8babe6" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_3ba6e5a3-234c-4494-81fa-2a6d533acac6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dna.com/role/ShareholdersEquityIssuancesofPrecigenCommonStockDetails" xlink:type="simple" xlink:href="pgen-20220331.xsd#ShareholdersEquityIssuancesofPrecigenCommonStockDetails"/>
  <link:presentationLink xlink:role="http://www.dna.com/role/ShareholdersEquityIssuancesofPrecigenCommonStockDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_5151e08e-7286-4887-ab56-d3688ab65d96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_908893c3-4200-4049-a017-52c5827f8780" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_5151e08e-7286-4887-ab56-d3688ab65d96" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_908893c3-4200-4049-a017-52c5827f8780" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_d60b6111-0cc5-4289-a7be-0eed7428b07e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_5151e08e-7286-4887-ab56-d3688ab65d96" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_d60b6111-0cc5-4289-a7be-0eed7428b07e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dna.com/role/ShareholdersEquityShareLendingAgreementDetails" xlink:type="simple" xlink:href="pgen-20220331.xsd#ShareholdersEquityShareLendingAgreementDetails"/>
  <link:presentationLink xlink:role="http://www.dna.com/role/ShareholdersEquityShareLendingAgreementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_381c67a0-9aef-4930-a8f9-3f3532a4c11f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesOther_caab8593-89e2-4ecf-80d7-983a4947e8d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesOther"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_381c67a0-9aef-4930-a8f9-3f3532a4c11f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesOther_caab8593-89e2-4ecf-80d7-983a4947e8d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_ShareLendingAgreementLengthOfTimeForSharesToBeReturnedUponTermination_3108193a-8d2d-48b5-8066-8a7e23b4ef9d" xlink:href="pgen-20220331.xsd#pgen_ShareLendingAgreementLengthOfTimeForSharesToBeReturnedUponTermination"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_381c67a0-9aef-4930-a8f9-3f3532a4c11f" xlink:to="loc_pgen_ShareLendingAgreementLengthOfTimeForSharesToBeReturnedUponTermination_3108193a-8d2d-48b5-8066-8a7e23b4ef9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_da5ad34f-c1cc-40fb-9898-ac2d213c0d7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_381c67a0-9aef-4930-a8f9-3f3532a4c11f" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_da5ad34f-c1cc-40fb-9898-ac2d213c0d7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dna.com/role/ShareholdersEquityComponentsofAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="pgen-20220331.xsd#ShareholdersEquityComponentsofAccumulatedOtherComprehensiveIncomeLossDetails"/>
  <link:presentationLink xlink:role="http://www.dna.com/role/ShareholdersEquityComponentsofAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_5fa39fa2-966d-4515-b909-2e474da17b71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_119299f2-6b44-4eb5-9441-5e7604f45fb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_5fa39fa2-966d-4515-b909-2e474da17b71" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_119299f2-6b44-4eb5-9441-5e7604f45fb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_86effc20-766d-4743-88e5-712dd803d95e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_119299f2-6b44-4eb5-9441-5e7604f45fb5" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_86effc20-766d-4743-88e5-712dd803d95e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_c7defe6f-a56f-4e07-ad6d-6edd0d5b52f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_86effc20-766d-4743-88e5-712dd803d95e" xlink:to="loc_us-gaap_EquityComponentDomain_c7defe6f-a56f-4e07-ad6d-6edd0d5b52f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_798a23c2-8afe-4ce7-8e8d-90b667d85132" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_c7defe6f-a56f-4e07-ad6d-6edd0d5b52f8" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_798a23c2-8afe-4ce7-8e8d-90b667d85132" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_3b67dd3c-5eee-4847-b41d-b8f6903b038a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_798a23c2-8afe-4ce7-8e8d-90b667d85132" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_3b67dd3c-5eee-4847-b41d-b8f6903b038a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_d8169c95-d1be-4213-a208-ca5cf88fe9c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_798a23c2-8afe-4ce7-8e8d-90b667d85132" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_d8169c95-d1be-4213-a208-ca5cf88fe9c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_80c551a0-8448-4cf9-997a-9afc403e0728" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_119299f2-6b44-4eb5-9441-5e7604f45fb5" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_80c551a0-8448-4cf9-997a-9afc403e0728" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_33a4614e-45a8-4e8d-968a-28e707033e66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_80c551a0-8448-4cf9-997a-9afc403e0728" xlink:to="loc_us-gaap_StockholdersEquity_33a4614e-45a8-4e8d-968a-28e707033e66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dna.com/role/ShareBasedPayments" xlink:type="simple" xlink:href="pgen-20220331.xsd#ShareBasedPayments"/>
  <link:presentationLink xlink:role="http://www.dna.com/role/ShareBasedPayments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_40ddd494-0231-4f70-bf60-1f62f2b97edd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_6a800500-d3cc-4cb3-9b66-d976331502e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_40ddd494-0231-4f70-bf60-1f62f2b97edd" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_6a800500-d3cc-4cb3-9b66-d976331502e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dna.com/role/ShareBasedPaymentsTables" xlink:type="simple" xlink:href="pgen-20220331.xsd#ShareBasedPaymentsTables"/>
  <link:presentationLink xlink:role="http://www.dna.com/role/ShareBasedPaymentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0f80bc8e-0224-45d8-ad96-c398bff0599e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_491f8b9c-363e-4c1f-8e3c-c384ee8f1741" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0f80bc8e-0224-45d8-ad96-c398bff0599e" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_491f8b9c-363e-4c1f-8e3c-c384ee8f1741" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_765ef1de-5050-4605-9ce3-b038f03f04cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0f80bc8e-0224-45d8-ad96-c398bff0599e" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_765ef1de-5050-4605-9ce3-b038f03f04cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_93396662-d041-4b3e-bf36-55bb654138c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0f80bc8e-0224-45d8-ad96-c398bff0599e" xlink:to="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_93396662-d041-4b3e-bf36-55bb654138c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dna.com/role/ShareBasedPaymentsScheduleofStockBasedCompensationCostsDetails" xlink:type="simple" xlink:href="pgen-20220331.xsd#ShareBasedPaymentsScheduleofStockBasedCompensationCostsDetails"/>
  <link:presentationLink xlink:role="http://www.dna.com/role/ShareBasedPaymentsScheduleofStockBasedCompensationCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_25e64ff9-d10a-4557-a902-e11a0119476f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_2cf9f353-774a-4b2d-8dde-b0e51e47d580" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_25e64ff9-d10a-4557-a902-e11a0119476f" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_2cf9f353-774a-4b2d-8dde-b0e51e47d580" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_43eb45ae-4a5c-4086-809e-59372f0d1608" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_2cf9f353-774a-4b2d-8dde-b0e51e47d580" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_43eb45ae-4a5c-4086-809e-59372f0d1608" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_159a6b2e-82ca-4645-bcf1-1eeca1fb1a62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_43eb45ae-4a5c-4086-809e-59372f0d1608" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_159a6b2e-82ca-4645-bcf1-1eeca1fb1a62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_CostOfProductsMember_8aaa7cda-e6c1-43f7-bd8f-5aadcab0c2ef" xlink:href="pgen-20220331.xsd#pgen_CostOfProductsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_159a6b2e-82ca-4645-bcf1-1eeca1fb1a62" xlink:to="loc_pgen_CostOfProductsMember_8aaa7cda-e6c1-43f7-bd8f-5aadcab0c2ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_CostOfServicesMember_ffd56764-1c6f-4b28-afc7-0a23e3b32f74" xlink:href="pgen-20220331.xsd#pgen_CostOfServicesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_159a6b2e-82ca-4645-bcf1-1eeca1fb1a62" xlink:to="loc_pgen_CostOfServicesMember_ffd56764-1c6f-4b28-afc7-0a23e3b32f74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_abbb0b96-c104-4483-9a69-ad5b3bc538f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_159a6b2e-82ca-4645-bcf1-1eeca1fb1a62" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_abbb0b96-c104-4483-9a69-ad5b3bc538f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_39aba409-b3b5-474e-8302-99a29cd8f122" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_159a6b2e-82ca-4645-bcf1-1eeca1fb1a62" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_39aba409-b3b5-474e-8302-99a29cd8f122" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_71e64f83-a727-424b-8434-0a410d7a6812" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_2cf9f353-774a-4b2d-8dde-b0e51e47d580" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_71e64f83-a727-424b-8434-0a410d7a6812" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_bd899892-3219-4350-aa72-b77eb394c65d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_71e64f83-a727-424b-8434-0a410d7a6812" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_bd899892-3219-4350-aa72-b77eb394c65d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dna.com/role/ShareBasedPaymentsAdditionalInformationDetails" xlink:type="simple" xlink:href="pgen-20220331.xsd#ShareBasedPaymentsAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.dna.com/role/ShareBasedPaymentsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_be6b349f-e3ef-4660-af0f-836f748a9c2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e82ba94f-6131-48b7-b542-16fab851089b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_be6b349f-e3ef-4660-af0f-836f748a9c2e" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e82ba94f-6131-48b7-b542-16fab851089b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_3e7076a9-1c46-422d-9255-9b5ebffcb01d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e82ba94f-6131-48b7-b542-16fab851089b" xlink:to="loc_us-gaap_PlanNameAxis_3e7076a9-1c46-422d-9255-9b5ebffcb01d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_71808811-6260-45e0-b027-aada346d1b2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_3e7076a9-1c46-422d-9255-9b5ebffcb01d" xlink:to="loc_us-gaap_PlanNameDomain_71808811-6260-45e0-b027-aada346d1b2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_PrecigenStockOptionPlan2008PlanMember_e885741f-86f8-4e0d-b36b-bc7bdd97408c" xlink:href="pgen-20220331.xsd#pgen_PrecigenStockOptionPlan2008PlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_71808811-6260-45e0-b027-aada346d1b2f" xlink:to="loc_pgen_PrecigenStockOptionPlan2008PlanMember_e885741f-86f8-4e0d-b36b-bc7bdd97408c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_PrecigenStockOptionPlan2013PlanMember_d5dc53cc-d14f-4b5b-a966-209213c31a95" xlink:href="pgen-20220331.xsd#pgen_PrecigenStockOptionPlan2013PlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_71808811-6260-45e0-b027-aada346d1b2f" xlink:to="loc_pgen_PrecigenStockOptionPlan2013PlanMember_d5dc53cc-d14f-4b5b-a966-209213c31a95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_PrecigenStockOptionPlan2019PlanMember_ac0ff4bd-bf84-4f28-a2ac-de0637fc99d9" xlink:href="pgen-20220331.xsd#pgen_PrecigenStockOptionPlan2019PlanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_71808811-6260-45e0-b027-aada346d1b2f" xlink:to="loc_pgen_PrecigenStockOptionPlan2019PlanMember_ac0ff4bd-bf84-4f28-a2ac-de0637fc99d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_44aad4e4-f8b6-4f3e-aad3-ca2e8cd567d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e82ba94f-6131-48b7-b542-16fab851089b" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_44aad4e4-f8b6-4f3e-aad3-ca2e8cd567d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_daab5cc7-76fd-464e-a7bc-fa7a45ffbf6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_44aad4e4-f8b6-4f3e-aad3-ca2e8cd567d1" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_daab5cc7-76fd-464e-a7bc-fa7a45ffbf6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_ba696664-705e-4cd4-81a4-ed0bab88ae51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_daab5cc7-76fd-464e-a7bc-fa7a45ffbf6a" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_ba696664-705e-4cd4-81a4-ed0bab88ae51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_76f0cd10-f5dc-4a0d-9e19-ff29fd0ab757" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e82ba94f-6131-48b7-b542-16fab851089b" xlink:to="loc_us-gaap_AwardTypeAxis_76f0cd10-f5dc-4a0d-9e19-ff29fd0ab757" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4b81cdac-68bc-49e5-8e8b-f8792deda180" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_76f0cd10-f5dc-4a0d-9e19-ff29fd0ab757" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4b81cdac-68bc-49e5-8e8b-f8792deda180" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_72c1649f-1813-4094-812b-188fbcba742a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4b81cdac-68bc-49e5-8e8b-f8792deda180" xlink:to="loc_us-gaap_EmployeeStockOptionMember_72c1649f-1813-4094-812b-188fbcba742a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_3ddba8d7-4589-4c76-9520-2f601a3c5e20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4b81cdac-68bc-49e5-8e8b-f8792deda180" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_3ddba8d7-4589-4c76-9520-2f601a3c5e20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_0f745f5e-d1fb-4314-af8b-54d01cb1ecc7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e82ba94f-6131-48b7-b542-16fab851089b" xlink:to="loc_srt_TitleOfIndividualAxis_0f745f5e-d1fb-4314-af8b-54d01cb1ecc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_e6c8dbc6-f485-4d73-bb00-48f44112e496" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_0f745f5e-d1fb-4314-af8b-54d01cb1ecc7" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_e6c8dbc6-f485-4d73-bb00-48f44112e496" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_ExecutiveChairmanMember_06cbf82f-a8e1-4ecd-a8dc-69a91efbd111" xlink:href="pgen-20220331.xsd#pgen_ExecutiveChairmanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_e6c8dbc6-f485-4d73-bb00-48f44112e496" xlink:to="loc_pgen_ExecutiveChairmanMember_06cbf82f-a8e1-4ecd-a8dc-69a91efbd111" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_71d5d87f-b5dc-4b2d-8d5b-30eb618ff356" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e82ba94f-6131-48b7-b542-16fab851089b" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_71d5d87f-b5dc-4b2d-8d5b-30eb618ff356" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_bd230a3b-3e82-4f06-8dc5-689fbbcc8ede" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_71d5d87f-b5dc-4b2d-8d5b-30eb618ff356" xlink:to="loc_us-gaap_RelatedPartyDomain_bd230a3b-3e82-4f06-8dc5-689fbbcc8ede" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_ExecutiveChairmanMember_21052a5c-9197-467b-b228-7905627ae83e" xlink:href="pgen-20220331.xsd#pgen_ExecutiveChairmanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_bd230a3b-3e82-4f06-8dc5-689fbbcc8ede" xlink:to="loc_pgen_ExecutiveChairmanMember_21052a5c-9197-467b-b228-7905627ae83e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_1242e1ff-32ee-4313-8fbc-de6a0fcd0742" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e82ba94f-6131-48b7-b542-16fab851089b" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_1242e1ff-32ee-4313-8fbc-de6a0fcd0742" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_d6b78f9c-d4ae-423b-bca9-4a91f8f6f333" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_1242e1ff-32ee-4313-8fbc-de6a0fcd0742" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_d6b78f9c-d4ae-423b-bca9-4a91f8f6f333" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_29aaf17e-96b1-4dfa-80c5-831dfbd3daa0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_d6b78f9c-d4ae-423b-bca9-4a91f8f6f333" xlink:to="loc_us-gaap_SubsequentEventMember_29aaf17e-96b1-4dfa-80c5-831dfbd3daa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_91a942c7-77cc-4ae5-82c7-6db9701275b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e82ba94f-6131-48b7-b542-16fab851089b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_91a942c7-77cc-4ae5-82c7-6db9701275b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_76762b45-58d7-4f03-97d5-30a083529fbc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_91a942c7-77cc-4ae5-82c7-6db9701275b1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_76762b45-58d7-4f03-97d5-30a083529fbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_ca18d168-5f1b-4e13-9a8b-98ab0749214d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_91a942c7-77cc-4ae5-82c7-6db9701275b1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_ca18d168-5f1b-4e13-9a8b-98ab0749214d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_0374eed9-8825-49ed-b7c7-1cb6a95684d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_91a942c7-77cc-4ae5-82c7-6db9701275b1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_0374eed9-8825-49ed-b7c7-1cb6a95684d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_a8099c74-ae71-4d70-80b5-41803d21459b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_91a942c7-77cc-4ae5-82c7-6db9701275b1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_a8099c74-ae71-4d70-80b5-41803d21459b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_CompensationArrangementWithIndividualAllocatedShareBasedCompensationExpenseMonthlyExpense_57b7da8a-69da-4639-82ab-a36b1cf845f6" xlink:href="pgen-20220331.xsd#pgen_CompensationArrangementWithIndividualAllocatedShareBasedCompensationExpenseMonthlyExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_91a942c7-77cc-4ae5-82c7-6db9701275b1" xlink:to="loc_pgen_CompensationArrangementWithIndividualAllocatedShareBasedCompensationExpenseMonthlyExpense_57b7da8a-69da-4639-82ab-a36b1cf845f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_LockupPeriodOnRestrictedStockUnitShares_518c6588-c94e-4c14-8d32-8581eb8438bb" xlink:href="pgen-20220331.xsd#pgen_LockupPeriodOnRestrictedStockUnitShares"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_91a942c7-77cc-4ae5-82c7-6db9701275b1" xlink:to="loc_pgen_LockupPeriodOnRestrictedStockUnitShares_518c6588-c94e-4c14-8d32-8581eb8438bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_CompensationArrangementWithIndividualAnnualCashRetainer_571c887a-1688-402e-bd0e-502df65ccbf2" xlink:href="pgen-20220331.xsd#pgen_CompensationArrangementWithIndividualAnnualCashRetainer"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_91a942c7-77cc-4ae5-82c7-6db9701275b1" xlink:to="loc_pgen_CompensationArrangementWithIndividualAnnualCashRetainer_571c887a-1688-402e-bd0e-502df65ccbf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_CompensationArrangementWithIndividualAnnualStockOptionGrantGrantDateFairValue_eb672fb2-4e14-4351-8b94-3e77937b5f7f" xlink:href="pgen-20220331.xsd#pgen_CompensationArrangementWithIndividualAnnualStockOptionGrantGrantDateFairValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_91a942c7-77cc-4ae5-82c7-6db9701275b1" xlink:to="loc_pgen_CompensationArrangementWithIndividualAnnualStockOptionGrantGrantDateFairValue_eb672fb2-4e14-4351-8b94-3e77937b5f7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_CompensationArrangementWithIndividualAnnualRSUGrantGrantDateFairValue_2fdbb31e-f395-4066-9149-0841bd1924c5" xlink:href="pgen-20220331.xsd#pgen_CompensationArrangementWithIndividualAnnualRSUGrantGrantDateFairValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_91a942c7-77cc-4ae5-82c7-6db9701275b1" xlink:to="loc_pgen_CompensationArrangementWithIndividualAnnualRSUGrantGrantDateFairValue_2fdbb31e-f395-4066-9149-0841bd1924c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_b9ee717e-49ee-43b7-b447-c639d99b1ed5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_91a942c7-77cc-4ae5-82c7-6db9701275b1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_b9ee717e-49ee-43b7-b447-c639d99b1ed5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_CompensationArrangementWithIndividualExpense_570ccc63-fe16-4f16-acb7-8252f47f0ad1" xlink:href="pgen-20220331.xsd#pgen_CompensationArrangementWithIndividualExpense"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_91a942c7-77cc-4ae5-82c7-6db9701275b1" xlink:to="loc_pgen_CompensationArrangementWithIndividualExpense_570ccc63-fe16-4f16-acb7-8252f47f0ad1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dna.com/role/ShareBasedPaymentsScheduleofStockOptionActivityDetails" xlink:type="simple" xlink:href="pgen-20220331.xsd#ShareBasedPaymentsScheduleofStockOptionActivityDetails"/>
  <link:presentationLink xlink:role="http://www.dna.com/role/ShareBasedPaymentsScheduleofStockOptionActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ba5b7ec0-de88-460f-8737-f8cbc4bec09f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_881aca6b-f57f-4e67-864f-991ddad302b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ba5b7ec0-de88-460f-8737-f8cbc4bec09f" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_881aca6b-f57f-4e67-864f-991ddad302b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_0f6fa9cb-6719-485c-aaf9-e2531dd52cb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_881aca6b-f57f-4e67-864f-991ddad302b5" xlink:to="loc_us-gaap_PlanNameAxis_0f6fa9cb-6719-485c-aaf9-e2531dd52cb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_b585dcc0-fd6d-428e-ab41-fe30e6a29a90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_0f6fa9cb-6719-485c-aaf9-e2531dd52cb1" xlink:to="loc_us-gaap_PlanNameDomain_b585dcc0-fd6d-428e-ab41-fe30e6a29a90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_PrecigenStockOptionPlanMember_e1befb35-9654-46fa-ba67-52c2b3b6e6b6" xlink:href="pgen-20220331.xsd#pgen_PrecigenStockOptionPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_b585dcc0-fd6d-428e-ab41-fe30e6a29a90" xlink:to="loc_pgen_PrecigenStockOptionPlanMember_e1befb35-9654-46fa-ba67-52c2b3b6e6b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ba358937-8f07-466d-8629-36ba1a824abc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_881aca6b-f57f-4e67-864f-991ddad302b5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ba358937-8f07-466d-8629-36ba1a824abc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_b1414294-1624-478f-9177-2a81cf6aaaa1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ba358937-8f07-466d-8629-36ba1a824abc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_b1414294-1624-478f-9177-2a81cf6aaaa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_819afb50-4d69-474b-9611-851084c749fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_b1414294-1624-478f-9177-2a81cf6aaaa1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_819afb50-4d69-474b-9611-851084c749fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3f08887d-3043-466c-bb58-12cb66d8245e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_b1414294-1624-478f-9177-2a81cf6aaaa1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3f08887d-3043-466c-bb58-12cb66d8245e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_28194c76-b405-4b82-8971-e9ea4848a2b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_b1414294-1624-478f-9177-2a81cf6aaaa1" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_28194c76-b405-4b82-8971-e9ea4848a2b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_116c1ae0-0e33-435c-ab0c-ce505a7713c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_b1414294-1624-478f-9177-2a81cf6aaaa1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_116c1ae0-0e33-435c-ab0c-ce505a7713c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_23c06d40-9062-4d26-b50c-f3bc05b740b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_b1414294-1624-478f-9177-2a81cf6aaaa1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_23c06d40-9062-4d26-b50c-f3bc05b740b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_418d7a54-9de6-498e-b212-6a2ec2c47138" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_b1414294-1624-478f-9177-2a81cf6aaaa1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_418d7a54-9de6-498e-b212-6a2ec2c47138" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0b5f72cc-1c33-4785-9290-dcc388ef8faf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ba358937-8f07-466d-8629-36ba1a824abc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0b5f72cc-1c33-4785-9290-dcc388ef8faf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_99475233-d520-4c54-9088-f8ff4d85ee40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ba358937-8f07-466d-8629-36ba1a824abc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_99475233-d520-4c54-9088-f8ff4d85ee40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_06bafe19-e674-4dff-b759-d1b11f11fa36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_99475233-d520-4c54-9088-f8ff4d85ee40" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_06bafe19-e674-4dff-b759-d1b11f11fa36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_f912ed95-1a7e-4ba4-8701-dba0a43dcf4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_99475233-d520-4c54-9088-f8ff4d85ee40" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_f912ed95-1a7e-4ba4-8701-dba0a43dcf4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_3a30291b-af2a-4417-bfe7-730dee723842" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_99475233-d520-4c54-9088-f8ff4d85ee40" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_3a30291b-af2a-4417-bfe7-730dee723842" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_bb77767a-d0a0-4500-810f-a81bbbf34ff4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_99475233-d520-4c54-9088-f8ff4d85ee40" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_bb77767a-d0a0-4500-810f-a81bbbf34ff4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_184b73a1-5039-42ee-8f6c-fc31c5fb0d74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_99475233-d520-4c54-9088-f8ff4d85ee40" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_184b73a1-5039-42ee-8f6c-fc31c5fb0d74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_5c9adc9c-7652-4d73-b25a-7c1b67bd9b57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_99475233-d520-4c54-9088-f8ff4d85ee40" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_5c9adc9c-7652-4d73-b25a-7c1b67bd9b57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0c66355c-a9b1-4903-85a9-1957fff3a4c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ba358937-8f07-466d-8629-36ba1a824abc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0c66355c-a9b1-4903-85a9-1957fff3a4c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_4997d927-7437-478b-8979-2a033c700955" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ba358937-8f07-466d-8629-36ba1a824abc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_4997d927-7437-478b-8979-2a033c700955" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_1de6ea81-3756-489b-a347-5c312a496a4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_4997d927-7437-478b-8979-2a033c700955" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_1de6ea81-3756-489b-a347-5c312a496a4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_c22fb4ea-ee6d-4b06-aaf6-780dd409aa86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_4997d927-7437-478b-8979-2a033c700955" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_c22fb4ea-ee6d-4b06-aaf6-780dd409aa86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dna.com/role/ShareBasedPaymentsScheduleofRestrictedStockUnitActivityDetails" xlink:type="simple" xlink:href="pgen-20220331.xsd#ShareBasedPaymentsScheduleofRestrictedStockUnitActivityDetails"/>
  <link:presentationLink xlink:role="http://www.dna.com/role/ShareBasedPaymentsScheduleofRestrictedStockUnitActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_606db9d0-6c34-4090-95d7-06b76317c44c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bed40850-6586-4531-84fb-ee9f2aab1e37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_606db9d0-6c34-4090-95d7-06b76317c44c" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bed40850-6586-4531-84fb-ee9f2aab1e37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_741962a4-6a53-4928-a6e6-a7a1c14e2f8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bed40850-6586-4531-84fb-ee9f2aab1e37" xlink:to="loc_us-gaap_PlanNameAxis_741962a4-6a53-4928-a6e6-a7a1c14e2f8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_f897d37a-d19a-46d0-a669-033f38d18f5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_741962a4-6a53-4928-a6e6-a7a1c14e2f8d" xlink:to="loc_us-gaap_PlanNameDomain_f897d37a-d19a-46d0-a669-033f38d18f5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_PrecigenStockOptionPlanMember_cb2d0019-6533-4438-a991-6286d60def70" xlink:href="pgen-20220331.xsd#pgen_PrecigenStockOptionPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_f897d37a-d19a-46d0-a669-033f38d18f5a" xlink:to="loc_pgen_PrecigenStockOptionPlanMember_cb2d0019-6533-4438-a991-6286d60def70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9244ddcd-6afc-4423-9b9c-c19de1e1052c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bed40850-6586-4531-84fb-ee9f2aab1e37" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9244ddcd-6afc-4423-9b9c-c19de1e1052c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_b536abd6-618b-4772-beef-66c31e967d3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9244ddcd-6afc-4423-9b9c-c19de1e1052c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_b536abd6-618b-4772-beef-66c31e967d3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_f184c65b-dacd-4abb-a730-8bb3f4cd3143" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_b536abd6-618b-4772-beef-66c31e967d3d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_f184c65b-dacd-4abb-a730-8bb3f4cd3143" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_3f94bde3-8d7c-4c7b-97be-118e711ce338" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_b536abd6-618b-4772-beef-66c31e967d3d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_3f94bde3-8d7c-4c7b-97be-118e711ce338" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_9996ca49-684c-4514-b149-3e088a07b9a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_b536abd6-618b-4772-beef-66c31e967d3d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_9996ca49-684c-4514-b149-3e088a07b9a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_6816157f-7025-44f9-a7b0-386eef372815" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_b536abd6-618b-4772-beef-66c31e967d3d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_6816157f-7025-44f9-a7b0-386eef372815" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_44849925-88fc-4a58-9457-926681d7cc12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_b536abd6-618b-4772-beef-66c31e967d3d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_44849925-88fc-4a58-9457-926681d7cc12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_34402aa9-5149-49cc-9372-51df029319ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9244ddcd-6afc-4423-9b9c-c19de1e1052c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_34402aa9-5149-49cc-9372-51df029319ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_c49427e5-d24c-41c3-a48a-08c3207d63c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_34402aa9-5149-49cc-9372-51df029319ef" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_c49427e5-d24c-41c3-a48a-08c3207d63c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_5a4b0060-f27a-4aee-a3b9-0220eadc7257" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_34402aa9-5149-49cc-9372-51df029319ef" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_5a4b0060-f27a-4aee-a3b9-0220eadc7257" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_d3f86650-f5c2-4282-befe-e8667251ebb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_34402aa9-5149-49cc-9372-51df029319ef" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_d3f86650-f5c2-4282-befe-e8667251ebb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_253672a3-f40f-4eaf-aa8f-c5a33437d8b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_34402aa9-5149-49cc-9372-51df029319ef" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_253672a3-f40f-4eaf-aa8f-c5a33437d8b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_8d3dd512-b74e-44f6-b0f7-4f700e46160a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_34402aa9-5149-49cc-9372-51df029319ef" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_8d3dd512-b74e-44f6-b0f7-4f700e46160a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_bf6ab47f-d0c6-4d0b-ba5a-7754f792de89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9244ddcd-6afc-4423-9b9c-c19de1e1052c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_bf6ab47f-d0c6-4d0b-ba5a-7754f792de89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dc0e6680-7d1f-4dde-9992-9d02c3f90890" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_bf6ab47f-d0c6-4d0b-ba5a-7754f792de89" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dc0e6680-7d1f-4dde-9992-9d02c3f90890" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dna.com/role/OperatingLeases" xlink:type="simple" xlink:href="pgen-20220331.xsd#OperatingLeases"/>
  <link:presentationLink xlink:role="http://www.dna.com/role/OperatingLeases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_3de26482-49fe-49fb-8442-35f37ad3e601" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_8ec39743-4c5d-48fd-83b1-8bdb9b576065" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3de26482-49fe-49fb-8442-35f37ad3e601" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_8ec39743-4c5d-48fd-83b1-8bdb9b576065" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dna.com/role/OperatingLeasesTables" xlink:type="simple" xlink:href="pgen-20220331.xsd#OperatingLeasesTables"/>
  <link:presentationLink xlink:role="http://www.dna.com/role/OperatingLeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_c868cb8c-21e2-4293-89da-5dba04ae5abc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_704ebb3d-8251-464b-b7dc-cc67d7c32058" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c868cb8c-21e2-4293-89da-5dba04ae5abc" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_704ebb3d-8251-464b-b7dc-cc67d7c32058" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_2f494885-f648-4417-80e3-e1caa19c5f0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c868cb8c-21e2-4293-89da-5dba04ae5abc" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_2f494885-f648-4417-80e3-e1caa19c5f0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dna.com/role/OperatingLeasesAdditionalInformationDetails" xlink:type="simple" xlink:href="pgen-20220331.xsd#OperatingLeasesAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.dna.com/role/OperatingLeasesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_ebc29dd9-8a8c-42c9-a9cf-4c79830d5f57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_731f9db1-db8a-4901-9fb0-dc9e9d9dc08b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_ebc29dd9-8a8c-42c9-a9cf-4c79830d5f57" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_731f9db1-db8a-4901-9fb0-dc9e9d9dc08b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_23e3378c-55be-4661-956d-948dd9170fdd" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_731f9db1-db8a-4901-9fb0-dc9e9d9dc08b" xlink:to="loc_srt_RangeAxis_23e3378c-55be-4661-956d-948dd9170fdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_04e5f71d-c363-49bf-b0f2-bbcf87dd15d0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_23e3378c-55be-4661-956d-948dd9170fdd" xlink:to="loc_srt_RangeMember_04e5f71d-c363-49bf-b0f2-bbcf87dd15d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_6481e45c-f939-42ab-b6b5-5f8b19ea9e34" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_04e5f71d-c363-49bf-b0f2-bbcf87dd15d0" xlink:to="loc_srt_MinimumMember_6481e45c-f939-42ab-b6b5-5f8b19ea9e34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a247bee9-95d6-4603-8156-05aa192ed058" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_04e5f71d-c363-49bf-b0f2-bbcf87dd15d0" xlink:to="loc_srt_MaximumMember_a247bee9-95d6-4603-8156-05aa192ed058" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_369164c9-4de2-4030-9b8e-52acaab9002f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_731f9db1-db8a-4901-9fb0-dc9e9d9dc08b" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_369164c9-4de2-4030-9b8e-52acaab9002f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_2734ff08-e211-49f7-afea-11e7542e1c83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_369164c9-4de2-4030-9b8e-52acaab9002f" xlink:to="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_2734ff08-e211-49f7-afea-11e7542e1c83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_LesseeOperatingLeaseTerminationPeriod_54d3a974-1cc8-4e59-9c6d-867cd4443b27" xlink:href="pgen-20220331.xsd#pgen_LesseeOperatingLeaseTerminationPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_369164c9-4de2-4030-9b8e-52acaab9002f" xlink:to="loc_pgen_LesseeOperatingLeaseTerminationPeriod_54d3a974-1cc8-4e59-9c6d-867cd4443b27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dna.com/role/OperatingLeasesComponentsofLeaseCostsDetails" xlink:type="simple" xlink:href="pgen-20220331.xsd#OperatingLeasesComponentsofLeaseCostsDetails"/>
  <link:presentationLink xlink:role="http://www.dna.com/role/OperatingLeasesComponentsofLeaseCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_16de0ae5-0715-4b46-83d3-af52bf60c8e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_efff17bd-d5e6-4875-96f8-a086973283a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_16de0ae5-0715-4b46-83d3-af52bf60c8e5" xlink:to="loc_us-gaap_OperatingLeaseCost_efff17bd-d5e6-4875-96f8-a086973283a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost_7457edfe-19be-4eda-8b4c-b8bc2dc867ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_16de0ae5-0715-4b46-83d3-af52bf60c8e5" xlink:to="loc_us-gaap_ShortTermLeaseCost_7457edfe-19be-4eda-8b4c-b8bc2dc867ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_c0ce8579-b1ad-481f-a4fc-658dbe22c869" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableLeaseCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_16de0ae5-0715-4b46-83d3-af52bf60c8e5" xlink:to="loc_us-gaap_VariableLeaseCost_c0ce8579-b1ad-481f-a4fc-658dbe22c869" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_80a969f5-0459-4496-a0b4-a86a6b341b65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_16de0ae5-0715-4b46-83d3-af52bf60c8e5" xlink:to="loc_us-gaap_LeaseCost_80a969f5-0459-4496-a0b4-a86a6b341b65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dna.com/role/OperatingLeasesMaturitiesofLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="pgen-20220331.xsd#OperatingLeasesMaturitiesofLeaseLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.dna.com/role/OperatingLeasesMaturitiesofLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_cb10f7d8-8e8f-48cf-80ef-e06796bf595b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_3781a2b3-9566-43fc-bf49-97bd93413984" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_cb10f7d8-8e8f-48cf-80ef-e06796bf595b" xlink:to="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_3781a2b3-9566-43fc-bf49-97bd93413984" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_8c18ed91-00ba-47e5-aed1-3d3c1691e248" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_3781a2b3-9566-43fc-bf49-97bd93413984" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_8c18ed91-00ba-47e5-aed1-3d3c1691e248" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_bc66c92a-2a6b-41d6-b4eb-f4cf1da80aa1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_3781a2b3-9566-43fc-bf49-97bd93413984" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_bc66c92a-2a6b-41d6-b4eb-f4cf1da80aa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_40232b8a-8464-4646-b2fc-8ede7ec43f00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_3781a2b3-9566-43fc-bf49-97bd93413984" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_40232b8a-8464-4646-b2fc-8ede7ec43f00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_fa9c5aa7-0f9f-4dbb-a7f1-fb768036680c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_3781a2b3-9566-43fc-bf49-97bd93413984" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_fa9c5aa7-0f9f-4dbb-a7f1-fb768036680c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_a4f074c8-6938-41d9-8d11-2be394d4b88b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_3781a2b3-9566-43fc-bf49-97bd93413984" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_a4f074c8-6938-41d9-8d11-2be394d4b88b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_9d7466b8-16e3-483b-91f8-a4a4aedeb297" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_3781a2b3-9566-43fc-bf49-97bd93413984" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_9d7466b8-16e3-483b-91f8-a4a4aedeb297" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_245b8c0e-c086-4abd-8df3-ff7a921dd71a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_3781a2b3-9566-43fc-bf49-97bd93413984" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_245b8c0e-c086-4abd-8df3-ff7a921dd71a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_5b0de96a-7165-407a-a095-2a5e434516f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_3781a2b3-9566-43fc-bf49-97bd93413984" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_5b0de96a-7165-407a-a095-2a5e434516f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_d014584a-bcf0-4c4b-871b-81b9650efcc7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_3781a2b3-9566-43fc-bf49-97bd93413984" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_d014584a-bcf0-4c4b-871b-81b9650efcc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_8513283f-9468-4e61-84f5-bf28645023c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_3781a2b3-9566-43fc-bf49-97bd93413984" xlink:to="loc_us-gaap_OperatingLeaseLiability_8513283f-9468-4e61-84f5-bf28645023c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_28cbf31c-6c44-492c-982e-637fd8b62823" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_cb10f7d8-8e8f-48cf-80ef-e06796bf595b" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_28cbf31c-6c44-492c-982e-637fd8b62823" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_7ce95e45-4e89-4a4e-b286-98df1a5f59b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_cb10f7d8-8e8f-48cf-80ef-e06796bf595b" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_7ce95e45-4e89-4a4e-b286-98df1a5f59b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dna.com/role/OperatingLeasesMaturitiesofLeaseLiabilitiesDetails_1" xlink:type="simple" xlink:href="pgen-20220331.xsd#OperatingLeasesMaturitiesofLeaseLiabilitiesDetails_1"/>
  <link:presentationLink xlink:role="http://www.dna.com/role/OperatingLeasesMaturitiesofLeaseLiabilitiesDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.dna.com/role/OperatingLeasesLeaseTermsandDiscountRatesDetails" xlink:type="simple" xlink:href="pgen-20220331.xsd#OperatingLeasesLeaseTermsandDiscountRatesDetails"/>
  <link:presentationLink xlink:role="http://www.dna.com/role/OperatingLeasesLeaseTermsandDiscountRatesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_3be15af1-5091-41c3-8b29-b034712c310d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_c6da1fd2-cb64-42b3-9f44-46c2ece6eafa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3be15af1-5091-41c3-8b29-b034712c310d" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_c6da1fd2-cb64-42b3-9f44-46c2ece6eafa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_79faad50-b09a-4e27-907d-3335d28d7ee2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3be15af1-5091-41c3-8b29-b034712c310d" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_79faad50-b09a-4e27-907d-3335d28d7ee2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dna.com/role/OperatingLeasesOtherInformationDetails" xlink:type="simple" xlink:href="pgen-20220331.xsd#OperatingLeasesOtherInformationDetails"/>
  <link:presentationLink xlink:role="http://www.dna.com/role/OperatingLeasesOtherInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_533a1f9d-c8ef-437c-add7-692947375407" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_c3374dc3-67e0-4a96-abdf-492782299357" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_533a1f9d-c8ef-437c-add7-692947375407" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_c3374dc3-67e0-4a96-abdf-492782299357" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_cac2fe10-3671-4755-aefd-18c819f96b97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_c3374dc3-67e0-4a96-abdf-492782299357" xlink:to="loc_us-gaap_OperatingLeasePayments_cac2fe10-3671-4755-aefd-18c819f96b97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_ccaaa14e-6ea2-4902-807b-a833a6e53f9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_c3374dc3-67e0-4a96-abdf-492782299357" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_ccaaa14e-6ea2-4902-807b-a833a6e53f9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dna.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="pgen-20220331.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.dna.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_06555f97-3a34-489a-a1df-d15721be4446" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_391eda03-dda9-455c-8346-b87b80030ca0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_06555f97-3a34-489a-a1df-d15721be4446" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_391eda03-dda9-455c-8346-b87b80030ca0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dna.com/role/CommitmentsandContingenciesContingenciesAdditionalInformationDetails" xlink:type="simple" xlink:href="pgen-20220331.xsd#CommitmentsandContingenciesContingenciesAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.dna.com/role/CommitmentsandContingenciesContingenciesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_8d4b7125-0e4a-4718-a701-b9f4348d9ae2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_ffa95efd-4feb-4d00-84c5-1369c39eca69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_8d4b7125-0e4a-4718-a701-b9f4348d9ae2" xlink:to="loc_us-gaap_LossContingenciesTable_ffa95efd-4feb-4d00-84c5-1369c39eca69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_e9e7fc8a-63d9-407f-ae95-b06ace27ed41" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_ffa95efd-4feb-4d00-84c5-1369c39eca69" xlink:to="loc_srt_CounterpartyNameAxis_e9e7fc8a-63d9-407f-ae95-b06ace27ed41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_fff7975b-8e0d-4639-816e-f2e8304443de" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_e9e7fc8a-63d9-407f-ae95-b06ace27ed41" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_fff7975b-8e0d-4639-816e-f2e8304443de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_XYLLCMember_282ec82a-0a44-47ba-b24a-14b9005cce89" xlink:href="pgen-20220331.xsd#pgen_XYLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_fff7975b-8e0d-4639-816e-f2e8304443de" xlink:to="loc_pgen_XYLLCMember_282ec82a-0a44-47ba-b24a-14b9005cce89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_SecuritiesAndExchangeCommissionMember_9e20976e-0521-4381-b0f4-daceeeb75206" xlink:href="pgen-20220331.xsd#pgen_SecuritiesAndExchangeCommissionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_fff7975b-8e0d-4639-816e-f2e8304443de" xlink:to="loc_pgen_SecuritiesAndExchangeCommissionMember_9e20976e-0521-4381-b0f4-daceeeb75206" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_IntrexonEnergyPartnersMember_6561d6ea-954f-4909-aa07-7c85f9457abc" xlink:href="pgen-20220331.xsd#pgen_IntrexonEnergyPartnersMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_fff7975b-8e0d-4639-816e-f2e8304443de" xlink:to="loc_pgen_IntrexonEnergyPartnersMember_6561d6ea-954f-4909-aa07-7c85f9457abc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_IntrexonEnergyPartnersIILLCMember_de4ebcdf-b19d-4634-badb-7c79596b1322" xlink:href="pgen-20220331.xsd#pgen_IntrexonEnergyPartnersIILLCMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_fff7975b-8e0d-4639-816e-f2e8304443de" xlink:to="loc_pgen_IntrexonEnergyPartnersIILLCMember_de4ebcdf-b19d-4634-badb-7c79596b1322" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_74dde634-601b-425c-b0b6-30195dd2a2df" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_ffa95efd-4feb-4d00-84c5-1369c39eca69" xlink:to="loc_srt_LitigationCaseAxis_74dde634-601b-425c-b0b6-30195dd2a2df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_011ccf2c-de0a-4df8-b4b9-bad047c99f91" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_74dde634-601b-425c-b0b6-30195dd2a2df" xlink:to="loc_srt_LitigationCaseTypeDomain_011ccf2c-de0a-4df8-b4b9-bad047c99f91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_LicensingAndPatentInfringementSuitMember_289f274a-387e-4bfb-aed4-212e3d8ea0bb" xlink:href="pgen-20220331.xsd#pgen_LicensingAndPatentInfringementSuitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_011ccf2c-de0a-4df8-b4b9-bad047c99f91" xlink:to="loc_pgen_LicensingAndPatentInfringementSuitMember_289f274a-387e-4bfb-aed4-212e3d8ea0bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_MethaneBioconversionPlatformDisclosuresMember_df104179-7840-40eb-a5ca-e4abcec95092" xlink:href="pgen-20220331.xsd#pgen_MethaneBioconversionPlatformDisclosuresMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_011ccf2c-de0a-4df8-b4b9-bad047c99f91" xlink:to="loc_pgen_MethaneBioconversionPlatformDisclosuresMember_df104179-7840-40eb-a5ca-e4abcec95092" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_b6ac54ae-9f9d-46ae-88f7-2c2609f3721d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_ffa95efd-4feb-4d00-84c5-1369c39eca69" xlink:to="loc_dei_LegalEntityAxis_b6ac54ae-9f9d-46ae-88f7-2c2609f3721d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_fd5b6395-dbb4-4acb-abd4-2bd21d6bb486" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_b6ac54ae-9f9d-46ae-88f7-2c2609f3721d" xlink:to="loc_dei_EntityDomain_fd5b6395-dbb4-4acb-abd4-2bd21d6bb486" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_IntrexonEnergyPartnersLLAndIntrexonEnergyPartnersIILLCMember_0dc5e43b-9f0e-46cf-af10-b5b185dd9d35" xlink:href="pgen-20220331.xsd#pgen_IntrexonEnergyPartnersLLAndIntrexonEnergyPartnersIILLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_fd5b6395-dbb4-4acb-abd4-2bd21d6bb486" xlink:to="loc_pgen_IntrexonEnergyPartnersLLAndIntrexonEnergyPartnersIILLCMember_0dc5e43b-9f0e-46cf-af10-b5b185dd9d35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_2725b463-609b-45db-87e7-e075244070df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_ffa95efd-4feb-4d00-84c5-1369c39eca69" xlink:to="loc_us-gaap_LossContingenciesLineItems_2725b463-609b-45db-87e7-e075244070df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyClaimsSettledNumber_4d40746e-7bbd-49ee-aa59-089d8ee1e68f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyClaimsSettledNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_2725b463-609b-45db-87e7-e075244070df" xlink:to="loc_us-gaap_LossContingencyClaimsSettledNumber_4d40746e-7bbd-49ee-aa59-089d8ee1e68f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_5aaed886-d928-4a79-92f4-7e1e2be16a6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_2725b463-609b-45db-87e7-e075244070df" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_5aaed886-d928-4a79-92f4-7e1e2be16a6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_LossContingencyNumberOfPatentsAtIssue_fc44b83e-9a78-46a8-8ef5-5fa294ddffa3" xlink:href="pgen-20220331.xsd#pgen_LossContingencyNumberOfPatentsAtIssue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_2725b463-609b-45db-87e7-e075244070df" xlink:to="loc_pgen_LossContingencyNumberOfPatentsAtIssue_fc44b83e-9a78-46a8-8ef5-5fa294ddffa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLegalSettlements_eea2bca7-ef9a-4055-a0a9-d963fb14e578" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForLegalSettlements"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_2725b463-609b-45db-87e7-e075244070df" xlink:to="loc_us-gaap_PaymentsForLegalSettlements_eea2bca7-ef9a-4055-a0a9-d963fb14e578" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_ProposedPaymentsForMembershipInterests_9e1df7c1-1525-4a0f-87e8-720a447823a0" xlink:href="pgen-20220331.xsd#pgen_ProposedPaymentsForMembershipInterests"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_2725b463-609b-45db-87e7-e075244070df" xlink:to="loc_pgen_ProposedPaymentsForMembershipInterests_9e1df7c1-1525-4a0f-87e8-720a447823a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestReceivable_6551e896-14b4-4176-944c-9670bf0453a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestReceivable"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_2725b463-609b-45db-87e7-e075244070df" xlink:to="loc_us-gaap_InterestReceivable_6551e896-14b4-4176-944c-9670bf0453a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_7fb9958f-500d-419a-a66f-b259236dcc54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_2725b463-609b-45db-87e7-e075244070df" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_7fb9958f-500d-419a-a66f-b259236dcc54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dna.com/role/RelatedPartyTransactions" xlink:type="simple" xlink:href="pgen-20220331.xsd#RelatedPartyTransactions"/>
  <link:presentationLink xlink:role="http://www.dna.com/role/RelatedPartyTransactions" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_fa82436b-90b5-4454-8418-3b75b476e827" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_4a654de1-6003-462e-a4ae-6608ee87eda6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_fa82436b-90b5-4454-8418-3b75b476e827" xlink:to="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_4a654de1-6003-462e-a4ae-6608ee87eda6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dna.com/role/RelatedPartyTransactionsAdditionalInformationDetails" xlink:type="simple" xlink:href="pgen-20220331.xsd#RelatedPartyTransactionsAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.dna.com/role/RelatedPartyTransactionsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_aa7606d1-c73d-43db-b42f-bd173a1ecc32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_8bf674aa-ef57-4eaf-8a0f-7c5df3d0718c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_aa7606d1-c73d-43db-b42f-bd173a1ecc32" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_8bf674aa-ef57-4eaf-8a0f-7c5df3d0718c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_60605f36-edb0-4770-82b1-a693ec99155e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_8bf674aa-ef57-4eaf-8a0f-7c5df3d0718c" xlink:to="loc_dei_LegalEntityAxis_60605f36-edb0-4770-82b1-a693ec99155e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_1e59e880-2bf5-4532-9046-646c0408199f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_60605f36-edb0-4770-82b1-a693ec99155e" xlink:to="loc_dei_EntityDomain_1e59e880-2bf5-4532-9046-646c0408199f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_ThirdSecurityMember_50aeeef3-3bf9-4142-ba2e-63eb0bd0d5e1" xlink:href="pgen-20220331.xsd#pgen_ThirdSecurityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_1e59e880-2bf5-4532-9046-646c0408199f" xlink:to="loc_pgen_ThirdSecurityMember_50aeeef3-3bf9-4142-ba2e-63eb0bd0d5e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_4a97154e-7f14-4ca4-8ccf-6ddf8968d9ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_8bf674aa-ef57-4eaf-8a0f-7c5df3d0718c" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_4a97154e-7f14-4ca4-8ccf-6ddf8968d9ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_44c68aca-09e7-41fb-a8d8-a1549f84e41b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_4a97154e-7f14-4ca4-8ccf-6ddf8968d9ea" xlink:to="loc_us-gaap_RelatedPartyDomain_44c68aca-09e7-41fb-a8d8-a1549f84e41b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_ExecutiveChairmanMember_8d7bd5f0-2a3c-4361-8f6c-09da2d4ff354" xlink:href="pgen-20220331.xsd#pgen_ExecutiveChairmanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_44c68aca-09e7-41fb-a8d8-a1549f84e41b" xlink:to="loc_pgen_ExecutiveChairmanMember_8d7bd5f0-2a3c-4361-8f6c-09da2d4ff354" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_ThirdSecurityMember_d233b099-2e9b-42fa-8f48-478d64657f58" xlink:href="pgen-20220331.xsd#pgen_ThirdSecurityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_44c68aca-09e7-41fb-a8d8-a1549f84e41b" xlink:to="loc_pgen_ThirdSecurityMember_d233b099-2e9b-42fa-8f48-478d64657f58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_1ef7434c-d54d-4e40-8b47-89d1a2522515" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_8bf674aa-ef57-4eaf-8a0f-7c5df3d0718c" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_1ef7434c-d54d-4e40-8b47-89d1a2522515" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_RelatedPartyOwnershipInterest_b9668dcf-fba9-4a45-92fb-b82e0fe491a0" xlink:href="pgen-20220331.xsd#pgen_RelatedPartyOwnershipInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1ef7434c-d54d-4e40-8b47-89d1a2522515" xlink:to="loc_pgen_RelatedPartyOwnershipInterest_b9668dcf-fba9-4a45-92fb-b82e0fe491a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfessionalAndContractServicesExpense_e33faa92-a12e-450f-b1ba-67600e65fb42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfessionalAndContractServicesExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1ef7434c-d54d-4e40-8b47-89d1a2522515" xlink:to="loc_us-gaap_ProfessionalAndContractServicesExpense_e33faa92-a12e-450f-b1ba-67600e65fb42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome_d4ef2de1-2d4c-43d0-b10b-72db20dc1204" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubleaseIncome"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1ef7434c-d54d-4e40-8b47-89d1a2522515" xlink:to="loc_us-gaap_SubleaseIncome_d4ef2de1-2d4c-43d0-b10b-72db20dc1204" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dna.com/role/Segments" xlink:type="simple" xlink:href="pgen-20220331.xsd#Segments"/>
  <link:presentationLink xlink:role="http://www.dna.com/role/Segments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_e5772274-d67f-4ea9-8089-974d5b77703c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_12e9047f-cfb8-456c-b534-bc1cbb4f2dc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_e5772274-d67f-4ea9-8089-974d5b77703c" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_12e9047f-cfb8-456c-b534-bc1cbb4f2dc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dna.com/role/SegmentsTables" xlink:type="simple" xlink:href="pgen-20220331.xsd#SegmentsTables"/>
  <link:presentationLink xlink:role="http://www.dna.com/role/SegmentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_a028a35a-c208-41d1-a2fa-99486ec349ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_c292fe0f-c5b1-4b61-8c64-1b57fac96eb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_a028a35a-c208-41d1-a2fa-99486ec349ea" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_c292fe0f-c5b1-4b61-8c64-1b57fac96eb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_5a6444e5-4f37-41ff-a719-cf07a07ae64a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_a028a35a-c208-41d1-a2fa-99486ec349ea" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_5a6444e5-4f37-41ff-a719-cf07a07ae64a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock_6b7ff254-e333-4fb9-8bd6-ecc84f3718f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_a028a35a-c208-41d1-a2fa-99486ec349ea" xlink:to="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock_6b7ff254-e333-4fb9-8bd6-ecc84f3718f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dna.com/role/SegmentsAdjustedEBITDAbyReportableSegmentDetails" xlink:type="simple" xlink:href="pgen-20220331.xsd#SegmentsAdjustedEBITDAbyReportableSegmentDetails"/>
  <link:presentationLink xlink:role="http://www.dna.com/role/SegmentsAdjustedEBITDAbyReportableSegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_931c26c6-0dc4-4c5d-ac55-d64b3c565f9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_9577337e-c763-44c7-a9d4-88252b408eb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_931c26c6-0dc4-4c5d-ac55-d64b3c565f9b" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_9577337e-c763-44c7-a9d4-88252b408eb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_a2a3a12a-2377-40d6-b73c-d055bcb18206" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_9577337e-c763-44c7-a9d4-88252b408eb2" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_a2a3a12a-2377-40d6-b73c-d055bcb18206" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c49375e6-e7d2-4f15-b829-639990c81ed3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a2a3a12a-2377-40d6-b73c-d055bcb18206" xlink:to="loc_us-gaap_SegmentDomain_c49375e6-e7d2-4f15-b829-639990c81ed3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_BiopharmaceuticalsSegmentMember_1c010e41-59b7-4aad-85ab-bfcabb8ba711" xlink:href="pgen-20220331.xsd#pgen_BiopharmaceuticalsSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c49375e6-e7d2-4f15-b829-639990c81ed3" xlink:to="loc_pgen_BiopharmaceuticalsSegmentMember_1c010e41-59b7-4aad-85ab-bfcabb8ba711" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_ExemplarSegmentMember_15238358-c35f-48bb-b95c-a9d599d196a4" xlink:href="pgen-20220331.xsd#pgen_ExemplarSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c49375e6-e7d2-4f15-b829-639990c81ed3" xlink:to="loc_pgen_ExemplarSegmentMember_15238358-c35f-48bb-b95c-a9d599d196a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_TransOvaSegmentMember_2336c33d-06f1-4c0b-a2ff-128ec4f6947d" xlink:href="pgen-20220331.xsd#pgen_TransOvaSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c49375e6-e7d2-4f15-b829-639990c81ed3" xlink:to="loc_pgen_TransOvaSegmentMember_2336c33d-06f1-4c0b-a2ff-128ec4f6947d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_f6ed4c5b-d199-4576-9095-487ab7a92f17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_9577337e-c763-44c7-a9d4-88252b408eb2" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_f6ed4c5b-d199-4576-9095-487ab7a92f17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_NetIncomeLossAttributabletoParentAdjustedEBITDAIncludingCashPaidforCapitalExpendituresandInvestmentsinAffiliates_a6af0ec5-3cc1-42f7-8909-df13a6f50878" xlink:href="pgen-20220331.xsd#pgen_NetIncomeLossAttributabletoParentAdjustedEBITDAIncludingCashPaidforCapitalExpendituresandInvestmentsinAffiliates"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f6ed4c5b-d199-4576-9095-487ab7a92f17" xlink:to="loc_pgen_NetIncomeLossAttributabletoParentAdjustedEBITDAIncludingCashPaidforCapitalExpendituresandInvestmentsinAffiliates_a6af0ec5-3cc1-42f7-8909-df13a6f50878" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dna.com/role/SegmentsReconciliationofNetLossBeforeIncomeTaxesDetails" xlink:type="simple" xlink:href="pgen-20220331.xsd#SegmentsReconciliationofNetLossBeforeIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.dna.com/role/SegmentsReconciliationofNetLossBeforeIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_18cd12f0-ac85-4794-97cd-2856657e23d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6650fc5c-d7a8-44ba-81e0-60a2b867ddd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_18cd12f0-ac85-4794-97cd-2856657e23d2" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6650fc5c-d7a8-44ba-81e0-60a2b867ddd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_e3ed2e69-bf03-46ee-8e30-86664113bfce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6650fc5c-d7a8-44ba-81e0-60a2b867ddd4" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_e3ed2e69-bf03-46ee-8e30-86664113bfce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_9d7081d8-66f5-45c9-bc8c-1b81e0284916" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e3ed2e69-bf03-46ee-8e30-86664113bfce" xlink:to="loc_us-gaap_SegmentDomain_9d7081d8-66f5-45c9-bc8c-1b81e0284916" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_ReportableSegmentsMember_b114a344-acef-4a52-b485-2f02dcc83407" xlink:href="pgen-20220331.xsd#pgen_ReportableSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_9d7081d8-66f5-45c9-bc8c-1b81e0284916" xlink:to="loc_pgen_ReportableSegmentsMember_b114a344-acef-4a52-b485-2f02dcc83407" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_b2d16806-db43-4122-a796-34dc44b1f576" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6650fc5c-d7a8-44ba-81e0-60a2b867ddd4" xlink:to="loc_srt_ConsolidationItemsAxis_b2d16806-db43-4122-a796-34dc44b1f576" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_bf8874c5-5b02-4051-abdd-d9f540472098" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_b2d16806-db43-4122-a796-34dc44b1f576" xlink:to="loc_srt_ConsolidationItemsDomain_bf8874c5-5b02-4051-abdd-d9f540472098" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_7b9e36f4-86f8-4a02-ab54-60876f22974d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_bf8874c5-5b02-4051-abdd-d9f540472098" xlink:to="loc_us-gaap_OperatingSegmentsMember_7b9e36f4-86f8-4a02-ab54-60876f22974d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_CorporateAndReconcilingItemsMember_5669b30e-ce86-43e5-b516-922ef496e7f5" xlink:href="pgen-20220331.xsd#pgen_CorporateAndReconcilingItemsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_bf8874c5-5b02-4051-abdd-d9f540472098" xlink:to="loc_pgen_CorporateAndReconcilingItemsMember_5669b30e-ce86-43e5-b516-922ef496e7f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_11c14c62-2bcd-4464-8ffc-87bfeb4666eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_bf8874c5-5b02-4051-abdd-d9f540472098" xlink:to="loc_us-gaap_CorporateNonSegmentMember_11c14c62-2bcd-4464-8ffc-87bfeb4666eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_b3d702b4-e8e6-4bac-a767-b756af665633" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_bf8874c5-5b02-4051-abdd-d9f540472098" xlink:to="loc_us-gaap_IntersegmentEliminationMember_b3d702b4-e8e6-4bac-a767-b756af665633" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_2793f0c9-401b-419d-8477-861255c49d3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6650fc5c-d7a8-44ba-81e0-60a2b867ddd4" xlink:to="loc_us-gaap_TypeOfArrangementAxis_2793f0c9-401b-419d-8477-861255c49d3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_09a6f8ee-5b7a-4781-8c32-5372bb9dce02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_2793f0c9-401b-419d-8477-861255c49d3c" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_09a6f8ee-5b7a-4781-8c32-5372bb9dce02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_UpfrontAndMilestonePaymentsMember_c2882ae0-a942-443c-8a7e-595efe80101d" xlink:href="pgen-20220331.xsd#pgen_UpfrontAndMilestonePaymentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_09a6f8ee-5b7a-4781-8c32-5372bb9dce02" xlink:to="loc_pgen_UpfrontAndMilestonePaymentsMember_c2882ae0-a942-443c-8a7e-595efe80101d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_dea874f7-073e-4266-a626-68802ec41643" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6650fc5c-d7a8-44ba-81e0-60a2b867ddd4" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_dea874f7-073e-4266-a626-68802ec41643" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_NetIncomeLossAttributabletoParentAdjustedEBITDAIncludingCashPaidforCapitalExpendituresandInvestmentsinAffiliates_90423b14-bd9b-4768-8022-c1618c0a9031" xlink:href="pgen-20220331.xsd#pgen_NetIncomeLossAttributabletoParentAdjustedEBITDAIncludingCashPaidforCapitalExpendituresandInvestmentsinAffiliates"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_dea874f7-073e-4266-a626-68802ec41643" xlink:to="loc_pgen_NetIncomeLossAttributabletoParentAdjustedEBITDAIncludingCashPaidforCapitalExpendituresandInvestmentsinAffiliates_90423b14-bd9b-4768-8022-c1618c0a9031" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_CapitalExpendituresNetOfProceedsFromSaleOfAssetsAndInvestmentsInAffiliates_d39c8095-7e8d-437d-82a7-39d13237ab24" xlink:href="pgen-20220331.xsd#pgen_CapitalExpendituresNetOfProceedsFromSaleOfAssetsAndInvestmentsInAffiliates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_dea874f7-073e-4266-a626-68802ec41643" xlink:to="loc_pgen_CapitalExpendituresNetOfProceedsFromSaleOfAssetsAndInvestmentsInAffiliates_d39c8095-7e8d-437d-82a7-39d13237ab24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_0f027369-c868-4526-994e-0d66b4930c51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_dea874f7-073e-4266-a626-68802ec41643" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_0f027369-c868-4526-994e-0d66b4930c51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_ccdbb5cb-d738-4920-96fc-06c9af0dba64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_dea874f7-073e-4266-a626-68802ec41643" xlink:to="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_ccdbb5cb-d738-4920-96fc-06c9af0dba64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_b606b83c-efc8-4244-a436-a105702e7275" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_ccdbb5cb-d738-4920-96fc-06c9af0dba64" xlink:to="loc_us-gaap_InterestExpense_b606b83c-efc8-4244-a436-a105702e7275" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_286aa1f0-2f63-4863-a9e6-e7304720d893" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_ccdbb5cb-d738-4920-96fc-06c9af0dba64" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_286aa1f0-2f63-4863-a9e6-e7304720d893" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets1_a895842d-725e-4abf-92b7-43c178b4997c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_ccdbb5cb-d738-4920-96fc-06c9af0dba64" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets1_a895842d-725e-4abf-92b7-43c178b4997c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_6333adb4-bd76-45cb-a11e-8b68c66fd306" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_ccdbb5cb-d738-4920-96fc-06c9af0dba64" xlink:to="loc_us-gaap_AssetImpairmentCharges_6333adb4-bd76-45cb-a11e-8b68c66fd306" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_725ca09b-de6f-459c-a0a3-086c57912b03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_ccdbb5cb-d738-4920-96fc-06c9af0dba64" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_725ca09b-de6f-459c-a0a3-086c57912b03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_AdjustmentForBonusesPaidInEquityAwards_04425a07-717d-42cf-ba33-6bbc2af7c83c" xlink:href="pgen-20220331.xsd#pgen_AdjustmentForBonusesPaidInEquityAwards"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_ccdbb5cb-d738-4920-96fc-06c9af0dba64" xlink:to="loc_pgen_AdjustmentForBonusesPaidInEquityAwards_04425a07-717d-42cf-ba33-6bbc2af7c83c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_84efdf28-487a-4edd-8427-ce4890d42956" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_ccdbb5cb-d738-4920-96fc-06c9af0dba64" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_84efdf28-487a-4edd-8427-ce4890d42956" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_079c1f22-bbfa-45da-a174-cf73dfa8e5e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract_ccdbb5cb-d738-4920-96fc-06c9af0dba64" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_079c1f22-bbfa-45da-a174-cf73dfa8e5e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_15ab752e-be9e-4061-88a2-30e7661a014d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_dea874f7-073e-4266-a626-68802ec41643" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_15ab752e-be9e-4061-88a2-30e7661a014d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dna.com/role/SegmentsRevenuesbyReportableSegmentDetails" xlink:type="simple" xlink:href="pgen-20220331.xsd#SegmentsRevenuesbyReportableSegmentDetails"/>
  <link:presentationLink xlink:role="http://www.dna.com/role/SegmentsRevenuesbyReportableSegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_7a4bf8f4-2f14-4012-906d-55844a3ad905" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e1c4c551-9a10-4abc-8735-c0b00161b8fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_7a4bf8f4-2f14-4012-906d-55844a3ad905" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e1c4c551-9a10-4abc-8735-c0b00161b8fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_cc38b4e8-5133-4432-adb5-2c45847ea439" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e1c4c551-9a10-4abc-8735-c0b00161b8fe" xlink:to="loc_srt_ConsolidationItemsAxis_cc38b4e8-5133-4432-adb5-2c45847ea439" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_2ab2b2d3-e0cc-442e-ab40-6fbe57ad8575" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_cc38b4e8-5133-4432-adb5-2c45847ea439" xlink:to="loc_srt_ConsolidationItemsDomain_2ab2b2d3-e0cc-442e-ab40-6fbe57ad8575" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_57ceaac6-502d-4103-81b0-fbc646a9712c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_2ab2b2d3-e0cc-442e-ab40-6fbe57ad8575" xlink:to="loc_us-gaap_OperatingSegmentsMember_57ceaac6-502d-4103-81b0-fbc646a9712c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_989122a5-2aa1-4f2f-aeb8-8075a1386ac5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_2ab2b2d3-e0cc-442e-ab40-6fbe57ad8575" xlink:to="loc_us-gaap_IntersegmentEliminationMember_989122a5-2aa1-4f2f-aeb8-8075a1386ac5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_EliminationsAndReconcilingItemsMember_42818d40-2b44-4108-8ba8-302f9d723f07" xlink:href="pgen-20220331.xsd#pgen_EliminationsAndReconcilingItemsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_2ab2b2d3-e0cc-442e-ab40-6fbe57ad8575" xlink:to="loc_pgen_EliminationsAndReconcilingItemsMember_42818d40-2b44-4108-8ba8-302f9d723f07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_e2306388-c6fb-4fb4-a5b6-f2597a3c7858" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e1c4c551-9a10-4abc-8735-c0b00161b8fe" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_e2306388-c6fb-4fb4-a5b6-f2597a3c7858" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_285787ed-cd1a-495e-8b11-9bcb5ba6107b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e2306388-c6fb-4fb4-a5b6-f2597a3c7858" xlink:to="loc_us-gaap_SegmentDomain_285787ed-cd1a-495e-8b11-9bcb5ba6107b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_BiopharmaceuticalsSegmentMember_6576bc55-a316-44dd-b4db-8f6e473975f0" xlink:href="pgen-20220331.xsd#pgen_BiopharmaceuticalsSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_285787ed-cd1a-495e-8b11-9bcb5ba6107b" xlink:to="loc_pgen_BiopharmaceuticalsSegmentMember_6576bc55-a316-44dd-b4db-8f6e473975f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_ExemplarSegmentMember_9afb165e-9375-4a69-b444-e6b2743fcfb3" xlink:href="pgen-20220331.xsd#pgen_ExemplarSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_285787ed-cd1a-495e-8b11-9bcb5ba6107b" xlink:to="loc_pgen_ExemplarSegmentMember_9afb165e-9375-4a69-b444-e6b2743fcfb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_TransOvaSegmentMember_72c83b96-9ffc-4bda-9edb-3766e94d6f99" xlink:href="pgen-20220331.xsd#pgen_TransOvaSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_285787ed-cd1a-495e-8b11-9bcb5ba6107b" xlink:to="loc_pgen_TransOvaSegmentMember_72c83b96-9ffc-4bda-9edb-3766e94d6f99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_ReportableSegmentsMember_3aa5a87d-3bda-4af9-86c8-44f264ecbf91" xlink:href="pgen-20220331.xsd#pgen_ReportableSegmentsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_285787ed-cd1a-495e-8b11-9bcb5ba6107b" xlink:to="loc_pgen_ReportableSegmentsMember_3aa5a87d-3bda-4af9-86c8-44f264ecbf91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_1f7a0660-af24-43ff-8823-a9993c57bd19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e1c4c551-9a10-4abc-8735-c0b00161b8fe" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_1f7a0660-af24-43ff-8823-a9993c57bd19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_80e86f43-bb75-440c-956d-948733f01426" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1f7a0660-af24-43ff-8823-a9993c57bd19" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_80e86f43-bb75-440c-956d-948733f01426" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_a7458c40-0208-4468-85c5-98201d2ddf2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1f7a0660-af24-43ff-8823-a9993c57bd19" xlink:to="loc_us-gaap_Revenues_a7458c40-0208-4468-85c5-98201d2ddf2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dna.com/role/SegmentsAdditionalInformationDetails" xlink:type="simple" xlink:href="pgen-20220331.xsd#SegmentsAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.dna.com/role/SegmentsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_727dd3c2-b9f6-4e7d-b87b-e489cc5a2c0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_93146917-860b-4f5e-8b07-5c7467030f1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_727dd3c2-b9f6-4e7d-b87b-e489cc5a2c0c" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_93146917-860b-4f5e-8b07-5c7467030f1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_a0bfc32c-1092-4af8-af94-6fc7f9d6a579" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_93146917-860b-4f5e-8b07-5c7467030f1b" xlink:to="loc_srt_StatementGeographicalAxis_a0bfc32c-1092-4af8-af94-6fc7f9d6a579" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_a8563744-e145-4a69-aaec-b3c0d8719dc8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_a0bfc32c-1092-4af8-af94-6fc7f9d6a579" xlink:to="loc_srt_SegmentGeographicalDomain_a8563744-e145-4a69-aaec-b3c0d8719dc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_26b02b7a-c6b6-4b65-81b2-575fd6294de6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonUsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_a8563744-e145-4a69-aaec-b3c0d8719dc8" xlink:to="loc_us-gaap_NonUsMember_26b02b7a-c6b6-4b65-81b2-575fd6294de6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_390af84d-56eb-4332-8d82-b315780b9079" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_93146917-860b-4f5e-8b07-5c7467030f1b" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_390af84d-56eb-4332-8d82-b315780b9079" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_6c70d811-8a83-4cf7-bfcd-57f5fb217c28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_390af84d-56eb-4332-8d82-b315780b9079" xlink:to="loc_us-gaap_SegmentDomain_6c70d811-8a83-4cf7-bfcd-57f5fb217c28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_ExemplarSegmentMember_f1c96e37-c085-4c47-a2b8-e7ceb31fdb6f" xlink:href="pgen-20220331.xsd#pgen_ExemplarSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_6c70d811-8a83-4cf7-bfcd-57f5fb217c28" xlink:to="loc_pgen_ExemplarSegmentMember_f1c96e37-c085-4c47-a2b8-e7ceb31fdb6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_d5fa4773-2ebb-4469-9fbc-e549a371c8cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_93146917-860b-4f5e-8b07-5c7467030f1b" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_d5fa4773-2ebb-4469-9fbc-e549a371c8cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_PercentageOfRevenueAttributableToCustomer_444fb514-a8ea-4408-8047-bb46bf5bb02f" xlink:href="pgen-20220331.xsd#pgen_PercentageOfRevenueAttributableToCustomer"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d5fa4773-2ebb-4469-9fbc-e549a371c8cf" xlink:to="loc_pgen_PercentageOfRevenueAttributableToCustomer_444fb514-a8ea-4408-8047-bb46bf5bb02f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pgen_LongLivedAssetsIncludingPropertyPlantandEquipmentandRightOfUseAssets_a75bfafc-9ec0-47cb-899b-f00b89157acf" xlink:href="pgen-20220331.xsd#pgen_LongLivedAssetsIncludingPropertyPlantandEquipmentandRightOfUseAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d5fa4773-2ebb-4469-9fbc-e549a371c8cf" xlink:to="loc_pgen_LongLivedAssetsIncludingPropertyPlantandEquipmentandRightOfUseAssets_a75bfafc-9ec0-47cb-899b-f00b89157acf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_f2632b73-5b84-43d3-8220-7783d63c7170" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d5fa4773-2ebb-4469-9fbc-e549a371c8cf" xlink:to="loc_us-gaap_Revenues_f2632b73-5b84-43d3-8220-7783d63c7170" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140329651920968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-36042<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">PRECIGEN, INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">VA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">26-0084895<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">20374 Seneca Meadows Parkway<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Germantown,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MD<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">20876<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">301<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">556-9900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, no par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">PGEN<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">207,693,277<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001356090<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140329651609208">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 40,321<span></span>
</td>
<td class="nump">$ 42,920<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term investments</a></td>
<td class="nump">71,821<span></span>
</td>
<td class="nump">72,240<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesNetCurrentAbstract', window );"><strong>Receivables</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Trade, less allowance for credit losses of $4,631 and $4,288 as of March&#160;31, 2022 and December&#160;31, 2021, respectively</a></td>
<td class="nump">24,308<span></span>
</td>
<td class="nump">20,832<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueFromRelatedPartiesCurrent', window );">Related parties, less allowance for credit losses of $1,509 as of March&#160;31, 2022 and December&#160;31, 2021</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">73<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Other</a></td>
<td class="nump">543<span></span>
</td>
<td class="nump">566<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryGross', window );">Inventory</a></td>
<td class="nump">12,730<span></span>
</td>
<td class="nump">13,261<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other</a></td>
<td class="nump">5,199<span></span>
</td>
<td class="nump">6,736<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">154,937<span></span>
</td>
<td class="nump">156,628<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent', window );">Long-term investments</a></td>
<td class="nump">29,914<span></span>
</td>
<td class="nump">48,562<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">33,583<span></span>
</td>
<td class="nump">34,315<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">51,427<span></span>
</td>
<td class="nump">54,115<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">53,613<span></span>
</td>
<td class="nump">54,148<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use assets</a></td>
<td class="nump">10,963<span></span>
</td>
<td class="nump">10,900<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">1,131<span></span>
</td>
<td class="nump">1,188<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">335,568<span></span>
</td>
<td class="nump">359,856<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">4,415<span></span>
</td>
<td class="nump">5,405<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation and benefits</a></td>
<td class="nump">6,052<span></span>
</td>
<td class="nump">11,223<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other accrued liabilities</a></td>
<td class="nump">10,494<span></span>
</td>
<td class="nump">11,595<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue</a></td>
<td class="nump">2,669<span></span>
</td>
<td class="nump">4,442<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">355<span></span>
</td>
<td class="nump">402<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of lease liabilities</a></td>
<td class="nump">1,590<span></span>
</td>
<td class="nump">1,551<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrent', window );">Related party payables</a></td>
<td class="nump">26<span></span>
</td>
<td class="nump">27<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">25,601<span></span>
</td>
<td class="nump">34,645<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, net of current portion</a></td>
<td class="nump">201,112<span></span>
</td>
<td class="nump">182,749<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">Contract with Customer, Liability, Noncurrent</a></td>
<td class="nump">23,023<span></span>
</td>
<td class="nump">23,023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Lease liabilities, net of current portion</a></td>
<td class="nump">9,508<span></span>
</td>
<td class="nump">9,502<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred tax liabilities</a></td>
<td class="nump">2,438<span></span>
</td>
<td class="nump">2,539<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">50<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">261,732<span></span>
</td>
<td class="nump">252,508<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 16)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Shareholders' equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValueOutstanding', window );">Common stock, no par value, 400,000,000 shares authorized as of March&#160;31, 2022 and December&#160;31, 2021; 207,693,277 shares and 206,739,874 shares issued and outstanding as of March&#160;31, 2022 and December&#160;31, 2021, respectively</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">1,991,670<span></span>
</td>
<td class="nump">2,022,701<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(1,916,135)<span></span>
</td>
<td class="num">(1,915,556)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive (loss) income</a></td>
<td class="num">(1,699)<span></span>
</td>
<td class="nump">203<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total shareholders' equity</a></td>
<td class="nump">73,836<span></span>
</td>
<td class="nump">107,348<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and shareholders' equity</a></td>
<td class="nump">$ 335,568<span></span>
</td>
<td class="nump">$ 359,856<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValueOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of all classes of common stock held by shareholders. May be all or portion of the number of common shares authorized. These shares exclude common shares repurchased by the entity and held as treasury shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValueOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130532-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueFromRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of receivables to be collected from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth, at the financial statement date. which are usually due within one year (or one business cycle).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(C))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueFromRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(C))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross amount, as of the balance sheet date, of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesNetCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesNetCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(g))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140329645800424">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Accounts receivable allowance for credit losses</a></td>
<td class="nump">$ 4,631<span></span>
</td>
<td class="nump">$ 4,288<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pgen_RelatedPartyReceivableAllowanceforCreditLossCurrent', window );">Related party receivable, allowance for credit losses</a></td>
<td class="nump">1,509<span></span>
</td>
<td class="nump">1,509<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">Deferred revenue, net of current portion, related party</a></td>
<td class="nump">$ 23,023<span></span>
</td>
<td class="nump">$ 23,023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Shareholders' equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockNoParValue', window );">Common stock, no par value (in usd per share)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">400,000,000<span></span>
</td>
<td class="nump">400,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">207,693,277<span></span>
</td>
<td class="nump">206,739,874<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">207,693,277<span></span>
</td>
<td class="nump">206,739,874<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=pgen_RelatedPartiesAggregatedMember', window );">Related Parties, Aggregated</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">Deferred revenue, net of current portion, related party</a></td>
<td class="nump">$ 21,205<span></span>
</td>
<td class="nump">$ 21,205<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pgen_RelatedPartyReceivableAllowanceforCreditLossCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Related Party Receivable, Allowance for Credit Loss, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pgen_RelatedPartyReceivableAllowanceforCreditLossCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pgen_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockNoParValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount per share of no-par value common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockNoParValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130532-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=pgen_RelatedPartiesAggregatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=pgen_RelatedPartiesAggregatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140329641665816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Operations - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 32,021<span></span>
</td>
<td class="nump">$ 24,511<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating Expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Impairment of goodwill</a></td>
<td class="nump">482<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other Expense, Net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity in net loss of affiliates</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss from continuing operations before income taxes</a></td>
<td class="num">(19,309)<span></span>
</td>
<td class="num">(21,896)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Income from discontinued operations, net of income taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,526<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (19,251)<span></span>
</td>
<td class="num">$ (17,318)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>Net Loss per Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Net loss from continuing operations per share, basic (in dollars per share)</a></td>
<td class="num">$ (0.10)<span></span>
</td>
<td class="num">$ (0.11)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare', window );">Net loss from continuing operating per share, diluted (in dollars per share)</a></td>
<td class="num">(0.10)<span></span>
</td>
<td class="num">(0.11)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare', window );">Net income (loss) from discontinued operations per share, diluted (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0.02<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare', window );">Net income (loss) from discontinued operations per share, basic (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0.02<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share, basic (in dollars per share)</a></td>
<td class="num">(0.10)<span></span>
</td>
<td class="num">(0.09)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per share, diluted (in dollars per share)</a></td>
<td class="num">$ (0.10)<span></span>
</td>
<td class="num">$ (0.09)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares outstanding, basic (in shares)</a></td>
<td class="nump">199,629,218<span></span>
</td>
<td class="nump">193,499,546<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average shares outstanding, diluted (in shares)</a></td>
<td class="nump">199,629,218<span></span>
</td>
<td class="nump">193,499,546<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember', window );">Collaboration and licensing agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 66<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOperatingActivitiesSegmentAxis=us-gaap_SegmentContinuingOperationsMember', window );">Continuing Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">32,021<span></span>
</td>
<td class="nump">24,511<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating Expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">12,760<span></span>
</td>
<td class="nump">10,521<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">19,576<span></span>
</td>
<td class="nump">18,702<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Impairment of goodwill</a></td>
<td class="nump">482<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">49,917<span></span>
</td>
<td class="nump">42,199<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating loss</a></td>
<td class="num">(17,896)<span></span>
</td>
<td class="num">(17,688)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other Expense, Net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(2,069)<span></span>
</td>
<td class="num">(4,539)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeNonoperating', window );">Interest income</a></td>
<td class="nump">434<span></span>
</td>
<td class="nump">392<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="nump">223<span></span>
</td>
<td class="num">(58)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other expense, net</a></td>
<td class="num">(1,412)<span></span>
</td>
<td class="num">(4,205)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity in net loss of affiliates</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss from continuing operations before income taxes</a></td>
<td class="num">(19,309)<span></span>
</td>
<td class="num">(21,896)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit</a></td>
<td class="nump">58<span></span>
</td>
<td class="nump">52<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Loss from continuing operations</a></td>
<td class="num">(19,251)<span></span>
</td>
<td class="num">(21,844)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOperatingActivitiesSegmentAxis=us-gaap_SegmentContinuingOperationsMember', window );">Continuing Operations | Collaboration and licensing agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">66<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOperatingActivitiesSegmentAxis=us-gaap_SegmentContinuingOperationsMember', window );">Continuing Operations | Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">8,724<span></span>
</td>
<td class="nump">6,381<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating Expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of products and services</a></td>
<td class="nump">7,510<span></span>
</td>
<td class="nump">5,574<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOperatingActivitiesSegmentAxis=us-gaap_SegmentContinuingOperationsMember', window );">Continuing Operations | Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">23,209<span></span>
</td>
<td class="nump">17,931<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating Expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of products and services</a></td>
<td class="nump">9,589<span></span>
</td>
<td class="nump">7,402<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOperatingActivitiesSegmentAxis=us-gaap_SegmentContinuingOperationsMember', window );">Continuing Operations | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 88<span></span>
</td>
<td class="nump">$ 133<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868656-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868656-224227<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109227538&amp;loc=d3e44648-109337<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1278-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 5.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398118&amp;loc=d3e355146-122828<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1278-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeNonoperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income from investments (for example, dividends) not considered a component of the entity's core operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeNonoperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOperatingActivitiesSegmentAxis=us-gaap_SegmentContinuingOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOperatingActivitiesSegmentAxis=us-gaap_SegmentContinuingOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=pgen_OtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=pgen_OtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140329651566392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Operations (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 32,021<span></span>
</td>
<td class="nump">$ 24,511<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOperatingActivitiesSegmentAxis=us-gaap_SegmentContinuingOperationsMember', window );">Continuing Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">32,021<span></span>
</td>
<td class="nump">24,511<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember', window );">Collaboration and licensing agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">66<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember', window );">Collaboration and licensing agreements | Continuing Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 66<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOperatingActivitiesSegmentAxis=us-gaap_SegmentContinuingOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOperatingActivitiesSegmentAxis=us-gaap_SegmentContinuingOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140329651268952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Comprehensive Loss - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss) Attributable to Parent</a></td>
<td class="num">$ (19,251)<span></span>
</td>
<td class="num">$ (17,318)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive loss:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Unrealized loss on investments</a></td>
<td class="num">(802)<span></span>
</td>
<td class="num">(48)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax', window );">Loss on foreign currency translation adjustments</a></td>
<td class="num">(1,100)<span></span>
</td>
<td class="num">(2,203)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="num">$ (21,153)<span></span>
</td>
<td class="num">$ (19,569)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123602790&amp;loc=d3e30304-110892<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=120253306&amp;loc=d3e28129-110885<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32022-110900<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a-c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140329641761448">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Shareholders' Equity - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Cumulative Effect, Period of Adoption, Adjustment</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th">
<div>Additional Paid-in Capital </div>
<div>Cumulative Effect, Period of Adoption, Adjustment</div>
</th>
<th class="th"><div>Accumulated Other Comprehensive Income (Loss)</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
<th class="th">
<div>Accumulated Deficit </div>
<div>Cumulative Effect, Period of Adoption, Adjustment</div>
</th>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balances (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">187,663,207<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balances at Dec. 31, 2020</a></td>
<td class="nump">$ 67,174<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,886,567<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,997<span></span>
</td>
<td class="num">$ (1,823,390)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">5,415<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,415<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pgen_StockIssuedDuringPeriodSharesStockOptionsExercisedAndRestrictedStockAwards', window );">Shares issued upon vesting of restricted stock units and for exercises of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,426,157<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pgen_StockIssuedDuringPeriodValueRestrictedStockAwardsVestedAndStockOptionsExercised', window );">Shares issued upon vesting of restricted stock units and for exercises of stock options</a></td>
<td class="nump">153<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">153<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Shares issued as payment for services (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74,771<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Shares issued as payment for services</a></td>
<td class="nump">$ 577<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">577<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued in private placement or in public offering, net of issuance costs (in shares)</a></td>
<td class="nump">17,250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Shares issued in private placement or in public offering, net of issuance costs</a></td>
<td class="nump">$ 121,045<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">121,045<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss) Attributable to Parent</a></td>
<td class="num">(17,318)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(17,318)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="num">(2,251)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,251)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balances (in shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">206,414,135<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balances at Mar. 31, 2021</a></td>
<td class="nump">$ 174,795<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">2,013,757<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,746<span></span>
</td>
<td class="num">(1,840,708)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balances (in shares) at Dec. 31, 2021</a></td>
<td class="nump">206,739,874<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">206,739,874<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balances at Dec. 31, 2021</a></td>
<td class="nump">$ 107,348<span></span>
</td>
<td class="num">$ (18,196)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">2,022,701<span></span>
</td>
<td class="num">$ (36,868)<span></span>
</td>
<td class="nump">203<span></span>
</td>
<td class="num">(1,915,556)<span></span>
</td>
<td class="nump">$ 18,672<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">3,562<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,562<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pgen_StockIssuedDuringPeriodSharesStockOptionsExercisedAndRestrictedStockAwards', window );">Shares issued upon vesting of restricted stock units and for exercises of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">354,089<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pgen_StockIssuedDuringPeriodValueRestrictedStockAwardsVestedAndStockOptionsExercised', window );">Shares issued upon vesting of restricted stock units and for exercises of stock options</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pgen_StockIssuedDuringThePeriodSharesAccruedCompensation', window );">Shares issued for accrued compensation (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">315,327<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pgen_StockIssuedDuringThePeriodValueAccruedCompensation', window );">Shares issued for accrued compensation</a></td>
<td class="nump">1,698<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,698<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Shares issued as payment for services (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">283,987<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Shares issued as payment for services</a></td>
<td class="nump">576<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">576<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss) Attributable to Parent</a></td>
<td class="num">(19,251)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(19,251)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="num">$ (1,902)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,902)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balances (in shares) at Mar. 31, 2022</a></td>
<td class="nump">207,693,277<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">207,693,277<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balances at Mar. 31, 2022</a></td>
<td class="nump">$ 73,836<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,991,670<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,699)<span></span>
</td>
<td class="num">$ (1,916,135)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingStandardsUpdateExtensibleList', window );">Accounting Standards Update [Extensible Enumeration]</a></td>
<td class="text">Accounting Standards Update 2020-06 [Member]<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pgen_StockIssuedDuringPeriodSharesStockOptionsExercisedAndRestrictedStockAwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period related to Restricted Stock Awards and exercises of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pgen_StockIssuedDuringPeriodSharesStockOptionsExercisedAndRestrictedStockAwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pgen_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pgen_StockIssuedDuringPeriodValueRestrictedStockAwardsVestedAndStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued related to Restricted Stock Awards vested during the period and as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pgen_StockIssuedDuringPeriodValueRestrictedStockAwardsVestedAndStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pgen_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pgen_StockIssuedDuringThePeriodSharesAccruedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for accrued compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pgen_StockIssuedDuringThePeriodSharesAccruedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pgen_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pgen_StockIssuedDuringThePeriodValueAccruedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued in lieu of cash for accrued compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pgen_StockIssuedDuringThePeriodValueAccruedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pgen_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingStandardsUpdateExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates amendment to accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL122642865-165497<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL120254526-165497<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=122150657&amp;loc=SL122150809-237846<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL122642865-165497<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S65<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124359872&amp;loc=SL124427846-239511<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124402435&amp;loc=SL124402458-218513<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124402435&amp;loc=SL124402458-218513<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL120254526-165497<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 45: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 50: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 51: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 52: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 53: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 54: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 55: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 56: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 57: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 58: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 59: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 60: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 61: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)<br><br>Reference 62: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(1)<br><br>Reference 63: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(2)<br><br>Reference 64: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(01)<br><br>Reference 65: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingStandardsUpdateExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123468992&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140329651313080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract', window );"><strong>Cash flows from operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss) Attributable to Parent</a></td>
<td class="num">$ (19,251)<span></span>
</td>
<td class="num">$ (17,318)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">3,292<span></span>
</td>
<td class="nump">3,523<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets1', window );">Loss (gain) on disposals of assets, net</a></td>
<td class="nump">125<span></span>
</td>
<td class="num">(343)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Impairment of goodwill</a></td>
<td class="nump">482<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments', window );">Amortization of premiums on investments, net</a></td>
<td class="nump">265<span></span>
</td>
<td class="nump">57<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity in net loss of affiliates</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">3,562<span></span>
</td>
<td class="nump">5,415<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pgen_SharesIssuedDuringPeriodValueIssuedForServices', window );">Shares issued as payment for services</a></td>
<td class="nump">576<span></span>
</td>
<td class="nump">577<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Provision for credit losses</a></td>
<td class="nump">334<span></span>
</td>
<td class="nump">162<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Accretion of debt discount and amortization of deferred financing costs</a></td>
<td class="nump">284<span></span>
</td>
<td class="nump">2,751<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="num">(58)<span></span>
</td>
<td class="num">(56)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pgen_NoncashGainLossOnTerminationOfLease', window );">Noncash gain on termination of operating leases</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(4,602)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other noncash items</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInReceivablesAbstract', window );"><strong>Receivables:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Trade</a></td>
<td class="num">(3,696)<span></span>
</td>
<td class="num">(4,949)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDueFromRelatedPartiesCurrent', window );">Related parties</a></td>
<td class="nump">58<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherReceivables', window );">Other</a></td>
<td class="nump">21<span></span>
</td>
<td class="num">(279)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventory</a></td>
<td class="nump">531<span></span>
</td>
<td class="nump">721<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other</a></td>
<td class="nump">1,571<span></span>
</td>
<td class="nump">844<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other assets</a></td>
<td class="nump">42<span></span>
</td>
<td class="nump">95<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableTrade', window );">Accounts payable</a></td>
<td class="num">(588)<span></span>
</td>
<td class="num">(189)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities', window );">Accrued compensation and benefits</a></td>
<td class="num">(3,462)<span></span>
</td>
<td class="num">(1,893)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities', window );">Other accrued liabilities</a></td>
<td class="num">(1,086)<span></span>
</td>
<td class="num">(2,216)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="num">(1,767)<span></span>
</td>
<td class="nump">1,054<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability', window );">Lease liabilities</a></td>
<td class="num">(18)<span></span>
</td>
<td class="nump">218<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent', window );">Related party payables</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">33<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(18,783)<span></span>
</td>
<td class="num">(16,384)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract', window );"><strong>Cash flows from investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInvestments', window );">Purchases of investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(174,221)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities', window );">Sales and maturities of investments</a></td>
<td class="nump">18,000<span></span>
</td>
<td class="nump">40,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property, plant and equipment</a></td>
<td class="num">(1,579)<span></span>
</td>
<td class="num">(1,014)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities', window );">Proceeds from sale of assets</a></td>
<td class="nump">147<span></span>
</td>
<td class="nump">1,944<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromCollectionOfNotesReceivable', window );">Proceeds from repayment of notes receivable</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,689<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by (used in) investing activities</a></td>
<td class="nump">16,568<span></span>
</td>
<td class="num">(129,102)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract', window );"><strong>Cash flows from financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of shares, net of issuance costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">121,045<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Payments of long-term debt</a></td>
<td class="num">(164)<span></span>
</td>
<td class="num">(116)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from stock option exercises</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">111<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash (used in) provided by financing activities</a></td>
<td class="num">(163)<span></span>
</td>
<td class="nump">121,040<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate changes on cash, cash equivalents, and restricted cash</a></td>
<td class="num">(230)<span></span>
</td>
<td class="num">(11)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net decrease in cash, cash equivalents, and restricted cash</a></td>
<td class="num">(2,608)<span></span>
</td>
<td class="num">(24,457)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract', window );"><strong>Cash, cash equivalents, and restricted cash</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Beginning of period</a></td>
<td class="nump">43,343<span></span>
</td>
<td class="nump">52,250<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">End of period</a></td>
<td class="nump">40,735<span></span>
</td>
<td class="nump">27,793<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosure of cash flow information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid during the period for interest</a></td>
<td class="nump">3,535<span></span>
</td>
<td class="nump">3,539<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Cash paid during the period for income taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Significant noncash activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pgen_AccruedCompensationPaidinEquityAwards', window );">Accrued compensation paid in equity awards</a></td>
<td class="nump">1,698<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Purchases of property and equipment included in accounts payable and other accrued liabilities</a></td>
<td class="nump">251<span></span>
</td>
<td class="nump">255<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pgen_SaleOfAssetsIncludedInAccountsReceivable', window );">Proceeds from sale of assets included in accounts receivable</a></td>
<td class="nump">132<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pgen_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsReconciliationAbstract', window );"><strong>Cash, cash equivalents, and restricted cash</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">40,321<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent', window );">Restricted cash included in other assets</a></td>
<td class="nump">414<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, and restricted cash</a></td>
<td class="nump">$ 40,735<span></span>
</td>
<td class="nump">$ 27,793<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pgen_AccruedCompensationPaidinEquityAwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Compensation Paid in Equity Awards</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pgen_AccruedCompensationPaidinEquityAwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pgen_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pgen_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsReconciliationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Reconciliation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pgen_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsReconciliationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pgen_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pgen_NoncashGainLossOnTerminationOfLease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncash Gain (Loss) on Termination of Lease</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pgen_NoncashGainLossOnTerminationOfLease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pgen_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pgen_SaleOfAssetsIncludedInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sale of Assets Included in Accounts Receivable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pgen_SaleOfAssetsIncludedInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pgen_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pgen_SharesIssuedDuringPeriodValueIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Shares Issued During Period, Value, Issued For Services . Stock Compensation Expense Is Related To Both Options And RSU's.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pgen_SharesIssuedDuringPeriodValueIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pgen_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCostsAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfAssets1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfAssets1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableTrade">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableTrade</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 310<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123371682&amp;loc=d3e55415-109406<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDueFromRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate increase (decrease) during the reporting period in the amount due from the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; an entity and its principal owners, management, or member of their immediate families, affiliates, or other parties with the ability to exert significant influence.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDueFromRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of obligations to be paid to the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management; an entity and its principal owners, management, or member of their immediate families, affiliates, or other parties with the ability to exert significant influence.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in other expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in receivables classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of all investments (debt, security, other) during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromCollectionOfNotesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with principal collections from a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromCollectionOfNotesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from sale, maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3151-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from the sale of other assets recognized in investing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6812-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140329646056008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Organization</a></td>
<td class="text">Organization<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Precigen, Inc. ("Precigen"), a Virginia corporation, is a synthetic biology company with an increasing focus on its discovery and clinical stage activities to advance the next generation of gene and cellular therapies to target the most urgent and intractable challenges in immuno-oncology, autoimmune disorders, and infectious diseases. Precigen operates through the following subsidiaries: </span></div><div style="margin-top:12pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PGEN Therapeutics, Inc. ("PGEN Therapeutics") is a dedicated discovery and clinical stage biopharmaceutical company advancing the next generation of gene and cell therapies using precision technology to target urgent and intractable diseases in immuno-oncology, autoimmune disorders, and infectious diseases. PGEN Therapeutics is a wholly owned subsidiary of Precigen with primary operations in Maryland.</span></div><div style="margin-top:12pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Precigen ActoBio, Inc. ("ActoBio") is pioneering a proprietary class of microbe-based biopharmaceuticals that enable expression and local delivery of disease-modifying therapeutics and is a wholly owned subsidiary of Precigen with primary operations in Belgium.</span></div><div style="margin-top:12pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exemplar Genetics, LLC, doing business as Precigen Exemplar ("Exemplar"), is committed to enabling the study of life-threatening human diseases through the development of MiniSwine Yucatan miniature pig research models and services, as well as enabling the production of cells and organs in its genetically engineered swine for regenerative medicine applications and is a wholly owned subsidiary of Precigen with primary operations in Iowa.</span></div><div style="margin-top:12pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trans Ova Genetics, L.C., including its wholly owned subsidiary Progentus, L.C., are providers of reproductive technologies, including services and products sold to cattle breeders and other producers and are hereinafter collectively referred to as "Trans Ova." Trans Ova is a wholly owned subsidiary with primary operations in California, Iowa, Maryland, Missouri, Texas, Washington, and Wisconsin.</span></div><div style="margin-top:12pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective October 1, 2019, Precigen transferred substantially all of its proprietary methane bioconversion platform ("MBP") assets to a wholly owned subsidiary, MBP Titan LLC ("MBP Titan"). MBP Titan's proprietary technology is designed to convert natural gas into more valuable and usable energy and chemical products through novel, highly engineered bacteria that utilize specific energy feedstocks. Prior to October 1, 2019, the operation transferred to MBP Titan was an operating division within Precigen. Beginning in the second quarter of 2020, the Company suspended MBP Titan's operations and began the process to wind down MBP Titan's activities and had substantially completed the wind down by December 31, 2020, with the final disposition of certain property and equipment and the facility operating lease occurring in January 2021. With the exception of certain assets and obligations with which the Company has a continuing involvement after the wind down, MBP Titan has been presented as discontinued operations for all periods presented. See Note 3 for further discussion.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Precigen and its consolidated subsidiaries are hereinafter referred to as the "Company."</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140329645776072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text">Summary of Significant Accounting Policies<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying interim condensed consolidated financial statements are unaudited and have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP"). Certain information and footnote disclosures normally included in the Company's annual financial statements have been condensed or omitted. These interim condensed consolidated financial statements, in the opinion of management, reflect all normal recurring adjustments necessary for fair statement of the Company's financial position as of March&#160;31, 2022 and results of operations and cash flows for the interim periods ended March&#160;31, 2022 and 2021. The year-end condensed consolidated balance sheet data was derived from the Company's audited financial statements but does not include all disclosures required by U.S. GAAP. These interim financial results are not necessarily indicative of the results to be expected for the year ending December&#160;31, 2022, or for any other future annual or interim period. The accompanying interim unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related notes thereto included in the Company's Annual Report on Form 10-K for the year ended December&#160;31, 2021.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying condensed consolidated financial statements reflect the operations of Precigen and its subsidiaries. All intercompany accounts and transactions have been eliminated.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Liquidity </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management believes that existing liquid assets as of March&#160;31, 2022 will allow the Company to continue its operations for at least a year from the issuance date of these condensed consolidated financial statements. These condensed consolidated financial statements are presented in United States dollars. The Company is subject to a number of risks similar to those of other companies conducting high-risk, early-stage research and development of therapeutic product candidates. Principal among these risks are dependence on key individuals and intellectual property, competition from other products and companies, and the technical risks associated with the successful research, development, and clinical manufacturing of its and its collaborators' therapeutic product candidates. Additionally, the accompanying condensed consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. During the three months ended March 31, 2022, the Company incurred a net loss of $19,251 and, as of March&#160;31, 2022, had an accumulated deficit of $1,916,135. Management expects operating losses and negative cash flows to continue for the foreseeable future and, as a result, the Company will require additional capital to fund its operations and execute its business plan. In the absence of a significant source of recurring revenue, the Company's long-term success is dependent upon its ability to continue to raise additional capital in order to fund ongoing research and development (which could occur through debt or equity issuances, sales or partnerships of non-core assets, corroborations or licensing of core or non-core assets, or other transactions), adequately satisfy or renegotiate long-term debt obligations, obtain regulatory approval of its therapeutic product candidates, successfully commercialize its therapeutic product candidates, generate revenue, meet its obligations and, ultimately, attain profitable operations.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Risks and Uncertainties</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">COVID-19 has had and continues to have an extensive impact on the global health and economic environments. Furthermore, there is uncertainty regarding the duration and severity of the ongoing pandemic, and the Company could experience delays or other pandemic-related events that may adversely impact the Company's clinical as well as preclinical pipeline candidates in the future.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is closely monitoring the impact of COVID-19 on all aspects of its businesses. Given the dynamic nature of these circumstances, the full impact of the COVID-19 pandemic on the Company's ongoing business, results of operations, and overall financial performance in future periods cannot be reasonably estimated at this time, and it could have a material adverse effect on the Company's results of operations, cash flows, and financial position, including resulting impairments to goodwill and long-lived assets and additional credit losses.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 3 for further discussion of the impact of COVID-19 on MBP Titan.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Method Investments</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for its investments in each of its joint ventures ("JVs")  using the equity method of accounting based upon relative ownership interest. See additional discussion related to certain of the Company's JVs in Note 4. </span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Variable Interest Entities</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022 and December&#160;31, 2021, the Company determined that its JVs were variable interest entities ("VIEs"). The Company was not the primary beneficiary for these entities since it did not have the power to direct the activities that most significantly impact the economic performance of the VIEs. As of March&#160;31, 2022 and December&#160;31, 2021, the Company had no risk of loss related to the identified VIEs. See Note 4 for discussion of the Company's future funding commitments for its significant JVs.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Loss per Share</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net loss per share is calculated by dividing net loss attributable to common shareholders by the weighted average shares outstanding during the period, without consideration of common stock equivalents. Diluted net loss per share is calculated by adjusting weighted average shares outstanding for the dilutive effect of common stock equivalents outstanding for the period, using the treasury-stock method. For purposes of the diluted net loss per share calculation, shares to be issued pursuant to convertible debt, stock options, RSUs, and warrants are considered to be common stock equivalents but are excluded from the </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">calculation of diluted net loss per share because their effect would be anti-dilutive and, therefore, basic and diluted net loss per share were the same for all periods presented.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following potentially dilutive securities as of March&#160;31, 2022 and 2021, have been excluded from the above computations of diluted weighted average shares outstanding for the three months then ended as they would have been anti-dilutive:</span></div><div style="margin-top:17pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:70.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.537%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible debt</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,732,440&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,732,440&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,034,553&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,451,614&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,185,205&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">790,364&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121,888&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133,264&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,074,086&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,107,682&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Segment Information</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's chief operating decision maker ("CODM") regularly reviews disaggregated financial information for various operating segments. Starting in 2021, the financial information regularly reviewed by the CODM was revised and the operating segments, which were determined to be operating and reportable segments, were (i) Biopharmaceuticals, (ii) Exemplar, and (iii) Trans Ova. The Biopharmaceuticals reportable segment is primarily comprised of the Company's legal entities of PGEN Therapeutics and ActoBio. All of Precigen's consolidated subsidiaries and operating divisions that did not meet the quantitative thresholds to report separately are combined and reported in a single category, All Other. See Note 1 for a description of PGEN Therapeutics, ActoBio, Exemplar, and Trans Ova. Corporate expenses, which are not allocated to the segments and are managed at a consolidated level, include costs associated with general and administrative functions, including the Company's finance, accounting, legal, human resources, information technology, corporate communication, and investor relations functions. Corporate expenses exclude interest expense, depreciation and amortization, gain or loss on disposals of assets, stock-based compensation expense, loss on settlement agreement, and equity in net loss of affiliates and include unrealized and realized gains and losses on the Company's securities portfolio as well as dividend income. See Note 18 for further discussion of the Company's segments.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In August 2020, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Debt&#8212;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#8212;Contracts in Entity's Own Equity (Subtopic 815-40)&#8212;Accounting for Convertible Instruments and Contracts in an Entity's Own Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> ("ASU 2020-06"</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Under ASU 2020-06, the embedded conversion features are no longer separated from the host contract for convertible instruments with conversion features that are not required to be accounted for as derivatives under Topic 815, or that do not result in substantial premiums accounted for as paid-in capital. Consequently, a convertible debt instrument will be accounted for as a single liability measured at its amortized cost, as long as no other features require bifurcation and recognition as derivatives. The new guidance also requires the if-converted method to be applied for all convertible instruments. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We adopted ASU 2020-06 on January 1, 2022 using the modified retrospective transition method, which resulted in an increase to our reported long-term debt outstanding, net of current portion, of $18,196, a decrease to our additional paid-in capital of $36,868, and a corresponding cumulative-effect reduction to our opening accumulated deficit of $18,672. The adoption of ASU 2020-06 is expected to reduce non-cash interest expense related to existing convertible debt outstanding by approximately $11,800 for the year ending December 31, 2022, and did not have an impact on our consolidated cash flows. The use of the if-converted method did not have an impact on our overall earnings per share calculation.</span></div>Recently Issued Accounting Pronouncements Not Yet Adopted<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140329645774408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Discontinued Operations<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock', window );">Discontinued Operations</a></td>
<td class="text">Discontinued Operations<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Where applicable, the notes to the accompanying condensed consolidated financial statements have been updated to reflect information pertaining to the Company's continuing operations based on the discontinued operations summarized below.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">MBP Titan</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of market uncertainty driven by the COVID-19 pandemic and the state of the energy sector raising significant challenges for the strategic alternatives pursued by MBP Titan, beginning in the second quarter of 2020 and throughout the remainder of 2020, the Company suspended MBP Titan's operations, preserved certain of MBP Titan's intellectual property, terminated all of its personnel, and undertook steps to dispose of its other assets and obligations. The wind down of MBP Titan's activities was substantially completed by December 31, 2020, with the final disposition of certain property and equipment and the facility operating lease occurring in January 2021. This discontinuation of operations represented the continuation of a strategic shift to becoming a primarily healthcare company advancing technologies and products that address complex healthcare challenges that the Company commenced in 2020. The assets, liabilities, and expenses related to the discontinued operations of MBP Titan are reclassified and presented as discontinued operations in the accompanying condensed consolidated financial statements for all periods.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The January 2021 sale of property and equipment resulted in a gain on disposal of assets of $464, which is included in income from discontinued operations in the accompanying condensed consolidated statement of operations for the three months ended March 31, 2021. In January 2021, the Company executed termination and recapture agreements with the landlord of the leased facility used in MBP Titan's operations, thereby relieving the Company of all of its obligations related to the facility that were originally due to expire in July 2025. This lease termination resulted in a gain of $4,602, which is also included in income from discontinued operations in the accompanying condensed consolidated statement of operations for the three months ended March 31, 2021.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After the wind down of MBP Titan, certain assets and contractual obligations which were previously managed by MBP Titan continue to be managed at the Precigen corporate level. These remaining assets and contractual obligations include the Company's equity interest in and collaboration agreements with Intrexon Energy Partners, LLC ("Intrexon Energy Partners"), and Intrexon Energy Partners II, LLC ("Intrexon Energy Partners II"), including the associated deferred revenue remaining under each collaboration agreement (Notes 4 and 5), as well as the associated intellectual property developed by MBP Titan to date. These assets, liabilities, and related historical revenue and equity losses are included in the Company's operating results from continuing operations in the accompanying condensed consolidated financial statements for all periods presented as a result of the Company's continuing involvement.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no discontinued operations related to MBP Titan for the three months ended March 31, 2022. The following table presents the financial results of discontinued operations related to MBP Titan for the three months ended March 31, 2021:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.274%"><tr><td style="width:1.0%"/><td style="width:83.696%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.426%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.478%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended&#160;<br/>&#160;March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating gains</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,526&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,526&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,526&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from discontinued operations</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,526&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the significant noncash items, purchases of property, plant and equipment, and proceeds from sales of assets for the discontinued operations related to MBP Titan for the three months ended March 31, 2021 that are included in the accompanying condensed consolidated statements of cash flows.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"><tr><td style="width:1.0%"/><td style="width:84.203%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.991%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended&#160;<br/>&#160;March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjustments to reconcile net loss to net cash used in operating activities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on disposals of assets, net</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(464)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncash gain on termination of leases</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,602)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from investing activities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sales of assets</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,083&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=2122178<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140329645697304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments in Joint Ventures<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract', window );"><strong>Equity Method Investments and Joint Ventures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsDisclosureTextBlock', window );">Investments in Joint Ventures</a></td>
<td class="text">Investments in Joint Ventures<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intrexon Energy Partners</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2014, the Company and certain investors (the "IEP Investors"), including an affiliate of Third Security, LLC ("Third Security"), entered into a Limited Liability Company Agreement that governs the affairs and conduct of business of Intrexon Energy Partners, a JV formed to optimize and scale-up the Company's MBP technology for the production of certain fuels and lubricants. The Company also entered into an exclusive channel collaboration ("ECC") with Intrexon Energy Partners providing exclusive rights to the Company's technology for the use in bioconversion for the production of certain fuels and lubricants, as a result of which the Company received a technology access fee of $25,000 while retaining a 50% membership interest in Intrexon Energy Partners. The IEP Investors made initial capital contributions, totaling $25,000 in the aggregate, in exchange for pro rata membership interests in Intrexon Energy Partners totaling 50%. In addition, Precigen committed to make capital contributions of up to $25,000, and the IEP Investors, as a group and pro rata in accordance with their respective membership interests in Intrexon Energy Partners, committed to make additional capital contributions of up to $25,000, at the request of Intrexon Energy Partners' board of managers (the "Intrexon Energy Partners Board") and subject to certain limitations. As of March&#160;31, 2022, the Company's remaining commitment was $4,225. Intrexon Energy Partners is governed by the Intrexon Energy Partners Board, which has five members. Two members of the Intrexon Energy Partners Board are designated by the Company and three members are designated by a majority of the IEP Investors. The Company and the IEP Investors have the right, but not the obligation, to make additional capital contributions above the initial limits when and if solicited by the Intrexon Energy Partners Board.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's investment in Intrexon Energy Partners was $(429) and $(428) as of March&#160;31, 2022 and December&#160;31, 2021, respectively, and is included in other accrued liabilities in the accompanying condensed consolidated balance sheets, which represents the Company's equity in losses for contractually committed contributions to Intrexon Energy Partners.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 3 and 16 for additional discussion regarding the Company's investment in Intrexon Energy Partners.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intrexon Energy Partners II</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2015, the Company and certain investors (the "IEPII Investors"), entered into a Limited Liability Company Agreement that governs the affairs and conduct of business of Intrexon Energy Partners II, a JV formed to utilize the Company's MBP technology for the production of 1,4-butanediol, an industrial chemical used to manufacture spandex, polyurethane, plastics, and polyester. The Company also entered into an ECC with Intrexon Energy Partners II that provides exclusive rights to the Company's technology for use in the field, as a result of which the Company received a technology access fee of $18,000 while retaining a 50% membership interest in Intrexon Energy Partners II. The IEPII Investors made initial capital contributions, totaling $18,000 in the aggregate, in exchange for pro rata membership interests in Intrexon Energy Partners II totaling 50%. In December 2015, the owners of Intrexon Energy Partners II made a capital contribution of $4,000, half of which was paid by the Company. Precigen committed to make additional capital contributions of up to $10,000, and the IEPII Investors, as a group and pro rata in accordance with their respective membership interests in Intrexon Energy Partners II, committed to make additional capital contributions of up to $10,000, at the request of Intrexon Energy Partners II's board of managers (the "Intrexon Energy Partners II Board") and subject to certain limitations. As of March&#160;31, 2022, the Company's remaining commitment was $10,000. Intrexon Energy Partners II is governed by the Intrexon Energy Partners II Board, which has five </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">members. One member of the Intrexon Energy Partners II Board is designated by the Company and four members are designated by a majority of the IEPII Investors. The Company and the IEPII Investors have the right, but not the obligation, to make additional capital contributions above the initial limits when and if solicited by the Intrexon Energy Partners II Board.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's investment in Intrexon Energy Partners II was $(435) as of March&#160;31, 2022 and December&#160;31, 2021, and is included in other accrued liabilities in the accompanying condensed consolidated balance sheets, which represents the Company's equity in losses for contractually committed contributions to Intrexon Energy Partners II.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Notes 3 and 16 for additional discussion regarding the Company's investment in Intrexon Energy Partners II.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -URI http://asc.fasb.org/topic&amp;trid=2196965<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140329645737976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Collaboration and Licensing Revenue<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementDisclosureTextBlock', window );">Collaboration and Licensing Revenue</a></td>
<td class="text">Collaboration and Licensing Revenue<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Historically, the Company has derived collaboration and licensing revenue through agreements with counterparties for the development and commercialization of products enabled by the Company's technology platforms. These collaborations and licensing agreements may provide for multiple promises to be satisfied by the Company and typically include a license to the Company's technology platforms, participation in collaboration committees, and performance of certain research and development services. Based on the nature of the promises in the Company's collaboration and licensing agreements, the Company typically combines most of its promises into a single performance obligation because the promises are highly interrelated and not individually distinct. Options to acquire additional services are considered to determine if they constitute material rights. At contract inception, the transaction price is typically the upfront payment received and is allocated to the performance obligations. The Company has determined the transaction price should be recognized as revenue based on its measure of progress under the agreement primarily based on inputs necessary to fulfill the performance obligation.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes the reimbursement payments received for research and development efforts in the period when the services are performed, in connection with the single performance obligation discussed above. The reimbursements relate specifically to the Company's efforts to provide services, and the reimbursements are consistent with what the Company would typically charge other collaborators for similar services. The Company assesses the uncertainty of when and if any milestones will be achieved to determine whether the milestone is included in the transaction price. The Company then assesses whether the revenue is constrained based on whether it is probable that a significant reversal of revenue would not occur when the uncertainty is resolved. Royalties, including sales-based milestones, received under the agreements will be recognized as revenue when sales have occurred because the Company applies the sales- or usage-based royalties recognition exception provided for under ASC Topic 606. The Company determined the application of this exception is appropriate because at the time the royalties are generated, the technology license granted in the agreement is the predominant item to which the royalties relate. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines whether collaborations and licensing agreements are individually significant for disclosure based on a number of factors, including total revenue recorded by the Company pursuant to collaboration and licensing agreements, collaborators or licensees with equity method investments, or other qualitative factors. Collaboration and licensing revenues generated from consolidated subsidiaries are eliminated in consolidation.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the amounts recorded as revenue in the condensed consolidated statements of operations for each significant counterparty to a collaboration or licensing agreement for the three months ended March&#160;31, 2022 and 2021.</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:70.728%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.616%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.619%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended&#160;<br/>&#160;March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Castle Creek Biosciences, Inc.</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total (1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:7pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Collaboration and licensing revenues include the recognition of $0 and $66 for the three months ended March 31, 2022 and 2021, respectively, associated with upfront and milestone payments which were previously deferred.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no significant changes to the agreements with our collaborators and licensees in the three months ended March 31, 2022.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deferred Revenue</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred revenue primarily consists of upfront and milestone consideration received for the Company's collaboration and licensing agreements. Revenue is recognized as services are performed. The arrangements classified as long-term (of which $21,205 is related to agreements with Intrexon Energy Partners L.L.C. and Intrexon Energy Partners II, L.L.C.) are not active while the respective counterparties evaluate the status of the project and its desired future development activities since the Company cannot reasonably estimate the amount of service to be performed over the next year.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred revenue consisted of the following:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:70.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.537%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Collaboration and licensing agreements</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,023&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,023&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid product and service revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,511&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,229&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,692&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,465&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of deferred revenue</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,669&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,442&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term portion of deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,023&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,023&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,692&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,465&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6931272&amp;loc=SL5834143-161434<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6931272&amp;loc=SL5834143-161434<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -URI http://asc.fasb.org/topic&amp;trid=5833765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140329645594616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Short-term and Long-term Investments<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock', window );">Short-term and Long-term Investments</a></td>
<td class="text">Short-term and Long-term Investments<div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's investments are classified as available-for-sale. The following table summarizes the amortized cost, gross unrealized gains and losses, and fair value of available-for-sale investments as of March&#160;31, 2022:</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.321%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.501%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate<br/>Fair&#160;Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government debt securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102,771&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,133)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101,638&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102,868&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,133)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101,735&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the amortized cost, gross unrealized gains and losses, and fair value of available-for-sale investments as of December&#160;31, 2021:</span></div><div style="margin-bottom:4pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.321%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.501%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate<br/>Fair&#160;Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government debt securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121,036&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(331)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,705&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121,133&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(331)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,802&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of available-for-sale investments classified by their contractual maturities as of March&#160;31, 2022 was:</span></div><div style="margin-top:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.303%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.497%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due within one year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,821&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After one year through two years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,914&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101,735&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>Changes in market interest rates and bond yields cause certain investments to fall below their cost basis, resulting in unrealized losses on investments.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for  investments in certain debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2209399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2324412<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2176304<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1403<br> -Paragraph (b)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140329646052424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">Fair Value Measurements<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amount of cash and cash equivalents, receivables, accounts payable, accrued compensation and benefits, other accrued liabilities, and related party payables approximate fair value due to the short maturity of these instruments.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the placement in the fair value hierarchy of financial assets that are measured at fair value on a recurring basis as of March&#160;31, 2022:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:41.988%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.579%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Quoted Prices in Active Markets<br/>(Level&#160;1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Significant Other Observable Inputs<br/>(Level&#160;2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Significant Unobservable Inputs<br/>(Level&#160;3)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government debt securities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101,638&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101,638&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101,735&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101,735&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the placement in the fair value hierarchy of financial assets that are measured at fair value on a recurring basis as of December&#160;31, 2021:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:41.988%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.579%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Quoted Prices in Active Markets<br/>(Level&#160;1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Significant Other Observable Inputs<br/>(Level&#160;2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Significant Unobservable Inputs<br/>(Level&#160;3)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government debt securities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,705&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,705&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,802&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,802&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The method used to estimate the fair value of the Level 2 short-term and long-term debt investments in the tables above is based on professional pricing sources for identical or comparable instruments, rather than direct observations of quoted prices in active markets.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Liabilities</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying values of the Company's long-term debt, excluding the 3.50% convertible senior notes due 2023 (the "Convertible Notes"), approximates fair value due to the length of time to maturity and/or the existence of interest rates that approximate prevailing market rates. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The calculated fair value of the Convertible Notes (Note 11) was approximately $164,000 and $160,000 as of March&#160;31, 2022 and December&#160;31, 2021, respectively, and is based on the recent third-party trades of the instrument as of the balance sheet date. The fair value of the Convertible Notes is classified as Level 2 within the fair value hierarchy as there is not an active market for the Convertible Notes, however, third-party trades of the instrument are considered observable inputs. The Convertible Notes are reflected on the accompanying condensed consolidated balance sheets at amortized cost, which was $198,362 and $179,882 as of March&#160;31, 2022 and December&#160;31, 2021, respectively (see Note 2 regarding adoption of ASU 2020-06 on January 1, 2022).</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140329650574936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventory<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">Inventory</a></td>
<td class="text">Inventory<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory consists of the following:</span></div><div style="margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplies, embryos and other production materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,931&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,588&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,539&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,564&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Livestock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,918&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,310&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Feed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,342&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,799&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventory</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,730&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,261&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140329645581848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Plant and Equipment, Net<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property, Plant and Equipment, Net</a></td>
<td class="text">Property, Plant and Equipment, Net<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment consist of the following:</span></div><div style="margin-top:17pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:70.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.537%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land and land improvements</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,118&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,118&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and building improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,903&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,896&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,193&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,162&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,304&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,584&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,822&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,822&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breeding stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">953&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer hardware and software</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,169&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,131&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction and other assets in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,596&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,824&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,058&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,537&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40,475)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39,222)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,583&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,315&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense was $1,483 and $1,593 for the three months ended March 31, 2022 and 2021, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140329645703512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets, Net<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Goodwill and Intangible Assets, Net</a></td>
<td class="text">Goodwill and Intangible Assets, Net<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the carrying amount of goodwill for the three months ended March 31, 2022 were as follows:</span></div><div style="margin-top:17pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:85.263%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.537%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,148&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(482)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at March 31, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,613&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded $482 of goodwill impairment related to the total goodwill assigned to one reporting unit within the biopharmaceutical segment during the first quarter of 2022.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had $44,125 and $43,643 of cumulative impairment losses as of March&#160;31, 2022 and December&#160;31, 2021, respectively.</span></div><div style="margin-top:15pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets consist of the following as of March&#160;31, 2022:</span></div><div style="margin-top:17pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:56.462%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.558%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents, developed technologies and know-how</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39,595)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,405&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,850&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,480)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,900&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,248)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">652&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,750&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55,323)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,427&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets consist of the following as of December&#160;31, 2021:</span></div><div style="margin-top:15pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:56.462%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.558%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents, developed technologies and know-how</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,373&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38,630)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,743&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,850&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,252)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">598&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,900&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,126)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">774&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,123&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54,008)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,115&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense was $1,809 and $1,930 for the three months ended March 31, 2022 and 2021, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140329645620872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Lines of Credit and Long-Term Debt<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Lines of Credit and Long-Term Debt</a></td>
<td class="text">Lines of Credit and Long-Term Debt<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Lines of Credit</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trans Ova had a $5,000 revolving line of credit with First National Bank of Omaha that matured on April 1, 2022. The line of credit bore interest at the greater of the U.S. Prime Rate or 3.00%, and the actual rate was 3.50% as of March&#160;31, 2022. As of March&#160;31, 2022 and December&#160;31, 2021, there was no outstanding balance. The amount available under the line of credit was based on eligible accounts receivable and inventory up to the maximum principal amount and was $5,000 as of March&#160;31, 2022.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exemplar has a $700 revolving line of credit with American State Bank that matures on October 31, 2022. As of March&#160;31, 2022, the line of credit bore interest at a stated rate of 4.00% per annum. As of March&#160;31, 2022 and December&#160;31, 2021, there was no outstanding balance.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-Term Debt</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt consists of the following:</span></div><div style="margin-top:17pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:70.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.537%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible debt (1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198,362&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179,882&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,217&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201,467&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183,151&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">355&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">402&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, less current portion</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201,112&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182,749&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:13pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">See Note 2 regarding adoption of ASU 2020-06 as of January 1, 2022.</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Convertible Debt</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Precigen Convertible Notes</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2018, Precigen completed a registered underwritten public offering of $200,000 aggregate principal amount of Convertible Notes and issued the Convertible Notes under an indenture (the "Base Indenture") between Precigen and The Bank of New York Mellon Trust Company, N.A., as trustee, as supplemented by the First Supplemental Indenture (together with the Base Indenture, the "Indenture"). Precigen received net proceeds of $193,958 after deducting underwriting discounts and offering expenses of $6,042.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Convertible Notes are senior unsecured obligations of Precigen and bear interest at a rate of 3.50% per year, payable semiannually in arrears on January 1 and July 1 of each year beginning on January 1, 2019. The Convertible Notes mature on July 1, 2023 and are repayable in cash, unless earlier repurchased or converted. Upon conversion by the holders, the Convertible Notes are convertible into cash, shares of Precigen's common stock or a combination of cash and shares, at Precigen's election. The initial conversion rate of the Convertible Notes is 58.6622 shares of Precigen common stock per $1,000 principal amount of Convertible Notes (equivalent to an initial conversion price of approximately $17.05 per share of common stock). The conversion rate is subject to adjustment upon the occurrence of certain events, but will not be adjusted for any accrued and unpaid interest. In addition, following certain corporate events that occur prior to the maturity date as defined in the Indenture, Precigen will increase the conversion rate for a holder who elects to convert its Convertible Notes in connection with such a corporate event in certain circumstances. Prior to April 1, 2023, the holders may convert the Convertible Notes at their option only upon the satisfaction of the following circumstances:</span></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">During any calendar quarter commencing after the calendar quarter ended on September 30, 2018, if the last reported sales price of Precigen's common stock for at least 20 trading days (whether or not consecutive) during the last 30 consecutive trading days of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day;</span></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">During the five business day period after any five consecutive trading day period in which the trading price, as defined in the Indenture, for the Convertible Notes is less than 98% of the product of the last reported sales price of Precigen's common stock and the conversion rate for the Convertible Notes on each such trading day; or</span></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Upon the occurrence of specified corporate events as defined in the Indenture.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None of the above events allowing for conversion prior to April 1, 2023 occurred during the three months ended March&#160;31, 2022. On or after April 1, 2023 until June 30, 2023, holders may convert their Convertible Notes at any time. Precigen may not redeem the Convertible Notes prior to the maturity date.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If Precigen undergoes a fundamental change, as defined in the Indenture, holders of the Convertible Notes may require Precigen to repurchase for cash all or any portion of their Convertible Notes at a fundamental change repurchase price equal to 100% of the principal amount of the Convertible Notes to be repurchased, plus accrued and unpaid interest to, but excluding, the fundamental change repurchase date. The Indenture contains customary events of default, as defined in the agreement, and, if any of the events occur, could require repayment of a portion or all of the Convertible Notes, including accrued and unpaid interest. Additionally, the Indenture provides that Precigen shall not consolidate with or merge with or into, or sell, convey, transfer or lease all or substantially all of its properties and assets to, another entity, unless (i) the surviving entity is organized under the laws of the United States and such entity expressly assumes all of Precigen's obligations under the Convertible Notes and the Indenture; and (ii) immediately after such transaction, no default or event of default has occurred and is continuing under the Indenture.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net proceeds received from the issuance of the Convertible Notes were initially allocated between long-term debt, the liability component, in the amount of $143,723, and additional paid-in capital, the equity component, in the amount of $50,235. Additional paid-in capital was further reduced by $13,367 of deferred taxes resulting from the difference between the carrying amount and the tax basis of the Convertible Notes that is created by the equity component, which also resulted in deferred tax benefit recognized from the reversal of valuation allowances on the then current year domestic operating losses in the same amount. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As described in Note 2, the Company adopted ASU 2020-06 on January 1, 2022. Pursuant to ASU 2020-06, the equity components of the Convertible Notes separated from the debt components as required under the cash conversion model is required to be recombined into the Convertible Notes as a single instrument upon the adoption of ASU 2020-06. The </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Convertible Notes shall be accounted for as if the conversion option had not been separated. As the Company elected the modified retrospective approach, the difference between the accounting under the cash conversion model and new model after the adoption of ASU 2020-06 (i.e., the single debt instrument with no separation) was recorded as an adjustment on the adoption date (i.e., January 1, 2022) through accumulated deficit. Tax accounting consequences of the adoption also required the reversal of the previously reported deferred tax benefit on the date of adoption.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Adoption of ASU 2020-06 resulted in an increase to long-term debt outstanding, net of current portion, of $18,196, a decrease to additional paid-in capital of $36,868, and a decrease to accumulated deficit of $18,672. Interest expense recognized on the convertible notes in future periods will be reduced as a result of accounting for the convertible debt instrument as a single liability measured at its amortized cost.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As of March&#160;31, 2022, the outstanding principal balance on the Convertible Notes was $200,000 and the carrying value of long-term debt was $198,362. The effective interest rate on the Convertible Notes, including amortization of the long-term debt discount and debt issuance costs, is 4.25%. As of March&#160;31, 2022, the unamortized long-term debt discount and debt issuance costs totaled $1,638.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of interest expense related to the Convertible Notes were as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.514%"><tr><td style="width:1.0%"/><td style="width:70.264%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.549%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.844%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended&#160;<br/>&#160;March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash interest expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,751&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total interest expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,034&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,501&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued interest of $1,750 is included in other accrued liabilities on the accompanying condensed consolidated balance sheet as of March&#160;31, 2022.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Notes Payable</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trans Ova has a note payable that matures in April 2033 and had an outstanding principal balance of $3,105 as of March&#160;31, 2022. Trans Ova pays monthly installments of $39, which includes interest at 3.95%. The note payable is collateralized by certain of Trans Ova's real estate and non-real estate assets.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Future Maturities</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future maturities of long-term debt as of March&#160;31, 2022 are as follows:</span></div><div style="margin-top:17pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:85.263%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.537%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200,365&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">380&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">411&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">428&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">861&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203,105&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140329645558648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income TaxesTax provisions for interim periods are calculated using an estimate of actual taxable income or loss for the respective period, rather than estimating the Company's annual effective income tax rate, as the Company is currently unable to reliably estimate its income for the full year. The Company has U.S. taxable loss of approximately $5,300 and $40,400 for the three months ended March 31, 2022 and 2021, respectively. The following table presents the components of income tax benefit from continuing operations.<div style="margin-top:17pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:70.728%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.616%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.619%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended&#160;<br/>&#160;March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current foreign income tax expense from continuing operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax benefit from continuing operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total income tax benefit from continuing operations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's net deferred tax assets, excluding certain deferred tax liabilities totaling $2,438, are offset by a valuation allowance due to the Company's history of net losses combined with an inability to confirm recovery of the tax benefits of the Company's losses and other net deferred tax assets. In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, the Company had net operating loss carryforwards for U.S. federal income tax purposes of approximately $861,000 available to offset future taxable income, including approximately $609,000 generated after 2017, U.S. capital loss carryforwards of approximately $212,500, and federal and state research and development tax credits of approximately $11,300, prior to consideration of annual limitations that may be imposed under Section&#160;382 of the Internal Revenue Code of 1986, as amended. Net operating loss carryforwards generated prior to 2018 have begun to expire in 2022, and capital loss carryforwards will expire if unutilized beginning in 2024. As of March&#160;31, 2022, the Company's foreign subsidiaries have foreign loss carryforwards of approximately $74,200, most of which do not expire.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140329645748616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Shareholders' Equity</a></td>
<td class="text">Shareholders' Equity<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Issuances of Precigen Common Stock</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, the Company closed a public offering of 17,250,000 shares of its common stock, resulting in net proceeds of $121,045, after deducting underwriting discounts and of capitalized offering expenses.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 11  for discussion regarding conversion features of the convertible notes.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Lending Agreement</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Concurrently with the offering of the Convertible Notes (Note 11), Precigen entered into a share lending agreement (the "Share Lending Agreement") with J.P. Morgan Securities LLC (the "Share Borrower") pursuant to which Precigen loaned and delivered 7,479,431 shares of its common stock (the "Borrowed Shares") to the Share Borrower. The Share Lending Agreement will terminate, and the Borrowed Shares will be returned to Precigen within <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83My9mcmFnOmM1ZGIyMTNkZWJkZjRlMzA5OGU3ODI0MjJjNjU2ZTg5L3RleHRyZWdpb246YzVkYjIxM2RlYmRmNGUzMDk4ZTc4MjQyMmM2NTZlODlfMTA3OA_34a88b8d-8f7c-4b2a-8636-4d319d40194f">five</span> business days of such termination, upon (i) termination by the Share Borrower or (ii) the earliest to occur of (a) October 1, 2023 and (b) the date, if any, on which the Share Lending Agreement is either mutually terminated or terminated by one party upon a default by the other party. The Share Borrower maintains collateral in the form of cash or certain permitted non-cash collateral with a market value at least equal to the market value of the Borrowed Shares as security for the obligation of the Share Borrower to return the Borrowed Shares when required by the terms above. The Borrowed Shares were offered and sold to the public at a price of $13.37 per share under a registered offering (the "Borrowed Shares Offering"). Precigen did not receive any proceeds from the sale of the Borrowed Shares to the public or any lending fees from the Share Lending Agreement. The Share Borrower or its affiliates received all the proceeds from the sale of the Borrowed Shares to the public. Affiliates of Third Security purchased all of the shares of common stock in the Borrowed Shares Offering.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Share Lending Agreement was entered into at fair value and met the requirements for equity classification. Therefore, the value is netted against the issuance of the Borrowed Shares in additional paid-in capital. Additionally, the Borrowed Shares are not included in the denominator for loss per share attributable to Precigen shareholders unless the Share Borrower defaults on the Share Lending Agreement.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Components of Accumulated Other Comprehensive (Loss) Income </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of accumulated other comprehensive (loss) income are as follows:</span></div><div style="margin-top:17pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:70.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.537%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized loss on investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,133)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(331)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) on foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(566)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">534&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accumulated other comprehensive (loss) income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,699)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140329646071640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Payments<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Share-Based Payments</a></td>
<td class="text">Share-Based Payments<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures the fair value of stock options and restricted stock units ("RSUs") issued to employees and nonemployees as of the grant date for recognition of stock-based compensation expense. Stock-based compensation expense for employees and nonemployees is recognized over the requisite service period, which is typically the vesting period. Stock-based compensation costs included in the condensed consolidated statements of operations are presented below:</span></div><div style="margin-top:17pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"><tr><td style="width:1.0%"/><td style="width:70.091%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.927%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.928%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended&#160;<br/>&#160;March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">548&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,038&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,975&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,303&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,562&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,415&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Precigen Stock Option Plans</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April&#160;2008, Precigen adopted the 2008 Equity Incentive Plan (the "2008 Plan") for employees and nonemployees pursuant to which Precigen's board of directors granted share-based awards, including stock options, to officers, key employees and nonemployees. Upon the effectiveness of the 2013 Omnibus Incentive Plan (the "2013 Plan"), no new awards may be granted under the 2008 Plan. As of March&#160;31, 2022, there were 14,843 stock options outstanding under the 2008 Plan.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Precigen adopted the 2013 Plan for employees and nonemployees pursuant to which Precigen's board of directors may grant share-based awards, including stock options and shares of common stock, to employees, officers, consultants, advisors, and nonemployee directors. The 2013 Plan became effective in August 2013, and as of March&#160;31, 2022, there were 27,000,000 shares authorized for issuance under the 2013 Plan, of which 14,121,502 stock options and 569,445 RSUs were outstanding and 2,085,537 shares were available for grant. In April 2022, Precigen's board of directors approved, subject to shareholder approval at Precigen's annual meeting in June 2022, an increase of 10,000,000 shares of common stock to be reserved for issuance under the 2013 Plan.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2019, Precigen adopted the 2019 Incentive Plan for Non-Employee Service Providers (the "2019 Plan"), which became effective upon shareholder approval in June 2019. The 2019 Plan permits the grant of share-based awards, including stock options, restricted stock awards, and RSUs, to non-employee service providers, including board members. As of March&#160;31, 2022, there were 5,000,000 shares authorized for issuance under the 2019 Plan, of which 1,898,208 stock options and 615,760 RSUs were outstanding and 243,025 shares were available for grant. In April 2022, Precigen's board of directors approved, subject to shareholder approval at Precigen's annual meeting in June 2022, an increase of 7,000,000 shares of common stock to be reserved for issuance under the 2019 Plan.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock option activity was as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.648%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.500%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Remaining Contractual Term (Years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,260,187&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.06&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.79</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,009,390&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(375)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(210,613)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,036)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.85&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances at March 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,034,553&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.31</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exercisable at March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,937,195&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.85&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.99</span></td></tr></table></div><div style="margin-bottom:17pt;margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSU activity was as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.648%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.500%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of Restricted Stock Units</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Grant Date Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Remaining Contractual Term (Years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">468,481&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.47&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.33</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,387,831&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(669,041)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.71&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,066)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances at March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,185,205&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.59</span></td></tr></table></div><div style="margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Precigen currently uses authorized and unissued shares to satisfy share award exercises.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's Executive Chairman ("Executive Chairman"), who previously served as an employee and executive officer until September 24, 2020, received a base salary of $200 per month through March 31, 2020, payable in fully-vested shares of Precigen common stock with such shares subject to a three-year lock-up on resale. In September 2020, the Company's board of directors, upon the recommendation of the compensation committee of the board, approved a new compensation arrangement for the Executive Chairman consisting of (i) an annual retainer of $100 payable in cash or, at the Executive Chairman's election, shares of Precigen common stock; (ii) an annual grant of fully vested stock options having a grant date fair value of $250; and (iii) an annual grant of RSUs having a grant date fair value of $250 vesting over one year. The new compensation arrangement began in calendar year 2021 and was prorated for the nine months of 2020 not covered by the Executive Chairman's previous compensation arrangement discussed above. Expense associated with the arrangements above is included in selling, general, and administrative expenses in the Company's condensed consolidated statements of operations and totaled $433 and $400 for the three months ended March 31, 2022 and 2021.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140329646062536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Operating Leases<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Operating Leases</a></td>
<td class="text">Operating LeasesThe Company leases certain facilities and equipment under operating leases. Leases with a lease term of twelve months or less are considered short-term leases and are not recorded on the balance sheet, and expense for these leases is recognized over the term of the lease. All other leases have remaining terms of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83OS9mcmFnOjgxNjNjNDA5NjZlOTQxMTdhMzUxODA5ZTdhYWE0ZDRkL3RleHRyZWdpb246ODE2M2M0MDk2NmU5NDExN2EzNTE4MDllN2FhYTRkNGRfMzQw_862490a9-7afa-4299-a0ee-2b7d4d6c6c09">one</span> to nine years, some of which may include options to extend the lease and some of which may include options to terminate the lease within one year. The Company uses judgment to determine whether it is reasonably possible to extend the lease beyond the initial term or terminate before the initial term ends and the length of the possible extension or early termination. The leases are renewable at the option of the Company and do not contain residual value guarantees, covenants, or other restrictions. <div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease costs were as follows:</span></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"><tr><td style="width:1.0%"/><td style="width:69.960%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.990%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.993%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended&#160;<br/>&#160;March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease costs</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">729&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">839&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">463&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">506&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease costs</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,309&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,575&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, maturities of lease liabilities, excluding short-term and variable leases, for continuing operations were as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.303%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.497%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,117&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,519&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,528&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,259&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,778&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,345&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,292&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,838&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,740)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,098&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,590&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,508&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,098&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other information related to operating leases in continuing operations was as follows:</span></div><div style="margin-bottom:4pt;margin-top:17pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term (years)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.30</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.65</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended&#160;<br/>&#160;March 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Supplemental disclosure of cash flow information</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for operating lease liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">744&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,005&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets obtained in exchange for new lease liabilities (includes new leases or modifications of existing leases)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">556&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140329645752184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingencies</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 1, 2020, Trans Ova settled one of two patent infringement lawsuits brought by XY, LLC ("XY"). The lawsuit, originally filed in 2012, was tried and appealed between 2016 and 2020. On December 1, 2020, the parties reached a settlement resolving all remaining disputes. As part of that settlement, Trans Ova remitted to XY a settlement payment, which, in addition to all the other monies Trans Ova had previously paid XY, constituted full payment and satisfaction of the judgment, including pre-judgment interest, post-judgment interest, costs, and all past, current and future royalty obligations under the judgment. In exchange, XY released and forever discharged Trans Ova from all obligations arising out of the judgment.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">XY filed a second lawsuit in December 2016, alleging infringement of seven additional patents. Two of those patents were later invalidated in different proceedings and dismissed from the lawsuit. A third patent was settled out of the case in April 2022. There are thus currently four patents remaining in the case. Of these, one patent expired on May 9, 2021, and another expires on May 21, 2022. As for the last two patents, Trans Ova has stopped practicing the technologies claimed therein. The Company expects a trial to occur sometime in 2023. While Trans Ova is confident in its claims and defenses, litigation is uncertain and there is a possibility that the Trans Ova is found liable and ordered to pay damages for past infringement. In the interim, Trans Ova shall continue to operate its business otherwise unaffected by the litigation.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2020, the Company reached a final settlement with the Securities and Exchange Commission ("SEC") with respect to an investigation concerning the Company's disclosures regarding its MBP program in the first three quarters of 2017. Under the terms of the settlement, the Company, without admitting or denying the allegations of the SEC, consented to the entry of an administrative order requiring that the Company: (i) cease and desist from committing or causing any violations and future violations under Section 13(a) of the Securities Exchange Act of 1934, as amended, and Rules 13a-11 and 12b-20 promulgated thereunder; and (ii) pay a $2,500 civil money penalty to the SEC (which was paid in September 2020).</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, several shareholder class action lawsuits were filed in the United States District Court for the Northern District of California on behalf of certain purchasers of the Company's common stock. The complaints name as defendants the Company and certain of its current and former officers. The plaintiffs' claims track the allegations in the SEC's administrative order described above but challenge disclosures about the MBP program through September 2020, i.e., the date of the SEC administrative order. The plaintiffs seek compensatory damages, interest, and an award of reasonable attorneys' fees and costs. In April 2021, the court granted an order consolidating the claims and appointed a lead plaintiff and lead counsel in the case, captioned </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Abailla v. Precigen, Inc., F/K/A Intrexon Corp., et al</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In May 2021, the lead plaintiff filed an amended complaint. The defendants moved to dismiss that complaint. In September 2021, the court issued an order mooting the defendants' motion to dismiss in light of the lead plaintiff's stated intent to file a second amended complaint in response to the motion to dismiss. On September 27, 2021, the lead plaintiff filed a second amended complaint. On April 7, 2022, at a hearing on the Company&#8217;s motion, the Court indicated that the second amended complaint would be dismissed with leave to amend. Plaintiffs&#8217; counsel indicated a new complaint would be filed. The defendants intend to move to dismiss that complaint.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2020, a derivative shareholder action, captioned </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Edward D. Wright, derivatively on behalf of Precigen, Inc. F/K/A Intrexon Corp. v. Alvarez et al</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, was filed in the Circuit Court for Fairfax County in Virginia on behalf of Precigen, Inc. asserting similar claims under state law against Precigen's current directors and certain officers. The plaintiff seeks damages, forfeiture of benefits received by defendants, and an award of reasonable attorneys' fees and costs. The case was stayed by an order entered on June 14, 2021. On September 24, 2021, an individual shareholder filed a lawsuit in the Circuit Court for Henrico County styled </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Kent v. Precigen, Inc.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Case CL21-6349. The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Kent</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> action demands inspection of certain books and records of the Company pursuant to Virginia statutory and common law. On April 1, 2022, the court denied the demurrer and referred the matter to a hearing on the merits. The Company is evaluating how best to proceed.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company intends to defend the lawsuits vigorously; however, there can be no assurances regarding the ultimate outcome of these lawsuits.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has previously entered into strategic collaborations, including ECCs and JVs, to fund and develop products enabled by its technologies. These relationships involve complex interests, and the Company's interests may diverge with those of its collaborators, which can occur as a result of operations under those collaborations, business or technological developments, or as the Company transitions away from, or terminates, certain strategic collaborations. The Company has had, and has, disagreements and disputes with certain collaborators and JV partners, including the IEP Investors and the IEPII Investors. While the Company believes it is entitled to payment for work performed per its collaborations and JVs, consistent with its policy for accounting for accounts receivable, in 2019, the Company has fully reserved the amount of any disputed accounts receivable that remained outstanding. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 29, 2021, the Company received a letter from a group of investors in each of Intrexon Energy Partners and Intrexon Energy Partners II, purporting to refer certain issues to arbitration pursuant to the arbitration provisions of the Amended and Restated Limited Liability Company Agreements of Intrexon Energy Partners and Intrexon Energy Partners II (the &#8220;Arbitration Matters&#8221;). On January 25, 2022, the Company filed a petition in the Court of Chancery for the State of Delaware seeking to enjoin the arbitration proceeding. In March 2022, the Court of Chancery for the State of Delaware determined that arbitration should proceed. The structure of the arbitration requires each party to propose terms for resolution of each matter and the arbitration panel will be required to award one of the two proposals for each matter without compromise. The Company has proposed terms that the Company would acquire the membership interests of the IEP Investors in exchange of $5,000, and the membership interests of the IEPII Investors in exchange of $2,000.  The investor group has proposed terms that the Company would acquire the membership interests of each individual investor in exchange of $34,000 for the membership interests of the IEP Investors and $12,000 for the membership interests of the IEPII Investors, representing the purchase price of their original investments, as well as, in addition, accrued interest from the date of their original investments, which approximates $18,000 for the IEP Investors and $6,000 for the IEPII Investors. The Company expects the arbitration will </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">be concluded in the second quarter of 2022</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the Company believes the investor groups&#8217; claims are without merit, there can be no assurance that the panel will award the Company&#8217;s proposal and will not award the investors&#8217; proposal with respect to either of the Arbitration Matters.  In addition, as disclosed in Note 5, as of March 31, 2022, the Company has a deferred revenue liability of $21,205 related to consideration previously received from Intrexon Energy Partners and Intrexon Energy Partners II that will be re-evaluated upon conclusion of the Arbitration Matters.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Such disagreements and disputes result in management distraction and may result in further litigation, arbitration, unfavorable settlements, or concessions by the Company, or adverse regulatory action, any of which could harm the Company's business or operations.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the course of its business, the Company is involved in litigation or legal matters, including governmental investigations. Such matters are subject to many uncertainties and outcomes are not predictable with assurance. The Company accrues liabilities for such matters when it is probable that future expenditures will be made and such expenditures can be reasonably estimated. As of March&#160;31, 2022, the Company does not believe that any such matters, individually or in the aggregate, will have a material adverse effect on the Company's business, financial condition, results of operations, or cash flows.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140329645767640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Party Transactions</a></td>
<td class="text">Related Party Transactions<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Third Security and Affiliates</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's Executive Chairman is also the Senior Managing Director and Chairman of Third Security and owns 100% of the equity interests of Third Security. The Company had an agreement with Third Security under which the Company reimbursed Third Security for certain tax-related services performed by Third Security as requested by the Company. The Company also reimburses Third Security for certain out-of-pocket expenses incurred on the Company's behalf. The agreement with Third Security expired on December 31, 2021. As the Company evaluates its alternatives, it continues to utilize these services on a limited basis under the terms of the original agreement. The total expenses incurred by the Company under these arrangements were $26 and $41 for the three months ended March 31, 2022 and 2021, respectively.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See also Note 14 regarding compensation arrangements between the Company and its Executive Chairman.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through November 2021, the Company also subleased certain administrative offices to Third Security. The significant terms of the lease mirrored the terms of the Company's lease with the landlord, and the Company recorded sublease income of $20 for the three months ended March 31, 2021.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Notes 1, 3, and 13 regarding additional transactions with affiliates of Third Security.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI http://asc.fasb.org/topic&amp;trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140329646041032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segments<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segments</a></td>
<td class="text">Segments<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's CODM assesses the operating performance of and allocates resources for several operating segments using Segment Adjusted EBITDA as a basis. Management believes this financial metric is a key indicator of operating results since it excludes noncash revenues and expenses that are not reflective of the underlying business performance of an individual enterprise.&#160;The Company defines Segment Adjusted EBITDA as net income (loss) before (i) interest expense, (ii) income tax expense or benefit, (iii) depreciation and amortization, (iv) stock-based compensation expense, (v) loss on settlement agreements where noncash consideration is paid, (vi) adjustments for accrued bonuses paid in equity awards, (vii) gain or loss on disposals of assets, (viii) loss on impairment of goodwill and other noncurrent assets, (ix) equity in net loss of affiliates, and (x) recognition of previously deferred revenue associated with upfront and milestone payments as well as cash outflows from capital expenditures and investments in affiliates, but includes proceeds from the sale of assets in the period sold. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because the Company uses Segment Adjusted EBITDA as its primary measure of segment performance, it has included this measure in its discussion of segment operating results.&#160;The Company has also disclosed revenues from external customers and intersegment revenues for each reportable segment.&#160;Corporate expenses are not allocated to the segments and are managed at a consolidated level.&#160;The CODM does not use total assets by segment to evaluate segment performance or allocate resources, and accordingly, these amounts are not required to be disclosed.&#160;The Company's segment presentation excludes amounts related to the operations of MBP Titan which are reported as discontinued operations (Note 3).</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March 31, 2022, the Company's reportable segments were (i) Biopharmaceuticals, (ii) Exemplar, and (iii) Trans Ova. These identified reportable segments met the quantitative thresholds to be reported separately for the three months ended March 31, 2022. See Note 2 for a description of Biopharmaceuticals. See Note 1 for a description of Exemplar and Trans Ova.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment Adjusted EBITDA by reportable segment was as follows:</span></div><div style="margin-top:15pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.736%"><tr><td style="width:1.0%"/><td style="width:69.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.251%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.571%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.254%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended&#160;<br/>&#160;March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biopharmaceuticals</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,620)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,854)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exemplar</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,558&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,806&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trans Ova</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,397&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,421&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment Adjusted EBITDA for reportable segments</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,665)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(627)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below reconciles Segment Adjusted EBITDA for reportable segments to consolidated net loss from continuing operations before income taxes:</span></div><div style="margin-top:17pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.538%"><tr><td style="width:1.0%"/><td style="width:70.561%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.698%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.541%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.700%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended&#160;<br/>&#160;March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment Adjusted EBITDA for reportable segments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,665)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(627)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remove cash paid for capital expenditures, net of proceeds from sale of assets, and cash paid for investments in affiliates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,314&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">597&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add recognition of previously deferred revenue associated with upfront and milestone payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,446&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">307&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,069)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,539)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,292)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,523)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on disposals of assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(125)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(121)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(482)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,562)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,415)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustment related to accrued bonuses paid in equity awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,698&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in net loss of affiliates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unallocated corporate costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,060)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,194)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eliminations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,511)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(371)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated net loss from continuing operations before income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,309)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21,896)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues by reportable segment were as follows:</span></div><div style="margin-top:17pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.841%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Biopharmaceuticals</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exemplar</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Trans Ova</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,429&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,508&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,021&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,446&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,593&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,530&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,429&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,655&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,614&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.841%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Biopharmaceuticals</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exemplar</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Trans Ova</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,257&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,076&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,511&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">348&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">419&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,257&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,183&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,859&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below reconciles total segment revenues from reportable segments to total consolidated revenues:</span></div><div style="margin-top:15pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.953%"><tr><td style="width:1.0%"/><td style="width:70.392%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.780%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.782%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended&#160;<br/>&#160;March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues from reportable segments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,614&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,859&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Elimination of intersegment revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,593)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(348)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total consolidated revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,021&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,511&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">For the three months ended March 31, 2022 and 2021,13.0% and 8.4%, respectively, of total consolidated revenue was attributable to one customer in the Exemplar segment.</span></div>As of March&#160;31, 2022 and December&#160;31, 2021, the Company had $4,148 and $4,463, respectively, of long-lived assets in foreign countries. The Company recognized revenues derived in foreign countries totaling $205 and $99 for the three months ended March 31, 2022 and 2021, respectively<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140329641518712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying interim condensed consolidated financial statements are unaudited and have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP"). Certain information and footnote disclosures normally included in the Company's annual financial statements have been condensed or omitted. These interim condensed consolidated financial statements, in the opinion of management, reflect all normal recurring adjustments necessary for fair statement of the Company's financial position as of March&#160;31, 2022 and results of operations and cash flows for the interim periods ended March&#160;31, 2022 and 2021. The year-end condensed consolidated balance sheet data was derived from the Company's audited financial statements but does not include all disclosures required by U.S. GAAP. These interim financial results are not necessarily indicative of the results to be expected for the year ending December&#160;31, 2022, or for any other future annual or interim period. The accompanying interim unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related notes thereto included in the Company's Annual Report on Form 10-K for the year ended December&#160;31, 2021.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Consolidation</a></td>
<td class="text">The accompanying condensed consolidated financial statements reflect the operations of Precigen and its subsidiaries. All intercompany accounts and transactions have been eliminated.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsPolicy', window );">Equity Method Investments</a></td>
<td class="text">Equity Method InvestmentsThe Company accounts for its investments in each of its joint ventures ("JVs")  using the equity method of accounting based upon relative ownership interest.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationVariableInterestEntityPolicy', window );">Variable Interest Entities</a></td>
<td class="text">Variable Interest EntitiesAs of March&#160;31, 2022 and December&#160;31, 2021, the Company determined that its JVs were variable interest entities ("VIEs"). The Company was not the primary beneficiary for these entities since it did not have the power to direct the activities that most significantly impact the economic performance of the VIEs.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net Loss Per Share</a></td>
<td class="text"><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Loss per Share</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net loss per share is calculated by dividing net loss attributable to common shareholders by the weighted average shares outstanding during the period, without consideration of common stock equivalents. Diluted net loss per share is calculated by adjusting weighted average shares outstanding for the dilutive effect of common stock equivalents outstanding for the period, using the treasury-stock method. For purposes of the diluted net loss per share calculation, shares to be issued pursuant to convertible debt, stock options, RSUs, and warrants are considered to be common stock equivalents but are excluded from the </span></div>calculation of diluted net loss per share because their effect would be anti-dilutive and, therefore, basic and diluted net loss per share were the same for all periods presented.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segment Information</a></td>
<td class="text">Segment InformationThe Company's chief operating decision maker ("CODM") regularly reviews disaggregated financial information for various operating segments. Starting in 2021, the financial information regularly reviewed by the CODM was revised and the operating segments, which were determined to be operating and reportable segments, were (i) Biopharmaceuticals, (ii) Exemplar, and (iii) Trans Ova. The Biopharmaceuticals reportable segment is primarily comprised of the Company's legal entities of PGEN Therapeutics and ActoBio. All of Precigen's consolidated subsidiaries and operating divisions that did not meet the quantitative thresholds to report separately are combined and reported in a single category, All Other. See Note 1 for a description of PGEN Therapeutics, ActoBio, Exemplar, and Trans Ova. Corporate expenses, which are not allocated to the segments and are managed at a consolidated level, include costs associated with general and administrative functions, including the Company's finance, accounting, legal, human resources, information technology, corporate communication, and investor relations functions. Corporate expenses exclude interest expense, depreciation and amortization, gain or loss on disposals of assets, stock-based compensation expense, loss on settlement agreement, and equity in net loss of affiliates and include unrealized and realized gains and losses on the Company's securities portfolio as well as dividend income.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Issued and Adopted Accounting Pronouncements</a></td>
<td class="text"><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In August 2020, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Debt&#8212;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#8212;Contracts in Entity's Own Equity (Subtopic 815-40)&#8212;Accounting for Convertible Instruments and Contracts in an Entity's Own Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> ("ASU 2020-06"</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Under ASU 2020-06, the embedded conversion features are no longer separated from the host contract for convertible instruments with conversion features that are not required to be accounted for as derivatives under Topic 815, or that do not result in substantial premiums accounted for as paid-in capital. Consequently, a convertible debt instrument will be accounted for as a single liability measured at its amortized cost, as long as no other features require bifurcation and recognition as derivatives. The new guidance also requires the if-converted method to be applied for all convertible instruments. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We adopted ASU 2020-06 on January 1, 2022 using the modified retrospective transition method, which resulted in an increase to our reported long-term debt outstanding, net of current portion, of $18,196, a decrease to our additional paid-in capital of $36,868, and a corresponding cumulative-effect reduction to our opening accumulated deficit of $18,672. The adoption of ASU 2020-06 is expected to reduce non-cash interest expense related to existing convertible debt outstanding by approximately $11,800 for the year ending December 31, 2022, and did not have an impact on our consolidated cash flows. The use of the if-converted method did not have an impact on our overall earnings per share calculation.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Pronouncements Not Yet Adopted</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are no accounting standards which have not yet been adopted that are expected to have a significant impact on our financial statements and related disclosures.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationVariableInterestEntityPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for consolidation to describe the significant judgments and assumptions made in determining whether a variable interest held by the entity requires the variable interest entity to be consolidated and (or) disclose information about its involvement with the variable interest entity; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; and the significant factors considered and judgments made in determining that the power to direct the activities that significantly impact the economic performance of the variable interest entity are shared (as defined).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5728-111685<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=SL6759159-111685<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2AA<br> -Subparagraph a<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=SL6759068-111685<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationVariableInterestEntityPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21D<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=SL94080555-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140329646041592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Antidilutive Securities Excluded from Computation of Net Loss per Share</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following potentially dilutive securities as of March&#160;31, 2022 and 2021, have been excluded from the above computations of diluted weighted average shares outstanding for the three months then ended as they would have been anti-dilutive:</span></div><div style="margin-top:17pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:70.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.537%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible debt</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,732,440&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,732,440&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,034,553&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,451,614&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,185,205&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">790,364&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121,888&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133,264&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,074,086&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,107,682&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140329645710392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Discontinued Operations (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock', window );">Disposal Groups, Including Discontinued Operations</a></td>
<td class="text">The following table presents the financial results of discontinued operations related to MBP Titan for the three months ended March 31, 2021:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.274%"><tr><td style="width:1.0%"/><td style="width:83.696%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.426%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.478%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended&#160;<br/>&#160;March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating gains</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,526&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,526&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,526&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from discontinued operations</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,526&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><div style="margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the significant noncash items, purchases of property, plant and equipment, and proceeds from sales of assets for the discontinued operations related to MBP Titan for the three months ended March 31, 2021 that are included in the accompanying condensed consolidated statements of cash flows.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"><tr><td style="width:1.0%"/><td style="width:84.203%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.991%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended&#160;<br/>&#160;March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjustments to reconcile net loss to net cash used in operating activities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on disposals of assets, net</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(464)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncash gain on termination of leases</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,602)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from investing activities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sales of assets</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,083&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=SL51724579-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1474-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5D<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721677-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721659-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721665-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721671-107760<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721663-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140329649642888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Collaboration and Licensing Revenue (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pgen_CollaborationandLicensingRevenueTableTextBlock', window );">Summarized Collaboration and Licensing Revenues</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the amounts recorded as revenue in the condensed consolidated statements of operations for each significant counterparty to a collaboration or licensing agreement for the three months ended March&#160;31, 2022 and 2021.</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:70.728%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.616%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.619%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended&#160;<br/>&#160;March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Castle Creek Biosciences, Inc.</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total (1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:7pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Collaboration and licensing revenues include the recognition of $0 and $66 for the three months ended March 31, 2022 and 2021, respectively, associated with upfront and milestone payments which were previously deferred.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock', window );">Summary of Deferred Revenue</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred revenue consisted of the following:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:70.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.537%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Collaboration and licensing agreements</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,023&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,023&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid product and service revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,511&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,229&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,692&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,465&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of deferred revenue</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,669&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,442&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term portion of deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,023&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,023&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,692&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,465&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock', window );">Summary of Deferred Revenue by Collaborator</a></td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pgen_CollaborationandLicensingRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of summarized revenues recognized for each significant collaboration and licensing agreement and aggregated nonsignificant collaborations and licensing agreements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pgen_CollaborationandLicensingRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pgen_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of expected timing for satisfying remaining performance obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140329647107352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Short-term and Long-term Investments (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock', window );">Summary of Amortized Cost, Gross Unrealized Gains and Losses, and Fair Value of Short-term and Long-term Investments</a></td>
<td class="text">The following table summarizes the amortized cost, gross unrealized gains and losses, and fair value of available-for-sale investments as of March&#160;31, 2022:<div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.321%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.501%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate<br/>Fair&#160;Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government debt securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102,771&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,133)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101,638&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102,868&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,133)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101,735&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the amortized cost, gross unrealized gains and losses, and fair value of available-for-sale investments as of December&#160;31, 2021:</span></div><div style="margin-bottom:4pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.321%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.501%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate<br/>Fair&#160;Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government debt securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121,036&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(331)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,705&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121,133&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(331)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,802&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock', window );">Contractual Obligation, Fiscal Year Maturity</a></td>
<td class="text"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of available-for-sale investments classified by their contractual maturities as of March&#160;31, 2022 was:</span></div><div style="margin-top:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.303%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.497%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due within one year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,821&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After one year through two years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,914&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101,735&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of contractual obligation by timing of payment due. Includes, but is not limited to, long-term debt obligation, lease obligation, and purchase obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher SEC<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 303<br> -Paragraph (a)<br> -Subparagraph (5)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140329645735224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock', window );">Summary of Placement in the Fair Value Hierarchy of Financial Assets that are Measured at Fair Value on a Recurring Basis</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the placement in the fair value hierarchy of financial assets that are measured at fair value on a recurring basis as of March&#160;31, 2022:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:41.988%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.579%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Quoted Prices in Active Markets<br/>(Level&#160;1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Significant Other Observable Inputs<br/>(Level&#160;2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Significant Unobservable Inputs<br/>(Level&#160;3)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government debt securities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101,638&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101,638&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101,735&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101,735&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the placement in the fair value hierarchy of financial assets that are measured at fair value on a recurring basis as of December&#160;31, 2021:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:41.988%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.579%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Quoted Prices in Active Markets<br/>(Level&#160;1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Significant Other Observable Inputs<br/>(Level&#160;2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Significant Unobservable Inputs<br/>(Level&#160;3)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government debt securities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,705&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,705&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,802&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,802&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140329645703512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventory (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of Inventory</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory consists of the following:</span></div><div style="margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplies, embryos and other production materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,931&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,588&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,539&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,564&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Livestock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,918&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,310&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Feed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,342&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,799&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventory</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,730&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,261&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140329645735224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Plant and Equipment, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property, Plant and Equipment</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment consist of the following:</span></div><div style="margin-top:17pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:70.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.537%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land and land improvements</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,118&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,118&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and building improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,903&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,896&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,193&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,162&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,304&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,584&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,822&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,822&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breeding stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">953&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer hardware and software</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,169&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,131&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction and other assets in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,596&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,824&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,058&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,537&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40,475)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39,222)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,583&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,315&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140329645646168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of Changes in Carrying Amount of Goodwill</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the carrying amount of goodwill for the three months ended March 31, 2022 were as follows:</span></div><div style="margin-top:17pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:85.263%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.537%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,148&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(482)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at March 31, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,613&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Intangible Assets</a></td>
<td class="text"><div style="margin-top:15pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets consist of the following as of March&#160;31, 2022:</span></div><div style="margin-top:17pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:56.462%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.558%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents, developed technologies and know-how</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39,595)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,405&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,850&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,480)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,900&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,248)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">652&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,750&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55,323)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,427&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets consist of the following as of December&#160;31, 2021:</span></div><div style="margin-top:15pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:56.462%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.558%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents, developed technologies and know-how</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,373&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38,630)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,743&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,850&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,252)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">598&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,900&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,126)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">774&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,123&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54,008)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,115&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140329650628680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Lines of Credit and Long-Term Debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Schedule of Long-Term Debt Instruments</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt consists of the following:</span></div><div style="margin-top:17pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:70.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.537%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible debt (1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198,362&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179,882&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,217&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201,467&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183,151&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">355&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">402&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, less current portion</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201,112&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182,749&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">See Note 2 regarding adoption of ASU 2020-06 as of January 1, 2022.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock', window );">Schedule of Components of Interest Expense</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of interest expense related to the Convertible Notes were as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.514%"><tr><td style="width:1.0%"/><td style="width:70.264%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.549%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.844%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended&#160;<br/>&#160;March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash interest expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,751&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total interest expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,034&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,501&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Schedule of Future Maturities of Long-Term Debt</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future maturities of long-term debt as of March&#160;31, 2022 are as follows:</span></div><div style="margin-top:17pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:85.263%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.537%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200,365&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">380&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">411&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">428&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">861&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203,105&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of interest income and expense, including, but not limited to, interest income and expense from investments, loans, and securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21506-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21521-112644<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21538-112644<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140329646075288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Effective Income Tax Rate Reconciliation</a></td>
<td class="text">The following table presents the components of income tax benefit from continuing operations.<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:70.728%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.616%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.619%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended&#160;<br/>&#160;March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current foreign income tax expense from continuing operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax benefit from continuing operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total income tax benefit from continuing operations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140329645720712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Components of Accumulated Other Comprehensive Income</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of accumulated other comprehensive (loss) income are as follows:</span></div><div style="margin-top:17pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:70.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.537%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized loss on investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,133)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(331)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) on foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(566)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">534&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accumulated other comprehensive (loss) income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,699)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140329647206936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Payments (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Schedule of Stock-Based Compensation Costs</a></td>
<td class="text">Stock-based compensation costs included in the condensed consolidated statements of operations are presented below:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"><tr><td style="width:1.0%"/><td style="width:70.091%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.927%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.928%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended&#160;<br/>&#160;March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">548&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,038&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,975&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,303&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,562&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,415&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Stock Option Activity</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock option activity was as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.648%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.500%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Remaining Contractual Term (Years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,260,187&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.06&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.79</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,009,390&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(375)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(210,613)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,036)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.85&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances at March 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,034,553&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.31</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exercisable at March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,937,195&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.85&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.99</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock', window );">Schedule of Restricted Stock Unit Activity</a></td>
<td class="text"><div style="margin-bottom:17pt;margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSU activity was as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.648%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.500%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of Restricted Stock Units</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Grant Date Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Remaining Contractual Term (Years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">468,481&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.47&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.33</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,387,831&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(669,041)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.71&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,066)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances at March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,185,205&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.59</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140329759384488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Operating Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Components of Lease Costs</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease costs were as follows:</span></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"><tr><td style="width:1.0%"/><td style="width:69.960%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.990%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.993%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended&#160;<br/>&#160;March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease costs</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">729&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">839&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">463&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">506&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease costs</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,309&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,575&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other information related to operating leases in continuing operations was as follows:</span></div><div style="margin-bottom:4pt;margin-top:17pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term (years)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.30</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.65</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended&#160;<br/>&#160;March 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Supplemental disclosure of cash flow information</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for operating lease liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">744&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,005&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets obtained in exchange for new lease liabilities (includes new leases or modifications of existing leases)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">556&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Maturities of Lease Liabilities</a></td>
<td class="text"><div style="margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, maturities of lease liabilities, excluding short-term and variable leases, for continuing operations were as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.303%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.497%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,117&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,519&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,528&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,259&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,778&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,345&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,292&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,838&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,740)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,098&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,590&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,508&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,098&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140329650345464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segments (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Information by Reportable Segment</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment Adjusted EBITDA by reportable segment was as follows:</span></div><div style="margin-top:15pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.736%"><tr><td style="width:1.0%"/><td style="width:69.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.251%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.571%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.254%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended&#160;<br/>&#160;March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biopharmaceuticals</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,620)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,854)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exemplar</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,558&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,806&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trans Ova</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,397&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,421&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment Adjusted EBITDA for reportable segments</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,665)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(627)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues by reportable segment were as follows:</span></div><div style="margin-top:17pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.841%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Biopharmaceuticals</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exemplar</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Trans Ova</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,429&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,508&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,021&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,446&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,593&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,530&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,429&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,655&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,614&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.841%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Biopharmaceuticals</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exemplar</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Trans Ova</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,257&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,076&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,511&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">348&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">419&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,257&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,183&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,859&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock', window );">Reconciliation of Operating Profit (Loss) from Segments to Consolidated</a></td>
<td class="text"><div style="margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below reconciles Segment Adjusted EBITDA for reportable segments to consolidated net loss from continuing operations before income taxes:</span></div><div style="margin-top:17pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.538%"><tr><td style="width:1.0%"/><td style="width:70.561%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.698%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.541%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.700%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended&#160;<br/>&#160;March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment Adjusted EBITDA for reportable segments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,665)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(627)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remove cash paid for capital expenditures, net of proceeds from sale of assets, and cash paid for investments in affiliates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,314&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">597&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add recognition of previously deferred revenue associated with upfront and milestone payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,446&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">307&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,069)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,539)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,292)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,523)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on disposals of assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(125)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(121)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(482)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,562)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,415)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustment related to accrued bonuses paid in equity awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,698&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in net loss of affiliates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unallocated corporate costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,060)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,194)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eliminations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,511)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(371)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated net loss from continuing operations before income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,309)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21,896)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock', window );">Reconciliation of Revenue from Segments to Consolidated</a></td>
<td class="text"><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below reconciles total segment revenues from reportable segments to total consolidated revenues:</span></div><div style="margin-top:15pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.953%"><tr><td style="width:1.0%"/><td style="width:70.392%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.780%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.782%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended&#160;<br/>&#160;March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment revenues from reportable segments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,614&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,859&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Elimination of intersegment revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,593)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(348)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total consolidated revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,021&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,511&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of all significant reconciling items in the reconciliation of total revenues from reportable segments to the entity's consolidated revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140329647368952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Liquidity - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss) attributable to parent</a></td>
<td class="num">$ (19,251)<span></span>
</td>
<td class="num">$ (17,318)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="nump">$ 1,916,135<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,915,556<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140329645751048">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Variable Interest Entities - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount', window );">Maximum risk of loss related to the identified VIEs</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The reporting entity's maximum amount of exposure to loss as a result of its involvement with the Variable Interest Entity (VIE).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5747-111685<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph b<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5728-111685<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140329641491064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Net Loss Per Share - Additional Information (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total</a></td>
<td class="nump">29,074,086<span></span>
</td>
<td class="nump">24,107,682<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleDebtMember', window );">Convertible debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total</a></td>
<td class="nump">11,732,440<span></span>
</td>
<td class="nump">11,732,440<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockOptionMember', window );">Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total</a></td>
<td class="nump">16,034,553<span></span>
</td>
<td class="nump">11,451,614<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total</a></td>
<td class="nump">1,185,205<span></span>
</td>
<td class="nump">790,364<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember', window );">Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total</a></td>
<td class="nump">121,888<span></span>
</td>
<td class="nump">133,264<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140329652622568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Recently Adopted Accounting Pronouncements - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Jan. 01, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, net of current portion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 201,112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 182,749<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Cumulative Effect, Period of Adoption, Adjustment | Accounting Standards Update 2020-06 Retrospective</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, net of current portion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,196<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Cumulative Effect, Period of Adoption, Adjustment | Accounting Standards Update 2020-06 Retrospective | Additional Paid-in Capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Stockholders' equity, including portion attributable to noncontrolling interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,868<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Cumulative Effect, Period of Adoption, Adjustment | Accounting Standards Update 2020-06 Retrospective | Accumulated Deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Stockholders' equity, including portion attributable to noncontrolling interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,672<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Cumulative Effect, Period of Adoption, Adjustment | Accounting Standards Update 2020-06 Retrospective | Forecast</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pgen_InterestExpenseDebtAmortizationofDebtDiscountPremiumandDebtIssuanceCosts', window );">Non-cash interest expense</a></td>
<td class="num">$ (11,800)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pgen_InterestExpenseDebtAmortizationofDebtDiscountPremiumandDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments and amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pgen_InterestExpenseDebtAmortizationofDebtDiscountPremiumandDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pgen_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate202006RetrospectiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate202006RetrospectiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140329641652136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Discontinued Operations - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets1', window );">Gain (loss) on disposition of assets</a></td>
<td class="num">$ (125,000)<span></span>
</td>
<td class="nump">$ 343,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=pgen_MBPTitanMember', window );">MBP Titan | Discontinued Operations, Disposed of by Means Other than Sale, Abandonment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets1', window );">Gain (loss) on disposition of assets</a></td>
<td class="nump">464,000<span></span>
</td>
<td class="nump">464,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnTerminationOfLease', window );">Gain on lease termination</a></td>
<td class="nump">4,602,000<span></span>
</td>
<td class="nump">4,602,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity', window );">Income from discontinued operations</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 4,526,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfAssets1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfAssets1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnTerminationOfLease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on termination of lease before expiration of lease term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 40<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123386189&amp;loc=SL77918607-209975<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnTerminationOfLease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation attributable to the parent. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=pgen_MBPTitanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=pgen_MBPTitanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleAbandonmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleAbandonmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140329641552472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Discontinued Operations - Summary of Financial Results for MBP Titan (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense', window );">Operating gains</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,526,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=pgen_MBPTitanMember', window );">MBP Titan | Discontinued Operations, Disposed of by Means Other than Sale, Abandonment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss', window );">Operating income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,526,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax', window );">Income before income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,526,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity', window );">Income from discontinued operations</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 4,526,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of income (loss) from a discontinued operation. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating expense attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating income (loss) attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation attributable to the parent. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=pgen_MBPTitanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=pgen_MBPTitanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleAbandonmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleAbandonmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140329651873560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Discontinued Operations - Non-cash Items and Purchases of Property, Plant and Equipment for MBP Titan (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets1', window );">Gain on disposals of assets, net</a></td>
<td class="nump">$ 125<span></span>
</td>
<td class="num">$ (343)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalCashFlowElementsInvestingActivitiesAbstract', window );"><strong>Additional Cash Flow Elements, Investing Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities', window );">Proceeds from sale of assets</a></td>
<td class="nump">147<span></span>
</td>
<td class="nump">1,944<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleAbandonmentMember', window );">Discontinued Operations, Disposed of by Means Other than Sale, Abandonment | MBP Titan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets1', window );">Gain on disposals of assets, net</a></td>
<td class="num">(464)<span></span>
</td>
<td class="num">(464)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnTerminationOfLease', window );">Noncash gain on termination of leases</a></td>
<td class="num">$ (4,602)<span></span>
</td>
<td class="num">(4,602)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalCashFlowElementsInvestingActivitiesAbstract', window );"><strong>Additional Cash Flow Elements, Investing Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities', window );">Proceeds from sale of assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,083<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalCashFlowElementsInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalCashFlowElementsInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfAssets1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfAssets1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnTerminationOfLease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on termination of lease before expiration of lease term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 40<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123386189&amp;loc=SL77918607-209975<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnTerminationOfLease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from the sale of other assets recognized in investing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleAbandonmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleAbandonmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=pgen_MBPTitanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=pgen_MBPTitanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140329651607576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments in Joint Ventures - Intrexon Energy Partners - Additional Information (Details)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2014 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($) </div>
<div>board_seat</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=pgen_IntrexonEnergyPartnersMember', window );">Intrexon Energy Partners, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pgen_JointVentureAdditionalCapitalContributionsCommitted', window );">Maximum additional capital contribution committed</a></td>
<td class="nump">$ 25,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pgen_JointVentureAdditionalCapitalContributionsCommittedRemainingCommitment', window );">Additional capital contributions committed, remaining commitment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,225,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pgen_NumberofSeatsonGoverningBoard', window );">Total number of seats on the joint venture's governing board | board_seat</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pgen_NumberofSeatsonGoverningBoardInternallySelected', window );">Total number of seats on the joint venture's governing board, internally selected | board_seat</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pgen_NumberofSeatsonGoverningBoardExternallySelected', window );">Total number of seats on the joint venture's governing board, externally selected | board_seat</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=pgen_IntrexonEnergyPartnersMember', window );">Intrexon Energy Partners, LLC | Other Accrued Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (429,000)<span></span>
</td>
<td class="num">$ (428,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=pgen_IntrexonEnergyPartnersMember', window );">Intrexon Energy Partners, LLC | Investors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInterestInJointVenture', window );">Capital contributions</a></td>
<td class="nump">$ 25,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pgen_JointVentureAdditionalCapitalContributionsCommitted', window );">Maximum additional capital contribution committed</a></td>
<td class="nump">25,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=pgen_IntrexonEnergyPartnersMember', window );">Intrexon Energy Partners, LLC | Collaboration and licensing agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pgen_CollaborativeArrangementConsiderationReceivedValue', window );">Collaborative arrangement consideration received, value</a></td>
<td class="nump">$ 25,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pgen_CollaborativeArrangementConsiderationReceivedValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of consideration received by the entity for collaboration</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pgen_CollaborativeArrangementConsiderationReceivedValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pgen_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pgen_JointVentureAdditionalCapitalContributionsCommitted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of additional capital contributions to the joint venture for which the entity is committed, maximum.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pgen_JointVentureAdditionalCapitalContributionsCommitted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pgen_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pgen_JointVentureAdditionalCapitalContributionsCommittedRemainingCommitment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Remaining amount of additional capital contributions to the joint venture for which the entity is committed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pgen_JointVentureAdditionalCapitalContributionsCommittedRemainingCommitment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pgen_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pgen_NumberofSeatsonGoverningBoard">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of seats on the governing board.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pgen_NumberofSeatsonGoverningBoard</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pgen_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pgen_NumberofSeatsonGoverningBoardExternallySelected">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of seats on the governing board, externally selected.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pgen_NumberofSeatsonGoverningBoardExternallySelected</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pgen_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pgen_NumberofSeatsonGoverningBoardInternallySelected">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of seats on the governing board selected internally.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pgen_NumberofSeatsonGoverningBoardInternallySelected</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pgen_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInterestInJointVenture">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the investment in or advances to an entity in which the reporting entity shares control of the entity with another party or group.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInterestInJointVenture</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEquityMethodInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=pgen_IntrexonEnergyPartnersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=pgen_IntrexonEnergyPartnersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=pgen_OtherAccruedLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=pgen_OtherAccruedLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_InvestorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_InvestorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=pgen_IntrexonEnergyPartnersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=pgen_IntrexonEnergyPartnersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140329651624616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments in Joint Ventures - Intrexon Energy Partners II - Additional Information (Details)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2015 </div>
<div>USD ($) </div>
<div>board_seat</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=pgen_IntrexonEnergyPartnersIILLCMember', window );">Intrexon Energy Partners II, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pgen_JointVentureAdditionalCapitalContributionsCommitted', window );">Maximum additional capital contribution committed</a></td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pgen_JointVentureAdditionalCapitalContributionsCommittedRemainingCommitment', window );">Additional capital contributions committed, remaining commitment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pgen_NumberofSeatsonGoverningBoard', window );">Total number of seats on the joint venture's governing board | board_seat</a></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pgen_NumberofSeatsonGoverningBoardInternallySelected', window );">Total number of seats on the joint venture's governing board, internally selected | board_seat</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pgen_NumberofSeatsonGoverningBoardExternallySelected', window );">Total number of seats on the joint venture's governing board, externally selected | board_seat</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=pgen_IntrexonEnergyPartnersIILLCMember', window );">Intrexon Energy Partners II, LLC | Other Accrued Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (435,000)<span></span>
</td>
<td class="num">$ (435,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=pgen_IntrexonEnergyPartnersIILLCMember', window );">Intrexon Energy Partners II, LLC | Investors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInterestInJointVenture', window );">Capital contributions</a></td>
<td class="nump">$ 18,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pgen_JointVentureAdditionalCapitalContributionsCommitted', window );">Maximum additional capital contribution committed</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=pgen_IntrexonEnergyPartnersIILLCMember', window );">Intrexon Energy Partners II, LLC | All Investors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInterestInJointVenture', window );">Capital contributions</a></td>
<td class="nump">4,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=pgen_IntrexonEnergyPartnersIILLCMember', window );">Intrexon Energy Partners II, LLC | Collaboration and licensing agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pgen_CollaborativeArrangementConsiderationReceivedValue', window );">Collaborative arrangement consideration received, value</a></td>
<td class="nump">$ 18,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pgen_CollaborativeArrangementConsiderationReceivedValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of consideration received by the entity for collaboration</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pgen_CollaborativeArrangementConsiderationReceivedValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pgen_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pgen_JointVentureAdditionalCapitalContributionsCommitted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of additional capital contributions to the joint venture for which the entity is committed, maximum.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pgen_JointVentureAdditionalCapitalContributionsCommitted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pgen_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pgen_JointVentureAdditionalCapitalContributionsCommittedRemainingCommitment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Remaining amount of additional capital contributions to the joint venture for which the entity is committed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pgen_JointVentureAdditionalCapitalContributionsCommittedRemainingCommitment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pgen_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pgen_NumberofSeatsonGoverningBoard">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of seats on the governing board.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pgen_NumberofSeatsonGoverningBoard</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pgen_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pgen_NumberofSeatsonGoverningBoardExternallySelected">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of seats on the governing board, externally selected.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pgen_NumberofSeatsonGoverningBoardExternallySelected</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pgen_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pgen_NumberofSeatsonGoverningBoardInternallySelected">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of seats on the governing board selected internally.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pgen_NumberofSeatsonGoverningBoardInternallySelected</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pgen_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInterestInJointVenture">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the investment in or advances to an entity in which the reporting entity shares control of the entity with another party or group.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInterestInJointVenture</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEquityMethodInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=pgen_IntrexonEnergyPartnersIILLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=pgen_IntrexonEnergyPartnersIILLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=pgen_OtherAccruedLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=pgen_OtherAccruedLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_InvestorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_InvestorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=pgen_AllInvestorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=pgen_AllInvestorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=pgen_IntrexonEnergyPartnersIILLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=pgen_IntrexonEnergyPartnersIILLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140329641989960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Collaboration and Licensing Revenue - Summarized Collaboration and Licensing Revenue (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 32,021<span></span>
</td>
<td class="nump">$ 24,511<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember', window );">Collaboration and licensing agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">66<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=pgen_UpfrontAndMilestonePaymentsMember', window );">Upfront and milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">66<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=pgen_CastleCreekBiosciencesIncMember', window );">Castle Creek Biosciences, Inc. | Collaboration and licensing agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">59<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=pgen_OtherMember', window );">Other | Collaboration and licensing agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=pgen_UpfrontAndMilestonePaymentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=pgen_UpfrontAndMilestonePaymentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=pgen_CastleCreekBiosciencesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=pgen_CastleCreekBiosciencesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=pgen_OtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=pgen_OtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140329642005384">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Collaboration and Licensing Revenue - Summary of Deferred Revenue (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pgen_ContractWithCustomerAssetAndLiabilityLineItems', window );"><strong>Contract With Customer, Asset And Liability [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">Long-term portion of deferred revenue</a></td>
<td class="nump">$ 23,023<span></span>
</td>
<td class="nump">$ 23,023<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="nump">25,692<span></span>
</td>
<td class="nump">27,465<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Current portion of deferred revenue</a></td>
<td class="nump">2,669<span></span>
</td>
<td class="nump">4,442<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=pgen_IntrexonEnergyPartnersLLAndIntrexonEnergyPartnersIILLCMember', window );">Intrexon Energy Partners L.L. and Intrexon Energy Partners II, L.L.C</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pgen_ContractWithCustomerAssetAndLiabilityLineItems', window );"><strong>Contract With Customer, Asset And Liability [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">Long-term portion of deferred revenue</a></td>
<td class="nump">21,205<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember', window );">Collaboration and licensing agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pgen_ContractWithCustomerAssetAndLiabilityLineItems', window );"><strong>Contract With Customer, Asset And Liability [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="nump">23,023<span></span>
</td>
<td class="nump">23,023<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=pgen_PrepaidProductAndServiceRevenuesMember', window );">Prepaid product and service revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pgen_ContractWithCustomerAssetAndLiabilityLineItems', window );"><strong>Contract With Customer, Asset And Liability [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="nump">2,511<span></span>
</td>
<td class="nump">4,229<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=pgen_DeferredRevenueOtherMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pgen_ContractWithCustomerAssetAndLiabilityLineItems', window );"><strong>Contract With Customer, Asset And Liability [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="nump">$ 158<span></span>
</td>
<td class="nump">$ 213<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pgen_ContractWithCustomerAssetAndLiabilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Contract With Customer, Asset And Liability [Table]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pgen_ContractWithCustomerAssetAndLiabilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pgen_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130532-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=pgen_IntrexonEnergyPartnersLLAndIntrexonEnergyPartnersIILLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=pgen_IntrexonEnergyPartnersLLAndIntrexonEnergyPartnersIILLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=pgen_PrepaidProductAndServiceRevenuesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=pgen_PrepaidProductAndServiceRevenuesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=pgen_DeferredRevenueOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=pgen_DeferredRevenueOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140329641491608">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Short-term and Long-term Investments - Summary of Amortized Cost, Gross Unrealized Gains and Losses, and Fair Value of Short-term and Long-term Investments (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">$ 102,868<span></span>
</td>
<td class="nump">$ 121,133<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(1,133)<span></span>
</td>
<td class="num">(331)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Aggregate Fair&#160;Value</a></td>
<td class="nump">101,735<span></span>
</td>
<td class="nump">120,802<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentDebtSecuritiesMember', window );">U.S. government debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">102,771<span></span>
</td>
<td class="nump">121,036<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(1,133)<span></span>
</td>
<td class="num">(331)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Aggregate Fair&#160;Value</a></td>
<td class="nump">101,638<span></span>
</td>
<td class="nump">120,705<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember', window );">Certificates of deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">97<span></span>
</td>
<td class="nump">97<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Aggregate Fair&#160;Value</a></td>
<td class="nump">$ 97<span></span>
</td>
<td class="nump">$ 97<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140329649642888">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Short-term and Long-term Investments - Contractual Obligation, Fiscal Year Maturity (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue', window );">Due within one year</a></td>
<td class="nump">$ 71,821<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue', window );">After one year through two years</a></td>
<td class="nump">29,914<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate', window );">Total</a></td>
<td class="nump">$ 101,735<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security, measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year through fifth year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=123599081&amp;loc=SL120269850-112803<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140329641887112">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Summary of Placement in the Fair Value Hierarchy of Financial Assets that are Measured at Fair Value on a Recurring Basis (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Fair value of financial assets measured at fair value on a recurring basis</a></td>
<td class="nump">$ 101,735<span></span>
</td>
<td class="nump">$ 120,802<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Quoted Prices in Active Markets (Level&#160;1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Fair value of financial assets measured at fair value on a recurring basis</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Significant Other Observable Inputs (Level&#160;2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Fair value of financial assets measured at fair value on a recurring basis</a></td>
<td class="nump">101,735<span></span>
</td>
<td class="nump">120,802<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Significant Unobservable Inputs (Level&#160;3)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Fair value of financial assets measured at fair value on a recurring basis</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentDebtSecuritiesMember', window );">U.S. government debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Fair value of financial assets measured at fair value on a recurring basis</a></td>
<td class="nump">101,638<span></span>
</td>
<td class="nump">120,705<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentDebtSecuritiesMember', window );">U.S. government debt securities | Quoted Prices in Active Markets (Level&#160;1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Fair value of financial assets measured at fair value on a recurring basis</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentDebtSecuritiesMember', window );">U.S. government debt securities | Significant Other Observable Inputs (Level&#160;2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Fair value of financial assets measured at fair value on a recurring basis</a></td>
<td class="nump">101,638<span></span>
</td>
<td class="nump">120,705<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentDebtSecuritiesMember', window );">U.S. government debt securities | Significant Unobservable Inputs (Level&#160;3)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Fair value of financial assets measured at fair value on a recurring basis</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember', window );">Certificates of deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Fair value of financial assets measured at fair value on a recurring basis</a></td>
<td class="nump">97<span></span>
</td>
<td class="nump">97<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember', window );">Certificates of deposit | Quoted Prices in Active Markets (Level&#160;1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Fair value of financial assets measured at fair value on a recurring basis</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember', window );">Certificates of deposit | Significant Other Observable Inputs (Level&#160;2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Fair value of financial assets measured at fair value on a recurring basis</a></td>
<td class="nump">97<span></span>
</td>
<td class="nump">97<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember', window );">Certificates of deposit | Significant Unobservable Inputs (Level&#160;3)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Fair value of financial assets measured at fair value on a recurring basis</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140329647548824">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Additional Information (Details) - 3.5% Convertible Notes Due 2023 - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Jul. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebtFairValueDisclosures', window );">Fair value of convertible debt</a></td>
<td class="nump">$ 164,000<span></span>
</td>
<td class="nump">$ 160,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebt', window );">Carrying value of convertible debt</a></td>
<td class="nump">$ 198,362<span></span>
</td>
<td class="nump">$ 179,882<span></span>
</td>
<td class="nump">$ 143,723<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtFairValueDisclosures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtFairValueDisclosures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pgen_A3.5ConvertibleNotesDue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pgen_A3.5ConvertibleNotesDue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140329641980792">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Inventory (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryLineItems', window );"><strong>Inventory [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryGross', window );">Inventory</a></td>
<td class="nump">$ 12,730<span></span>
</td>
<td class="nump">$ 13,261<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PublicUtilitiesInventoryAxis=pgen_SuppliesEmbryosAndOtherProductionMaterialsMember', window );">Supplies, embryos and other production materials</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryLineItems', window );"><strong>Inventory [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryGross', window );">Inventory</a></td>
<td class="nump">2,931<span></span>
</td>
<td class="nump">2,588<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PublicUtilitiesInventoryAxis=pgen_WorkInProcessMember', window );">Work in process</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryLineItems', window );"><strong>Inventory [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryGross', window );">Inventory</a></td>
<td class="nump">2,539<span></span>
</td>
<td class="nump">2,564<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PublicUtilitiesInventoryAxis=pgen_LivestockMember', window );">Livestock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryLineItems', window );"><strong>Inventory [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryGross', window );">Inventory</a></td>
<td class="nump">5,918<span></span>
</td>
<td class="nump">6,310<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PublicUtilitiesInventoryAxis=pgen_FeedMember', window );">Feed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryLineItems', window );"><strong>Inventory [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryGross', window );">Inventory</a></td>
<td class="nump">$ 1,342<span></span>
</td>
<td class="nump">$ 1,799<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross amount, as of the balance sheet date, of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PublicUtilitiesInventoryAxis=pgen_SuppliesEmbryosAndOtherProductionMaterialsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PublicUtilitiesInventoryAxis=pgen_SuppliesEmbryosAndOtherProductionMaterialsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PublicUtilitiesInventoryAxis=pgen_WorkInProcessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PublicUtilitiesInventoryAxis=pgen_WorkInProcessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PublicUtilitiesInventoryAxis=pgen_LivestockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PublicUtilitiesInventoryAxis=pgen_LivestockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PublicUtilitiesInventoryAxis=pgen_FeedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PublicUtilitiesInventoryAxis=pgen_FeedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140329641692344">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Property, Plant and Equipment, Net - Schedule of Property, Plant and Equipment (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LandAndLandImprovements', window );">Land and land improvements</a></td>
<td class="nump">$ 11,118<span></span>
</td>
<td class="nump">$ 11,118<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BuildingsAndImprovementsGross', window );">Buildings and building improvements</a></td>
<td class="nump">12,903<span></span>
</td>
<td class="nump">12,896<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FurnitureAndFixturesGross', window );">Furniture and fixtures</a></td>
<td class="nump">1,193<span></span>
</td>
<td class="nump">1,162<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MachineryAndEquipmentGross', window );">Equipment</a></td>
<td class="nump">34,304<span></span>
</td>
<td class="nump">33,584<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseholdImprovementsGross', window );">Leasehold improvements</a></td>
<td class="nump">4,822<span></span>
</td>
<td class="nump">4,822<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pgen_BreedingandProductionAnimalsGross', window );">Breeding stock</a></td>
<td class="nump">953<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pgen_ComputerHardwareandSoftware', window );">Computer hardware and software</a></td>
<td class="nump">5,169<span></span>
</td>
<td class="nump">5,131<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConstructionInProgressGross', window );">Construction and other assets in progress</a></td>
<td class="nump">3,596<span></span>
</td>
<td class="nump">3,824<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">74,058<span></span>
</td>
<td class="nump">73,537<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: Accumulated depreciation and amortization</a></td>
<td class="num">(40,475)<span></span>
</td>
<td class="num">(39,222)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">$ 33,583<span></span>
</td>
<td class="nump">$ 34,315<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pgen_BreedingandProductionAnimalsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of animals maintained to create offspring or to produce goods to be sold for profit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pgen_BreedingandProductionAnimalsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pgen_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pgen_ComputerHardwareandSoftware">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation and amortization of computer hardware and purchased software.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pgen_ComputerHardwareandSoftware</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pgen_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BuildingsAndImprovementsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of building structures held for productive use including addition, improvement, or renovation to the structure, including, but not limited to, interior masonry, interior flooring, electrical, and plumbing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6812-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BuildingsAndImprovementsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConstructionInProgressGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConstructionInProgressGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FurnitureAndFixturesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FurnitureAndFixturesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LandAndLandImprovements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated deprecation and depletion of real estate held for productive use and additions or improvements to real estate held for productive use, examples include, but are not limited to, walkways, driveways, fences, and parking lots. Excludes land held for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6812-107765<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LandAndLandImprovements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseholdImprovementsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of additions or improvements to assets held under a lease arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6812-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseholdImprovementsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MachineryAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6812-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MachineryAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140329647105960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Plant and Equipment, Net - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">$ 1,483<span></span>
</td>
<td class="nump">$ 1,593<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140329647155432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets, Net - Schedule of Changes in Carrying Amount of Goodwill (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">$ 54,148<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Impairment</a></td>
<td class="num">(482)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation adjustments</a></td>
<td class="num">(53)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">$ 53,613<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140329651736936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets, Net - Additional Information (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($) </div>
<div>reporting_unit</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Impairment of goodwill</a></td>
<td class="nump">$ 482<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pgen_NumberOfReportingUnitsImpaired', window );">Number of reporting units impaired | reporting_unit</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Goodwill accumulated impairment losses</a></td>
<td class="nump">$ 44,125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 43,643<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense</a></td>
<td class="nump">$ 1,809<span></span>
</td>
<td class="nump">$ 1,930<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pgen_NumberOfReportingUnitsImpaired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Reporting Units Impaired</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pgen_NumberOfReportingUnitsImpaired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pgen_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairedAccumulatedImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140329641836920">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Goodwill and Intangible Assets, Net - Schedule of Intangible Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Finite-Lived Intangible Assets, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 106,750<span></span>
</td>
<td class="nump">$ 108,123<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(55,323)<span></span>
</td>
<td class="num">(54,008)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">51,427<span></span>
</td>
<td class="nump">54,115<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_IntellectualPropertyMember', window );">Patents, developed technologies and know-how</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Finite-Lived Intangible Assets, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">90,000<span></span>
</td>
<td class="nump">91,373<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(39,595)<span></span>
</td>
<td class="num">(38,630)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">50,405<span></span>
</td>
<td class="nump">52,743<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Finite-Lived Intangible Assets, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">10,850<span></span>
</td>
<td class="nump">10,850<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(10,480)<span></span>
</td>
<td class="num">(10,252)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">370<span></span>
</td>
<td class="nump">598<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember', window );">Trademarks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Finite-Lived Intangible Assets, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">5,900<span></span>
</td>
<td class="nump">5,900<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(5,248)<span></span>
</td>
<td class="num">(5,126)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">$ 652<span></span>
</td>
<td class="nump">$ 774<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_IntellectualPropertyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_IntellectualPropertyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140329641496904">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Lines of Credit and Long-Term Debt - Lines of Credit - Additional Information (Details) - Revolving Line of Credit - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Trans Ova Genetics, LC | First National Bank of Omaha</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility, maximum borrowing capacity</a></td>
<td class="nump">$ 5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd', window );">Line of credit facility, interest rate at period end</a></td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Line of credit facility, outstanding balance</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity', window );">Line of credit facility, current borrowing capacity</a></td>
<td class="nump">$ 5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Trans Ova Genetics, LC | First National Bank of Omaha | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Exemplar Genetics, LLC | American State Bank</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility, maximum borrowing capacity</a></td>
<td class="nump">$ 700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Line of credit facility, outstanding balance</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The effective interest rate at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=pgen_TransOvaGeneticsLcMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=pgen_TransOvaGeneticsLcMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=pgen_FirstNationalBankofOmahaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=pgen_FirstNationalBankofOmahaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=pgen_ExemplarGeneticsLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=pgen_ExemplarGeneticsLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=pgen_AmericanStateBankMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=pgen_AmericanStateBankMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140329641787816">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Lines of Credit and Long-Term Debt - Schedule of Long-Term Debt Instruments (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 201,467<span></span>
</td>
<td class="nump">$ 183,151<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Less current portion</a></td>
<td class="nump">355<span></span>
</td>
<td class="nump">402<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, less current portion</a></td>
<td class="nump">201,112<span></span>
</td>
<td class="nump">182,749<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">198,362<span></span>
</td>
<td class="nump">179,882<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableToBanksMember', window );">Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">3,105<span></span>
</td>
<td class="nump">3,217<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=pgen_OtherLongTermDebtMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 52<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableToBanksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableToBanksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=pgen_OtherLongTermDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=pgen_OtherLongTermDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140329639935208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Lines of Credit and Long-Term Debt - Long-Term Debt - Additional Information (Details)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jul. 31, 2018 </div>
<div>USD ($) </div>
<div>day </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 01, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (58,000)<span></span>
</td>
<td class="num">$ (56,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, net of current portion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">201,112,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 182,749,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPayableCurrentAndNoncurrent', window );">Accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">201,467,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">183,151,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Cumulative Effect, Period of Adoption, Adjustment | Accounting Standards Update 2020-06 Retrospective</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, net of current portion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,196,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Cumulative Effect, Period of Adoption, Adjustment | Accounting Standards Update 2020-06 Retrospective | Additional Paid-in Capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Stockholders' equity, including portion attributable to noncontrolling interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,868,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Cumulative Effect, Period of Adoption, Adjustment | Accounting Standards Update 2020-06 Retrospective | Accumulated Deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Stockholders' equity, including portion attributable to noncontrolling interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,672,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">198,362,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">179,882,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableToBanksMember', window );">Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,105,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,217,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=pgen_TransOvaGeneticsLcMember', window );">Trans Ova Genetics, LC | Notes payable | American State Bank</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,105,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPayment', window );">Debt instrument, periodic payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pgen_A3.5ConvertibleNotesDue2023Member', window );">3.5% Convertible Notes Due 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount</a></td>
<td class="nump">$ 200,000,000<span></span>
</td>
<td class="nump">$ 200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from long-term debt, net of issuance costs</a></td>
<td class="nump">193,958,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsGross', window );">Debt issuance costs</a></td>
<td class="nump">$ 6,042,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="nump">3.50%<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionRatio1', window );">Conversion rate</a></td>
<td class="nump">58.6622<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pgen_ConvertibleDebtPrincipalAmountInitialConversionRate', window );">Principal amount used in conversion</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price (in usd per share) | $ / shares</a></td>
<td class="nump">$ 17.05<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Debt instrument redemption price, percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebt', window );">Carrying value of convertible debt</a></td>
<td class="nump">$ 143,723,000<span></span>
</td>
<td class="nump">$ 198,362,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 179,882,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt', window );">Equity component of convertible debt, net of issuance costs and deferred taxes</a></td>
<td class="nump">50,235,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="nump">$ 13,367,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate on convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">425.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Convertible notes, unamortized discount and issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,638,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pgen_A3.5ConvertibleNotesDue2023Member', window );">3.5% Convertible Notes Due 2023 | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays', window );">Common stock price trading days | day</a></td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Common stock price consecutive trading days | day</a></td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Percentage of common share price over conversion price for conversion</a></td>
<td class="nump">130.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=pgen_A3.5ConvertibleNotesDue2023Member', window );">3.5% Convertible Notes Due 2023 | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays', window );">Common stock price trading days | day</a></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Common stock price consecutive trading days | day</a></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Debt instrument redemption price, percentage</a></td>
<td class="nump">98.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pgen_ConvertibleDebtPrincipalAmountInitialConversionRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount in principal used in the initial conversion rate of the Convertible Notes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pgen_ConvertibleDebtPrincipalAmountInitialConversionRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pgen_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustment to additional paid in capital resulting from the recognition of convertible debt instruments as two separate components - a debt component and an equity component. This bifurcation may result in a basis difference associated with the liability component that represents a temporary difference for purposes of applying accounting for income taxes. The initial recognition of deferred taxes for the tax effect of that temporary difference is as an adjustment to additional paid in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 25<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123466103&amp;loc=SL6014347-161799<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031898-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionRatio1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21521-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21506-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionRatio1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Threshold number of specified trading days that common stock price to conversion price of convertible debt instruments must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payments including both interest and principal payments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPricePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph e<br> -URI http://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPricePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unamortized debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest payable on debt, including, but not limited to, trade payables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate202006RetrospectiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate202006RetrospectiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableToBanksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableToBanksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=pgen_TransOvaGeneticsLcMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=pgen_TransOvaGeneticsLcMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=pgen_AmericanStateBankMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=pgen_AmericanStateBankMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pgen_A3.5ConvertibleNotesDue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pgen_A3.5ConvertibleNotesDue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140329647359208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Lines of Credit and Long-Term Debt - Schedule of Components of Interest Expense (Details) - 3.5% Convertible Notes Due 2023 - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebtExcludingAmortization', window );">Cash interest expense</a></td>
<td class="nump">$ 1,750<span></span>
</td>
<td class="nump">$ 1,750<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pgen_InterestExpenseDebtAmortizationofDebtDiscountPremiumandDebtIssuanceCosts', window );">Non-cash interest expense</a></td>
<td class="nump">284<span></span>
</td>
<td class="nump">2,751<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Total interest expense</a></td>
<td class="nump">$ 2,034<span></span>
</td>
<td class="nump">$ 4,501<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pgen_InterestExpenseDebtAmortizationofDebtDiscountPremiumandDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments and amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pgen_InterestExpenseDebtAmortizationofDebtDiscountPremiumandDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pgen_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebtExcludingAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebtExcludingAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=pgen_A3.5ConvertibleNotesDue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=pgen_A3.5ConvertibleNotesDue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140329646993416">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Lines of Credit and Long-Term Debt - Schedule of Future Maturities of Long-Term Debt (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear', window );">2022</a></td>
<td class="nump">$ 265<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2023</a></td>
<td class="nump">200,365<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2024</a></td>
<td class="nump">380<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2025</a></td>
<td class="nump">395<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2026</a></td>
<td class="nump">411<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive', window );">2027</a></td>
<td class="nump">428<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive', window );">Thereafter</a></td>
<td class="nump">861<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total</a></td>
<td class="nump">$ 203,105<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140329642014392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Deferred tax liabilities</a></td>
<td class="nump">$ 2,438<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Domestic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pgen_TaxableIncomeLoss', window );">Taxable loss</a></td>
<td class="num">(5,300)<span></span>
</td>
<td class="num">$ (40,400)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="nump">861,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards', window );">Deferred tax assets, capital loss carryforwards</a></td>
<td class="nump">212,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch', window );">Research and development tax credits</a></td>
<td class="nump">11,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="nump">74,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAxis=pgen_GeneratedAfter2017Member', window );">Generated After 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="nump">$ 609,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pgen_TaxableIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Taxable income (loss)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pgen_TaxableIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pgen_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible capital loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsCapitalLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAxis=pgen_GeneratedAfter2017Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAxis=pgen_GeneratedAfter2017Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140329646923320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Components of Income Tax Benefits (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income tax benefit from continuing operations</a></td>
<td class="num">$ (58)<span></span>
</td>
<td class="num">$ (56)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOperatingActivitiesSegmentAxis=us-gaap_SegmentContinuingOperationsMember', window );">Continuing Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income tax benefit from continuing operations</a></td>
<td class="num">(58)<span></span>
</td>
<td class="num">(56)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total income tax benefit from continuing operations</a></td>
<td class="num">(58)<span></span>
</td>
<td class="num">(52)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOperatingActivitiesSegmentAxis=us-gaap_SegmentContinuingOperationsMember', window );">Continuing Operations | Foreign</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Current income tax expense from continuing operations</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOperatingActivitiesSegmentAxis=us-gaap_SegmentContinuingOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOperatingActivitiesSegmentAxis=us-gaap_SegmentContinuingOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140329645862232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity - Issuances of Precigen Common Stock (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued (in shares)</a></td>
<td class="nump">17,250,000<span></span>
</td>
<td class="nump">17,250,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Shares issued during the period, value</a></td>
<td class="nump">$ 121,045<span></span>
</td>
<td class="nump">$ 121,045<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140329641547512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity - Share Lending Agreement (Details)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jul. 31, 2018 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Borrowed shares, number issued (in shares) | shares</a></td>
<td class="nump">7,479,431<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pgen_ShareLendingAgreementLengthOfTimeForSharesToBeReturnedUponTermination', window );">Share lending agreement, length of time for shares to be returned upon termination</a></td>
<td class="text">5 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Borrowed shares, public offering price per share (in usd per share) | $ / shares</a></td>
<td class="nump">$ 13.37<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pgen_ShareLendingAgreementLengthOfTimeForSharesToBeReturnedUponTermination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share Lending Agreement, Length Of Time For Shares To Be Returned Upon Termination</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pgen_ShareLendingAgreementLengthOfTimeForSharesToBeReturnedUponTermination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pgen_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140329641915512">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Shareholders' Equity - Components of Accumulated Other Comprehensive Income (Loss) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Precigen shareholders' equity</a></td>
<td class="nump">$ 73,836<span></span>
</td>
<td class="nump">$ 107,348<span></span>
</td>
<td class="nump">$ 174,795<span></span>
</td>
<td class="nump">$ 67,174<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">Total accumulated other comprehensive (loss) income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Precigen shareholders' equity</a></td>
<td class="num">(1,699)<span></span>
</td>
<td class="nump">203<span></span>
</td>
<td class="nump">$ 1,746<span></span>
</td>
<td class="nump">$ 3,997<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember', window );">Unrealized loss on investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Precigen shareholders' equity</a></td>
<td class="num">(1,133)<span></span>
</td>
<td class="num">(331)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Income (loss) on foreign currency translation adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Precigen shareholders' equity</a></td>
<td class="num">$ (566)<span></span>
</td>
<td class="nump">$ 534<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140329641674232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Payments - Schedule of Stock-Based Compensation Costs (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation costs</a></td>
<td class="nump">$ 3,562<span></span>
</td>
<td class="nump">$ 5,415<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=pgen_CostOfProductsMember', window );">Cost of products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation costs</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=pgen_CostOfServicesMember', window );">Cost of services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation costs</a></td>
<td class="nump">31<span></span>
</td>
<td class="nump">65<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation costs</a></td>
<td class="nump">548<span></span>
</td>
<td class="nump">1,038<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling, general and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation costs</a></td>
<td class="nump">$ 2,975<span></span>
</td>
<td class="nump">$ 4,303<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=pgen_CostOfProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=pgen_CostOfProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=pgen_CostOfServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=pgen_CostOfServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140329641212408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Payments - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=pgen_ExecutiveChairmanMember', window );">Executive Chairman</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pgen_CompensationArrangementWithIndividualAllocatedShareBasedCompensationExpenseMonthlyExpense', window );">Monthly compensation, in the form of equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=pgen_ExecutiveChairmanMember', window );">Executive Chairman</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pgen_LockupPeriodOnRestrictedStockUnitShares', window );">Lock-up period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pgen_CompensationArrangementWithIndividualAnnualCashRetainer', window );">Yearly compensation, payable in cash or equity</a></td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Share-based Payment Arrangement, Option | Executive Chairman</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pgen_CompensationArrangementWithIndividualAnnualStockOptionGrantGrantDateFairValue', window );">Compensation arrangement with individual, annual stock option grant, grant date fair value</a></td>
<td class="nump">250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units | Executive Chairman</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pgen_CompensationArrangementWithIndividualAnnualRSUGrantGrantDateFairValue', window );">Compensation arrangement with individual, annual RSU grant, grant date fair value</a></td>
<td class="nump">$ 250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based compensation arrangement by share-based payment award, award vesting period</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling, general and administrative | Executive Chairman</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pgen_CompensationArrangementWithIndividualExpense', window );">Expense for certain compensation arrangements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 433<span></span>
</td>
<td class="nump">$ 400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=pgen_PrecigenStockOptionPlan2008PlanMember', window );">Precigen Stock Option Plan 2008 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Remaining shares available to grant (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,843<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=pgen_PrecigenStockOptionPlan2013PlanMember', window );">Precigen Stock Option Plan 2013 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Remaining shares available to grant (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,085,537<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,121,502<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized for issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">RSUs outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">569,445<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=pgen_PrecigenStockOptionPlan2013PlanMember', window );">Precigen Stock Option Plan 2013 Plan | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized for issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=pgen_PrecigenStockOptionPlan2019PlanMember', window );">Precigen Stock Option Plan 2019 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Remaining shares available to grant (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">243,025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,898,208<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized for issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">RSUs outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">615,760<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=pgen_PrecigenStockOptionPlan2019PlanMember', window );">Precigen Stock Option Plan 2019 Plan | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized for issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pgen_CompensationArrangementWithIndividualAllocatedShareBasedCompensationExpenseMonthlyExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of monthly expense recognized from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments), awarded to key employees or individuals.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pgen_CompensationArrangementWithIndividualAllocatedShareBasedCompensationExpenseMonthlyExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pgen_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pgen_CompensationArrangementWithIndividualAnnualCashRetainer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Compensation Arrangement With Individual, Annual Cash Retainer</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pgen_CompensationArrangementWithIndividualAnnualCashRetainer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pgen_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pgen_CompensationArrangementWithIndividualAnnualRSUGrantGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Compensation Arrangement With Individual, Annual RSU Grant, Grant Date Fair Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pgen_CompensationArrangementWithIndividualAnnualRSUGrantGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pgen_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pgen_CompensationArrangementWithIndividualAnnualStockOptionGrantGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Compensation Arrangement With Individual, Annual Stock Option Grant, Grant Date Fair Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pgen_CompensationArrangementWithIndividualAnnualStockOptionGrantGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pgen_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pgen_CompensationArrangementWithIndividualExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Compensation Arrangement With Individual, Expense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pgen_CompensationArrangementWithIndividualExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pgen_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pgen_LockupPeriodOnRestrictedStockUnitShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period of time during which issued shares are subject to a lock-up on resale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pgen_LockupPeriodOnRestrictedStockUnitShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pgen_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=pgen_ExecutiveChairmanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=pgen_ExecutiveChairmanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=pgen_ExecutiveChairmanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=pgen_ExecutiveChairmanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=pgen_PrecigenStockOptionPlan2008PlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=pgen_PrecigenStockOptionPlan2008PlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=pgen_PrecigenStockOptionPlan2013PlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=pgen_PrecigenStockOptionPlan2013PlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=pgen_PrecigenStockOptionPlan2019PlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=pgen_PrecigenStockOptionPlan2019PlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140329641944504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Payments - Schedule of Stock Option Activity (Details) - Precigen Stock Option Plans - $ / shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Balances at beginning of period (in shares)</a></td>
<td class="nump">12,260,187<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
<td class="nump">4,009,390<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares)</a></td>
<td class="num">(375)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Forfeited (in shares)</a></td>
<td class="num">(210,613)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod', window );">Expired (in shares)</a></td>
<td class="num">(24,036)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Balances at end of period (in shares)</a></td>
<td class="nump">16,034,553<span></span>
</td>
<td class="nump">12,260,187<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable at end of period (in shares)</a></td>
<td class="nump">8,937,195<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Balances at beginning of period (in usd per share)</a></td>
<td class="nump">$ 14.06<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in usd per share)</a></td>
<td class="nump">2.27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in usd per share)</a></td>
<td class="nump">2.28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Forfeited (in usd per share)</a></td>
<td class="nump">5.63<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice', window );">Expired (in usd per share)</a></td>
<td class="nump">11.85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Balances at period end (in usd per share)</a></td>
<td class="nump">11.22<span></span>
</td>
<td class="nump">$ 14.06<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Exercisable, weighted average exercise price, at end of period (in usd per share)</a></td>
<td class="nump">$ 14.85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Weighted Average Remaining Contractual Term (Years)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Balances, weighted average remaining contractual period</a></td>
<td class="text">7 years 3 months 21 days<span></span>
</td>
<td class="text">6 years 9 months 14 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Exercisable at period end, weighted average remaining contractual period</a></td>
<td class="text">5 years 11 months 26 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=pgen_PrecigenStockOptionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=pgen_PrecigenStockOptionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140329641672376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Payments - Schedule of Restricted Stock Unit Activity (Details) - Precigen Stock Option Plans - $ / shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number of Restricted Stock Units</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Balances at beginning of period (in shares)</a></td>
<td class="nump">468,481<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">1,387,831<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares)</a></td>
<td class="num">(669,041)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares)</a></td>
<td class="num">(2,066)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Balances at end of period (in shares)</a></td>
<td class="nump">1,185,205<span></span>
</td>
<td class="nump">468,481<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted Average Grant Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Balances at beginning of period (in usd per share)</a></td>
<td class="nump">$ 8.47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in usd per share)</a></td>
<td class="nump">2.12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in usd per share)</a></td>
<td class="nump">5.71<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited</a></td>
<td class="nump">7.26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Balances at end of period (in usd per share)</a></td>
<td class="nump">$ 2.60<span></span>
</td>
<td class="nump">$ 8.47<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract', window );"><strong>Additional Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms', window );">Weighted Average Remaining Contractual Term (Years)</a></td>
<td class="text">7 months 2 days<span></span>
</td>
<td class="text">3 months 29 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=pgen_PrecigenStockOptionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=pgen_PrecigenStockOptionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140329729883880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Operating Leases - Additional Information (Details)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pgen_LesseeOperatingLeaseTerminationPeriod', window );">Termination period</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm', window );">Term of contract</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm', window );">Term of contract</a></td>
<td class="text">9 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pgen_LesseeOperatingLeaseTerminationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Termination Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pgen_LesseeOperatingLeaseTerminationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pgen_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRemainingLeaseTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140329651797368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Operating Leases - Components of Lease Costs (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease costs</a></td>
<td class="nump">$ 729<span></span>
</td>
<td class="nump">$ 839<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermLeaseCost', window );">Short-term lease costs</a></td>
<td class="nump">463<span></span>
</td>
<td class="nump">506<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableLeaseCost', window );">Variable lease costs</a></td>
<td class="nump">117<span></span>
</td>
<td class="nump">230<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Lease costs</a></td>
<td class="nump">$ 1,309<span></span>
</td>
<td class="nump">$ 1,575<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term lease cost, excluding expense for lease with term of one month or less.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140329642045800">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Operating Leases - Maturities of Lease Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Lessee, Operating Lease, Liability, Payment, Due [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">2022</a></td>
<td class="nump">$ 2,117<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2023</a></td>
<td class="nump">2,519<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2024</a></td>
<td class="nump">2,528<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2025</a></td>
<td class="nump">2,259<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2026</a></td>
<td class="nump">1,778<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2027</a></td>
<td class="nump">1,345<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">3,292<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total</a></td>
<td class="nump">15,838<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Present value adjustment</a></td>
<td class="num">(4,740)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total</a></td>
<td class="nump">11,098<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of lease liabilities</a></td>
<td class="nump">1,590<span></span>
</td>
<td class="nump">$ 1,551<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term portion of operating lease liabilities</a></td>
<td class="nump">$ 9,508<span></span>
</td>
<td class="nump">$ 9,502<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140329645813528">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Operating Leases - Lease Terms and Discount Rates (Details)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term (years)</a></td>
<td class="text">6 years 3 months 18 days<span></span>
</td>
<td class="text">6 years 7 months 24 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate</a></td>
<td class="nump">10.99%<span></span>
</td>
<td class="nump">10.99%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140329641450616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Operating Leases - Other Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosure of cash flow information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Cash paid for operating lease liabilities</a></td>
<td class="nump">$ 744<span></span>
</td>
<td class="nump">$ 1,005<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Operating lease right-of-use assets obtained in exchange for new lease liabilities (includes new leases or modifications of existing leases)</a></td>
<td class="nump">$ 556<span></span>
</td>
<td class="nump">$ 55<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140329641021432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies - Contingencies - Additional Information (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 01, 2020 </div>
<div>claim</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($) </div>
<div>patent</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 30, 2020 </div>
<div>claim</div>
</th>
<th class="th">
<div>Dec. 31, 2016 </div>
<div>claim</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">Deferred revenue, net of current portion, related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23,023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23,023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=pgen_XYLLCMember', window );">XY, LLC | Licensing and patent infringement suit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyClaimsSettledNumber', window );">Loss contingency, claims settled, number | claim</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Claims pending resolution | claim</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pgen_LossContingencyNumberOfPatentsAtIssue', window );">Loss contingency, number of patents | patent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=pgen_SecuritiesAndExchangeCommissionMember', window );">Division Of Enforcement Of The Securities And Exchange Commission | Methane Bioconversion Platform Disclosures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForLegalSettlements', window );">Payments for civil money penalty</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=pgen_IntrexonEnergyPartnersMember', window );">Intrexon Energy Partners [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pgen_ProposedPaymentsForMembershipInterests', window );">Payments for membership interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestReceivable', window );">Interest receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=pgen_IntrexonEnergyPartnersMember', window );">Intrexon Energy Partners [Member] | Intrexon Energy Partners L.L. and Intrexon Energy Partners II, L.L.C</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pgen_ProposedPaymentsForMembershipInterests', window );">Payments for membership interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=pgen_IntrexonEnergyPartnersIILLCMember', window );">Intrexon Energy Partners II, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pgen_ProposedPaymentsForMembershipInterests', window );">Payments for membership interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestReceivable', window );">Interest receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=pgen_IntrexonEnergyPartnersIILLCMember', window );">Intrexon Energy Partners II, LLC | Intrexon Energy Partners L.L. and Intrexon Energy Partners II, L.L.C</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pgen_ProposedPaymentsForMembershipInterests', window );">Payments for membership interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pgen_LossContingencyNumberOfPatentsAtIssue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number Of Patents At Issue</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pgen_LossContingencyNumberOfPatentsAtIssue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pgen_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pgen_ProposedPaymentsForMembershipInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proposed Payments For Membership Interests</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pgen_ProposedPaymentsForMembershipInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pgen_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130532-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of interest earned but not received. Also called accrued interest or accrued interest receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyClaimsSettledNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of claims settled.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyClaimsSettledNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPendingClaimsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of pending claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPendingClaimsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForLegalSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid for the settlement of litigation or for other legal issues during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForLegalSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=pgen_XYLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=pgen_XYLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=pgen_LicensingAndPatentInfringementSuitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=pgen_LicensingAndPatentInfringementSuitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=pgen_SecuritiesAndExchangeCommissionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=pgen_SecuritiesAndExchangeCommissionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=pgen_MethaneBioconversionPlatformDisclosuresMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=pgen_MethaneBioconversionPlatformDisclosuresMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=pgen_IntrexonEnergyPartnersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=pgen_IntrexonEnergyPartnersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=pgen_IntrexonEnergyPartnersLLAndIntrexonEnergyPartnersIILLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=pgen_IntrexonEnergyPartnersLLAndIntrexonEnergyPartnersIILLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=pgen_IntrexonEnergyPartnersIILLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=pgen_IntrexonEnergyPartnersIILLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140329641789752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=pgen_ThirdSecurityMember', window );">Third Security, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfessionalAndContractServicesExpense', window );">Expense for services</a></td>
<td class="nump">$ 26<span></span>
</td>
<td class="nump">$ 41<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubleaseIncome', window );">Sublease rental income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=pgen_ThirdSecurityMember', window );">Third Security, LLC | Executive Chairman</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pgen_RelatedPartyOwnershipInterest', window );">Ownership interest</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pgen_RelatedPartyOwnershipInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in a related party.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pgen_RelatedPartyOwnershipInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pgen_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfessionalAndContractServicesExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Professional and contract service expense includes cost reimbursements for support services related to contracted projects, outsourced management, technical and staff support.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfessionalAndContractServicesExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubleaseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of sublease income excluding finance and operating lease expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubleaseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=pgen_ThirdSecurityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=pgen_ThirdSecurityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=pgen_ThirdSecurityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=pgen_ThirdSecurityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=pgen_ExecutiveChairmanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=pgen_ExecutiveChairmanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140329639913096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segments - Adjusted EBITDA by Reportable Segment (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pgen_NetIncomeLossAttributabletoParentAdjustedEBITDAIncludingCashPaidforCapitalExpendituresandInvestmentsinAffiliates', window );">Segment Adjusted EBITDA for reportable segments</a></td>
<td class="num">$ (2,665)<span></span>
</td>
<td class="num">$ (627)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pgen_BiopharmaceuticalsSegmentMember', window );">Biopharmaceuticals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pgen_NetIncomeLossAttributabletoParentAdjustedEBITDAIncludingCashPaidforCapitalExpendituresandInvestmentsinAffiliates', window );">Segment Adjusted EBITDA for reportable segments</a></td>
<td class="num">(11,620)<span></span>
</td>
<td class="num">(8,854)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pgen_ExemplarSegmentMember', window );">Exemplar</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pgen_NetIncomeLossAttributabletoParentAdjustedEBITDAIncludingCashPaidforCapitalExpendituresandInvestmentsinAffiliates', window );">Segment Adjusted EBITDA for reportable segments</a></td>
<td class="nump">3,558<span></span>
</td>
<td class="nump">1,806<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pgen_TransOvaSegmentMember', window );">Trans Ova</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pgen_NetIncomeLossAttributabletoParentAdjustedEBITDAIncludingCashPaidforCapitalExpendituresandInvestmentsinAffiliates', window );">Segment Adjusted EBITDA for reportable segments</a></td>
<td class="nump">$ 5,397<span></span>
</td>
<td class="nump">$ 6,421<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pgen_NetIncomeLossAttributabletoParentAdjustedEBITDAIncludingCashPaidforCapitalExpendituresandInvestmentsinAffiliates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Segment Adjusted EBITDA defined as net income (loss) before (i) interest expense, (ii) income tax expense/benefit, (iii) depreciation and amortization, (iv) stock-based compensation expense, (v) loss on settlement agreements where noncash consideration is paid; (vi) adjustments for accrued bonuses paid in equity awards; (vii) gain or loss on disposal of assets; (viii) loss on impairment of goodwill and other noncurrent assets, (ix) write-off of reacquired in-process research and development, (x) equity in net income (loss) of affiliates, and (xi) recognition of previously deferred revenue associated with upfront and milestone payments as well as cash outflows from capital expenditures and investments in affiliates, but includes proceeds from the sale of assets in the period sold.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pgen_NetIncomeLossAttributabletoParentAdjustedEBITDAIncludingCashPaidforCapitalExpendituresandInvestmentsinAffiliates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pgen_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=pgen_BiopharmaceuticalsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=pgen_BiopharmaceuticalsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=pgen_ExemplarSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=pgen_ExemplarSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=pgen_TransOvaSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=pgen_TransOvaSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140329641050504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segments - Reconciliation of Net Loss Before Income Taxes (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pgen_NetIncomeLossAttributabletoParentAdjustedEBITDAIncludingCashPaidforCapitalExpendituresandInvestmentsinAffiliates', window );">Segment Adjusted EBITDA for reportable segments</a></td>
<td class="num">$ (2,665)<span></span>
</td>
<td class="num">$ (627)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract', window );"><strong>Other expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="num">(3,292)<span></span>
</td>
<td class="num">(3,523)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets1', window );">Loss on disposals of assets</a></td>
<td class="num">(125)<span></span>
</td>
<td class="nump">343<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="num">(3,562)<span></span>
</td>
<td class="num">(5,415)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity in net loss of affiliates</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Consolidated net loss from continuing operations before income taxes</a></td>
<td class="num">(19,309)<span></span>
</td>
<td class="num">(21,896)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=pgen_UpfrontAndMilestonePaymentsMember', window );">Add recognition of previously deferred revenue associated with upfront and milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Add recognition of previously deferred revenue associated with upfront and milestone payments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">66<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pgen_CapitalExpendituresNetOfProceedsFromSaleOfAssetsAndInvestmentsInAffiliates', window );">Remove cash paid for capital expenditures, net of proceeds from sale of assets, and cash paid for investments in affiliates</a></td>
<td class="nump">1,314<span></span>
</td>
<td class="nump">597<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating segments | Add recognition of previously deferred revenue associated with upfront and milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Add recognition of previously deferred revenue associated with upfront and milestone payments</a></td>
<td class="nump">1,446<span></span>
</td>
<td class="nump">307<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=pgen_CorporateAndReconcilingItemsMember', window );">Corporate And Reconciling Items</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract', window );"><strong>Other expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(2,069)<span></span>
</td>
<td class="num">(4,539)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="num">(3,292)<span></span>
</td>
<td class="num">(3,523)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets1', window );">Loss on disposals of assets</a></td>
<td class="num">(125)<span></span>
</td>
<td class="num">(121)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment losses</a></td>
<td class="num">(482)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="num">(3,562)<span></span>
</td>
<td class="num">(5,415)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pgen_AdjustmentForBonusesPaidInEquityAwards', window );">Adjustment related to accrued bonuses paid in equity awards</a></td>
<td class="nump">1,698<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity in net loss of affiliates</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Unallocated corporate costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract', window );"><strong>Other expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Consolidated net loss from continuing operations before income taxes</a></td>
<td class="num">(10,060)<span></span>
</td>
<td class="num">(8,194)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Eliminations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract', window );"><strong>Other expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Consolidated net loss from continuing operations before income taxes</a></td>
<td class="num">(1,511)<span></span>
</td>
<td class="num">(371)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pgen_ReportableSegmentsMember', window );">Segment Adjusted EBITDA for reportable segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pgen_NetIncomeLossAttributabletoParentAdjustedEBITDAIncludingCashPaidforCapitalExpendituresandInvestmentsinAffiliates', window );">Segment Adjusted EBITDA for reportable segments</a></td>
<td class="num">$ (2,665)<span></span>
</td>
<td class="num">$ (627)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pgen_AdjustmentForBonusesPaidInEquityAwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustment For Bonuses Paid In Equity Awards</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pgen_AdjustmentForBonusesPaidInEquityAwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pgen_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pgen_CapitalExpendituresNetOfProceedsFromSaleOfAssetsAndInvestmentsInAffiliates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Capital Expenditures and Investments in Affiliates</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pgen_CapitalExpendituresNetOfProceedsFromSaleOfAssetsAndInvestmentsInAffiliates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pgen_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pgen_NetIncomeLossAttributabletoParentAdjustedEBITDAIncludingCashPaidforCapitalExpendituresandInvestmentsinAffiliates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Segment Adjusted EBITDA defined as net income (loss) before (i) interest expense, (ii) income tax expense/benefit, (iii) depreciation and amortization, (iv) stock-based compensation expense, (v) loss on settlement agreements where noncash consideration is paid; (vi) adjustments for accrued bonuses paid in equity awards; (vii) gain or loss on disposal of assets; (viii) loss on impairment of goodwill and other noncurrent assets, (ix) write-off of reacquired in-process research and development, (x) equity in net income (loss) of affiliates, and (xi) recognition of previously deferred revenue associated with upfront and milestone payments as well as cash outflows from capital expenditures and investments in affiliates, but includes proceeds from the sale of assets in the period sold.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pgen_NetIncomeLossAttributabletoParentAdjustedEBITDAIncludingCashPaidforCapitalExpendituresandInvestmentsinAffiliates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pgen_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfAssets1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfAssets1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=pgen_UpfrontAndMilestonePaymentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=pgen_UpfrontAndMilestonePaymentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=pgen_CorporateAndReconcilingItemsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=pgen_CorporateAndReconcilingItemsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=pgen_ReportableSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=pgen_ReportableSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140329641060008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segments - Revenues by Reportable Segment (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues from external customers</a></td>
<td class="nump">$ 32,021<span></span>
</td>
<td class="nump">$ 24,511<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pgen_ReportableSegmentsMember', window );">Total segment revenues from reportable segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">33,614<span></span>
</td>
<td class="nump">24,859<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues from external customers</a></td>
<td class="nump">32,021<span></span>
</td>
<td class="nump">24,511<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">33,614<span></span>
</td>
<td class="nump">24,859<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating segments | Biopharmaceuticals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues from external customers</a></td>
<td class="nump">84<span></span>
</td>
<td class="nump">178<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">1,530<span></span>
</td>
<td class="nump">419<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating segments | Exemplar</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues from external customers</a></td>
<td class="nump">5,429<span></span>
</td>
<td class="nump">3,257<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">5,429<span></span>
</td>
<td class="nump">3,257<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating segments | Trans Ova</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues from external customers</a></td>
<td class="nump">26,508<span></span>
</td>
<td class="nump">21,076<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">26,655<span></span>
</td>
<td class="nump">21,183<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">1,593<span></span>
</td>
<td class="nump">348<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment revenues | Biopharmaceuticals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">1,446<span></span>
</td>
<td class="nump">241<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment revenues | Exemplar</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment revenues | Trans Ova</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">147<span></span>
</td>
<td class="nump">107<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=pgen_EliminationsAndReconcilingItemsMember', window );">Elimination of intersegment revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="num">$ (1,593)<span></span>
</td>
<td class="num">$ (348)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=pgen_ReportableSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=pgen_ReportableSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=pgen_BiopharmaceuticalsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=pgen_BiopharmaceuticalsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=pgen_ExemplarSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=pgen_ExemplarSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=pgen_TransOvaSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=pgen_TransOvaSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=pgen_EliminationsAndReconcilingItemsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=pgen_EliminationsAndReconcilingItemsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140329651870472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segments - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pgen_ExemplarSegmentMember', window );">Exemplar</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pgen_PercentageOfRevenueAttributableToCustomer', window );">Percentage of revenue attributable to customer</a></td>
<td class="nump">13.00%<span></span>
</td>
<td class="nump">8.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember', window );">Non-US</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pgen_LongLivedAssetsIncludingPropertyPlantandEquipmentandRightOfUseAssets', window );">Long-lived assets</a></td>
<td class="nump">$ 4,148<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,463<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 205<span></span>
</td>
<td class="nump">$ 99<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pgen_LongLivedAssetsIncludingPropertyPlantandEquipmentandRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-Lived Assets, Including Property, Plant, and Equipment and Right Of Use Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pgen_LongLivedAssetsIncludingPropertyPlantandEquipmentandRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pgen_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pgen_PercentageOfRevenueAttributableToCustomer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage Of Revenue Attributable To Customer</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pgen_PercentageOfRevenueAttributableToCustomer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pgen_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=pgen_ExemplarSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=pgen_ExemplarSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R9999.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140329652582680">
<tr>
<th class="tl" colspan="1">Label</th>
<th class="tl"><strong>Element</strong></th>
<th class="th" colspan="1">Value</th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent', window );">Restricted Cash and Cash Equivalents, Noncurrent</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_RestrictedCashAndCashEquivalentsNoncurrent</td>
<td class="nump">$ 423,000<span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6812-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>pgen-20220331_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:pgen="http://www.dna.com/20220331"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="pgen-20220331.xsd" xlink:type="simple"/>
    <context id="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="idd1a990cf89548329a16f155a243b641_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="i1449114c17b04272b57978d40430259c_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="if864bcd9dba1429abb391816fd5eca4a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2d74b8a9aabd40c7b32c2739892226f3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">pgen:RelatedPartiesAggregatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0af1a8b31e524c11a45ac7677dc93883_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">pgen:RelatedPartiesAggregatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i4c74e34c64854220ad796ce8372be421_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie204f1c632a1470eb0dd741618a1aadb_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ic80f3fa4ad914e09aed3f5c24de3aa03_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i553b0d1d547844e597e5fce605969c48_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i999d1a77cd4548c9868b086286dd0c31_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i7bb2ea92baa54c14ac275f16ff730de2_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i436ff3c3e4284ab2abb2d891f39c72e5_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pgen:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic08aaf9f98534b94a2b999b85acdb0cd_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pgen:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i7b33b3bdd85544d6853b80b9b9363fdc_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ica51236575994a4ab8e30322fc2f55a4_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ic68a1c0debad4505be9f262586727573_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8630822867d746dcb299e334c2f62bb2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic1386437e5414589a78d1e1f9863e05e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9419bc7141e84a9d88053ffc38b7a8dd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3be10a01a9624d3ab98ae41d043b6197_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7abd6540a1a64f77872b8ddc7e797fff_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3d0633214e1c47539bd414801031b325_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5814e59f587a427ca84c1523af21ce68_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ibf63cfed8810400aacf2e390e0bc4982_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ifac0484be833462696c138be338f4ac6_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i8fddc81d9d8244a98bf2f57ae43c0bae_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id1795fa79607445cbc20904ee4dda36d_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="idc509430d95b4d7eb55ea6c26d1c41c3_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ia10c8c844d4940a3b0ebde37f5f75f25_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i6855b33dd4b34c1793117831d12003ea_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i64c8fed916fd4230bfb10137e40b9037_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia32c9ea65a164766b40eee00dd09cb45_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7048090cfae14c5c8420c6cad3ffd931_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6fad92c0b19f40d8b718694baf49e9b0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i54a90f374db746b78de00be9871944ac_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i71fe82fdf1f84583b3319fa0acac22be_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ic2060c890f6b479aab80d7691e262567_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i0dd2258d887948a091305e7302f4f7ed_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ia65599dbd22c42928733e6325a88a14e_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ibbe9dcfa0a15492fae0547b188e7d154_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i943c56b57428465184de8ac8b4b0a16a_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ibd2510608a8747ddbc103832b4650fb2_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="iae096e93867e42a99d564859635c4326_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="if7b79aae0fa241fb908efc36ca29e3d3_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i13ea040140e440418a940e8363605b6b_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ied4a3135345f415ca6385fc1d425993e_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="idf47d6aef2e44be1a923ae69756f5dae_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i5aabaff5f1154c5891d0a750ae3d1e8f_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i2ae4da9032b64f15ae1225c9f68e0a94_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i37cfff500eac4815a708c1afd75ce14a_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i63eddf4feb1441d8920e87a7e333621c_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i0d80cdb2ed0f480faecf8cdc7f92f497_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i026820ce93f04afc9c498f6af35f806b_I20220101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006RetrospectiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-01</instant>
        </period>
    </context>
    <context id="icf421d5fc50e4e85892b55cbde212eab_I20220101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006RetrospectiveMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-01</instant>
        </period>
    </context>
    <context id="i4f92c06e9bad430cac755e9610e9f9b5_I20220101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006RetrospectiveMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-01</instant>
        </period>
    </context>
    <context id="ia9d87a352497452f99e9459f9be7d3fa_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006RetrospectiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="icdf8637396524cf1ace92d8e586b1a80_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfByMeansOtherThanSaleAbandonmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">pgen:MBPTitanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if6cb7e8397b34ee6a457ba010484ed09_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfByMeansOtherThanSaleAbandonmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">pgen:MBPTitanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i9c206d84156440a49a72497604ec8972_D20140301-20140331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pgen:IntrexonEnergyPartnersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2014-03-01</startDate>
            <endDate>2014-03-31</endDate>
        </period>
    </context>
    <context id="i2e48cd233bc847118ac00256b671c120_I20140331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">pgen:IntrexonEnergyPartnersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-03-31</instant>
        </period>
    </context>
    <context id="i06c7dcadcbde427c93346762e97a9ff8_D20140301-20140331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">pgen:IntrexonEnergyPartnersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2014-03-01</startDate>
            <endDate>2014-03-31</endDate>
        </period>
    </context>
    <context id="i116e7745d66e431e9372cd8064a125ac_I20140331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">pgen:IntrexonEnergyPartnersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-03-31</instant>
        </period>
    </context>
    <context id="ia8700e0f55454cbba3fb9fd96a94fbbb_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">pgen:IntrexonEnergyPartnersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i3f3182d245524e2f81bd8b3e49a24b72_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">pgen:IntrexonEnergyPartnersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">pgen:OtherAccruedLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ic5473cecc9e948a696238d2b93f19451_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">pgen:IntrexonEnergyPartnersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">pgen:OtherAccruedLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icbe6e461c61143b794043bae863a8df6_D20151201-20151231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pgen:IntrexonEnergyPartnersIILLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2015-12-01</startDate>
            <endDate>2015-12-31</endDate>
        </period>
    </context>
    <context id="ib9f1d3ecd2254255a55eaec2585ccedb_I20151231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">pgen:IntrexonEnergyPartnersIILLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-12-31</instant>
        </period>
    </context>
    <context id="i5ae9c5a2b8e94b08b425df57ed7b8b69_D20151201-20151231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">pgen:IntrexonEnergyPartnersIILLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2015-12-01</startDate>
            <endDate>2015-12-31</endDate>
        </period>
    </context>
    <context id="iab1aff7710f9412391af1e5fd6967099_I20151231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">pgen:IntrexonEnergyPartnersIILLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-12-31</instant>
        </period>
    </context>
    <context id="iebe277ea9243444d8b84ba5c80f13e43_D20151201-20151231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">pgen:IntrexonEnergyPartnersIILLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">pgen:AllInvestorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2015-12-01</startDate>
            <endDate>2015-12-31</endDate>
        </period>
    </context>
    <context id="i68a8c3e611e7457496584dcd01bb9d77_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">pgen:IntrexonEnergyPartnersIILLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i66b17135fbc04c12a62fb56fd2cabc18_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">pgen:IntrexonEnergyPartnersIILLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">pgen:OtherAccruedLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1cd2167114c44a24bb2c013a330df7c4_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">pgen:IntrexonEnergyPartnersIILLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">pgen:OtherAccruedLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ie03a332075e24203bc226247706f4c0b_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pgen:CastleCreekBiosciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i2d962f9fc84242dfaab1b8772723f495_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pgen:CastleCreekBiosciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i8b919455fac14c5b89317ce54cc48c01_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pgen:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie1435bc431da4d2fbeee0800a5bb6070_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pgen:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i7ee3165dd570445e98d48bc112a7c856_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i57c5cf448af9439d8ce80e1a7c173246_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ic5c07296b0ad4a3795796cdd98b70bfe_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">pgen:UpfrontAndMilestonePaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i63f44e56a2d54df9a4c54a505c5e504c_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">pgen:UpfrontAndMilestonePaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ie8e1602cebb942fe9f1248b8494a1a7d_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pgen:IntrexonEnergyPartnersLLAndIntrexonEnergyPartnersIILLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i59e18c9f66844d49a7936ec00a3794ef_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i5d4f45253f074c3c817131697acd88c6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0b9d5326a05846d7a58b2f6cf8712aa2_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pgen:PrepaidProductAndServiceRevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i87bf374ed035409bafb6050993401656_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pgen:PrepaidProductAndServiceRevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0fb51aa6c5ef4219b2b7da5ce705fc81_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pgen:DeferredRevenueOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ie776f343946740da9a363c1b9559d961_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">pgen:DeferredRevenueOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7a7efd03f87243c8b506adee6b95d76e_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ib61d2084282545aeadc53945fd070cea_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i138b7762559a4bd0bef0907b1fc149a0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7e69243d3b7549888b5f4fb6f0bb9475_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8efdfb34bb074c228a7b56cd68c54e92_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i21f7dad991b3443cabf8b801717a7102_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i872f3add0d1843ac827dc54132c0479a_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i19f61ce6754f4459a9aef0d9e6199717_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i7c555a88343545dd9e8dbf1fba6af596_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i852b481436844bb180bbb9ccb677b04e_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i93715ce18b404d1e829abbd13ffd87fa_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i2c91bed02b6948bc8b34c10b4ed941d8_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="icd71ea23afbd46ddbe3c2deffaf893b0_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="if8a7409f0d5e4c7aac820b7c228efe86_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i271b0c1c542f467982ba61825dd48dd5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ied4c7ca414574920a941d3fac029e286_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i531349a928d146fa9cfde02f1ec3e68f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idb99f08c2199410b935f7e65fbd62cb9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie74b31c2e1fd45cdacc1a2277e851ddc_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i09a9ddaf3caa4498b7f5d33b60e82854_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0c064cf87f8c47afbfc9a5d1fbd79533_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia1c952fbceb14ed981c1efbc9b58c1f5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if6f497049bf74c16a1396dfc4d1e650a_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pgen:A3.5ConvertibleNotesDue2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i3e4b384138dc464ea318892a265c9e5f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pgen:A3.5ConvertibleNotesDue2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie8e3dddd71c4443985fe28d70f1e2c9a_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PublicUtilitiesInventoryAxis">pgen:SuppliesEmbryosAndOtherProductionMaterialsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i3940f9d38d364dccb21e61d867617045_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PublicUtilitiesInventoryAxis">pgen:SuppliesEmbryosAndOtherProductionMaterialsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idf3c07cd4a91470ba7f63dbc88e4bc6a_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PublicUtilitiesInventoryAxis">pgen:WorkInProcessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i92fec9005efa4d79987abea15d951226_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PublicUtilitiesInventoryAxis">pgen:WorkInProcessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i42bf8b0d2e814be082d3b0bf6da63af4_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PublicUtilitiesInventoryAxis">pgen:LivestockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="iecc97711a44b47019e38b94af754e168_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PublicUtilitiesInventoryAxis">pgen:LivestockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i22be83bf68b14b30a42ca5908e204306_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PublicUtilitiesInventoryAxis">pgen:FeedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i5527892baeab40f6a59e15f38b3b3dc4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PublicUtilitiesInventoryAxis">pgen:FeedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i677ca2bcecca4536be4af0d96b5861f8_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i35dfe924439843b5af0a65df16408eaa_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i93a0684a8757410bb11d784429689ade_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i2492744906d942a6a9d8a0cdfa3ac7c6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i23dbbf6a562e498c8fa7683328ca8a94_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i64684d6563664cf59533e60bfe5b9921_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9d132006c1d145eaac64d45ccb86b656_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">pgen:FirstNationalBankofOmahaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">pgen:TransOvaGeneticsLcMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i19a165412c0146749eb84baeba26cbf7_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">pgen:FirstNationalBankofOmahaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">pgen:TransOvaGeneticsLcMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i3207747902c548a1a820a9bbe7e15b04_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">pgen:FirstNationalBankofOmahaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">pgen:TransOvaGeneticsLcMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6a365a7536554cd6b37d69868458c0ae_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">pgen:AmericanStateBankMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">pgen:ExemplarGeneticsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i822f03f707534638b1196ee45d5740e2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">pgen:AmericanStateBankMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">pgen:ExemplarGeneticsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2d8dc6d1111e4706a024929613e40a55_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i5d949c0fb90e44e48aa23d89122c630b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i30632d5609ff45ee847fb10488a6417a_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableToBanksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i4adfe5f20a0a4ef987ffe40825f234ad_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableToBanksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib33f36cb52e14c6e8a14e68692d39463_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">pgen:OtherLongTermDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ia99a2463349745cc99f7555e4c6a7a5d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">pgen:OtherLongTermDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9756753ac1d54cf49cebd859fa402242_I20180731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pgen:A3.5ConvertibleNotesDue2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-07-31</instant>
        </period>
    </context>
    <context id="i36c9e83acbc5433596f7bc29c25d3981_D20180701-20180731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pgen:A3.5ConvertibleNotesDue2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2018-07-31</endDate>
        </period>
    </context>
    <context id="i78bbba80cecb4e08a63655e020bbcd37_D20180701-20180731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pgen:A3.5ConvertibleNotesDue2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2018-07-31</endDate>
        </period>
    </context>
    <context id="i3c051e9f9a3d440f9f4a49368f5c7480_D20180701-20180731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pgen:A3.5ConvertibleNotesDue2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2018-07-31</endDate>
        </period>
    </context>
    <context id="i735cf6b5a38a4c71b70373ae0908abde_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pgen:A3.5ConvertibleNotesDue2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i3c9c4caf2a40476d8e1647cd3cd7dab5_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">pgen:A3.5ConvertibleNotesDue2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ib8940548e4f34495a851495a8177a0e5_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">pgen:AmericanStateBankMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableToBanksMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">pgen:TransOvaGeneticsLcMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i4eac7d5551844a73b17f500e6471b7d6_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">pgen:AmericanStateBankMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableToBanksMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">pgen:TransOvaGeneticsLcMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic4808534316144d29d8b9683055df43b_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i30c081f8014842aabc417374b020f10a_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i72d8140387894893965c60c951b48995_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i942228f442bc4c7185a791f7d76e9464_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i1fd4ac078b6b4bd3b73092a493efc484_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i6a7f574cfb2544578c335065e1d56a9c_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">pgen:GeneratedAfter2017Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ied3594fa3f424f1284f8857f0f9d9e48_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ie2a968b6094d45cda5605e526b7e92bf_D20210101-20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="i8598f9bdba3a401d83a4f654f841906a_D20180701-20180731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2018-07-31</endDate>
        </period>
    </context>
    <context id="i93aa43f8711240658d7f03498645c20e_I20180731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
        </entity>
        <period>
            <instant>2018-07-31</instant>
        </period>
    </context>
    <context id="i3cffe5138aae46519a9c02056913cbba_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="if3b3a8896f5b4e35ac21bb5d15996bf1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i356ed50b56d84ebc908b0db1a4e37562_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ib4e65996659d4890b8c61dca95aca459_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2fae103728264503ab2e0c1e85de1fa1_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">pgen:CostOfProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ifbf81220cc4d45d9aa7386783cc59848_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">pgen:CostOfProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="id10f7e933b844c0c974c05850b687893_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">pgen:CostOfServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i5b6126b9ae8a467c975a767e23eefb22_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">pgen:CostOfServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ifc7b7a85c17a4f719952d2594387e412_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i45c4b76fe6d6445d8c45f82b8265fa07_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ibd0d01ceff2445fda5c004b555eca6e7_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ice47f63e56544bee9874b31fbdaf9439_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i76c7b4e5ff1a48fcadf331282aabc8db_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pgen:PrecigenStockOptionPlan2008PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i7b18ccdba7b24f00b51da1d09ef35311_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pgen:PrecigenStockOptionPlan2013PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i2cb8b077e2f643509dd676e06445a3b0_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pgen:PrecigenStockOptionPlan2013PlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="i41a9bb8a5068442cb2b3e00d415ced02_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pgen:PrecigenStockOptionPlan2019PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ie9b2e87da42e47ccab3223507b32451a_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pgen:PrecigenStockOptionPlan2019PlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="i5431bc10b5384e398f2da6195a9b96c3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pgen:PrecigenStockOptionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifbfcb80618ad460ab47bac77d7292bc6_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pgen:PrecigenStockOptionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib0b5090cc97842718a2c0490412cb4ca_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pgen:PrecigenStockOptionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ia76d4feded9342679caddb3d64f9f4ff_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pgen:PrecigenStockOptionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i48d145e276444d3888545e838877b8de_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">pgen:ExecutiveChairmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="if5b1b22e280a4090aecc9398d2cdea50_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">pgen:ExecutiveChairmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="id74f0b524f01452d8d2d8d74d2292022_D20200901-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">pgen:ExecutiveChairmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i0af19287e90a415ea59ea804de00d129_D20200901-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">pgen:ExecutiveChairmanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ideb4dd8ae78341f79f57af0fb7ddc27a_D20200901-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">pgen:ExecutiveChairmanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i59bc005983d548a9b090b14a8066e997_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">pgen:ExecutiveChairmanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i5189760c78094b18a54d1b9ae10c326e_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">pgen:ExecutiveChairmanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ia09e6a5c583541aba441ce841c40debc_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="id3592de1ea59450cab6771569bdb2819_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i1e1e4f70ee384bbdbc72a4af43c0088e_D20201201-20201201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pgen:XYLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">pgen:LicensingAndPatentInfringementSuitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-01</startDate>
            <endDate>2020-12-01</endDate>
        </period>
    </context>
    <context id="i4e403613e684438d80d697b08493e995_I20201130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pgen:XYLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">pgen:LicensingAndPatentInfringementSuitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-11-30</instant>
        </period>
    </context>
    <context id="i531c6a806994442783b99222cf391d82_I20161231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pgen:XYLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">pgen:LicensingAndPatentInfringementSuitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-12-31</instant>
        </period>
    </context>
    <context id="i92eb050585b540e3800cec27efae3099_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pgen:XYLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">pgen:LicensingAndPatentInfringementSuitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i6c06e66e33bb485785e90d05f2a08b59_D20200901-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pgen:SecuritiesAndExchangeCommissionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">pgen:MethaneBioconversionPlatformDisclosuresMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i95a19f694d074542bcb9b8a97cf37bd8_D20220301-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pgen:IntrexonEnergyPartnersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i6ae0faf7e643440fae62e6c31bc0d0b0_D20220301-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pgen:IntrexonEnergyPartnersIILLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i23eaa581e78f4aea9ecce173012954db_D20220301-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pgen:IntrexonEnergyPartnersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">pgen:IntrexonEnergyPartnersLLAndIntrexonEnergyPartnersIILLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic7d0ad563c924cf39cfee9ad185abd2d_D20220301-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pgen:IntrexonEnergyPartnersIILLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">pgen:IntrexonEnergyPartnersLLAndIntrexonEnergyPartnersIILLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i87cc2f18c9f0471f8bc8ab42417029c1_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pgen:IntrexonEnergyPartnersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i823414b73a894b4b82ccc11ca83d746e_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pgen:IntrexonEnergyPartnersIILLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ib9c7f0031bb24fe38f91d5540eda5855_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">pgen:ExecutiveChairmanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">pgen:ThirdSecurityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i65e674d88ff54f86a6d42d5a8329e35c_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">pgen:ThirdSecurityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i033c578bc61340d6be52ccd5a2c876ac_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">pgen:ThirdSecurityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="iac54c563a6c7429ebca9d25950c5a88a_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pgen:BiopharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i130e7434090749d3927853a57ecb1485_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pgen:BiopharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ic90cdb87070e4510bfb77391109bd015_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pgen:ExemplarSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i1379bdeed3124397a5045d15e0c107f8_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pgen:ExemplarSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ie637642bb2524234aedb229fe66afbf3_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pgen:TransOvaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ida88d53a25ce48349d9f4162d6b088a5_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pgen:TransOvaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ia48b472a445a4200a8254bcce2227a72_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pgen:ReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i5e8ae689a8804c098cef0e54bd63c3ef_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pgen:ReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i6f12f7718c574755bd4056b0eb47020b_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i2d2c97b816ee436cb18d90482a754e10_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i8c2fe0628bc145c2966d9bc2ce259b60_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">pgen:UpfrontAndMilestonePaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i6841cb0561af477da53d5c395af9e6cc_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">pgen:UpfrontAndMilestonePaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i576c4b11dd9b44298653de992854ba4e_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">pgen:CorporateAndReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i72f2477327d94768809a6aa578dd8221_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">pgen:CorporateAndReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ifa062aac5f0147e2a1dfff1ad00a491c_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i64f363e45b3f4b5f871a0d7d9ea6ca4f_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i6408cfb01bd44cebadc3b26397941b33_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="icc375dc8cd7b45b48cfab364c5a82fa5_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i9b3c7721f0ef415c9513b33bb836c7ee_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pgen:BiopharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i2ac6979a51bb4a92b3b04995d0432dbc_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pgen:ExemplarSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i8edc30ca4e6f4b8993b2065b289bfbd5_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pgen:TransOvaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i04211b6ebbd848dda476f17cf818169c_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pgen:BiopharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie2bd06ad475c4200a82ace0d4ad7872d_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pgen:ExemplarSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie8790f324a3d408fb7149e93f1d33708_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pgen:TransOvaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i9051a486c0e7466bac7d683d545e64a6_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pgen:BiopharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i31eca9c164994ce3ad55697fdabbc18f_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pgen:ExemplarSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i7aee8cbc73ec4aad80c7b5ec0d52e55c_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pgen:TransOvaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i13cba4a8d5c742ce8d33b04cbd96f97a_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pgen:BiopharmaceuticalsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i87b549534d7048538c9a43c0eba0ccc2_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pgen:ExemplarSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i0cfc596ca5a04165b80a4b0e08e40e65_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pgen:TransOvaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="if3a5fe3120f24eb38dace9b8bfea5b2f_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">pgen:EliminationsAndReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ied5b0b30354b46978a4d414674afd3d4_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">pgen:EliminationsAndReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="idbeb7dcf502e424db307e185fd1e576a_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i46d345a1060047b6af3e5f2700f3127b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idec0f08a8c3d49fc821a1cf2c9544f25_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id6db753435f04670b618c70cb75e3463_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001356090</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="board_seat">
        <measure>pgen:board_seat</measure>
    </unit>
    <unit id="reporting_unit">
        <measure>pgen:reporting_unit</measure>
    </unit>
    <unit id="day">
        <measure>pgen:day</measure>
    </unit>
    <unit id="claim">
        <measure>pgen:claim</measure>
    </unit>
    <unit id="patent">
        <measure>pgen:patent</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80L2ZyYWc6Y2QyM2MxODljN2Y5NGFmNGEyZmJlMjE5ZTBmMWE4MzIvdGFibGU6ZjE0NzNhMjMyNzgyNGE5NTg2NjQ2MGQwMjE0OTg3YTEvdGFibGVyYW5nZTpmMTQ3M2EyMzI3ODI0YTk1ODY2NDYwZDAyMTQ5ODdhMV8zLTEtMS0xLTE1NjA0_00eb5578-c45f-42f5-ba78-e4c0e9a5e5ed">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80L2ZyYWc6Y2QyM2MxODljN2Y5NGFmNGEyZmJlMjE5ZTBmMWE4MzIvdGFibGU6ZjE0NzNhMjMyNzgyNGE5NTg2NjQ2MGQwMjE0OTg3YTEvdGFibGVyYW5nZTpmMTQ3M2EyMzI3ODI0YTk1ODY2NDYwZDAyMTQ5ODdhMV80LTEtMS0xLTE1NjA0_f0540bf5-3a61-4469-857c-a5b9cb37f076">2022</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80L2ZyYWc6Y2QyM2MxODljN2Y5NGFmNGEyZmJlMjE5ZTBmMWE4MzIvdGFibGU6ZjE0NzNhMjMyNzgyNGE5NTg2NjQ2MGQwMjE0OTg3YTEvdGFibGVyYW5nZTpmMTQ3M2EyMzI3ODI0YTk1ODY2NDYwZDAyMTQ5ODdhMV81LTEtMS0xLTE1NjA0_1f929a46-6a32-4bfc-a547-0cbb0b187e86">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80L2ZyYWc6Y2QyM2MxODljN2Y5NGFmNGEyZmJlMjE5ZTBmMWE4MzIvdGFibGU6ZjE0NzNhMjMyNzgyNGE5NTg2NjQ2MGQwMjE0OTg3YTEvdGFibGVyYW5nZTpmMTQ3M2EyMzI3ODI0YTk1ODY2NDYwZDAyMTQ5ODdhMV82LTEtMS0xLTE1NjA0_5cf859e9-8239-4a96-b7d7-22d70ded8aca">0001356090</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80L2ZyYWc6Y2QyM2MxODljN2Y5NGFmNGEyZmJlMjE5ZTBmMWE4MzIvdGFibGU6ZjE0NzNhMjMyNzgyNGE5NTg2NjQ2MGQwMjE0OTg3YTEvdGFibGVyYW5nZTpmMTQ3M2EyMzI3ODI0YTk1ODY2NDYwZDAyMTQ5ODdhMV83LTEtMS0xLTE1NjA0_aead33e0-42b6-4edd-83c8-c9c79f4c2779">--12-31</dei:CurrentFiscalYearEndDate>
    <us-gaap:AccountingStandardsUpdateExtensibleList
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOjBhOTMzMGI4ZDdjNjRlNjJhZGYxZjYyOTEyOTcxNzk2L3RhYmxlcmFuZ2U6MGE5MzMwYjhkN2M2NGU2MmFkZjFmNjI5MTI5NzE3OTZfMy0wLTEtMS0yNzgyOA_dceab1cb-aeda-411c-b999-aa5bab34bbb4">http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate202006Member</us-gaap:AccountingStandardsUpdateExtensibleList>
    <pgen:ShareLendingAgreementLengthOfTimeForSharesToBeReturnedUponTermination
      contextRef="i8598f9bdba3a401d83a4f654f841906a_D20180701-20180731"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83My9mcmFnOmM1ZGIyMTNkZWJkZjRlMzA5OGU3ODI0MjJjNjU2ZTg5L3RleHRyZWdpb246YzVkYjIxM2RlYmRmNGUzMDk4ZTc4MjQyMmM2NTZlODlfMTA3OA_34a88b8d-8f7c-4b2a-8636-4d319d40194f">P5D</pgen:ShareLendingAgreementLengthOfTimeForSharesToBeReturnedUponTermination>
    <us-gaap:LesseeOperatingLeaseRemainingLeaseTerm
      contextRef="ia09e6a5c583541aba441ce841c40debc_I20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83OS9mcmFnOjgxNjNjNDA5NjZlOTQxMTdhMzUxODA5ZTdhYWE0ZDRkL3RleHRyZWdpb246ODE2M2M0MDk2NmU5NDExN2EzNTE4MDllN2FhYTRkNGRfMzQw_862490a9-7afa-4299-a0ee-2b7d4d6c6c09">P1Y</us-gaap:LesseeOperatingLeaseRemainingLeaseTerm>
    <dei:DocumentType
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xL2ZyYWc6OTE2N2U0MzAyNTBlNGY2ZDk5MjAwMDUyMmIyZmMzZGUvdGV4dHJlZ2lvbjo5MTY3ZTQzMDI1MGU0ZjZkOTkyMDAwNTIyYjJmYzNkZV8yMDY3_fb891eea-c5a8-45d8-b09c-01636fc415d7">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xL2ZyYWc6OTE2N2U0MzAyNTBlNGY2ZDk5MjAwMDUyMmIyZmMzZGUvdGFibGU6Nzg1ZTE5MTBkZmFmNDlkOGE1OWFmMWVjMTk3ZDdhMTgvdGFibGVyYW5nZTo3ODVlMTkxMGRmYWY0OWQ4YTU5YWYxZWMxOTdkN2ExOF8wLTAtMS0xLTE1NjA0_a92e52d0-5933-4d9e-ac4d-86e37fae7ab2">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xL2ZyYWc6OTE2N2U0MzAyNTBlNGY2ZDk5MjAwMDUyMmIyZmMzZGUvdGV4dHJlZ2lvbjo5MTY3ZTQzMDI1MGU0ZjZkOTkyMDAwNTIyYjJmYzNkZV8xMjM_c1cb6a61-06ea-4340-86f5-63a46eb15b3f">2022-03-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xL2ZyYWc6OTE2N2U0MzAyNTBlNGY2ZDk5MjAwMDUyMmIyZmMzZGUvdGFibGU6MGNjMTRhNmFiNzdmNDNiOTkyYjEyOWE4NzQ0YjUwNGUvdGFibGVyYW5nZTowY2MxNGE2YWI3N2Y0M2I5OTJiMTI5YTg3NDRiNTA0ZV8wLTAtMS0xLTE1NjA0_30d6d371-c573-4f86-ae7c-8d439237ae3c">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xL2ZyYWc6OTE2N2U0MzAyNTBlNGY2ZDk5MjAwMDUyMmIyZmMzZGUvdGV4dHJlZ2lvbjo5MTY3ZTQzMDI1MGU0ZjZkOTkyMDAwNTIyYjJmYzNkZV8yMDY4_54993760-416a-4268-8fdf-c002494f5061">001-36042</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xL2ZyYWc6OTE2N2U0MzAyNTBlNGY2ZDk5MjAwMDUyMmIyZmMzZGUvdGV4dHJlZ2lvbjo5MTY3ZTQzMDI1MGU0ZjZkOTkyMDAwNTIyYjJmYzNkZV8yMDY5_e6496588-ac7c-4568-a7d2-4138eeea2c80">PRECIGEN, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xL2ZyYWc6OTE2N2U0MzAyNTBlNGY2ZDk5MjAwMDUyMmIyZmMzZGUvdGFibGU6MzAyZGI2MzM5OGZhNGJjOGI0MWYwZDJmZWYxYTIyZjIvdGFibGVyYW5nZTozMDJkYjYzMzk4ZmE0YmM4YjQxZjBkMmZlZjFhMjJmMl8wLTEtMS0xLTE1NjA0_801d34bc-e44f-4ea5-af4f-fd300e60773f">VA</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xL2ZyYWc6OTE2N2U0MzAyNTBlNGY2ZDk5MjAwMDUyMmIyZmMzZGUvdGFibGU6MzAyZGI2MzM5OGZhNGJjOGI0MWYwZDJmZWYxYTIyZjIvdGFibGVyYW5nZTozMDJkYjYzMzk4ZmE0YmM4YjQxZjBkMmZlZjFhMjJmMl8wLTQtMS0xLTE1NjA0_15be6bf0-fc5b-4710-bc91-7cd64e44d3a2">26-0084895</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xL2ZyYWc6OTE2N2U0MzAyNTBlNGY2ZDk5MjAwMDUyMmIyZmMzZGUvdGFibGU6MzAyZGI2MzM5OGZhNGJjOGI0MWYwZDJmZWYxYTIyZjIvdGFibGVyYW5nZTozMDJkYjYzMzk4ZmE0YmM4YjQxZjBkMmZlZjFhMjJmMl8zLTEtMS0xLTE1NjA0_82b29ef8-087e-458f-882b-860e03c02647">20374 Seneca Meadows Parkway</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xL2ZyYWc6OTE2N2U0MzAyNTBlNGY2ZDk5MjAwMDUyMmIyZmMzZGUvdGFibGU6MzAyZGI2MzM5OGZhNGJjOGI0MWYwZDJmZWYxYTIyZjIvdGFibGVyYW5nZTozMDJkYjYzMzk4ZmE0YmM4YjQxZjBkMmZlZjFhMjJmMl80LTEtMS0xLTE1NjA0_86588631-850c-4afa-966c-ef8248866aa2">Germantown,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xL2ZyYWc6OTE2N2U0MzAyNTBlNGY2ZDk5MjAwMDUyMmIyZmMzZGUvdGFibGU6MzAyZGI2MzM5OGZhNGJjOGI0MWYwZDJmZWYxYTIyZjIvdGFibGVyYW5nZTozMDJkYjYzMzk4ZmE0YmM4YjQxZjBkMmZlZjFhMjJmMl80LTItMS0xLTE1NjA0_47df00ae-262d-46de-a706-bb7860e6c284">MD</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xL2ZyYWc6OTE2N2U0MzAyNTBlNGY2ZDk5MjAwMDUyMmIyZmMzZGUvdGFibGU6MzAyZGI2MzM5OGZhNGJjOGI0MWYwZDJmZWYxYTIyZjIvdGFibGVyYW5nZTozMDJkYjYzMzk4ZmE0YmM4YjQxZjBkMmZlZjFhMjJmMl80LTQtMS0xLTE1NjA0_f59f0192-b2df-4c8b-b54d-79bcc1fa95c6">20876</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xL2ZyYWc6OTE2N2U0MzAyNTBlNGY2ZDk5MjAwMDUyMmIyZmMzZGUvdGV4dHJlZ2lvbjo5MTY3ZTQzMDI1MGU0ZjZkOTkyMDAwNTIyYjJmYzNkZV8yMDcw_cc94fbe3-71d7-4750-994a-dd3765021dce">301</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xL2ZyYWc6OTE2N2U0MzAyNTBlNGY2ZDk5MjAwMDUyMmIyZmMzZGUvdGV4dHJlZ2lvbjo5MTY3ZTQzMDI1MGU0ZjZkOTkyMDAwNTIyYjJmYzNkZV8yMDcx_fe950010-d5c9-44c2-8d81-a8157d8906e8">556-9900</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xL2ZyYWc6OTE2N2U0MzAyNTBlNGY2ZDk5MjAwMDUyMmIyZmMzZGUvdGFibGU6YTc1YzI0Y2ViZjk3NGI4MjlhYjI3MGQ3ZDI0ZWFlY2UvdGFibGVyYW5nZTphNzVjMjRjZWJmOTc0YjgyOWFiMjcwZDdkMjRlYWVjZV8xLTAtMS0xLTE1NjA0_f2463e05-5130-48ab-83ff-c804f6c6c631">Common Stock, no par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xL2ZyYWc6OTE2N2U0MzAyNTBlNGY2ZDk5MjAwMDUyMmIyZmMzZGUvdGFibGU6YTc1YzI0Y2ViZjk3NGI4MjlhYjI3MGQ3ZDI0ZWFlY2UvdGFibGVyYW5nZTphNzVjMjRjZWJmOTc0YjgyOWFiMjcwZDdkMjRlYWVjZV8xLTItMS0xLTE1NjA0_fa1dbe16-02c2-4557-8ff5-68f6571ff22e">PGEN</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xL2ZyYWc6OTE2N2U0MzAyNTBlNGY2ZDk5MjAwMDUyMmIyZmMzZGUvdGFibGU6YTc1YzI0Y2ViZjk3NGI4MjlhYjI3MGQ3ZDI0ZWFlY2UvdGFibGVyYW5nZTphNzVjMjRjZWJmOTc0YjgyOWFiMjcwZDdkMjRlYWVjZV8xLTQtMS0xLTE1NjA0_10a4c48e-0410-45f1-b705-c1e969a192d7">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xL2ZyYWc6OTE2N2U0MzAyNTBlNGY2ZDk5MjAwMDUyMmIyZmMzZGUvdGV4dHJlZ2lvbjo5MTY3ZTQzMDI1MGU0ZjZkOTkyMDAwNTIyYjJmYzNkZV8yMDY0_c2288ba1-b5e5-40b9-9aff-d4e69d2b518e">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xL2ZyYWc6OTE2N2U0MzAyNTBlNGY2ZDk5MjAwMDUyMmIyZmMzZGUvdGV4dHJlZ2lvbjo5MTY3ZTQzMDI1MGU0ZjZkOTkyMDAwNTIyYjJmYzNkZV8yMDY2_9293dcd7-d699-4e0a-8470-e947ea274d1f">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xL2ZyYWc6OTE2N2U0MzAyNTBlNGY2ZDk5MjAwMDUyMmIyZmMzZGUvdGFibGU6ZjJiMWVhNzU1YWU1NDUxODkwODQwYTU4MzhhOTc2ZDQvdGFibGVyYW5nZTpmMmIxZWE3NTVhZTU0NTE4OTA4NDBhNTgzOGE5NzZkNF8wLTAtMS0xLTI3ODQ0_76d83332-2e86-4388-a236-de2fba2eb596">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xL2ZyYWc6OTE2N2U0MzAyNTBlNGY2ZDk5MjAwMDUyMmIyZmMzZGUvdGFibGU6ZjJiMWVhNzU1YWU1NDUxODkwODQwYTU4MzhhOTc2ZDQvdGFibGVyYW5nZTpmMmIxZWE3NTVhZTU0NTE4OTA4NDBhNTgzOGE5NzZkNF8yLTYtMS0xLTE1NjA0_00bc9370-bbe3-4179-9dc8-96f83e2c33c0">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xL2ZyYWc6OTE2N2U0MzAyNTBlNGY2ZDk5MjAwMDUyMmIyZmMzZGUvdGFibGU6ZjJiMWVhNzU1YWU1NDUxODkwODQwYTU4MzhhOTc2ZDQvdGFibGVyYW5nZTpmMmIxZWE3NTVhZTU0NTE4OTA4NDBhNTgzOGE5NzZkNF80LTYtMS0xLTE1NjA0_63943451-1922-477a-897d-ca16ef8d0e1f">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xL2ZyYWc6OTE2N2U0MzAyNTBlNGY2ZDk5MjAwMDUyMmIyZmMzZGUvdGV4dHJlZ2lvbjo5MTY3ZTQzMDI1MGU0ZjZkOTkyMDAwNTIyYjJmYzNkZV8yMDY1_9e87f6c0-779e-43ed-b9bb-659b903dcbc9">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="idd1a990cf89548329a16f155a243b641_I20220430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xL2ZyYWc6OTE2N2U0MzAyNTBlNGY2ZDk5MjAwMDUyMmIyZmMzZGUvdGV4dHJlZ2lvbjo5MTY3ZTQzMDI1MGU0ZjZkOTkyMDAwNTIyYjJmYzNkZV8xOTg2_0b741f79-aebc-482c-b99c-5b468f6d7c46"
      unitRef="shares">207693277</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjRlMzYxNzEwNjFjNjRhYzI5ZTM3YTcxYWNkYjYxZDI5L3RhYmxlcmFuZ2U6NGUzNjE3MTA2MWM2NGFjMjllMzdhNzFhY2RiNjFkMjlfMy0xLTEtMS0xNTYwNA_00b8da1b-fab5-45d7-9bdb-8cfc94464932"
      unitRef="usd">40321000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjRlMzYxNzEwNjFjNjRhYzI5ZTM3YTcxYWNkYjYxZDI5L3RhYmxlcmFuZ2U6NGUzNjE3MTA2MWM2NGFjMjllMzdhNzFhY2RiNjFkMjlfMy0zLTEtMS0xNTYwNA_e638ae8c-3978-4ed1-ac22-306932f0b970"
      unitRef="usd">42920000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ShortTermInvestments
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjRlMzYxNzEwNjFjNjRhYzI5ZTM3YTcxYWNkYjYxZDI5L3RhYmxlcmFuZ2U6NGUzNjE3MTA2MWM2NGFjMjllMzdhNzFhY2RiNjFkMjlfNS0xLTEtMS0xNTYwNA_032227d7-87f8-46fc-98f3-9de53232f5e1"
      unitRef="usd">71821000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments
      contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjRlMzYxNzEwNjFjNjRhYzI5ZTM3YTcxYWNkYjYxZDI5L3RhYmxlcmFuZ2U6NGUzNjE3MTA2MWM2NGFjMjllMzdhNzFhY2RiNjFkMjlfNS0zLTEtMS0xNTYwNA_a7700db0-65b8-4c93-9c02-ebd2d4f74958"
      unitRef="usd">72240000</us-gaap:ShortTermInvestments>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjRlMzYxNzEwNjFjNjRhYzI5ZTM3YTcxYWNkYjYxZDI5L3RhYmxlcmFuZ2U6NGUzNjE3MTA2MWM2NGFjMjllMzdhNzFhY2RiNjFkMjlfOC0wLTEtMS0xNTYwNC90ZXh0cmVnaW9uOjJmNmNiNjBiYzMzOTRhNmE4ZWUxNDNiODRlNzM3OWFhXzQ3_f993ad38-d182-42e3-aa23-a498e3132518"
      unitRef="usd">4631000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjRlMzYxNzEwNjFjNjRhYzI5ZTM3YTcxYWNkYjYxZDI5L3RhYmxlcmFuZ2U6NGUzNjE3MTA2MWM2NGFjMjllMzdhNzFhY2RiNjFkMjlfOC0wLTEtMS0xNTYwNC90ZXh0cmVnaW9uOjJmNmNiNjBiYzMzOTRhNmE4ZWUxNDNiODRlNzM3OWFhXzU0_25d1309a-fa5d-4542-bace-447cbf4b51fe"
      unitRef="usd">4288000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjRlMzYxNzEwNjFjNjRhYzI5ZTM3YTcxYWNkYjYxZDI5L3RhYmxlcmFuZ2U6NGUzNjE3MTA2MWM2NGFjMjllMzdhNzFhY2RiNjFkMjlfOC0xLTEtMS0xNTYwNA_905b1534-4644-4973-94be-5ed18db78f92"
      unitRef="usd">24308000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjRlMzYxNzEwNjFjNjRhYzI5ZTM3YTcxYWNkYjYxZDI5L3RhYmxlcmFuZ2U6NGUzNjE3MTA2MWM2NGFjMjllMzdhNzFhY2RiNjFkMjlfOC0zLTEtMS0xNTYwNA_030b6476-89bb-42f3-87b5-91536340f815"
      unitRef="usd">20832000</us-gaap:AccountsReceivableNetCurrent>
    <pgen:RelatedPartyReceivableAllowanceforCreditLossCurrent
      contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjRlMzYxNzEwNjFjNjRhYzI5ZTM3YTcxYWNkYjYxZDI5L3RhYmxlcmFuZ2U6NGUzNjE3MTA2MWM2NGFjMjllMzdhNzFhY2RiNjFkMjlfOS0wLTEtMS0xNTYwNC90ZXh0cmVnaW9uOmIyMzI1NTg5MzNlMDQyNTViZTZkYjkwYzRhZTEyZmIzXzU3_4f0de8dd-3a13-40a8-b8e8-dc22729d5394"
      unitRef="usd">1509000</pgen:RelatedPartyReceivableAllowanceforCreditLossCurrent>
    <pgen:RelatedPartyReceivableAllowanceforCreditLossCurrent
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjRlMzYxNzEwNjFjNjRhYzI5ZTM3YTcxYWNkYjYxZDI5L3RhYmxlcmFuZ2U6NGUzNjE3MTA2MWM2NGFjMjllMzdhNzFhY2RiNjFkMjlfOS0wLTEtMS0xNTYwNC90ZXh0cmVnaW9uOmIyMzI1NTg5MzNlMDQyNTViZTZkYjkwYzRhZTEyZmIzXzU3_c197b940-2cf2-4adf-8c3a-8a4e4105edec"
      unitRef="usd">1509000</pgen:RelatedPartyReceivableAllowanceforCreditLossCurrent>
    <us-gaap:DueFromRelatedPartiesCurrent
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjRlMzYxNzEwNjFjNjRhYzI5ZTM3YTcxYWNkYjYxZDI5L3RhYmxlcmFuZ2U6NGUzNjE3MTA2MWM2NGFjMjllMzdhNzFhY2RiNjFkMjlfOS0xLTEtMS0xNTYwNA_6f5e1c53-b97f-4bb8-bd56-d43860eccfdb"
      unitRef="usd">15000</us-gaap:DueFromRelatedPartiesCurrent>
    <us-gaap:DueFromRelatedPartiesCurrent
      contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjRlMzYxNzEwNjFjNjRhYzI5ZTM3YTcxYWNkYjYxZDI5L3RhYmxlcmFuZ2U6NGUzNjE3MTA2MWM2NGFjMjllMzdhNzFhY2RiNjFkMjlfOS0zLTEtMS0xNTYwNA_b46f515d-9bbd-4e23-a476-2cc4a6347f0e"
      unitRef="usd">73000</us-gaap:DueFromRelatedPartiesCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjRlMzYxNzEwNjFjNjRhYzI5ZTM3YTcxYWNkYjYxZDI5L3RhYmxlcmFuZ2U6NGUzNjE3MTA2MWM2NGFjMjllMzdhNzFhY2RiNjFkMjlfMTEtMS0xLTEtMTU2MDQ_61cf4ee8-0bf7-446e-8bd6-df6ee0a2a564"
      unitRef="usd">543000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjRlMzYxNzEwNjFjNjRhYzI5ZTM3YTcxYWNkYjYxZDI5L3RhYmxlcmFuZ2U6NGUzNjE3MTA2MWM2NGFjMjllMzdhNzFhY2RiNjFkMjlfMTEtMy0xLTEtMTU2MDQ_d321c342-b933-407d-b449-d8ced2ad83f8"
      unitRef="usd">566000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:InventoryGross
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjRlMzYxNzEwNjFjNjRhYzI5ZTM3YTcxYWNkYjYxZDI5L3RhYmxlcmFuZ2U6NGUzNjE3MTA2MWM2NGFjMjllMzdhNzFhY2RiNjFkMjlfMTItMS0xLTEtMTU2MDQ_e174490f-c2ef-438b-8a27-196088ec02a8"
      unitRef="usd">12730000</us-gaap:InventoryGross>
    <us-gaap:InventoryGross
      contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjRlMzYxNzEwNjFjNjRhYzI5ZTM3YTcxYWNkYjYxZDI5L3RhYmxlcmFuZ2U6NGUzNjE3MTA2MWM2NGFjMjllMzdhNzFhY2RiNjFkMjlfMTItMy0xLTEtMTU2MDQ_92cd0bdb-cdda-4e2f-aedc-0f6b949efd21"
      unitRef="usd">13261000</us-gaap:InventoryGross>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjRlMzYxNzEwNjFjNjRhYzI5ZTM3YTcxYWNkYjYxZDI5L3RhYmxlcmFuZ2U6NGUzNjE3MTA2MWM2NGFjMjllMzdhNzFhY2RiNjFkMjlfMTMtMS0xLTEtMTU2MDQ_afd08244-2dfd-47d6-a135-736df0c261c1"
      unitRef="usd">5199000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjRlMzYxNzEwNjFjNjRhYzI5ZTM3YTcxYWNkYjYxZDI5L3RhYmxlcmFuZ2U6NGUzNjE3MTA2MWM2NGFjMjllMzdhNzFhY2RiNjFkMjlfMTMtMy0xLTEtMTU2MDQ_7ddc551d-8dee-4d3f-832e-20a4e3621e6c"
      unitRef="usd">6736000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjRlMzYxNzEwNjFjNjRhYzI5ZTM3YTcxYWNkYjYxZDI5L3RhYmxlcmFuZ2U6NGUzNjE3MTA2MWM2NGFjMjllMzdhNzFhY2RiNjFkMjlfMTUtMS0xLTEtMTU2MDQ_206ade53-a5a9-4a7a-b906-a61954a731b5"
      unitRef="usd">154937000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjRlMzYxNzEwNjFjNjRhYzI5ZTM3YTcxYWNkYjYxZDI5L3RhYmxlcmFuZ2U6NGUzNjE3MTA2MWM2NGFjMjllMzdhNzFhY2RiNjFkMjlfMTUtMy0xLTEtMTU2MDQ_c11127f0-a5f9-4e33-9ab3-3d40a3696a71"
      unitRef="usd">156628000</us-gaap:AssetsCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjRlMzYxNzEwNjFjNjRhYzI5ZTM3YTcxYWNkYjYxZDI5L3RhYmxlcmFuZ2U6NGUzNjE3MTA2MWM2NGFjMjllMzdhNzFhY2RiNjFkMjlfMTYtMS0xLTEtMTU2MDQ_d1b01cbd-f2b0-4e76-a042-7056776dd5a1"
      unitRef="usd">29914000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjRlMzYxNzEwNjFjNjRhYzI5ZTM3YTcxYWNkYjYxZDI5L3RhYmxlcmFuZ2U6NGUzNjE3MTA2MWM2NGFjMjllMzdhNzFhY2RiNjFkMjlfMTYtMy0xLTEtMTU2MDQ_43064f21-e818-4b94-9386-f3de9a46f37b"
      unitRef="usd">48562000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjRlMzYxNzEwNjFjNjRhYzI5ZTM3YTcxYWNkYjYxZDI5L3RhYmxlcmFuZ2U6NGUzNjE3MTA2MWM2NGFjMjllMzdhNzFhY2RiNjFkMjlfMTgtMS0xLTEtMTU2MDQ_ab83efa5-e63a-4824-a963-7e5a8e88ba63"
      unitRef="usd">33583000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjRlMzYxNzEwNjFjNjRhYzI5ZTM3YTcxYWNkYjYxZDI5L3RhYmxlcmFuZ2U6NGUzNjE3MTA2MWM2NGFjMjllMzdhNzFhY2RiNjFkMjlfMTgtMy0xLTEtMTU2MDQ_a26d1361-f9bd-4d84-9653-2adbd9a1427e"
      unitRef="usd">34315000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjRlMzYxNzEwNjFjNjRhYzI5ZTM3YTcxYWNkYjYxZDI5L3RhYmxlcmFuZ2U6NGUzNjE3MTA2MWM2NGFjMjllMzdhNzFhY2RiNjFkMjlfMTktMS0xLTEtMTU2MDQ_f0af5d61-cdd6-4938-8064-c4ccc031f967"
      unitRef="usd">51427000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjRlMzYxNzEwNjFjNjRhYzI5ZTM3YTcxYWNkYjYxZDI5L3RhYmxlcmFuZ2U6NGUzNjE3MTA2MWM2NGFjMjllMzdhNzFhY2RiNjFkMjlfMTktMy0xLTEtMTU2MDQ_e17b6eaa-70b0-4ec5-a40f-8be2dfb671d5"
      unitRef="usd">54115000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:Goodwill
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjRlMzYxNzEwNjFjNjRhYzI5ZTM3YTcxYWNkYjYxZDI5L3RhYmxlcmFuZ2U6NGUzNjE3MTA2MWM2NGFjMjllMzdhNzFhY2RiNjFkMjlfMjAtMS0xLTEtMTU2MDQ_036ec93c-caa9-4cfa-bd43-9ba8eddf6d3e"
      unitRef="usd">53613000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjRlMzYxNzEwNjFjNjRhYzI5ZTM3YTcxYWNkYjYxZDI5L3RhYmxlcmFuZ2U6NGUzNjE3MTA2MWM2NGFjMjllMzdhNzFhY2RiNjFkMjlfMjAtMy0xLTEtMTU2MDQ_e516ee0a-54d0-4163-ba01-803438dd6559"
      unitRef="usd">54148000</us-gaap:Goodwill>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjRlMzYxNzEwNjFjNjRhYzI5ZTM3YTcxYWNkYjYxZDI5L3RhYmxlcmFuZ2U6NGUzNjE3MTA2MWM2NGFjMjllMzdhNzFhY2RiNjFkMjlfMjItMS0xLTEtMTU2MDQ_d819bc1e-4caa-425f-a2f1-d08d129c77ef"
      unitRef="usd">10963000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjRlMzYxNzEwNjFjNjRhYzI5ZTM3YTcxYWNkYjYxZDI5L3RhYmxlcmFuZ2U6NGUzNjE3MTA2MWM2NGFjMjllMzdhNzFhY2RiNjFkMjlfMjItMy0xLTEtMTU2MDQ_d19df57c-31ce-4f6e-bc35-90bd324d3ad7"
      unitRef="usd">10900000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjRlMzYxNzEwNjFjNjRhYzI5ZTM3YTcxYWNkYjYxZDI5L3RhYmxlcmFuZ2U6NGUzNjE3MTA2MWM2NGFjMjllMzdhNzFhY2RiNjFkMjlfMjMtMS0xLTEtMTU2MDQ_69060085-9232-4881-b084-a119f0ea7d22"
      unitRef="usd">1131000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjRlMzYxNzEwNjFjNjRhYzI5ZTM3YTcxYWNkYjYxZDI5L3RhYmxlcmFuZ2U6NGUzNjE3MTA2MWM2NGFjMjllMzdhNzFhY2RiNjFkMjlfMjMtMy0xLTEtMTU2MDQ_5c04024b-0c79-4443-9673-04a75d79057c"
      unitRef="usd">1188000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjRlMzYxNzEwNjFjNjRhYzI5ZTM3YTcxYWNkYjYxZDI5L3RhYmxlcmFuZ2U6NGUzNjE3MTA2MWM2NGFjMjllMzdhNzFhY2RiNjFkMjlfMjQtMS0xLTEtMTU2MDQ_769ebefd-54d2-4008-9589-72b7ecb54b1d"
      unitRef="usd">335568000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjRlMzYxNzEwNjFjNjRhYzI5ZTM3YTcxYWNkYjYxZDI5L3RhYmxlcmFuZ2U6NGUzNjE3MTA2MWM2NGFjMjllMzdhNzFhY2RiNjFkMjlfMjQtMy0xLTEtMTU2MDQ_efb19348-cc7d-421f-8337-a8e3451126bf"
      unitRef="usd">359856000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfMy0xLTEtMS0xNTYwNA_e4d08b23-2f96-47e2-b9ff-79f5fc4cfae9"
      unitRef="usd">4415000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfMy0zLTEtMS0xNTYwNA_15a8e7db-bf37-4907-8389-03d4f14d2a0e"
      unitRef="usd">5405000</us-gaap:AccountsPayableCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfNC0xLTEtMS0xNTYwNA_a17058b5-fdcc-45c0-8411-9811bef3d29b"
      unitRef="usd">6052000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfNC0zLTEtMS0xNTYwNA_efee86bf-ca2a-4b92-8c01-b6f51e1b0c44"
      unitRef="usd">11223000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfNS0xLTEtMS0xNTYwNA_f376cc6a-0682-41c3-83c4-f0ae24d418e3"
      unitRef="usd">10494000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfNS0zLTEtMS0xNTYwNA_19b21a76-b1e0-48b3-9073-6778320b9309"
      unitRef="usd">11595000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfNi0xLTEtMS0xNTYwNA_fb8ca5b7-9fe3-4112-afc5-edb00be60d7b"
      unitRef="usd">2669000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfNi0zLTEtMS0xNTYwNA_acb0fbeb-abb9-4049-8bef-8508d80866d8"
      unitRef="usd">4442000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfOC0xLTEtMS0xNTYwNA_b25a94c2-f92c-42d0-884a-6353ac4797dd"
      unitRef="usd">355000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfOC0zLTEtMS0xNTYwNA_6cb8546e-a5e6-49d4-a3bf-9c2d37bc54e2"
      unitRef="usd">402000</us-gaap:LongTermDebtCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfMTAtMS0xLTEtMTU2MDQ_9799016e-b9b5-4df4-b016-769a0df79d2a"
      unitRef="usd">1590000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfMTAtMy0xLTEtMTU2MDQ_2219a016-e32d-421e-85dd-1bf0fcddefcd"
      unitRef="usd">1551000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:DueToRelatedPartiesCurrent
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfMTEtMS0xLTEtMTU2MDQ_998e7a47-007b-4efc-b934-567ddcd1fb92"
      unitRef="usd">26000</us-gaap:DueToRelatedPartiesCurrent>
    <us-gaap:DueToRelatedPartiesCurrent
      contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfMTEtMy0xLTEtMTU2MDQ_8e363afc-6548-4b44-aa5f-cdbd1008e25f"
      unitRef="usd">27000</us-gaap:DueToRelatedPartiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfMTMtMS0xLTEtMTU2MDQ_ca6862de-1507-44d5-85b4-ed45026913ff"
      unitRef="usd">25601000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfMTMtMy0xLTEtMTU2MDQ_0e3b2160-c53b-498e-9f24-3bc96e1360cc"
      unitRef="usd">34645000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfMTQtMS0xLTEtMTU2MDQ_a3c810c6-d3a9-43c4-99b9-ff554dad2ef2"
      unitRef="usd">201112000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfMTQtMy0xLTEtMTU2MDQ_59ebb6db-f246-481a-a547-270daa480a2f"
      unitRef="usd">182749000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="i2d74b8a9aabd40c7b32c2739892226f3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfMTYtMC0xLTEtMTU2MDQvdGV4dHJlZ2lvbjpmNDVlZGI2MjdjNTg0OWEzOGU1OTY3YjQyMTlhNDcyZV81Ng_99ce89f6-56a4-4a88-ae7f-b8503f29c1d3"
      unitRef="usd">21205000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="i0af1a8b31e524c11a45ac7677dc93883_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfMTYtMC0xLTEtMTU2MDQvdGV4dHJlZ2lvbjpmNDVlZGI2MjdjNTg0OWEzOGU1OTY3YjQyMTlhNDcyZV81Ng_a2480ee5-24ea-4408-ad07-1616a9764587"
      unitRef="usd">21205000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfMTYtMS0xLTEtMTU2MDQ_4c5c8a31-9bc2-4127-8fd1-e61762e9f5c0"
      unitRef="usd">23023000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfMTYtMy0xLTEtMTU2MDQ_54cc7153-080b-441e-b5b8-101a028393ae"
      unitRef="usd">23023000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfMTctMS0xLTEtMTU2MDQ_daedd81c-98bd-4c35-9031-f5daf1ec182a"
      unitRef="usd">9508000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfMTctMy0xLTEtMTU2MDQ_001af610-1811-40b8-9cc4-7f025365dadc"
      unitRef="usd">9502000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfMTgtMS0xLTEtMTU2MDQ_1616f2fc-9abb-4c7a-aece-f7e141adbe89"
      unitRef="usd">2438000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfMTgtMy0xLTEtMTU2MDQ_4177c241-f3dd-479d-819a-87cffc209c5d"
      unitRef="usd">2539000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfMTktMS0xLTEtMTU2MDQ_71084ee2-0057-4ad4-995f-975921682b11"
      unitRef="usd">50000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfMTktMy0xLTEtMTU2MDQ_6603048c-d0f1-4c66-8c96-7a3a2a6d1c2c"
      unitRef="usd">50000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfMjAtMS0xLTEtMTU2MDQ_575c3122-584d-4fd3-8b1a-5c5cce02a012"
      unitRef="usd">261732000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfMjAtMy0xLTEtMTU2MDQ_decf67bc-2353-40f5-a058-08c85a857c4d"
      unitRef="usd">252508000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfMjEtMS0xLTEtMTU2MDQ_61dc2308-1243-4756-bf53-57502467f75d"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfMjEtMy0xLTEtMTU2MDQ_c1d4b005-184b-425c-9d69-dff716e9050c"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommonStockNoParValue
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfMjMtMC0xLTEtMTU2MDQvdGV4dHJlZ2lvbjpkNjI5OWZkMDc5YTQ0N2U2ODA3YWFmYWI4Y2U0Yzc1Yl8xOA_0ae9f19c-6c81-402f-bff1-6c5468fd3670"
      unitRef="usdPerShare">0</us-gaap:CommonStockNoParValue>
    <us-gaap:CommonStockNoParValue
      contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfMjMtMC0xLTEtMTU2MDQvdGV4dHJlZ2lvbjpkNjI5OWZkMDc5YTQ0N2U2ODA3YWFmYWI4Y2U0Yzc1Yl8xOA_d34da9e3-007c-42c8-9298-5251e2edfe79"
      unitRef="usdPerShare">0</us-gaap:CommonStockNoParValue>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfMjMtMC0xLTEtMTU2MDQvdGV4dHJlZ2lvbjpkNjI5OWZkMDc5YTQ0N2U2ODA3YWFmYWI4Y2U0Yzc1Yl8zMg_1324be32-f778-4d4a-96ad-5afa265924f9"
      unitRef="shares">400000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfMjMtMC0xLTEtMTU2MDQvdGV4dHJlZ2lvbjpkNjI5OWZkMDc5YTQ0N2U2ODA3YWFmYWI4Y2U0Yzc1Yl8zMg_47375297-657e-4a5c-91ec-17a54b13241e"
      unitRef="shares">400000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfMjMtMC0xLTEtMTU2MDQvdGV4dHJlZ2lvbjpkNjI5OWZkMDc5YTQ0N2U2ODA3YWFmYWI4Y2U0Yzc1Yl83MA_0e560657-ce7d-4986-bf20-646aac56da6f"
      unitRef="shares">207693277</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfMjMtMC0xLTEtMTU2MDQvdGV4dHJlZ2lvbjpkNjI5OWZkMDc5YTQ0N2U2ODA3YWFmYWI4Y2U0Yzc1Yl83MA_b6b5b8c3-90ab-4b1f-a970-2d61081d1f51"
      unitRef="shares">207693277</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfMjMtMC0xLTEtMTU2MDQvdGV4dHJlZ2lvbjpkNjI5OWZkMDc5YTQ0N2U2ODA3YWFmYWI4Y2U0Yzc1Yl84NA_5ba0b332-8936-46e1-b0f5-d3bca8107d74"
      unitRef="shares">206739874</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfMjMtMC0xLTEtMTU2MDQvdGV4dHJlZ2lvbjpkNjI5OWZkMDc5YTQ0N2U2ODA3YWFmYWI4Y2U0Yzc1Yl84NA_d05b8a66-47a5-4d2b-a2d8-dd18c97f0a5d"
      unitRef="shares">206739874</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValueOutstanding
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfMjMtMS0xLTEtMTU2MDQ_fbbaf2b7-f232-4128-9a88-e8fcc8289949"
      unitRef="usd">0</us-gaap:CommonStockValueOutstanding>
    <us-gaap:CommonStockValueOutstanding
      contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfMjMtMy0xLTEtMTU2MDQ_5194c52d-2145-45dc-83fa-c4c79e6c4d85"
      unitRef="usd">0</us-gaap:CommonStockValueOutstanding>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfMjQtMS0xLTEtMTU2MDQ_34e595ee-f323-4eb8-ac2a-da773b7d870e"
      unitRef="usd">1991670000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfMjQtMy0xLTEtMTU2MDQ_66ae9f2d-d434-46aa-a847-76a4e570ef18"
      unitRef="usd">2022701000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfMjUtMS0xLTEtMTU2MDQ_1efbf4df-252f-4513-9d21-9b53f43b7ece"
      unitRef="usd">-1916135000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfMjUtMy0xLTEtMTU2MDQ_54712c24-519f-45f1-91e9-360b9acf6b9a"
      unitRef="usd">-1915556000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfMjYtMS0xLTEtMTU2MDQ_7994e893-c1c6-43a0-a472-1fe743ecd52a"
      unitRef="usd">-1699000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfMjYtMy0xLTEtMTU2MDQ_7dac784a-d6af-41b1-93c4-325c08947596"
      unitRef="usd">203000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfMjctMS0xLTEtMTU2MDQ_d762aea5-7c09-4344-b41b-b43d4c784320"
      unitRef="usd">73836000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfMjctMy0xLTEtMTU2MDQ_9912220c-4327-4341-a400-6944567d960a"
      unitRef="usd">107348000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfMzAtMS0xLTEtMTU2MDQ_ea511310-c875-40b0-8560-bad6d611f8e9"
      unitRef="usd">335568000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8xOS9mcmFnOmEwY2E3NmRmNzQwZDRiMGY4MjY3MThmMGMxMDdjOWVjL3RhYmxlOjMzMTc3Y2RhYjdkNzQwMzZhNDEyMGUwOGVhZTU4ZjdhL3RhYmxlcmFuZ2U6MzMxNzdjZGFiN2Q3NDAzNmE0MTIwZTA4ZWFlNThmN2FfMzAtMy0xLTEtMTU2MDQ_c478e2d9-386b-48af-941f-f4b80d73c561"
      unitRef="usd">359856000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4c74e34c64854220ad796ce8372be421_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMy0xLTEtMS0xNTYwNA_23be207b-4676-42af-835f-d099a2861a35"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie204f1c632a1470eb0dd741618a1aadb_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMy0zLTEtMS0xNTYwNA_95dbf3ef-3fef-418e-a1a4-a79a985fcaff"
      unitRef="usd">66000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic80f3fa4ad914e09aed3f5c24de3aa03_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfNC0xLTEtMS0xNTYwNA_72dc61a9-1a1f-450e-9474-2108f6ca1f92"
      unitRef="usd">8724000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i553b0d1d547844e597e5fce605969c48_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfNC0zLTEtMS0xNTYwNA_1ceb22be-6b45-47d4-8ae0-9c11a70df2d2"
      unitRef="usd">6381000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i999d1a77cd4548c9868b086286dd0c31_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfNS0xLTEtMS0xNTYwNA_11fc59cc-2451-4dc1-bffc-b52b3c491042"
      unitRef="usd">23209000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7bb2ea92baa54c14ac275f16ff730de2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfNS0zLTEtMS0xNTYwNA_1563c55d-3fb7-490c-b017-67ccd05ddd1c"
      unitRef="usd">17931000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i436ff3c3e4284ab2abb2d891f39c72e5_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfNi0xLTEtMS0xNTYwNA_124b6440-3762-481b-9515-bbe2264a045c"
      unitRef="usd">88000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic08aaf9f98534b94a2b999b85acdb0cd_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfNi0zLTEtMS0xNTYwNA_a85b1cb3-ff8a-4a6e-bcae-411a70d267b8"
      unitRef="usd">133000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7b33b3bdd85544d6853b80b9b9363fdc_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfNy0xLTEtMS0xNTYwNA_d51c2cf3-3a03-4de2-9a02-5e27beead174"
      unitRef="usd">32021000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ica51236575994a4ab8e30322fc2f55a4_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfNy0zLTEtMS0xNTYwNA_b7cf3f2c-8c7e-41cc-a17c-f1162968982f"
      unitRef="usd">24511000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ic80f3fa4ad914e09aed3f5c24de3aa03_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfOS0xLTEtMS0xNTYwNA_4710ff9e-5905-43a9-9228-f1b641e949cc"
      unitRef="usd">7510000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i553b0d1d547844e597e5fce605969c48_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfOS0zLTEtMS0xNTYwNA_863b7baa-b0ed-444f-a155-b7539e8a24d1"
      unitRef="usd">5574000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i999d1a77cd4548c9868b086286dd0c31_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMTAtMS0xLTEtMTU2MDQ_03d05b52-111a-47ef-b57b-e086e0b66bfc"
      unitRef="usd">9589000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i7bb2ea92baa54c14ac275f16ff730de2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMTAtMy0xLTEtMTU2MDQ_89842ee2-d8c1-4ca9-af73-4be8ff863917"
      unitRef="usd">7402000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i7b33b3bdd85544d6853b80b9b9363fdc_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMTEtMS0xLTEtMTU2MDQ_5f82e422-49f4-425a-b1d3-9971e9cc5ff1"
      unitRef="usd">12760000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ica51236575994a4ab8e30322fc2f55a4_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMTEtMy0xLTEtMTU2MDQ_c66eb572-80eb-42a1-806b-670fc1d5791b"
      unitRef="usd">10521000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i7b33b3bdd85544d6853b80b9b9363fdc_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMTItMS0xLTEtMTU2MDQ_d3f42171-8a8a-42e4-912c-dfc426af7d80"
      unitRef="usd">19576000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ica51236575994a4ab8e30322fc2f55a4_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMTItMy0xLTEtMTU2MDQ_add0d2fe-d816-45fc-a2ec-d84b734c6902"
      unitRef="usd">18702000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i7b33b3bdd85544d6853b80b9b9363fdc_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMTMtMS0xLTEtMTU2MDQ_22e8fb86-7e4c-4b47-99d3-962b779546fd"
      unitRef="usd">482000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="ica51236575994a4ab8e30322fc2f55a4_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMTMtMy0xLTEtMTU2MDQ_b694488c-9f7d-4fc5-bf2f-a38d342be19c"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:OperatingExpenses
      contextRef="i7b33b3bdd85544d6853b80b9b9363fdc_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMTUtMS0xLTEtMTU2MDQ_745f3a85-9297-4d90-bf48-3fa02d2b951d"
      unitRef="usd">49917000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="ica51236575994a4ab8e30322fc2f55a4_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMTUtMy0xLTEtMTU2MDQ_ff3f14cf-3328-4bd4-a68f-dbefbb89313a"
      unitRef="usd">42199000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i7b33b3bdd85544d6853b80b9b9363fdc_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMTYtMS0xLTEtMTU2MDQ_18e2395d-1e76-4283-9b10-86d0271a8b09"
      unitRef="usd">-17896000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ica51236575994a4ab8e30322fc2f55a4_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMTYtMy0xLTEtMTU2MDQ_98c83525-ac03-4474-9ffc-0571393adc28"
      unitRef="usd">-17688000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="i7b33b3bdd85544d6853b80b9b9363fdc_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMjAtMS0xLTEtMTU2MDQ_649325fb-f5fe-48fb-9afc-ed15f9468db4"
      unitRef="usd">2069000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ica51236575994a4ab8e30322fc2f55a4_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMjAtMy0xLTEtMTU2MDQ_b1f01bd1-11d6-4ee8-949b-1970ca2cbc9c"
      unitRef="usd">4539000</us-gaap:InterestExpense>
    <us-gaap:InvestmentIncomeNonoperating
      contextRef="i7b33b3bdd85544d6853b80b9b9363fdc_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMjEtMS0xLTEtMTU2MDQ_fe98d6f3-39a5-45f7-9203-3ae2a18e9efa"
      unitRef="usd">434000</us-gaap:InvestmentIncomeNonoperating>
    <us-gaap:InvestmentIncomeNonoperating
      contextRef="ica51236575994a4ab8e30322fc2f55a4_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMjEtMy0xLTEtMTU2MDQ_79b2da58-b476-41f5-aaf1-be09bb8b7870"
      unitRef="usd">392000</us-gaap:InvestmentIncomeNonoperating>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i7b33b3bdd85544d6853b80b9b9363fdc_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMjItMS0xLTEtMTU2MDQ_6933a01e-8909-4044-b9a5-0f523ed3d68c"
      unitRef="usd">223000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ica51236575994a4ab8e30322fc2f55a4_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMjItMy0xLTEtMTU2MDQ_fe3fcd17-f5c5-412c-a4fc-4de87811537f"
      unitRef="usd">-58000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i7b33b3bdd85544d6853b80b9b9363fdc_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMjMtMS0xLTEtMTU2MDQ_fc8be1a3-7414-4356-898e-a2ebd1ef2833"
      unitRef="usd">-1412000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="ica51236575994a4ab8e30322fc2f55a4_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMjMtMy0xLTEtMTU2MDQ_d20d0131-eff2-4cdb-9df2-87304367b526"
      unitRef="usd">-4205000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i7b33b3bdd85544d6853b80b9b9363fdc_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMjQtMS0xLTEtMTU2MDQ_0b94980b-4161-4fb3-a368-9fe91d5183a5"
      unitRef="usd">-1000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ica51236575994a4ab8e30322fc2f55a4_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMjQtMy0xLTEtMTU2MDQ_61fc7589-c856-4e80-9776-ba90bce2605e"
      unitRef="usd">-3000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i7b33b3bdd85544d6853b80b9b9363fdc_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMjUtMS0xLTEtMTU2MDQ_bde86072-3d82-4ee3-bb4c-94000301e23c"
      unitRef="usd">-19309000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ica51236575994a4ab8e30322fc2f55a4_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMjUtMy0xLTEtMTU2MDQ_7be0dec1-ff66-4190-a563-9825f1a2f143"
      unitRef="usd">-21896000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i7b33b3bdd85544d6853b80b9b9363fdc_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMjYtMS0xLTEtMTU2MDQ_eac24baf-1668-4ae1-aa13-159b16f45b76"
      unitRef="usd">-58000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ica51236575994a4ab8e30322fc2f55a4_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMjYtMy0xLTEtMTU2MDQ_6b736b79-51d1-4c9c-a981-0b53c7c6a7b9"
      unitRef="usd">-52000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7b33b3bdd85544d6853b80b9b9363fdc_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMjctMS0xLTEtMTU2MDQ_a149bac9-a622-43d1-b1af-84675926cb35"
      unitRef="usd">-19251000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ica51236575994a4ab8e30322fc2f55a4_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMjctMy0xLTEtMTU2MDQ_299bbbb3-c4f2-47a6-a4a3-bf13da7499e5"
      unitRef="usd">-21844000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMjgtMS0xLTEtMTU2MDQ_1e585bbf-88f9-44c8-a90b-31f795e45e2a"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMjgtMy0xLTEtMTU2MDQ_e4892879-ae1f-4d88-8e7e-97b8f4973626"
      unitRef="usd">4526000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMjktMS0xLTEtMTU2MDQ_6c0ecc9e-d617-4a44-9e5e-ed1707406428"
      unitRef="usd">-19251000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMjktMy0xLTEtMTU2MDQ_880235a0-834a-43e2-8c0e-49de7f77c856"
      unitRef="usd">-17318000</us-gaap:NetIncomeLoss>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMzctMS0xLTEtMTU2MDQ_861d8925-3c67-480f-a4d1-193b52891769"
      unitRef="usdPerShare">-0.10</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMzctMS0xLTEtMTU2MDQ_e30ac5bf-4067-40e5-b564-de3e9a621f69"
      unitRef="usdPerShare">-0.10</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMzctMy0xLTEtMTU2MDQ_8ef84829-0d3f-4818-9c2e-76d735e32a72"
      unitRef="usdPerShare">-0.11</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMzctMy0xLTEtMTU2MDQ_deb126de-0546-4750-988f-fb1ca90cfbb7"
      unitRef="usdPerShare">-0.11</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMzgtMS0xLTEtMTU2MDQ_37438b7e-947c-4669-990f-c8d76600afc4"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMzgtMS0xLTEtMTU2MDQ_b677d259-a71b-4daf-845a-a7f56e160e20"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMzgtMy0xLTEtMTU2MDQ_3e689e20-f804-40f3-8404-9f668e02e5bd"
      unitRef="usdPerShare">0.02</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMzgtMy0xLTEtMTU2MDQ_ce710377-b434-42ad-82d8-a9f9d353d9a3"
      unitRef="usdPerShare">0.02</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMzktMS0xLTEtMTU2MDQ_06692149-c64d-4eec-9239-a59920fa3cdc"
      unitRef="usdPerShare">-0.10</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMzktMS0xLTEtMTU2MDQ_1ecc99f1-ef55-4a99-8a7b-bedd98bf0865"
      unitRef="usdPerShare">-0.10</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMzktMy0xLTEtMTU2MDQ_27880b9e-1fef-4d9d-9fb0-0aaef9525920"
      unitRef="usdPerShare">-0.09</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfMzktMy0xLTEtMTU2MDQ_336d8ea2-0f1b-4a06-b7db-8f432081ccac"
      unitRef="usdPerShare">-0.09</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfNDAtMS0xLTEtMTU2MDQ_922f64f2-cce4-44e6-a45a-f795fd4d34b4"
      unitRef="shares">199629218</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfNDAtMS0xLTEtMTU2MDQ_9ec8d592-6068-4a90-af4b-4f6be5686c30"
      unitRef="shares">199629218</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfNDAtMy0xLTEtMTU2MDQ_1e4471f2-0912-4ede-b8c8-c57a28b053da"
      unitRef="shares">193499546</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yMi9mcmFnOjUxYWY2NmE1MWViNTQxOGViYWNmMzRlYjYyNTA2ZDU2L3RhYmxlOmE3ZDc4OGIxYWU1ZDRmYjI5MjE1OTMyYjRjMzY2ZTM3L3RhYmxlcmFuZ2U6YTdkNzg4YjFhZTVkNGZiMjkyMTU5MzJiNGMzNjZlMzdfNDAtMy0xLTEtMTU2MDQ_e580fb76-9c84-48ab-887b-d945eacc3ac7"
      unitRef="shares">193499546</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:NetIncomeLoss
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yNS9mcmFnOmI5MDhmNzFkYjRjYzRlNjNhMDdkODJmMDY0MDcyZmVjL3RhYmxlOjE0MTNlMGE2ZDBjNDRmNThhYjVkNjMzY2ZhZTAyMjY1L3RhYmxlcmFuZ2U6MTQxM2UwYTZkMGM0NGY1OGFiNWQ2MzNjZmFlMDIyNjVfMi0xLTEtMS0xNTYwNA_914d5f4d-ba94-4c31-85b8-67927b24ddb7"
      unitRef="usd">-19251000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yNS9mcmFnOmI5MDhmNzFkYjRjYzRlNjNhMDdkODJmMDY0MDcyZmVjL3RhYmxlOjE0MTNlMGE2ZDBjNDRmNThhYjVkNjMzY2ZhZTAyMjY1L3RhYmxlcmFuZ2U6MTQxM2UwYTZkMGM0NGY1OGFiNWQ2MzNjZmFlMDIyNjVfMi0zLTEtMS0xNTYwNA_b4af0aa4-500d-4b69-8251-0df7ef3be659"
      unitRef="usd">-17318000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yNS9mcmFnOmI5MDhmNzFkYjRjYzRlNjNhMDdkODJmMDY0MDcyZmVjL3RhYmxlOjE0MTNlMGE2ZDBjNDRmNThhYjVkNjMzY2ZhZTAyMjY1L3RhYmxlcmFuZ2U6MTQxM2UwYTZkMGM0NGY1OGFiNWQ2MzNjZmFlMDIyNjVfNC0xLTEtMS0xNTYwNA_81da0813-1252-4666-a27b-b76009c6e9a6"
      unitRef="usd">-802000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yNS9mcmFnOmI5MDhmNzFkYjRjYzRlNjNhMDdkODJmMDY0MDcyZmVjL3RhYmxlOjE0MTNlMGE2ZDBjNDRmNThhYjVkNjMzY2ZhZTAyMjY1L3RhYmxlcmFuZ2U6MTQxM2UwYTZkMGM0NGY1OGFiNWQ2MzNjZmFlMDIyNjVfNC0zLTEtMS0xNTYwNA_825b6ea0-8fe5-4342-9686-3f663f1ea972"
      unitRef="usd">-48000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yNS9mcmFnOmI5MDhmNzFkYjRjYzRlNjNhMDdkODJmMDY0MDcyZmVjL3RhYmxlOjE0MTNlMGE2ZDBjNDRmNThhYjVkNjMzY2ZhZTAyMjY1L3RhYmxlcmFuZ2U6MTQxM2UwYTZkMGM0NGY1OGFiNWQ2MzNjZmFlMDIyNjVfNS0xLTEtMS0xNTYwNA_30998d8b-d5b8-4c06-8d38-7121f90489f9"
      unitRef="usd">-1100000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yNS9mcmFnOmI5MDhmNzFkYjRjYzRlNjNhMDdkODJmMDY0MDcyZmVjL3RhYmxlOjE0MTNlMGE2ZDBjNDRmNThhYjVkNjMzY2ZhZTAyMjY1L3RhYmxlcmFuZ2U6MTQxM2UwYTZkMGM0NGY1OGFiNWQ2MzNjZmFlMDIyNjVfNS0zLTEtMS0xNTYwNA_34fe9edd-7443-459f-97dd-3b211b8bb737"
      unitRef="usd">-2203000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yNS9mcmFnOmI5MDhmNzFkYjRjYzRlNjNhMDdkODJmMDY0MDcyZmVjL3RhYmxlOjE0MTNlMGE2ZDBjNDRmNThhYjVkNjMzY2ZhZTAyMjY1L3RhYmxlcmFuZ2U6MTQxM2UwYTZkMGM0NGY1OGFiNWQ2MzNjZmFlMDIyNjVfNy0xLTEtMS0xNTYwNA_c991b769-e75f-4959-8ccf-c4ba4bc3ae7d"
      unitRef="usd">-21153000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yNS9mcmFnOmI5MDhmNzFkYjRjYzRlNjNhMDdkODJmMDY0MDcyZmVjL3RhYmxlOjE0MTNlMGE2ZDBjNDRmNThhYjVkNjMzY2ZhZTAyMjY1L3RhYmxlcmFuZ2U6MTQxM2UwYTZkMGM0NGY1OGFiNWQ2MzNjZmFlMDIyNjVfNy0zLTEtMS0xNTYwNA_957ad770-a88b-4825-ab47-f1c5ddc2bac5"
      unitRef="usd">-19569000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ic68a1c0debad4505be9f262586727573_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOjBhOTMzMGI4ZDdjNjRlNjJhZGYxZjYyOTEyOTcxNzk2L3RhYmxlcmFuZ2U6MGE5MzMwYjhkN2M2NGU2MmFkZjFmNjI5MTI5NzE3OTZfMi0xLTEtMS0xNTYwNA_7d644f3f-a7e8-454d-94f9-878570173489"
      unitRef="shares">206739874</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ic68a1c0debad4505be9f262586727573_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOjBhOTMzMGI4ZDdjNjRlNjJhZGYxZjYyOTEyOTcxNzk2L3RhYmxlcmFuZ2U6MGE5MzMwYjhkN2M2NGU2MmFkZjFmNjI5MTI5NzE3OTZfMi0zLTEtMS0xNTYwNA_8dd2b669-3c19-4673-ae42-2167800bad4f"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8630822867d746dcb299e334c2f62bb2_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOjBhOTMzMGI4ZDdjNjRlNjJhZGYxZjYyOTEyOTcxNzk2L3RhYmxlcmFuZ2U6MGE5MzMwYjhkN2M2NGU2MmFkZjFmNjI5MTI5NzE3OTZfMi01LTEtMS0xNTYwNA_dd959d4d-2230-451c-bcd8-bfa256c0c8d4"
      unitRef="usd">2022701000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic1386437e5414589a78d1e1f9863e05e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOjBhOTMzMGI4ZDdjNjRlNjJhZGYxZjYyOTEyOTcxNzk2L3RhYmxlcmFuZ2U6MGE5MzMwYjhkN2M2NGU2MmFkZjFmNjI5MTI5NzE3OTZfMi03LTEtMS0xNTYwNA_431eb5a9-94c5-4903-be78-60aeaf1b7058"
      unitRef="usd">203000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9419bc7141e84a9d88053ffc38b7a8dd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOjBhOTMzMGI4ZDdjNjRlNjJhZGYxZjYyOTEyOTcxNzk2L3RhYmxlcmFuZ2U6MGE5MzMwYjhkN2M2NGU2MmFkZjFmNjI5MTI5NzE3OTZfMi05LTEtMS0xNTYwNA_beb301ff-715e-4c29-93eb-e882788fd470"
      unitRef="usd">-1915556000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOjBhOTMzMGI4ZDdjNjRlNjJhZGYxZjYyOTEyOTcxNzk2L3RhYmxlcmFuZ2U6MGE5MzMwYjhkN2M2NGU2MmFkZjFmNjI5MTI5NzE3OTZfMi0xMS0xLTEtMTU2MDQ_8717564d-a43e-49bd-bd69-737ce07d202a"
      unitRef="usd">107348000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3be10a01a9624d3ab98ae41d043b6197_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOjBhOTMzMGI4ZDdjNjRlNjJhZGYxZjYyOTEyOTcxNzk2L3RhYmxlcmFuZ2U6MGE5MzMwYjhkN2M2NGU2MmFkZjFmNjI5MTI5NzE3OTZfMy01LTEtMS0yNzM4OQ_28735025-dc16-4cfb-9e24-b8badca77c4e"
      unitRef="usd">-36868000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7abd6540a1a64f77872b8ddc7e797fff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOjBhOTMzMGI4ZDdjNjRlNjJhZGYxZjYyOTEyOTcxNzk2L3RhYmxlcmFuZ2U6MGE5MzMwYjhkN2M2NGU2MmFkZjFmNjI5MTI5NzE3OTZfMy05LTEtMS0yNzM4OQ_8895cebd-4f29-4bfb-82b3-f81064009bdd"
      unitRef="usd">18672000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3d0633214e1c47539bd414801031b325_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOjBhOTMzMGI4ZDdjNjRlNjJhZGYxZjYyOTEyOTcxNzk2L3RhYmxlcmFuZ2U6MGE5MzMwYjhkN2M2NGU2MmFkZjFmNjI5MTI5NzE3OTZfMy0xMS0xLTEtMjczODk_ad2627b7-0aaa-4ca6-949d-3a9c88885949"
      unitRef="usd">-18196000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i5814e59f587a427ca84c1523af21ce68_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOjBhOTMzMGI4ZDdjNjRlNjJhZGYxZjYyOTEyOTcxNzk2L3RhYmxlcmFuZ2U6MGE5MzMwYjhkN2M2NGU2MmFkZjFmNjI5MTI5NzE3OTZfMy01LTEtMS0xNTYwNA_aa4dbdb4-9ac1-437a-98d8-5734b572d182"
      unitRef="usd">3562000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOjBhOTMzMGI4ZDdjNjRlNjJhZGYxZjYyOTEyOTcxNzk2L3RhYmxlcmFuZ2U6MGE5MzMwYjhkN2M2NGU2MmFkZjFmNjI5MTI5NzE3OTZfMy0xMS0xLTEtMTU2MDQ_6f2a527c-fff0-431e-8a0a-bf9f663f3ca4"
      unitRef="usd">3562000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <pgen:StockIssuedDuringPeriodSharesStockOptionsExercisedAndRestrictedStockAwards
      contextRef="ibf63cfed8810400aacf2e390e0bc4982_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOjBhOTMzMGI4ZDdjNjRlNjJhZGYxZjYyOTEyOTcxNzk2L3RhYmxlcmFuZ2U6MGE5MzMwYjhkN2M2NGU2MmFkZjFmNjI5MTI5NzE3OTZfNC0xLTEtMS0xNTYwNA_663b06dd-1229-42a2-89c8-5ada42e23550"
      unitRef="shares">354089</pgen:StockIssuedDuringPeriodSharesStockOptionsExercisedAndRestrictedStockAwards>
    <pgen:StockIssuedDuringPeriodValueRestrictedStockAwardsVestedAndStockOptionsExercised
      contextRef="i5814e59f587a427ca84c1523af21ce68_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOjBhOTMzMGI4ZDdjNjRlNjJhZGYxZjYyOTEyOTcxNzk2L3RhYmxlcmFuZ2U6MGE5MzMwYjhkN2M2NGU2MmFkZjFmNjI5MTI5NzE3OTZfNC01LTEtMS0xNTYwNA_34882586-930e-490c-8d47-65e2585269d4"
      unitRef="usd">1000</pgen:StockIssuedDuringPeriodValueRestrictedStockAwardsVestedAndStockOptionsExercised>
    <pgen:StockIssuedDuringPeriodValueRestrictedStockAwardsVestedAndStockOptionsExercised
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOjBhOTMzMGI4ZDdjNjRlNjJhZGYxZjYyOTEyOTcxNzk2L3RhYmxlcmFuZ2U6MGE5MzMwYjhkN2M2NGU2MmFkZjFmNjI5MTI5NzE3OTZfNC0xMS0xLTEtMTU2MDQ_212585c0-7ce9-44be-b36c-fb18b1e751d5"
      unitRef="usd">1000</pgen:StockIssuedDuringPeriodValueRestrictedStockAwardsVestedAndStockOptionsExercised>
    <pgen:StockIssuedDuringThePeriodSharesAccruedCompensation
      contextRef="ibf63cfed8810400aacf2e390e0bc4982_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOjBhOTMzMGI4ZDdjNjRlNjJhZGYxZjYyOTEyOTcxNzk2L3RhYmxlcmFuZ2U6MGE5MzMwYjhkN2M2NGU2MmFkZjFmNjI5MTI5NzE3OTZfNS0xLTEtMS0xNTYwNA_e7700d70-31aa-45f9-99a3-fa41060ae88e"
      unitRef="shares">315327</pgen:StockIssuedDuringThePeriodSharesAccruedCompensation>
    <pgen:StockIssuedDuringThePeriodValueAccruedCompensation
      contextRef="i5814e59f587a427ca84c1523af21ce68_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOjBhOTMzMGI4ZDdjNjRlNjJhZGYxZjYyOTEyOTcxNzk2L3RhYmxlcmFuZ2U6MGE5MzMwYjhkN2M2NGU2MmFkZjFmNjI5MTI5NzE3OTZfNS01LTEtMS0xNTYwNA_2ecb4ca6-32e7-498c-a319-bad94f21ab59"
      unitRef="usd">1698000</pgen:StockIssuedDuringThePeriodValueAccruedCompensation>
    <pgen:StockIssuedDuringThePeriodValueAccruedCompensation
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOjBhOTMzMGI4ZDdjNjRlNjJhZGYxZjYyOTEyOTcxNzk2L3RhYmxlcmFuZ2U6MGE5MzMwYjhkN2M2NGU2MmFkZjFmNjI5MTI5NzE3OTZfNS0xMS0xLTEtMTU2MDQ_358ca2e7-cf43-4108-9b7b-020564f11afb"
      unitRef="usd">1698000</pgen:StockIssuedDuringThePeriodValueAccruedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="ibf63cfed8810400aacf2e390e0bc4982_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOjBhOTMzMGI4ZDdjNjRlNjJhZGYxZjYyOTEyOTcxNzk2L3RhYmxlcmFuZ2U6MGE5MzMwYjhkN2M2NGU2MmFkZjFmNjI5MTI5NzE3OTZfNi0xLTEtMS0xNTYwNA_6d5a4761-433c-4ff5-aeca-0cf4d1e51c8d"
      unitRef="shares">283987</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="i5814e59f587a427ca84c1523af21ce68_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOjBhOTMzMGI4ZDdjNjRlNjJhZGYxZjYyOTEyOTcxNzk2L3RhYmxlcmFuZ2U6MGE5MzMwYjhkN2M2NGU2MmFkZjFmNjI5MTI5NzE3OTZfNi01LTEtMS0xNTYwNA_bde2ae73-eefd-4a29-ab26-9c592c0171af"
      unitRef="usd">576000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOjBhOTMzMGI4ZDdjNjRlNjJhZGYxZjYyOTEyOTcxNzk2L3RhYmxlcmFuZ2U6MGE5MzMwYjhkN2M2NGU2MmFkZjFmNjI5MTI5NzE3OTZfNi0xMS0xLTEtMTU2MDQ_0a4cd6e5-5589-412c-9159-44c3c2c65990"
      unitRef="usd">576000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:NetIncomeLoss
      contextRef="ifac0484be833462696c138be338f4ac6_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOjBhOTMzMGI4ZDdjNjRlNjJhZGYxZjYyOTEyOTcxNzk2L3RhYmxlcmFuZ2U6MGE5MzMwYjhkN2M2NGU2MmFkZjFmNjI5MTI5NzE3OTZfMjAtOS0xLTEtMTU2MDQ_ea6dc8b0-5a4e-47f9-a0de-c905f08ad5d2"
      unitRef="usd">-19251000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOjBhOTMzMGI4ZDdjNjRlNjJhZGYxZjYyOTEyOTcxNzk2L3RhYmxlcmFuZ2U6MGE5MzMwYjhkN2M2NGU2MmFkZjFmNjI5MTI5NzE3OTZfMjAtMTEtMS0xLTE1NjA0_cf32c078-d96a-4965-91ac-3cd7266cb035"
      unitRef="usd">-19251000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i8fddc81d9d8244a98bf2f57ae43c0bae_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOjBhOTMzMGI4ZDdjNjRlNjJhZGYxZjYyOTEyOTcxNzk2L3RhYmxlcmFuZ2U6MGE5MzMwYjhkN2M2NGU2MmFkZjFmNjI5MTI5NzE3OTZfMjItNy0xLTEtMTU2MDQ_7077e4fc-b7b5-4606-9730-a571e1db1853"
      unitRef="usd">-1902000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOjBhOTMzMGI4ZDdjNjRlNjJhZGYxZjYyOTEyOTcxNzk2L3RhYmxlcmFuZ2U6MGE5MzMwYjhkN2M2NGU2MmFkZjFmNjI5MTI5NzE3OTZfMjItMTEtMS0xLTE1NjA0_ff4fb6c4-1ac4-44b4-b53b-abb2c49818b1"
      unitRef="usd">-1902000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="id1795fa79607445cbc20904ee4dda36d_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOjBhOTMzMGI4ZDdjNjRlNjJhZGYxZjYyOTEyOTcxNzk2L3RhYmxlcmFuZ2U6MGE5MzMwYjhkN2M2NGU2MmFkZjFmNjI5MTI5NzE3OTZfMjMtMS0xLTEtMTU2MDQ_5d6311d9-7659-4cc7-a255-012641a8f9b6"
      unitRef="shares">207693277</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="id1795fa79607445cbc20904ee4dda36d_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOjBhOTMzMGI4ZDdjNjRlNjJhZGYxZjYyOTEyOTcxNzk2L3RhYmxlcmFuZ2U6MGE5MzMwYjhkN2M2NGU2MmFkZjFmNjI5MTI5NzE3OTZfMjMtMy0xLTEtMTU2MDQ_34a2af5f-43f3-4e02-a894-10281d33257d"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="idc509430d95b4d7eb55ea6c26d1c41c3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOjBhOTMzMGI4ZDdjNjRlNjJhZGYxZjYyOTEyOTcxNzk2L3RhYmxlcmFuZ2U6MGE5MzMwYjhkN2M2NGU2MmFkZjFmNjI5MTI5NzE3OTZfMjMtNS0xLTEtMTU2MDQ_8253dc0a-091b-41f0-bfd4-d3e6d397b937"
      unitRef="usd">1991670000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia10c8c844d4940a3b0ebde37f5f75f25_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOjBhOTMzMGI4ZDdjNjRlNjJhZGYxZjYyOTEyOTcxNzk2L3RhYmxlcmFuZ2U6MGE5MzMwYjhkN2M2NGU2MmFkZjFmNjI5MTI5NzE3OTZfMjMtNy0xLTEtMTU2MDQ_863fada6-90ad-49c5-93ab-c6224a753c51"
      unitRef="usd">-1699000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6855b33dd4b34c1793117831d12003ea_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOjBhOTMzMGI4ZDdjNjRlNjJhZGYxZjYyOTEyOTcxNzk2L3RhYmxlcmFuZ2U6MGE5MzMwYjhkN2M2NGU2MmFkZjFmNjI5MTI5NzE3OTZfMjMtOS0xLTEtMTU2MDQ_a6e7a7d0-00c8-4480-9558-2d5f1e407f08"
      unitRef="usd">-1916135000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOjBhOTMzMGI4ZDdjNjRlNjJhZGYxZjYyOTEyOTcxNzk2L3RhYmxlcmFuZ2U6MGE5MzMwYjhkN2M2NGU2MmFkZjFmNjI5MTI5NzE3OTZfMjMtMTEtMS0xLTE1NjA0_c5b5f53a-9d8b-4bbf-a0aa-4c0cdc1d43d8"
      unitRef="usd">73836000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i64c8fed916fd4230bfb10137e40b9037_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOmNlNzc3ZmE3ZWYwNDQ4MGRhYWY5MjhhZTA0MDk3NmJhL3RhYmxlcmFuZ2U6Y2U3NzdmYTdlZjA0NDgwZGFhZjkyOGFlMDQwOTc2YmFfMi0xLTEtMS0xNTYwNA_ad9e0e81-0174-42fd-ae85-b58f503ccfec"
      unitRef="shares">187663207</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i64c8fed916fd4230bfb10137e40b9037_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOmNlNzc3ZmE3ZWYwNDQ4MGRhYWY5MjhhZTA0MDk3NmJhL3RhYmxlcmFuZ2U6Y2U3NzdmYTdlZjA0NDgwZGFhZjkyOGFlMDQwOTc2YmFfMi0zLTEtMS0xNTYwNA_2c320731-299a-4344-8649-8e5c71fa6c0e"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia32c9ea65a164766b40eee00dd09cb45_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOmNlNzc3ZmE3ZWYwNDQ4MGRhYWY5MjhhZTA0MDk3NmJhL3RhYmxlcmFuZ2U6Y2U3NzdmYTdlZjA0NDgwZGFhZjkyOGFlMDQwOTc2YmFfMi01LTEtMS0xNTYwNA_070e667b-5357-425c-8560-b5f9f539164e"
      unitRef="usd">1886567000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7048090cfae14c5c8420c6cad3ffd931_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOmNlNzc3ZmE3ZWYwNDQ4MGRhYWY5MjhhZTA0MDk3NmJhL3RhYmxlcmFuZ2U6Y2U3NzdmYTdlZjA0NDgwZGFhZjkyOGFlMDQwOTc2YmFfMi03LTEtMS0xNTYwNA_327cf159-387f-47ac-a24e-4d5b1fe05981"
      unitRef="usd">3997000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6fad92c0b19f40d8b718694baf49e9b0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOmNlNzc3ZmE3ZWYwNDQ4MGRhYWY5MjhhZTA0MDk3NmJhL3RhYmxlcmFuZ2U6Y2U3NzdmYTdlZjA0NDgwZGFhZjkyOGFlMDQwOTc2YmFfMi05LTEtMS0xNTYwNA_c6fdc035-002c-4a46-961e-27b31a8fa749"
      unitRef="usd">-1823390000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i54a90f374db746b78de00be9871944ac_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOmNlNzc3ZmE3ZWYwNDQ4MGRhYWY5MjhhZTA0MDk3NmJhL3RhYmxlcmFuZ2U6Y2U3NzdmYTdlZjA0NDgwZGFhZjkyOGFlMDQwOTc2YmFfMi0xMS0xLTEtMTU2MDQ_162a53e2-54a2-4b68-aaa9-2217a790c837"
      unitRef="usd">67174000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i71fe82fdf1f84583b3319fa0acac22be_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOmNlNzc3ZmE3ZWYwNDQ4MGRhYWY5MjhhZTA0MDk3NmJhL3RhYmxlcmFuZ2U6Y2U3NzdmYTdlZjA0NDgwZGFhZjkyOGFlMDQwOTc2YmFfMy01LTEtMS0xNTYwNA_5435daf3-8420-4532-a701-d315b602de15"
      unitRef="usd">5415000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOmNlNzc3ZmE3ZWYwNDQ4MGRhYWY5MjhhZTA0MDk3NmJhL3RhYmxlcmFuZ2U6Y2U3NzdmYTdlZjA0NDgwZGFhZjkyOGFlMDQwOTc2YmFfMy0xMS0xLTEtMTU2MDQ_836b83c3-89bb-4ec7-88ea-bd95e6b00265"
      unitRef="usd">5415000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <pgen:StockIssuedDuringPeriodSharesStockOptionsExercisedAndRestrictedStockAwards
      contextRef="ic2060c890f6b479aab80d7691e262567_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOmNlNzc3ZmE3ZWYwNDQ4MGRhYWY5MjhhZTA0MDk3NmJhL3RhYmxlcmFuZ2U6Y2U3NzdmYTdlZjA0NDgwZGFhZjkyOGFlMDQwOTc2YmFfNC0xLTEtMS0xNTYwNA_ab889a0a-6d46-46de-a061-834e8b5451d0"
      unitRef="shares">1426157</pgen:StockIssuedDuringPeriodSharesStockOptionsExercisedAndRestrictedStockAwards>
    <pgen:StockIssuedDuringPeriodValueRestrictedStockAwardsVestedAndStockOptionsExercised
      contextRef="i71fe82fdf1f84583b3319fa0acac22be_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOmNlNzc3ZmE3ZWYwNDQ4MGRhYWY5MjhhZTA0MDk3NmJhL3RhYmxlcmFuZ2U6Y2U3NzdmYTdlZjA0NDgwZGFhZjkyOGFlMDQwOTc2YmFfNC01LTEtMS0xNTYwNA_3ff239f0-081f-436c-bed3-484736b1d897"
      unitRef="usd">153000</pgen:StockIssuedDuringPeriodValueRestrictedStockAwardsVestedAndStockOptionsExercised>
    <pgen:StockIssuedDuringPeriodValueRestrictedStockAwardsVestedAndStockOptionsExercised
      contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOmNlNzc3ZmE3ZWYwNDQ4MGRhYWY5MjhhZTA0MDk3NmJhL3RhYmxlcmFuZ2U6Y2U3NzdmYTdlZjA0NDgwZGFhZjkyOGFlMDQwOTc2YmFfNC0xMS0xLTEtMTU2MDQ_531ae180-7feb-4ec9-b63b-2b58983f8b3a"
      unitRef="usd">153000</pgen:StockIssuedDuringPeriodValueRestrictedStockAwardsVestedAndStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="ic2060c890f6b479aab80d7691e262567_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOmNlNzc3ZmE3ZWYwNDQ4MGRhYWY5MjhhZTA0MDk3NmJhL3RhYmxlcmFuZ2U6Y2U3NzdmYTdlZjA0NDgwZGFhZjkyOGFlMDQwOTc2YmFfNi0xLTEtMS0xNTYwNA_cbdcdc2e-19b8-4dff-a6a8-f454b5852324"
      unitRef="shares">74771</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="i71fe82fdf1f84583b3319fa0acac22be_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOmNlNzc3ZmE3ZWYwNDQ4MGRhYWY5MjhhZTA0MDk3NmJhL3RhYmxlcmFuZ2U6Y2U3NzdmYTdlZjA0NDgwZGFhZjkyOGFlMDQwOTc2YmFfNi01LTEtMS0xNTYwNA_f5d36855-42b6-44d6-8418-4bdaa1d24e85"
      unitRef="usd">577000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOmNlNzc3ZmE3ZWYwNDQ4MGRhYWY5MjhhZTA0MDk3NmJhL3RhYmxlcmFuZ2U6Y2U3NzdmYTdlZjA0NDgwZGFhZjkyOGFlMDQwOTc2YmFfNi0xMS0xLTEtMTU2MDQ_8649d179-7041-4153-9275-f2713c2458f2"
      unitRef="usd">577000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOmNlNzc3ZmE3ZWYwNDQ4MGRhYWY5MjhhZTA0MDk3NmJhL3RhYmxlcmFuZ2U6Y2U3NzdmYTdlZjA0NDgwZGFhZjkyOGFlMDQwOTc2YmFfNy0xLTEtMS0xNTYwNA_ab14abc0-19c3-4a68-9c8a-184b49294130"
      unitRef="shares">17250000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i71fe82fdf1f84583b3319fa0acac22be_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOmNlNzc3ZmE3ZWYwNDQ4MGRhYWY5MjhhZTA0MDk3NmJhL3RhYmxlcmFuZ2U6Y2U3NzdmYTdlZjA0NDgwZGFhZjkyOGFlMDQwOTc2YmFfNy01LTEtMS0xNTYwNA_6e7f4ecb-cd43-45cb-ba8b-3c594e777a38"
      unitRef="usd">121045000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOmNlNzc3ZmE3ZWYwNDQ4MGRhYWY5MjhhZTA0MDk3NmJhL3RhYmxlcmFuZ2U6Y2U3NzdmYTdlZjA0NDgwZGFhZjkyOGFlMDQwOTc2YmFfNy0xMS0xLTEtMTU2MDQ_46e63df1-44e3-4e57-ab31-95739c509b94"
      unitRef="usd">121045000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:NetIncomeLoss
      contextRef="i0dd2258d887948a091305e7302f4f7ed_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOmNlNzc3ZmE3ZWYwNDQ4MGRhYWY5MjhhZTA0MDk3NmJhL3RhYmxlcmFuZ2U6Y2U3NzdmYTdlZjA0NDgwZGFhZjkyOGFlMDQwOTc2YmFfMjAtOS0xLTEtMTU2MDQ_c33729af-0f5f-45bf-a26c-0dd6b114844c"
      unitRef="usd">-17318000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOmNlNzc3ZmE3ZWYwNDQ4MGRhYWY5MjhhZTA0MDk3NmJhL3RhYmxlcmFuZ2U6Y2U3NzdmYTdlZjA0NDgwZGFhZjkyOGFlMDQwOTc2YmFfMjAtMTEtMS0xLTE1NjA0_ef7dc2d0-21f1-4201-a975-35e807087d27"
      unitRef="usd">-17318000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ia65599dbd22c42928733e6325a88a14e_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOmNlNzc3ZmE3ZWYwNDQ4MGRhYWY5MjhhZTA0MDk3NmJhL3RhYmxlcmFuZ2U6Y2U3NzdmYTdlZjA0NDgwZGFhZjkyOGFlMDQwOTc2YmFfMjItNy0xLTEtMTU2MDQ_2410d162-f3de-42d7-8049-39a926224884"
      unitRef="usd">-2251000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOmNlNzc3ZmE3ZWYwNDQ4MGRhYWY5MjhhZTA0MDk3NmJhL3RhYmxlcmFuZ2U6Y2U3NzdmYTdlZjA0NDgwZGFhZjkyOGFlMDQwOTc2YmFfMjItMTEtMS0xLTE1NjA0_1ff621a7-7acc-4287-a19c-7d590229c9c7"
      unitRef="usd">-2251000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ibbe9dcfa0a15492fae0547b188e7d154_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOmNlNzc3ZmE3ZWYwNDQ4MGRhYWY5MjhhZTA0MDk3NmJhL3RhYmxlcmFuZ2U6Y2U3NzdmYTdlZjA0NDgwZGFhZjkyOGFlMDQwOTc2YmFfMjMtMS0xLTEtMTU2MDQ_a55f90a6-e0fb-41b3-9134-38fe31e5f0c1"
      unitRef="shares">206414135</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ibbe9dcfa0a15492fae0547b188e7d154_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOmNlNzc3ZmE3ZWYwNDQ4MGRhYWY5MjhhZTA0MDk3NmJhL3RhYmxlcmFuZ2U6Y2U3NzdmYTdlZjA0NDgwZGFhZjkyOGFlMDQwOTc2YmFfMjMtMy0xLTEtMTU2MDQ_e0561e6e-31d7-40b8-88f1-86094d7267e5"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i943c56b57428465184de8ac8b4b0a16a_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOmNlNzc3ZmE3ZWYwNDQ4MGRhYWY5MjhhZTA0MDk3NmJhL3RhYmxlcmFuZ2U6Y2U3NzdmYTdlZjA0NDgwZGFhZjkyOGFlMDQwOTc2YmFfMjMtNS0xLTEtMTU2MDQ_0e7d1c9d-9152-4b1f-b7f7-9a19306c749a"
      unitRef="usd">2013757000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ibd2510608a8747ddbc103832b4650fb2_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOmNlNzc3ZmE3ZWYwNDQ4MGRhYWY5MjhhZTA0MDk3NmJhL3RhYmxlcmFuZ2U6Y2U3NzdmYTdlZjA0NDgwZGFhZjkyOGFlMDQwOTc2YmFfMjMtNy0xLTEtMTU2MDQ_908c8d58-d0ed-4a2c-aa7a-33b476856771"
      unitRef="usd">1746000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iae096e93867e42a99d564859635c4326_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOmNlNzc3ZmE3ZWYwNDQ4MGRhYWY5MjhhZTA0MDk3NmJhL3RhYmxlcmFuZ2U6Y2U3NzdmYTdlZjA0NDgwZGFhZjkyOGFlMDQwOTc2YmFfMjMtOS0xLTEtMTU2MDQ_0870a53f-417b-4d83-8d9b-bc29fedc62b1"
      unitRef="usd">-1840708000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if7b79aae0fa241fb908efc36ca29e3d3_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8yOC9mcmFnOjhjNDFkNDY5N2RlOTRiMzNiMWQ1OWMyZjM5MGViYjZiL3RhYmxlOmNlNzc3ZmE3ZWYwNDQ4MGRhYWY5MjhhZTA0MDk3NmJhL3RhYmxlcmFuZ2U6Y2U3NzdmYTdlZjA0NDgwZGFhZjkyOGFlMDQwOTc2YmFfMjMtMTEtMS0xLTE1NjA0_fc3f9eca-05eb-4258-895e-051eed34b59e"
      unitRef="usd">174795000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMy0xLTEtMS0xNTYwNA_7f8826b8-5c26-4cb9-8cf2-65748e10886a"
      unitRef="usd">-19251000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMy0zLTEtMS0xNTYwNA_2d6fc7a0-7181-4452-9b74-90ea95f07c87"
      unitRef="usd">-17318000</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfNS0xLTEtMS0xNTYwNA_e62e036e-b94d-4aab-851a-904ebdd356a4"
      unitRef="usd">3292000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfNS0zLTEtMS0xNTYwNA_987f272d-7387-4e2f-a89c-2ab1247d7aa0"
      unitRef="usd">3523000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:GainLossOnDispositionOfAssets1
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfNi0xLTEtMS0xNTYwNA_de2c74c3-735d-43dc-8be4-e232616509a9"
      unitRef="usd">-125000</us-gaap:GainLossOnDispositionOfAssets1>
    <us-gaap:GainLossOnDispositionOfAssets1
      contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfNi0zLTEtMS0xNTYwNA_b0baa570-19e1-410d-852f-965c33a247f1"
      unitRef="usd">343000</us-gaap:GainLossOnDispositionOfAssets1>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfNy0xLTEtMS0xNTYwNA_bb1ec256-3940-4323-9f0c-b2f790678dad"
      unitRef="usd">482000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfNy0zLTEtMS0xNTYwNA_ef784fc9-f966-4c08-83bf-a3db57eaf4e0"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMTMtMS0xLTEtMTU2MDQ_c4bc9773-edc3-44e9-8fc1-a9ab6ea21032"
      unitRef="usd">-265000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMTMtMy0xLTEtMTU2MDQ_e9907966-5859-43c4-9bc2-a097b297be21"
      unitRef="usd">-57000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMTQtMS0xLTEtMTU2MDQ_b8394fb6-47ed-4f25-b0dc-ad4e5b6133f4"
      unitRef="usd">-1000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMTQtMy0xLTEtMTU2MDQ_fc047362-7365-4c16-aab8-2771cfce52f7"
      unitRef="usd">-3000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:ShareBasedCompensation
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMTUtMS0xLTEtMTU2MDQ_452fe974-a55a-4f88-8852-18538452d9a4"
      unitRef="usd">3562000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMTUtMy0xLTEtMTU2MDQ_f2d0b9e2-8c38-417d-b642-f400cd5816f4"
      unitRef="usd">5415000</us-gaap:ShareBasedCompensation>
    <pgen:SharesIssuedDuringPeriodValueIssuedForServices
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMTYtMS0xLTEtMTU2MDQ_f7dd4775-940f-435d-b631-1a739017e13b"
      unitRef="usd">576000</pgen:SharesIssuedDuringPeriodValueIssuedForServices>
    <pgen:SharesIssuedDuringPeriodValueIssuedForServices
      contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMTYtMy0xLTEtMTU2MDQ_916565fd-8e62-4667-89d8-4e4bc147934e"
      unitRef="usd">577000</pgen:SharesIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMTctMS0xLTEtMTU2MDQ_e234077c-d9e2-4c0e-9604-141bad415aec"
      unitRef="usd">334000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMTctMy0xLTEtMTU2MDQ_ac02c8a1-3e82-453c-9773-dbb5e0235346"
      unitRef="usd">162000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMTgtMS0xLTEtMTU2MDQ_14bffbbb-cd2c-421a-bed9-2da702e8d404"
      unitRef="usd">284000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMTgtMy0xLTEtMTU2MDQ_0ad35c33-d96e-4b4a-bfa9-253bcb16b4aa"
      unitRef="usd">2751000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMTktMS0xLTEtMTU2MDQ_907f5c1e-8626-4c62-9963-8532348c91dd"
      unitRef="usd">-58000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMTktMy0xLTEtMTU2MDQ_63d2ba9d-5b88-4435-94b4-7f02b6f2b575"
      unitRef="usd">-56000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <pgen:NoncashGainLossOnTerminationOfLease
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMjAtMS0xLTEtMjczOTY_14397878-57c6-4db1-ae09-71a77e4b6b36"
      unitRef="usd">0</pgen:NoncashGainLossOnTerminationOfLease>
    <pgen:NoncashGainLossOnTerminationOfLease
      contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMjAtMy0xLTEtMjczOTY_7420725b-b8f7-4a3e-9870-fff6eeb860ff"
      unitRef="usd">4602000</pgen:NoncashGainLossOnTerminationOfLease>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMjAtMS0xLTEtMTU2MDQ_7291666c-3f52-4c44-82d2-ed144935c848"
      unitRef="usd">0</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMjAtMy0xLTEtMTU2MDQ_9dae3f44-963b-4930-a1d2-aea1324a3b4c"
      unitRef="usd">-1000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMjMtMS0xLTEtMTU2MDQ_1c0c3353-ef23-43a8-8ac1-7e11818c11b9"
      unitRef="usd">3696000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMjMtMy0xLTEtMTU2MDQ_8c046fea-0b17-4126-b435-1b2a7649a7f1"
      unitRef="usd">4949000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInDueFromRelatedPartiesCurrent
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMjQtMS0xLTEtMTU2MDQ_8f8b4c60-38f2-4968-ab1a-1f88cce9c541"
      unitRef="usd">-58000</us-gaap:IncreaseDecreaseInDueFromRelatedPartiesCurrent>
    <us-gaap:IncreaseDecreaseInDueFromRelatedPartiesCurrent
      contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMjQtMy0xLTEtMTU2MDQ_dc65adc4-321b-4b57-b761-034ccb71f5b3"
      unitRef="usd">-7000</us-gaap:IncreaseDecreaseInDueFromRelatedPartiesCurrent>
    <us-gaap:IncreaseDecreaseInOtherReceivables
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMjYtMS0xLTEtMTU2MDQ_7fa941e4-960e-40c3-8c2c-038fda16e590"
      unitRef="usd">-21000</us-gaap:IncreaseDecreaseInOtherReceivables>
    <us-gaap:IncreaseDecreaseInOtherReceivables
      contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMjYtMy0xLTEtMTU2MDQ_dc9c1be8-694c-45a3-90dc-bb518f60f442"
      unitRef="usd">279000</us-gaap:IncreaseDecreaseInOtherReceivables>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMjctMS0xLTEtMTU2MDQ_e26f506c-4343-4835-8af0-f0d7f73d4138"
      unitRef="usd">-531000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMjctMy0xLTEtMTU2MDQ_b3516d21-819c-48da-a097-1ddca8a424e2"
      unitRef="usd">-721000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMjgtMS0xLTEtMTU2MDQ_81ab0ad0-c5f2-4b42-bb6e-56ddde3edc4d"
      unitRef="usd">-1571000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMjgtMy0xLTEtMTU2MDQ_8663c6c4-aa28-4a8d-9002-d119267eba02"
      unitRef="usd">-844000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMjktMS0xLTEtMTU2MDQ_60255235-edc6-4177-87ac-06598ff99e54"
      unitRef="usd">-42000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMjktMy0xLTEtMTU2MDQ_837189f3-bc05-42a9-906e-8630b67e8ffb"
      unitRef="usd">-95000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayableTrade
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMzAtMS0xLTEtMTU2MDQ_b4499e29-a102-4736-8df3-8f0e5440bb05"
      unitRef="usd">-588000</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
    <us-gaap:IncreaseDecreaseInAccountsPayableTrade
      contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMzAtMy0xLTEtMTU2MDQ_c73c38ab-130c-4722-abec-c4119e876260"
      unitRef="usd">-189000</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMzEtMS0xLTEtMTU2MDQ_14761a1f-2d20-477b-8845-231831c5fce3"
      unitRef="usd">-3462000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMzEtMy0xLTEtMTU2MDQ_b8523d43-4ba5-400b-989a-86042a5c2dc7"
      unitRef="usd">-1893000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherAccruedLiabilities
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMzItMS0xLTEtMTU2MDQ_27b9a9da-465b-4ee5-b982-8a7aedfbc400"
      unitRef="usd">-1086000</us-gaap:IncreaseDecreaseInOtherAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherAccruedLiabilities
      contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMzItMy0xLTEtMTU2MDQ_ba757d08-a616-42fb-815d-9674859db805"
      unitRef="usd">-2216000</us-gaap:IncreaseDecreaseInOtherAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMzMtMS0xLTEtMTU2MDQ_4d70b85b-e77a-431c-96f0-9a8e9fdac7d7"
      unitRef="usd">-1767000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMzMtMy0xLTEtMTU2MDQ_41628ca9-ac04-4d76-aa07-ca4c1c69e7e6"
      unitRef="usd">1054000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMzQtMS0xLTEtMTU2MDQ_6d3b4c05-17a9-4127-a0d8-d9e37635e2d1"
      unitRef="usd">-18000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMzQtMy0xLTEtMTU2MDQ_63e6a9c8-7a16-40d7-b542-5c6b31d524cd"
      unitRef="usd">218000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMzUtMS0xLTEtMTU2MDQ_afe3f8fb-4e38-4629-bb2c-f437052b38e4"
      unitRef="usd">-1000</us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent>
    <us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent
      contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMzUtMy0xLTEtMTU2MDQ_2e3e591b-310d-4e92-9bb5-2c0b451764d9"
      unitRef="usd">33000</us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMzctMS0xLTEtMTU2MDQ_807e52b2-dc41-432b-ae25-2736423cace4"
      unitRef="usd">-18783000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjQwMzRjMjJkZGNjMzRlNWM5YjIxYzc0Y2RiNDQ2YmZiL3RhYmxlcmFuZ2U6NDAzNGMyMmRkY2MzNGU1YzliMjFjNzRjZGI0NDZiZmJfMzctMy0xLTEtMTU2MDQ_e0c3f4f1-7729-4019-a6c3-6b22344f68c8"
      unitRef="usd">-16384000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjhlYjgwOTUzMjk0ODQ4NzU4YjU3NWQyZjk5NjM2NTBmL3RhYmxlcmFuZ2U6OGViODA5NTMyOTQ4NDg3NThiNTc1ZDJmOTk2MzY1MGZfMy0xLTEtMS0xNTYwNA_28366ac6-dc25-4b86-bee6-8f11c4922267"
      unitRef="usd">0</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjhlYjgwOTUzMjk0ODQ4NzU4YjU3NWQyZjk5NjM2NTBmL3RhYmxlcmFuZ2U6OGViODA5NTMyOTQ4NDg3NThiNTc1ZDJmOTk2MzY1MGZfMy0zLTEtMS0xNTYwNA_26cacc86-f8c4-4177-bdb6-5466cca65ed0"
      unitRef="usd">174221000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjhlYjgwOTUzMjk0ODQ4NzU4YjU3NWQyZjk5NjM2NTBmL3RhYmxlcmFuZ2U6OGViODA5NTMyOTQ4NDg3NThiNTc1ZDJmOTk2MzY1MGZfNC0xLTEtMS0xNTYwNA_c2014849-7d64-4aa5-a6f1-09e812723847"
      unitRef="usd">18000000</us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
      contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjhlYjgwOTUzMjk0ODQ4NzU4YjU3NWQyZjk5NjM2NTBmL3RhYmxlcmFuZ2U6OGViODA5NTMyOTQ4NDg3NThiNTc1ZDJmOTk2MzY1MGZfNC0zLTEtMS0xNTYwNA_9d1acaf6-6973-4686-a8dd-e4f2bb69b7cf"
      unitRef="usd">40500000</us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjhlYjgwOTUzMjk0ODQ4NzU4YjU3NWQyZjk5NjM2NTBmL3RhYmxlcmFuZ2U6OGViODA5NTMyOTQ4NDg3NThiNTc1ZDJmOTk2MzY1MGZfMTAtMS0xLTEtMTU2MDQ_a6e55c37-b7a8-42d3-af68-168998fd0512"
      unitRef="usd">1579000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjhlYjgwOTUzMjk0ODQ4NzU4YjU3NWQyZjk5NjM2NTBmL3RhYmxlcmFuZ2U6OGViODA5NTMyOTQ4NDg3NThiNTc1ZDJmOTk2MzY1MGZfMTAtMy0xLTEtMTU2MDQ_ce00562b-2fbd-4ee2-9c6d-f0c5db4e085a"
      unitRef="usd">1014000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfOtherAssetsInvestingActivities
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjhlYjgwOTUzMjk0ODQ4NzU4YjU3NWQyZjk5NjM2NTBmL3RhYmxlcmFuZ2U6OGViODA5NTMyOTQ4NDg3NThiNTc1ZDJmOTk2MzY1MGZfMTEtMS0xLTEtMTU2MDQ_41c8cb03-2b67-47f1-90da-1c5b4acb323a"
      unitRef="usd">147000</us-gaap:ProceedsFromSaleOfOtherAssetsInvestingActivities>
    <us-gaap:ProceedsFromSaleOfOtherAssetsInvestingActivities
      contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjhlYjgwOTUzMjk0ODQ4NzU4YjU3NWQyZjk5NjM2NTBmL3RhYmxlcmFuZ2U6OGViODA5NTMyOTQ4NDg3NThiNTc1ZDJmOTk2MzY1MGZfMTEtMy0xLTEtMTU2MDQ_c051bf8a-cddb-4ba3-bee9-8b8140695e51"
      unitRef="usd">1944000</us-gaap:ProceedsFromSaleOfOtherAssetsInvestingActivities>
    <us-gaap:ProceedsFromCollectionOfNotesReceivable
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjhlYjgwOTUzMjk0ODQ4NzU4YjU3NWQyZjk5NjM2NTBmL3RhYmxlcmFuZ2U6OGViODA5NTMyOTQ4NDg3NThiNTc1ZDJmOTk2MzY1MGZfMTQtMS0xLTEtMTU2MDQ_c18fc676-0852-4d46-8691-1434558b02e0"
      unitRef="usd">0</us-gaap:ProceedsFromCollectionOfNotesReceivable>
    <us-gaap:ProceedsFromCollectionOfNotesReceivable
      contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjhlYjgwOTUzMjk0ODQ4NzU4YjU3NWQyZjk5NjM2NTBmL3RhYmxlcmFuZ2U6OGViODA5NTMyOTQ4NDg3NThiNTc1ZDJmOTk2MzY1MGZfMTQtMy0xLTEtMTU2MDQ_48609359-84d5-4efb-a663-c45257e1f0ae"
      unitRef="usd">3689000</us-gaap:ProceedsFromCollectionOfNotesReceivable>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjhlYjgwOTUzMjk0ODQ4NzU4YjU3NWQyZjk5NjM2NTBmL3RhYmxlcmFuZ2U6OGViODA5NTMyOTQ4NDg3NThiNTc1ZDJmOTk2MzY1MGZfMTUtMS0xLTEtMTU2MDQ_ada59aa6-909b-4cf2-9299-8181df39587f"
      unitRef="usd">16568000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjhlYjgwOTUzMjk0ODQ4NzU4YjU3NWQyZjk5NjM2NTBmL3RhYmxlcmFuZ2U6OGViODA5NTMyOTQ4NDg3NThiNTc1ZDJmOTk2MzY1MGZfMTUtMy0xLTEtMTU2MDQ_befcdaa1-dc62-40a1-81bd-f1c7c69279b8"
      unitRef="usd">-129102000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjhlYjgwOTUzMjk0ODQ4NzU4YjU3NWQyZjk5NjM2NTBmL3RhYmxlcmFuZ2U6OGViODA5NTMyOTQ4NDg3NThiNTc1ZDJmOTk2MzY1MGZfMTctMS0xLTEtMTU2MDQ_969bb0ca-b2b9-4d5c-9f53-0b7e220a2eb7"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjhlYjgwOTUzMjk0ODQ4NzU4YjU3NWQyZjk5NjM2NTBmL3RhYmxlcmFuZ2U6OGViODA5NTMyOTQ4NDg3NThiNTc1ZDJmOTk2MzY1MGZfMTctMy0xLTEtMTU2MDQ_d0af8d59-aa26-497d-b96f-7b54b5cc328e"
      unitRef="usd">121045000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjhlYjgwOTUzMjk0ODQ4NzU4YjU3NWQyZjk5NjM2NTBmL3RhYmxlcmFuZ2U6OGViODA5NTMyOTQ4NDg3NThiNTc1ZDJmOTk2MzY1MGZfMjItMS0xLTEtMTU2MDQ_44b20660-33f4-47e0-ab67-06c5c3b023c0"
      unitRef="usd">164000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjhlYjgwOTUzMjk0ODQ4NzU4YjU3NWQyZjk5NjM2NTBmL3RhYmxlcmFuZ2U6OGViODA5NTMyOTQ4NDg3NThiNTc1ZDJmOTk2MzY1MGZfMjItMy0xLTEtMTU2MDQ_45c7d0c3-00d7-4e31-8312-306fd72aa9ed"
      unitRef="usd">116000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjhlYjgwOTUzMjk0ODQ4NzU4YjU3NWQyZjk5NjM2NTBmL3RhYmxlcmFuZ2U6OGViODA5NTMyOTQ4NDg3NThiNTc1ZDJmOTk2MzY1MGZfMjMtMS0xLTEtMTU2MDQ_edb7a559-72f5-41ef-8c0d-2d4397dccaae"
      unitRef="usd">1000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjhlYjgwOTUzMjk0ODQ4NzU4YjU3NWQyZjk5NjM2NTBmL3RhYmxlcmFuZ2U6OGViODA5NTMyOTQ4NDg3NThiNTc1ZDJmOTk2MzY1MGZfMjMtMy0xLTEtMTU2MDQ_a954d784-46cf-442a-8c04-a6846f18df3e"
      unitRef="usd">111000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjhlYjgwOTUzMjk0ODQ4NzU4YjU3NWQyZjk5NjM2NTBmL3RhYmxlcmFuZ2U6OGViODA5NTMyOTQ4NDg3NThiNTc1ZDJmOTk2MzY1MGZfMjUtMS0xLTEtMTU2MDQ_ad411274-832a-4cc7-952c-ac42d597e026"
      unitRef="usd">-163000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjhlYjgwOTUzMjk0ODQ4NzU4YjU3NWQyZjk5NjM2NTBmL3RhYmxlcmFuZ2U6OGViODA5NTMyOTQ4NDg3NThiNTc1ZDJmOTk2MzY1MGZfMjUtMy0xLTEtMTU2MDQ_6cba4e8b-90d4-4b9c-b9ee-80bf5f69dbe0"
      unitRef="usd">121040000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjhlYjgwOTUzMjk0ODQ4NzU4YjU3NWQyZjk5NjM2NTBmL3RhYmxlcmFuZ2U6OGViODA5NTMyOTQ4NDg3NThiNTc1ZDJmOTk2MzY1MGZfMjYtMS0xLTEtMTU2MDQ_e0008fa6-f364-4c01-996c-52efb263d1b8"
      unitRef="usd">-230000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjhlYjgwOTUzMjk0ODQ4NzU4YjU3NWQyZjk5NjM2NTBmL3RhYmxlcmFuZ2U6OGViODA5NTMyOTQ4NDg3NThiNTc1ZDJmOTk2MzY1MGZfMjYtMy0xLTEtMTU2MDQ_ff3d3839-45f9-4b01-972b-18c4242b21ed"
      unitRef="usd">-11000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjhlYjgwOTUzMjk0ODQ4NzU4YjU3NWQyZjk5NjM2NTBmL3RhYmxlcmFuZ2U6OGViODA5NTMyOTQ4NDg3NThiNTc1ZDJmOTk2MzY1MGZfMjctMS0xLTEtMTU2MDQ_0d2b1196-bc4a-4355-8743-56a5422d0501"
      unitRef="usd">-2608000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjhlYjgwOTUzMjk0ODQ4NzU4YjU3NWQyZjk5NjM2NTBmL3RhYmxlcmFuZ2U6OGViODA5NTMyOTQ4NDg3NThiNTc1ZDJmOTk2MzY1MGZfMjctMy0xLTEtMTU2MDQ_196b66d9-78dc-4a6a-aa0a-66b2791799c2"
      unitRef="usd">-24457000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjhlYjgwOTUzMjk0ODQ4NzU4YjU3NWQyZjk5NjM2NTBmL3RhYmxlcmFuZ2U6OGViODA5NTMyOTQ4NDg3NThiNTc1ZDJmOTk2MzY1MGZfMjktMS0xLTEtMTU2MDQ_e6727e3e-a347-4fcb-87c7-3c1e7fa79962"
      unitRef="usd">43343000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i54a90f374db746b78de00be9871944ac_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjhlYjgwOTUzMjk0ODQ4NzU4YjU3NWQyZjk5NjM2NTBmL3RhYmxlcmFuZ2U6OGViODA5NTMyOTQ4NDg3NThiNTc1ZDJmOTk2MzY1MGZfMjktMy0xLTEtMTU2MDQ_f24ec33d-8166-41a6-b42e-7f37786f2fc9"
      unitRef="usd">52250000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjhlYjgwOTUzMjk0ODQ4NzU4YjU3NWQyZjk5NjM2NTBmL3RhYmxlcmFuZ2U6OGViODA5NTMyOTQ4NDg3NThiNTc1ZDJmOTk2MzY1MGZfMzAtMS0xLTEtMTU2MDQ_a40c1449-f1bb-4566-bd38-5e16b2dbef59"
      unitRef="usd">40735000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="if7b79aae0fa241fb908efc36ca29e3d3_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjhlYjgwOTUzMjk0ODQ4NzU4YjU3NWQyZjk5NjM2NTBmL3RhYmxlcmFuZ2U6OGViODA5NTMyOTQ4NDg3NThiNTc1ZDJmOTk2MzY1MGZfMzAtMy0xLTEtMTU2MDQ_06ebc34b-c48b-46d3-9598-fa2d780a18d1"
      unitRef="usd">27793000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjhlYjgwOTUzMjk0ODQ4NzU4YjU3NWQyZjk5NjM2NTBmL3RhYmxlcmFuZ2U6OGViODA5NTMyOTQ4NDg3NThiNTc1ZDJmOTk2MzY1MGZfMzItMS0xLTEtMTU2MDQ_686568a9-2f86-46c5-9c71-38c29981c0cd"
      unitRef="usd">3535000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjhlYjgwOTUzMjk0ODQ4NzU4YjU3NWQyZjk5NjM2NTBmL3RhYmxlcmFuZ2U6OGViODA5NTMyOTQ4NDg3NThiNTc1ZDJmOTk2MzY1MGZfMzItMy0xLTEtMTU2MDQ_dfa39306-04f9-44c0-9dc0-13df81c592db"
      unitRef="usd">3539000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaid
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjhlYjgwOTUzMjk0ODQ4NzU4YjU3NWQyZjk5NjM2NTBmL3RhYmxlcmFuZ2U6OGViODA5NTMyOTQ4NDg3NThiNTc1ZDJmOTk2MzY1MGZfMzMtMS0xLTEtMTU2MDQ_5e50cc4c-6600-47bd-87a0-d1ef7101fb2b"
      unitRef="usd">0</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjhlYjgwOTUzMjk0ODQ4NzU4YjU3NWQyZjk5NjM2NTBmL3RhYmxlcmFuZ2U6OGViODA5NTMyOTQ4NDg3NThiNTc1ZDJmOTk2MzY1MGZfMzMtMy0xLTEtMTU2MDQ_3b682430-1d65-41ee-88db-17c0c648166e"
      unitRef="usd">4000</us-gaap:IncomeTaxesPaid>
    <pgen:AccruedCompensationPaidinEquityAwards
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjhlYjgwOTUzMjk0ODQ4NzU4YjU3NWQyZjk5NjM2NTBmL3RhYmxlcmFuZ2U6OGViODA5NTMyOTQ4NDg3NThiNTc1ZDJmOTk2MzY1MGZfMzctMS0xLTEtMTU2MDQ_644fff22-0980-4851-9045-05893080fd3c"
      unitRef="usd">1698000</pgen:AccruedCompensationPaidinEquityAwards>
    <pgen:AccruedCompensationPaidinEquityAwards
      contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjhlYjgwOTUzMjk0ODQ4NzU4YjU3NWQyZjk5NjM2NTBmL3RhYmxlcmFuZ2U6OGViODA5NTMyOTQ4NDg3NThiNTc1ZDJmOTk2MzY1MGZfMzctMy0xLTEtMTU2MDQ_c760ab8e-1257-4ea8-81aa-d5baed32e048"
      unitRef="usd">0</pgen:AccruedCompensationPaidinEquityAwards>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjhlYjgwOTUzMjk0ODQ4NzU4YjU3NWQyZjk5NjM2NTBmL3RhYmxlcmFuZ2U6OGViODA5NTMyOTQ4NDg3NThiNTc1ZDJmOTk2MzY1MGZfMzgtMS0xLTEtMTU2MDQ_64a236e4-0194-47ac-9794-178e705218e2"
      unitRef="usd">251000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjhlYjgwOTUzMjk0ODQ4NzU4YjU3NWQyZjk5NjM2NTBmL3RhYmxlcmFuZ2U6OGViODA5NTMyOTQ4NDg3NThiNTc1ZDJmOTk2MzY1MGZfMzgtMy0xLTEtMTU2MDQ_c8d27fc5-9244-4b05-9f0d-c63c45c6b913"
      unitRef="usd">255000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <pgen:SaleOfAssetsIncludedInAccountsReceivable
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjhlYjgwOTUzMjk0ODQ4NzU4YjU3NWQyZjk5NjM2NTBmL3RhYmxlcmFuZ2U6OGViODA5NTMyOTQ4NDg3NThiNTc1ZDJmOTk2MzY1MGZfNDAtMS0xLTEtMTU2MDQ_6401b1e1-200b-4f35-bc11-519c77172e01"
      unitRef="usd">132000</pgen:SaleOfAssetsIncludedInAccountsReceivable>
    <pgen:SaleOfAssetsIncludedInAccountsReceivable
      contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjhlYjgwOTUzMjk0ODQ4NzU4YjU3NWQyZjk5NjM2NTBmL3RhYmxlcmFuZ2U6OGViODA5NTMyOTQ4NDg3NThiNTc1ZDJmOTk2MzY1MGZfNDAtMy0xLTEtMTU2MDQ_28437ade-4ba3-40f9-a4e8-447609deacb3"
      unitRef="usd">23000</pgen:SaleOfAssetsIncludedInAccountsReceivable>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjU5OWNjNTQ4Y2UyNzQzYjg4NjMxNjJjOWRkNDhlNjE4L3RhYmxlcmFuZ2U6NTk5Y2M1NDhjZTI3NDNiODg2MzE2MmM5ZGQ0OGU2MThfMS0xLTEtMS0xNTYwNA_4320d194-5626-44ba-8578-0da368f77124"
      unitRef="usd">40321000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjU5OWNjNTQ4Y2UyNzQzYjg4NjMxNjJjOWRkNDhlNjE4L3RhYmxlcmFuZ2U6NTk5Y2M1NDhjZTI3NDNiODg2MzE2MmM5ZGQ0OGU2MThfMS0zLTEtMS0xNTYwNA_89a058d9-f69e-4d12-833a-1b18da41e804"
      unitRef="usd">42920000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsNoncurrent
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjU5OWNjNTQ4Y2UyNzQzYjg4NjMxNjJjOWRkNDhlNjE4L3RhYmxlcmFuZ2U6NTk5Y2M1NDhjZTI3NDNiODg2MzE2MmM5ZGQ0OGU2MThfNC0xLTEtMS0xNTYwNA_7d01add1-0fce-45b9-a112-cd9b6597cd41"
      unitRef="usd">414000</us-gaap:RestrictedCashAndCashEquivalentsNoncurrent>
    <us-gaap:RestrictedCashAndCashEquivalentsNoncurrent
      contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjU5OWNjNTQ4Y2UyNzQzYjg4NjMxNjJjOWRkNDhlNjE4L3RhYmxlcmFuZ2U6NTk5Y2M1NDhjZTI3NDNiODg2MzE2MmM5ZGQ0OGU2MThfNC0zLTEtMS0xNTYwNA_f2c33531-bab4-4bb7-9264-4d1698292d69"
      unitRef="usd">423000</us-gaap:RestrictedCashAndCashEquivalentsNoncurrent>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjU5OWNjNTQ4Y2UyNzQzYjg4NjMxNjJjOWRkNDhlNjE4L3RhYmxlcmFuZ2U6NTk5Y2M1NDhjZTI3NDNiODg2MzE2MmM5ZGQ0OGU2MThfNS0xLTEtMS0xNTYwNA_9f3cb61e-2374-42a3-b765-c9d4f82a1df9"
      unitRef="usd">40735000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zMS9mcmFnOjE1OWEwZmQ3MzBhZjRiZWFiMDVkYjBkZTU1MDBhZGM5L3RhYmxlOjU5OWNjNTQ4Y2UyNzQzYjg4NjMxNjJjOWRkNDhlNjE4L3RhYmxlcmFuZ2U6NTk5Y2M1NDhjZTI3NDNiODg2MzE2MmM5ZGQ0OGU2MThfNS0zLTEtMS0xNTYwNA_205d5fa6-fe0c-46f8-afc1-e30670141212"
      unitRef="usd">43343000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl8zNy9mcmFnOjVhYjUzYjVlY2JjNzRmYjBiM2VhNGYyNWU1NjgzNTk5L3RleHRyZWdpb246NWFiNTNiNWVjYmM3NGZiMGIzZWE0ZjI1ZTU2ODM1OTlfMzMzNA_62f6432e-1740-421b-9125-f3ddaea8185b">Organization&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Precigen, Inc. ("Precigen"), a Virginia corporation, is a synthetic biology company with an increasing focus on its discovery and clinical stage activities to advance the next generation of gene and cellular therapies to target the most urgent and intractable challenges in immuno-oncology, autoimmune disorders, and infectious diseases. Precigen operates through the following subsidiaries: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;PGEN Therapeutics, Inc. ("PGEN Therapeutics") is a dedicated discovery and clinical stage biopharmaceutical company advancing the next generation of gene and cell therapies using precision technology to target urgent and intractable diseases in immuno-oncology, autoimmune disorders, and infectious diseases. PGEN Therapeutics is a wholly owned subsidiary of Precigen with primary operations in Maryland.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Precigen ActoBio, Inc. ("ActoBio") is pioneering a proprietary class of microbe-based biopharmaceuticals that enable expression and local delivery of disease-modifying therapeutics and is a wholly owned subsidiary of Precigen with primary operations in Belgium.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Exemplar Genetics, LLC, doing business as Precigen Exemplar ("Exemplar"), is committed to enabling the study of life-threatening human diseases through the development of MiniSwine Yucatan miniature pig research models and services, as well as enabling the production of cells and organs in its genetically engineered swine for regenerative medicine applications and is a wholly owned subsidiary of Precigen with primary operations in Iowa.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Trans Ova Genetics, L.C., including its wholly owned subsidiary Progentus, L.C., are providers of reproductive technologies, including services and products sold to cattle breeders and other producers and are hereinafter collectively referred to as "Trans Ova." Trans Ova is a wholly owned subsidiary with primary operations in California, Iowa, Maryland, Missouri, Texas, Washington, and Wisconsin.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Effective October 1, 2019, Precigen transferred substantially all of its proprietary methane bioconversion platform ("MBP") assets to a wholly owned subsidiary, MBP Titan LLC ("MBP Titan"). MBP Titan's proprietary technology is designed to convert natural gas into more valuable and usable energy and chemical products through novel, highly engineered bacteria that utilize specific energy feedstocks. Prior to October 1, 2019, the operation transferred to MBP Titan was an operating division within Precigen. Beginning in the second quarter of 2020, the Company suspended MBP Titan's operations and began the process to wind down MBP Titan's activities and had substantially completed the wind down by December 31, 2020, with the final disposition of certain property and equipment and the facility operating lease occurring in January 2021. With the exception of certain assets and obligations with which the Company has a continuing involvement after the wind down, MBP Titan has been presented as discontinued operations for all periods presented. See Note 3 for further discussion.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Precigen and its consolidated subsidiaries are hereinafter referred to as the "Company."&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80MC9mcmFnOmJlNWZjYmY0ODg0YTQ3MjNhNzllZDYyYzFlM2U1MTYyL3RleHRyZWdpb246YmU1ZmNiZjQ4ODRhNDcyM2E3OWVkNjJjMWUzZTUxNjJfMTA1NTU_9d29198d-73ef-43d7-a405-27d7535dd05e">Summary of Significant Accounting Policies&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying interim condensed consolidated financial statements are unaudited and have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP"). Certain information and footnote disclosures normally included in the Company's annual financial statements have been condensed or omitted. These interim condensed consolidated financial statements, in the opinion of management, reflect all normal recurring adjustments necessary for fair statement of the Company's financial position as of March&#160;31, 2022 and results of operations and cash flows for the interim periods ended March&#160;31, 2022 and 2021. The year-end condensed consolidated balance sheet data was derived from the Company's audited financial statements but does not include all disclosures required by U.S. GAAP. These interim financial results are not necessarily indicative of the results to be expected for the year ending December&#160;31, 2022, or for any other future annual or interim period. The accompanying interim unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related notes thereto included in the Company's Annual Report on Form 10-K for the year ended December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying condensed consolidated financial statements reflect the operations of Precigen and its subsidiaries. All intercompany accounts and transactions have been eliminated.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Liquidity &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Management believes that existing liquid assets as of March&#160;31, 2022 will allow the Company to continue its operations for at least a year from the issuance date of these condensed consolidated financial statements. These condensed consolidated financial statements are presented in United States dollars. The Company is subject to a number of risks similar to those of other companies conducting high-risk, early-stage research and development of therapeutic product candidates. Principal among these risks are dependence on key individuals and intellectual property, competition from other products and companies, and the technical risks associated with the successful research, development, and clinical manufacturing of its and its collaborators' therapeutic product candidates. Additionally, the accompanying condensed consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. During the three months ended March 31, 2022, the Company incurred a net loss of $19,251 and, as of March&#160;31, 2022, had an accumulated deficit of $1,916,135. Management expects operating losses and negative cash flows to continue for the foreseeable future and, as a result, the Company will require additional capital to fund its operations and execute its business plan. In the absence of a significant source of recurring revenue, the Company's long-term success is dependent upon its ability to continue to raise additional capital in order to fund ongoing research and development (which could occur through debt or equity issuances, sales or partnerships of non-core assets, corroborations or licensing of core or non-core assets, or other transactions), adequately satisfy or renegotiate long-term debt obligations, obtain regulatory approval of its therapeutic product candidates, successfully commercialize its therapeutic product candidates, generate revenue, meet its obligations and, ultimately, attain profitable operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Risks and Uncertainties&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;COVID-19 has had and continues to have an extensive impact on the global health and economic environments. Furthermore, there is uncertainty regarding the duration and severity of the ongoing pandemic, and the Company could experience delays or other pandemic-related events that may adversely impact the Company's clinical as well as preclinical pipeline candidates in the future.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is closely monitoring the impact of COVID-19 on all aspects of its businesses. Given the dynamic nature of these circumstances, the full impact of the COVID-19 pandemic on the Company's ongoing business, results of operations, and overall financial performance in future periods cannot be reasonably estimated at this time, and it could have a material adverse effect on the Company's results of operations, cash flows, and financial position, including resulting impairments to goodwill and long-lived assets and additional credit losses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See Note 3 for further discussion of the impact of COVID-19 on MBP Titan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Equity Method Investments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for its investments in each of its joint ventures ("JVs")  using the equity method of accounting based upon relative ownership interest. See additional discussion related to certain of the Company's JVs in Note 4. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Variable Interest Entities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2022 and December&#160;31, 2021, the Company determined that its JVs were variable interest entities ("VIEs"). The Company was not the primary beneficiary for these entities since it did not have the power to direct the activities that most significantly impact the economic performance of the VIEs. As of March&#160;31, 2022 and December&#160;31, 2021, the Company had no risk of loss related to the identified VIEs. See Note 4 for discussion of the Company's future funding commitments for its significant JVs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Net Loss per Share&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic net loss per share is calculated by dividing net loss attributable to common shareholders by the weighted average shares outstanding during the period, without consideration of common stock equivalents. Diluted net loss per share is calculated by adjusting weighted average shares outstanding for the dilutive effect of common stock equivalents outstanding for the period, using the treasury-stock method. For purposes of the diluted net loss per share calculation, shares to be issued pursuant to convertible debt, stock options, RSUs, and warrants are considered to be common stock equivalents but are excluded from the &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;calculation of diluted net loss per share because their effect would be anti-dilutive and, therefore, basic and diluted net loss per share were the same for all periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following potentially dilutive securities as of March&#160;31, 2022 and 2021, have been excluded from the above computations of diluted weighted average shares outstanding for the three months then ended as they would have been anti-dilutive:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:17pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Convertible debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,732,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,732,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,034,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,451,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,185,205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;790,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121,888&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,074,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,107,682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Segment Information&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's chief operating decision maker ("CODM") regularly reviews disaggregated financial information for various operating segments. Starting in 2021, the financial information regularly reviewed by the CODM was revised and the operating segments, which were determined to be operating and reportable segments, were (i) Biopharmaceuticals, (ii) Exemplar, and (iii) Trans Ova. The Biopharmaceuticals reportable segment is primarily comprised of the Company's legal entities of PGEN Therapeutics and ActoBio. All of Precigen's consolidated subsidiaries and operating divisions that did not meet the quantitative thresholds to report separately are combined and reported in a single category, All Other. See Note 1 for a description of PGEN Therapeutics, ActoBio, Exemplar, and Trans Ova. Corporate expenses, which are not allocated to the segments and are managed at a consolidated level, include costs associated with general and administrative functions, including the Company's finance, accounting, legal, human resources, information technology, corporate communication, and investor relations functions. Corporate expenses exclude interest expense, depreciation and amortization, gain or loss on disposals of assets, stock-based compensation expense, loss on settlement agreement, and equity in net loss of affiliates and include unrealized and realized gains and losses on the Company's securities portfolio as well as dividend income. See Note 18 for further discussion of the Company's segments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In August 2020, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2020-06, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Debt&#x2014;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#x2014;Contracts in Entity's Own Equity (Subtopic 815-40)&#x2014;Accounting for Convertible Instruments and Contracts in an Entity's Own Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; ("ASU 2020-06"&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;. Under ASU 2020-06, the embedded conversion features are no longer separated from the host contract for convertible instruments with conversion features that are not required to be accounted for as derivatives under Topic 815, or that do not result in substantial premiums accounted for as paid-in capital. Consequently, a convertible debt instrument will be accounted for as a single liability measured at its amortized cost, as long as no other features require bifurcation and recognition as derivatives. The new guidance also requires the if-converted method to be applied for all convertible instruments. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We adopted ASU 2020-06 on January 1, 2022 using the modified retrospective transition method, which resulted in an increase to our reported long-term debt outstanding, net of current portion, of $18,196, a decrease to our additional paid-in capital of $36,868, and a corresponding cumulative-effect reduction to our opening accumulated deficit of $18,672. The adoption of ASU 2020-06 is expected to reduce non-cash interest expense related to existing convertible debt outstanding by approximately $11,800 for the year ending December 31, 2022, and did not have an impact on our consolidated cash flows. The use of the if-converted method did not have an impact on our overall earnings per share calculation.&lt;/span&gt;&lt;/div&gt;Recently Issued Accounting Pronouncements Not Yet Adopted</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80MC9mcmFnOmJlNWZjYmY0ODg0YTQ3MjNhNzllZDYyYzFlM2U1MTYyL3RleHRyZWdpb246YmU1ZmNiZjQ4ODRhNDcyM2E3OWVkNjJjMWUzZTUxNjJfMTA2MTM_f2b393c8-4c61-42f6-8e8e-f52308d87961">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying interim condensed consolidated financial statements are unaudited and have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP"). Certain information and footnote disclosures normally included in the Company's annual financial statements have been condensed or omitted. These interim condensed consolidated financial statements, in the opinion of management, reflect all normal recurring adjustments necessary for fair statement of the Company's financial position as of March&#160;31, 2022 and results of operations and cash flows for the interim periods ended March&#160;31, 2022 and 2021. The year-end condensed consolidated balance sheet data was derived from the Company's audited financial statements but does not include all disclosures required by U.S. GAAP. These interim financial results are not necessarily indicative of the results to be expected for the year ending December&#160;31, 2022, or for any other future annual or interim period. The accompanying interim unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related notes thereto included in the Company's Annual Report on Form 10-K for the year ended December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80MC9mcmFnOmJlNWZjYmY0ODg0YTQ3MjNhNzllZDYyYzFlM2U1MTYyL3RleHRyZWdpb246YmU1ZmNiZjQ4ODRhNDcyM2E3OWVkNjJjMWUzZTUxNjJfMTA2MjU_7d6e4d7a-ab40-4007-9f49-096bdb07a713">The accompanying condensed consolidated financial statements reflect the operations of Precigen and its subsidiaries. All intercompany accounts and transactions have been eliminated.</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80MC9mcmFnOmJlNWZjYmY0ODg0YTQ3MjNhNzllZDYyYzFlM2U1MTYyL3RleHRyZWdpb246YmU1ZmNiZjQ4ODRhNDcyM2E3OWVkNjJjMWUzZTUxNjJfMjU2Mw_c9a29005-d88d-4217-9c1d-bf7053d5ddd5"
      unitRef="usd">-19251000</us-gaap:NetIncomeLoss>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80MC9mcmFnOmJlNWZjYmY0ODg0YTQ3MjNhNzllZDYyYzFlM2U1MTYyL3RleHRyZWdpb246YmU1ZmNiZjQ4ODRhNDcyM2E3OWVkNjJjMWUzZTUxNjJfMjYxMQ_1efbf4df-252f-4513-9d21-9b53f43b7ece"
      unitRef="usd">-1916135000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:EquityMethodInvestmentsPolicy
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80MC9mcmFnOmJlNWZjYmY0ODg0YTQ3MjNhNzllZDYyYzFlM2U1MTYyL3RleHRyZWdpb246YmU1ZmNiZjQ4ODRhNDcyM2E3OWVkNjJjMWUzZTUxNjJfMTA2MDE_fc7dbb4c-8ea1-42e3-a1c4-7715e3bd1714">Equity Method InvestmentsThe Company accounts for its investments in each of its joint ventures ("JVs")  using the equity method of accounting based upon relative ownership interest.</us-gaap:EquityMethodInvestmentsPolicy>
    <us-gaap:ConsolidationVariableInterestEntityPolicy
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80MC9mcmFnOmJlNWZjYmY0ODg0YTQ3MjNhNzllZDYyYzFlM2U1MTYyL3RleHRyZWdpb246YmU1ZmNiZjQ4ODRhNDcyM2E3OWVkNjJjMWUzZTUxNjJfMTA2MTY_999a47cc-0792-44b5-83c4-8996a4a58180">Variable Interest EntitiesAs of March&#160;31, 2022 and December&#160;31, 2021, the Company determined that its JVs were variable interest entities ("VIEs"). The Company was not the primary beneficiary for these entities since it did not have the power to direct the activities that most significantly impact the economic performance of the VIEs.</us-gaap:ConsolidationVariableInterestEntityPolicy>
    <us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80MC9mcmFnOmJlNWZjYmY0ODg0YTQ3MjNhNzllZDYyYzFlM2U1MTYyL3RleHRyZWdpb246YmU1ZmNiZjQ4ODRhNDcyM2E3OWVkNjJjMWUzZTUxNjJfNjM5NQ_738f05e0-ed93-4ecb-b75c-794ae7879f76"
      unitRef="usd">0</us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount>
    <us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount
      contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80MC9mcmFnOmJlNWZjYmY0ODg0YTQ3MjNhNzllZDYyYzFlM2U1MTYyL3RleHRyZWdpb246YmU1ZmNiZjQ4ODRhNDcyM2E3OWVkNjJjMWUzZTUxNjJfNjM5NQ_9be33a57-5996-49fb-b410-a1a1f7ea735e"
      unitRef="usd">0</us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80MC9mcmFnOmJlNWZjYmY0ODg0YTQ3MjNhNzllZDYyYzFlM2U1MTYyL3RleHRyZWdpb246YmU1ZmNiZjQ4ODRhNDcyM2E3OWVkNjJjMWUzZTUxNjJfMzI5ODUzNDkwMzI1OA_19ff09b2-0be7-4c04-8f7f-6b08b7800e41">&lt;div style="margin-top:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Net Loss per Share&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic net loss per share is calculated by dividing net loss attributable to common shareholders by the weighted average shares outstanding during the period, without consideration of common stock equivalents. Diluted net loss per share is calculated by adjusting weighted average shares outstanding for the dilutive effect of common stock equivalents outstanding for the period, using the treasury-stock method. For purposes of the diluted net loss per share calculation, shares to be issued pursuant to convertible debt, stock options, RSUs, and warrants are considered to be common stock equivalents but are excluded from the &lt;/span&gt;&lt;/div&gt;calculation of diluted net loss per share because their effect would be anti-dilutive and, therefore, basic and diluted net loss per share were the same for all periods presented.</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80MC9mcmFnOmJlNWZjYmY0ODg0YTQ3MjNhNzllZDYyYzFlM2U1MTYyL3RleHRyZWdpb246YmU1ZmNiZjQ4ODRhNDcyM2E3OWVkNjJjMWUzZTUxNjJfMzI5ODUzNDkwMzMwMw_ee0a05b0-0ebc-44ac-8d24-7bdf936a3c33">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following potentially dilutive securities as of March&#160;31, 2022 and 2021, have been excluded from the above computations of diluted weighted average shares outstanding for the three months then ended as they would have been anti-dilutive:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:17pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Convertible debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,732,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,732,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,034,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,451,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,185,205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;790,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121,888&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,074,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,107,682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i13ea040140e440418a940e8363605b6b_D20220101-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80MC9mcmFnOmJlNWZjYmY0ODg0YTQ3MjNhNzllZDYyYzFlM2U1MTYyL3RhYmxlOjMyYWRkZWUwZTQ0MjQ0NjJiYzFjMzA0NWE0YTQ5NzEyL3RhYmxlcmFuZ2U6MzJhZGRlZTBlNDQyNDQ2MmJjMWMzMDQ1YTRhNDk3MTJfMi0xLTEtMS0yNTU1OQ_8689bf46-8068-4e93-ac5d-9b6adf12a1c8"
      unitRef="shares">11732440</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i13ea040140e440418a940e8363605b6b_D20220101-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80MC9mcmFnOmJlNWZjYmY0ODg0YTQ3MjNhNzllZDYyYzFlM2U1MTYyL3RhYmxlOjMyYWRkZWUwZTQ0MjQ0NjJiYzFjMzA0NWE0YTQ5NzEyL3RhYmxlcmFuZ2U6MzJhZGRlZTBlNDQyNDQ2MmJjMWMzMDQ1YTRhNDk3MTJfMi0xLTEtMS0yNTU1OQ_d5c45955-6f85-4f23-9780-e1acabbef105"
      unitRef="shares">11732440</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ied4a3135345f415ca6385fc1d425993e_D20210101-20210331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80MC9mcmFnOmJlNWZjYmY0ODg0YTQ3MjNhNzllZDYyYzFlM2U1MTYyL3RhYmxlOjMyYWRkZWUwZTQ0MjQ0NjJiYzFjMzA0NWE0YTQ5NzEyL3RhYmxlcmFuZ2U6MzJhZGRlZTBlNDQyNDQ2MmJjMWMzMDQ1YTRhNDk3MTJfMi0zLTEtMS0yNTU1OQ_024a0f3c-d132-4907-80dc-9b7399de7649"
      unitRef="shares">11732440</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ied4a3135345f415ca6385fc1d425993e_D20210101-20210331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80MC9mcmFnOmJlNWZjYmY0ODg0YTQ3MjNhNzllZDYyYzFlM2U1MTYyL3RhYmxlOjMyYWRkZWUwZTQ0MjQ0NjJiYzFjMzA0NWE0YTQ5NzEyL3RhYmxlcmFuZ2U6MzJhZGRlZTBlNDQyNDQ2MmJjMWMzMDQ1YTRhNDk3MTJfMi0zLTEtMS0yNTU1OQ_baa896fd-ebb4-4f2f-a348-ee7b7c8b30d5"
      unitRef="shares">11732440</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="idf47d6aef2e44be1a923ae69756f5dae_D20220101-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80MC9mcmFnOmJlNWZjYmY0ODg0YTQ3MjNhNzllZDYyYzFlM2U1MTYyL3RhYmxlOjMyYWRkZWUwZTQ0MjQ0NjJiYzFjMzA0NWE0YTQ5NzEyL3RhYmxlcmFuZ2U6MzJhZGRlZTBlNDQyNDQ2MmJjMWMzMDQ1YTRhNDk3MTJfMy0xLTEtMS0yNTU1OQ_34782806-8a1f-47aa-914e-e0d5901f6787"
      unitRef="shares">16034553</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="idf47d6aef2e44be1a923ae69756f5dae_D20220101-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80MC9mcmFnOmJlNWZjYmY0ODg0YTQ3MjNhNzllZDYyYzFlM2U1MTYyL3RhYmxlOjMyYWRkZWUwZTQ0MjQ0NjJiYzFjMzA0NWE0YTQ5NzEyL3RhYmxlcmFuZ2U6MzJhZGRlZTBlNDQyNDQ2MmJjMWMzMDQ1YTRhNDk3MTJfMy0xLTEtMS0yNTU1OQ_94766b78-2d8e-45e1-8347-1b0d32041a96"
      unitRef="shares">16034553</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i5aabaff5f1154c5891d0a750ae3d1e8f_D20210101-20210331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80MC9mcmFnOmJlNWZjYmY0ODg0YTQ3MjNhNzllZDYyYzFlM2U1MTYyL3RhYmxlOjMyYWRkZWUwZTQ0MjQ0NjJiYzFjMzA0NWE0YTQ5NzEyL3RhYmxlcmFuZ2U6MzJhZGRlZTBlNDQyNDQ2MmJjMWMzMDQ1YTRhNDk3MTJfMy0zLTEtMS0yNTU1OQ_192af577-464c-4ae0-be7d-d6a1932287e6"
      unitRef="shares">11451614</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i5aabaff5f1154c5891d0a750ae3d1e8f_D20210101-20210331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80MC9mcmFnOmJlNWZjYmY0ODg0YTQ3MjNhNzllZDYyYzFlM2U1MTYyL3RhYmxlOjMyYWRkZWUwZTQ0MjQ0NjJiYzFjMzA0NWE0YTQ5NzEyL3RhYmxlcmFuZ2U6MzJhZGRlZTBlNDQyNDQ2MmJjMWMzMDQ1YTRhNDk3MTJfMy0zLTEtMS0yNTU1OQ_c36e6235-706e-45ba-8558-21275c23145d"
      unitRef="shares">11451614</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i2ae4da9032b64f15ae1225c9f68e0a94_D20220101-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80MC9mcmFnOmJlNWZjYmY0ODg0YTQ3MjNhNzllZDYyYzFlM2U1MTYyL3RhYmxlOjMyYWRkZWUwZTQ0MjQ0NjJiYzFjMzA0NWE0YTQ5NzEyL3RhYmxlcmFuZ2U6MzJhZGRlZTBlNDQyNDQ2MmJjMWMzMDQ1YTRhNDk3MTJfNC0xLTEtMS0yNTU1OQ_1a4e1756-e558-49f6-b480-37ce5a53b43f"
      unitRef="shares">1185205</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i2ae4da9032b64f15ae1225c9f68e0a94_D20220101-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80MC9mcmFnOmJlNWZjYmY0ODg0YTQ3MjNhNzllZDYyYzFlM2U1MTYyL3RhYmxlOjMyYWRkZWUwZTQ0MjQ0NjJiYzFjMzA0NWE0YTQ5NzEyL3RhYmxlcmFuZ2U6MzJhZGRlZTBlNDQyNDQ2MmJjMWMzMDQ1YTRhNDk3MTJfNC0xLTEtMS0yNTU1OQ_1d5c605f-0194-4511-b0a2-99fb42400339"
      unitRef="shares">1185205</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i37cfff500eac4815a708c1afd75ce14a_D20210101-20210331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80MC9mcmFnOmJlNWZjYmY0ODg0YTQ3MjNhNzllZDYyYzFlM2U1MTYyL3RhYmxlOjMyYWRkZWUwZTQ0MjQ0NjJiYzFjMzA0NWE0YTQ5NzEyL3RhYmxlcmFuZ2U6MzJhZGRlZTBlNDQyNDQ2MmJjMWMzMDQ1YTRhNDk3MTJfNC0zLTEtMS0yNTU1OQ_97ccfbcb-d9cd-4b38-9a12-c6091cbcb00e"
      unitRef="shares">790364</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i37cfff500eac4815a708c1afd75ce14a_D20210101-20210331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80MC9mcmFnOmJlNWZjYmY0ODg0YTQ3MjNhNzllZDYyYzFlM2U1MTYyL3RhYmxlOjMyYWRkZWUwZTQ0MjQ0NjJiYzFjMzA0NWE0YTQ5NzEyL3RhYmxlcmFuZ2U6MzJhZGRlZTBlNDQyNDQ2MmJjMWMzMDQ1YTRhNDk3MTJfNC0zLTEtMS0yNTU1OQ_f13fa212-9abf-4e77-8946-139c2c37cf7b"
      unitRef="shares">790364</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i63eddf4feb1441d8920e87a7e333621c_D20220101-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80MC9mcmFnOmJlNWZjYmY0ODg0YTQ3MjNhNzllZDYyYzFlM2U1MTYyL3RhYmxlOjMyYWRkZWUwZTQ0MjQ0NjJiYzFjMzA0NWE0YTQ5NzEyL3RhYmxlcmFuZ2U6MzJhZGRlZTBlNDQyNDQ2MmJjMWMzMDQ1YTRhNDk3MTJfNS0xLTEtMS0yNTU1OQ_373394fe-710d-4c25-958c-56fe2655b5d2"
      unitRef="shares">121888</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i63eddf4feb1441d8920e87a7e333621c_D20220101-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80MC9mcmFnOmJlNWZjYmY0ODg0YTQ3MjNhNzllZDYyYzFlM2U1MTYyL3RhYmxlOjMyYWRkZWUwZTQ0MjQ0NjJiYzFjMzA0NWE0YTQ5NzEyL3RhYmxlcmFuZ2U6MzJhZGRlZTBlNDQyNDQ2MmJjMWMzMDQ1YTRhNDk3MTJfNS0xLTEtMS0yNTU1OQ_bb612d5f-9e68-4bae-9dbd-70351adfcdbe"
      unitRef="shares">121888</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i0d80cdb2ed0f480faecf8cdc7f92f497_D20210101-20210331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80MC9mcmFnOmJlNWZjYmY0ODg0YTQ3MjNhNzllZDYyYzFlM2U1MTYyL3RhYmxlOjMyYWRkZWUwZTQ0MjQ0NjJiYzFjMzA0NWE0YTQ5NzEyL3RhYmxlcmFuZ2U6MzJhZGRlZTBlNDQyNDQ2MmJjMWMzMDQ1YTRhNDk3MTJfNS0zLTEtMS0yNTU1OQ_166a1aea-ced7-44db-9c5a-d58f17d41341"
      unitRef="shares">133264</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i0d80cdb2ed0f480faecf8cdc7f92f497_D20210101-20210331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80MC9mcmFnOmJlNWZjYmY0ODg0YTQ3MjNhNzllZDYyYzFlM2U1MTYyL3RhYmxlOjMyYWRkZWUwZTQ0MjQ0NjJiYzFjMzA0NWE0YTQ5NzEyL3RhYmxlcmFuZ2U6MzJhZGRlZTBlNDQyNDQ2MmJjMWMzMDQ1YTRhNDk3MTJfNS0zLTEtMS0yNTU1OQ_28482338-f59f-44b8-829d-cff6b72d2de5"
      unitRef="shares">133264</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80MC9mcmFnOmJlNWZjYmY0ODg0YTQ3MjNhNzllZDYyYzFlM2U1MTYyL3RhYmxlOjMyYWRkZWUwZTQ0MjQ0NjJiYzFjMzA0NWE0YTQ5NzEyL3RhYmxlcmFuZ2U6MzJhZGRlZTBlNDQyNDQ2MmJjMWMzMDQ1YTRhNDk3MTJfNi0xLTEtMS0yNTU1OQ_4b1c0f22-b57a-4e1e-b0c5-bd13a50b406b"
      unitRef="shares">29074086</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80MC9mcmFnOmJlNWZjYmY0ODg0YTQ3MjNhNzllZDYyYzFlM2U1MTYyL3RhYmxlOjMyYWRkZWUwZTQ0MjQ0NjJiYzFjMzA0NWE0YTQ5NzEyL3RhYmxlcmFuZ2U6MzJhZGRlZTBlNDQyNDQ2MmJjMWMzMDQ1YTRhNDk3MTJfNi0xLTEtMS0yNTU1OQ_b4bead26-2735-4dcd-97d8-c03c262f669c"
      unitRef="shares">29074086</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80MC9mcmFnOmJlNWZjYmY0ODg0YTQ3MjNhNzllZDYyYzFlM2U1MTYyL3RhYmxlOjMyYWRkZWUwZTQ0MjQ0NjJiYzFjMzA0NWE0YTQ5NzEyL3RhYmxlcmFuZ2U6MzJhZGRlZTBlNDQyNDQ2MmJjMWMzMDQ1YTRhNDk3MTJfNi0zLTEtMS0yNTU1OQ_17e449bb-fefb-4cab-9e02-80e5ffb3b453"
      unitRef="shares">24107682</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80MC9mcmFnOmJlNWZjYmY0ODg0YTQ3MjNhNzllZDYyYzFlM2U1MTYyL3RhYmxlOjMyYWRkZWUwZTQ0MjQ0NjJiYzFjMzA0NWE0YTQ5NzEyL3RhYmxlcmFuZ2U6MzJhZGRlZTBlNDQyNDQ2MmJjMWMzMDQ1YTRhNDk3MTJfNi0zLTEtMS0yNTU1OQ_4464e212-4cc4-4d3b-a3a5-1c96bcfde708"
      unitRef="shares">24107682</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80MC9mcmFnOmJlNWZjYmY0ODg0YTQ3MjNhNzllZDYyYzFlM2U1MTYyL3RleHRyZWdpb246YmU1ZmNiZjQ4ODRhNDcyM2E3OWVkNjJjMWUzZTUxNjJfMTA2MDU_adf3ade6-61af-4ed2-9cdd-31e8221c78dd">Segment InformationThe Company's chief operating decision maker ("CODM") regularly reviews disaggregated financial information for various operating segments. Starting in 2021, the financial information regularly reviewed by the CODM was revised and the operating segments, which were determined to be operating and reportable segments, were (i) Biopharmaceuticals, (ii) Exemplar, and (iii) Trans Ova. The Biopharmaceuticals reportable segment is primarily comprised of the Company's legal entities of PGEN Therapeutics and ActoBio. All of Precigen's consolidated subsidiaries and operating divisions that did not meet the quantitative thresholds to report separately are combined and reported in a single category, All Other. See Note 1 for a description of PGEN Therapeutics, ActoBio, Exemplar, and Trans Ova. Corporate expenses, which are not allocated to the segments and are managed at a consolidated level, include costs associated with general and administrative functions, including the Company's finance, accounting, legal, human resources, information technology, corporate communication, and investor relations functions. Corporate expenses exclude interest expense, depreciation and amortization, gain or loss on disposals of assets, stock-based compensation expense, loss on settlement agreement, and equity in net loss of affiliates and include unrealized and realized gains and losses on the Company's securities portfolio as well as dividend income.</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80MC9mcmFnOmJlNWZjYmY0ODg0YTQ3MjNhNzllZDYyYzFlM2U1MTYyL3RleHRyZWdpb246YmU1ZmNiZjQ4ODRhNDcyM2E3OWVkNjJjMWUzZTUxNjJfMTA2MjM_989b3f77-ee0e-42e1-a27a-1061bcca5fc3">&lt;div style="margin-top:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates.&lt;/span&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80MC9mcmFnOmJlNWZjYmY0ODg0YTQ3MjNhNzllZDYyYzFlM2U1MTYyL3RleHRyZWdpb246YmU1ZmNiZjQ4ODRhNDcyM2E3OWVkNjJjMWUzZTUxNjJfMTA1MjA_006485b5-7678-4021-b82c-12fae14f5170">&lt;div style="margin-top:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In August 2020, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2020-06, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Debt&#x2014;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#x2014;Contracts in Entity's Own Equity (Subtopic 815-40)&#x2014;Accounting for Convertible Instruments and Contracts in an Entity's Own Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; ("ASU 2020-06"&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;. Under ASU 2020-06, the embedded conversion features are no longer separated from the host contract for convertible instruments with conversion features that are not required to be accounted for as derivatives under Topic 815, or that do not result in substantial premiums accounted for as paid-in capital. Consequently, a convertible debt instrument will be accounted for as a single liability measured at its amortized cost, as long as no other features require bifurcation and recognition as derivatives. The new guidance also requires the if-converted method to be applied for all convertible instruments. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We adopted ASU 2020-06 on January 1, 2022 using the modified retrospective transition method, which resulted in an increase to our reported long-term debt outstanding, net of current portion, of $18,196, a decrease to our additional paid-in capital of $36,868, and a corresponding cumulative-effect reduction to our opening accumulated deficit of $18,672. The adoption of ASU 2020-06 is expected to reduce non-cash interest expense related to existing convertible debt outstanding by approximately $11,800 for the year ending December 31, 2022, and did not have an impact on our consolidated cash flows. The use of the if-converted method did not have an impact on our overall earnings per share calculation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Issued Accounting Pronouncements Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There are no accounting standards which have not yet been adopted that are expected to have a significant impact on our financial statements and related disclosures.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i026820ce93f04afc9c498f6af35f806b_I20220101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80MC9mcmFnOmJlNWZjYmY0ODg0YTQ3MjNhNzllZDYyYzFlM2U1MTYyL3RleHRyZWdpb246YmU1ZmNiZjQ4ODRhNDcyM2E3OWVkNjJjMWUzZTUxNjJfMjE5OTAyMzI3NTUzMQ_79ac055d-2150-4103-9e59-b38075c17a7c"
      unitRef="usd">18196000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="icf421d5fc50e4e85892b55cbde212eab_I20220101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80MC9mcmFnOmJlNWZjYmY0ODg0YTQ3MjNhNzllZDYyYzFlM2U1MTYyL3RleHRyZWdpb246YmU1ZmNiZjQ4ODRhNDcyM2E3OWVkNjJjMWUzZTUxNjJfMjE5OTAyMzI3NTU0Ng_9871878d-ccfd-45ab-8aa2-aa90748fb15d"
      unitRef="usd">36868000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4f92c06e9bad430cac755e9610e9f9b5_I20220101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80MC9mcmFnOmJlNWZjYmY0ODg0YTQ3MjNhNzllZDYyYzFlM2U1MTYyL3RleHRyZWdpb246YmU1ZmNiZjQ4ODRhNDcyM2E3OWVkNjJjMWUzZTUxNjJfMjE5OTAyMzI3NTUzOQ_78307361-5530-42d5-8a79-757ffe524ef3"
      unitRef="usd">18672000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <pgen:InterestExpenseDebtAmortizationofDebtDiscountPremiumandDebtIssuanceCosts
      contextRef="ia9d87a352497452f99e9459f9be7d3fa_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80MC9mcmFnOmJlNWZjYmY0ODg0YTQ3MjNhNzllZDYyYzFlM2U1MTYyL3RleHRyZWdpb246YmU1ZmNiZjQ4ODRhNDcyM2E3OWVkNjJjMWUzZTUxNjJfMjE5OTAyMzI3NTU1Mw_ca1bf7f1-2270-47f7-8c83-8e64a296c167"
      unitRef="usd">-11800000</pgen:InterestExpenseDebtAmortizationofDebtDiscountPremiumandDebtIssuanceCosts>
    <us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80My9mcmFnOmZiOTRjN2FlZjIyYzQ5OWNiZmJkM2ExNzE2NzMyMDY4L3RleHRyZWdpb246ZmI5NGM3YWVmMjJjNDk5Y2JmYmQzYTE3MTY3MzIwNjhfODM4Ng_dd7052c6-5328-4bbe-83b8-99b44726529e">Discontinued Operations&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Where applicable, the notes to the accompanying condensed consolidated financial statements have been updated to reflect information pertaining to the Company's continuing operations based on the discontinued operations summarized below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;MBP Titan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a result of market uncertainty driven by the COVID-19 pandemic and the state of the energy sector raising significant challenges for the strategic alternatives pursued by MBP Titan, beginning in the second quarter of 2020 and throughout the remainder of 2020, the Company suspended MBP Titan's operations, preserved certain of MBP Titan's intellectual property, terminated all of its personnel, and undertook steps to dispose of its other assets and obligations. The wind down of MBP Titan's activities was substantially completed by December 31, 2020, with the final disposition of certain property and equipment and the facility operating lease occurring in January 2021. This discontinuation of operations represented the continuation of a strategic shift to becoming a primarily healthcare company advancing technologies and products that address complex healthcare challenges that the Company commenced in 2020. The assets, liabilities, and expenses related to the discontinued operations of MBP Titan are reclassified and presented as discontinued operations in the accompanying condensed consolidated financial statements for all periods.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The January 2021 sale of property and equipment resulted in a gain on disposal of assets of $464, which is included in income from discontinued operations in the accompanying condensed consolidated statement of operations for the three months ended March 31, 2021. In January 2021, the Company executed termination and recapture agreements with the landlord of the leased facility used in MBP Titan's operations, thereby relieving the Company of all of its obligations related to the facility that were originally due to expire in July 2025. This lease termination resulted in a gain of $4,602, which is also included in income from discontinued operations in the accompanying condensed consolidated statement of operations for the three months ended March 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;After the wind down of MBP Titan, certain assets and contractual obligations which were previously managed by MBP Titan continue to be managed at the Precigen corporate level. These remaining assets and contractual obligations include the Company's equity interest in and collaboration agreements with Intrexon Energy Partners, LLC ("Intrexon Energy Partners"), and Intrexon Energy Partners II, LLC ("Intrexon Energy Partners II"), including the associated deferred revenue remaining under each collaboration agreement (Notes 4 and 5), as well as the associated intellectual property developed by MBP Titan to date. These assets, liabilities, and related historical revenue and equity losses are included in the Company's operating results from continuing operations in the accompanying condensed consolidated financial statements for all periods presented as a result of the Company's continuing involvement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no discontinued operations related to MBP Titan for the three months ended March 31, 2022. The following table presents the financial results of discontinued operations related to MBP Titan for the three months ended March 31, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.274%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:83.696%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.478%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&#160;&lt;br/&gt;&#160;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:7pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the significant noncash items, purchases of property, plant and equipment, and proceeds from sales of assets for the discontinued operations related to MBP Titan for the three months ended March 31, 2021 that are included in the accompanying condensed consolidated statements of cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.203%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.991%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&#160;&lt;br/&gt;&#160;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Adjustments to reconcile net loss to net cash used in operating activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain on disposals of assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(464)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncash gain on termination of leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,602)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash flows from investing activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proceeds from sales of assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,083&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock>
    <us-gaap:GainLossOnDispositionOfAssets1
      contextRef="icdf8637396524cf1ace92d8e586b1a80_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80My9mcmFnOmZiOTRjN2FlZjIyYzQ5OWNiZmJkM2ExNzE2NzMyMDY4L3RleHRyZWdpb246ZmI5NGM3YWVmMjJjNDk5Y2JmYmQzYTE3MTY3MzIwNjhfMTU3MA_7347517d-f394-45bd-a956-0fafc6005193"
      unitRef="usd">464000</us-gaap:GainLossOnDispositionOfAssets1>
    <us-gaap:GainLossOnTerminationOfLease
      contextRef="icdf8637396524cf1ace92d8e586b1a80_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80My9mcmFnOmZiOTRjN2FlZjIyYzQ5OWNiZmJkM2ExNzE2NzMyMDY4L3RleHRyZWdpb246ZmI5NGM3YWVmMjJjNDk5Y2JmYmQzYTE3MTY3MzIwNjhfMjAzMg_db59c864-8aa4-40b1-ae41-2197a893ae9d"
      unitRef="usd">4602000</us-gaap:GainLossOnTerminationOfLease>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="icdf8637396524cf1ace92d8e586b1a80_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80My9mcmFnOmZiOTRjN2FlZjIyYzQ5OWNiZmJkM2ExNzE2NzMyMDY4L3RleHRyZWdpb246ZmI5NGM3YWVmMjJjNDk5Y2JmYmQzYTE3MTY3MzIwNjhfMzI5ODUzNDg5NzM3Mg_788d4ff6-08f2-4ac4-a2af-1b8b5f35b58a"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80My9mcmFnOmZiOTRjN2FlZjIyYzQ5OWNiZmJkM2ExNzE2NzMyMDY4L3RleHRyZWdpb246ZmI5NGM3YWVmMjJjNDk5Y2JmYmQzYTE3MTY3MzIwNjhfODM4Nw_6c607219-ec87-41dd-bc88-5b8671779c43">The following table presents the financial results of discontinued operations related to MBP Titan for the three months ended March 31, 2021:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.274%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:83.696%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.478%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&#160;&lt;br/&gt;&#160;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:7pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the significant noncash items, purchases of property, plant and equipment, and proceeds from sales of assets for the discontinued operations related to MBP Titan for the three months ended March 31, 2021 that are included in the accompanying condensed consolidated statements of cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.203%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.991%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&#160;&lt;br/&gt;&#160;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Adjustments to reconcile net loss to net cash used in operating activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain on disposals of assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(464)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncash gain on termination of leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,602)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash flows from investing activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proceeds from sales of assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,083&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense
      contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80My9mcmFnOmZiOTRjN2FlZjIyYzQ5OWNiZmJkM2ExNzE2NzMyMDY4L3RhYmxlOmM4MmM5MmIxYzA3NTQwYmRiNjgwOWIwYmY4ZDhmYzEwL3RhYmxlcmFuZ2U6YzgyYzkyYjFjMDc1NDBiZGI2ODA5YjBiZjhkOGZjMTBfMy0zLTEtMS0xNTYwNA_fde0dbd5-2cc6-470b-a7ef-bf32d86f66a3"
      unitRef="usd">4526000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss
      contextRef="if6cb7e8397b34ee6a457ba010484ed09_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80My9mcmFnOmZiOTRjN2FlZjIyYzQ5OWNiZmJkM2ExNzE2NzMyMDY4L3RhYmxlOmM4MmM5MmIxYzA3NTQwYmRiNjgwOWIwYmY4ZDhmYzEwL3RhYmxlcmFuZ2U6YzgyYzkyYjFjMDc1NDBiZGI2ODA5YjBiZjhkOGZjMTBfNC0zLTEtMS0xNTYwNA_8e2ce411-2afd-4f16-af2f-c108c30a6590"
      unitRef="usd">4526000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
      contextRef="if6cb7e8397b34ee6a457ba010484ed09_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80My9mcmFnOmZiOTRjN2FlZjIyYzQ5OWNiZmJkM2ExNzE2NzMyMDY4L3RhYmxlOmM4MmM5MmIxYzA3NTQwYmRiNjgwOWIwYmY4ZDhmYzEwL3RhYmxlcmFuZ2U6YzgyYzkyYjFjMDc1NDBiZGI2ODA5YjBiZjhkOGZjMTBfOS0zLTEtMS0xNTYwNA_3005d26d-a927-4862-8f72-297d547cf22c"
      unitRef="usd">4526000</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="if6cb7e8397b34ee6a457ba010484ed09_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80My9mcmFnOmZiOTRjN2FlZjIyYzQ5OWNiZmJkM2ExNzE2NzMyMDY4L3RhYmxlOmM4MmM5MmIxYzA3NTQwYmRiNjgwOWIwYmY4ZDhmYzEwL3RhYmxlcmFuZ2U6YzgyYzkyYjFjMDc1NDBiZGI2ODA5YjBiZjhkOGZjMTBfMTEtMy0xLTEtMTU2MDQ_5a380377-44c4-46b2-b52d-c8bd8e3b56a7"
      unitRef="usd">4526000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:GainLossOnDispositionOfAssets1
      contextRef="if6cb7e8397b34ee6a457ba010484ed09_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80My9mcmFnOmZiOTRjN2FlZjIyYzQ5OWNiZmJkM2ExNzE2NzMyMDY4L3RhYmxlOmE4MTVhNWM4NzEwMTQ4MDBiMTgyMzgxNjVkZTAxY2JkL3RhYmxlcmFuZ2U6YTgxNWE1Yzg3MTAxNDgwMGIxODIzODE2NWRlMDFjYmRfNi0zLTEtMS0xNTYwNA_85f5984a-65b7-4313-8112-7e3a8375fac8"
      unitRef="usd">464000</us-gaap:GainLossOnDispositionOfAssets1>
    <us-gaap:GainLossOnTerminationOfLease
      contextRef="if6cb7e8397b34ee6a457ba010484ed09_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80My9mcmFnOmZiOTRjN2FlZjIyYzQ5OWNiZmJkM2ExNzE2NzMyMDY4L3RhYmxlOmE4MTVhNWM4NzEwMTQ4MDBiMTgyMzgxNjVkZTAxY2JkL3RhYmxlcmFuZ2U6YTgxNWE1Yzg3MTAxNDgwMGIxODIzODE2NWRlMDFjYmRfMTItMy0xLTEtMTU2MDQ_d0f24592-4402-43a2-9c29-57bba01a31e9"
      unitRef="usd">4602000</us-gaap:GainLossOnTerminationOfLease>
    <us-gaap:ProceedsFromSaleOfOtherAssetsInvestingActivities
      contextRef="if6cb7e8397b34ee6a457ba010484ed09_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80My9mcmFnOmZiOTRjN2FlZjIyYzQ5OWNiZmJkM2ExNzE2NzMyMDY4L3RhYmxlOmE4MTVhNWM4NzEwMTQ4MDBiMTgyMzgxNjVkZTAxY2JkL3RhYmxlcmFuZ2U6YTgxNWE1Yzg3MTAxNDgwMGIxODIzODE2NWRlMDFjYmRfMTctMy0xLTEtMTU2MDQ_2bd2b7aa-5dc3-4cf1-aa44-7f2a3ff71770"
      unitRef="usd">1083000</us-gaap:ProceedsFromSaleOfOtherAssetsInvestingActivities>
    <us-gaap:EquityMethodInvestmentsDisclosureTextBlock
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80Ni9mcmFnOmQ1MDJiMjAyNTU4MzQ4NGNhZGIyZjJhZDJiMzEwMjliL3RleHRyZWdpb246ZDUwMmIyMDI1NTgzNDg0Y2FkYjJmMmFkMmIzMTAyOWJfNDY5OQ_8470753c-d45b-4310-ad9d-b8ef732c761b">Investments in Joint Ventures&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Intrexon Energy Partners&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2014, the Company and certain investors (the "IEP Investors"), including an affiliate of Third Security, LLC ("Third Security"), entered into a Limited Liability Company Agreement that governs the affairs and conduct of business of Intrexon Energy Partners, a JV formed to optimize and scale-up the Company's MBP technology for the production of certain fuels and lubricants. The Company also entered into an exclusive channel collaboration ("ECC") with Intrexon Energy Partners providing exclusive rights to the Company's technology for the use in bioconversion for the production of certain fuels and lubricants, as a result of which the Company received a technology access fee of $25,000 while retaining a 50% membership interest in Intrexon Energy Partners. The IEP Investors made initial capital contributions, totaling $25,000 in the aggregate, in exchange for pro rata membership interests in Intrexon Energy Partners totaling 50%. In addition, Precigen committed to make capital contributions of up to $25,000, and the IEP Investors, as a group and pro rata in accordance with their respective membership interests in Intrexon Energy Partners, committed to make additional capital contributions of up to $25,000, at the request of Intrexon Energy Partners' board of managers (the "Intrexon Energy Partners Board") and subject to certain limitations. As of March&#160;31, 2022, the Company's remaining commitment was $4,225. Intrexon Energy Partners is governed by the Intrexon Energy Partners Board, which has five members. Two members of the Intrexon Energy Partners Board are designated by the Company and three members are designated by a majority of the IEP Investors. The Company and the IEP Investors have the right, but not the obligation, to make additional capital contributions above the initial limits when and if solicited by the Intrexon Energy Partners Board.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's investment in Intrexon Energy Partners was $(429) and $(428) as of March&#160;31, 2022 and December&#160;31, 2021, respectively, and is included in other accrued liabilities in the accompanying condensed consolidated balance sheets, which represents the Company's equity in losses for contractually committed contributions to Intrexon Energy Partners.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See Note 3 and 16 for additional discussion regarding the Company's investment in Intrexon Energy Partners.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Intrexon Energy Partners II&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2015, the Company and certain investors (the "IEPII Investors"), entered into a Limited Liability Company Agreement that governs the affairs and conduct of business of Intrexon Energy Partners II, a JV formed to utilize the Company's MBP technology for the production of 1,4-butanediol, an industrial chemical used to manufacture spandex, polyurethane, plastics, and polyester. The Company also entered into an ECC with Intrexon Energy Partners II that provides exclusive rights to the Company's technology for use in the field, as a result of which the Company received a technology access fee of $18,000 while retaining a 50% membership interest in Intrexon Energy Partners II. The IEPII Investors made initial capital contributions, totaling $18,000 in the aggregate, in exchange for pro rata membership interests in Intrexon Energy Partners II totaling 50%. In December 2015, the owners of Intrexon Energy Partners II made a capital contribution of $4,000, half of which was paid by the Company. Precigen committed to make additional capital contributions of up to $10,000, and the IEPII Investors, as a group and pro rata in accordance with their respective membership interests in Intrexon Energy Partners II, committed to make additional capital contributions of up to $10,000, at the request of Intrexon Energy Partners II's board of managers (the "Intrexon Energy Partners II Board") and subject to certain limitations. As of March&#160;31, 2022, the Company's remaining commitment was $10,000. Intrexon Energy Partners II is governed by the Intrexon Energy Partners II Board, which has five &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;members. One member of the Intrexon Energy Partners II Board is designated by the Company and four members are designated by a majority of the IEPII Investors. The Company and the IEPII Investors have the right, but not the obligation, to make additional capital contributions above the initial limits when and if solicited by the Intrexon Energy Partners II Board.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's investment in Intrexon Energy Partners II was $(435) as of March&#160;31, 2022 and December&#160;31, 2021, and is included in other accrued liabilities in the accompanying condensed consolidated balance sheets, which represents the Company's equity in losses for contractually committed contributions to Intrexon Energy Partners II.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See Notes 3 and 16 for additional discussion regarding the Company's investment in Intrexon Energy Partners II.&lt;/span&gt;&lt;/div&gt;</us-gaap:EquityMethodInvestmentsDisclosureTextBlock>
    <pgen:CollaborativeArrangementConsiderationReceivedValue
      contextRef="i9c206d84156440a49a72497604ec8972_D20140301-20140331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80Ni9mcmFnOmQ1MDJiMjAyNTU4MzQ4NGNhZGIyZjJhZDJiMzEwMjliL3RleHRyZWdpb246ZDUwMmIyMDI1NTgzNDg0Y2FkYjJmMmFkMmIzMTAyOWJfNzMz_6d493a6e-c139-4c0d-a1b3-17e5616bcaf0"
      unitRef="usd">25000000</pgen:CollaborativeArrangementConsiderationReceivedValue>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i2e48cd233bc847118ac00256b671c120_I20140331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80Ni9mcmFnOmQ1MDJiMjAyNTU4MzQ4NGNhZGIyZjJhZDJiMzEwMjliL3RleHRyZWdpb246ZDUwMmIyMDI1NTgzNDg0Y2FkYjJmMmFkMmIzMTAyOWJfNzU0_e763b7a8-4152-4871-8624-ea4af09bd995"
      unitRef="number">0.50</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:PaymentsToAcquireInterestInJointVenture
      contextRef="i06c7dcadcbde427c93346762e97a9ff8_D20140301-20140331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80Ni9mcmFnOmQ1MDJiMjAyNTU4MzQ4NGNhZGIyZjJhZDJiMzEwMjliL3RleHRyZWdpb246ZDUwMmIyMDI1NTgzNDg0Y2FkYjJmMmFkMmIzMTAyOWJfODY5_1aaf79bc-90a3-4280-b872-0925830ed930"
      unitRef="usd">25000000</us-gaap:PaymentsToAcquireInterestInJointVenture>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i116e7745d66e431e9372cd8064a125ac_I20140331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80Ni9mcmFnOmQ1MDJiMjAyNTU4MzQ4NGNhZGIyZjJhZDJiMzEwMjliL3RleHRyZWdpb246ZDUwMmIyMDI1NTgzNDg0Y2FkYjJmMmFkMmIzMTAyOWJfOTcz_aa13521c-551e-4e88-8578-343360bdcaca"
      unitRef="number">0.50</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <pgen:JointVentureAdditionalCapitalContributionsCommitted
      contextRef="i2e48cd233bc847118ac00256b671c120_I20140331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80Ni9mcmFnOmQ1MDJiMjAyNTU4MzQ4NGNhZGIyZjJhZDJiMzEwMjliL3RleHRyZWdpb246ZDUwMmIyMDI1NTgzNDg0Y2FkYjJmMmFkMmIzMTAyOWJfMTA0OA_ea1444a4-6cdb-4574-9068-1ec2b3c8837a"
      unitRef="usd">25000000</pgen:JointVentureAdditionalCapitalContributionsCommitted>
    <pgen:JointVentureAdditionalCapitalContributionsCommitted
      contextRef="i116e7745d66e431e9372cd8064a125ac_I20140331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80Ni9mcmFnOmQ1MDJiMjAyNTU4MzQ4NGNhZGIyZjJhZDJiMzEwMjliL3RleHRyZWdpb246ZDUwMmIyMDI1NTgzNDg0Y2FkYjJmMmFkMmIzMTAyOWJfMTI0NQ_338fe5d8-47b1-43dc-9c2c-830514bfe7c1"
      unitRef="usd">25000000</pgen:JointVentureAdditionalCapitalContributionsCommitted>
    <pgen:JointVentureAdditionalCapitalContributionsCommittedRemainingCommitment
      contextRef="ia8700e0f55454cbba3fb9fd96a94fbbb_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80Ni9mcmFnOmQ1MDJiMjAyNTU4MzQ4NGNhZGIyZjJhZDJiMzEwMjliL3RleHRyZWdpb246ZDUwMmIyMDI1NTgzNDg0Y2FkYjJmMmFkMmIzMTAyOWJfMTQzNQ_f9144e9b-4ba6-416b-9141-810058f6e52c"
      unitRef="usd">4225000</pgen:JointVentureAdditionalCapitalContributionsCommittedRemainingCommitment>
    <pgen:NumberofSeatsonGoverningBoard
      contextRef="ia8700e0f55454cbba3fb9fd96a94fbbb_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80Ni9mcmFnOmQ1MDJiMjAyNTU4MzQ4NGNhZGIyZjJhZDJiMzEwMjliL3RleHRyZWdpb246ZDUwMmIyMDI1NTgzNDg0Y2FkYjJmMmFkMmIzMTAyOWJfMTUyNQ_caebb5d8-4913-437e-8e8d-840032f881d9"
      unitRef="board_seat">5</pgen:NumberofSeatsonGoverningBoard>
    <pgen:NumberofSeatsonGoverningBoardInternallySelected
      contextRef="ia8700e0f55454cbba3fb9fd96a94fbbb_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80Ni9mcmFnOmQ1MDJiMjAyNTU4MzQ4NGNhZGIyZjJhZDJiMzEwMjliL3RleHRyZWdpb246ZDUwMmIyMDI1NTgzNDg0Y2FkYjJmMmFkMmIzMTAyOWJfMTUzNw_db48f5ae-f4e7-4aa4-8655-16f8b77302c9"
      unitRef="board_seat">2</pgen:NumberofSeatsonGoverningBoardInternallySelected>
    <pgen:NumberofSeatsonGoverningBoardExternallySelected
      contextRef="ia8700e0f55454cbba3fb9fd96a94fbbb_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80Ni9mcmFnOmQ1MDJiMjAyNTU4MzQ4NGNhZGIyZjJhZDJiMzEwMjliL3RleHRyZWdpb246ZDUwMmIyMDI1NTgzNDg0Y2FkYjJmMmFkMmIzMTAyOWJfMTYyMA_a41bd40b-2622-4648-a3d8-830bb3b504d4"
      unitRef="board_seat">3</pgen:NumberofSeatsonGoverningBoardExternallySelected>
    <us-gaap:EquityMethodInvestments
      contextRef="i3f3182d245524e2f81bd8b3e49a24b72_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80Ni9mcmFnOmQ1MDJiMjAyNTU4MzQ4NGNhZGIyZjJhZDJiMzEwMjliL3RleHRyZWdpb246ZDUwMmIyMDI1NTgzNDg0Y2FkYjJmMmFkMmIzMTAyOWJfMTk0MA_f5187665-b6f1-4c74-8f1c-277c74f6af5e"
      unitRef="usd">-429000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="ic5473cecc9e948a696238d2b93f19451_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80Ni9mcmFnOmQ1MDJiMjAyNTU4MzQ4NGNhZGIyZjJhZDJiMzEwMjliL3RleHRyZWdpb246ZDUwMmIyMDI1NTgzNDg0Y2FkYjJmMmFkMmIzMTAyOWJfMTk0Nw_ca1e12ad-c9cb-450f-9385-008f9fdc0e88"
      unitRef="usd">-428000</us-gaap:EquityMethodInvestments>
    <pgen:CollaborativeArrangementConsiderationReceivedValue
      contextRef="icbe6e461c61143b794043bae863a8df6_D20151201-20151231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80Ni9mcmFnOmQ1MDJiMjAyNTU4MzQ4NGNhZGIyZjJhZDJiMzEwMjliL3RleHRyZWdpb246ZDUwMmIyMDI1NTgzNDg0Y2FkYjJmMmFkMmIzMTAyOWJfMjk2Mw_62f612c4-3b54-4359-9d4f-a293952f448d"
      unitRef="usd">18000000</pgen:CollaborativeArrangementConsiderationReceivedValue>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="ib9f1d3ecd2254255a55eaec2585ccedb_I20151231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80Ni9mcmFnOmQ1MDJiMjAyNTU4MzQ4NGNhZGIyZjJhZDJiMzEwMjliL3RleHRyZWdpb246ZDUwMmIyMDI1NTgzNDg0Y2FkYjJmMmFkMmIzMTAyOWJfMjk4NA_caa7863b-be1d-4841-b459-1542e0d91421"
      unitRef="number">0.50</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:PaymentsToAcquireInterestInJointVenture
      contextRef="i5ae9c5a2b8e94b08b425df57ed7b8b69_D20151201-20151231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80Ni9mcmFnOmQ1MDJiMjAyNTU4MzQ4NGNhZGIyZjJhZDJiMzEwMjliL3RleHRyZWdpb246ZDUwMmIyMDI1NTgzNDg0Y2FkYjJmMmFkMmIzMTAyOWJfMzEwNA_eff67aa5-adc5-4d99-9141-bade50f25d90"
      unitRef="usd">18000000</us-gaap:PaymentsToAcquireInterestInJointVenture>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="iab1aff7710f9412391af1e5fd6967099_I20151231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80Ni9mcmFnOmQ1MDJiMjAyNTU4MzQ4NGNhZGIyZjJhZDJiMzEwMjliL3RleHRyZWdpb246ZDUwMmIyMDI1NTgzNDg0Y2FkYjJmMmFkMmIzMTAyOWJfMzIxMQ_bed30ff5-5ee6-4f82-bfaf-003d6f8bf62f"
      unitRef="number">0.50</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:PaymentsToAcquireInterestInJointVenture
      contextRef="iebe277ea9243444d8b84ba5c80f13e43_D20151201-20151231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80Ni9mcmFnOmQ1MDJiMjAyNTU4MzQ4NGNhZGIyZjJhZDJiMzEwMjliL3RleHRyZWdpb246ZDUwMmIyMDI1NTgzNDg0Y2FkYjJmMmFkMmIzMTAyOWJfMzMwNg_f9ffe823-8742-47e9-8a52-3607b2fcf2ac"
      unitRef="usd">4000000</us-gaap:PaymentsToAcquireInterestInJointVenture>
    <pgen:JointVentureAdditionalCapitalContributionsCommitted
      contextRef="ib9f1d3ecd2254255a55eaec2585ccedb_I20151231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80Ni9mcmFnOmQ1MDJiMjAyNTU4MzQ4NGNhZGIyZjJhZDJiMzEwMjliL3RleHRyZWdpb246ZDUwMmIyMDI1NTgzNDg0Y2FkYjJmMmFkMmIzMTAyOWJfMzQxOA_e11bf182-e5ad-4b50-b11c-9377b2847baf"
      unitRef="usd">10000000</pgen:JointVentureAdditionalCapitalContributionsCommitted>
    <pgen:JointVentureAdditionalCapitalContributionsCommitted
      contextRef="iab1aff7710f9412391af1e5fd6967099_I20151231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80Ni9mcmFnOmQ1MDJiMjAyNTU4MzQ4NGNhZGIyZjJhZDJiMzEwMjliL3RleHRyZWdpb246ZDUwMmIyMDI1NTgzNDg0Y2FkYjJmMmFkMmIzMTAyOWJfMzYyMA_7f7f67e2-cc05-4c12-997b-8accf480501a"
      unitRef="usd">10000000</pgen:JointVentureAdditionalCapitalContributionsCommitted>
    <pgen:JointVentureAdditionalCapitalContributionsCommittedRemainingCommitment
      contextRef="i68a8c3e611e7457496584dcd01bb9d77_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80Ni9mcmFnOmQ1MDJiMjAyNTU4MzQ4NGNhZGIyZjJhZDJiMzEwMjliL3RleHRyZWdpb246ZDUwMmIyMDI1NTgzNDg0Y2FkYjJmMmFkMmIzMTAyOWJfMzgxNw_a1933e6b-3831-4f83-abcf-87aff9e20e66"
      unitRef="usd">10000000</pgen:JointVentureAdditionalCapitalContributionsCommittedRemainingCommitment>
    <pgen:NumberofSeatsonGoverningBoard
      contextRef="ib9f1d3ecd2254255a55eaec2585ccedb_I20151231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80Ni9mcmFnOmQ1MDJiMjAyNTU4MzQ4NGNhZGIyZjJhZDJiMzEwMjliL3RleHRyZWdpb246ZDUwMmIyMDI1NTgzNDg0Y2FkYjJmMmFkMmIzMTAyOWJfMzkxMw_ff34e383-0c62-4de2-a8cc-4a47eb4b960a"
      unitRef="board_seat">5</pgen:NumberofSeatsonGoverningBoard>
    <pgen:NumberofSeatsonGoverningBoardInternallySelected
      contextRef="ib9f1d3ecd2254255a55eaec2585ccedb_I20151231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80Ni9mcmFnOmQ1MDJiMjAyNTU4MzQ4NGNhZGIyZjJhZDJiMzEwMjliL3RleHRyZWdpb246ZDUwMmIyMDI1NTgzNDg0Y2FkYjJmMmFkMmIzMTAyOWJfMzkyNQ_1edbd0b1-ca03-4600-a1f7-b1c8f7afebfe"
      unitRef="board_seat">1</pgen:NumberofSeatsonGoverningBoardInternallySelected>
    <pgen:NumberofSeatsonGoverningBoardExternallySelected
      contextRef="ib9f1d3ecd2254255a55eaec2585ccedb_I20151231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80Ni9mcmFnOmQ1MDJiMjAyNTU4MzQ4NGNhZGIyZjJhZDJiMzEwMjliL3RleHRyZWdpb246ZDUwMmIyMDI1NTgzNDg0Y2FkYjJmMmFkMmIzMTAyOWJfNDAwOQ_6aeb8916-f412-4649-9246-36c1a9ff9951"
      unitRef="board_seat">4</pgen:NumberofSeatsonGoverningBoardExternallySelected>
    <us-gaap:EquityMethodInvestments
      contextRef="i66b17135fbc04c12a62fb56fd2cabc18_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80Ni9mcmFnOmQ1MDJiMjAyNTU4MzQ4NGNhZGIyZjJhZDJiMzEwMjliL3RleHRyZWdpb246ZDUwMmIyMDI1NTgzNDg0Y2FkYjJmMmFkMmIzMTAyOWJfNDMzOQ_5ca440be-0e7d-47b5-94a0-6135d494bd29"
      unitRef="usd">-435000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="i1cd2167114c44a24bb2c013a330df7c4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80Ni9mcmFnOmQ1MDJiMjAyNTU4MzQ4NGNhZGIyZjJhZDJiMzEwMjliL3RleHRyZWdpb246ZDUwMmIyMDI1NTgzNDg0Y2FkYjJmMmFkMmIzMTAyOWJfNDMzOQ_a3ddfeee-61fd-4ad0-9b5b-7a7ee68c434f"
      unitRef="usd">-435000</us-gaap:EquityMethodInvestments>
    <us-gaap:CollaborativeArrangementDisclosureTextBlock
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80OS9mcmFnOjg2NGZhYzcxZGQ0YzQ0YWM4YjA3ZmI5NDM1ZGY5YThiL3RleHRyZWdpb246ODY0ZmFjNzFkZDRjNDRhYzhiMDdmYjk0MzVkZjlhOGJfNDIzMA_3f545884-bd9c-412b-b436-4cf8292a0f81">Collaboration and Licensing Revenue&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Historically, the Company has derived collaboration and licensing revenue through agreements with counterparties for the development and commercialization of products enabled by the Company's technology platforms. These collaborations and licensing agreements may provide for multiple promises to be satisfied by the Company and typically include a license to the Company's technology platforms, participation in collaboration committees, and performance of certain research and development services. Based on the nature of the promises in the Company's collaboration and licensing agreements, the Company typically combines most of its promises into a single performance obligation because the promises are highly interrelated and not individually distinct. Options to acquire additional services are considered to determine if they constitute material rights. At contract inception, the transaction price is typically the upfront payment received and is allocated to the performance obligations. The Company has determined the transaction price should be recognized as revenue based on its measure of progress under the agreement primarily based on inputs necessary to fulfill the performance obligation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes the reimbursement payments received for research and development efforts in the period when the services are performed, in connection with the single performance obligation discussed above. The reimbursements relate specifically to the Company's efforts to provide services, and the reimbursements are consistent with what the Company would typically charge other collaborators for similar services. The Company assesses the uncertainty of when and if any milestones will be achieved to determine whether the milestone is included in the transaction price. The Company then assesses whether the revenue is constrained based on whether it is probable that a significant reversal of revenue would not occur when the uncertainty is resolved. Royalties, including sales-based milestones, received under the agreements will be recognized as revenue when sales have occurred because the Company applies the sales- or usage-based royalties recognition exception provided for under ASC Topic 606. The Company determined the application of this exception is appropriate because at the time the royalties are generated, the technology license granted in the agreement is the predominant item to which the royalties relate. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determines whether collaborations and licensing agreements are individually significant for disclosure based on a number of factors, including total revenue recorded by the Company pursuant to collaboration and licensing agreements, collaborators or licensees with equity method investments, or other qualitative factors. Collaboration and licensing revenues generated from consolidated subsidiaries are eliminated in consolidation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the amounts recorded as revenue in the condensed consolidated statements of operations for each significant counterparty to a collaboration or licensing agreement for the three months ended March&#160;31, 2022 and 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.728%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.616%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&#160;&lt;br/&gt;&#160;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Castle Creek Biosciences, Inc.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total (1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:7pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;Collaboration and licensing revenues include the recognition of $0 and $66 for the three months ended March 31, 2022 and 2021, respectively, associated with upfront and milestone payments which were previously deferred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There have been no significant changes to the agreements with our collaborators and licensees in the three months ended March 31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Deferred Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred revenue primarily consists of upfront and milestone consideration received for the Company's collaboration and licensing agreements. Revenue is recognized as services are performed. The arrangements classified as long-term (of which $21,205 is related to agreements with Intrexon Energy Partners L.L.C. and Intrexon Energy Partners II, L.L.C.) are not active while the respective counterparties evaluate the status of the project and its desired future development activities since the Company cannot reasonably estimate the amount of service to be performed over the next year.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred revenue consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Collaboration and licensing agreements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid product and service revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term portion of deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:CollaborativeArrangementDisclosureTextBlock>
    <pgen:CollaborationandLicensingRevenueTableTextBlock
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80OS9mcmFnOjg2NGZhYzcxZGQ0YzQ0YWM4YjA3ZmI5NDM1ZGY5YThiL3RleHRyZWdpb246ODY0ZmFjNzFkZDRjNDRhYzhiMDdmYjk0MzVkZjlhOGJfNDIxNg_27384353-7b4a-437a-b365-c4f86a5779bf">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the amounts recorded as revenue in the condensed consolidated statements of operations for each significant counterparty to a collaboration or licensing agreement for the three months ended March&#160;31, 2022 and 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.728%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.616%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&#160;&lt;br/&gt;&#160;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Castle Creek Biosciences, Inc.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total (1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:7pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;Collaboration and licensing revenues include the recognition of $0 and $66 for the three months ended March 31, 2022 and 2021, respectively, associated with upfront and milestone payments which were previously deferred.&lt;/span&gt;&lt;/div&gt;</pgen:CollaborationandLicensingRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie03a332075e24203bc226247706f4c0b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80OS9mcmFnOjg2NGZhYzcxZGQ0YzQ0YWM4YjA3ZmI5NDM1ZGY5YThiL3RhYmxlOjFhMzY3ODZmMzlmNzRiMjg5YmU0ZWNmNzAwZDM4YjU0L3RhYmxlcmFuZ2U6MWEzNjc4NmYzOWY3NGIyODliZTRlY2Y3MDBkMzhiNTRfNi0xLTEtMS0xNTYwNA_01c9419f-692d-48ad-ab71-db7b8523da98"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2d962f9fc84242dfaab1b8772723f495_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80OS9mcmFnOjg2NGZhYzcxZGQ0YzQ0YWM4YjA3ZmI5NDM1ZGY5YThiL3RhYmxlOjFhMzY3ODZmMzlmNzRiMjg5YmU0ZWNmNzAwZDM4YjU0L3RhYmxlcmFuZ2U6MWEzNjc4NmYzOWY3NGIyODliZTRlY2Y3MDBkMzhiNTRfNi0zLTEtMS0xNTYwNA_93f476e4-e31a-427e-aa26-3a0141b37db8"
      unitRef="usd">59000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8b919455fac14c5b89317ce54cc48c01_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80OS9mcmFnOjg2NGZhYzcxZGQ0YzQ0YWM4YjA3ZmI5NDM1ZGY5YThiL3RhYmxlOjFhMzY3ODZmMzlmNzRiMjg5YmU0ZWNmNzAwZDM4YjU0L3RhYmxlcmFuZ2U6MWEzNjc4NmYzOWY3NGIyODliZTRlY2Y3MDBkMzhiNTRfNy0xLTEtMS0xNTYwNA_81e93b21-409f-4155-a0e7-10e04183f84f"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie1435bc431da4d2fbeee0800a5bb6070_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80OS9mcmFnOjg2NGZhYzcxZGQ0YzQ0YWM4YjA3ZmI5NDM1ZGY5YThiL3RhYmxlOjFhMzY3ODZmMzlmNzRiMjg5YmU0ZWNmNzAwZDM4YjU0L3RhYmxlcmFuZ2U6MWEzNjc4NmYzOWY3NGIyODliZTRlY2Y3MDBkMzhiNTRfNy0zLTEtMS0xNTYwNA_7a181153-7337-4e22-abcc-6d8f7615252d"
      unitRef="usd">7000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7ee3165dd570445e98d48bc112a7c856_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80OS9mcmFnOjg2NGZhYzcxZGQ0YzQ0YWM4YjA3ZmI5NDM1ZGY5YThiL3RhYmxlOjFhMzY3ODZmMzlmNzRiMjg5YmU0ZWNmNzAwZDM4YjU0L3RhYmxlcmFuZ2U6MWEzNjc4NmYzOWY3NGIyODliZTRlY2Y3MDBkMzhiNTRfOC0xLTEtMS0xNTYwNA_3f8f5374-42a4-4140-8ac3-cc7c07670456"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i57c5cf448af9439d8ce80e1a7c173246_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80OS9mcmFnOjg2NGZhYzcxZGQ0YzQ0YWM4YjA3ZmI5NDM1ZGY5YThiL3RhYmxlOjFhMzY3ODZmMzlmNzRiMjg5YmU0ZWNmNzAwZDM4YjU0L3RhYmxlcmFuZ2U6MWEzNjc4NmYzOWY3NGIyODliZTRlY2Y3MDBkMzhiNTRfOC0zLTEtMS0xNTYwNA_8b23f13d-30cf-4d63-913d-76fee8ec8cea"
      unitRef="usd">66000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="ic5c07296b0ad4a3795796cdd98b70bfe_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80OS9mcmFnOjg2NGZhYzcxZGQ0YzQ0YWM4YjA3ZmI5NDM1ZGY5YThiL3RleHRyZWdpb246ODY0ZmFjNzFkZDRjNDRhYzhiMDdmYjk0MzVkZjlhOGJfMzIzMA_2351b5b8-d34e-4d90-9616-5dd1d3ee9b8d"
      unitRef="usd">0</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="i63f44e56a2d54df9a4c54a505c5e504c_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80OS9mcmFnOjg2NGZhYzcxZGQ0YzQ0YWM4YjA3ZmI5NDM1ZGY5YThiL3RleHRyZWdpb246ODY0ZmFjNzFkZDRjNDRhYzhiMDdmYjk0MzVkZjlhOGJfMzIzNw_0c88f7b7-71f0-4df3-a1b1-87873e5b4c55"
      unitRef="usd">66000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="ie8e1602cebb942fe9f1248b8494a1a7d_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80OS9mcmFnOjg2NGZhYzcxZGQ0YzQ0YWM4YjA3ZmI5NDM1ZGY5YThiL3RleHRyZWdpb246ODY0ZmFjNzFkZDRjNDRhYzhiMDdmYjk0MzVkZjlhOGJfMzg0ODI5MDcwMjU2MA_150eb5cc-55cd-4a8b-8a9c-05ebe7d3da89"
      unitRef="usd">21205000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80OS9mcmFnOjg2NGZhYzcxZGQ0YzQ0YWM4YjA3ZmI5NDM1ZGY5YThiL3RleHRyZWdpb246ODY0ZmFjNzFkZDRjNDRhYzhiMDdmYjk0MzVkZjlhOGJfNDIzMw_288c07bd-5c32-43c8-a92b-5b035c43e17b">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred revenue consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Collaboration and licensing agreements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid product and service revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term portion of deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i59e18c9f66844d49a7936ec00a3794ef_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80OS9mcmFnOjg2NGZhYzcxZGQ0YzQ0YWM4YjA3ZmI5NDM1ZGY5YThiL3RhYmxlOjU5M2E3ZjMxNGNiZjQ1OTliNjZkZDZkY2ExNzYxYmIzL3RhYmxlcmFuZ2U6NTkzYTdmMzE0Y2JmNDU5OWI2NmRkNmRjYTE3NjFiYjNfMS0xLTEtMS0xNTYwNA_86e7fbb9-4907-4c45-b13b-382b8246d8fa"
      unitRef="usd">23023000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i5d4f45253f074c3c817131697acd88c6_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80OS9mcmFnOjg2NGZhYzcxZGQ0YzQ0YWM4YjA3ZmI5NDM1ZGY5YThiL3RhYmxlOjU5M2E3ZjMxNGNiZjQ1OTliNjZkZDZkY2ExNzYxYmIzL3RhYmxlcmFuZ2U6NTkzYTdmMzE0Y2JmNDU5OWI2NmRkNmRjYTE3NjFiYjNfMS0zLTEtMS0xNTYwNA_e3f86bd8-5fb5-47df-9d61-85e9b4fd454f"
      unitRef="usd">23023000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i0b9d5326a05846d7a58b2f6cf8712aa2_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80OS9mcmFnOjg2NGZhYzcxZGQ0YzQ0YWM4YjA3ZmI5NDM1ZGY5YThiL3RhYmxlOjU5M2E3ZjMxNGNiZjQ1OTliNjZkZDZkY2ExNzYxYmIzL3RhYmxlcmFuZ2U6NTkzYTdmMzE0Y2JmNDU5OWI2NmRkNmRjYTE3NjFiYjNfMi0xLTEtMS0xNTYwNA_5c895f0f-38cf-4b0d-bae3-5905f72827bf"
      unitRef="usd">2511000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i87bf374ed035409bafb6050993401656_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80OS9mcmFnOjg2NGZhYzcxZGQ0YzQ0YWM4YjA3ZmI5NDM1ZGY5YThiL3RhYmxlOjU5M2E3ZjMxNGNiZjQ1OTliNjZkZDZkY2ExNzYxYmIzL3RhYmxlcmFuZ2U6NTkzYTdmMzE0Y2JmNDU5OWI2NmRkNmRjYTE3NjFiYjNfMi0zLTEtMS0xNTYwNA_f5efa5d5-5d9b-4452-b81b-a8cdd791ccaf"
      unitRef="usd">4229000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i0fb51aa6c5ef4219b2b7da5ce705fc81_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80OS9mcmFnOjg2NGZhYzcxZGQ0YzQ0YWM4YjA3ZmI5NDM1ZGY5YThiL3RhYmxlOjU5M2E3ZjMxNGNiZjQ1OTliNjZkZDZkY2ExNzYxYmIzL3RhYmxlcmFuZ2U6NTkzYTdmMzE0Y2JmNDU5OWI2NmRkNmRjYTE3NjFiYjNfMy0xLTEtMS0xNTYwNA_f3ccdcfe-ae31-4933-b7d4-894f018077fd"
      unitRef="usd">158000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="ie776f343946740da9a363c1b9559d961_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80OS9mcmFnOjg2NGZhYzcxZGQ0YzQ0YWM4YjA3ZmI5NDM1ZGY5YThiL3RhYmxlOjU5M2E3ZjMxNGNiZjQ1OTliNjZkZDZkY2ExNzYxYmIzL3RhYmxlcmFuZ2U6NTkzYTdmMzE0Y2JmNDU5OWI2NmRkNmRjYTE3NjFiYjNfMy0zLTEtMS0xNTYwNA_0440a7b1-d8ca-4ed3-a714-57d193b48b24"
      unitRef="usd">213000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80OS9mcmFnOjg2NGZhYzcxZGQ0YzQ0YWM4YjA3ZmI5NDM1ZGY5YThiL3RhYmxlOjU5M2E3ZjMxNGNiZjQ1OTliNjZkZDZkY2ExNzYxYmIzL3RhYmxlcmFuZ2U6NTkzYTdmMzE0Y2JmNDU5OWI2NmRkNmRjYTE3NjFiYjNfNC0xLTEtMS0xNTYwNA_38a45ad6-f415-4bd3-856f-9ed94e9fe96b"
      unitRef="usd">25692000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80OS9mcmFnOjg2NGZhYzcxZGQ0YzQ0YWM4YjA3ZmI5NDM1ZGY5YThiL3RhYmxlOjU5M2E3ZjMxNGNiZjQ1OTliNjZkZDZkY2ExNzYxYmIzL3RhYmxlcmFuZ2U6NTkzYTdmMzE0Y2JmNDU5OWI2NmRkNmRjYTE3NjFiYjNfNC0zLTEtMS0xNTYwNA_054e3293-9363-4187-8a0c-deb3098b7c75"
      unitRef="usd">27465000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80OS9mcmFnOjg2NGZhYzcxZGQ0YzQ0YWM4YjA3ZmI5NDM1ZGY5YThiL3RhYmxlOjU5M2E3ZjMxNGNiZjQ1OTliNjZkZDZkY2ExNzYxYmIzL3RhYmxlcmFuZ2U6NTkzYTdmMzE0Y2JmNDU5OWI2NmRkNmRjYTE3NjFiYjNfNS0xLTEtMS0xNTYwNA_579e0677-26a8-4755-9cf5-61ee13c2920b"
      unitRef="usd">2669000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80OS9mcmFnOjg2NGZhYzcxZGQ0YzQ0YWM4YjA3ZmI5NDM1ZGY5YThiL3RhYmxlOjU5M2E3ZjMxNGNiZjQ1OTliNjZkZDZkY2ExNzYxYmIzL3RhYmxlcmFuZ2U6NTkzYTdmMzE0Y2JmNDU5OWI2NmRkNmRjYTE3NjFiYjNfNS0zLTEtMS0xNTYwNA_47980d84-8073-4322-9a9f-820d20a0ba5b"
      unitRef="usd">4442000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80OS9mcmFnOjg2NGZhYzcxZGQ0YzQ0YWM4YjA3ZmI5NDM1ZGY5YThiL3RhYmxlOjU5M2E3ZjMxNGNiZjQ1OTliNjZkZDZkY2ExNzYxYmIzL3RhYmxlcmFuZ2U6NTkzYTdmMzE0Y2JmNDU5OWI2NmRkNmRjYTE3NjFiYjNfNi0xLTEtMS0xNTYwNA_91bff512-6c76-4885-ba05-3eac6b2e1fe3"
      unitRef="usd">23023000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80OS9mcmFnOjg2NGZhYzcxZGQ0YzQ0YWM4YjA3ZmI5NDM1ZGY5YThiL3RhYmxlOjU5M2E3ZjMxNGNiZjQ1OTliNjZkZDZkY2ExNzYxYmIzL3RhYmxlcmFuZ2U6NTkzYTdmMzE0Y2JmNDU5OWI2NmRkNmRjYTE3NjFiYjNfNi0zLTEtMS0xNTYwNA_79f9f20c-7d74-4d8b-8dc6-bfa3963d237b"
      unitRef="usd">23023000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80OS9mcmFnOjg2NGZhYzcxZGQ0YzQ0YWM4YjA3ZmI5NDM1ZGY5YThiL3RhYmxlOjU5M2E3ZjMxNGNiZjQ1OTliNjZkZDZkY2ExNzYxYmIzL3RhYmxlcmFuZ2U6NTkzYTdmMzE0Y2JmNDU5OWI2NmRkNmRjYTE3NjFiYjNfNy0xLTEtMS0xNTYwNA_446bc4a8-1876-4ece-a70b-2d31ed5825ee"
      unitRef="usd">25692000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80OS9mcmFnOjg2NGZhYzcxZGQ0YzQ0YWM4YjA3ZmI5NDM1ZGY5YThiL3RhYmxlOjU5M2E3ZjMxNGNiZjQ1OTliNjZkZDZkY2ExNzYxYmIzL3RhYmxlcmFuZ2U6NTkzYTdmMzE0Y2JmNDU5OWI2NmRkNmRjYTE3NjFiYjNfNy0zLTEtMS0xNTYwNA_5780696c-2e47-451a-994d-d2608847f3b8"
      unitRef="usd">27465000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl80OS9mcmFnOjg2NGZhYzcxZGQ0YzQ0YWM4YjA3ZmI5NDM1ZGY5YThiL3RleHRyZWdpb246ODY0ZmFjNzFkZDRjNDRhYzhiMDdmYjk0MzVkZjlhOGJfNDIzOA_e5abbfae-b0fe-4f9a-86d7-d53e790571ec"
      xsi:nil="true"/>
    <us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81Mi9mcmFnOjU4Zjc1NjhmZmQ5YTRiZmI4NDYxZmZjZDhjMWEzOTk5L3RleHRyZWdpb246NThmNzU2OGZmZDlhNGJmYjg0NjFmZmNkOGMxYTM5OTlfNzg1_599f4f12-ccf5-4550-9dd0-f5b1bff25bb9">Short-term and Long-term Investments&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's investments are classified as available-for-sale. The following table summarizes the amortized cost, gross unrealized gains and losses, and fair value of available-for-sale investments as of March&#160;31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.321%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.501%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Fair&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102,771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101,638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:7pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the amortized cost, gross unrealized gains and losses, and fair value of available-for-sale investments as of December&#160;31, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.321%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.501%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Fair&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121,036&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(331)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(331)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated fair value of available-for-sale investments classified by their contractual maturities as of March&#160;31, 2022 was:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:7pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.303%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due within one year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;After one year through two years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,914&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;Changes in market interest rates and bond yields cause certain investments to fall below their cost basis, resulting in unrealized losses on investments.</us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock>
    <us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81Mi9mcmFnOjU4Zjc1NjhmZmQ5YTRiZmI4NDYxZmZjZDhjMWEzOTk5L3RleHRyZWdpb246NThmNzU2OGZmZDlhNGJmYjg0NjFmZmNkOGMxYTM5OTlfNzgz_92d5d06f-5e4c-46c4-9952-40186848b0ac">The following table summarizes the amortized cost, gross unrealized gains and losses, and fair value of available-for-sale investments as of March&#160;31, 2022:&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.321%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.501%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Fair&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102,771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101,638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:7pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the amortized cost, gross unrealized gains and losses, and fair value of available-for-sale investments as of December&#160;31, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.321%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.501%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Fair&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121,036&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(331)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(331)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i7a7efd03f87243c8b506adee6b95d76e_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81Mi9mcmFnOjU4Zjc1NjhmZmQ5YTRiZmI4NDYxZmZjZDhjMWEzOTk5L3RhYmxlOmNmNWU2YzdjNmJiMTRmZGY5MDlkYTNjY2Y0MzYxZWVkL3RhYmxlcmFuZ2U6Y2Y1ZTZjN2M2YmIxNGZkZjkwOWRhM2NjZjQzNjFlZWRfMS0xLTEtMS0xNTYwNA_b6633f4e-2c44-4c26-800a-0f1f2c50b770"
      unitRef="usd">102771000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i7a7efd03f87243c8b506adee6b95d76e_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81Mi9mcmFnOjU4Zjc1NjhmZmQ5YTRiZmI4NDYxZmZjZDhjMWEzOTk5L3RhYmxlOmNmNWU2YzdjNmJiMTRmZGY5MDlkYTNjY2Y0MzYxZWVkL3RhYmxlcmFuZ2U6Y2Y1ZTZjN2M2YmIxNGZkZjkwOWRhM2NjZjQzNjFlZWRfMS0zLTEtMS0xNTYwNA_101e8366-939d-4c6e-a0ed-ac56244c6270"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i7a7efd03f87243c8b506adee6b95d76e_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81Mi9mcmFnOjU4Zjc1NjhmZmQ5YTRiZmI4NDYxZmZjZDhjMWEzOTk5L3RhYmxlOmNmNWU2YzdjNmJiMTRmZGY5MDlkYTNjY2Y0MzYxZWVkL3RhYmxlcmFuZ2U6Y2Y1ZTZjN2M2YmIxNGZkZjkwOWRhM2NjZjQzNjFlZWRfMS01LTEtMS0xNTYwNA_cd9ae467-9710-47ad-968e-a0de01fc197f"
      unitRef="usd">1133000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7a7efd03f87243c8b506adee6b95d76e_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81Mi9mcmFnOjU4Zjc1NjhmZmQ5YTRiZmI4NDYxZmZjZDhjMWEzOTk5L3RhYmxlOmNmNWU2YzdjNmJiMTRmZGY5MDlkYTNjY2Y0MzYxZWVkL3RhYmxlcmFuZ2U6Y2Y1ZTZjN2M2YmIxNGZkZjkwOWRhM2NjZjQzNjFlZWRfMS03LTEtMS0xNTYwNA_8e47e966-04a6-47b7-8b58-39f071735895"
      unitRef="usd">101638000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ib61d2084282545aeadc53945fd070cea_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81Mi9mcmFnOjU4Zjc1NjhmZmQ5YTRiZmI4NDYxZmZjZDhjMWEzOTk5L3RhYmxlOmNmNWU2YzdjNmJiMTRmZGY5MDlkYTNjY2Y0MzYxZWVkL3RhYmxlcmFuZ2U6Y2Y1ZTZjN2M2YmIxNGZkZjkwOWRhM2NjZjQzNjFlZWRfMi0xLTEtMS0xNTYwNA_10df7c01-c88f-4d33-af3a-77a51f0b1ad3"
      unitRef="usd">97000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ib61d2084282545aeadc53945fd070cea_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81Mi9mcmFnOjU4Zjc1NjhmZmQ5YTRiZmI4NDYxZmZjZDhjMWEzOTk5L3RhYmxlOmNmNWU2YzdjNmJiMTRmZGY5MDlkYTNjY2Y0MzYxZWVkL3RhYmxlcmFuZ2U6Y2Y1ZTZjN2M2YmIxNGZkZjkwOWRhM2NjZjQzNjFlZWRfMi0zLTEtMS0xNTYwNA_f9927fdc-de46-4c04-a90d-aeaa8346f9b7"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ib61d2084282545aeadc53945fd070cea_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81Mi9mcmFnOjU4Zjc1NjhmZmQ5YTRiZmI4NDYxZmZjZDhjMWEzOTk5L3RhYmxlOmNmNWU2YzdjNmJiMTRmZGY5MDlkYTNjY2Y0MzYxZWVkL3RhYmxlcmFuZ2U6Y2Y1ZTZjN2M2YmIxNGZkZjkwOWRhM2NjZjQzNjFlZWRfMi01LTEtMS0xNTYwNA_0b2af56f-3029-4835-a3c3-36057f332928"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib61d2084282545aeadc53945fd070cea_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81Mi9mcmFnOjU4Zjc1NjhmZmQ5YTRiZmI4NDYxZmZjZDhjMWEzOTk5L3RhYmxlOmNmNWU2YzdjNmJiMTRmZGY5MDlkYTNjY2Y0MzYxZWVkL3RhYmxlcmFuZ2U6Y2Y1ZTZjN2M2YmIxNGZkZjkwOWRhM2NjZjQzNjFlZWRfMi03LTEtMS0xNTYwNA_8589311c-65cb-454e-9ece-83dc984109cb"
      unitRef="usd">97000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81Mi9mcmFnOjU4Zjc1NjhmZmQ5YTRiZmI4NDYxZmZjZDhjMWEzOTk5L3RhYmxlOmNmNWU2YzdjNmJiMTRmZGY5MDlkYTNjY2Y0MzYxZWVkL3RhYmxlcmFuZ2U6Y2Y1ZTZjN2M2YmIxNGZkZjkwOWRhM2NjZjQzNjFlZWRfMy0xLTEtMS0xNTYwNA_cda2d359-6df7-4586-aed0-d6c11b1f23f5"
      unitRef="usd">102868000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81Mi9mcmFnOjU4Zjc1NjhmZmQ5YTRiZmI4NDYxZmZjZDhjMWEzOTk5L3RhYmxlOmNmNWU2YzdjNmJiMTRmZGY5MDlkYTNjY2Y0MzYxZWVkL3RhYmxlcmFuZ2U6Y2Y1ZTZjN2M2YmIxNGZkZjkwOWRhM2NjZjQzNjFlZWRfMy0zLTEtMS0xNTYwNA_c0434aca-178e-40fe-b8fb-65c2b573d878"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81Mi9mcmFnOjU4Zjc1NjhmZmQ5YTRiZmI4NDYxZmZjZDhjMWEzOTk5L3RhYmxlOmNmNWU2YzdjNmJiMTRmZGY5MDlkYTNjY2Y0MzYxZWVkL3RhYmxlcmFuZ2U6Y2Y1ZTZjN2M2YmIxNGZkZjkwOWRhM2NjZjQzNjFlZWRfMy01LTEtMS0xNTYwNA_e0c10806-c580-49bf-91e1-c3655ea190ae"
      unitRef="usd">1133000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81Mi9mcmFnOjU4Zjc1NjhmZmQ5YTRiZmI4NDYxZmZjZDhjMWEzOTk5L3RhYmxlOmNmNWU2YzdjNmJiMTRmZGY5MDlkYTNjY2Y0MzYxZWVkL3RhYmxlcmFuZ2U6Y2Y1ZTZjN2M2YmIxNGZkZjkwOWRhM2NjZjQzNjFlZWRfMy03LTEtMS0xNTYwNA_f3e6875b-ab7b-4de7-becd-ee709b81be52"
      unitRef="usd">101735000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i138b7762559a4bd0bef0907b1fc149a0_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81Mi9mcmFnOjU4Zjc1NjhmZmQ5YTRiZmI4NDYxZmZjZDhjMWEzOTk5L3RhYmxlOmU0YjZkNTNjY2Q3NzQ3YzE4NzRjMDQ5N2QwM2M2OThmL3RhYmxlcmFuZ2U6ZTRiNmQ1M2NjZDc3NDdjMTg3NGMwNDk3ZDAzYzY5OGZfMS0xLTEtMS0xNTYwNA_819b508f-a374-497c-9bfd-8334d924f473"
      unitRef="usd">121036000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i138b7762559a4bd0bef0907b1fc149a0_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81Mi9mcmFnOjU4Zjc1NjhmZmQ5YTRiZmI4NDYxZmZjZDhjMWEzOTk5L3RhYmxlOmU0YjZkNTNjY2Q3NzQ3YzE4NzRjMDQ5N2QwM2M2OThmL3RhYmxlcmFuZ2U6ZTRiNmQ1M2NjZDc3NDdjMTg3NGMwNDk3ZDAzYzY5OGZfMS0zLTEtMS0xNTYwNA_e03fd3ec-c18a-4029-8a9c-51b04a50d759"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i138b7762559a4bd0bef0907b1fc149a0_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81Mi9mcmFnOjU4Zjc1NjhmZmQ5YTRiZmI4NDYxZmZjZDhjMWEzOTk5L3RhYmxlOmU0YjZkNTNjY2Q3NzQ3YzE4NzRjMDQ5N2QwM2M2OThmL3RhYmxlcmFuZ2U6ZTRiNmQ1M2NjZDc3NDdjMTg3NGMwNDk3ZDAzYzY5OGZfMS01LTEtMS0xNTYwNA_023eb7ea-3f0d-4c67-88d9-8fd39917be41"
      unitRef="usd">331000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i138b7762559a4bd0bef0907b1fc149a0_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81Mi9mcmFnOjU4Zjc1NjhmZmQ5YTRiZmI4NDYxZmZjZDhjMWEzOTk5L3RhYmxlOmU0YjZkNTNjY2Q3NzQ3YzE4NzRjMDQ5N2QwM2M2OThmL3RhYmxlcmFuZ2U6ZTRiNmQ1M2NjZDc3NDdjMTg3NGMwNDk3ZDAzYzY5OGZfMS03LTEtMS0xNTYwNA_c1f16d53-21be-46a1-9176-536795244513"
      unitRef="usd">120705000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i7e69243d3b7549888b5f4fb6f0bb9475_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81Mi9mcmFnOjU4Zjc1NjhmZmQ5YTRiZmI4NDYxZmZjZDhjMWEzOTk5L3RhYmxlOmU0YjZkNTNjY2Q3NzQ3YzE4NzRjMDQ5N2QwM2M2OThmL3RhYmxlcmFuZ2U6ZTRiNmQ1M2NjZDc3NDdjMTg3NGMwNDk3ZDAzYzY5OGZfMi0xLTEtMS0xNTYwNA_a50bd8bf-8b3d-464b-bf46-e90be6de6ef7"
      unitRef="usd">97000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i7e69243d3b7549888b5f4fb6f0bb9475_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81Mi9mcmFnOjU4Zjc1NjhmZmQ5YTRiZmI4NDYxZmZjZDhjMWEzOTk5L3RhYmxlOmU0YjZkNTNjY2Q3NzQ3YzE4NzRjMDQ5N2QwM2M2OThmL3RhYmxlcmFuZ2U6ZTRiNmQ1M2NjZDc3NDdjMTg3NGMwNDk3ZDAzYzY5OGZfMi0zLTEtMS0xNTYwNA_f0f76066-1ef2-4797-9bcc-af0b744fdc0e"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i7e69243d3b7549888b5f4fb6f0bb9475_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81Mi9mcmFnOjU4Zjc1NjhmZmQ5YTRiZmI4NDYxZmZjZDhjMWEzOTk5L3RhYmxlOmU0YjZkNTNjY2Q3NzQ3YzE4NzRjMDQ5N2QwM2M2OThmL3RhYmxlcmFuZ2U6ZTRiNmQ1M2NjZDc3NDdjMTg3NGMwNDk3ZDAzYzY5OGZfMi01LTEtMS0xNTYwNA_9991692e-e2f5-4253-b073-cc84dbda3318"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7e69243d3b7549888b5f4fb6f0bb9475_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81Mi9mcmFnOjU4Zjc1NjhmZmQ5YTRiZmI4NDYxZmZjZDhjMWEzOTk5L3RhYmxlOmU0YjZkNTNjY2Q3NzQ3YzE4NzRjMDQ5N2QwM2M2OThmL3RhYmxlcmFuZ2U6ZTRiNmQ1M2NjZDc3NDdjMTg3NGMwNDk3ZDAzYzY5OGZfMi03LTEtMS0xNTYwNA_c3f99999-9469-460d-acf3-92e1fbd209b2"
      unitRef="usd">97000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81Mi9mcmFnOjU4Zjc1NjhmZmQ5YTRiZmI4NDYxZmZjZDhjMWEzOTk5L3RhYmxlOmU0YjZkNTNjY2Q3NzQ3YzE4NzRjMDQ5N2QwM2M2OThmL3RhYmxlcmFuZ2U6ZTRiNmQ1M2NjZDc3NDdjMTg3NGMwNDk3ZDAzYzY5OGZfMy0xLTEtMS0xNTYwNA_e18006af-9c9d-487b-b620-c8e59606bb5e"
      unitRef="usd">121133000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81Mi9mcmFnOjU4Zjc1NjhmZmQ5YTRiZmI4NDYxZmZjZDhjMWEzOTk5L3RhYmxlOmU0YjZkNTNjY2Q3NzQ3YzE4NzRjMDQ5N2QwM2M2OThmL3RhYmxlcmFuZ2U6ZTRiNmQ1M2NjZDc3NDdjMTg3NGMwNDk3ZDAzYzY5OGZfMy0zLTEtMS0xNTYwNA_a360cc52-0184-4291-bb2e-b12a13ccf81e"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81Mi9mcmFnOjU4Zjc1NjhmZmQ5YTRiZmI4NDYxZmZjZDhjMWEzOTk5L3RhYmxlOmU0YjZkNTNjY2Q3NzQ3YzE4NzRjMDQ5N2QwM2M2OThmL3RhYmxlcmFuZ2U6ZTRiNmQ1M2NjZDc3NDdjMTg3NGMwNDk3ZDAzYzY5OGZfMy01LTEtMS0xNTYwNA_84ae6b44-0d66-43ce-a709-14e060b84a1b"
      unitRef="usd">331000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81Mi9mcmFnOjU4Zjc1NjhmZmQ5YTRiZmI4NDYxZmZjZDhjMWEzOTk5L3RhYmxlOmU0YjZkNTNjY2Q3NzQ3YzE4NzRjMDQ5N2QwM2M2OThmL3RhYmxlcmFuZ2U6ZTRiNmQ1M2NjZDc3NDdjMTg3NGMwNDk3ZDAzYzY5OGZfMy03LTEtMS0xNTYwNA_e8591ec0-83c5-41d8-a203-6ac18008b368"
      unitRef="usd">120802000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81Mi9mcmFnOjU4Zjc1NjhmZmQ5YTRiZmI4NDYxZmZjZDhjMWEzOTk5L3RleHRyZWdpb246NThmNzU2OGZmZDlhNGJmYjg0NjFmZmNkOGMxYTM5OTlfNzgw_1bd0d8aa-e069-49e4-bb53-92e035a58faf">&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated fair value of available-for-sale investments classified by their contractual maturities as of March&#160;31, 2022 was:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:7pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.303%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due within one year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;After one year through two years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,914&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81Mi9mcmFnOjU4Zjc1NjhmZmQ5YTRiZmI4NDYxZmZjZDhjMWEzOTk5L3RhYmxlOjJmZGQ4MGJjZjlhNDQ4MGM4NGQ0YTEyZTNkNmVlNTVjL3RhYmxlcmFuZ2U6MmZkZDgwYmNmOWE0NDgwYzg0ZDRhMTJlM2Q2ZWU1NWNfMC0xLTEtMS0xNTYwNA_880ef763-2819-44ae-9f50-186a2c8276ff"
      unitRef="usd">71821000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81Mi9mcmFnOjU4Zjc1NjhmZmQ5YTRiZmI4NDYxZmZjZDhjMWEzOTk5L3RhYmxlOjJmZGQ4MGJjZjlhNDQ4MGM4NGQ0YTEyZTNkNmVlNTVjL3RhYmxlcmFuZ2U6MmZkZDgwYmNmOWE0NDgwYzg0ZDRhMTJlM2Q2ZWU1NWNfMS0xLTEtMS0xNTYwNA_b67983ae-c7b1-4958-b64f-5ce3d7d2572a"
      unitRef="usd">29914000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81Mi9mcmFnOjU4Zjc1NjhmZmQ5YTRiZmI4NDYxZmZjZDhjMWEzOTk5L3RhYmxlOjJmZGQ4MGJjZjlhNDQ4MGM4NGQ0YTEyZTNkNmVlNTVjL3RhYmxlcmFuZ2U6MmZkZDgwYmNmOWE0NDgwYzg0ZDRhMTJlM2Q2ZWU1NWNfMi0xLTEtMS0xNTYwNA_6a18f1bf-9c80-4d39-a78f-eaf0875352b3"
      unitRef="usd">101735000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81NS9mcmFnOjMzMjkyOWUzOGUyNTQzMzg4ZmY3NjY5OGZjOWJhMjc1L3RleHRyZWdpb246MzMyOTI5ZTM4ZTI1NDMzODhmZjc2Njk4ZmM5YmEyNzVfMTc3OQ_d2221b21-fc03-4ec5-a5ed-32980aec7750">Fair Value Measurements&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying amount of cash and cash equivalents, receivables, accounts payable, accrued compensation and benefits, other accrued liabilities, and related party payables approximate fair value due to the short maturity of these instruments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the placement in the fair value hierarchy of financial assets that are measured at fair value on a recurring basis as of March&#160;31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.988%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.579%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Quoted Prices in Active Markets&lt;br/&gt;(Level&#160;1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Significant Other Observable Inputs&lt;br/&gt;(Level&#160;2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Significant Unobservable Inputs&lt;br/&gt;(Level&#160;3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101,638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101,638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:7pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the placement in the fair value hierarchy of financial assets that are measured at fair value on a recurring basis as of December&#160;31, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.988%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.579%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Quoted Prices in Active Markets&lt;br/&gt;(Level&#160;1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Significant Other Observable Inputs&lt;br/&gt;(Level&#160;2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Significant Unobservable Inputs&lt;br/&gt;(Level&#160;3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:7pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The method used to estimate the fair value of the Level 2 short-term and long-term debt investments in the tables above is based on professional pricing sources for identical or comparable instruments, rather than direct observations of quoted prices in active markets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying values of the Company's long-term debt, excluding the 3.50% convertible senior notes due 2023 (the "Convertible Notes"), approximates fair value due to the length of time to maturity and/or the existence of interest rates that approximate prevailing market rates. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The calculated fair value of the Convertible Notes (Note 11) was approximately $164,000 and $160,000 as of March&#160;31, 2022 and December&#160;31, 2021, respectively, and is based on the recent third-party trades of the instrument as of the balance sheet date. The fair value of the Convertible Notes is classified as Level 2 within the fair value hierarchy as there is not an active market for the Convertible Notes, however, third-party trades of the instrument are considered observable inputs. The Convertible Notes are reflected on the accompanying condensed consolidated balance sheets at amortized cost, which was $198,362 and $179,882 as of March&#160;31, 2022 and December&#160;31, 2021, respectively (see Note 2 regarding adoption of ASU 2020-06 on January 1, 2022).&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81NS9mcmFnOjMzMjkyOWUzOGUyNTQzMzg4ZmY3NjY5OGZjOWJhMjc1L3RleHRyZWdpb246MzMyOTI5ZTM4ZTI1NDMzODhmZjc2Njk4ZmM5YmEyNzVfMTc3NA_47935a56-a095-4fb4-bc7f-502c6f14fa8d">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the placement in the fair value hierarchy of financial assets that are measured at fair value on a recurring basis as of March&#160;31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.988%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.579%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Quoted Prices in Active Markets&lt;br/&gt;(Level&#160;1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Significant Other Observable Inputs&lt;br/&gt;(Level&#160;2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Significant Unobservable Inputs&lt;br/&gt;(Level&#160;3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101,638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101,638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:7pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the placement in the fair value hierarchy of financial assets that are measured at fair value on a recurring basis as of December&#160;31, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.988%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.579%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Quoted Prices in Active Markets&lt;br/&gt;(Level&#160;1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Significant Other Observable Inputs&lt;br/&gt;(Level&#160;2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Significant Unobservable Inputs&lt;br/&gt;(Level&#160;3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i8efdfb34bb074c228a7b56cd68c54e92_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81NS9mcmFnOjMzMjkyOWUzOGUyNTQzMzg4ZmY3NjY5OGZjOWJhMjc1L3RhYmxlOmM1MTg5ZDY3ZTE5MzQ4NTQ4ZjkwODc5MjkzOTI0YmYwL3RhYmxlcmFuZ2U6YzUxODlkNjdlMTkzNDg1NDhmOTA4NzkyOTM5MjRiZjBfMi0xLTEtMS0xNTYwNA_0341f6ec-599e-467a-86ec-bfdd7cae2959"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i21f7dad991b3443cabf8b801717a7102_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81NS9mcmFnOjMzMjkyOWUzOGUyNTQzMzg4ZmY3NjY5OGZjOWJhMjc1L3RhYmxlOmM1MTg5ZDY3ZTE5MzQ4NTQ4ZjkwODc5MjkzOTI0YmYwL3RhYmxlcmFuZ2U6YzUxODlkNjdlMTkzNDg1NDhmOTA4NzkyOTM5MjRiZjBfMi0zLTEtMS0xNTYwNA_bb0a769a-727b-417d-af09-5e4f09dfc0d9"
      unitRef="usd">101638000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i872f3add0d1843ac827dc54132c0479a_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81NS9mcmFnOjMzMjkyOWUzOGUyNTQzMzg4ZmY3NjY5OGZjOWJhMjc1L3RhYmxlOmM1MTg5ZDY3ZTE5MzQ4NTQ4ZjkwODc5MjkzOTI0YmYwL3RhYmxlcmFuZ2U6YzUxODlkNjdlMTkzNDg1NDhmOTA4NzkyOTM5MjRiZjBfMi01LTEtMS0xNTYwNA_2c4464da-9728-40c9-8381-261ed82e7df3"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i7a7efd03f87243c8b506adee6b95d76e_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81NS9mcmFnOjMzMjkyOWUzOGUyNTQzMzg4ZmY3NjY5OGZjOWJhMjc1L3RhYmxlOmM1MTg5ZDY3ZTE5MzQ4NTQ4ZjkwODc5MjkzOTI0YmYwL3RhYmxlcmFuZ2U6YzUxODlkNjdlMTkzNDg1NDhmOTA4NzkyOTM5MjRiZjBfMi03LTEtMS0xNTYwNA_5e20133f-1fc6-40a6-a01e-8fa677d42e74"
      unitRef="usd">101638000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i19f61ce6754f4459a9aef0d9e6199717_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81NS9mcmFnOjMzMjkyOWUzOGUyNTQzMzg4ZmY3NjY5OGZjOWJhMjc1L3RhYmxlOmM1MTg5ZDY3ZTE5MzQ4NTQ4ZjkwODc5MjkzOTI0YmYwL3RhYmxlcmFuZ2U6YzUxODlkNjdlMTkzNDg1NDhmOTA4NzkyOTM5MjRiZjBfMy0xLTEtMS0xNTYwNA_bf1c351f-1efb-4784-9111-5a66619d73d8"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i7c555a88343545dd9e8dbf1fba6af596_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81NS9mcmFnOjMzMjkyOWUzOGUyNTQzMzg4ZmY3NjY5OGZjOWJhMjc1L3RhYmxlOmM1MTg5ZDY3ZTE5MzQ4NTQ4ZjkwODc5MjkzOTI0YmYwL3RhYmxlcmFuZ2U6YzUxODlkNjdlMTkzNDg1NDhmOTA4NzkyOTM5MjRiZjBfMy0zLTEtMS0xNTYwNA_9f7940d8-74f3-4cae-bacb-ba928ca31880"
      unitRef="usd">97000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i852b481436844bb180bbb9ccb677b04e_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81NS9mcmFnOjMzMjkyOWUzOGUyNTQzMzg4ZmY3NjY5OGZjOWJhMjc1L3RhYmxlOmM1MTg5ZDY3ZTE5MzQ4NTQ4ZjkwODc5MjkzOTI0YmYwL3RhYmxlcmFuZ2U6YzUxODlkNjdlMTkzNDg1NDhmOTA4NzkyOTM5MjRiZjBfMy01LTEtMS0xNTYwNA_6f132093-b240-4926-aa30-6c930edaac2c"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ib61d2084282545aeadc53945fd070cea_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81NS9mcmFnOjMzMjkyOWUzOGUyNTQzMzg4ZmY3NjY5OGZjOWJhMjc1L3RhYmxlOmM1MTg5ZDY3ZTE5MzQ4NTQ4ZjkwODc5MjkzOTI0YmYwL3RhYmxlcmFuZ2U6YzUxODlkNjdlMTkzNDg1NDhmOTA4NzkyOTM5MjRiZjBfMy03LTEtMS0xNTYwNA_da97bcfe-2a73-4868-9e2e-28096500b6b7"
      unitRef="usd">97000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i93715ce18b404d1e829abbd13ffd87fa_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81NS9mcmFnOjMzMjkyOWUzOGUyNTQzMzg4ZmY3NjY5OGZjOWJhMjc1L3RhYmxlOmM1MTg5ZDY3ZTE5MzQ4NTQ4ZjkwODc5MjkzOTI0YmYwL3RhYmxlcmFuZ2U6YzUxODlkNjdlMTkzNDg1NDhmOTA4NzkyOTM5MjRiZjBfNC0xLTEtMS0xNTYwNA_a1b38a5e-30d6-4f82-b180-5ccd1d644130"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i2c91bed02b6948bc8b34c10b4ed941d8_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81NS9mcmFnOjMzMjkyOWUzOGUyNTQzMzg4ZmY3NjY5OGZjOWJhMjc1L3RhYmxlOmM1MTg5ZDY3ZTE5MzQ4NTQ4ZjkwODc5MjkzOTI0YmYwL3RhYmxlcmFuZ2U6YzUxODlkNjdlMTkzNDg1NDhmOTA4NzkyOTM5MjRiZjBfNC0zLTEtMS0xNTYwNA_b4bba836-5d0a-4121-8ef8-f5f35842a75a"
      unitRef="usd">101735000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="icd71ea23afbd46ddbe3c2deffaf893b0_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81NS9mcmFnOjMzMjkyOWUzOGUyNTQzMzg4ZmY3NjY5OGZjOWJhMjc1L3RhYmxlOmM1MTg5ZDY3ZTE5MzQ4NTQ4ZjkwODc5MjkzOTI0YmYwL3RhYmxlcmFuZ2U6YzUxODlkNjdlMTkzNDg1NDhmOTA4NzkyOTM5MjRiZjBfNC01LTEtMS0xNTYwNA_40e1a374-1864-44d2-9204-4179ebcd0f1e"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81NS9mcmFnOjMzMjkyOWUzOGUyNTQzMzg4ZmY3NjY5OGZjOWJhMjc1L3RhYmxlOmM1MTg5ZDY3ZTE5MzQ4NTQ4ZjkwODc5MjkzOTI0YmYwL3RhYmxlcmFuZ2U6YzUxODlkNjdlMTkzNDg1NDhmOTA4NzkyOTM5MjRiZjBfNC03LTEtMS0xNTYwNA_5517146b-df47-4da6-b140-176f825ec787"
      unitRef="usd">101735000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="if8a7409f0d5e4c7aac820b7c228efe86_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81NS9mcmFnOjMzMjkyOWUzOGUyNTQzMzg4ZmY3NjY5OGZjOWJhMjc1L3RhYmxlOmMxNTNmMTQ5YjVhZjQwMzA5N2EyNzFhODE1ZjU0NDkxL3RhYmxlcmFuZ2U6YzE1M2YxNDliNWFmNDAzMDk3YTI3MWE4MTVmNTQ0OTFfMi0xLTEtMS0xNTYwNA_faa49e44-45d8-4ba5-acc6-7593697ca4ce"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i271b0c1c542f467982ba61825dd48dd5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81NS9mcmFnOjMzMjkyOWUzOGUyNTQzMzg4ZmY3NjY5OGZjOWJhMjc1L3RhYmxlOmMxNTNmMTQ5YjVhZjQwMzA5N2EyNzFhODE1ZjU0NDkxL3RhYmxlcmFuZ2U6YzE1M2YxNDliNWFmNDAzMDk3YTI3MWE4MTVmNTQ0OTFfMi0zLTEtMS0xNTYwNA_5713f1b6-06a7-45a1-80e5-f15d1eb6c732"
      unitRef="usd">120705000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ied4c7ca414574920a941d3fac029e286_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81NS9mcmFnOjMzMjkyOWUzOGUyNTQzMzg4ZmY3NjY5OGZjOWJhMjc1L3RhYmxlOmMxNTNmMTQ5YjVhZjQwMzA5N2EyNzFhODE1ZjU0NDkxL3RhYmxlcmFuZ2U6YzE1M2YxNDliNWFmNDAzMDk3YTI3MWE4MTVmNTQ0OTFfMi01LTEtMS0xNTYwNA_1e3d3afa-94f3-4e67-8fa9-d37e07b15855"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i138b7762559a4bd0bef0907b1fc149a0_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81NS9mcmFnOjMzMjkyOWUzOGUyNTQzMzg4ZmY3NjY5OGZjOWJhMjc1L3RhYmxlOmMxNTNmMTQ5YjVhZjQwMzA5N2EyNzFhODE1ZjU0NDkxL3RhYmxlcmFuZ2U6YzE1M2YxNDliNWFmNDAzMDk3YTI3MWE4MTVmNTQ0OTFfMi03LTEtMS0xNTYwNA_8415407c-874f-4303-b6f8-1c703ec35099"
      unitRef="usd">120705000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i531349a928d146fa9cfde02f1ec3e68f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81NS9mcmFnOjMzMjkyOWUzOGUyNTQzMzg4ZmY3NjY5OGZjOWJhMjc1L3RhYmxlOmMxNTNmMTQ5YjVhZjQwMzA5N2EyNzFhODE1ZjU0NDkxL3RhYmxlcmFuZ2U6YzE1M2YxNDliNWFmNDAzMDk3YTI3MWE4MTVmNTQ0OTFfMy0xLTEtMS0xNTYwNA_0869e9fa-ae9b-4f2c-905d-d71482d97291"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="idb99f08c2199410b935f7e65fbd62cb9_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81NS9mcmFnOjMzMjkyOWUzOGUyNTQzMzg4ZmY3NjY5OGZjOWJhMjc1L3RhYmxlOmMxNTNmMTQ5YjVhZjQwMzA5N2EyNzFhODE1ZjU0NDkxL3RhYmxlcmFuZ2U6YzE1M2YxNDliNWFmNDAzMDk3YTI3MWE4MTVmNTQ0OTFfMy0zLTEtMS0xNTYwNA_fba2602d-6a21-4d9f-a2a4-54f359ace45b"
      unitRef="usd">97000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ie74b31c2e1fd45cdacc1a2277e851ddc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81NS9mcmFnOjMzMjkyOWUzOGUyNTQzMzg4ZmY3NjY5OGZjOWJhMjc1L3RhYmxlOmMxNTNmMTQ5YjVhZjQwMzA5N2EyNzFhODE1ZjU0NDkxL3RhYmxlcmFuZ2U6YzE1M2YxNDliNWFmNDAzMDk3YTI3MWE4MTVmNTQ0OTFfMy01LTEtMS0xNTYwNA_71b1997d-0d2f-4461-9293-99ba4131a417"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i7e69243d3b7549888b5f4fb6f0bb9475_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81NS9mcmFnOjMzMjkyOWUzOGUyNTQzMzg4ZmY3NjY5OGZjOWJhMjc1L3RhYmxlOmMxNTNmMTQ5YjVhZjQwMzA5N2EyNzFhODE1ZjU0NDkxL3RhYmxlcmFuZ2U6YzE1M2YxNDliNWFmNDAzMDk3YTI3MWE4MTVmNTQ0OTFfMy03LTEtMS0xNTYwNA_fc588386-31e3-4003-82d3-d648f20bc4f7"
      unitRef="usd">97000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i09a9ddaf3caa4498b7f5d33b60e82854_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81NS9mcmFnOjMzMjkyOWUzOGUyNTQzMzg4ZmY3NjY5OGZjOWJhMjc1L3RhYmxlOmMxNTNmMTQ5YjVhZjQwMzA5N2EyNzFhODE1ZjU0NDkxL3RhYmxlcmFuZ2U6YzE1M2YxNDliNWFmNDAzMDk3YTI3MWE4MTVmNTQ0OTFfNC0xLTEtMS0xNTYwNA_99a8260b-2145-4140-9812-6869f9f06248"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i0c064cf87f8c47afbfc9a5d1fbd79533_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81NS9mcmFnOjMzMjkyOWUzOGUyNTQzMzg4ZmY3NjY5OGZjOWJhMjc1L3RhYmxlOmMxNTNmMTQ5YjVhZjQwMzA5N2EyNzFhODE1ZjU0NDkxL3RhYmxlcmFuZ2U6YzE1M2YxNDliNWFmNDAzMDk3YTI3MWE4MTVmNTQ0OTFfNC0zLTEtMS0xNTYwNA_898a7968-483b-4dc3-90c0-d0fb6b2170ba"
      unitRef="usd">120802000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ia1c952fbceb14ed981c1efbc9b58c1f5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81NS9mcmFnOjMzMjkyOWUzOGUyNTQzMzg4ZmY3NjY5OGZjOWJhMjc1L3RhYmxlOmMxNTNmMTQ5YjVhZjQwMzA5N2EyNzFhODE1ZjU0NDkxL3RhYmxlcmFuZ2U6YzE1M2YxNDliNWFmNDAzMDk3YTI3MWE4MTVmNTQ0OTFfNC01LTEtMS0xNTYwNA_9443e5ab-8119-499a-b2b5-9929067dfc96"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81NS9mcmFnOjMzMjkyOWUzOGUyNTQzMzg4ZmY3NjY5OGZjOWJhMjc1L3RhYmxlOmMxNTNmMTQ5YjVhZjQwMzA5N2EyNzFhODE1ZjU0NDkxL3RhYmxlcmFuZ2U6YzE1M2YxNDliNWFmNDAzMDk3YTI3MWE4MTVmNTQ0OTFfNC03LTEtMS0xNTYwNA_76cddfb1-cf42-4991-a93b-31fa1765d74d"
      unitRef="usd">120802000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="if6f497049bf74c16a1396dfc4d1e650a_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81NS9mcmFnOjMzMjkyOWUzOGUyNTQzMzg4ZmY3NjY5OGZjOWJhMjc1L3RleHRyZWdpb246MzMyOTI5ZTM4ZTI1NDMzODhmZjc2Njk4ZmM5YmEyNzVfOTQy_79db7b9a-0594-44a0-aa4c-c2a453bb92a7"
      unitRef="number">0.0350</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ConvertibleDebtFairValueDisclosures
      contextRef="if6f497049bf74c16a1396dfc4d1e650a_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81NS9mcmFnOjMzMjkyOWUzOGUyNTQzMzg4ZmY3NjY5OGZjOWJhMjc1L3RleHRyZWdpb246MzMyOTI5ZTM4ZTI1NDMzODhmZjc2Njk4ZmM5YmEyNzVfMTIyOQ_9583d9fa-df14-4a12-823a-e203c81eebc9"
      unitRef="usd">164000000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:ConvertibleDebtFairValueDisclosures
      contextRef="i3e4b384138dc464ea318892a265c9e5f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81NS9mcmFnOjMzMjkyOWUzOGUyNTQzMzg4ZmY3NjY5OGZjOWJhMjc1L3RleHRyZWdpb246MzMyOTI5ZTM4ZTI1NDMzODhmZjc2Njk4ZmM5YmEyNzVfMTIzNg_ccf9b4c1-cf0e-4612-885b-64b46b81339a"
      unitRef="usd">160000000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:ConvertibleDebt
      contextRef="if6f497049bf74c16a1396dfc4d1e650a_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81NS9mcmFnOjMzMjkyOWUzOGUyNTQzMzg4ZmY3NjY5OGZjOWJhMjc1L3RleHRyZWdpb246MzMyOTI5ZTM4ZTI1NDMzODhmZjc2Njk4ZmM5YmEyNzVfMTcyNA_bd29c03a-6d99-4546-9bc8-a7f6c24026b3"
      unitRef="usd">198362000</us-gaap:ConvertibleDebt>
    <us-gaap:ConvertibleDebt
      contextRef="i3e4b384138dc464ea318892a265c9e5f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81NS9mcmFnOjMzMjkyOWUzOGUyNTQzMzg4ZmY3NjY5OGZjOWJhMjc1L3RleHRyZWdpb246MzMyOTI5ZTM4ZTI1NDMzODhmZjc2Njk4ZmM5YmEyNzVfMTczMQ_cfe7a677-2fa3-41e3-87e2-34ebce70bdba"
      unitRef="usd">179882000</us-gaap:ConvertibleDebt>
    <us-gaap:InventoryDisclosureTextBlock
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81OC9mcmFnOjYwNGVkYzRkYjExYjRmOGJhZjZjMTAyYmI1YTc1YTc5L3RleHRyZWdpb246NjA0ZWRjNGRiMTFiNGY4YmFmNmMxMDJiYjVhNzVhNzlfNTY_9ce43cfe-6105-486e-8563-c7cf6d66529d">Inventory&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory consists of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Supplies, embryos and other production materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Livestock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Feed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,799&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total inventory&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81OC9mcmFnOjYwNGVkYzRkYjExYjRmOGJhZjZjMTAyYmI1YTc1YTc5L3RleHRyZWdpb246NjA0ZWRjNGRiMTFiNGY4YmFmNmMxMDJiYjVhNzVhNzlfNjA_d1e5b736-4eab-46f8-8269-f0c19cdf0b46">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory consists of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Supplies, embryos and other production materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Livestock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Feed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,799&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total inventory&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryGross
      contextRef="ie8e3dddd71c4443985fe28d70f1e2c9a_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81OC9mcmFnOjYwNGVkYzRkYjExYjRmOGJhZjZjMTAyYmI1YTc1YTc5L3RhYmxlOmIwYjQ1NDA1ZWY1ODRiZWY4ZDQzZGI3ZGZhODdkOTA5L3RhYmxlcmFuZ2U6YjBiNDU0MDVlZjU4NGJlZjhkNDNkYjdkZmE4N2Q5MDlfMS0xLTEtMS0xNTYwNA_e46e5b7e-1e5c-4e37-9fec-05fccfd00431"
      unitRef="usd">2931000</us-gaap:InventoryGross>
    <us-gaap:InventoryGross
      contextRef="i3940f9d38d364dccb21e61d867617045_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81OC9mcmFnOjYwNGVkYzRkYjExYjRmOGJhZjZjMTAyYmI1YTc1YTc5L3RhYmxlOmIwYjQ1NDA1ZWY1ODRiZWY4ZDQzZGI3ZGZhODdkOTA5L3RhYmxlcmFuZ2U6YjBiNDU0MDVlZjU4NGJlZjhkNDNkYjdkZmE4N2Q5MDlfMS0zLTEtMS0xNTYwNA_6fe61b35-76da-4853-aa03-71b6f87e4127"
      unitRef="usd">2588000</us-gaap:InventoryGross>
    <us-gaap:InventoryGross
      contextRef="idf3c07cd4a91470ba7f63dbc88e4bc6a_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81OC9mcmFnOjYwNGVkYzRkYjExYjRmOGJhZjZjMTAyYmI1YTc1YTc5L3RhYmxlOmIwYjQ1NDA1ZWY1ODRiZWY4ZDQzZGI3ZGZhODdkOTA5L3RhYmxlcmFuZ2U6YjBiNDU0MDVlZjU4NGJlZjhkNDNkYjdkZmE4N2Q5MDlfMi0xLTEtMS0xNTYwNA_68d8ed12-f007-4118-89a5-fa5b7b44efb3"
      unitRef="usd">2539000</us-gaap:InventoryGross>
    <us-gaap:InventoryGross
      contextRef="i92fec9005efa4d79987abea15d951226_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81OC9mcmFnOjYwNGVkYzRkYjExYjRmOGJhZjZjMTAyYmI1YTc1YTc5L3RhYmxlOmIwYjQ1NDA1ZWY1ODRiZWY4ZDQzZGI3ZGZhODdkOTA5L3RhYmxlcmFuZ2U6YjBiNDU0MDVlZjU4NGJlZjhkNDNkYjdkZmE4N2Q5MDlfMi0zLTEtMS0xNTYwNA_5b117eda-74a2-4717-b3f3-65c30f7193ec"
      unitRef="usd">2564000</us-gaap:InventoryGross>
    <us-gaap:InventoryGross
      contextRef="i42bf8b0d2e814be082d3b0bf6da63af4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81OC9mcmFnOjYwNGVkYzRkYjExYjRmOGJhZjZjMTAyYmI1YTc1YTc5L3RhYmxlOmIwYjQ1NDA1ZWY1ODRiZWY4ZDQzZGI3ZGZhODdkOTA5L3RhYmxlcmFuZ2U6YjBiNDU0MDVlZjU4NGJlZjhkNDNkYjdkZmE4N2Q5MDlfMy0xLTEtMS0xNTYwNA_5c20c8f2-4c5b-4c72-948a-70025e994523"
      unitRef="usd">5918000</us-gaap:InventoryGross>
    <us-gaap:InventoryGross
      contextRef="iecc97711a44b47019e38b94af754e168_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81OC9mcmFnOjYwNGVkYzRkYjExYjRmOGJhZjZjMTAyYmI1YTc1YTc5L3RhYmxlOmIwYjQ1NDA1ZWY1ODRiZWY4ZDQzZGI3ZGZhODdkOTA5L3RhYmxlcmFuZ2U6YjBiNDU0MDVlZjU4NGJlZjhkNDNkYjdkZmE4N2Q5MDlfMy0zLTEtMS0xNTYwNA_eddae0f8-c542-44c4-b216-7f5d6895ba65"
      unitRef="usd">6310000</us-gaap:InventoryGross>
    <us-gaap:InventoryGross
      contextRef="i22be83bf68b14b30a42ca5908e204306_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81OC9mcmFnOjYwNGVkYzRkYjExYjRmOGJhZjZjMTAyYmI1YTc1YTc5L3RhYmxlOmIwYjQ1NDA1ZWY1ODRiZWY4ZDQzZGI3ZGZhODdkOTA5L3RhYmxlcmFuZ2U6YjBiNDU0MDVlZjU4NGJlZjhkNDNkYjdkZmE4N2Q5MDlfNC0xLTEtMS0xNTYwNA_0bdb714d-2bae-43ec-bde1-50251dff9d2a"
      unitRef="usd">1342000</us-gaap:InventoryGross>
    <us-gaap:InventoryGross
      contextRef="i5527892baeab40f6a59e15f38b3b3dc4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81OC9mcmFnOjYwNGVkYzRkYjExYjRmOGJhZjZjMTAyYmI1YTc1YTc5L3RhYmxlOmIwYjQ1NDA1ZWY1ODRiZWY4ZDQzZGI3ZGZhODdkOTA5L3RhYmxlcmFuZ2U6YjBiNDU0MDVlZjU4NGJlZjhkNDNkYjdkZmE4N2Q5MDlfNC0zLTEtMS0xNTYwNA_40a9cd17-7951-467c-99d1-de34aff8f413"
      unitRef="usd">1799000</us-gaap:InventoryGross>
    <us-gaap:InventoryGross
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81OC9mcmFnOjYwNGVkYzRkYjExYjRmOGJhZjZjMTAyYmI1YTc1YTc5L3RhYmxlOmIwYjQ1NDA1ZWY1ODRiZWY4ZDQzZGI3ZGZhODdkOTA5L3RhYmxlcmFuZ2U6YjBiNDU0MDVlZjU4NGJlZjhkNDNkYjdkZmE4N2Q5MDlfNS0xLTEtMS0xNTYwNA_d45d35fe-6ade-48a7-ab96-5c15bba2501b"
      unitRef="usd">12730000</us-gaap:InventoryGross>
    <us-gaap:InventoryGross
      contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl81OC9mcmFnOjYwNGVkYzRkYjExYjRmOGJhZjZjMTAyYmI1YTc1YTc5L3RhYmxlOmIwYjQ1NDA1ZWY1ODRiZWY4ZDQzZGI3ZGZhODdkOTA5L3RhYmxlcmFuZ2U6YjBiNDU0MDVlZjU4NGJlZjhkNDNkYjdkZmE4N2Q5MDlfNS0zLTEtMS0xNTYwNA_a368aa82-6e88-47d2-a4d9-64469292e580"
      unitRef="usd">13261000</us-gaap:InventoryGross>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82MS9mcmFnOjIxNDY0N2Q2NmZmMTQzZDQ4MjYyYTJlZDM1ZmQ0NTgyL3RleHRyZWdpb246MjE0NjQ3ZDY2ZmYxNDNkNDgyNjJhMmVkMzVmZDQ1ODJfMjI3_2540b99e-fb3d-4ca9-b391-4d9603de6cea">Property, Plant and Equipment, Net&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment consist of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:17pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land and land improvements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings and building improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breeding stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer hardware and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction and other assets in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,058&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40,475)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39,222)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation expense was $1,483 and $1,593 for the three months ended March 31, 2022 and 2021, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82MS9mcmFnOjIxNDY0N2Q2NmZmMTQzZDQ4MjYyYTJlZDM1ZmQ0NTgyL3RleHRyZWdpb246MjE0NjQ3ZDY2ZmYxNDNkNDgyNjJhMmVkMzVmZDQ1ODJfMjI4_a666dd0a-6198-4016-9788-1c3fb12a13ca">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment consist of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:17pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land and land improvements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings and building improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breeding stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer hardware and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction and other assets in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,058&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40,475)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39,222)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:LandAndLandImprovements
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82MS9mcmFnOjIxNDY0N2Q2NmZmMTQzZDQ4MjYyYTJlZDM1ZmQ0NTgyL3RhYmxlOjZmZmIxNmI1NGU2YTQyM2FiMTIyODI0MjI3ZGNlNWI4L3RhYmxlcmFuZ2U6NmZmYjE2YjU0ZTZhNDIzYWIxMjI4MjQyMjdkY2U1YjhfMS0xLTEtMS0xNTYwNA_28d17571-9312-4187-a8ea-db2772a975f3"
      unitRef="usd">11118000</us-gaap:LandAndLandImprovements>
    <us-gaap:LandAndLandImprovements
      contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82MS9mcmFnOjIxNDY0N2Q2NmZmMTQzZDQ4MjYyYTJlZDM1ZmQ0NTgyL3RhYmxlOjZmZmIxNmI1NGU2YTQyM2FiMTIyODI0MjI3ZGNlNWI4L3RhYmxlcmFuZ2U6NmZmYjE2YjU0ZTZhNDIzYWIxMjI4MjQyMjdkY2U1YjhfMS0zLTEtMS0xNTYwNA_c6c686f7-585c-4f4e-ae0c-209130837bac"
      unitRef="usd">11118000</us-gaap:LandAndLandImprovements>
    <us-gaap:BuildingsAndImprovementsGross
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82MS9mcmFnOjIxNDY0N2Q2NmZmMTQzZDQ4MjYyYTJlZDM1ZmQ0NTgyL3RhYmxlOjZmZmIxNmI1NGU2YTQyM2FiMTIyODI0MjI3ZGNlNWI4L3RhYmxlcmFuZ2U6NmZmYjE2YjU0ZTZhNDIzYWIxMjI4MjQyMjdkY2U1YjhfMi0xLTEtMS0xNTYwNA_67ac664d-fc0a-41fe-b4c4-f2c4840b7591"
      unitRef="usd">12903000</us-gaap:BuildingsAndImprovementsGross>
    <us-gaap:BuildingsAndImprovementsGross
      contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82MS9mcmFnOjIxNDY0N2Q2NmZmMTQzZDQ4MjYyYTJlZDM1ZmQ0NTgyL3RhYmxlOjZmZmIxNmI1NGU2YTQyM2FiMTIyODI0MjI3ZGNlNWI4L3RhYmxlcmFuZ2U6NmZmYjE2YjU0ZTZhNDIzYWIxMjI4MjQyMjdkY2U1YjhfMi0zLTEtMS0xNTYwNA_9de0cd96-0b9a-4b17-a0ac-7ba959d9b99f"
      unitRef="usd">12896000</us-gaap:BuildingsAndImprovementsGross>
    <us-gaap:FurnitureAndFixturesGross
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82MS9mcmFnOjIxNDY0N2Q2NmZmMTQzZDQ4MjYyYTJlZDM1ZmQ0NTgyL3RhYmxlOjZmZmIxNmI1NGU2YTQyM2FiMTIyODI0MjI3ZGNlNWI4L3RhYmxlcmFuZ2U6NmZmYjE2YjU0ZTZhNDIzYWIxMjI4MjQyMjdkY2U1YjhfMy0xLTEtMS0xNTYwNA_83457b3a-af98-431c-8f5d-f538dffc2664"
      unitRef="usd">1193000</us-gaap:FurnitureAndFixturesGross>
    <us-gaap:FurnitureAndFixturesGross
      contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82MS9mcmFnOjIxNDY0N2Q2NmZmMTQzZDQ4MjYyYTJlZDM1ZmQ0NTgyL3RhYmxlOjZmZmIxNmI1NGU2YTQyM2FiMTIyODI0MjI3ZGNlNWI4L3RhYmxlcmFuZ2U6NmZmYjE2YjU0ZTZhNDIzYWIxMjI4MjQyMjdkY2U1YjhfMy0zLTEtMS0xNTYwNA_d5706319-db67-428c-96fc-1e3c33f22122"
      unitRef="usd">1162000</us-gaap:FurnitureAndFixturesGross>
    <us-gaap:MachineryAndEquipmentGross
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82MS9mcmFnOjIxNDY0N2Q2NmZmMTQzZDQ4MjYyYTJlZDM1ZmQ0NTgyL3RhYmxlOjZmZmIxNmI1NGU2YTQyM2FiMTIyODI0MjI3ZGNlNWI4L3RhYmxlcmFuZ2U6NmZmYjE2YjU0ZTZhNDIzYWIxMjI4MjQyMjdkY2U1YjhfNC0xLTEtMS0xNTYwNA_053ca392-8c3a-477f-8c76-b1040e7deeac"
      unitRef="usd">34304000</us-gaap:MachineryAndEquipmentGross>
    <us-gaap:MachineryAndEquipmentGross
      contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82MS9mcmFnOjIxNDY0N2Q2NmZmMTQzZDQ4MjYyYTJlZDM1ZmQ0NTgyL3RhYmxlOjZmZmIxNmI1NGU2YTQyM2FiMTIyODI0MjI3ZGNlNWI4L3RhYmxlcmFuZ2U6NmZmYjE2YjU0ZTZhNDIzYWIxMjI4MjQyMjdkY2U1YjhfNC0zLTEtMS0xNTYwNA_3f6de83b-94ff-4dc2-a147-16c7e47fab74"
      unitRef="usd">33584000</us-gaap:MachineryAndEquipmentGross>
    <us-gaap:LeaseholdImprovementsGross
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82MS9mcmFnOjIxNDY0N2Q2NmZmMTQzZDQ4MjYyYTJlZDM1ZmQ0NTgyL3RhYmxlOjZmZmIxNmI1NGU2YTQyM2FiMTIyODI0MjI3ZGNlNWI4L3RhYmxlcmFuZ2U6NmZmYjE2YjU0ZTZhNDIzYWIxMjI4MjQyMjdkY2U1YjhfNS0xLTEtMS0xNTYwNA_d3ebf0d3-c16e-4971-9bf9-194e0364bcff"
      unitRef="usd">4822000</us-gaap:LeaseholdImprovementsGross>
    <us-gaap:LeaseholdImprovementsGross
      contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82MS9mcmFnOjIxNDY0N2Q2NmZmMTQzZDQ4MjYyYTJlZDM1ZmQ0NTgyL3RhYmxlOjZmZmIxNmI1NGU2YTQyM2FiMTIyODI0MjI3ZGNlNWI4L3RhYmxlcmFuZ2U6NmZmYjE2YjU0ZTZhNDIzYWIxMjI4MjQyMjdkY2U1YjhfNS0zLTEtMS0xNTYwNA_d0521df1-b409-4227-9912-680be8e9d74a"
      unitRef="usd">4822000</us-gaap:LeaseholdImprovementsGross>
    <pgen:BreedingandProductionAnimalsGross
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82MS9mcmFnOjIxNDY0N2Q2NmZmMTQzZDQ4MjYyYTJlZDM1ZmQ0NTgyL3RhYmxlOjZmZmIxNmI1NGU2YTQyM2FiMTIyODI0MjI3ZGNlNWI4L3RhYmxlcmFuZ2U6NmZmYjE2YjU0ZTZhNDIzYWIxMjI4MjQyMjdkY2U1YjhfNi0xLTEtMS0xNTYwNA_49870a84-e110-4d79-ba4d-47d4bf15f65b"
      unitRef="usd">953000</pgen:BreedingandProductionAnimalsGross>
    <pgen:BreedingandProductionAnimalsGross
      contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82MS9mcmFnOjIxNDY0N2Q2NmZmMTQzZDQ4MjYyYTJlZDM1ZmQ0NTgyL3RhYmxlOjZmZmIxNmI1NGU2YTQyM2FiMTIyODI0MjI3ZGNlNWI4L3RhYmxlcmFuZ2U6NmZmYjE2YjU0ZTZhNDIzYWIxMjI4MjQyMjdkY2U1YjhfNi0zLTEtMS0xNTYwNA_3ed28ac8-bf31-4a7b-bcc3-4cb584380044"
      unitRef="usd">1000000</pgen:BreedingandProductionAnimalsGross>
    <pgen:ComputerHardwareandSoftware
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82MS9mcmFnOjIxNDY0N2Q2NmZmMTQzZDQ4MjYyYTJlZDM1ZmQ0NTgyL3RhYmxlOjZmZmIxNmI1NGU2YTQyM2FiMTIyODI0MjI3ZGNlNWI4L3RhYmxlcmFuZ2U6NmZmYjE2YjU0ZTZhNDIzYWIxMjI4MjQyMjdkY2U1YjhfNy0xLTEtMS0xNTYwNA_0a5b28f2-3f28-462b-aced-eeecdb50f084"
      unitRef="usd">5169000</pgen:ComputerHardwareandSoftware>
    <pgen:ComputerHardwareandSoftware
      contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82MS9mcmFnOjIxNDY0N2Q2NmZmMTQzZDQ4MjYyYTJlZDM1ZmQ0NTgyL3RhYmxlOjZmZmIxNmI1NGU2YTQyM2FiMTIyODI0MjI3ZGNlNWI4L3RhYmxlcmFuZ2U6NmZmYjE2YjU0ZTZhNDIzYWIxMjI4MjQyMjdkY2U1YjhfNy0zLTEtMS0xNTYwNA_a2c71bc3-1032-490a-9715-c5127dde120e"
      unitRef="usd">5131000</pgen:ComputerHardwareandSoftware>
    <us-gaap:ConstructionInProgressGross
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82MS9mcmFnOjIxNDY0N2Q2NmZmMTQzZDQ4MjYyYTJlZDM1ZmQ0NTgyL3RhYmxlOjZmZmIxNmI1NGU2YTQyM2FiMTIyODI0MjI3ZGNlNWI4L3RhYmxlcmFuZ2U6NmZmYjE2YjU0ZTZhNDIzYWIxMjI4MjQyMjdkY2U1YjhfOC0xLTEtMS0xNTYwNA_263a054e-d133-4cfa-b14e-f87c7da24382"
      unitRef="usd">3596000</us-gaap:ConstructionInProgressGross>
    <us-gaap:ConstructionInProgressGross
      contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82MS9mcmFnOjIxNDY0N2Q2NmZmMTQzZDQ4MjYyYTJlZDM1ZmQ0NTgyL3RhYmxlOjZmZmIxNmI1NGU2YTQyM2FiMTIyODI0MjI3ZGNlNWI4L3RhYmxlcmFuZ2U6NmZmYjE2YjU0ZTZhNDIzYWIxMjI4MjQyMjdkY2U1YjhfOC0zLTEtMS0xNTYwNA_248aba36-5dc7-4a84-861a-b60801059658"
      unitRef="usd">3824000</us-gaap:ConstructionInProgressGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82MS9mcmFnOjIxNDY0N2Q2NmZmMTQzZDQ4MjYyYTJlZDM1ZmQ0NTgyL3RhYmxlOjZmZmIxNmI1NGU2YTQyM2FiMTIyODI0MjI3ZGNlNWI4L3RhYmxlcmFuZ2U6NmZmYjE2YjU0ZTZhNDIzYWIxMjI4MjQyMjdkY2U1YjhfOS0xLTEtMS0xNTYwNA_a90c4964-5b69-4c1e-be4a-056c525f6305"
      unitRef="usd">74058000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82MS9mcmFnOjIxNDY0N2Q2NmZmMTQzZDQ4MjYyYTJlZDM1ZmQ0NTgyL3RhYmxlOjZmZmIxNmI1NGU2YTQyM2FiMTIyODI0MjI3ZGNlNWI4L3RhYmxlcmFuZ2U6NmZmYjE2YjU0ZTZhNDIzYWIxMjI4MjQyMjdkY2U1YjhfOS0zLTEtMS0xNTYwNA_3c0a0156-7921-4f7a-a867-ea9e1ec5e9ed"
      unitRef="usd">73537000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82MS9mcmFnOjIxNDY0N2Q2NmZmMTQzZDQ4MjYyYTJlZDM1ZmQ0NTgyL3RhYmxlOjZmZmIxNmI1NGU2YTQyM2FiMTIyODI0MjI3ZGNlNWI4L3RhYmxlcmFuZ2U6NmZmYjE2YjU0ZTZhNDIzYWIxMjI4MjQyMjdkY2U1YjhfMTAtMS0xLTEtMTU2MDQ_7c05c5ad-76f8-453b-808c-ef3bb37a7b10"
      unitRef="usd">40475000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82MS9mcmFnOjIxNDY0N2Q2NmZmMTQzZDQ4MjYyYTJlZDM1ZmQ0NTgyL3RhYmxlOjZmZmIxNmI1NGU2YTQyM2FiMTIyODI0MjI3ZGNlNWI4L3RhYmxlcmFuZ2U6NmZmYjE2YjU0ZTZhNDIzYWIxMjI4MjQyMjdkY2U1YjhfMTAtMy0xLTEtMTU2MDQ_9b1b2572-10a7-4c38-b4ba-c8824c98c4ce"
      unitRef="usd">39222000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82MS9mcmFnOjIxNDY0N2Q2NmZmMTQzZDQ4MjYyYTJlZDM1ZmQ0NTgyL3RhYmxlOjZmZmIxNmI1NGU2YTQyM2FiMTIyODI0MjI3ZGNlNWI4L3RhYmxlcmFuZ2U6NmZmYjE2YjU0ZTZhNDIzYWIxMjI4MjQyMjdkY2U1YjhfMTEtMS0xLTEtMTU2MDQ_3adedaff-6900-4283-a5a3-6b32ff07df92"
      unitRef="usd">33583000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82MS9mcmFnOjIxNDY0N2Q2NmZmMTQzZDQ4MjYyYTJlZDM1ZmQ0NTgyL3RhYmxlOjZmZmIxNmI1NGU2YTQyM2FiMTIyODI0MjI3ZGNlNWI4L3RhYmxlcmFuZ2U6NmZmYjE2YjU0ZTZhNDIzYWIxMjI4MjQyMjdkY2U1YjhfMTEtMy0xLTEtMTU2MDQ_b7387e4f-819a-4d26-8f51-664eceb75416"
      unitRef="usd">34315000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82MS9mcmFnOjIxNDY0N2Q2NmZmMTQzZDQ4MjYyYTJlZDM1ZmQ0NTgyL3RleHRyZWdpb246MjE0NjQ3ZDY2ZmYxNDNkNDgyNjJhMmVkMzVmZDQ1ODJfMTI3_1298478f-5bca-4653-8754-3da49fb33e75"
      unitRef="usd">1483000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82MS9mcmFnOjIxNDY0N2Q2NmZmMTQzZDQ4MjYyYTJlZDM1ZmQ0NTgyL3RleHRyZWdpb246MjE0NjQ3ZDY2ZmYxNDNkNDgyNjJhMmVkMzVmZDQ1ODJfMTM0_5cc3a40a-572e-4056-9b2e-467cbb52051d"
      unitRef="usd">1593000</us-gaap:Depreciation>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82NC9mcmFnOjI3N2RmOTkyZjJlMjRlMDhhZjQwMzNhZTFhYzE4YThlL3RleHRyZWdpb246Mjc3ZGY5OTJmMmUyNGUwOGFmNDAzM2FlMWFjMThhOGVfNDE3_724a7db9-b157-4c5e-9a43-e917a61ca55b">Goodwill and Intangible Assets, Net&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The changes in the carrying amount of goodwill for the three months ended March 31, 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:17pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.263%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(482)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recorded $482 of goodwill impairment related to the total goodwill assigned to one reporting unit within the biopharmaceutical segment during the first quarter of 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company had $44,125 and $43,643 of cumulative impairment losses as of March&#160;31, 2022 and December&#160;31, 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:15pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets consist of the following as of March&#160;31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:17pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.462%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patents, developed technologies and know-how&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39,595)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,480)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,248)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55,323)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets consist of the following as of December&#160;31, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:15pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.462%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patents, developed technologies and know-how&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91,373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38,630)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,252)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,126)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54,008)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization expense was $1,809 and $1,930 for the three months ended March 31, 2022 and 2021, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82NC9mcmFnOjI3N2RmOTkyZjJlMjRlMDhhZjQwMzNhZTFhYzE4YThlL3RleHRyZWdpb246Mjc3ZGY5OTJmMmUyNGUwOGFmNDAzM2FlMWFjMThhOGVfNDI0_7f7da55c-1bf5-43ca-85b9-4e19b657ff66">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The changes in the carrying amount of goodwill for the three months ended March 31, 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:17pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.263%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(482)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82NC9mcmFnOjI3N2RmOTkyZjJlMjRlMDhhZjQwMzNhZTFhYzE4YThlL3RhYmxlOjZiY2NjNDlkMDIwZDQ1ZTI4MDZhYTU3ZjQ0ODg5OTBmL3RhYmxlcmFuZ2U6NmJjY2M0OWQwMjBkNDVlMjgwNmFhNTdmNDQ4ODk5MGZfMC0xLTEtMS0xNTYwNA_5ef67d83-a5f6-4865-8e5f-b7bdae1a5b49"
      unitRef="usd">54148000</us-gaap:Goodwill>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82NC9mcmFnOjI3N2RmOTkyZjJlMjRlMDhhZjQwMzNhZTFhYzE4YThlL3RhYmxlOjZiY2NjNDlkMDIwZDQ1ZTI4MDZhYTU3ZjQ0ODg5OTBmL3RhYmxlcmFuZ2U6NmJjY2M0OWQwMjBkNDVlMjgwNmFhNTdmNDQ4ODk5MGZfMS0xLTEtMS0xNTYwNA_5281b6ba-0e40-406f-9b22-22ed24517e21"
      unitRef="usd">482000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82NC9mcmFnOjI3N2RmOTkyZjJlMjRlMDhhZjQwMzNhZTFhYzE4YThlL3RhYmxlOjZiY2NjNDlkMDIwZDQ1ZTI4MDZhYTU3ZjQ0ODg5OTBmL3RhYmxlcmFuZ2U6NmJjY2M0OWQwMjBkNDVlMjgwNmFhNTdmNDQ4ODk5MGZfMi0xLTEtMS0xNTYwNA_b733300d-c9f8-48ca-bb86-59bd12ccf14b"
      unitRef="usd">-53000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82NC9mcmFnOjI3N2RmOTkyZjJlMjRlMDhhZjQwMzNhZTFhYzE4YThlL3RhYmxlOjZiY2NjNDlkMDIwZDQ1ZTI4MDZhYTU3ZjQ0ODg5OTBmL3RhYmxlcmFuZ2U6NmJjY2M0OWQwMjBkNDVlMjgwNmFhNTdmNDQ4ODk5MGZfMy0xLTEtMS0xNTYwNA_6e370045-2f52-43c1-aa2f-d818a3446c5a"
      unitRef="usd">53613000</us-gaap:Goodwill>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82NC9mcmFnOjI3N2RmOTkyZjJlMjRlMDhhZjQwMzNhZTFhYzE4YThlL3RleHRyZWdpb246Mjc3ZGY5OTJmMmUyNGUwOGFmNDAzM2FlMWFjMThhOGVfMzg0ODI5MDY5OTA1NQ_b62786c2-c95c-4d1c-9d5c-1132990747c1"
      unitRef="usd">482000</us-gaap:GoodwillImpairmentLoss>
    <pgen:NumberOfReportingUnitsImpaired
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82NC9mcmFnOjI3N2RmOTkyZjJlMjRlMDhhZjQwMzNhZTFhYzE4YThlL3RleHRyZWdpb246Mjc3ZGY5OTJmMmUyNGUwOGFmNDAzM2FlMWFjMThhOGVfMjE5OTAyMzI1Nzg2MA_d4cae2d7-0289-46de-87ee-6d11a062fe5b"
      unitRef="reporting_unit">1</pgen:NumberOfReportingUnitsImpaired>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82NC9mcmFnOjI3N2RmOTkyZjJlMjRlMDhhZjQwMzNhZTFhYzE4YThlL3RleHRyZWdpb246Mjc3ZGY5OTJmMmUyNGUwOGFmNDAzM2FlMWFjMThhOGVfMTM4_ad90c179-abaf-45f8-ac1e-5bff50f3ab3a"
      unitRef="usd">44125000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82NC9mcmFnOjI3N2RmOTkyZjJlMjRlMDhhZjQwMzNhZTFhYzE4YThlL3RleHRyZWdpb246Mjc3ZGY5OTJmMmUyNGUwOGFmNDAzM2FlMWFjMThhOGVfMjE5OTAyMzI1NjAyMQ_5da73370-22bb-4c23-8c64-c2ad9df1edf6"
      unitRef="usd">43643000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82NC9mcmFnOjI3N2RmOTkyZjJlMjRlMDhhZjQwMzNhZTFhYzE4YThlL3RleHRyZWdpb246Mjc3ZGY5OTJmMmUyNGUwOGFmNDAzM2FlMWFjMThhOGVfNDM4_10b1eef2-91f5-4071-9a94-586b52a2ce71">&lt;div style="margin-top:15pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets consist of the following as of March&#160;31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:17pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.462%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patents, developed technologies and know-how&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39,595)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,480)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,248)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55,323)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets consist of the following as of December&#160;31, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:15pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.462%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patents, developed technologies and know-how&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91,373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38,630)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,252)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,126)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54,008)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i677ca2bcecca4536be4af0d96b5861f8_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82NC9mcmFnOjI3N2RmOTkyZjJlMjRlMDhhZjQwMzNhZTFhYzE4YThlL3RhYmxlOjM1Y2M0ZTFlNmYyMjQ1YmI4YjhkNTJiZGJmNTgyN2E3L3RhYmxlcmFuZ2U6MzVjYzRlMWU2ZjIyNDViYjhiOGQ1MmJkYmY1ODI3YTdfMS0xLTEtMS0xNTYwNA_05d35e2b-a251-48ff-9e38-644736e7a2d8"
      unitRef="usd">90000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i677ca2bcecca4536be4af0d96b5861f8_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82NC9mcmFnOjI3N2RmOTkyZjJlMjRlMDhhZjQwMzNhZTFhYzE4YThlL3RhYmxlOjM1Y2M0ZTFlNmYyMjQ1YmI4YjhkNTJiZGJmNTgyN2E3L3RhYmxlcmFuZ2U6MzVjYzRlMWU2ZjIyNDViYjhiOGQ1MmJkYmY1ODI3YTdfMS0zLTEtMS0xNTYwNA_aebc915e-2df3-47e1-8556-4dd2ff66b3d0"
      unitRef="usd">39595000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i677ca2bcecca4536be4af0d96b5861f8_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82NC9mcmFnOjI3N2RmOTkyZjJlMjRlMDhhZjQwMzNhZTFhYzE4YThlL3RhYmxlOjM1Y2M0ZTFlNmYyMjQ1YmI4YjhkNTJiZGJmNTgyN2E3L3RhYmxlcmFuZ2U6MzVjYzRlMWU2ZjIyNDViYjhiOGQ1MmJkYmY1ODI3YTdfMS01LTEtMS0xNTYwNA_a60ca44d-381c-4f23-b795-94e4a51b3e62"
      unitRef="usd">50405000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i35dfe924439843b5af0a65df16408eaa_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82NC9mcmFnOjI3N2RmOTkyZjJlMjRlMDhhZjQwMzNhZTFhYzE4YThlL3RhYmxlOjM1Y2M0ZTFlNmYyMjQ1YmI4YjhkNTJiZGJmNTgyN2E3L3RhYmxlcmFuZ2U6MzVjYzRlMWU2ZjIyNDViYjhiOGQ1MmJkYmY1ODI3YTdfMi0xLTEtMS0xNTYwNA_425feed6-056c-410c-9ff4-2cb4f1a5b3da"
      unitRef="usd">10850000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i35dfe924439843b5af0a65df16408eaa_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82NC9mcmFnOjI3N2RmOTkyZjJlMjRlMDhhZjQwMzNhZTFhYzE4YThlL3RhYmxlOjM1Y2M0ZTFlNmYyMjQ1YmI4YjhkNTJiZGJmNTgyN2E3L3RhYmxlcmFuZ2U6MzVjYzRlMWU2ZjIyNDViYjhiOGQ1MmJkYmY1ODI3YTdfMi0zLTEtMS0xNTYwNA_359b6d16-0ca3-409d-a176-e3ea38579db9"
      unitRef="usd">10480000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i35dfe924439843b5af0a65df16408eaa_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82NC9mcmFnOjI3N2RmOTkyZjJlMjRlMDhhZjQwMzNhZTFhYzE4YThlL3RhYmxlOjM1Y2M0ZTFlNmYyMjQ1YmI4YjhkNTJiZGJmNTgyN2E3L3RhYmxlcmFuZ2U6MzVjYzRlMWU2ZjIyNDViYjhiOGQ1MmJkYmY1ODI3YTdfMi01LTEtMS0xNTYwNA_3684970b-98c8-48ca-a860-ac09ea464761"
      unitRef="usd">370000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i93a0684a8757410bb11d784429689ade_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82NC9mcmFnOjI3N2RmOTkyZjJlMjRlMDhhZjQwMzNhZTFhYzE4YThlL3RhYmxlOjM1Y2M0ZTFlNmYyMjQ1YmI4YjhkNTJiZGJmNTgyN2E3L3RhYmxlcmFuZ2U6MzVjYzRlMWU2ZjIyNDViYjhiOGQ1MmJkYmY1ODI3YTdfMy0xLTEtMS0xNTYwNA_c7bc9681-15ac-4a6d-b3d8-e7917ec11090"
      unitRef="usd">5900000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i93a0684a8757410bb11d784429689ade_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82NC9mcmFnOjI3N2RmOTkyZjJlMjRlMDhhZjQwMzNhZTFhYzE4YThlL3RhYmxlOjM1Y2M0ZTFlNmYyMjQ1YmI4YjhkNTJiZGJmNTgyN2E3L3RhYmxlcmFuZ2U6MzVjYzRlMWU2ZjIyNDViYjhiOGQ1MmJkYmY1ODI3YTdfMy0zLTEtMS0xNTYwNA_2123f432-9ab3-44ec-8a22-c5dafa847965"
      unitRef="usd">5248000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i93a0684a8757410bb11d784429689ade_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82NC9mcmFnOjI3N2RmOTkyZjJlMjRlMDhhZjQwMzNhZTFhYzE4YThlL3RhYmxlOjM1Y2M0ZTFlNmYyMjQ1YmI4YjhkNTJiZGJmNTgyN2E3L3RhYmxlcmFuZ2U6MzVjYzRlMWU2ZjIyNDViYjhiOGQ1MmJkYmY1ODI3YTdfMy01LTEtMS0xNTYwNA_797b9e02-96ef-44fd-9c9a-43541e59a36f"
      unitRef="usd">652000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82NC9mcmFnOjI3N2RmOTkyZjJlMjRlMDhhZjQwMzNhZTFhYzE4YThlL3RhYmxlOjM1Y2M0ZTFlNmYyMjQ1YmI4YjhkNTJiZGJmNTgyN2E3L3RhYmxlcmFuZ2U6MzVjYzRlMWU2ZjIyNDViYjhiOGQ1MmJkYmY1ODI3YTdfNC0xLTEtMS0xNTYwNA_1ae15016-31c7-4b0f-8e87-bf5179ad317b"
      unitRef="usd">106750000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82NC9mcmFnOjI3N2RmOTkyZjJlMjRlMDhhZjQwMzNhZTFhYzE4YThlL3RhYmxlOjM1Y2M0ZTFlNmYyMjQ1YmI4YjhkNTJiZGJmNTgyN2E3L3RhYmxlcmFuZ2U6MzVjYzRlMWU2ZjIyNDViYjhiOGQ1MmJkYmY1ODI3YTdfNC0zLTEtMS0xNTYwNA_73b5e685-c358-4832-a19a-be47d77df32a"
      unitRef="usd">55323000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82NC9mcmFnOjI3N2RmOTkyZjJlMjRlMDhhZjQwMzNhZTFhYzE4YThlL3RhYmxlOjM1Y2M0ZTFlNmYyMjQ1YmI4YjhkNTJiZGJmNTgyN2E3L3RhYmxlcmFuZ2U6MzVjYzRlMWU2ZjIyNDViYjhiOGQ1MmJkYmY1ODI3YTdfNC01LTEtMS0xNTYwNA_cfee2d81-9431-49a9-bf52-1747ef2e0334"
      unitRef="usd">51427000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i2492744906d942a6a9d8a0cdfa3ac7c6_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82NC9mcmFnOjI3N2RmOTkyZjJlMjRlMDhhZjQwMzNhZTFhYzE4YThlL3RhYmxlOjMyNGE5N2ExNzNlYjQzMDQ4YzM2YjJlMzE5NjQ2NzA5L3RhYmxlcmFuZ2U6MzI0YTk3YTE3M2ViNDMwNDhjMzZiMmUzMTk2NDY3MDlfMS0xLTEtMS0xNTYwNA_23144934-46b2-4b31-a948-b08dabac2a9a"
      unitRef="usd">91373000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i2492744906d942a6a9d8a0cdfa3ac7c6_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82NC9mcmFnOjI3N2RmOTkyZjJlMjRlMDhhZjQwMzNhZTFhYzE4YThlL3RhYmxlOjMyNGE5N2ExNzNlYjQzMDQ4YzM2YjJlMzE5NjQ2NzA5L3RhYmxlcmFuZ2U6MzI0YTk3YTE3M2ViNDMwNDhjMzZiMmUzMTk2NDY3MDlfMS0zLTEtMS0xNTYwNA_6a073f56-5870-400d-b5dc-4a63d0a8bc44"
      unitRef="usd">38630000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i2492744906d942a6a9d8a0cdfa3ac7c6_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82NC9mcmFnOjI3N2RmOTkyZjJlMjRlMDhhZjQwMzNhZTFhYzE4YThlL3RhYmxlOjMyNGE5N2ExNzNlYjQzMDQ4YzM2YjJlMzE5NjQ2NzA5L3RhYmxlcmFuZ2U6MzI0YTk3YTE3M2ViNDMwNDhjMzZiMmUzMTk2NDY3MDlfMS01LTEtMS0xNTYwNA_1a196394-2592-410b-9a6b-ab3ce2b61c36"
      unitRef="usd">52743000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i23dbbf6a562e498c8fa7683328ca8a94_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82NC9mcmFnOjI3N2RmOTkyZjJlMjRlMDhhZjQwMzNhZTFhYzE4YThlL3RhYmxlOjMyNGE5N2ExNzNlYjQzMDQ4YzM2YjJlMzE5NjQ2NzA5L3RhYmxlcmFuZ2U6MzI0YTk3YTE3M2ViNDMwNDhjMzZiMmUzMTk2NDY3MDlfMi0xLTEtMS0xNTYwNA_62cbe9e2-76b8-45c2-9c98-c386b22b9502"
      unitRef="usd">10850000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i23dbbf6a562e498c8fa7683328ca8a94_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82NC9mcmFnOjI3N2RmOTkyZjJlMjRlMDhhZjQwMzNhZTFhYzE4YThlL3RhYmxlOjMyNGE5N2ExNzNlYjQzMDQ4YzM2YjJlMzE5NjQ2NzA5L3RhYmxlcmFuZ2U6MzI0YTk3YTE3M2ViNDMwNDhjMzZiMmUzMTk2NDY3MDlfMi0zLTEtMS0xNTYwNA_d8cfca6f-3e88-4fda-8abd-f7b42b5858ae"
      unitRef="usd">10252000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i23dbbf6a562e498c8fa7683328ca8a94_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82NC9mcmFnOjI3N2RmOTkyZjJlMjRlMDhhZjQwMzNhZTFhYzE4YThlL3RhYmxlOjMyNGE5N2ExNzNlYjQzMDQ4YzM2YjJlMzE5NjQ2NzA5L3RhYmxlcmFuZ2U6MzI0YTk3YTE3M2ViNDMwNDhjMzZiMmUzMTk2NDY3MDlfMi01LTEtMS0xNTYwNA_cf27c9d9-5ba3-4bc1-9025-03487e8b9156"
      unitRef="usd">598000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i64684d6563664cf59533e60bfe5b9921_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82NC9mcmFnOjI3N2RmOTkyZjJlMjRlMDhhZjQwMzNhZTFhYzE4YThlL3RhYmxlOjMyNGE5N2ExNzNlYjQzMDQ4YzM2YjJlMzE5NjQ2NzA5L3RhYmxlcmFuZ2U6MzI0YTk3YTE3M2ViNDMwNDhjMzZiMmUzMTk2NDY3MDlfMy0xLTEtMS0xNTYwNA_c53683e6-3d36-4d34-aad5-d609e36046e9"
      unitRef="usd">5900000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i64684d6563664cf59533e60bfe5b9921_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82NC9mcmFnOjI3N2RmOTkyZjJlMjRlMDhhZjQwMzNhZTFhYzE4YThlL3RhYmxlOjMyNGE5N2ExNzNlYjQzMDQ4YzM2YjJlMzE5NjQ2NzA5L3RhYmxlcmFuZ2U6MzI0YTk3YTE3M2ViNDMwNDhjMzZiMmUzMTk2NDY3MDlfMy0zLTEtMS0xNTYwNA_7a25d2ab-c51b-4266-ba09-2e7fe1c12d40"
      unitRef="usd">5126000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i64684d6563664cf59533e60bfe5b9921_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82NC9mcmFnOjI3N2RmOTkyZjJlMjRlMDhhZjQwMzNhZTFhYzE4YThlL3RhYmxlOjMyNGE5N2ExNzNlYjQzMDQ4YzM2YjJlMzE5NjQ2NzA5L3RhYmxlcmFuZ2U6MzI0YTk3YTE3M2ViNDMwNDhjMzZiMmUzMTk2NDY3MDlfMy01LTEtMS0xNTYwNA_2bc3e9c0-60f9-452f-b1bc-d8d4f98b4b5c"
      unitRef="usd">774000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82NC9mcmFnOjI3N2RmOTkyZjJlMjRlMDhhZjQwMzNhZTFhYzE4YThlL3RhYmxlOjMyNGE5N2ExNzNlYjQzMDQ4YzM2YjJlMzE5NjQ2NzA5L3RhYmxlcmFuZ2U6MzI0YTk3YTE3M2ViNDMwNDhjMzZiMmUzMTk2NDY3MDlfNC0xLTEtMS0xNTYwNA_4e44ca9a-7b00-42f4-9ea2-7bcbc06adeff"
      unitRef="usd">108123000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82NC9mcmFnOjI3N2RmOTkyZjJlMjRlMDhhZjQwMzNhZTFhYzE4YThlL3RhYmxlOjMyNGE5N2ExNzNlYjQzMDQ4YzM2YjJlMzE5NjQ2NzA5L3RhYmxlcmFuZ2U6MzI0YTk3YTE3M2ViNDMwNDhjMzZiMmUzMTk2NDY3MDlfNC0zLTEtMS0xNTYwNA_bac567af-9e2c-41a5-84f0-5ca13e3c8e81"
      unitRef="usd">54008000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82NC9mcmFnOjI3N2RmOTkyZjJlMjRlMDhhZjQwMzNhZTFhYzE4YThlL3RhYmxlOjMyNGE5N2ExNzNlYjQzMDQ4YzM2YjJlMzE5NjQ2NzA5L3RhYmxlcmFuZ2U6MzI0YTk3YTE3M2ViNDMwNDhjMzZiMmUzMTk2NDY3MDlfNC01LTEtMS0xNTYwNA_5d0735b4-25d3-46c2-95e4-51d0047117c6"
      unitRef="usd">54115000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82NC9mcmFnOjI3N2RmOTkyZjJlMjRlMDhhZjQwMzNhZTFhYzE4YThlL3RleHRyZWdpb246Mjc3ZGY5OTJmMmUyNGUwOGFmNDAzM2FlMWFjMThhOGVfMzI1_69535904-a9ff-44ae-9cb3-bf73acc12554"
      unitRef="usd">1809000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82NC9mcmFnOjI3N2RmOTkyZjJlMjRlMDhhZjQwMzNhZTFhYzE4YThlL3RleHRyZWdpb246Mjc3ZGY5OTJmMmUyNGUwOGFmNDAzM2FlMWFjMThhOGVfMzMy_14120bee-07ee-4112-aad3-781e391ef1ac"
      unitRef="usd">1930000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RleHRyZWdpb246MjdiMjcyODZiZDVlNDYzMTliY2UxMjZmYTUyZjliNWRfNzcwNw_b145808e-40b8-432b-82fa-a64ca67e1a77">Lines of Credit and Long-Term Debt&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Lines of Credit&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Trans Ova had a $5,000 revolving line of credit with First National Bank of Omaha that matured on April 1, 2022. The line of credit bore interest at the greater of the U.S. Prime Rate or 3.00%, and the actual rate was 3.50% as of March&#160;31, 2022. As of March&#160;31, 2022 and December&#160;31, 2021, there was no outstanding balance. The amount available under the line of credit was based on eligible accounts receivable and inventory up to the maximum principal amount and was $5,000 as of March&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Exemplar has a $700 revolving line of credit with American State Bank that matures on October 31, 2022. As of March&#160;31, 2022, the line of credit bore interest at a stated rate of 4.00% per annum. As of March&#160;31, 2022 and December&#160;31, 2021, there was no outstanding balance.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Long-Term Debt&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term debt consists of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:17pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Convertible debt (1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;198,362&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;179,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Notes payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183,151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt, less current portion&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182,749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:13pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;See Note 2 regarding adoption of ASU 2020-06 as of January 1, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Convertible Debt&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Precigen Convertible Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2018, Precigen completed a registered underwritten public offering of $200,000 aggregate principal amount of Convertible Notes and issued the Convertible Notes under an indenture (the "Base Indenture") between Precigen and The Bank of New York Mellon Trust Company, N.A., as trustee, as supplemented by the First Supplemental Indenture (together with the Base Indenture, the "Indenture"). Precigen received net proceeds of $193,958 after deducting underwriting discounts and offering expenses of $6,042.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Convertible Notes are senior unsecured obligations of Precigen and bear interest at a rate of 3.50% per year, payable semiannually in arrears on January 1 and July 1 of each year beginning on January 1, 2019. The Convertible Notes mature on July 1, 2023 and are repayable in cash, unless earlier repurchased or converted. Upon conversion by the holders, the Convertible Notes are convertible into cash, shares of Precigen's common stock or a combination of cash and shares, at Precigen's election. The initial conversion rate of the Convertible Notes is 58.6622 shares of Precigen common stock per $1,000 principal amount of Convertible Notes (equivalent to an initial conversion price of approximately $17.05 per share of common stock). The conversion rate is subject to adjustment upon the occurrence of certain events, but will not be adjusted for any accrued and unpaid interest. In addition, following certain corporate events that occur prior to the maturity date as defined in the Indenture, Precigen will increase the conversion rate for a holder who elects to convert its Convertible Notes in connection with such a corporate event in certain circumstances. Prior to April 1, 2023, the holders may convert the Convertible Notes at their option only upon the satisfaction of the following circumstances:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;During any calendar quarter commencing after the calendar quarter ended on September 30, 2018, if the last reported sales price of Precigen's common stock for at least 20 trading days (whether or not consecutive) during the last 30 consecutive trading days of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;During the five business day period after any five consecutive trading day period in which the trading price, as defined in the Indenture, for the Convertible Notes is less than 98% of the product of the last reported sales price of Precigen's common stock and the conversion rate for the Convertible Notes on each such trading day; or&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Upon the occurrence of specified corporate events as defined in the Indenture.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;None of the above events allowing for conversion prior to April 1, 2023 occurred during the three months ended March&#160;31, 2022. On or after April 1, 2023 until June 30, 2023, holders may convert their Convertible Notes at any time. Precigen may not redeem the Convertible Notes prior to the maturity date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If Precigen undergoes a fundamental change, as defined in the Indenture, holders of the Convertible Notes may require Precigen to repurchase for cash all or any portion of their Convertible Notes at a fundamental change repurchase price equal to 100% of the principal amount of the Convertible Notes to be repurchased, plus accrued and unpaid interest to, but excluding, the fundamental change repurchase date. The Indenture contains customary events of default, as defined in the agreement, and, if any of the events occur, could require repayment of a portion or all of the Convertible Notes, including accrued and unpaid interest. Additionally, the Indenture provides that Precigen shall not consolidate with or merge with or into, or sell, convey, transfer or lease all or substantially all of its properties and assets to, another entity, unless (i) the surviving entity is organized under the laws of the United States and such entity expressly assumes all of Precigen's obligations under the Convertible Notes and the Indenture; and (ii) immediately after such transaction, no default or event of default has occurred and is continuing under the Indenture.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The net proceeds received from the issuance of the Convertible Notes were initially allocated between long-term debt, the liability component, in the amount of $143,723, and additional paid-in capital, the equity component, in the amount of $50,235. Additional paid-in capital was further reduced by $13,367 of deferred taxes resulting from the difference between the carrying amount and the tax basis of the Convertible Notes that is created by the equity component, which also resulted in deferred tax benefit recognized from the reversal of valuation allowances on the then current year domestic operating losses in the same amount. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;As described in Note 2, the Company adopted ASU 2020-06 on January 1, 2022. Pursuant to ASU 2020-06, the equity components of the Convertible Notes separated from the debt components as required under the cash conversion model is required to be recombined into the Convertible Notes as a single instrument upon the adoption of ASU 2020-06. The &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Convertible Notes shall be accounted for as if the conversion option had not been separated. As the Company elected the modified retrospective approach, the difference between the accounting under the cash conversion model and new model after the adoption of ASU 2020-06 (i.e., the single debt instrument with no separation) was recorded as an adjustment on the adoption date (i.e., January 1, 2022) through accumulated deficit. Tax accounting consequences of the adoption also required the reversal of the previously reported deferred tax benefit on the date of adoption.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Adoption of ASU 2020-06 resulted in an increase to long-term debt outstanding, net of current portion, of $18,196, a decrease to additional paid-in capital of $36,868, and a decrease to accumulated deficit of $18,672. Interest expense recognized on the convertible notes in future periods will be reduced as a result of accounting for the convertible debt instrument as a single liability measured at its amortized cost.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;As of March&#160;31, 2022, the outstanding principal balance on the Convertible Notes was $200,000 and the carrying value of long-term debt was $198,362. The effective interest rate on the Convertible Notes, including amortization of the long-term debt discount and debt issuance costs, is 4.25%. As of March&#160;31, 2022, the unamortized long-term debt discount and debt issuance costs totaled $1,638.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of interest expense related to the Convertible Notes were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.514%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.264%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.549%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&#160;&lt;br/&gt;&#160;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-cash interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,034&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued interest of $1,750 is included in other accrued liabilities on the accompanying condensed consolidated balance sheet as of March&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Notes Payable&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Trans Ova has a note payable that matures in April 2033 and had an outstanding principal balance of $3,105 as of March&#160;31, 2022. Trans Ova pays monthly installments of $39, which includes interest at 3.95%. The note payable is collateralized by certain of Trans Ova's real estate and non-real estate assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Future Maturities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future maturities of long-term debt as of March&#160;31, 2022 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:17pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.263%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;203,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i9d132006c1d145eaac64d45ccb86b656_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RleHRyZWdpb246MjdiMjcyODZiZDVlNDYzMTliY2UxMjZmYTUyZjliNWRfNzY_278f3764-bf14-445b-98db-742b0a8c2258"
      unitRef="usd">5000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i19a165412c0146749eb84baeba26cbf7_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RleHRyZWdpb246MjdiMjcyODZiZDVlNDYzMTliY2UxMjZmYTUyZjliNWRfMjQ0_b2942942-f8c4-42d4-96d7-32de3be6e477"
      unitRef="number">0.0300</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd
      contextRef="i9d132006c1d145eaac64d45ccb86b656_I20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RleHRyZWdpb246MjdiMjcyODZiZDVlNDYzMTliY2UxMjZmYTUyZjliNWRfMjcy_361079c4-0ae0-4ef7-a06e-cf643d58da16"
      unitRef="number">0.0350</us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd>
    <us-gaap:LineOfCredit
      contextRef="i9d132006c1d145eaac64d45ccb86b656_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RleHRyZWdpb246MjdiMjcyODZiZDVlNDYzMTliY2UxMjZmYTUyZjliNWRfMzEy_e1ca45a8-7b41-42db-ad6d-e6fffa3fe627"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="i3207747902c548a1a820a9bbe7e15b04_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RleHRyZWdpb246MjdiMjcyODZiZDVlNDYzMTliY2UxMjZmYTUyZjliNWRfMzEy_fe291902-9e0e-43d0-8755-52fe377c1dbd"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity
      contextRef="i9d132006c1d145eaac64d45ccb86b656_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RleHRyZWdpb246MjdiMjcyODZiZDVlNDYzMTliY2UxMjZmYTUyZjliNWRfNDgw_4df77f52-8343-4c21-a9c7-111bcb9edd20"
      unitRef="usd">5000000</us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i6a365a7536554cd6b37d69868458c0ae_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RleHRyZWdpb246MjdiMjcyODZiZDVlNDYzMTliY2UxMjZmYTUyZjliNWRfNzQz_abdfa51c-52d1-450d-8402-dbf81c954dec"
      unitRef="usd">700000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i6a365a7536554cd6b37d69868458c0ae_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RleHRyZWdpb246MjdiMjcyODZiZDVlNDYzMTliY2UxMjZmYTUyZjliNWRfODc2_57a4dbc8-c290-4fed-9b8d-9c9c997cf87f"
      unitRef="number">0.0400</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LineOfCredit
      contextRef="i6a365a7536554cd6b37d69868458c0ae_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RleHRyZWdpb246MjdiMjcyODZiZDVlNDYzMTliY2UxMjZmYTUyZjliNWRfOTE3_91e299cb-ae32-4263-8c7a-e03c80bad037"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="i822f03f707534638b1196ee45d5740e2_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RleHRyZWdpb246MjdiMjcyODZiZDVlNDYzMTliY2UxMjZmYTUyZjliNWRfOTE3_9b8d0067-393a-460e-819f-3f44141c392d"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RleHRyZWdpb246MjdiMjcyODZiZDVlNDYzMTliY2UxMjZmYTUyZjliNWRfNzY5OQ_653cfece-00fb-42d4-9f1d-b441e9e27e64">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term debt consists of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:17pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Convertible debt (1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;198,362&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;179,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Notes payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183,151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt, less current portion&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182,749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;See Note 2 regarding adoption of ASU 2020-06 as of January 1, 2022.&lt;/span&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:LongTermDebt
      contextRef="i2d8dc6d1111e4706a024929613e40a55_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RhYmxlOjk5MWExY2MzYzgxNzQzNzU5OTZiYmRhMjgyZDQ1YTljL3RhYmxlcmFuZ2U6OTkxYTFjYzNjODE3NDM3NTk5NmJiZGEyODJkNDVhOWNfMS0xLTEtMS0xNTYwNA_ad107e7e-9e6a-4035-81ec-dd7d6f687c04"
      unitRef="usd">198362000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i5d949c0fb90e44e48aa23d89122c630b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RhYmxlOjk5MWExY2MzYzgxNzQzNzU5OTZiYmRhMjgyZDQ1YTljL3RhYmxlcmFuZ2U6OTkxYTFjYzNjODE3NDM3NTk5NmJiZGEyODJkNDVhOWNfMS0zLTEtMS0xNTYwNA_e5fa00bb-91b7-441b-a811-293f7d15bffc"
      unitRef="usd">179882000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i30632d5609ff45ee847fb10488a6417a_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RhYmxlOjk5MWExY2MzYzgxNzQzNzU5OTZiYmRhMjgyZDQ1YTljL3RhYmxlcmFuZ2U6OTkxYTFjYzNjODE3NDM3NTk5NmJiZGEyODJkNDVhOWNfMi0xLTEtMS0xNTYwNA_1547cff3-d12d-47c3-9b58-22ab0d163b47"
      unitRef="usd">3105000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i4adfe5f20a0a4ef987ffe40825f234ad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RhYmxlOjk5MWExY2MzYzgxNzQzNzU5OTZiYmRhMjgyZDQ1YTljL3RhYmxlcmFuZ2U6OTkxYTFjYzNjODE3NDM3NTk5NmJiZGEyODJkNDVhOWNfMi0zLTEtMS0xNTYwNA_44bb374f-b818-41cd-8ecc-d980df8448a7"
      unitRef="usd">3217000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ib33f36cb52e14c6e8a14e68692d39463_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RhYmxlOjk5MWExY2MzYzgxNzQzNzU5OTZiYmRhMjgyZDQ1YTljL3RhYmxlcmFuZ2U6OTkxYTFjYzNjODE3NDM3NTk5NmJiZGEyODJkNDVhOWNfMy0xLTEtMS0xNTYwNA_7b2f143b-ad48-4e3b-8af2-102d4627b3e6"
      unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ia99a2463349745cc99f7555e4c6a7a5d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RhYmxlOjk5MWExY2MzYzgxNzQzNzU5OTZiYmRhMjgyZDQ1YTljL3RhYmxlcmFuZ2U6OTkxYTFjYzNjODE3NDM3NTk5NmJiZGEyODJkNDVhOWNfMy0zLTEtMS0xNTYwNA_35f003e3-4738-4e5d-851b-3c90356db42f"
      unitRef="usd">52000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RhYmxlOjk5MWExY2MzYzgxNzQzNzU5OTZiYmRhMjgyZDQ1YTljL3RhYmxlcmFuZ2U6OTkxYTFjYzNjODE3NDM3NTk5NmJiZGEyODJkNDVhOWNfNC0xLTEtMS0xNTYwNA_442f3cb6-4078-4bb1-ab01-298408785b6d"
      unitRef="usd">201467000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RhYmxlOjk5MWExY2MzYzgxNzQzNzU5OTZiYmRhMjgyZDQ1YTljL3RhYmxlcmFuZ2U6OTkxYTFjYzNjODE3NDM3NTk5NmJiZGEyODJkNDVhOWNfNC0zLTEtMS0xNTYwNA_efa35f39-c48a-4b89-b8fd-0b6334c6b965"
      unitRef="usd">183151000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebtCurrent
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RhYmxlOjk5MWExY2MzYzgxNzQzNzU5OTZiYmRhMjgyZDQ1YTljL3RhYmxlcmFuZ2U6OTkxYTFjYzNjODE3NDM3NTk5NmJiZGEyODJkNDVhOWNfNS0xLTEtMS0xNTYwNA_f93884ec-00b2-417e-bd6e-8b2ee386c24b"
      unitRef="usd">355000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RhYmxlOjk5MWExY2MzYzgxNzQzNzU5OTZiYmRhMjgyZDQ1YTljL3RhYmxlcmFuZ2U6OTkxYTFjYzNjODE3NDM3NTk5NmJiZGEyODJkNDVhOWNfNS0zLTEtMS0xNTYwNA_37bae98e-e553-438e-b29f-da41048029c9"
      unitRef="usd">402000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RhYmxlOjk5MWExY2MzYzgxNzQzNzU5OTZiYmRhMjgyZDQ1YTljL3RhYmxlcmFuZ2U6OTkxYTFjYzNjODE3NDM3NTk5NmJiZGEyODJkNDVhOWNfNi0xLTEtMS0xNTYwNA_e19ccc92-540e-495f-9561-8295bb74398d"
      unitRef="usd">201112000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RhYmxlOjk5MWExY2MzYzgxNzQzNzU5OTZiYmRhMjgyZDQ1YTljL3RhYmxlcmFuZ2U6OTkxYTFjYzNjODE3NDM3NTk5NmJiZGEyODJkNDVhOWNfNi0zLTEtMS0xNTYwNA_2c8aca98-356d-44c1-80cf-a789f5810aa9"
      unitRef="usd">182749000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i9756753ac1d54cf49cebd859fa402242_I20180731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RleHRyZWdpb246MjdiMjcyODZiZDVlNDYzMTliY2UxMjZmYTUyZjliNWRfMTEyMg_87bd9d74-ce1c-4904-b5b4-8420753b5ca7"
      unitRef="usd">200000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i36c9e83acbc5433596f7bc29c25d3981_D20180701-20180731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RleHRyZWdpb246MjdiMjcyODZiZDVlNDYzMTliY2UxMjZmYTUyZjliNWRfMTQ2OQ_4e428bb4-49e3-4569-aed7-de668e9b4369"
      unitRef="usd">193958000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:DeferredFinanceCostsGross
      contextRef="i9756753ac1d54cf49cebd859fa402242_I20180731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RleHRyZWdpb246MjdiMjcyODZiZDVlNDYzMTliY2UxMjZmYTUyZjliNWRfMTUzNg_c55e508c-18f3-45c4-87f1-f25cff69f542"
      unitRef="usd">6042000</us-gaap:DeferredFinanceCostsGross>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i9756753ac1d54cf49cebd859fa402242_I20180731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RleHRyZWdpb246MjdiMjcyODZiZDVlNDYzMTliY2UxMjZmYTUyZjliNWRfMTYzOA_d5489a47-dbdf-47b6-9c88-ca2e890075cc"
      unitRef="number">0.0350</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentConvertibleConversionRatio1
      contextRef="i36c9e83acbc5433596f7bc29c25d3981_D20180701-20180731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RleHRyZWdpb246MjdiMjcyODZiZDVlNDYzMTliY2UxMjZmYTUyZjliNWRfMjA5NQ_0938b100-0d9e-4113-aacf-15234b49848f"
      unitRef="number">58.6622</us-gaap:DebtInstrumentConvertibleConversionRatio1>
    <pgen:ConvertibleDebtPrincipalAmountInitialConversionRate
      contextRef="i36c9e83acbc5433596f7bc29c25d3981_D20180701-20180731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RleHRyZWdpb246MjdiMjcyODZiZDVlNDYzMTliY2UxMjZmYTUyZjliNWRfMjEzNA_b30511a6-8192-45ac-82ee-e0870a3b165f"
      unitRef="usd">1000</pgen:ConvertibleDebtPrincipalAmountInitialConversionRate>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="i9756753ac1d54cf49cebd859fa402242_I20180731"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RleHRyZWdpb246MjdiMjcyODZiZDVlNDYzMTliY2UxMjZmYTUyZjliNWRfMjIzNQ_3a3df1a0-4b55-425c-a404-894d78dc9d1f"
      unitRef="usdPerShare">17.05</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentConvertibleThresholdTradingDays
      contextRef="i78bbba80cecb4e08a63655e020bbcd37_D20180701-20180731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RleHRyZWdpb246MjdiMjcyODZiZDVlNDYzMTliY2UxMjZmYTUyZjliNWRfMzAwOQ_5fdb0a73-fa5e-4137-8d24-8b32347de0eb"
      unitRef="day">20</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="i78bbba80cecb4e08a63655e020bbcd37_D20180701-20180731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RleHRyZWdpb246MjdiMjcyODZiZDVlNDYzMTliY2UxMjZmYTUyZjliNWRfMzA3MA_74ee9c76-9b05-4e4e-8b6f-5124851237cd"
      unitRef="day">30</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="i78bbba80cecb4e08a63655e020bbcd37_D20180701-20180731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RleHRyZWdpb246MjdiMjcyODZiZDVlNDYzMTliY2UxMjZmYTUyZjliNWRfMzE3Mg_66ebf62d-e34e-488d-b538-13adbbe08321"
      unitRef="number">1.30</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <us-gaap:DebtInstrumentConvertibleThresholdTradingDays
      contextRef="i3c051e9f9a3d440f9f4a49368f5c7480_D20180701-20180731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RleHRyZWdpb246MjdiMjcyODZiZDVlNDYzMTliY2UxMjZmYTUyZjliNWRfMzI0Mg_2df6eb62-8e99-47b6-a3d7-1b4ac8b759d4"
      unitRef="day">5</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="i3c051e9f9a3d440f9f4a49368f5c7480_D20180701-20180731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RleHRyZWdpb246MjdiMjcyODZiZDVlNDYzMTliY2UxMjZmYTUyZjliNWRfMzI3NQ_93384b64-527e-45b6-a23e-793886ca32ef"
      unitRef="day">5</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="i3c051e9f9a3d440f9f4a49368f5c7480_D20180701-20180731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RleHRyZWdpb246MjdiMjcyODZiZDVlNDYzMTliY2UxMjZmYTUyZjliNWRfMzQwNQ_7b2af2fc-54eb-48de-aa36-346f7f2f7566"
      unitRef="number">0.98</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="i36c9e83acbc5433596f7bc29c25d3981_D20180701-20180731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RleHRyZWdpb246MjdiMjcyODZiZDVlNDYzMTliY2UxMjZmYTUyZjliNWRfNDE4MA_e1bd2998-f545-4211-9c91-d24f2bbb9065"
      unitRef="number">1</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:ConvertibleDebt
      contextRef="i9756753ac1d54cf49cebd859fa402242_I20180731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RleHRyZWdpb246MjdiMjcyODZiZDVlNDYzMTliY2UxMjZmYTUyZjliNWRfNTI1Ng_5b3a96fc-24fa-4e30-83ac-0cd55b712b14"
      unitRef="usd">143723000</us-gaap:ConvertibleDebt>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
      contextRef="i36c9e83acbc5433596f7bc29c25d3981_D20180701-20180731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RleHRyZWdpb246MjdiMjcyODZiZDVlNDYzMTliY2UxMjZmYTUyZjliNWRfNTMzMQ_87ddf4d5-c44f-43cd-8745-c8435b5bce66"
      unitRef="usd">50235000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i36c9e83acbc5433596f7bc29c25d3981_D20180701-20180731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RleHRyZWdpb246MjdiMjcyODZiZDVlNDYzMTliY2UxMjZmYTUyZjliNWRfNTM4NQ_23116c86-b146-44bb-9be0-c728bdfe378b"
      unitRef="usd">13367000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i026820ce93f04afc9c498f6af35f806b_I20220101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RleHRyZWdpb246MjdiMjcyODZiZDVlNDYzMTliY2UxMjZmYTUyZjliNWRfMjE5OTAyMzI2OTQ1Ng_79ac055d-2150-4103-9e59-b38075c17a7c"
      unitRef="usd">18196000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="icf421d5fc50e4e85892b55cbde212eab_I20220101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RleHRyZWdpb246MjdiMjcyODZiZDVlNDYzMTliY2UxMjZmYTUyZjliNWRfMjE5OTAyMzI2OTQ2OA_9871878d-ccfd-45ab-8aa2-aa90748fb15d"
      unitRef="usd">36868000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4f92c06e9bad430cac755e9610e9f9b5_I20220101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RleHRyZWdpb246MjdiMjcyODZiZDVlNDYzMTliY2UxMjZmYTUyZjliNWRfMjE5OTAyMzI2OTQ2Mg_78307361-5530-42d5-8a79-757ffe524ef3"
      unitRef="usd">18672000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="if6f497049bf74c16a1396dfc4d1e650a_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RleHRyZWdpb246MjdiMjcyODZiZDVlNDYzMTliY2UxMjZmYTUyZjliNWRfNTc4OQ_ee3a9b72-561a-4fd6-b852-2636223ee295"
      unitRef="usd">200000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ConvertibleDebt
      contextRef="if6f497049bf74c16a1396dfc4d1e650a_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RleHRyZWdpb246MjdiMjcyODZiZDVlNDYzMTliY2UxMjZmYTUyZjliNWRfNTgzNw_bd29c03a-6d99-4546-9bc8-a7f6c24026b3"
      unitRef="usd">198362000</us-gaap:ConvertibleDebt>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="if6f497049bf74c16a1396dfc4d1e650a_I20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RleHRyZWdpb246MjdiMjcyODZiZDVlNDYzMTliY2UxMjZmYTUyZjliNWRfNTk3Nw_afb2d3ec-6789-48fa-b477-1caa7a077da0"
      unitRef="number">4.25</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="if6f497049bf74c16a1396dfc4d1e650a_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RleHRyZWdpb246MjdiMjcyODZiZDVlNDYzMTliY2UxMjZmYTUyZjliNWRfNjA2Mw_db5e02ab-c628-428e-a264-fd574218584e"
      unitRef="usd">1638000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RleHRyZWdpb246MjdiMjcyODZiZDVlNDYzMTliY2UxMjZmYTUyZjliNWRfNzcxNQ_b524e638-ee3d-4b37-b2cf-f85de467d3a8">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of interest expense related to the Convertible Notes were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.514%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.264%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.549%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&#160;&lt;br/&gt;&#160;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-cash interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,034&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock>
    <us-gaap:InterestExpenseDebtExcludingAmortization
      contextRef="i735cf6b5a38a4c71b70373ae0908abde_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RhYmxlOjJhZjcwZGUzZGI1ODQ0ZGQ5MDMxNGU1ZmRhYjM1YzIxL3RhYmxlcmFuZ2U6MmFmNzBkZTNkYjU4NDRkZDkwMzE0ZTVmZGFiMzVjMjFfMi0xLTEtMS0xNTYwNA_4eae4757-86ef-4b7f-b5f3-28a23f65b609"
      unitRef="usd">1750000</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:InterestExpenseDebtExcludingAmortization
      contextRef="i3c9c4caf2a40476d8e1647cd3cd7dab5_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RhYmxlOjJhZjcwZGUzZGI1ODQ0ZGQ5MDMxNGU1ZmRhYjM1YzIxL3RhYmxlcmFuZ2U6MmFmNzBkZTNkYjU4NDRkZDkwMzE0ZTVmZGFiMzVjMjFfMi0zLTEtMS0xNTYwNA_5a49da87-53de-4486-a6ef-3219c0a2101a"
      unitRef="usd">1750000</us-gaap:InterestExpenseDebtExcludingAmortization>
    <pgen:InterestExpenseDebtAmortizationofDebtDiscountPremiumandDebtIssuanceCosts
      contextRef="i735cf6b5a38a4c71b70373ae0908abde_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RhYmxlOjJhZjcwZGUzZGI1ODQ0ZGQ5MDMxNGU1ZmRhYjM1YzIxL3RhYmxlcmFuZ2U6MmFmNzBkZTNkYjU4NDRkZDkwMzE0ZTVmZGFiMzVjMjFfMy0xLTEtMS0xNTYwNA_e04a24b5-e2af-468f-b1fd-11dfbeea61d3"
      unitRef="usd">284000</pgen:InterestExpenseDebtAmortizationofDebtDiscountPremiumandDebtIssuanceCosts>
    <pgen:InterestExpenseDebtAmortizationofDebtDiscountPremiumandDebtIssuanceCosts
      contextRef="i3c9c4caf2a40476d8e1647cd3cd7dab5_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RhYmxlOjJhZjcwZGUzZGI1ODQ0ZGQ5MDMxNGU1ZmRhYjM1YzIxL3RhYmxlcmFuZ2U6MmFmNzBkZTNkYjU4NDRkZDkwMzE0ZTVmZGFiMzVjMjFfMy0zLTEtMS0xNTYwNA_c5bc5274-486d-42c5-8d49-ab9eb883e9e8"
      unitRef="usd">2751000</pgen:InterestExpenseDebtAmortizationofDebtDiscountPremiumandDebtIssuanceCosts>
    <us-gaap:InterestExpenseDebt
      contextRef="i735cf6b5a38a4c71b70373ae0908abde_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RhYmxlOjJhZjcwZGUzZGI1ODQ0ZGQ5MDMxNGU1ZmRhYjM1YzIxL3RhYmxlcmFuZ2U6MmFmNzBkZTNkYjU4NDRkZDkwMzE0ZTVmZGFiMzVjMjFfNC0xLTEtMS0xNTYwNA_4d22ac76-0824-4051-bb69-e782678b16cc"
      unitRef="usd">2034000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="i3c9c4caf2a40476d8e1647cd3cd7dab5_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RhYmxlOjJhZjcwZGUzZGI1ODQ0ZGQ5MDMxNGU1ZmRhYjM1YzIxL3RhYmxlcmFuZ2U6MmFmNzBkZTNkYjU4NDRkZDkwMzE0ZTVmZGFiMzVjMjFfNC0zLTEtMS0xNTYwNA_fb3f79f1-ecd8-4f8d-8f62-381f30e1a4be"
      unitRef="usd">4501000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RleHRyZWdpb246MjdiMjcyODZiZDVlNDYzMTliY2UxMjZmYTUyZjliNWRfNjE3NA_d9935721-63e1-4aca-80e9-e21918b28734"
      unitRef="usd">1750000</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:LongTermDebt
      contextRef="ib8940548e4f34495a851495a8177a0e5_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RleHRyZWdpb246MjdiMjcyODZiZDVlNDYzMTliY2UxMjZmYTUyZjliNWRfNzQzMg_619651e9-5e08-47bb-9971-b62c2cf6a2b2"
      unitRef="usd">3105000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentPeriodicPayment
      contextRef="i4eac7d5551844a73b17f500e6471b7d6_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RleHRyZWdpb246MjdiMjcyODZiZDVlNDYzMTliY2UxMjZmYTUyZjliNWRfNzQ4NA_70248988-ef46-4d09-ade7-a89cd226f7b0"
      unitRef="usd">39000</us-gaap:DebtInstrumentPeriodicPayment>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib8940548e4f34495a851495a8177a0e5_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RleHRyZWdpb246MjdiMjcyODZiZDVlNDYzMTliY2UxMjZmYTUyZjliNWRfNzUxNQ_80925dea-8150-463f-b9ad-ebd1f3cbe523"
      unitRef="number">0.0395</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RleHRyZWdpb246MjdiMjcyODZiZDVlNDYzMTliY2UxMjZmYTUyZjliNWRfNzcwNA_a2782f18-8a47-4c03-9d22-cb717255deef">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future maturities of long-term debt as of March&#160;31, 2022 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:17pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.263%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;203,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RhYmxlOmYwOTlkNzkyNGJkODQwMzY4NzhiMWYyMjBmYzhhYzdkL3RhYmxlcmFuZ2U6ZjA5OWQ3OTI0YmQ4NDAzNjg3OGIxZjIyMGZjOGFjN2RfMC0xLTEtMS0xNTYwNA_faf68894-ecb6-4c48-bf52-8e881f81246e"
      unitRef="usd">265000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RhYmxlOmYwOTlkNzkyNGJkODQwMzY4NzhiMWYyMjBmYzhhYzdkL3RhYmxlcmFuZ2U6ZjA5OWQ3OTI0YmQ4NDAzNjg3OGIxZjIyMGZjOGFjN2RfMS0xLTEtMS0xNTYwNA_f611599b-f539-4319-b206-7eb8be878133"
      unitRef="usd">200365000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RhYmxlOmYwOTlkNzkyNGJkODQwMzY4NzhiMWYyMjBmYzhhYzdkL3RhYmxlcmFuZ2U6ZjA5OWQ3OTI0YmQ4NDAzNjg3OGIxZjIyMGZjOGFjN2RfMi0xLTEtMS0xNTYwNA_7921b8d6-4bbb-4d6a-b609-4aff17dff529"
      unitRef="usd">380000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RhYmxlOmYwOTlkNzkyNGJkODQwMzY4NzhiMWYyMjBmYzhhYzdkL3RhYmxlcmFuZ2U6ZjA5OWQ3OTI0YmQ4NDAzNjg3OGIxZjIyMGZjOGFjN2RfMy0xLTEtMS0xNTYwNA_dceb4132-571f-4864-8c4b-33401df2a14a"
      unitRef="usd">395000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RhYmxlOmYwOTlkNzkyNGJkODQwMzY4NzhiMWYyMjBmYzhhYzdkL3RhYmxlcmFuZ2U6ZjA5OWQ3OTI0YmQ4NDAzNjg3OGIxZjIyMGZjOGFjN2RfNC0xLTEtMS0xNTYwNA_6bec2dc6-f60b-4871-b2d6-85a9e564775a"
      unitRef="usd">411000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RhYmxlOmYwOTlkNzkyNGJkODQwMzY4NzhiMWYyMjBmYzhhYzdkL3RhYmxlcmFuZ2U6ZjA5OWQ3OTI0YmQ4NDAzNjg3OGIxZjIyMGZjOGFjN2RfNS0xLTEtMS0xNTYwNA_a87e53a6-3259-40b3-a882-3af0b6c444f8"
      unitRef="usd">428000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RhYmxlOmYwOTlkNzkyNGJkODQwMzY4NzhiMWYyMjBmYzhhYzdkL3RhYmxlcmFuZ2U6ZjA5OWQ3OTI0YmQ4NDAzNjg3OGIxZjIyMGZjOGFjN2RfNi0xLTEtMS0xNTYwNA_def1b21b-1d9d-4540-8811-a236bc242a21"
      unitRef="usd">861000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl82Ny9mcmFnOjI3YjI3Mjg2YmQ1ZTQ2MzE5YmNlMTI2ZmE1MmY5YjVkL3RhYmxlOmYwOTlkNzkyNGJkODQwMzY4NzhiMWYyMjBmYzhhYzdkL3RhYmxlcmFuZ2U6ZjA5OWQ3OTI0YmQ4NDAzNjg3OGIxZjIyMGZjOGFjN2RfNy0xLTEtMS0xNTYwNA_f56acbf4-62a0-4c1e-85f7-f8a3b5f9d62a"
      unitRef="usd">203105000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83MC9mcmFnOjIwOWNjNDk5ZjQ3NDQyMGI5N2Q5ZTFkODQ4MjYwMDUwL3RleHRyZWdpb246MjA5Y2M0OTlmNDc0NDIwYjk3ZDllMWQ4NDgyNjAwNTBfMjE0MQ_65b1bc9a-6ec7-45e7-a3e0-c05d03c349e3">Income TaxesTax provisions for interim periods are calculated using an estimate of actual taxable income or loss for the respective period, rather than estimating the Company's annual effective income tax rate, as the Company is currently unable to reliably estimate its income for the full year. The Company has U.S. taxable loss of approximately $5,300 and $40,400 for the three months ended March 31, 2022 and 2021, respectively. The following table presents the components of income tax benefit from continuing operations.&lt;div style="margin-top:17pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.728%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.616%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&#160;&lt;br/&gt;&#160;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current foreign income tax expense from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income tax benefit from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(58)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total income tax benefit from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(58)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's net deferred tax assets, excluding certain deferred tax liabilities totaling $2,438, are offset by a valuation allowance due to the Company's history of net losses combined with an inability to confirm recovery of the tax benefits of the Company's losses and other net deferred tax assets. In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2022, the Company had net operating loss carryforwards for U.S. federal income tax purposes of approximately $861,000 available to offset future taxable income, including approximately $609,000 generated after 2017, U.S. capital loss carryforwards of approximately $212,500, and federal and state research and development tax credits of approximately $11,300, prior to consideration of annual limitations that may be imposed under Section&#160;382 of the Internal Revenue Code of 1986, as amended. Net operating loss carryforwards generated prior to 2018 have begun to expire in 2022, and capital loss carryforwards will expire if unutilized beginning in 2024. As of March&#160;31, 2022, the Company's foreign subsidiaries have foreign loss carryforwards of approximately $74,200, most of which do not expire.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <pgen:TaxableIncomeLoss
      contextRef="ic4808534316144d29d8b9683055df43b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83MC9mcmFnOjIwOWNjNDk5ZjQ3NDQyMGI5N2Q5ZTFkODQ4MjYwMDUwL3RleHRyZWdpb246MjA5Y2M0OTlmNDc0NDIwYjk3ZDllMWQ4NDgyNjAwNTBfMzU4_cde9c116-cea8-44ef-b1d2-1fafbff573c5"
      unitRef="usd">-5300000</pgen:TaxableIncomeLoss>
    <pgen:TaxableIncomeLoss
      contextRef="i30c081f8014842aabc417374b020f10a_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83MC9mcmFnOjIwOWNjNDk5ZjQ3NDQyMGI5N2Q5ZTFkODQ4MjYwMDUwL3RleHRyZWdpb246MjA5Y2M0OTlmNDc0NDIwYjk3ZDllMWQ4NDgyNjAwNTBfMzY1_6bfb1a3a-4778-437a-9368-d72f177ee30f"
      unitRef="usd">-40400000</pgen:TaxableIncomeLoss>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83MC9mcmFnOjIwOWNjNDk5ZjQ3NDQyMGI5N2Q5ZTFkODQ4MjYwMDUwL3RleHRyZWdpb246MjA5Y2M0OTlmNDc0NDIwYjk3ZDllMWQ4NDgyNjAwNTBfMjEzOA_ab262226-572e-45d1-a552-be98c662357b">The following table presents the components of income tax benefit from continuing operations.&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.728%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.616%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&#160;&lt;br/&gt;&#160;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current foreign income tax expense from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income tax benefit from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(58)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total income tax benefit from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(58)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i72d8140387894893965c60c951b48995_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83MC9mcmFnOjIwOWNjNDk5ZjQ3NDQyMGI5N2Q5ZTFkODQ4MjYwMDUwL3RhYmxlOjZhMzMxY2ZlY2M2ZjRkODViMTUxYzdiNmU0MWI0YmU0L3RhYmxlcmFuZ2U6NmEzMzFjZmVjYzZmNGQ4NWIxNTFjN2I2ZTQxYjRiZTRfNC0xLTEtMS0xNTYwNA_f7572628-b56a-4eb2-887c-5712cb124ff5"
      unitRef="usd">0</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i942228f442bc4c7185a791f7d76e9464_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83MC9mcmFnOjIwOWNjNDk5ZjQ3NDQyMGI5N2Q5ZTFkODQ4MjYwMDUwL3RhYmxlOjZhMzMxY2ZlY2M2ZjRkODViMTUxYzdiNmU0MWI0YmU0L3RhYmxlcmFuZ2U6NmEzMzFjZmVjYzZmNGQ4NWIxNTFjN2I2ZTQxYjRiZTRfNC0zLTEtMS0xNTYwNA_858bb173-0bd0-4b75-a7b5-7be3d3d7af0e"
      unitRef="usd">4000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i7b33b3bdd85544d6853b80b9b9363fdc_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83MC9mcmFnOjIwOWNjNDk5ZjQ3NDQyMGI5N2Q5ZTFkODQ4MjYwMDUwL3RhYmxlOjZhMzMxY2ZlY2M2ZjRkODViMTUxYzdiNmU0MWI0YmU0L3RhYmxlcmFuZ2U6NmEzMzFjZmVjYzZmNGQ4NWIxNTFjN2I2ZTQxYjRiZTRfNS0xLTEtMS0xNTYwNA_30659237-ebf3-454a-ad67-6adae7e89533"
      unitRef="usd">-58000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="ica51236575994a4ab8e30322fc2f55a4_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83MC9mcmFnOjIwOWNjNDk5ZjQ3NDQyMGI5N2Q5ZTFkODQ4MjYwMDUwL3RhYmxlOjZhMzMxY2ZlY2M2ZjRkODViMTUxYzdiNmU0MWI0YmU0L3RhYmxlcmFuZ2U6NmEzMzFjZmVjYzZmNGQ4NWIxNTFjN2I2ZTQxYjRiZTRfNS0zLTEtMS0xNTYwNA_7d91a626-49a5-4c5d-927b-72e93356422d"
      unitRef="usd">-56000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i7b33b3bdd85544d6853b80b9b9363fdc_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83MC9mcmFnOjIwOWNjNDk5ZjQ3NDQyMGI5N2Q5ZTFkODQ4MjYwMDUwL3RhYmxlOjZhMzMxY2ZlY2M2ZjRkODViMTUxYzdiNmU0MWI0YmU0L3RhYmxlcmFuZ2U6NmEzMzFjZmVjYzZmNGQ4NWIxNTFjN2I2ZTQxYjRiZTRfNi0xLTEtMS0xNTYwNA_54ca1fb9-1e54-4d5d-a7b2-eba26dbd8c04"
      unitRef="usd">-58000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ica51236575994a4ab8e30322fc2f55a4_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83MC9mcmFnOjIwOWNjNDk5ZjQ3NDQyMGI5N2Q5ZTFkODQ4MjYwMDUwL3RhYmxlOjZhMzMxY2ZlY2M2ZjRkODViMTUxYzdiNmU0MWI0YmU0L3RhYmxlcmFuZ2U6NmEzMzFjZmVjYzZmNGQ4NWIxNTFjN2I2ZTQxYjRiZTRfNi0zLTEtMS0xNTYwNA_e9d897b5-7bbe-40c3-bb0f-f0eb9f404ce6"
      unitRef="usd">-52000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:DeferredTaxLiabilities
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83MC9mcmFnOjIwOWNjNDk5ZjQ3NDQyMGI5N2Q5ZTFkODQ4MjYwMDUwL3RleHRyZWdpb246MjA5Y2M0OTlmNDc0NDIwYjk3ZDllMWQ4NDgyNjAwNTBfNjM1_389c9175-052c-444e-8915-c3bdc39263d1"
      unitRef="usd">2438000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i1fd4ac078b6b4bd3b73092a493efc484_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83MC9mcmFnOjIwOWNjNDk5ZjQ3NDQyMGI5N2Q5ZTFkODQ4MjYwMDUwL3RleHRyZWdpb246MjA5Y2M0OTlmNDc0NDIwYjk3ZDllMWQ4NDgyNjAwNTBfMTQ4NA_aa78a1ce-1cda-4b4e-980b-f31654e25869"
      unitRef="usd">861000000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i6a7f574cfb2544578c335065e1d56a9c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83MC9mcmFnOjIwOWNjNDk5ZjQ3NDQyMGI5N2Q5ZTFkODQ4MjYwMDUwL3RleHRyZWdpb246MjA5Y2M0OTlmNDc0NDIwYjk3ZDllMWQ4NDgyNjAwNTBfMTU1NA_662def9b-6187-477d-947c-53c514534d20"
      unitRef="usd">609000000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsCapitalLossCarryforwards
      contextRef="i1fd4ac078b6b4bd3b73092a493efc484_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83MC9mcmFnOjIwOWNjNDk5ZjQ3NDQyMGI5N2Q5ZTFkODQ4MjYwMDUwL3RleHRyZWdpb246MjA5Y2M0OTlmNDc0NDIwYjk3ZDllMWQ4NDgyNjAwNTBfMTYyOA_df5e9935-3ef4-48a3-b3ae-e42d1f0c1339"
      unitRef="usd">212500000</us-gaap:DeferredTaxAssetsCapitalLossCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch
      contextRef="i1fd4ac078b6b4bd3b73092a493efc484_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83MC9mcmFnOjIwOWNjNDk5ZjQ3NDQyMGI5N2Q5ZTFkODQ4MjYwMDUwL3RleHRyZWdpb246MjA5Y2M0OTlmNDc0NDIwYjk3ZDllMWQ4NDgyNjAwNTBfMTcwOA_f4770e8c-bbd9-4178-930b-f98cb4b78b8c"
      unitRef="usd">11300000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <us-gaap:OperatingLossCarryforwards
      contextRef="ied3594fa3f424f1284f8857f0f9d9e48_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83MC9mcmFnOjIwOWNjNDk5ZjQ3NDQyMGI5N2Q5ZTFkODQ4MjYwMDUwL3RleHRyZWdpb246MjA5Y2M0OTlmNDc0NDIwYjk3ZDllMWQ4NDgyNjAwNTBfMjEwMg_d6734cf3-2d41-4d7a-958a-cf6a782713a8"
      unitRef="usd">74200000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83My9mcmFnOmM1ZGIyMTNkZWJkZjRlMzA5OGU3ODI0MjJjNjU2ZTg5L3RleHRyZWdpb246YzVkYjIxM2RlYmRmNGUzMDk4ZTc4MjQyMmM2NTZlODlfMjcyMQ_cf08cc5e-bbc0-4c6c-ae51-4004c5c19102">Shareholders' Equity&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Issuances of Precigen Common Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2021, the Company closed a public offering of 17,250,000 shares of its common stock, resulting in net proceeds of $121,045, after deducting underwriting discounts and of capitalized offering expenses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See Note 11  for discussion regarding conversion features of the convertible notes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share Lending Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Concurrently with the offering of the Convertible Notes (Note 11), Precigen entered into a share lending agreement (the "Share Lending Agreement") with J.P. Morgan Securities LLC (the "Share Borrower") pursuant to which Precigen loaned and delivered 7,479,431 shares of its common stock (the "Borrowed Shares") to the Share Borrower. The Share Lending Agreement will terminate, and the Borrowed Shares will be returned to Precigen within &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83My9mcmFnOmM1ZGIyMTNkZWJkZjRlMzA5OGU3ODI0MjJjNjU2ZTg5L3RleHRyZWdpb246YzVkYjIxM2RlYmRmNGUzMDk4ZTc4MjQyMmM2NTZlODlfMTA3OA_34a88b8d-8f7c-4b2a-8636-4d319d40194f"&gt;five&lt;/span&gt; business days of such termination, upon (i) termination by the Share Borrower or (ii) the earliest to occur of (a) October 1, 2023 and (b) the date, if any, on which the Share Lending Agreement is either mutually terminated or terminated by one party upon a default by the other party. The Share Borrower maintains collateral in the form of cash or certain permitted non-cash collateral with a market value at least equal to the market value of the Borrowed Shares as security for the obligation of the Share Borrower to return the Borrowed Shares when required by the terms above. The Borrowed Shares were offered and sold to the public at a price of $13.37 per share under a registered offering (the "Borrowed Shares Offering"). Precigen did not receive any proceeds from the sale of the Borrowed Shares to the public or any lending fees from the Share Lending Agreement. The Share Borrower or its affiliates received all the proceeds from the sale of the Borrowed Shares to the public. Affiliates of Third Security purchased all of the shares of common stock in the Borrowed Shares Offering.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Share Lending Agreement was entered into at fair value and met the requirements for equity classification. Therefore, the value is netted against the issuance of the Borrowed Shares in additional paid-in capital. Additionally, the Borrowed Shares are not included in the denominator for loss per share attributable to Precigen shareholders unless the Share Borrower defaults on the Share Lending Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Components of Accumulated Other Comprehensive (Loss) Income &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of accumulated other comprehensive (loss) income are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:17pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized loss on investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(331)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) on foreign currency translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(566)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total accumulated other comprehensive (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,699)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="ie2a968b6094d45cda5605e526b7e92bf_D20210101-20210131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83My9mcmFnOmM1ZGIyMTNkZWJkZjRlMzA5OGU3ODI0MjJjNjU2ZTg5L3RleHRyZWdpb246YzVkYjIxM2RlYmRmNGUzMDk4ZTc4MjQyMmM2NTZlODlfMTIy_b6bd501e-2d50-4ef9-a83d-787e570d700e"
      unitRef="shares">17250000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="ie2a968b6094d45cda5605e526b7e92bf_D20210101-20210131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83My9mcmFnOmM1ZGIyMTNkZWJkZjRlMzA5OGU3ODI0MjJjNjU2ZTg5L3RleHRyZWdpb246YzVkYjIxM2RlYmRmNGUzMDk4ZTc4MjQyMmM2NTZlODlfMTgy_1ae4921d-c253-4f84-af9b-f6ca6f8c39c3"
      unitRef="usd">121045000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesOther
      contextRef="i8598f9bdba3a401d83a4f654f841906a_D20180701-20180731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83My9mcmFnOmM1ZGIyMTNkZWJkZjRlMzA5OGU3ODI0MjJjNjU2ZTg5L3RleHRyZWdpb246YzVkYjIxM2RlYmRmNGUzMDk4ZTc4MjQyMmM2NTZlODlfODk3_bec30f7d-4fd7-4698-af26-9e1d6708c754"
      unitRef="shares">7479431</us-gaap:StockIssuedDuringPeriodSharesOther>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="i93aa43f8711240658d7f03498645c20e_I20180731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83My9mcmFnOmM1ZGIyMTNkZWJkZjRlMzA5OGU3ODI0MjJjNjU2ZTg5L3RleHRyZWdpb246YzVkYjIxM2RlYmRmNGUzMDk4ZTc4MjQyMmM2NTZlODlfMTczMw_4cc04bef-07f8-4891-88b5-69b901233e84"
      unitRef="usdPerShare">13.37</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83My9mcmFnOmM1ZGIyMTNkZWJkZjRlMzA5OGU3ODI0MjJjNjU2ZTg5L3RleHRyZWdpb246YzVkYjIxM2RlYmRmNGUzMDk4ZTc4MjQyMmM2NTZlODlfMjcxNg_2a8eb43d-f69e-4d69-8db8-ac5e76f6002b">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of accumulated other comprehensive (loss) income are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:17pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized loss on investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(331)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) on foreign currency translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(566)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total accumulated other comprehensive (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,699)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquity
      contextRef="i3cffe5138aae46519a9c02056913cbba_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83My9mcmFnOmM1ZGIyMTNkZWJkZjRlMzA5OGU3ODI0MjJjNjU2ZTg5L3RhYmxlOmJhMmNlMTY2NmE4ZTRhNTNiNTU0NWQ0ZTcwNjk1N2NkL3RhYmxlcmFuZ2U6YmEyY2UxNjY2YThlNGE1M2I1NTQ1ZDRlNzA2OTU3Y2RfMS0xLTEtMS0xNTYwNA_ffa6d51b-98f6-4527-97cb-94272de1951c"
      unitRef="usd">-1133000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if3b3a8896f5b4e35ac21bb5d15996bf1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83My9mcmFnOmM1ZGIyMTNkZWJkZjRlMzA5OGU3ODI0MjJjNjU2ZTg5L3RhYmxlOmJhMmNlMTY2NmE4ZTRhNTNiNTU0NWQ0ZTcwNjk1N2NkL3RhYmxlcmFuZ2U6YmEyY2UxNjY2YThlNGE1M2I1NTQ1ZDRlNzA2OTU3Y2RfMS0zLTEtMS0xNTYwNA_a44769dc-f85b-4a37-93e2-9f45d9e85079"
      unitRef="usd">-331000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i356ed50b56d84ebc908b0db1a4e37562_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83My9mcmFnOmM1ZGIyMTNkZWJkZjRlMzA5OGU3ODI0MjJjNjU2ZTg5L3RhYmxlOmJhMmNlMTY2NmE4ZTRhNTNiNTU0NWQ0ZTcwNjk1N2NkL3RhYmxlcmFuZ2U6YmEyY2UxNjY2YThlNGE1M2I1NTQ1ZDRlNzA2OTU3Y2RfMi0xLTEtMS0xNTYwNA_ad91b12b-c10e-476d-a580-e7e89b2ea41f"
      unitRef="usd">-566000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib4e65996659d4890b8c61dca95aca459_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83My9mcmFnOmM1ZGIyMTNkZWJkZjRlMzA5OGU3ODI0MjJjNjU2ZTg5L3RhYmxlOmJhMmNlMTY2NmE4ZTRhNTNiNTU0NWQ0ZTcwNjk1N2NkL3RhYmxlcmFuZ2U6YmEyY2UxNjY2YThlNGE1M2I1NTQ1ZDRlNzA2OTU3Y2RfMi0zLTEtMS0xNTYwNA_a58e401c-d12f-4897-90e5-713faccf953b"
      unitRef="usd">534000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia10c8c844d4940a3b0ebde37f5f75f25_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83My9mcmFnOmM1ZGIyMTNkZWJkZjRlMzA5OGU3ODI0MjJjNjU2ZTg5L3RhYmxlOmJhMmNlMTY2NmE4ZTRhNTNiNTU0NWQ0ZTcwNjk1N2NkL3RhYmxlcmFuZ2U6YmEyY2UxNjY2YThlNGE1M2I1NTQ1ZDRlNzA2OTU3Y2RfMy0xLTEtMS0xNTYwNA_4d77c894-2fdb-4299-a1a3-c9d3093b3478"
      unitRef="usd">-1699000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic1386437e5414589a78d1e1f9863e05e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83My9mcmFnOmM1ZGIyMTNkZWJkZjRlMzA5OGU3ODI0MjJjNjU2ZTg5L3RhYmxlOmJhMmNlMTY2NmE4ZTRhNTNiNTU0NWQ0ZTcwNjk1N2NkL3RhYmxlcmFuZ2U6YmEyY2UxNjY2YThlNGE1M2I1NTQ1ZDRlNzA2OTU3Y2RfMy0zLTEtMS0xNTYwNA_100f5c4f-e59e-45e7-9f6b-b0a16fa3bf96"
      unitRef="usd">203000</us-gaap:StockholdersEquity>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RleHRyZWdpb246NDM1NTMzZTBlZmRhNGM3ZThlNDgxMGVkNDMwZGFiNmVfMzQ1Ng_3d36eced-b801-472b-b812-660835627cb3">Share-Based Payments&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company measures the fair value of stock options and restricted stock units ("RSUs") issued to employees and nonemployees as of the grant date for recognition of stock-based compensation expense. Stock-based compensation expense for employees and nonemployees is recognized over the requisite service period, which is typically the vesting period. Stock-based compensation costs included in the condensed consolidated statements of operations are presented below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:17pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.091%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.927%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.928%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&#160;&lt;br/&gt;&#160;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Precigen Stock Option Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April&#160;2008, Precigen adopted the 2008 Equity Incentive Plan (the "2008 Plan") for employees and nonemployees pursuant to which Precigen's board of directors granted share-based awards, including stock options, to officers, key employees and nonemployees. Upon the effectiveness of the 2013 Omnibus Incentive Plan (the "2013 Plan"), no new awards may be granted under the 2008 Plan. As of March&#160;31, 2022, there were 14,843 stock options outstanding under the 2008 Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Precigen adopted the 2013 Plan for employees and nonemployees pursuant to which Precigen's board of directors may grant share-based awards, including stock options and shares of common stock, to employees, officers, consultants, advisors, and nonemployee directors. The 2013 Plan became effective in August 2013, and as of March&#160;31, 2022, there were 27,000,000 shares authorized for issuance under the 2013 Plan, of which 14,121,502 stock options and 569,445 RSUs were outstanding and 2,085,537 shares were available for grant. In April 2022, Precigen's board of directors approved, subject to shareholder approval at Precigen's annual meeting in June 2022, an increase of 10,000,000 shares of common stock to be reserved for issuance under the 2013 Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 2019, Precigen adopted the 2019 Incentive Plan for Non-Employee Service Providers (the "2019 Plan"), which became effective upon shareholder approval in June 2019. The 2019 Plan permits the grant of share-based awards, including stock options, restricted stock awards, and RSUs, to non-employee service providers, including board members. As of March&#160;31, 2022, there were 5,000,000 shares authorized for issuance under the 2019 Plan, of which 1,898,208 stock options and 615,760 RSUs were outstanding and 243,025 shares were available for grant. In April 2022, Precigen's board of directors approved, subject to shareholder approval at Precigen's annual meeting in June 2022, an increase of 7,000,000 shares of common stock to be reserved for issuance under the 2019 Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock option activity was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Remaining Contractual Term (Years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balances at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,260,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.79&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,009,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(375)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(210,613)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24,036)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balances at March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,034,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.31&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Exercisable at March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,937,195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.99&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:17pt;margin-top:7pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;RSU activity was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of Restricted Stock Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Remaining Contractual Term (Years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balances at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;468,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.33&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,387,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(669,041)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,066)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balances at March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,185,205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.59&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:7pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Precigen currently uses authorized and unissued shares to satisfy share award exercises.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's Executive Chairman ("Executive Chairman"), who previously served as an employee and executive officer until September 24, 2020, received a base salary of $200 per month through March 31, 2020, payable in fully-vested shares of Precigen common stock with such shares subject to a three-year lock-up on resale. In September 2020, the Company's board of directors, upon the recommendation of the compensation committee of the board, approved a new compensation arrangement for the Executive Chairman consisting of (i) an annual retainer of $100 payable in cash or, at the Executive Chairman's election, shares of Precigen common stock; (ii) an annual grant of fully vested stock options having a grant date fair value of $250; and (iii) an annual grant of RSUs having a grant date fair value of $250 vesting over one year. The new compensation arrangement began in calendar year 2021 and was prorated for the nine months of 2020 not covered by the Executive Chairman's previous compensation arrangement discussed above. Expense associated with the arrangements above is included in selling, general, and administrative expenses in the Company's condensed consolidated statements of operations and totaled $433 and $400 for the three months ended March 31, 2022 and 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RleHRyZWdpb246NDM1NTMzZTBlZmRhNGM3ZThlNDgxMGVkNDMwZGFiNmVfMzQ1OQ_1007994f-7f18-423a-86c2-12d3549c3eef">Stock-based compensation costs included in the condensed consolidated statements of operations are presented below:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.091%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.927%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.554%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.928%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&#160;&lt;br/&gt;&#160;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i2fae103728264503ab2e0c1e85de1fa1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RhYmxlOjU5MzhjNzkzZjgyYTQ1YTNiMjZmYmY3N2MwNDdlMzQyL3RhYmxlcmFuZ2U6NTkzOGM3OTNmODJhNDVhM2IyNmZiZjc3YzA0N2UzNDJfMi0xLTEtMS0xNTYwNA_2bb35ec5-f1b3-4528-8b0a-927abb87d4ec"
      unitRef="usd">8000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ifbf81220cc4d45d9aa7386783cc59848_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RhYmxlOjU5MzhjNzkzZjgyYTQ1YTNiMjZmYmY3N2MwNDdlMzQyL3RhYmxlcmFuZ2U6NTkzOGM3OTNmODJhNDVhM2IyNmZiZjc3YzA0N2UzNDJfMi0zLTEtMS0xNTYwNA_75bbc3dc-f764-47cc-8a90-d43f53b33fe4"
      unitRef="usd">9000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="id10f7e933b844c0c974c05850b687893_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RhYmxlOjU5MzhjNzkzZjgyYTQ1YTNiMjZmYmY3N2MwNDdlMzQyL3RhYmxlcmFuZ2U6NTkzOGM3OTNmODJhNDVhM2IyNmZiZjc3YzA0N2UzNDJfMy0xLTEtMS0xNTYwNA_f02f4455-93dd-40f8-aeb8-856a554d8ee6"
      unitRef="usd">31000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i5b6126b9ae8a467c975a767e23eefb22_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RhYmxlOjU5MzhjNzkzZjgyYTQ1YTNiMjZmYmY3N2MwNDdlMzQyL3RhYmxlcmFuZ2U6NTkzOGM3OTNmODJhNDVhM2IyNmZiZjc3YzA0N2UzNDJfMy0zLTEtMS0xNTYwNA_845f2bc3-c7c9-490c-9513-196678abe78e"
      unitRef="usd">65000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ifc7b7a85c17a4f719952d2594387e412_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RhYmxlOjU5MzhjNzkzZjgyYTQ1YTNiMjZmYmY3N2MwNDdlMzQyL3RhYmxlcmFuZ2U6NTkzOGM3OTNmODJhNDVhM2IyNmZiZjc3YzA0N2UzNDJfNC0xLTEtMS0xNTYwNA_cd727173-6e7e-40ec-926f-e5c11d0ea9b9"
      unitRef="usd">548000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i45c4b76fe6d6445d8c45f82b8265fa07_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RhYmxlOjU5MzhjNzkzZjgyYTQ1YTNiMjZmYmY3N2MwNDdlMzQyL3RhYmxlcmFuZ2U6NTkzOGM3OTNmODJhNDVhM2IyNmZiZjc3YzA0N2UzNDJfNC0zLTEtMS0xNTYwNA_76de6ddd-7502-49b0-b051-f2905c920d75"
      unitRef="usd">1038000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ibd0d01ceff2445fda5c004b555eca6e7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RhYmxlOjU5MzhjNzkzZjgyYTQ1YTNiMjZmYmY3N2MwNDdlMzQyL3RhYmxlcmFuZ2U6NTkzOGM3OTNmODJhNDVhM2IyNmZiZjc3YzA0N2UzNDJfNS0xLTEtMS0xNTYwNA_ee745c51-8096-4f6b-8087-3ad75ad9b859"
      unitRef="usd">2975000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ice47f63e56544bee9874b31fbdaf9439_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RhYmxlOjU5MzhjNzkzZjgyYTQ1YTNiMjZmYmY3N2MwNDdlMzQyL3RhYmxlcmFuZ2U6NTkzOGM3OTNmODJhNDVhM2IyNmZiZjc3YzA0N2UzNDJfNS0zLTEtMS0xNTYwNA_ab88dee6-2beb-40ec-97e1-082d6741d03b"
      unitRef="usd">4303000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RhYmxlOjU5MzhjNzkzZjgyYTQ1YTNiMjZmYmY3N2MwNDdlMzQyL3RhYmxlcmFuZ2U6NTkzOGM3OTNmODJhNDVhM2IyNmZiZjc3YzA0N2UzNDJfNy0xLTEtMS0xNTYwNA_02dae7e5-8c6e-446d-aeb6-71d6d392209a"
      unitRef="usd">3562000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RhYmxlOjU5MzhjNzkzZjgyYTQ1YTNiMjZmYmY3N2MwNDdlMzQyL3RhYmxlcmFuZ2U6NTkzOGM3OTNmODJhNDVhM2IyNmZiZjc3YzA0N2UzNDJfNy0zLTEtMS0xNTYwNA_73a7e4bb-186f-43cb-beea-69bd90c629ad"
      unitRef="usd">5415000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i76c7b4e5ff1a48fcadf331282aabc8db_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RleHRyZWdpb246NDM1NTMzZTBlZmRhNGM3ZThlNDgxMGVkNDMwZGFiNmVfODYz_f94f57b4-b628-4cce-acf7-7b06369da161"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i76c7b4e5ff1a48fcadf331282aabc8db_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RleHRyZWdpb246NDM1NTMzZTBlZmRhNGM3ZThlNDgxMGVkNDMwZGFiNmVfOTM0_a670f8f0-23aa-403b-9930-422424a81dde"
      unitRef="shares">14843</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i7b18ccdba7b24f00b51da1d09ef35311_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RleHRyZWdpb246NDM1NTMzZTBlZmRhNGM3ZThlNDgxMGVkNDMwZGFiNmVfMTMyMg_f05b13c5-0c99-48b6-897c-86dfa0c0a143"
      unitRef="shares">27000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i7b18ccdba7b24f00b51da1d09ef35311_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RleHRyZWdpb246NDM1NTMzZTBlZmRhNGM3ZThlNDgxMGVkNDMwZGFiNmVfMTM4Ng_3ad9c0f5-f465-48db-aeda-4d006a9ec1ce"
      unitRef="shares">14121502</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i7b18ccdba7b24f00b51da1d09ef35311_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RleHRyZWdpb246NDM1NTMzZTBlZmRhNGM3ZThlNDgxMGVkNDMwZGFiNmVfMTQwNw_f3e5bd1f-5ee3-4696-921c-7c18727372bf"
      unitRef="shares">569445</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i7b18ccdba7b24f00b51da1d09ef35311_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RleHRyZWdpb246NDM1NTMzZTBlZmRhNGM3ZThlNDgxMGVkNDMwZGFiNmVfMTQzNg_2ed4ba2a-c193-4cc5-9c07-ed86acfad7d0"
      unitRef="shares">2085537</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i2cb8b077e2f643509dd676e06445a3b0_I20220430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RleHRyZWdpb246NDM1NTMzZTBlZmRhNGM3ZThlNDgxMGVkNDMwZGFiNmVfMzI5ODUzNDg4NzM0Mg_c2f1adbc-ab01-40ee-b468-603757fb47c0"
      unitRef="shares">10000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i41a9bb8a5068442cb2b3e00d415ced02_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RleHRyZWdpb246NDM1NTMzZTBlZmRhNGM3ZThlNDgxMGVkNDMwZGFiNmVfMTg0MQ_c91572a5-3f65-4e67-b5e0-6c9d196cda0a"
      unitRef="shares">5000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i41a9bb8a5068442cb2b3e00d415ced02_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RleHRyZWdpb246NDM1NTMzZTBlZmRhNGM3ZThlNDgxMGVkNDMwZGFiNmVfMTkwNQ_9b38bcca-ebb5-457b-8f17-f9d5be961c6f"
      unitRef="shares">1898208</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i41a9bb8a5068442cb2b3e00d415ced02_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RleHRyZWdpb246NDM1NTMzZTBlZmRhNGM3ZThlNDgxMGVkNDMwZGFiNmVfMTkyNg_b3f899bb-9d8a-4930-a381-807e32196747"
      unitRef="shares">615760</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i41a9bb8a5068442cb2b3e00d415ced02_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RleHRyZWdpb246NDM1NTMzZTBlZmRhNGM3ZThlNDgxMGVkNDMwZGFiNmVfMTk1NQ_4533c1d9-b20a-4eec-be31-775c40a6f000"
      unitRef="shares">243025</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="ie9b2e87da42e47ccab3223507b32451a_I20220430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RleHRyZWdpb246NDM1NTMzZTBlZmRhNGM3ZThlNDgxMGVkNDMwZGFiNmVfMzI5ODUzNDg4NzM1NA_536200fa-61ff-46c3-a00b-280e53b3b569"
      unitRef="shares">7000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RleHRyZWdpb246NDM1NTMzZTBlZmRhNGM3ZThlNDgxMGVkNDMwZGFiNmVfMzQ2MA_c949757c-c222-411d-ae64-c9ea62b42606">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock option activity was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Remaining Contractual Term (Years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balances at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,260,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.79&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,009,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(375)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(210,613)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24,036)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balances at March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,034,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.31&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Exercisable at March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,937,195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.99&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i5431bc10b5384e398f2da6195a9b96c3_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RhYmxlOjAxMGM3YmY0ZjFiZTRkNmJhZmFjOTIxMWY3ZGVhOWU1L3RhYmxlcmFuZ2U6MDEwYzdiZjRmMWJlNGQ2YmFmYWM5MjExZjdkZWE5ZTVfMS0xLTEtMS0xNTYwNA_c6491f8e-c246-41b8-97da-e8e416c5e0e3"
      unitRef="shares">12260187</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i5431bc10b5384e398f2da6195a9b96c3_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RhYmxlOjAxMGM3YmY0ZjFiZTRkNmJhZmFjOTIxMWY3ZGVhOWU1L3RhYmxlcmFuZ2U6MDEwYzdiZjRmMWJlNGQ2YmFmYWM5MjExZjdkZWE5ZTVfMS0zLTEtMS0xNTYwNA_61762991-590d-426f-8c53-46647dde4e48"
      unitRef="usdPerShare">14.06</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="ifbfcb80618ad460ab47bac77d7292bc6_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RhYmxlOjAxMGM3YmY0ZjFiZTRkNmJhZmFjOTIxMWY3ZGVhOWU1L3RhYmxlcmFuZ2U6MDEwYzdiZjRmMWJlNGQ2YmFmYWM5MjExZjdkZWE5ZTVfMS01LTEtMS0xNTYwNA_128262f6-02c3-4fd3-88a6-ce6f7799c6f1">P6Y9M14D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="ib0b5090cc97842718a2c0490412cb4ca_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RhYmxlOjAxMGM3YmY0ZjFiZTRkNmJhZmFjOTIxMWY3ZGVhOWU1L3RhYmxlcmFuZ2U6MDEwYzdiZjRmMWJlNGQ2YmFmYWM5MjExZjdkZWE5ZTVfMi0xLTEtMS0xNTYwNA_e6427fba-6d31-458b-abbc-d3dfde65feb3"
      unitRef="shares">4009390</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="ib0b5090cc97842718a2c0490412cb4ca_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RhYmxlOjAxMGM3YmY0ZjFiZTRkNmJhZmFjOTIxMWY3ZGVhOWU1L3RhYmxlcmFuZ2U6MDEwYzdiZjRmMWJlNGQ2YmFmYWM5MjExZjdkZWE5ZTVfMi0zLTEtMS0xNTYwNA_4cab46ab-6515-4b26-9f49-ed07beabdd02"
      unitRef="usdPerShare">2.27</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ib0b5090cc97842718a2c0490412cb4ca_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RhYmxlOjAxMGM3YmY0ZjFiZTRkNmJhZmFjOTIxMWY3ZGVhOWU1L3RhYmxlcmFuZ2U6MDEwYzdiZjRmMWJlNGQ2YmFmYWM5MjExZjdkZWE5ZTVfNC0xLTEtMS0xNTYwNA_58f9aafc-c499-4c3b-a328-652b036fdc4d"
      unitRef="shares">375</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="ib0b5090cc97842718a2c0490412cb4ca_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RhYmxlOjAxMGM3YmY0ZjFiZTRkNmJhZmFjOTIxMWY3ZGVhOWU1L3RhYmxlcmFuZ2U6MDEwYzdiZjRmMWJlNGQ2YmFmYWM5MjExZjdkZWE5ZTVfNC0zLTEtMS0xNTYwNA_4e517ccc-bec7-4b34-a05b-55f0c16a4e9a"
      unitRef="usdPerShare">2.28</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="ib0b5090cc97842718a2c0490412cb4ca_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RhYmxlOjAxMGM3YmY0ZjFiZTRkNmJhZmFjOTIxMWY3ZGVhOWU1L3RhYmxlcmFuZ2U6MDEwYzdiZjRmMWJlNGQ2YmFmYWM5MjExZjdkZWE5ZTVfNS0xLTEtMS0xNTYwNA_843a50eb-7a1b-4ed8-9b3d-3d92ddb6f7aa"
      unitRef="shares">210613</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="ib0b5090cc97842718a2c0490412cb4ca_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RhYmxlOjAxMGM3YmY0ZjFiZTRkNmJhZmFjOTIxMWY3ZGVhOWU1L3RhYmxlcmFuZ2U6MDEwYzdiZjRmMWJlNGQ2YmFmYWM5MjExZjdkZWE5ZTVfNS0zLTEtMS0xNTYwNA_fa136e82-ad51-4036-b284-a997d7b372b7"
      unitRef="usdPerShare">5.63</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
      contextRef="ib0b5090cc97842718a2c0490412cb4ca_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RhYmxlOjAxMGM3YmY0ZjFiZTRkNmJhZmFjOTIxMWY3ZGVhOWU1L3RhYmxlcmFuZ2U6MDEwYzdiZjRmMWJlNGQ2YmFmYWM5MjExZjdkZWE5ZTVfNi0xLTEtMS0xNTYwNA_3a10a05e-cf91-46f3-a79b-459f0c0102a0"
      unitRef="shares">24036</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="ib0b5090cc97842718a2c0490412cb4ca_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RhYmxlOjAxMGM3YmY0ZjFiZTRkNmJhZmFjOTIxMWY3ZGVhOWU1L3RhYmxlcmFuZ2U6MDEwYzdiZjRmMWJlNGQ2YmFmYWM5MjExZjdkZWE5ZTVfNi0zLTEtMS0xNTYwNA_b0e5fdba-3e44-433e-8ece-6b8d96405afd"
      unitRef="usdPerShare">11.85</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="ia76d4feded9342679caddb3d64f9f4ff_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RhYmxlOjAxMGM3YmY0ZjFiZTRkNmJhZmFjOTIxMWY3ZGVhOWU1L3RhYmxlcmFuZ2U6MDEwYzdiZjRmMWJlNGQ2YmFmYWM5MjExZjdkZWE5ZTVfNy0xLTEtMS0xNTYwNA_67f98fe3-8fe6-4205-8c27-29f354dd0677"
      unitRef="shares">16034553</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="ia76d4feded9342679caddb3d64f9f4ff_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RhYmxlOjAxMGM3YmY0ZjFiZTRkNmJhZmFjOTIxMWY3ZGVhOWU1L3RhYmxlcmFuZ2U6MDEwYzdiZjRmMWJlNGQ2YmFmYWM5MjExZjdkZWE5ZTVfNy0zLTEtMS0xNTYwNA_d260b47f-20aa-42c9-8b97-abb7fabf9a30"
      unitRef="usdPerShare">11.22</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="ib0b5090cc97842718a2c0490412cb4ca_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RhYmxlOjAxMGM3YmY0ZjFiZTRkNmJhZmFjOTIxMWY3ZGVhOWU1L3RhYmxlcmFuZ2U6MDEwYzdiZjRmMWJlNGQ2YmFmYWM5MjExZjdkZWE5ZTVfNy01LTEtMS0xNTYwNA_bdaa955e-afd7-41f9-9eda-eec745d31a28">P7Y3M21D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="ia76d4feded9342679caddb3d64f9f4ff_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RhYmxlOjAxMGM3YmY0ZjFiZTRkNmJhZmFjOTIxMWY3ZGVhOWU1L3RhYmxlcmFuZ2U6MDEwYzdiZjRmMWJlNGQ2YmFmYWM5MjExZjdkZWE5ZTVfOC0xLTEtMS0xNTYwNA_22835b2b-ba3c-47c0-a6be-9484cd99337e"
      unitRef="shares">8937195</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="ia76d4feded9342679caddb3d64f9f4ff_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RhYmxlOjAxMGM3YmY0ZjFiZTRkNmJhZmFjOTIxMWY3ZGVhOWU1L3RhYmxlcmFuZ2U6MDEwYzdiZjRmMWJlNGQ2YmFmYWM5MjExZjdkZWE5ZTVfOC0zLTEtMS0xNTYwNA_41d94437-8df1-4c15-a975-c73891a24fda"
      unitRef="usdPerShare">14.85</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="ib0b5090cc97842718a2c0490412cb4ca_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RhYmxlOjAxMGM3YmY0ZjFiZTRkNmJhZmFjOTIxMWY3ZGVhOWU1L3RhYmxlcmFuZ2U6MDEwYzdiZjRmMWJlNGQ2YmFmYWM5MjExZjdkZWE5ZTVfOC01LTEtMS0xNTYwNA_e9989327-e159-444e-a2e0-cffc25e7526e">P5Y11M26D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RleHRyZWdpb246NDM1NTMzZTBlZmRhNGM3ZThlNDgxMGVkNDMwZGFiNmVfMzQ0Nw_42ca791f-767f-42d3-9b75-450df9ac2b96">&lt;div style="margin-bottom:17pt;margin-top:7pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;RSU activity was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of Restricted Stock Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Remaining Contractual Term (Years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balances at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;468,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.33&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,387,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(669,041)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,066)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balances at March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,185,205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.59&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i5431bc10b5384e398f2da6195a9b96c3_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RhYmxlOjhlZWM5MmZmY2JlYzRkYjBiYjBmOGYzMWUyOTU5YWY0L3RhYmxlcmFuZ2U6OGVlYzkyZmZjYmVjNGRiMGJiMGY4ZjMxZTI5NTlhZjRfMS0xLTEtMS0xNTYwNA_62414282-3e43-4395-b4df-d92a3a35d3e6"
      unitRef="shares">468481</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i5431bc10b5384e398f2da6195a9b96c3_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RhYmxlOjhlZWM5MmZmY2JlYzRkYjBiYjBmOGYzMWUyOTU5YWY0L3RhYmxlcmFuZ2U6OGVlYzkyZmZjYmVjNGRiMGJiMGY4ZjMxZTI5NTlhZjRfMS0zLTEtMS0xNTYwNA_0175802c-2a49-4295-a340-9709d0230029"
      unitRef="usdPerShare">8.47</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
      contextRef="ifbfcb80618ad460ab47bac77d7292bc6_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RhYmxlOjhlZWM5MmZmY2JlYzRkYjBiYjBmOGYzMWUyOTU5YWY0L3RhYmxlcmFuZ2U6OGVlYzkyZmZjYmVjNGRiMGJiMGY4ZjMxZTI5NTlhZjRfMS01LTEtMS0xNTYwNA_e13dc75b-4287-409b-b4d7-ce9af4687784">P0Y3M29D</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ib0b5090cc97842718a2c0490412cb4ca_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RhYmxlOjhlZWM5MmZmY2JlYzRkYjBiYjBmOGYzMWUyOTU5YWY0L3RhYmxlcmFuZ2U6OGVlYzkyZmZjYmVjNGRiMGJiMGY4ZjMxZTI5NTlhZjRfMi0xLTEtMS0xNTYwNA_50bd51d0-83aa-4a57-996c-ab13aa279fce"
      unitRef="shares">1387831</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ib0b5090cc97842718a2c0490412cb4ca_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RhYmxlOjhlZWM5MmZmY2JlYzRkYjBiYjBmOGYzMWUyOTU5YWY0L3RhYmxlcmFuZ2U6OGVlYzkyZmZjYmVjNGRiMGJiMGY4ZjMxZTI5NTlhZjRfMi0zLTEtMS0xNTYwNA_6a1c2297-ea1a-4aaa-ba52-0de7f724330e"
      unitRef="usdPerShare">2.12</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="ib0b5090cc97842718a2c0490412cb4ca_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RhYmxlOjhlZWM5MmZmY2JlYzRkYjBiYjBmOGYzMWUyOTU5YWY0L3RhYmxlcmFuZ2U6OGVlYzkyZmZjYmVjNGRiMGJiMGY4ZjMxZTI5NTlhZjRfMy0xLTEtMS0xNTYwNA_4e6fb0d6-77c6-44a7-8b66-2d33f2041383"
      unitRef="shares">669041</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="ib0b5090cc97842718a2c0490412cb4ca_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RhYmxlOjhlZWM5MmZmY2JlYzRkYjBiYjBmOGYzMWUyOTU5YWY0L3RhYmxlcmFuZ2U6OGVlYzkyZmZjYmVjNGRiMGJiMGY4ZjMxZTI5NTlhZjRfMy0zLTEtMS0xNTYwNA_6af9e7f7-1f0b-47d8-9e3a-abc7c7916259"
      unitRef="usdPerShare">5.71</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="ib0b5090cc97842718a2c0490412cb4ca_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RhYmxlOjhlZWM5MmZmY2JlYzRkYjBiYjBmOGYzMWUyOTU5YWY0L3RhYmxlcmFuZ2U6OGVlYzkyZmZjYmVjNGRiMGJiMGY4ZjMxZTI5NTlhZjRfNC0xLTEtMS0xNTYwNA_120bed37-6d5a-40ea-93e7-8d292f7eafed"
      unitRef="shares">2066</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="ib0b5090cc97842718a2c0490412cb4ca_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RhYmxlOjhlZWM5MmZmY2JlYzRkYjBiYjBmOGYzMWUyOTU5YWY0L3RhYmxlcmFuZ2U6OGVlYzkyZmZjYmVjNGRiMGJiMGY4ZjMxZTI5NTlhZjRfNC0zLTEtMS0xNTYwNA_a70f919a-3f0a-4fd4-b92a-f92522e73c7a"
      unitRef="usdPerShare">7.26</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="ia76d4feded9342679caddb3d64f9f4ff_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RhYmxlOjhlZWM5MmZmY2JlYzRkYjBiYjBmOGYzMWUyOTU5YWY0L3RhYmxlcmFuZ2U6OGVlYzkyZmZjYmVjNGRiMGJiMGY4ZjMxZTI5NTlhZjRfNS0xLTEtMS0xNTYwNA_bb9c4056-8220-4041-8d5c-bf1bd64aae13"
      unitRef="shares">1185205</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="ia76d4feded9342679caddb3d64f9f4ff_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RhYmxlOjhlZWM5MmZmY2JlYzRkYjBiYjBmOGYzMWUyOTU5YWY0L3RhYmxlcmFuZ2U6OGVlYzkyZmZjYmVjNGRiMGJiMGY4ZjMxZTI5NTlhZjRfNS0zLTEtMS0xNTYwNA_4fe13bc3-eee1-4b57-9907-0bd8d31777a7"
      unitRef="usdPerShare">2.60</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
      contextRef="ib0b5090cc97842718a2c0490412cb4ca_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RhYmxlOjhlZWM5MmZmY2JlYzRkYjBiYjBmOGYzMWUyOTU5YWY0L3RhYmxlcmFuZ2U6OGVlYzkyZmZjYmVjNGRiMGJiMGY4ZjMxZTI5NTlhZjRfNS01LTEtMS0xNTYwNA_9a5d74ee-036c-422e-842e-3048ff12e9f5">P0Y7M2D</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms>
    <pgen:CompensationArrangementWithIndividualAllocatedShareBasedCompensationExpenseMonthlyExpense
      contextRef="i48d145e276444d3888545e838877b8de_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RleHRyZWdpb246NDM1NTMzZTBlZmRhNGM3ZThlNDgxMGVkNDMwZGFiNmVfMjMxOQ_6d04a09e-167b-4d63-a723-692944488e8a"
      unitRef="usd">200000</pgen:CompensationArrangementWithIndividualAllocatedShareBasedCompensationExpenseMonthlyExpense>
    <pgen:LockupPeriodOnRestrictedStockUnitShares
      contextRef="if5b1b22e280a4090aecc9398d2cdea50_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RleHRyZWdpb246NDM1NTMzZTBlZmRhNGM3ZThlNDgxMGVkNDMwZGFiNmVfMzQ1NQ_7e702971-6035-48a3-950d-d266b95f4629">P3Y</pgen:LockupPeriodOnRestrictedStockUnitShares>
    <pgen:CompensationArrangementWithIndividualAnnualCashRetainer
      contextRef="id74f0b524f01452d8d2d8d74d2292022_D20200901-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RleHRyZWdpb246NDM1NTMzZTBlZmRhNGM3ZThlNDgxMGVkNDMwZGFiNmVfMjY5Nw_5b20042f-a8da-43c8-a765-66f60b497d62"
      unitRef="usd">100000</pgen:CompensationArrangementWithIndividualAnnualCashRetainer>
    <pgen:CompensationArrangementWithIndividualAnnualStockOptionGrantGrantDateFairValue
      contextRef="i0af19287e90a415ea59ea804de00d129_D20200901-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RleHRyZWdpb246NDM1NTMzZTBlZmRhNGM3ZThlNDgxMGVkNDMwZGFiNmVfMjg3Ng_e1a47d6b-b252-4284-8fe7-3adba4a7a3db"
      unitRef="usd">250000</pgen:CompensationArrangementWithIndividualAnnualStockOptionGrantGrantDateFairValue>
    <pgen:CompensationArrangementWithIndividualAnnualRSUGrantGrantDateFairValue
      contextRef="ideb4dd8ae78341f79f57af0fb7ddc27a_D20200901-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RleHRyZWdpb246NDM1NTMzZTBlZmRhNGM3ZThlNDgxMGVkNDMwZGFiNmVfMjk0OA_7a86eebc-d301-44a8-ad33-d46a47935f71"
      unitRef="usd">250000</pgen:CompensationArrangementWithIndividualAnnualRSUGrantGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ideb4dd8ae78341f79f57af0fb7ddc27a_D20200901-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RleHRyZWdpb246NDM1NTMzZTBlZmRhNGM3ZThlNDgxMGVkNDMwZGFiNmVfMjk2NA_2f3a8645-24da-4763-9e80-f5d62af1c65b">P1Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <pgen:CompensationArrangementWithIndividualExpense
      contextRef="i59bc005983d548a9b090b14a8066e997_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RleHRyZWdpb246NDM1NTMzZTBlZmRhNGM3ZThlNDgxMGVkNDMwZGFiNmVfMzM1MA_a234cc23-ec3e-479b-8340-436a56c5924e"
      unitRef="usd">433000</pgen:CompensationArrangementWithIndividualExpense>
    <pgen:CompensationArrangementWithIndividualExpense
      contextRef="i5189760c78094b18a54d1b9ae10c326e_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83Ni9mcmFnOjQzNTUzM2UwZWZkYTRjN2U4ZTQ4MTBlZDQzMGRhYjZlL3RleHRyZWdpb246NDM1NTMzZTBlZmRhNGM3ZThlNDgxMGVkNDMwZGFiNmVfMzM1Nw_9666b628-7310-428f-bb72-2657079e1882"
      unitRef="usd">400000</pgen:CompensationArrangementWithIndividualExpense>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83OS9mcmFnOjgxNjNjNDA5NjZlOTQxMTdhMzUxODA5ZTdhYWE0ZDRkL3RleHRyZWdpb246ODE2M2M0MDk2NmU5NDExN2EzNTE4MDllN2FhYTRkNGRfMTEwMw_5d525017-3777-4dce-ae18-cd7a3342941a">Operating LeasesThe Company leases certain facilities and equipment under operating leases. Leases with a lease term of twelve months or less are considered short-term leases and are not recorded on the balance sheet, and expense for these leases is recognized over the term of the lease. All other leases have remaining terms of &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83OS9mcmFnOjgxNjNjNDA5NjZlOTQxMTdhMzUxODA5ZTdhYWE0ZDRkL3RleHRyZWdpb246ODE2M2M0MDk2NmU5NDExN2EzNTE4MDllN2FhYTRkNGRfMzQw_862490a9-7afa-4299-a0ee-2b7d4d6c6c09"&gt;one&lt;/span&gt; to nine years, some of which may include options to extend the lease and some of which may include options to terminate the lease within one year. The Company uses judgment to determine whether it is reasonably possible to extend the lease beyond the initial term or terminate before the initial term ends and the length of the possible extension or early termination. The leases are renewable at the option of the Company and do not contain residual value guarantees, covenants, or other restrictions. &lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of lease costs were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.960%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.990%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.557%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.993%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&#160;&lt;br/&gt;&#160;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,575&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:7pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2022, maturities of lease liabilities, excluding short-term and variable leases, for continuing operations were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.303%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Present value adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,740)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term portion of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:7pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other information related to operating leases in continuing operations was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;margin-top:17pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average remaining lease term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.65&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:7pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&#160;&lt;br/&gt;&#160;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Supplemental disclosure of cash flow information&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,005&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets obtained in exchange for new lease liabilities (includes new leases or modifications of existing leases)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LesseeOperatingLeaseRemainingLeaseTerm
      contextRef="id3592de1ea59450cab6771569bdb2819_I20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83OS9mcmFnOjgxNjNjNDA5NjZlOTQxMTdhMzUxODA5ZTdhYWE0ZDRkL3RleHRyZWdpb246ODE2M2M0MDk2NmU5NDExN2EzNTE4MDllN2FhYTRkNGRfMzQ2_e75dbeb2-9999-4f4b-91ac-8e862433dbf0">P9Y</us-gaap:LesseeOperatingLeaseRemainingLeaseTerm>
    <pgen:LesseeOperatingLeaseTerminationPeriod
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83OS9mcmFnOjgxNjNjNDA5NjZlOTQxMTdhMzUxODA5ZTdhYWE0ZDRkL3RleHRyZWdpb246ODE2M2M0MDk2NmU5NDExN2EzNTE4MDllN2FhYTRkNGRfNDcy_c2c8aa5f-71c3-4834-9d7a-ceb3d91012fc">P1Y</pgen:LesseeOperatingLeaseTerminationPeriod>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83OS9mcmFnOjgxNjNjNDA5NjZlOTQxMTdhMzUxODA5ZTdhYWE0ZDRkL3RleHRyZWdpb246ODE2M2M0MDk2NmU5NDExN2EzNTE4MDllN2FhYTRkNGRfMTExMQ_5c8f1339-56b7-4159-8992-6bdaab9b93e7">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of lease costs were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.960%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.990%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.557%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.993%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&#160;&lt;br/&gt;&#160;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,575&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:7pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other information related to operating leases in continuing operations was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;margin-top:17pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average remaining lease term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.65&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:7pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&#160;&lt;br/&gt;&#160;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Supplemental disclosure of cash flow information&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,005&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets obtained in exchange for new lease liabilities (includes new leases or modifications of existing leases)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83OS9mcmFnOjgxNjNjNDA5NjZlOTQxMTdhMzUxODA5ZTdhYWE0ZDRkL3RhYmxlOjljNGMwYzc5YWY1YTQwODk4MWViYWQ1YWEyYzkzMjE4L3RhYmxlcmFuZ2U6OWM0YzBjNzlhZjVhNDA4OTgxZWJhZDVhYTJjOTMyMThfMi0xLTEtMS0xNTYwNA_b33990c1-1f02-4d98-b26b-e8750f78a702"
      unitRef="usd">729000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83OS9mcmFnOjgxNjNjNDA5NjZlOTQxMTdhMzUxODA5ZTdhYWE0ZDRkL3RhYmxlOjljNGMwYzc5YWY1YTQwODk4MWViYWQ1YWEyYzkzMjE4L3RhYmxlcmFuZ2U6OWM0YzBjNzlhZjVhNDA4OTgxZWJhZDVhYTJjOTMyMThfMi0zLTEtMS0xNTYwNA_dc6329dd-0f1f-499f-8a8f-8e708d4bec54"
      unitRef="usd">839000</us-gaap:OperatingLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83OS9mcmFnOjgxNjNjNDA5NjZlOTQxMTdhMzUxODA5ZTdhYWE0ZDRkL3RhYmxlOjljNGMwYzc5YWY1YTQwODk4MWViYWQ1YWEyYzkzMjE4L3RhYmxlcmFuZ2U6OWM0YzBjNzlhZjVhNDA4OTgxZWJhZDVhYTJjOTMyMThfMy0xLTEtMS0xNTYwNA_79700c44-52b5-4bde-8382-597316bea9af"
      unitRef="usd">463000</us-gaap:ShortTermLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83OS9mcmFnOjgxNjNjNDA5NjZlOTQxMTdhMzUxODA5ZTdhYWE0ZDRkL3RhYmxlOjljNGMwYzc5YWY1YTQwODk4MWViYWQ1YWEyYzkzMjE4L3RhYmxlcmFuZ2U6OWM0YzBjNzlhZjVhNDA4OTgxZWJhZDVhYTJjOTMyMThfMy0zLTEtMS0xNTYwNA_76778c38-cc81-41e0-b9d9-31e13d430023"
      unitRef="usd">506000</us-gaap:ShortTermLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83OS9mcmFnOjgxNjNjNDA5NjZlOTQxMTdhMzUxODA5ZTdhYWE0ZDRkL3RhYmxlOjljNGMwYzc5YWY1YTQwODk4MWViYWQ1YWEyYzkzMjE4L3RhYmxlcmFuZ2U6OWM0YzBjNzlhZjVhNDA4OTgxZWJhZDVhYTJjOTMyMThfNC0xLTEtMS0xNTYwNA_8a7c6263-096c-4e06-ab1b-ba5a93f72657"
      unitRef="usd">117000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83OS9mcmFnOjgxNjNjNDA5NjZlOTQxMTdhMzUxODA5ZTdhYWE0ZDRkL3RhYmxlOjljNGMwYzc5YWY1YTQwODk4MWViYWQ1YWEyYzkzMjE4L3RhYmxlcmFuZ2U6OWM0YzBjNzlhZjVhNDA4OTgxZWJhZDVhYTJjOTMyMThfNC0zLTEtMS0xNTYwNA_35f8fd12-9682-4db4-8f1e-0784591f369e"
      unitRef="usd">230000</us-gaap:VariableLeaseCost>
    <us-gaap:LeaseCost
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83OS9mcmFnOjgxNjNjNDA5NjZlOTQxMTdhMzUxODA5ZTdhYWE0ZDRkL3RhYmxlOjljNGMwYzc5YWY1YTQwODk4MWViYWQ1YWEyYzkzMjE4L3RhYmxlcmFuZ2U6OWM0YzBjNzlhZjVhNDA4OTgxZWJhZDVhYTJjOTMyMThfNS0xLTEtMS0xNTYwNA_b36c8a7d-b7a4-4b11-a682-539537e50779"
      unitRef="usd">1309000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83OS9mcmFnOjgxNjNjNDA5NjZlOTQxMTdhMzUxODA5ZTdhYWE0ZDRkL3RhYmxlOjljNGMwYzc5YWY1YTQwODk4MWViYWQ1YWEyYzkzMjE4L3RhYmxlcmFuZ2U6OWM0YzBjNzlhZjVhNDA4OTgxZWJhZDVhYTJjOTMyMThfNS0zLTEtMS0xNTYwNA_6a92b72b-7aba-4189-a466-ba2a75cb2e27"
      unitRef="usd">1575000</us-gaap:LeaseCost>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83OS9mcmFnOjgxNjNjNDA5NjZlOTQxMTdhMzUxODA5ZTdhYWE0ZDRkL3RleHRyZWdpb246ODE2M2M0MDk2NmU5NDExN2EzNTE4MDllN2FhYTRkNGRfMTEwNQ_80e35b6e-9764-4425-be9d-5d703c40fa3b">&lt;div style="margin-top:7pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2022, maturities of lease liabilities, excluding short-term and variable leases, for continuing operations were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.303%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Present value adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,740)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term portion of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83OS9mcmFnOjgxNjNjNDA5NjZlOTQxMTdhMzUxODA5ZTdhYWE0ZDRkL3RhYmxlOmMxMTA5ZjcxN2RmNzQ3ZGQ4MzdlZDQ4YzQwYTU2NmY5L3RhYmxlcmFuZ2U6YzExMDlmNzE3ZGY3NDdkZDgzN2VkNDhjNDBhNTY2ZjlfMC0xLTEtMS0xNTYwNA_a314eb25-e489-4ec3-b980-c6c8b4c6267d"
      unitRef="usd">2117000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83OS9mcmFnOjgxNjNjNDA5NjZlOTQxMTdhMzUxODA5ZTdhYWE0ZDRkL3RhYmxlOmMxMTA5ZjcxN2RmNzQ3ZGQ4MzdlZDQ4YzQwYTU2NmY5L3RhYmxlcmFuZ2U6YzExMDlmNzE3ZGY3NDdkZDgzN2VkNDhjNDBhNTY2ZjlfMS0xLTEtMS0xNTYwNA_96f14645-ef0e-4502-a6eb-fe22940175d3"
      unitRef="usd">2519000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83OS9mcmFnOjgxNjNjNDA5NjZlOTQxMTdhMzUxODA5ZTdhYWE0ZDRkL3RhYmxlOmMxMTA5ZjcxN2RmNzQ3ZGQ4MzdlZDQ4YzQwYTU2NmY5L3RhYmxlcmFuZ2U6YzExMDlmNzE3ZGY3NDdkZDgzN2VkNDhjNDBhNTY2ZjlfMi0xLTEtMS0xNTYwNA_9ae4c2cb-8d84-46f0-aae0-766d371303b0"
      unitRef="usd">2528000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83OS9mcmFnOjgxNjNjNDA5NjZlOTQxMTdhMzUxODA5ZTdhYWE0ZDRkL3RhYmxlOmMxMTA5ZjcxN2RmNzQ3ZGQ4MzdlZDQ4YzQwYTU2NmY5L3RhYmxlcmFuZ2U6YzExMDlmNzE3ZGY3NDdkZDgzN2VkNDhjNDBhNTY2ZjlfMy0xLTEtMS0xNTYwNA_9bd37341-47df-406c-b4b4-f82197ac6d3a"
      unitRef="usd">2259000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83OS9mcmFnOjgxNjNjNDA5NjZlOTQxMTdhMzUxODA5ZTdhYWE0ZDRkL3RhYmxlOmMxMTA5ZjcxN2RmNzQ3ZGQ4MzdlZDQ4YzQwYTU2NmY5L3RhYmxlcmFuZ2U6YzExMDlmNzE3ZGY3NDdkZDgzN2VkNDhjNDBhNTY2ZjlfNC0xLTEtMS0xNTYwNA_975068ab-da9d-4c41-9fdd-9633ae1cfbe0"
      unitRef="usd">1778000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83OS9mcmFnOjgxNjNjNDA5NjZlOTQxMTdhMzUxODA5ZTdhYWE0ZDRkL3RhYmxlOmMxMTA5ZjcxN2RmNzQ3ZGQ4MzdlZDQ4YzQwYTU2NmY5L3RhYmxlcmFuZ2U6YzExMDlmNzE3ZGY3NDdkZDgzN2VkNDhjNDBhNTY2ZjlfNS0xLTEtMS0xNTYwNA_20639b66-6bb8-43f8-a754-d779847f54b7"
      unitRef="usd">1345000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83OS9mcmFnOjgxNjNjNDA5NjZlOTQxMTdhMzUxODA5ZTdhYWE0ZDRkL3RhYmxlOmMxMTA5ZjcxN2RmNzQ3ZGQ4MzdlZDQ4YzQwYTU2NmY5L3RhYmxlcmFuZ2U6YzExMDlmNzE3ZGY3NDdkZDgzN2VkNDhjNDBhNTY2ZjlfNi0xLTEtMS0xNTYwNA_bf61e3c6-7505-45c6-8f5b-49d39f476561"
      unitRef="usd">3292000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83OS9mcmFnOjgxNjNjNDA5NjZlOTQxMTdhMzUxODA5ZTdhYWE0ZDRkL3RhYmxlOmMxMTA5ZjcxN2RmNzQ3ZGQ4MzdlZDQ4YzQwYTU2NmY5L3RhYmxlcmFuZ2U6YzExMDlmNzE3ZGY3NDdkZDgzN2VkNDhjNDBhNTY2ZjlfNy0xLTEtMS0xNTYwNA_e821892c-6164-454f-b732-4f2098b310cb"
      unitRef="usd">15838000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83OS9mcmFnOjgxNjNjNDA5NjZlOTQxMTdhMzUxODA5ZTdhYWE0ZDRkL3RhYmxlOmMxMTA5ZjcxN2RmNzQ3ZGQ4MzdlZDQ4YzQwYTU2NmY5L3RhYmxlcmFuZ2U6YzExMDlmNzE3ZGY3NDdkZDgzN2VkNDhjNDBhNTY2ZjlfOC0xLTEtMS0xNTYwNA_487d32f1-ea1d-4244-9225-0b267cd84733"
      unitRef="usd">4740000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83OS9mcmFnOjgxNjNjNDA5NjZlOTQxMTdhMzUxODA5ZTdhYWE0ZDRkL3RhYmxlOmMxMTA5ZjcxN2RmNzQ3ZGQ4MzdlZDQ4YzQwYTU2NmY5L3RhYmxlcmFuZ2U6YzExMDlmNzE3ZGY3NDdkZDgzN2VkNDhjNDBhNTY2ZjlfOS0xLTEtMS0xNTYwNA_e310bbc2-1bbd-41a5-a4e5-6fed0391c4f3"
      unitRef="usd">11098000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83OS9mcmFnOjgxNjNjNDA5NjZlOTQxMTdhMzUxODA5ZTdhYWE0ZDRkL3RhYmxlOmMxMTA5ZjcxN2RmNzQ3ZGQ4MzdlZDQ4YzQwYTU2NmY5L3RhYmxlcmFuZ2U6YzExMDlmNzE3ZGY3NDdkZDgzN2VkNDhjNDBhNTY2ZjlfMTAtMS0xLTEtMTU2MDQ_245dc8ec-9b6d-47ac-beb7-87d0cc4a6081"
      unitRef="usd">1590000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83OS9mcmFnOjgxNjNjNDA5NjZlOTQxMTdhMzUxODA5ZTdhYWE0ZDRkL3RhYmxlOmMxMTA5ZjcxN2RmNzQ3ZGQ4MzdlZDQ4YzQwYTU2NmY5L3RhYmxlcmFuZ2U6YzExMDlmNzE3ZGY3NDdkZDgzN2VkNDhjNDBhNTY2ZjlfMTEtMS0xLTEtMTU2MDQ_c7178307-480a-4926-9460-169c7a0d7b17"
      unitRef="usd">9508000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiability
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83OS9mcmFnOjgxNjNjNDA5NjZlOTQxMTdhMzUxODA5ZTdhYWE0ZDRkL3RhYmxlOmMxMTA5ZjcxN2RmNzQ3ZGQ4MzdlZDQ4YzQwYTU2NmY5L3RhYmxlcmFuZ2U6YzExMDlmNzE3ZGY3NDdkZDgzN2VkNDhjNDBhNTY2ZjlfMTItMS0xLTEtMTU2MDQ_5e8005c9-ae16-454a-8c2a-230be9243c99"
      unitRef="usd">11098000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83OS9mcmFnOjgxNjNjNDA5NjZlOTQxMTdhMzUxODA5ZTdhYWE0ZDRkL3RhYmxlOmI1OWU0ODgwNTI4MjQ3OWZhYTVhOWFmNDUyMzUwNzc4L3RhYmxlcmFuZ2U6YjU5ZTQ4ODA1MjgyNDc5ZmFhNWE5YWY0NTIzNTA3NzhfMS0xLTEtMS0xNTYwNA_c24400cd-6b1c-4c38-b6a5-0bb93535e5cc">P6Y3M18D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83OS9mcmFnOjgxNjNjNDA5NjZlOTQxMTdhMzUxODA5ZTdhYWE0ZDRkL3RhYmxlOmI1OWU0ODgwNTI4MjQ3OWZhYTVhOWFmNDUyMzUwNzc4L3RhYmxlcmFuZ2U6YjU5ZTQ4ODA1MjgyNDc5ZmFhNWE5YWY0NTIzNTA3NzhfMS0zLTEtMS0xNTYwNA_16dd08b5-d031-4861-ae8b-58a4832b5ace">P6Y7M24D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i1449114c17b04272b57978d40430259c_I20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83OS9mcmFnOjgxNjNjNDA5NjZlOTQxMTdhMzUxODA5ZTdhYWE0ZDRkL3RhYmxlOmI1OWU0ODgwNTI4MjQ3OWZhYTVhOWFmNDUyMzUwNzc4L3RhYmxlcmFuZ2U6YjU5ZTQ4ODA1MjgyNDc5ZmFhNWE5YWY0NTIzNTA3NzhfMi0xLTEtMS0xNTYwNA_cb4dfda4-ecdf-4112-8194-c49c4b23ad62"
      unitRef="number">0.1099</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="if864bcd9dba1429abb391816fd5eca4a_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83OS9mcmFnOjgxNjNjNDA5NjZlOTQxMTdhMzUxODA5ZTdhYWE0ZDRkL3RhYmxlOmI1OWU0ODgwNTI4MjQ3OWZhYTVhOWFmNDUyMzUwNzc4L3RhYmxlcmFuZ2U6YjU5ZTQ4ODA1MjgyNDc5ZmFhNWE5YWY0NTIzNTA3NzhfMi0zLTEtMS0xNTYwNA_4ad26024-56d0-4053-8302-5ca2147b0589"
      unitRef="number">0.1099</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeasePayments
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83OS9mcmFnOjgxNjNjNDA5NjZlOTQxMTdhMzUxODA5ZTdhYWE0ZDRkL3RhYmxlOjk4MjZlNDM4ODExNDRkYjc5NzE4NmM3OGM5M2VjNmJhL3RhYmxlcmFuZ2U6OTgyNmU0Mzg4MTE0NGRiNzk3MTg2Yzc4YzkzZWM2YmFfMy0xLTEtMS0xNTYwNA_797572cd-f9ad-45bb-b101-a7fa53f5c134"
      unitRef="usd">744000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83OS9mcmFnOjgxNjNjNDA5NjZlOTQxMTdhMzUxODA5ZTdhYWE0ZDRkL3RhYmxlOjk4MjZlNDM4ODExNDRkYjc5NzE4NmM3OGM5M2VjNmJhL3RhYmxlcmFuZ2U6OTgyNmU0Mzg4MTE0NGRiNzk3MTg2Yzc4YzkzZWM2YmFfMy0zLTEtMS0xNTYwNA_858829b3-cda2-4ad9-8c7c-6fabdd3db1c0"
      unitRef="usd">1005000</us-gaap:OperatingLeasePayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83OS9mcmFnOjgxNjNjNDA5NjZlOTQxMTdhMzUxODA5ZTdhYWE0ZDRkL3RhYmxlOjk4MjZlNDM4ODExNDRkYjc5NzE4NmM3OGM5M2VjNmJhL3RhYmxlcmFuZ2U6OTgyNmU0Mzg4MTE0NGRiNzk3MTg2Yzc4YzkzZWM2YmFfNC0xLTEtMS0xNTYwNA_2c977505-661d-42ab-80c9-b5b28678ea73"
      unitRef="usd">556000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl83OS9mcmFnOjgxNjNjNDA5NjZlOTQxMTdhMzUxODA5ZTdhYWE0ZDRkL3RhYmxlOjk4MjZlNDM4ODExNDRkYjc5NzE4NmM3OGM5M2VjNmJhL3RhYmxlcmFuZ2U6OTgyNmU0Mzg4MTE0NGRiNzk3MTg2Yzc4YzkzZWM2YmFfNC0zLTEtMS0xNTYwNA_2ea2c078-c64b-4846-8dce-de7f501ab69a"
      unitRef="usd">55000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl84Mi9mcmFnOmJlNjkyYzJjZDI5NDQ4MGE4NmFmZjc2ZGM4ZTVkNWEyL3RleHRyZWdpb246YmU2OTJjMmNkMjk0NDgwYTg2YWZmNzZkYzhlNWQ1YTJfNzkyNw_eb6cef51-34e9-4e0b-b17a-14088951e70f">Commitments and Contingencies&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Contingencies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 1, 2020, Trans Ova settled one of two patent infringement lawsuits brought by XY, LLC ("XY"). The lawsuit, originally filed in 2012, was tried and appealed between 2016 and 2020. On December 1, 2020, the parties reached a settlement resolving all remaining disputes. As part of that settlement, Trans Ova remitted to XY a settlement payment, which, in addition to all the other monies Trans Ova had previously paid XY, constituted full payment and satisfaction of the judgment, including pre-judgment interest, post-judgment interest, costs, and all past, current and future royalty obligations under the judgment. In exchange, XY released and forever discharged Trans Ova from all obligations arising out of the judgment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;XY filed a second lawsuit in December 2016, alleging infringement of seven additional patents. Two of those patents were later invalidated in different proceedings and dismissed from the lawsuit. A third patent was settled out of the case in April 2022. There are thus currently four patents remaining in the case. Of these, one patent expired on May 9, 2021, and another expires on May 21, 2022. As for the last two patents, Trans Ova has stopped practicing the technologies claimed therein. The Company expects a trial to occur sometime in 2023. While Trans Ova is confident in its claims and defenses, litigation is uncertain and there is a possibility that the Trans Ova is found liable and ordered to pay damages for past infringement. In the interim, Trans Ova shall continue to operate its business otherwise unaffected by the litigation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2020, the Company reached a final settlement with the Securities and Exchange Commission ("SEC") with respect to an investigation concerning the Company's disclosures regarding its MBP program in the first three quarters of 2017. Under the terms of the settlement, the Company, without admitting or denying the allegations of the SEC, consented to the entry of an administrative order requiring that the Company: (i) cease and desist from committing or causing any violations and future violations under Section 13(a) of the Securities Exchange Act of 1934, as amended, and Rules 13a-11 and 12b-20 promulgated thereunder; and (ii) pay a $2,500 civil money penalty to the SEC (which was paid in September 2020).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2020, several shareholder class action lawsuits were filed in the United States District Court for the Northern District of California on behalf of certain purchasers of the Company's common stock. The complaints name as defendants the Company and certain of its current and former officers. The plaintiffs' claims track the allegations in the SEC's administrative order described above but challenge disclosures about the MBP program through September 2020, i.e., the date of the SEC administrative order. The plaintiffs seek compensatory damages, interest, and an award of reasonable attorneys' fees and costs. In April 2021, the court granted an order consolidating the claims and appointed a lead plaintiff and lead counsel in the case, captioned &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Abailla v. Precigen, Inc., F/K/A Intrexon Corp., et al&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. In May 2021, the lead plaintiff filed an amended complaint. The defendants moved to dismiss that complaint. In September 2021, the court issued an order mooting the defendants' motion to dismiss in light of the lead plaintiff's stated intent to file a second amended complaint in response to the motion to dismiss. On September 27, 2021, the lead plaintiff filed a second amended complaint. On April 7, 2022, at a hearing on the Company&#x2019;s motion, the Court indicated that the second amended complaint would be dismissed with leave to amend. Plaintiffs&#x2019; counsel indicated a new complaint would be filed. The defendants intend to move to dismiss that complaint.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2020, a derivative shareholder action, captioned &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Edward D. Wright, derivatively on behalf of Precigen, Inc. F/K/A Intrexon Corp. v. Alvarez et al&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, was filed in the Circuit Court for Fairfax County in Virginia on behalf of Precigen, Inc. asserting similar claims under state law against Precigen's current directors and certain officers. The plaintiff seeks damages, forfeiture of benefits received by defendants, and an award of reasonable attorneys' fees and costs. The case was stayed by an order entered on June 14, 2021. On September 24, 2021, an individual shareholder filed a lawsuit in the Circuit Court for Henrico County styled &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Kent v. Precigen, Inc.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, Case CL21-6349. The &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Kent&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; action demands inspection of certain books and records of the Company pursuant to Virginia statutory and common law. On April 1, 2022, the court denied the demurrer and referred the matter to a hearing on the merits. The Company is evaluating how best to proceed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company intends to defend the lawsuits vigorously; however, there can be no assurances regarding the ultimate outcome of these lawsuits.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has previously entered into strategic collaborations, including ECCs and JVs, to fund and develop products enabled by its technologies. These relationships involve complex interests, and the Company's interests may diverge with those of its collaborators, which can occur as a result of operations under those collaborations, business or technological developments, or as the Company transitions away from, or terminates, certain strategic collaborations. The Company has had, and has, disagreements and disputes with certain collaborators and JV partners, including the IEP Investors and the IEPII Investors. While the Company believes it is entitled to payment for work performed per its collaborations and JVs, consistent with its policy for accounting for accounts receivable, in 2019, the Company has fully reserved the amount of any disputed accounts receivable that remained outstanding. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 29, 2021, the Company received a letter from a group of investors in each of Intrexon Energy Partners and Intrexon Energy Partners II, purporting to refer certain issues to arbitration pursuant to the arbitration provisions of the Amended and Restated Limited Liability Company Agreements of Intrexon Energy Partners and Intrexon Energy Partners II (the &#x201c;Arbitration Matters&#x201d;). On January 25, 2022, the Company filed a petition in the Court of Chancery for the State of Delaware seeking to enjoin the arbitration proceeding. In March 2022, the Court of Chancery for the State of Delaware determined that arbitration should proceed. The structure of the arbitration requires each party to propose terms for resolution of each matter and the arbitration panel will be required to award one of the two proposals for each matter without compromise. The Company has proposed terms that the Company would acquire the membership interests of the IEP Investors in exchange of $5,000, and the membership interests of the IEPII Investors in exchange of $2,000.  The investor group has proposed terms that the Company would acquire the membership interests of each individual investor in exchange of $34,000 for the membership interests of the IEP Investors and $12,000 for the membership interests of the IEPII Investors, representing the purchase price of their original investments, as well as, in addition, accrued interest from the date of their original investments, which approximates $18,000 for the IEP Investors and $6,000 for the IEPII Investors. The Company expects the arbitration will &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;be concluded in the second quarter of 2022&lt;/span&gt;&lt;span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;While the Company believes the investor groups&#x2019; claims are without merit, there can be no assurance that the panel will award the Company&#x2019;s proposal and will not award the investors&#x2019; proposal with respect to either of the Arbitration Matters.  In addition, as disclosed in Note 5, as of March 31, 2022, the Company has a deferred revenue liability of $21,205 related to consideration previously received from Intrexon Energy Partners and Intrexon Energy Partners II that will be re-evaluated upon conclusion of the Arbitration Matters.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Such disagreements and disputes result in management distraction and may result in further litigation, arbitration, unfavorable settlements, or concessions by the Company, or adverse regulatory action, any of which could harm the Company's business or operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the course of its business, the Company is involved in litigation or legal matters, including governmental investigations. Such matters are subject to many uncertainties and outcomes are not predictable with assurance. The Company accrues liabilities for such matters when it is probable that future expenditures will be made and such expenditures can be reasonably estimated. As of March&#160;31, 2022, the Company does not believe that any such matters, individually or in the aggregate, will have a material adverse effect on the Company's business, financial condition, results of operations, or cash flows.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LossContingencyClaimsSettledNumber
      contextRef="i1e1e4f70ee384bbdbc72a4af43c0088e_D20201201-20201201"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl84Mi9mcmFnOmJlNjkyYzJjZDI5NDQ4MGE4NmFmZjc2ZGM4ZTVkNWEyL3RleHRyZWdpb246YmU2OTJjMmNkMjk0NDgwYTg2YWZmNzZkYzhlNWQ1YTJfOTI_e6614b97-6a8f-4cf5-b25b-1fc36b39f31d"
      unitRef="claim">1</us-gaap:LossContingencyClaimsSettledNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i4e403613e684438d80d697b08493e995_I20201130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl84Mi9mcmFnOmJlNjkyYzJjZDI5NDQ4MGE4NmFmZjc2ZGM4ZTVkNWEyL3RleHRyZWdpb246YmU2OTJjMmNkMjk0NDgwYTg2YWZmNzZkYzhlNWQ1YTJfOTg_9b07f671-f900-43f2-9c22-96d27a145768"
      unitRef="claim">2</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i531c6a806994442783b99222cf391d82_I20161231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl84Mi9mcmFnOmJlNjkyYzJjZDI5NDQ4MGE4NmFmZjc2ZGM4ZTVkNWEyL3RleHRyZWdpb246YmU2OTJjMmNkMjk0NDgwYTg2YWZmNzZkYzhlNWQ1YTJfMzI5ODUzNDkxMTIyMw_a1923fac-f6b4-403d-acc7-50735693a5d1"
      unitRef="claim">7</us-gaap:LossContingencyPendingClaimsNumber>
    <pgen:LossContingencyNumberOfPatentsAtIssue
      contextRef="i92eb050585b540e3800cec27efae3099_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl84Mi9mcmFnOmJlNjkyYzJjZDI5NDQ4MGE4NmFmZjc2ZGM4ZTVkNWEyL3RleHRyZWdpb246YmU2OTJjMmNkMjk0NDgwYTg2YWZmNzZkYzhlNWQ1YTJfMzg0ODI5MDcxNjg0NA_1ef64dad-a491-40e9-b256-943b48e088e3"
      unitRef="patent">4</pgen:LossContingencyNumberOfPatentsAtIssue>
    <us-gaap:PaymentsForLegalSettlements
      contextRef="i6c06e66e33bb485785e90d05f2a08b59_D20200901-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl84Mi9mcmFnOmJlNjkyYzJjZDI5NDQ4MGE4NmFmZjc2ZGM4ZTVkNWEyL3RleHRyZWdpb246YmU2OTJjMmNkMjk0NDgwYTg2YWZmNzZkYzhlNWQ1YTJfMjIxNA_a4df1675-3bb0-414a-b781-f66e18fc49b3"
      unitRef="usd">2500000</us-gaap:PaymentsForLegalSettlements>
    <pgen:ProposedPaymentsForMembershipInterests
      contextRef="i95a19f694d074542bcb9b8a97cf37bd8_D20220301-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl84Mi9mcmFnOmJlNjkyYzJjZDI5NDQ4MGE4NmFmZjc2ZGM4ZTVkNWEyL3RleHRyZWdpb246YmU2OTJjMmNkMjk0NDgwYTg2YWZmNzZkYzhlNWQ1YTJfMzg0ODI5MDczMDU0MA_0d4f2980-4836-4835-80f3-18045d02db7b"
      unitRef="usd">5000</pgen:ProposedPaymentsForMembershipInterests>
    <pgen:ProposedPaymentsForMembershipInterests
      contextRef="i6ae0faf7e643440fae62e6c31bc0d0b0_D20220301-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl84Mi9mcmFnOmJlNjkyYzJjZDI5NDQ4MGE4NmFmZjc2ZGM4ZTVkNWEyL3RleHRyZWdpb246YmU2OTJjMmNkMjk0NDgwYTg2YWZmNzZkYzhlNWQ1YTJfMzg0ODI5MDczMDU2Nw_44b514ce-c45a-46bb-8733-319f00122220"
      unitRef="usd">2000</pgen:ProposedPaymentsForMembershipInterests>
    <pgen:ProposedPaymentsForMembershipInterests
      contextRef="i23eaa581e78f4aea9ecce173012954db_D20220301-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl84Mi9mcmFnOmJlNjkyYzJjZDI5NDQ4MGE4NmFmZjc2ZGM4ZTVkNWEyL3RleHRyZWdpb246YmU2OTJjMmNkMjk0NDgwYTg2YWZmNzZkYzhlNWQ1YTJfMzg0ODI5MDczMDU3MA_bcea20fd-bbf7-444d-9fe7-ec1e92f980a1"
      unitRef="usd">34000</pgen:ProposedPaymentsForMembershipInterests>
    <pgen:ProposedPaymentsForMembershipInterests
      contextRef="ic7d0ad563c924cf39cfee9ad185abd2d_D20220301-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl84Mi9mcmFnOmJlNjkyYzJjZDI5NDQ4MGE4NmFmZjc2ZGM4ZTVkNWEyL3RleHRyZWdpb246YmU2OTJjMmNkMjk0NDgwYTg2YWZmNzZkYzhlNWQ1YTJfMzg0ODI5MDczMDU4OQ_c927ba00-0259-4839-82cf-f905c55ffa71"
      unitRef="usd">12000</pgen:ProposedPaymentsForMembershipInterests>
    <us-gaap:InterestReceivable
      contextRef="i87cc2f18c9f0471f8bc8ab42417029c1_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl84Mi9mcmFnOmJlNjkyYzJjZDI5NDQ4MGE4NmFmZjc2ZGM4ZTVkNWEyL3RleHRyZWdpb246YmU2OTJjMmNkMjk0NDgwYTg2YWZmNzZkYzhlNWQ1YTJfMzg0ODI5MDczMDYwMw_16d9a65a-b92b-4f0d-bce9-f121c0edc56d"
      unitRef="usd">18000</us-gaap:InterestReceivable>
    <us-gaap:InterestReceivable
      contextRef="i823414b73a894b4b82ccc11ca83d746e_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl84Mi9mcmFnOmJlNjkyYzJjZDI5NDQ4MGE4NmFmZjc2ZGM4ZTVkNWEyL3RleHRyZWdpb246YmU2OTJjMmNkMjk0NDgwYTg2YWZmNzZkYzhlNWQ1YTJfMzg0ODI5MDczMDYwNg_0fdf9c00-278d-4ced-abf0-7e92dc95a70a"
      unitRef="usd">6000</us-gaap:InterestReceivable>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="ie8e1602cebb942fe9f1248b8494a1a7d_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl84Mi9mcmFnOmJlNjkyYzJjZDI5NDQ4MGE4NmFmZjc2ZGM4ZTVkNWEyL3RleHRyZWdpb246YmU2OTJjMmNkMjk0NDgwYTg2YWZmNzZkYzhlNWQ1YTJfMzg0ODI5MDczMDU1NA_150eb5cc-55cd-4a8b-8a9c-05ebe7d3da89"
      unitRef="usd">21205000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl84NS9mcmFnOjJkNTJjMjkyZDQxNDQwYWNhNTA2YmVhZjRlOTU2OTk1L3RleHRyZWdpb246MmQ1MmMyOTJkNDE0NDBhY2E1MDZiZWFmNGU5NTY5OTVfMjE2Nw_4bdd879d-9c74-4dd5-8bce-7836600e4892">Related Party Transactions&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Third Security and Affiliates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's Executive Chairman is also the Senior Managing Director and Chairman of Third Security and owns 100% of the equity interests of Third Security. The Company had an agreement with Third Security under which the Company reimbursed Third Security for certain tax-related services performed by Third Security as requested by the Company. The Company also reimburses Third Security for certain out-of-pocket expenses incurred on the Company's behalf. The agreement with Third Security expired on December 31, 2021. As the Company evaluates its alternatives, it continues to utilize these services on a limited basis under the terms of the original agreement. The total expenses incurred by the Company under these arrangements were $26 and $41 for the three months ended March 31, 2022 and 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See also Note 14 regarding compensation arrangements between the Company and its Executive Chairman.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Through November 2021, the Company also subleased certain administrative offices to Third Security. The significant terms of the lease mirrored the terms of the Company's lease with the landlord, and the Company recorded sublease income of $20 for the three months ended March 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See Notes 1, 3, and 13 regarding additional transactions with affiliates of Third Security.&lt;/span&gt;&lt;/div&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <pgen:RelatedPartyOwnershipInterest
      contextRef="ib9c7f0031bb24fe38f91d5540eda5855_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl84NS9mcmFnOjJkNTJjMjkyZDQxNDQwYWNhNTA2YmVhZjRlOTU2OTk1L3RleHRyZWdpb246MmQ1MmMyOTJkNDE0NDBhY2E1MDZiZWFmNGU5NTY5OTVfMTc2_738b8197-1f51-4c3d-8927-ad752996717f"
      unitRef="number">1</pgen:RelatedPartyOwnershipInterest>
    <us-gaap:ProfessionalAndContractServicesExpense
      contextRef="i65e674d88ff54f86a6d42d5a8329e35c_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl84NS9mcmFnOjJkNTJjMjkyZDQxNDQwYWNhNTA2YmVhZjRlOTU2OTk1L3RleHRyZWdpb246MmQ1MmMyOTJkNDE0NDBhY2E1MDZiZWFmNGU5NTY5OTVfNTk2_1bf6d4e3-c2b5-454b-a78c-d60938bc0b10"
      unitRef="usd">26000</us-gaap:ProfessionalAndContractServicesExpense>
    <us-gaap:ProfessionalAndContractServicesExpense
      contextRef="i033c578bc61340d6be52ccd5a2c876ac_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl84NS9mcmFnOjJkNTJjMjkyZDQxNDQwYWNhNTA2YmVhZjRlOTU2OTk1L3RleHRyZWdpb246MmQ1MmMyOTJkNDE0NDBhY2E1MDZiZWFmNGU5NTY5OTVfNjAz_a4e7ddd0-61ff-4dba-b462-1d7e5611809d"
      unitRef="usd">41000</us-gaap:ProfessionalAndContractServicesExpense>
    <us-gaap:SubleaseIncome
      contextRef="i033c578bc61340d6be52ccd5a2c876ac_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl84NS9mcmFnOjJkNTJjMjkyZDQxNDQwYWNhNTA2YmVhZjRlOTU2OTk1L3RleHRyZWdpb246MmQ1MmMyOTJkNDE0NDBhY2E1MDZiZWFmNGU5NTY5OTVfMTAwOQ_032e4763-0290-4039-90ad-a3b5e5bcdd22"
      unitRef="usd">20000</us-gaap:SubleaseIncome>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RleHRyZWdpb246MDg2Y2EwY2I3NTUxNGNkN2JhZmRhN2VhMjUwMDVmZDhfMzA5OA_69a64268-cb64-48c3-b734-3acac639d628">Segments&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's CODM assesses the operating performance of and allocates resources for several operating segments using Segment Adjusted EBITDA as a basis. Management believes this financial metric is a key indicator of operating results since it excludes noncash revenues and expenses that are not reflective of the underlying business performance of an individual enterprise.&#160;The Company defines Segment Adjusted EBITDA as net income (loss) before (i) interest expense, (ii) income tax expense or benefit, (iii) depreciation and amortization, (iv) stock-based compensation expense, (v) loss on settlement agreements where noncash consideration is paid, (vi) adjustments for accrued bonuses paid in equity awards, (vii) gain or loss on disposals of assets, (viii) loss on impairment of goodwill and other noncurrent assets, (ix) equity in net loss of affiliates, and (x) recognition of previously deferred revenue associated with upfront and milestone payments as well as cash outflows from capital expenditures and investments in affiliates, but includes proceeds from the sale of assets in the period sold. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Because the Company uses Segment Adjusted EBITDA as its primary measure of segment performance, it has included this measure in its discussion of segment operating results.&#160;The Company has also disclosed revenues from external customers and intersegment revenues for each reportable segment.&#160;Corporate expenses are not allocated to the segments and are managed at a consolidated level.&#160;The CODM does not use total assets by segment to evaluate segment performance or allocate resources, and accordingly, these amounts are not required to be disclosed.&#160;The Company's segment presentation excludes amounts related to the operations of MBP Titan which are reported as discontinued operations (Note 3).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended March 31, 2022, the Company's reportable segments were (i) Biopharmaceuticals, (ii) Exemplar, and (iii) Trans Ova. These identified reportable segments met the quantitative thresholds to be reported separately for the three months ended March 31, 2022. See Note 2 for a description of Biopharmaceuticals. See Note 1 for a description of Exemplar and Trans Ova.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Segment Adjusted EBITDA by reportable segment was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:15pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.736%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.251%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.571%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.254%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&#160;&lt;br/&gt;&#160;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Biopharmaceuticals&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,620)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,854)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exemplar&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trans Ova&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Segment Adjusted EBITDA for reportable segments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,665)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(627)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:7pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below reconciles Segment Adjusted EBITDA for reportable segments to consolidated net loss from continuing operations before income taxes:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:17pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.538%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.561%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.698%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.541%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&#160;&lt;br/&gt;&#160;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Segment Adjusted EBITDA for reportable segments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,665)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(627)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remove cash paid for capital expenditures, net of proceeds from sale of assets, and cash paid for investments in affiliates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add recognition of previously deferred revenue associated with upfront and milestone payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expenses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,069)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,539)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,292)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,523)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss on disposals of assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(125)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(121)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(482)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,562)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,415)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustment related to accrued bonuses paid in equity awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity in net loss of affiliates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unallocated corporate costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,060)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,194)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Eliminations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,511)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(371)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consolidated net loss from continuing operations before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19,309)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21,896)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:7pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues by reportable segment were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:17pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Biopharmaceuticals&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Exemplar&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Trans Ova&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Biopharmaceuticals&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Exemplar&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Trans Ova&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below reconciles total segment revenues from reportable segments to total consolidated revenues:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:15pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.953%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.392%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.780%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.782%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&#160;&lt;br/&gt;&#160;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment revenues from reportable segments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Elimination of intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,593)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(348)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total consolidated revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;For the three months ended March 31, 2022 and 2021,13.0% and 8.4%, respectively, of total consolidated revenue was attributable to one customer in the Exemplar segment.&lt;/span&gt;&lt;/div&gt;As of March&#160;31, 2022 and December&#160;31, 2021, the Company had $4,148 and $4,463, respectively, of long-lived assets in foreign countries. The Company recognized revenues derived in foreign countries totaling $205 and $99 for the three months ended March 31, 2022 and 2021, respectively</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RleHRyZWdpb246MDg2Y2EwY2I3NTUxNGNkN2JhZmRhN2VhMjUwMDVmZDhfMzA5NQ_a53c0a31-c0c5-4d5b-a337-dc0f9686c11b">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Segment Adjusted EBITDA by reportable segment was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:15pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.736%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.251%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.571%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.254%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&#160;&lt;br/&gt;&#160;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Biopharmaceuticals&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,620)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,854)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exemplar&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trans Ova&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Segment Adjusted EBITDA for reportable segments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,665)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(627)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:7pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues by reportable segment were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:17pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Biopharmaceuticals&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Exemplar&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Trans Ova&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Biopharmaceuticals&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Exemplar&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Trans Ova&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <pgen:NetIncomeLossAttributabletoParentAdjustedEBITDAIncludingCashPaidforCapitalExpendituresandInvestmentsinAffiliates
      contextRef="iac54c563a6c7429ebca9d25950c5a88a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmYxYTIxZTM1ZGRhNjQzMTJhYzM2OWYzZDJhNjM4ZTY2L3RhYmxlcmFuZ2U6ZjFhMjFlMzVkZGE2NDMxMmFjMzY5ZjNkMmE2MzhlNjZfMi0xLTEtMS0xNTYwNA_4aeda177-ac38-434a-b0fe-315cd327ed83"
      unitRef="usd">-11620000</pgen:NetIncomeLossAttributabletoParentAdjustedEBITDAIncludingCashPaidforCapitalExpendituresandInvestmentsinAffiliates>
    <pgen:NetIncomeLossAttributabletoParentAdjustedEBITDAIncludingCashPaidforCapitalExpendituresandInvestmentsinAffiliates
      contextRef="i130e7434090749d3927853a57ecb1485_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmYxYTIxZTM1ZGRhNjQzMTJhYzM2OWYzZDJhNjM4ZTY2L3RhYmxlcmFuZ2U6ZjFhMjFlMzVkZGE2NDMxMmFjMzY5ZjNkMmE2MzhlNjZfMi0zLTEtMS0xNTYwNA_6c50c4e7-cc96-42d1-abbe-c603542c970d"
      unitRef="usd">-8854000</pgen:NetIncomeLossAttributabletoParentAdjustedEBITDAIncludingCashPaidforCapitalExpendituresandInvestmentsinAffiliates>
    <pgen:NetIncomeLossAttributabletoParentAdjustedEBITDAIncludingCashPaidforCapitalExpendituresandInvestmentsinAffiliates
      contextRef="ic90cdb87070e4510bfb77391109bd015_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmYxYTIxZTM1ZGRhNjQzMTJhYzM2OWYzZDJhNjM4ZTY2L3RhYmxlcmFuZ2U6ZjFhMjFlMzVkZGE2NDMxMmFjMzY5ZjNkMmE2MzhlNjZfMy0xLTEtMS0xNTYwNA_a9e36ae4-2ba3-4df6-8b62-e7a340f1beff"
      unitRef="usd">3558000</pgen:NetIncomeLossAttributabletoParentAdjustedEBITDAIncludingCashPaidforCapitalExpendituresandInvestmentsinAffiliates>
    <pgen:NetIncomeLossAttributabletoParentAdjustedEBITDAIncludingCashPaidforCapitalExpendituresandInvestmentsinAffiliates
      contextRef="i1379bdeed3124397a5045d15e0c107f8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmYxYTIxZTM1ZGRhNjQzMTJhYzM2OWYzZDJhNjM4ZTY2L3RhYmxlcmFuZ2U6ZjFhMjFlMzVkZGE2NDMxMmFjMzY5ZjNkMmE2MzhlNjZfMy0zLTEtMS0xNTYwNA_936331d7-5f48-4c9f-aea5-1e9a53b91fc6"
      unitRef="usd">1806000</pgen:NetIncomeLossAttributabletoParentAdjustedEBITDAIncludingCashPaidforCapitalExpendituresandInvestmentsinAffiliates>
    <pgen:NetIncomeLossAttributabletoParentAdjustedEBITDAIncludingCashPaidforCapitalExpendituresandInvestmentsinAffiliates
      contextRef="ie637642bb2524234aedb229fe66afbf3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmYxYTIxZTM1ZGRhNjQzMTJhYzM2OWYzZDJhNjM4ZTY2L3RhYmxlcmFuZ2U6ZjFhMjFlMzVkZGE2NDMxMmFjMzY5ZjNkMmE2MzhlNjZfNC0xLTEtMS0xNTYwNA_7a84f290-b234-4090-8dd8-c48ff465e10b"
      unitRef="usd">5397000</pgen:NetIncomeLossAttributabletoParentAdjustedEBITDAIncludingCashPaidforCapitalExpendituresandInvestmentsinAffiliates>
    <pgen:NetIncomeLossAttributabletoParentAdjustedEBITDAIncludingCashPaidforCapitalExpendituresandInvestmentsinAffiliates
      contextRef="ida88d53a25ce48349d9f4162d6b088a5_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmYxYTIxZTM1ZGRhNjQzMTJhYzM2OWYzZDJhNjM4ZTY2L3RhYmxlcmFuZ2U6ZjFhMjFlMzVkZGE2NDMxMmFjMzY5ZjNkMmE2MzhlNjZfNC0zLTEtMS0xNTYwNA_c49dcd51-9e4e-45c6-853b-78f9798e3fb2"
      unitRef="usd">6421000</pgen:NetIncomeLossAttributabletoParentAdjustedEBITDAIncludingCashPaidforCapitalExpendituresandInvestmentsinAffiliates>
    <pgen:NetIncomeLossAttributabletoParentAdjustedEBITDAIncludingCashPaidforCapitalExpendituresandInvestmentsinAffiliates
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmYxYTIxZTM1ZGRhNjQzMTJhYzM2OWYzZDJhNjM4ZTY2L3RhYmxlcmFuZ2U6ZjFhMjFlMzVkZGE2NDMxMmFjMzY5ZjNkMmE2MzhlNjZfNS0xLTEtMS0xNTYwNA_52fdae20-54f5-4846-b650-c5565925f162"
      unitRef="usd">-2665000</pgen:NetIncomeLossAttributabletoParentAdjustedEBITDAIncludingCashPaidforCapitalExpendituresandInvestmentsinAffiliates>
    <pgen:NetIncomeLossAttributabletoParentAdjustedEBITDAIncludingCashPaidforCapitalExpendituresandInvestmentsinAffiliates
      contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmYxYTIxZTM1ZGRhNjQzMTJhYzM2OWYzZDJhNjM4ZTY2L3RhYmxlcmFuZ2U6ZjFhMjFlMzVkZGE2NDMxMmFjMzY5ZjNkMmE2MzhlNjZfNS0zLTEtMS0xNTYwNA_fcd5ec91-a7f6-4f85-851a-c018a4962129"
      unitRef="usd">-627000</pgen:NetIncomeLossAttributabletoParentAdjustedEBITDAIncludingCashPaidforCapitalExpendituresandInvestmentsinAffiliates>
    <us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RleHRyZWdpb246MDg2Y2EwY2I3NTUxNGNkN2JhZmRhN2VhMjUwMDVmZDhfMzA5Ng_85248f02-5928-4d93-848f-48a66b38e8d9">&lt;div style="margin-top:7pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below reconciles Segment Adjusted EBITDA for reportable segments to consolidated net loss from continuing operations before income taxes:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:17pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.538%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.561%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.698%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.541%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&#160;&lt;br/&gt;&#160;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Segment Adjusted EBITDA for reportable segments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,665)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(627)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remove cash paid for capital expenditures, net of proceeds from sale of assets, and cash paid for investments in affiliates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add recognition of previously deferred revenue associated with upfront and milestone payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expenses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,069)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,539)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,292)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,523)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss on disposals of assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(125)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(121)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(482)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,562)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,415)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustment related to accrued bonuses paid in equity awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity in net loss of affiliates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unallocated corporate costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,060)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,194)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Eliminations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,511)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(371)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consolidated net loss from continuing operations before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19,309)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21,896)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock>
    <pgen:NetIncomeLossAttributabletoParentAdjustedEBITDAIncludingCashPaidforCapitalExpendituresandInvestmentsinAffiliates
      contextRef="ia48b472a445a4200a8254bcce2227a72_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmY5OGNiOTNlMjQyNzQzOWM4NGYxMzlkYWYyYTg3NDUzL3RhYmxlcmFuZ2U6Zjk4Y2I5M2UyNDI3NDM5Yzg0ZjEzOWRhZjJhODc0NTNfMi0xLTEtMS0xNTYwNA_a2a91cd3-58b4-4999-9d63-652c0864fcc2"
      unitRef="usd">-2665000</pgen:NetIncomeLossAttributabletoParentAdjustedEBITDAIncludingCashPaidforCapitalExpendituresandInvestmentsinAffiliates>
    <pgen:NetIncomeLossAttributabletoParentAdjustedEBITDAIncludingCashPaidforCapitalExpendituresandInvestmentsinAffiliates
      contextRef="i5e8ae689a8804c098cef0e54bd63c3ef_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmY5OGNiOTNlMjQyNzQzOWM4NGYxMzlkYWYyYTg3NDUzL3RhYmxlcmFuZ2U6Zjk4Y2I5M2UyNDI3NDM5Yzg0ZjEzOWRhZjJhODc0NTNfMi0zLTEtMS0xNTYwNA_11ee35b8-faf2-4d6d-ac92-655dfb0b6fb7"
      unitRef="usd">-627000</pgen:NetIncomeLossAttributabletoParentAdjustedEBITDAIncludingCashPaidforCapitalExpendituresandInvestmentsinAffiliates>
    <pgen:CapitalExpendituresNetOfProceedsFromSaleOfAssetsAndInvestmentsInAffiliates
      contextRef="i6f12f7718c574755bd4056b0eb47020b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmY5OGNiOTNlMjQyNzQzOWM4NGYxMzlkYWYyYTg3NDUzL3RhYmxlcmFuZ2U6Zjk4Y2I5M2UyNDI3NDM5Yzg0ZjEzOWRhZjJhODc0NTNfNC0xLTEtMS0xNTYwNA_e3933cd1-7dca-45d6-bf40-790417d537c7"
      unitRef="usd">1314000</pgen:CapitalExpendituresNetOfProceedsFromSaleOfAssetsAndInvestmentsInAffiliates>
    <pgen:CapitalExpendituresNetOfProceedsFromSaleOfAssetsAndInvestmentsInAffiliates
      contextRef="i2d2c97b816ee436cb18d90482a754e10_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmY5OGNiOTNlMjQyNzQzOWM4NGYxMzlkYWYyYTg3NDUzL3RhYmxlcmFuZ2U6Zjk4Y2I5M2UyNDI3NDM5Yzg0ZjEzOWRhZjJhODc0NTNfNC0zLTEtMS0xNTYwNA_62d8754a-fcce-4f97-b266-3de7c1a377d0"
      unitRef="usd">597000</pgen:CapitalExpendituresNetOfProceedsFromSaleOfAssetsAndInvestmentsInAffiliates>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="i8c2fe0628bc145c2966d9bc2ce259b60_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmY5OGNiOTNlMjQyNzQzOWM4NGYxMzlkYWYyYTg3NDUzL3RhYmxlcmFuZ2U6Zjk4Y2I5M2UyNDI3NDM5Yzg0ZjEzOWRhZjJhODc0NTNfNS0xLTEtMS0xNTYwNA_0088fd34-2c49-421e-a0ae-ef45ffedc79e"
      unitRef="usd">1446000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="i6841cb0561af477da53d5c395af9e6cc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmY5OGNiOTNlMjQyNzQzOWM4NGYxMzlkYWYyYTg3NDUzL3RhYmxlcmFuZ2U6Zjk4Y2I5M2UyNDI3NDM5Yzg0ZjEzOWRhZjJhODc0NTNfNS0zLTEtMS0xNTYwNA_521c407c-9c3d-4337-aec9-3b06639fa258"
      unitRef="usd">307000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:InterestExpense
      contextRef="i576c4b11dd9b44298653de992854ba4e_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmY5OGNiOTNlMjQyNzQzOWM4NGYxMzlkYWYyYTg3NDUzL3RhYmxlcmFuZ2U6Zjk4Y2I5M2UyNDI3NDM5Yzg0ZjEzOWRhZjJhODc0NTNfNy0xLTEtMS0xNTYwNA_7d9df5f8-d8bd-42d0-b11f-9dc430a48a72"
      unitRef="usd">2069000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i72f2477327d94768809a6aa578dd8221_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmY5OGNiOTNlMjQyNzQzOWM4NGYxMzlkYWYyYTg3NDUzL3RhYmxlcmFuZ2U6Zjk4Y2I5M2UyNDI3NDM5Yzg0ZjEzOWRhZjJhODc0NTNfNy0zLTEtMS0xNTYwNA_4136c553-b4a8-493b-a6e0-55326976683c"
      unitRef="usd">4539000</us-gaap:InterestExpense>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i576c4b11dd9b44298653de992854ba4e_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmY5OGNiOTNlMjQyNzQzOWM4NGYxMzlkYWYyYTg3NDUzL3RhYmxlcmFuZ2U6Zjk4Y2I5M2UyNDI3NDM5Yzg0ZjEzOWRhZjJhODc0NTNfOC0xLTEtMS0xNTYwNA_3ac3b93c-8627-4f57-8c97-c04b34e25cf3"
      unitRef="usd">3292000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i72f2477327d94768809a6aa578dd8221_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmY5OGNiOTNlMjQyNzQzOWM4NGYxMzlkYWYyYTg3NDUzL3RhYmxlcmFuZ2U6Zjk4Y2I5M2UyNDI3NDM5Yzg0ZjEzOWRhZjJhODc0NTNfOC0zLTEtMS0xNTYwNA_a78e4498-af14-4c88-8825-c7dc8812dc0f"
      unitRef="usd">3523000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:GainLossOnDispositionOfAssets1
      contextRef="i576c4b11dd9b44298653de992854ba4e_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmY5OGNiOTNlMjQyNzQzOWM4NGYxMzlkYWYyYTg3NDUzL3RhYmxlcmFuZ2U6Zjk4Y2I5M2UyNDI3NDM5Yzg0ZjEzOWRhZjJhODc0NTNfOS0xLTEtMS0xNTYwNA_3b03952c-fd57-4701-8ad6-2c6c60897aa9"
      unitRef="usd">-125000</us-gaap:GainLossOnDispositionOfAssets1>
    <us-gaap:GainLossOnDispositionOfAssets1
      contextRef="i72f2477327d94768809a6aa578dd8221_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmY5OGNiOTNlMjQyNzQzOWM4NGYxMzlkYWYyYTg3NDUzL3RhYmxlcmFuZ2U6Zjk4Y2I5M2UyNDI3NDM5Yzg0ZjEzOWRhZjJhODc0NTNfOS0zLTEtMS0xNTYwNA_e0a9cfb8-a4a6-4bee-ab66-1bacc6c62ddb"
      unitRef="usd">-121000</us-gaap:GainLossOnDispositionOfAssets1>
    <us-gaap:AssetImpairmentCharges
      contextRef="i576c4b11dd9b44298653de992854ba4e_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmY5OGNiOTNlMjQyNzQzOWM4NGYxMzlkYWYyYTg3NDUzL3RhYmxlcmFuZ2U6Zjk4Y2I5M2UyNDI3NDM5Yzg0ZjEzOWRhZjJhODc0NTNfMTAtMS0xLTEtMTU2MDQ_4bb4f3ca-6bc4-4936-bac2-ca1f5c5ed59c"
      unitRef="usd">482000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i72f2477327d94768809a6aa578dd8221_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmY5OGNiOTNlMjQyNzQzOWM4NGYxMzlkYWYyYTg3NDUzL3RhYmxlcmFuZ2U6Zjk4Y2I5M2UyNDI3NDM5Yzg0ZjEzOWRhZjJhODc0NTNfMTAtMy0xLTEtMTU2MDQ_16376ea5-2e31-4245-9647-060a1cde682a"
      unitRef="usd">0</us-gaap:AssetImpairmentCharges>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i576c4b11dd9b44298653de992854ba4e_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmY5OGNiOTNlMjQyNzQzOWM4NGYxMzlkYWYyYTg3NDUzL3RhYmxlcmFuZ2U6Zjk4Y2I5M2UyNDI3NDM5Yzg0ZjEzOWRhZjJhODc0NTNfMTItMS0xLTEtMTU2MDQ_9f6bc394-1ffc-4383-a49c-377950039971"
      unitRef="usd">3562000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i72f2477327d94768809a6aa578dd8221_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmY5OGNiOTNlMjQyNzQzOWM4NGYxMzlkYWYyYTg3NDUzL3RhYmxlcmFuZ2U6Zjk4Y2I5M2UyNDI3NDM5Yzg0ZjEzOWRhZjJhODc0NTNfMTItMy0xLTEtMTU2MDQ_3dfab2d6-0bbc-4127-8a53-9ab8cce18dda"
      unitRef="usd">5415000</us-gaap:AllocatedShareBasedCompensationExpense>
    <pgen:AdjustmentForBonusesPaidInEquityAwards
      contextRef="i576c4b11dd9b44298653de992854ba4e_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmY5OGNiOTNlMjQyNzQzOWM4NGYxMzlkYWYyYTg3NDUzL3RhYmxlcmFuZ2U6Zjk4Y2I5M2UyNDI3NDM5Yzg0ZjEzOWRhZjJhODc0NTNfMTMtMS0xLTEtMTU2MDQ_a61041d2-6dd1-43a9-9e48-c9cc4912be67"
      unitRef="usd">1698000</pgen:AdjustmentForBonusesPaidInEquityAwards>
    <pgen:AdjustmentForBonusesPaidInEquityAwards
      contextRef="i72f2477327d94768809a6aa578dd8221_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmY5OGNiOTNlMjQyNzQzOWM4NGYxMzlkYWYyYTg3NDUzL3RhYmxlcmFuZ2U6Zjk4Y2I5M2UyNDI3NDM5Yzg0ZjEzOWRhZjJhODc0NTNfMTMtMy0xLTEtMTU2MDQ_a1dddffe-f524-4291-b71d-e13e4044f1fe"
      unitRef="usd">0</pgen:AdjustmentForBonusesPaidInEquityAwards>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i576c4b11dd9b44298653de992854ba4e_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmY5OGNiOTNlMjQyNzQzOWM4NGYxMzlkYWYyYTg3NDUzL3RhYmxlcmFuZ2U6Zjk4Y2I5M2UyNDI3NDM5Yzg0ZjEzOWRhZjJhODc0NTNfMTQtMS0xLTEtMTU2MDQ_73b5bada-ab28-47a6-b325-f0f27928b09c"
      unitRef="usd">-1000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i72f2477327d94768809a6aa578dd8221_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmY5OGNiOTNlMjQyNzQzOWM4NGYxMzlkYWYyYTg3NDUzL3RhYmxlcmFuZ2U6Zjk4Y2I5M2UyNDI3NDM5Yzg0ZjEzOWRhZjJhODc0NTNfMTQtMy0xLTEtMTU2MDQ_925efd00-8097-4936-8ba9-18136f0bdb90"
      unitRef="usd">-3000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i576c4b11dd9b44298653de992854ba4e_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmY5OGNiOTNlMjQyNzQzOWM4NGYxMzlkYWYyYTg3NDUzL3RhYmxlcmFuZ2U6Zjk4Y2I5M2UyNDI3NDM5Yzg0ZjEzOWRhZjJhODc0NTNfMTUtMS0xLTEtMTU2MDQ_a4470195-d4f2-44a4-a6f3-4a1c00830996"
      unitRef="usd">0</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i72f2477327d94768809a6aa578dd8221_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmY5OGNiOTNlMjQyNzQzOWM4NGYxMzlkYWYyYTg3NDUzL3RhYmxlcmFuZ2U6Zjk4Y2I5M2UyNDI3NDM5Yzg0ZjEzOWRhZjJhODc0NTNfMTUtMy0xLTEtMTU2MDQ_7e707853-5e2c-4e5c-9b10-1b6c1c3c485c"
      unitRef="usd">-7000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ifa062aac5f0147e2a1dfff1ad00a491c_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmY5OGNiOTNlMjQyNzQzOWM4NGYxMzlkYWYyYTg3NDUzL3RhYmxlcmFuZ2U6Zjk4Y2I5M2UyNDI3NDM5Yzg0ZjEzOWRhZjJhODc0NTNfMTYtMS0xLTEtMTU2MDQ_44edbaa2-4e74-4a51-ba90-6b3d43c836cf"
      unitRef="usd">-10060000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i64f363e45b3f4b5f871a0d7d9ea6ca4f_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmY5OGNiOTNlMjQyNzQzOWM4NGYxMzlkYWYyYTg3NDUzL3RhYmxlcmFuZ2U6Zjk4Y2I5M2UyNDI3NDM5Yzg0ZjEzOWRhZjJhODc0NTNfMTYtMy0xLTEtMTU2MDQ_5c995e66-ab80-4d7d-897b-dd4c91a562a4"
      unitRef="usd">-8194000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i6408cfb01bd44cebadc3b26397941b33_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmY5OGNiOTNlMjQyNzQzOWM4NGYxMzlkYWYyYTg3NDUzL3RhYmxlcmFuZ2U6Zjk4Y2I5M2UyNDI3NDM5Yzg0ZjEzOWRhZjJhODc0NTNfMTctMS0xLTEtMTU2MDQ_b0c200e7-1d0e-4a97-b5ef-d47f32878974"
      unitRef="usd">-1511000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="icc375dc8cd7b45b48cfab364c5a82fa5_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmY5OGNiOTNlMjQyNzQzOWM4NGYxMzlkYWYyYTg3NDUzL3RhYmxlcmFuZ2U6Zjk4Y2I5M2UyNDI3NDM5Yzg0ZjEzOWRhZjJhODc0NTNfMTctMy0xLTEtMTU2MDQ_82c1a506-1c70-459f-a26b-10fb2cc96bc2"
      unitRef="usd">-371000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmY5OGNiOTNlMjQyNzQzOWM4NGYxMzlkYWYyYTg3NDUzL3RhYmxlcmFuZ2U6Zjk4Y2I5M2UyNDI3NDM5Yzg0ZjEzOWRhZjJhODc0NTNfMTgtMS0xLTEtMTU2MDQ_1d1f6a97-a0bc-4f6b-958f-2a2aa6116c45"
      unitRef="usd">-19309000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmY5OGNiOTNlMjQyNzQzOWM4NGYxMzlkYWYyYTg3NDUzL3RhYmxlcmFuZ2U6Zjk4Y2I5M2UyNDI3NDM5Yzg0ZjEzOWRhZjJhODc0NTNfMTgtMy0xLTEtMTU2MDQ_e8901185-d88b-4e19-aff1-00e9a502b9d6"
      unitRef="usd">-21896000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9b3c7721f0ef415c9513b33bb836c7ee_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmU5MmViYmMzYjQ0MzRiZjZiMTk5OGUwYjU3NDA1ZDc2L3RhYmxlcmFuZ2U6ZTkyZWJiYzNiNDQzNGJmNmIxOTk4ZTBiNTc0MDVkNzZfMi0xLTEtMS0xNTYwNA_f074554d-391c-480e-a4b6-53cab0841cfb"
      unitRef="usd">84000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2ac6979a51bb4a92b3b04995d0432dbc_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmU5MmViYmMzYjQ0MzRiZjZiMTk5OGUwYjU3NDA1ZDc2L3RhYmxlcmFuZ2U6ZTkyZWJiYzNiNDQzNGJmNmIxOTk4ZTBiNTc0MDVkNzZfMi0zLTEtMS0xNTYwNA_be9b1c96-b885-4f70-ba7f-fe0d3d14d3ed"
      unitRef="usd">5429000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8edc30ca4e6f4b8993b2065b289bfbd5_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmU5MmViYmMzYjQ0MzRiZjZiMTk5OGUwYjU3NDA1ZDc2L3RhYmxlcmFuZ2U6ZTkyZWJiYzNiNDQzNGJmNmIxOTk4ZTBiNTc0MDVkNzZfMi01LTEtMS0xNTYwNA_20631f6d-4cd2-45da-8fe0-5769aa8db430"
      unitRef="usd">26508000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6f12f7718c574755bd4056b0eb47020b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmU5MmViYmMzYjQ0MzRiZjZiMTk5OGUwYjU3NDA1ZDc2L3RhYmxlcmFuZ2U6ZTkyZWJiYzNiNDQzNGJmNmIxOTk4ZTBiNTc0MDVkNzZfMi03LTEtMS0xNTYwNA_286b00e3-c9bc-433c-8941-687917cba5ff"
      unitRef="usd">32021000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:Revenues
      contextRef="i04211b6ebbd848dda476f17cf818169c_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmU5MmViYmMzYjQ0MzRiZjZiMTk5OGUwYjU3NDA1ZDc2L3RhYmxlcmFuZ2U6ZTkyZWJiYzNiNDQzNGJmNmIxOTk4ZTBiNTc0MDVkNzZfMy0xLTEtMS0xNTYwNA_ac9b07c0-f31a-43e2-b585-7131a2aee3c4"
      unitRef="usd">1446000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie2bd06ad475c4200a82ace0d4ad7872d_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmU5MmViYmMzYjQ0MzRiZjZiMTk5OGUwYjU3NDA1ZDc2L3RhYmxlcmFuZ2U6ZTkyZWJiYzNiNDQzNGJmNmIxOTk4ZTBiNTc0MDVkNzZfMy0zLTEtMS0xNTYwNA_d9dfd126-3fde-48cc-8305-eb00eace6766"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie8790f324a3d408fb7149e93f1d33708_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmU5MmViYmMzYjQ0MzRiZjZiMTk5OGUwYjU3NDA1ZDc2L3RhYmxlcmFuZ2U6ZTkyZWJiYzNiNDQzNGJmNmIxOTk4ZTBiNTc0MDVkNzZfMy01LTEtMS0xNTYwNA_a295f395-c468-420a-bcfc-97e125251c2f"
      unitRef="usd">147000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6408cfb01bd44cebadc3b26397941b33_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmU5MmViYmMzYjQ0MzRiZjZiMTk5OGUwYjU3NDA1ZDc2L3RhYmxlcmFuZ2U6ZTkyZWJiYzNiNDQzNGJmNmIxOTk4ZTBiNTc0MDVkNzZfMy03LTEtMS0xNTYwNA_6edeeec8-111e-4aa8-81b3-d9b082473b8b"
      unitRef="usd">1593000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9b3c7721f0ef415c9513b33bb836c7ee_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmU5MmViYmMzYjQ0MzRiZjZiMTk5OGUwYjU3NDA1ZDc2L3RhYmxlcmFuZ2U6ZTkyZWJiYzNiNDQzNGJmNmIxOTk4ZTBiNTc0MDVkNzZfNC0xLTEtMS0xNTYwNA_0554e127-b1f6-478c-abc1-8e92c9eba828"
      unitRef="usd">1530000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2ac6979a51bb4a92b3b04995d0432dbc_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmU5MmViYmMzYjQ0MzRiZjZiMTk5OGUwYjU3NDA1ZDc2L3RhYmxlcmFuZ2U6ZTkyZWJiYzNiNDQzNGJmNmIxOTk4ZTBiNTc0MDVkNzZfNC0zLTEtMS0xNTYwNA_a99818b1-47e4-43b5-95e0-32d115102b16"
      unitRef="usd">5429000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8edc30ca4e6f4b8993b2065b289bfbd5_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmU5MmViYmMzYjQ0MzRiZjZiMTk5OGUwYjU3NDA1ZDc2L3RhYmxlcmFuZ2U6ZTkyZWJiYzNiNDQzNGJmNmIxOTk4ZTBiNTc0MDVkNzZfNC01LTEtMS0xNTYwNA_26ecd6ab-6eaa-4baf-9170-d498ca16b707"
      unitRef="usd">26655000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6f12f7718c574755bd4056b0eb47020b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmU5MmViYmMzYjQ0MzRiZjZiMTk5OGUwYjU3NDA1ZDc2L3RhYmxlcmFuZ2U6ZTkyZWJiYzNiNDQzNGJmNmIxOTk4ZTBiNTc0MDVkNzZfNC03LTEtMS0xNTYwNA_e4592262-7bf9-435c-a2ca-34ca1ca33efa"
      unitRef="usd">33614000</us-gaap:Revenues>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9051a486c0e7466bac7d683d545e64a6_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOjYwZmQ2YjAzNzg5MDRlMjhhMDQ0OWM1ZmNmZmFiODIwL3RhYmxlcmFuZ2U6NjBmZDZiMDM3ODkwNGUyOGEwNDQ5YzVmY2ZmYWI4MjBfMi0xLTEtMS0xNTYwNA_f1aefe05-3337-4c08-9003-329452746cb5"
      unitRef="usd">178000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i31eca9c164994ce3ad55697fdabbc18f_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOjYwZmQ2YjAzNzg5MDRlMjhhMDQ0OWM1ZmNmZmFiODIwL3RhYmxlcmFuZ2U6NjBmZDZiMDM3ODkwNGUyOGEwNDQ5YzVmY2ZmYWI4MjBfMi0zLTEtMS0xNTYwNA_20f3a6b0-33fe-4c84-9fac-9e093bae734e"
      unitRef="usd">3257000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7aee8cbc73ec4aad80c7b5ec0d52e55c_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOjYwZmQ2YjAzNzg5MDRlMjhhMDQ0OWM1ZmNmZmFiODIwL3RhYmxlcmFuZ2U6NjBmZDZiMDM3ODkwNGUyOGEwNDQ5YzVmY2ZmYWI4MjBfMi01LTEtMS0xNTYwNA_7435484a-475b-4014-a790-e99f600ef996"
      unitRef="usd">21076000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2d2c97b816ee436cb18d90482a754e10_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOjYwZmQ2YjAzNzg5MDRlMjhhMDQ0OWM1ZmNmZmFiODIwL3RhYmxlcmFuZ2U6NjBmZDZiMDM3ODkwNGUyOGEwNDQ5YzVmY2ZmYWI4MjBfMi03LTEtMS0xNTYwNA_59494875-3af1-45f7-aeed-36c3c715067d"
      unitRef="usd">24511000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:Revenues
      contextRef="i13cba4a8d5c742ce8d33b04cbd96f97a_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOjYwZmQ2YjAzNzg5MDRlMjhhMDQ0OWM1ZmNmZmFiODIwL3RhYmxlcmFuZ2U6NjBmZDZiMDM3ODkwNGUyOGEwNDQ5YzVmY2ZmYWI4MjBfMy0xLTEtMS0xNTYwNA_588dc1cb-2c74-43b1-a5e7-1d1e13274c3a"
      unitRef="usd">241000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i87b549534d7048538c9a43c0eba0ccc2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOjYwZmQ2YjAzNzg5MDRlMjhhMDQ0OWM1ZmNmZmFiODIwL3RhYmxlcmFuZ2U6NjBmZDZiMDM3ODkwNGUyOGEwNDQ5YzVmY2ZmYWI4MjBfMy0zLTEtMS0xNTYwNA_a8013696-acd1-4bcb-8ea5-cc36e95c546e"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0cfc596ca5a04165b80a4b0e08e40e65_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOjYwZmQ2YjAzNzg5MDRlMjhhMDQ0OWM1ZmNmZmFiODIwL3RhYmxlcmFuZ2U6NjBmZDZiMDM3ODkwNGUyOGEwNDQ5YzVmY2ZmYWI4MjBfMy01LTEtMS0xNTYwNA_a3b266b0-7c28-4dea-b3a0-1b0e1b6869da"
      unitRef="usd">107000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="icc375dc8cd7b45b48cfab364c5a82fa5_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOjYwZmQ2YjAzNzg5MDRlMjhhMDQ0OWM1ZmNmZmFiODIwL3RhYmxlcmFuZ2U6NjBmZDZiMDM3ODkwNGUyOGEwNDQ5YzVmY2ZmYWI4MjBfMy03LTEtMS0xNTYwNA_6d6696ca-7a34-40bb-b504-12d32dea12e5"
      unitRef="usd">348000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9051a486c0e7466bac7d683d545e64a6_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOjYwZmQ2YjAzNzg5MDRlMjhhMDQ0OWM1ZmNmZmFiODIwL3RhYmxlcmFuZ2U6NjBmZDZiMDM3ODkwNGUyOGEwNDQ5YzVmY2ZmYWI4MjBfNC0xLTEtMS0xNTYwNA_75aa59cc-6e46-4cb1-afb9-d30ac2ec9059"
      unitRef="usd">419000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i31eca9c164994ce3ad55697fdabbc18f_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOjYwZmQ2YjAzNzg5MDRlMjhhMDQ0OWM1ZmNmZmFiODIwL3RhYmxlcmFuZ2U6NjBmZDZiMDM3ODkwNGUyOGEwNDQ5YzVmY2ZmYWI4MjBfNC0zLTEtMS0xNTYwNA_7e040938-0af0-463f-be1d-3f3d4b815f0e"
      unitRef="usd">3257000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7aee8cbc73ec4aad80c7b5ec0d52e55c_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOjYwZmQ2YjAzNzg5MDRlMjhhMDQ0OWM1ZmNmZmFiODIwL3RhYmxlcmFuZ2U6NjBmZDZiMDM3ODkwNGUyOGEwNDQ5YzVmY2ZmYWI4MjBfNC01LTEtMS0xNTYwNA_cd758d9c-7aaf-4f55-b804-72c932363bfc"
      unitRef="usd">21183000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2d2c97b816ee436cb18d90482a754e10_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOjYwZmQ2YjAzNzg5MDRlMjhhMDQ0OWM1ZmNmZmFiODIwL3RhYmxlcmFuZ2U6NjBmZDZiMDM3ODkwNGUyOGEwNDQ5YzVmY2ZmYWI4MjBfNC03LTEtMS0xNTYwNA_25263648-f69e-419d-b07b-7467661fc091"
      unitRef="usd">24859000</us-gaap:Revenues>
    <us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RleHRyZWdpb246MDg2Y2EwY2I3NTUxNGNkN2JhZmRhN2VhMjUwMDVmZDhfMzA5Nw_36fc5704-483a-41f0-b449-336f40e3f731">&lt;div style="margin-bottom:12pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below reconciles total segment revenues from reportable segments to total consolidated revenues:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:15pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.953%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.392%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.780%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.782%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&#160;&lt;br/&gt;&#160;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment revenues from reportable segments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Elimination of intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,593)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(348)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total consolidated revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock>
    <us-gaap:Revenues
      contextRef="ia48b472a445a4200a8254bcce2227a72_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmJhZTBmMTA1YzgyZjQ0NjBhZWY4YTExYTc0MTM4MTNiL3RhYmxlcmFuZ2U6YmFlMGYxMDVjODJmNDQ2MGFlZjhhMTFhNzQxMzgxM2JfMi0xLTEtMS0xNTYwNA_83bd4301-050e-4de8-afcb-c2bce98306a7"
      unitRef="usd">33614000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5e8ae689a8804c098cef0e54bd63c3ef_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmJhZTBmMTA1YzgyZjQ0NjBhZWY4YTExYTc0MTM4MTNiL3RhYmxlcmFuZ2U6YmFlMGYxMDVjODJmNDQ2MGFlZjhhMTFhNzQxMzgxM2JfMi0zLTEtMS0xNTYwNA_c279c68c-26c5-4b31-aa8b-7c330e2e54e5"
      unitRef="usd">24859000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if3a5fe3120f24eb38dace9b8bfea5b2f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmJhZTBmMTA1YzgyZjQ0NjBhZWY4YTExYTc0MTM4MTNiL3RhYmxlcmFuZ2U6YmFlMGYxMDVjODJmNDQ2MGFlZjhhMTFhNzQxMzgxM2JfNC0xLTEtMS0xNTYwNA_681ea202-edc8-4084-8d20-784a8e142a1c"
      unitRef="usd">-1593000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ied5b0b30354b46978a4d414674afd3d4_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmJhZTBmMTA1YzgyZjQ0NjBhZWY4YTExYTc0MTM4MTNiL3RhYmxlcmFuZ2U6YmFlMGYxMDVjODJmNDQ2MGFlZjhhMTFhNzQxMzgxM2JfNC0zLTEtMS0xNTYwNA_a66ba46e-52ee-4cfb-85cc-19942c2d996a"
      unitRef="usd">-348000</us-gaap:Revenues>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmJhZTBmMTA1YzgyZjQ0NjBhZWY4YTExYTc0MTM4MTNiL3RhYmxlcmFuZ2U6YmFlMGYxMDVjODJmNDQ2MGFlZjhhMTFhNzQxMzgxM2JfNS0xLTEtMS0xNTYwNA_74917924-cf7e-47af-ac1b-bb60ef821a3a"
      unitRef="usd">32021000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RhYmxlOmJhZTBmMTA1YzgyZjQ0NjBhZWY4YTExYTc0MTM4MTNiL3RhYmxlcmFuZ2U6YmFlMGYxMDVjODJmNDQ2MGFlZjhhMTFhNzQxMzgxM2JfNS0zLTEtMS0xNTYwNA_f2ca2fb8-5d91-4cb6-86df-35486581c628"
      unitRef="usd">24511000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <pgen:PercentageOfRevenueAttributableToCustomer
      contextRef="ic90cdb87070e4510bfb77391109bd015_D20220101-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RleHRyZWdpb246MDg2Y2EwY2I3NTUxNGNkN2JhZmRhN2VhMjUwMDVmZDhfMjE5OTAyMzI1OTc3Mg_c0438876-4387-4e94-b3c6-6f6b25025369"
      unitRef="number">0.130</pgen:PercentageOfRevenueAttributableToCustomer>
    <pgen:PercentageOfRevenueAttributableToCustomer
      contextRef="i1379bdeed3124397a5045d15e0c107f8_D20210101-20210331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RleHRyZWdpb246MDg2Y2EwY2I3NTUxNGNkN2JhZmRhN2VhMjUwMDVmZDhfMjE5OTAyMzI1OTc4MA_30cb3373-b6c1-45f3-ac44-36f8699e6152"
      unitRef="number">0.084</pgen:PercentageOfRevenueAttributableToCustomer>
    <pgen:LongLivedAssetsIncludingPropertyPlantandEquipmentandRightOfUseAssets
      contextRef="idbeb7dcf502e424db307e185fd1e576a_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RleHRyZWdpb246MDg2Y2EwY2I3NTUxNGNkN2JhZmRhN2VhMjUwMDVmZDhfMjg2OQ_42434fa4-6b7d-4e19-baf7-2ee3b99368c1"
      unitRef="usd">4148000</pgen:LongLivedAssetsIncludingPropertyPlantandEquipmentandRightOfUseAssets>
    <pgen:LongLivedAssetsIncludingPropertyPlantandEquipmentandRightOfUseAssets
      contextRef="i46d345a1060047b6af3e5f2700f3127b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RleHRyZWdpb246MDg2Y2EwY2I3NTUxNGNkN2JhZmRhN2VhMjUwMDVmZDhfMjg3Ng_cb2d6a78-cca9-47cd-a634-a21fce2f6e39"
      unitRef="usd">4463000</pgen:LongLivedAssetsIncludingPropertyPlantandEquipmentandRightOfUseAssets>
    <us-gaap:Revenues
      contextRef="idec0f08a8c3d49fc821a1cf2c9544f25_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RleHRyZWdpb246MDg2Y2EwY2I3NTUxNGNkN2JhZmRhN2VhMjUwMDVmZDhfMzAwNw_467a4e6e-072a-4cab-b306-953adde618ab"
      unitRef="usd">205000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id6db753435f04670b618c70cb75e3463_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcxNjlhODAzYTZhYTQ0ZWE5ODE2MDNkMjIwY2FiODRmL3NlYzo3MTY5YTgwM2E2YWE0NGVhOTgxNjAzZDIyMGNhYjg0Zl85MS9mcmFnOjA4NmNhMGNiNzU1MTRjZDdiYWZkYTdlYTI1MDA1ZmQ4L3RleHRyZWdpb246MDg2Y2EwY2I3NTUxNGNkN2JhZmRhN2VhMjUwMDVmZDhfMzAxNA_71b8744d-48bb-41b1-9a55-fcab64e93dcd"
      unitRef="usd">99000</us-gaap:Revenues>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>100
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( '""J50'04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    " !P@JE4)GT,3.\    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9+/
M2L0P$(=?17)O)^VBLJ';B^))07!!\1:2V=U@\X=DI-VW-XV[740?P&-F?OGF
M&YA.!:%\Q.?H T8RF*XF.[@D5-BP U$0 $D=T,I4YX3+S9V/5E)^QCT$J3[D
M'J'E_ 8LDM22),S *BQ$UG=:"151DH\GO%8+/GS&H<"T AS0HJ,$3=T Z^>)
MX3@-'5P ,XPPVO1=0+T02_5/;.D .R6G9);4.([UN"JYO$,#;T^/+V7=RKA$
MTBG,OY(1= RX8>?)KZN[^^T#ZUO>MA6_KOAZVW+1K$5S^SZ[_O"["%NOS<[\
M8^.S8-_!K[OHOP!02P,$%     @ <(*I5)E<G",0!@  G"<  !,   !X;"]T
M:&5M92]T:&5M93$N>&UL[5I;<]HX%'[OK]!X9_9M"\8V@;:T$W-I=MNTF83M
M3A^%$5B-;'EDD81_OT<V$,N6#>V23;J;/ 0LZ?O.14?GZ#AY\^XN8NB&B)3R
M>&#9+]O6N[<OWN!7,B0103 9IZ_PP JE3%ZU6FD PSA]R1,2P]R"BPA+>!3+
MUES@6QHO(];JM-O=5H1I;*$81V1@?5XL:$#05%%:;U\@M.4?,_@5RU2-9:,!
M$U=!)KF(M/+Y;,7\VMX^9<_I.ATR@6XP&U@@?\YOI^1.6HCA5,+$P&IG/U9K
MQ]'22(""R7V4!;I)]J/3%0@R#3LZG5C.=GSVQ.V?C,K:=#1M&N#C\7@XMLO2
MBW <!.!1NY["G?1LOZ1!";2C:=!DV/;:KI&FJHU33]/W?=_KFVB<"HU;3]-K
M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MX/>-!+P,-_;5Y/@J^OH_4$L#!!0    ( '""J50Q6HDX;0,  #\+   8
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M%\DFEW=B^R?O #'M;R[RNOF+MIVM-T'S32U%T0U6$119V?Y/GKI$] 8H/_
MW W PP'4,H!T T@#M(VL@?4^D<GU926VJ-+6RIN^:'+3C%9HLE)/X[VLU+>9
M&B>O9Z),U:3P%*FK6N19FDAU<R_5/S5;LD9B@?Y>\RK16:_1&_3U_CUZ_>H,
MO4)9B;ZLQ*9.RK2^G$H5C?8YG7=/OFF?C"U/)NB3*.6J1A]4!.GS\5.%8@\%
M[Z#<8*?#3TEU@8A_CK"',1#/[/CAOB,<LL\L:?P1B[\[_LC+#:\=KNC>%6U<
M48NK+T(FN5HTD,,V,^WXH!FO5^[C-6EA//83,+;"E/G&ZEEP;!\<<^+LBJ-<
MH@]/:UU*+L3!WFG@1/RQ6"=9I0M0U]]2B'2;Y3F$O/7#>IAHA >XQS8>C#G<
MAQ>Z,<L5KW9XS]%G+AV8H[W3R(GYPX]-)G_J554J^LY%W:R]9+'(\DRM1G#>
MHQ&R-\-)!TP(C#[>!QH[ _U+A[:H1('F:@5GY49/OC <\<"5O' %9"X*CF3R
M!,<> [''Q(L'\0-FV(_B ,;@>X;X/'>)M>$U.-*L[J H[C-(SIN94)-P"$KW
M*+C"6AB "678AJ)'W[X3Q>>N5,"H_-%Z5QG&;%@AH%U(_,@2'#;!8><RT<$U
MQ:(RBNY72<4=R\0WQ.J3HS"[:E _L=9//-<JG\W1:[6N4I'G2=7[\@Q,6_OT
ML)\.[V*4--C*0J:^H7K?S?6'P*FK'K8TRS=:KU^ KGU\=  =;&5#9[3"9P?1
M=8OIM49YYEQ_)R)EAQ<E&\'T+CQL06G$RW>KUZ^C?'&MNJ2MPQB\!*-10#\\
MKDY/B3X\JA9!JYY./$=@Y-9WZRV$X!>J+#J*+4 K*P:CQ+Y;BK\U;8H*.'E4
MY;3D;:!JX["1M53[<D47_6EIOX5QC'76C^, Q[BG QT8R)30.&;4HF?8J#)V
MJ_)1@/JSY("$QY)K@P2:NB$9B<9NB9[I.GH0[6I'"@/*L[ENA!65)\N*MWV6
MJP$R@HO=@GM$SX&-S&*WS![N.CH'@8-] )/ EE&CD=BMD3.CBJ8U=6$V^H3=
MS<PQ"30R@-TR<$0"Q_0-]6V F:-QPX;#\8$VYB6M&S;$BMW$>L=KGE3S55/K
MJ8*?B[6N<3 #X_;$QV$P*B/ S&/8E@'#G]C-G_<\SQM*6?)2Y2)O0D[2(BNS
M6NK</'(P:H@!61@,HP;,HM"FO<20)#G0NAS='1.@ZQBUQX"1I3\FAO2(F_3:
MVC=[5@X66!>D/PXRCOUP&"9@AA6A6T(UI$FP,U2S"FR-5.?@>:L:]GO0+D+0
M+H@LC13I'26YSY)>=-Y #(\2-X]^+"57XBEWLP-BIT#_[07#+ATRHXS8)L<0
M,G$W#/L0V_TT&.%XGT\)'<8W-B*Q;2$:AB=NAF_G9;?5[[)XUAP;@)$"/([)
M,-*QT1MFJR!#]<2]7>_68Q,OW]61+<P0*&/JCV@#,*/88Y90C7R0WW\.1HXX
M"(-L+"=AQ @(^5_.PLB1AV&0G>,TC!I)H4>=AJD 5<@E7V1@9="Q4K#A5AJR
ML2PT:N2$NN7D0)K!6,=R 9Y^078JI91:8C:Z0MVZ NY2T;_HY'Z &MV@I_\&
MT?L1XN1?(<8B,-S( 2:V?H :D:!ND;!E^K82Z6;NSJ7A>AJ<G$M#Q_08.G;F
M<LRN48B'L@98!22R;(NIH6 :_;[&@!JRI&ZRG(FZV;&NNWEIBK_FU:.J?S@)
M8[H+F3^JJ;$58Z%E_3)#B<Q-B;:JN@<#?OX00VS,/[6JF&$<YF:<PU7%QCM4
MK#K.H<P 9GX8$]LOA8:/V(%][$OJBAEF8H?. UY85VS,0C&+1ED86X74UKVQ
MWN^EO\96S6;2E0]#5>QDJF*&JMBI5-4YZ)_Q1,-= 6#CD^'N:]I[CZ'@U;)Y
MO:-6DK\I9?L>P/[3_2LD[YH7)P:?W_AO9^V+(,9-^U[*IZ1:9BK=.5\HE]Y%
MJ.:J:E_U:&^D6#=O2SP(*4717*YXDO)*&ZCO%T+(W8U^P/Z%F^O_ %!+ P04
M    " !P@JE4ZJ@".]X"  """0  &    'AL+W=O<FMS:&5E=',O<VAE970U
M+GAM;+56;4_;,!#^*U;$!Y V\M:6%[65:-DT)- J"MN':1_<Y-I8.'9G.RU(
M^_$[.VD:Z N;&%\2V[GG[KGG')^[2ZD>= 9@R&/.A>YYF3'S<]_7208YU<=R
M#@*_3*7*J<&IFOEZKH"F#I1S/PJ"CI]3)KQ^UZV-5+\K"\.9@)$BNLASJIX&
MP.6RYX7>:N&6S3)C%_Q^=TYG, 9S/Q\IG/FUEY3E(#23@BB8]KR+\'P8QA;@
M++XQ6.K&F-A4)E(^V,E5VO,"RP@X),:ZH/A:P! XMYZ0QZ_*J5?'M,#F>.7]
MLTL>DYE0#4/)O[/49#WOU",I3&G!S:U<?H$JH;;UETBNW9,L*]O (TFAC<PK
M,#+(F2C?]+$2H@% /]L!406(7@):.P!Q!7#*^24SE]8E-;3?57))E+5&;W;@
MM'%HS(8)6\:Q4?B5(<[TAU*D6!1("8ZTY"RE!B=C@R^LEM%$3LG7.2AJ5=?D
M<$05+F=@6$+Y$?E([L>7Y/#@B!P0)LA=)@M-1:J[OD%V-H:?5$P&)9-H!Y.8
MW$ATK,DG9)0^Q_N859U:M$IM$.UU>$/5,8G##R0*HF@+G^'?P\,]=.):Z=CY
MBW?XNP7NI$4!S1.Y4U1H6F[E']=H2JY0</US3Z!6':CE K5V!+J3AG+\Q18@
M"MA:B!+?<7C[GR_Z<9GDHBG/IE74:H=KJV?DVC6Y]EYRN,L,$P43L\:NVI-T
MI_;;>5]U3^I )V]4M\2W7U%WTVJ/NJ<UN=-7U.6<3F0I*\'_D'"6V#,7Y:8S
M!>4OO4>%LSK0V?O*'0;K RIXH^"5@Z:6P0NUMYAT.MNU#AM'9_@?U":_R;]N
M^C!:4XC>N0[KXRN,WUJ'>./$V*C#ILE&'?Q&-\M!S5R3UR21A3#EZ5^OUA>)
M"]<^7ZP/[ 7#=<FUF_)V@F?[C&$WXS!%E\'Q"6X,53;\<F+DW/7,B338@=TP
MPTL2*&N WZ=2FM7$!JBO7?T_4$L#!!0    ( '""J53W^\/7Y (  +$'   8
M    >&PO=V]R:W-H965T<R]S:&5E=#8N>&ULC57;;MLP#/T5P=A#"ZSU+;<6
M28 DW; "[18TZ_8P[$&QE5BK+&42G;3[^E&RZZ6)8^PEUH4\.CQDR.%.Z2>3
M,0;D.1?2C+P,8'/M^R;)6$[-I=HPB3<KI7,*N-5KWVPTHZESRH4?!4'/SRF7
MWGCHSN9Z/%0%""[97!-3Y#G5+U,FU&[DA=[KP0-?9V /_/%P0]=LP>!Q,]>X
M\VN4E.=,&JXDT6PU\B;A]6Q@[9W!-\YV9F]-;"1+I9[LYC8=>8$EQ 1+P")0
M_&S9C EA@9#&[PK3JY^TCOOK5_2/+G:,94D-FRGQG:>0C;R!1U*VHH6 ![7[
MQ*IXNA8O4<*X7[*K; ./)(4!E5?.R"#GLOS2YTJ'/0?$:7:(*H?HT*%SPB&N
M'&(7:,G,A75#@8Z'6NV(MM:(9A=.&^>-T7!IL[@ C;<<_6 \4S+%G+"4X,HH
MP5,*N%D ?C!98(A:X56.)9+9W&T9N5/&D ORN+@A9^_.R3O")?F:J<)0F9JA
M#\C*8OM)Q6!:,HA.,(C)O9*0&?(!F:1O_7V,I@XI>@UI&K4"WE-]2>+P/8F"
M*&K@,_M_]["%3EPK'#N\^ 1>+>6QDK<R43DC/R9+ QH+^F?+<YWZN8Y[KG/B
MN<_XSZ]PSVRFSLD$0/-E 70I& %%YE0CFZ9$E<@]AVS__MOQ17@5=5&%[;Y^
M36;].!S49F^(=VOBW5:=OD#&-$G>""0P@.L647HU=J]5E$>)'4[P/UC9%I)@
M_^!RRPRX$F^2HL3K[L<X"*(#(1J,.B=4Z-=,^ZU,[RIZV)^Q TEL 1JSE;P0
M+!!I!"U[7_JK:.'>/Z85AD%P0+[!*HJ"N)G^H*8_:*4_.TI?$\'!<0%%8=B-
M#Q@VF(57W=[5 45_K_OE3*_=4#!8286$LFO4I_7<F;AV>W ^Q7E4CH]_,.4P
MPYZPYM(0P58(&5SV439=#HAR VKC>NQ2 79LM\QPIC)M#?!^I12\;NP#]90>
M_P502P,$%     @ <(*I5*'4>^N(!@  Z!T  !@   !X;"]W;W)K<VAE971S
M+W-H965T-RYX;6S%66UOVS80_BN$46 -4-<B]4*I2 +$2=H$6+>@:;</13\P
M$AUKE417I)+TW^\HJY9%4;*3=ED_U))]=WSN>,?G471X+\JO<LFY0@]Y5LBC
MR5*IU9O93,9+GC/Y6JQX ;\L1)DS!;?E[4RN2LZ2VBG/9L1Q@EG.TF)R?%A_
M=U4>'XI*96G!KTHDJSQGY?<YS\3]T01/?GSQ(;U=*OW%[/APQ6[Y-5>?5E<E
MW,TV49(TYX5,18%*OCB:G. WEV[M4%O\E?)[N76-="HW0GS5-Y?)T<31B'C&
M8Z5#,/BXXZ<\RW0DP/&M"3K9K*D=MZ]_1'];)P_)W##)3T7V=YJHY=$DG*"$
M+UB5J0_B_H(W"?DZ7BPR6?^/[AM;9X+B2BJ1-\Z ($^+]2=[: JQY>#Y PZD
M<2"&@S^T@MLXN(8#=@<<O,;!,QP('7#P&P??<*#!@$/0. 1FTD,.M'&@)J2A
MI,/&(30<@FC (6H<HKH=UOM7;_X94^SXL!3WJ-36$$U?U!U4>\.>IX5N]FM5
MPJ\I^*GC4U$DT+H\07 E198F3,'-M8(/Z&DED5B@ZR4K^5)D"2_E;^C\6Y6J
M[VB*/EV?H9<O#M +E!;HXU)4DA6)/)PIP*6CS^(&PWR-@0Q@^"@4RRQNI^-N
MIU5>94S/"CI?+&!X7J$K7J8BT9!/$K'2T_0*KOZ!,NI<+$N<[5A"Y#E,Y+42
M\5>+]_FX]TF2I!H#R] 52Y,I5.F4K5)[LF^?&NM7E.'=CL7C>+T(=,:?:LE+
M:)8<SM:E/O1@W<LB%CE'+W\74AY8PE_L'_Z,+](XM6&\?'20GZS,#$9I,T]D
M,T^DAN$-P)BSC!4QE^@E[)#4<R,/$%, *7Z-7/P*$8<XMD9<A_7KL)JA[HYQ
M2(/ )0X]G-U9$+D;1.Y^B/9 ,5^'"K90!!13;X-@C;5OY70MSOL6. P#/Z!=
MNW=].S>*#*.+OM$4A\1U(\=>&6]3&:_V= <J VT+^D!"XT)=ZJL#?9+5TVZ<
M=B.=X6]6\T?WH0X[U<2<(!@74"N2U7S/'_0UMVV'WVL*W\.^4>L=1AVPP09L
M, ZV[ER42ED!W&H%,.^X5&EQJV<'?E)E&NM1DSHK5!4I, 6<_@CD%R3$RSB5
MO.:.M<%ZUCI381N"H#\$'@FP/S "=),-_3^RL>T8[6?@N\:&C=MT,@PW&8:/
MR)!)M&+?]8E69R!Y>9<:9Y*M^F$/%_4HQ79DT099]//(;)6,>E/O4^-D.(_Z
MK4\'>@4[K2)R'H$82K8JTSO@%;3*6%R+(@30]??539;&T!8+8)7B]A4JX.$$
MFD1[ZB,7QERJ756?-V@Z[4")[\"_@4RVM!U^SDRLZ''_I"?8\<Q#JK'SA^VZ
M.;9\B\<)]P] VM$?Z$3!.-]4BMUD'"D!>JFTJYXY[I/N%%,7AP8![;;K@F^I
M&8]S\UI,Q1TQE3;)9 -B:M[$[* AQ,<&M>XTZV)N21-[3U(X[UFYT1;8*K6]
M'B#B!![VL#O4!2VWXG%RW18YNX#,FUB=GH63+C)Z]LQB9^H<W"=?XF"7^J;0
ML1C"FH'9:'TKD#J>0YVA5FL)'8\S^C["U%ZM/BG#ME$W"GNZ<"_3+OZ6PO$X
MAP_)6#MFVM]AA[J>,=BG%CNH-XX",[&^7:\3^JP.Z AUC+E\:UO3#<(@-#O&
M%M U&Z9O-,41]GW?2.'25I(PH&1@7UKA@<-G$-&XE1-XAYYX@HS&?9W@^@$Q
M=W"'5?=YL)43Y#%RXMFD-.G+"M?WG# :R*<5%>0QHN(_%=/$(AJ,31LUZ6:X
M]0@_+BFZ&6K8+([+RFRX71O0%PTNZ'PRH$])*QK(N&C8#YZUGGU)@(,H-$NZ
MPZH+N]4-9%PW_))'%&+1$*'FEP%TK8 @.Y[.G_J80BR/WS0P2SINU,7<4CH9
MI_2?D;ZD3]5 '#T5>;';K@N^Y7,RSN=/DK[$QM>18YSD[XB5%9VAH[SE.C+^
ME+V/]"56W/U':^+0((+3P!"*9WN9=O&WW$G&N7-()=LQ]Q_ J1NZIC2RF)G2
MR&*"HP@'U#'WK6\XA:,G,GO29@;Q!I\CW):L7><9U(S;DJD[3J8G<2RJHB;/
M:P4DR<I$HD\K_1(&?3Y_4'HP]"R?%U7.R_I@_V+]N^W3E]%_"IXZ ?K\GN<W
MO/QBRVNV]8))OP.%YKE-08-D? 'K.:\IM&NY?JVXOE%B5;]SNA%*B;R^7'(&
MY=,&\/M""/7C1K_&VKS</?X74$L#!!0    ( '""J53)^#(T(@D   $I   8
M    >&PO=V]R:W-H965T<R]S:&5E=#@N>&ULO9IM;]LX$L>_"F'LBQ:H:XD4
M_5 D 9*TBRNP[07)[MUK1J)M7F71I>@\[*<_DI)-6QS2V3W@WK2V,Z+^' [G
M-QSIXEFJ'^V:<XU>-G737H[66F\_329MN>8;UGZ46]Z8ORREVC!MOJK5I-TJ
MSBIWT::>X"R;3C9,-*.K"_?;G;JZD#M=BX;?*=3N-ANF7F]X+9\O1_EH_\.]
M6*VU_6%R=;%E*_[ ]1_;.V6^30ZC5&+#FU;(!BF^O!Q=YY]NZ<)>X"S^)?AS
M>_09V:D\2OG#?OE:78XRJXC7O-1V"&;^>^*WO*[M2$;'SW[0T>&>]L+CS_O1
M?W63-Y-Y9"V_E?6_1:77EZ/Y"%5\R7:UOI?/_^#]A*@=KY1UZ_Y%S[UM-D+E
MKM5RTU]L%&Q$T_W/7GI''%U@QH$OP/T%>'A!$;F ]!<0-]%.F9O69Z;9U862
MSTA9:S.:_>!\XZXVLQ&-7<8'K<Q?A;E.7]W*IC*+PBMD/K6R%A73YLN#-O^9
MU=(MDDMTR]HU^M6L>(O&Z(^'S^C=+^_1+T@TZ/>UW+6LJ=J+B39J[)B3LK_S
M37=G'+DS0=]DH]<M^F(45*?73\PL#E/!^ZG<X.2 WYCZB$C^ >$,8T#/[=LO
MSQ-RR,&SQ(U'8IZU3ELZIRV5W""S\Q33HEEUH2NTX&WB-L7A-H6[31&YS7>S
MU;\VI=QP].XWV;;OT;762CSN-'NL.=(2W3%E%A):H&[DJ1O9[O>GJW&^P-3,
M_NG8;Y#9C.3S@]F)<'H03I/^N:[^8\*[BS&C4O%2-J4PDALSH]K,Q/YJ/Y?6
MD3L;HB;@("]^2KAQ>E S3;KQ,S=9L!2LRRU-A=A&*BW^=#] ONN&HT=.(7B!
M!YX#C"@FL-]F!Z6SI%*[R.C=RF3H]\AHK42[E2VKW49E;<MU^\&Z#=(\"^3D
MF XDAS9C4D0DSP^2YTG)7S=;)I1=:BMR)67U+.H:4C@/[E[,ATX-;3)8WN(@
M;Y&4=WVTU%:@B82-V&U:ZU[1//$^2J-N702"\'3HUM"&SF#5>>93=Y;4_>7G
M3NA7NRL.6\;&P'(I:A/(P^S2Y^0LC(&!5, DLO[Y$67RI-0'+<L?8\O;"IE<
M98J0MG,W?[&?.2@U!W;/=!@-@!4M<AH1C+U@G!:\-EFS1:)M=T8R:]&6O;H
M-I43:KEZ$F7$P1A8Z>E0-&04BP</G)PD-=\I^21<?65%EHI7H@N+B%(2^I<4
M0Z6A47ZT!J=*/;/R-+2N2Z-NO]TJ_JAM&BOESOAWF'L[BR579CIH*1IF(&&R
M?RE;#<^J"'?C/)@58#0[XM[IM#S1<GH&(KU.T0%9LY>(ZVF89>E\*!(RFD8T
M>L[E:=!]-Y2U0+4 L0E.<V7*RH.K/5]KSF*!$V(M&VH/3<;%-(L%CF=?GH;?
M/_6:*]3T<Q"F1H45AA0+% (PC*CSF,OGR9+FGI=</-FZ*UF3Y!Y,>9I,ORM6
MP;DQY,F83!=!G@',BD6Q@">*/7EPFCSWO';'A"U381G;U^HA18((!VPB21![
MTN T:5R$@()"4. A^@";,9[%W.5A@M,P^6J*B$9+]0KJ EA  F&AT0Q'XA5[
M8.!SP."F,*OV$&Y=\I51!P(HH+- :6@U+XJ(4@\,G 9&M^^[\A;4%B;T8E@I
M #:+2)V ?<K'Z91O2&:QY>H#N_%!<6"V#S8#8)7/8['G\SU.YWN+VMVPZK+K
M_,@;OA01=P+IFQ1![069&<F1:A'[+(_?DN59K]P4LX^FHHTF&N#$DF?S82J$
MS##.(SS%/N?C]-GFP'S%S2;?P0$0'EG,"7HZ&TH,S?*,QO:.APA.0^0W"_*S
M7@1(D0<A"IQT8FT XF%"W@Z3U_T^ D62D!?C8?X!;$@D((F'"DE#Y?M;VA"@
M8@ H^7PV)T/5D-V4S".+3SQZ"/Y+7:CN//OF+A0YZG:=8<E.E6M;,=HJ\NC4
M#'HE9,2P/ -,S)8I< QZQ*.$I%'RP.J>=!NF=\IYX"V:0WKD\RP+= ,@RF@6
MZ5 0SQF2YLR)>[?*QI]^_8"V->O/3/SG3FPWD48?@=A"CPJ;7CQDEN6Q(/0,
M(FD&F8-IR7G5AV!K%L WJT"Y(5?R8I@M(:-%K-(@GCTDS9Y3K;9 >MTWKAJI
MC?_5H<@'I9\_>0 F9!H#/?$@(FD0'7+4UK8!*I.G'E_1NSYAO7_#QN\G $!H
M2J=#% !FXQPO\M@1CWA<D<5?REC^S/^VOKGG3I'FSNE*VTZ/N8^+S-8U?UR_
MSV6&_9^B38<BA,YPU0&3'.=9$:E "\^F(LVFNRY 76*H9;,:VQ.]:ZJ 2D'0
M#/LCH%6L5BH\C(KT.6B0!VQ/T)"T[P-R58I(PZ$(3S_!,PK )(^PHO!0*])0
M.^PIOX^.=]?YT.SU0S";#FL P,I%2(0=Q=$3HC3QOBR7O'21S%\,1)H51Z9X
M,>'L/KLVMYWDAVZJ%B1/)D6[CK<EB]D*6HG2EFC6 )Q@2+TQ)L$6 *RB:^3)
M6*3):->HXJ5R5:[XWZ<",!!/LV'^ \V*(M;4+SPKB^G9]/>WY)_>S_.N2//N
MAJ]$T]@8MH4%5T)6H%M":!7D^,%0[Y;0C&),8R'LX5:DX?;%-B:2^H G1]F,
M#!_# &9X-HN=6 L/K2(-K8?==EN[!^:L=KWL6K8[Y6!2[GEF@K-[[2)XHGCZ
M_-0#C*8!YDCI&CB5J6/-"IIC<^\B]P1 - 8%)F0@?U'@F$0#=\%6D5*%>F31
M-++."T^WSVF(IV&N 4PBI2'U^*+IL]2#6#5B*4I;<N];T&^J2:@'#DT#!^S6
M.$^9S,:[YWWLF2GXA0L*/:Q9#%,78!79G]0CAJ81 QY/3L\E=E7K7=6=G]F@
M;>8[CV]M^U#@$4[PY@)H%*FXZ-&+"V?.8HGC##S+])F!ABS)R;#7!AC%WB2@
M'C;T_P$;ZF%#T[!Q&]\./KPEZ!8 .1F)-0"H9PE-L^3^=&(G*R;/])DI@)G8
M^9AZ>M!TA^YO+T,OJAM]>H9]@!G$OLG1RV0;KE;N';L6N4CN7L8Z_'IXC^_:
MO;TV^/TF_W3;O8WGA^E>#OS&E"DZ6E3SI1DR^S@S_E3=^W;=%RVW[I6U1ZFU
MW+B/:\XJKJR!^?M2FJ-X_\7>X/#6X]5_ 5!+ P04    " !P@JE4IQ)8+\\&
M  !X$   &    'AL+W=O<FMS:&5E=',O<VAE970Y+GAM;*U8[V_;-A#]5PA]
M60NX=N)TOXHD0)-U6X=V#9INQ3#L RV=)*(2J9*4'>^OW[NC),O9&A1#O\02
MQ3N^>W?W2.9\Y_R'4!-%==<V-EQD=8S=L]4JY#6U.BQ=1Q9?2N=;'?'JJU7H
M/.E"C-IFM3XY^6;5:F.SRW,9N_&7YZZ/C;%TXU7HVU;[_14U;G>1G6;CP%M3
MU9$'5I?GG:[HEN)OW8W'VVKR4IB6;##.*D_E1?;\]-G54YXO$WXWM NS9\61
M;)S[P"\OBXOLA %10WED#QH_6[JFIF%'@/%Q\)E-2[+A_'GT_J/$CE@V.M"U
M:]Z;(M87V7>9*JC4?1/?NMW/-,3S-?O+71/DK]H-<T\RE?<ANG8P!H+6V/2K
M[P8>/L=@/1BL!7=:2%#^H*.^//=NISS/AC=^D%#%&N",Y:3<1H^O!G;Q\HVO
MM#5_:Z;H?!7AD<=7^6!]E:S7G[ ^4Z^=C750+VQ!Q;']"D@F..L1SM7Z08>O
MM5^JL].%6I^LUP_X.YO".Q-_9Y\1WD)=.QM<8PJ="L(6ZL93(!O3@"O5C\9J
MFQO=J%L,$JHO!O7G\TV('O7SUP.(GDZ(G@JBI_^3\,^W9O"YJ0B!O;3Y4CW*
MQH'L\4)I];OQE;%&J]SYSOF! Q/P*>R1-8HF5QOC&E?M,:?MM-VC^F(-9I2Q
M.7H\&%NITJ$.%=8SX*(P(7=;\GNA+P<^DX.M$-'!J<5,-!14=$H76W!)"BLI
M2W=1 1GYB6I^2T[0DGVC/4_TNANLH_85-(F-6Q>BZO%JHQ@8*]G0FX947NNF
M(5O!R !AV_;6/7$VEZC 0A^=#!(C=[X@'Q:#DU*$H9>8$"J%Y<2H@N@!*2.I
MO>NK6G"4KH&&,26AWP13&.T!]IFZ^>G%K^J=@*<>I(9#0NY_R1ZG!*!;P%ND
MXF%"D9VNUA"?7,PQ/N8ID<M8/H?>&;6]Y+3C0$58(^6U335P8/T39(]$?1&J
M[U.3B-G5('FOW,Z"FXGF/4<T)4=JM/.FE0_=$+2@@G[L&ZPY2^7S/+HKXZ:<
M#.\I$QT,B3Q3HN'2P2M%=ILW.@1>M36Y=QMZPM)?_#LA7"$Z*K)"$-V!V!!&
M=6D<IZR@QDB"X6V(_TGK"E/NA_0=*!"VO@ -V&PKT[=+]>*.VHY[ZR>40RK-
M5Z^N%ZIPO/:&BP%XE0X'MY/)HVQ\9#T!+-1>:R(7+2I%(A[K+\2^$'"-*>D)
M>H90VY:_UGT+-9D*9]Y.!6UQ)NA88]GT-2K_%MU%ZH\>K0&KEM4K]IZ0IDJQ
M4FN?UY #,)JX"N2W)B>NLZ!V7.CX/4*&G!9]/C8%]T*R="RDJ9"A:E5B1S/G
M$!/#-<'$"QR<?+#XV%U;Z!$W+W_17==P&POM7RIW+]U.+]4[S_#>;/4\<\OK
MY8*5N>D+CH^1?VJQ&^^XA?O)3'LA8VNX+QF+IY$;A#2I@&$R#TN,!$MTP_R@
ML(E*#2#TB*K?>"+Q*L1R00]3QS%>&Z.$S;6,^ K)D%,9\K_GDQUYGXH*V<NF
MR)?9C(4'F7V S6N-DG0>A;009A>31.#)A.!Z;Q;J'=UIQ/U>AQI11]XG&?=[
MUF:</RT:J2P38O4&^K%!$')(.?U^<4AJ9+1#,(P.-1R-U!3^,.6<L+G(M 3Q
ML"+S6 <:(<J!CHM\VD8#OKZZ@4Y!B2BF+?53%""8JQOUSG#;H,&3:7K/'B\/
M'[\Z!C 3?Q!<4#"539E(>**RW( 0L4HSG?C0.B1SJYM>!(]9ZD/2/O1'->QB
MN#G(;C55S-CW%EM=LU USLK'K;;!'@,=UDE.H8:-^1NZTH':$L>4P7F)0L.1
M./\@>[5!8P+1OQ+"?3]5P5%6,/O TTYS=8XS4>P%#B^2 :XG<SA?+:&G "IZ
MAF$1/ )!A?K8:\\%C=SBP'J2EKX>MNC0 SZ?BX_HGY4G4[4AZ-"H5#EK,3!"
M=G P0(Z/+&>G*[:L]?TJX[-!0Z+/\'=PLMFK'RBGEDD:SM: *DTCQQJT9<,2
MW;E@#DKI(ZYT4BUX3'FEC[U)>LUO8JMS9"KN9RPVK/3*Y7GO_<#8+]KV7&Y8
M^'2)KAH6IKN<NOL+#L4N4@(9KP:N!.VN-GE]Q''-.>1BQ=)]6FWKFBTED"(V
M1US,^X1M-T0<HUP"P)L>#KCB#N^S9/$NP&V,$>.*<#!:JELB]:N+I,YD5ME[
MT4#VU,MA8'8:D5TB\EXZ7D7F?2RYO2>6]_21P\F&\)?9?UU(5K/;8(NVD3LO
MK]C;F"Z&T^ATK7Z>;I.'Z>E.#JU$X0?DM(3IR?+;KS/ETSTWO437R=URXR)N
MJO)8D\9FP!/PO73@97CA!:9_-ES^ U!+ P04    " !P@JE4V^_[LO 0   $
M+0  &0   'AL+W=O<FMS:&5E=',O<VAE970Q,"YX;6RU6EUSV[B2_2LH[=9.
M4D7+DOP19S9)E9UDYN;NS205)YF'K7V 2$C"A"0T &C']]?OZ6Z I&PI,YFZ
M]\661'QT-[I/GV[PV:WS7\+&F*B^-G4;GD\V,6Y_/#X.Y<8T.DS=UK1XLG*^
MT1%?_?HX;+W1%4]JZN/%;'9^W&C;3EX\X]_>^Q?/7!=KVYKW7H6N:;2_NS*U
MNWT^F4_R#Q_L>A/IA^,7S[9Z;:Y-_+1][_'MN%^ELHUI@W6M\F;U?'(Y__'J
ME,;S@,_6W(;19T6:+)W[0E_>5,\G,Q+(U*:,M(+&OQOSTM0U+00Q?D]K3OHM
M:>+X<U[])]8=NBQU,"]=_:NMXN;YY&*B*K/271T_N-N_F:3/&:U7NCKP7W4K
M8T]/)JKL0G1-F@P)&MO*?_TUV6$TX6)V8,(B35BPW+(12_E*1_WBF7>WRM-H
MK$8?6%6>#>%L2X=R'3V>6LR++Z[E,)1;J6N[;NW*EKJ-ZK(L7==&VZ[5>U?;
MTIKP[#AB/YIU7*:UKV3MQ8&U3]1;U\9-4*_;RE2[\X\A9R_L(@M[M?CF@F^U
MGZJ3>:$6L\7B&^N=],J?\'HG!];;HZ7ZW\MEB![.\G_?V."TW^"4-SC]MUCW
M7[6VNM+!!AKXWIM@VJ@Y(#YN#(*B=,U6MW<TWK;1>-NHTN&\VF J^A2P2*4C
MOJQLJ]O2ZEH%K& 0F3$H[8WJ6MU5EH;HME(;?6/4TIA6 26V>%YA8=[(5YAO
MX.!QP]^3F%MOL>RVAJ!KTQJOZ_J.GIMME+D1@GYJ>8-KVIE5N6P@:ZG5H\FG
MZ?54_7QY^7[R>*I>&A\!19@F@,61#ZE6SL761:,J&\K:A0Z64"T-H=T@0-U5
MPVXOQ2@_0+^V[:#Q7MT'30>+.:]<8R-DG9*!@_DK5BVR'&YK6]( ^C:Z!4C2
MXX+ D%!-0?:D WXJ.^_)G+KZ#; A$K:F-"&0E\ ::J6M'W:A17=U'439NF#%
M=&QKQ%VYZ0./[0GS ??X*1*$9T,'?E+JL%$K@'W@36F+; (,M*X*RA >[%L5
M'^9L-W5GM#\R;77(;$M=LS-)YL)O6MU"V H[W)!5O6ONGV3RT;U'N>RPB&.7
MB-D;V+QC=_'F]\Z2/R_O5.]T]X]Y6#Z;B$*$ELV'8=GA*C@O):1\#'ET=' I
M9;YN<< D;3(AV8/L1B?\"@LU2^-[VQ7D=C02FBJ'X?C61<B<W1>/=L]@>CCZ
MAVC^'AP(&]?5%8E.U(#\%W-^ZUK)O1SRI,9HZ3\"%G:RF@=0X ::[PW,<SA8
M+T7;#V;K//R[592XU7QV]#\/[(CI]\TXWV.4[S%!CDH)W#XF!'9+"VQCI2Q9
MJUL&6UGX@@E3=0D_8^NGC3,XBA&0C-J@2UEL@!Q36] !S4#S#PO'A&'O$%,9
M)3"JMN:&[:8C',H&1MN:QR*P@Z$-]L7WK85 <'[DNI%]R3-A!"S2&59BI"/[
M7E2UT0&H)$;N0]"&T'&LDNV2NR-@OL.T.<:^-S%M)=V)J^QFD,K5M?:R<J^A
MY9/YC0_108^V8_^ R-Z&+W@(DV,6/8P;%U@9"3<Y.<JU)&-7LJDW8(1'-+-0
M,$A]=P3QUASIA@U.IUOAB&JW'0&RUUO315M">D<K 5 1]J0II'TON1*JZL9A
M"S&E2$<:5V9+SDW6AOM_,8(T-[9"7(@[D:/5Y*<4*=@"AQCO"E; 1 %]/CG1
M*\F0D#TK68ACPG+1E)L62%9G&4)P. DR=!_SH2L)^%9=W:M>C/66U4KP&UX(
MB:Y;P=\[SF:PB4W;T_^2CFWIX'?.AQ_^T%R75<4J49(O!(#^:G3OH364']7:
MI95*XULJ$"S,<[NQ.%^*%M-L:YW0BZ"QMO\44@+%<@PF6P8\""N)='I<6[VT
M->3'[ 1U*=D#';QXW[(+H(4!JKX2>_&A;+PQJA'NO2_7%CMQ#8\"=2#VAA2%
M(':!0>$_YT^+Q=F<Q"OVXD0!FQ#E(YMV32=0C8((G#/* L73^7DQ/SF;CG%)
M4EL/'P1)V-&('5JSEJPX8A%CW,DPCO]P):.7M1E2G<BI4RK=59(Q+25P4*3L
M%MAG:R/^8Y-5EYSL'J$Q7\&MHF!>MK?"J;93]4:.12^#A!S.%" QD/& @Y+?
M!W[FX?E0I;B7NVJ$\Q%R0)/CA= HAW-4W19.P9' /K&+QOCLM0U[%8/G@'@;
MWVN(?9S(<0"&'F7OI83N<+9D<N^Z]0;#EI'(!-DQWO7(#H\/FO@['B$T(DA\
MV-@M^TSKVB-0?Y.\G9#&>\<A+.G1P]%+JO(EVGDL?GPPCY@U8](X(3[&D5>0
M!KX'5B41=$=#/2J)M8L$12/3BOS+VJYE=ZRZY'+!FS4YL -3UEL@R0V1)H&>
M;V-,,8(W2 !P05U"V&'_:?[4="EYHAG\HB%&RWXX""K>#:^V#:L*M2,+CB57
M.&>*@\%MI^J#H#%.]A,!$PUE''GY[O.;5T?SIPC=D,*WZOV(0XUQ#D%MOD8Z
M%'RQ<-&2Z11Y[+IVX-YJ RB+XCL&\U'SE(":&^M=FU+V3YTGW1N<82'<C3RZ
MZ\6Y(Z-K7V74JCH_E&L!QO#D8HD=9Z=%L%0&>PT9* >XN"N!"T@5LPV0Q[LP
MN$V>>I19)=D[)GK4:!Q\A3T#^5'2>#= ^P0%R]V:FO\C%?0_;^W64(T^.MT,
MVX)0#[@&%1:T'9#:PO6R(;*]5\-ID55XQP2=JQTPHDSW,TY*-JON6DVG 6Y(
ML#CP+>L!T\AH$K B%S'/?CO6-V^9S97/?3!$/HN\?;&_&)0C<C=<T(]K2^.Y
M-*<S@GT2>N?2$,:C6DGJB  D6\) )HC?5T0RXP:FPW=3)%:0CEX<5]$X3_ND
MXU1FM3*#^PYJ'!!Z2#RR_L.BN$@52 )1"DHJG["N]<(5$$9KYRKAT5B# :CF
MPG24\\=@C?1K8TJ$4W6-]/T+-2M.I&Z72.):M LAT8/#KO+VZKWZ"%! @GHM
M0/W6@*]62%>H!U)K8.R+?;U!NY%GV=% G)'1R ?)Z7[#V4=%H<,U\:/)WS^'
MR6/5A>R^*3<TLB6EQ*'50_W32G(91R'7O[<I74@-A'W% "/SC!3/P4OI+[5Z
M'O0Q(!%)S18\G:K/*+,8(-^D]=7K-@JMNCS4WGA0&^ZRB<I0.H'W5P(?9!C:
M]990[B;OE_4!,*;]'DT^OWD=J$\U-C\U+LCI:8<M2G#JURR1%HA)Y=Z-Q'"_
M$*Q-X1-A&BZ/Q?MY 7<KR;X"TTD@QJUOF2AHYR#4B*?L0EZ/Y^-(348F\:=_
MV6R4<%K'I0(37&*:HP-ECR:V ['PB^S5Q\(IV^%A#(SZ5P(EQ'*$DS>-34Z<
M'7M,SG!@4_4+<NT_2 XHJZXW5$-1M[0<J# ]"/R (%O796*Z2[@!55:T53\8
M6=G;92<)F2E: W27^1M7@X<%FDARW_*% 4$"0>3:R"!8MHL$TKQN-9!Z <B"
MRRH,X8H%QO)]-9&WBJ[\PD$(#B.9^)6M.VZC_ F5I'M(F_X9^3(=KV@'"N8,
MMH?%V3L_*S>@2"3X[SS5S+2 H,F4&CIJVWE L72!^\WWJY=U8]1.\DN#C:@K
MYF MHK QT6EH&BT='1'%(@GOMBDU?+C^E)+"K?8@H:G+D$]"G'AI#JM.74::
M8;ZF#E;?(QD)2FI]0Z6E*747.-:MS_:^S<TW"&6/^M-@TLC4:\4L;,F>S7S_
M\ :,85*/-E)P4?[.^;EOJ0B$K1RUB9B9(4:Q.;?3>P$"53T"/ <[R0(3H\;6
M ^.@X+]AJVZ[.#35L@K?XZ<[E3%^:%-YK/G;7;+C(,N..7^\+SU)#OC9]1HU
MGQ=/3A;%Z>EL_/&=.)%"03P[.2W.SD[HZ>G9O#B?GZH/R!+><L-7O*9K":WF
MQ?SBK%C,SM23I[/BY/Q4_9H=;PZC75Q<J/G)2;' @X^.BKW%TV+VY+2879RK
MQ6DQGSTISB\6@- U%W9O1G<B'W>0L]Q8LQI5Y)4I+6-LH[_ ,1Y-7KY[]199
M7LHD7Q-WOZ$+4L)CO5X3D]_MG(SO7\CZE!1=-Z[Z@TA%$!]1,TH+>I0T]J]U
M7P)!+6&NK]YR*J4'(5U&C7JQHRUS@X9=?9S+.7R'\=*#IF8RX_EH.DU\9!^K
M*^NV<+=&EUSAZ1H/'UD\>/V5.S]>\ (_X;>/5+BJ=S=:8N?AW#V;$4(+)[!2
M7N(+WS/=3WXUCJ >" )UG7]^_0MME,M/89V797386;K.H][T#V&W"39N40N3
M'[P#:2^P-S.;R!2$ZU82ZG="5!N%WE'(!4I]C+RB()3;:B\UNR!HL^0#& R>
M;@V)Z*QKPL>(<MZC[B6QWQ&FC:C!7& *1QE*;[<911\8H,C:%_?.9W0R+QVR
M"Q?D5$NVP?3>DN]QJ#->CCE+]@MA]1@E=W5<K>A=J];49RGZ&Z821.QATS3=
M@J8B :YIZ4::K;E*-RIA7(3LN\6CZJCGW85X!U"V@VA4M'!?BA<90HM[N:YV
M:VX'9RM0,NM:OJRB)"HM9*H.N,E2YPN +-<^ V9('Q%B>4)M8"JA[5#XZP:'
MGWJDA5HSO_>I)]D2VB#U4Z3T[=.4I8^DM. V=AMDO7Z7/!WC8RU=2 W,,D/W
M.3>TVIT6J%ZM;&VYDA>]18VNE49N[[#I"TD;4L'''<T'-><H'Y*3(WM:-^XG
M,*$TLI5KS-C%+_Z@%!QODH'UDS2)7Z?R68H^:5_W5&-OLUNN[\@UR"KLE/V%
M9^ZBAM&5-$4"I8J^4D^Q )+5I,3'4*&%KD@O/(4Y3IQKS]V&^*CY7226ER]B
MA5VR8_-)[ITDG8*=.Z<#5^TY3>P3*/7D<A\XN?.(E<LDYC]"D*8$,=WH]E>:
M$Y6%YOV=&%T=]9::(ON7AHNPR\KQ.P_C=S@\BC%JFLG!O&G59;<&0Z=$.1/+
M_-2K-9IW3=1'>Z#NE<,_I/"?+J^OD,(3\=T[]-.6S?5H<GG]"4-IBZ/9>8&R
M;AG_ZS\N%O/%?]-'<0@A/B$'+F-R3W,>77?+Z+9@FZ=/9D>+V>-4'GIP80(R
ML>C?3+6&!&EI+,@OWK#[<8E.WOSNMLU=C&'1B_G9T>GL<9HXTH5B9,S(WK2
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M<X$SQM("O$\-8M'<D(/Y]_3COP%02P,$%     @ <(*I5+(' JN!"   FA8
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MUFAG*E4,,;BWY$C[.&!6XA>EI<Z5K,17#!)(Z9WXY_72>0M:_>L%1*<]HM.
MZ/3_FX<7C7)!OW>-S.ERTK!'=D.3U^PD?E4@GE6YK*K=5/B2$*.ZD7HG2NE
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M_:P8N,.D7?<#YE&]'].41^4Z2F!)IO%H.@E ]Z.O)ZS:^7&S59:&E]_6]+>
MVBF0O%3*G@CG8/C_6'T%4$L#!!0    ( '""J51AGVRB904   D.   9
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M;4VO&AH?0.>5UNY@^ 3#.[GZ#5!+ P04    " !P@JE4IH%-V"@#   '!P
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M<Z9I"C=:]H.C%#MFFA.;W%O=NJ!4Y'CEUR(C4T5W8I@F"5EI*IP!9BV2-ZZ
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M<O"0C2E@%9><\6DZ->O<A?Y,.-EMI%4':O[>45"6((Z2-/M,#$BZL]25C-A
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ME$2Y0@OP?&5@MW!!![2??KW\+U!+ P04    " !P@JE4V]KB@*(%  "A#0
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M/B 1@ J$DBC,KE/>-EMP+\ !/A$ZT:=:^ZX/RA^+2\\46.:-#,7A4CLXJ4,
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M?0@8+"*?8H#<N2+FZ%A0U<;8QJXI6JI&(O_7](53VD2$ ?9UTNR)"21V*)?
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M\+:C^265&4G!ROQJ$X4#O:6):FI0T"]/F/GCE]4J0DFNB,MK_(:KU$F> L@
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MTV>#9Q2Q".!\Z1%WOQ #VX?9_&]02P,$%     @ <(*I5 =XZ![S!P  @A4
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M%+YXM.V#T?[L[[+Y:^J 6YFFR$ET:O,4O[CS5U.%-LHI3VKT2/]38>$@*_@
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MM/16XI.#KGZ/P8=G@3<!2W'/R WO,/M[8HOQ $FO]@ZW7\KG'XD#MHAILP2
M)70P#EY\W;J@=V]&"%1:M)I+@_^ 6UY/9Y? +1$7[CQZ4[-KCP;3V0V.$HN3
M\?D0$^#<__#=Q=GD[&?Z&(+WBM&D2]6*&Y%X%R/S:-;,O:DQ9CQ^.CXY&Q_'
M2=("*E+U#M[_5>5+2!!)@R!OV3E5>#2E.O%N@R^A)'5$+R9/3AZ/C^/%GB[4
M_*YZ,/=-A7[1="UIBX?<PX;43\H/Q+$8B9L*\%?T?@Z6I[$XS\,B)]EBH638
M*80>B?J'E+)MF^]!XA4-G5D4B"7O W3=DYSMO8M'* "Q&;>[S(#=8L^+"\>T
M2(W6;UBA#\F8O&T,",9$6I1I9"0"/YY #.V0K2IU4[J'M&NI\Q.J<+(&VBFH
M]2&M/S<<U\/0^K=FCYY^4 \E?Y?$+>9)18CV,30U!4!!2X;8)-D'CCJ88XL+
MWB"DQ6DR5[20F.L%FG[7:=%W#6;_M![O&2K TTIMQ++1X5T'6J[IZC7OPA<G
M43V($1=&T0=U7>BD#Y3<X^"1^!-G4_)W449=\S=9-;3S2!N9;H(L#2H@4;?*
M6^-HN\PHDP!<T"7(DD!;\&E$D_0Z):,1E*=X8*"N5I/]3F@0"([JC;-#A@34
M*AIKR7-<J F=X+?O)Q?#R8_G0P:?VZ1EGK- %$+;@<(7'YT/+\XO0M>@2 %M
M8)LP0&=-V80-VTD<O>'\)JR@(W5Z,\TC2A8/0X><=T4^R77^]"RNQW/38N*^
MH;7K]O.,S<&#LJHZX7<?]]%:N\;&676KPS[A08CW%P&T>:AK:VZY0:'6?S^9
M#"_&XR]]&T"VV5IMD0?#BHJT:>PVN.[>V 2]&]=V[%W1>IBR6?,;/ $)R=![
M]@\C<;]?[F]C&%7$?Q!*J>'19*)2Q>PM6EW;FD((LWPDZ!TN\\HZ94U;"?MN
M#.KT%WOW-/O'UQ2]=T4[,<5I[XU[J>R2_ZZ  4KEP\OW]M?V;Q>FX8U]=SS\
MX<-;:9<$F@NUP-7QZ.F3@;#A;PG"%[0^?G\_-]Z;DC^NE$2QH@-X3N]#TQ=B
MT/Y%QXO_ U!+ P04    " !P@JE4I==_MQ(#  !C!@  &0   'AL+W=O<FMS
M:&5E=',O<VAE970R."YX;6R-5=MNVS ,_17"3QO@U==<&B0!DJ[#!JQ;T73K
MP[ 'Q:9CH;+D27+3_OTH.773H2WV8HOBY1S2)#W?*WUK:D0+]XV09A'4UK:S
M*#)%C0TS)ZI%29I*Z899$O4N,JU&5GJG1D1I'(^CAG$9+.?^[E(OYZJS@DN\
MU&"ZIF'Z88U"[1=!$CQ>7/%=;=U%M)RW;(<;M#_:2TU2-$0I>8/2<"5!8[4(
M5LELG3M[;_"3X]X<G<%ELE7JU@E?RD40.T(HL+ N J/7'9ZA$"X0T?ASB!D,
MD,[Q^/P8_9//G7+9,H-G2MSPTM:+8!I B17KA+U2^\]XR&?DXA5*&/^$_<$V
M#J#HC%7-P9D8-%SV;W9_J,/_.*0'A]3S[H$\RX_,LN5<JSUH9TW1W,&GZKV)
M')?NHVRL)BTG/[O<]!\#5 4;OI.\X@63%E9%H3IIN=S!I1*\X&C@W37;"C3O
MYY$E8.<>%0>0=0^2O@*2P862MC9P+DLLG_M'1'A@G3ZR7J=O!KQ@^@2R)(0T
M3M,WXF5#%3(?+WLEWDOI_EIMC=74-;_? ,@'@-P#Y*^5F8:I[ 2Z.J\(J.2B
M<^T(&RPZS:T#/+\O1$?U@4JK!LY4TW:6^=8EIV\TGU^5,="BADW--+[T&=XD
MX>9[9EI6X"*@ 3:H[S!87M<(E1(TG"[[5EDD>DR(!Q@XFB>.S#@R5/ZB'NH/
M3);N0&+-R'R+* &?)6,)A&T5*8NGM'PH#T)F>S\^=* (FK8!&)<CF7366 )P
MY&@%^4BVUHC0]"U%%X3F^LJ1(^F!]D GRB,NU-#\PV,VLW_9.^94;4FXEE.#
MTTQO+21).,G2,,_CX^/WMB>>C,,XR\/1*'/:?)2$XR2'*Z2&X87+@N:VN(5.
M<DO&83(=A6D\@LEI'&;C'&Z8UD2*5%2TZ70*29:%*2FNE64"TM,PGN1A/!U#
MFH=)/ G'TQ1>ZL+H:/ ;U#N_W@SX9NYWP' [;-!5OSB>S/OU2U79<4I-8$6N
M\<ED%(#N5UHO6-7Z-;)5EI:2/];T%T#M#$A?*>J=@^  AO_*\B]02P,$%
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M)]T^5^:3U*YO%Z9E!:X":DR#^@&#H]3:T0>.J16*VLI8%XRM$2HEJ#NYW"^
M2ES4OL8W6&"S0^V5]P[O'N$6WK1:/:"C,O *DB1,DMD?8=-Q41*;\8C=H/V-
M2M)P'F?N-9M?PIM.2VX[C1Y1\4<GDU&8S#.W7J9'YY+E81;GD&7A9);#>Z2F
MK)7X)ZH\G*7IL&XTHH^ VJFXA_G$<<9Q#->J:3M+*=9,EP<VN#>JLEZ9D..Y
M6[.$3"5=AFZ8)62EJ' :F#%(WK@$\KVGF U06)111IYSF.9A/)G!E/:R*85J
MS *NBJ)K.L$LEC0_Z,0*SD96UBAM^:]^XRR/PWPZ.8>S;!ZF:7H.)T\U!$GM
M^JHO3.8$*E0R@>=N;W0T,AK4>S\8#=V+3MI^>HR[X^R]ZD?.'_-^<-.-V7-I
M0&!%T/AB.@E ]\.P5ZQJ_0#:*4OCS(LU_3]0.P/Z7BEEGQ3G8/PCK7\#4$L#
M!!0    ( '""J51,QAN,EP,  )@(   9    >&PO=V]R:W-H965T<R]S:&5E
M=#,U+GAM;+U639/B1@S]*RK7'J#*&7^#H8 J8)+-'#8UM3/9'%(Y-+; SK2[
MG>YFV,FOC[H-7G:'H38YY(*[94E/>I(L9@>IGG2%:.!SPX6>>Y4Q[30(=%%A
MP_2-;%'0FZU4#3-T5;M MPI9Z8P:'L1A. H:5@MO,7.R>[68R;WAM<![!7K?
M-$R]K)#+P]R+O)/@8[VKC!4$BUG+=OB YM?V7M$MZ+V4=8-"UU* PNW<6T;3
M56;UG<*G&@_Z[ PVDXV43_9R5\Z]T :$' MC/3!Z/.,:.;>.*(R_CCZ]'M(:
MGI]/WG]RN5,N&Z9Q+?EO=6FJN9=[4.*6[;GY* \_XS$?%V AN7:_<.ATL\2#
M8J^-;([&%$%3B^[)/A]Y.#/(PS<,XJ-![.+N@%R4M\RPQ4S) RBK3=[LP:7J
MK"FX6MBB/!A%;VNR,XOW4I:'FG-@HH0[89C8U1N.L-0:C?;A%^J+P2,CD1[.
M D.(UBXHCMY7G??X#>\)?)#"5!I^%"667]L'%&D?;GP*=Q5?=?B!J1M((A_B
M,(ZO^$OZ]!/G+_E/Z<-MK0LN]5XA_+[<:*.HB?ZX IOVL*F#3=^ ?:#9*O>$
M([>PK@@4-=0"UDRIEUKL8-G(O3#V[2G 2]Q?Q;#3/-4M*W#NT;AJ5,_H+1XK
MA.(+H+'7$RCK07<G5FCHG8ZI%"(T72W1UA*H$D75EP(.2!PQ31:<YEQ/8<4X
M$P7)#-QB@<T&U4D[@G>0I7Z4YG#7M*Q6-.3496D>#X%&C09)4.LKA:)X >)<
M:,ZZ$2[_I(FPVAH&63(\!_DF'D)(_%&4P)5J97VULN^NUJL>N528J^XN%^;,
M+^MZKY#TY=.N'K8$';&N3MK*OLYW"N^5U/I5!RV+8M_LB3ZJ&(F4J?_NJ+1S
M?4]B88>\Q&?Z.K>D8["HA.1R5U.#V)EX$O+P0T5\O8-)Z(=A2(=!,O&S23:T
M)(=^&F:P=A\JJK#"KE2ZJEL-4>CG60@#>J9Y.(1D',*C8B7M%=HYD/D3\C?(
M_#C-AS#*8GB4AG%R&X4C?YPYK"SSDSAQ6)&?QF/XUTR]:K__A:S(3\:)(ROW
M1TGH$HC]<9I\!UEQ1I.03?*+9$7Q: CC<7I&5DY"AT53%8;Y\#A?47:Q^X.S
M;4%A[-Q.M"P2!]WBZ*7]VEUVV^:+>K>SJ0EWM=# <4NFX<V8.E]U>["[&-FZ
MW;.1AG)VQXK^.J"R"O1^*Z4Y72Q _V=D\0]02P,$%     @ <(*I5 C=:2"N
M P  L0@  !D   !X;"]W;W)K<VAE971S+W-H965T,S8N>&ULC5;;;MLX$/V5
M@;98M( 32=3%BM<VD#@M-HND&]1N]V&Q#[0TMH1*I$K2<?KW.Z1LU4X=HR^\
M:>;,Y<R0&F^E^JI+1 //32WTQ"N-:4>^K_,2&ZXO98N"OJRD:KBAK5K[NE7(
M"Z?4U#X+@M1O>"6\Z=B=/:KI6&Y,70E\5* W3</5]QNLY7;BA=[^X%.U+HT]
M\*?CEJ]QCN9S^ZAHY_<H1=6@T)44H' U\:[#T4UJY9W EPJW^F --I*EE%_M
MYJZ8>(%U"&O,C47@-#WA#.O: I$;WW:87F_2*AZN]^@?7.P4RY)KG,GZGZHP
MY<3+/"APQ3>U^22W?^(NGL3BY;+6;H1M)QN3<+[11C8[9?*@J40W\^=='@X4
MLN 5!;938,[OSI#S\I8;/ATKN05EI0G-+ERH3IN<JX0E96X4?:U(STSO::]!
MKF"FL*@,<%' O13KBP6J!FYQ:>#M@B]KU._&OB&#5LW/=^ W'3A[!3R"!RE,
MJ>&]*+ XUO?)T=Y;MO?VAIT%?.#J$J)P "Q@[ Q>U$<?.;SH%3P7WVVE\UKJ
MC4+X]WJIC:)*^>\,>-R#QPX\?@5\3@U4;&JTV7V1TCM!9C94VT:?RNIY7(=E
M+%9AL7))':*-(]&4""M94Z=58CT"2E=>NGS=8H[-$I7;S*1X0F4J8K6#>!N^
M@S<07F6#*&5V-;P:9!F#C])0<;3\NRT B 9AD-#(PB'\3984_/Y;QD+V!R0,
M7CC%@G 0IT,(,])*0KA'K:F<E:*0H97*=624)! '+W4'4)\2?N,PP]#YE['!
M,+YR?L\1G9_ Z(Y8<U50Y, +V3HMRLGU_+,ME^ B2(&[+/W%Q88N(-C5T>49
MKI.>Z^27N9[)II7"<FMW=X(B0VW@_3-=I!I/\7T6VU[+(]WR'"<>W;L:U1-Z
MTP4QG1\9JO:&L#-$Z:BYP0*,='5QR'I'[);D;4JZBM$C6)2*LGG8LRY!=@AA
MQG7YLQ$B8S!,@G[^*,5%?E*293$0;50,"VEX?0J*#8(HICD>)$$(9VA)>UK2
M7Z;EP\;8%G_@-%6FZFZ]X[X\Q<U9 Z>YV5EJCBS5QPW25>*/!G5YYB_X<(>4
MEC2QRXB&@#K4;6*(LL NJ".OW$D*<1C:Q1!BEA&7E%V^(HN0I?N<VR;JVOA4
M<OV#9Z1!M7:/)76BW C3O2C]:?\>7W?/T _Q[C&GP-:5T-3**U(-+H=4XJI[
M(+N-D:U[E);2T!/GEB7]4Z"R O1]):E$=QMKH/]+F?X/4$L#!!0    ( '""
MJ50IVG(C>@(  +,%   9    >&PO=V]R:W-H965T<R]S:&5E=#,W+GAM;)54
MW6_:,!#_5TY9-15I(A"@0QT@%>BT/E2J*-L>ICV8Y$*L.G9F7P;[[W=V(*-2
MR]27^.M^'Q?[;K(S]LD5B 3[4FDWC0JBZCJ.75I@*5S75*CY)#>V%,1+NXU=
M95%D 52J..GUKN)22!W-)F'OP<XFIB8E-3Y8<'59"OMGCLKLIE$_.FZLY+8@
MOQ'/)I78XB/2U^K!\BIN63)9HG;2:+"83Z.;_O5\Z.-#P#>).W<R!Y_)QI@G
MO[C+IE'/&T*%*7D&P<-O7*!2GHAM_#IP1JVD!Y[.C^R?0^Z<RT8X7!CU7694
M3*-Q!!GFHE:T,KLO>,AGY/E2HUSXPJZ)'0TB2&M'ICR V4$I=3.*_>$_G #&
MO5< R0&0!-^-4'"Y%"1F$VMV8'TTL_E)2#6@V9S4_E(>R?*I9!S-[G1J2H2U
MV*.#R[78*'2=24Q,[0/B]$ S;VB25V@&<&\T%0YN=8;9<WS,EEI?R='7/#E+
M>"]L%P;]#Y#TDN0,WZ#-<Q#X!O_-$Y;2I<JXVB+\N-DXLOPR?IZ1&+82PR Q
M?$7BD0LFJQ6"R>$VSS&\-S@17@E"6&%J="J5%/Y5OO2GSZNL"X3<*"XFJ;=
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M*W\I#\[0*2><FST4S&"A18[&?H:KEXJ[-^@\LJ5 VYW$CD)XQSAKZ!8U77*
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M.LM+FA00ND%<P(HZN.9;%[;(R;/&BK**>J,VS)DFA\B=Y"DD;AS$<"\T"7V
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M,E"T =>74IKM"P$,7WGG_P)02P,$%     @ <(*I5$)Y&+N> @  <P8  !D
M  !X;"]W;W)K<VAE971S+W-H965T-#(N>&ULC57;;MLP#/T5P>A#"ZQU;,?I
M!4F 7#:LP#H$S;H]#'M0;"86*DNI1#?MWX^2'2_IDJ(O-B7Q'!Z2%MW?:/-H
M"P!D+Z54=A 4B.N;,+19 26W%WH-BDZ6VI0<:6E6H5T;X+D'E3*,.YU>6'*A
M@F'?[\W,L*\KE$+!S#!;E24WKV.0>C,(HF"[<2]6!;J-<-A?\Q7, 1_6,T.K
ML&7)10G*"JV8@>4@&$4WT]3Y>X>? C9VQV8NDX76CVYQFP^"CA,$$C)T#)Q>
MSS !*1T1R7AJ.(,VI /NVEOV+SYWRF7!+4RT_"5R+ ;!5<!R6/)*XKW>?(4F
M'R\PT]+Z)]LTOIV 995%739@4E *5;_Y2U.''0#Q' ;$#2!^"^@> 20-(/DH
MH-L NKXR=2J^#E..?-@W>L.,\R8V9_AB>C2E+Y1K^QP-G0K"X7!>MYOI)9N+
ME1)+D7&%;)1ENE(HU(K-M!29 ,O.V3?Q5(E<X"O9HYP,ZAR7[%;5GY_KX^D4
MD MIS\CE83YEIR=G[(0)Q7X4NK)<Y;8?(NEVT<.LT3BN-<9'-";L3BLL+/NL
M<LCW\2'EVR8=;Y,>Q^\2WG%SP9+H$XL[<7Q S^3C\.@ ?/H^? K9,?A>-DG;
MPL3S)4?X#O7J]VAAT="E^O-.@&X;H.L#=(\$^$[31ZA,E\!.I;;46XYHQ*)"
MOI# 4+,U-Z#P4&=KYIYG=B/H>7@>7<<IY?V\6_!#;I=)=-6Z[0E/6^'IN\*I
M,E5928Z0NUE I3FH,?TO>'0=]:(DW1<Y/>B7IFGOC<IPYSJ68%9^K%GFNU1_
MI.UN.SE'?F"\V1]'-Y-Z /ZCJ<<Q?8(KH2R3L"3*SL4E:3/UB*L7J-?^TB\T
MT@CQ9D%_!3#.@<Z76N-VX0*T_YGA7U!+ P04    " !P@JE4ER@79"\"  "\
M!   &0   'AL+W=O<FMS:&5E=',O<VAE970T,RYX;6R-5$N/VC 0_BM6U,.N
MU.(0=K?5*D1B8:MRJ(06+3U4/9ADDE@X-K6'1_]]QTZ(J 2HE\3CF6_FFY?3
M@[$;5P,@.S9*NW%4(VZ?.7=Y#8UP [,%39K2V$8@B;;B;FM!% '4*)[$\1-O
MA-11EH:[A<U2LT,E-2PL<[NF$?;/"RAS&$?#Z'3Q)JL:_07/TJVH8 GXOEU8
MDGCOI9 -:">-9A;*<309/D]'WCX8K"0<W-F9^4S6QFR\,"_&4>P)@8(<O0=!
MOSU,02GOB&C\[GQ&?4@//#^?O'\-N5,N:^%@:M0/66 ]CKY$K(!2[!2^F<,W
MZ/)Y]/YRHUSXLD-G&T<LWSDT30<F!HW4[5\<NSJ< 88/5P!)!TC^%S#J *%R
MO&46TIH)%%EJS8%9;TW>_"'4)J I&ZE]%Y=H22L)A]FR[1XS)5O*2LM2YD(C
MF^2YV6F4NF(+HV0NP;%/;"6L%&L%;*X1+#ADKV2#K7)2%-)W1BA2M^/E^W0W
M Q12N7LR>5_.V-V'^Y0C,??Q>=ZQ?&E9)E=8?A=VP$;#CRR)D^0"?'H;/H.\
MAP__A7.J5U^TI"]:$OR-KOB[5)V?D[5#2U/YZT: 41]@% (\7,WW*)M=PZQT
M&]\:99RCG5$"H6!H&-; 9 %$H91TLYJ_NDM%;8,\A2!^G?=9G/+]>=UN6;3,
M^=EL^;VF5E12.Z:@)$P\^/P8$<VP*ZV 9AO&;6V0AC<<:WI>P'H#TI?&X$GP
M$]P_6-E?4$L#!!0    ( '""J519G,H'/P,  ( +   9    >&PO=V]R:W-H
M965T<R]S:&5E=#0T+GAM;,U676_:,!3]*U:>-FEK8N>#= (DRCJMTCY0V=:'
M:0\F,6#5L9GME.[?[]I) Z4057WJ2XF=>T[./2=U[G"K]*U9,V;1?26D&05K
M:S<?PM 4:U91<Z8V3,*=I=(5M;#4J]!L-*.E!U4B)%&4A17E,A@/_=Y,CX>J
MMH)+-M/(U%5%];\+)M1V%.#@8>.:K];6;83CX8:NV)S9GYN9AE78L92\8M)P
M)9%FRU$PP1^F.', 7_&+LZW9NT:NE852MVYQ58Z"R"EB@A7645#XN6-3)H1C
M AU_6]*@>Z8#[E\_L'_RS4,S"VK85(D;7MKU*,@#5+(EK86]5MO/K&TH=7R%
M$L;_1=NV-@I041NKJA8,"BHNFU]ZWQJQ!P">XP#2 L@A(#D!B%M [!MME/FV
M/E)+QT.MMDB[:F!S%]X;CX9NN'0QSJV&NQQP=CQOXD-JB>9\)?F2%U1:-"D*
M54O+Y0K-E. %9P:]1]_@M?JBC$$SIM%\336#S4E9<I<(%>A*-N^5R^?-1V8I
M%^8ME!A7:H:A!<'NL6'1BKMHQ)$3XF+T54F[-NA2EJQ\C ^AT:Y;\M#M!>DE
M_$KU&8KQ.T0B0H[HF3X?CGODQ)WYL>>+3_!-P.&2B]J]R6C.BEJ#D^#TY7TA
M:N@8+;6JT%15F]HVKD),EU1+R&4_A-]?@!A=65:9/SVRDDY6XF4E)V3]4):*
M8VDUL-3#W/EP-R;GT2")\FP8WNW;>*0PP=$@RTE7^$A9VBE+>Y5-E;QCVO*%
M8/"_NK ]S68=9?::,AATL@8ORV#PQ%J,!S%)DN@@@V<4/E*6=\KR7F7?-\X%
MT]/C><=T_IJLQ]'N3(Q>9GZ+>V1J%L5)FL8'[A^KQ$F*,YP<MQ_OG=BX5]TU
M,U;SPH)!\'DH;E$MN>W+ Y,=-7E5B>P.2AR_,)'XB,]Y2J+T,)"GA8/S*,Y.
MQ;$[+''_:7E#M89/9F\ N_,-IZ\J@-TIB;,7!I ]#8#@/,\/_3]2%\?DB?_A
MWBQ3,;WR(YY!?AQI/O3=;C=&3OSP=+!_X<9+/R/M:)K9%#[C*RX-$FP)E-'9
M $3I9MQK%E9M_,2T4!;F+W^YAA&9:5< ]Y=*V8>%>T W=(__ U!+ P04
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M\KYSWG5,*^/V.7TUZ _;Q[1L30<L? RPZ0UT\+V)*3DH'4Q$TQ?H\!D3T70
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M Y.$,R1@VG<N_/.1'QF M?A&8"EK:V1">>#\T6RNDK[C&49 (5;&!=:/!8R
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M49M9O-D8N733:2H-S3JW7-#G"Y4%T/U,TDQI-G;@M1_$] ]02P,$%     @
M<(*I5+W!0SZ\ @  ;PD  !D   !X;"]W;W)K<VAE971S+W-H965T-3<N>&UL
MK99=;YLP%(;_BH5ZT4I=P7PDH2*1UD35*G52U:SKQ;0+!TZ"5<#,-DG[[V<;
M2FA$Z=3E!FQ\WI=S'N1CHAWC3R(%D.@YSPHQM5(IRTO;%G$*.1$7K(1"K:P9
MSXE44[ZQ1<F!)$:49[;K.",[)[2P9I%Y=L=G$:MD1@NXXTA4>4[XRQ5D;#>U
ML/7ZX)YN4JD?V+.H)!M8@GPH[[B:V:U+0G,H!&4%XK">6E_QY1P'6F B?E+8
MB<X8Z5)6C#WIR4TRM1R=$6002VU!U&T+<\@R[:3R^-.86NT[M; [?G6_-L6K
M8E9$P)QECS21Z=2:6"B!-:DR><]VWZ IR"08LTR8*]K5L7YHH;@2DN6-6&60
MTZ*^D^<&1$> _7<$;B-P_U7@-0+/%%IG9LI:$$EF$6<[Q'6T<M,#P\:H536T
MT)]Q*;E:I4HG9S?%%@K)^ LZ78 D-!-GZ MZ6"[0Z<D9.D&T0#]25@E2)"*R
MI7JCUMEQXWY5N[OON'\G_ )Y^!RYCNOVR.?#\@7$K1R_E=NJSK98MRW6-7[>
MA\7^NE5+Z$9"+GX/&'NML6>,_8^,^Q#5TI&1ZEVUG6%W[#F1O>V2Z(GRW!%N
MH][DY;=Y^8-Y+:NRS"B(<P3YBK\P@=1W1$RFP%')65+5>TGM!N"49&( 1="^
M,C@NXU%K//H\XUH:=.BYH8</$/<$!9-)/^%QF]5X,*M'U:3T)E$T8Q!# ">M
MX^2X ,/6./P\P+"'C1<> .P+&OG] +&S[T#.8%ZWJH^K/A<_#=2(._T,'Q<?
MWG</['X>8*/MP@E"/#D@V!,U\K#S#L)]^\'#_><:(!DJ<=\OL']D>ON^@(/_
MH!?TM#_?/:37$S4.PP-Z=N<TU+\BZA#:T$*@#-9*YER,E0NO3_=Z(EEI#L@5
MD^JX-<-4_1$!UP%J?<V8?)WH,[?]QYK]!5!+ P04    " !P@JE4!J RS8,#
M  !R"P  &0   'AL+W=O<FMS:&5E=',O<VAE970U."YX;6R=EFV/VC@0@/^*
M%?5#*VTW<5X@K !IEVUU)_5.J-OV/ISZP22&6.O$J>TLV_OU-S;9P"8F5$4"
M[&1>'H_'XYGOA7Q4!:4:/9>\4@NOT+J^\7V5%;0DZEK4M((W6R%+HF$J=[ZJ
M)26Y52JY'P;!Q"\)J[SEW#Y;R^5<-)JSBJXE4DU9$OGSCG*Q7WC8>WGPF>T*
M;1[XRWE-=O2!ZJ_U6L+,[ZSDK*258J)"DFX7WBV^6>'(*%B);XSNU<D8F:5L
MA'@TDS_SA1<8(LIIIHT) G]/=$4Y-Y: XT=KU.M\&L73\8OUCW;QL)@-470E
M^#\LU\7"2SV4TRUIN/XL]G_0=D&)L9<)KNPOVK>R@8>R1FE1MLI 4++J\$^>
MVT"<*.#XC$+8*H2_JA"U"C9R_H',+NN>:+*<2[%'TDB#-3.PL;':L!I6F6U\
MT!+>,M#3R[6$C)#ZYQ5:<U)I1*H<??C1L!JV2E^AOR&1WJ,'2)Z\X12)+1I5
M0&_OJ2:,JW>@]?7A'KU]\PZ]0:Q"7PK1*)!5<U\#MG'N9RWBW0$Q/(/X%Y'7
M*,)7* S"T*&^&E>_IUFGCE^K^Q"L+F)A%['0VHM^)V+HW]N-TA*2\_N(JZAS
M%5E7\1E7GXQM\^7FAY6U%$_4N'%&\6!K8FV9T_NTQ/!)Y_[3:; N2;T"C3O0
M>!3TKF$\9]5.6=I-.[M(?#":G+*$LR#J$;NDTMG$39QTQ,DH\<=&5DPWDEKB
M+7LV8R=D,G2/9WU&E] D="-..L3)*&*75"ZJR<!A%$=!W,-R2$5)&KNYIAW7
M=#PK*93-0O#+&3D=N(_3,.PQ7A!ZA9AVB.EX/DI*;09"_<P>76CIP.LLZ6_J
M4 8'0> FFW5DLU&RE2CK1E.)"B+S/6GS3XFM-A,7Z6Q D>#)K(?J$HJP&Q4'
MQ[LAN !;03%KV@L7.(4N )TH1;4R51VV?P?'QEW4@V'R)2?'MJW=#JDT/).A
M^.16PZ/DQR)==T6:'J^UG11GH/$ 9QH'2;^(NL2B))J>P3Y>+3B\<+24ND&W
M6=:4#2>:YM"10'>6,=)M 2F%U.P_^\"Y@G" ]CX.XFG27X)#+IJ%YTX>/MY9
M>/S2NA#ZBCKK&1[>2Z94]8^D2RR.<-*#]D\:(M.-0@NQ8Y5"G&Y!+[B>PK+E
MH<$[3+2H;8^T$1HZ+CLLH"FFT@C ^ZT0^F5BVJZNS5[^#U!+ P04    " !P
M@JE4\OJI\4D"   [!0  &0   'AL+W=O<FMS:&5E=',O<VAE970U.2YX;6R=
M5%M/VS 4_BM6Q -(K$F3PAA*(_7"-!Z8*AC;P[0'-SEM+!P[V">T_'N.G31T
MJ*!I+XDOY_O.=VY.-]H\V!( V;:2RHZ#$K&^#$.;EU!Q.] U*+I9:5-QI*U9
MA[8VP L/JF081]%Y6'&A@BSU9PN3I;I!*10L#+--57'S/ 6I-^-@&.P.;L6Z
M1'<09FG-UW '>%\O#.W"GJ40%2@KM&(&5N-@,KR<C9R]-_@I8&/WULQ%LM3Z
MP6VNBW$0.4$@(4?'P.GW!#.0TA&1C,>.,^A=.N#^>L?^U<=.L2RYA9F6OT2!
MY3BX"%@!*]Y(O-6;;]#%<^;X<BVM_[)-9QL%+&\LZJH#DX)*J/;/MUT>]@#$
M<Q@0=X#X+6#T#B#I (D/M%7FPYISY%EJ](899TUL;N%SX]$4C5"NBG=HZ%80
M#K.%H88P^'S*%I(K9%P5[.JQ$355"D_9=^JC3VQ2%,(EG4MVK=K.<24XG@-R
M(>T)F=S?S=GQT0D[8D*Q'Z5N+#'9-$32Z#R%>:=GVNJ)W]&3L!NML+3L2A50
M_(T/*;8^P'@7X#3^D/"&FP%+AJ<LCN+X@)[9O\.''\A)^GPGGB_YGWRSWY.E
M14.M_><#5Z/>U<B[&KWC:@XTU[EH:P5;FGL+APK2LIQ[%C?T3]EP=)&DX=-^
ME@X8G7UY-6H%AGM]6(%9^_&T+->-PK9B_6G_ DQ\X[\YG]++T [R*TW[K% ]
MUD)9)F%%E-'@,\V5:4>UW:"N?;<O-=+L^&5)KQL89T#W*ZUQMW$.^O<R>P%0
M2P,$%     @ <(*I5'4[J9VB @  JP8  !D   !X;"]W;W)K<VAE971S+W-H
M965T-C N>&ULC57;4MLP$/T5C8<'F 'LV+DPC..9)/3" QV&E/99L3>VBBRY
MDHS)WW<E.VX*)O0ED58Z9\]J+XX;J9YT 6#(2\F%GGN%,=6U[^NT@)+J2UF!
MP).M5"4UN%6YKRL%-'.@DOMA$$S]DC+A);&SW:LDEK7A3,"](KHN2ZIV2^"R
MF7LC;V]X8'EAK,%/XHKFL ;S6-TKW/D]2\9*$)I)011LY]YB=+V:V?ONP@\&
MC3Y8$QO)1LHGN[G-YEY@!0&'U%@&BG_/L +.+1'*^-UQ>KU+"SQ<[]D_N]@Q
ME@W5L)+\)\M,,?>N/)+!EM;</,CF*W3Q3"Q?*KEVOZ3I[@8>26MM9-F!44')
M1/M/7[IW.  @SS @[ #A:\#X'4#4 2(7:*O,A75##4UB)1NB[&UDLPOW-@Z-
MT3!AL[@V"D\9XDSR1<JL89P3*C)R*PP5.=MP( NMP>AS\@T+Z8*LL7BR&LUR
M2U8%W@%-F" KJM2.B9PL2ED+8T][OM,;,)1Q?8;PQ_4-.3TY(R<6]+V0M49O
M.O8-!F!E^&DG=MF*#=\1&Y$[*4RAR2>10?8OWL? ^^C#??3+\"CA'567)!J=
MDS (PP$]J_^'CX[(B?ID1(XO^B 91ZC&/=7848W?H5I"SH2PN=E03D4*0Z_=
M4DP=A6WWYV0R'HVO8O]YP/.D]SPYZOFVK"A3V.AFR&6+G1RXO!A?A;W']M4G
M;W0%PYJFO:;I44W8\=C/ AM**1#ICAA%A>:TG239+^PS*WBP)*=O%4^B83FS
M7L[LJ!PLWP\R,WN;F6@Z>NW6/^C[$E3NQJ$FJ6W&M@EZ:S]Q%V[0O+(O<1*W
M@_,O33O&L<2QD#3AL$7*X'*&#Z':T=ANC*S<=-E(@[/*+0O\FH"R%_!\*Z79
M;ZR#_ON4_ %02P,$%     @ <(*I5$'$C$'B @  LP<  !D   !X;"]W;W)K
M<VAE971S+W-H965T-C$N>&ULC57);MLP$/T50N@A =)HM9T$M@$O70PT01 W
M[:$H"EH:2T2XN"05IT4_OB0E*[8C.[E(7.:]>3-#<OIK(1]4 :#1$Z-<#;Q"
MZ]65[ZNT (;5N5@!-SM+(1G69BIS7ZTDX,R!&/6C(.CZ#!/N#?MN[58.^Z+4
ME'"XE4B5C&'Y9PQ4K =>Z&T6[DA>:+O@#_LKG,,<]/WJ5IJ9W[!DA %71' D
M83GP1N'5M&?MG<$W FNU-48VDH40#W8RRP9>8 4!A51;!FQ^CS !2BV1D?&[
MYO0:EQ:X/=ZP?W2QFU@66,%$T.\DT\7 N_!0!DM<4GTGUI^ACJ=C^5)!E?NB
M=6T;>"@ME1:L!AL%C/#JCY_J/&P!XLX!0%0#HCU %!X Q#4@?BL@J0&)RTP5
MBLO#%&L\[$NQ1M):&S8[<,ET:!,^X;;L<RW-+C$X/?PD1+8FE"+,,S3C&O.<
M+"B@D5*@U1FZ,2?O/1IE&;%EPM385&?-%NUD"AH3JD[1.T0X^EJ(4AD>U?>U
MD68=^&DM8US)B [(B-&UX+I0Z //(-O%^R:D)JYH$]<X.DIXC>4YBL,S% 51
M=#^?HI-WIQ)60FK"\U\E)[I%Y.3MG&'-V<(R/<XRA?05EIV XZ:0L:.-#]#.
M(3>W4:.[39 [E?KQQ9BCF0:F?AYQEC3.$N<L.>!LQE:82.=/+%%>GZ&VLE<\
M7<=CGZ#'87(1]?W'[:R_M D:BQUYG49>YZB\FY(M0%II3<F1+;E"Q F'#/U#
MKYZ&<>6DLZ4K;-?5;71UC^IZOFQI6K*28FV4D.=<4F%N7>OMZ;Y,8Q)&G=U$
M3ENLXFX2MXON-:)[1T6/F$W3W^H<P9/I-PK:)/9>. \O@LN]4K<87<;[U?:W
MGC,&,G=M0:%4E%Q7+T"SVG2>D7MP]];'X=6D:B#/-%4[,U<Y)UPA"DM#&9SW
M3)5EU2*JB18K]V@NA#9/L!L6IJN"M 9F?RF$WDRL@Z9/#_\#4$L#!!0    (
M '""J51%'2\CF0,   ,.   9    >&PO=V]R:W-H965T<R]S:&5E=#8R+GAM
M;+V778^;.!2&_XJ%>M%*G0$;"*1*(J49=;=2NQIU^G%1[84#3K &[*QMAK:_
M?FW"  F&5J-HYF+"QWN.'Q\.+_:BXN)>9H0H\*/(F5PZF5*'-ZXKDXP46%[S
M V'ZSHZ+ BM]*O:N/ B"TSJHR%WD>3.WP)0YJT5][5:L%KQ4.67D5@!9%@46
M/]^2G%=+!SJ/%S[1?:;,!7>U.. ]N2/JR^%6Z#.WS9+2@C!).0."[);.&K[9
M(,\$U(JOE%2R=PS,5+:<WYN3]^G2\0P1R4FB3 JL?Q[(AN2YR:0Y_FN2.NV8
M)K!__)C]73UY/9DMEF3#\V\T5=G2B1V0DATN<_6)5W^39D*AR9?P7-;_0=5H
M/0<DI52\:((U04'9\1?_: K1"X#!2 !J M"?!OA-@%]/]$A63^L&*[Q:"%X!
M8=0ZFSFH:U-'Z]E09A[CG1+Z+M5Q:O47YVE%\QQ@EH+W3&&VI]N<@+641,G7
MX!_=25?@3G=/6NK+?#<4@9<W1&&:RU=:^>7N!KQ\\0J\ )2!SQDOI4XL%Z[2
MK&9$-VFXWAZYT C71RRN@0]? ^0A9 G?3(??D*0-AZ?AKJY06R;4E@G5^?R1
M?.\HHXI<?= M-UJF[^NM5$+WY;\3 _KM@'X]8##V7 27$FRP$#\IVX-UP4NF
M;&4\IIG5:<P[^[""WBP*O87[T"^7319#Y+>R$\J@I0PF*==)4A9ECI6NBD84
MBO["YNVT@1XSA3V"JS#T>P1'4)LL\+S8#AJVH.$DJ'X^-J9P,%@( Q2=(5E4
M 82AG6C6$LTFB6YUT9AIG90\:#,]Z HJDF2,YWQ/B:S?QWO&JZN,5Q/]%+7#
M1<_3P'$[8'R9!HX'U9U[^N_L&5A4T(]&VG?>,LXOUK[S85_Z\W >GG':9/',
M]^R@T.MLVGM* S=1)[WI!=XYE4V&HF"D?+#W\8"35)OZ T6$_J#G=>5D1@]R
MHGM@9[CPF1P7=I8++^2Y39[PU$T'GOM;V2EG9[KP<JX++7X*O2 >L%IU*$0C
ML)WQPB<Y+QR:JA\-H"S..Q_Y$L#.>.&T\WX6.-5K8;U.GNJ:SECA,SDK[*P5
M7LA;X= VP_G 6W^G.J7LS!5>SEVAQ3=#%,3GI#891#,[*NK<%3W)79NH_JII
MUGLCCDP6410%9T1N;X5NMD=Z>;NG3(*<['24=QWI*8GCCN-XHOBA7K1ON=(.
M6Q]F>I=&A!'H^SO.U>.)V0>T^[[5_U!+ P04    " !P@JE4V>B)*TL#  "<
M"P  &0   'AL+W=O<FMS:&5E=',O<VAE970V,RYX;6R]5MMNVS@0_15"V (M
MD%@W7]+"-I#8S39 V@9)NONPZ ,MC6TBO*@D;2= /[Y#2I&=K,/-!FW]8)'B
MG)DS%XYFN%'ZQBP!++D57)I1M+2V>A?'IEB"H*:C*I!X,E=:4(M;O8A-I8&6
M'B1XG"5)/Q:4R6@\].\N]'BH5I8S"1>:F)405-^= %>;491&]R\NV6)IW8MX
M/*SH J[ ?JDN-.[B5DO)!$C#E"0:YJ/H.'TW27L.X"7^8K Q.VOB7)DI=>,V
M9^4H2APCX%!8IX+B8PT3X-QI0A[?&J51:],!=]?WVD^]\^C,C!J8*/XW*^UR
M%!U%I(0Y77%[J38?H''($RP4-_Z?;!K9)"+%RE@E&C R$$S63WK;!&('D':?
M &0-('LN(&\ N7>T9N;=FE)+QT.M-D0[:=3F%CXV'HW>,.G2>&4UGC+$V?$Y
M[@U1<S+14#)+J"S)N9*+PVO0@DQA9LDA>2QT2(Y+?&(:*"=GLBXFEY374["4
M<?,&12YAK?B:R86'/T!_N9J2UW^\&<86/7 \XJ)A>U*SS9Y@^Y'J#LG3 Y(E
M6;8'/@G#IU"T\/0A/,:XM<'+VN!E7E_W"7W7FDI#/J\I^1,D6%:8 W(^(=_)
M*=/&DD^T"=$)E3<N )\%7=* W;RUFWN[>2!I.P$]I07CS-Z1?_S!F05AO@;,
M=%LSW:![]V:*VLR\,7/@ZH^)E2 SI5&E2W%!*SRU=_M26AOI>R.NJZS'O<3_
MAO%Z#[M>RZ[W,G9,6M" \=?4 J&65*"9*@G(<A^]L)6\TTM>!6+9;]GV7\86
M6ZNQ>.M<%&>44UG /I;]?P5Q&[ZZ]$,2#R@/6LJ#EU$N5EJ#M,],_^#_I?^H
M97?T\^\>'G]DTM5N(*5O6P9O?^4M3)-MBTZ"KOHNS*2Q>H4?4/NHP@\(UH^%
MTI5Y@<?X\=W;6,,V\DX2K/-TYX.2!C6]OP51<:IW\^(3<RSP'A94DBO'UR<F
M9'#;A-/LE^9AVW73_'?TP\;*[HT8!"Y$NFW7:;A?_YPZ"=OH_E>=;-MW^L+^
M_<R.V*@/M<2@2$T[WAF=W-R*$\8"0T@XS!&3= :H0M>C8+VQJO+3U$Q9G,W\
M<HGC,V@G@.=SI>S]Q@UH[4 ^_@%02P,$%     @ <(*I5+J#-Y?R @  U D
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MA##GRT3?B?47*!/R#=],)*KX)>LRUK'(;*FT2$LP*DCC;///GTHC=@"8:#.
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MLPND"<#QN<!]6W;,Q5X]Y(;_ %!+ P04    " !P@JE4R)"*[UT'   G(@
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MY^;CEM&$"3T OE]SV '-A9Y@]V[(Y?\ 4$L#!!0    ( '""J51SI^WPJ (
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M&73.*6NZ[HZU@6KE&LQ<(;4K-\SI00%M'6A]H>C>-X;=H'VBAG\!4$L#!!0
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M*SNP43D'>[Z2TFP-=\'P"<A^ U!+ P04    " !P@JE4CJ2*;I<"   )!@
M&0   'AL+W=O<FMS:&5E=',O<VAE970W,2YX;6R55&UKVS 0_BN'&:R%+D[B
MO'0E"33MQC96*"W;/HQ]4.R++2I+KG1N6MB/WTEVW&PD@7VQI9/NN>>YT]UL
M8^R#*Q )GDNEW3PJB*J+.'9I@:5P/5.AYI.UL:4@WMH\=I5%D06G4L7#?G\2
MET+J:#$+MEN[F)F:E-1X:\'592GLRQ*5V<RC0;0UW,F\(&^(%[-*Y'B/]*VZ
MM;R+.Y1,EJB=-!HLKN?1Y>!B.?'WPX7O$C=N9PU>R<J8![_YG,VCOB>$"E/R
M"()_3WB%2GD@IO'88D9=2.^XN]ZB?PS:6<M*.+PRZH?,J)A'YQ%DN!:UHCNS
M^82MGK''2XURX0N;]FX_@K1V9,K6F1F44C=_\=SF8<<A.>0P;!V&@7<3*+"\
M%B06,VLV8/UM1O.+(#5X,SFI?5'NR?*I9#]:W!?"8F%4AM:]A0^/M:07> ?!
M#%]19U+G<)E;1*X$P<DUDI#*G<YBXN@>(T[;2,LFTO! I '<&$V%@P\ZP^QO
M_YA9=]2'6^K+X5' +[7J03(X@V%_</X&8G">M&N^1_"3+C5)P$\.X+?)^'FY
M<F3Y]?PZ@CGJ,$<!<W0 <VDL>V#6<CT#79<KM""=J]EZ(G5[<@J_89^2)C%-
MD'$(XMON:3$=3=^/DL$L?MK#;MRQ&Q]EUU1=M547VZJ?>5-.!9@U$'<D\"QH
MR0$96"%W)]56LX"ZXDXCM/Q2A>^Z?>2/<QA#)EZ.E6_2B9G\7ZJK>J5DRB+6
M:+V^RLH4H<)62TA^[;)7BZ_!Z[O:)Z5A,-VIPR#I)=-_JA#OM&>)-@]#R$%J
M:DU-IW;6;LY=-NW]>KT9DC?"YE([+LB:7?N]*2?3-H.GV9"I0K.O#/'H",N"
M9S5:?X'/U\;0=N,#=--_\0=02P,$%     @ <(*I5*6(6H K P  % L  !D
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MF61B)VJ0N@&I^\8&]@)3[Z:!1&U(AG^4QC-]R;YZA)OV]8.4?KU]]'##OD%
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M)HF)MP&/#-9J:TU,)C,AGHSQ/1\ZGA$$)<RU8:#X>88)E*4A0AE_6TZG.](
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M!"LEF]G:&%K4=CS-A,9A9Y<%/D<@30#N+X30&\,<T#UPV3]02P,$%     @
M<(*I5(V 9/,1 P  UPD  !D   !X;"]W;W)K<VAE971S+W-H965T-SDN>&UL
MG99=;]HP%(;_BA7MHI5H$SL)(14@M:!IDUH-]6.[F'9AP!"O3IS9!MI_/]M)
M VL<J'9#8L?O><Y[B(\SW''Q+#-"%'C)62%'7J94>>7[<I&1',M+7I)"/UEQ
MD6.EAV+MRU(0O+2BG/DH"/I^CFGAC8=V;B;&0[Y1C!9D)H#<Y#D6KS>$\=W(
M@][;Q#U=9\I,^.-AB=?D@:BG<B;TR&^B+&E."DEY 019C;QK>#6!D1'8%=\I
MV<F#>V"LS#E_-H.ORY$7F(P((PME0F!]V9()8<Q$TGG\J8-Z#=,(#^_?HG^V
MYK69.99DPMD/NE39R!MX8$E6>,/4/=]](;6AV,1;<";M+]C5:P,/+#92\;P6
MZPQR6E17_%(7XD"@C;H%J!:@CPK"6A!:HU5FUM84*SP>"KX#PJS6T<R-K8U5
M:S>T,'_C@Q+Z*=4Z-?Y6$H$5+=;@ENAJ2' ![K#:"*JH'O!5-0UN*9Y35DV>
M38G"E,ESO?;I80K./IV#3X 6X#'C&XF+I1SZ2J=F /ZB3N.F2@-UI'&'Q24(
M80^@ "&'?')</B6+1@[_E?NZ($U54%,59..%'?%NB92$],"[ZO2:.KSVP R_
MZM=9]<!T0\#/Z[E40K^3OX[0PX8>6GK40>^HP4VEZEN5V9[;,8(P&?I;!RMJ
M6-$I5NAB5:KXD!7#U,V*&U9\BA6Y6+&#A09N5K]A]4^Q8A>KWV:AN,-7TK"2
M4ZR^BY6T6#!).GP-&M;@%"MQL09M5AC%;E;:L-*CK,>,Z)-AI8AP$=,6,40I
M<A-AL&]'P7$F5Y@Y^T?0=A@/PHYRPH/^!X\"9X)(O8W!%C.]C_'RM^ZY9E\[
M<X"M'"ZB) HZ<MAW&XC^TS1JFX9!VF5ZWV#@\0XSV0AA3)=<V,-4]WEF^SS;
M]WEG/J'C3TCW_NM>W6Y4,(YA1]+[3@6/MZI;7JPO],N8'Z;-FP[],0-1*[4T
M#@;O#3A7O7^W_8-3UWSRZ#-L30NI$UEI67"9Z#*)ZBNB&BA>VH-XSI4^UNUM
MIK^\B# +]/,5Y^IM8,[VYEMN_!=02P,$%     @ <(*I5'L?8)LQ @  D04
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MQ0]+:ORH70#MYTK9S<0EZ/]*DG]02P,$%     @ <(*I5'$UZ$-^!   LQ$
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M<D7)G(H<H+]?<*Y>;O(%ZL/B\?]02P,$%     @ <(*I5,NR'T/( @   P@
M !D   !X;"]W;W)K<VAE971S+W-H965T.#<N>&ULM551;]HP$/XK5M1)K;22
MD 0*%2 5Z+1*[81@W1ZF/9CD2*PZ=F8[T/[[V4[(@(:H+WM);.>^[[[S7>Y&
M.RY>9 J@T&M&F1P[J5+YK>O**(4,RP[/@>DO&RXRK/16)*[,!>#8@C+J^I[7
M=S-,F#,9V;.%F(QXH2AAL!!(%EF&Q=L4*-^-G:ZS/UB2)%7FP)V,<IS "M1S
MOA!ZY]8L,<F 2<(9$K 9.W?=V_G0V%N#'P1V\F"-3"1KSE_,YB$>.YX1!!0B
M91BP?FUA!I0:(BWC3\7IU"X-\'"]9_]B8]>QK+&$&:<_2:S2L3-P4 P;7%"U
MY+NO4,73,WP1I](^T:ZT[0\=%!52\:P":P498>4;OU;W< #0/,T OP+XIX#P
M#""H ,%' 6$%".W-E*'8>YACA2<CP7=(&&O-9A;V,BU:AT^82?M*"?V5:)R:
MK"#125027:.[."8F%YBB!U86E,G,Y1P4)E1>:9/GU1Q=7ERA"T08^I[R0F(6
MRY&KM!+#YT:5UVGIU3_C-4!/G*E4HGL60WR,=W4$=1C^/HRIWTKXA$4'!=W/
MR/=\OT'/[./P;@-\W@Z?0W0.?A1-4"<EL'SA&;[[5\ARBD4+55A3A98J:,\O
M6D+.A2(L.<KMKT=MCAX49/)WB[->[:S7JGL!(M+.=+M ?*.;PA98 0@K)<BZ
M4'A- 2E>536(IK)IY^\&'<_[U)3>=MR@$Y["CN+KU_'U6WF^<7;]O&HANJF)
M;OY_5@:ULT&KZD?.DFNJNVN,L)2@&O_7DJ)O*<RHV$[";C@8N=O#OZ#!*.P'
MM=&1NF&M;MBJ;EE62:.HX3M_OM<[UC1[;S,<GBAR#]JCKKO$CAF)(EXP5;:8
M^K2>9'>V@9^<3[NWLW(@_:,IQZ-N( EA$E'8:$JO<Z,+4I0CI]PHGMLFO.9*
M%[]=IGI*@S &^ON&<[7?& ?UW)_\!5!+ P04    " !P@JE41YK;']\!   B
M!   &0   'AL+W=O<FMS:&5E=',O<VAE970X."YX;6Q]E&UOFS 0Q[^*Y==;
M34C2;15!:EBG3=JF*-7:EY,#!U@U-K6/T'W[V88P5C5Y@^_L^_WOS@\DO39/
MM@9 \M)(93>T1FQO&+-Y#0VW5[H%Y59*;1J.SC45LZT!7@2HD2R.HFO6<*%H
MFH2YG4D3W:$4"G:&V*YIN/FS!:G[#5W0T\1>5#7Z"98F+:_@'O!7NS/.8Y-*
M(1I05FA%#)0;>KNXR6(?'P(>!/1V9A/?R4'K)^]\*S8T\@6!A!R] G?#$3*0
MT@NY,IY'33JE].#</JE_";V[7@[<0J;EHRBPWM"/E!10\D[B7O=?8>QG[?5R
M+6WXDGZ(77VB).\LZF:$706-4,/(7\9]F 'KQ1D@'H'X%;!8G@&6([ ,C0Z5
MA;8^<^1I8G1/C(]V:MX(>Q-HUXU0_A3OT;A5X3A,O_,#R(2AD_(3+!^Q[67L
M3H([2GP#S 8P/@,^<-G!_QAS)4]UQU/=<=!9G='9@T4C<H2"9-S6A*O1N'ON
MQ)%+5YQ]1WYJE7?&O%WI]G*&SKZO.&]__\OD]6]5&&99+N;(AAS7(8=_4<=T
M%2^C*$K8<=X]FYV@?ST_N*F$LD1"Z<#HZL.:$C/<R,%!W8;3.6AT5R28M7O$
M8'R 6R^UQI/C[\GT6TC_ E!+ P04    " !P@JE4)JW9RA0#   2$0  #0
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M*8GC-/4C@/D5Q#&&P-.((Y@"T( A<6S/P8/S*.K.J6C[*\CT%U!+ P04
M" !P@JE4EXJ[',     3 @  "P   %]R96QS+RYR96QSG9*Y;L,P#$!_Q=">
M, ?0(8@S9?$6!/D!5J(/V!(%BD6=OZ_:I7&0"QEY/3P2W!YI0.TXI+:+J1C]
M$%)I6M6X 4BV)8]ISI%"KM0L'C6'TD!$VV-#L%HL/D N&6:WO606IW.D5XA<
MUYVE/=LO3T%O@*\Z3'%":4A+,P[PS=)_,O?S##5%Y4HCE5L:>-/E_G;@2=&A
M(E@6FD7)TZ(=I7\=Q_:0T^FO8R*T>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X
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M:T61M:+(6E%DK?ZGK#_&\?"/XY=GVIMV>,[/EK^3W/P"4$L! A0#%     @
M<(*I5 =!36*!    L0   !               ( !     &1O8U!R;W!S+V%P
M<"YX;6Q02P$"% ,4    " !P@JE4)GT,3.\    K @  $0
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M965T-"YX;6Q02P$"% ,4    " !P@JE4ZJ@".]X"  """0  &
M    @(','P  >&PO=V]R:W-H965T<R]S:&5E=#4N>&UL4$L! A0#%     @
M<(*I5/?[P]?D @  L0<  !@              ("!X"(  'AL+W=O<FMS:&5E
M=',O<VAE970V+GAM;%!+ 0(4 Q0    ( '""J52AU'OKB 8  .@=   8
M          " @?HE  !X;"]W;W)K<VAE971S+W-H965T-RYX;6Q02P$"% ,4
M    " !P@JE4R?@R-"()   !*0  &               @(&X+   >&PO=V]R
M:W-H965T<R]S:&5E=#@N>&UL4$L! A0#%     @ <(*I5*<26"_/!@  >!
M !@              ("!$#8  'AL+W=O<FMS:&5E=',O<VAE970Y+GAM;%!+
M 0(4 Q0    ( '""J53;[_NR\!    0M   9              " @14]  !X
M;"]W;W)K<VAE971S+W-H965T,3 N>&UL4$L! A0#%     @ <(*I5%TRJ] T
M!P  7Q0  !D              ("!/$X  'AL+W=O<FMS:&5E=',O<VAE970Q
M,2YX;6Q02P$"% ,4    " !P@JE4/F#SB'\&  !;%P  &0
M@(&G50  >&PO=V]R:W-H965T<R]S:&5E=#$R+GAM;%!+ 0(4 Q0    ( '""
MJ52R!P*K@0@  )H6   9              " @5U<  !X;"]W;W)K<VAE971S
M+W-H965T,3,N>&UL4$L! A0#%     @ <(*I5(<_(V): P  BP@  !D
M         ("!%64  'AL+W=O<FMS:&5E=',O<VAE970Q-"YX;6Q02P$"% ,4
M    " !P@JE489]LHF4%   )#@  &0              @(&F:   >&PO=V]R
M:W-H965T<R]S:&5E=#$U+GAM;%!+ 0(4 Q0    ( '""J51HP+NG= (  #,%
M   9              " @4)N  !X;"]W;W)K<VAE971S+W-H965T,38N>&UL
M4$L! A0#%     @ <(*I5*:!3=@H P  !P<  !D              ("![7
M 'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6Q02P$"% ,4    " !P@JE4TO_*
M P,$  "'"0  &0              @(%,=   >&PO=V]R:W-H965T<R]S:&5E
M=#$X+GAM;%!+ 0(4 Q0    ( '""J53TD=/5SPT   8F   9
M  " @89X  !X;"]W;W)K<VAE971S+W-H965T,3DN>&UL4$L! A0#%     @
M<(*I5-O:XH"B!0  H0T  !D              ("!C(8  'AL+W=O<FMS:&5E
M=',O<VAE970R,"YX;6Q02P$"% ,4    " !P@JE4KJ#<ZJ($  !X"@  &0
M            @(%EC   >&PO=V]R:W-H965T<R]S:&5E=#(Q+GAM;%!+ 0(4
M Q0    ( '""J50!]H*!? @   $7   9              " @3Z1  !X;"]W
M;W)K<VAE971S+W-H965T,C(N>&UL4$L! A0#%     @ <(*I5$;4A )9!
MY0D  !D              ("!\9D  'AL+W=O<FMS:&5E=',O<VAE970R,RYX
M;6Q02P$"% ,4    " !P@JE4UA_DD[D.  !4)P  &0              @(&!
MG@  >&PO=V]R:W-H965T<R]S:&5E=#(T+GAM;%!+ 0(4 Q0    ( '""J50[
MA, Z]@,  *0)   9              " @7&M  !X;"]W;W)K<VAE971S+W-H
M965T,C4N>&UL4$L! A0#%     @ <(*I5 =XZ![S!P  @A4  !D
M     ("!GK$  'AL+W=O<FMS:&5E=',O<VAE970R-BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( '""J50L%@81D@,  #4)   9              "
M@4C1  !X;"]W;W)K<VAE971S+W-H965T,S$N>&UL4$L! A0#%     @ <(*I
M5!<R;JX, P  5 @  !D              ("!$=4  'AL+W=O<FMS:&5E=',O
M<VAE970S,BYX;6Q02P$"% ,4    " !P@JE4&*P$SX4"   ^!0  &0
M        @(%4V   >&PO=V]R:W-H965T<R]S:&5E=#,S+GAM;%!+ 0(4 Q0
M   ( '""J53>T8IE$P,  )T&   9              " @1#;  !X;"]W;W)K
M<VAE971S+W-H965T,S0N>&UL4$L! A0#%     @ <(*I5$S&&XR7 P  F @
M !D              ("!6MX  'AL+W=O<FMS:&5E=',O<VAE970S-2YX;6Q0
M2P$"% ,4    " !P@JE4"-UI(*X#  "Q"   &0              @($HX@
M>&PO=V]R:W-H965T<R]S:&5E=#,V+GAM;%!+ 0(4 Q0    ( '""J50IVG(C
M>@(  +,%   9              " @0WF  !X;"]W;W)K<VAE971S+W-H965T
M,S<N>&UL4$L! A0#%     @ <(*I5/:TBC68 @  F 4  !D
M ("!ON@  'AL+W=O<FMS:&5E=',O<VAE970S."YX;6Q02P$"% ,4    " !P
M@JE4#+'+%1L$  "C"0  &0              @(&-ZP  >&PO=V]R:W-H965T
M<R]S:&5E=#,Y+GAM;%!+ 0(4 Q0    ( '""J52@7G!N\0,  %()   9
M          " @=_O  !X;"]W;W)K<VAE971S+W-H965T-# N>&UL4$L! A0#
M%     @ <(*I5"/X*OA"!0  \0T  !D              ("!!_0  'AL+W=O
M<FMS:&5E=',O<VAE970T,2YX;6Q02P$"% ,4    " !P@JE40GD8NYX"  !S
M!@  &0              @(& ^0  >&PO=V]R:W-H965T<R]S:&5E=#0R+GAM
M;%!+ 0(4 Q0    ( '""J527*!=D+P(  +P$   9              " @57\
M  !X;"]W;W)K<VAE971S+W-H965T-#,N>&UL4$L! A0#%     @ <(*I5%F<
MR@<_ P  @ L  !D              ("!N_X  'AL+W=O<FMS:&5E=',O<VAE
M970T-"YX;6Q02P$"% ,4    " !P@JE42]0O?]<#   A#@  &0
M    @($Q @$ >&PO=V]R:W-H965T<R]S:&5E=#0U+GAM;%!+ 0(4 Q0    (
M '""J50&,T-L#@,  .@(   9              " @3\& 0!X;"]W;W)K<VAE
M971S+W-H965T-#8N>&UL4$L! A0#%     @ <(*I5*1'6Q'V @  ; @  !D
M             ("!A D! 'AL+W=O<FMS:&5E=',O<VAE970T-RYX;6Q02P$"
M% ,4    " !P@JE428'5[GX#  !3"@  &0              @(&Q# $ >&PO
M=V]R:W-H965T<R]S:&5E=#0X+GAM;%!+ 0(4 Q0    ( '""J53<*;M%$P0
M %P/   9              " @680 0!X;"]W;W)K<VAE971S+W-H965T-#DN
M>&UL4$L! A0#%     @ <(*I5-ED8"DT!   VQ   !D              ("!
ML!0! 'AL+W=O<FMS:&5E=',O<VAE970U,"YX;6Q02P$"% ,4    " !P@JE4
MZ6UP[1X#  #J"P  &0              @($;&0$ >&PO=V]R:W-H965T<R]S
M:&5E=#4Q+GAM;%!+ 0(4 Q0    ( '""J53]3X5 10,  !8,   9
M      " @7 < 0!X;"]W;W)K<VAE971S+W-H965T-3(N>&UL4$L! A0#%
M  @ <(*I5.WN]&&. P  JPT  !D              ("![!\! 'AL+W=O<FMS
M:&5E=',O<VAE970U,RYX;6Q02P$"% ,4    " !P@JE4:PN--U<"   9!0
M&0              @(&Q(P$ >&PO=V]R:W-H965T<R]S:&5E=#4T+GAM;%!+
M 0(4 Q0    ( '""J50<ROQ*+@0   47   9              " @3\F 0!X
M;"]W;W)K<VAE971S+W-H965T-34N>&UL4$L! A0#%     @ <(*I5)GFU"2_
M @  ' <  !D              ("!I"H! 'AL+W=O<FMS:&5E=',O<VAE970U
M-BYX;6Q02P$"% ,4    " !P@JE4O<%#/KP"  !O"0  &0
M@(&:+0$ >&PO=V]R:W-H965T<R]S:&5E=#4W+GAM;%!+ 0(4 Q0    ( '""
MJ50&H#+-@P,  '(+   9              " @8TP 0!X;"]W;W)K<VAE971S
M+W-H965T-3@N>&UL4$L! A0#%     @ <(*I5/+ZJ?%) @  .P4  !D
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M=#8S+GAM;%!+ 0(4 Q0    ( '""J52Z@S>7\@(  -0)   9
M  " @0M$ 0!X;"]W;W)K<VAE971S+W-H965T-C0N>&UL4$L! A0#%     @
M<(*I5,B0BN]=!P  )R(  !D              ("!-$<! 'AL+W=O<FMS:&5E
M=',O<VAE970V-2YX;6Q02P$"% ,4    " !P@JE4<Z?M\*@"  "N!@  &0
M            @('(3@$ >&PO=V]R:W-H965T<R]S:&5E=#8V+GAM;%!+ 0(4
M Q0    ( '""J50RP0\Y?@(  /<&   9              " @:=1 0!X;"]W
M;W)K<VAE971S+W-H965T-C<N>&UL4$L! A0#%     @ <(*I5/L)6[0T P
MC0H  !D              ("!7%0! 'AL+W=O<FMS:&5E=',O<VAE970V."YX
M;6Q02P$"% ,4    " !P@JE4W/OJ9]\"   E"0  &0              @(''
M5P$ >&PO=V]R:W-H965T<R]S:&5E=#8Y+GAM;%!+ 0(4 Q0    ( '""J51+
MJA+Y<P(   X&   9              " @=U: 0!X;"]W;W)K<VAE971S+W-H
M965T-S N>&UL4$L! A0#%     @ <(*I5(ZDBFZ7 @  "08  !D
M     ("!AUT! 'AL+W=O<FMS:&5E=',O<VAE970W,2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( '""J51#@:=AH ,  $H,   9              "
M@4!Q 0!X;"]W;W)K<VAE971S+W-H965T-S8N>&UL4$L! A0#%     @ <(*I
M5*A4R%U: @  ]@8  !D              ("!%W4! 'AL+W=O<FMS:&5E=',O
M<VAE970W-RYX;6Q02P$"% ,4    " !P@JE4LH-2H8P"  #L!@  &0
M        @(&H=P$ >&PO=V]R:W-H965T<R]S:&5E=#<X+GAM;%!+ 0(4 Q0
M   ( '""J52-@&3S$0,  -<)   9              " @6MZ 0!X;"]W;W)K
M<VAE971S+W-H965T-SDN>&UL4$L! A0#%     @ <(*I5'L?8)LQ @  D04
M !D              ("!LWT! 'AL+W=O<FMS:&5E=',O<VAE970X,"YX;6Q0
M2P$"% ,4    " !P@JE4'\47X*<"  !6!@  &0              @($;@ $
M>&PO=V]R:W-H965T<R]S:&5E=#@Q+GAM;%!+ 0(4 Q0    ( '""J51Q->A#
M?@0  +,1   9              " @?F" 0!X;"]W;W)K<VAE971S+W-H965T
M.#(N>&UL4$L! A0#%     @ <(*I5)7K<F&Y @  80<  !D
M ("!KH<! 'AL+W=O<FMS:&5E=',O<VAE970X,RYX;6Q02P$"% ,4    " !P
M@JE4M=1SH.@"  #%"0  &0              @(&>B@$ >&PO=V]R:W-H965T
M<R]S:&5E=#@T+GAM;%!+ 0(4 Q0    ( '""J50&9HGDW@4  %@:   9
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M;',O+G)E;'-02P$"% ,4    " !P@JE4+,4GSET&   ,.@  #P
M    @ &HH0$ >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ <(*I5,,EV4B4
M @  WS,  !H              ( !,J@! 'AL+U]R96QS+W=O<FMB;V]K+GAM
M;"YR96QS4$L! A0#%     @ <(*I5(V<RZLT @  5C(  !,
M ( !_JH! %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&     &  8 !7&@  8ZT!
#

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>237</ContextCount>
  <ElementCount>360</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>90</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>9</UnitCount>
  <MyReports>
    <Report instance="pgen-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dna.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="pgen-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - Condensed Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dna.com/role/CondensedConsolidatedBalanceSheets</Role>
      <ShortName>Condensed Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="pgen-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dna.com/role/CondensedConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="pgen-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - Condensed Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dna.com/role/CondensedConsolidatedStatementsofOperations</Role>
      <ShortName>Condensed Consolidated Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="pgen-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - Condensed Consolidated Statements of Operations (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dna.com/role/CondensedConsolidatedStatementsofOperationsParenthetical</Role>
      <ShortName>Condensed Consolidated Statements of Operations (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="pgen-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - Condensed Consolidated Statements of Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dna.com/role/CondensedConsolidatedStatementsofComprehensiveLoss</Role>
      <ShortName>Condensed Consolidated Statements of Comprehensive Loss</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="pgen-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1006007 - Statement - Condensed Consolidated Statements of Shareholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dna.com/role/CondensedConsolidatedStatementsofShareholdersEquity</Role>
      <ShortName>Condensed Consolidated Statements of Shareholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="pgen-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>1007008 - Statement - Condensed Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="pgen-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - Organization</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dna.com/role/Organization</Role>
      <ShortName>Organization</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="pgen-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2102102 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dna.com/role/SummaryofSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="pgen-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2109103 - Disclosure - Discontinued Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dna.com/role/DiscontinuedOperations</Role>
      <ShortName>Discontinued Operations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="pgen-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2114104 - Disclosure - Investments in Joint Ventures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dna.com/role/InvestmentsinJointVentures</Role>
      <ShortName>Investments in Joint Ventures</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="pgen-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2117105 - Disclosure - Collaboration and Licensing Revenue</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dna.com/role/CollaborationandLicensingRevenue</Role>
      <ShortName>Collaboration and Licensing Revenue</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="pgen-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2121106 - Disclosure - Short-term and Long-term Investments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dna.com/role/ShorttermandLongtermInvestments</Role>
      <ShortName>Short-term and Long-term Investments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="pgen-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2125107 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dna.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="pgen-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2129108 - Disclosure - Inventory</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dna.com/role/Inventory</Role>
      <ShortName>Inventory</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="pgen-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2132109 - Disclosure - Property, Plant and Equipment, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dna.com/role/PropertyPlantandEquipmentNet</Role>
      <ShortName>Property, Plant and Equipment, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="pgen-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2136110 - Disclosure - Goodwill and Intangible Assets, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dna.com/role/GoodwillandIntangibleAssetsNet</Role>
      <ShortName>Goodwill and Intangible Assets, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="pgen-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2141111 - Disclosure - Lines of Credit and Long-Term Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dna.com/role/LinesofCreditandLongTermDebt</Role>
      <ShortName>Lines of Credit and Long-Term Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="pgen-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2148112 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dna.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="pgen-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2152113 - Disclosure - Shareholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dna.com/role/ShareholdersEquity</Role>
      <ShortName>Shareholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="pgen-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2157114 - Disclosure - Share-Based Payments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dna.com/role/ShareBasedPayments</Role>
      <ShortName>Share-Based Payments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="pgen-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2163115 - Disclosure - Operating Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dna.com/role/OperatingLeases</Role>
      <ShortName>Operating Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="pgen-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2170116 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dna.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="pgen-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2172117 - Disclosure - Related Party Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dna.com/role/RelatedPartyTransactions</Role>
      <ShortName>Related Party Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="pgen-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2174118 - Disclosure - Segments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dna.com/role/Segments</Role>
      <ShortName>Segments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="pgen-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2203201 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dna.com/role/SummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.dna.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="pgen-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2304301 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dna.com/role/SummaryofSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.dna.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="pgen-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2310302 - Disclosure - Discontinued Operations (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dna.com/role/DiscontinuedOperationsTables</Role>
      <ShortName>Discontinued Operations (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.dna.com/role/DiscontinuedOperations</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="pgen-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2318303 - Disclosure - Collaboration and Licensing Revenue (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dna.com/role/CollaborationandLicensingRevenueTables</Role>
      <ShortName>Collaboration and Licensing Revenue (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.dna.com/role/CollaborationandLicensingRevenue</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="pgen-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2322304 - Disclosure - Short-term and Long-term Investments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dna.com/role/ShorttermandLongtermInvestmentsTables</Role>
      <ShortName>Short-term and Long-term Investments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.dna.com/role/ShorttermandLongtermInvestments</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="pgen-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2326305 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dna.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.dna.com/role/FairValueMeasurements</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="pgen-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2330306 - Disclosure - Inventory (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dna.com/role/InventoryTables</Role>
      <ShortName>Inventory (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.dna.com/role/Inventory</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="pgen-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2333307 - Disclosure - Property, Plant and Equipment, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dna.com/role/PropertyPlantandEquipmentNetTables</Role>
      <ShortName>Property, Plant and Equipment, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.dna.com/role/PropertyPlantandEquipmentNet</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="pgen-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2337308 - Disclosure - Goodwill and Intangible Assets, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dna.com/role/GoodwillandIntangibleAssetsNetTables</Role>
      <ShortName>Goodwill and Intangible Assets, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.dna.com/role/GoodwillandIntangibleAssetsNet</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="pgen-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2342309 - Disclosure - Lines of Credit and Long-Term Debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dna.com/role/LinesofCreditandLongTermDebtTables</Role>
      <ShortName>Lines of Credit and Long-Term Debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.dna.com/role/LinesofCreditandLongTermDebt</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="pgen-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2349310 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dna.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.dna.com/role/IncomeTaxes</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="pgen-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2353311 - Disclosure - Shareholders' Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dna.com/role/ShareholdersEquityTables</Role>
      <ShortName>Shareholders' Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.dna.com/role/ShareholdersEquity</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="pgen-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2358312 - Disclosure - Share-Based Payments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dna.com/role/ShareBasedPaymentsTables</Role>
      <ShortName>Share-Based Payments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.dna.com/role/ShareBasedPayments</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="pgen-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2364313 - Disclosure - Operating Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dna.com/role/OperatingLeasesTables</Role>
      <ShortName>Operating Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.dna.com/role/OperatingLeases</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="pgen-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2375314 - Disclosure - Segments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dna.com/role/SegmentsTables</Role>
      <ShortName>Segments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.dna.com/role/Segments</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="pgen-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2405401 - Disclosure - Summary of Significant Accounting Policies - Liquidity - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dna.com/role/SummaryofSignificantAccountingPoliciesLiquidityAdditionalInformationDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Liquidity - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="pgen-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2406402 - Disclosure - Summary of Significant Accounting Policies - Variable Interest Entities - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dna.com/role/SummaryofSignificantAccountingPoliciesVariableInterestEntitiesAdditionalInformationDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Variable Interest Entities - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="pgen-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2407403 - Disclosure - Summary of Significant Accounting Policies - Net Loss Per Share - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dna.com/role/SummaryofSignificantAccountingPoliciesNetLossPerShareAdditionalInformationDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Net Loss Per Share - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="pgen-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2408404 - Disclosure - Summary of Significant Accounting Policies - Recently Adopted Accounting Pronouncements - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dna.com/role/SummaryofSignificantAccountingPoliciesRecentlyAdoptedAccountingPronouncementsAdditionalInformationDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Recently Adopted Accounting Pronouncements - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="pgen-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2411405 - Disclosure - Discontinued Operations - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dna.com/role/DiscontinuedOperationsNarrativeDetails</Role>
      <ShortName>Discontinued Operations - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="pgen-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2412406 - Disclosure - Discontinued Operations - Summary of Financial Results for MBP Titan (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dna.com/role/DiscontinuedOperationsSummaryofFinancialResultsforMBPTitanDetails</Role>
      <ShortName>Discontinued Operations - Summary of Financial Results for MBP Titan (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="pgen-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2413407 - Disclosure - Discontinued Operations - Non-cash Items and Purchases of Property, Plant and Equipment for MBP Titan (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dna.com/role/DiscontinuedOperationsNoncashItemsandPurchasesofPropertyPlantandEquipmentforMBPTitanDetails</Role>
      <ShortName>Discontinued Operations - Non-cash Items and Purchases of Property, Plant and Equipment for MBP Titan (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="pgen-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2415408 - Disclosure - Investments in Joint Ventures - Intrexon Energy Partners - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dna.com/role/InvestmentsinJointVenturesIntrexonEnergyPartnersAdditionalInformationDetails</Role>
      <ShortName>Investments in Joint Ventures - Intrexon Energy Partners - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="pgen-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2416409 - Disclosure - Investments in Joint Ventures - Intrexon Energy Partners II - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dna.com/role/InvestmentsinJointVenturesIntrexonEnergyPartnersIIAdditionalInformationDetails</Role>
      <ShortName>Investments in Joint Ventures - Intrexon Energy Partners II - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="pgen-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2419410 - Disclosure - Collaboration and Licensing Revenue - Summarized Collaboration and Licensing Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dna.com/role/CollaborationandLicensingRevenueSummarizedCollaborationandLicensingRevenueDetails</Role>
      <ShortName>Collaboration and Licensing Revenue - Summarized Collaboration and Licensing Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="pgen-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2420411 - Disclosure - Collaboration and Licensing Revenue - Summary of Deferred Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dna.com/role/CollaborationandLicensingRevenueSummaryofDeferredRevenueDetails</Role>
      <ShortName>Collaboration and Licensing Revenue - Summary of Deferred Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="pgen-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2423412 - Disclosure - Short-term and Long-term Investments - Summary of Amortized Cost, Gross Unrealized Gains and Losses, and Fair Value of Short-term and Long-term Investments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dna.com/role/ShorttermandLongtermInvestmentsSummaryofAmortizedCostGrossUnrealizedGainsandLossesandFairValueofShorttermandLongtermInvestmentsDetails</Role>
      <ShortName>Short-term and Long-term Investments - Summary of Amortized Cost, Gross Unrealized Gains and Losses, and Fair Value of Short-term and Long-term Investments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="pgen-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2424413 - Disclosure - Short-term and Long-term Investments - Contractual Obligation, Fiscal Year Maturity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dna.com/role/ShorttermandLongtermInvestmentsContractualObligationFiscalYearMaturityDetails</Role>
      <ShortName>Short-term and Long-term Investments - Contractual Obligation, Fiscal Year Maturity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="pgen-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2427414 - Disclosure - Fair Value Measurements - Summary of Placement in the Fair Value Hierarchy of Financial Assets that are Measured at Fair Value on a Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dna.com/role/FairValueMeasurementsSummaryofPlacementintheFairValueHierarchyofFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails</Role>
      <ShortName>Fair Value Measurements - Summary of Placement in the Fair Value Hierarchy of Financial Assets that are Measured at Fair Value on a Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="pgen-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2428415 - Disclosure - Fair Value Measurements - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dna.com/role/FairValueMeasurementsAdditionalInformationDetails</Role>
      <ShortName>Fair Value Measurements - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="pgen-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2431416 - Disclosure - Inventory (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dna.com/role/InventoryDetails</Role>
      <ShortName>Inventory (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.dna.com/role/InventoryTables</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="pgen-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2434417 - Disclosure - Property, Plant and Equipment, Net - Schedule of Property, Plant and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dna.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetails</Role>
      <ShortName>Property, Plant and Equipment, Net - Schedule of Property, Plant and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="pgen-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>2435418 - Disclosure - Property, Plant and Equipment, Net - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dna.com/role/PropertyPlantandEquipmentNetAdditionalInformationDetails</Role>
      <ShortName>Property, Plant and Equipment, Net - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="pgen-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>2438419 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Changes in Carrying Amount of Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dna.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesinCarryingAmountofGoodwillDetails</Role>
      <ShortName>Goodwill and Intangible Assets, Net - Schedule of Changes in Carrying Amount of Goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="pgen-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>2439420 - Disclosure - Goodwill and Intangible Assets, Net - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dna.com/role/GoodwillandIntangibleAssetsNetAdditionalInformationDetails</Role>
      <ShortName>Goodwill and Intangible Assets, Net - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="pgen-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>2440421 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dna.com/role/GoodwillandIntangibleAssetsNetScheduleofIntangibleAssetsDetails</Role>
      <ShortName>Goodwill and Intangible Assets, Net - Schedule of Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="pgen-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>2443422 - Disclosure - Lines of Credit and Long-Term Debt - Lines of Credit - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dna.com/role/LinesofCreditandLongTermDebtLinesofCreditAdditionalInformationDetails</Role>
      <ShortName>Lines of Credit and Long-Term Debt - Lines of Credit - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="pgen-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>2444423 - Disclosure - Lines of Credit and Long-Term Debt - Schedule of Long-Term Debt Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dna.com/role/LinesofCreditandLongTermDebtScheduleofLongTermDebtInstrumentsDetails</Role>
      <ShortName>Lines of Credit and Long-Term Debt - Schedule of Long-Term Debt Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="pgen-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>2445424 - Disclosure - Lines of Credit and Long-Term Debt - Long-Term Debt - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dna.com/role/LinesofCreditandLongTermDebtLongTermDebtAdditionalInformationDetails</Role>
      <ShortName>Lines of Credit and Long-Term Debt - Long-Term Debt - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="pgen-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>2446425 - Disclosure - Lines of Credit and Long-Term Debt - Schedule of Components of Interest Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dna.com/role/LinesofCreditandLongTermDebtScheduleofComponentsofInterestExpenseDetails</Role>
      <ShortName>Lines of Credit and Long-Term Debt - Schedule of Components of Interest Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="pgen-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>2447426 - Disclosure - Lines of Credit and Long-Term Debt - Schedule of Future Maturities of Long-Term Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dna.com/role/LinesofCreditandLongTermDebtScheduleofFutureMaturitiesofLongTermDebtDetails</Role>
      <ShortName>Lines of Credit and Long-Term Debt - Schedule of Future Maturities of Long-Term Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="pgen-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>2450427 - Disclosure - Income Taxes - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dna.com/role/IncomeTaxesNarrativeDetails</Role>
      <ShortName>Income Taxes - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="pgen-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>2451428 - Disclosure - Income Taxes - Components of Income Tax Benefits (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dna.com/role/IncomeTaxesComponentsofIncomeTaxBenefitsDetails</Role>
      <ShortName>Income Taxes - Components of Income Tax Benefits (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="pgen-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>2454429 - Disclosure - Shareholders' Equity - Issuances of Precigen Common Stock (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dna.com/role/ShareholdersEquityIssuancesofPrecigenCommonStockDetails</Role>
      <ShortName>Shareholders' Equity - Issuances of Precigen Common Stock (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="pgen-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>2455430 - Disclosure - Shareholders' Equity - Share Lending Agreement (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dna.com/role/ShareholdersEquityShareLendingAgreementDetails</Role>
      <ShortName>Shareholders' Equity - Share Lending Agreement (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="pgen-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>2456431 - Disclosure - Shareholders' Equity - Components of Accumulated Other Comprehensive Income (Loss) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dna.com/role/ShareholdersEquityComponentsofAccumulatedOtherComprehensiveIncomeLossDetails</Role>
      <ShortName>Shareholders' Equity - Components of Accumulated Other Comprehensive Income (Loss) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="pgen-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>2459432 - Disclosure - Share-Based Payments - Schedule of Stock-Based Compensation Costs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dna.com/role/ShareBasedPaymentsScheduleofStockBasedCompensationCostsDetails</Role>
      <ShortName>Share-Based Payments - Schedule of Stock-Based Compensation Costs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="pgen-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>2460433 - Disclosure - Share-Based Payments - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dna.com/role/ShareBasedPaymentsAdditionalInformationDetails</Role>
      <ShortName>Share-Based Payments - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="pgen-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>2461434 - Disclosure - Share-Based Payments - Schedule of Stock Option Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dna.com/role/ShareBasedPaymentsScheduleofStockOptionActivityDetails</Role>
      <ShortName>Share-Based Payments - Schedule of Stock Option Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="pgen-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>2462435 - Disclosure - Share-Based Payments - Schedule of Restricted Stock Unit Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dna.com/role/ShareBasedPaymentsScheduleofRestrictedStockUnitActivityDetails</Role>
      <ShortName>Share-Based Payments - Schedule of Restricted Stock Unit Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="pgen-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>2465436 - Disclosure - Operating Leases - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dna.com/role/OperatingLeasesAdditionalInformationDetails</Role>
      <ShortName>Operating Leases - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="pgen-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>2466437 - Disclosure - Operating Leases - Components of Lease Costs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dna.com/role/OperatingLeasesComponentsofLeaseCostsDetails</Role>
      <ShortName>Operating Leases - Components of Lease Costs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="pgen-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>2467438 - Disclosure - Operating Leases - Maturities of Lease Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dna.com/role/OperatingLeasesMaturitiesofLeaseLiabilitiesDetails</Role>
      <ShortName>Operating Leases - Maturities of Lease Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="pgen-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>2468439 - Disclosure - Operating Leases - Lease Terms and Discount Rates (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dna.com/role/OperatingLeasesLeaseTermsandDiscountRatesDetails</Role>
      <ShortName>Operating Leases - Lease Terms and Discount Rates (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="pgen-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>2469440 - Disclosure - Operating Leases - Other Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dna.com/role/OperatingLeasesOtherInformationDetails</Role>
      <ShortName>Operating Leases - Other Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="pgen-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>2471441 - Disclosure - Commitments and Contingencies - Contingencies - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dna.com/role/CommitmentsandContingenciesContingenciesAdditionalInformationDetails</Role>
      <ShortName>Commitments and Contingencies - Contingencies - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>82</Position>
    </Report>
    <Report instance="pgen-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>2473442 - Disclosure - Related Party Transactions - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dna.com/role/RelatedPartyTransactionsAdditionalInformationDetails</Role>
      <ShortName>Related Party Transactions - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>83</Position>
    </Report>
    <Report instance="pgen-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>2476443 - Disclosure - Segments - Adjusted EBITDA by Reportable Segment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dna.com/role/SegmentsAdjustedEBITDAbyReportableSegmentDetails</Role>
      <ShortName>Segments - Adjusted EBITDA by Reportable Segment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>84</Position>
    </Report>
    <Report instance="pgen-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>2477444 - Disclosure - Segments - Reconciliation of Net Loss Before Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dna.com/role/SegmentsReconciliationofNetLossBeforeIncomeTaxesDetails</Role>
      <ShortName>Segments - Reconciliation of Net Loss Before Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>85</Position>
    </Report>
    <Report instance="pgen-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>2478445 - Disclosure - Segments - Revenues by Reportable Segment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dna.com/role/SegmentsRevenuesbyReportableSegmentDetails</Role>
      <ShortName>Segments - Revenues by Reportable Segment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>86</Position>
    </Report>
    <Report instance="pgen-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>2479446 - Disclosure - Segments - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dna.com/role/SegmentsAdditionalInformationDetails</Role>
      <ShortName>Segments - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>87</Position>
    </Report>
    <Report instance="pgen-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9999.htm</HtmlFileName>
      <LongName>Uncategorized Items - pgen-20220331.htm</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/role/uncategorizedFacts</Role>
      <ShortName>Uncategorized Items - pgen-20220331.htm</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>88</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="pgen-20220331.htm">pgen-20220331.htm</File>
    <File>pgen-20220331.xsd</File>
    <File>pgen-20220331_cal.xml</File>
    <File>pgen-20220331_def.xml</File>
    <File>pgen-20220331_lab.xml</File>
    <File>pgen-20220331_pre.xml</File>
    <File>pgen-20220331xexx311.htm</File>
    <File>pgen-20220331xexx312.htm</File>
    <File>pgen-20220331xexx321.htm</File>
    <File>pgen-20220331xexx322.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="1">http://fasb.org/srt/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy items="758">http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy items="29">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>106
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "pgen-20220331.htm": {
   "axisCustom": 0,
   "axisStandard": 35,
   "contextCount": 237,
   "dts": {
    "calculationLink": {
     "local": [
      "pgen-20220331_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "pgen-20220331_def.xml"
     ]
    },
    "inline": {
     "local": [
      "pgen-20220331.htm"
     ]
    },
    "labelLink": {
     "local": [
      "pgen-20220331_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "pgen-20220331_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "pgen-20220331.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 611,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2021-01-31": 2,
    "http://www.dna.com/20220331": 1,
    "http://xbrl.sec.gov/dei/2021q4": 5,
    "total": 8
   },
   "keyCustom": 38,
   "keyStandard": 322,
   "memberCustom": 41,
   "memberStandard": 41,
   "nsprefix": "pgen",
   "nsuri": "http://www.dna.com/20220331",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover Page",
     "role": "http://www.dna.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2102102 - Disclosure - Summary of Significant Accounting Policies",
     "role": "http://www.dna.com/role/SummaryofSignificantAccountingPolicies",
     "shortName": "Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2109103 - Disclosure - Discontinued Operations",
     "role": "http://www.dna.com/role/DiscontinuedOperations",
     "shortName": "Discontinued Operations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2114104 - Disclosure - Investments in Joint Ventures",
     "role": "http://www.dna.com/role/InvestmentsinJointVentures",
     "shortName": "Investments in Joint Ventures",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2117105 - Disclosure - Collaboration and Licensing Revenue",
     "role": "http://www.dna.com/role/CollaborationandLicensingRevenue",
     "shortName": "Collaboration and Licensing Revenue",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2121106 - Disclosure - Short-term and Long-term Investments",
     "role": "http://www.dna.com/role/ShorttermandLongtermInvestments",
     "shortName": "Short-term and Long-term Investments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2125107 - Disclosure - Fair Value Measurements",
     "role": "http://www.dna.com/role/FairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2129108 - Disclosure - Inventory",
     "role": "http://www.dna.com/role/Inventory",
     "shortName": "Inventory",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2132109 - Disclosure - Property, Plant and Equipment, Net",
     "role": "http://www.dna.com/role/PropertyPlantandEquipmentNet",
     "shortName": "Property, Plant and Equipment, Net",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2136110 - Disclosure - Goodwill and Intangible Assets, Net",
     "role": "http://www.dna.com/role/GoodwillandIntangibleAssetsNet",
     "shortName": "Goodwill and Intangible Assets, Net",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2141111 - Disclosure - Lines of Credit and Long-Term Debt",
     "role": "http://www.dna.com/role/LinesofCreditandLongTermDebt",
     "shortName": "Lines of Credit and Long-Term Debt",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i1449114c17b04272b57978d40430259c_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - Condensed Consolidated Balance Sheets",
     "role": "http://www.dna.com/role/CondensedConsolidatedBalanceSheets",
     "shortName": "Condensed Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i1449114c17b04272b57978d40430259c_I20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ShortTermInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2148112 - Disclosure - Income Taxes",
     "role": "http://www.dna.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2152113 - Disclosure - Shareholders' Equity",
     "role": "http://www.dna.com/role/ShareholdersEquity",
     "shortName": "Shareholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2157114 - Disclosure - Share-Based Payments",
     "role": "http://www.dna.com/role/ShareBasedPayments",
     "shortName": "Share-Based Payments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2163115 - Disclosure - Operating Leases",
     "role": "http://www.dna.com/role/OperatingLeases",
     "shortName": "Operating Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2170116 - Disclosure - Commitments and Contingencies",
     "role": "http://www.dna.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2172117 - Disclosure - Related Party Transactions",
     "role": "http://www.dna.com/role/RelatedPartyTransactions",
     "shortName": "Related Party Transactions",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2174118 - Disclosure - Segments",
     "role": "http://www.dna.com/role/Segments",
     "shortName": "Segments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2203201 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "role": "http://www.dna.com/role/SummaryofSignificantAccountingPoliciesPolicies",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2304301 - Disclosure - Summary of Significant Accounting Policies (Tables)",
     "role": "http://www.dna.com/role/SummaryofSignificantAccountingPoliciesTables",
     "shortName": "Summary of Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2310302 - Disclosure - Discontinued Operations (Tables)",
     "role": "http://www.dna.com/role/DiscontinuedOperationsTables",
     "shortName": "Discontinued Operations (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i1449114c17b04272b57978d40430259c_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)",
     "role": "http://www.dna.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
     "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i1449114c17b04272b57978d40430259c_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "pgen:CollaborationandLicensingRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2318303 - Disclosure - Collaboration and Licensing Revenue (Tables)",
     "role": "http://www.dna.com/role/CollaborationandLicensingRevenueTables",
     "shortName": "Collaboration and Licensing Revenue (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "pgen:CollaborationandLicensingRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2322304 - Disclosure - Short-term and Long-term Investments (Tables)",
     "role": "http://www.dna.com/role/ShorttermandLongtermInvestmentsTables",
     "shortName": "Short-term and Long-term Investments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2326305 - Disclosure - Fair Value Measurements (Tables)",
     "role": "http://www.dna.com/role/FairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2330306 - Disclosure - Inventory (Tables)",
     "role": "http://www.dna.com/role/InventoryTables",
     "shortName": "Inventory (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2333307 - Disclosure - Property, Plant and Equipment, Net (Tables)",
     "role": "http://www.dna.com/role/PropertyPlantandEquipmentNetTables",
     "shortName": "Property, Plant and Equipment, Net (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2337308 - Disclosure - Goodwill and Intangible Assets, Net (Tables)",
     "role": "http://www.dna.com/role/GoodwillandIntangibleAssetsNetTables",
     "shortName": "Goodwill and Intangible Assets, Net (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2342309 - Disclosure - Lines of Credit and Long-Term Debt (Tables)",
     "role": "http://www.dna.com/role/LinesofCreditandLongTermDebtTables",
     "shortName": "Lines of Credit and Long-Term Debt (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2349310 - Disclosure - Income Taxes (Tables)",
     "role": "http://www.dna.com/role/IncomeTaxesTables",
     "shortName": "Income Taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2353311 - Disclosure - Shareholders' Equity (Tables)",
     "role": "http://www.dna.com/role/ShareholdersEquityTables",
     "shortName": "Shareholders' Equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2358312 - Disclosure - Share-Based Payments (Tables)",
     "role": "http://www.dna.com/role/ShareBasedPaymentsTables",
     "shortName": "Share-Based Payments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - Condensed Consolidated Statements of Operations",
     "role": "http://www.dna.com/role/CondensedConsolidatedStatementsofOperations",
     "shortName": "Condensed Consolidated Statements of Operations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2364313 - Disclosure - Operating Leases (Tables)",
     "role": "http://www.dna.com/role/OperatingLeasesTables",
     "shortName": "Operating Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2375314 - Disclosure - Segments (Tables)",
     "role": "http://www.dna.com/role/SegmentsTables",
     "shortName": "Segments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2405401 - Disclosure - Summary of Significant Accounting Policies - Liquidity - Additional Information (Details)",
     "role": "http://www.dna.com/role/SummaryofSignificantAccountingPoliciesLiquidityAdditionalInformationDetails",
     "shortName": "Summary of Significant Accounting Policies - Liquidity - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i1449114c17b04272b57978d40430259c_I20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406402 - Disclosure - Summary of Significant Accounting Policies - Variable Interest Entities - Additional Information (Details)",
     "role": "http://www.dna.com/role/SummaryofSignificantAccountingPoliciesVariableInterestEntitiesAdditionalInformationDetails",
     "shortName": "Summary of Significant Accounting Policies - Variable Interest Entities - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i1449114c17b04272b57978d40430259c_I20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407403 - Disclosure - Summary of Significant Accounting Policies - Net Loss Per Share - Additional Information (Details)",
     "role": "http://www.dna.com/role/SummaryofSignificantAccountingPoliciesNetLossPerShareAdditionalInformationDetails",
     "shortName": "Summary of Significant Accounting Policies - Net Loss Per Share - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i1449114c17b04272b57978d40430259c_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtNoncurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408404 - Disclosure - Summary of Significant Accounting Policies - Recently Adopted Accounting Pronouncements - Additional Information (Details)",
     "role": "http://www.dna.com/role/SummaryofSignificantAccountingPoliciesRecentlyAdoptedAccountingPronouncementsAdditionalInformationDetails",
     "shortName": "Summary of Significant Accounting Policies - Recently Adopted Accounting Pronouncements - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "ia9d87a352497452f99e9459f9be7d3fa_D20220101-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "pgen:InterestExpenseDebtAmortizationofDebtDiscountPremiumandDebtIssuanceCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GainLossOnDispositionOfAssets1",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2411405 - Disclosure - Discontinued Operations - Narrative (Details)",
     "role": "http://www.dna.com/role/DiscontinuedOperationsNarrativeDetails",
     "shortName": "Discontinued Operations - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2412406 - Disclosure - Discontinued Operations - Summary of Financial Results for MBP Titan (Details)",
     "role": "http://www.dna.com/role/DiscontinuedOperationsSummaryofFinancialResultsforMBPTitanDetails",
     "shortName": "Discontinued Operations - Summary of Financial Results for MBP Titan (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i891fbe433c724601800b0ef23b5ff9a0_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GainLossOnDispositionOfAssets1",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2413407 - Disclosure - Discontinued Operations - Non-cash Items and Purchases of Property, Plant and Equipment for MBP Titan (Details)",
     "role": "http://www.dna.com/role/DiscontinuedOperationsNoncashItemsandPurchasesofPropertyPlantandEquipmentforMBPTitanDetails",
     "shortName": "Discontinued Operations - Non-cash Items and Purchases of Property, Plant and Equipment for MBP Titan (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "if6cb7e8397b34ee6a457ba010484ed09_D20210101-20210331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromSaleOfOtherAssetsInvestingActivities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i2e48cd233bc847118ac00256b671c120_I20140331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415408 - Disclosure - Investments in Joint Ventures - Intrexon Energy Partners - Additional Information (Details)",
     "role": "http://www.dna.com/role/InvestmentsinJointVenturesIntrexonEnergyPartnersAdditionalInformationDetails",
     "shortName": "Investments in Joint Ventures - Intrexon Energy Partners - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i2e48cd233bc847118ac00256b671c120_I20140331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - Condensed Consolidated Statements of Operations (Parenthetical)",
     "role": "http://www.dna.com/role/CondensedConsolidatedStatementsofOperationsParenthetical",
     "shortName": "Condensed Consolidated Statements of Operations (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "ib9f1d3ecd2254255a55eaec2585ccedb_I20151231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2416409 - Disclosure - Investments in Joint Ventures - Intrexon Energy Partners II - Additional Information (Details)",
     "role": "http://www.dna.com/role/InvestmentsinJointVenturesIntrexonEnergyPartnersIIAdditionalInformationDetails",
     "shortName": "Investments in Joint Ventures - Intrexon Energy Partners II - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "ib9f1d3ecd2254255a55eaec2585ccedb_I20151231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2419410 - Disclosure - Collaboration and Licensing Revenue - Summarized Collaboration and Licensing Revenue (Details)",
     "role": "http://www.dna.com/role/CollaborationandLicensingRevenueSummarizedCollaborationandLicensingRevenueDetails",
     "shortName": "Collaboration and Licensing Revenue - Summarized Collaboration and Licensing Revenue (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "pgen:CollaborationandLicensingRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "ie03a332075e24203bc226247706f4c0b_D20220101-20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i1449114c17b04272b57978d40430259c_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiabilityNoncurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2420411 - Disclosure - Collaboration and Licensing Revenue - Summary of Deferred Revenue (Details)",
     "role": "http://www.dna.com/role/CollaborationandLicensingRevenueSummaryofDeferredRevenueDetails",
     "shortName": "Collaboration and Licensing Revenue - Summary of Deferred Revenue (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i1449114c17b04272b57978d40430259c_I20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i1449114c17b04272b57978d40430259c_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2423412 - Disclosure - Short-term and Long-term Investments - Summary of Amortized Cost, Gross Unrealized Gains and Losses, and Fair Value of Short-term and Long-term Investments (Details)",
     "role": "http://www.dna.com/role/ShorttermandLongtermInvestmentsSummaryofAmortizedCostGrossUnrealizedGainsandLossesandFairValueofShorttermandLongtermInvestmentsDetails",
     "shortName": "Short-term and Long-term Investments - Summary of Amortized Cost, Gross Unrealized Gains and Losses, and Fair Value of Short-term and Long-term Investments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i1449114c17b04272b57978d40430259c_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i1449114c17b04272b57978d40430259c_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2424413 - Disclosure - Short-term and Long-term Investments - Contractual Obligation, Fiscal Year Maturity (Details)",
     "role": "http://www.dna.com/role/ShorttermandLongtermInvestmentsContractualObligationFiscalYearMaturityDetails",
     "shortName": "Short-term and Long-term Investments - Contractual Obligation, Fiscal Year Maturity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i1449114c17b04272b57978d40430259c_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i1449114c17b04272b57978d40430259c_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AssetsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2427414 - Disclosure - Fair Value Measurements - Summary of Placement in the Fair Value Hierarchy of Financial Assets that are Measured at Fair Value on a Recurring Basis (Details)",
     "role": "http://www.dna.com/role/FairValueMeasurementsSummaryofPlacementintheFairValueHierarchyofFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails",
     "shortName": "Fair Value Measurements - Summary of Placement in the Fair Value Hierarchy of Financial Assets that are Measured at Fair Value on a Recurring Basis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i1449114c17b04272b57978d40430259c_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AssetsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "if6f497049bf74c16a1396dfc4d1e650a_I20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentInterestRateStatedPercentage",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2428415 - Disclosure - Fair Value Measurements - Additional Information (Details)",
     "role": "http://www.dna.com/role/FairValueMeasurementsAdditionalInformationDetails",
     "shortName": "Fair Value Measurements - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "if6f497049bf74c16a1396dfc4d1e650a_I20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ConvertibleDebtFairValueDisclosures",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i1449114c17b04272b57978d40430259c_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryGross",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2431416 - Disclosure - Inventory (Details)",
     "role": "http://www.dna.com/role/InventoryDetails",
     "shortName": "Inventory (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "ie8e3dddd71c4443985fe28d70f1e2c9a_I20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:InventoryGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i1449114c17b04272b57978d40430259c_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LandAndLandImprovements",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2434417 - Disclosure - Property, Plant and Equipment, Net - Schedule of Property, Plant and Equipment (Details)",
     "role": "http://www.dna.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetails",
     "shortName": "Property, Plant and Equipment, Net - Schedule of Property, Plant and Equipment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i1449114c17b04272b57978d40430259c_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LandAndLandImprovements",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2435418 - Disclosure - Property, Plant and Equipment, Net - Additional Information (Details)",
     "role": "http://www.dna.com/role/PropertyPlantandEquipmentNetAdditionalInformationDetails",
     "shortName": "Property, Plant and Equipment, Net - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - Condensed Consolidated Statements of Comprehensive Loss",
     "role": "http://www.dna.com/role/CondensedConsolidatedStatementsofComprehensiveLoss",
     "shortName": "Condensed Consolidated Statements of Comprehensive Loss",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "if864bcd9dba1429abb391816fd5eca4a_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2438419 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Changes in Carrying Amount of Goodwill (Details)",
     "role": "http://www.dna.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesinCarryingAmountofGoodwillDetails",
     "shortName": "Goodwill and Intangible Assets, Net - Schedule of Changes in Carrying Amount of Goodwill (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:GoodwillForeignCurrencyTranslationGainLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillImpairmentLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2439420 - Disclosure - Goodwill and Intangible Assets, Net - Additional Information (Details)",
     "role": "http://www.dna.com/role/GoodwillandIntangibleAssetsNetAdditionalInformationDetails",
     "shortName": "Goodwill and Intangible Assets, Net - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": "INF",
      "lang": "en-US",
      "name": "pgen:NumberOfReportingUnitsImpaired",
      "reportCount": 1,
      "unique": true,
      "unitRef": "reporting_unit",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i1449114c17b04272b57978d40430259c_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2440421 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Intangible Assets (Details)",
     "role": "http://www.dna.com/role/GoodwillandIntangibleAssetsNetScheduleofIntangibleAssetsDetails",
     "shortName": "Goodwill and Intangible Assets, Net - Schedule of Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i1449114c17b04272b57978d40430259c_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i9d132006c1d145eaac64d45ccb86b656_I20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2443422 - Disclosure - Lines of Credit and Long-Term Debt - Lines of Credit - Additional Information (Details)",
     "role": "http://www.dna.com/role/LinesofCreditandLongTermDebtLinesofCreditAdditionalInformationDetails",
     "shortName": "Lines of Credit and Long-Term Debt - Lines of Credit - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i9d132006c1d145eaac64d45ccb86b656_I20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i1449114c17b04272b57978d40430259c_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2444423 - Disclosure - Lines of Credit and Long-Term Debt - Schedule of Long-Term Debt Instruments (Details)",
     "role": "http://www.dna.com/role/LinesofCreditandLongTermDebtScheduleofLongTermDebtInstrumentsDetails",
     "shortName": "Lines of Credit and Long-Term Debt - Schedule of Long-Term Debt Instruments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "ib33f36cb52e14c6e8a14e68692d39463_I20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredIncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2445424 - Disclosure - Lines of Credit and Long-Term Debt - Long-Term Debt - Additional Information (Details)",
     "role": "http://www.dna.com/role/LinesofCreditandLongTermDebtLongTermDebtAdditionalInformationDetails",
     "shortName": "Lines of Credit and Long-Term Debt - Long-Term Debt - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i1449114c17b04272b57978d40430259c_I20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:InterestPayableCurrentAndNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i735cf6b5a38a4c71b70373ae0908abde_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestExpenseDebtExcludingAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2446425 - Disclosure - Lines of Credit and Long-Term Debt - Schedule of Components of Interest Expense (Details)",
     "role": "http://www.dna.com/role/LinesofCreditandLongTermDebtScheduleofComponentsofInterestExpenseDetails",
     "shortName": "Lines of Credit and Long-Term Debt - Schedule of Components of Interest Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i735cf6b5a38a4c71b70373ae0908abde_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestExpenseDebtExcludingAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i1449114c17b04272b57978d40430259c_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2447426 - Disclosure - Lines of Credit and Long-Term Debt - Schedule of Future Maturities of Long-Term Debt (Details)",
     "role": "http://www.dna.com/role/LinesofCreditandLongTermDebtScheduleofFutureMaturitiesofLongTermDebtDetails",
     "shortName": "Lines of Credit and Long-Term Debt - Schedule of Future Maturities of Long-Term Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i1449114c17b04272b57978d40430259c_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i1449114c17b04272b57978d40430259c_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxLiabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2450427 - Disclosure - Income Taxes - Narrative (Details)",
     "role": "http://www.dna.com/role/IncomeTaxesNarrativeDetails",
     "shortName": "Income Taxes - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i1449114c17b04272b57978d40430259c_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxLiabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredIncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2451428 - Disclosure - Income Taxes - Components of Income Tax Benefits (Details)",
     "role": "http://www.dna.com/role/IncomeTaxesComponentsofIncomeTaxBenefitsDetails",
     "shortName": "Income Taxes - Components of Income Tax Benefits (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i7b33b3bdd85544d6853b80b9b9363fdc_D20220101-20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DeferredIncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i64c8fed916fd4230bfb10137e40b9037_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006007 - Statement - Condensed Consolidated Statements of Shareholders' Equity",
     "role": "http://www.dna.com/role/CondensedConsolidatedStatementsofShareholdersEquity",
     "shortName": "Condensed Consolidated Statements of Shareholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i64c8fed916fd4230bfb10137e40b9037_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "ie2a968b6094d45cda5605e526b7e92bf_D20210101-20210131",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2454429 - Disclosure - Shareholders' Equity - Issuances of Precigen Common Stock (Details)",
     "role": "http://www.dna.com/role/ShareholdersEquityIssuancesofPrecigenCommonStockDetails",
     "shortName": "Shareholders' Equity - Issuances of Precigen Common Stock (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "ie2a968b6094d45cda5605e526b7e92bf_D20210101-20210131",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i8598f9bdba3a401d83a4f654f841906a_D20180701-20180731",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockIssuedDuringPeriodSharesOther",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2455430 - Disclosure - Shareholders' Equity - Share Lending Agreement (Details)",
     "role": "http://www.dna.com/role/ShareholdersEquityShareLendingAgreementDetails",
     "shortName": "Shareholders' Equity - Share Lending Agreement (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i8598f9bdba3a401d83a4f654f841906a_D20180701-20180731",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockIssuedDuringPeriodSharesOther",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i1449114c17b04272b57978d40430259c_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2456431 - Disclosure - Shareholders' Equity - Components of Accumulated Other Comprehensive Income (Loss) (Details)",
     "role": "http://www.dna.com/role/ShareholdersEquityComponentsofAccumulatedOtherComprehensiveIncomeLossDetails",
     "shortName": "Shareholders' Equity - Components of Accumulated Other Comprehensive Income (Loss) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i3cffe5138aae46519a9c02056913cbba_I20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2459432 - Disclosure - Share-Based Payments - Schedule of Stock-Based Compensation Costs (Details)",
     "role": "http://www.dna.com/role/ShareBasedPaymentsScheduleofStockBasedCompensationCostsDetails",
     "shortName": "Share-Based Payments - Schedule of Stock-Based Compensation Costs (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i2fae103728264503ab2e0c1e85de1fa1_D20220101-20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i48d145e276444d3888545e838877b8de_D20200701-20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "pgen:CompensationArrangementWithIndividualAllocatedShareBasedCompensationExpenseMonthlyExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2460433 - Disclosure - Share-Based Payments - Additional Information (Details)",
     "role": "http://www.dna.com/role/ShareBasedPaymentsAdditionalInformationDetails",
     "shortName": "Share-Based Payments - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i48d145e276444d3888545e838877b8de_D20200701-20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "pgen:CompensationArrangementWithIndividualAllocatedShareBasedCompensationExpenseMonthlyExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i5431bc10b5384e398f2da6195a9b96c3_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2461434 - Disclosure - Share-Based Payments - Schedule of Stock Option Activity (Details)",
     "role": "http://www.dna.com/role/ShareBasedPaymentsScheduleofStockOptionActivityDetails",
     "shortName": "Share-Based Payments - Schedule of Stock Option Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "ib0b5090cc97842718a2c0490412cb4ca_D20220101-20220331",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i5431bc10b5384e398f2da6195a9b96c3_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2462435 - Disclosure - Share-Based Payments - Schedule of Restricted Stock Unit Activity (Details)",
     "role": "http://www.dna.com/role/ShareBasedPaymentsScheduleofRestrictedStockUnitActivityDetails",
     "shortName": "Share-Based Payments - Schedule of Restricted Stock Unit Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "ib0b5090cc97842718a2c0490412cb4ca_D20220101-20220331",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "pgen:LesseeOperatingLeaseTerminationPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2465436 - Disclosure - Operating Leases - Additional Information (Details)",
     "role": "http://www.dna.com/role/OperatingLeasesAdditionalInformationDetails",
     "shortName": "Operating Leases - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "pgen:LesseeOperatingLeaseTerminationPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2466437 - Disclosure - Operating Leases - Components of Lease Costs (Details)",
     "role": "http://www.dna.com/role/OperatingLeasesComponentsofLeaseCostsDetails",
     "shortName": "Operating Leases - Components of Lease Costs (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i1449114c17b04272b57978d40430259c_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2467438 - Disclosure - Operating Leases - Maturities of Lease Liabilities (Details)",
     "role": "http://www.dna.com/role/OperatingLeasesMaturitiesofLeaseLiabilitiesDetails",
     "shortName": "Operating Leases - Maturities of Lease Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i1449114c17b04272b57978d40430259c_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1007008 - Statement - Condensed Consolidated Statements of Cash Flows",
     "role": "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows",
     "shortName": "Condensed Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i1449114c17b04272b57978d40430259c_I20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2468439 - Disclosure - Operating Leases - Lease Terms and Discount Rates (Details)",
     "role": "http://www.dna.com/role/OperatingLeasesLeaseTermsandDiscountRatesDetails",
     "shortName": "Operating Leases - Lease Terms and Discount Rates (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i1449114c17b04272b57978d40430259c_I20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2469440 - Disclosure - Operating Leases - Other Information (Details)",
     "role": "http://www.dna.com/role/OperatingLeasesOtherInformationDetails",
     "shortName": "Operating Leases - Other Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R82": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i1449114c17b04272b57978d40430259c_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiabilityNoncurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2471441 - Disclosure - Commitments and Contingencies - Contingencies - Additional Information (Details)",
     "role": "http://www.dna.com/role/CommitmentsandContingenciesContingenciesAdditionalInformationDetails",
     "shortName": "Commitments and Contingencies - Contingencies - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i1e1e4f70ee384bbdbc72a4af43c0088e_D20201201-20201201",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:LossContingencyClaimsSettledNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "claim",
      "xsiNil": "false"
     }
    },
    "R83": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i65e674d88ff54f86a6d42d5a8329e35c_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfessionalAndContractServicesExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2473442 - Disclosure - Related Party Transactions - Additional Information (Details)",
     "role": "http://www.dna.com/role/RelatedPartyTransactionsAdditionalInformationDetails",
     "shortName": "Related Party Transactions - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i65e674d88ff54f86a6d42d5a8329e35c_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfessionalAndContractServicesExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R84": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "pgen:NetIncomeLossAttributabletoParentAdjustedEBITDAIncludingCashPaidforCapitalExpendituresandInvestmentsinAffiliates",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2476443 - Disclosure - Segments - Adjusted EBITDA by Reportable Segment (Details)",
     "role": "http://www.dna.com/role/SegmentsAdjustedEBITDAbyReportableSegmentDetails",
     "shortName": "Segments - Adjusted EBITDA by Reportable Segment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "iac54c563a6c7429ebca9d25950c5a88a_D20220101-20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "pgen:NetIncomeLossAttributabletoParentAdjustedEBITDAIncludingCashPaidforCapitalExpendituresandInvestmentsinAffiliates",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R85": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "pgen:NetIncomeLossAttributabletoParentAdjustedEBITDAIncludingCashPaidforCapitalExpendituresandInvestmentsinAffiliates",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2477444 - Disclosure - Segments - Reconciliation of Net Loss Before Income Taxes (Details)",
     "role": "http://www.dna.com/role/SegmentsReconciliationofNetLossBeforeIncomeTaxesDetails",
     "shortName": "Segments - Reconciliation of Net Loss Before Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i6f12f7718c574755bd4056b0eb47020b_D20220101-20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "pgen:CapitalExpendituresNetOfProceedsFromSaleOfAssetsAndInvestmentsInAffiliates",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R86": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2478445 - Disclosure - Segments - Revenues by Reportable Segment (Details)",
     "role": "http://www.dna.com/role/SegmentsRevenuesbyReportableSegmentDetails",
     "shortName": "Segments - Revenues by Reportable Segment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "ia48b472a445a4200a8254bcce2227a72_D20220101-20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R87": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "ic90cdb87070e4510bfb77391109bd015_D20220101-20220331",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "pgen:PercentageOfRevenueAttributableToCustomer",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2479446 - Disclosure - Segments - Additional Information (Details)",
     "role": "http://www.dna.com/role/SegmentsAdditionalInformationDetails",
     "shortName": "Segments - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "ic90cdb87070e4510bfb77391109bd015_D20220101-20220331",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "pgen:PercentageOfRevenueAttributableToCustomer",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - Organization",
     "role": "http://www.dna.com/role/Organization",
     "shortName": "Organization",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "i0eeafa06d8194793b9c4456d76defac3_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9999": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "if864bcd9dba1429abb391816fd5eca4a_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestrictedCashAndCashEquivalentsNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "",
     "isDefault": "false",
     "longName": "Uncategorized Items - pgen-20220331.htm",
     "role": "http://xbrl.sec.gov/role/uncategorizedFacts",
     "shortName": "Uncategorized Items - pgen-20220331.htm",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pgen-20220331.htm",
      "contextRef": "if864bcd9dba1429abb391816fd5eca4a_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestrictedCashAndCashEquivalentsNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 90,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.dna.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.dna.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.dna.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.dna.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.dna.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.dna.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r756"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.dna.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r757"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.dna.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.dna.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.dna.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.dna.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.dna.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.dna.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r754"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.dna.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.dna.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.dna.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.dna.com/role/CommitmentsandContingenciesContingenciesAdditionalInformationDetails",
      "http://www.dna.com/role/LinesofCreditandLongTermDebtLinesofCreditAdditionalInformationDetails",
      "http://www.dna.com/role/LinesofCreditandLongTermDebtLongTermDebtAdditionalInformationDetails",
      "http://www.dna.com/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r754"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.dna.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.dna.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r754"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.dna.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.dna.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r767"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.dna.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r754"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.dna.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r754"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.dna.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r754"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.dna.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r754"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.dna.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.dna.com/role/CommitmentsandContingenciesContingenciesAdditionalInformationDetails",
      "http://www.dna.com/role/LinesofCreditandLongTermDebtLinesofCreditAdditionalInformationDetails",
      "http://www.dna.com/role/LinesofCreditandLongTermDebtLongTermDebtAdditionalInformationDetails",
      "http://www.dna.com/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.dna.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r753"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.dna.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r755"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.dna.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.dna.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "pgen_A3.5ConvertibleNotesDue2023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.5% Convertible Notes Due 2023 [Member]",
        "label": "3.5% Convertible Notes Due 2023 [Member]",
        "terseLabel": "3.5% Convertible Notes Due 2023"
       }
      }
     },
     "localname": "A3.5ConvertibleNotesDue2023Member",
     "nsuri": "http://www.dna.com/20220331",
     "presentation": [
      "http://www.dna.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://www.dna.com/role/LinesofCreditandLongTermDebtLongTermDebtAdditionalInformationDetails",
      "http://www.dna.com/role/LinesofCreditandLongTermDebtScheduleofComponentsofInterestExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pgen_AccruedCompensationPaidinEquityAwards": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Compensation Paid in Equity Awards",
        "label": "Accrued Compensation Paid in Equity Awards",
        "terseLabel": "Accrued compensation paid in equity awards"
       }
      }
     },
     "localname": "AccruedCompensationPaidinEquityAwards",
     "nsuri": "http://www.dna.com/20220331",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pgen_AdjustmentForBonusesPaidInEquityAwards": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustment For Bonuses Paid In Equity Awards",
        "label": "Adjustment For Bonuses Paid In Equity Awards",
        "terseLabel": "Adjustment related to accrued bonuses paid in equity awards"
       }
      }
     },
     "localname": "AdjustmentForBonusesPaidInEquityAwards",
     "nsuri": "http://www.dna.com/20220331",
     "presentation": [
      "http://www.dna.com/role/SegmentsReconciliationofNetLossBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pgen_AllInvestorsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All Investors of Entity [Member]",
        "label": "All Investors [Member]",
        "terseLabel": "All Investors"
       }
      }
     },
     "localname": "AllInvestorsMember",
     "nsuri": "http://www.dna.com/20220331",
     "presentation": [
      "http://www.dna.com/role/InvestmentsinJointVenturesIntrexonEnergyPartnersIIAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pgen_AmericanStateBankMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "American State Bank [Member]",
        "label": "American State Bank [Member]",
        "terseLabel": "American State Bank"
       }
      }
     },
     "localname": "AmericanStateBankMember",
     "nsuri": "http://www.dna.com/20220331",
     "presentation": [
      "http://www.dna.com/role/LinesofCreditandLongTermDebtLinesofCreditAdditionalInformationDetails",
      "http://www.dna.com/role/LinesofCreditandLongTermDebtLongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pgen_BiopharmaceuticalsSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PGEN Therapeutics Segment [Member]",
        "label": "Biopharmaceuticals Segment [Member]",
        "terseLabel": "Biopharmaceuticals"
       }
      }
     },
     "localname": "BiopharmaceuticalsSegmentMember",
     "nsuri": "http://www.dna.com/20220331",
     "presentation": [
      "http://www.dna.com/role/GoodwillandIntangibleAssetsNetAdditionalInformationDetails",
      "http://www.dna.com/role/SegmentsAdjustedEBITDAbyReportableSegmentDetails",
      "http://www.dna.com/role/SegmentsRevenuesbyReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pgen_BreedingandProductionAnimalsGross": {
     "auth_ref": [],
     "calculation": {
      "http://www.dna.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of animals maintained to create offspring or to produce goods to be sold for profit.",
        "label": "Breeding and Production Animals, Gross",
        "terseLabel": "Breeding stock"
       }
      }
     },
     "localname": "BreedingandProductionAnimalsGross",
     "nsuri": "http://www.dna.com/20220331",
     "presentation": [
      "http://www.dna.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pgen_CapitalExpendituresNetOfProceedsFromSaleOfAssetsAndInvestmentsInAffiliates": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Capital Expenditures and Investments in Affiliates",
        "label": "Capital Expenditures, Net Of Proceeds From Sale Of Assets, And Investments in Affiliates",
        "terseLabel": "Remove cash paid for capital expenditures, net of proceeds from sale of assets, and cash paid for investments in affiliates"
       }
      }
     },
     "localname": "CapitalExpendituresNetOfProceedsFromSaleOfAssetsAndInvestmentsInAffiliates",
     "nsuri": "http://www.dna.com/20220331",
     "presentation": [
      "http://www.dna.com/role/SegmentsReconciliationofNetLossBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pgen_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsReconciliationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Reconciliation",
        "label": "Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Reconciliation [Abstract]",
        "terseLabel": "Cash, cash equivalents, and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsReconciliationAbstract",
     "nsuri": "http://www.dna.com/20220331",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "pgen_CastleCreekBiosciencesIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Castle Creek Biosciences, Inc.",
        "label": "Castle Creek Biosciences, Inc. [Member]",
        "terseLabel": "Castle Creek Biosciences, Inc."
       }
      }
     },
     "localname": "CastleCreekBiosciencesIncMember",
     "nsuri": "http://www.dna.com/20220331",
     "presentation": [
      "http://www.dna.com/role/CollaborationandLicensingRevenueSummarizedCollaborationandLicensingRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pgen_CollaborationandLicensingRevenueTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of summarized revenues recognized for each significant collaboration and licensing agreement and aggregated nonsignificant collaborations and licensing agreements.",
        "label": "Collaboration and Licensing Revenue [Table Text Block]",
        "terseLabel": "Summarized Collaboration and Licensing Revenues"
       }
      }
     },
     "localname": "CollaborationandLicensingRevenueTableTextBlock",
     "nsuri": "http://www.dna.com/20220331",
     "presentation": [
      "http://www.dna.com/role/CollaborationandLicensingRevenueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "pgen_CollaborativeArrangementConsiderationReceivedValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of consideration received by the entity for collaboration",
        "label": "Collaborative Arrangement Consideration Received Value",
        "terseLabel": "Collaborative arrangement consideration received, value"
       }
      }
     },
     "localname": "CollaborativeArrangementConsiderationReceivedValue",
     "nsuri": "http://www.dna.com/20220331",
     "presentation": [
      "http://www.dna.com/role/InvestmentsinJointVenturesIntrexonEnergyPartnersAdditionalInformationDetails",
      "http://www.dna.com/role/InvestmentsinJointVenturesIntrexonEnergyPartnersIIAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pgen_CompensationArrangementWithIndividualAllocatedShareBasedCompensationExpenseMonthlyExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of monthly expense recognized from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments), awarded to key employees or individuals.",
        "label": "Compensation Arrangement With Individual, Allocated Share-Based Compensation Expense, Monthly Expense",
        "verboseLabel": "Monthly compensation, in the form of equity"
       }
      }
     },
     "localname": "CompensationArrangementWithIndividualAllocatedShareBasedCompensationExpenseMonthlyExpense",
     "nsuri": "http://www.dna.com/20220331",
     "presentation": [
      "http://www.dna.com/role/ShareBasedPaymentsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pgen_CompensationArrangementWithIndividualAnnualCashRetainer": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Compensation Arrangement With Individual, Annual Cash Retainer",
        "label": "Compensation Arrangement With Individual, Annual Cash Retainer",
        "terseLabel": "Yearly compensation, payable in cash or equity"
       }
      }
     },
     "localname": "CompensationArrangementWithIndividualAnnualCashRetainer",
     "nsuri": "http://www.dna.com/20220331",
     "presentation": [
      "http://www.dna.com/role/ShareBasedPaymentsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pgen_CompensationArrangementWithIndividualAnnualRSUGrantGrantDateFairValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Compensation Arrangement With Individual, Annual RSU Grant, Grant Date Fair Value",
        "label": "Compensation Arrangement With Individual, Annual RSU Grant, Grant Date Fair Value",
        "terseLabel": "Compensation arrangement with individual, annual RSU grant, grant date fair value"
       }
      }
     },
     "localname": "CompensationArrangementWithIndividualAnnualRSUGrantGrantDateFairValue",
     "nsuri": "http://www.dna.com/20220331",
     "presentation": [
      "http://www.dna.com/role/ShareBasedPaymentsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pgen_CompensationArrangementWithIndividualAnnualStockOptionGrantGrantDateFairValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Compensation Arrangement With Individual, Annual Stock Option Grant, Grant Date Fair Value",
        "label": "Compensation Arrangement With Individual, Annual Stock Option Grant, Grant Date Fair Value",
        "terseLabel": "Compensation arrangement with individual, annual stock option grant, grant date fair value"
       }
      }
     },
     "localname": "CompensationArrangementWithIndividualAnnualStockOptionGrantGrantDateFairValue",
     "nsuri": "http://www.dna.com/20220331",
     "presentation": [
      "http://www.dna.com/role/ShareBasedPaymentsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pgen_CompensationArrangementWithIndividualExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Compensation Arrangement With Individual, Expense",
        "label": "Compensation Arrangement With Individual, Expense",
        "terseLabel": "Expense for certain compensation arrangements"
       }
      }
     },
     "localname": "CompensationArrangementWithIndividualExpense",
     "nsuri": "http://www.dna.com/20220331",
     "presentation": [
      "http://www.dna.com/role/ShareBasedPaymentsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pgen_ComputerHardwareandSoftware": {
     "auth_ref": [],
     "calculation": {
      "http://www.dna.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation and amortization of computer hardware and purchased software.",
        "label": "Computer Hardware and Software",
        "terseLabel": "Computer hardware and software"
       }
      }
     },
     "localname": "ComputerHardwareandSoftware",
     "nsuri": "http://www.dna.com/20220331",
     "presentation": [
      "http://www.dna.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pgen_ContractWithCustomerAssetAndLiabilityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Line Items] for Contract With Customer, Asset And Liability [Table]",
        "label": "Contract With Customer, Asset And Liability [Line Items]",
        "terseLabel": "Contract With Customer, Asset And Liability [Line Items]"
       }
      }
     },
     "localname": "ContractWithCustomerAssetAndLiabilityLineItems",
     "nsuri": "http://www.dna.com/20220331",
     "presentation": [
      "http://www.dna.com/role/CollaborationandLicensingRevenueSummaryofDeferredRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "pgen_ContractWithCustomerAssetAndLiabilityTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract With Customer, Asset And Liability [Table]",
        "label": "Contract With Customer, Asset And Liability [Table]",
        "terseLabel": "Contract With Customer, Asset And Liability [Table]"
       }
      }
     },
     "localname": "ContractWithCustomerAssetAndLiabilityTable",
     "nsuri": "http://www.dna.com/20220331",
     "presentation": [
      "http://www.dna.com/role/CollaborationandLicensingRevenueSummaryofDeferredRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "pgen_ConvertibleDebtPrincipalAmountInitialConversionRate": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount in principal used in the initial conversion rate of the Convertible Notes.",
        "label": "Convertible Debt Principal Amount Initial Conversion Rate",
        "terseLabel": "Principal amount used in conversion"
       }
      }
     },
     "localname": "ConvertibleDebtPrincipalAmountInitialConversionRate",
     "nsuri": "http://www.dna.com/20220331",
     "presentation": [
      "http://www.dna.com/role/LinesofCreditandLongTermDebtLongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pgen_CorporateAndReconcilingItemsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate And Reconciling Items [Member]",
        "label": "Corporate And Reconciling Items [Member]",
        "terseLabel": "Corporate And Reconciling Items"
       }
      }
     },
     "localname": "CorporateAndReconcilingItemsMember",
     "nsuri": "http://www.dna.com/20220331",
     "presentation": [
      "http://www.dna.com/role/SegmentsReconciliationofNetLossBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pgen_CostOfProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cost Of Products [Member]",
        "label": "Cost Of Products [Member]",
        "terseLabel": "Cost of products"
       }
      }
     },
     "localname": "CostOfProductsMember",
     "nsuri": "http://www.dna.com/20220331",
     "presentation": [
      "http://www.dna.com/role/ShareBasedPaymentsScheduleofStockBasedCompensationCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pgen_CostOfServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cost Of Services [Member]",
        "label": "Cost Of Services [Member]",
        "terseLabel": "Cost of services"
       }
      }
     },
     "localname": "CostOfServicesMember",
     "nsuri": "http://www.dna.com/20220331",
     "presentation": [
      "http://www.dna.com/role/ShareBasedPaymentsScheduleofStockBasedCompensationCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pgen_DeferredRevenueOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other deferred revenue",
        "label": "Deferred Revenue Other [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "DeferredRevenueOtherMember",
     "nsuri": "http://www.dna.com/20220331",
     "presentation": [
      "http://www.dna.com/role/CollaborationandLicensingRevenueSummaryofDeferredRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pgen_EliminationsAndReconcilingItemsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Eliminations And Reconciling Items [Member]",
        "label": "Eliminations And Reconciling Items [Member]",
        "terseLabel": "Elimination of intersegment revenues"
       }
      }
     },
     "localname": "EliminationsAndReconcilingItemsMember",
     "nsuri": "http://www.dna.com/20220331",
     "presentation": [
      "http://www.dna.com/role/SegmentsRevenuesbyReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pgen_ExecutiveChairmanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Executive Chairman [Member]",
        "label": "Executive Chairman [Member]",
        "verboseLabel": "Executive Chairman"
       }
      }
     },
     "localname": "ExecutiveChairmanMember",
     "nsuri": "http://www.dna.com/20220331",
     "presentation": [
      "http://www.dna.com/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.dna.com/role/ShareBasedPaymentsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pgen_ExemplarGeneticsLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exemplar Genetics, LLC [Member]",
        "label": "Exemplar Genetics, LLC [Member]",
        "terseLabel": "Exemplar Genetics, LLC"
       }
      }
     },
     "localname": "ExemplarGeneticsLLCMember",
     "nsuri": "http://www.dna.com/20220331",
     "presentation": [
      "http://www.dna.com/role/LinesofCreditandLongTermDebtLinesofCreditAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pgen_ExemplarSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exemplar Segment",
        "label": "Exemplar Segment [Member]",
        "terseLabel": "Exemplar"
       }
      }
     },
     "localname": "ExemplarSegmentMember",
     "nsuri": "http://www.dna.com/20220331",
     "presentation": [
      "http://www.dna.com/role/SegmentsAdditionalInformationDetails",
      "http://www.dna.com/role/SegmentsAdjustedEBITDAbyReportableSegmentDetails",
      "http://www.dna.com/role/SegmentsRevenuesbyReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pgen_FeedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Feed [Member]",
        "label": "Feed [Member]",
        "terseLabel": "Feed"
       }
      }
     },
     "localname": "FeedMember",
     "nsuri": "http://www.dna.com/20220331",
     "presentation": [
      "http://www.dna.com/role/InventoryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pgen_FirstNationalBankofOmahaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First National Bank of Omaha [Member]",
        "label": "First National Bank of Omaha [Member]",
        "terseLabel": "First National Bank of Omaha"
       }
      }
     },
     "localname": "FirstNationalBankofOmahaMember",
     "nsuri": "http://www.dna.com/20220331",
     "presentation": [
      "http://www.dna.com/role/LinesofCreditandLongTermDebtLinesofCreditAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pgen_GeneratedAfter2017Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generated After 2017 [Member]",
        "label": "Generated After 2017 [Member]",
        "terseLabel": "Generated After 2017"
       }
      }
     },
     "localname": "GeneratedAfter2017Member",
     "nsuri": "http://www.dna.com/20220331",
     "presentation": [
      "http://www.dna.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pgen_InterestExpenseDebtAmortizationofDebtDiscountPremiumandDebtIssuanceCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.dna.com/role/LinesofCreditandLongTermDebtScheduleofComponentsofInterestExpenseDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InterestExpenseDebt",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments and amortization expense attributable to debt issuance costs.",
        "label": "Interest Expense, Debt, Amortization of Debt Discount (Premium) and Debt Issuance Costs",
        "terseLabel": "Non-cash interest expense"
       }
      }
     },
     "localname": "InterestExpenseDebtAmortizationofDebtDiscountPremiumandDebtIssuanceCosts",
     "nsuri": "http://www.dna.com/20220331",
     "presentation": [
      "http://www.dna.com/role/LinesofCreditandLongTermDebtScheduleofComponentsofInterestExpenseDetails",
      "http://www.dna.com/role/SummaryofSignificantAccountingPoliciesRecentlyAdoptedAccountingPronouncementsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pgen_IntrexonEnergyPartnersIILLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intrexon Energy Partners II, LLC [Member]",
        "label": "Intrexon Energy Partners II, LLC [Member]",
        "verboseLabel": "Intrexon Energy Partners II, LLC"
       }
      }
     },
     "localname": "IntrexonEnergyPartnersIILLCMember",
     "nsuri": "http://www.dna.com/20220331",
     "presentation": [
      "http://www.dna.com/role/CommitmentsandContingenciesContingenciesAdditionalInformationDetails",
      "http://www.dna.com/role/InvestmentsinJointVenturesIntrexonEnergyPartnersIIAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pgen_IntrexonEnergyPartnersLLAndIntrexonEnergyPartnersIILLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intrexon Energy Partners L.L. and Intrexon Energy Partners II, L.L.C",
        "label": "Intrexon Energy Partners L.L. and Intrexon Energy Partners II, L.L.C [Member]",
        "terseLabel": "Intrexon Energy Partners L.L. and Intrexon Energy Partners II, L.L.C"
       }
      }
     },
     "localname": "IntrexonEnergyPartnersLLAndIntrexonEnergyPartnersIILLCMember",
     "nsuri": "http://www.dna.com/20220331",
     "presentation": [
      "http://www.dna.com/role/CollaborationandLicensingRevenueSummaryofDeferredRevenueDetails",
      "http://www.dna.com/role/CommitmentsandContingenciesContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pgen_IntrexonEnergyPartnersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intrexon Energy Partners, LLC",
        "label": "Intrexon Energy Partners [Member]",
        "terseLabel": "Intrexon Energy Partners [Member]",
        "verboseLabel": "Intrexon Energy Partners, LLC"
       }
      }
     },
     "localname": "IntrexonEnergyPartnersMember",
     "nsuri": "http://www.dna.com/20220331",
     "presentation": [
      "http://www.dna.com/role/CommitmentsandContingenciesContingenciesAdditionalInformationDetails",
      "http://www.dna.com/role/InvestmentsinJointVenturesIntrexonEnergyPartnersAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pgen_JointVentureAdditionalCapitalContributionsCommitted": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of additional capital contributions to the joint venture for which the entity is committed, maximum.",
        "label": "Joint Venture Additional Capital Contributions Committed",
        "terseLabel": "Maximum additional capital contribution committed"
       }
      }
     },
     "localname": "JointVentureAdditionalCapitalContributionsCommitted",
     "nsuri": "http://www.dna.com/20220331",
     "presentation": [
      "http://www.dna.com/role/InvestmentsinJointVenturesIntrexonEnergyPartnersAdditionalInformationDetails",
      "http://www.dna.com/role/InvestmentsinJointVenturesIntrexonEnergyPartnersIIAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pgen_JointVentureAdditionalCapitalContributionsCommittedRemainingCommitment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remaining amount of additional capital contributions to the joint venture for which the entity is committed.",
        "label": "Joint Venture Additional Capital Contributions Committed, Remaining Commitment",
        "terseLabel": "Additional capital contributions committed, remaining commitment"
       }
      }
     },
     "localname": "JointVentureAdditionalCapitalContributionsCommittedRemainingCommitment",
     "nsuri": "http://www.dna.com/20220331",
     "presentation": [
      "http://www.dna.com/role/InvestmentsinJointVenturesIntrexonEnergyPartnersAdditionalInformationDetails",
      "http://www.dna.com/role/InvestmentsinJointVenturesIntrexonEnergyPartnersIIAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pgen_LesseeOperatingLeaseTerminationPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Termination Period",
        "label": "Lessee, Operating Lease, Termination Period",
        "terseLabel": "Termination period"
       }
      }
     },
     "localname": "LesseeOperatingLeaseTerminationPeriod",
     "nsuri": "http://www.dna.com/20220331",
     "presentation": [
      "http://www.dna.com/role/OperatingLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "pgen_LicensingAndPatentInfringementSuitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Licensing And Patent Infringement Suit [Member]",
        "label": "Licensing And Patent Infringement Suit [Member]",
        "terseLabel": "Licensing and patent infringement suit"
       }
      }
     },
     "localname": "LicensingAndPatentInfringementSuitMember",
     "nsuri": "http://www.dna.com/20220331",
     "presentation": [
      "http://www.dna.com/role/CommitmentsandContingenciesContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pgen_LivestockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Livestock [Member]",
        "label": "Livestock [Member]",
        "terseLabel": "Livestock"
       }
      }
     },
     "localname": "LivestockMember",
     "nsuri": "http://www.dna.com/20220331",
     "presentation": [
      "http://www.dna.com/role/InventoryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pgen_LockupPeriodOnRestrictedStockUnitShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of time during which issued shares are subject to a lock-up on resale.",
        "label": "Lockup Period On Restricted Stock Unit Shares",
        "terseLabel": "Lock-up period"
       }
      }
     },
     "localname": "LockupPeriodOnRestrictedStockUnitShares",
     "nsuri": "http://www.dna.com/20220331",
     "presentation": [
      "http://www.dna.com/role/ShareBasedPaymentsAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "pgen_LongLivedAssetsIncludingPropertyPlantandEquipmentandRightOfUseAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-Lived Assets, Including Property, Plant, and Equipment and Right Of Use Assets",
        "label": "Long-Lived Assets, Including Property, Plant, and Equipment and Right Of Use Assets",
        "verboseLabel": "Long-lived assets"
       }
      }
     },
     "localname": "LongLivedAssetsIncludingPropertyPlantandEquipmentandRightOfUseAssets",
     "nsuri": "http://www.dna.com/20220331",
     "presentation": [
      "http://www.dna.com/role/SegmentsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pgen_LossContingencyNumberOfPatentsAtIssue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number Of Patents At Issue",
        "label": "Loss Contingency, Number Of Patents At Issue",
        "terseLabel": "Loss contingency, number of patents"
       }
      }
     },
     "localname": "LossContingencyNumberOfPatentsAtIssue",
     "nsuri": "http://www.dna.com/20220331",
     "presentation": [
      "http://www.dna.com/role/CommitmentsandContingenciesContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "pgen_MBPTitanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "MBP Titan",
        "label": "MBP Titan [Member]",
        "terseLabel": "MBP Titan"
       }
      }
     },
     "localname": "MBPTitanMember",
     "nsuri": "http://www.dna.com/20220331",
     "presentation": [
      "http://www.dna.com/role/DiscontinuedOperationsNarrativeDetails",
      "http://www.dna.com/role/DiscontinuedOperationsNoncashItemsandPurchasesofPropertyPlantandEquipmentforMBPTitanDetails",
      "http://www.dna.com/role/DiscontinuedOperationsSummaryofFinancialResultsforMBPTitanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pgen_MethaneBioconversionPlatformDisclosuresMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Methane Bioconversion Platform Disclosures",
        "label": "Methane Bioconversion Platform Disclosures [Member]",
        "terseLabel": "Methane Bioconversion Platform Disclosures"
       }
      }
     },
     "localname": "MethaneBioconversionPlatformDisclosuresMember",
     "nsuri": "http://www.dna.com/20220331",
     "presentation": [
      "http://www.dna.com/role/CommitmentsandContingenciesContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pgen_NetIncomeLossAttributabletoParentAdjustedEBITDAIncludingCashPaidforCapitalExpendituresandInvestmentsinAffiliates": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Segment Adjusted EBITDA defined as net income (loss) before (i) interest expense, (ii) income tax expense/benefit, (iii) depreciation and amortization, (iv) stock-based compensation expense, (v) loss on settlement agreements where noncash consideration is paid; (vi) adjustments for accrued bonuses paid in equity awards; (vii) gain or loss on disposal of assets; (viii) loss on impairment of goodwill and other noncurrent assets, (ix) write-off of reacquired in-process research and development, (x) equity in net income (loss) of affiliates, and (xi) recognition of previously deferred revenue associated with upfront and milestone payments as well as cash outflows from capital expenditures and investments in affiliates, but includes proceeds from the sale of assets in the period sold.",
        "label": "Net Income (Loss) Attributable to Parent, Adjusted EBITDA, Including Cash Paid for Capital Expenditures and Investments in Affiliates",
        "verboseLabel": "Segment Adjusted EBITDA for reportable segments"
       }
      }
     },
     "localname": "NetIncomeLossAttributabletoParentAdjustedEBITDAIncludingCashPaidforCapitalExpendituresandInvestmentsinAffiliates",
     "nsuri": "http://www.dna.com/20220331",
     "presentation": [
      "http://www.dna.com/role/SegmentsAdjustedEBITDAbyReportableSegmentDetails",
      "http://www.dna.com/role/SegmentsReconciliationofNetLossBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pgen_NoncashGainLossOnTerminationOfLease": {
     "auth_ref": [],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncash Gain (Loss) on Termination of Lease",
        "label": "Noncash Gain (Loss) on Termination of Lease",
        "negatedTerseLabel": "Noncash gain on termination of operating leases"
       }
      }
     },
     "localname": "NoncashGainLossOnTerminationOfLease",
     "nsuri": "http://www.dna.com/20220331",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pgen_NumberOfReportingUnitsImpaired": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Reporting Units Impaired",
        "label": "Number Of Reporting Units Impaired",
        "terseLabel": "Number of reporting units impaired"
       }
      }
     },
     "localname": "NumberOfReportingUnitsImpaired",
     "nsuri": "http://www.dna.com/20220331",
     "presentation": [
      "http://www.dna.com/role/GoodwillandIntangibleAssetsNetAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "pgen_NumberofSeatsonGoverningBoard": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of seats on the governing board.",
        "label": "Number of Seats on Governing Board",
        "terseLabel": "Total number of seats on the joint venture's governing board"
       }
      }
     },
     "localname": "NumberofSeatsonGoverningBoard",
     "nsuri": "http://www.dna.com/20220331",
     "presentation": [
      "http://www.dna.com/role/InvestmentsinJointVenturesIntrexonEnergyPartnersAdditionalInformationDetails",
      "http://www.dna.com/role/InvestmentsinJointVenturesIntrexonEnergyPartnersIIAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "pgen_NumberofSeatsonGoverningBoardExternallySelected": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of seats on the governing board, externally selected.",
        "label": "Number of Seats on Governing Board, Externally Selected",
        "terseLabel": "Total number of seats on the joint venture's governing board, externally selected"
       }
      }
     },
     "localname": "NumberofSeatsonGoverningBoardExternallySelected",
     "nsuri": "http://www.dna.com/20220331",
     "presentation": [
      "http://www.dna.com/role/InvestmentsinJointVenturesIntrexonEnergyPartnersAdditionalInformationDetails",
      "http://www.dna.com/role/InvestmentsinJointVenturesIntrexonEnergyPartnersIIAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "pgen_NumberofSeatsonGoverningBoardInternallySelected": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of seats on the governing board selected internally.",
        "label": "Number of Seats on Governing Board, Internally Selected",
        "terseLabel": "Total number of seats on the joint venture's governing board, internally selected"
       }
      }
     },
     "localname": "NumberofSeatsonGoverningBoardInternallySelected",
     "nsuri": "http://www.dna.com/20220331",
     "presentation": [
      "http://www.dna.com/role/InvestmentsinJointVenturesIntrexonEnergyPartnersAdditionalInformationDetails",
      "http://www.dna.com/role/InvestmentsinJointVenturesIntrexonEnergyPartnersIIAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "pgen_OtherAccruedLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Accrued Liabilities [Member]",
        "label": "Other Accrued Liabilities [Member]",
        "terseLabel": "Other Accrued Liabilities"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesMember",
     "nsuri": "http://www.dna.com/20220331",
     "presentation": [
      "http://www.dna.com/role/InvestmentsinJointVenturesIntrexonEnergyPartnersAdditionalInformationDetails",
      "http://www.dna.com/role/InvestmentsinJointVenturesIntrexonEnergyPartnersIIAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pgen_OtherLongTermDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Long-Term Debt [Member]",
        "label": "Other Long-Term Debt [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherLongTermDebtMember",
     "nsuri": "http://www.dna.com/20220331",
     "presentation": [
      "http://www.dna.com/role/LinesofCreditandLongTermDebtScheduleofLongTermDebtInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pgen_OtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other [Member]",
        "label": "Other [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherMember",
     "nsuri": "http://www.dna.com/20220331",
     "presentation": [
      "http://www.dna.com/role/CollaborationandLicensingRevenueSummarizedCollaborationandLicensingRevenueDetails",
      "http://www.dna.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "domainItemType"
    },
    "pgen_PercentageOfRevenueAttributableToCustomer": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage Of Revenue Attributable To Customer",
        "label": "Percentage Of Revenue Attributable To Customer",
        "terseLabel": "Percentage of revenue attributable to customer"
       }
      }
     },
     "localname": "PercentageOfRevenueAttributableToCustomer",
     "nsuri": "http://www.dna.com/20220331",
     "presentation": [
      "http://www.dna.com/role/SegmentsAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "pgen_PrecigenStockOptionPlan2008PlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Precigen Stock Option Plan 2008 Plan [Member]",
        "label": "Precigen Stock Option Plan 2008 Plan [Member]",
        "terseLabel": "Precigen Stock Option Plan 2008 Plan"
       }
      }
     },
     "localname": "PrecigenStockOptionPlan2008PlanMember",
     "nsuri": "http://www.dna.com/20220331",
     "presentation": [
      "http://www.dna.com/role/ShareBasedPaymentsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pgen_PrecigenStockOptionPlan2013PlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Precigen Stock Option Plan 2013 Plan [Member] [Member]",
        "label": "Precigen Stock Option Plan 2013 Plan [Member]",
        "terseLabel": "Precigen Stock Option Plan 2013 Plan"
       }
      }
     },
     "localname": "PrecigenStockOptionPlan2013PlanMember",
     "nsuri": "http://www.dna.com/20220331",
     "presentation": [
      "http://www.dna.com/role/ShareBasedPaymentsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pgen_PrecigenStockOptionPlan2019PlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Precigen Stock Option Plan 2019 Plan [Member]",
        "label": "Precigen Stock Option Plan 2019 Plan [Member]",
        "terseLabel": "Precigen Stock Option Plan 2019 Plan"
       }
      }
     },
     "localname": "PrecigenStockOptionPlan2019PlanMember",
     "nsuri": "http://www.dna.com/20220331",
     "presentation": [
      "http://www.dna.com/role/ShareBasedPaymentsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pgen_PrecigenStockOptionPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Precigen Stock Option Plan",
        "label": "Precigen Stock Option Plan [Member]",
        "terseLabel": "Precigen Stock Option Plans"
       }
      }
     },
     "localname": "PrecigenStockOptionPlanMember",
     "nsuri": "http://www.dna.com/20220331",
     "presentation": [
      "http://www.dna.com/role/ShareBasedPaymentsScheduleofRestrictedStockUnitActivityDetails",
      "http://www.dna.com/role/ShareBasedPaymentsScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pgen_PrepaidProductAndServiceRevenuesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepaid Product And Service Revenues [Member]",
        "label": "Prepaid Product And Service Revenues [Member]",
        "terseLabel": "Prepaid product and service revenues"
       }
      }
     },
     "localname": "PrepaidProductAndServiceRevenuesMember",
     "nsuri": "http://www.dna.com/20220331",
     "presentation": [
      "http://www.dna.com/role/CollaborationandLicensingRevenueSummaryofDeferredRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pgen_ProposedPaymentsForMembershipInterests": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proposed Payments For Membership Interests",
        "label": "Proposed Payments For Membership Interests",
        "terseLabel": "Payments for membership interests"
       }
      }
     },
     "localname": "ProposedPaymentsForMembershipInterests",
     "nsuri": "http://www.dna.com/20220331",
     "presentation": [
      "http://www.dna.com/role/CommitmentsandContingenciesContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pgen_RelatedPartiesAggregatedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related Parties, Aggregated [Member]",
        "label": "Related Parties, Aggregated [Member]",
        "terseLabel": "Related Parties, Aggregated"
       }
      }
     },
     "localname": "RelatedPartiesAggregatedMember",
     "nsuri": "http://www.dna.com/20220331",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.dna.com/role/CondensedConsolidatedStatementsofOperationsParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "pgen_RelatedPartyOwnershipInterest": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of ownership of common stock or equity participation in a related party.",
        "label": "Related Party Ownership Interest",
        "terseLabel": "Ownership interest"
       }
      }
     },
     "localname": "RelatedPartyOwnershipInterest",
     "nsuri": "http://www.dna.com/20220331",
     "presentation": [
      "http://www.dna.com/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "pgen_RelatedPartyReceivableAllowanceforCreditLossCurrent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related Party Receivable, Allowance for Credit Loss, Current",
        "label": "Related Party Receivable, Allowance for Credit Loss, Current",
        "terseLabel": "Related party receivable, allowance for credit losses"
       }
      }
     },
     "localname": "RelatedPartyReceivableAllowanceforCreditLossCurrent",
     "nsuri": "http://www.dna.com/20220331",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pgen_ReportableSegmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reportable Segments [Member]",
        "label": "Reportable Segments [Member]",
        "terseLabel": "Total segment revenues from reportable segments",
        "verboseLabel": "Segment Adjusted EBITDA for reportable segments"
       }
      }
     },
     "localname": "ReportableSegmentsMember",
     "nsuri": "http://www.dna.com/20220331",
     "presentation": [
      "http://www.dna.com/role/SegmentsReconciliationofNetLossBeforeIncomeTaxesDetails",
      "http://www.dna.com/role/SegmentsRevenuesbyReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pgen_SaleOfAssetsIncludedInAccountsReceivable": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of Assets Included in Accounts Receivable",
        "label": "Sale of Assets Included in Accounts Receivable",
        "terseLabel": "Proceeds from sale of assets included in accounts receivable"
       }
      }
     },
     "localname": "SaleOfAssetsIncludedInAccountsReceivable",
     "nsuri": "http://www.dna.com/20220331",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pgen_SecuritiesAndExchangeCommissionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities And Exchange Commission",
        "label": "Securities And Exchange Commission [Member]",
        "terseLabel": "Division Of Enforcement Of The Securities And Exchange Commission"
       }
      }
     },
     "localname": "SecuritiesAndExchangeCommissionMember",
     "nsuri": "http://www.dna.com/20220331",
     "presentation": [
      "http://www.dna.com/role/CommitmentsandContingenciesContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pgen_ShareLendingAgreementLengthOfTimeForSharesToBeReturnedUponTermination": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share Lending Agreement, Length Of Time For Shares To Be Returned Upon Termination",
        "label": "Share Lending Agreement, Length Of Time For Shares To Be Returned Upon Termination",
        "terseLabel": "Share lending agreement, length of time for shares to be returned upon termination"
       }
      }
     },
     "localname": "ShareLendingAgreementLengthOfTimeForSharesToBeReturnedUponTermination",
     "nsuri": "http://www.dna.com/20220331",
     "presentation": [
      "http://www.dna.com/role/ShareholdersEquityShareLendingAgreementDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "pgen_SharesIssuedDuringPeriodValueIssuedForServices": {
     "auth_ref": [],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares Issued During Period, Value, Issued For Services . Stock Compensation Expense Is Related To Both Options And RSU's.",
        "label": "Shares Issued During Period, Value, Issued For Services",
        "terseLabel": "Shares issued as payment for services"
       }
      }
     },
     "localname": "SharesIssuedDuringPeriodValueIssuedForServices",
     "nsuri": "http://www.dna.com/20220331",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pgen_StockIssuedDuringPeriodSharesStockOptionsExercisedAndRestrictedStockAwards": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period related to Restricted Stock Awards and exercises of stock options.",
        "label": "Stock Issued During Period, Shares, Stock Options Exercised and Restricted Stock Awards",
        "terseLabel": "Shares issued upon vesting of restricted stock units and for exercises of stock options (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercisedAndRestrictedStockAwards",
     "nsuri": "http://www.dna.com/20220331",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "pgen_StockIssuedDuringPeriodValueRestrictedStockAwardsVestedAndStockOptionsExercised": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued related to Restricted Stock Awards vested during the period and as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Restricted Stock Awards Vested and Stock Options Exercised",
        "terseLabel": "Shares issued upon vesting of restricted stock units and for exercises of stock options"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardsVestedAndStockOptionsExercised",
     "nsuri": "http://www.dna.com/20220331",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pgen_StockIssuedDuringThePeriodSharesAccruedCompensation": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued in lieu of cash for accrued compensation.",
        "label": "Stock Issued During The Period, Shares, Accrued Compensation",
        "terseLabel": "Shares issued for accrued compensation (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringThePeriodSharesAccruedCompensation",
     "nsuri": "http://www.dna.com/20220331",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "pgen_StockIssuedDuringThePeriodValueAccruedCompensation": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued in lieu of cash for accrued compensation.",
        "label": "Stock Issued During The Period, Value, Accrued Compensation",
        "terseLabel": "Shares issued for accrued compensation"
       }
      }
     },
     "localname": "StockIssuedDuringThePeriodValueAccruedCompensation",
     "nsuri": "http://www.dna.com/20220331",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pgen_SuppliesEmbryosAndOtherProductionMaterialsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplies, Embryos And Other Production Materials [Member]",
        "label": "Supplies, Embryos And Other Production Materials [Member]",
        "terseLabel": "Supplies, embryos and other production materials"
       }
      }
     },
     "localname": "SuppliesEmbryosAndOtherProductionMaterialsMember",
     "nsuri": "http://www.dna.com/20220331",
     "presentation": [
      "http://www.dna.com/role/InventoryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pgen_TaxableIncomeLoss": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Taxable income (loss)",
        "label": "Taxable Income Loss",
        "terseLabel": "Taxable loss"
       }
      }
     },
     "localname": "TaxableIncomeLoss",
     "nsuri": "http://www.dna.com/20220331",
     "presentation": [
      "http://www.dna.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pgen_ThirdSecurityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Third Security, LLC",
        "label": "Third Security [Member]",
        "terseLabel": "Third Security, LLC"
       }
      }
     },
     "localname": "ThirdSecurityMember",
     "nsuri": "http://www.dna.com/20220331",
     "presentation": [
      "http://www.dna.com/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pgen_TransOvaGeneticsLcMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trans Ova Genetics LC [Member]",
        "label": "Trans Ova Genetics Lc [Member]",
        "terseLabel": "Trans Ova Genetics, LC"
       }
      }
     },
     "localname": "TransOvaGeneticsLcMember",
     "nsuri": "http://www.dna.com/20220331",
     "presentation": [
      "http://www.dna.com/role/LinesofCreditandLongTermDebtLinesofCreditAdditionalInformationDetails",
      "http://www.dna.com/role/LinesofCreditandLongTermDebtLongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pgen_TransOvaSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trans Ova Segment [Member]",
        "label": "Trans Ova Segment [Member]",
        "terseLabel": "Trans Ova"
       }
      }
     },
     "localname": "TransOvaSegmentMember",
     "nsuri": "http://www.dna.com/20220331",
     "presentation": [
      "http://www.dna.com/role/SegmentsAdjustedEBITDAbyReportableSegmentDetails",
      "http://www.dna.com/role/SegmentsRevenuesbyReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pgen_UpfrontAndMilestonePaymentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Upfront and milestone payments received as collaboration for the entity's collaborations",
        "label": "Upfront And Milestone Payments [Member]",
        "terseLabel": "Add recognition of previously deferred revenue associated with upfront and milestone payments",
        "verboseLabel": "Upfront and milestone payments"
       }
      }
     },
     "localname": "UpfrontAndMilestonePaymentsMember",
     "nsuri": "http://www.dna.com/20220331",
     "presentation": [
      "http://www.dna.com/role/CollaborationandLicensingRevenueSummarizedCollaborationandLicensingRevenueDetails",
      "http://www.dna.com/role/SegmentsReconciliationofNetLossBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pgen_WorkInProcessMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Work In Process [Member]",
        "label": "Work In Process [Member]",
        "terseLabel": "Work in process"
       }
      }
     },
     "localname": "WorkInProcessMember",
     "nsuri": "http://www.dna.com/20220331",
     "presentation": [
      "http://www.dna.com/role/InventoryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pgen_XYLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "XY, LLC [Member]",
        "label": "XY, LLC [Member]",
        "terseLabel": "XY, LLC"
       }
      }
     },
     "localname": "XYLLCMember",
     "nsuri": "http://www.dna.com/20220331",
     "presentation": [
      "http://www.dna.com/role/CommitmentsandContingenciesContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r161",
      "r205",
      "r224",
      "r225",
      "r226",
      "r227",
      "r229",
      "r231",
      "r235",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r348",
      "r349",
      "r351",
      "r353",
      "r354",
      "r779",
      "r780",
      "r781",
      "r782",
      "r783",
      "r784",
      "r785",
      "r786",
      "r787",
      "r788",
      "r789"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by components, eliminations, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments.",
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/SegmentsReconciliationofNetLossBeforeIncomeTaxesDetails",
      "http://www.dna.com/role/SegmentsRevenuesbyReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r161",
      "r205",
      "r224",
      "r225",
      "r226",
      "r227",
      "r229",
      "r231",
      "r235",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r348",
      "r349",
      "r351",
      "r353",
      "r354",
      "r779",
      "r780",
      "r781",
      "r782",
      "r783",
      "r784",
      "r785",
      "r786",
      "r787",
      "r788",
      "r789"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components, elimination, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments.",
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/SegmentsReconciliationofNetLossBeforeIncomeTaxesDetails",
      "http://www.dna.com/role/SegmentsRevenuesbyReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock": {
     "auth_ref": [
      "r766"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of contractual obligation by timing of payment due. Includes, but is not limited to, long-term debt obligation, lease obligation, and purchase obligation.",
        "label": "Contractual Obligation, Fiscal Year Maturity [Table Text Block]",
        "terseLabel": "Contractual Obligation, Fiscal Year Maturity"
       }
      }
     },
     "localname": "ContractualObligationFiscalYearMaturityScheduleTableTextBlock",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/ShorttermandLongtermInvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r85",
      "r87",
      "r159",
      "r160",
      "r362",
      "r399",
      "r790"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of counterparty. A counterparty is the other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution.",
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CollaborationandLicensingRevenueSummarizedCollaborationandLicensingRevenueDetails",
      "http://www.dna.com/role/CollaborationandLicensingRevenueSummaryofDeferredRevenueDetails",
      "http://www.dna.com/role/CommitmentsandContingenciesContingenciesAdditionalInformationDetails",
      "http://www.dna.com/role/InvestmentsinJointVenturesIntrexonEnergyPartnersAdditionalInformationDetails",
      "http://www.dna.com/role/InvestmentsinJointVenturesIntrexonEnergyPartnersIIAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": {
     "auth_ref": [
      "r2",
      "r166",
      "r174",
      "r180",
      "r275",
      "r475",
      "r476",
      "r477",
      "r501",
      "r502",
      "r544",
      "r547",
      "r549",
      "r550",
      "r793"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (decrease) to financial statements for cumulative-effect adjustment in period of adoption of amendment to accounting standards.",
        "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]",
        "terseLabel": "Cumulative Effect, Period of Adoption, Adjustment"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofShareholdersEquity",
      "http://www.dna.com/role/LinesofCreditandLongTermDebtLongTermDebtAdditionalInformationDetails",
      "http://www.dna.com/role/SummaryofSignificantAccountingPoliciesRecentlyAdoptedAccountingPronouncementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAxis": {
     "auth_ref": [
      "r2",
      "r166",
      "r174",
      "r180",
      "r275",
      "r475",
      "r476",
      "r477",
      "r501",
      "r502",
      "r544",
      "r547",
      "r549",
      "r550",
      "r793"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by cumulative-effect adjustment to financial statements in period of adoption of amendment to accounting standards.",
        "label": "Cumulative Effect, Period of Adoption [Axis]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Axis]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofShareholdersEquity",
      "http://www.dna.com/role/LinesofCreditandLongTermDebtLongTermDebtAdditionalInformationDetails",
      "http://www.dna.com/role/SummaryofSignificantAccountingPoliciesRecentlyAdoptedAccountingPronouncementsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionDomain": {
     "auth_ref": [
      "r2",
      "r166",
      "r174",
      "r180",
      "r275",
      "r475",
      "r476",
      "r477",
      "r501",
      "r502",
      "r544",
      "r547",
      "r549",
      "r550",
      "r793"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cumulative-effect adjustment to financial statements in period of adoption of amendment to accounting standards.",
        "label": "Cumulative Effect, Period of Adoption [Domain]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Domain]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofShareholdersEquity",
      "http://www.dna.com/role/LinesofCreditandLongTermDebtLongTermDebtAdditionalInformationDetails",
      "http://www.dna.com/role/SummaryofSignificantAccountingPoliciesRecentlyAdoptedAccountingPronouncementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of investment including named security. Excludes entity that is consolidated.",
        "label": "Investment, Name [Domain]",
        "terseLabel": "Investment, Name [Domain]"
       }
      }
     },
     "localname": "EquityMethodInvesteeNameDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/InvestmentsinJointVenturesIntrexonEnergyPartnersAdditionalInformationDetails",
      "http://www.dna.com/role/InvestmentsinJointVenturesIntrexonEnergyPartnersIIAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_LitigationCaseAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of judicial proceeding, alternative dispute resolution or claim.",
        "label": "Litigation Case [Axis]",
        "terseLabel": "Litigation Case [Axis]"
       }
      }
     },
     "localname": "LitigationCaseAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CommitmentsandContingenciesContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Judicial proceeding, alternative dispute resolution or claim. For example, but not limited to, name of case, category of litigation, or other differentiating information.",
        "label": "Litigation Case [Domain]",
        "terseLabel": "Litigation Case [Domain]"
       }
      }
     },
     "localname": "LitigationCaseTypeDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CommitmentsandContingenciesContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r361",
      "r398",
      "r441",
      "r444",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r647",
      "r718",
      "r721",
      "r750",
      "r751"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Upper limit of the provided range.",
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/LinesofCreditandLongTermDebtLongTermDebtAdditionalInformationDetails",
      "http://www.dna.com/role/OperatingLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r361",
      "r398",
      "r441",
      "r444",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r647",
      "r718",
      "r721",
      "r750",
      "r751"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lower limit of the provided range.",
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/LinesofCreditandLongTermDebtLinesofCreditAdditionalInformationDetails",
      "http://www.dna.com/role/LinesofCreditandLongTermDebtLongTermDebtAdditionalInformationDetails",
      "http://www.dna.com/role/OperatingLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r238",
      "r425",
      "r428",
      "r650",
      "r717",
      "r719"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by product and service, or group of similar products and similar services.",
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CollaborationandLicensingRevenueSummaryofDeferredRevenueDetails",
      "http://www.dna.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r238",
      "r425",
      "r428",
      "r650",
      "r717",
      "r719"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product or service, or a group of similar products or similar services.",
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CollaborationandLicensingRevenueSummaryofDeferredRevenueDetails",
      "http://www.dna.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r361",
      "r398",
      "r430",
      "r441",
      "r444",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r647",
      "r718",
      "r721",
      "r750",
      "r751"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/LinesofCreditandLongTermDebtLinesofCreditAdditionalInformationDetails",
      "http://www.dna.com/role/LinesofCreditandLongTermDebtLongTermDebtAdditionalInformationDetails",
      "http://www.dna.com/role/OperatingLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r361",
      "r398",
      "r430",
      "r441",
      "r444",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r647",
      "r718",
      "r721",
      "r750",
      "r751"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/LinesofCreditandLongTermDebtLinesofCreditAdditionalInformationDetails",
      "http://www.dna.com/role/LinesofCreditandLongTermDebtLongTermDebtAdditionalInformationDetails",
      "http://www.dna.com/role/OperatingLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [
      "r86",
      "r87",
      "r159",
      "r160",
      "r362",
      "r399"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Named other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution.",
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CollaborationandLicensingRevenueSummarizedCollaborationandLicensingRevenueDetails",
      "http://www.dna.com/role/CollaborationandLicensingRevenueSummaryofDeferredRevenueDetails",
      "http://www.dna.com/role/CommitmentsandContingenciesContingenciesAdditionalInformationDetails",
      "http://www.dna.com/role/InvestmentsinJointVenturesIntrexonEnergyPartnersAdditionalInformationDetails",
      "http://www.dna.com/role/InvestmentsinJointVenturesIntrexonEnergyPartnersIIAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioForecastMember": {
     "auth_ref": [
      "r175",
      "r442",
      "r768"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information reported for future period. Excludes information expected to be reported in future period for effect on historical fact.",
        "label": "Forecast [Member]",
        "terseLabel": "Forecast"
       }
      }
     },
     "localname": "ScenarioForecastMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/SummaryofSignificantAccountingPoliciesRecentlyAdoptedAccountingPronouncementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r175",
      "r180",
      "r442"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts.",
        "label": "Scenario [Domain]",
        "terseLabel": "Scenario [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/SummaryofSignificantAccountingPoliciesRecentlyAdoptedAccountingPronouncementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "auth_ref": [
      "r267"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of investment including named security. Excludes entity that is consolidated.",
        "label": "Investment, Name [Axis]",
        "terseLabel": "Investment, Name [Axis]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/InvestmentsinJointVenturesIntrexonEnergyPartnersAdditionalInformationDetails",
      "http://www.dna.com/role/InvestmentsinJointVenturesIntrexonEnergyPartnersIIAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r239",
      "r240",
      "r425",
      "r429",
      "r720",
      "r741",
      "r742",
      "r743",
      "r744",
      "r745",
      "r746",
      "r747",
      "r748",
      "r749",
      "r769",
      "r771",
      "r772",
      "r773",
      "r774",
      "r775",
      "r776",
      "r777",
      "r778"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Geographical area.",
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/SegmentsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r239",
      "r240",
      "r425",
      "r429",
      "r720",
      "r735",
      "r741",
      "r742",
      "r743",
      "r744",
      "r745",
      "r746",
      "r747",
      "r748",
      "r749",
      "r769",
      "r770"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by geographical components.",
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/SegmentsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r175",
      "r180",
      "r328",
      "r442",
      "r616"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts.",
        "label": "Scenario [Axis]",
        "terseLabel": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/SummaryofSignificantAccountingPoliciesRecentlyAdoptedAccountingPronouncementsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r244",
      "r608"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by title of individual or nature of relationship to individual or group of individuals.",
        "label": "Title of Individual [Axis]",
        "terseLabel": "Title of Individual [Axis]"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/ShareBasedPaymentsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of individual, or nature of relationship to individual or group of individuals.",
        "label": "Title of Individual [Domain]",
        "terseLabel": "Title of Individual [Domain]"
       }
      }
     },
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/ShareBasedPaymentsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingStandardsUpdate202006RetrospectiveMember": {
     "auth_ref": [
      "r545",
      "r548"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting Standards Update 2020-06 Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity's Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity's Own Equity applied using retrospective transition method.",
        "label": "Accounting Standards Update 2020-06 Retrospective [Member]",
        "terseLabel": "Accounting Standards Update 2020-06 Retrospective"
       }
      }
     },
     "localname": "AccountingStandardsUpdate202006RetrospectiveMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/LinesofCreditandLongTermDebtLongTermDebtAdditionalInformationDetails",
      "http://www.dna.com/role/SummaryofSignificantAccountingPoliciesRecentlyAdoptedAccountingPronouncementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingStandardsUpdateExtensibleList": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r167",
      "r168",
      "r169",
      "r170",
      "r249",
      "r250",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r340",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r501",
      "r502",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r602",
      "r722",
      "r723",
      "r724",
      "r725",
      "r726",
      "r727",
      "r728",
      "r729",
      "r730",
      "r731",
      "r732",
      "r733",
      "r791",
      "r792",
      "r793",
      "r794",
      "r795"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates amendment to accounting standards.",
        "label": "Accounting Standards Update [Extensible Enumeration]",
        "terseLabel": "Accounting Standards Update [Extensible Enumeration]"
       }
      }
     },
     "localname": "AccountingStandardsUpdateExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r70",
      "r614"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r30",
      "r52",
      "r245",
      "r246"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Trade, less allowance for credit losses of $4,631 and $4,288 as of March\u00a031, 2022 and December\u00a031, 2021, respectively"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments": {
     "auth_ref": [
      "r142"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Accretion (Amortization) of Discounts and Premiums, Investments",
        "negatedLabel": "Amortization of premiums on investments, net"
       }
      }
     },
     "localname": "AccretionAmortizationOfDiscountsAndPremiumsInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r68",
      "r314"
     ],
     "calculation": {
      "http://www.dna.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedLabel": "Less: Accumulated depreciation and amortization"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember": {
     "auth_ref": [
      "r90",
      "r91",
      "r92",
      "r96",
      "r103",
      "r104",
      "r105"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), attributable to parent.",
        "label": "AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent [Member]",
        "terseLabel": "Unrealized loss on investments"
       }
      }
     },
     "localname": "AccumulatedNetUnrealizedInvestmentGainLossMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/ShareholdersEquityComponentsofAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/ShareholdersEquityComponentsofAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r55",
      "r94",
      "r95",
      "r96",
      "r702",
      "r729",
      "r733"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive (loss) income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [
      "r103",
      "r104",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r576"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/ShareholdersEquityComponentsofAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r93",
      "r96",
      "r103",
      "r104",
      "r105",
      "r163",
      "r164",
      "r165",
      "r527",
      "r724",
      "r725",
      "r795"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss)",
        "verboseLabel": "Total accumulated other comprehensive (loss) income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofShareholdersEquity",
      "http://www.dna.com/role/ShareholdersEquityComponentsofAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedTranslationAdjustmentMember": {
     "auth_ref": [
      "r88",
      "r96",
      "r103",
      "r104",
      "r105",
      "r527",
      "r571",
      "r572",
      "r573",
      "r574",
      "r576"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]",
        "terseLabel": "Income (loss) on foreign currency translation adjustments"
       }
      }
     },
     "localname": "AccumulatedTranslationAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/ShareholdersEquityComponentsofAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalCashFlowElementsInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Cash Flow Elements, Investing Activities [Abstract]",
        "terseLabel": "Additional Cash Flow Elements, Investing Activities [Abstract]"
       }
      }
     },
     "localname": "AdditionalCashFlowElementsInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/DiscontinuedOperationsNoncashItemsandPurchasesofPropertyPlantandEquipmentforMBPTitanDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r53",
      "r478",
      "r614"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r163",
      "r164",
      "r165",
      "r475",
      "r476",
      "r477",
      "r549"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofShareholdersEquity",
      "http://www.dna.com/role/LinesofCreditandLongTermDebtLongTermDebtAdditionalInformationDetails",
      "http://www.dna.com/role/SummaryofSignificantAccountingPoliciesRecentlyAdoptedAccountingPronouncementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r167",
      "r168",
      "r169",
      "r170",
      "r180",
      "r249",
      "r250",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r340",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r499",
      "r500",
      "r501",
      "r502",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r602",
      "r652",
      "r653",
      "r654",
      "r722",
      "r723",
      "r724",
      "r725",
      "r726",
      "r727",
      "r728",
      "r729",
      "r730",
      "r731",
      "r732",
      "r733",
      "r791",
      "r792",
      "r793",
      "r794",
      "r795"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by amendment to accounting standards.",
        "label": "Accounting Standards Update [Axis]",
        "terseLabel": "Accounting Standards Update [Axis]"
       }
      }
     },
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/LinesofCreditandLongTermDebtLongTermDebtAdditionalInformationDetails",
      "http://www.dna.com/role/SummaryofSignificantAccountingPoliciesRecentlyAdoptedAccountingPronouncementsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt": {
     "auth_ref": [
      "r357"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustment to additional paid in capital resulting from the recognition of convertible debt instruments as two separate components - a debt component and an equity component. This bifurcation may result in a basis difference associated with the liability component that represents a temporary difference for purposes of applying accounting for income taxes. The initial recognition of deferred taxes for the tax effect of that temporary difference is as an adjustment to additional paid in capital.",
        "label": "Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt",
        "terseLabel": "Equity component of convertible debt, net of issuance costs and deferred taxes"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/LinesofCreditandLongTermDebtLongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r445",
      "r447",
      "r480",
      "r481"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.dna.com/role/DiscontinuedOperationsNoncashItemsandPurchasesofPropertyPlantandEquipmentforMBPTitanDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r447",
      "r468",
      "r479"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-based Payment Arrangement, Expense",
        "negatedTerseLabel": "Stock-based compensation expense",
        "verboseLabel": "Stock-based compensation costs"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/SegmentsReconciliationofNetLossBeforeIncomeTaxesDetails",
      "http://www.dna.com/role/ShareBasedPaymentsScheduleofStockBasedCompensationCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r59",
      "r247",
      "r278"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable allowance for credit losses"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCostsAndDiscounts": {
     "auth_ref": [
      "r141",
      "r381",
      "r394",
      "r395",
      "r581"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs and Discounts",
        "terseLabel": "Accretion of debt discount and amortization of deferred financing costs"
       }
      }
     },
     "localname": "AmortizationOfFinancingCostsAndDiscounts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r141",
      "r302",
      "r308"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization expense"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/GoodwillandIntangibleAssetsNetAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r189"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/SummaryofSignificantAccountingPoliciesNetLossPerShareAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r189"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/SummaryofSignificantAccountingPoliciesNetLossPerShareAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/SummaryofSignificantAccountingPoliciesNetLossPerShareAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r189"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/SummaryofSignificantAccountingPoliciesNetLossPerShareAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]"
       }
      }
     },
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CollaborationandLicensingRevenueSummarizedCollaborationandLicensingRevenueDetails",
      "http://www.dna.com/role/CollaborationandLicensingRevenueSummaryofDeferredRevenueDetails",
      "http://www.dna.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.dna.com/role/CondensedConsolidatedStatementsofOperationsParenthetical",
      "http://www.dna.com/role/InvestmentsinJointVenturesIntrexonEnergyPartnersAdditionalInformationDetails",
      "http://www.dna.com/role/InvestmentsinJointVenturesIntrexonEnergyPartnersIIAdditionalInformationDetails",
      "http://www.dna.com/role/SegmentsReconciliationofNetLossBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AssetImpairmentCharges": {
     "auth_ref": [
      "r141",
      "r311"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.",
        "label": "Asset Impairment Charges",
        "negatedLabel": "Impairment losses"
       }
      }
     },
     "localname": "AssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/SegmentsReconciliationofNetLossBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r154",
      "r213",
      "r226",
      "r233",
      "r270",
      "r341",
      "r342",
      "r343",
      "r345",
      "r346",
      "r347",
      "r348",
      "r350",
      "r352",
      "r354",
      "r355",
      "r524",
      "r529",
      "r557",
      "r612",
      "r614",
      "r671",
      "r700"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r32",
      "r33",
      "r84",
      "r154",
      "r270",
      "r341",
      "r342",
      "r343",
      "r345",
      "r346",
      "r347",
      "r348",
      "r350",
      "r352",
      "r354",
      "r355",
      "r524",
      "r529",
      "r557",
      "r612",
      "r614"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r552"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "verboseLabel": "Fair value of financial assets measured at fair value on a recurring basis"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/FairValueMeasurementsSummaryofPlacementintheFairValueHierarchyofFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Fair Value Disclosure [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/FairValueMeasurementsSummaryofPlacementintheFairValueHierarchyofFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r256"
     ],
     "calculation": {
      "http://www.dna.com/role/ShorttermandLongtermInvestmentsSummaryofAmortizedCostGrossUnrealizedGainsandLossesandFairValueofShorttermandLongtermInvestmentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax",
        "verboseLabel": "Gross Unrealized Gains"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/ShorttermandLongtermInvestmentsSummaryofAmortizedCostGrossUnrealizedGainsandLossesandFairValueofShorttermandLongtermInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [
      "r257"
     ],
     "calculation": {
      "http://www.dna.com/role/ShorttermandLongtermInvestmentsSummaryofAmortizedCostGrossUnrealizedGainsandLossesandFairValueofShorttermandLongtermInvestmentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax",
        "negatedLabel": "Gross Unrealized Losses"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/ShorttermandLongtermInvestmentsSummaryofAmortizedCostGrossUnrealizedGainsandLossesandFairValueofShorttermandLongtermInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "auth_ref": [
      "r254",
      "r285"
     ],
     "calculation": {
      "http://www.dna.com/role/ShorttermandLongtermInvestmentsSummaryofAmortizedCostGrossUnrealizedGainsandLossesandFairValueofShorttermandLongtermInvestmentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Amortized Cost",
        "totalLabel": "Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/ShorttermandLongtermInvestmentsSummaryofAmortizedCostGrossUnrealizedGainsandLossesandFairValueofShorttermandLongtermInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue": {
     "auth_ref": [],
     "calculation": {
      "http://www.dna.com/role/ShorttermandLongtermInvestmentsContractualObligationFiscalYearMaturityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.",
        "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Fair Value",
        "terseLabel": "Due within one year"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/ShorttermandLongtermInvestmentsContractualObligationFiscalYearMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue": {
     "auth_ref": [],
     "calculation": {
      "http://www.dna.com/role/ShorttermandLongtermInvestmentsContractualObligationFiscalYearMaturityDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security, measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year through fifth year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.",
        "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Fair Value",
        "terseLabel": "After one year through two years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/ShorttermandLongtermInvestmentsContractualObligationFiscalYearMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate": {
     "auth_ref": [
      "r258",
      "r259",
      "r691"
     ],
     "calculation": {
      "http://www.dna.com/role/ShorttermandLongtermInvestmentsContractualObligationFiscalYearMaturityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date.",
        "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/ShorttermandLongtermInvestmentsContractualObligationFiscalYearMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r251",
      "r255",
      "r285",
      "r677"
     ],
     "calculation": {
      "http://www.dna.com/role/ShorttermandLongtermInvestmentsSummaryofAmortizedCostGrossUnrealizedGainsandLossesandFairValueofShorttermandLongtermInvestmentsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale",
        "terseLabel": "Aggregate Fair\u00a0Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/ShorttermandLongtermInvestmentsSummaryofAmortizedCostGrossUnrealizedGainsandLossesandFairValueofShorttermandLongtermInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent": {
     "auth_ref": [
      "r253",
      "r285"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as noncurrent.",
        "label": "Debt Securities, Available-for-sale, Noncurrent",
        "verboseLabel": "Long-term investments"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecuritiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r448",
      "r469"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/ShareBasedPaymentsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/InvestmentsinJointVenturesIntrexonEnergyPartnersAdditionalInformationDetails",
      "http://www.dna.com/role/InvestmentsinJointVenturesIntrexonEnergyPartnersIIAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r538",
      "r539"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/InvestmentsinJointVenturesIntrexonEnergyPartnersAdditionalInformationDetails",
      "http://www.dna.com/role/InvestmentsinJointVenturesIntrexonEnergyPartnersIIAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BuildingsAndImprovementsGross": {
     "auth_ref": [
      "r35",
      "r313"
     ],
     "calculation": {
      "http://www.dna.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of building structures held for productive use including addition, improvement, or renovation to the structure, including, but not limited to, interior masonry, interior flooring, electrical, and plumbing.",
        "label": "Buildings and Improvements, Gross",
        "terseLabel": "Buildings and building improvements"
       }
      }
     },
     "localname": "BuildingsAndImprovementsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "auth_ref": [
      "r145",
      "r146",
      "r147"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "terseLabel": "Purchases of property and equipment included in accounts payable and other accrued liabilities"
       }
      }
     },
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r29",
      "r65",
      "r143"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r135",
      "r143",
      "r148"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "End of period",
        "periodStartLabel": "Beginning of period",
        "totalLabel": "Cash, cash equivalents, and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Abstract]",
        "terseLabel": "Cash, cash equivalents, and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r135",
      "r568"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net decrease in cash, cash equivalents, and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]",
        "terseLabel": "Significant noncash activities"
       }
      }
     },
     "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CertificatesOfDepositMember": {
     "auth_ref": [
      "r694"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Short to medium-term investment available at banks and savings and loan institutions where a customer agrees to lend money to the institution for a certain amount of time and is paid a predetermined rate of interest. Certificates of deposit (CD) are typically Federal Deposit Insurance Corporation (FDIC) insured.",
        "label": "Certificates of Deposit [Member]",
        "terseLabel": "Certificates of deposit"
       }
      }
     },
     "localname": "CertificatesOfDepositMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/FairValueMeasurementsSummaryofPlacementintheFairValueHierarchyofFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.dna.com/role/ShorttermandLongtermInvestmentsSummaryofAmortizedCostGrossUnrealizedGainsandLossesandFairValueofShorttermandLongtermInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CollaborativeArrangementDisclosureTextBlock": {
     "auth_ref": [
      "r517",
      "r518",
      "r520"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.",
        "label": "Collaborative Arrangement Disclosure [Text Block]",
        "terseLabel": "Collaboration and Licensing Revenue"
       }
      }
     },
     "localname": "CollaborativeArrangementDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CollaborationandLicensingRevenue"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CollaborativeArrangementMember": {
     "auth_ref": [
      "r519"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual arrangement that involves two or more parties that both: (i) actively participate in a joint operating activity and (ii) are exposed to significant risks and rewards that depend on the commercial success of the joint operating activity.",
        "label": "Collaborative Arrangement [Member]",
        "terseLabel": "Collaboration and licensing agreements"
       }
      }
     },
     "localname": "CollaborativeArrangementMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CollaborationandLicensingRevenueSummarizedCollaborationandLicensingRevenueDetails",
      "http://www.dna.com/role/CollaborationandLicensingRevenueSummaryofDeferredRevenueDetails",
      "http://www.dna.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.dna.com/role/CondensedConsolidatedStatementsofOperationsParenthetical",
      "http://www.dna.com/role/InvestmentsinJointVenturesIntrexonEnergyPartnersAdditionalInformationDetails",
      "http://www.dna.com/role/InvestmentsinJointVenturesIntrexonEnergyPartnersIIAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]"
       }
      }
     },
     "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CollaborationandLicensingRevenueSummarizedCollaborationandLicensingRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r80",
      "r327",
      "r679",
      "r706"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies (Note 16)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r324",
      "r325",
      "r326",
      "r335",
      "r737"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r163",
      "r164",
      "r549"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockNoParValue": {
     "auth_ref": [
      "r50"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount per share of no-par value common stock.",
        "label": "Common Stock, No Par Value",
        "terseLabel": "Common stock, no par value (in usd per share)"
       }
      }
     },
     "localname": "CommonStockNoParValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r50"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "verboseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r50"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r50",
      "r412"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Balances (in shares)",
        "periodStartLabel": "Balances (in shares)",
        "terseLabel": "Common stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.dna.com/role/CondensedConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValueOutstanding": {
     "auth_ref": [
      "r50"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of all classes of common stock held by shareholders. May be all or portion of the number of common shares authorized. These shares exclude common shares repurchased by the entity and held as treasury shares.",
        "label": "Common Stock, Value, Outstanding",
        "terseLabel": "Common stock, no par value, 400,000,000 shares authorized as of March\u00a031, 2022 and December\u00a031, 2021; 207,693,277 shares and 206,739,874 shares issued and outstanding as of March\u00a031, 2022 and December\u00a031, 2021, respectively"
       }
      }
     },
     "localname": "CommonStockValueOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r99",
      "r101",
      "r102",
      "r115",
      "r686",
      "r713"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedStatementsofComprehensiveLoss": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive loss"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r150",
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConsolidationVariableInterestEntityPolicy": {
     "auth_ref": [
      "r528",
      "r531",
      "r533"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for consolidation to describe the significant judgments and assumptions made in determining whether a variable interest held by the entity requires the variable interest entity to be consolidated and (or) disclose information about its involvement with the variable interest entity; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; and the significant factors considered and judgments made in determining that the power to direct the activities that significantly impact the economic performance of the variable interest entity are shared (as defined).",
        "label": "Consolidation, Variable Interest Entity, Policy [Policy Text Block]",
        "terseLabel": "Variable Interest Entities"
       }
      }
     },
     "localname": "ConsolidationVariableInterestEntityPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConstructionInProgressGross": {
     "auth_ref": [
      "r313"
     ],
     "calculation": {
      "http://www.dna.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction in Progress, Gross",
        "terseLabel": "Construction and other assets in progress"
       }
      }
     },
     "localname": "ConstructionInProgressGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": {
     "auth_ref": [
      "r422"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.",
        "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]",
        "terseLabel": "Summary of Deferred Revenue"
       }
      }
     },
     "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CollaborationandLicensingRevenueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerLiability": {
     "auth_ref": [
      "r420",
      "r421",
      "r426"
     ],
     "calculation": {
      "http://www.dna.com/role/CollaborationandLicensingRevenueSummaryofDeferredRevenueDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Contract with Customer, Liability",
        "totalLabel": "Deferred revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CollaborationandLicensingRevenueSummaryofDeferredRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r420",
      "r421",
      "r426"
     ],
     "calculation": {
      "http://www.dna.com/role/CollaborationandLicensingRevenueSummaryofDeferredRevenueDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_ContractWithCustomerLiability",
       "weight": 1.0
      },
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract with Customer, Liability, Current",
        "terseLabel": "Deferred revenue",
        "verboseLabel": "Current portion of deferred revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CollaborationandLicensingRevenueSummaryofDeferredRevenueDetails",
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityNoncurrent": {
     "auth_ref": [
      "r420",
      "r421",
      "r426"
     ],
     "calculation": {
      "http://www.dna.com/role/CollaborationandLicensingRevenueSummaryofDeferredRevenueDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_ContractWithCustomerLiability",
       "weight": 1.0
      },
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.",
        "label": "Contract with Customer, Liability, Noncurrent",
        "netLabel": "Deferred revenue, net of current portion, related party",
        "terseLabel": "Contract with Customer, Liability, Noncurrent",
        "verboseLabel": "Long-term portion of deferred revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CollaborationandLicensingRevenueSummaryofDeferredRevenueDetails",
      "http://www.dna.com/role/CommitmentsandContingenciesContingenciesAdditionalInformationDetails",
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "auth_ref": [
      "r427"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.",
        "label": "Contract with Customer, Liability, Revenue Recognized",
        "terseLabel": "Add recognition of previously deferred revenue associated with upfront and milestone payments",
        "verboseLabel": "Revenues"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CollaborationandLicensingRevenueSummarizedCollaborationandLicensingRevenueDetails",
      "http://www.dna.com/role/SegmentsReconciliationofNetLossBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertibleDebt": {
     "auth_ref": [
      "r48",
      "r673",
      "r701"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company.",
        "label": "Convertible Debt",
        "verboseLabel": "Carrying value of convertible debt"
       }
      }
     },
     "localname": "ConvertibleDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://www.dna.com/role/LinesofCreditandLongTermDebtLongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertibleDebtFairValueDisclosures": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.",
        "label": "Convertible Debt, Fair Value Disclosures",
        "terseLabel": "Fair value of convertible debt"
       }
      }
     },
     "localname": "ConvertibleDebtFairValueDisclosures",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/FairValueMeasurementsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertibleDebtMember": {
     "auth_ref": [
      "r356",
      "r358",
      "r359",
      "r361",
      "r371",
      "r372",
      "r373",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r392",
      "r393",
      "r394",
      "r395"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.",
        "label": "Convertible Debt [Member]",
        "terseLabel": "Convertible debt"
       }
      }
     },
     "localname": "ConvertibleDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/LinesofCreditandLongTermDebtLongTermDebtAdditionalInformationDetails",
      "http://www.dna.com/role/LinesofCreditandLongTermDebtScheduleofLongTermDebtInstrumentsDetails",
      "http://www.dna.com/role/SummaryofSignificantAccountingPoliciesNetLossPerShareAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporateNonSegmentMember": {
     "auth_ref": [
      "r224",
      "r225",
      "r226",
      "r227",
      "r229",
      "r235",
      "r237"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.",
        "label": "Corporate, Non-Segment [Member]",
        "terseLabel": "Unallocated corporate costs"
       }
      }
     },
     "localname": "CorporateNonSegmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/SegmentsReconciliationofNetLossBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r118",
      "r650"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of products and services"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/LinesofCreditandLongTermDebtLinesofCreditAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/LinesofCreditandLongTermDebtLinesofCreditAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r155",
      "r497",
      "r505",
      "r507"
     ],
     "calculation": {
      "http://www.dna.com/role/IncomeTaxesComponentsofIncomeTaxBenefitsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.",
        "label": "Current Income Tax Expense (Benefit)",
        "terseLabel": "Current income tax expense from continuing operations"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/IncomeTaxesComponentsofIncomeTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r515"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/GoodwillandIntangibleAssetsNetScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r151",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r375",
      "r382",
      "r383",
      "r385",
      "r396"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Lines of Credit and Long-Term Debt"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/LinesofCreditandLongTermDebt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r45",
      "r47",
      "r48",
      "r153",
      "r161",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r365",
      "r371",
      "r372",
      "r373",
      "r374",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r392",
      "r393",
      "r394",
      "r395",
      "r582",
      "r672",
      "r673",
      "r698"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://www.dna.com/role/LinesofCreditandLongTermDebtLongTermDebtAdditionalInformationDetails",
      "http://www.dna.com/role/LinesofCreditandLongTermDebtScheduleofComponentsofInterestExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r48",
      "r386",
      "r673",
      "r698"
     ],
     "calculation": {
      "http://www.dna.com/role/LinesofCreditandLongTermDebtScheduleofFutureMaturitiesofLongTermDebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-term Debt, Gross",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/LinesofCreditandLongTermDebtScheduleofFutureMaturitiesofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentConvertibleConversionPrice1": {
     "auth_ref": [
      "r360",
      "r389"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The price per share of the conversion feature embedded in the debt instrument.",
        "label": "Debt Instrument, Convertible, Conversion Price",
        "verboseLabel": "Conversion price (in usd per share)"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionPrice1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/LinesofCreditandLongTermDebtLongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_DebtInstrumentConvertibleConversionRatio1": {
     "auth_ref": [
      "r77",
      "r360",
      "r413",
      "r414",
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.",
        "label": "Debt Instrument, Convertible, Conversion Ratio",
        "terseLabel": "Conversion rate"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionRatio1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/LinesofCreditandLongTermDebtLongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature.",
        "label": "Debt Instrument, Convertible, Threshold Consecutive Trading Days",
        "terseLabel": "Common stock price consecutive trading days"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdConsecutiveTradingDays1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/LinesofCreditandLongTermDebtLongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.",
        "label": "Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger",
        "terseLabel": "Percentage of common share price over conversion price for conversion"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/LinesofCreditandLongTermDebtLongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdTradingDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Threshold number of specified trading days that common stock price to conversion price of convertible debt instruments must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature.",
        "label": "Debt Instrument, Convertible, Threshold Trading Days",
        "terseLabel": "Common stock price trading days"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdTradingDays",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/LinesofCreditandLongTermDebtLongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r358",
      "r392",
      "r393",
      "r580",
      "r582",
      "r583"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Aggregate principal amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/LinesofCreditandLongTermDebtLongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateEffectivePercentage": {
     "auth_ref": [
      "r76",
      "r390",
      "r580",
      "r582"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.",
        "label": "Debt Instrument, Interest Rate, Effective Percentage",
        "terseLabel": "Effective interest rate on convertible notes"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateEffectivePercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/LinesofCreditandLongTermDebtLongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r76",
      "r359"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Debt instrument, interest rate, stated percentage"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://www.dna.com/role/LinesofCreditandLongTermDebtLinesofCreditAdditionalInformationDetails",
      "http://www.dna.com/role/LinesofCreditandLongTermDebtLongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/LinesofCreditandLongTermDebtLongTermDebtAdditionalInformationDetails",
      "http://www.dna.com/role/LinesofCreditandLongTermDebtScheduleofComponentsofInterestExpenseDetails",
      "http://www.dna.com/role/LinesofCreditandLongTermDebtScheduleofLongTermDebtInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r78",
      "r153",
      "r161",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r365",
      "r371",
      "r372",
      "r373",
      "r374",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r392",
      "r393",
      "r394",
      "r395",
      "r582"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://www.dna.com/role/LinesofCreditandLongTermDebtLongTermDebtAdditionalInformationDetails",
      "http://www.dna.com/role/LinesofCreditandLongTermDebtScheduleofComponentsofInterestExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentPeriodicPayment": {
     "auth_ref": [
      "r78",
      "r695"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the required periodic payments including both interest and principal payments.",
        "label": "Debt Instrument, Periodic Payment",
        "terseLabel": "Debt instrument, periodic payment"
       }
      }
     },
     "localname": "DebtInstrumentPeriodicPayment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/LinesofCreditandLongTermDebtLongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPricePercentage": {
     "auth_ref": [
      "r696"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.",
        "label": "Debt Instrument, Redemption Price, Percentage",
        "terseLabel": "Debt instrument redemption price, percentage"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPricePercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/LinesofCreditandLongTermDebtLongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r78",
      "r153",
      "r161",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r365",
      "r371",
      "r372",
      "r373",
      "r374",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r384",
      "r392",
      "r393",
      "r394",
      "r395",
      "r413",
      "r415",
      "r416",
      "r417",
      "r579",
      "r580",
      "r582",
      "r583",
      "r697"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/LinesofCreditandLongTermDebtLongTermDebtAdditionalInformationDetails",
      "http://www.dna.com/role/LinesofCreditandLongTermDebtScheduleofComponentsofInterestExpenseDetails",
      "http://www.dna.com/role/LinesofCreditandLongTermDebtScheduleofLongTermDebtInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet": {
     "auth_ref": [
      "r371",
      "r387",
      "r392",
      "r393",
      "r581"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unamortized debt discount (premium) and debt issuance costs.",
        "label": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net",
        "terseLabel": "Convertible notes, unamortized discount and issuance costs"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/LinesofCreditandLongTermDebtLongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTable": {
     "auth_ref": [
      "r262"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale [Table]",
        "terseLabel": "Debt Securities, Available-for-sale [Table]"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/ShorttermandLongtermInvestmentsSummaryofAmortizedCostGrossUnrealizedGainsandLossesandFairValueofShorttermandLongtermInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock": {
     "auth_ref": [
      "r262"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale [Table Text Block]",
        "terseLabel": "Summary of Amortized Cost, Gross Unrealized Gains and Losses, and Fair Value of Short-term and Long-term Investments"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/ShorttermandLongtermInvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DeferredFinanceCostsGross": {
     "auth_ref": [
      "r581"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Gross",
        "terseLabel": "Debt issuance costs"
       }
      }
     },
     "localname": "DeferredFinanceCostsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/LinesofCreditandLongTermDebtLongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r141",
      "r155",
      "r498",
      "r505",
      "r506",
      "r507"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.dna.com/role/IncomeTaxesComponentsofIncomeTaxBenefitsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred income taxes",
        "verboseLabel": "Deferred income tax benefit from continuing operations"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.dna.com/role/IncomeTaxesComponentsofIncomeTaxBenefitsDetails",
      "http://www.dna.com/role/LinesofCreditandLongTermDebtLongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r484",
      "r485"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsCapitalLossCarryforwards": {
     "auth_ref": [
      "r495",
      "r496"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible capital loss carryforwards.",
        "label": "Deferred Tax Assets, Capital Loss Carryforwards",
        "terseLabel": "Deferred tax assets, capital loss carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsCapitalLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch": {
     "auth_ref": [
      "r493",
      "r495",
      "r496"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.",
        "label": "Deferred Tax Assets, Tax Credit Carryforwards, Research",
        "terseLabel": "Research and development tax credits"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxCreditCarryforwardsResearch",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilities": {
     "auth_ref": [
      "r485",
      "r491"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.",
        "label": "Deferred Tax Liabilities, Net",
        "terseLabel": "Deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r141",
      "r312"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation expense"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/PropertyPlantandEquipmentNetAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r141",
      "r208"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "negatedTerseLabel": "Depreciation and amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.dna.com/role/SegmentsReconciliationofNetLossBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r482"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement [Text Block]",
        "terseLabel": "Share-Based Payments"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/ShareBasedPayments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]",
        "terseLabel": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax": {
     "auth_ref": [
      "r7",
      "r8",
      "r9",
      "r10",
      "r11",
      "r19",
      "r112",
      "r710"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of income (loss) from a discontinued operation. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.",
        "label": "Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax",
        "terseLabel": "Income before income taxes"
       }
      }
     },
     "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/DiscontinuedOperationsSummaryofFinancialResultsforMBPTitanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Discontinued Operations and Disposal Groups [Abstract]",
        "terseLabel": "Discontinued Operations and Disposal Groups [Abstract]"
       }
      }
     },
     "localname": "DiscontinuedOperationsAndDisposalGroupsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleAbandonmentMember": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components disposed of by means of abandonment and representing a strategic shift that has or will have a major effect on operations and financial results.",
        "label": "Discontinued Operations, Disposed of by Means Other than Sale, Abandonment [Member]",
        "terseLabel": "Discontinued Operations, Disposed of by Means Other than Sale, Abandonment"
       }
      }
     },
     "localname": "DiscontinuedOperationsDisposedOfByMeansOtherThanSaleAbandonmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/DiscontinuedOperationsNarrativeDetails",
      "http://www.dna.com/role/DiscontinuedOperationsNoncashItemsandPurchasesofPropertyPlantandEquipmentforMBPTitanDetails",
      "http://www.dna.com/role/DiscontinuedOperationsSummaryofFinancialResultsforMBPTitanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupClassificationAxis": {
     "auth_ref": [
      "r22"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by disposal group classification.",
        "label": "Disposal Group Classification [Axis]",
        "terseLabel": "Disposal Group Classification [Axis]"
       }
      }
     },
     "localname": "DisposalGroupClassificationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/DiscontinuedOperationsNarrativeDetails",
      "http://www.dna.com/role/DiscontinuedOperationsNoncashItemsandPurchasesofPropertyPlantandEquipmentforMBPTitanDetails",
      "http://www.dna.com/role/DiscontinuedOperationsSummaryofFinancialResultsforMBPTitanDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.",
        "label": "Disposal Group Classification [Domain]",
        "terseLabel": "Disposal Group Classification [Domain]"
       }
      }
     },
     "localname": "DisposalGroupClassificationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/DiscontinuedOperationsNarrativeDetails",
      "http://www.dna.com/role/DiscontinuedOperationsNoncashItemsandPurchasesofPropertyPlantandEquipmentforMBPTitanDetails",
      "http://www.dna.com/role/DiscontinuedOperationsSummaryofFinancialResultsforMBPTitanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense": {
     "auth_ref": [
      "r20"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating expense attributable to disposal group, including, but not limited to, discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Operating Expense",
        "verboseLabel": "Operating gains"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/DiscontinuedOperationsSummaryofFinancialResultsforMBPTitanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss": {
     "auth_ref": [
      "r20"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating income (loss) attributable to disposal group, including, but not limited to, discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Operating Income (Loss)",
        "terseLabel": "Operating income"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/DiscontinuedOperationsSummaryofFinancialResultsforMBPTitanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock": {
     "auth_ref": [
      "r27",
      "r320"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]",
        "terseLabel": "Discontinued Operations"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/DiscontinuedOperations"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "auth_ref": [
      "r440",
      "r443"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of disposal group.",
        "label": "Disposal Group Name [Domain]",
        "terseLabel": "Disposal Group Name [Domain]"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/DiscontinuedOperationsNarrativeDetails",
      "http://www.dna.com/role/DiscontinuedOperationsNoncashItemsandPurchasesofPropertyPlantandEquipmentforMBPTitanDetails",
      "http://www.dna.com/role/DiscontinuedOperationsSummaryofFinancialResultsforMBPTitanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DomesticCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.",
        "label": "Domestic Tax Authority [Member]",
        "terseLabel": "Domestic"
       }
      }
     },
     "localname": "DomesticCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DueFromRelatedPartiesCurrent": {
     "auth_ref": [
      "r31",
      "r41",
      "r51",
      "r158",
      "r344",
      "r346",
      "r347",
      "r353",
      "r354",
      "r355",
      "r606"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of receivables to be collected from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth, at the financial statement date. which are usually due within one year (or one business cycle).",
        "label": "Due from Related Parties, Current",
        "terseLabel": "Related parties, less allowance for credit losses of $1,509 as of March\u00a031, 2022 and December\u00a031, 2021"
       }
      }
     },
     "localname": "DueFromRelatedPartiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DueToRelatedPartiesCurrent": {
     "auth_ref": [
      "r70",
      "r158",
      "r344",
      "r346",
      "r347",
      "r353",
      "r354",
      "r355",
      "r606"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Due to Related Parties, Current",
        "terseLabel": "Related party payables"
       }
      }
     },
     "localname": "DueToRelatedPartiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r116",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r181",
      "r183",
      "r186",
      "r187",
      "r188",
      "r191",
      "r192",
      "r550",
      "r551",
      "r687",
      "r714"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "totalLabel": "Net loss per share, basic (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic and Diluted [Abstract]",
        "verboseLabel": "Net Loss per Share"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r116",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r183",
      "r186",
      "r187",
      "r188",
      "r191",
      "r192",
      "r550",
      "r551",
      "r687",
      "r714"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "totalLabel": "Net loss per share, diluted (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r189",
      "r190"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Net Loss Per Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r568"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "terseLabel": "Effect of exchange rate changes on cash, cash equivalents, and restricted cash"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r74"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Accrued compensation and benefits"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/ShareBasedPaymentsScheduleofStockBasedCompensationCostsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r466"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Share-based Payment Arrangement, Option"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/ShareBasedPaymentsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r2",
      "r103",
      "r104",
      "r105",
      "r163",
      "r164",
      "r165",
      "r168",
      "r177",
      "r179",
      "r193",
      "r275",
      "r412",
      "r418",
      "r475",
      "r476",
      "r477",
      "r501",
      "r502",
      "r549",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r576",
      "r724",
      "r725",
      "r726",
      "r795"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofShareholdersEquity",
      "http://www.dna.com/role/LinesofCreditandLongTermDebtLongTermDebtAdditionalInformationDetails",
      "http://www.dna.com/role/ShareholdersEquityComponentsofAccumulatedOtherComprehensiveIncomeLossDetails",
      "http://www.dna.com/role/SummaryofSignificantAccountingPoliciesRecentlyAdoptedAccountingPronouncementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "auth_ref": [
      "r267"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.",
        "label": "Equity Method Investment, Ownership Percentage",
        "verboseLabel": "Ownership interest"
       }
      }
     },
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/InvestmentsinJointVenturesIntrexonEnergyPartnersAdditionalInformationDetails",
      "http://www.dna.com/role/InvestmentsinJointVenturesIntrexonEnergyPartnersIIAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EquityMethodInvestments": {
     "auth_ref": [
      "r66",
      "r214",
      "r266"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.",
        "label": "Equity Method Investments",
        "terseLabel": "Investment"
       }
      }
     },
     "localname": "EquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/InvestmentsinJointVenturesIntrexonEnergyPartnersAdditionalInformationDetails",
      "http://www.dna.com/role/InvestmentsinJointVenturesIntrexonEnergyPartnersIIAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Method Investments and Joint Ventures [Abstract]",
        "terseLabel": "Equity Method Investments and Joint Ventures [Abstract]"
       }
      }
     },
     "localname": "EquityMethodInvestmentsAndJointVenturesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityMethodInvestmentsDisclosureTextBlock": {
     "auth_ref": [
      "r271"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group.",
        "label": "Equity Method Investments and Joint Ventures Disclosure [Text Block]",
        "terseLabel": "Investments in Joint Ventures"
       }
      }
     },
     "localname": "EquityMethodInvestmentsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/InvestmentsinJointVentures"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquityMethodInvestmentsPolicy": {
     "auth_ref": [
      "r66",
      "r134",
      "r268",
      "r557"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.",
        "label": "Equity Method Investments [Policy Text Block]",
        "terseLabel": "Equity Method Investments"
       }
      }
     },
     "localname": "EquityMethodInvestmentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://www.dna.com/role/FairValueMeasurementsSummaryofPlacementintheFairValueHierarchyofFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r552",
      "r553",
      "r554",
      "r556"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://www.dna.com/role/FairValueMeasurementsSummaryofPlacementintheFairValueHierarchyofFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": {
     "auth_ref": [
      "r552",
      "r553"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Fair Value, Assets Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Summary of Placement in the Fair Value Hierarchy of Financial Assets that are Measured at Fair Value on a Recurring Basis"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r373",
      "r392",
      "r393",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r439",
      "r553",
      "r620",
      "r621",
      "r622"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/FairValueMeasurementsSummaryofPlacementintheFairValueHierarchyofFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r555"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/FairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r373",
      "r431",
      "r432",
      "r437",
      "r439",
      "r553",
      "r620"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Quoted Prices in Active Markets (Level\u00a01)"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/FairValueMeasurementsSummaryofPlacementintheFairValueHierarchyofFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r373",
      "r392",
      "r393",
      "r431",
      "r432",
      "r437",
      "r439",
      "r553",
      "r621"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Significant Other Observable Inputs (Level\u00a02)"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/FairValueMeasurementsSummaryofPlacementintheFairValueHierarchyofFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r373",
      "r392",
      "r393",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r439",
      "r553",
      "r622"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Significant Unobservable Inputs (Level\u00a03)"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/FairValueMeasurementsSummaryofPlacementintheFairValueHierarchyofFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r373",
      "r392",
      "r393",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r439",
      "r620",
      "r621",
      "r622"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/FairValueMeasurementsSummaryofPlacementintheFairValueHierarchyofFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r260",
      "r261",
      "r263",
      "r264",
      "r265",
      "r279",
      "r281",
      "r282",
      "r283",
      "r284",
      "r286",
      "r287",
      "r288",
      "r289",
      "r384",
      "r410",
      "r540",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r758",
      "r759",
      "r760",
      "r761",
      "r762",
      "r763",
      "r764"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/FairValueMeasurementsSummaryofPlacementintheFairValueHierarchyofFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.dna.com/role/ShorttermandLongtermInvestmentsSummaryofAmortizedCostGrossUnrealizedGainsandLossesandFairValueofShorttermandLongtermInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r307"
     ],
     "calculation": {
      "http://www.dna.com/role/GoodwillandIntangibleAssetsNetScheduleofIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedLabel": "Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/GoodwillandIntangibleAssetsNetScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r303",
      "r304",
      "r307",
      "r309",
      "r651",
      "r655"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/GoodwillandIntangibleAssetsNetScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r307",
      "r655"
     ],
     "calculation": {
      "http://www.dna.com/role/GoodwillandIntangibleAssetsNetScheduleofIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Gross Carrying Amount"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/GoodwillandIntangibleAssetsNetScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/GoodwillandIntangibleAssetsNetScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r303",
      "r306"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/GoodwillandIntangibleAssetsNetScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r307",
      "r651"
     ],
     "calculation": {
      "http://www.dna.com/role/GoodwillandIntangibleAssetsNetScheduleofIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "totalLabel": "Net"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/GoodwillandIntangibleAssetsNetScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets, Net [Abstract]",
        "terseLabel": "Finite-Lived Intangible Assets, Net [Abstract]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/GoodwillandIntangibleAssetsNetScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ForeignCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.",
        "label": "Foreign Tax Authority [Member]",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "ForeignCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/IncomeTaxesComponentsofIncomeTaxBenefitsDetails",
      "http://www.dna.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FurnitureAndFixturesGross": {
     "auth_ref": [
      "r313"
     ],
     "calculation": {
      "http://www.dna.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures, Gross",
        "terseLabel": "Furniture and fixtures"
       }
      }
     },
     "localname": "FurnitureAndFixturesGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnDispositionOfAssets1": {
     "auth_ref": [
      "r141"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.",
        "label": "Gain (Loss) on Disposition of Assets",
        "negatedLabel": "Loss (gain) on disposals of assets, net",
        "negatedTerseLabel": "Gain on disposals of assets, net",
        "netLabel": "Gain (loss) on disposition of assets",
        "terseLabel": "Loss on disposals of assets"
       }
      }
     },
     "localname": "GainLossOnDispositionOfAssets1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.dna.com/role/DiscontinuedOperationsNarrativeDetails",
      "http://www.dna.com/role/DiscontinuedOperationsNoncashItemsandPurchasesofPropertyPlantandEquipmentforMBPTitanDetails",
      "http://www.dna.com/role/SegmentsReconciliationofNetLossBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnTerminationOfLease": {
     "auth_ref": [
      "r584"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on termination of lease before expiration of lease term.",
        "label": "Gain (Loss) on Termination of Lease",
        "negatedLabel": "Noncash gain on termination of leases",
        "terseLabel": "Gain on lease termination"
       }
      }
     },
     "localname": "GainLossOnTerminationOfLease",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/DiscontinuedOperationsNarrativeDetails",
      "http://www.dna.com/role/DiscontinuedOperationsNoncashItemsandPurchasesofPropertyPlantandEquipmentforMBPTitanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r291",
      "r293",
      "r614",
      "r670"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.dna.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesinCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r310"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Goodwill and Intangible Assets, Net"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/GoodwillandIntangibleAssetsNet"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r296"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Foreign currency translation adjustments"
       }
      }
     },
     "localname": "GoodwillForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesinCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillImpairedAccumulatedImpairmentLoss": {
     "auth_ref": [
      "r294",
      "r297"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impaired, Accumulated Impairment Loss",
        "terseLabel": "Goodwill accumulated impairment losses"
       }
      }
     },
     "localname": "GoodwillImpairedAccumulatedImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/GoodwillandIntangibleAssetsNetAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "auth_ref": [
      "r141",
      "r292",
      "r295",
      "r299"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.dna.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impairment Loss",
        "negatedLabel": "Impairment",
        "terseLabel": "Impairment of goodwill"
       }
      }
     },
     "localname": "GoodwillImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.dna.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.dna.com/role/GoodwillandIntangibleAssetsNetAdditionalInformationDetails",
      "http://www.dna.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesinCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesinCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r110",
      "r213",
      "r225",
      "r229",
      "r232",
      "r235",
      "r668",
      "r682",
      "r689",
      "r715"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "terseLabel": "Consolidated net loss from continuing operations before income taxes",
        "totalLabel": "Loss from continuing operations before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.dna.com/role/SegmentsReconciliationofNetLossBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r154",
      "r167",
      "r213",
      "r225",
      "r229",
      "r232",
      "r235",
      "r270",
      "r341",
      "r342",
      "r343",
      "r346",
      "r347",
      "r348",
      "r350",
      "r352",
      "r354",
      "r355",
      "r523",
      "r551",
      "r557"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Loss from continuing operations"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsPerBasicShare": {
     "auth_ref": [
      "r107",
      "r116",
      "r167",
      "r172",
      "r173",
      "r174",
      "r175",
      "r183",
      "r186",
      "r187",
      "r551",
      "r680",
      "r683",
      "r687",
      "r709"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_EarningsPerShareBasic",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.",
        "label": "Income (Loss) from Continuing Operations, Per Basic Share",
        "terseLabel": "Net loss from continuing operations per share, basic (in dollars per share)"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsPerBasicShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare": {
     "auth_ref": [
      "r107",
      "r116",
      "r167",
      "r172",
      "r173",
      "r174",
      "r175",
      "r183",
      "r186",
      "r187",
      "r188",
      "r551",
      "r687",
      "r709",
      "r712",
      "r714"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_EarningsPerShareDiluted",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Income (Loss) from Continuing Operations, Per Diluted Share",
        "terseLabel": "Net loss from continuing operating per share, diluted (in dollars per share)"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsPerDilutedShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax": {
     "auth_ref": [
      "r7",
      "r8",
      "r9",
      "r10",
      "r11",
      "r23",
      "r26",
      "r510",
      "r710"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.",
        "label": "Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Income from discontinued operations, net of income taxes"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity": {
     "auth_ref": [
      "r7",
      "r8",
      "r9",
      "r10",
      "r11",
      "r19",
      "r23",
      "r523"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from a discontinued operation attributable to the parent. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.",
        "label": "Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent",
        "terseLabel": "Income from discontinued operations"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/DiscontinuedOperationsNarrativeDetails",
      "http://www.dna.com/role/DiscontinuedOperationsSummaryofFinancialResultsforMBPTitanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare": {
     "auth_ref": [
      "r112",
      "r116",
      "r184",
      "r186",
      "r187",
      "r687",
      "r710",
      "r712",
      "r714"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_EarningsPerShareBasic",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.",
        "label": "Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share",
        "terseLabel": "Net income (loss) from discontinued operations per share, basic (in dollars per share)"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare": {
     "auth_ref": [
      "r184",
      "r186",
      "r187",
      "r536"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_EarningsPerShareDiluted",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.",
        "label": "Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share",
        "terseLabel": "Net income (loss) from discontinued operations per share, diluted (in dollars per share)"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r111",
      "r141",
      "r210",
      "r266",
      "r681",
      "r708"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 19.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.dna.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).",
        "label": "Income (Loss) from Equity Method Investments",
        "negatedLabel": "Equity in net loss of affiliates",
        "terseLabel": "Equity in net loss of affiliates"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.dna.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.dna.com/role/SegmentsReconciliationofNetLossBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "auth_ref": [
      "r440",
      "r443"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of disposal group.",
        "label": "Disposal Group Name [Axis]",
        "terseLabel": "Disposal Group Name [Axis]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/DiscontinuedOperationsNarrativeDetails",
      "http://www.dna.com/role/DiscontinuedOperationsNoncashItemsandPurchasesofPropertyPlantandEquipmentforMBPTitanDetails",
      "http://www.dna.com/role/DiscontinuedOperationsSummaryofFinancialResultsforMBPTitanDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]",
        "terseLabel": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/DiscontinuedOperationsNarrativeDetails",
      "http://www.dna.com/role/DiscontinuedOperationsNoncashItemsandPurchasesofPropertyPlantandEquipmentforMBPTitanDetails",
      "http://www.dna.com/role/DiscontinuedOperationsSummaryofFinancialResultsforMBPTitanDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": {
     "auth_ref": [
      "r5",
      "r13",
      "r14",
      "r15",
      "r16",
      "r17",
      "r18",
      "r21",
      "r24",
      "r25",
      "r26",
      "r318",
      "r319"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table]",
        "terseLabel": "Disposal Groups, Including Discontinued Operations [Table]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/DiscontinuedOperationsNarrativeDetails",
      "http://www.dna.com/role/DiscontinuedOperationsNoncashItemsandPurchasesofPropertyPlantandEquipmentforMBPTitanDetails",
      "http://www.dna.com/role/DiscontinuedOperationsSummaryofFinancialResultsforMBPTitanDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r316",
      "r321"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/ShareBasedPaymentsAdditionalInformationDetails",
      "http://www.dna.com/role/ShareBasedPaymentsScheduleofStockBasedCompensationCostsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r321"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/ShareBasedPaymentsAdditionalInformationDetails",
      "http://www.dna.com/role/ShareBasedPaymentsScheduleofStockBasedCompensationCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r489"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]",
        "terseLabel": "Income Tax Authority [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/IncomeTaxesComponentsofIncomeTaxBenefitsDetails",
      "http://www.dna.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]",
        "terseLabel": "Income Tax Authority [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/IncomeTaxesComponentsofIncomeTaxBenefitsDetails",
      "http://www.dna.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r156",
      "r488",
      "r490",
      "r492",
      "r503",
      "r508",
      "r511",
      "r512",
      "r513"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r157",
      "r178",
      "r179",
      "r211",
      "r486",
      "r504",
      "r509",
      "r716"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
       "weight": -1.0
      },
      "http://www.dna.com/role/IncomeTaxesComponentsofIncomeTaxBenefitsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedLabel": "Income tax benefit",
        "totalLabel": "Total income tax benefit from continuing operations"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.dna.com/role/IncomeTaxesComponentsofIncomeTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaid": {
     "auth_ref": [
      "r137",
      "r144"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.",
        "label": "Income Taxes Paid",
        "terseLabel": "Cash paid during the period for income taxes"
       }
      }
     },
     "localname": "IncomeTaxesPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableTrade": {
     "auth_ref": [
      "r140"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Payable, Trade",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableTrade",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r140"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 22.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Trade"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": {
     "auth_ref": [
      "r140",
      "r648"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Contract with Customer, Liability",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "IncreaseDecreaseInContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDueFromRelatedPartiesCurrent": {
     "auth_ref": [
      "r140"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate increase (decrease) during the reporting period in the amount due from the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; an entity and its principal owners, management, or member of their immediate families, affiliates, or other parties with the ability to exert significant influence.",
        "label": "Increase (Decrease) in Due from Related Parties, Current",
        "negatedLabel": "Related parties"
       }
      }
     },
     "localname": "IncreaseDecreaseInDueFromRelatedPartiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent": {
     "auth_ref": [
      "r140"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 20.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations to be paid to the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management; an entity and its principal owners, management, or member of their immediate families, affiliates, or other parties with the ability to exert significant influence.",
        "label": "Increase (Decrease) in Due to Related Parties, Current",
        "terseLabel": "Related party payables"
       }
      }
     },
     "localname": "IncreaseDecreaseInDueToRelatedPartiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities": {
     "auth_ref": [
      "r140"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 18.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Increase (Decrease) in Employee Related Liabilities",
        "terseLabel": "Accrued compensation and benefits"
       }
      }
     },
     "localname": "IncreaseDecreaseInEmployeeRelatedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r140"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventory"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": {
     "auth_ref": [
      "r140",
      "r594"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 21.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation for operating lease.",
        "label": "Increase (Decrease) in Operating Lease Liability",
        "terseLabel": "Lease liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherAccruedLiabilities": {
     "auth_ref": [
      "r140"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in other expenses incurred but not yet paid.",
        "label": "Increase (Decrease) in Other Accrued Liabilities",
        "terseLabel": "Other accrued liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssets": {
     "auth_ref": [
      "r140"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 24.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets",
        "negatedLabel": "Other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherReceivables": {
     "auth_ref": [
      "r140"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in receivables classified as other.",
        "label": "Increase (Decrease) in Other Receivables",
        "negatedLabel": "Other"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherReceivables",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r140"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid expenses and other"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInReceivablesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Receivables [Abstract]",
        "terseLabel": "Receivables:"
       }
      }
     },
     "localname": "IncreaseDecreaseInReceivablesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r301",
      "r305"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntellectualPropertyMember": {
     "auth_ref": [
      "r516"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible asset arising from original creative thought. Include, but is not limited to, trademarks, patents, and copyrights.",
        "label": "Intellectual Property [Member]",
        "terseLabel": "Patents, developed technologies and know-how"
       }
      }
     },
     "localname": "IntellectualPropertyMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/GoodwillandIntangibleAssetsNetScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r108",
      "r207",
      "r578",
      "r581",
      "r688"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedLabel": "Interest expense",
        "negatedTerseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.dna.com/role/SegmentsReconciliationofNetLossBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebt": {
     "auth_ref": [
      "r121",
      "r379",
      "r391",
      "r394",
      "r395"
     ],
     "calculation": {
      "http://www.dna.com/role/LinesofCreditandLongTermDebtScheduleofComponentsofInterestExpenseDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.",
        "label": "Interest Expense, Debt",
        "totalLabel": "Total interest expense"
       }
      }
     },
     "localname": "InterestExpenseDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/LinesofCreditandLongTermDebtScheduleofComponentsofInterestExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebtExcludingAmortization": {
     "auth_ref": [
      "r123",
      "r380",
      "r394",
      "r395"
     ],
     "calculation": {
      "http://www.dna.com/role/LinesofCreditandLongTermDebtScheduleofComponentsofInterestExpenseDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InterestExpenseDebt",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs.",
        "label": "Interest Expense, Debt, Excluding Amortization",
        "terseLabel": "Cash interest expense"
       }
      }
     },
     "localname": "InterestExpenseDebtExcludingAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/LinesofCreditandLongTermDebtScheduleofComponentsofInterestExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of interest income and expense, including, but not limited to, interest income and expense from investments, loans, and securities.",
        "label": "Interest Income and Interest Expense Disclosure [Table Text Block]",
        "terseLabel": "Schedule of Components of Interest Expense"
       }
      }
     },
     "localname": "InterestIncomeAndInterestExpenseDisclosureTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/LinesofCreditandLongTermDebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r133",
      "r136",
      "r144"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Cash paid during the period for interest"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPayableCurrentAndNoncurrent": {
     "auth_ref": [
      "r678",
      "r707"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest payable on debt, including, but not limited to, trade payables.",
        "label": "Interest Payable",
        "terseLabel": "Accrued interest"
       }
      }
     },
     "localname": "InterestPayableCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/LinesofCreditandLongTermDebtLongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestReceivable": {
     "auth_ref": [
      "r83"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of interest earned but not received. Also called accrued interest or accrued interest receivable.",
        "label": "Interest Receivable",
        "terseLabel": "Interest receivable"
       }
      }
     },
     "localname": "InterestReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CommitmentsandContingenciesContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntersegmentEliminationMember": {
     "auth_ref": [
      "r205",
      "r224",
      "r225",
      "r226",
      "r227",
      "r229",
      "r231",
      "r235"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Eliminating entries used in operating segment consolidation.",
        "label": "Intersegment Eliminations [Member]",
        "terseLabel": "Intersegment revenues",
        "verboseLabel": "Eliminations"
       }
      }
     },
     "localname": "IntersegmentEliminationMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/SegmentsReconciliationofNetLossBeforeIncomeTaxesDetails",
      "http://www.dna.com/role/SegmentsRevenuesbyReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryCurrentTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about inventory expected to be sold or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Current [Table]",
        "terseLabel": "Inventory, Current [Table]"
       }
      }
     },
     "localname": "InventoryCurrentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/InventoryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Abstract]",
        "terseLabel": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "localname": "InventoryDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "auth_ref": [
      "r290"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.",
        "label": "Inventory Disclosure [Text Block]",
        "terseLabel": "Inventory"
       }
      }
     },
     "localname": "InventoryDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/Inventory"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryGross": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross amount, as of the balance sheet date, of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Inventory, Gross",
        "terseLabel": "Inventory"
       }
      }
     },
     "localname": "InventoryGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.dna.com/role/InventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Inventory [Line Items]",
        "terseLabel": "Inventory [Line Items]"
       }
      }
     },
     "localname": "InventoryLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/InventoryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentIncomeNonoperating": {
     "auth_ref": [
      "r120"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income from investments (for example, dividends) not considered a component of the entity's core operations.",
        "label": "Investment Income, Nonoperating",
        "terseLabel": "Interest income"
       }
      }
     },
     "localname": "InvestmentIncomeNonoperating",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments, Debt and Equity Securities [Abstract]",
        "terseLabel": "Investments, Debt and Equity Securities [Abstract]"
       }
      }
     },
     "localname": "InvestmentsDebtAndEquitySecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r262",
      "r669",
      "r692",
      "r734",
      "r765"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for  investments in certain debt and equity securities.",
        "label": "Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]",
        "terseLabel": "Short-term and Long-term Investments"
       }
      }
     },
     "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/ShorttermandLongtermInvestments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestorMember": {
     "auth_ref": [
      "r605",
      "r606"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business entity or individual that puts money, by purchase or expenditure, in something offering potential profitable returns, such as interest income or appreciation in value.",
        "label": "Investor [Member]",
        "terseLabel": "Investors"
       }
      }
     },
     "localname": "InvestorMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/InvestmentsinJointVenturesIntrexonEnergyPartnersAdditionalInformationDetails",
      "http://www.dna.com/role/InvestmentsinJointVenturesIntrexonEnergyPartnersIIAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LandAndLandImprovements": {
     "auth_ref": [
      "r36",
      "r42"
     ],
     "calculation": {
      "http://www.dna.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated deprecation and depletion of real estate held for productive use and additions or improvements to real estate held for productive use, examples include, but are not limited to, walkways, driveways, fences, and parking lots. Excludes land held for sale.",
        "label": "Land and Land Improvements",
        "terseLabel": "Land and land improvements"
       }
      }
     },
     "localname": "LandAndLandImprovements",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCost": {
     "auth_ref": [
      "r598",
      "r600"
     ],
     "calculation": {
      "http://www.dna.com/role/OperatingLeasesComponentsofLeaseCostsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease cost recognized by lessee for lease contract.",
        "label": "Lease, Cost",
        "totalLabel": "Lease costs"
       }
      }
     },
     "localname": "LeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/OperatingLeasesComponentsofLeaseCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r598"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Components of Lease Costs"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/OperatingLeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseholdImprovementsGross": {
     "auth_ref": [
      "r35",
      "r313"
     ],
     "calculation": {
      "http://www.dna.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements, Gross",
        "terseLabel": "Leasehold improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Lessee, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/OperatingLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r589"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/OperatingLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r599"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Maturities of Lease Liabilities"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/OperatingLeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r599"
     ],
     "calculation": {
      "http://www.dna.com/role/OperatingLeasesMaturitiesofLeaseLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.dna.com/role/OperatingLeasesMaturitiesofLeaseLiabilitiesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/OperatingLeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r599"
     ],
     "calculation": {
      "http://www.dna.com/role/OperatingLeasesMaturitiesofLeaseLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/OperatingLeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r599"
     ],
     "calculation": {
      "http://www.dna.com/role/OperatingLeasesMaturitiesofLeaseLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/OperatingLeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r599"
     ],
     "calculation": {
      "http://www.dna.com/role/OperatingLeasesMaturitiesofLeaseLiabilitiesDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/OperatingLeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r599"
     ],
     "calculation": {
      "http://www.dna.com/role/OperatingLeasesMaturitiesofLeaseLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/OperatingLeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r599"
     ],
     "calculation": {
      "http://www.dna.com/role/OperatingLeasesMaturitiesofLeaseLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/OperatingLeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r599"
     ],
     "calculation": {
      "http://www.dna.com/role/OperatingLeasesMaturitiesofLeaseLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/OperatingLeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "auth_ref": [
      "r599"
     ],
     "calculation": {
      "http://www.dna.com/role/OperatingLeasesMaturitiesofLeaseLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/OperatingLeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r599"
     ],
     "calculation": {
      "http://www.dna.com/role/OperatingLeasesMaturitiesofLeaseLiabilitiesDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Present value adjustment"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/OperatingLeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseRemainingLeaseTerm": {
     "auth_ref": [
      "r588"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Remaining Lease Term",
        "terseLabel": "Term of contract"
       }
      }
     },
     "localname": "LesseeOperatingLeaseRemainingLeaseTerm",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/OperatingLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r601"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Operating Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/OperatingLeases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r73",
      "r154",
      "r227",
      "r270",
      "r341",
      "r342",
      "r343",
      "r346",
      "r347",
      "r348",
      "r350",
      "r352",
      "r354",
      "r355",
      "r525",
      "r529",
      "r530",
      "r557",
      "r612",
      "r613"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r58",
      "r154",
      "r270",
      "r557",
      "r614",
      "r674",
      "r704"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and shareholders' equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "Liabilities and Shareholders' Equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r75",
      "r154",
      "r270",
      "r341",
      "r342",
      "r343",
      "r346",
      "r347",
      "r348",
      "r350",
      "r352",
      "r354",
      "r355",
      "r525",
      "r529",
      "r530",
      "r557",
      "r612",
      "r613",
      "r614"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCredit": {
     "auth_ref": [
      "r48",
      "r673",
      "r698"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Long-term Line of Credit",
        "terseLabel": "Line of credit facility, outstanding balance"
       }
      }
     },
     "localname": "LineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/LinesofCreditandLongTermDebtLinesofCreditAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityAxis": {
     "auth_ref": [
      "r71",
      "r153"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of lender, which may be a single entity (for example, but not limited to, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit.",
        "label": "Lender Name [Axis]",
        "terseLabel": "Lender Name [Axis]"
       }
      }
     },
     "localname": "LineOfCreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/LinesofCreditandLongTermDebtLinesofCreditAdditionalInformationDetails",
      "http://www.dna.com/role/LinesofCreditandLongTermDebtLongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity": {
     "auth_ref": [
      "r71"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Current Borrowing Capacity",
        "terseLabel": "Line of credit facility, current borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityCurrentBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/LinesofCreditandLongTermDebtLinesofCreditAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd": {
     "auth_ref": [
      "r71"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The effective interest rate at the end of the reporting period.",
        "label": "Line of Credit Facility, Interest Rate at Period End",
        "terseLabel": "Line of credit facility, interest rate at period end"
       }
      }
     },
     "localname": "LineOfCreditFacilityInterestRateAtPeriodEnd",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/LinesofCreditandLongTermDebtLinesofCreditAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LineOfCreditFacilityLenderDomain": {
     "auth_ref": [
      "r71",
      "r153"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the lender, which may be a single entity (for example, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit, including a letter of credit facility.",
        "label": "Line of Credit Facility, Lender [Domain]",
        "terseLabel": "Line of Credit Facility, Lender [Domain]"
       }
      }
     },
     "localname": "LineOfCreditFacilityLenderDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/LinesofCreditandLongTermDebtLinesofCreditAdditionalInformationDetails",
      "http://www.dna.com/role/LinesofCreditandLongTermDebtLongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LineOfCreditFacilityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Line of Credit Facility [Line Items]",
        "terseLabel": "Line of Credit Facility [Line Items]"
       }
      }
     },
     "localname": "LineOfCreditFacilityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/LinesofCreditandLongTermDebtLinesofCreditAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r71"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Line of credit facility, maximum borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/LinesofCreditandLongTermDebtLinesofCreditAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityTable": {
     "auth_ref": [
      "r71",
      "r153"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.",
        "label": "Line of Credit Facility [Table]",
        "terseLabel": "Line of Credit Facility [Table]"
       }
      }
     },
     "localname": "LineOfCreditFacilityTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/LinesofCreditandLongTermDebtLinesofCreditAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r48",
      "r372",
      "r388",
      "r392",
      "r393",
      "r673",
      "r701"
     ],
     "calculation": {
      "http://www.dna.com/role/LinesofCreditandLongTermDebtScheduleofLongTermDebtInstrumentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "terseLabel": "Long-term debt",
        "totalLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/LinesofCreditandLongTermDebtLongTermDebtAdditionalInformationDetails",
      "http://www.dna.com/role/LinesofCreditandLongTermDebtScheduleofLongTermDebtInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r72"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.dna.com/role/LinesofCreditandLongTermDebtScheduleofLongTermDebtInstrumentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Current Maturities",
        "terseLabel": "Current portion of long-term debt",
        "verboseLabel": "Less current portion"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.dna.com/role/LinesofCreditandLongTermDebtScheduleofLongTermDebtInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive": {
     "auth_ref": [
      "r161",
      "r338",
      "r377"
     ],
     "calculation": {
      "http://www.dna.com/role/LinesofCreditandLongTermDebtScheduleofFutureMaturitiesofLongTermDebtDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/LinesofCreditandLongTermDebtScheduleofFutureMaturitiesofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [
      "r161",
      "r338",
      "r377"
     ],
     "calculation": {
      "http://www.dna.com/role/LinesofCreditandLongTermDebtScheduleofFutureMaturitiesofLongTermDebtDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/LinesofCreditandLongTermDebtScheduleofFutureMaturitiesofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive": {
     "auth_ref": [
      "r161",
      "r338",
      "r377"
     ],
     "calculation": {
      "http://www.dna.com/role/LinesofCreditandLongTermDebtScheduleofFutureMaturitiesofLongTermDebtDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Five",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/LinesofCreditandLongTermDebtScheduleofFutureMaturitiesofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": {
     "auth_ref": [
      "r161",
      "r338",
      "r377"
     ],
     "calculation": {
      "http://www.dna.com/role/LinesofCreditandLongTermDebtScheduleofFutureMaturitiesofLongTermDebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/LinesofCreditandLongTermDebtScheduleofFutureMaturitiesofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "auth_ref": [
      "r161",
      "r338",
      "r377"
     ],
     "calculation": {
      "http://www.dna.com/role/LinesofCreditandLongTermDebtScheduleofFutureMaturitiesofLongTermDebtDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/LinesofCreditandLongTermDebtScheduleofFutureMaturitiesofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [
      "r161",
      "r338",
      "r377"
     ],
     "calculation": {
      "http://www.dna.com/role/LinesofCreditandLongTermDebtScheduleofFutureMaturitiesofLongTermDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/LinesofCreditandLongTermDebtScheduleofFutureMaturitiesofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear": {
     "auth_ref": [
      "r161"
     ],
     "calculation": {
      "http://www.dna.com/role/LinesofCreditandLongTermDebtScheduleofFutureMaturitiesofLongTermDebtDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year.",
        "label": "Long-Term Debt, Maturity, Remainder of Fiscal Year",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/LinesofCreditandLongTermDebtScheduleofFutureMaturitiesofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r78"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://www.dna.com/role/LinesofCreditandLongTermDebtScheduleofLongTermDebtInstrumentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Excluding Current Maturities",
        "terseLabel": "Long-term debt, net of current portion",
        "verboseLabel": "Long-term debt, less current portion"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.dna.com/role/LinesofCreditandLongTermDebtLongTermDebtAdditionalInformationDetails",
      "http://www.dna.com/role/LinesofCreditandLongTermDebtScheduleofLongTermDebtInstrumentsDetails",
      "http://www.dna.com/role/SummaryofSignificantAccountingPoliciesRecentlyAdoptedAccountingPronouncementsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r78"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/LinesofCreditandLongTermDebtLongTermDebtAdditionalInformationDetails",
      "http://www.dna.com/role/LinesofCreditandLongTermDebtScheduleofLongTermDebtInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r78",
      "r339"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/LinesofCreditandLongTermDebtLongTermDebtAdditionalInformationDetails",
      "http://www.dna.com/role/LinesofCreditandLongTermDebtScheduleofLongTermDebtInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CommitmentsandContingenciesContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r327",
      "r328",
      "r329",
      "r331",
      "r332",
      "r333",
      "r334",
      "r336",
      "r337"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CommitmentsandContingenciesContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyClaimsSettledNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of claims settled.",
        "label": "Loss Contingency, Claims Settled, Number",
        "terseLabel": "Loss contingency, claims settled, number"
       }
      }
     },
     "localname": "LossContingencyClaimsSettledNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CommitmentsandContingenciesContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_LossContingencyPendingClaimsNumber": {
     "auth_ref": [
      "r330"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of pending claims pertaining to a loss contingency.",
        "label": "Loss Contingency, Pending Claims, Number",
        "terseLabel": "Claims pending resolution"
       }
      }
     },
     "localname": "LossContingencyPendingClaimsNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CommitmentsandContingenciesContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_MachineryAndEquipmentGross": {
     "auth_ref": [
      "r35",
      "r313"
     ],
     "calculation": {
      "http://www.dna.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.",
        "label": "Machinery and Equipment, Gross",
        "terseLabel": "Equipment"
       }
      }
     },
     "localname": "MachineryAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r135"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash (used in) provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract]",
        "terseLabel": "Cash flows from financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r135"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash provided by (used in) investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract]",
        "terseLabel": "Cash flows from investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r135",
      "r139",
      "r142"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]",
        "terseLabel": "Cash flows from operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r26",
      "r97",
      "r100",
      "r105",
      "r113",
      "r142",
      "r154",
      "r167",
      "r172",
      "r173",
      "r174",
      "r175",
      "r178",
      "r179",
      "r185",
      "r213",
      "r225",
      "r229",
      "r232",
      "r235",
      "r270",
      "r341",
      "r342",
      "r343",
      "r346",
      "r347",
      "r348",
      "r350",
      "r352",
      "r354",
      "r355",
      "r551",
      "r557",
      "r684",
      "r711"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.dna.com/role/CondensedConsolidatedStatementsofComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      },
      "http://www.dna.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "netLabel": "Net income (loss) attributable to parent",
        "terseLabel": "Net Income (Loss) Attributable to Parent",
        "totalLabel": "Net loss"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.dna.com/role/CondensedConsolidatedStatementsofComprehensiveLoss",
      "http://www.dna.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.dna.com/role/CondensedConsolidatedStatementsofShareholdersEquity",
      "http://www.dna.com/role/SummaryofSignificantAccountingPoliciesLiquidityAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]",
        "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/SummaryofSignificantAccountingPoliciesRecentlyAdoptedAccountingPronouncementsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r166",
      "r167",
      "r168",
      "r169",
      "r170",
      "r171",
      "r174",
      "r180",
      "r191",
      "r249",
      "r250",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r340",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r499",
      "r500",
      "r501",
      "r502",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r602",
      "r652",
      "r653",
      "r654",
      "r722",
      "r723",
      "r724",
      "r725",
      "r726",
      "r727",
      "r728",
      "r729",
      "r730",
      "r731",
      "r732",
      "r733",
      "r791",
      "r792",
      "r793",
      "r794",
      "r795"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of the changes in an accounting principle or a new accounting pronouncement, including the line items affected by the change and the financial effects of the change on those particular line items.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Table]",
        "terseLabel": "Accounting Standards Update and Change in Accounting Principle [Table]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/SummaryofSignificantAccountingPoliciesRecentlyAdoptedAccountingPronouncementsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recently Issued and Adopted Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NonUsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Countries excluding the United States of America (US).",
        "label": "Non-US [Member]",
        "terseLabel": "Non-US"
       }
      }
     },
     "localname": "NonUsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/SegmentsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r120"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "totalLabel": "Total other expense, net"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonoperating Income (Expense) [Abstract]",
        "terseLabel": "Other Expense, Net"
       }
      }
     },
     "localname": "NonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NotesPayableToBanksMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A written promise to pay a note to a bank.",
        "label": "Notes Payable to Banks [Member]",
        "terseLabel": "Notes payable"
       }
      }
     },
     "localname": "NotesPayableToBanksMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/LinesofCreditandLongTermDebtLongTermDebtAdditionalInformationDetails",
      "http://www.dna.com/role/LinesofCreditandLongTermDebtScheduleofLongTermDebtInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating Expenses"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r213",
      "r225",
      "r229",
      "r232",
      "r235"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Operating loss"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r590",
      "r600"
     ],
     "calculation": {
      "http://www.dna.com/role/OperatingLeasesComponentsofLeaseCostsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating lease costs"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/OperatingLeasesComponentsofLeaseCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, Payment, Due [Abstract]",
        "terseLabel": "Lessee, Operating Lease, Liability, Payment, Due [Abstract]"
       }
      }
     },
     "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/OperatingLeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r586"
     ],
     "calculation": {
      "http://www.dna.com/role/OperatingLeasesMaturitiesofLeaseLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.dna.com/role/OperatingLeasesMaturitiesofLeaseLiabilitiesDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/OperatingLeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r586"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.dna.com/role/OperatingLeasesMaturitiesofLeaseLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Current portion of lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.dna.com/role/OperatingLeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r586"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://www.dna.com/role/OperatingLeasesMaturitiesofLeaseLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Lease liabilities, net of current portion",
        "verboseLabel": "Long-term portion of operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.dna.com/role/OperatingLeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r587",
      "r594"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Cash paid for operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/OperatingLeasesOtherInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r585"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r597",
      "r600"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted average discount rate"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/OperatingLeasesLeaseTermsandDiscountRatesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r596",
      "r600"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted average remaining lease term (years)"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/OperatingLeasesLeaseTermsandDiscountRatesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r493"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Operating Loss Carryforwards",
        "terseLabel": "Operating loss carryforwards"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLossCarryforwardsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Operating Loss Carryforwards [Line Items]",
        "terseLabel": "Operating Loss Carryforwards [Line Items]"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/IncomeTaxesComponentsofIncomeTaxBenefitsDetails",
      "http://www.dna.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLossCarryforwardsTable": {
     "auth_ref": [
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.",
        "label": "Operating Loss Carryforwards [Table]",
        "terseLabel": "Operating Loss Carryforwards [Table]"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/IncomeTaxesComponentsofIncomeTaxBenefitsDetails",
      "http://www.dna.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r224",
      "r225",
      "r226",
      "r227",
      "r229",
      "r235"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating segments"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/SegmentsReconciliationofNetLossBeforeIncomeTaxesDetails",
      "http://www.dna.com/role/SegmentsRevenuesbyReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r28",
      "r537"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "terseLabel": "Organization"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/Organization"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r37",
      "r38",
      "r39",
      "r74"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other accrued liabilities"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r69"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r89",
      "r94",
      "r566",
      "r567",
      "r569"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedStatementsofComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax",
        "terseLabel": "Loss on foreign currency translation adjustments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax": {
     "auth_ref": [
      "r90",
      "r91",
      "r94"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedStatementsofComprehensiveLoss": {
       "order": 3.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax",
        "terseLabel": "Unrealized loss on investments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r98",
      "r101",
      "r103",
      "r104",
      "r106",
      "r114",
      "r412",
      "r570",
      "r575",
      "r576",
      "r685",
      "r712"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Other comprehensive income (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive loss:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofComprehensiveLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r79"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r142"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 23.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedLabel": "Other noncash items",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.dna.com/role/SegmentsReconciliationofNetLossBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r122"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other income (expense), net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherReceivablesNetCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.",
        "label": "Other Receivables, Net, Current",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherReceivablesNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForLegalSettlements": {
     "auth_ref": [
      "r138"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid for the settlement of litigation or for other legal issues during the period.",
        "label": "Payments for Legal Settlements",
        "terseLabel": "Payments for civil money penalty"
       }
      }
     },
     "localname": "PaymentsForLegalSettlements",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CommitmentsandContingenciesContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireInterestInJointVenture": {
     "auth_ref": [
      "r127"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the investment in or advances to an entity in which the reporting entity shares control of the entity with another party or group.",
        "label": "Payments to Acquire Interest in Joint Venture",
        "verboseLabel": "Capital contributions"
       }
      }
     },
     "localname": "PaymentsToAcquireInterestInJointVenture",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/InvestmentsinJointVenturesIntrexonEnergyPartnersAdditionalInformationDetails",
      "http://www.dna.com/role/InvestmentsinJointVenturesIntrexonEnergyPartnersIIAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireInvestments": {
     "auth_ref": [
      "r129"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of all investments (debt, security, other) during the period.",
        "label": "Payments to Acquire Investments",
        "negatedLabel": "Purchases of investments"
       }
      }
     },
     "localname": "PaymentsToAcquireInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r128"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property, plant and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r448",
      "r469"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/ShareBasedPaymentsAdditionalInformationDetails",
      "http://www.dna.com/role/ShareBasedPaymentsScheduleofRestrictedStockUnitActivityDetails",
      "http://www.dna.com/role/ShareBasedPaymentsScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/ShareBasedPaymentsAdditionalInformationDetails",
      "http://www.dna.com/role/ShareBasedPaymentsScheduleofRestrictedStockUnitActivityDetails",
      "http://www.dna.com/role/ShareBasedPaymentsScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r32",
      "r63",
      "r64"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromCollectionOfNotesReceivable": {
     "auth_ref": [
      "r125"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with principal collections from a borrowing supported by a written promise to pay an obligation.",
        "label": "Proceeds from Collection of Notes Receivable",
        "terseLabel": "Proceeds from repayment of notes receivable"
       }
      }
     },
     "localname": "ProceedsFromCollectionOfNotesReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r130"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds from Issuance of Common Stock",
        "terseLabel": "Proceeds from issuance of shares, net of issuance costs"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "auth_ref": [
      "r131"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.",
        "label": "Proceeds from Issuance of Long-term Debt",
        "terseLabel": "Proceeds from long-term debt, net of issuance costs"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/LinesofCreditandLongTermDebtLongTermDebtAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities": {
     "auth_ref": [
      "r124",
      "r125",
      "r252"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from sale, maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Proceeds from Sale and Maturity of Debt Securities, Available-for-sale",
        "terseLabel": "Sales and maturities of investments"
       }
      }
     },
     "localname": "ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities": {
     "auth_ref": [
      "r126"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from the sale of other assets recognized in investing activities.",
        "label": "Proceeds from Sale of Other Assets, Investing Activities",
        "terseLabel": "Proceeds from sale of assets"
       }
      }
     },
     "localname": "ProceedsFromSaleOfOtherAssetsInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.dna.com/role/DiscontinuedOperationsNoncashItemsandPurchasesofPropertyPlantandEquipmentforMBPTitanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r130",
      "r470"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Proceeds from stock option exercises"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductMember": {
     "auth_ref": [
      "r428"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Article or substance produced by nature, labor or machinery.",
        "label": "Product [Member]",
        "terseLabel": "Products"
       }
      }
     },
     "localname": "ProductMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProfessionalAndContractServicesExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Professional and contract service expense includes cost reimbursements for support services related to contracted projects, outsourced management, technical and staff support.",
        "label": "Professional and Contract Services Expense",
        "terseLabel": "Expense for services"
       }
      }
     },
     "localname": "ProfessionalAndContractServicesExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]",
        "terseLabel": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r320",
      "r738",
      "r739",
      "r740"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "terseLabel": "Property, Plant and Equipment, Net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/PropertyPlantandEquipmentNet"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r67",
      "r313"
     ],
     "calculation": {
      "http://www.dna.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "totalLabel": "Property, plant and equipment, gross"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r42",
      "r43",
      "r315",
      "r614",
      "r693",
      "r705"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.dna.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "totalLabel": "Property, plant and equipment, net",
        "verboseLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.dna.com/role/PropertyPlantandEquipmentNetScheduleofPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r42",
      "r315"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Schedule of Property, Plant and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/PropertyPlantandEquipmentNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "auth_ref": [
      "r117",
      "r280"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 25.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.",
        "label": "Accounts Receivable, Credit Loss Expense (Reversal)",
        "terseLabel": "Provision for credit losses"
       }
      }
     },
     "localname": "ProvisionForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PublicUtilitiesInventoryAxis": {
     "auth_ref": [
      "r60"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of inventory held.",
        "label": "Inventory [Axis]",
        "terseLabel": "Inventory [Axis]"
       }
      }
     },
     "localname": "PublicUtilitiesInventoryAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/InventoryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PublicUtilitiesInventoryTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property that is held for sale in the ordinary course of business, in process of production for such sale or is to be currently consumed in the production of goods or services to be available for sale.",
        "label": "Inventory [Domain]",
        "terseLabel": "Inventory [Domain]"
       }
      }
     },
     "localname": "PublicUtilitiesInventoryTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/InventoryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReceivablesNetCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Receivables, Net, Current [Abstract]",
        "terseLabel": "Receivables"
       }
      }
     },
     "localname": "ReceivablesNetCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock": {
     "auth_ref": [
      "r225",
      "r229"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.",
        "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]",
        "terseLabel": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated"
       }
      }
     },
     "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/SegmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock": {
     "auth_ref": [
      "r224",
      "r229"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of all significant reconciling items in the reconciliation of total revenues from reportable segments to the entity's consolidated revenues.",
        "label": "Reconciliation of Revenue from Segments to Consolidated [Table Text Block]",
        "terseLabel": "Reconciliation of Revenue from Segments to Consolidated"
       }
      }
     },
     "localname": "ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/SegmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r438",
      "r605",
      "r606"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]",
        "terseLabel": "Related Party [Domain]"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.dna.com/role/CondensedConsolidatedStatementsofOperationsParenthetical",
      "http://www.dna.com/role/InvestmentsinJointVenturesIntrexonEnergyPartnersAdditionalInformationDetails",
      "http://www.dna.com/role/InvestmentsinJointVenturesIntrexonEnergyPartnersIIAdditionalInformationDetails",
      "http://www.dna.com/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.dna.com/role/ShareBasedPaymentsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Related Party Transaction [Line Items]",
        "terseLabel": "Related Party Transaction [Line Items]"
       }
      }
     },
     "localname": "RelatedPartyTransactionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofOperationsParenthetical",
      "http://www.dna.com/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]",
        "terseLabel": "Related Party Transactions [Abstract]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r438",
      "r605",
      "r609",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]",
        "terseLabel": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.dna.com/role/CondensedConsolidatedStatementsofOperationsParenthetical",
      "http://www.dna.com/role/InvestmentsinJointVenturesIntrexonEnergyPartnersAdditionalInformationDetails",
      "http://www.dna.com/role/InvestmentsinJointVenturesIntrexonEnergyPartnersIIAdditionalInformationDetails",
      "http://www.dna.com/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.dna.com/role/ShareBasedPaymentsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "auth_ref": [
      "r603",
      "r604",
      "r606",
      "r610",
      "r611"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Related Party Transactions Disclosure [Text Block]",
        "terseLabel": "Related Party Transactions"
       }
      }
     },
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/RelatedPartyTransactions"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r132"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-term Debt",
        "negatedLabel": "Payments of long-term debt"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r483",
      "r649",
      "r752"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/ShareBasedPaymentsScheduleofStockBasedCompensationCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsNoncurrent": {
     "auth_ref": [
      "r34",
      "r44",
      "r143",
      "r148",
      "r736"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Restricted Cash and Cash Equivalents, Noncurrent",
        "terseLabel": "Restricted cash included in other assets"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted stock units"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/ShareBasedPaymentsAdditionalInformationDetails",
      "http://www.dna.com/role/SummaryofSignificantAccountingPoliciesNetLossPerShareAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r54",
      "r418",
      "r478",
      "r614",
      "r703",
      "r728",
      "r733"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "negatedTerseLabel": "Accumulated deficit",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.dna.com/role/SummaryofSignificantAccountingPoliciesLiquidityAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r2",
      "r163",
      "r164",
      "r165",
      "r168",
      "r177",
      "r179",
      "r275",
      "r475",
      "r476",
      "r477",
      "r501",
      "r502",
      "r549",
      "r724",
      "r726"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated Deficit"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofShareholdersEquity",
      "http://www.dna.com/role/LinesofCreditandLongTermDebtLongTermDebtAdditionalInformationDetails",
      "http://www.dna.com/role/SummaryofSignificantAccountingPoliciesRecentlyAdoptedAccountingPronouncementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r204",
      "r205",
      "r224",
      "r230",
      "r231",
      "r238",
      "r239",
      "r242",
      "r424",
      "r425",
      "r650"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Total revenues",
        "verboseLabel": "Revenues from external customers"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CollaborationandLicensingRevenueSummarizedCollaborationandLicensingRevenueDetails",
      "http://www.dna.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.dna.com/role/CondensedConsolidatedStatementsofOperationsParenthetical",
      "http://www.dna.com/role/SegmentsRevenuesbyReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock": {
     "auth_ref": [
      "r423"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of expected timing for satisfying remaining performance obligation.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table Text Block]",
        "terseLabel": "Summary of Deferred Revenue by Collaborator"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CollaborationandLicensingRevenueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r109",
      "r154",
      "r204",
      "r205",
      "r224",
      "r230",
      "r231",
      "r238",
      "r239",
      "r242",
      "r270",
      "r341",
      "r342",
      "r343",
      "r346",
      "r347",
      "r348",
      "r350",
      "r352",
      "r354",
      "r355",
      "r557",
      "r689"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "terseLabel": "Revenues"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/SegmentsAdditionalInformationDetails",
      "http://www.dna.com/role/SegmentsRevenuesbyReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "terseLabel": "Revenues"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Line of Credit"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/LinesofCreditandLongTermDebtLinesofCreditAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r595",
      "r600"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "verboseLabel": "Operating lease right-of-use assets obtained in exchange for new lease liabilities (includes new leases or modifications of existing leases)"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/OperatingLeasesOtherInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r96",
      "r575",
      "r576"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Components of Accumulated Other Comprehensive Income"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/ShareholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r189"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/SummaryofSignificantAccountingPoliciesNetLossPerShareAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r189"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Net Loss per Share"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Securities, Available-for-sale [Line Items]",
        "terseLabel": "Debt Securities, Available-for-sale [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/ShorttermandLongtermInvestmentsSummaryofAmortizedCostGrossUnrealizedGainsandLossesandFairValueofShorttermandLongtermInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": {
     "auth_ref": [
      "r519"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]"
       }
      }
     },
     "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CollaborationandLicensingRevenueSummarizedCollaborationandLicensingRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "auth_ref": [
      "r78",
      "r161",
      "r392",
      "r394",
      "r413",
      "r415",
      "r416",
      "r417",
      "r579",
      "r580",
      "r583",
      "r697"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table Text Block]",
        "terseLabel": "Schedule of Long-Term Debt Instruments"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/LinesofCreditandLongTermDebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock": {
     "auth_ref": [
      "r5",
      "r13",
      "r14",
      "r15",
      "r16",
      "r17",
      "r18",
      "r21",
      "r24",
      "r25",
      "r26",
      "r318",
      "r319"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table Text Block]",
        "terseLabel": "Disposal Groups, Including Discontinued Operations"
       }
      }
     },
     "localname": "ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/DiscontinuedOperationsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r487"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Effective Income Tax Rate Reconciliation"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "auth_ref": [
      "r447",
      "r467",
      "r479"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/ShareBasedPaymentsScheduleofStockBasedCompensationCostsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "auth_ref": [
      "r447",
      "r467",
      "r479"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "terseLabel": "Schedule of Stock-Based Compensation Costs"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/ShareBasedPaymentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Schedule of Equity Method Investments [Line Items]",
        "terseLabel": "Schedule of Equity Method Investments [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/InvestmentsinJointVenturesIntrexonEnergyPartnersAdditionalInformationDetails",
      "http://www.dna.com/role/InvestmentsinJointVenturesIntrexonEnergyPartnersIIAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsTable": {
     "auth_ref": [
      "r26",
      "r154",
      "r269",
      "r270",
      "r557"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of information required and determined to be disclosed concerning equity method investments in common stock. The summarized information includes: (a) the name of each investee or group of investees for which combined disclosure is appropriate, (2) the percentage ownership of common stock, (3) the difference, if any, between the carrying amount of an investment and the value of the underlying equity in the net assets and the accounting treatment of difference, if any, and (4) the aggregate value of each identified investment based on its quoted market price, if available.",
        "label": "Schedule of Equity Method Investments [Table]",
        "terseLabel": "Schedule of Equity Method Investments [Table]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/InvestmentsinJointVenturesIntrexonEnergyPartnersAdditionalInformationDetails",
      "http://www.dna.com/role/InvestmentsinJointVenturesIntrexonEnergyPartnersIIAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r303",
      "r306",
      "r651"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/GoodwillandIntangibleAssetsNetScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r303",
      "r306"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/GoodwillandIntangibleAssetsNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r298",
      "r300"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Schedule of Changes in Carrying Amount of Goodwill"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/GoodwillandIntangibleAssetsNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r40",
      "r60",
      "r61",
      "r62"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Schedule of Inventory"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/InventoryTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "auth_ref": [
      "r338"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.",
        "label": "Schedule of Maturities of Long-term Debt [Table Text Block]",
        "terseLabel": "Schedule of Future Maturities of Long-Term Debt"
       }
      }
     },
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/LinesofCreditandLongTermDebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "auth_ref": [
      "r607",
      "r609"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Schedule of Related Party Transactions, by Related Party [Table]",
        "terseLabel": "Schedule of Related Party Transactions, by Related Party [Table]"
       }
      }
     },
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofOperationsParenthetical",
      "http://www.dna.com/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r213",
      "r216",
      "r228",
      "r298"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/GoodwillandIntangibleAssetsNetAdditionalInformationDetails",
      "http://www.dna.com/role/SegmentsAdditionalInformationDetails",
      "http://www.dna.com/role/SegmentsAdjustedEBITDAbyReportableSegmentDetails",
      "http://www.dna.com/role/SegmentsReconciliationofNetLossBeforeIncomeTaxesDetails",
      "http://www.dna.com/role/SegmentsRevenuesbyReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r213",
      "r216",
      "r228",
      "r298"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Information by Reportable Segment"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/SegmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r448",
      "r469"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/ShareBasedPaymentsAdditionalInformationDetails",
      "http://www.dna.com/role/ShareBasedPaymentsScheduleofRestrictedStockUnitActivityDetails",
      "http://www.dna.com/role/ShareBasedPaymentsScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r452",
      "r463",
      "r464"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Schedule of Stock Option Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/ShareBasedPaymentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.",
        "label": "Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]",
        "terseLabel": "Schedule of Restricted Stock Unit Activity"
       }
      }
     },
     "localname": "ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/ShareBasedPaymentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentContinuingOperationsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component of an entity expected to operate in the foreseeable future.",
        "label": "Continuing Operations [Member]",
        "terseLabel": "Continuing Operations"
       }
      }
     },
     "localname": "SegmentContinuingOperationsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.dna.com/role/CondensedConsolidatedStatementsofOperationsParenthetical",
      "http://www.dna.com/role/IncomeTaxesComponentsofIncomeTaxBenefitsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r201",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r224",
      "r225",
      "r226",
      "r227",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r235",
      "r242",
      "r322",
      "r323",
      "r717"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/GoodwillandIntangibleAssetsNetAdditionalInformationDetails",
      "http://www.dna.com/role/SegmentsAdditionalInformationDetails",
      "http://www.dna.com/role/SegmentsAdjustedEBITDAbyReportableSegmentDetails",
      "http://www.dna.com/role/SegmentsReconciliationofNetLossBeforeIncomeTaxesDetails",
      "http://www.dna.com/role/SegmentsRevenuesbyReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentOperatingActivitiesDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operations of an entity including continuing and discontinued operations.",
        "label": "Operating Activities [Domain]",
        "terseLabel": "Operating Activities [Domain]"
       }
      }
     },
     "localname": "SegmentOperatingActivitiesDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.dna.com/role/CondensedConsolidatedStatementsofOperationsParenthetical",
      "http://www.dna.com/role/IncomeTaxesComponentsofIncomeTaxBenefitsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r201",
      "r202",
      "r203",
      "r213",
      "r217",
      "r229",
      "r233",
      "r234",
      "r235",
      "r236",
      "r238",
      "r241",
      "r242",
      "r243"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Segments"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/Segments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/GoodwillandIntangibleAssetsNetAdditionalInformationDetails",
      "http://www.dna.com/role/SegmentsAdditionalInformationDetails",
      "http://www.dna.com/role/SegmentsAdjustedEBITDAbyReportableSegmentDetails",
      "http://www.dna.com/role/SegmentsReconciliationofNetLossBeforeIncomeTaxesDetails",
      "http://www.dna.com/role/SegmentsRevenuesbyReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting, Other Significant Reconciling Item, Consolidated [Abstract]",
        "terseLabel": "Other expenses:"
       }
      }
     },
     "localname": "SegmentReportingOtherSignificantReconcilingItemConsolidatedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/SegmentsReconciliationofNetLossBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "auth_ref": [
      "r218",
      "r219",
      "r220",
      "r221",
      "r222",
      "r223",
      "r239"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for segment reporting.",
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "terseLabel": "Segment Information"
       }
      }
     },
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r119"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.",
        "label": "Selling, General and Administrative Expenses [Member]",
        "terseLabel": "Selling, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpensesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/ShareBasedPaymentsAdditionalInformationDetails",
      "http://www.dna.com/role/ShareBasedPaymentsScheduleofStockBasedCompensationCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ServiceMember": {
     "auth_ref": [
      "r428"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assistance, including, but not limited to, technology, license and maintenance, license and service, maintenance, oil and gas, and financial service.",
        "label": "Service [Member]",
        "terseLabel": "Services"
       }
      }
     },
     "localname": "ServiceMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r140"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r449"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period",
        "terseLabel": "Share-based compensation arrangement by share-based payment award, award vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/ShareBasedPaymentsAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]",
        "terseLabel": "Additional Information"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/ShareBasedPaymentsScheduleofRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r457"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedTerseLabel": "Forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/ShareBasedPaymentsScheduleofRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r462"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Forfeited"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/ShareBasedPaymentsScheduleofRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r460"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "verboseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/ShareBasedPaymentsScheduleofRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r460"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "verboseLabel": "Granted (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/ShareBasedPaymentsScheduleofRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r459"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Balances at end of period (in shares)",
        "periodStartLabel": "Balances at beginning of period (in shares)",
        "terseLabel": "RSUs outstanding (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/ShareBasedPaymentsAdditionalInformationDetails",
      "http://www.dna.com/role/ShareBasedPaymentsScheduleofRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Number of Restricted Stock Units"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/ShareBasedPaymentsScheduleofRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r459"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Balances at end of period (in usd per share)",
        "periodStartLabel": "Balances at beginning of period (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/ShareBasedPaymentsScheduleofRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted Average Grant Date Fair Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/ShareBasedPaymentsScheduleofRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms": {
     "auth_ref": [
      "r465"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms",
        "terseLabel": "Weighted Average Remaining Contractual Term (Years)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/ShareBasedPaymentsScheduleofRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r461"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedLabel": "Vested (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/ShareBasedPaymentsScheduleofRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r461"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Vested (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/ShareBasedPaymentsScheduleofRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/ShareBasedPaymentsAdditionalInformationDetails",
      "http://www.dna.com/role/ShareBasedPaymentsScheduleofRestrictedStockUnitActivityDetails",
      "http://www.dna.com/role/ShareBasedPaymentsScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r450"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized",
        "terseLabel": "Number of shares authorized for issuance (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/ShareBasedPaymentsAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r469"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant",
        "terseLabel": "Remaining shares available to grant (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/ShareBasedPaymentsAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]",
        "terseLabel": "Weighted Average Remaining Contractual Term (Years)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/ShareBasedPaymentsScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r455"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number",
        "verboseLabel": "Exercisable at end of period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/ShareBasedPaymentsScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r455"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Exercisable, weighted average exercise price, at end of period (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/ShareBasedPaymentsScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": {
     "auth_ref": [
      "r458"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period",
        "negatedLabel": "Expired (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/ShareBasedPaymentsScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r457"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period",
        "negatedLabel": "Forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/ShareBasedPaymentsScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/ShareBasedPaymentsScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r454",
      "r469"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Balances at end of period (in shares)",
        "periodStartLabel": "Balances at beginning of period (in shares)",
        "terseLabel": "Options outstanding (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/ShareBasedPaymentsAdditionalInformationDetails",
      "http://www.dna.com/role/ShareBasedPaymentsScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Number of Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/ShareBasedPaymentsScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r453"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Balances at period end (in usd per share)",
        "periodStartLabel": "Balances at beginning of period (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/ShareBasedPaymentsScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/ShareBasedPaymentsScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r446",
      "r451"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/ShareBasedPaymentsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Exercised (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/ShareBasedPaymentsScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price",
        "verboseLabel": "Expired (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/ShareBasedPaymentsScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "verboseLabel": "Forfeited (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/ShareBasedPaymentsScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Granted (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/ShareBasedPaymentsScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r469"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Exercisable at period end, weighted average remaining contractual period"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/ShareBasedPaymentsScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r465"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Balances, weighted average remaining contractual period"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/ShareBasedPaymentsScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharesIssuedPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or per unit amount of equity securities issued.",
        "label": "Shares Issued, Price Per Share",
        "terseLabel": "Borrowed shares, public offering price per share (in usd per share)"
       }
      }
     },
     "localname": "SharesIssuedPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/ShareholdersEquityShareLendingAgreementDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShortTermInvestments": {
     "auth_ref": [
      "r46",
      "r675",
      "r676",
      "r699"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.",
        "label": "Short-term Investments",
        "terseLabel": "Short-term investments"
       }
      }
     },
     "localname": "ShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortTermLeaseCost": {
     "auth_ref": [
      "r591",
      "r600"
     ],
     "calculation": {
      "http://www.dna.com/role/OperatingLeasesComponentsofLeaseCostsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less.",
        "label": "Short-term Lease, Cost",
        "terseLabel": "Short-term lease costs"
       }
      }
     },
     "localname": "ShortTermLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/OperatingLeasesComponentsofLeaseCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r149",
      "r162"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/SummaryofSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r12",
      "r201",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r224",
      "r225",
      "r226",
      "r227",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r235",
      "r242",
      "r298",
      "r317",
      "r322",
      "r323",
      "r717"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/GoodwillandIntangibleAssetsNetAdditionalInformationDetails",
      "http://www.dna.com/role/SegmentsAdditionalInformationDetails",
      "http://www.dna.com/role/SegmentsAdjustedEBITDAbyReportableSegmentDetails",
      "http://www.dna.com/role/SegmentsReconciliationofNetLossBeforeIncomeTaxesDetails",
      "http://www.dna.com/role/SegmentsRevenuesbyReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r2",
      "r81",
      "r103",
      "r104",
      "r105",
      "r163",
      "r164",
      "r165",
      "r168",
      "r177",
      "r179",
      "r193",
      "r275",
      "r412",
      "r418",
      "r475",
      "r476",
      "r477",
      "r501",
      "r502",
      "r549",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r576",
      "r724",
      "r725",
      "r726",
      "r795"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofShareholdersEquity",
      "http://www.dna.com/role/LinesofCreditandLongTermDebtLongTermDebtAdditionalInformationDetails",
      "http://www.dna.com/role/ShareholdersEquityComponentsofAccumulatedOtherComprehensiveIncomeLossDetails",
      "http://www.dna.com/role/SummaryofSignificantAccountingPoliciesRecentlyAdoptedAccountingPronouncementsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.dna.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.dna.com/role/CondensedConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOperatingActivitiesSegmentAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by continuing and discontinuing operations.",
        "label": "Operating Activities [Axis]",
        "terseLabel": "Operating Activities [Axis]"
       }
      }
     },
     "localname": "StatementOperatingActivitiesSegmentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.dna.com/role/CondensedConsolidatedStatementsofOperationsParenthetical",
      "http://www.dna.com/role/IncomeTaxesComponentsofIncomeTaxBenefitsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r163",
      "r164",
      "r165",
      "r193",
      "r650"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.dna.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.dna.com/role/CondensedConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.",
        "label": "Stock Issued During Period, Shares, Issued for Services",
        "terseLabel": "Shares issued as payment for services (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesIssuedForServices",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r49",
      "r50",
      "r412",
      "r418"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period, Shares, New Issues",
        "terseLabel": "Shares issued (in shares)",
        "verboseLabel": "Shares issued in private placement or in public offering, net of issuance costs (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofShareholdersEquity",
      "http://www.dna.com/role/ShareholdersEquityIssuancesofPrecigenCommonStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesOther": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued attributable to transactions classified as other.",
        "label": "Stock Issued During Period, Shares, Other",
        "verboseLabel": "Borrowed shares, number issued (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/ShareholdersEquityShareLendingAgreementDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r49",
      "r50",
      "r412",
      "r418",
      "r456"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedTerseLabel": "Exercised (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/ShareBasedPaymentsScheduleofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.",
        "label": "Stock Issued During Period, Value, Issued for Services",
        "terseLabel": "Shares issued as payment for services"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueIssuedForServices",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r49",
      "r50",
      "r412",
      "r418"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Stock Issued During Period, Value, New Issues",
        "terseLabel": "Shares issued during the period, value",
        "verboseLabel": "Shares issued in private placement or in public offering, net of issuance costs"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofShareholdersEquity",
      "http://www.dna.com/role/ShareholdersEquityIssuancesofPrecigenCommonStockDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contracts conveying rights, but not obligations, to buy or sell a specific quantity of stock at a specified price during a specified period (an American option) or at a specified date (a European option).",
        "label": "Equity Option [Member]",
        "terseLabel": "Options"
       }
      }
     },
     "localname": "StockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/SummaryofSignificantAccountingPoliciesNetLossPerShareAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r50",
      "r56",
      "r57",
      "r154",
      "r248",
      "r270",
      "r557",
      "r614"
     ],
     "calculation": {
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Balances",
        "periodStartLabel": "Balances",
        "terseLabel": "Precigen shareholders' equity",
        "totalLabel": "Total shareholders' equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.dna.com/role/CondensedConsolidatedStatementsofShareholdersEquity",
      "http://www.dna.com/role/ShareholdersEquityComponentsofAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r2",
      "r3",
      "r104",
      "r154",
      "r163",
      "r164",
      "r165",
      "r168",
      "r177",
      "r270",
      "r275",
      "r418",
      "r475",
      "r476",
      "r477",
      "r501",
      "r502",
      "r521",
      "r522",
      "r535",
      "r549",
      "r557",
      "r570",
      "r571",
      "r576",
      "r725",
      "r726",
      "r795"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Stockholders' equity, including portion attributable to noncontrolling interest"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/LinesofCreditandLongTermDebtLongTermDebtAdditionalInformationDetails",
      "http://www.dna.com/role/SummaryofSignificantAccountingPoliciesRecentlyAdoptedAccountingPronouncementsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]",
        "terseLabel": "Shareholders' equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.dna.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r152",
      "r397",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r411",
      "r418",
      "r419"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Shareholders' Equity"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/ShareholdersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubleaseIncome": {
     "auth_ref": [
      "r593",
      "r600"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of sublease income excluding finance and operating lease expense.",
        "label": "Sublease Income",
        "terseLabel": "Sublease rental income"
       }
      }
     },
     "localname": "SubleaseIncome",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r577",
      "r615"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/ShareBasedPaymentsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r577",
      "r615"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/ShareBasedPaymentsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r577",
      "r615"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/ShareBasedPaymentsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental disclosure of cash flow information",
        "verboseLabel": "Supplemental disclosure of cash flow information"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.dna.com/role/OperatingLeasesOtherInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardAxis": {
     "auth_ref": [
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by specific tax credit related to an unused tax credit.",
        "label": "Tax Credit Carryforward [Axis]",
        "terseLabel": "Tax Credit Carryforward [Axis]"
       }
      }
     },
     "localname": "TaxCreditCarryforwardAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardNameDomain": {
     "auth_ref": [
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name of the tax credit carryforward.",
        "label": "Tax Credit Carryforward, Name [Domain]",
        "terseLabel": "Tax Credit Carryforward, Name [Domain]"
       }
      }
     },
     "localname": "TaxCreditCarryforwardNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TrademarksMember": {
     "auth_ref": [
      "r514"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style.",
        "label": "Trademarks [Member]",
        "terseLabel": "Trademarks"
       }
      }
     },
     "localname": "TrademarksMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/GoodwillandIntangibleAssetsNetScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r260",
      "r261",
      "r263",
      "r264",
      "r265",
      "r384",
      "r410",
      "r540",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r758",
      "r759",
      "r760",
      "r761",
      "r762",
      "r763",
      "r764"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/FairValueMeasurementsSummaryofPlacementintheFairValueHierarchyofFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.dna.com/role/ShorttermandLongtermInvestmentsSummaryofAmortizedCostGrossUnrealizedGainsandLossesandFairValueofShorttermandLongtermInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfAdoptionMember": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r167",
      "r168",
      "r169",
      "r170",
      "r180",
      "r249",
      "r250",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r340",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r499",
      "r500",
      "r501",
      "r502",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r602",
      "r652",
      "r653",
      "r654",
      "r722",
      "r723",
      "r724",
      "r725",
      "r726",
      "r727",
      "r728",
      "r729",
      "r730",
      "r731",
      "r732",
      "r733",
      "r791",
      "r792",
      "r793",
      "r794",
      "r795"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment to accounting standards.",
        "label": "Accounting Standards Update [Domain]",
        "terseLabel": "Accounting Standards Update [Domain]"
       }
      }
     },
     "localname": "TypeOfAdoptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/LinesofCreditandLongTermDebtLongTermDebtAdditionalInformationDetails",
      "http://www.dna.com/role/SummaryofSignificantAccountingPoliciesRecentlyAdoptedAccountingPronouncementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfArrangementAxis": {
     "auth_ref": [
      "r519"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]"
       }
      }
     },
     "localname": "TypeOfArrangementAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CollaborationandLicensingRevenueSummarizedCollaborationandLicensingRevenueDetails",
      "http://www.dna.com/role/CollaborationandLicensingRevenueSummaryofDeferredRevenueDetails",
      "http://www.dna.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.dna.com/role/CondensedConsolidatedStatementsofOperationsParenthetical",
      "http://www.dna.com/role/InvestmentsinJointVenturesIntrexonEnergyPartnersAdditionalInformationDetails",
      "http://www.dna.com/role/InvestmentsinJointVenturesIntrexonEnergyPartnersIIAdditionalInformationDetails",
      "http://www.dna.com/role/SegmentsReconciliationofNetLossBeforeIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_USGovernmentDebtSecuritiesMember": {
     "auth_ref": [
      "r690"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities issued by the United States government.",
        "label": "US Government Debt Securities [Member]",
        "terseLabel": "U.S. government debt securities",
        "verboseLabel": "U.S. government debt securities"
       }
      }
     },
     "localname": "USGovernmentDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/FairValueMeasurementsSummaryofPlacementintheFairValueHierarchyofFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.dna.com/role/ShorttermandLongtermInvestmentsSummaryofAmortizedCostGrossUnrealizedGainsandLossesandFairValueofShorttermandLongtermInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount": {
     "auth_ref": [
      "r532",
      "r534"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The reporting entity's maximum amount of exposure to loss as a result of its involvement with the Variable Interest Entity (VIE).",
        "label": "Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount",
        "terseLabel": "Maximum risk of loss related to the identified VIEs"
       }
      }
     },
     "localname": "VariableInterestEntityEntityMaximumLossExposureAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/SummaryofSignificantAccountingPoliciesVariableInterestEntitiesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableLeaseCost": {
     "auth_ref": [
      "r592",
      "r600"
     ],
     "calculation": {
      "http://www.dna.com/role/OperatingLeasesComponentsofLeaseCostsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.",
        "label": "Variable Lease, Cost",
        "terseLabel": "Variable lease costs"
       }
      }
     },
     "localname": "VariableLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/OperatingLeasesComponentsofLeaseCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_WarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.",
        "label": "Warrant [Member]",
        "terseLabel": "Warrants"
       }
      }
     },
     "localname": "WarrantMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/SummaryofSignificantAccountingPoliciesNetLossPerShareAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r182",
      "r188"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Weighted average shares outstanding, diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r181",
      "r188"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Weighted average shares outstanding, basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.dna.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 9
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e1012-107759"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(13))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868656-224227"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(12))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(14))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(5))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "8",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3151-108585"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21D",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=SL94080555-108585"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4313-108586"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21728-107793"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8657-108599"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8844-108599"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8981-108599"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8475-108599"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26626-111562"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27198-111563"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27232-111563"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=SL120269820-111563"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "http://asc.fasb.org/topic&trid=2196928"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(b)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/subtopic&trid=2122178"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "323",
   "URI": "http://asc.fasb.org/topic&trid=2196965"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "http://asc.fasb.org/topic&trid=2122149"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "http://asc.fasb.org/topic&trid=2126998"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2420-110228"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "http://asc.fasb.org/topic&trid=2155823"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6812-107765"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S65",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359872&loc=SL124427846-239511"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6812-107765"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466302&loc=d3e4852-112606"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466103&loc=SL6014347-161799"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6812-107765"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e7018-107765"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(11))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130531-203044"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130532-203044"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=d3e4534-113899"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(4)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(2))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11149-113907"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11178-113907"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)(a)(2))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=109227538&loc=d3e44648-109337"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "44",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5558-128473"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "808",
   "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "808",
   "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "808",
   "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "808",
   "URI": "http://asc.fasb.org/topic&trid=5833765"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568447-111683"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568740-111683"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2AA",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "a",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=SL6759068-111685"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5728-111685"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "b",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5728-111685"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=SL6759159-111685"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5747-111685"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.E)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120398118&loc=d3e355146-122828"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=120253306&loc=d3e28129-110885"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123602790&loc=d3e30304-110892"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32022-110900"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123386189&loc=SL77918607-209975"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918701-209980"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721494-107759"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888251"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "http://asc.fasb.org/extlink&oid=122150657&loc=SL122150809-237846"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "850",
   "URI": "http://asc.fasb.org/topic&trid=2122745"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=123371682&loc=d3e55415-109406"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.12)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "940",
   "URI": "http://asc.fasb.org/subtopic&trid=2176304"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(4))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(20))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62557-112803"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=SL120269850-112803"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/subtopic&trid=2209399"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=116652737&loc=d3e64164-112818"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "(c)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "e",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(g))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e957-107759"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.15(a))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(10))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(11))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r721": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r722": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r723": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r724": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r725": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r726": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r727": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r728": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r729": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r730": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r731": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r732": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r733": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r734": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "946",
   "URI": "http://asc.fasb.org/subtopic&trid=2324412"
  },
  "r735": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r736": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=120413173&loc=SL116631458-115580"
  },
  "r737": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r738": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916"
  },
  "r739": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r740": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=SL120174063-112916"
  },
  "r741": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r742": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r743": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r744": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r745": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r746": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r747": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r748": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r749": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r750": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r751": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r752": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r753": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r754": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r755": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r756": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r757": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r758": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r759": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r760": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)"
  },
  "r761": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)"
  },
  "r762": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)"
  },
  "r763": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)"
  },
  "r764": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)"
  },
  "r765": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1403"
  },
  "r766": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "303",
   "Subparagraph": "(5)"
  },
  "r767": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r768": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "11",
   "Subsection": "03"
  },
  "r769": {
   "Footnote": "2",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(5))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r770": {
   "Footnote": "4",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "29"
  },
  "r771": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column B",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r772": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column C",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r773": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column D",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r774": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column E",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r775": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column F",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r776": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column G",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r777": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column H",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r778": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column I",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r779": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(i)",
   "Subsection": "01"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r780": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(i)",
   "Subsection": "02"
  },
  "r781": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(ii)",
   "Subsection": "01"
  },
  "r782": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)",
   "Subsection": "01"
  },
  "r783": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(A)",
   "Subsection": "01"
  },
  "r784": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(A)",
   "Subsection": "02"
  },
  "r785": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(B)",
   "Subsection": "01"
  },
  "r786": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(B)",
   "Subsection": "02"
  },
  "r787": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(C)",
   "Subsection": "02"
  },
  "r788": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iv)",
   "Subsection": "01"
  },
  "r789": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iv)",
   "Subsection": "02"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r790": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(m)",
   "Publisher": "SEC",
   "Section": "4",
   "Subparagraph": "(1)(iii)",
   "Subsection": "08"
  },
  "r791": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848"
  },
  "r792": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "848"
  },
  "r793": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848"
  },
  "r794": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848"
  },
  "r795": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721523-107759"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a-c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721525-107759"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>107
<FILENAME>0001356090-22-000006-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001356090-22-000006-xbrl.zip
M4$L#!!0    ( '""J50Z"PA/SS," $.Q%P 1    <&=E;BTR,#(R,#,S,2YH
M=&WLO6E3&\FV+OS]_ J][+AG=T=8=LZ#N]LWL,$^]+7 !F$?^-*1(RJ05.PJ
MB<&__EU9DIAM8UL@E=#NV$8J9>6TIF>MS%SYY_\]ZW4;)Z$HL[S_UPI^CE8:
M__?5G_]?L_F_K[??-]9R-^R%_J#QI@AF$'SC-!MT&I]]*(\:L<A[C<]Y<92=
MF&:S>N=-?GQ>9 >=08,@0F[\6+P,@5EBK&_"OZ')A Q-K2-N8LN4YH0[QNVS
M@Y=4*:,E,\TH FVRZ'73N,B;0@IB3 S<!??,OY18:*,0-<(8QH+1"@M$/2'(
M&:M83,UV!C Z&&&_?'EFBZ[/_EKI# ;'+U^\2%^?Y\7!"X*0>#'Z<65<-#L;
M-,O@+LJ>GIX^A^_/#_*3%UF_F_5#FIP7@\+TRY@7/3. R8.*,&\BU:1X7,^U
M]T]IU1K66K\X2]V:-.;#C4Y-6H(?H$Z"_\,F1<^@Z:.OUYI^G10MB\%%P6A*
M6Q6#AU6-380O>_GRK,SNJA/F!;_XW];['=<)/=/,^N7 ]%V8O#4LFP?&'-]N
M9/S#'0W=ZOU5&M 7Z6=KRHL6C@]"_UIQWS?/7=Y+-1-$+^L%<MU=[;=H15 3
MD28F*U?8(_M&[VZ./SO[6F%,KS1\4;S,&<'R6PV,2E0OO.R:_L%?*Z'?W-U9
M 2X.QK_ZLQ<&II%>;X;_#+.3OU;>Y/T!R&:S?7X,W7*C;W^M#,+9X$7%82]>
M_==__=>?@VS0#:_2;#8G,_?GB]'#/U^,JK:Y/W_UI\].&N7@O!O^6O%9>=PU
MYR_[>3] ![*SEZE@*$8?,^]#O_H(OV^"@B@R-VK_;+ =XE\K&0K!1(.$5U@S
MJ:G5CC$NO!0^1./H/VM55S#PQR4U^Z:7F@[9RU70.3[IG;==<[#2R#Q4Z>FG
M<[N6G[PGVR=[M#7TA^LG^^_TX=:A.]L\[':VUE:_[+7W.WOMCVC_\SK?6ELG
MK;7-H];AQND>>9MMK6WWWM/-[MZ7G+;:>WRO?7#:(NMD[_,ZVGSWJ;/5/H!Z
M5K_LKVV<M]YM=O8.#]!^5Z'W9/]\[[,3>^3C>8NTSK;6NH>;9(]OOGO;VWRW
M?K[?^[O;.ESG^^W7O=;G==;ZLG'BW[W-[+M=L7\(=7_9[+0.6^>;7P[.H3S?
M;!^0S<./I/7NXRF\AZ!=NM=>'[_S"=KB_?WV<:_5_DBA?^=0']U:VT![[2.\
MM;9'-M?V3O?75L_A=QBC[[0^J2_OV^N#U@XZ@[\8QH#^02A8SJ5J@DJ-349
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M42L8'HL=HV@.IFL4U!J,9X UZ65%XU_N-P/#?C8:?EDI^(N1]4!9#(OP:DR
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M=%4NHXPQ<*44LX:GN^,Q.%6T!CILYK1\$(ZO^K3:[4XX_J%CA#-18D(9Y6@
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MYX5:41G)D 8 S@-STB0'#EF90D4A!C7'RZWU1..U#_@2B2UR&%Q\$IF06A$
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MGU7)AMU13:0E7>4B)<:&,0MJ#.M E=7,1,E9P*(&R6?GABA37/$D-B@*DJ'
M7[44&4:<X1HI *.,HAIL0KP'4=Z&X&LB))P3"4Z.-<%8P&K"I)08/(*D4$N]
MJT%L;A[H\4OR<7$Q6A&.\R)=-?]/>G3WY6C7RTQJO/<%:4)*9XA-UUP9QJFP
M ?0A\EI8K@2.==C]E<'80E)[*?^,Z1\DAW:U+,.@?'W>,H=Y45V+??-FB$'H
M=H,;#$T7D 70(R4^KH6 4NYCT*3R>1FU',AE!#S#@H'2-#4 XS]%L3=#L&J]
M4%1W'Z1K$#K9<6U@.C5(*&:4Y#*MHUJ,O52,$2V4-KX.FZ=_AF3M L;6,\51
M7>A$F":2,8V$UXP88;17!CD?#35.UB&[4#V4X131(_76)I B2&!:.16-%(I2
MHIQ11M< K=1$&4Z/9(*!*O2""RK2LB)/2XA!I/25W&I-YCB=2AV4X?3HI#VF
M!"'AL,>, [!P@J6='<XJ82>IHN;::+W/^F$KOBF"SP9OC4O^P#4G("O*P68E
M/Z;[VO2/\KC5,QTSK2T<=S5\>;?32=X] =1^O="O-NU#]O)].##=]8H25P9;
M72"U=6+>A7X89*Y\_[W\_?-BD[$V6'"&TS4O*0&3#M6=8\$:(IR-<WR@-65?
MVD[Y^T9D2%];H#EZP]ZT.&S)X O X.DN&LFD1L1QI@PV*NWBMC;(@+E%-8 P
M2S:<&1M.$989*KB1'/[ES'EAJ?1"*\!J7#EDYMA'_3HQUL]"[[AKB@MB3.]R
MQN_P_"J \\R9_L[ #$+B^?EE]GG1@XJ0B&B4"'B0":HLQEJ$P+CGDJ% YE</
M+AEPA@PXQ5B"5]X)C^%_@4DD#$KQ("W2S;;(<#Z_&O"")_+^P2 4O;3M*^69
MOIE:^F*_5RI0$[7 O6;:H6@U"HP%0$B&4*\T)L0)BNS\JH7YH\KT9(4B08E/
M4Q4CXR$H)J/%B"EE!,.R!HL0WZ9*M2'R@SDW0)9VGO1G76+8S/@8> 0? AD6
MHE8R1M!?BL S"C_675X>FS+3DQE+::3"64X"9DX$\/58$$IHXE-N:5I7F;F\
M'RW]WA[_7A-Q,5H; I-/F98IN*EUE)RG; W"2,-K*RXS(,H40\^2"_ "C,,>
M?-$(]C]8K[B.A@'M6>4*8(7D_!)EWC;>8]5$<DJF7S@=%!#'.LXHY5I$:1W1
MCG#08ZJZI#01I[JN:DFE[U/IZEU5(SK=ZZZJFR3]E3L@E;76*.2"LRP@P' I
M"A000=8Z3V4-2/KPP?8GS"P7&]*\.;][%QK\,'GWWEO/J$,<!QVUH9ZE8R&1
M&::I4)$[R12J =<](&_\%,>;LWMP?%VX[KJ*HMQ%8;FARC GL96(2FH"$%(9
MZ^MT]>7\*9+9W'M)G7;,F4@ U3$I?+HPD4FP-\Y+;RROT;V7<TC2F5QZ:95F
MB#,56*2,:6X4Q]4?+*5!H?8AU!\//MR_X4>.Y\_-$N840U_!..G!>\>*,2.I
MQ3)RA )H%; 7ODY7F2_9\%'8</9&T '059PRB@5FS!/ME=5"4<2YCXS:&O'L
M1M_EO= V9ZO#02<O;JT.KL&O)5"RNENX>(!5P=E3DR*'%(X*8:88,<8ZAB65
MS((K'3$R-8(T\T7-F: 92;S"#%$E =8H3;7@3B"G.;;P5?,%DLVW>1&R@_[]
MB'GO5BLKD7JZ!;-NTB&U53?(3JIC>3NC,5SOQO@A(&8H/(3RXQ?S_D/?$3\3
M=:$9(41%Q@@H"G!J%3=2IRNBI B:";9 ZN+),]A,-%C*Q6@<DLH*RVRZ1I B
M35*4+41 'C5(0S!S,_0@GHHPX)E(YJ(EG#$NE:.4(\$#]EP8[>:?+D"1D9/P
MQA3%><R+4U/X*^@]H780K.!7(_@Q8"1E34@3/.6:14,C(RQBHEA4BLN8TA;I
MP&IP('JJJGANR$(,N$46YHJ-TLO"M/' B; R:&+C35.)'YX^#VL!\'0L@.):
M16V]-=0PA+V"/U%P8&J&-1)F!HLLM5AOT-08EJX7QY@PT,S*@PJ@3"L!W$=0
M>+PM"#\D<=-<YW<Q!HZI,B8PP;$&NP1N+!<:4V=M#;;X7:##]?\,H5]O\MYQ
MWH>O-TYFKCHW[ V[R5AMAL%NOPBFFWU)9SM3)IWT_CN3]=_GM<D*%JFE1BDM
M(K<L4&X<P=9RC[G6PL8:G+"M%^6FN*V6B^ YLEQXQ8)U&J4D8A8;(*/DH@;W
M _\XY:HX[^@8^ZH_'([H5A-) _$22:C@'\^41E8Y@;TS&F3.,%Z#"Q+J0*\I
M'O&()F!$)5$$[#BBQI* ' Z*^X"CP;6+Z%V0[WWN1B2Y=,'>Y.5@*XZSCBYD
M_"S:J#"0R;GD%'AMC*1*2$6= ]@+OEK=XF=S0\Z91*L\1A&\.4JM8LPAIR7\
MRQ780Y%"\'0!I7,G%">9>XC+HV8OG=P*#/ZY-D$9)B20DQLI9" TA&@)64#I
M?"1RSD0ZHY-6&L4=EH9%B;7FQ!.N&54R,$P613HO#[.6(5TYL0I3EJZ4R(\K
MF'1V#+6%1917QAVS4L0@O&!@3I5C/"IB 2OQ:)!<%'F=!P+/9G>>1QYA%V(D
M0-_H#7<(,9N..SDC@EPT"=X)W6[6/Q@M172!S*N^E_6S<I!6_$["F-(+:7M=
M8"E'?^"",V9#T*JZGBU:;R)H;+UHLCP?I)[-+A4!AID%'B,V3$5G? 1J@H>;
MMA\I;^<_9O2A:_J;IG?UY.*'(K@,/NRD3.9;QXG@J11!2*6_-0D/28N5<]X:
M:0F+"%F.O<$>Z1 IIQ@O%FDPK1%IB+/*(@G>2!2,<J2]%U($E)"/H1:-2<,H
MFE?2[ QM&?XS3) E)3B_O4OX1H%I[;F9/Y9@38JFP!(,I[1KRO"4JYD!@Q!+
M T*>8>Z"1S4(OO\0:72-I#5H2X*2WC "P,8Y8RDA(+42_C*.S5):Z\,24Y)6
MSBBV#H--I8H%JE4DW@BL.0BQ%JX&MY+>GS0U65U)-\-:A016QC.!C&72&B>E
MET03Z\0-IV-)FVF[%-<(^2N! I JF-!T79)B1 (]B4-,HY2%US)G:A0HF!M"
MSB0,8*3P+ 8?O*:,"*G!._26>L'2:?L8%PG2U 3*,%6E4R<2/ WFJ5**PU<%
M'Z2T:GR0'8TWY,$'/;^8IKI](/@/P,GGU:X 4]UN6;X^O_K+]728;ICB,6\Z
M)BMZ#RYSZ-X[!U-1?068_,HZ";?8$A*(0H;!C)MT[1S@$T^<#^!<U(# *9=$
M.QMTPU;<Z/OL)/-#TWUJ=/221;"#*7 # IN2@Z;_2^8)H!DT7KX$\BWI^"-T
MU(].1V0BUD3) *((KGQ(%]H9A9A/OCTFN@9TO-B%E0Y9W'8=UWO'W?P\A"L&
M\5?=QR7G) T0+/->F2 593A*';DT$44KO7=$FOISSG8H!T7FP%17O+/;SP;E
M]L[NDGNFP#U<6X<0UXKZ=*^#MD!2BQFH'B&"ULO5UL7@K=ELK<)*2X&<5$@S
M"_XY9QZGG588.4I$6"[O+@1OS60]V2 =A.&.*\H9-M8PAEU0\ ]#8!'G^&SJ
M3^> G)?80#IZ2GS ":,RCIRQ0DK,13J_1Q36]9KZATI&^##7C,&LLRA1"%0Q
M"_/M)#',1$;!B"LU#LM@,L9ZZ<,\TJ ZU!N*XQ1XN1$V^]^]*=P^DMIXGPVR
M@TI)OS'EU1;>9RZ5ZQ^ @OX VJ<_V.C' KY7FGUG.*GP 7$>)O?&>=>*_F0^
M5-<U6>_NC*C53Y/W[YT3E06&:+IQ)"U!4^45\D)+BU1*V9!2SFQ4W(?GS]-X
MDMQW114!0^$IK6Q2[$1R$[1FC!%P/M.]J(2X2#7V:I3]7,SCZMD3YP$LII<!
MGP2+>#K\8CE#8)-02LY-9(@F4*3G' D\81[X-4AR85B.JX[?;5E&O_VP:1$.
MB2!$H-1:IKA4/&CD$8_$(&5Y'>*@WZ1[*PPZIA]>9[FK$NZ6HW7!0<R+WEI6
MNFZ>YFDJ/N(W^'L'/,2BRC\%[+=^YCH)%+_)>[VL++\?EZUEH$MS@W44FGDD
M&4^YS*RVRF@)!DM:K\:!+CK'@:[O$'6C/RC"6=Y?[X?BX#RM:L*'1S@W0!\]
ML"1,0-%$&02C*2>_"8($X=)6*] 5%BTJ+3<VOF^6:DE00H,Q7.$@560F&!V<
M"U@" 8GFS-M%)>BOJOFOYR6^N[WW[T'?/S'><M(CX[F@3A.6O!,70]#&ISR6
MUA-? ]YZ9#(OE=>/)2^3SI&(E=,1,8FCLDX9RPC#$A'MYOC\S)P B@>ZJ)DR
MS*RD1FEFF57$.8>Q,XIZR<0<WQ0^3]+U,/F(M),1(8!KZ<!9H"IJ['F*('@
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MS;R_6Y<,4$QXRKC!2"#$I!4FTL CD0A%T*?2SN_=NW-#C.G=NNO!U8](&>5
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M]@]G6E,I4)-A 7X($:JIHH]-AQ!AFD6.!$XKZ;A)!6(_X'T\?IS_/E'UJ?:
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M,D@"5A8Y\B@[!G5 6AJ"/,.1DB)-F;:""^&L(E*24K::9>%:"N'2.-H^[QG
MU&M *8S"Y:  B".NE8@^N!21W*(ZOJ,EV-0+M=#KGM1Z-]+U17/B?D+&HG_U
MR) 25*\E$2M:6UUV<K[UUG4KY]$)#+GLZ"6VBV8=7I .3WB8U#(K-4% &9LZ
M4F !9' (>(X$QUX%9F%40E*'E6J4DVL)*^I@9J5^":6>]#BIM0(Q J"$)EI6
MY(%A1@($D898$D6TKZ!2KWXH>W*;0HYF5VS[0D:H12"4G:(=3GOG)+) 2>,
MM80!!2,+"<Q%#]%;)-,.!E5G4%8H(I;#VA5E'5F;GU>;)_/JD5<$CB"(:X<
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M(:Z I"Y]N/>A_<1)FOM)FNLUH_LM6],=5W.M]G#@W3R]GE<T3+(JP9"_?*_
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MJ5<CTR!U"@N..D+-0]G7EQ28*4D9V_DL+@L4%V^EBXP/<%@<PY .KPDTTH'
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MTUS>N-#1B6,4:J0Y#4)(@8UTS@HOE(B/G[WQ2@ LFP!8*16S/KK@-& %J(D
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MAKE*FZOGWE2=]3O#<%ZFO$Q+NDPO$97*UO+EK>54D"DJ:[2*%@)A??1=J/'
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MK'1K&UB2NI)S1X=RAFTIN&Y>IJK@\3/L@'LH%WH'%&<R^QBTG0S_&.>Q]H*
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M%(@J*:P+6$)1= ;4#*BO#% ?@:=!&*%T1-6@,47!1,+C@R7<:JP\<203TVK
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MS\V71<W23.O(***9S@B8_89D/HE)I(6#G5/,Z>6=S6T#N:O+T_?JT;L!3[<
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M(<L[E[A[*-GP[#T^;[UW)J1/N9_F2/4/7:=00]>I/I<=8&;$1>L5.L*Z7#^
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MD^,!@O*L#P(<('='YS#8P[-.#50[I_GPJ *HH?4Z E<_,*.R@^L$,@>[GPP
MKE=E- P,"G$[XM)#-U6T$%6$LC_PC$%0%7V@_PZ,S!7C(POX5_40U^V.NJK
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M^WPV.IL #X*^'$?/FTK;P0^(#M8JJ7L:,[IN#@(.1[-QM5'\& Z=6UH__^2
MARSZ.5?;Y-D9@VC8@V[N?K@F7OTS+ROO;)C)V,MZ*?P]S3%8B0DF%_RM560@
MB+I )[,.TF%P_P)RKY#'&)SF93D**!;)\]<2S&OT>5OC;>+<!?QTT<JR6,ZS
MJ)X\GF$>B/\X\ D&7/JCX#?' %]>?H>+0-4A.PB33@=EF$R%02OF0"<ICA$#
M@1A?AMTA>.=Z!Q:D>T:JQ)1QL!@9:";0/)4AT 10P-X 0(PSK0(?:$_"5%5O
M4(6181C5Z$)ZI0MA!UQM4&#?787!?^1VI.K@,O)RB!B.JAA-\/"O5VTKAY5A
M%'9N.O98,_MXDNOC&$ ((H5P3SV&LAS 3N!"CX%P.3)H$OA1=SSU]>EYKU_,
MW@%&&(%B&5;MZ^O(V<0Y#=NF$1 ,BO*_KUVN36O#E- 0K@(TORQ %YC^:$-V
M#@?UDXPK^F"PE3DL3Q6L"'H4DQ1J2(_V0K=."YQJ8]"L)39+*[T:)P1,]7=J
M\']M$(, +BKJ:[(D-CI;U7J%30%TA*EJ_>'1!5.T,S&BIODZK_N?(,&#E0EV
M8) ,__6P#04P_ B?9K'#KAM6G;?_@6$]B0-=#X\ICC^SG=-O)E,LBZ*$6"DM
M)K8"I##4$NU%E,0VL=8F8,-DZXM:)G5"$/]2E; >(HXJN+I&O5%EJL+6YB8?
MWI96?OTT]B4D\M&A5\S9MZK ,&VY.1GC5C7$EFX6T\W!SYT/WZCSVG/K"4N8
M)SRA,<DLHR332>QYK(4S#IN:9C1=IPN.3V]TII!'Y=$IIT/"P+=UU+KO#BMG
MT)0';1I4-(X+^#_H"1?,MK%SIR)/57N0+DJP %AJOU5'C64^O"<T>\*7^%&M
M06:<>>ZG,Z-A!6C&*6<@LOL;G>U*YBI=5OK48[;R5 0(\UVJ[R<.R@+4&DQE
M?<9;TP5=30!#]QIE6*5<5+IZV!F=U"G-E<"_"+7@<Z'R<N'$L#@7)HN.9PCO
M&53CN 1C_-:H)G1AA4#].#_#.CU$]UG=K+J!;:#.L.].B9?PB&#?%>51?A)$
M!= !,9@44JDRA!%%,="#L7E1@!8SKE_6JCS\%KZ<NP]=RP%P3!L4F#IN833
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MY*I8P0DF3J">&77#&B2UDJE4T?3,%W'URO#O_F2@>_X?'/L3"0(\-&O#&';
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M>W"]=KYS_BVU/ -$Y(BA<0;P,;)$41T3*ER2TE0;Y0$^LF0]6M08&VBGBQT
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M)*4 ?%WDI5S=51XN,T78:+RPU&GP%!S6#F0J)*%B4$X[:6X/-24S9142!_<
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M_6PJK#KU\1'$J:0^WI+LY.WI[J<#::/3ADB4P,7-J8\&&;@38M*37%%K -G
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M)X1:Y;60Q;1\)KO1[KL%TQ)LQR28XN"I6_A".,XL?PQYKSQ6$A9<R >*4*Y
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M 0JF3R;>]8/1>+,&-MAH!$;\,(*%DO]\"' Y)3X?Y+XVF]7/R;:'M<Q?6A%
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M-!8IFMN $Q4RM:I!(G+X%I+'P4SR8"33!94**CT35-**)@9/A@/1G-E<<Q#
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M.&-A,MV@Q<A:[I&GE@OFG*%6;;QA6P(OX/U_Y[6KD+4B/(K]-NAY?Y S/ ,
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M^CID-2&(&I94(,*EE$.5E6EK_6SP[0<5MG[23;DU.(6+G=CS;#8W):VOC<W
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MO]:GSUB>+#]Z[KK]M5P.KGRK5K5<8RT89T0"9PC4!.V,U"QWU4V<N1MD(8T
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MS=NO6_0M;(VWO/.FU]NBO\.X/W[>>O<Q=7;>GG7 $@X"6!\!0T(IA7CP$0&
M:.0#F!2,4\.)K7 '!"Z&S4RG3'0V<I]A!L@C<_E\DZ1@I=3P5V9U5XOL3F>\
M54WYM0<>WY!,^61^_?\WM^$J,?G^',S-&>Q-%A1P+!X!,(S&0G.'N:*.6F!?
M5\X/6KTR3RT?A]E? Z:8[_:ZI]U8,8+XOW'WI+";,0#'<$(88'ZK[ZW7\UP1
M&UN]VCK-I2"SB^PL]KY<,JXAO#V"ZPYCY>X*A72-#@?#4U2^4H^E\!SX4*9F
MV2LWS)!5>^E<%<\&WXKQM%V?550TJ\8[^*V^#A"J_/6#?CD(*D9%P</)Z [K
M3ZZW-GN]UB"?:TZ^"E9J]@A.ZESFKQ3"=$4L,M-'W:_HL!N :OWR>O;SQ8>S
M?2TI-]@:!(97;O%F#+( G(B"#<:#]-)C4QA^O>6R+_Z;)AT#PA(BR9X@+K(:
MD4H1(8T+C@(0S\:W?!]KIT?/Y:]\Z+S"-MH3K!_=CTH$%QU%!OZ'>.(.&6(]
MTC&O+&/!);RV42RF;%DM(&F[-1H<%W_-V6$7R,2Q/9^8+U.7(2PYK&_,EL5D
MKY4=>Z-OYCW7[6?WT.67,\H 2#V2\JY.=)9(TTX]%!C:DH27URU,6V_\^;ZG
M7ELK$@*MPQ ',P09T.K(1\>"@;FFR7_/W)\HI'* ?S0.!T7M@""$6(D"+/]A
M+"#=/:VPW8X&?>MZYZV3P6C4S:[R91+GXOF@?@$@X;1K>[4*&,[(F(NPHG'Q
M0W"IVC8NU^L?@)JK=<?TIN6.HW)H-&S!\\& 3B\EIGJZB6H;9K72CV>3WF_Y
M0I703RX[F8=\TS"H_1/]HIR'<51LH]I7>C"VI;Y4'+6+"Z.?BXZT\R J73:L
MCR/SC@+&NTCGKR-#-2GA=%WE<OOPH-W\A5^&L5?<#I=5]O_O:E^#.N047W[%
MNM&@-SZ]_BL+M:^?B'M1,6?\S/P\'%Y6[CZ(R('D?48VP6!_L;TS>SY:^_=5
M,@E,<FX.YQ^_>LB-_^>&_]Y8=N/E3/"[S.[1S1J0XM\&H].5:@+R!/;,U\Z'
M?>%U(HP9)*3+W2Z%0=H8BF1N@^F,RUEZ\]P<OF-T"MKS',VKL-$Z!NU(D#83
M('V#IB$S336>*O8HNT !S&LG8H6R'J0"S("8HZENWC1D\C"+)?!_>,\0(]>Y
M(7=I&2+-NI&/TMC"F+M=]CM=.(1ZG,&RFUYV213O9!D!O>)J?/*^W4+,,^WW
ML%/\A9W*:'^;_85UU'C65=6O4__A#?IB/.TBS(2)W[%P[PJNT#?3]V[YQ*]N
MYJ[OR/&,P>BA$E6?- 5B^ZISL:(4CU?JOVEU\ SR86X42W87PV;9Z>3$S+GJ
M_<GVSLH<0][1UJE35'I'6^\Z9[L7/J>A$!C;V?:;S[SSS]_=W7\^$/C\^>[%
MYXO.T5N^D*+R3P?O7OQZM'61TU#^/H3[\CS&O7_^.-Q[\S<\YQ]'VSN=\\[.
MX;)JO@[L)(,]R36B*.+!:.2H="AJ)7!2VBI,US84-:^L\T"#9@V:S:&9-B2Y
MR!GSBG*)B<;8X9@H<R(E8_&-8RT:-'LH-)M/P U>,FI"0#B1A+@Q"6FKX4=4
M6 ?NHA=\;4.S9XYF+X %WZU:WI-"Q5]SY^'+:? KKH[UV.RO+$ ^\FOP\DYX
MN5A&6!FPQF%5D*!.(.Y"1)IIBH11C$@7K;$IM^Y;C%1\.16J7OT^?7!>T^S3
M^^[3>5ZCI%+:,XV\UP1Q$C%R)AC$2&[XQ'.#.+:V(?#J5Y)[ =3E&3KP_K;#
M;CFSNR]Q>9F5G1Z;N$RFO\'#N^#ADM*[VBHOJ60(Y\Y3/&*9VT^YW%S&&I94
M#L)?VR#DH?IEKI!CJMFFC\9;FFUZSVTZ3UN82#H%0I&1.CN774Y8)A%AI;F
MU6/2Y/9/;/7+H;T VO(-:D?,BO.7_][AV+%^WF_6W,3?*KOYTCWY#S]!+T:U
M/#@#G%$I-ZGJV^B;&^B;)55]F?1 #0-RRG+$'2'(9LTCF!%,18%5SGXD;8;O
M?0#PX)OGB=UA#8PV,+KZ#+V!T<> T<6^888Z11U2UEG$B3;(<BG!NJ96">]H
MI-FZ;@MU[\+H*PZC*TK[OUT+]L<GT/\7S.:<G'S>L:?C(?S[VK-0SK8^[&L<
MF7 R(J,DD!%.!7+1!"2"PLQSG"QS-\PJ>;HZOILED:1$E5<[>U*:HMTZKM:Z
M&V=R37JU('1SYEO\FE-'<]3H3"9Y3I[[<L4;#9_,">)U.DZI,G59_.:N:2L_
M/$D%=.,ZKO3C;;-4M%AG^,89&K=)_.#F9ODD+ZC9SG+.LBPN_][.TV?,69<]
MXHMAG81S0PCW1#G,*? 8H8S2@6/.,!7&+V_(L8QL?D/3U87G1E4] \"6[?1[
M-]/._Y^]+VUNXTC2_BL([LX[=BR+[CKZ\FPH@A(EK[PF*,F4O=0715U-M 2@
M,=T *>K7OYE5W4#C($5*I A2/>&Q0:"/.C*?O+-.7+?\1Z^=C@[A&O@-Q\C>
MC/J?7_-WO[T6AY\--EH2)Y]?GY\<OP59>1*N:J<GGY]_ ID)]SR'>TYX_\!\
M?'=P^KG/L-'2 ,;Q= ":*'OW89@=KL=^)*?"*I"F5H!B*JSF1*5)0#38_DI@
M6"AVQRYN5_3GT1\G"SS%NURXK<"D@YGMPYN/79,?7R[8(=*M(=*ZVS&-,BJP
MIZ;- DM$&# B(ZM(9AE+14#CT'!$I)#>EMOQ7A#I 2I]HDMRV19$0KWH^+SH
M@.C6@&B]F"O%=G1,*Y*81! 190&1T@8DCB+#8PI6I@H<$+&D4XV^*Q"%G6JT
M54"$G10Z*+HU*%JO+$@5( X7E(C89$0$D29**$&RA-$TEAH "8\CVF5AIQ-]
M7RB*.IUHFZ#H13'K_$6WAD0;<H73. RB1"IB9&J(T(!):68,22/.I:4Z4S;
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M&2C1<,$XEZA<* O2+7.5*;7@G<Q*8.^JQLAEV$5H*7#A"OW1JPKPS03$.JI
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MIN*8IYC(ITQ PVO7_W2P_+!A^6)-R<4P5"2M($Q)3H3)(I*HB!$;2Y#G&54
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MBC<!=VC@36/1]5K6S+&X<E 6L]-![RP')-L%[6%,ZH\X[5$.W*8L41)EN9S
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MQH(K75K:N+<+*N40K1N,ALR4]]M[X^8"N3F?%F.+:BH^%+3%&ZI.SR2"=_Z
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MZ3'LB=W-,X.+%UN./6U ?QGC#K^ I>T=PR9]K T^V>#><MH.;!UN#]I!^%;
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M.LQ$NGK 'E*=]7%Q(U[A>A#9E#J),6F#H5VQ;HF?C$(J[F\TJK*H2W *ID=
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MX)!I&#!B#&9_(J81V,1*#<S '\C_5)FH[:0[:I^>\Z <_=L?XIR7(2.#U##
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M8KI%%I/I'\,AW?\&57NC2VMR#;IQ5E"3AS39NL&9WDQ(*5L)IQX))[E+%2E
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M$4R^%Q1'5N[NZ:*PE'G=AKUZ83J8"NVF?)\G5W1(!Y5H+PYX0.66]=\9>7R
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M&WNUWJ>$G9#U;&?-H"6G]Y\"A8TO;KFA66,=<4\IF@;8RG4'1 46("LWI:9
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M0&9.N!MJ,P-MI,(-"H*S!67^@!EE*51 ?Z-\%;P,WVAK 2&9XMN<_1QA6LI
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MSX11!HN,_YGW%<B C.=BB :BLC5M-J0(0AC/C,R)3%NB[L/E?&5SB54GE3C
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MN*1 >#^/2*RXS3@1/$Y&,D6\4^.28$F&&DTQ6."8:@E^&(E12 RI6<DE$5_
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M:N_URTUKO;AH]+O]K1Y[#ZKWAH$S?,,/A(:VPHQ$5,E_=*4^A)E,7 _'M^-
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MO_['Y>?/_V=]^<?'WRYOKB\_6+]\/FI5=O$X5'^FVU\[J1Z75YD;49#XKJ]
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MN"+P-[2FX[D(YE1(1L.L6U<(IH*.WQZA<^^D/NQ/GXQ> R=ID0*!O 'BYV,
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M;#4;".KMYM3I7NS-;H;#UG3RR1*^3T9!W*-"[WC#7$P*XI-[^D2AOS5*D=B
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M(G='61P0X%[?752^ SF]09PZ?3/GO1[H9+BP%!MK5[,E@="OR,K?#M=H+@E
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M B]=ZKWK=@3;TVGL$.<CY>C4@/<Q!#V]KGVF-X[J\DVPCRLUY27Q+@R,QNY
M=2Z;@T]25^4,<8F,^%?+>3%,9M<XNRUP-5;/[^F8"J"03 D9!( ZB";H^I(%
M<PA.9L2E@-L%U1EYMXU@39"M]&@L^#V1T]OQ(YM1C+E49/887()'DI'@U/LR
M#[+S*_J8;G?L/S_:&?1?GV2:Z>< M\%$M-?M]?5&8 #8"#.@;K+%"GJ6#\^N
MN@1,I9:'Z'+T,AH"-T'.Y80U<'H'?A3=ZQB[757N(6(;VK0Y?!.DK1%%9Z*)
M%XS53:C\%\3LBWOJ4O:$7 Y\/_B.U'%U4/6K./M\%0E<4*RLLJUPU9C-_*$=
MOIG^038795Z=6)*%2R; /@5<3OU%\FM'B]N*8E.M#^_0#3+'O$#'&7N:<,KF
MZ31B]>2**7ACHTK09KS,'H@-\^=E)9O@C!^(3V_'\;UY<6X!]89\X*JYW7#E
M!:J#*6,$335B,#1!GZ'MP<ANLD#O!P\;U*F':81BH_G<A^#GPVPD%@'&0&H$
MDRPA8P $7DC $&Z#I/7Q-$'Z= X'A^LPR@EO;J[,)GU* )H@#Z918=Z>EVUH
M."]3=5\Z/-^SR53>CK^$R9V<U;.[>T&^?2#PHJW[$L9W* SPO++9 6<SJ &@
MHDG]-(!LJ,QQMDBZ*&&26;)>M@DV_^GR[A$O(MJ0[[56J@F<X^YFY!1#OS3K
M5#63 5\NGB]N&*<JUZ5:,_6PO-2*FQ1)5LX&J;_,QP)8!NX^,1\C'4[3P$ZO
M0@/ )FCUFHE0?HZ3S/Q+PK\%X]L9F9(-2;P;H)H@68VQ,J:=WN.>$*Y)Q=X:
M7U-#Q.S(^/8[SP]0C,;3)5#[S@/:)@D=JQ__QZ[]"2)Y%;*GZSOX(;? 7RB9
MW<<W2"JATIV]!*F?[?,>ITQXR4SC0N\(2HLVH_4OTV>?:*:Y0O\3,H_&Y..!
M'/4V3;K51]78P;V1%]O+I%#CYWG*A[O#X<9AE0%@(YH ":5/KR#@_W;)@M!E
M%&_$@8'0AMAY$U@39!M V,A<PA\D=$88@&R8J*HJW@19_ADP+K_"JTC0U8[5
M9/^+BI=Q]PSF'L0'$.EV2VR%JZFSW;\'XMN0PS 5[&]#M%U:M G*_>-?&]U)
MKD@3>/[@LW1!.*R] <(0N ER&HU%']<GBFN/9A_KSQ172.S)-],%QL'12(V/
MMXSO[@2=$Y;._V!^4SQ1DAYUL#&IW BZ"1HN' FQ0;;J\DV0)MXTB>^N W$9
M\"BD(>Z6'/+X'JP-B="FX(V-76\"]ULTC[/V;GG)G0MQ?HMF2M@0_N<GP93L
M?OU,X\UR+J5>>"V"67:1:I#;&CLTV:.[3Q*--9DMXJ%[BLT1-R,OCWO<9[A5
MBKZI$5C%!J*M=ATUR9.J9(_E:9V+]&B/.,TH'*@=/]7#7T/HG[TE3KMC[\/S
M?G9@E^'YV8+C]$0$;/T#^(,^C1*(48*QQ$?ME$8E3$-7Q-3IE[=/9+F\NV%D
M7UV^"6WRPS-U(YQBNYH2)F:;O$QE\2;(4K+O%R,M9ABHF4$WMM--[<PH=;NB
M<!.T6'VF57^7 ['Z3>L-R^<S;VY4Q+?7.5)3G$VHE>J]_6J.?S_'!%2C^OFM
M6YT;%[I3"%C?_?(?4$L#!!0    ( '&"J513'W5IZ24  $N! 0 5    <&=E
M;BTR,#(R,#,S,5]C86PN>&ULY7U;<UO)D>:[?X6VYW73JOO%87M"W9*\BI!;
M"DD],_N$J$N6B#4(< Y 7?;7;Q8(DJ!X$0A4D4?:"%M-4A3.5Y7?R5ME9?[U
MW[\<SYY\PF$Y7<S_]@O_,_OE"<[3(D_G'__VRQ\?7H+[Y=___J<__?5_ /S7
MK^]>/WF^2*?'.%\]^6W L,+\Y/-T=?3D/S,N__6D#(OC)_^Y&/XU_10 _K[^
M1[\M3KX.TX]'JR>""?'MWPY_0511A)B!_D10QB)X7SCPJ)S70B>EX__\^!?I
M7/!6!2@&):B2/814-!AK1 @%=<*T_M#9=/ZOO]0_8ECB$UK<?+G^]F^_'*U6
M)W]Y^O3SY\]__A*'V9\7P\>G@C'Y]/RW?]G\^I=KO_]9KG^;>^^?KO_VXE>7
MTYM^D3Z6/_VO?[Y^GX[P.,!TOER%>:H/6$[_LES_\/4BA=5ZS[^+Z\FMOU&_
M@_-?@_HCX (D__.79?[E[W]Z\N1L.X;%#-]A>5+_^\>[5U<>F>?ASVEQ_+3^
MW=/?%O.,\R5F^F*YF$USE?"O85;!OS]"7"UI">N/7'T]P;_]LIP>G\SP_&='
M Y:__7+R$>=09<WD&9!_V^%3GUZ"36&63F?KO7E-WV\^N\)KAQN_K)#^Q=D>
MG3]XMDA7?FE6);08SO_E+$2<K7\Z.5W"QQ!.)J^G(4YGT]44E\_F^?UJD?YU
MM)AE>IE>_/?I=/5UHJ40W+("+!H#RFD-P;(,05IG+!$\%G-U]^H*E[3$M9Q+
M6,:UL#</)*$+_A1GJ^7Y3^I&<V!\(_-_VQ79V88W6?E$"QZ921R24IE>S23!
MB^0A&Y4PT'JURKT7>74]6Q1Z-J0GBX$63KKMER>?L6JBC9H[0Q2&=(U;5U^R
MS6\\79X>'Z\_$Z8K/#[_]U7G=63%:M%FX\\$2TLY5/*_+8Z/IZMJ >KJZ'U;
MD:4@BU$!>6V%C-D!5S*"\MQ!B":#L$9S[E5F(G9APAV@=F&&^!F8T4HPS9AR
MP_J"H"79;"!XF4 %0SB4<,""TES9$@T/70CR/0UX,R_DS\"+ \70C Y;B_SM
M=!B(IQ.,QGL;B)%">E!<*_#,%#!,.50%G7?8VW)LL!RZNF<I+4[IU7L;OH8X
MP_,5LJ*2R(IVNCA-WJTBMS5Z\G,Q,/0B2I5YEQ7>C&>D9G(?/GQ+\P8":$;U
M%^05+[XB^=RSZHC>L%*>C6:E9.#H*9P1F@"*XD%;F7-QBHF4NO#BN]!&:B];
M4*2M6)JQY<WJ" >B[W!Z(Z;$.7..]+24B71_+!*"XPQR4-R:$IG6?=SKNW&-
MU'ZVX$E#@31TN^>K(:35?TY71[^=+E>+8QS.L7V]4';6B6(9 Z,+(1.$S'$D
MXRXYYF(<)UW8R?_^/KI="*-^3,(T%TX[IVLQ__@!A^/G&%?G0(PL6L=4P*%F
MH+11I.00063F!;KHM61]O*[K8'8AA?XQ27'HUC?CP/-3_+#8V+RW8=A>G\M!
M6_0)2B %1O8NT_JX!,S*^N2\R9ULR^V8=F&$^3$9T4@0[1R/$QQ"S1*\QK#$
M:PJK*,%#=@I,RA84N3_@K79 )'8VN:!HS7T<CSMQ[4(0^V,2I*% >F9QG%(H
M! 5126:*J;0K$"W78!5:X72..O?1&NWSV#5IMIBO/_<_PNP4WYRNZE%-/?V:
M>!]R8$*#P4+O9-2DMJ77D'T(GGN-TKINV<Q;0(TI@#^0&3?E+UN(HAGSG^4\
MK=L09F_#-+^:_Q9.IJLPFT3%(@L^D_C(="LK WCC"P6)R%R17&5F^^1T;@8T
MIHB],2=:B* 9'][A*DSGF%^$84ZD7%*$>'I\NK;FS[%,TW0UB9:<>4<492X&
ML@!(_EUV$9!QA9DV@+L^KO7WL8TI7F_,DL:"::= +G&L4PJDX4X&/,+Y<OH)
M7\T3A8FO%\OE[[AZ4SZ$+Q-T"KD(%C(B18C>)0@I*T!O8L(</7-]3D?N"71,
MD7QKA=-19.UXM5SB:CDQ.F;CR11BRID\S>@ALH*@%<].2,&YZ62'UL]OLXIS
MWS;HZ+CQ$B1J\IT=/=5S9L"5'&+F3*;4Z:!D&\:8W*L]I'R-S7MO<>/D]AK'
M[XMYVD"A(*:XF!D(GLB?D][1*^HC,.$0D6%BN0]U;X0S)@>J@=0/W_)FTO_'
M8I$_3V>SB0C")Z,-)"LH='4I@.-"D9@4)H<Z:^P32YTC&)/[TT#&>VUL,[&^
M'18G.*R^OIV%^>K9/%?#>U(K3\@N3B*J;"P+$"PM1G'B&!'- C-2>0KBLI1]
M#O7O0C4FEZ6!^)L)H%,N\5W=QC?ECR6N%SM)I&&D<AJT=PI4(7 .52#EHS"&
MR)W,?8Z[[X0UIL.'%GJ_F0B:L>+5?!7F'Z=QAAM[A*L77]+LM"9U+E18#ER5
M8!3XH&O&U"#$)$W-\"3MN(Y)]+$-NZ ;TW%$ XXT%TB[H.93F,YJY<[+Q? ^
MS/ ]DN>RSJS7 [3+[[9<&ND8X\FG&G>1HA/&0 S9@C5.^Y2%],;WB1GNC75,
MAQ8M HN^PNI1<UB+'NL5D@SD*!$*E00X(SEPS*Z4D SR/FRYM4R]20VE-BAX
M#IJT>12@T%CP@O1ZC$9F,O[!=$HY[E<2] C5A?>2_!WU]OOL>)="CJVWBN)W
M9WP.8+ >.3I>(#!-WP8N,'@NBNP32-^,9TR1=#,&'+[S#U,%M@6N,$L!OA0$
MR9 %#S9"<#)"ME)Z41S2SQ^^$.Q^/'F$XL&#>-)#-NUJ@+ @/3Z?I; _A"];
MJZXQHT4CD[ .$DOD#"B4X+POX)S6(?M"P/H8Q^\ &U/<WHHH+671NQ9HB[=!
M>)T%25!Y+4'90DN.A,VCU$PAX>SD:'P7VICB^%8D:2N/MNG\;;Y>XG&.I: (
M"GGR1%OAR"TJ9!6S<T*'E(/J5!5T.Z8Q!>_-B-%& HT/(\]]X^AB=(0?>"SK
M<_8"Y".1K1/*J,B8B+I/\O>.8[Q]TE:?Z%,6P]=_#(OE<J(8U]X8#DD& ZIX
M!B[4JET6M0Q<"\W[G$U>Q3&F\&I_J5_/2.V]URTKI%_2$F\NS0U.J*PKF&!K
MXL(:LL2HP :-')D3A?<I@[T+U9@"K79<:":'MO;N'2:<?JKIKNJ?7=P5X]Y&
M=+40MQ;Z>EIM5-F2KQ:R#3EGU:G\XG9,8PJKVK&BD0S:!>%A>51OV--_ZKG;
MIS!;W[E?_1:&X2MY;.OJU8FU*2;F%03%(J@4(CA>N]8XBV2CG5:V#SUV@C>F
MN*H=4]I+IN&1.9Z$:7[QY:3VJ2&06U4:YTNGT,XG,G#@2BW14-J!UXQ!8"69
MP'R,I8\'O0.X,<58[0C36BHM2T?7M]DOU=Z6UHM&!YLLJYT;UEK/@Z^7RE+V
MF'@IDOD^I^EWH1I3K-6.(,WDT.X^SM%B6-5\='6<EV?]7B;%:.,=/3_5V\@4
M^7$(1CH0AO2<9M9$U\='O0G-^,XZ6S#AX'W_A@%_??KM]KRF[UOU;'N_HC_7
M&!=EDTJBO[T*Y8#F;;=\?(\N;KNLI%$[M_/[ V]Q>'\4!OPU+*=I4AA/)7(&
MVD=ZRTTMG E9@7>V6!]SYD)V>;=NA'-X:N.\AKU&6F==HD[I*9=;2X];/VG]
MS E2>"5M)K^ZOC?*!4=?^0C6,FT$CPY%GSL)]P0ZIN3(X3RZGB3I)[6&Q5[;
M()]/E^D,)^9+F.<7)Z["=;5DM6@#+$B*Y9*4$#PSD+0M$DD;I=RG;]S>D,>4
M?^E-MUZ2;$8\@G*)>!*XY<84$K=+!"$&,O*I-DET-1_  MI.MZBNP.BOI^DW
MSNKVWI)C4IFW6@W3>+JJ3NJ'13T6J ?2BQD]X>.K^0H'\EHFPOD@&1HPO"A0
MW%J*@DDQ).8*QY2MQSZ% 7W6,R:MOS\+[Z_MN\O^48S"1"HCD#03<$UAE!*\
M9O*R)(0^%XM!H^^3,[L/RC&I_EZ<:RBG3DRZZ:WX%<MBP(NR"ER^^+(: HED
M.@_#UU>TD\M;7@V>LW1!1XA19%#668BT$F"LMM9EFOG0)_/6<5'-*D*V&.8,
M5X*1-RETKFD/R\"1JUG="^8M;1;JSBUA;K.PCZO[Q\+-6ZM(]I1A.Q=M,5]<
MQ;+)N4X$FI*8E6"E"J"0>W"91Q!<>B&,=0S[5)[="FE,"GZLQ&HCSTZVX:P/
MP#]Q=;3(V]DZ4R1900J),&2SN0*;>2VQBU%Z:U4(?3(Y.\$;T^'M6&G77LX/
MZ)[LY;0G#"([KB$522O(CD%TM3PFRV)9W4O=IZ7G0P1LXW("32;FU8P)2EX;
M="H.47('/'&C,;@0F/ZQG<"Q.TG=WY#[1]H/0Z?&6HB ;LSQKSC',EU-K.>Z
MF" I--2NMB9TX'@,0,;:D0<8DPP]N7T-T#U]+/C_DYB'R;']W8"M*$)$I^KH
M+4#GB-W,E]I77X 57ON<2HZZ3\K^NY'@ >O;;#:MSJ*ODP- >$Y.K*1 R1N!
MM$Y.WH.)6K,^GN(U*/=4X'U?E$.)<&MXNM?&-VSL]PGG9Z6G-UWBNK@@7XL)
MZ'^YIL",ED8&JT'4-JP*DX2@R,?4R449LY>E]$E5[@%V3 %M:PKUEMT#9$ P
MQE"B*:""LA2D, %.>P0NK)=*8+2NC[+9,0.RCQ=R9@+/5QAM#$P% =G4\5-:
MU(#,)#!%)YVML-:63M['%2"C4J9M"'%#@X^]M[ZA%WH>C)\M;'NI$\&9M3PC
M,,GK$;'3Y,*P!-9Z8[)#93KUG+\+U9A49"]B-)))V[L5MR\VVV)B[5!4E*L-
MZTH&I[P'AYDID[4(K$_FXVY<8TK3]6%*0[FT#T$N/$5GI=?%YSK#CIP&Y01$
MAA:T82$Q"K%-IYN&WW'1]ZCHQ77<^ \*\88P>S;/S_+Q=#Y=KNIC/EWLNV7)
M.)9CO1DGZ@1D!2[79L84]145/>>^S_WKW?"-*=-T&%NN5?ZVET_#AB#+U9M2
M.W>M)T?B\&F:</E^,<N3F$LM\F*TT-IUB7-'> J':%-24>>"I<\+<CNF,5G9
MMAQI)(?FC5=?'9^$Z5"M_CK22LH$0QH:O*WG(2&1-Z@EV7FGM4IHD^CDB-^,
M9TRVM"T?&NQ_P_3&$NECZLVXYQ0MSQ;K3J$7 8)73M4L94;-0>4Z6L.@!IN=
MT)D\O]RI]O9.6&.ZG]B6&>VDT6Y<Z3<%Q,^GL],5Y@E*;8/R!;AR%#MFZ\&G
MP"#E8B4++LA.'3UN ?0@=Q\VSSHK9ZYM,#F%R21HO3Y)3A#J/ $3K#.Q6.;L
M8YV^?@-U3.Y7"S[M=0-B;]D]UAV(*X"#-\QK5CO*&7=V.RUF8D?DK)"BT2A#
M'X?M -!C\NCZTZZ?/!_M<N"5 2=KG^P*HD9W!*\_I?=5P>^LJ]&-P1O&PUR.
MAO%*1NLU!)>(=M$$<A*,!>EMT0[)84B]XJ];035)V=WP^2\7 [WA\[-[MNGK
MAR',ER&M]< \K[\[D^\_PG1>A?%LF"[I57U^.M0S=1RFBWRQ;R;6YEB9U^.8
M4(_-.7A%.QA#1B&,YU'U:0?^ (L;DY5NQ=T;TX<CXDBG:V;9H9;2,\ 24DV#
M,O":1]"T-2QSC5KU:0IVQS6SQ[6_O0BU_[ZW/:JX91;8[;W0G^7_<WIVY')Y
M<P:E4$@>"&-)4N2H++A X1XYJL4KA<5UJG9OM8(QI6P>6H-UE?;C>8!A>?1R
MMOC<R?.[^/3N'M_-ZVCEZ=&G?]-7ZATN5\,T$8Q-WZFK/]CZS3/K120::C/7
MYWCVWXNBPA=?TE&8?\1WM)@7I6!:]P!6EB)5<"6J>H@7P67M 4,113.>N.K3
MXN=AU]G )%<(;X?%IRG)^->O?RQK7^6SL^Y:]4/^Q:>SGJM):*V%EL!RS*00
MI(7H!06%SDL,QM0!&+WL]8X81^4=CI?O-_@'/4C0TF^\"=_+Z3S,TU5\Q"#4
M$0WP+.I0 <,@JF*!7%U=K\:PD/ID7'?'."J/\X<GZ:$D:'<&L%[BF[*][#?S
M@S9XPJUGT1I1KSQH4)RM[V$50!]*,FBS=7UJ9#LL9E1^[X]#^\>F56\E?G$V
MN/W^>A=,<;I>>:4(-?,$3M8+CKR68JK@F.[38V5WC&,Z7OV!V-R)!(_A:5@>
M5&))0(H10?GD(1I=Y\9&GJ-/##MUM=O7T[C_;M C$F)>G]R\6BY/Z?/Q33T8
M.%[,UV/C)\%E)71A8')M[6I4+=G2!%DP)X1*(OL^Q[O?A3:F4* 3JVZ8:=M0
M7 VK9T["UW6*X4W9'@4V2;'XR+0#K;VMW3,*>($"A$6>I9<BI3[UF+<A&M6=
MR@<B31/IM)R+?4'A-67?G*Q/B%]\P2%-:0,F]%BT46LPMJZU=I1V+"C(DB?!
M@T>.?4X-O@MM3 [N(VB<P\75VXK?E,]0C$M9^SL&80*HVE##>4E>AN:6!5JZ
MYWV*]_9-:NWQ3FW>[P^+9XG\OGH7_[+3AS=HO$,-GM?^R]P;"-PBN*!L])+3
M7G2:-7\'JG'=,NM#IFNO4BLI=='%ORUF,UP?-;\IOR]6N-7.?6*2"CR2 @G>
MU&FN3@+9#0U:)1MC5"&87D,7=@(XIGS;0Y&I@^CZV'@*0BDZ_6=8U3/ KV_*
M[:>#D\)U<,EXD#*X.JZ/0]3%@W Q>"NDS:R/JMX3\ _@#_3D72_1MN/AMQJ7
MT)_@L/KZ=A;F*X)>LR3KVO*)4QI3,!J"4J1_<V"U"W0$--*9XG.)G1)2NV.\
M9T+JY[29;2383=.]*5O3<6[:#![1"QX+"%]K+FKS;Z^"@220NVA4S)V:#-T7
MZ9B&&3V2;FLJS,?(LDO'<ZF=YBTWA,]*>CE2CN 9^I*BU$$\Z%'I=[/L>UTF
M^":M?3XL<\T&QXOSVH(WI!A4](S\('2 SDIAN$JJT_WX.V']",'/H72ZX9)
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MMA?V%W^/%<@7H*[!63R;YM]FTW#UG>N.TSF%MX';U(+H"/@P9D4/JK[=<GD
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MG592"@D*:T<*R[(2446+W\+^K?7>->S?16D#A_V]XVBS]^33U4&4.3BH V^
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M3A@@DR#"RJ\*6J6<V@P-N1_7$V1,CXIH,+[H:BS//8)X_N7\A^=Y \<R$]:
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M<(]JY'M?71DA@^;))ELF6+/HHS&FD!V=(B@3Z;OZ_!.5<"H)::182UI^]%/
M1XEAR!3P,3QL_'KVXOK3]076FJUE\=8R,_I-.4O311>-A5)SJV-MF@!,9$/X
M%!E,PD40I8CH6'0YM\LX&8+HL9L073C?L#'<$'RKS3 $8?,4EF'8#I_=TEZF
M(Q1F#X$TSJH8B!1UT5P%!9;5=G5!1T"9%7@M#097YW^W2Y<YILKLR*0Y!8T9
M(X<#:\J/]BO?)X)CTI:NW82R#MQ#PNJ"!ILP)L%MDGI06*/-5;2&[K I(#VD
M.^9^VD<T'4)AMSKU_#&=_9G_YRPN*H1KWX/9])*^C8N"G/G-@VY0='6#R I!
MD457*[X2<,4P(\J459\FIJ-@/G8[I[]L.K0QK9'"'VI^$]T;@*EKS&03JN/$
M23H*<]I)$AT")ANQR22YYL%#%/4(#-+1;I$>D#%GI:!SN%,I_^&TXY[ R)&5
M8XP .BC%#V+?UQ%>.$OSOS\G<O9);(R9=_EJ-IU_7O9(N5%G64Q$5LC9K]=S
ME 9<3,0'DZU*R1B9^[2!'(_U\*&8_66\?A'U%5 'LV81*ZH[9JW+X'(#*4>P
MK<R0%?.@"EE?J.KL<ATU"]R&K/I,9ML)ZZF8+>UXWZ$%]AJFE;4_!%17.V4C
MK.,8*@W%-^W%^PZ7T&9P,GJIDL]@E35T:BI/^\ MMD7!7!QWND]&R $5XA[;
MY-#Z,(;E/8R1S=UJ5]=:U-'S&D3B&0LHX02!LPE2*,P%)V+HE#6Z$];A38P&
MHKOC[+;B>P=SXET=%'N9TTN<79(5=).\PH5"YIT&3#S4E)@"WM%WR3G,.6F;
M\J#*M]':L!G/4U"#!IS>>B@<8N#S^_@QI^N+3+_^?E!.RTTKM54/XTY#GT>M
MW6_P\\-9L#;\.1?K%&E2)@]%J<*\0>6U45H@R=ZGG<.?1Z'H,P!:&!^E]1*B
MK6T42Z%#"[V"&'GF.7E9\B'&I7P'U*HMXW?F!?IVU23W;-EB<C%6^]PX95!P
M(E?K6EI)1[8+VH(KL41>4*/I0_A0A,?NN_$P'=G6H+&I/!K>GHOLC0T@;V.;
MEOJ3M;ZDN*$OZ7E*@BS+R,$ZN@=4J%T(;10@F?0IU5&2<MALQE:('K<2'4\X
M'8SV#72<YYA$8J3JH10&*L<,/FH/3B3)@S1"A#Y!G@U@'K>JM.)RPY8PNV)7
M(424@I/165)]]T^+1'6$H)GP49 5P?L(_@1;0.XC[GUY>\(M((,UWD1<],,4
M="'6!M=T1T T&K/P2H9N(^A/N07D*.G>WP)R#)</V>MO"*[GW0)RE.2&-OU[
M"-L/J18E6^0U6.%\CJ#(B '4R4%PF,E CI:VQA-0A_$M(+MHPQAN'[X%)&.8
MC*UUKLZ1QV1M!.3U(1,]\PI%#)$/<C8>4PO(42(9UP)R##^W>J"MXG??1XKE
M^9\XFRVR]?8(R>WZN/VB;(.!K@7.,&+)T7K#BU-D@R//01N/3"GMC"OGNSYX
MO]/U#9D@6#,%7D_G\Q?TV=_*=/8_-6/@AU&:,'O&N07&:K5/8K6P/ <P3H0D
MI7)%]0D/#0"W7[L8_%KMJ"5WZQKG$E7TB4?PQ'=0DM'F*DE!,L4GLKTCM\/.
MD3L???ASH[5H?^X=LQ?K.CSYW,P?)&"O)QAJ/=,DS\\5XR5:8T$4KD!I N24
M,R 4TSFHI+#3 ^!F/$]'"QKRO8/1N)WJ<Z5M8%QC36TB%SO6JRUBHB]U_J"G
M"R_T\26W8WIZ6M&(_UTB4-_U]6P^SU?SU</U7: A%^Z<TL!M[:)B8P!G'9UO
MVF;MF*P1U-Y'QVZ(3T]O^DBG8=?'K4#IF^6[YD\PW^5YIG4_GG,9A=3*@=">
M;D<Z'<$%YH#L]<0LJ^'X/OTI1@)]!BK54%(=VI]M9\<RYE<2\]K0>9DK Q3+
M'K"0WAO-6#+>FQS[Y+#< ^Q0D?/CW5SC^7\J$?6-&K\(%:&4=./6R]C640^&
M>PB>&&=D,HH\S^!3GSMN*Z1CQ=>;RGV]B*,)_WN4]VP"=BO"- 1>WWJPW0"/
M$X!O),XA2K*G+(Z@,L;J&.L<[2RXKG-I&*!$!*\P<N\+YZI3<=@Q5.6>X/QQ
M-&6,"%J'ZFLO83I'<SHK5WDF&+??ZZ9=4DXGL(S7X89D8*$/M0^,1H-D:TFU
M%HC9$EG;ML(1ZK9:RF':FHD=8FS?P]!GUU<?I[.;;E#$:RN3(.JT9G6F GVG
M-.W1D!)3-D7=Z2%N,YZG:$$TX'R'6,I=5"O-'X*KJ]VP#=EQ#(86TKM7(?9@
M?9<,ORWX@JFM7+2J3XF^[@(%+J($K;(P6@4G19\*K<.JQ#V&P2$U8@S'>^1O
M$*KYU22^J#FILV\W!4*9N1C0@W"U.RT7@2PASL @VH!:I*+[-%K<".?PMD,;
M::V'NO9F=0>CX8_I+$\^7/Z,R:G,;)09-->&J)0)@H@*1 HV,^Z5S'U,ADUH
MGHCT]V9T]T*L6VD,/Q?YK'[\&]F]97(U;Y/<,6B)9@D?XPE:2P(QO&0Z]27M
M4JT\YX%G$Y(.+*J (8GSL8OU3PRQR6"P+@.A)2<VTG=8A\6$6-!)(@,[36;O
MF!ARL\2+Z]F,&/R=NZLD^A63SZ5VJA91@"NU/0>7"A#)B5?"<<-R%IC[!$YW
MXSK-YYLQ>G)G($$[.73,.MD&CWO+C<D%<B;'3Q5?(!BF0 9C5.2)7+X^?6_N
M ?;T]*2E)'KZ0VNPT,3,9;9@HY:@= E5?VUU &J>1 S6]+&#GXUBM.!\A]C)
M?=$B81C313M(S%M0$A>U'1I$1LEL"@2XS\GQB-YY]U&+EOP_E7?>[ZU?OA-W
M5GM\+3+RWB^76,Z'TC[)Y#74MJB@0K#@K#<@M#,\D@.B?.ZB6P,!GFH$=Y1.
M;.NRU5 V'>ZI%90-(&]&P@W US6T>Q_"(W?A:BG>=17J(9MCZ%!</&(E!]HK
M0::Z9N"\2V3#:Y]I)W'ZT1/2G:$-NXZI.F-$TD]E7DQKU\IK KA".KV\Z2@D
M"OK%;%OC#=9Q).3RL<0@<I=8$;KV/.RI,]NA'=YD;BO-S:K22!2'>X5VVJ/W
MY.!%YLC_3T&"+S8#2[)D)5#(]=*=9_D*O8\-TX#SAWR%'H+KUROT*.D-?7-\
M".L/^0J=M5,VRUR[WB0Z((VK$W(%A,R$X2%KZ?JDXS^&5^@N&C&&XQTT8>/C
MF,F%F[#(GQ*J=BDD0G5!,+%X97(MH8Y=M.#$7R%'R6K(*^081G<O)W__$6?Y
MX_2"/GN^WB-W6LYB7(Z$R>G-U<<\J[^COUYWU)=;Y:Y[/%$V77^_]\M^K%A[
MW+0\11NBTE8Z53A)/2-I!$]2^5)R.6^*9._Q!D,6^Q&&="QJS9%L;*5J&+)X
M\-XBV54E*B8SLZ+/6^!8I/O'%Z?QOWX2TKF4J ROO:HT$NV9G QO'()PN4YB
MDC*;/N5(=[$<_@#MJBEW XA[,;_'+*IAY"_]#LZ]\+X(,$'1%9"#!J\4!YVM
M8:K4]Y<^,9\Q* _UN'%0Q>DFII-[]MC8\=Z1\5&B8&"-(6/&*@F.K!FP7*3D
M6(VH=7[L.*7A(?V48=14D3%".=CPB"&@?DT5&2V^05,D'L+[@RE&M+1R-@50
MTY>:40F8"*;)*;&D@Q:ECX'W6*:*M->',2SO,^+LOF-RY=I:[U#(*,!A?96)
MV9*O7 TQ%HRQR6DN^[23&0SQ5,9,C!+I>!OF ?+H:Q/_F:_^OIQEO)C\JZ:E
M?<G+B8'_(%[4*_9FSEL@5$E&NE1K.QRG+ 3%$P17C&<R,.GZU,.,17J2[M5#
MA+Y=M=I+K._1]-<,+^<7N'E.L>/&1Z\A<;(,E> 24# '$74LSI7L8_=S:0>^
M9Z!-K:2S]<FL:4#T-R1_[2U^6XPM_3&,91%U6/RN\HN8M:!G,41@WQ#HPU=L
M$/1L1.Y:F+,D%[63W-MDE3'!Q>124,&2-42'@SO?<^T]C5L2S?1;SN_S[,LD
MYA]8;J]W=K'X(/KN37F7X_3#93T,EV/1%UA^!"4LST851ZIKA24E5@'J_!]@
MJ#A+%HWC?8Z8QH3L?2(O5\II,Y!5WO%Y2,Y[YP4L6K8KJ1D@<0Z"M3E(KZ+1
M?=X<A^$[@IEX1'V\<VZWEV&/,;FKP^)-:<.[54I(++Y(+<':.I\ZB 0NI0R!
M9<VSLDF[/CU2NY!SJ!CN*6GO\?7B5&+!2T/N>[3B]8K.Y>Q3F8/22/8665F@
MF#/@F,^@O;2BL,0-ZQ/&V0'J6''@$]"8C9DC^TNN6QK1'6@W Y$'@#M FMD6
M>,?,-6L@S&%*LH<D#JXN7'LT061P(F+MX:1KO1('GG-$7@)'T\=J/H*:#,H_
M.[26C!% Z_9H]:Q\4][.INDZ7MT$E!R2#1D30C:1DU%9+)"=64 CIHB!19'+
M?1[UUD\_5EI9$^Y/6[*N]:3,):#5M7D#J)2DC34*>*Q![B <8(F6K#@ALPQ2
M%#MLZN6F3W]BLMR#=1U.[9L&T&=U7N:7?#']O'CN6CI^*X@80F#!&XB<*5"*
MK'7B@ =,.L@0M71%=3F[!X!["LK12Q8=J@[>YPOZU8=EJ\8+ GJ6/A''YU?+
MZ3PKK-_?##P&5,P#0=/U@938(ID [U'X2"<6%WTN_5$PGY(*]9//UFD"_>+Q
M9RDM/A O7EV6Z>S3DDDMX^\[5V@=;Q].SEI\/49%=P%Z[XU6/-B0K7/"^Q"P
M%)WDAOCZSK7V/ (VN\JS&5Y^6*CS;]_NX#FKI5@_@CZ>UU(ZNN2LC63E8M95
MURV8%+QE7%@=^A2M[8]][P/TH0C^O*Y;ELR'^MOYV1>29 T^_#&=_8/^WZMS
M2T:$(-\!M$L65&%T,=BD03)D3FKA2^A3U=&+HB,4F!Y6L^^<W:>@&CW"]P^E
MZ\WG1?WMF^NK^15>)KK7EI2>TS7HR!5VH L/H#*O1I +X!TY/U9YP3N-E6E.
MRB\E/Z@R]*CA;[1KE\5H_\KIG$DRQ'+R0)=\;:">$P1+[.4Q&/3:.)4ZU?RW
M)N67=A]4&7KX>P\E:)D,^6. [WR1??371[Q<;>0_IXM,L[PB_1P=\SY:!9@M
M!Z**@6/5*^$UDY8VL?9]QJT>C,1?N^$DE*?A6+Q55&\C;?\YN?KXBNZI+Y-T
M39[XH$2+?TXOKSY>?+M)N] VV(0.P?A4 P&23@&! 5":P&-Q2A=SG\_;%^*S
M4>D3DG3#Z7L+JEY/XW]=?UX^:K^Y?$?;:C:)%7]-S/N;Y+F\D\XU=]%HYR#Z
M6GL9N0*7I "G'<_!*>E"&*2- Q=\7KK50PIW-44?X*2[O*2O+W#^\5T--UW2
MZ:PMC\Y9!++2ZVQ)D2$DED$SD8K1,88B&IYC=P \+TTZA)3N:I8YE&8M-L32
M#%A$-Q9??J<#]P^<S/X#+Z[S>0[&BA)$=09535?DX()7(+.U7MJ@BQWZLMP0
MUB\M/(Q$[^JF/91NOGO_]S8*1$DA2)ZA2$]V*3,&/%<>F%,\).Z%BKJU3FZ'
M\TL7^TKPK@ZZHWGBBR__42?D7'Y8VA?\//A,CI+--:"0:R_#6LRE+$2R/)/W
M@>?4J15I0RJ>C1(?707NJK/O?Z3^\(U8C(0*2N8&5*$O&&L76*%%4;8P3+S=
MR?G+L6TICPWQ]H;5(/>R;+Z-9\N\[>Q$((X5,+Q.47%U"V@ER  N&)SFS/4*
M.;8BX5!5'\<^^(XB\E,I[GA[@9=UONXB05C6'E<&/?"H:/<)D< +K<$'G4,I
M,3#>Y^GS-HKCEV\<5 ^FC>31X?7Q!LLJ=6P(FJY%&3_C.4X5QL/ELT70>S"W
MO\@M=\PYSL$(PT#IS" P80$QH50F\2#Z3*,[A*COJ:3H)>DQ/&U=*_%VEN.$
MOKD5%:GH!&.N_G>5N9F=TU;Q LZ4V@.1)0C2! C1AI2\5<S%04;QH.4.;PWO
M(Y!I5VZVKJ?8BI#+6PB33E%+,IP25[5*0 = ;PP)U LNHR3C:ECX:-!R3U#>
M#^;FP?8W][<08F2EJ$!Z6)PB)ZM6A0@DP)D9:4OTY*/O*6__M.7]4&YV&]6P
MI>!/$8TJ*R@N5&]:YDJTA(@BNUA+@]:C&\^A.ON8YGTK:1U.D6[J@ > ^U61
M_4!ACJO(?H D#EZ1G1"#CC4@8TJJ948$TH8(!2TJ74HHID\+OD=6D=U-2\8(
MH,OPL3&E8@$-64A&@66ZYITD!8ZC@IQ8H"/58=:=2G8><RG?*!'O5<HW1CX]
M&H N[E[ZRXL]0]2RF#B#0H8V*"1_RF?NH13A2V(8K.Z3P?X3C.=MQCQ<(@T3
M9 >_'VQEQ \R+M.ZTS" IKXS63M0=1PS:0]E&?M&?2A)'Z/4YR&TJ>!X3.2,
M&E<G1?GZ+I9=('/#>I%R0MZK#=VCT=Y[K+<35]XQ N[1V_^FT=F/",E-PU\1
MN5&^ '=<@F*^F@PBT!]="3&@5:*/ [ 5T@EF7727^/I<@";BZF#A;4A)G[][
M__=-)XF4 BZJBW4=GABM :\% U$,XRBCSJ+/*;83UB]]:BBVAF?3?'9U_M?D
MJIK(MQ(PZ^G-BB6_B#R8Q$L );D"),<;M$J,Q\ S.5-#](A6N*5#]*=U_=D*
MX7EZ#6TDTK T:2.@FI#V+B^;R\\_3C[_-7UY>?5C@.<0J&,<@H<IT6Z0A[7O
M&XEUEY)TD$GOD^8>R-E$ET(T4)33M9A40@B,T4XJ2G$NLO*#ACL^'O798F ?
M7WO&B*+U0^W+KSE>UTC;BX\XF7WZ_IC(3 S%B0+H,AVO.2;ZCEP-X]'S7$+B
M?%@^\I8%#F>T=)?(M#$[NYBUBZDE;W%V]6TQN@3C@O+?OMW^S=*SY$DG9PO=
MIM6S7+9YU@$DR\%P5XK4?8:^#L?X/(V7SK)L6$:[">GW%(C[$76-9M[%=)Q8
M9"\I[E"6/430I27K'60A"<E0$A3:'[6#ER%D49-#Z$L(,;J<^DQS/912W!/B
M.YY.C.'\H2P0P9D6M3^XYYY<=V,#!"$<6,^T$1:SD_?VPCP-"Z05XX<8&F.X
MUJ,+WG68Y_^^IMONY1?Z\CU>S842F9<"4BSJ\+B$&L^C<](@*S$QJSKUR-T,
MZ'F;$"VDU+ YP@Y8-\V"!P#K^PBZ#=J1)CBW$.#]2K$']WL\3&X%F$RPKGA"
MI.I0"2%K4CMZ4.1<%5=,D5(^!;6X;X[S0;5B#-/[:\/-]><12ZWW]B;4%FD%
MP3&Z3YWDB;QLF1 [O3-O@G.$EYDVXMJM! _@]593XV!S3I>OC&=D47^I<9Z.
M\TTWK]1YKND \M;ZK2<;&"H3N:#S@7$?HD:?I-,2)3*-]\\SW;SFT?NN!Y3:
M>6GID&/5!#;D&QGA09J ')U0>&H]PE\?O>_ZW;[#[Z87%W],9_67YX$KKH17
M9%P*!8K.$7(OK 6!CL=BD/XYL4[V.^DYP0?SMEK=L1WU0]7B471<=]QC"9K1
M969\G102Z&[C'!;NE(I6^?*KXWIK%6^H8]V[L(]1D%/JPKXB:-'O:_[J<MD=
MZ1^SZ7Q^+@MSSMD$DBE9SY4((6@'7,1 APP=++I/T+4#,;^T_@24I$=_]FIM
MOIK/KW/Z_7KVO;W7LEGL+5-T_O)KGL4)T74N:*LN,KV"8AI4< *<MQRRSZB<
M<BAZ#=\9C?67UO87\3&J/>YA(G&MY,G5-=%WL]G..2=_##,#EJ6L'4 CU$&7
M$+,FC\Q:+F.?&80=B/FEUB>@) US%5N1]/+KY\ELF7CSG20A(S-),?#,"#*N
M!&UJ3205&2+3P2H6.CT/M2?FE]Z?@))TR&9I[TTH[I)%K<"G;$!YER$(+L"@
MR%%$13O9G:36W^-N'N-,61@%]6%TQ5M6NV6+&(''>DA:I\$+SR#%*)W+Q17L
MTS"L.2F/Z#PYC6C5?LIP@F[[K>WVGWGRX>-53F=?\@P_Y!MC^.UL$G,]N\OJ
M[/9>62V(V%0+752LAPRY<$"D%I6<SED=J=ZR.:V_]L=IJ=,IS6<;1_$Y(^Z7
M6D:;C57U1;- L-I#XH'S0O^B[)/[?" "']%6.9"N'F=KC5*TDRKQWQ@CW$EJ
M\5SDY#5PK&WX RIPEG9 "LA0R13+L:;8MB/RU[[:=U\=2>&.<5?=1^H--<.H
ME2B9\#P %H&@%+<02K9@)4LY6R%=K\3:@]+Y:X?UWF']U.ZD.BUMCZONI#<$
M:ZVQ"(EA;=W*&#C.:CD?#R$4J4A"I[G-1E+Z:Z/UWF@]5>\8X?[[#Y8[H=R=
M]'*G@I7(03/I0=6495=,A!(EC[H$ENR);K61E/[::OWOM'ZJ=]HO##O)U-%C
MBCZ"-5JLJMN%1K"1!V-#\J%3X\JCA#F.^AJQ.PH0C9&Z/M_ZFD#OF02GZV@/
MKVTI1:**IQFD'4C@(SK@3B,RVT-Q3C#SY2REA1[@Q>^3>9TQ5FVALU![_L:K
M<^6]35Z0+Z%("LJZ4--Z/ AD4D;+F-<G-K5S"%F_]L+1E*2741SN)RZ,OLC>
MY2I<^OF+Z>6"U&N\^"O//HESGK+)9/2#M-J <IZ<;ZDL:#).!"IO:-?WVQ>'
M)?81[9;VZKII(YVPKO5ZG]B#Y.WWZ#:2^7D4H@25$7*F8TX%9@"Q&+".I:28
M1W0=W_X.2^RO[?5X=*W'$T6S)A3.<8QH A0R/$%E0Z:"406\YREADDR$3K;:
M,YPMO)<U=A21G^1L859,01\#&,L]W6W5C<+B(0LMB00M8J?*D*<U6WB4'NR:
M+3Q&'OT'S0Y!\[QF"X^2S^Z)LP]A;G^1!^UTBI%!2?4V%BX#!L6A9,FR0>'1
M]PG#G<!4B5Z2'L/3 \T>O9F"RT,N06KP1BNZ10M"0#J\B#H19##9A#4[?]S,
MT1.9-3I*  -FC3Z >T?M^;)A(D#GWB\#5NS7 V8LN6N]8$K!P))4G,2GBDT8
M71"I,.'0LN#USEXP ]8^>D\8+Y1**28P6"(H)23XX"-$[E/FN39-_-439@W!
MR_^^)A&^NB3I7B]$_N;J8Y[]]1$O5Z[OG]/++R3[G'ZJ&M/28$@&#"<W7%DK
M(.1<P)@H>?;&)GEB/30>1.<C"J$\;!<TB^?W5Z-3ZBTSG-I5;5+A3D6C ]"A
M2Q<UA@!H)0,7@BPJ)LE5I]Z%AR+Q$6V5 ^CJX;?5 Q3ME(K@[B7TY]SP<UF\
M"BE+<,G&.NTI@+<A ^<N6\YCEJ=653N2PE_[Z2C[:0\U.Z62N'OI_(^%/+[3
MZ;TW$94'0\<'*,T5!$Y_E)DYA\P&CR?6FF$DA;^VTU&VTQYJ=DHI3??2N4KW
MOD6J<=SP&C2W3&BRPHNOX](92&=(+-(*QT\LP6D\D;\VU5$VU7[*=DK-@D:;
MMTHYY3W1Z%SU;5$[\$I;\,(0#^B.CORQW5,[_:B3E,5:!L3"9/H=K_(?.)G]
M!UY<Y]M;2"K%!*('70]ZY6,$3PI)?ZR11R^YSR?6HJ4/(Q[16?EH0DG=%/%1
M><;#V7$>E5?"9@U)5/N+1PFH' )S40IFDY'QT1Z?]U+_B';@*6R!$]S.H_3W
M4>WAG9T/-C!"HPJ,&09%6"0[*&= &3S49\R,*5IQ:L5=K5GP:S>?YF[NJ<F/
M.,)V/R.2+,X838S04=1<CNIKE@R9?DI,X#GTZF5]*BSXM:5/<TOWU.3'&.6K
M50GW<T%H2=2BA*)839W% HBN0-0HI9(VN7!B7;Z;TO]K,Y_F9NZFPX\SKG@_
M#UR2*6E.9YA5N<96#016+*AB&<O*<,/PD>WCA_K,IR3!W;5BH1@,RA9(+!I0
MB04(6)M?6$UR\R)EYQ^9T)Y>X?EI1A?;*=:C<E?&%Q#/SU-DV1C'P"9.UT-*
M&;SW GQB(LKBF>M44W%2;'A$>^^0RG^P#=M;<WL$$IL5Z(6<%'/D:QGM2"1:
M<G"J!,C9%S(^ \^R4R#P&=;F[G5A'47D)UF;:Q7W1J B-FI)CI%P@"8;0(L\
M<I5%<7V*!YY6;>XH/=A5FSM&'OT+-8>@>5ZUN:/DL[MB\R',[2_RXKQ-LC8_
MY1Y!F<0(E?' I"S2)>Z*[N-BGUIM;D-)C^'I86MS8Q"),>[IW*IS>I0D(KWG
M8(0SR3#BNUWS&AYE;>XH 0ROS1W#O>ZUN6_HXJ-;Z_+#ZTQWU"WOX=5EF<X^
M+2ZT/0IQQWS\?E6W#R9DK<16&%5<Y!;1*>6D]]DK1.911YF8-^=C%MKOC'V=
MY_.<%\O\GN=Q-OF\XLC*F)7&<Z.B)^\G"U!,,C)F708M,)+UX!D3?1+S[@&V
M[]VR_/B?^?S=$5S\J;J Y\+6GMK,01:\=M<L%K!D!,XS>;,B\^CZ5.0-PW?X
MXZNEOJS?31UDTK <=''J;H)804TN%WMRE6BM59+HK0(>HP.5M0<?%RV:;$R*
M3N,@[*"[:]!R3T,).K&W@UFZF?JEMV4E+SZ%.F'&8>W&R\&74*<+TAF??(K,
MA0,>EP<-G?0_&O;G^;$C'?/9U?F[ZKDO#'DALY361= ZY-K%C9!K4F2O7$J>
M6U;2H! '?>HM3:$_K6O)3\L>*Z;13(;3?7G9\%#X#F)E> ^!,28N,5RT[1V:
M^P,1>XA@78A[\*^C.!G=+L7R!%&:ZFJ'4I_U!800B[,I<9T&O5V=AABW!!G:
M2W$,VQI+[Y_$J4_7GU9 C'(\*QVA^,44#PP03-"@BPO<9_19#DJO&B2_GY8^
MG%6V%_.G+3C7T,I> ,&OMX"@4#;D3#:>3H;TL0XXX-H TXC<BYR8'M3#89@(
M;R_]"$7X8,YMW86M@D OII\^3:X6#Q9XF>I3*QGX^3).\ORG/[2.#C59=[^P
M47O2U^-)F$)VQ@F46G'-D*F2G6!<R,+)F#IO@F!/KVDZ_WFM'XZ!L$('18IN
MF ^@= K@;+:0F=5"*699ZA1CVHII;Q_QIT_^]N(")Y_F[_/5U<6/(N5$E"F3
MP8:0:(_7D@8D5Y8YGUS./!MW"*HW83M"1*&-=MQQ&]N*H4-SL36$;_,B0V4)
M=(603NN<G#.0ZDN/0DL'NB@*+($3(7.#ID^_PONQ/55%V5<,K9_*UN M$;TI
M;_&J'NEG5Z_F\^M\7J)2P<D,'BTA-.C Y5)--A1>I50*RONNR^'+/7K9=^)L
MAWS.FSZK?TQGK_,'O%B>8(L?G>>,(D0D4DM]0&1: S+TI*5&EL#)D+1]6ISM
M /7H5:,UXQO6+ZT>?Z>?I[<:\!*^I<T__SCY_.KR*L_RG"#ZS%.QD0/7M>$+
MLE))=V %0Z6L$Q*'OJ$/6>_1B[T7;SL4O=P >9=CGGQ9Q%"-UCP[;X"KH$!Q
M:\ K%<$;RT)A2M^1=J.3X"Z61Z\)C=C<83#L39+R?TZN/KZXGE]-/^79ZPF&
MR<7DZMN?T\MX/9N1VI[;$KS7KH!FC.S:FEV"QI0ZW=4+:5*,ND]AX4" 3T9%
M>@CDKMZ8MHX&4;]\>"'+Q>M<"%#)H2;K,W J:N#2^"A]CFCZE$!MQG.PM\I#
MN!$/8O(IO%"^F%[7<^\SSDB#;[(.L\^V1(=@9/)D[]@"F+V&P S&+&Q.:E#G
M@4%QV$T(CO9NV4"HTX;,;?W<E3]?S^)'G.>S#[.\4*)UB*M<Q2$@V[]M#H5W
M^)?/_24Y/908CJ8SI13KK:8S--=;ST@/CIL,160G64W62?FIZ,J.Y]4CJ<H8
M[K>.6?V?__OZ]8N;5WTG<G0"H?I&H&Q ,GL45A/:,Z9CO%-HO<41O?6A!WZ=
MZ\/S:0.&M<YQ?)_)9"56YOG997KYE8BFBV_Q@C2O>KY"Z+-@WA)=3-,^5-+Q
M^D2IZD2!G',@6XD-FYTU:+DG)^SV3&Z]?\GUG>6OT\N7EWGVX=M;(IR^F=]D
M!VC#D\D(7JM2\[4\(#(+-CI=:J_=6_-'=TI_URI/3NC-6-HPQKP#V*M7/PZD
ME%4.,9&[ROV"9@4!R36RT7KM3>!2B#T$?FNI9R+UAS*W82BYTO^:>/MA\<S_
MHO)@65Z64JX8#./DV @=Z= )!B3C7J<D4 Q[CA]DLMU=_XFX>7LRMN$.OXOF
M+_H_OI=ZWH^IN4^W#<WA7;A]I;15X'NRN+&_MA4;XSS&(B)QB2%I=W$0R,2L
MQP]3-GI??+N@SF'%OL,;.X34QW"V>;K )%8N7'X@VW+YDOWJLLPFJX8![Z\G
M5]_=#%^$);]".IM!A1+( TT*!!=9)I>1A3#H5A^ZXF$O]S;"F?;F;&L'[I_Y
MBMR)_-MD&FL+M]E\61M\53/Z;C7LN3$^"F>*6P_6*0:*T2V'.B)D109GCEXS
M/\RR&[7L8U>$?CQN>!BD/#E?Y"V\)+/FZMOBH L&HU:8@4BKMB9]YURQ(*(P
MS-<I,'Q7S=$\QW_[,/WR[_31BP/_OU7]%I;?+G1APZ)/P*3;EY4-S?8*98GB
M9K[W !P#;+AAHKV]\F'MM;U%,&W(O\:[]"<\)>E [J6&%&J& 48Z+4*].T(B
M)(9^Z,PCD.,6 ZR;&,>P[3#!LM>OR4RXW_UG*>JL9"#J6:VXB@60+@P(.G!'
MQJ=/4@^Z@?=!<;@+>3_!W1]9Z<#U[BU2WF6R'6K.V>SJVU\SO)QC7.NTV*8:
MYD'K[%?]LC]I:]4N7(N"0BB>2Z9K.WO)<@K<1AY*4MF</VC%_;)KMBSY^GM6
M"8&U2BHR-+6B$RZK.FQ967 ^<11:"-UIT.-]R/8Z]FY_^)O_N?PY1_(\>&-<
MHGU5 GK:UTK7C/D P8G,2':>#TP_W;G,X1/)F@K[IP.M'3\[E*J\G4U+7KQ.
MX<79LHJLYKV]S[,OY!7/7WZMW0GS>9:R('H!2*XN*,UJ6#L@&&L8RT:7H/I,
M#QN&[XFH2T>A].AD>TU^%WG>KR[I6LCG=$H7D3('D>J +IGHUN4L@!4I"+J7
MN6"=AE[\A..)J<(>3.[1@_Q[!]-MU_%OWW[ZS<(U=Z$8JQ A%VV7HR1<3:VW
M4:=")%CN^M2Z/0CNH;)5^ZI-=T$=.Z5UD\=IF&&Z2 -D.K(ZLYDX)@('-%[F
MZ#W7>E=>VJ,*@QU PCNB9&,XW3.J,@3'$XV2C1+!MO#*0_C74YX\:Y^=8R!"
MT;6QM0#/E %#KCQ3S''O=Z4IG(H<1T3)FHAQ#-M:1\G^^CB9I57FV[=5&$8S
MS'7Z/,A0R*GA2D! LE&-S(&%Q)+.:R_06YS$#1]^Q)C6*#9/&_*H@^,W[-98
MJ*A";[E6&6SA"E1$!2Z2QVI2*LZ3]^ISGQ[=PS$^_5NXL]PZ. NW\:PVT!!$
M71O\W\5TG";_O:2X0UGV$$&'X,$F9"H:AQ&!^4R[@M?L"I<<(,'UQ9$#Q/NT
M63V44MPS#N"(.C&"\ZW-AY=?Z5J\FGS)+S[B9/;I>[-[EVQ(NM!=B[)&.@P'
M5TPDB E%4J7(]5+G+2;$E@6.&R=Z"..GC;G6.D-IDY&3A)2!>0\BU[I;49#P
M*$=VKDMD-6E;UOO\G:(AV$."^W*K>V^_]\OXS/PL_;_K.C#TY6^O_OK]+-!A
M]'DZNZIVS.IO[/%R.7J-_5XM]R-I[<42@[12R!B"S,I&$526F:PZG771QH;S
MT:OM&9M=?MCRTR>7'VX]A_Z(*1:3DXHZU,DDY'3HVN>">?)EG,5@T8O".\V,
M&X!NK]/GSWRUC)'7_+"SJZO9)%POF'PUI?U:QV?]) ;ZNQ?7BW9@./_X%B>)
MX+S SY,K<L[K\TI:SDG&FG10!^8N)#FY/"ME<C&A0V!^C@8+RU&#C)'7S5HC
ML\Q#*ERB*9JY]1Y-6XZV0R,_PM#*UJKYTTEZTI+OX+G?&B.WG:^_?5O]<NEQ
M>FVME#9#M+7WK(H6T">R&IW0='(QET.?]]L'@#W85,A>6GDH01W[">8[G5>T
M+19C-*]IH^3Y_/O-5WT5)%,4N4 0TI*%Q)*!8,DX34SK$ -W=VJ*6ZG>+EC'
M#QAUTHEU'6PFFQX9!"O[9VE*#P'3-3CT$YSCQ(4:BFM=$?;F=7<%B,I+J[.!
M;), 5;BN65 >C/3>L^AX3GWF<AU \/?$?@XE]S$L;AWI^6TR_?P1Z8B+^?IJ
M$O'BALB5]\LCXXS\9= ^$)6("9RN$PI*Q!!<0,N'/1K=L]#1[-^'R&#:B8&M
M@S\OOV9R^'&VAD@+Z:1V$*4N9#,% N-UK->7]IY,*H.#@WAW/_[1"G)_9C5_
MQ*WQYC=?\&=$0DH3I4S 3"%')[( *$H!+ER.JABO;!HDOHT?_VC%MS^SMKZV
MM0[>O<MD\\>%XTH?-BWD*U<O^;=,MN8JI_ O_)KG#6)X8Y=J$\K;B\"UB)X)
M,BC%1#$8E%/2DXN7F2[:J>!,_A'1&[OH 0)[*:.SJEA@5F90PAA (PP8YY@@
M_>-&=;6=GE!@SS,E9. *0JI1>&L<$ \%1&ZXBPP]D\/LD%^!O=&J>=S WAC)
MMS:@-B E^M^4M[-IS#G-_R#FO\<:.#B;S_/5_.PG,E[=)B-)'UT-4MGL$BAI
MR0X4:$&2$2')A< @AEE=[3 ]-=4\DK0ZN. [.UV_RU_RY76N]]V'R\F_<CIG
MA0DKC8?H:'<H3<SR7F4@G]0$,JA8U(-ZR[3M0'X'YQ/2MP,(JD>ER!H[WEQ]
MS+/W$P)7R'.MOUB94,0I8@T1-Y]>3%)]7C\+\P6AYS&F$'0,D*PD$KQ@X$V)
M9&!'CX6E@*931='^X)^@ AY:I V[:ZQ/?KBIH N&F>!DA%SJT'&A%*"2Q!/.
MM"6&6&'[%/"N 3F^MG07YI89' ^11(=;\/?\>9;C9%4\3E[O@ON7Z>Q39<^_
M%C\_%\X@\II<5>H[C*,OZ!?Q \F4%2PYW\?'&H+N^:E0<YEUN ;_08RLWLN;
MR]\G\\_3^4(D-T8A/T?GM5,B@16:CF,,!;RHL5L9N75T37O;IS)R-Z[GITL-
MY=3AVEK >/7I<TWUK+UL/^+L WD.1DJ)*51WU1HR\6J+%<XSN&!<-*8DV>EE
M?3.>YZ<U#>3288K8V<7B[^3TGO#DWW">TXOIIWK-+H[$FQN75#EBG8:3LBF$
MTL<ZZDX"<R9JZ[D(K,]M-@S?,]2F]G)K.*IL$?98!MPJE_Z8SGZ;7E[/\[Q&
MVEY=OOSOZUK1^#\X2_-SII30BS;GW"8RYF*!@%*""2$*+#:2H3<H #5LO>>C
M*KV$T&$TV8_(;8V%+9'5_IK3VX&P<Z=R2:6.WG460>64@.Y9"S$KYUE2PNL^
M5]@@>,]'L?I)[:YJV7U5:\&4.H0/YQ^7@&_.1F9]Y$4("*%@'?.&=/-:!;%8
MF0JZK'.?.VTKI.>G0FVD<U=M7-L3:=E"]KHRZ'.>X;+2;OT!]^57X@>M/[G$
MV;=%!*T25@.QTXL% V^Z>'&-=7!+AI ].0BLUETY%"!9ML9P9%SM:L#;ZAQK
M2M3Q5;=Y"/-45*"#U?^0Q&)C-"M11]KF2-M<!03',P/#4 1G;$JI4X#]D5<%
M[!5&[RRHQU$5D&5.(AL/H3 )RF1RC[-DX(PQBG,92APT0O#Y5@6,THE150%C
M9-,]*7P(F.==%3!*7#NSPQ_"Z^X*X)-ECB<'QBR:[D2"%UT$'JJZ"Z<\[U0_
M=.)5 >WD/H;%K3./[U1#WXS7")PKE/4=,.8""C7Y#<II$(6)%*.3BJV5*F]M
M-+QYA6/G'X_B^K0URQKFKRUGX=ZXD<3!A9&TG $@$C>.&4A!D8YR<O[0>@-2
MI4A7%B_:#MJ\ ^>+;\+PU._T1MQO/)ON+J*;N1P#,#6?3;<-S3'&B^\OJ9V"
MWX/-C>?3;<=6''E/48,.3)"GK'D=#9$@^:+5XE7>NT<J^IW3P@\D^1'<[6"\
MK4(IEQ_6[B8;?):F*#)/"AUM2-@PZ#J:SUE3A/"V4X1L"Z##SBIK(ZWU2&L#
M5C=/8Y_.Z)8CL_7L,JU%FF_@:6-\D"Q#S,Z DEE#T-R %R(7Y4VV9=ADG/O7
M>L1"[L'-+NGC*X1_3B_7RAEYY"H: 2+$1+:,(7TL)8*SH>2@R$G)?=KY;87T
MB+6A+;L[)+HMPN"KR.'+B\FGR>6"[AO'1)*O(X*"[#(I:<!(EYRQ$*PV6,CJ
M-;+/N]Q.6$] ']JQO4/:6AW)^::<S6:X&J6Z,'B$];(P<G;58BAO'8[NE+5T
M67&A=50^K2>'--*%C7">NG?83A8]\AI_P*D54G2FX8^?W&Z!>E-B/0!NUUCP
M2,#'B18W$/5Z9MH!Y-3!-AD+FWDD@SEG.HAK6HMU'%R4 K2T(@2?8F9]FJ2=
MA%K=$XL^OE:-$4_K*/7?GXDC1/-E^N?D(L^OII?Y+7Z[[71%X9Q .HW1*[K%
ME233"RV!K5.)LV.<K8]@WN+5W+O4X>/6724U[<;F[@,^?_2#6%1?SOLTQQWP
MZ:UZ:8PC8ZU]1LC9"\LUYS8J%,F1F<DRDEO*6#(LG8]8YP =,WBQR(PA32I"
MD>-<2FVH5\N#O)=1VY"X[W+:]^R8<;/&BL4W64[K=<,OOZY:)=0*!OHW_85?
MSQTC414E(9#@:&NQ"%Z;!%XY*^F4YTKT>6A] -@3S4T;HU-W^_+W%5F7&3++
MC7R.5FD7%0,F6/5,:N,,31ZM=X+.8Y%2$;TFQ"P1/%U]&,?<'MD8#_!4,X\J
M:LW!(V>U7J[&H:2&R )CW/#@2J?LKD>>6+B/PO06U+$3"W<\HL4H75#9@>:R
M=L@E6Q-3T" B;1UE,RHYZ"Y_)FD&HZ1^?YK!&.X?ZHUY"*;GEV8P2E)#'IL?
MPN9#J8# (()($C*+D;")#!CH&C4E9&TQ.3VLN<<)BGY\FD%SR8_A[@'3#+2-
M&3$:T$PD4)Q)<#PP*"$:9>K8+-'G=>&TTPQ&26M@FL$85G=P/G8_?7GGN1!(
M"H[(0151 '.H_?RL1BZ=P=BQL\^)OSCNHPWMV-Y\DMP/-//M^1)*..Z2JC-<
ME:I:2^ ".I!,%)^L(*]Y6%KQH.4>L< [\;1'K[G=:?)",B.=@TC4DDH&!:B#
M@2*TMRBC=>LCZ'Y5&NWO+K273;\FA3?5+P/ //-*HS'BVEUI] !>=Z\T$G0,
M.IL3Q,01E->U90\GM0\QZ("&,]LG8^WD*XV:R7T,BP\]?\1H:P*=<X"2&[HD
M4X*@4J@#5+.RTEM=V"#+X,3GCXR2P9CY(V,8>)CY(QY+X(8(K),>Z.:JQ7**
M3)1L@K!*EEB"'&;LG>+\D0<+<G]F'6;^B!71R> -^)K)JD)"\)D42EICLE?)
M%.\'B>\DYX\\6'S[,ZNA+;6[(E$B:G0V@:QX%!8/SM0&K^0:&I5C*'[8+(53
M+>)\L!";L&QK3F;[(=!I\3%X<<M-:#+X><?GMAKV/!3Z6CY+3#)ASL(7.OYL
M\N0FIY(823N0/ZO9^: 5#C'[11=4UDH0.83Z0.SI#" G+6OE45H>72R/+I-E
ML4G>DF-+"^ '\E=7[^&WYX#\-;W)CCBGBZH$S<DP=1EK)D2-.2D+(2@3B@Z!
MB3+HH!F\Y(FF'(Q1AI\.I#Z\;FWGO9Y>?G@]^9+3LC7O]YDO;V?3SWEV]>WM
M!1(-EZFVKOM<N47?OYM\^'CUIOP]S\O_Z1RM#@7IEO0Y,E VDHWJ?8#"6'">
M:XOK&V:+LK1 \]3TZ. 2ZA 7^)Y[0U>N%(&XH(.K^1A)@B,E &N=3(8\7VY9
MEZ/UQ!.;'J(=>S&W1_3O(:.8)2=:>4UP9S42LC#WF 4=K3*6259XIQ#1(T]L
MVD=A>@OJ%!*;O@?@_I&G'V;X^6.-KRR'_[)0HA01./.B^@,.R"=08$JTQ2>#
MVK;+;=H*XS&]5XR2_;2U#!JGMZPHNPWI9H;W %#-4YRVPCE\CE,C<4U[\?IP
MBN"TD;9&ZKA:!>X0<X0@(TO.<I]BNWXJ!U: '9E.!Y7_"!9WL$?_G%[^_;VX
MTI!_5>NJH@FUJ-OHFG8C0%M=DA%>I=RG3.,6B,.F-302R[0-3SND,NU^?9.>
MD0:K!-IDNLZD%."2$T0D^4&.!<^&&0#/-X'A(09!>]ET3V 8 N9Y)S",$M?.
MA^R'\+I[ H.)EHX]SL&ADZ!BL4 7(6&T19<@N(VB4ZK3B2<PM)/[&!8W3W#<
M^&Q;>/0F2PN1.;H#H[)0VX% MC$3?24%,RR8>9)OW*/X??\;]QAFM2X?O[.]
M%ES).7WZ]Y?UY6D^H;OJY>7UI]4L@M>3^=6 Q[416[@N.%_?PQ7 N*>V!H1\
M?VIKTF$H33_?RK'N<<!M7&C?]B0Q3J\O%XGU-09>AS;]_;G.82$,C)F.U Q;
M^> [?Y<T[S0/&<.\L3MY]>/Z)> \_^__]?\!4$L#!!0    ( '&"J525@E2<
MJ20! 'P*#  5    <&=E;BTR,#(R,#,S,5]L86(N>&ULW+UK<]PXEB;\?7X%
MWNJ(?:LB$EV\@!?TSLR&+-LUBG!97MO5O1,5&QFX2IQ.9:I)IFSUKU^ 9&92
M>6$"3)!B34R/RY9(XIP'Y(-S@'/YU__U_6$!GD1>9*OEO_W@_]G[ 8@E6_%L
M>?=O/_SV]3U,?_A?__XO__*O_Q^$_^?-YP_@[8JM'\2R!->Y(*7@X%M6WH._
M<5'\'<A\]0#^MLK_GCT1"/^]NNEZ]?B<9W?W)0B\(-C_;?X7(1 -".50_2D@
MBA,!,98^]"E*<11$#$5T=O>7,$T)3A"!,A8A1))C2)B,8)S$ 2%21$RPZJ&+
M;/GWO^@_*"D$4,HMB^J?__;#?5D^_N7GG[]]^_;G[S1?_'F5W_T<>%[X\^;J
M'YK+OQ]<_RVLKO8QQC]7O]U>6F3'+E2/]7_^/[]^^,+NQ0.!V;(HR9+I 8KL
M+T7UPP\K1LH*\[-R@9-7Z'_!S650_PCZ 0S]/W\O^ ___B\ U'#DJX7X+"30
M__WM\\W)(?'/^HJ?E^).S^PGD6<K_J4D>?F!4+%0TE=/*Y\?Q;_]4&0/CPNQ
M^=E]+N3QQR[R_,53M9182^G'6LH_G1KLYPO$=R1O>2BK ^$J=3^ZDK$+TX_.
MQ/VJ^$$,+W!KF(M%KE^H=TL^UKN['>IBT8>7V-5KL2K)8H378C=,2^2%_L$'
M];=F&/V@#C*MQFFHNR6J^%Z*)1<U6[YX-,CXO_V@_C9_O!/+^:=\];@JU%R3
M9[WZ%>]7^:_B@:H7]CY[O%F6(A=%6<Q#+^7$8Q0F+,40,9%"["4(4N2'.(C4
M,N4E\W+[FL_%$O[V92-1-:SUF#]8Z%^>^([5@U;KG.U6P(?%L65-K6AZ#4Q_
M7I('43R2Y@8EN#86:EW^?2,MD*L</&SE!=E&X'_]>:>M&]07KX'E8F 8&X'!
M%D\E,MC)#&Z&PY,W-EYEH(R-ZXO!)XWOBKV0;J$MNE6^C]2*]4&J)DU](]1V
MLQ?61MV?;![U\\';<)5O1"8Y.S,9S14_LY6R7!]+^.)]UY9^;]W*5>\7J$9:
MB?8#6.5<Y,IC.:+FRY?^"UF(6WE5%*(L;I9LL59T?[.\8FRU5N-]%DPHAX0N
MQ!PE(?9]+&& _ @BP0E,O32$L? 0CWU*O2@U)F_342='W_F*"<&+VIDKE!9@
M)0&I]% <7BNB_@)(HPK(M[I8,)'QI!AP^Q!0#\SN7QI<:Z'!30O7C=S@\Z"X
M6G#\$/B.Q/*.<+9C>EN\.KG>^&'CL;VM?B_XWOIF.\9?%_".D,?YE_6C<D&J
M-VQQ38K[]XO5MYNE,DD?JC?NBA9E3E@Y#U*/)3&7,,7*]4!>Y,,T#3CTJ8A(
M&'$>4V3"^9;C3HWUVV(#GA5LL2K6>?7I,*4%D$H-]=%L]3!C)-O)B&,><IYZ
M,"$RABA!%*:AI_Z)$AF$@6 T\>=/(J>K5YR.]OC_W2>D>_$=$.2AE]\VNEID
MH&4&+:'![QNQ_^_EJT)/H'8;)X72L4))DH)6:C:/5) %_L]B41:;G^@EQ(>>
MW^P"_\EV[%&6D9Z ;!:2OK?W6TK4VK1^6"^:'=7?EKD@B^R?>M5Z4JZ)'OT7
MDBT_K(JB=ESF@?"X)PF&1"8!1)PJ/\(/&(Q]+_$0P8D7^C9KBJT 4UM<=A(#
MQ6(%4%]7MA7=</NB]V284=B0$ _,95>WUS<ST%( :%'!CUK8GV;@K: E^"+8
M.L_*3!3JRB>2+;2%!=6' K6#-P.?2*Z/]'ZOE7/(>'UQ=4I]UD*,RH%](=HG
MP][/Z<>*[TB^S)9WQ2>1?[E7K\^GU2)CSU_%]_*-TN[O<QDPR80?0A:$J3*L
M:01I%&'(X\!C1 9>' L;$CPSWM0X3TT!T%@#)2^H!+;CN7/PFM&:0] &9K&-
MI#N\%"M5TH+?F_]JL4$EMT.",D3(*1^=&W-4^C$$8)]M3&_K1R[7*T5:>9FI
M54JO7\U2CKS0"Y%/8"2QA C%!%+IQ1#''D-"(!\C*THY.LK4B*0E).!*2CL:
M.0ZD&7E<#,_ E-%&IK)RW)LOG1 XY83C(XW*!)W*[G__W1?WW+/31/*&%()?
MKQX>Q;*HO;@\5[->>7EOGG>7-.=%5]](SM_]8YV5SS=+Y>Y5F\K%;7DO\J_W
M9'G[J!]1_%590-H2JB,UYCBAB1\E$FHC13EH$8,$<0[#).9)1&-?(#YOATJ<
MWP(9272CS^]L-(G+K["6#_RH7(Y":UC\9+D5-=:D&^YE36DB1]H,T_I '4'(
M05MIT-(:T&?0OJ[1'%2JST"M/&AI#RKU0:GT!PT ,]"\*^I5J4%PN+,V\K2Y
MW9H;2_AQ]_9&GI*#S<&QQ^^WZ+TG6?Y7LEB+7P71._QU$,3FA_^1B5P]\O[Y
M[>I!>>_SQ/?3,.3*H:8>U]'2%%*A_J86-!($$9'")S8FL-7H4S.-M9R@$A1L
M)05DR<''J[^"WVN93QN##F;#;$D9#..!UX7+X+6F\%XP.>5A.PE&)=->X.PS
M8K^']*.UCZ*\6;+5@]";8'/B)R(,2 (CS(0RN+GRW&.I",PC88*3)/ 3;UYN
MPWS/?E(OGFY%2R<BEEUO_>ES#COF>0D8YC@,4C^!TJ<,(D05S\>$0^I3+V4(
MLX S&Y[O#]A(>Z6U=,VI!;@JRSRCZU(?4X!RU9Q/7 )HK%XZ23P"DSA1[YT@
M 21AA&&0>#*.&"<<!_--?L< <';FIK@&,VO 7%1@DCTP'R\&TVS=Z_W.#;RN
M7?RZ62]M1Y%PNG2]'&'4I>FH<OM+S_&+^BTMMX]JH2JSY=T'M8R)SSJW\%;^
M5H@JIFR.41J%6'I01)$/D<0(DH@Q&'&2D"C!D>]A&^;L'&UJ3%J)!U<2K@O1
MQ.S:?>?=V)I]]\X0&Y@'MG*"2M 9V**GA*TC1MU1@!$H3BFA>\11*<)(^7W*
M,+NIY^'UP^-B]2S$9U&=EW_(",T657S$]3K7W#_GV(L]O3N<$%]"E/@>)(0&
M,)!^R#'E(@I#J^/K<R-.C4JN&,O7@@/6WA'4WA\52R$S6V(YC[CAB;9+'(<^
MTVYDA7DM+&A).P.-O Z/LDVA<7N8?7;4<8^S34$X.- VOK$?Y=3FSY=2/5S[
MW9OT_ZOO63&GE/C*&TFA%VKG1(H(XBB04&<<1305& DKFZ5CK*G13&.(;V4%
M&V'![UI<R^V[+I#-^,41= ,S2V_4K$G%  ^G=-(UWJA$8J#X/H68W-*//'9I
M,87RI!I"VD;I4XIX&B $PX @B%*IZ,.7(4Q\KB/M*/&$E:W2.=K4"*0EK!U7
M=&-JQA;.D!J8+UIRSH"2=&M]#)+F8(2*4];H'G%4WC!2?I\YS&ZRXXXB+^>?
M]5EG$_0E4$HX22F,JBWE ,<0(R^&01S&)"%Q2G!@PA)[SYT:'VCZS8HR8V0!
M6N<<EN>!^^!UT\$%D S\X?=&P_BC/Z%[U^>M;FE]VNI?^Y_U_C-'^8!/*++Y
M5$_]NN>I?[;,2O$A>])Q!*5ZK ZDJY-B6W'\5P^KO,S^6:=HISREH1=)&-!
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M"!80BX3"((IX("+$"+'*O;458&I6]O9\@#3G _E&9K#00H,J'?3'9T%RVT7
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MBRZ-X#X<UNB]'S5>6Z?+&<;06>%K2@Z.,'O5L.N-S& G])"1UJ<A&CBN^LC
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M7;C";>BCCD8D\%DPD3WI7M0S<%TC5S5I:UY9\.-G\:2FD"P<TH@)1DZ9I'/
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M*/9@BG@((U^$,0]((JA5131; ::V**@7,;$\D[:%W/",>D @ASZS-@@$+%>
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MI\;9&^'J\(-UP7N''HS\&IAQ_'0G=VA+5"L%J=8*M%4';=T!?0;M"QO]007
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MOXKP1H.=%@M1RYL'@1>[T+F?$$.7/ ^"Z$3Q\[#G!#I2\D&K9SO,[0\^G=E
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M8?.C.M4]2H3JOCK03WH6LZG\?=7F[]C\T;F9HY>Z:);4NLPEU "G@ADS)>=
M:&3_1@MFWJ)2^760[QIL;(2Q$2ZH*EDGK(X.4"2P>C=%'''R]W$< (CKWG0-
M.*QGXZ#ZD5/C<D]@ZI)2TZ:=PU<^51_G;37P=7MH7*2J3'.0T\R6,^3,K!VE
M!$ICE)4YXKCT"J1TCC8VFM@*FUAI@;'"6WD],XTZ(79CC&C ]4P9YS'KX9B]
M$RAQ4W@Z1QPV-<=%^:.4&Z>; E-IC-EX.U?V/S;H\H//[.GSVU5=S6,ZOZ^K
M@TT*E$.8XP)H6N_$D,RX* H#R3#)2H)96CCU0/<:=6S,8J6M(XFUJ:VW<GLF
MS3@A[D8PT7'LF6@V$-9_V1'Y)N&K9"UU4V\P8HZ,#TIQLV.<1AXV+\8'C*.,
M&*^; _N?ZJ>%EM/&@<\Q5"(7.2C3H@!(:PDH2BD@/!.4E#C7J5-WOE,/'QN_
M[,H6%@79@\Z-04(!Z7N?=T>LB-U 3R@;M[WG[@##]NL\H=I1 \Y3UX1]I)^J
M^;WY)AYM]N^=>43;O:.DL%1":I!)\Y$BC&S&1IH")25!D"&2,:\"7:>'&=N'
M:Z4$5LS$RGF36$D]>Z)<P-7M6[X>K9Z_ZC"@O#_S;ARB?O!GAAKTT^]6]Y $
M+EP=NK_:M%SZRE_LADE[/LM8"C8PW1X>I%I0F6D"(",0(%@*(+1$@):TP(*F
M1""OV*7#F&,CBELI%[:"]K05W7=_]3+(KKNK4:'K/:#9]F1KQ8VY?>J,0^3-
MT\OC#KQUZ@S$\<:I^ZT!W;O_JUK\\^.\+K&Q7*Y;=@N=8T5R $ENG )1$, P
MS0 M,BDE*[.BI,XMNT\,,#;:L"+:;(*G1DB/_M*GT.NFB!B8],P'-1P?YTDK
M7TC?[5.X>#3;OA*?@3IL>^/DUU2[ X3.3MJG[ANN?7:'U'L]L[NNNZ:9W&]Z
M]5"IIBI07>CS:S6;RI<)RS+.\XP#*3/C.6EC(HD4,D!2Q#-NO*<<>^W9=(XV
M-H)K3XPTTB8[XH:TG#N'L)MI% VWGDGP+&3)'XVL22_'#9W@Z:%WW;D17Z&5
MW07E3W>VNW13X#;P-@=HV5A<?/N;._.W)9=U8^AVB8.$LT+J E!%)$"<<2!(
MID&JI$*9SHGR*X'H.?[8:.?\L5V[1;'[<U.Y;_7 Y\G^36%1'M]Y<Z.N'F>C
M[VVA 2;"?Y\Z#,ZX.]>>,@R[EQT&T-'N=N!C@D\"5(^V!(5>VLWT"2YTF2*&
M :*LM#O;#' E"$B9+A BD!;"J2G5F>>/CO+LONN3$2Q138LW\STE3W4?L+JO
MV[0IB;RR\GMG_^\!ZQJ)"H:K]ZA3C40M6IT5$S5K_Y32L?/S]\88.A/_E((G
M<NY/7A9H#-EZJQ\?S<N]L,SQ]H$O[O5RHC54)"T8T*7-KD<P SS/<U"0C.J4
M9GF92\_Z7"<'<GIU!RVXM16QKO[N76KK-)Z.MD@X1@.EO%D!DQV(6A$CV@^=
M$,0U$TX/-:PUT*GNT:+??75@L5!K'!K[H=HO-M\>BIA@F1J/ARCC[A "4 8+
M("@40%$L&>9*0^YUO*][N+&M_(WEW*[OO[3I)7^]2>;:<QOJ LIN_! /NYYY
MHH%M5])-VXA6V)B=(YQ0B5LCM'O(86N$.JE_5"/4[:Z O:?OST]/LZE>OG\4
MBY?*.B?U6%\7E7JN79+?S"J^F/+9VD_'68I+F!? 4 D$2&ABL]5*0"BDJ4H%
MQJ53?"5H]+$1SEK^FT0W&M3.?%5_3T\;)9+'M18>VS?>$^.PY]4GW#USU!;I
M5OC$2-^&2K;R)QL%0G;,O"'WV$[K$_J!]MKB3X'?9EPHA)T[==X/'6X;+U3?
MO3V^X(<$GNQL3NXN[ZI;^3_/TX4^6_5B@C(E"3/+1Z%LT=*T* %'10&(ADBI
M@J4I9GY.J_O@XW-DOYH'/7#CP-H*]T^;TBY/F](N>BV[YYE0]PEQLVHC@SQ0
MK9Q6Z&15):W8R4']G)O] CH13Y1Z Q;W?*G[\,.>-O6&Y>CLJ?\30@QD6\/A
MXW+YK-6[.IS\M8XDUZ= ONGE:C&5AAWJJV[KMM!_-[_4R@Q?_^[+4QW7?_]3
M+^1TJ96QGS-E>SG;#4D-D!:&]J!$ )>4FL7)>.O<*1C?AW"C,Z]M\8%E,JT5
M3)Z?C'6Q[B=F6'*Q43!9UNV2G^?356.!VS"_;K6J&;6YH&KT]3$)(\^^BY'^
M>G/:MPU?3T*C6M+HEC3*W33'X6Z2K8)M"^Q&Q:31L9[;YO>MFLE&SU><5!\W
MX/4F=R OH59E^\FUW^Y"-^T6S/I[;HI_-%-\O&=G)YV;[]I^\,^SE7VV_=?U
M]WWT>?\MEK_1SUQUNR.1QQS06^D'K7UGIJ<Q_,R"Y6(U^8W_G#X^/[9Q@(SQ
MDN62 $84!XAEW/S-K.F$Y&6A1290ZI38>/3DL2W(K7!N7'N,4_?J=Y7V/2]=
MK5P10QIGM>VR_LU-.Y:_^>G0ZC]^ZB ,<%:9]>=[_H+ LYG3N?Y2OEUH-5U]
MX++NF+4^I?'-K#2WJX8:WL_5A"C()>,:0 IMQ!HBP"G5($]SJ$3&<TR]VH-Z
MC#VV[]>*;M=+60N?E*WT-YO36LG"*&#K%+1KKYX[&E8A$^,6<.@)[IX)8XUT
M(W?R88/TYJ37MQ;I1OKD?0?2_J=#_3&+>V348_QASY'Z W-TN#3@$0%QAV^-
MQ?R5+U8OVS*=M[-9]2<WJAH/MQ'!]IQ:]Z[,&"P91QF@J<@ TH4$'$)N*^D1
M(M(\U<3)#@D58&QTUZJ0/%D=C/NP5N(FX6LUZE!!2X<^&43!<^00 >@9^9Z9
M;PUZ+?Y.=>";Y'8/])89FWY[EUJ1QL'>PU'O>0X&<L9[F0L_+_H*(#L]Y9#G
M#N<-7Z'UGL=[S7,"2Q-M&G^916ZGY&LKR=MJN5K6<=FZ5.\Z!K\I?5YR 3.<
M:9 )S  B6@/.N+$1E.*(R#35N5>N^77BC&U!NE#D.+C_Q963YF:(#S<5?<>A
MKY\%_[),4<"+6\CI.I&&+?T4!;ZC8E%QGAI&M+]__[7ZH1?SNMOB7H/9=:9=
MJ4E6$ E@!@5 *6- 0,6 YK@@6:G3E'GE\EX:<&QD^?O?OO\MN=^(G"C;VWFY
M$=J/(2^B+;,<85DR4 J" (** "8(!3F"QJM2.=19,3%/$-5KX+T[\/\IB+NM
M.C%1['E=^?U[LI4U.6A%WD.585=HHJX:%P<==%UPA>"0^9WO"XC<?)RO%OIG
M-7\_UXO[%VNZF[\L/WVZG:O3__3QXZ=/;]N/@@J"BYPJ0"BW-3(X J)0&*0Z
MU661,Z&D4S'0JR49VVJP%CAI)$[6(B>?_O;I;_4>\=DK/GZ\J:]ZZQ%>N&H2
M'6(\0TU-SY078U9"4K6OFAZ/,-!0TS10/*C7C\@O+A0#V<X T54##!<IBH'#
M7L@HR@,#EKUSG>3?5O/E5-7GEJJVX9AN4C8F*H7<K&<$"(0P0 4B@"-B_I I
M+C.:PCQSVID-'']L2]Q^M8^="A&)W-6AW<C0ZB;YT5E$/LH<.:QE_2+?\PIV
MOB[+GOC)6OX+A?OC?!?N"U2_V ^=,WCZ/4_$2Y/Q-U_9>F#UCMU6[1C%TZ^$
MLG,="GCL<*M/N,Y[:\X5CPG-_^&B[3DU*13+!&+,+"#,N$RBS $CE &L:(Z4
M1$@I,5E5*SYSB]OL/-MKA=B,T-^'<F?'2&9; 7V3<[:HN45? K'HF;,_.0 0
MD#-SI&KDG)CM\P?.>3E2[#BGY?B2(!-PN?I2?M>+'U.Y"?-!9AA1&D@(3Y$U
M\BA@&1, 4DI2J?."P=S#R#L>87QFW+).4E^V4GK9"B< =++ KH.E=QO+(/*E
M3-8"AGC\)Z'Q,I2N@V@@4\@?*E\CYSP,%\R8$S<.::B<E_O %.FX,+#JECU+
M8/M(U(U4<\U1"DD*$*.9^8.70.0$&C[+2$%5AF7FU?]E[^ECX[):N+:'24!'
MVGWDW$R.8#QZ)C%W*/S+:)U2.6[UK+T1ABV:=4JYHUI9)R\*^UQ/MZS>+<'Y
MYF5[3;NK7PO0'A#ZU5RY6GZ<-WF\_Z6G]P_V%-$/X\?<Z_7IH:\+PR^3DA6"
MI5R"7"M#!GFI ..Z ))1IB@I"<;E]7WM>Y%];%132VZ<_5^F\^1YJ>P)A&1I
M53U??.K5I]^-T48ZJ3WSY6Z6U:[>NS&VI0WMG$S'LMK?K$_YWB0- K9!R/K
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MF/H%KYPAZ@Q@77[*<$$L9XWV EGN=_E1L-+3R=OIZN5VH?G;2NE)R3G"@F#
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M>5-P /OY\7EFM^7J/';[\(5^,&0U_:&;F+F- =8-ER89XTB7*@.%D#9$1 O
M.,F 0$6I[8ZB@<0SH.T\^-BH94?V]@3)GO1)N^OSBU7@KVW'*D_>\9H;YS!U
M+XCW;RE&!#LD7.V-6NSPM;L 0X>SO:$Y$=[V?T9HL>4[_O.C,N0Y+:>RML>:
M<F,3C5B:2J9!BBVW(9W:3EX,I(02*@@AL'"RDRZ.-#8B:PL-V^WI?7&31E[?
M0LSG +X<,(\&6]\V4BAB 46:+Z!Q9;7F<T\?N&SS!26/ZS=?NB'PC "?+OYN
MB^)MZ[SN=,_AI5!(:T PR0T_I 40F E09H01)D@FL=^A@([!QD815M:D%G:G
M++%3.Q5_G-WLF%CH]<P4X<#Y9_ [(!(W9;]KP&%S]!U4/TK*=[DGT*4RO*2F
MLV>;B?)=R^?%=#75R_<_;6ZH5C: ;PV<YU7;U_0]KZN;+K_J17->ZN7T ^I@
M0TZ9H,1V[L*8VMX0'/!2ED!*E*8"PYQF3E6A!Y!U;"2V*VFR%34H(M3G%#LZ
M<N.8N+[]OK Y\W?P^D<SKC_8H[S#NH_] W_D;0XPI+]S^J[=%/I@EB,^:X[#
M?C"_6TZXR#%AO 0EI@*@U%B?'"(!B(*8E3F%!7(R/#M'&1M9KP5-&DG;D_!)
M+:N[0WH>U,O.:!2H>J;'()2\G-"+* 0[H.>?/)CS>5&Y7<?S\L6!UF)]$'2=
M;%S"E&<LIZ#,20F0<3J!<2T1((74*B=8<-LOR/V,R=[3O3[RP4Z6R$:XA->B
M>MIA>^ Y6DZAD/1MZ]1R]9%L?4KAN.;(W@C#&A"GE#M:\D]>%'K@;J5G,RU7
MSX8%%O;,D^WWW)2$A"J7-+5%7C*S4I=VI28X!ZE-K::IRG3FE:]Y?JBQ+==?
M^4K7'7F5_J%G1E*5K+1\F%>SZM[:Z_;8QC_GU9_@H?K3]W#86;C=/O<X(/;\
M[>\*F:RE[*'VW&4P(I\3.SO<P$?%+JE]?%KLXAUA]/%)&R[2;36Y^?TGS<W'
M.>5B.INN7MHJ.<MWSWK"20:+/->@@+Q.^8: EAB"#*<BS5.<YT3X6 *N X_2
M2/#C#&>,W1BD#^1ZYI-&Y)MD(W122WV3;.2^L?4,A*X3 N/QBR]44=G&>?!!
MN<<7DD,F\KZ_ISJ3YZIYK2L?+%>+VC_:EL/<K_-EB]\T7M-$$5M8*\\ 5<)0
M&^0",%(4@ G&M2(9HQ"N:Q/<^73+&$P%IT]]O^C!W1#[='MU)NOZDLO8!28C
MO@=N]#NV:1U/6<D+527;5,X= '9+'1_6G-1J6W%RP(*2\2=OV%J2$>4?5QG)
M^!/C74&R!Q$"%T?YH-7S3'\IVRK^35G_NHI/62T>:\&-M,T_WNF?JS<&ZW].
MN"8R%P4""I8"()TBP%@J0%G"@A1$95A)K]S[,#G&%BW8$=92V''/"<\E*W!V
M')>?_C'O>REI-6@Z #>-9#9*)#M:W-0+2GM%DT2;6(626J.81P"NPS0NPP?*
M,BQ;7P?8$?->^;@KT^N:<.SM7*W]F*E>_F;\FN>%5E_FW^R6ZL+(8B[X7,T7
MZQ_-,C!=?IK.]<>5?EQ.H,@08YD$12$U0"*E0)#<$*S J$"E5$QX<6M4Z<;&
MN-L\M)MU05D;DMW1,%FK:!M;;Y2LK]I5,ZGU3/ZPFB:UJJ&Y?U%> C<*?[6I
M[9G87V56PQ,38Z+?3R9C% E?)_4Q)KAG<R6C#A*VB#2V_V]Z]5"IG>:.9LC_
MK*;SU=_-#WOIQ+*4.2($ X@P!DAI"FB.,H 05[#(A.;<J:I1X/AC6PC:F$ C
M_VY+TIH3:A62M0[!^=V^<^3&XCTBWS-/QP;=FX(#H8M*LKXR#$JC@0 =$F7H
M8ZX\]_^E_#"=\[F<\MG7:CFMHRCK;RLM<,FQ8( QC@!*A0 <<0XPS'5N_R?R
M+.CX?\>@8R.]C<S6 ]Y(G:S%#N8YIPEPC#)$AK7OD,+UB(;7#7" J)_R 5T#
MOTX5 0<HSA83<+GWE7K6O?_Y-&U+23LU*4.4<()U!E2JC)&'H"U=*3) LTS#
MG!0%UHY=N%]+!9]O>YB>=;4"8^A8Y_LR1-I5?,4)'L'6HG/'NAT8_C4[U@7.
MX[@ZUODJ,:ZMQIZF*'K'NE YPE;1<Z4P/E0+,^B\R6:6+W=&_*59LZTJ<U7_
M-*ME_)5/Y[9LQNUBNIS.[]\]VUA,(_5G;5;_._YSHDA&*38K)93:MK2P2882
M%4"D&JN\@!02[N,=#"#SV)P+*ZZ-KI:-BNUQ!OF2K+9J)5S]X[EU!OU6SR%>
M K<%<V13V_,:>;'(4)TW4T_X6O-D1_4ZL+.C?&*U7Y<G:A%(&@@V2^;GIIJQ
MP2'>ZCC@I$5=$(>0>] U<,").%SVAARZWYSX6]NGXK\U7WPP2DQ@J76>4P1*
M11! Q/8KX"D%&!&,.2FD^9_/VA4DQ=A6HSLSU[KNY]%/ROS^%+BM'+T#V_-:
MX)=,OVZG8A5)K";#9]>?!/)54NWW)1EEWOU)L$*3\$\_+* @NR%5FWZU+7XW
MP84J*9(%@!#:SM2( $9H 4I)D2*49SEV:B9U^O&CX[%&P+I+E$?Q[V/8NBGJ
M>C!ZYIXU#JWM^>E:.#SJGE\%RT USM?PM-T)?[&O2X2>>MWZ=Y8N/[YKN#+E
M9R7>*TE^_JI ZVVG!\7Z)+XLB:20:" 43VTO*0TX41D@1$)>(@&Y7P?I$V.,
MC;%:L39MGXTKM]^OQM,@.X$J1CPOD2Q!*10!*,L88&F!@- EE1(Q5"CAM\UQ
M):[#[$38Q7=3):*%]WHP'6W7ZP#JVS+=Z]:S*1V1_,97;56BB,;G>23BFI8G
MQAG6<#ROZ)%9V'&I'YDN%RO;XD<]R]67Q7>]^#&5NJX&1W*%TUP*8_:EI6'2
MG  J-02(:B$11*2D3@7_S@TP-AIM9:P#:*V87A7ZS@+9_;W'@*?GCST &>>/
M_)+Z75^XN7?GZS8_'7[99Q\^R&=]2;7U-WWQNC#KR#;JY,L'\^0?4Z75FY??
ME_986IMZ,;^_M0UK:ZI^N^FD_6732'N3141@"2E"!2#"IG%E66%+RRA@5GR<
MEQ*EE D?@RJ.6&,C#ZM24LZJ/]O.=N5:G81O]/&S'")-GYNQ,?RD]$Q9=DNC
MGI.U2C:KX!>KE?'8_IIL%$NVFADC9MM1?JM<+QEE<?&.:@5%$FU0PRDNG(>V
M5N2G7W/Z8-. YUWUR*?S"35&6$8T!QE#"B!8:F.C20E8F169Y!SFTJLH\\E1
MQL:UAXVBDC\:.8/."APBZL:75^/4,_WY0Q28V7\&@A[R]P]'>H4L_3/*GL[%
M/W=Q:&)KM5A9AZ_> 'A;+5<3)'.",R% 23$Q7AG%@&N8 :TPSQG)60:=PO+G
MAQC;AU]+V$0=9E;&D+;+)X!T^^2O@Z?G[WT'F7:'T H8,]?QG/*1LQ&/AADX
M7_"<FL<9?6>O[#<3X;/^N;K[4\]^Z-^,L?&PG*0IHR+/%8 \14UK9 HU-OX9
MSH523*:%EPD0*LC8R,*\8GD_F0A'4^ 8T!T V+ZCOI[Y"'4FPI?Y*R0BG /Q
M57(1CH0993K".<A",Q+./B\PG%6M]-(\WNX@WE5O^/R?R[8:+RN(+"BG *=V
MRT^;O[%4$U R5N8E0P5#7JG$9T<:&\75@B9/C:2>T:6S:#H&C&)@U'<,J(:G
M%=+R4BUF#[6-+X(1-T!S=K1A8RZ7E#X*HUR\(8P8WDV73]62SWY=5,]/RX]S
MVTW%9HM.E[()QVBUC<9\-N]+Z^D7&F6YC9U0I;6M!:H 33,,I"H*PE6))?(*
M; ?*,3926:N1U'HD5M#  $OHQ+@QT !P]\Q/04A[D].5.$6EKE!9!B6V*P$[
MI+UK'W=MW<@SE2&:UMU8E!D7O !4EQ2@ C/ "P4!1%"SE)-""1U6)K)KV+%1
MWFZ9PO,54X(:J3O.@V,(*CJZ?8>EH@![19%'%YQZJNG8.?0KE7!T@>-\Q4:G
MNP,RSD\YE#:T-IW7I-B6[*9:"X32#+!<VSR$5 &&,PFPQ$7!(20X<_+RW(<<
M&TWM"&AK(G15RPX%N9N'^H'NM6)6NW!>*#X>"J='SGMT6 ?*@X\!KU]VO!=2
MG1GS;D\:+HO>2[.]S'J_.P,X^G9SC/Q#M7A3S9^7UI>?FG6@617J8@7+25'(
MHB0$ 5QFQJ?.!04"2@(R13$40N02.O4A\QAS;"R]E3I9Z)GMOV%#3US*Q;/-
M0FK42)Z,'K9JB6ZL(EZKXL$_CO/AP.?Q4>Z9T'< -A(GK<CUCH,Q*]=VYFU/
MB'I0>GQD!^+T* C[D;H?5IVL[OBHX6C=3[<]7O>\-3" JDN]6&C5)+35F]G+
M7Q?VS!XM*,&(2R 8*0#B3 *:Z0Q(6F04(\U5X768ZNQ(8R-Q>ZPBF2Z7SU;,
MD#23\Y@Z1C=C(-5W_-*"]'$-4BWB35(+&3%Z>0F'N/')LZ,-&X&\I/11C/'B
M#5?6>?VTJ7N/4\89-LYW5N;8N.$Y XR6#&#->8DRDE'A5=7Z>(BQ<<&VXFAX
M[X$30#J&_*Z"I^_PGA\RX757CY3OI\KJI]>II']>S;,55(^O]#_T]VFZFM[7
MEN1;XRTV1_Y4P51*-9 8,IM2F@%:&, 8QCA3&),,.FT'G'[\V#[LK83VJ(C_
M8;\3 '9_U-?#TG>LS \1KT-^YQ6_^HC?B4</=L#OO%J[Q_LZK@KM!2\7-LCS
M3C?__3BW9T_L.9/_FJX>WAJGH7K4BTU:UL1V;H9%K@%F) 4(T1(((FU[N#3C
M*LU0RKQ*5GF./[9/?VTP)0O]0\^?/9.G?,%W6^I[A+1GVEA+GORREOVO-K:U
M%C_YT\B?K!7821:-V5T^"+O(+>?]9!BX#WT00,?-Z<,>$Q!QWNU;<:M4726>
MS][RI^G*_,>..A7/==+$V^KQ<;I::37A1*=8YQ1D.N, E64.>,$TR' .,RF,
MXX*=6DZ$"C VFON-_YP^/C\F?"-^(AOY$[FC@/FA5< C7AHR/P[AZ)Y1[YD)
M]SKJ)%OYDU:!9$^#Y.U N'L$K7O&?Z@(]F/UW+0(N?#J+^WFS.I!)_^H9^Y'
M.W-EM4C^?)C*A_K?S"]MP'NZW'XH-\EC\VW]+5( _ K<.Z/A(<\=+C1^A=9[
M<?)KGM-3IY$+%=V_/*^6*SZWJ8!=E=R_5;.9>1GMC1-$B&2I-C8\9A@@;DP0
M2F@.,D(15@55.?4+O0VNPMC6Q]!>$6-Y(QQCB*.>Y[YCE XM1UP[CNP <;'/
M2#^-J%YM)H=M.A)?C7&U'>EMFKP;C_0G2=BR>ON#3V<VH?1#M?C.9_J[;>5:
MUU:QNXW;GSZ;F5A7_*0ES&$J0<:$<?J$ED"4! %C!B%)5)KEI?2K3>DOA _A
M#52Z<E.@<;I-U?5;T +FPFU!ZA??(7:]MS+>)!MM@/D$P-+H<Y-L)8]'_N&H
M127O #$&)=]PF [)\XHGA9'?^O#T774K_^=YNM [6?:30F8%+K/2T)PM]Z)2
M!&B18T#27#)),419/IGK>YMQZ$9S7<,Y?7"L^>!V!^WON_MJ'O3 ;1Z:\>J#
M.:T38C?VNAJV@8IVMF+: $<KZ.ZIFWB\Y()'5 ;J''!0KG%1_9!5G.X)3.2K
MS.NPFLJW-OBU>&D/]"LL2Y2Q' A5KI/X.,H!*0UE\+S(<IYZ)?&=&F5LGOU:
M2,^LO9, NM'"U;#T;;>T\MDV7\GM\^JA6MB@9OQJ")U Q$W7.SG2L*EZ7<H>
MI>EU7MROPS21BN>4$PA821E ,.6 \X*# B-(C 61H\*K';OKP&-CAMO[^T5M
ML"0?^'3Q[_\&B_0__LYGOCD SKC'=8G&1"B7':'AG9]7=7G&Z>A<Z]Y<D6+X
M33^U5ONM^>CJ@%/-?7KQQ!>KEYV:'RHO=9%I"3+%4H"83 '3J0 \%S2#95D*
M2%TS#YU''1LU[4H94GC%#_)N8NH-R)Y9*0!#KS1&;TRNSFYT'W&PI$=O$'9S
M(?UO#K.,WE;&L5JLIH;A+*'9U;Y>YVWEE5FU?#9OW23%I- P9:#,H 3(I@XQ
M3@H@B=2RI#DCJ1/M>(PY-M*Q,B8_K) VL"*W"@2TCG*!W,T>B@QD[Z2S1:WI
MAU2C6DN<[(@<SQ[RP">J*>0R[J!6D <0AP:0SZW]%O6M^W::MW%"$<,PS1#(
MN2H PED&*),8E-#\?T(D9\2K'I.O &,C)_,6%OT4\=U [L9'?0+9,SD%%>VU
M.@Q?M?<0O5>IUKL18I15>@\A"JW.>_2<T+/C8K7ERTW7(4BX1$(70".8 510
M8U?9YB2L5)0H5*30S9WK'F9L;%5'1+9BNJ0 ^8#J&(>^&JHAXD9^* 4<&^\"
M(?*9\9-##7Q@O$O=X]/BG5<''TAKF_I^,.*=:H3T1I?5HFW^>\=_ZN7[GV9@
M,\9TSA<O]6E6NY-NDW6KF1GI_J/U"?5R-2$$THS;PQS,N&I(%@)0*@4HD642
M9*OVDLFJ6O&9&YOT**L7)6TD[C,-:-EVI)/;YF;5MKF9J!5==[%>656]S\+U
M-N^Z+"4OS43G(J-FWC$$@E $,D:@,8@%$<*KL/M8YGV04.)\6<VFJJX_-=>K
MNIW]O^R+X+;RC61Z>UX^/[8-YZV>?VUF]'3?PG9&V^MK=9O$M*UZR5J_J"<Q
M^YZ$V*<V>Y-WZ!.>?0-_XC1H[T.&62.;6,['^=/S:OE)_]"S;)T/PZ!&:4Y
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MWU0[VLYCF, !+>B-9;PU7V[6Q[!4PN=JG7=H]:JW3&P^VQ]W]<GZ7H*<O<]
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M,0?=U;6^1%:@VO'##5 %WP6T];Z;QJS[,M^=6+-="Z=N@]=[MJY^F-1N_T7
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M7.M/NE&IV#NHQTSM?X!A1/Y!MR#7S:_,P_9N!,Z1I!DL01YGBI8397WBK,B
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M)XOKW"!3H\E61D?2.H>>)3'=B$EH\FG$,Q[&^\WZ^[)I=NV]MV,?#'[9X]Q
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MS>ZB"^4' A0G\8NW5\/=DVBC&NI^X3PVS#T_?6 NDOXBZ)),,YX1]7]J[J#
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M88A@%).$ V1<^$61 <09!B@O2XYPD16)4[O+XP&F1EE[^=R8Z 0X.[:Y!8[
MC+(7+8"W_9+>7EGA9)!15_XE%8]7]\7K!CBVFF/II?PJR+I>+GY;_A"KA6*'
M5TNRXF]_J@6T(//Y\U<Q%TQM3&89+UD:8P$2SG7%0IX#RED!<,JI+' "DQ):
M.[4<!Y_<RC?%#!?[@WVM1K1<1,J@C/Y[6:EOJ#Y:VJS$O]71PU8Y9<(H[>XB
ML=-/W=@HZ.!S<9TW"U]7P-D(3#Q[W\K7[13LI(]>-7#O%8B^AH?;P;T5$/:1
M7%O:I7AA%=B\];X\6P.![/5JN3YS/(_60&T/O%E#G^%O4]PD<N)<$IC1&.28
M$=W"A0(DL?JR0(FE^MI(5LA;=\"33,>]L <;EF1[&=_A^]BI);L.!<S+!C5<
M&NKET5Y\Z]F;#GK]AL$G^LM'H5O#O%-"ZDK<ID/,1O#VG&ZYJ#^*]2?YC?S\
M+%:O2%TQXX"?R0RE'.6*0.*BT$F?J=J'2@PPH9G )<&Q<**2P9),C6J4D%%E
ME(E^F2MU?HWT_$>\H]&V+K=2*5(_-8$J=Q'5.IFP+*Z#=U>=7UI&:-T^K=8.
MA?"3%=['8.;HPWZ.NHI$>TU,!*KZW=.RUC75Y:7K3/,'_7NE]9V._8J,XDWT
MEU<OQ6W@^W9<#)1F;%_&;:"=<6_<^,"!-5[.Y__O _Q?/>\O:?-0[_]29N:G
M)R/3I\VZ7JL76EF??Q?5PW=E;MXK:Y0\B+<_Q8I5M?B\JIB8I:5(8X8AP$G,
M 10L 81""$J<L 1!&F<PGSTU$5EKLEK;L?Q(TKO0S+$.X1CG%5%_94+QR3JB
MXJ%:F/V:XHM&!,/\FYH/9OVQ7HVLI)!DNA%07B0 <IH#C$@!6(;*M"QPJO84
M[:OQ=F'IX9_LB['58)S7HGT3Q.)?YVVPLQ@F.+^![8MNN:"NS@?)<O0Y.EM6
MZ"]SAM/JKG[8:W\7;?6/6@"B+0*1@<!C=:%QY\QOO:&19!^W M&X$W)2DVCD
MX8<92'\G6J!MVBW+I/HT80KR(DL!A(0#G"$.N$@$HY)"*IV<I =/G]K6LQ7.
MT3]Z")@=G0^&(3#IMG(%<(N>U=@K91V.,"JQG%7N>/F?OVB *_0">_R]6G]_
MK]CA1\4W9'Z_6*@_31I(0Q^_Z<'-'V_(6KPCU>IO9+X1,P235-"<@U@D)8!Q
M00#)* <)@5DLXUR'GEH[2KV*-C5Z.+!"2,<*^4NI%U4[_>XB8C2,:I/6MC0Z
M1@]:O[OF/Q%7>D92*1K]T)HZ./C\3KZ%M_7%IC0PU5VT*;5FT?O.;#;*14V2
M8J->]%LSF^8_D58QTCI&?WO1V71PYK[8K([DZGV!V75S @>9@%X7L=\1QW,@
M!T'JP+T<9H2!SN=.[;!.^RD$N4"$4D 2F ,H(0,HQQ)(S)5YSF7,[7+T^X>9
MVA?WPT'M/].%W@1=MX&_3\N5?0;X%8 A+W.&<PF(,H8 %#D$.*<2E#EF-$MB
MDF;E3.VVZ'(\B+O#C0?R7-1U$(@MO?LWPQ;:M7]09%$';+'YQE1LVP:D_T[6
MFU5_^SEW/W\O+'Z=_.>'&M?#WZONB7N__^I;NP%\$7.=[/:9K-;/WQ3AUX29
M YE7SP>_,2$L)24E3>(2X$(G[^4D53Q29D#FA, XBWD!Z;!J_PY23(W'N]TW
M6F$C(VW45>1.'^<>_OK&(OXN$V=Y#A]Z.D*?JH>:B1MJ[P] ,E!M?1=)7JAV
M_@"P+M?&'_*P863:%M@7_/PA>-OZ809)3HM,31%)::FL,*YX%%$&(*:0Q3'G
M.8O=K#"[@:=GE9F-1NO6.B@[Q70[ C="M 1?L+C ."U @8D ,$$8($)*D*!4
MPDS]8YKEV[SS;_9?,(\S<)A\_FV,+]>E:1"-V$$FPNY3Y/_-'M&CV]< QM\W
MQ@TBKQ\5RZ%'_8JXP7'\V7"\^X;P+'K=1THO^$A;3ZC^8AWY2+^(1U+IB*'7
MR\5ZI3YT&S+7>X9DEG A&$XP( 47NM."!(A)#$1**,'JHU.0PLED'U^'J1G\
M'14.PW+NHK^VX1>D#;]8;96*V%ZK]I8!(3LCOSP.X3O3?27^A4)Y.DB<">79
MH1%UX(@T'I[#>EYF+OV'^(RLQ_CA/B\S46=#?UY(E)M[8?YC4ZV??Q?K[TNN
M:]#5:U/=_\.NS19DG)=%&NLJCXGZ?J:ZI$*& *&E+/,2"9X,//*Z-O34/GO=
MTY5&]J@1/NI(?T.C,X=)<3W.\@GUB&=8-Z)\2\=(2\!"M8&\-OQ+]7:TA*6G
M8:/M$]P[*KU=K/<%9KX(X]Q:/'Q=D_5&T5B2QRE/4H (I #FO 2D+ 1@68D)
M28B@I=4VX-I 4R.M1M:=\VHG;=2(:]^ J1?=?C[RB5E@]AD*EU._)ALL!K=O
MZGWX:-V<;%3L-G>RNGZ8K?.6F&H"]6>QVIYM5.Q^P=]4\XVVM&AM+*L9S"6D
M&1<*T(P Q1=ID]/%$2(RAI@4D+F=3EN./+WC:9VIJ9/W3'I-?X+F39#;F3$!
M8 S-(JW$)LWU:Y._W&2[-LFR1N[HSZWD'BT81ZR\FB^V8X]JNS@"<FRXN-X^
M<MIJ8TWM^];6IHKHM^]DT6XM/RZ-C27XT<;R-++MRW(^?[=<Z:?.I)(RI50"
MEJ!"GYEB@'$I@. B9G%!"2RMNE%.5+^IV6@G!UTW!!Y/%/+0B9 O_Z),_Y2U
MW4UW0&IK1J\53/LSV!U29TY@S[Z803YD$WT3II&&&4C'?XUTS; 3["VM,["8
M P-U&%L)H\"CWF']TRCS29H"'1LEH[)L/J_$8[5YK#N',S.92"RRI 22YKJ-
M"$P (H*  M,XB0M6DK1TZUDP3) !822!/]U=\4VQBE9H77FPV@MN@ML=HTF&
M395E=$DX^,?Y'.X4B'[IJO#KK@"1UL+LMK9ZW'7/CST&H=R$I-^@E&&BC!ND
M<A-<)T$KMSW-C4/KU7KV6C]6K)YTX.1']7K>_ZSJ&6>R0#PG@"80 IAE!"#)
M"B @PDF.)$D1L=DM71I@:MN5KHR1%E(9@$I,2V_711C[F<L'.($YR1D7:[*Y
MIGP?C:A[.Q2B_G9,'Q<?/@HQ7%-MN^2O7C?PY.6XDV*WC:*QV&8Q1;@@B ,6
M0V7\Z&1ZDF80<)ID60%QQ@EW.Q>^/NCTCH2;A@UJ*UBWW5K;4LMM_U#G=KD.
M$V!Y=. 5U-"[^3,M<8_;X1J9/6ZHK?'QN\>]/NRXVTYK&$YV@O9W#N.BUZ3^
MKO^G=XX_R%R;*E^4S;*J=-5K_0MESAS^0^?*&<T++*'>E.E&K!"5:H\&LUQS
M%4XSRK,4E>XE"6^2R67!C5AH\+2XH!MEW39/<<J*1!0)P$CW8Y=%"G!&2D"E
M,B-9CAC+$]?Z@"//4OBJ?VJ$EYF=G,2T2 4"C.I5) H$4"EB0#"-,8,0%7DV
M6^N.&Q.;F;U, 0U<)=Y=TQ]<[*6\,]OLU4X)<\&8<V9G'XPV$Z%W&682])_1
MV^XD[&5O?JDGY?C?.C?X,RR\ .O5YKA-HE'-$2_@'5LJ?AXZH';9VWGU6"V:
M\LYF#(U"I:Y^,+%];1&]LA!0,@(!*U$)8,%30%F6ZEKY.<2(8DI+ZYID5D-.
M[02E([3^S%4+,^B#<=:MG%I9.\#>3Y-AP P=9].1-[HWA+>3N D.OE[K<"B<
M#N6XO,,Z4IDM'_"ZU<UR0JJW'I;=D\:K<^6DV4']*K<[![;/)#^;]BFOR6KU
M+!M?HSYB>[/4"2BS)"]%EI6YVJK$2)G%&004*P-9P 0+ G-82.S43;-_O*GQ
MM1)WV^NG*_!=>\K;".V8[7$-<CNKUB.0@;GZ1@S=.W7:(>.W<>>5,<?MXVD'
MP$E;3\O;AIZWD[4)F_@DFQXABM%T8,5*?!>+NOHAVG_=!65S3A*1Y4#P(@,P
MEQE HN0Z^RPI:9JB+'%JI.0X_M2(:">^Z3[6E3MJ._98Q&)YF1C;0_E@< <_
MH?> ](!#^D%X>3ZQ=Y-AY./[00"=GN4/>\S J*NZ%NNZ36[9K2!!,E0H"@,)
MC75-2IX!FNJ8:Y:4(I=Y*@NKTMR]HTR-P+:)5<0(ZQ@1=19&.R*Z&9S =-/(
M=[=+/ M!+KT8^(U$.CO2N(%&?<J>Q!'U7CQLT;^K%M5:?%!<PM^KG?KBH:)S
MT0STVVI9U[.<,\99+$",BQ+ 5*9Z_0M0DK+@-%.F36%U#&8[X-2HP C5[ 7T
M><+]HX[N<&.$JQC;D8-/Y +S1",J,+)&>V&C+7\8>?U1ABTR7MGCZJ"C$HDM
M!,><8GW?P$KB@M2BWGT%D>0%HID$&.4$0&U6$(XAX D318Y1F0NK&,3SCY\:
M=332#=[K'&%G1Q+#$0E,"?9@N)>E/JNSWW+4AT.,6X;ZK'HGY:?/7^7=*O@H
M]D9MD1<ED;($A)0<P SK.!Y. 9,9@H1)93<X[0WLAIW:,K_VL=-IZD,YP'(B
M;C8@!L+[PF:$);(^[8DS0(UE572'GHIM<08.!POCW-VW5@KK&<[4D/XF?JY?
M*>W^9Y86I2(H#@$CI=K9X*P B*8"X!2FHD0<R3(=5C+,6H:I45FWJM7)>AM:
M)LQ^1BQ/:\/B'/K$M@-Q/[^UY>XCK45DU A20\P9Q$#%Q.SE>*&J8LY 72XO
MYOZH 6%.O9'@G1Y2V\*.@A\$7)DK3(YP/:,4YT628U#D:LL&"8H!H;@ %&(N
M"I(1-;G6L5#^Y)H<?1H5MLDFFZ?E(M+I?&T0=R?VM&G*N%$O09/]*9>K2+3:
MUOK:;M?&VCUMQ??\]Q/S"\YJ</?:]028;M.^>M?'FQ]'MC:7-1J^S"0ZA(*]
MS&2.%"_VL4D)TZOL8+WR9G[7W\6V5OBJ[3ZS7EZ:23/+EU?NOWL*./,_'[U1
M:1Z'&R]TS3]&!_%M 1X_N#C&YG%C7DR3SG7&(:R+XGW85>&E,J8%EQ3 DL0
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M[!1T]N*!!]5BK<^^/Z^6/RHN^*OG/VI-.F=B>&<YY#*E- 8<(0@@YRE "15
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M\@30/$T!H@F'F"9ISJQ"UMV'GAK-M1*WGA;V'*WW,D=DWWK+C=L<IL*.V<(
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M)G#GP8N#O>!YRO5>@E>O'^@J7Y.UH9LFK .)&":R*$"6JRT+%%(" B%6%H>
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M*G(_(^_6'/E0>7T% _P%A"5#C'/;#(A8)M=*<% S S.C6J/2[#5P)=V:D"?
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M3^TJK$D'YZN)Y28J;Q "PTP^K'?@@O101'96.F?"]19]9*#P, 6[P:/[5.4
MXNT")J_G]&DDCNE7_#6LPP5;$\-0:94*8+"&7)^@B0^>P;B(.@7R@/7Q9^=/
M4; ;3+I/6 X@WBY@4H]_ER_#&C\MEM\G(@KA:MTI]YQV1.L,>,L12N;H&6IE
M^%"'9+<>O%OY5?>YRL.%V046/IR%V>R7\]5TCJO5A"?/I,X4)"DN0&G'($1F
M@>7,&1-.J(P#8>'6@W?#0O=9R<.%V0467IWA\A-M?W];+OY8?WZY./L2YM\G
MDB1A158D#4?.DB,.',7+X*,1S/KBE8D#8>)! G;#1O?IR..%VP5&/GS&V>R2
M>L5=8<536,4-)^K)VKE &Z%6WFDER>BEX^/2^\_=#1$=YR:/%&470"#"SVH9
MR"+]^X?/)+?5V_-UO1]2HVZ"=9(N% \Y2HJW34:(11)SF;%8+'E,=K# Y DZ
M=@-*QUG,@44],G!>G.$\USK4WV;ATR0FG0PGPDL2$13S$:+-E@BG%Z/.: :H
ML[GUR-W@T'%&\W !=E+6_=MTE<+L?V)8_D:OK";:&>9+I(!)2@U*60\A6P13
MC%/12&[=<%7==QZ^&QHZ3G$.(=2N<+&]M;!E@F(EM,P;L$76_3 1.\IJT,@#
MTSYF%X_W.A]]_&[8Z#CM.8Q@^W TB(UEF+V>9_SV?^/W273!)2<HCA*:PBIE
MJJ=DZXF^XH7BZ\#X4"4T=QZ]&RKZSW8>(="Q:R*V*;=KBW=YQ<D8=-QHBK6-
M":#JKN@5?4'GT$3&<T)[-"@>>_INN.@XO3F(6 >#QC__?$^.;^B%@RZ"$\;G
M*\STS6HQF^9ZU?^7,*NWV"GZPO7J-O&[WA#_X:<>?W5\/\*/O%-^OH)/(7R9
M;,KIZK;QMOPVG=/#IK1W++8WQJY QKEW)BH&EA4R%TP%",)XX$7;E+GB&)[:
MF4M8Q0T +AZZ66\_XVR]NGQEL^R \8L. /]U'^H.-2Z7SWBQ6I%PKWAEM=(T
M<2)%TA:Y2>T'J15PVBF=]CY(\Y1_>CBOM^D8Y]9Z,U1<FIX!A#[B?G2;^@L3
M>L6$ESEQJ3.XF TH+RDX(\\*2!0"*50WFH>&R+E#SK@ .D:_#T+E&&%W@)B7
M8?7YQ3S7?U[]Q_GT:Y@1,ZL7ZY=AN?P^G7_ZUS [QXD,.DGA&>0D:3-'$6CO
M38%65,DQY93*DZT1#D?03N3U@*BC8+!HK9,.@/;A\V*Y_HC+L]?SK[A:5QN^
MFBCTTAM!3IQ/]?Y5W"0,$0RY^4DZ%:U\ZM[T$?OW ]2,TX.C'8R.EG@'J'F/
M"6D!Q!FN?L?U/>D8X[2J)]R2D70L3\2,+N!3$M8@&7+#FL#G2;+&:=S1#D?#
MZ: #0+U(J5X47ETS=<W3I#@ON48!(N1"WH"RX'AVD#)%LE(%P9XL.3C"47J"
MJG%WMP&5?]=]&DH3':#JUW/\C43W'F<U.'X7ENLIKJYJLBCJD#YJD,%S4+EP
MB!GIBX[<F1"5#D\=0!Z.JJ>H&G>S:X>JP331 :K>KC_C\D%13;*5*!T/8$SQ
M=1NW$+2FX,5Z)AUBXK:-I7J<IG&WO7:(&D@+'>"I^H%S>LOWORT7J^H*1EU8
M(LO*+*T&;1E1S\DQ8"0K\A.-UVWLTFTZQFEHU<Y=.D+*'6#DW1*_A&E^]>U+
MS?E2%+J!_RTI34)T+FD=0* OM6N&@6!4 >N0\]H5@3]9ZG\X<'8@;IRF6.W0
M-+0^.H#8;>(5+8\<B.02% FG^$Q+@^RS#K:(H W]\]01ZD#)R7$Z:+6#S>$R
M/AP@BW68#0.0KV$ZJWOM;XOEAS##BWM3Y,C]BG%]_=/OBWFZX- %FU (!RJ:
M#(K7YH&T^T*./,KL%0KW5*.3(U"T-ZT]I)F&R7^W5=/!0/R*R[@8;#M<?,'E
M^ON[6:"5.<\U'_NE9M+("YPX<N\<UQ9*J1TK0R'A^7HQ"RF\L$ESHY^Z"GW,
M/O@X53UDGP:!UV"B[P)(KTD)\T]36BU;$1$3K[ZEV7FMF_W;8I'_F,YF$Z>S
M<84[0%-8;8&:P9?,@:/*1LEZ+;R-%=N%NA[\]$& -;@J.O"IKNA&M-)@4N#1
M4TB:K0!'02_H%)@VFH)@U>:D;B^8-'; !X')02+M  IOR6J&>G/X#885OJ^#
M0MZ6?ZRV8)^D()@D^TB^7Z@E^CZ04QD,,(.L&(XVV]P$'T^2U8/[/0AHAA-^
M#TBZ#C5O^'#(74CU[J#T,=!RD @N% 512.VC2CP]>4?WR-3C77+&:6?; CE'
M"[L#Q&SIG^28I/7,T)99J5:*@V-* TNQ&"$"=[K1.=KF^>/TK&U68;27.#L(
MW]],0YS.-J$?N>V;JV*?%S,2^JJZ\.OO5Z(I$8M37D,V9!.5YYKXB@6*2JA5
M0$+^4[>N#H?)KA2.&ZHWKW5LHJ@.K- -ON[FU))!8Z23P(0G<=E4(,10P'M3
M3"J*:=:F8N1QFL8]WV^#@<>!=HQ".H#69='"N_"]9KZN,O .M:XWIH5PF;9I
M<NQ\Y@*LXUQP-%F5-G7H#]/3#:2.TO8C]2)'B+X# +TZ^S);?$>\*%"X+ZM)
MD#84%CW8>IZLO*1P$RGFS,%E;[-!G]OLBC\D;=SML!&LAE5(!PC;!A(I+<\?
MY,;K+**(&3!G!ZI8A*#J; R=4LR"D65O6#GR*%WCIJT;86M 570 K)>+^48D
M_S9=?WYYOEHOSG!YR=5EV[I)BD9P)Q2@J>(RFD&P6D"RD>1H4!O;IJ)[%^K&
M36$W MG@:ND :F\6\T^U<KT>)%ZR8*.1M% B%)UJ:SN9P 4TP'*MLPJIQ$9Y
MIP>(&3?)W0A(QPJ] ]S<3K_>6P4D&$[0=R!BHA@FQ4 Q#%K@V3!ABL]>/W4S
M>ZCD]T%FJ5GVN]7>-YPJ.@#6K^?X<?%P4;$2KG@K(X1<BVM(8. ,)M ^.Y:4
M$J+1'>3':1HW*=X(4 .IH ,P/> *2DUF-:.')!,)IG[GE+40DDD^8ZP-$TZ4
MEQHW>]YJ;SM.Y#UDU6_LSC<.B$Q@FB<I@>N003'F(6 =JIQ808I;C8I/S><9
MQBOJI;CM-,G,XQ71@0UZ,FJXP1:MC4*10H+ 45.,*K$>6?,ZK4"6Y!7J,$(\
MMR?@3I$W: >X%JKJ (&/.(@W&%)U'HX*%J1A!91,M;Z/2S Q<R5MO;AS4G=]
M3]2=(I'0#G7#JJ<#O/UZ\=@Z.O@,/X9O-\182THMQ;.!60E$N"5_@-6)/$90
MY(M):HTZVC9H^P%AW>0:VF%M2-5T@+1-VO<F"S?63,PV2<) ]"+4"K!$-EHS
M($)=G?Q6TI,S-X_,OC](4S?9AX:V;!B%= "M&TQ,N'=)"V7!>%,OM<H,CM/2
M\,:II JS7K>I%K]!1#>9AI,4+^PE\@YBQMJL>[IM_%+["9$?2?LYSM.&%40I
M9%80F&*@1,WL*B7!<\MD\<X*WV:[>X*H;E(/+9WY8532@2VZ+R':O[?7*-[5
MV56DM?5Z.8WGZUJO\7%1K6X-918S^L1/FP%&N+J1WBDZD]%5D$6H0W -K2U=
MQ^%*EQG/9)Z?'"QX3"_'(?G8"<.#]U\]*89'5'P'L+\Q 6'3B.WF (3(+85$
MR8 5@?8'S6DMHY% >T:IG6N8T&W. IX@:NR&G>-AY0'3.X3B.L#@BYPW9<!A
M]BY,*6QZ&;Y,R6F8&&9Y*(I#$19!<>GJE?$$(5'DQ&6).3?J$?LP06,74'>#
MO2$4U@'NWN,Z3.>87X7EG$2T>I'2^=GYYDB.8OAIFJXGSAJ5K5<4JV=)4DH:
MZ',<.,_0E5Q8D6WJRWY,V[BYXH[0.+ :.P#F#0XVP7X=9;7$SSA?3;_B-JWT
M9K&JR:2WY6/X-C&!8OX<+=@B"KD_M7FJ3 48+<;(I4S)MKD'L">AXR::.X)L
M2P5W@-_[DIX$IRSJ.OLB:$=;@Q80A-7 9$15&*N=[$X4#XV;@NX(A4>JJ8.4
MT(\"Q(G,O$Z7B) E(\-?[YY&KFKG,O2:.4G^<9L+XC^B;+<X9O 9O6/E&H_7
MSF!H.^40E'<;97S&]311^'"+DZ$FHMQ^1/OQ*$^P=,I9*3XRD;FP(&T@Z.04
MR9G3 9!<O91$Q!@;]5H_P:R4JV=\K'O )$7I>*JWK+UCH%R@L,KJ0LX ANPT
M%NW;="B\3<?8J9>!47%_-SQ8Z!VX7#=*2;]_7(;YBL1!DEG]\OWF;UY\FZXF
M(<=D2QU>I6*M=* OD3L+1FON?4DNQ3:IZ=UI[ 1J!R#A7FS:1"V= >[7Q1E%
MX).DF2?-<XA(>[JB'VGU102>2V I>!-#F[N>]VD9N\U\&ZT_ :X#5# BB*JC
M,[E=_?[BTZ<E?JHO_!W/(BXG'(4D+S#0LK.T[*(C6YZKYXDE<QV-8S[]R'W:
MX3G](.40%2[:R+,#^W)EA,EWQ=?T[6J2A<5L#<6EVM$7AK7O-!,@9? D,X<4
MGK;U@ZYH&?LH8+ -ZD@Q=P"4.QV*0A(Z$ZE@N4^@>+T]@T@QI9%*R%QD5HUR
MH3T.%CQ0JT^/$=Q'Q-T Y.[]&Q:#\O6"E8]2@"HEU?LW$:RE+=FZ6)QI4S'4
M_QC!O?2[TQC!?83= V)FL\4?->7QVV+YZ^(\KLOY[/Z G\NK5U$RI7DD<;&4
M0=F,$(I.D+@2*1-_RC9JE[,/F3T@["A8W 5:,QUUY!=_O^;DBM^R6+XDBJ;K
M>D)TU7PC:B-S9, 5^76*O$2(!C4XJ8JRR:+(;E]G>=>']] "?@ADG43X'5BW
MW7/_/$K4%B%'37SQS:EC3O6 J3!O+<\C'9YTUM%P&">KB5KZ@MO]55HBEU8!
MYH(4ZN8(048'PI@2F;+<-+J.^?S[%^Z#@=W[%^ZCD Z@M>M=TF"89-E'2(S1
M[I^(M\A,/1O@WAIFM,B-!CX/>.VW@WOF1X"NA:KV1Z#?(G".ZQ[O#*!5/I;B
MR$O1Y+3(("'P6( 7&4+(UJ5&$UA&N#/0L#!QT%UY1!5W86"OBLQ_7Y!/O)W5
M[KP)0J::'U D3ZDYN&(YD&-=@M2&%=G&+WR0G+$S;>/AX_$; 0<JJR_$??A,
M&EB].%]_7BRG_QOS1$:AN.$>6):T-_C,:/_1 5C2PNKDI&N4VGV"J+%#D![1
M=Y3BNIAO=8^9UZO5.3%26W-);P-D2TZRHM6S;=KD2F&*Z^B$"*=!X):@L;?:
M?M%W@,)ZM'XW;W5A"L%)Y2$F4]-,(8,CSX7<;ZMY,;2@PHG,W[[W\9Y+2?^@
M"#Q4=8/!L'&AZY6CO5J4B_8Z]-O!BEP?^?@F!:Z[L#)0<>OV<L?5 Z\K%[4K
M(J4"1CE=ZX ,V:A4.]7ZDKTG>?DVJ;!'"!JXA#5R9BVOV?&Z[Y-5-A RHRB?
M5ESQ/-*_;=H=]U3".H3N?U"UNH^<.]COKHMZ+_MSO4CKZ==-+NH#?MI(J5;)
M>8R!IR2 RUQKHE2"4$*H;)D<4#EIVES#W)' L6/0PS'P&)P&5$@/.-N2_@!3
M%T5WR'4PM=J!,>M)9CZ"3Z(&S55>+"4?&J7>?D!9)\@:$@YW(3>D;OK!VK89
MSCDQ=.U17%1B2IV%5M)!PIJ2J?<57,F.N K<V82AB#;YLQ^2-C+:!D7"PS ;
M2"TCXFRU7-=IXOD\K=\N/^#RZS3A9A%:$D4T.4%2]?(+,HIU>:D);Z&RXU84
MMQ.LZ $W($4_W8738Q2,G0L[>A<<1+1]0&-SE+?EX'+U>.LU\>W)KXQ$NHH(
MP68&623.ZHAY+7=JKKT//NZ3,8Z)&4:S]V%RI)@[V*XN&+FP@9AD8"QS"-%G
M4%$S\#Z0F?5%!E]<M*9-@O,6&:-CY%BU+H:2<0< N9##Y2T2%KV+RH)D,8'2
MM/N&4KOZ:6ZC=(RSTJBOW4TRQMEIV@'D<!F/7:RZ:5]R0;>AYZ-0!:RI1;8J
M,HBR]FTWS(D22F'F3I+GD2+4&Q\ZS@G'\)H^2E@=6(&/]+ZWY<5R&>:?\"KN
M0RX4,T$1-*,F)RMIB!$-<%>X85$[J=O<^'R0G+%/PP;+PAPO[ X0<X/\NH9^
M7\S#]2LW;\5>+@C%I62U=0TJ8L]8,GC(')D^%IPP)6O5J-O??H2.&R,/ (V[
M%RD:ZJD#&+Y<S.C510WUO^(-7B^=L:!L-+: 3(&X85E 0%$[IAL,1A9O5)O,
M\M-TC7Q;IR4D[IV;#J:?#M#V0/5AX<H5ELF_MU&1<+!>/:J'/5F4A%PF^MKV
M[.+-7K>6&Q[6#W],<9B8.P#*>_R*\W.\OG2I*1J,5EM(Q=:9MI;$(8PE?]!%
M,N_29=[F%N%=2CHY<3A0L_=:9!PAYGY@\AO)Z:$*^E??+JI=ZBTX^E^NS2)Y
MT4%MAKMKCZ"BD36_4 <-AJ21%Y=84R3M0^S8W3>.0<?#4&NFJ@[0>'4R\^K;
MEUI$<RVX(KW<M!@7V=G:AK* -X*6K N.<:4Y;S3Q\U&2.CF,&,:,#2/X#A#T
M<K%:ORU_6RSRS;S*A\4L3R17D2DA*&AA]0S9U%NT.=!:*,YQIP4W;69_/D[3
MN-9I(*7?\[<'T4 '6'I/ZB "/A,;OY+MG2V^U 5W(:Q)=B8IQ1(XE!R4I7#$
MQ>B :Z^YXR%RVR:=\"19XUJE-H@:3@\=@.H#;DJ#_X9S$M6,6'J1SZ;S:153
M#5 ON3+HI<V:@TFIIH S!Q\Y[=XN)2]0"Q7:H&LW^L;-A+:!60/-=("W:HC_
MF,YFK\^^A.ERXS$L5JL)N:$YYR@A1ZR5+LF"LRJ"U-*CT,JHU":Q_C ]XR8.
MVN!I ,EW@)][LIDX922S&" G30R8K(B!),$4PZ2.669L$_[=(V7<1OMM4'.<
MO#MHF7_%P/68B0ERBG3K@;.-F.N]%PI- H6]*L80-'/1F3;6Y@%B.CG$&SAN
M.U#8'>#E]\5\<9N+"^1?CZ! )[P0&DS(",HE)%&1NFNKAJA\IB70ICWY#TGK
M)-\]#):&540'6]?E];M+S\UJI@(Q (8'$HY@"H+'VEZ$9V.2MAG;U.#?(63<
MJ']@-2^&D_D1[58V?8@' LU7(K^NJJUP;HIKDF5!4V@7#LK05NSJ12I+S(D2
M$D_&2K2M$/0X5>.&_*WA-) V.C!'F^*L1\4U4;S(Q"4#KNN@I5"(+^\=Q*B9
M5"[+$!K.NG^4KG'=I;;H&E C'>#K<4:25C)[;\"0%P *A0#ON:D]"WSB)D:G
M3NQ C>LXM475,'KHP#._CBGJF>.V_<'?<?UYD:_-\FH2B\7$"@6[-A=0.4OP
MP14H5FCC2S7&;<"U$WECS^(;U$,?7B$=F*W;3#UT?>Z7VA7W8FKEQ_ -5Z^^
MT2HEW4WG8?E](]:'^VY,BC9.%*& N1QJ\9BI->Z!EK'F+@KG;6ZSIS9D:B=$
MFV>)Z/&4WXVU)18O=HM?<(YENIXHQ:2A6(F@5GO&**EITV".$"<VR3^EL,V-
MJ4<(V@E_]EGA[SBA=Q*V_F@A'=*X:!*9%861,&/*=::/H?"]]OHKV68G-/.A
M43^R-OSLA%WWK+ [JLJ[,9N74OAUNDI;06"^EL/5F&O.DXPZ6G"JWHDR14-
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M0H=1]H6 )LGZ;'PQ4&K3(Q5$J!>$R%-FSEG%,TK79FM^A*!QC^W&@-,AFN@
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M(RSS1,=JXBFTI45'TI*)T3I #QG)1XTIN.*;=0W>A]!.LI\'XN)^6^!F2NH
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ML;=/435 ,%D_\]UR\75*\OOE^S](^*_G#TR[>6A&S95L$D_*1)Z ZSJEQJ*
M8)T%+DK(6FIA9!O9#$-_)Z7:QZ+N@5#UU,KM(,2X': KC]'E[ %]\'7ZH0!7
M*%Z7*MG@M?"<M1EKU5&KYS%P\&369!^E=("H6[63M?!QGJ8SO,72Q\6.$KYN
M@B70"24=\%1J%^Q"W@8CMZ8.V'$A,1^Q34_H%MR,6S/> ;Y'AT@'R^17I">G
MZ4:J]/T,+[J>OCA;+-?3_[TMVC A*"-B 8V*A$P.-H3" \3HI$\NB81M/(5=
MJ!MYL._H&%HT5F@'(+WLN_MV_NMT]66QVE2PORUUQ,IZQ2<\B>+K_8\L$@6"
MZ!TX(R,8XL)JAR7P-K'[TW2-:U^[ ^: 2MP?DGX+R?EV7-DPH%PL\A_3V>SU
MV9<P76YN;58WB:%1/G $O>FGGDVN)42.O"9&PI'1<=&F]='#](Q[6:8_$!ZO
MM [L82VLW-KU&T;];:%UM<F<U0GS[Y9X-CT_6[V>?\4+#4PT"SSZH $SDZ",
MJ]VA90"GK? F"*D;)4,.HW?<*S'=0?<$2N_"KE[+M\Y8VZ:6_X[KS[6G^C5;
MS-HDB'0HV2=02FH(RKF:<4'M8Y \M2EFW(F\<>_!= ?=X57:!5(WYZV_W+UZ
M.:'(DT== U'.7#T;,_0=8:D4[FN_(V2LC0?P,#WC7H#I#HL#*&WTNS WJM=W
MJ!RVY$:;K&I]DZ^LZ0)NDR=!65 57:*]T]'_L7LP>SUWW#LPW>"NM<8Z<$<W
M(ER18HF'7Q?G<5W.9Q>'N*N)RD4D'2-X8WF=":W L820K"M!>T?,M+D2\Q15
MXUZ Z0:;@RNP S#>]HY_F\X#27?^Z>5BM7&1K]SE"?.9<QYEY8;5128@,K+]
MCCA47#IR.-H,;MB5PG%OPG0'TB:*[0"POUX\=BO7C^';JV_5+<%?<(YENIZD
M3)XOI_7G''?U,)D8\U+5@6)9.:F\36T,Z \(&_EN3'?X'%*/8WN8OY,T2737
M*=N/N#RC%;==>V]J!=C$A.)I"TB EM7;X[0E>$<QFX_),)4"&MSM4O\.#QOY
M DPW6&NBG&-CZ8_#WG2X8&\KVHLU-*'8S#N;"S#M$534";S('IA5Z+A*C.>&
MPY@?(FGDVS/=0')8W761U[E?['HEM(NF6]?E!UYF5XM.F=)DU"4R"$5K,%YS
MJT614K<9D;D[C2-?OND.J(VTVX$G>9\SDC=.O]9^Q=>RBU:28ZP56$;\**,$
MR2Z&6CNM9'$"]<D@^P!YO;5('08;/X3@L8KJ$GV7*81KYB;>1X6>,=!<5K\D
M9/!:("3G2Q(,14YM2C5VH:XW[!T-BA_"[D@-=;I;_WJ.]9SI/6[&(;T+RTT5
MX6:X-ZU;H9S+R=9$/R=O)&6(PM:KF&@QE,@<MCF=V8_.WAKZML?B8%KK%)4;
M!_F&&"?HDZB%TY!KJ8E2UD 0/((VC!NKK!+L9+[C'=IZ:[';'GU'::=3Q-7#
M]3G]T;1VM@J,::,"<5(K/@N:6EZ7H(AHE J186[3:.=)LGJS<B?R]@Y53*<X
M>[?$+V&:+Q.@%W'_B_EV$N&VP'/"BG5U25&TQNNLR^1II08)Q6BN,I)L?9OB
ML\/H[<T"G@B9@ZNR4\ANV+G.,&SY"@65TB:"R(IVE"P91 P>&$IR?1W7B9\*
MH@_1UUN+\!-!\FA5=0K!R]CK7?A>/8Z/RY!QHC4:6CX(.4JL;?AK8ROR/P3W
MLK HK6S4ZF(W^GKK[WTB"!ZMJB[3,Z_.OLP6WQ$O(JXWTQ"GLTV>=8+,^,3J
M( B!M<M?4!1N:08NL)*X-3KR-A=P]Z&RM\[>)P+C0&KK$I);+V/;-OHF8UI:
MDB$YR5R)4MT.#<[G!"(&%I)Q/-A3I0T?(;&WCM^GW)R/5%B72*R7CJN\_FVZ
M_OSR?+5>G.'RDL'O$Y&T53$FR,5[4#I'",(BH<A%$XK(VI\JFGZ2T-X:?9\(
ME<,IKTML7DEQ4^MQS5BQ3(3:E,N94ENC9DWFWQ703*9D3)#B9"'V(R3VUMS[
M5%9R (5UB<1?S[$>ZC^4L9<1,_/*0;(V5]XX!%LS!=9&\D0,UR?+;C].97?]
MO4\$R('TU@$F=V\C,HDZ2QZX %:,!!69AUBGAB7/74S91]&NJ]".-';7Z+L)
M'AOI[' T+HBSEFC<WG+<O:F-C@J+*QF*#Q3'\:3!&ZSS<@46+DT,O(U[.0S]
MXY[JG+HS6TOE=F!@WX7OEP-(TW^<3Y=X\\JN8S$JQP(X;FH+3BW!8;V\ZS4K
MT63N2IM;V$]1U67?MJ8HN7N=:RB5=9$Y)TDFQ+RY.OXAS.IAU-_#^GQ)#O3;
M\N)KF,YJ3K9>GZ1??L!4?[-)ACEG,?H"4F_NK3E)/@PSX"T&KY.*7+HVV#R,
MX"[;L9T4MB=0=(\&E?@F0:Z_OYN%^9J8KOT1OM2W3(RD'<E&I*@PDB_.?6UN
M["*@<4$&[GRKTZ#=:1SWG+P'U+919Y>F]VVY40;P@) G0D34V4;(7I&[GGB]
M<11)D%SX)$1BV"@ONB^EXYZE]P#;EJKMP<K>X._E8C;#M+T>]_MBC3?+G5/6
M2CF;0&:+M>\'!X]!0]$E^!!]#J)-SG1' L<]<>\,J$,IL@-\[B[9B?;6H38.
M2E 15*P=O&P6M=9%LB DBM(FD[H[C>,>Q7> TD;J[#>E==5_84?ALN"%LDQ3
MG,E\O592\X7*U98V0>K"F6DTGVP8^L=U<T^=TFJIW YL[\TMI39?(E[)_[DQ
M2&N"OI!3C@8LJ[5=PM163)K<'N6CS3PI*]K4F_R0M"Z36TWQ\H0_<+SR.D#C
M>_QR$4*^+6\6\T^UF\.O&&D_\DDE8024HBTH4_<C2;Y-<9HK'7G,C?H(/D91
MEQFJ4V)O$%7U%]G75?/VRT9,K[[A,DU)L!,4T7.6:%N)=;H6,@..20,%K;$L
M"69"L[YM3Y/69<II+!-XO/(Z,(&[RW0B?287W3+@*=>)EFB),W*AK8]"DP#I
MA3:#NG>GL<O<TBGQV4B='01#KTK!1%[XJV_I<YA_PO=DD-_.*[/U_S73^S7,
M<'.AGN0X362NZR]>S//M%VZ\<X+:&L,9$N", 95\IGC09(@4)597Q9?2QM=L
MP,RXT&\6)HVM]@Y,]%',;IO=WJ\N2K/S.J;XIEBWHIZH'+++-H#6FI%=<!Z<
M=S6EQ\EDQ" *MCF\/2V?XV9WFZV7CL'2P29RE'2N]%.4+%DS!B+42[BUPY\K
MY.)1%!*RT%%B;N.?#T+^N GC/H%_D&J?^]8PL=R[$$P$E3-]"4) ]*R %4$2
MMS)'UB8QW-[1:9:&&P%F0P)]+YT?.4>>EOIRW0',LW,FQL1 *E:'FP0)GJ4$
MVGAT+,CL>)MD7GN8-\OX/7>8[Z/S(V'^:C[02)OS+U]FFZTQS"ZWQM?SLEB>
M;;5^U8 S,F\X+Y"U">1R90:^H 26C:*P74D9VOCG.Q(X[G7<9OY%"_5TX$&\
MGM-GT3)Z%Z;Y=UQ/K)!):.> BWH2'Z,&9TP"[Y4P*0H*C]OXMG<(&7G$? ME
MW[L:=KCDNP#.1:]]7%4.)JB4L<8Q<#Q;\BZ$!9>UAF)<B$('852S&[ W"1GY
M!LQ)@'.XY#L SJ58KAJ67];IS/,#:>HZ6V2V6)TO\4IVU6E-2@JPGL2FBB4K
MGD,&I3%BD-9)URY!=0SEX[8$:!IYGTRA8X_GN&BX<7. 75V$T_EVM.*+/\(R
MKR;(8[+:DP7/C)8DHP#+D3,,)F..V:;HQ9VCLD<&=.STN/$CXM.I?]%4%UV8
MQ\UMWTW[OSQ=G]?A=?-4;XCG7\[7OR_6_Q,W+L/$A9RYK?U7+2-_(?M 8G,<
MC/!"I1QIQ;8I^-^5PO$CV)/#LJD2QS9]V[L*E]<4ZIE /5I^H(\Y)D=^;+'@
MN2*F"O?@G)20,1FALT'MS4[6;]<GCEN6,IX!;**1L6%V5.+G<LK)]+:[C3YI
M:>LDIF(*[0&*00RT$0@EBM(Z*WMW$N8CB&Q W+B->0;W"KO081?[^(;+NZG1
M]<NP7'XGB["9/TOV7]I0I^F44#PH[Q1$+ :8RKEH;;1B;89K[43>.(YE'PAZ
M(,@95IT=8/2>1.^P5W>TB]Y$D6ON?>&0N*PWO;.H!_T9BB;I,262D&V NCN-
MX_B;7:*UD6([@.QQQT)"%L-T3975&:!*1?*#F- 0G3>HL$3$-H.'VQ\%#N[>
M=@GLTZE_L&JE?_[YGMK>T N;7VU^4__J/9:?ZK__>/_ZUN?G>?AK6IQM/_GM
M\E.87XQAODWF:GKV988_\F!O_?W/UP3<)>WB8^ZA:$=B\-N:HE[,?SER(NF-
M![Q<S%>+V31O@33/[VY0?#60.LRNG-D;XPIC+H8'\EFUH-A*>@5>< ?6!)9B
MT46:-BM^$/*/GNIZ#!'7D>I'4NDOL\T%+[36%94AL'JMBX0+P08#5L=:FJY=
M5&W:H@S-R;@YT]-C^][,V#&1,9@?,9QM_7!^=A:6WQ?EP_33?%JFJ7:0V292
MR+M_1^))]7[) 59WQT\^UAX?PL! EOK^8ZXO]@N>.:M9+<<C*!0&?,J1]OI2
MBK.!1\V:V(O':3JZ3N<I^5ZOAZP+"[HF=84VY&LP0:&@%I!HA1:'SEO3IN7I
M;O2-:_\&0LR]&IWA5?-L355[DW5BTS66"6/6ZF 9@Q3K!>.(!J)Q"K3 E&+2
M&,)S,V&_A-5T];;<><#W[=?K=6(<TS%( V%3*VQ"@J X@I,ZH0]9)M^FT&(W
M^KHU8?L@YJX):Z":'K(V-SW,N[RHE"GH%QD$LECS 1Z"Y 54PE"D#%HWFC#S
M%%7C'EXW M=@:N@ 4ML:C[_C^G.]L7;59'?+U23)5%22'KPOJEYSB+123(!H
M11:<Z8 \-<'4DV2->T[="%3#*:(#5-U:(?\:EM-Z?'Y9J?N*A+>^,,7UEGYD
M(I1ZB9@6"1)/GF<#.A:GA:"(G+5Q"W8F<=P;X:<P88,IJ /DO0K+.0FKWL']
M\)DD?,\\<QZLSAJTI7A%!64A!D$VVE@M193.QC;E7C\@;-Q[U*ULVH#*Z !;
M'_!3M<GO\<MB^;A/6;S%6'*"'&0F!P U.#0,@LLI,QX,NC86;2?RQKVVW AG
MPRNF [3]8X5ORZO5>GH6UK5[L;'D3*('LL D'YX5.&898!TDDU,Q);>I'+A-
MQ[C7TAKAYPA1=P"4W_&/&W)9+N;T;<(;WN.]A1 *)FD$2!4";>G.5K?20M92
MH^08N&YS.6U?2L>]Z=$(;$W5]6SSK!^K ]HPRWKQ^:?)L3[$3/L,JR].:%,$
M,/+*04E'CI1#!9XA8=(J&QH5038\)$J?,9]OJK/I\_-T=KZ>?KTQ.>75MVVU
M]K:U^MF7\\O3UKN>YXV4G\Y6<NV!RWHZ8B52).TC(,;H$A9:3&VZ=0S/2[>9
MVWV0>,^7&U?ES]: OIG^QSF):_W]1::O]+0PNW%C]E=<A^FLH7W=[?&G,;\'
MB**]=59%9/(D.>AL:I](Z< [E2&)% J30@33YA2HG77^'=?;2]1O%JO51$E-
MH;S5D$RB598IF/<F20C*1*^9<4RT8? 6&=W:Q'WT_T [T@,%?42KYF%Z#KVO
MJVV.^=(ZDX3.S\XW8WM_15K T_6$<R&<X 6,$(K\6^00K1. M;(T6"DI7F]4
M$_\CVKH]OCH&30.KY-ANX!]'WC@?S'Y768^RCQY$S6FVU>,%U7Z7+4;:$ ("
MLJ#J-8P,T=?:)QVMB$85Z]N,<VVWRSY\.K/]^O?P;7IV?E:WA5??OFROPYY5
M.B:%6<]]U)"YK76DQH#C*$$Z7E3,VNO0)A@\B-QN=^U]\'37SK97W+,-5LBA
MJ:Q?AFKCF-I]B#B-A3U8+.T-:W+,"T8.1Q&20GH>-C53$C"GFIN4UOHV.>/G
MD%S:-@=@6C#-!#CDKH[JR>"#*N 9.>32*!-,FY/E8?GHUA3O@\!V2:6]5=W!
M =&1//_R_>$/>/%MNIH82[M3# QR\!94L F\B@(TUH8L6FDN&MF%=DR-W#1Q
M1*PN^@1.MVOH]W"&OR[.*)R>1*>,9HG\-NLB*.?JN!FK*4!/F@?)3&YU^O(#
MRD8VZ+U :"=H'ZC/#O#Y<C'_BLOUE)9\G>?V=SR+N)P(X:V/T@#GOAX=1PG1
M" _&1<,3RI!DHXOZ#Y'3(Q(/U?C]>LHCQ=\!AFY,8KM@(*9,<6]&D+EN'BDZ
M\#49*"0O&761JE4MVUU21L[$ML3.<6+O #?7G2(VK/QC/EVOWG_XQP4S"DW*
M26@22&W([ KY[6XSS!1%5(Y^&]O<(7B2K)'O$+3$TW#JZ !;_Q:6RS"_-*C9
MYV!RL&"R4Q0#(H+SC+;]PDQTI4BOVW3'OD7&R#<"6F+G<'%W@)4C?<TWTSF^
M7N/9:D)[LW!&,-"J.I;9Z=I.M("4*8=ZEUJF1G=5!^)@Y.[M?YH(]C!(//^E
M<'$6893P&$N$I),@IH. D"TYL6BLU<*45I=E!B&_QW"C-?*&A?\!,'BV1U*U
MS>]\/?O^(B^^D.OT6(GV.$=50Q!WFB.LP<78_F@K*./02@V&UQO;%+2#5UR!
M*)$<)IY4R6TJ@EM6YCUZQ^#M\N5F^NA5@^O-.Z;S-"6T;C?<:"TM^! AZ'K_
M12(%"XE)D,8FE3*/CK=Q?XXBN]N#JWWPM<=ED8$5.:+3LEJN)R^W)6BT3VU'
MXFYGZ)('6>U(U6%-^*)43$5M@)4ZCBX:#E'P>@&'NZ2UDT;O5"E(#[P!2OKI
M+B!WI6A<S)T0'(N&FNH<>1=1M<]:HJ]Y$Y:)(V$M4 @LH;B(5F3'G-LIE3X(
M]L8\V6F#@3T =H!".H?8B_R_SK?]/BX2+TXDQF,($(JLB1?R_GVHEPR=TTP%
M9E/:J3_H,(;N#G7]PNX09.QCV8Y14P])@2OZ5[\MED_L'IOE*SCCW%/49T+T
MH$@@X#U]E[C0G*+!F%F;>;][D3ENINOT.W![778 U(_TONME=['8I$?)@PS
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MP@Q?Q##/B_F--@O",1L*+W7TD@6%68,/EH-*CK'LF4R-BG8&(;];N!X"J?N
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MCA_?3WN^3CPM27-5D@0F!9V4OF1P*!QDQ97011)+VPQU'7\M/X.-/P3?N_.
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M:8:7-WT!2I2!!ZZ!UL;)2E0!4&L'"5/"DI/)2CQG"QWTYC[Q=*C8%Z>2P=0
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M^#=U+XI-F]@W7_%O>9[7L[AZ';>ZK BA8TFJ#IJ+-=&&@4LN;=+&A#<BN/C
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MG.&2?A(X![)]ZJO %_(_]+UK\<W]YJ]7F>0J;XKA%$O6Y3KA([F:&R_ 259
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M]-F!860]-XCCAX-FL<;+":\Y7UVMKY;Y#Z2OL_6L_H7[O]?\IG._UY_FLO,
M5K2][RP^)Q&+AR(X^1?"*/ J$0J-12LC4SJWF;W8YK[S/C?ON/PN?[D.*ZS>
ME-L2[G>Y.EBD1MZ45T0'7OZ_C$NR,;00J69FVCK+N\0 (3 &J!23AC''79N;
MKF,IG]XN/!)=3X48FXNR@P-YP'I_G_])6N'#/_+EU_S'8K[^1 <3LTFJ&H0C
M8P,4EP70:0:%?'NFL^8FMYN\>S#9T]N2TX'V2"&>&V+KEOSPC\6%Y\):FSUP
M#(&XRS,X(S2P)'3(S@;).P#JEMKIC= I\7F(R,X2EH2S?%%R]#Q'A&2(HRH@
M)[9J RQ[[K*/PHAV4ZB'TSM]X[#)H3E8;.<(SE>+J^6%EAY-#!P2J]DP.HAZ
M\\6 ,6.9-D%GW^96\B!RI^\M-C4T!POM+)$Y^YHO E/&&B7 UG[=*CEB:](>
M3%)9,VX"V3.=()/(G;X[V>3('"JT\T+FBT*OO5UGYD+*(C,PKUTUJBV0M<*A
M*.Z++L&B:=-Y_U"*I^]?-AT^#Q==!Q!]T-8%E\MOU]&KV@E<!&N+0@DY!GD]
M:<4E,E&$RT4489AH5-/P%%73=RH;&6JCB:##>_;;8O)\T#WY_;]^[#WW3E)&
MNJ>^??XC\,#,% G*08F"@6(L ?F> 40JGO.2N8]MDG.?(.KX.-P/C_Y K/R%
M?N?O%[X85FPP@-8)4*X("%HK,*;&AD)@,;4ILW^*JFEOFL?"QX_1N9'DT&$U
MPKT]N\D(.E:);!\RHBIYC*P3*)2 KCIG#I % HRTALZ;$(#SR#AB24:VN?-I
MJ%!N@HUORFVQ\^W;:@GTNQP79'%=SC;"VC#^#NB(.A1F'<1 :%=>24!-D(\F
M6HZI!-6H7NX8JOM52$/P]4.'A5/)L6^%]2<9<IN!XT?D"3SUN!&5V-.DGD"=
MY<2CYV0^,Q\]J" DN!(B.#H3@^.%Q=@J?Z>9.GOS)5>FSC^^7JQ6&ZN^+);_
MJ.-QKY-;2R(/T6""S'.@,S][P.(B&$W'O_'>Y-C&QW^&L'Z5TA"4/%1*8TJC
M [>=&'2=L'-_*9O:#)32.Z<1@B7UK0SW$#RW8&0RRA"_?&KC:NPD:5I C2KX
MA[/61Y%"KW"Z5\QAK(ZQ]CC*@FLZE1T#E(AD$V#DWA?.59N+H&<(FWB4^CCB
MWP=4!\IBZF3RO^5YW7TY;>Y(!>-V6\*3K$O*Z026\5I_KVHW.%+ERF@T*+3_
M(?JR(SE\UQLZ1,:A,ER,S= .%,[M,?_B:OUIL9RMOVWV3<K%RB2(&UK7*0RE
M)KUI4@PAD3MB4]2-2B\?IV?:+*^6)]<(_.\21=O]%8QCT6E52P)]98T"%U&"
M5ED8K8*3HDVKL%T4=6)4'R'M9P%T .L[@!!1G5?K67Q9HRW+;S?SVS-S,: '
MX5SMK"<"G>2<@4&T ;5(1;=IV_DH.;V!YQ!)/XQY'<WV#K#S:K',LX_S[]?@
M5&8VR@R::T-<J6V2150@4K"9<:]D;G.$/4;-M =8$^0<S?0.@+/[9']]6["5
M,'O&R6=@K.95)Q;KD)\ QHF0I%2NJ#:9<WL0-VUV<4N[:&S)3.V T>:K/+G>
MB75-%Q)5](E'\,[461?,@RM)03+%IY)#Y':_QA0_/+K7>YX#);<8C8T=:)R;
MYOZTD-<S#+/+33K3A6*\1&LLB%)'+VI:@%/.@%!,YZ"20MLF"?)Q>GKUMXY#
MT(@RZ !)N[ETH;0-C-=;+U-'?,7:ER62'L98F_M[YUQH4X*XFZ9>3ZIQ$#62
M+#I U;V]\6*URNO5=M[-CPL+N7#GE 9N#=F.-@9PEDYWKVW6CLG:RZ"URGJ:
MQ&D+7$ZHQ4:45(\0?/02=_6.Q$ET?KK@,@JIE0.A/5D I,7!!>:@-F!DEM6F
M&JTF_PTB=-JBEI/#<42I]9U?\GW[V>VWM\.:5N/DG.SUBA'S4(8OZ02Y*4Y%
MC<$6B%G5'G,8P?$LH7AFM,B)>]]F!-F$N2G",*:+=D"N=!TSC)O&:QI$1LEL
M"DJ7-K,GSS8W90A*AN:F#)%&!P?I>Y)(KJ4,M^MZ49, -][.^_SQMHNHUC[)
MY#486[OOAU K93PY/MH9'EETRN<F(-N3P%[O,PX Q0\SL,:74 _ NR;]D45M
M[YWC)D2>Z+3W2H 2FH'S+H$KVF?B&J=OM4'<,Y1-"[4F<'@(N3%ETP_67B[F
MM)HK6M!V98OY:AN3$ 5I)9*!\0:A]D0&QQ*#R,G2+$*KI-J<H<^2-C':1D7"
MXS ;22P=X&Q'Z-YIC]YG,C>8JV-^@P1?; :69,E*H) /;_'_A1-ECCDJ1^!_
MERC:[K6LG;)9YMKQ,]6Z50<N:P$A,V%XR%JZQG5ZYY H,TC:^R;*#&%]!Q!Z
M-.YN<N$F;-(,A0)EY6:.'X*)Q2N3:YOW-E57!R<[G#Y-9I"<]TEV&,+T#H"S
MSPV@38:<9Y>!\^! 1?J$KC (L:"33BN,;<H9SS[9X9BS;6S)= "V[1S(73/L
M)>W%VNZ:;$G):Y]"!8B<5+IPW+"<!>8VP:.GZ>KUIN% &"R:R:0#A-T$''8M
MAWO+#:EHR!E)W1=?(!BF0 9C5.0I1]/&[7N&L%Y-]'$P-J94#@;9U[P,B[$M
M]@<+01,SE]F"C5H":?=0=XNM*=PUXA^#-6TRDX^!U:0)%L? :@PI=-B5Y_TG
MXNZGQ24)9_7;_UR1K7I(H/"1IQP;"WR.L)'"?=>/OHW=,.-+\*H G39D56N6
M %/4$%7$'+7SHE$KP._I.#[NLHA__XYY=7;68UUA@K?>2$?V(OD+H!P+X)E1
MP"-YM4JIZ&.C>_!]29S6(CH"'S^&6EH(I</,A!^W[N$=>W8^:WS]TK!_SP,4
MJ12MS[:*MK;VY[QVA_,2L&BIHPOT@#;]'D;6,K?=75[$>/7YZK)6H[Y9?\K+
MFKU!W*5S\K;C2SV6'S1XD0%-UBA!2%7G GH%CA<$@29I*3%BH[871Q+>E48:
M@J7=[7G:"_ L]-3--*S5HKQ=YC@C=42<^+R8;W3W$9E4A[YJ?"UWP!+;*$'-
M-<^,3' KG"'TTG&'01M(TCB'P>CDST()5K95IN;TZ]62_(^W>3E;I WC5W_F
M?VQ^M+KPS#DO(WD(A&Q03'E 1FZ"%F0U"%N<=6T,R_WHZTJE#4'&HT;6N.+H
MX*9IQZK^$R^O\MVBDF'!<$XHB&22*N%H43;D:JLF2W\,S+;*HMJ#O&EOG=I#
M[ AAG,79N/G.:SH(:J+&QV7>I F->B0^^8;Q3\+]%]3F )2.1V.1@<=<0'G)
MZFV4!UFDKA41D?,VD:X3'H ;8_(B(@:GR2AU/HLZ(;+41!L+WDDDH]%FE]K<
M5#Y/6U<'WQ!$##KXAHMATIOO3:'MH]N3_OQQ_>E-^3#[G%\MEM>K^[#XA93:
M^FHYS^FO+XMY;=8_FU_/6Y:<.>XE@DLBD:(/FM9L##BT6<B@<O'I.4TU'CE=
MG8&'H&TBR?1@@FT6=+W!WBYG,=/^VGSO(J'&)%6!R"-YP:P$VE'> 4:1!)>1
MME@;/;Z3I&DC,6,JM5&8?A;FU?V"ISUO8T8UOHYX__BFV5C,:'1S45#Z@@*\
M,74H%M<0//,@LK(J(;>A4<;MN(;;D#N_"\Z]\+X(,$$ILAU(6WNE..AL#5.E
MQCW;Q(F&4-F5,3<$)0_U7C/1]'"0WI28/-SJU_FU)I?-Y N[X9I59*VZK,%R
MD9)CM>:D<2788V1-"ZQV:-A5#':T:#K V8,UW%24V$3DF *HZ4OM%0:8:#DF
MI\22#EJ4-FE_CY+32;'7\>)>C,W[#@"TQ[;;IF%;[U#(*,AWJ=5P,5MPY$R#
M9\$8FYSFLDVWF[U)[.%D/ H.PP_( V331;K?O:7]F==_S9<9+V?_6_,9O^;5
MNF[7OQ'WJL+?KE &6D>2D51\[>_CE(6@>(+@BO%,!B9=FPZW0RGM_A0]!#*[
M@3F^]/I2BA^6.%]=7LLO_??5]>IN>I [;GST&A(/N8Y;EX"".8BH8W&NU*'6
MK3'Y!'W3WL.='(EC2:HO_#UE"[^^S?EU+&K-D8%3JN;\%@_>6P2/)2HFZ=01
M;0R^H91VC\EQ?(RF NP H#]F>5Y(B<IP1;M+(ZU@LX&-PSJXU3++I,R-1CC_
M2$OW1_ 1LG\VW7:0('J]-/X%5SF]W8Z>/OCJ]_NGC'*!^P1A(UW#WJ5*ORD5
M.H2;#9WO\@92+Q>K]6I#2KA/REVF)$LIU1Q%)FIU6;$,0C$,>#&BB.!M;C2(
M]CBZCZY2V_?MWPGP+LG3H&-,,P9DI$;:@[7BG:P/2-X:PI1F(C=J#'P<X=.J
MNA-B]8<"N!,*_"RTY)'5!X\]:WR-V;#ZX$@LLN)8J+5RQ)E-5VH'F+R!*+T+
MI3#M&S5GFU9OWIM=2U!9?,OY?5Y^G<5\)[O[1+VXW#R2/KTI=:SMQWEU^Z^3
M<#:4WFTPY7EQP4>01E:OKC8>S3(20YW*V15N59OX8;,EG;6N'8+O)P8<3PB2
M'MR>6T8\OO*--?[FRZ;]UK;-U[<'U236Z%QXRJ!9G4%E&'F5,4NH5V"%R<)4
M;#VW^U#:I_7=N\#_2<3>']##PQ6_R\36622^;];^8IX>?.>O^6R]BQ=>2F^,
M$9"8(K,OT,X/11K0.@2C%9>N>47<^*N:-ANMG\TQ'53.PDJ_X=:B;-;^@RK9
M2.K8E+?#WSB^Q7_X@OOP"X3.1I7B(7&&M#6T!?1,0.8<&>=>6=,F[_4G\PNN
MFW?%XFM"+%BKL ZT3^ 2'8J!9<VSLDFWJ@]LL9RS]@>&X+JY/S 8'!V82-<W
M^;?91:^W2]QD%2F9@])('@WJFK?M##CFR?CSTHK"$C>L33CN":(FSL*:'C*/
MMCHZ7G[]0G&;@<2U1Q-$!B<BUDGINK:"XL!SCLA+X&C:9"D\258/S4M'$/Y^
MH#I $E,/TJR[[$UYNURDJ[B^2>-QB&AC0L@FDCDNBX607 &-F"(&%D4NSUFH
M.Y_>)2(.D=QB3#;V@8.MLKY90"E)&[OIU523&H,@?[%$"PR%S#)(4:P:@(/O
MG][##.=&.#B"C1T<,S<SQ<B%_S5_S9>++YNTZNM.@=LE80B!A7IUP)D"I9P$
MXI@'3#K($+5TI<WPJ#V(F_:*9GQ@M9)+!U![GR_I1Q__EN=YB9>TL!?I\VP^
MJ[[+>O8U;]=VFUWJ,:!B'F@INB;Q$QLE^3+>H_"1-"L7;2R<061..R:S'?S:
MR:H#(([CK;R^:\[*J]M-NP^ML*"$"N"45*3R%6?)HG&\#51'7LBTAW1_WN24
M..E@FVQ7EM/C"]_J@ NR<KUW7H 4M>&YU S($A80K,U!>A6-;I.<MA]]$]</
M30FAA_G+X\MSQ+*CE@&:%RG-Z@/Q\O=Y62P_7Y^28P9DGGS#^ &8_1?41\ E
M9!.D\@6RK)TTC"%,%5;(2C#D#CGTY!W_U &7'1M_N<3YQXWMMOKEVP]B?E&;
MP%\?8]F)@+5[L^$UJ](%"T$K =R4VAF),^=#&VMXK"6<=6!E"'Z')IJT 4$'
M]L/;2YS_B9_SY@)6UCH%@QYX5(8.+K+#O- :?- YE!(#XVVLA/M4]!(N.2D0
M%B-)I2-$;1U<RQUSCG,P@C:DTIF164]F$6)"J4SB0;0)XW]/Q[2H.ER>.X!Q
M '.GOL^^:0=]+V>OKH;>X^K_M[<4V3EM5<U&-:764+$$09H (=J0DK>*N?B<
MY;?_Z_I Q2'"7#3E;+=8X?+>BI).4=<BDL15O<77 = ;0V#PM4>;Y.CU<5BY
M_[II+UZ:8^5@SO:+%7]O11A9*2H0YHM3H$J-^ BD!69FI"W1^^2/Q(H?B)5F
M 8_V6#F4LQV8)T\F("CBB<H*B@MT,A>9*Y,D1!39Q1HR3"UG71^>/72"^]XI
MS>&Q9-8O_+9;-2$&':,%:TJJT:!<N[I'*&A1Z5)",6UZ[9QKQM 0X0_*&!HB
MB0Y@-2P4&-#4Y'X%ENE:_)7J8!U4D!,+M!D=9MVH0G#TL.U$:4F#X'%4V':(
MK#H XK7&IU_>[$_B#HN),RAD4()"\CE\YAY*$;XDAL'J-B-JOR-C6FNLCR/T
M<+ET *K#&7>W['EZ8!:KX'A,9*@:5R?<^ZQK\ZM 1XGU(N6$O%5)1(/53-QX
MYW!P/=:1?4I)=X#VVW#TG=MUTZ]-1&YJA(,[+D&QS4 \$>B/KH08T"K1QCS<
M2=+$E_63HV57,LI1HNL @X]5BKY[_]=-*EE* 5VRH+3S9)-8 UX+!J(8QE%&
MG44;U?DD61-[RKUA<3P13HC'U7)]\6&VKM;3[_,T^SI+5V0RUU.&%4N&-IG$
MB9< 2G(%2%X@:)48CX%GLL[WP2"]X1[^Z$\/L;>3A&G32J<U*\>12V_ ^J_9
M^M,FV:#VD_@T^_)A\=M\/5M_V^[&;*)+(1HHRFE0R4H(H<YW=$4ISD56^XT4
M/0QR3Q,WS4$\$@R> M6(,IDZ4O';/W.\JB[^RT\X6WZ^O4%G)H;B1 %TF=?!
M:8D^D>EL/'J>2TB</[B.V1&;V/&"CK QIC07([.VB_;LVURGM[A<?]OT5<:X
MX=4OW^[_Y-K/XDDG9PMIZ^IG76=-ZP"2Y6"X*T7J-MU<]J=Q+^3IG_.(;"S1
M+IR$._JW&S@D(1E*(IE8!JHP0RN(FNQ77T*(T>74)H?T1UJF=4U;2?T)<!T@
M@EY/1,&9%K4(W'-/+HJQ 8(0#JQGV@B+V<EG\[_[.Q''$MH^!]\0#G9Q\+V_
M"JO\/U>U?O(K?;F]3>1"B<Q+ 2GJ  O))=0;$TC9("LQ,:L:E1@^3M!>T#$_
M]Y$VAJPZ.+\>6<9->,\$ZXHGRE5M1R%D39-##PIKV\QBBI2-)DKO(FGBB]8Q
M!/X\B [@?G\PNE' 'K%PF\&;0/LK%80Z;@"<Y(G\#ID0&X67'B.G._@<(NJG
M 70 WWL SW-J?)<6?WU;;N@YZ7%1<Q%L;:B.]9*X_M&DX"WCPNK0*)OC:-KW
M@J7]R0_3TR+@G#'_YU7=XEMQK5Y\Q=EE9?^KQ?)O]'?7%]98(X+2H#>1C<(D
M>)LT>5+(G-2";.E&+9X;K:CS\.K(R!QK8XP)DW/>+MO&V&^NUJLUSM-L_O&:
M,Q<1N4O<.-"%!U"9UYXTKHZXQT FFQ=<M:GS&WTIG<=\.]T@HP#CG'?& PUQ
MM?ZT6-9V#A=,6I5S\N"<T#7@GB!8$@>/P:#7QJG4)F%Q]*5,G/1XICMC%&"<
M\\ZX'F7W^WRU7EYM#-_-)+T/GW"^51I_+C:C9O.651?HF/?1*L!LJ[]E&?E;
MM<$4KT.\26'H5DT/3K7$B?,\SG0G-072U'&+';RHT>U[>1![M?+Y8S%??[K\
M=M/81]M@$SH$XU/M!R=)XP@,@-($'HM3NCP(ZNYL\-F(Q(ECNM-LAXZD/FFT
M9L.'UXOX]ZLOUZVOWCP<,U+S#*]/SPO-733:.8A>;69,*7!)"G#:\1R<DBZ$
MO;"\YPLG#LU,B,P6$CD/'3N?T]>7N/KTKC;6FM,YHBV/SED$\F,<*"8RA,3J
M_">1BM$QAB)&U* _$##QG6;W^O$XB9T1*N\5 6SNG39??J6CX17.EO^)EU?Y
M(@=C10FBNMJJMO'CX()7(+.U7MJ@B]VWK?N(9.V%8/<OCN"1I7M&N'[W_J]=
M*Q8EA2!YAB(]6>[,&/!<>6!.\9"X%RKNUY%E%'+VPK'_%\?Q2-(\YSN/S9?_
M)*-I-O]X;4/QB^ SN:$VUZN>FME0(WI*68ADFR?O \_I 9*GOM9X9!7[A8_8
M3[8#)L?#6>CR.]>3Q4BK@))Y;:%!7S#2ZIS0HBA;&#[L>7.,RA[4[_EG"VRV
M%<XY3N&\MI]N1I"VG+[Y^)N:3]W<8X&=-']&'6R.#%*N/IBI?7.MM%!<#%$%
M^HG_N:=M'IL"Y!S'B"9 T;:0Q6]HEQI5P'N>$B;)1&AD,/R[^?- _+9K_CP$
M!!U8S-^UI67%%/0Q@+%UI(#3$1"+ARRT).JUB(W2"'_&YL^#@/!4\^<A4ND(
M43=E+=KI%&E7EF02*.$R8%"<S!G)LD'AT;=)@NZI.\[A\GRZ^?,0YD[MDNQH
M)7K3FIB'7(+4X(U6I+P+0D#:,L0-$60PV83]@IY/OJ8/%!PBO#V:LA[ R0[4
MQ0B.6$"IG:>3WA56"]V(F\X(#]($Y.B$PMYR?E_W-LIKRL/NQ @X9\S_F+7Y
M;G%Y^6JQK#^\"%QQ);P";@3M?.N(_]Q:$.AX+ ;IG\ZJ0)Y<S]EGO@]"9;O$
MWD,A\G-ME&V*F>,>2] ,5#*^CL ,=$YR#IL*'16M\N5GRGOO;WN,B,_FN?!#
MP'+P;OFR"2^\7^-RW<6>V40!5[_/K\,>?ULN5JL+69ASSB:03,FJR2($,E^!
MDZ]":HU4F6[3TZ/!8LZT7J3??7,L8'HX9ZHG]?MJ=973KU?+VYC?=<K</3=K
M]=L_\S+.B \7@I3#IF?B_V_O2YOCN)DTO^]_R1W<QY>-D&5Y0A&RI;#TSNQ\
M8N!(2+U+=6O8I%]I?OTDFDV*5Y-5W046FIZP@N99E<A\D!<2F5$Q#2HZ <Y;
M#N@Q**=<$*VNW(ZF]4CO@31$?%MQCP>TOP3T$C_71/>G;OPG8G;!Q?D%L>5J
M?Y]P;A(/R("AE+6D*4&(+$%"S72PELNDNK0%#RSF2.]U]&L+#@7,H5NGBUWS
MYONWQ=EE?\-K)@B9F,F*@6=&D#\I2)-H8D*1,3$=K6*Q40^CZ1=SI-<_^MTU
MAP+F1>R:^^&7XB[;H!7XC :4=PA1< $F"$PB*=(<KLL]LU^LWM^UE'YWS&%@
M.3!6?[/L8\=LO=.:@-\R@=6"<I$2\%1-K74:O/ ,<DK2.2RNA#8E/),OY4BC
M]#Z2OX<!HX]>D-,IB'_'Q><O9.5>$7WA,U[%=!_.%@FK/BM;?>:]LEH0>W*=
M@J!2U27,.2#F%)6=1E0S30.:?*U'FA'H8W<UAE8/Z;#GX= )(VF5.A<*C56U
M45^!:+6'S"/GA?X%V:9]^3,M\,4<T33!^3S;<A3HCN=09V=]QH-)^D<95#P7
MF+T&'NIEEQ@4.$M[*,? @I(YE;E:@TVWR"-U+SO=F3.![Q@LY5.LN5K],.[(
M()GP/$(H(H!2W$(L:,%*EA&MD*Y5)_1G7>>1NJ='NCO;0? E;- '3C0>Y4^,
MUEIC V062)2:,7"<U>E#/,98I"*)]KE%1Z[TQ9R='<4F;0G#XTCX/*W&[AVB
M/,HA[E2T,G#03'I0=7J!*R9!29(G72++MM.-.G*E+^:X[B@V:DL8'L=&G2A.
MU\F'G'P":[38#@(4.H!-/!H;LX^ZLSZ\#9)#QW FV,6VG %T+^\4\?&\63)&
MZEJ\X^M4%<\D.!T\<*]M*44&E?H\'AFXP"/U9_LX$VD!HF.('I]@RZN<%_63
M</JSM\'/A@7*>YN]H-A9D=24=;'6E'H0@4F9+&->=]9@:LBRCM3=[&,?30>8
M7G9/?)H9<;31_A/K#6KZ_NO5<L.:BW#Z"<^^BA.>T2 %N2"M-J"<KQV4E05-
M[K0(RAO2,.WVU/,N]KB/%R>$^D.;L&/<O8"MN=O>[V(1/TE"E*@P &+M=Q"9
MJ7TO#%C'<E;,A^ :GO8_[V*/^WRQWZW9&G='UD'O@3;OC3OI#7ACRXYZ8Q?<
M1V<]PVI/R,S )*F (,? ZVR!F6B-Y#:I1D[)2^FL%Y$VJM/$0.W(NFK)P:D2
M:4?[(D*('&6C7.#_=-8;B=]VG?7&@* #%^M6SR^KN#?D!X()6H+RPD$P2(;(
M!IZX0E%<FYJJE]A9;Q00'NNL-T8J'2%JVS^LD->593WBY;Y.#*+]&8SQ0':\
M2)>Y*SHTQ51WG?5&R?/QSGICF-MW9[T416:,>]HM]>J'DL04[SD8X4PV+&.Q
M["F/\,@ZZXT2WO#.>F,XV8&ZF" 5ZH52.:=,&ZHD6K&0X*-/D+C/R)$S+?ZG
MLUZ_QNZ9$7#,F!\^J_+6%5@M38C9@.$N@K)60$0L8,A1YN@-::'.NHGMM<XC
M333OB>+G'W^Z+Z3^'AMN>X6U<*>2T1%R($&J$"/Y=9*!BU$6E;+D2A[K7COJ
MCG[/@//9)A*/ =WQ7!;;FSVW+_*<R.)5S"C!94MJ-=D(WD8$SAU:SA/*WAIT
MC%SAD1[CO*0=>0#DCKM<]DG._-M&@M><\=Z;%!1%IZ2R*%#@"F(=U2>1.1>8
MC3YTUF%JY J/]%;82]J,!T#NN'M4/<F9[?V<&\PQCAM>N^%;)C3%',63ZQ 9
M2&=(D-(*QSNK[AN_R".MF7U)6_(PX+V 5J6C?7JEG/*>6.-<308$[< K;<$+
M0ZPCMR+Q8S.4^P22_97@OJ1M>0CHCOUBR7#FW*GANC^ ^J:@I5),A.!!5Q]#
M^93 DS:C+W-APDONL;/F=FT8<:1!Z=%D8YN!\N^1KGV2?2=)>24L:LBBA@T\
M20C*!6 N2<%L-C(=K0%^<O4O/LG;;OMTJ I&8?EOER!^FGTZJ,B885"$#76&
M.D*0T4,M/L&0DQ6]7?*>F@5':LW_5OJ@):K_5DGJIUF797'&:&*=3J(.1:W1
M7$% ^BZQC6-L-5:G%Q:\^#3W"U (+5']HJ.$&VVLGN::T)*X$R04Q>I0V5 @
M!%<@Z2"EDC:[V-FDH4G7_^*3ZR] $33#\XO6 B/B*Y=ESIJ3OK0*ZV&&@<B*
M!54L8Z@,-ZS-)8<>5O_B\_@O0 ,TPO*+/P-X_(YY+"9$90MDE@RHS"+$4/MP
M64W<\B*C\T>V[0]OFM.?T]][3G\ZD+UH>SR^X<GZ)">&QC@&-G-R9G)&\-X+
M\)F))(MGSG?6#JX%&UYJ-G_"C?-LF[TUBCOL#?*>K#W]_?+S.R1V[=7LX^XC
M#NW>\2A)$[7CN'ST-1QE1F&4$^03%JP?(CBR0"!UD39DB8:UR1G>IN-0_?X.
MUVO$._S[1"S[A7[K_Y\X3-+;.DT]Z0S*E0Q.1@XNYEC;DAIFVM03/D[7O!KP
M "3<54P3LK]_3;&Y6SJ%OM@^:&*M\1!Y;71'<L:EZ!((CC4SZR4XGP/H' -3
M ?6-9H]=ZPYZ6FWCLN'<3]1:IC!&25@5FH,RBBRUS>26)V.SK4?4NLT-G1T$
M=:4MQLC^OK8XG.$=Q!0/*;UWBQ 7I^1K_1[.+\[H_W>6*(KRRCD-A53MY008
MQU "\A0"]TD7UFK+C"9VWM/U2?'65E#]FZR?(<G;95F=?=T\^H N=V,>/[%Y
M&[Z4-D8/8Q(^9P\N$!J52!Z"3Z5>I_-.LJQ+HZJ;%@[SYIF_XCJ=+39QX&7;
M#"MY\3G6P7$NU$;C',@;K .//?KL*>YSL:&2>I"HKHS?& P\K(P.9_R,!G!]
M=G[R9TTY;!I'"8E26N*#UA%KRV\B6IL,I#Z)1=RRD@?U\:"GWD *?747);=>
M.S<>)A+BZE".]@"#;8LG\MYTL3Q#DJ9V$(NE'M$(B#$59W/F.@_*:@X'PISM
MLPX0V5VA[\&_F<7^^V*Y^'KQ=4LX>4@<E4Y0_&8,4R"_W40-NKC(/0:/<E"M
MR2#!WWKUS*+?1W"K*;@XM_C#]QN$!Z%L1/2UKZDA[->Y)%P;8+IZR@+SP#AY
MF/AOOGJ>"&4R\>_-Q6Z"W[L6\.>9IC2>&T6.D<HU7F.2@8\.08M  53TC(DV
M%\Z>(&SNH'9:OZ&%-+H!U^W [_H<:O-5/8$Z$;:.XF0.4/ Z$*E8" 4#<(Y6
M*T&ANFO3U6H8?3VZJ'M"8D!"Y4#YS-T']J$EU44LEAN);=L#:)5E\%8!3\D!
MZ7U2UVDSX\BFK)224=P)_G?T@QWTNAYUU6$ :L3J_A-P];Q^M:PG[ZMRG?Y>
M3Y>!>_SY$Z?@1BRF30Z.FXPLH 9FN085E0$GLR3MHD4LAB6'K8YSI\S!W69K
M9>()EE*XC1FRQCH*R6KPIC@(S!EOI7 RM*D,ND_+W.9K;XG?M58'LKD#?^CC
ME]79>561/U=@E;:8"P+W->& .8"+*D%T,8F<2$MBJ^[2=VF9VTQ-!I0#V=P!
M4/XMG"UJ,/%S 8DE=-IZB#S4T@M>(*B2:D?L'%$(6D*;8N![I,Q;ICLA3 YC
M<@<H^4FX8\$;7X@-BOPKI;PA%1@5!&>"B5+QV*PN:@PJFEW4FA 5^S%U?S2L
MSL/I<WBNV_/Q!5XY>U<GY_2=Z?S7(6^9V(L=O;!&1521LV*S X>ND.Y(I18:
M%$!FK#>Q:*];';:V\V5OL/)J(-:O%_BSU- Z'D24]8R$W"])JC(6Y6LWVNQI
M@TCOVEQ.'4-E5_[O&)0\[O].*)HN3-DCI3U7Z[M,39&\WI??%NL43O\#P]F)
M2]QA]@03%@.HVH<F8";(9)FX\1R%:E7>MR_-\T*R'8[&U&M-)]1C@2^Q]0^R
M/9_^B:=_X>^KY?F7]4E,QB0O @AR*4#Q;" JC%!4*CP'<D%"J[+]_2B>-TCL
M"[J'"O2(@%LWY:=_KDX4$U+4<RVGC*JEO;0\08RES8H40A.369N\UDA"YPU2
MNX/I/N([-G02W/"D!)]T"!98\?4NVV962>%0HC6.R7K-;8:Z[(=(G3=@[A.A
MHT5X9!C];75Q=A)4858E!\9+5RV$!Y<Y!Q%1>I55=$VK<H=3.F_GC2X1.EJ
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MI=[S9/4V# N>=H21)7*%VK9I"/((49TY4].HHZF$,+<>^G"V^K9:8[ZQGLL
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M@!@V';XQLIA9ULB?\HEV/;R3<I-1(EI-R*\.4D?#5.%F.ZC@+=<*P1:N0*5
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MN-/32Z@'N-UJ<29HKSF+&5+F 937M;2 $Y=BBCH&PYEM.C/K"!H CA'OHPT
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MK+DU]'&Y3$1(B.9&)9P*!3>X&HCP$LRY#N>0PT4@^$A(86=$*3:9I07HT.F
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MHB<0!MF#R>(8-WM?P861EYJ-1X)OCQSLWJZL@QP@TIAUBH@*<"D2<>4.[W,
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M7]YK^]/Q":S=9ELN%)?[JLLN?(2K);/K79ZY )=_^NMX[F+@V?\ 4$L#!!0
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MQJNULP7F*G]<<+IEF,I:L"LP0^PB91%4H'^9&#["S;XE;L\)I[7881JG"K=
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M_C," '!G96XM,C R,C S,S$N>'-D4$L! A0#%     @ <8*I5%,?=6GI)0
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M2P$"% ,4    " !Q@JE46Z!\,3$(   B)P  &               @ &2Z@0
M<&=E;BTR,#(R,#,S,7AE>'@S,3(N:'1M4$L! A0#%     @ <8*I5-TH[@$<
M!@  E18  !@              ( !^?($ '!G96XM,C R,C S,S%X97AX,S(Q
M+FAT;5!+ 0(4 Q0    ( '&"J53/SQ;Z( 8  .(6   8              "
M 4OY! !P9V5N+3(P,C(P,S,Q>&5X>#,R,BYH=&U02P4&      H "@"B @
&H?\$

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
